Citrus Sinensis ID: 011384

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------
Protein Sequence
MGYLSCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFNNPCLMVETVGRPVEVRKTQEGGIAGENLDLLDGKLSRMSMKDSRRVYSDLGLRSNLMELMAGMDEEHEFRGEADGVEPSIKSAKQVSSSSHGSGRYLYKGRVRSHAHGNDKGRGSRLRRNLSIGDGSELFSGRDDAMIPIGFSSRTANNI
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccEEEEEEEcccEEEEEEccccccHHHHHHHHHHHHHccccccccccccEEcccccEEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHcccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccEEEEEHHHHHHHEHHcccccccccccccccccccccccccccEcHHHHHHHHccccHHccccccccccEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHEEEcccccEEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHccccEEEEcccHcHEEccccccccHcHccHHEEccccccEEccEEEEEEcccccHHHHHcccEcccccHEHHHEEEEEEEccccccccccccccHHHHHHHHHHcccHHHHccccHcccccHHHHHHHHHHHHHHHHccHHccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccHcHccccccccccHHHHHHHHHHcccccHHHcccccccccHHccccccEEEEccccccccccc
Coil and Loop (DISEMBL)
mgylsckaeSAISVIStnsnsvathqtqssktsqkqekpikiqhfdysdleaatngfseqkllgkgshgsVYKAVLRGRQVavkkpsknqeisQEVDNEIEILSKihsprlvnllgfsndskDRLLVVEFMSNGTLYDVLhsnnrplnwGRRIRLALQVAKAVEILhsemppiihrdIKSANVLIDRnfnarlgdfglalrcgvdnfrfrstppagtigyldpcyvtpdnlstktdvFSFGILLLEIISCRkaidigfsppsivdwaaplikkgkilsvfdpripppkdpivRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLsklvplhswngfnnpclmvetvgrpvevrktqeggiagenldlldgklsrmsmkdsRRVYSDLGLRSNLMELMAgmdeehefrgeadgvepsiksakqvsssshgsgrylykgrvrshahgndkgrgsrlrrnlsigdgselfsgrddamipigfssrtanni
Flexible Loop (DISEMBL)
MGYLSCKAESAISVistnsnsvathqtqssktsqkqekpIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGrqvavkkpsknqeisqeVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIlhsemppiihRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFdpripppkdpivrkqlaVIAVRcvrscrerrpsmKEIVDWLTGLSKLVPLHSWNGFNNPCLMVETVGRPVEVrktqeggiagenldlldgklsrmsmkdsrrvysdlglRSNLMELMAGMDEEHEFRGEAdgvepsiksakqvsssshgsgrylykgrvrshahgndkgrgsrlrrnlsigdgselfsgrddamipigfssrtanni
Low Complexity Region (SEG)
MGYLSCKAESAISVISTNSNSVAthqtqssktsqkqekPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFNNPCLMVETVGRPVEVRKTQEGGIAGENLDLLDGKLSRMSMKDSRRVYSDLGLRSNLMELMAGMDEEHEFRGEADGVEPsiksakqvsssshgsGRYLYKGRVRSHAHGNDKGRGSRLRRNLSIGDGSELFSGRDDAMIPIGFSSRTANNI
Disordered region (IsUnstruct)
********************************************F*Y**********************SVYKAVLRG********************EIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFNNPCLMVETVGRPVEVRKT***GIA******************************************************************************************************************************
Disordered Region (DISOPRED)
*G******************************************FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKP*******QEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL*******************************************************************************************************************************************************************
Disordered Region (DISEMBL)
********ESAISVISTN*********************IKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQV************QEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFNNPCLMVETVGRPVEVRKTQEGGIAGENLDLLDGKLSRMSMKDSRRVYSDLGLRSNLMELMAGMDEEH**************************GRYLYKGRVR************RLRRNLSIGDGSELFSGRDDAMIPIGFSSRTANNI
Disordered Region (DISPRO)
MGYLSCKAESAISVISTNSN******************PIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFNN********************GIAGENLDLLDG************************************************************************************************FSGRDDAMIPIGFSSR*A***
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGYLSCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFNNPCLMVETVGRPVEVRKTQEGGIAGENLDLLDGKLSRMSMKDSRRVYSDLGLRSNLMELMAGMDEEHEFRGEADGVEPSIKSAKQVSSSSHGSGRYLYKGRVRSHAHGNDKGRGSRLRRNLSIGDGSELFSGRDDAMIPIGFSSRTANNI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	487	2.2.26 [Sep-21-2011]
Q9SV05	362	Serine/threonine-protein	yes	no	0.714	0.961	0.613	1e-116
Q9SGN7	470	Serine/threonine-protein	no	no	0.669	0.693	0.501	2e-82
O24585	901	Putative receptor protein	N/A	no	0.577	0.311	0.472	4e-67
Q9LX29	895	Serine/threonine-protein	no	no	0.568	0.309	0.454	7e-65
Q9FMY3	341	Serine/threonine-protein	no	no	0.554	0.791	0.456	4e-59
Q9S7D9	775	Serine/threonine-protein	no	no	0.533	0.335	0.418	2e-54
Q9LK03	717	Proline-rich receptor-lik	no	no	0.570	0.387	0.411	7e-52
Q9LV48	652	Proline-rich receptor-lik	no	no	0.570	0.426	0.408	3e-51
Q8GX23	670	Proline-rich receptor-lik	no	no	0.570	0.414	0.416	6e-50
Q9FIJ6	751	Serine/threonine-protein	no	no	0.574	0.372	0.380	1e-49

>sp|Q9SV05|CCR35_ARATH Serine/threonine-protein kinase-like protein At3g51990 OS=Arabidopsis thaliana GN=At3g51990 PE=2 SV=1

 Score =  417 bits (1073), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 224/365 (61%), Positives = 276/365 (75%), Gaps = 17/365 (4%)

Query: 1   MGYLSCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPI----KIQHFDYSDLEAATNG 56
           MGYLSCKA    +V    S++ +T  + SSK S   E PI    +++ F + DLE+AT G
Sbjct: 1   MGYLSCKA--GSAVAIAVSSAASTSGSTSSKASAPPESPIEDRPRLRRFLHRDLESATGG 58

Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           F    LLG+GSHGSVYKAV+  R +AVK+PSK++EIS+E  NE EILS+I SPR VNLLG
Sbjct: 59  FDINNLLGRGSHGSVYKAVIGSRHIAVKRPSKSREISREFHNEFEILSRIRSPRFVNLLG 118

Query: 117 FSND-SKDRLLVVEFMSNGTLYDVLHSNNRPLN------WGRRIRLALQVAKAVEILHSE 169
           FS D SK+ LLVVEFM NG+LYDV+HS+   LN      W +RI++ALQ+AKAV +LHS+
Sbjct: 119 FSADNSKEPLLVVEFMGNGSLYDVIHSDT-VLNSGAISSWSKRIKIALQIAKAVHLLHSQ 177

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
             PIIHRDIKSANVL+D+N NA+LGDFGLA+RC VD+ + +STPPAGT+GYLDP YVT D
Sbjct: 178 ETPIIHRDIKSANVLMDKNLNAKLGDFGLAIRCNVDDQKVKSTPPAGTMGYLDPDYVTAD 237

Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD 289
            LSTKTDVFSFGILLLEIIS RKAID+ +SP  IVDWA P+IK+GKI  ++DPRI PP D
Sbjct: 238 RLSTKTDVFSFGILLLEIISGRKAIDVRYSPSFIVDWAIPMIKRGKIGGIYDPRIGPPID 297

Query: 290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWN--GFNNPCLMVETV- 346
             VR  L ++A +CVR+CRE+RP M+E+V WLTGL+K V    W+     NPC+MVETV 
Sbjct: 298 VSVRNHLGLVAAKCVRTCREKRPGMEEVVGWLTGLTKSVRSRRWDELSIGNPCMMVETVG 357

Query: 347 GRPVE 351
           GRPVE
Sbjct: 358 GRPVE 362

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SGN7|CCR12_ARATH Serine/threonine-protein kinase-like protein At1g28390 OS=Arabidopsis thaliana GN=At1g28390 PE=2 SV=1

 Score =  306 bits (784), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 175/349 (50%), Positives = 232/349 (66%), Gaps = 23/349 (6%)

Query: 1   MGYLSCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQ 60
           MGYLSC  ESA+++  T +     +  + SK  +K+  P K++ F+Y +L  ATNGFS  
Sbjct: 1   MGYLSCNGESAVAICDTYN----WNPRRRSKVPEKRHPP-KLRVFNYDELAVATNGFSAN 55

Query: 61  KLLGKGSHGSVYKAVLRGRQV--AVKKPSKNQEIS------QEVDNEIEILSKIHSPRLV 112
             LGKGSHG VYKAVL   ++  AVK+ +    +        +VDNEIEILS++    +V
Sbjct: 56  NFLGKGSHGRVYKAVLDDGKLLAAVKRTTITTTVGNNNNNVSQVDNEIEILSRVRHRWMV 115

Query: 113 NLLGFSNDS--KDRLLVVEFMSNGTLYDVLHSNNRPLN----WGRRIRLALQVAKAVEIL 166
           NL+G+  D   K +LLVVE+M NGTL+D LHS +   +    W RRI+ ALQ+A AV  L
Sbjct: 116 NLIGYCVDHRRKTKLLVVEYMPNGTLHDQLHSRSSLDSRLSSWNRRIKHALQIAIAVHAL 175

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
           H+    +IHRDIKS NVLID + NARL DFGLAL   VD+ R + TPPAGT+GYLDP Y+
Sbjct: 176 HTAETQVIHRDIKSCNVLIDGDGNARLADFGLALIGNVDDERLKYTPPAGTLGYLDPSYL 235

Query: 227 TPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP 286
            P +L+ K+DVFSFGILLLEIIS R+AID+ +SP  IVDWA PLIK+G   ++ D +I  
Sbjct: 236 APADLTAKSDVFSFGILLLEIISGREAIDLNYSPSCIVDWAVPLIKRGDYDAICDLKIKN 295

Query: 287 -PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWN 334
            P   ++RK LAV+A RCVRS  ++RP M E+V+ L  + +L P  +WN
Sbjct: 296 RPYYAVIRK-LAVMAARCVRSTAKKRPDMLEVVECLKTVRQLSP--AWN 341

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O24585|CRI4_MAIZE Putative receptor protein kinase CRINKLY4 OS=Zea mays GN=CR4 PE=2 SV=1

 Score =  255 bits (652), Expect = 4e-67,   Method: Compositional matrix adjust.
 Identities = 137/290 (47%), Positives = 193/290 (66%), Gaps = 9/290 (3%)

Query: 41  KIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEI---SQEV 96
           + Q F Y +LE AT GFSE   +GKGS   V+K +LR G  VAVK+  K  ++   S+E 
Sbjct: 489 RAQEFSYEELEQATGGFSEDSQVGKGSFSCVFKGILRDGTVVAVKRAIKASDVKKSSKEF 548

Query: 97  DNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN----RPLNWGRR 152
            NE+++LS+++   L+NLLG+  D  +RLLV EFM++G+LY  LH  +    + LNW RR
Sbjct: 549 HNELDLLSRLNHAHLLNLLGYCEDGSERLLVYEFMAHGSLYQHLHGKDPNLKKRLNWARR 608

Query: 153 IRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
           + +A+Q A+ +E LH    PP+IHRDIKS+N+LID + NAR+ DFGL++    D+    S
Sbjct: 609 VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEDHNARVADFGLSILGPADSGTPLS 668

Query: 212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI 271
             PAGT+GYLDP Y     L+TK+DV+SFG++LLEI+S RKAID+ F   +IV+WA PLI
Sbjct: 669 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVVLLEILSGRKAIDMQFEEGNIVEWAVPLI 728

Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           K G I ++ DP + PP D    K++A +A +CVR   + RPSM ++   L
Sbjct: 729 KAGDIFAILDPVLSPPSDLEALKKIASVACKCVRMRGKDRPSMDKVTTAL 778

Putative receptor protein kinase. Could play a role in a differentiation signal. The CRINKLY4 (CR4) mutation affects leaf epidermis differentiation such that cell size and morphology are altered, and surface functions are compromised, allowing graft-like fusions between organs.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LX29|ACR4_ARATH Serine/threonine-protein kinase-like protein ACR4 OS=Arabidopsis thaliana GN=ACR4 PE=1 SV=1

 Score =  248 bits (633), Expect = 7e-65,   Method: Compositional matrix adjust.
 Identities = 130/286 (45%), Positives = 189/286 (66%), Gaps = 9/286 (3%)

Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKP---SKNQEISQEVDNEI 100
           F Y +LE A +GF E+ ++GKGS   VYK VLR G  VAVK+    S  Q+ S E   E+
Sbjct: 500 FTYEELEKAADGFKEESIVGKGSFSCVYKGVLRDGTTVAVKRAIMSSDKQKNSNEFRTEL 559

Query: 101 EILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPL----NWGRRIRLA 156
           ++LS+++   L++LLG+  +  +RLLV EFM++G+L++ LH  N+ L    +W +R+ +A
Sbjct: 560 DLLSRLNHAHLLSLLGYCEECGERLLVYEFMAHGSLHNHLHGKNKALKEQLDWVKRVTIA 619

Query: 157 LQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA 215
           +Q A+ +E LH    PP+IHRDIKS+N+LID   NAR+ DFGL+L   VD+    +  PA
Sbjct: 620 VQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPVDSGSPLAELPA 679

Query: 216 GTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK 275
           GT+GYLDP Y     L+TK+DV+SFG+LLLEI+S RKAID+ +   +IV+WA PLIK G 
Sbjct: 680 GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMHYEEGNIVEWAVPLIKAGD 739

Query: 276 ILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           I ++ DP +  P +    K++  +A +CVR   + RPSM ++   L
Sbjct: 740 INALLDPVLKHPSEIEALKRIVSVACKCVRMRGKDRPSMDKVTTAL 785

Controls formative cell division in meristems, including root tips and lateral root initiation zones of the pericycle, in response to CLE40 signal. Acts with CLE40p peptide as a ligand-receptor pair in a signal transduction pathway, coordinating movement of the root tip and organization of cell divisions in the root meristem. Required during embryogenesis and development, probably for the differentiation of protoderm and epidermal cells. Involved in the regulation of cellular organization during the development of sepal margins and ovule integument outgrowth. Can phosphorylate ALE2.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FMY3|STPKL_ARATH Serine/threonine-protein kinase-like protein At5g23170 OS=Arabidopsis thaliana GN=At5g23170 PE=2 SV=1

 Score =  229 bits (584), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 136/298 (45%), Positives = 180/298 (60%), Gaps = 28/298 (9%)

Query: 42  IQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVL--------RGRQVAVKKPSKNQ--- 90
           ++ FDY  L  A + FS  KL+GKGSHG VYKA+L        R R VA+K PS      
Sbjct: 1   MKEFDYDKLVTAIDRFSPSKLIGKGSHGYVYKALLHHQDVDETRQRVVAIKTPSSLSPSS 60

Query: 91  ---------EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH 141
                    E +++++NEI+++S +  P   ++L F   ++ +L+VVE+M N +LY +LH
Sbjct: 61  PSSSSSSKSEQTKKLENEIDVMSSL--PYHPHVLSFLGHAEKKLMVVEYMPNESLYQLLH 118

Query: 142 SNNRPL-NWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL 200
            +  PL  W +RI +ALQ+A AV  LH     IIHRDIKS N+L D N+ A+L DFGLA+
Sbjct: 119 VSTDPLPTWLKRIEIALQIASAVHFLHEH--GIIHRDIKSENILFDSNWEAKLADFGLAV 176

Query: 201 RCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
             G D  + R  P AGTIGYLDPCY  P+NLS KTDV+S+G++LLEI+SCRKAID+  SP
Sbjct: 177 DFGGDK-KIRPAP-AGTIGYLDPCYTLPENLSMKTDVYSYGVVLLEIVSCRKAIDVSRSP 234

Query: 261 PSIVDWAAPLIKK-GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
            SIVDWA PLIK+                   +  +L  +A RCV S  E RP   EI
Sbjct: 235 ASIVDWAVPLIKEGRIGEICGGGGGGSGVFRGMSLRLLRMAARCVSSDVESRPCFGEI 292

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9S7D9|ACCR1_ARATH Serine/threonine-protein kinase-like protein CCR1 OS=Arabidopsis thaliana GN=CCR1 PE=1 SV=1

 Score =  213 bits (543), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 121/289 (41%), Positives = 172/289 (59%), Gaps = 29/289 (10%)

Query: 43  QHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEI---SQEVDN 98
           Q F  S+L+ ATNGF E   LG+GS+G VYKAVL  GRQVAVK+ +    I   ++E + 
Sbjct: 506 QVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLADGRQVAVKRANAATIIHTNTREFET 565

Query: 99  EIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQ 158
           E+EIL  I    +VNLLG+S +  +RLLV E+M +GTL+D LHS   PL+W  RI++A+Q
Sbjct: 566 ELEILCNIRHCNIVNLLGYSTEMGERLLVYEYMPHGTLHDHLHSGFSPLSWSLRIKIAMQ 625

Query: 159 VAKAVEILHSEMPP-IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT 217
            AK +E LH+E  P IIH D+KS+NVL+D  + AR+ DFGL                   
Sbjct: 626 TAKGLEYLHNEAEPRIIHGDVKSSNVLLDSEWVARVADFGLVTS---------------- 669

Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKIL 277
                       NL  K DV+ FG++LLEI++ RK  D    PP IV+W  P+I++GK  
Sbjct: 670 --------SNEKNLDIKRDVYDFGVVLLEILTGRKRYDRDCDPPEIVEWTVPVIREGKAA 721

Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
           ++ D  I  P++     +LA +A  CVR    ++P+M E+ +WL  +++
Sbjct: 722 AIVDTYIALPRNVEPLLKLADVAELCVREDPNQQPTMSELANWLEHVAR 770

Serine/threonine-protein kinase with low activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  205 bits (521), Expect = 7e-52,   Method: Compositional matrix adjust.
 Identities = 119/289 (41%), Positives = 169/289 (58%), Gaps = 11/289 (3%)

Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSK-NQEISQEVDNEIEI 102
           F+Y +L  ATNGFSE  LLG+G  G V+K +LR G++VAVK+  + + +  +E   E+ I
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401

Query: 103 LSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP-LNWGRRIRLALQVAK 161
           +S++H   LV L+G+      RLLV EF+ N TL   LH   RP + W  R+++A+  AK
Sbjct: 402 ISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAVGSAK 461

Query: 162 AVEILHSEM-PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGY 220
            +  LH    P IIHRDIK++N+LID  F A++ DFGLA +   D     ST   GT GY
Sbjct: 462 GLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLA-KIASDTNTHVSTRVMGTFGY 520

Query: 221 LDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIG--FSPPSIVDWAAPLIKK----G 274
           L P Y +   L+ K+DVFSFG++LLE+I+ R+ ID+    +  S+VDWA PL+ +    G
Sbjct: 521 LAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSELG 580

Query: 275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG 323
               V D ++    D     ++   A  CVRS   RRP M ++   L G
Sbjct: 581 NFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEG 629

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  203 bits (516), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 118/289 (40%), Positives = 168/289 (58%), Gaps = 11/289 (3%)

Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVL-RGRQVAVKK-PSKNQEISQEVDNEIEI 102
           F Y +L  ATNGFSE  LLG+G  G V+K +L  G++VAVK+  + + +  +E   E+EI
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327

Query: 103 LSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP-LNWGRRIRLALQVAK 161
           +S++H   LV+L+G+      RLLV EF+ N  L   LH   RP + W  R+++AL  AK
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAK 387

Query: 162 AVEILHSEM-PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGY 220
            +  LH +  P IIHRDIK++N+LID  F A++ DFGLA +   D     ST   GT GY
Sbjct: 388 GLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLA-KIASDTNTHVSTRVMGTFGY 446

Query: 221 LDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIG--FSPPSIVDWAAPLI----KKG 274
           L P Y     L+ K+DVFSFG++LLE+I+ R+ +D    +   S+VDWA PL+    ++G
Sbjct: 447 LAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEEG 506

Query: 275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG 323
               + D ++    D     ++   A  CVR    RRP M +IV  L G
Sbjct: 507 DFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEG 555

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1

 Score =  198 bits (504), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 120/288 (41%), Positives = 168/288 (58%), Gaps = 10/288 (3%)

Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVL-RGRQVAVKKPS-KNQEISQEVDNEIEI 102
           F Y +L  AT GF++  LLG+G  G V+K VL  G++VAVK     + +  +E   E++I
Sbjct: 300 FTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLGSGQGEREFQAEVDI 359

Query: 103 LSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP-LNWGRRIRLALQVAK 161
           +S++H   LV+L+G+      RLLV EF+ N TL   LH   RP L+W  R+++AL  A+
Sbjct: 360 ISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHGKGRPVLDWPTRVKIALGSAR 419

Query: 162 AVEILHSEMPP-IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGY 220
            +  LH +  P IIHRDIK+AN+L+D +F  ++ DFGLA +   DN+   ST   GT GY
Sbjct: 420 GLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLA-KLSQDNYTHVSTRVMGTFGY 478

Query: 221 LDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDI-GFSPPSIVDWAAPLIKK----GK 275
           L P Y +   LS K+DVFSFG++LLE+I+ R  +D+ G    S+VDWA PL  K    G 
Sbjct: 479 LAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTGEMEDSLVDWARPLCLKAAQDGD 538

Query: 276 ILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG 323
              + DPR+          Q+A  A   +R    RRP M +IV  L G
Sbjct: 539 YNQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQIVRALEG 586

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIJ6|ACCR4_ARATH Serine/threonine-protein kinase-like protein CCR4 OS=Arabidopsis thaliana GN=CCR4 PE=1 SV=1

 Score =  198 bits (503), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 115/302 (38%), Positives = 176/302 (58%), Gaps = 22/302 (7%)

Query: 39  PIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPS---------- 87
           P ++  F   +L  AT+GFS +  LG GS GSVY+ VL  GR VA+K+            
Sbjct: 425 PGQLMEFSIDELALATDGFSVRFHLGIGSFGSVYQGVLSDGRHVAIKRAELTNPTLSGTT 484

Query: 88  ---KNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN 144
              +  +      NE+E +S+++   LV LLGF  D+++R+LV E+M NG+L D LH+  
Sbjct: 485 MRHRRADKDSAFVNELESMSRLNHKNLVRLLGFYEDTEERILVYEYMKNGSLADHLHNPQ 544

Query: 145 -RPLNWGRRIRLALQVAKAVEILHSEM-PPIIHRDIKSANVLIDRNFNARLGDFGLALRC 202
             PL+W  R+ +AL  A+ ++ LH  + PP+IHRDIKS+N+L+D  + A++ DFGL+   
Sbjct: 545 FDPLSWQTRLMIALDAARGIQYLHEFIVPPVIHRDIKSSNILLDATWTAKVSDFGLSQMG 604

Query: 203 GV--DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAI--DIGF 258
               D+    S   AGT+GY+DP Y     L+TK+DV+SFG++LLE++S  KAI  +   
Sbjct: 605 PTEEDDVSHLSLHAAGTLGYIDPEYYKFQQLTTKSDVYSFGVVLLELLSGHKAIHNNEDE 664

Query: 259 SPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR--KQLAVIAVRCVRSCRERRPSMKE 316
           +P ++V++  P I   +   + D RIPPP    +     +  +A  C+  C  +RPSM E
Sbjct: 665 NPRNLVEYVVPYILLDEAHRILDQRIPPPTPYEIEAVAHVGYLAAECLMPCSRKRPSMVE 724

Query: 317 IV 318
           +V
Sbjct: 725 VV 726

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	487
255574072	486	Protein kinase APK1B, chloroplast precur	0.985	0.987	0.732	0.0
225449969	472	PREDICTED: serine/threonine-protein kina	0.942	0.972	0.678	0.0
449464026	456	PREDICTED: serine/threonine-protein kina	0.874	0.934	0.696	1e-180
147844250	1697	hypothetical protein VITISV_009093 [Viti	0.827	0.237	0.714	1e-178
224055069	413	predicted protein [Populus trichocarpa]	0.827	0.975	0.753	1e-178
356529852	505	PREDICTED: serine/threonine-protein kina	0.893	0.861	0.676	1e-168
356544300	488	PREDICTED: serine/threonine-protein kina	0.782	0.780	0.747	1e-167
224106159	333	predicted protein [Populus trichocarpa]	0.681	0.996	0.813	1e-155
297816460	361	kinase family protein [Arabidopsis lyrat	0.714	0.963	0.612	1e-115
15231097	362	serine/threonine-protein kinase-like pro	0.714	0.961	0.613	1e-114

>gi|255574072|ref|XP_002527952.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223532656|gb|EEF34441.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  721 bits (1862), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/493 (73%), Positives = 410/493 (83%), Gaps = 13/493 (2%)

Query: 1   MGYLSCKAESAISVISTNSNSVATHQTQSSKTSQ-KQEKPIKIQHFDYSDLEAATNGFSE 59
           MGYLSCKAESAI++++  S      QT SSK +Q KQEKPIKIQ F YSDLEAATNGFS+
Sbjct: 1   MGYLSCKAESAIAILTPVS------QTTSSKPTQDKQEKPIKIQQFHYSDLEAATNGFSD 54

Query: 60  QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           QKLLGKGSHG VYKAV+RGR VA+KKPSK  E+ QEVDNE+EILSKIHSPRLVNLLGF+N
Sbjct: 55  QKLLGKGSHGCVYKAVIRGRHVAIKKPSKGVEVGQEVDNEMEILSKIHSPRLVNLLGFAN 114

Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
           D+KDRLLVVEFMSNGTLYDVLHSN+RP NWGRRIRLALQ+AK ++ILHS+ PPIIHRDIK
Sbjct: 115 DTKDRLLVVEFMSNGTLYDVLHSNSRPPNWGRRIRLALQIAKGIDILHSQNPPIIHRDIK 174

Query: 180 SANVLIDRNFNARLGDFGLALRCGV-DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVF 238
           SANVLIDRNFNARLGDFGLALRCG+ D++R +STPPAGTIGYLDPCYVTPDNLSTKTDVF
Sbjct: 175 SANVLIDRNFNARLGDFGLALRCGIDDDYRLKSTPPAGTIGYLDPCYVTPDNLSTKTDVF 234

Query: 239 SFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAV 298
           SFGILLLEIIS RKAID+G SPPSIVDWA PL+KKGK+ +++DPRI P KDP  RKQLA+
Sbjct: 235 SFGILLLEIISGRKAIDVGHSPPSIVDWAIPLVKKGKLGAIYDPRIDPLKDPTTRKQLAL 294

Query: 299 IAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFNNPCLMVETVGRPVEVRKTQEG 358
           IA +CVRSCRERRP+MKE+ +WLT LSKLVPLHSWNGFNNPC+MVET+GRPVE+R TQ G
Sbjct: 295 IATKCVRSCRERRPAMKEVANWLTTLSKLVPLHSWNGFNNPCMMVETMGRPVELRNTQFG 354

Query: 359 ----GIAGENLDLLDGKLSRMSMKDSRRVYSDLGLRSNLMELMAGMDEEHEFRGEADGVE 414
               G+  ENLD +D KL   S+KDSRRVYSDLG RSNLMELMAG + E  F GEADGVE
Sbjct: 355 LRPEGVGEENLDGIDSKLGVQSVKDSRRVYSDLGFRSNLMELMAGTEGESGFLGEADGVE 414

Query: 415 PSIKSAKQVSSSSHGSGRYLYKGRVRSHAHGNDKGRGSRLRRNLSIGDGSELFSGRDDAM 474
            ++KS   VSSS  GS RY  KG  R    GN KG    +RRN S G+GSELFS +DD +
Sbjct: 415 SNLKSGSWVSSSRFGSARYGIKGIPRLRGRGNGKGLFP-MRRNQSAGNGSELFSKQDDTV 473

Query: 475 IPIGFSSRTANNI 487
               FS++  ++I
Sbjct: 474 ACSSFSTQGCHDI 486

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225449969|ref|XP_002271281.1| PREDICTED: serine/threonine-protein kinase-like protein At3g51990 [Vitis vinifera]

 Score =  667 bits (1720), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/500 (67%), Positives = 387/500 (77%), Gaps = 41/500 (8%)

Query: 1   MGYLSCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPI-KIQHFDYSDLEAATNGFSE 59
           MGY SC AESAIS                + +SQ  +KPI +IQ F YSDLEAATNGFSE
Sbjct: 1   MGYFSCSAESAIS----------------TSSSQLPQKPINRIQQFQYSDLEAATNGFSE 44

Query: 60  QKLLGKGSHGSVYKAVLRGRQVAVKKPSK------------NQEISQEVDNEIEILSKIH 107
           QKLLGKGSHG VYKAVLRGR VAVKKPS+            +   + EV+NEIEILSKI 
Sbjct: 45  QKLLGKGSHGCVYKAVLRGRLVAVKKPSRGSGAGVSPRVATSSSSTNEVENEIEILSKIQ 104

Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
           SPRLVNL+GF+NDSK RLLVVEFMSNGTLYDVLHSN+R  NWGRRIRLALQ AKA++ LH
Sbjct: 105 SPRLVNLVGFTNDSKQRLLVVEFMSNGTLYDVLHSNSRTPNWGRRIRLALQTAKAIDTLH 164

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
           S +PP+IHRDIKSANVLIDRNFNARLGDFGLALRC VD++R RSTPPAGT+GYLDPCYVT
Sbjct: 165 SSVPPVIHRDIKSANVLIDRNFNARLGDFGLALRCHVDDYRLRSTPPAGTMGYLDPCYVT 224

Query: 228 PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP 287
           PDNLSTKTDVFSFGILLLEIIS RKAID+G SPPSIVDWA PLI+KGK+L+++DP I PP
Sbjct: 225 PDNLSTKTDVFSFGILLLEIISGRKAIDVGHSPPSIVDWAIPLIRKGKLLAIYDPTIAPP 284

Query: 288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFNNPCLMVETVG 347
           K+P VRKQLAVIA +CVRSCRERRPSMKE+V+WL GLSKLVPLH+WNGFNNPCLMVET+G
Sbjct: 285 KEPFVRKQLAVIAAKCVRSCRERRPSMKEVVEWLGGLSKLVPLHTWNGFNNPCLMVETMG 344

Query: 348 RPVEVRKTQEGGIAGENLDLLDGKLSRMSMKDSRRVYSDLGLRSNLMELMAGMDEEHEFR 407
            PVE  K    G+ G N+D +D K  R  +++SRRVYSDLG R+NLM+LMAG D E EFR
Sbjct: 345 CPVEASKMD--GVEGGNMDGMDAKFGRTPLRNSRRVYSDLGFRNNLMDLMAGTDGESEFR 402

Query: 408 GEADGVEPSIKSAKQVSSSSHGSGRYLYKGRVRSHAHGNDKGRGSRLRRNLSIGDGSELF 467
           GEA+G  P  KS       + GS     +G  +S   GNDKG   RLRRNLS G+GSE+F
Sbjct: 403 GEAEGFGPMSKSV------NWGSSFRFDRGSSQSRTRGNDKGGLFRLRRNLSAGEGSEIF 456

Query: 468 SGRDDAMIPIGFSSRTANNI 487
           S RD +     FS+  A++I
Sbjct: 457 SRRDQS----SFSASKASHI 472

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449464026|ref|XP_004149730.1| PREDICTED: serine/threonine-protein kinase-like protein At3g51990-like [Cucumis sativus] gi|449511307|ref|XP_004163921.1| PREDICTED: serine/threonine-protein kinase-like protein At3g51990-like [Cucumis sativus]

 Score =  636 bits (1640), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 317/455 (69%), Positives = 368/455 (80%), Gaps = 29/455 (6%)

Query: 1   MGYLSCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQ 60
           MGYLSC+AESAIS     SNS+    + S+ +S K EKP+KIQ FDYSDLEAATNGFS+Q
Sbjct: 1   MGYLSCRAESAIST----SNSLTP--SSSTNSSHKLEKPLKIQQFDYSDLEAATNGFSDQ 54

Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQ-------------------EISQEVDNEIE 101
           KLLGKGSHG VYKAVL GR VAVKK S+ Q                   EI+ EVDNEIE
Sbjct: 55  KLLGKGSHGYVYKAVLGGRLVAVKKSSRAQIVAPPPARPASLSSSMASCEITNEVDNEIE 114

Query: 102 ILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK 161
           ILSKI SPRLVNL+GF+NDSKDRLLVVEFMSNGTLYDV+HS +RPL WGRRIRLALQ AK
Sbjct: 115 ILSKIQSPRLVNLVGFTNDSKDRLLVVEFMSNGTLYDVIHSGSRPLYWGRRIRLALQTAK 174

Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
           A+E LH+  PP+IHRDIKSANVLIDRN+NARLGDFGLA++   D++R RSTPPAGT+GYL
Sbjct: 175 AIETLHASNPPVIHRDIKSANVLIDRNYNARLGDFGLAIQGYADDYRLRSTPPAGTMGYL 234

Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD 281
           DPCYVTPDNLSTKTDVFSFGILLLEIIS RKAID+G+SPPSIVDWA PLIKKGK+++++D
Sbjct: 235 DPCYVTPDNLSTKTDVFSFGILLLEIISGRKAIDVGYSPPSIVDWAVPLIKKGKLMAIYD 294

Query: 282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFNNPCL 341
           PRI PPKDPIVRKQLAVIA +CVRSCRERRPSMK++V WLTGLSKLVPLHSWNGFNNPCL
Sbjct: 295 PRIAPPKDPIVRKQLAVIAAKCVRSCRERRPSMKDVVVWLTGLSKLVPLHSWNGFNNPCL 354

Query: 342 MVETVGRPVEVRKTQEG----GIAGENLDLLDGKLSRMSMKDSRRVYSDLGLRSNLMELM 397
           MVETVGRPVE+R +Q       +   +LD+ + K+SR  +K+SRRVYSDLG+ +NLM+LM
Sbjct: 355 MVETVGRPVEMRNSQSNLRSPSVEDGDLDVGNAKMSRRDIKNSRRVYSDLGISNNLMDLM 414

Query: 398 AGMDEEHEFRGEADGVEPSIKSAKQVSSSSHGSGR 432
           A ++EE  FR E++ V    + + +  SS   SGR
Sbjct: 415 ACIEEESGFRDESNRVGSHSRFSNRFFSSRFVSGR 449

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147844250|emb|CAN82122.1| hypothetical protein VITISV_009093 [Vitis vinifera]

 Score =  630 bits (1625), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 310/434 (71%), Positives = 351/434 (80%), Gaps = 31/434 (7%)

Query: 1    MGYLSCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPI-KIQHFDYSDLEAATNGFSE 59
            MGY SC AESAIS                + +SQ  +KPI +IQ F YSDLEAATNGFSE
Sbjct: 1279 MGYFSCSAESAIS----------------TSSSQLPQKPINRIQQFQYSDLEAATNGFSE 1322

Query: 60   QKLLGKGSHGSVYKAVLRGRQVAVKKPSK------------NQEISQEVDNEIEILSKIH 107
            QKLLGKGSHG VYKAVLRGR VAVKKPS+            +   + EV+NEIEILSKI 
Sbjct: 1323 QKLLGKGSHGCVYKAVLRGRLVAVKKPSRGSGAGVSPRVAXSSSSTNEVENEIEILSKIQ 1382

Query: 108  SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
            SPRLVNL+GF+NDSK RLLVVEFMSNGTLYDVLHSN+R  NWGRRIRLALQ AKA++ LH
Sbjct: 1383 SPRLVNLVGFTNDSKQRLLVVEFMSNGTLYDVLHSNSRTPNWGRRIRLALQTAKAIDTLH 1442

Query: 168  SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
            S +PP+IHRDIKSANVLIDRNFNARLGDFGLALRC VD++R RSTPPAGT+GYLDPCYVT
Sbjct: 1443 SSVPPVIHRDIKSANVLIDRNFNARLGDFGLALRCHVDDYRLRSTPPAGTMGYLDPCYVT 1502

Query: 228  PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP 287
            PDNLSTKTDVFSFGILLLEIIS RKAID+G SPPSIVDWA PLI+KGK+L+++DP I PP
Sbjct: 1503 PDNLSTKTDVFSFGILLLEIISGRKAIDVGHSPPSIVDWAIPLIRKGKLLAIYDPTIAPP 1562

Query: 288  KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFNNPCLMVETVG 347
            K+P VRKQLAVIA +CVRSCRERRPSMKE+V+WL GLSKLVPLH+WNGFNNPCLMVET+G
Sbjct: 1563 KEPFVRKQLAVIAAKCVRSCRERRPSMKEVVEWLGGLSKLVPLHTWNGFNNPCLMVETMG 1622

Query: 348  RPVEVRKTQEGGIAGENLDLLDGKLSRMSMKDSRRVYSDLGLRSNLMELMAGMDEEHEFR 407
             PVE  K    G+ G N+D +D K  R  +++SRRVYSDLG R+NLM+LMAG D E EFR
Sbjct: 1623 CPVEASKMD--GVEGGNMDGMDAKFGRTPLRNSRRVYSDLGFRNNLMDLMAGTDGESEFR 1680

Query: 408  GEADGVEPSIKSAK 421
            GEA+G  P  K ++
Sbjct: 1681 GEAEGFGPMFKVSE 1694

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224055069|ref|XP_002298411.1| predicted protein [Populus trichocarpa] gi|222845669|gb|EEE83216.1| predicted protein [Populus trichocarpa]

 Score =  629 bits (1623), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 309/410 (75%), Positives = 355/410 (86%), Gaps = 7/410 (1%)

Query: 1   MGYLSCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQ 60
           MGYLSCKA+SAI++IST  +S A+    +S+T  KQEKPIKI+ F+YSD+EAAT+GFS+Q
Sbjct: 1   MGYLSCKADSAIAIISTTPSSQASSSPSTSRT--KQEKPIKIRQFNYSDIEAATDGFSDQ 58

Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND 120
           KLLGKGSHG VYKAVLRGR VAVKKPSK+ EI QEVDNEIEILSKIHSPR VNLLGF+ND
Sbjct: 59  KLLGKGSHGCVYKAVLRGRHVAVKKPSKDLEIGQEVDNEIEILSKIHSPRFVNLLGFAND 118

Query: 121 SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +KDRLLVVEFMSNGTLYD LHSN+RP NWGRRI +ALQ+AKAV+ LHS+ PP+IHRDIKS
Sbjct: 119 TKDRLLVVEFMSNGTLYDTLHSNSRPPNWGRRITMALQIAKAVDTLHSQNPPVIHRDIKS 178

Query: 181 ANVLIDRNFNARLGDFGLALRCGV-DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           ANVLIDRNFNARLGDFGLAL CGV D++R +STPPAGTIGYLDPCYVTPDNLSTKTDVFS
Sbjct: 179 ANVLIDRNFNARLGDFGLALMCGVDDDYRLKSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 238

Query: 240 FGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVI 299
           FGI LLEIIS RKAID+G SP SIVDWA PLIKKGK+++++DPR  P KDP++RKQLA+I
Sbjct: 239 FGIFLLEIISGRKAIDVGHSPSSIVDWAIPLIKKGKLVAIYDPRTVPLKDPMIRKQLALI 298

Query: 300 AVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFNNPCLMVETVGRPVEVRKTQEGG 359
           A +CVRSCRERRPSMKE+VDWL  LSKLVPLHSWNGFNNPC+MVET+GRP E+R TQ G 
Sbjct: 299 ASKCVRSCRERRPSMKEVVDWLAALSKLVPLHSWNGFNNPCMMVETMGRPAELRNTQFGS 358

Query: 360 IAGEN----LDLLDGKLSRMSMKDSRRVYSDLGLRSNLMELMAGMDEEHE 405
              ++    L+ + GK+ R S+ D+RRVYSDLG RSNLMELMA  D E +
Sbjct: 359 RPQDDGEEILEGIYGKMGRKSVMDTRRVYSDLGFRSNLMELMAWTDAETD 408

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356529852|ref|XP_003533501.1| PREDICTED: serine/threonine-protein kinase-like protein At3g51990-like [Glycine max]

 Score =  596 bits (1537), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 318/470 (67%), Positives = 363/470 (77%), Gaps = 35/470 (7%)

Query: 3   YLSCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKL 62
           YLSC+AESA+S  ++ S+S    ++ S          IKIQ F YSDLEAATNGFS++KL
Sbjct: 5   YLSCRAESAVSTSNSVSSSKENEKSSS----------IKIQEFQYSDLEAATNGFSDRKL 54

Query: 63  LGKGSHGSVYKAVLRGRQVAVKKPSKNQ-------------EISQEVDNEIEILSKIHSP 109
           LGKGSHG VYKAV+RGR VAVK+PS+               EI+ EVDNEI+ILSKI SP
Sbjct: 55  LGKGSHGYVYKAVVRGRPVAVKRPSRPHHNVPRPVSSSAPSEITNEVDNEIDILSKIQSP 114

Query: 110 RLVNLLGFSN-DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           RLVNL+GF+N DS+DRLLVVEFMSNGTLYDVLH++ RP NWGRRIRLALQ AKA++ LHS
Sbjct: 115 RLVNLVGFTNNDSRDRLLVVEFMSNGTLYDVLHTSPRPPNWGRRIRLALQTAKAIDTLHS 174

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
             PP+IHRDIKSANVLIDR++NARLGDFGLALR  VD++R RSTPPAGT+GYLDPCYVTP
Sbjct: 175 STPPVIHRDIKSANVLIDRSYNARLGDFGLALRGHVDDYRLRSTPPAGTMGYLDPCYVTP 234

Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
           DNLSTKTDVFSFGILLLEIIS RKAIDI +SPPSIVDWA PLIKKGK+L+V+DPRI PPK
Sbjct: 235 DNLSTKTDVFSFGILLLEIISGRKAIDITYSPPSIVDWAIPLIKKGKLLAVYDPRIAPPK 294

Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFNNPCLMVETVGR 348
           DPIVRKQLAVIA +CVRSCRERRPSMKE+V WL GL KLVPLHSWNGFNNPC+MVET GR
Sbjct: 295 DPIVRKQLAVIAAKCVRSCRERRPSMKEVVTWLCGLCKLVPLHSWNGFNNPCMMVETAGR 354

Query: 349 PVEVRKTQEG--------GIAGENLDLLDGKLSRMSMKDSRRVYSDLGLRSNLMELMAGM 400
           PVE    +          G+     D LDG+LS+ +M+ SRRVYSDLG   NLM+LMA  
Sbjct: 355 PVEAAAARNNGQFSSRLEGVEEGKFDALDGRLSKSAMRYSRRVYSDLGFSRNLMDLMA-T 413

Query: 401 DEEHEFRGEADGVEPSIKSAKQVSSSSHGSGRYLY--KGRVRSHAHGNDK 448
            EE EF  +ADG E S KSA+QVS SS   G   Y  +GR      G+DK
Sbjct: 414 TEEPEFLRDADGTEHSSKSAEQVSGSSSRFGSGRYSIRGRNLYRPCGSDK 463

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356544300|ref|XP_003540591.1| PREDICTED: serine/threonine-protein kinase-like protein At3g51990-like [Glycine max]

 Score =  595 bits (1533), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 293/392 (74%), Positives = 328/392 (83%), Gaps = 11/392 (2%)

Query: 42  IQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIE 101
           IQ F YSDLEAATNGFS++KLLGKGSHG VYKAV+RGR VAVK+PS+ Q     VDNEI+
Sbjct: 32  IQEFLYSDLEAATNGFSDRKLLGKGSHGYVYKAVVRGRPVAVKRPSRPQHHHNNVDNEID 91

Query: 102 ILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK 161
           ILSKI SPRLVNL+GF+NDS+DRLLVVEFMSNGTLYDVLHS+ RP NWGRRIRLALQ AK
Sbjct: 92  ILSKIQSPRLVNLVGFTNDSRDRLLVVEFMSNGTLYDVLHSSPRPPNWGRRIRLALQTAK 151

Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
           A++ LHS  PP+IHRDIKSANVLIDR++NARLGDFGLALR  VD++R RSTPPAGT+GYL
Sbjct: 152 AIDTLHSSTPPVIHRDIKSANVLIDRSYNARLGDFGLALRGHVDDYRLRSTPPAGTMGYL 211

Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD 281
           DPCYVTPDNLSTKTDVFSFGILLLEIIS RKAIDI +SPPSIVDWA PLIKKGK+L+V+D
Sbjct: 212 DPCYVTPDNLSTKTDVFSFGILLLEIISGRKAIDITYSPPSIVDWAIPLIKKGKLLAVYD 271

Query: 282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFNNPCL 341
           PRI PPKDPIVRKQLAVIA +CVRSCRERRPSMKE+V WL GL KLVPLHSWNGFNNPC+
Sbjct: 272 PRIAPPKDPIVRKQLAVIAAKCVRSCRERRPSMKELVTWLCGLCKLVPLHSWNGFNNPCM 331

Query: 342 MVETVGRPVEVR----------KTQEGGIAGENLDLLDGKLSRMSMKDSRRVYSDLGLRS 391
           M E  GRPVE             ++  G+     D LDG+LS+ +M+ SRRVYSDLG  S
Sbjct: 332 MAEIAGRPVEAAAAAARNYGQFSSRLEGVEEGKFDALDGRLSKSAMRYSRRVYSDLGFSS 391

Query: 392 NLMELMAGMDEEHEFRGEADGVEPSIKSAKQV 423
           NLM+LMA   EE EF  +ADGVE S KSA+QV
Sbjct: 392 NLMDLMA-TTEEPEFLRDADGVEHSSKSAEQV 422

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224106159|ref|XP_002314064.1| predicted protein [Populus trichocarpa] gi|222850472|gb|EEE88019.1| predicted protein [Populus trichocarpa]

 Score =  553 bits (1426), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 274/337 (81%), Positives = 303/337 (89%), Gaps = 5/337 (1%)

Query: 1   MGYLSCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQ 60
           MGYLSCKA+SAI +IST S S    QT SS +  KQEKPIKIQ F+YSD+EAATNGFS+Q
Sbjct: 1   MGYLSCKADSAIGIISTTSAS----QTSSSSSKNKQEKPIKIQEFNYSDIEAATNGFSDQ 56

Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND 120
           KLLGKGSHG VYKAVLRGR VAVKKPSK  EI QEVDNEIEILSKIHSPRLVNLLGF+ND
Sbjct: 57  KLLGKGSHGCVYKAVLRGRHVAVKKPSKGFEIGQEVDNEIEILSKIHSPRLVNLLGFAND 116

Query: 121 SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +KDRLLVVEFMSNGTLYD+LHSN+RP NWGRRIR+ALQ+A A++ LHS+ PPIIHRDIKS
Sbjct: 117 TKDRLLVVEFMSNGTLYDILHSNSRPPNWGRRIRMALQIANAIDTLHSQNPPIIHRDIKS 176

Query: 181 ANVLIDRNFNARLGDFGLALRCGV-DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           ANVLIDRNFNARLGDFGLALRCGV D++R +STPPAGTIGYLDPCYVTPDNLSTKTDVFS
Sbjct: 177 ANVLIDRNFNARLGDFGLALRCGVDDDYRLKSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 236

Query: 240 FGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVI 299
           FGIL LEIIS RKAID+G SPPSIVDWA PLIKKGK+ +++DPR  P KDP++RKQLA+I
Sbjct: 237 FGILFLEIISGRKAIDVGHSPPSIVDWAIPLIKKGKLAAIYDPRTFPLKDPMIRKQLALI 296

Query: 300 AVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGF 336
           A +CVRSCRERRP+MKE+VDWLT LSKLVPLHSWNG 
Sbjct: 297 ASKCVRSCRERRPAMKEVVDWLTTLSKLVPLHSWNGL 333

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297816460|ref|XP_002876113.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297321951|gb|EFH52372.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  420 bits (1080), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 223/364 (61%), Positives = 279/364 (76%), Gaps = 16/364 (4%)

Query: 1   MGYLSCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPI----KIQHFDYSDLEAATNG 56
           MGYLSCKA    +V    S+S +T  + SSK S + E PI    +++ F + DL++AT G
Sbjct: 1   MGYLSCKA--GSAVAIAVSSSASTSGSTSSKASARPESPIEDRPRLRRFLHRDLDSATGG 58

Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           F    LLG+GSHGSVYKAV+  R VAVK+PSK++EIS+E  NE EILS+I SPR VNLLG
Sbjct: 59  FDINNLLGRGSHGSVYKAVIGSRLVAVKRPSKSREISREFHNEFEILSRIRSPRFVNLLG 118

Query: 117 FSND-SKDRLLVVEFMSNGTLYDVLHSNNRPLN------WGRRIRLALQVAKAVEILHSE 169
           FS D SK+ LLVVE+M NG+LYDV+HS++  LN      W +RI++ALQ+AKAV +LHS+
Sbjct: 119 FSADNSKEPLLVVEYMGNGSLYDVIHSDS-VLNSGAISSWSKRIKIALQIAKAVHLLHSQ 177

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
             PIIHRDIKSANVL+D+N NA+LGDFGLA+RC VD+ + +STPPAGT+GYLDP YVT D
Sbjct: 178 ETPIIHRDIKSANVLMDKNLNAKLGDFGLAIRCNVDDQKVKSTPPAGTMGYLDPDYVTAD 237

Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD 289
            LSTKTDVFSFGILLLEIIS RKAID+ +SP  IVDWA P+IK+GKI  ++DPRI PP D
Sbjct: 238 RLSTKTDVFSFGILLLEIISGRKAIDVRYSPSFIVDWAIPMIKRGKIGGIYDPRIGPPID 297

Query: 290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFN--NPCLMVETVG 347
             VR  L ++A +CVR+CRE+RP M+E+V WLTGL+K V    W+  +  NPC+MVETVG
Sbjct: 298 VSVRNHLGLVAAKCVRTCREKRPGMEEVVGWLTGLTKSVRSRRWDDLSIGNPCMMVETVG 357

Query: 348 RPVE 351
           RPV+
Sbjct: 358 RPVQ 361

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15231097|ref|NP_190767.1| serine/threonine-protein kinase-like protein [Arabidopsis thaliana] gi|75337704|sp|Q9SV05.1|CCR35_ARATH RecName: Full=Serine/threonine-protein kinase-like protein At3g51990; AltName: Full=CRINKLY 4-related kinase; Flags: Precursor gi|4678928|emb|CAB41319.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|16648895|gb|AAL24299.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|20148431|gb|AAM10106.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|332645351|gb|AEE78872.1| serine/threonine-protein kinase-like protein [Arabidopsis thaliana]

 Score =  417 bits (1073), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 224/365 (61%), Positives = 276/365 (75%), Gaps = 17/365 (4%)

Query: 1   MGYLSCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPI----KIQHFDYSDLEAATNG 56
           MGYLSCKA    +V    S++ +T  + SSK S   E PI    +++ F + DLE+AT G
Sbjct: 1   MGYLSCKA--GSAVAIAVSSAASTSGSTSSKASAPPESPIEDRPRLRRFLHRDLESATGG 58

Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           F    LLG+GSHGSVYKAV+  R +AVK+PSK++EIS+E  NE EILS+I SPR VNLLG
Sbjct: 59  FDINNLLGRGSHGSVYKAVIGSRHIAVKRPSKSREISREFHNEFEILSRIRSPRFVNLLG 118

Query: 117 FSND-SKDRLLVVEFMSNGTLYDVLHSNNRPLN------WGRRIRLALQVAKAVEILHSE 169
           FS D SK+ LLVVEFM NG+LYDV+HS+   LN      W +RI++ALQ+AKAV +LHS+
Sbjct: 119 FSADNSKEPLLVVEFMGNGSLYDVIHSDT-VLNSGAISSWSKRIKIALQIAKAVHLLHSQ 177

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
             PIIHRDIKSANVL+D+N NA+LGDFGLA+RC VD+ + +STPPAGT+GYLDP YVT D
Sbjct: 178 ETPIIHRDIKSANVLMDKNLNAKLGDFGLAIRCNVDDQKVKSTPPAGTMGYLDPDYVTAD 237

Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD 289
            LSTKTDVFSFGILLLEIIS RKAID+ +SP  IVDWA P+IK+GKI  ++DPRI PP D
Sbjct: 238 RLSTKTDVFSFGILLLEIISGRKAIDVRYSPSFIVDWAIPMIKRGKIGGIYDPRIGPPID 297

Query: 290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWN--GFNNPCLMVETV- 346
             VR  L ++A +CVR+CRE+RP M+E+V WLTGL+K V    W+     NPC+MVETV 
Sbjct: 298 VSVRNHLGLVAAKCVRTCREKRPGMEEVVGWLTGLTKSVRSRRWDELSIGNPCMMVETVG 357

Query: 347 GRPVE 351
           GRPVE
Sbjct: 358 GRPVE 362

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	487
TAIR|locus:2083815	362	AT3G51990 [Arabidopsis thalian	0.716	0.964	0.598	6.1e-110
UNIPROTKB|O24585	901	CR4 "Putative receptor protein	0.671	0.362	0.436	2.2e-66
TAIR|locus:2081227	895	CR4 "crinkly4" [Arabidopsis th	0.613	0.334	0.439	2.4e-60
TAIR|locus:2166761	341	AT5G23170 [Arabidopsis thalian	0.550	0.785	0.463	5.9e-57
TAIR|locus:2075074	775	CCR1 "CRINKLY4 related 1" [Ara	0.320	0.201	0.521	2.1e-52
TAIR|locus:2099009	400	AT3G58690 [Arabidopsis thalian	0.579	0.705	0.398	2.8e-50
TAIR|locus:2010282	699	PERK7 "proline-rich extensin-l	0.577	0.402	0.411	9.5e-50
TAIR|locus:2093999	700	PERK6 "proline-rich extensin-l	0.568	0.395	0.401	2e-49
TAIR|locus:2139474	670	PERK5 "proline-rich extensin-l	0.568	0.413	0.422	2e-49
TAIR|locus:2091722	652	PERK1 "proline-rich extensin-l	0.587	0.438	0.404	2.5e-49

TAIR|locus:2083815 AT3G51990 [Arabidopsis thaliana (taxid:3702)]

 Score = 1086 (387.4 bits), Expect = 6.1e-110, P = 6.1e-110
 Identities = 218/364 (59%), Positives = 273/364 (75%)

Query:     1 MGYLSCKAESAISVISTNSNSVAXXXXXXXXXXXXXXXPI----KIQHFDYSDLEAATNG 56
             MGYLSCKA SA+++    S++ +               PI    +++ F + DLE+AT G
Sbjct:     1 MGYLSCKAGSAVAIAV--SSAASTSGSTSSKASAPPESPIEDRPRLRRFLHRDLESATGG 58

Query:    57 FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
             F    LLG+GSHGSVYKAV+  R +AVK+PSK++EIS+E  NE EILS+I SPR VNLLG
Sbjct:    59 FDINNLLGRGSHGSVYKAVIGSRHIAVKRPSKSREISREFHNEFEILSRIRSPRFVNLLG 118

Query:   117 FSND-SKDRLLVVEFMSNGTLYDVLHS----NNRPLN-WGRRIRLALQVAKAVEILHSEM 170
             FS D SK+ LLVVEFM NG+LYDV+HS    N+  ++ W +RI++ALQ+AKAV +LHS+ 
Sbjct:   119 FSADNSKEPLLVVEFMGNGSLYDVIHSDTVLNSGAISSWSKRIKIALQIAKAVHLLHSQE 178

Query:   171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
              PIIHRDIKSANVL+D+N NA+LGDFGLA+RC VD+ + +STPPAGT+GYLDP YVT D 
Sbjct:   179 TPIIHRDIKSANVLMDKNLNAKLGDFGLAIRCNVDDQKVKSTPPAGTMGYLDPDYVTADR 238

Query:   231 LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP 290
             LSTKTDVFSFGILLLEIIS RKAID+ +SP  IVDWA P+IK+GKI  ++DPRI PP D 
Sbjct:   239 LSTKTDVFSFGILLLEIISGRKAIDVRYSPSFIVDWAIPMIKRGKIGGIYDPRIGPPIDV 298

Query:   291 IVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWN--GFNNPCLMVETVG- 347
              VR  L ++A +CVR+CRE+RP M+E+V WLTGL+K V    W+     NPC+MVETVG 
Sbjct:   299 SVRNHLGLVAAKCVRTCREKRPGMEEVVGWLTGLTKSVRSRRWDELSIGNPCMMVETVGG 358

Query:   348 RPVE 351
             RPVE
Sbjct:   359 RPVE 362

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|O24585 CR4 "Putative receptor protein kinase CRINKLY4" [Zea mays (taxid:4577)]

 Score = 675 (242.7 bits), Expect = 2.2e-66, P = 2.2e-66
 Identities = 150/344 (43%), Positives = 212/344 (61%)

Query:    41 KIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEI---SQEV 96
             + Q F Y +LE AT GFSE   +GKGS   V+K +LR G  VAVK+  K  ++   S+E 
Sbjct:   489 RAQEFSYEELEQATGGFSEDSQVGKGSFSCVFKGILRDGTVVAVKRAIKASDVKKSSKEF 548

Query:    97 DNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN----RPLNWGRR 152
              NE+++LS+++   L+NLLG+  D  +RLLV EFM++G+LY  LH  +    + LNW RR
Sbjct:   549 HNELDLLSRLNHAHLLNLLGYCEDGSERLLVYEFMAHGSLYQHLHGKDPNLKKRLNWARR 608

Query:   153 IRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
             + +A+Q A+ +E LH    PP+IHRDIKS+N+LID + NAR+ DFGL++    D+    S
Sbjct:   609 VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEDHNARVADFGLSILGPADSGTPLS 668

Query:   212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI 271
               PAGT+GYLDP Y     L+TK+DV+SFG++LLEI+S RKAID+ F   +IV+WA PLI
Sbjct:   669 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVVLLEILSGRKAIDMQFEEGNIVEWAVPLI 728

Query:   272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLH 331
             K G I ++ DP + PP D    K++A +A +CVR   + RPSM ++    T L   + L 
Sbjct:   729 KAGDIFAILDPVLSPPSDLEALKKIASVACKCVRMRGKDRPSMDKVT---TALEHALALL 785

Query:   332 SWNG-FNNPCLMVETV---GRPVEVRKTQEGGIAGENLDLLDGK 371
               +     P L  E V    R  +V +        EN +L DG+
Sbjct:   786 MGSPCIEQPILPTEVVLGSSRMHKVSQMSSNHSCSEN-ELADGE 828

GO:0042803 "protein homodimerization activity" evidence=IDA

TAIR|locus:2081227 CR4 "crinkly4" [Arabidopsis thaliana (taxid:3702)]

 Score = 620 (223.3 bits), Expect = 2.4e-60, P = 2.4e-60
 Identities = 137/312 (43%), Positives = 197/312 (63%)

Query:    45 FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKP---SKNQEISQEVDNEI 100
             F Y +LE A +GF E+ ++GKGS   VYK VLR G  VAVK+    S  Q+ S E   E+
Sbjct:   500 FTYEELEKAADGFKEESIVGKGSFSCVYKGVLRDGTTVAVKRAIMSSDKQKNSNEFRTEL 559

Query:   101 EILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPL----NWGRRIRLA 156
             ++LS+++   L++LLG+  +  +RLLV EFM++G+L++ LH  N+ L    +W +R+ +A
Sbjct:   560 DLLSRLNHAHLLSLLGYCEECGERLLVYEFMAHGSLHNHLHGKNKALKEQLDWVKRVTIA 619

Query:   157 LQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA 215
             +Q A+ +E LH    PP+IHRDIKS+N+LID   NAR+ DFGL+L   VD+    +  PA
Sbjct:   620 VQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPVDSGSPLAELPA 679

Query:   216 GTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK 275
             GT+GYLDP Y     L+TK+DV+SFG+LLLEI+S RKAID+ +   +IV+WA PLIK G 
Sbjct:   680 GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMHYEEGNIVEWAVPLIKAGD 739

Query:   276 ILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK-LVPLHSWN 334
             I ++ DP +  P +    K++  +A +CVR   + RPSM ++    T L + L  L    
Sbjct:   740 INALLDPVLKHPSEIEALKRIVSVACKCVRMRGKDRPSMDKVT---TALERALAQLMGNP 796

Query:   335 GFNNPCLMVETV 346
                 P L  E V
Sbjct:   797 SSEQPILPTEVV 808

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009793 "embryo development ending in seed dormancy" evidence=RCA;IMP

GO:0009986 "cell surface" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030139 "endocytic vesicle" evidence=IDA

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0009786 "regulation of asymmetric cell division" evidence=IMP

GO:0010311 "lateral root formation" evidence=IMP

GO:0048829 "root cap development" evidence=IMP

GO:0000280 "nuclear division" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0007000 "nucleolus organization" evidence=RCA

GO:0008356 "asymmetric cell division" evidence=RCA

GO:0009640 "photomorphogenesis" evidence=RCA

GO:0009737 "response to abscisic acid stimulus" evidence=RCA

GO:0009845 "seed germination" evidence=RCA

GO:0009909 "regulation of flower development" evidence=RCA

GO:0009933 "meristem structural organization" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

GO:0010182 "sugar mediated signaling pathway" evidence=RCA

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA

GO:0016567 "protein ubiquitination" evidence=RCA

GO:0019915 "lipid storage" evidence=RCA

GO:0048825 "cotyledon development" evidence=RCA

GO:0050826 "response to freezing" evidence=RCA

GO:0051301 "cell division" evidence=RCA

TAIR|locus:2166761 AT5G23170 [Arabidopsis thaliana (taxid:3702)]

 Score = 586 (211.3 bits), Expect = 5.9e-57, P = 5.9e-57
 Identities = 139/300 (46%), Positives = 185/300 (61%)

Query:    42 IQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVL--------RGRQVAVKKPSK----- 88
             ++ FDY  L  A + FS  KL+GKGSHG VYKA+L        R R VA+K PS      
Sbjct:     1 MKEFDYDKLVTAIDRFSPSKLIGKGSHGYVYKALLHHQDVDETRQRVVAIKTPSSLSPSS 60

Query:    89 -------NQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH 141
                      E +++++NEI+++S +  P   ++L F   ++ +L+VVE+M N +LY +LH
Sbjct:    61 PSSSSSSKSEQTKKLENEIDVMSSL--PYHPHVLSFLGHAEKKLMVVEYMPNESLYQLLH 118

Query:   142 SNNRPL-NWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL 200
              +  PL  W +RI +ALQ+A AV  LH     IIHRDIKS N+L D N+ A+L DFGLA+
Sbjct:   119 VSTDPLPTWLKRIEIALQIASAVHFLHEH--GIIHRDIKSENILFDSNWEAKLADFGLAV 176

Query:   201 RCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
               G D  + R  P AGTIGYLDPCY  P+NLS KTDV+S+G++LLEI+SCRKAID+  SP
Sbjct:   177 DFGGDK-KIRPAP-AGTIGYLDPCYTLPENLSMKTDVYSYGVVLLEIVSCRKAIDVSRSP 234

Query:   261 PSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRK---QLAVIAVRCVRSCRERRPSMKEI 317
              SIVDWA PLIK+G+I  +           + R    +L  +A RCV S  E RP   EI
Sbjct:   235 ASIVDWAVPLIKEGRIGEICGGG--GGGSGVFRGMSLRLLRMAARCVSSDVESRPCFGEI 292

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075074 CCR1 "CRINKLY4 related 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 384 (140.2 bits), Expect = 2.1e-52, Sum P(2) = 2.1e-52
 Identities = 84/161 (52%), Positives = 112/161 (69%)

Query:    43 QHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEI---SQEVDN 98
             Q F  S+L+ ATNGF E   LG+GS+G VYKAVL  GRQVAVK+ +    I   ++E + 
Sbjct:   506 QVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLADGRQVAVKRANAATIIHTNTREFET 565

Query:    99 EIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQ 158
             E+EIL  I    +VNLLG+S +  +RLLV E+M +GTL+D LHS   PL+W  RI++A+Q
Sbjct:   566 ELEILCNIRHCNIVNLLGYSTEMGERLLVYEYMPHGTLHDHLHSGFSPLSWSLRIKIAMQ 625

Query:   159 VAKAVEILHSEMPP-IIHRDIKSANVLIDRNFNARLGDFGL 198
              AK +E LH+E  P IIH D+KS+NVL+D  + AR+ DFGL
Sbjct:   626 TAKGLEYLHNEAEPRIIHGDVKSSNVLLDSEWVARVADFGL 666

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0009062 "fatty acid catabolic process" evidence=RCA

TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)]

 Score = 523 (189.2 bits), Expect = 2.8e-50, P = 2.8e-50
 Identities = 118/296 (39%), Positives = 183/296 (61%)

Query:    42 IQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVK-KPSKNQEISQEVDNE 99
             +Q F +  L +AT GFS+  ++G G  G VY+ VL  GR+VA+K      ++  +E   E
Sbjct:    72 LQIFTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVAIKLMDHAGKQGEEEFKME 131

Query:   100 IEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-----P-LNWGRRI 153
             +E+LS++ SP L+ LLG+ +D+  +LLV EFM+NG L + L+  NR     P L+W  R+
Sbjct:   132 VELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLYLPNRSGSVPPRLDWETRM 191

Query:   154 RLALQVAKAVEILHSEM-PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR-S 211
             R+A++ AK +E LH ++ PP+IHRD KS+N+L+DRNFNA++ DFGLA + G D      S
Sbjct:   192 RIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLA-KVGSDKAGGHVS 250

Query:   212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS--IVDWAAP 269
             T   GT GY+ P Y    +L+TK+DV+S+G++LLE+++ R  +D+  +     +V WA P
Sbjct:   251 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRATGEGVLVSWALP 310

Query:   270 -LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
              L  + K++ + DP +          Q+A IA  CV++  + RP M ++V  L  L
Sbjct:   311 QLADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPLMADVVQSLVPL 366

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 518 (187.4 bits), Expect = 9.5e-50, P = 9.5e-50
 Identities = 121/294 (41%), Positives = 174/294 (59%)

Query:    45 FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVL-RGRQVAVK--KPSKNQEISQEVDNEIE 101
             F Y +L +AT GFS+ +LLG+G  G V+K +L  G+++AVK  K    Q   +E   E+E
Sbjct:   324 FTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQG-EREFQAEVE 382

Query:   102 ILSKIHSPRLVNLLGF-SNDSKDRLLVVEFMSNGTLYDVLHSNNRP-LNWGRRIRLALQV 159
             I+S++H   LV+L+G+ SN    RLLV EF+ N TL   LH  +   ++W  R+++AL  
Sbjct:   383 IISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHGKSGTVMDWPTRLKIALGS 442

Query:   160 AKAVEILHSEM-PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTI 218
             AK +  LH +  P IIHRDIK++N+L+D NF A++ DFGLA +   DN    ST   GT 
Sbjct:   443 AKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLA-KLSQDNNTHVSTRVMGTF 501

Query:   219 GYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDI-GFSPPSIVDWAAPLIKK---- 273
             GYL P Y +   L+ K+DVFSFG++LLE+I+ R  +D+ G    S+VDWA PL  +    
Sbjct:   502 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDMEDSLVDWARPLCMRVAQD 561

Query:   274 GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL 327
             G+   + DP +    +P    ++   A   VR    RRP M +IV  L G + L
Sbjct:   562 GEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSGRRRPKMSQIVRTLEGDASL 615

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 515 (186.3 bits), Expect = 2.0e-49, P = 2.0e-49
 Identities = 116/289 (40%), Positives = 172/289 (59%)

Query:    45 FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVL-RGRQVAVK--KPSKNQEISQEVDNEIE 101
             F Y +L AAT GFS+ +LLG+G  G V+K +L  G+++AVK  K    Q   +E   E++
Sbjct:   325 FTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQG-EREFQAEVD 383

Query:   102 ILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVA 160
             I+S++H   LV+L+G+      R+LV EF+ N TL   LH  + + L+W  R+++AL  A
Sbjct:   384 IISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLKIALGSA 443

Query:   161 KAVEILHSEMPP-IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG 219
             K +  LH +  P IIHRDIK++N+L+D +F A++ DFGLA +   DN    ST   GT G
Sbjct:   444 KGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLA-KLSQDNVTHVSTRIMGTFG 502

Query:   220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDI-GFSPPSIVDWAAPLI----KKG 274
             YL P Y +   L+ ++DVFSFG++LLE+++ R+ +D+ G    S+VDWA P+     + G
Sbjct:   503 YLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEMEDSLVDWARPICLNAAQDG 562

Query:   275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG 323
                 + DPR+    +P    Q+   A   VR    RRP M +IV  L G
Sbjct:   563 DYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEG 611

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 515 (186.3 bits), Expect = 2.0e-49, P = 2.0e-49
 Identities = 122/289 (42%), Positives = 168/289 (58%)

Query:    45 FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVL-RGRQVAVK--KPSKNQEISQEVDNEIE 101
             F Y +L  AT GF++  LLG+G  G V+K VL  G++VAVK  K    Q   +E   E++
Sbjct:   300 FTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLGSGQG-EREFQAEVD 358

Query:   102 ILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP-LNWGRRIRLALQVA 160
             I+S++H   LV+L+G+      RLLV EF+ N TL   LH   RP L+W  R+++AL  A
Sbjct:   359 IISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHGKGRPVLDWPTRVKIALGSA 418

Query:   161 KAVEILHSEMPP-IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG 219
             + +  LH +  P IIHRDIK+AN+L+D +F  ++ DFGLA +   DN+   ST   GT G
Sbjct:   419 RGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLA-KLSQDNYTHVSTRVMGTFG 477

Query:   220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDI-GFSPPSIVDWAAPLIKK----G 274
             YL P Y +   LS K+DVFSFG++LLE+I+ R  +D+ G    S+VDWA PL  K    G
Sbjct:   478 YLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTGEMEDSLVDWARPLCLKAAQDG 537

Query:   275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG 323
                 + DPR+          Q+A  A   +R    RRP M +IV  L G
Sbjct:   538 DYNQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQIVRALEG 586

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0048610 "cellular process involved in reproduction" evidence=RCA

GO:0048868 "pollen tube development" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 514 (186.0 bits), Expect = 2.5e-49, P = 2.5e-49
 Identities = 120/297 (40%), Positives = 170/297 (57%)

Query:    45 FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVL-RGRQVAVKK-PSKNQEISQEVDNEIEI 102
             F Y +L  ATNGFSE  LLG+G  G V+K +L  G++VAVK+  + + +  +E   E+EI
Sbjct:   268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327

Query:   103 LSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP-LNWGRRIRLALQVAK 161
             +S++H   LV+L+G+      RLLV EF+ N  L   LH   RP + W  R+++AL  AK
Sbjct:   328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAK 387

Query:   162 AVEILHSEM-PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGY 220
              +  LH +  P IIHRDIK++N+LID  F A++ DFGLA +   D     ST   GT GY
Sbjct:   388 GLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLA-KIASDTNTHVSTRVMGTFGY 446

Query:   221 LDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIG--FSPPSIVDWAAPLIKK----G 274
             L P Y     L+ K+DVFSFG++LLE+I+ R+ +D    +   S+VDWA PL+ +    G
Sbjct:   447 LAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEEG 506

Query:   275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLH 331
                 + D ++    D     ++   A  CVR    RRP M +IV  L G   L  L+
Sbjct:   507 DFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLN 563

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;ISS;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9SV05	CCR35_ARATH	2, ., 7, ., 1, 1, ., 1	0.6136	0.7145	0.9613	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	487
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-52
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-46
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-44
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-44
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-43
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-43
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-34
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-28
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-26
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-25
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-25
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-19
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-19
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-19
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	9e-18
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-17
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-17
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-16
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-16
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-15
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-14
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-14
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	9e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-13
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	8e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-11
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-09
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	9e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	9e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-06
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-04
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-04
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	7e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.001
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	0.001
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	0.003
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  175 bits (445), Expect = 4e-52
 Identities = 68/199 (34%), Positives = 107/199 (53%), Gaps = 10/199 (5%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           LG+G  G+VY A  +  G++VA+K  K   +  + +E+  EIEIL K++ P +V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
            D     LV+E+   G+L D+L  N   L+    +R+ LQ+ + +E LHS    IIHRD+
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN--GIIHRDL 118

Query: 179 KSANVLID-RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTPDNLSTKTD 236
           K  N+L+D  N   +L DFGL+     D    ++    GT  Y+ P   +     S K+D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI--VGTPAYMAPEVLLGKGYYSEKSD 176

Query: 237 VFSFGILLLEIISCRKAID 255
           ++S G++L E+   +  I 
Sbjct: 177 IWSLGVILYELPELKDLIR 195

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  160 bits (407), Expect = 7e-46
 Identities = 81/277 (29%), Positives = 130/277 (46%), Gaps = 40/277 (14%)

Query: 61  KLLGKGSHGSVYKAVLRGR------QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           K LG+G+ G VYK  L+G+      +VAVK  K   +++  +E   E  I+ K+  P +V
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            LLG   + +   +V+E+M  G L   L  N   L+    +  ALQ+A+ +E L S+   
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK--N 122

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP------CYV 226
            IHRD+ + N L+  N   ++ DFGL+ R   D+  +R       I ++ P       + 
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLS-RDLYDDDYYRKRGGKLPIRWMAPESLKEGKF- 180

Query: 227 TPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA--APLIKKGKILSVFDPRI 284
                ++K+DV+SFG+LL EI +       G  P   +        +K G  L       
Sbjct: 181 -----TSKSDVWSFGVLLWEIFTL------GEQPYPGMSNEEVLEYLKNGYRLP------ 223

Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
            PP  P    +L  + ++C     E RP+  E+V+ L
Sbjct: 224 QPPNCP---PELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  156 bits (397), Expect = 2e-44
 Identities = 83/278 (29%), Positives = 135/278 (48%), Gaps = 41/278 (14%)

Query: 61  KLLGKGSHGSVYKAVLRGR------QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           K LG+G+ G VYK  L+G+      +VAVK  K   +++  +E   E  I+ K+  P +V
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMP 171
            LLG   + +  ++V+E+M  G L D L  N  + L+    +  ALQ+A+ +E L S+  
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK-- 122

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP------CY 225
             IHRD+ + N L+  N   ++ DFGL+ R   D+  ++       I ++ P       +
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLS-RDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181

Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA--APLIKKGKILSVFDPR 283
                 ++K+DV+SFG+LL EI +       G  P   +  A     +KKG  L      
Sbjct: 182 ------TSKSDVWSFGVLLWEIFTL------GEEPYPGMSNAEVLEYLKKGYRLP----- 224

Query: 284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
             PP  P    +L  + ++C     E RP+  E+V+ L
Sbjct: 225 -KPPNCP---PELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  155 bits (394), Expect = 5e-44
 Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 49/279 (17%)

Query: 61  KLLGKGSHGSVYKAVLRGR------QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           K LG+G+ G VYK  L+G       +VAVK  K   ++E  +E   E  I+ K+  P +V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            LLG     +   +V E+M  G L D L  +   L     +++ALQ+AK +E L S+   
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK--N 122

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPP-----AGTIGYLDPCYVT 227
            +HRD+ + N L+  N   ++ DFGL+          R             G L   ++ 
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLS----------RDIYEDDYYRKRGGGKLPIKWMA 172

Query: 228 PDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA--APLIKKGKILSVF 280
           P++L     ++K+DV+SFG+LL EI +       G  P   +       L++ G      
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTL------GEQPYPGMSNEEVLELLEDGY----- 221

Query: 281 DPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
             R+P P++ P    +L  + ++C     E RP+  E+V
Sbjct: 222 --RLPRPENCP---DELYELMLQCWAYDPEDRPTFSELV 255

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  154 bits (391), Expect = 1e-43
 Identities = 82/268 (30%), Positives = 129/268 (48%), Gaps = 19/268 (7%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVK---KPSKNQEISQEVDNEIEILSKIHSPRL 111
           +   + LG GS G+VYKA  +  G+ VAVK   K S+  +  Q    EI IL ++  P +
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V L+    D     LV+E+   G L+D L S   PL+     ++ALQ+ + +E LHS   
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLHSN-- 117

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTPDN 230
            IIHRD+K  N+L+D N   ++ DFGLA +    +     T   GT  Y+ P   +  + 
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGNG 175

Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP 290
              K DV+S G++L E+++       G  P S  +    L    +IL         PK  
Sbjct: 176 YGPKVDVWSLGVILYELLT-------GKPPFSGENILDQLQLIRRILG-PPLEFDEPKWS 227

Query: 291 IVRKQLAVIAVRCVRSCRERRPSMKEIV 318
              ++   +  +C+     +RP+ +EI+
Sbjct: 228 SGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  151 bits (385), Expect = 8e-43
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 12/200 (6%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE--VDNEIEILSKIHSPRLV 112
           +   + LG+GS G VY A  +  G+ VA+K   K +       +  EI+IL K+  P +V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMP 171
            L     D     LV+E+   G L+D+L    R   +  R      Q+  A+E LHS+  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFY--LRQILSALEYLHSKG- 117

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            I+HRD+K  N+L+D + + +L DFGLA +          T   GT  Y+ P  +     
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYMAPEVLLGKGY 173

Query: 232 STKTDVFSFGILLLEIISCR 251
               D++S G++L E+++ +
Sbjct: 174 GKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  143 bits (362), Expect = 2e-39
 Identities = 77/279 (27%), Positives = 133/279 (47%), Gaps = 34/279 (12%)

Query: 61  KLLGKGSHGSVYKAVLRG-----RQVAVKKPSKNQEISQEVD--NEIEILSKIHSPRLVN 113
           K LG+G+ G VYK  L+G      +VAVK   ++    +  D   E  ++ K+  P +V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP--------LNWGRRIRLALQVAKAVEI 165
           LLG   + +   LV+E+M  G L D L  +           L+    +  A+Q+AK +E 
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           L S+    +HRD+ + N L+  +   ++ DFGL+     D++  + T     I ++ P  
Sbjct: 121 LASK--KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178

Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLIKKGKILSVFDPR 283
           +     ++K+DV+SFG+LL EI +       G +P P +  +     ++KG        R
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTL------GATPYPGLSNEEVLEYLRKGY-------R 225

Query: 284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT 322
           +P P+      +L  + + C +   E RP+  E+V+ L 
Sbjct: 226 LPKPEY--CPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  132 bits (335), Expect = 2e-35
 Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 23/232 (9%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           +LLG+GS GSVY A+ +  G  +AVK       ++E  + ++ EI ILS +  P +V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 116 GF--SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           G     +     + +E++S G+L  +L      L      +   Q+ + +  LHS    I
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPVIRKYTRQILEGLAYLHSNG--I 122

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDIK AN+L+D +   +L DFG A R G       +    GT  ++ P  +  +    
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGR 182

Query: 234 KTDVFSFGILLLEIISCRK-------------AIDIGFSPPSIVDWAAPLIK 272
             D++S G  ++E+ + +               I     PP I +  +   K
Sbjct: 183 AADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  128 bits (325), Expect = 3e-34
 Identities = 69/194 (35%), Positives = 109/194 (56%), Gaps = 10/194 (5%)

Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVN 113
           F   + +GKG  G VYKA     G++VA+K    +++E  +++ NEI+IL K   P +V 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 114 LLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
             G S   KD L +V+EF S G+L D+L S N+ L   +   +  ++ K +E LHS    
Sbjct: 62  YYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG-- 118

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           IIHRDIK+AN+L+  +   +L DFGL+ +  + + + R+T   GT  ++ P  +      
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQ--LSDTKARNT-MVGTPYWMAPEVINGKPYD 175

Query: 233 TKTDVFSFGILLLE 246
            K D++S GI  +E
Sbjct: 176 YKADIWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  113 bits (285), Expect = 9e-29
 Identities = 62/191 (32%), Positives = 95/191 (49%), Gaps = 12/191 (6%)

Query: 62  LLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
            +GKG  G V     RG++VAVK    +   +Q    E  +++ +  P LV LLG     
Sbjct: 13  TIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72

Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGR-RIRLALQVAKAVEILHSEMPPIIHRDIKS 180
               +V E+M+ G+L D L S  R +     ++  AL V + +E L  +    +HRD+ +
Sbjct: 73  NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK--NFVHRDLAA 130

Query: 181 ANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVF 238
            NVL+  +  A++ DFGLA     G D+ +         + +  P  +     STK+DV+
Sbjct: 131 RNVLVSEDLVAKVSDFGLAKEASQGQDSGKL-------PVKWTAPEALREKKFSTKSDVW 183

Query: 239 SFGILLLEIIS 249
           SFGILL EI S
Sbjct: 184 SFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  111 bits (281), Expect = 5e-28
 Identities = 67/286 (23%), Positives = 123/286 (43%), Gaps = 56/286 (19%)

Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           +   K +GKGS G VY       G+   +K+    + +++  ++  NE++IL K++ P +
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 112 VNLLGFSNDS---KDRLLVV-EFMSNGTLYDVLHS---NNRP------LNWGRRIRLALQ 158
           +       +S   K +L +V E+   G L   +       +P      L+W       +Q
Sbjct: 62  IKY----YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW------FVQ 111

Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTI 218
           +  A++ LHS    I+HRDIK  N+ +  N   +LGDFG++ +          T     +
Sbjct: 112 LCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGIS-KVLSSTVDLAKT----VV 164

Query: 219 GYLDPCYVTP-----DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK 273
           G   P Y++P        + K+D++S G +L E+ + +   + G +   +          
Sbjct: 165 G--TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE-GENLLELAL-------- 213

Query: 274 GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
            KIL        PP       +L  +    ++   E RPS+ +I+ 
Sbjct: 214 -KILK----GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 9e-28
 Identities = 52/195 (26%), Positives = 98/195 (50%), Gaps = 10/195 (5%)

Query: 62  LLGKGSHGSVYKAV--LRGRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLG 116
           L+G+G+ G VYK +    G  VA+K+ S     +E  + +  EI++L  +  P +V  +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
               S    +++E+  NG+L  ++     P           QV + +  LH +   +IHR
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQ--GVIHR 123

Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTD 236
           DIK+AN+L  ++   +L DFG+A +  +++         GT  ++ P  +     ST +D
Sbjct: 124 DIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPEVIEMSGASTASD 181

Query: 237 VFSFGILLLEIISCR 251
           ++S G  ++E+++  
Sbjct: 182 IWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  106 bits (267), Expect = 4e-26
 Identities = 72/269 (26%), Positives = 121/269 (44%), Gaps = 36/269 (13%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           K+LG+GS G VYK   +  G+  A+KK       +   Q +  E++ L    SP +V   
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ-LLRELKTLRSCESPYVVKCY 65

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI--RLALQVAKAVEILHSEMPPI 173
           G      +  +V+E+M  G+L D+L            +   +A Q+ K ++ LH++   I
Sbjct: 66  GAFYKEGEISIVLEYMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKRH-I 121

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFR-FRSTPPAGTIGYLDPCYVTPDN 230
           IHRDIK +N+LI+     ++ DFG++  L   +D    F      GT+ Y+ P  +  ++
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-----VGTVTYMSPERIQGES 176

Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIG---FSPPSIVDWAAPLIKKGKILSVFDPRIPPP 287
            S   D++S G+ LLE         +G   F PP    +   +     I     P    P
Sbjct: 177 YSYAADIWSLGLTLLECA-------LGKFPFLPPGQPSFFELMQ---AI--CDGPPPSLP 224

Query: 288 KDPIVRKQLAVIAVRCVRSCRERRPSMKE 316
            +    +    I+  C++   ++RPS  E
Sbjct: 225 AEEFSPEFRDFIS-ACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  106 bits (268), Expect = 5e-26
 Identities = 56/188 (29%), Positives = 102/188 (54%), Gaps = 6/188 (3%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND 120
           +G+G+ G VYKA  R  G++VA+KK    ++  + + NEI I+     P +V+       
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86

Query: 121 SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
             +  +V+E+M  G+L D++  N   +N  +   +  +V + +E LHS+   +IHRDIKS
Sbjct: 87  GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ--NVIHRDIKS 144

Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
            N+L+ ++ + +L DFG A +   +  +  S    GT  ++ P  +   +   K D++S 
Sbjct: 145 DNILLSKDGSVKLADFGFAAQLTKEKSKRNSV--VGTPYWMAPEVIKRKDYGPKVDIWSL 202

Query: 241 GILLLEII 248
           GI+ +E+ 
Sbjct: 203 GIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 2e-25
 Identities = 80/274 (29%), Positives = 129/274 (47%), Gaps = 39/274 (14%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEV---DNEIEILSKIHSPRLV 112
           KLLG+G+ G VY    V  GR++AVK+      + E  +EV   + EI++L  +   R+V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
              G   D +   + +E+M  G++ D L +    L      +   Q+ + VE LHS M  
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNM-- 124

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST---PPAGTIGYLDPCYVTPD 229
           I+HRDIK AN+L D   N +LGDFG + R  +       T      GT  ++ P  ++ +
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKR--LQTICSSGTGMKSVTGTPYWMSPEVISGE 182

Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA-----APLIKKGKILSVFDPRI 284
               K DV+S G  ++E+++ +        PP    WA     A + K     +  +P++
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEK--------PP----WAEFEAMAAIFKIATQPT--NPQL 228

Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           P    P  R  L    V   +    +RPS +E++
Sbjct: 229 PSHVSPDARNFLRRTFVENAK----KRPSAEELL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  103 bits (258), Expect = 8e-25
 Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 28/283 (9%)

Query: 61  KLLGKGSHGSVYKAVL------RGRQVAVKKPSKNQEISQEVD--NEIEILSKIHSPRLV 112
           K LG+G  G V            G QVAVK  + + E     D   EIEIL  +    +V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 113 NLLGFSNDSKDR--LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
              G       R   L++E++ +G+L D L  +   +N  R +  + Q+ K ++ L S+ 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
              IHRD+ + N+L++     ++ DFGLA  L    D +  +  P    I +  P  +  
Sbjct: 130 --YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKE-PGESPIFWYAPECLRT 186

Query: 229 DNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVF------D 281
              S+ +DV+SFG+ L E+ +    +     SPP+       + +   I++         
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPS----QSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242

Query: 282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            R+P P  P    ++  +   C  +  + RPS  +++  +  L
Sbjct: 243 ERLPRP--PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  105 bits (261), Expect = 1e-24
 Identities = 74/279 (26%), Positives = 126/279 (45%), Gaps = 20/279 (7%)

Query: 56  GFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQE----VDNEIEILSKI-HSPR 110
            +   + LG+GS G VY A  R + VA+K  +K  E   +       EI+IL+ + H P 
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSN--NRPLNWGRRIRLALQVAKAVEILHS 168
           +V L  F  D     LV+E++  G+L D+L       PL+    + +  Q+  A+E LHS
Sbjct: 60  IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119

Query: 169 EMPPIIHRDIKSANVLIDRN-FNARLGDFGLA--LRCGVDNF--RFRSTPPAGTIGYLDP 223
           +   IIHRDIK  N+L+DR+    +L DFGLA  L             +   GT GY+ P
Sbjct: 120 K--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 224 CYVTPDNL---STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF 280
             +   +L   S+ +D++S GI L E+++     +   +  +       +++        
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP--TPSL 235

Query: 281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
              + P    ++ K  + +  + +    + R S    + 
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  100 bits (251), Expect = 6e-24
 Identities = 65/194 (33%), Positives = 105/194 (54%), Gaps = 9/194 (4%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           F   + LG+GS+GSVYKA+ +  G+ VA+K     +++ QE+  EI IL +  SP +V  
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYIVKY 63

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL-QVAKAVEILHSEMPPI 173
            G    + D  +V+E+   G++ D++   N+ L     I   L Q  K +E LHS     
Sbjct: 64  YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT-EEEIAAILYQTLKGLEYLHSNK--K 120

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           IHRDIK+ N+L++    A+L DFG++ +   D    R+T   GT  ++ P  +     + 
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQL-TDTMAKRNT-VIGTPFWMAPEVIQEIGYNN 178

Query: 234 KTDVFSFGILLLEI 247
           K D++S GI  +E+
Sbjct: 179 KADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 98.3 bits (245), Expect = 3e-23
 Identities = 79/264 (29%), Positives = 122/264 (46%), Gaps = 28/264 (10%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F     +GKGS G V+K V +   R  A+K+      N+   +E  +E  +L+K+ S  +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEM 170
           +       D     +V+E+  NG L+ +L     RPL   +  R  +Q+   +  LHS+ 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK- 120

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP--CYVTP 228
             I+HRDIKS N+ +D   N ++GD G+A     DN  F +T   GT  YL P  C   P
Sbjct: 121 -KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANT-IVGTPYYLSPELCEDKP 177

Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
            N   K+DV++ G++L E  + +   D         +    LI K  I  VF P +    
Sbjct: 178 YN--EKSDVWALGVVLYECCTGKHPFD--------ANNQGALILK-IIRGVFPP-VSQMY 225

Query: 289 DPIVRKQLAVIAVRCVRSCRERRP 312
                 QLA +  +C+     +RP
Sbjct: 226 SQ----QLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 97.2 bits (242), Expect = 1e-22
 Identities = 79/265 (29%), Positives = 118/265 (44%), Gaps = 33/265 (12%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND 120
           LG G +G VY+ V +     VAVK   ++    +E   E  ++ +I  P LV LLG    
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 121 SKDRLLVVEFMSNGTLYDVLHSNNRP-LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
                ++ EFM+ G L D L   NR  +N    + +A Q++ A+E L  E    IHRD+ 
Sbjct: 74  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKNFIHRDLA 131

Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTPDNLSTKTD 236
           + N L+  N   ++ DFGL+     D +    T  AG    I +  P  +  +  S K+D
Sbjct: 132 ARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKFSIKSD 187

Query: 237 VFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQL 296
           V++FG+LL EI +       G SP   +D +       K   +  P   PPK        
Sbjct: 188 VWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKGYRMERPEGCPPK-------- 233

Query: 297 AVIAVRCVRSCRE----RRPSMKEI 317
                  +R+C +     RPS  EI
Sbjct: 234 ---VYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 48/142 (33%), Positives = 70/142 (49%), Gaps = 8/142 (5%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G+G+HG V+KA  R  G  VA+KK         I  +   EI+ L     P +V LL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
                  +LV+E+M    L +VL    RPL   +       + K V  +H+    I+HRD
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN--GIMHRD 124

Query: 178 IKSANVLIDRNFNARLGDFGLA 199
           +K AN+LI  +   ++ DFGLA
Sbjct: 125 LKPANLLISADGVLKIADFGLA 146

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 94.7 bits (236), Expect = 6e-22
 Identities = 75/263 (28%), Positives = 125/263 (47%), Gaps = 32/263 (12%)

Query: 60  QKLLGKGSHGSVYKAVLRGR-QVAVK--KPSKNQEISQE-VDNEIEILSKIHSPRLVNLL 115
           ++ LG G  G V+     G  +VAVK  KP     +S E    E +I+ K+   +LV L 
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLY 67

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPII 174
              ++ +   +V E+MS G+L D L S   + L   + + +A Q+A+ +  L S     I
Sbjct: 68  AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YI 125

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTPDNL 231
           HRD+ + N+L+  N   ++ DFGLA     D +    T   G    I +  P        
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEY----TAREGAKFPIKWTAPEAANYGRF 181

Query: 232 STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDP 290
           + K+DV+SFGILL EI++  +    G +   +++     +++G        R+P PP  P
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLE----QVERGY-------RMPRPPNCP 230

Query: 291 IVRKQLAVIAVRCVRSCRERRPS 313
              ++L  + ++C     E RP+
Sbjct: 231 ---EELYDLMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 63/195 (32%), Positives = 100/195 (51%), Gaps = 15/195 (7%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS-QEVD---NEIEILSKIHSPRLVNLLG 116
           LGKGS G V     +  G+  A+K   K + I  +EV+    E  ILS+I+ P +V L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 117 FSNDSKDRL-LVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPII 174
           ++  ++++L LV+E+   G L+  L    R      R    A ++  A+E LHS    II
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFY--AAEIVLALEYLHSL--GII 115

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           +RD+K  N+L+D + + +L DFGLA    + +   R+    GT  YL P  +        
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKE--LSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173

Query: 235 TDVFSFGILLLEIIS 249
            D +S G+LL E+++
Sbjct: 174 VDWWSLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 92.4 bits (229), Expect = 4e-21
 Identities = 67/194 (34%), Positives = 99/194 (51%), Gaps = 14/194 (7%)

Query: 60  QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
            + +GKG  G V     RG +VAVK   KN   +Q    E  +++++    LV LLG   
Sbjct: 11  LQTIGKGEFGDVMLGDYRGNKVAVK-CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 120 DSKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGRR-IRLALQVAKAVEILHSEMPPIIHRD 177
           + K  L +V E+M+ G+L D L S  R +  G   ++ +L V +A+E L  E    +HRD
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EANNFVHRD 127

Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT--IGYLDPCYVTPDNLSTKT 235
           + + NVL+  +  A++ DFGL            ST   G   + +  P  +     STK+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREKKFSTKS 180

Query: 236 DVFSFGILLLEIIS 249
           DV+SFGILL EI S
Sbjct: 181 DVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.9 bits (229), Expect = 7e-21
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 20/201 (9%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F+  + +GKGS G VYKA+ +   + VA+K         EI +++  EI+ LS+  SP +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI-EDIQQEIQFLSQCRSPYI 61

Query: 112 VNLLG-FSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
               G F   SK  L +++E+   G+  D+L      L+      +  +V   +E LH E
Sbjct: 62  TKYYGSFLKGSK--LWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE 117

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
               IHRDIK+AN+L+    + +L DFG++  L         R+T   GT  ++ P  + 
Sbjct: 118 GK--IHRDIKAANILLSEEGDVKLADFGVSGQLT---STMSKRNT-FVGTPFWMAPEVIK 171

Query: 228 PDNLSTKTDVFSFGILLLEII 248
                 K D++S GI  +E+ 
Sbjct: 172 QSGYDEKADIWSLGITAIELA 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 92.2 bits (230), Expect = 7e-21
 Identities = 69/212 (32%), Positives = 101/212 (47%), Gaps = 33/212 (15%)

Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQ-EVD---NEIEILSKIHSPRLVNL 114
           K LG GS G V     +G     A+K  SK + +   +V+   NE  IL  I  P LVNL
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPI 173
            G   D  +  LV+E++  G L+  L  + R P    R    A QV  A+E LHS    I
Sbjct: 67  YGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVAR--FYAAQVVLALEYLHSL--DI 122

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           ++RD+K  N+L+D +   ++ DFG A R  V     R+    GT     P Y+ P+ + +
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAKR--VKG---RTYTLCGT-----PEYLAPEIILS 172

Query: 234 K-----TDVFSFGILLLEIISCRKAIDIGFSP 260
           K      D ++ GIL+ E++        G+ P
Sbjct: 173 KGYGKAVDWWALGILIYEML-------AGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 91.1 bits (226), Expect = 1e-20
 Identities = 74/279 (26%), Positives = 126/279 (45%), Gaps = 43/279 (15%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKK-------PSKNQEISQEVDNEIEILSKIHSPRL 111
           + LG G+  S Y+A  V  G  +AVK+        S+ +E+ + +  EI ++++++ P +
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           + +LG + +     L VE+M+ G++  +L            I    Q+ + +  LH    
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKEAVIINYTEQLLRGLSYLHENQ- 123

Query: 172 PIIHRDIKSANVLIDRN-FNARLGDFGLALR-----CGVDNFRFRSTPPAGTIGYLDPCY 225
            IIHRD+K AN+LID      R+ DFG A R      G   F+ +     GTI ++ P  
Sbjct: 124 -IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL---GTIAFMAPEV 179

Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG-----KILSVF 280
           +  +      DV+S G +++E+ + +        PP    W A           KI S  
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAK--------PP----WNAEKHSNHLALIFKIASAT 227

Query: 281 D-PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
             P IP    P +R     + +RC+    E RP  +E++
Sbjct: 228 TAPSIPEHLSPGLRD----VTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 69/282 (24%), Positives = 129/282 (45%), Gaps = 43/282 (15%)

Query: 63  LGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEISQ--EVDNEIEILSKIHSPRLVN 113
           LG+GS G VY+ + +G        +VA+K  ++N  + +  E  NE  ++ + +   +V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHS---NNR------PLNWGRRIRLALQVAKAVE 164
           LLG  +  +  L+V+E M+ G L   L S            P    + I++A ++A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            L ++    +HRD+ + N ++  +   ++GDFG+  R   D +        G  G L   
Sbjct: 134 YLAAK--KFVHRDLAARNCMVAEDLTVKIGDFGMT-R---DIYETDYYRKGGK-GLLPVR 186

Query: 225 YVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV 279
           ++ P++L     +TK+DV+SFG++L E+ +  +    G S   ++      +  G  L  
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK----FVIDGGHL-- 240

Query: 280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
                  P++     +L  +   C +   + RP+  EIV  L
Sbjct: 241 -----DLPENCPD--KLLELMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 90.2 bits (224), Expect = 4e-20
 Identities = 85/297 (28%), Positives = 136/297 (45%), Gaps = 62/297 (20%)

Query: 61  KLLGKGSHGSVYKAVLRG-------RQVAVKKPSKN---QEISQEVDNEIEILSKI-HSP 109
           K LG+G+ G V KA   G         VAVK    +   +++S  V +E+E++  I    
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLV-SEMEMMKMIGKHK 76

Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP----------------LNWGRRI 153
            ++NLLG         +VVE+ ++G L D L +  RP                L     +
Sbjct: 77  NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLTQKDLV 135

Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRS 211
             A QVA+ +E L S+    IHRD+ + NVL+  +   ++ DFGLA  +   +D +R   
Sbjct: 136 SFAYQVARGMEFLASK--KCIHRDLAARNVLVTEDHVMKIADFGLARDIHH-IDYYRKT- 191

Query: 212 TPPAGTIGYLDPCYVTPDNLS-----TKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-V 264
                T G L   ++ P+ L       ++DV+SFG+LL EI +      +G SP P I V
Sbjct: 192 -----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT------LGGSPYPGIPV 240

Query: 265 DWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           +    L+K+G        R+  P      ++L  +   C      +RP+ K++V+ L
Sbjct: 241 EELFKLLKEGY-------RMEKP--QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 89.4 bits (222), Expect = 5e-20
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 18/196 (9%)

Query: 63  LGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVD-----NEIEILSKIHSPRLVNLL-G 116
           LG G+ G VYKA  + ++  +   +K  +I  E +      EI+ILS+   P +V L   
Sbjct: 13  LGDGAFGKVYKA--QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
           +  ++K  +L+ EF   G L  ++    R L   +   +  Q+ +A+  LHS    +IHR
Sbjct: 71  YFYENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHR 127

Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP----CYVTPDN-L 231
           D+K+ N+L+  + + +L DFG++ +      + R T   GT  ++ P    C    DN  
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKRDT-FIGTPYWMAPEVVACETFKDNPY 185

Query: 232 STKTDVFSFGILLLEI 247
             K D++S GI L+E+
Sbjct: 186 DYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 88.9 bits (220), Expect = 6e-20
 Identities = 73/262 (27%), Positives = 129/262 (49%), Gaps = 27/262 (10%)

Query: 63  LGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK 122
           +G+G  G+V +    G++VAVK   K    +Q    E  +++K+H   LV LLG      
Sbjct: 14  IGEGEFGAVLQGEYTGQKVAVKN-IKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL-HN 71

Query: 123 DRLLVVEFMSNGTLYDVLHSNNRPL-NWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSA 181
              +V+E MS G L + L +  R L +  + ++ +L VA+ +E L S+   ++HRD+ + 
Sbjct: 72  GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK--KLVHRDLAAR 129

Query: 182 NVLIDRNFNARLGDFGLAL--RCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           N+L+  +  A++ DFGLA     GVDN +         + +  P  +     S+K+DV+S
Sbjct: 130 NILVSEDGVAKVSDFGLARVGSMGVDNSKL-------PVKWTAPEALKHKKFSSKSDVWS 182

Query: 240 FGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVI 299
           +G+LL E+ S  +A      P   +      ++KG        R+ PP+       + V+
Sbjct: 183 YGVLLWEVFSYGRAP----YPKMSLKEVKECVEKGY-------RMEPPEG--CPADVYVL 229

Query: 300 AVRCVRSCRERRPSMKEIVDWL 321
              C  +  ++RPS  ++ + L
Sbjct: 230 MTSCWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 89.4 bits (222), Expect = 6e-20
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 19/214 (8%)

Query: 61  KLLGKGSHGSVYKAVL------RGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           + LGKG+ GSV            G  VAVKK   S  + + ++ + EIEIL  +    +V
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL-RDFEREIEILKSLQHDNIV 68

Query: 113 NLLG--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
              G  +S   ++  LV+E++  G+L D L  +   L+  + +  A Q+ K +E L S+ 
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
              +HRD+ + N+L++     ++GDFGL   L    + ++ R  P    I +  P  +T 
Sbjct: 129 --YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVRE-PGESPIFWYAPESLTE 185

Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS 262
              S  +DV+SFG++L E+ +     D   SPP+
Sbjct: 186 SKFSVASDVWSFGVVLYELFT---YSDKSCSPPA 216

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 88.7 bits (221), Expect = 1e-19
 Identities = 47/149 (31%), Positives = 76/149 (51%), Gaps = 10/149 (6%)

Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           + + + LG+G++G VYKA     G  VA+KK    ++ + I      EI +L ++  P +
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIR-LALQVAKAVEILHSEM 170
           V LL   +  +   LV E+     L   L     PL+    I+ +  Q+ + +   HS  
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS-PNLIKSIMYQLLRGLAYCHSHR 118

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLA 199
             I+HRD+K  N+LI+R+   +L DFGLA
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLA 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 60/195 (30%), Positives = 93/195 (47%), Gaps = 11/195 (5%)

Query: 63  LGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G+G++G VYKA   L G  VA+KK     +++ I +    EI++L +++ P ++ LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
                D  LV EFM    LY ++    R L          Q+ + +   HS    I+HRD
Sbjct: 67  FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRD 123

Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTPDNLSTKTD 236
           +K  N+LI+     +L DFGLA   G     +  T    T  Y  P   +     ST  D
Sbjct: 124 LKPENLLINTEGVLKLADFGLARSFGSPVRPY--THYVVTRWYRAPELLLGDKGYSTPVD 181

Query: 237 VFSFGILLLEIISCR 251
           ++S G +  E++S R
Sbjct: 182 IWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 72/263 (27%), Positives = 117/263 (44%), Gaps = 17/263 (6%)

Query: 61  KLLGKGSHGSVYKAVLRG-RQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           K LG G  G V+    RG   VA+K   +      +   E +++ K+  P LV L G   
Sbjct: 10  KELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
             +   +V E+M+NG L + L      L     + +   V +A+E L  E    IHRD+ 
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL--ESNGFIHRDLA 127

Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           + N L+  +   ++ DFGLA R  +D+    S      + +  P        S+K+DV+S
Sbjct: 128 ARNCLVGEDNVVKVSDFGLA-RYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186

Query: 240 FGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVI 299
           FG+L+ E+ S  K     FS   +V+     +  G  L  + P++ P +       +  I
Sbjct: 187 FGVLMWEVFSEGKMPYERFSNSEVVE----SVSAGYRL--YRPKLAPTE-------VYTI 233

Query: 300 AVRCVRSCRERRPSMKEIVDWLT 322
              C     E RP+ K+++  LT
Sbjct: 234 MYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 63/199 (31%), Positives = 96/199 (48%), Gaps = 18/199 (9%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLG 116
           LGKG  G V    ++  G+  A KK  K     ++  Q   NE +IL K+ S  +V+L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 117 FSNDSKDRL-LVVEFMSNGTL-YDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
           ++ ++KD L LV+  M+ G L Y + +         R I  A Q+   +E LH     I+
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IV 117

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPP--AGTIGYLDPCYVTPDNLS 232
           +RD+K  NVL+D + N R+ D GLA+       +        AGT GY+ P  +  +   
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAV-----ELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172

Query: 233 TKTDVFSFGILLLEIISCR 251
              D F+ G  L E+I+ R
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 27/209 (12%)

Query: 61  KLLGKGSHGSVYKAV--LRGRQVAVK----KPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
             +G G+ G VY AV    G  +AVK    + +   +  +E+ +E+++L  +  P LV  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKY 64

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVL-HSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
            G     +   + +E+ S GTL ++L H      +  R     LQ+ + +  LHS    I
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV--YTLQLLEGLAYLHSHG--I 120

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPP-------AGTIGYLDPCYV 226
           +HRDIK AN+ +D N   +LGDFG A++         +T         AGT  Y+ P  +
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKN-----NTTTMGEEVQSLAGTPAYMAPEVI 175

Query: 227 TPDNLSTK---TDVFSFGILLLEIISCRK 252
           T           D++S G ++LE+ + ++
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 23/201 (11%)

Query: 63  LGKGSHGSVYKA--VLRGRQVAVKKP--SKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           +G G+   VY A  +    +VA+K+    K Q    E+  E++ +S+ + P +V     S
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT-S 67

Query: 119 NDSKDRL-LVVEFMSNGTLYDVL-HSNNRPLNWGRRIRLAL-QVAKAVEILHSEMPPIIH 175
               D L LV+ ++S G+L D++  S  R       I   L +V K +E LHS     IH
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN--GQIH 125

Query: 176 RDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           RDIK+ N+L+  + + ++ DFG++  L  G D  R       GT     PC++ P+ +  
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT-----PCWMAPEVMEQ 180

Query: 234 ------KTDVFSFGILLLEII 248
                 K D++SFGI  +E+ 
Sbjct: 181 VHGYDFKADIWSFGITAIELA 201

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 74/286 (25%), Positives = 133/286 (46%), Gaps = 43/286 (15%)

Query: 57  FSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIEILSKIH 107
           F E+  LG+G+ G VYK  L G         VA+K  K +   ++ QE   E E++S + 
Sbjct: 9   FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66

Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN---------------RPLNWGRR 152
            P +V LLG     +   ++ E++++G L++ L  N+                 L+    
Sbjct: 67  HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA-LRCGVDNFRFRS 211
           + +A+Q+A  +E L S     +HRD+ + N L+      ++ DFGL+      D +R +S
Sbjct: 127 LHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184

Query: 212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI 271
                 + ++ P  +     +T++D++SFG++L EI S       GFS   +++    +I
Sbjct: 185 KSLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE----MI 239

Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
           +  ++L       P P+D   R  +  + + C      RRP  K+I
Sbjct: 240 RSRQLL-------PCPEDCPAR--VYALMIECWNEIPARRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 86.7 bits (215), Expect = 3e-19
 Identities = 75/276 (27%), Positives = 126/276 (45%), Gaps = 40/276 (14%)

Query: 56  GFSEQKLLGKGSHGSVYKAVLR---GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSP 109
            F   K LGKGS+GSVYK V R    +  A+K+    S +Q+  ++  NEI IL+ ++ P
Sbjct: 1   DFKVLKKLGKGSYGSVYK-VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHP 59

Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVL---HSNNRPLNWGRRIRLALQVAKAVEIL 166
            +++      D     +V+E+   G L   +       + +      R+ +Q+ + ++ L
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
           H +   I+HRD+KSAN+L+  N   ++GD G++    V       T     IG   P Y+
Sbjct: 120 HEQ--KILHRDLKSANILLVANDLVKIGDLGIS---KVLKKNMAKT----QIG--TPHYM 168

Query: 227 TPD-----NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD 281
            P+       S K+D++S G LL E+ +        F+PP        L  + K+     
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMAT--------FAPPFEARSMQDL--RYKVQRGKY 218

Query: 282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
           P IP    PI  + L       ++   + RP+  +I
Sbjct: 219 PPIP----PIYSQDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 86.7 bits (215), Expect = 4e-19
 Identities = 76/268 (28%), Positives = 119/268 (44%), Gaps = 29/268 (10%)

Query: 60  QKLLGKGSHGSVYKAVLRGR-QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
            + LG G  G V++ +      VAVK  KP       ++   E +I+ K+  P+L+ L  
Sbjct: 11  LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP--KDFLAEAQIMKKLRHPKLIQLYA 68

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
                +   +V E M  G+L + L     R L   + I +A QVA  +  L  E    IH
Sbjct: 69  VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL--EAQNYIH 126

Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTPDNLS 232
           RD+ + NVL+  N   ++ DFGLA     D +  R     G    I +  P     +  S
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFS 182

Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV 292
            K+DV+SFGILL EI++  +    G +   ++      + +G        R+P P  P  
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ----QVDQGY-------RMPCP--PGC 229

Query: 293 RKQLAVIAVRCVRSCRERRPSMKEIVDW 320
            K+L  I + C +   + RP+  E + W
Sbjct: 230 PKELYDIMLDCWKEDPDDRPTF-ETLQW 256

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 63/264 (23%), Positives = 114/264 (43%), Gaps = 51/264 (19%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQ----EVDNEIEILSKI-HSPRLVN 113
           K++G+GS  +V  A  +   ++ A+K   K Q I +     V  E E+L+++   P ++ 
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 114 LLG-FSNDSKDRL-LVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEM 170
           L   F ++    L  V+E+  NG L   +    +      R    A ++  A+E LHS+ 
Sbjct: 67  LYYTFQDEEN--LYFVLEYAPNGELLQYIRKYGSLDEKCTRFY--AAEILLALEYLHSK- 121

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLA----------LRCGVDNFRFRSTPPA----- 215
             IIHRD+K  N+L+D++ + ++ DFG A             G                 
Sbjct: 122 -GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 216 ---GTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCR-------------KAIDIGFS 259
              GT  Y+ P  +        +D+++ G ++ ++++ +             K + + +S
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240

Query: 260 -PPSIVDWAAPLIKKGKILSVFDP 282
            PP+    A  LI+K   L V DP
Sbjct: 241 FPPNFPPDAKDLIEK---LLVLDP 261

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 86.3 bits (214), Expect = 5e-19
 Identities = 71/265 (26%), Positives = 122/265 (46%), Gaps = 26/265 (9%)

Query: 57  FSEQKLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQ-EVDNEIEILSKIHSPRLVNL 114
           F+ ++ LG G  G V++ + + R +VA+K    +  + Q +   E++ L ++    L++L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
               +  +   ++ E M  G+L   L S   + L     I +A QVA+ +  L  +    
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--S 125

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGY--LDPCYVTPDNL 231
           IHRD+ + N+L+  +   ++ DFGLA R   ++           I Y    P   +    
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLA-RLIKEDV---YLSSDKKIPYKWTAPEAASHGTF 181

Query: 232 STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDP 290
           STK+DV+SFGILL E+ +  +    G +   + D     I  G        R+P P K P
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD----QITAGY-------RMPCPAKCP 230

Query: 291 IVRKQLAVIAVRCVRSCRERRPSMK 315
              +++  I + C  +  E RPS K
Sbjct: 231 ---QEIYKIMLECWAAEPEDRPSFK 252

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 73/292 (25%), Positives = 132/292 (45%), Gaps = 57/292 (19%)

Query: 60  QKLLGKGSHGSVYKAVLR--GRQ---VAVKKPSKNQEISQEVD--NEIEILSKIHSPRLV 112
           +K++G G  G V +  L+  G++   VA+K         Q +D   E  I+ +   P ++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            L G    S+  +++ E+M NG+L   L  N+     G+ + +   +A  ++ L SEM  
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL-SEM-N 126

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG--YLDPCYVTPDN 230
            +HRD+ + N+L++ N   ++ DFGL+ R  +++     T   G I   +  P  +    
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYTTKGGKIPIRWTAPEAIAYRK 184

Query: 231 LSTKTDVFSFGILLLEIIS-------------CRKAIDIGFSPPSIVDWAAPLIKKGKIL 277
            ++ +DV+SFGI++ E++S               KA++ G+                   
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY------------------- 225

Query: 278 SVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLV 328
                R+PPP D P    QL    + C +  R  RP+  +IV   + L K++
Sbjct: 226 -----RLPPPMDCPSALYQL---MLDCWQKDRNERPTFSQIV---STLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 86.3 bits (214), Expect = 6e-19
 Identities = 73/281 (25%), Positives = 135/281 (48%), Gaps = 38/281 (13%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQ----VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           K+LG G+ G+VYK V    G +    VA+K  +   + + ++E+ +E  +++ +  P +V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP-------LNWGRRIRLALQVAKAVEI 165
            LLG    S    L+ + M  G L D +  N++        LNW        Q+AK +  
Sbjct: 73  RLLGICL-SSQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCV------QIAKGMSY 124

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           L  E   ++HRD+ + NVL+    + ++ DFGLA    VD   + +      I ++    
Sbjct: 125 L--EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP 285
           +     + K+DV+S+G+ + E+++       G     I D    L++KG+       R+P
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD----LLEKGE-------RLP 231

Query: 286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
            P  PI    + ++ V+C     E RP+ KE+++  + +++
Sbjct: 232 QP--PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 86.1 bits (214), Expect = 7e-19
 Identities = 61/199 (30%), Positives = 91/199 (45%), Gaps = 26/199 (13%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQE--VDNEIEILSKIHSPRLVNLLG 116
           LG G  G V    ++   R  A+K   K    E  Q+  + +E EIL + + P +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
              D K   +++E+   G L+ +L        +  R  +A  V  A E LH+    II+R
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAFEYLHNR--GIIYR 117

Query: 177 DIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           D+K  N+L+D N   +L DFG A  L+ G   + F  TP           YV P+ +  K
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE----------YVAPEIILNK 167

Query: 235 -----TDVFSFGILLLEII 248
                 D +S GILL E++
Sbjct: 168 GYDFSVDYWSLGILLYELL 186

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 86.5 bits (215), Expect = 7e-19
 Identities = 63/206 (30%), Positives = 90/206 (43%), Gaps = 32/206 (15%)

Query: 61  KLLGKGSHGSVYKAV--LRGRQVAVKKPSKNQEISQEVDN-------EIEILSKIHSPRL 111
           K LG+G++  VYKA     GR VA+KK  K  E  +  D        EI++L ++  P +
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKK-IKLGERKEAKDGINFTALREIKLLQELKHPNI 64

Query: 112 VNLLG-FSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           + LL  F    K  + LV EFM    L  V+   +  L         L   + +E LHS 
Sbjct: 65  IGLLDVFG--HKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN 121

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP------ 223
              I+HRD+K  N+LI  +   +L DFGLA   G  N +   T    T  Y  P      
Sbjct: 122 W--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM--THQVVTRWYRAPELLFGA 177

Query: 224 -CYVTPDNLSTKTDVFSFGILLLEII 248
             Y          D++S G +  E++
Sbjct: 178 RHY------GVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 86.3 bits (213), Expect = 1e-18
 Identities = 79/284 (27%), Positives = 143/284 (50%), Gaps = 30/284 (10%)

Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVN 113
           ++  + +G+G+ G+V+ A  V  G++VA+K+ +  ++  +E + NEI ++ ++ +P +VN
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
            L       +  +V+E+++ G+L DV+      ++  +   +  +  +A+E LH+    +
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHANQ--V 136

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           IHRDIKS NVL+  + + +L DFG   +   +  + RST   GT  ++ P  VT      
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RST-MVGTPYWMAPEVVTRKAYGP 194

Query: 234 KTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK--DPI 291
           K D++S GI+ +E++           PP + +   PL     I +   P +  P+   PI
Sbjct: 195 KVDIWSLGIMAIEMVEGE--------PPYLNE--NPLRALYLIATNGTPELQNPEKLSPI 244

Query: 292 VRKQLAVIAVRCVRSCRERRPSMKEIVD-----WLTGLSKLVPL 330
            R  L     RC+    E+R S KE++          LS L PL
Sbjct: 245 FRDFLN----RCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPL 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 10/144 (6%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLG- 116
           +G+G++G VYKA  +  G  VA+KK     E          EI++L K+  P +V L   
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 117 -FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
             S       +V E+M +  L  +L S        +      Q+ + ++ LHS    I+H
Sbjct: 67  VTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN--GILH 123

Query: 176 RDIKSANVLIDRNFNARLGDFGLA 199
           RDIK +N+LI+ +   +L DFGLA
Sbjct: 124 RDIKGSNILINNDGVLKLADFGLA 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 54/188 (28%), Positives = 92/188 (48%), Gaps = 4/188 (2%)

Query: 63  LGKGSHGSVYKAV-LRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           +G G  G V+    L  R+VA+K   +     ++   E +++ K+  P+LV L G   + 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71

Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSA 181
               LV EFM +G L D L +     +    + + L V + +  L  E   +IHRD+ + 
Sbjct: 72  SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL--ESSNVIHRDLAAR 129

Query: 182 NVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFG 241
           N L+  N   ++ DFG+  R  +D+    ST     + +  P   +    S+K+DV+SFG
Sbjct: 130 NCLVGENQVVKVSDFGMT-RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFG 188

Query: 242 ILLLEIIS 249
           +L+ E+ S
Sbjct: 189 VLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 85/295 (28%), Positives = 125/295 (42%), Gaps = 63/295 (21%)

Query: 61  KLLGKGSHGSVYKAVLRGR-------QVAVKKPSKNQEISQEVD--NEIEILSKIHSPRL 111
           + LG G+ G VY+ + RGR       QVAVK   ++     E D   E  I+SK +   +
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSN----NRP--LNWGRRIRLALQVAKAVEI 165
           V L+G S +   R +++E M+ G L   L  N     RP  L     +  A  VAK  + 
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 166 LHSEMPPIIHRDIKSANVLI-----DRNFNARLGDFGLALRC-GVDNFR--------FRS 211
           L  E    IHRDI + N L+      R   A++ DFG+A        +R         + 
Sbjct: 132 L--EENHFIHRDIAARNCLLTCKGPGRV--AKIADFGMARDIYRASYYRKGGRAMLPIKW 187

Query: 212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSIVDWAAPL 270
            PP     +LD  +      ++KTDV+SFG+LL EI S      +G+ P P   +     
Sbjct: 188 MPPEA---FLDGIF------TSKTDVWSFGVLLWEIFS------LGYMPYPGRTNQEVME 232

Query: 271 IKKGKILSVFDPRIPPPK---DPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT 322
                       R+ PPK    P+ R     I   C +   E RP+   I++ + 
Sbjct: 233 ------FVTGGGRLDPPKGCPGPVYR-----IMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 19/201 (9%)

Query: 63  LGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSKIHSPRLVNLLG 116
           + KG++G V+  K    G   A+K   K   I      +V  E +ILS+  SP +V L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 117 FSNDSKDRL-LVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
           +S   K  L LV+E++  G L  +L +  +   +  R I +A ++  A+E LHS    II
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIA-EIVLALEYLHSN--GII 115

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA------GTIGYLDPCYVTP 228
           HRD+K  N+LID N + +L DFGL+    V      +          GT  Y+ P  +  
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Query: 229 DNLSTKTDVFSFGILLLEIIS 249
              S   D +S G +L E + 
Sbjct: 176 QGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 82/276 (29%), Positives = 128/276 (46%), Gaps = 42/276 (15%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPS---KNQEISQEVDN---EIEILSKIHSPRLV 112
           KLLG+G+ G VY       GR++AVK+     ++ E S+EV+    EI++L  +   R+V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 113 NLLGFSNDSKDRLLVV--EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
              G   D  +R L +  E M  G++ D L S    L      +   Q+ + V  LHS M
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNM 126

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCG---VDNFRFRSTPPAGTIGYLDPCYVT 227
             I+HRDIK AN+L D   N +LGDFG + R     +     +S    GT  ++ P  ++
Sbjct: 127 --IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV--TGTPYWMSPEVIS 182

Query: 228 PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA-----APLIKKGKILSVFDP 282
            +    K D++S G  ++E+++ +        PP    WA     A + K     +  +P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEK--------PP----WAEFEAMAAIFKIATQPT--NP 228

Query: 283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            +PP      R  L  I V       + RPS  E++
Sbjct: 229 VLPPHVSDHCRDFLKRIFVEA-----KLRPSADELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 18/202 (8%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDN---EIEILSKIHSPRLV 112
           KLLG+G+ G VY       GR++AVK+      +QE S+EV+    EI++L  +   R+V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 113 NLLGFSNDSKDRLL--VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
              G   D +++ L   VE+M  G++ D L +    L      R   Q+ + V  LHS M
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNM 126

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST---PPAGTIGYLDPCYVT 227
             I+HRDIK AN+L D   N +LGDFG + R  +       T      GT  ++ P  ++
Sbjct: 127 --IVHRDIKGANILRDSAGNVKLGDFGASKR--IQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 228 PDNLSTKTDVFSFGILLLEIIS 249
            +    K DV+S    ++E+++
Sbjct: 183 GEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 62/191 (32%), Positives = 102/191 (53%), Gaps = 13/191 (6%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPS-KNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           +G+GS G V  A  +  GRQVAVKK   + Q+  + + NE+ I+     P +V +   S 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS-SY 85

Query: 120 DSKDRLLVV-EFMSNGTLYD-VLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
              D L VV EF+  G L D V H+    +N  +   + L V KA+  LH++   +IHRD
Sbjct: 86  LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLHAQ--GVIHRD 140

Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           IKS ++L+  +   +L DFG   +   +  R +S    GT  ++ P  ++     T+ D+
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL--VGTPYWMAPEVISRLPYGTEVDI 198

Query: 238 FSFGILLLEII 248
           +S GI+++E++
Sbjct: 199 WSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 16/201 (7%)

Query: 56  GFSEQKLLGKGSHGSVYKAVLR-GRQV-AVKKPSKNQEIS----QEVDNEIEILSKIHSP 109
            F   +++GKG+ G V     R  +++ A+K  +K + +     + V NE  IL +++ P
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTL-YDVLHSNNRPLNWGRRIRL-ALQVAKAVEILH 167
            LVNL     D ++  LVV+ +  G L Y +        +  + ++    ++  A+E LH
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ--KVKFSEEQ-VKFWICEIVLALEYLH 117

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
           S+   IIHRDIK  N+L+D   +  + DF +A +   D     +T  +GT GY+ P  + 
Sbjct: 118 SKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLC 172

Query: 228 PDNLSTKTDVFSFGILLLEII 248
               S   D +S G+   E +
Sbjct: 173 RQGYSVAVDWWSLGVTAYECL 193

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 83.3 bits (206), Expect = 5e-18
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 11/210 (5%)

Query: 61  KLLGKGSHGS--VYKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           ++LGKG+ G   +Y+       V  K+      +++  ++  NEI ILS +  P ++   
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL-QVAKAVEILHSEMPPII 174
               D    L+ +E+ + GTLYD +      L     +   L Q+  AV  +H     I+
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA--GIL 123

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           HRDIK+ N+ + +    +LGDFG++   G +     +    GT  Y+ P        + K
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV--VGTPYYMSPELCQGVKYNFK 181

Query: 235 TDVFSFGILLLEIISCRKAIDIGFSPPSIV 264
           +D+++ G +L E+++ ++  D   +P ++V
Sbjct: 182 SDIWALGCVLYELLTLKRTFD-ATNPLNLV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 83.8 bits (207), Expect = 6e-18
 Identities = 59/189 (31%), Positives = 107/189 (56%), Gaps = 9/189 (4%)

Query: 63  LGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVNLLGFSN 119
           +G+G+ G+VY A  V  G++VA+K+ +  Q+  +E + NEI ++ +   P +VN L    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+E+++ G+L DV+      ++ G+   +  +  +A+E LHS    +IHRDIK
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIK 142

Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S N+L+  + + +L DFG   +   +  + RST   GT  ++ P  VT      K D++S
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSK-RST-MVGTPYWMAPEVVTRKAYGPKVDIWS 200

Query: 240 FGILLLEII 248
            GI+ +E++
Sbjct: 201 LGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 82.8 bits (204), Expect = 9e-18
 Identities = 77/274 (28%), Positives = 130/274 (47%), Gaps = 38/274 (13%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKK-------PSKNQEISQEVDNEIEILSKIHSPRL 111
           KLLG+G+ G VY    V  GR++A K+       P  ++E+S  ++ EI++L  +   R+
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSA-LECEIQLLKNLQHERI 66

Query: 112 VNLLGFSNDSKDRLLVV--EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V   G   D  ++ L +  E+M  G++ D L +    L      +   Q+ + +  LHS 
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSN 125

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG---VDNFRFRSTPPAGTIGYLDPCYV 226
           M  I+HRDIK AN+L D   N +LGDFG + R     +     RS    GT  ++ P  +
Sbjct: 126 M--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV--TGTPYWMSPEVI 181

Query: 227 TPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP 286
           + +    K DV+S G  ++E+++ +        PP    WA    +   + ++F     P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEK--------PP----WA----EYEAMAAIFKIATQP 225

Query: 287 --PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
             P+ P    + A   + C+      RPS +E++
Sbjct: 226 TNPQLPSHISEHARDFLGCIFVEARHRPSAEELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 66/197 (33%), Positives = 97/197 (49%), Gaps = 14/197 (7%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN----EIEILSKIHSPRLVNLLG 116
           LGKG  G V    ++  G+  A KK  K +   +  +     E EIL K++SP +VNL  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 117 FSNDSKDRL-LVVEFMSNGTL-YDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
           ++ +SK  L LV+  M+ G L Y + +   R L   R I  + Q+     ILH     I+
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCG--ILHLHSMDIV 117

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           +RD+K  NVL+D   N RL D GLA+           T  AGT GY+ P  +  +  S  
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPYSYP 174

Query: 235 TDVFSFGILLLEIISCR 251
            D F+ G  + E+++ R
Sbjct: 175 VDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 78/281 (27%), Positives = 130/281 (46%), Gaps = 43/281 (15%)

Query: 61  KLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIEILSKIHS-PR 110
           K LG G+ G V +A   G        +VAVK  KP+ +    + + +E++I+S + +   
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP-LNWGRRIRLALQVAKAVEILHSE 169
           +VNLLG        L++ E+   G L + L       L     +  + QVAK +  L S+
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK 160

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDPCYVTP 228
               IHRD+ + NVL+      ++ DFGLA     D N+  +          L   ++ P
Sbjct: 161 --NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN------ARLPVKWMAP 212

Query: 229 DNL-----STKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWA-APLIKKGKILSVF 280
           +++     + ++DV+S+GILL EI S      +G +P P + VD     LIK+G  ++  
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS------LGSNPYPGMPVDSKFYKLIKEGYRMA-- 264

Query: 281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
            P   P        ++  I   C  +   +RP+ K+IV  +
Sbjct: 265 QPEHAP-------AEIYDIMKTCWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 82.2 bits (203), Expect = 1e-17
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 4/193 (2%)

Query: 61  KLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           K LG G  G V     RG+  VA+K   +      E   E +++ K+   +LV L G   
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
             +   +V E+MSNG L + L  + +     + + +   V + +  L S+    IHRD+ 
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLA 127

Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           + N L+D     ++ DFGL+ R  +D+    S      + +  P  +     S+K+DV++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186

Query: 240 FGILLLEIISCRK 252
           FG+L+ E+ S  K
Sbjct: 187 FGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 78/278 (28%), Positives = 138/278 (49%), Gaps = 30/278 (10%)

Query: 63  LGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVNLLGFSN 119
           +G+G+ G+VY A  V  G++VA+++ +  Q+  +E + NEI ++ +  +P +VN L    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+E+++ G+L DV+      ++ G+   +  +  +A+E LHS    +IHRDIK
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIK 143

Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S N+L+  + + +L DFG   +   +  + + +   GT  ++ P  VT      K D++S
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201

Query: 240 FGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK--DPIVRKQLA 297
            GI+ +E+I           PP + +   PL     I +   P +  P+    I R  L 
Sbjct: 202 LGIMAIEMIEGE--------PPYLNE--NPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251

Query: 298 VIAVRCVRSCRERRPSMKEIVDW-----LTGLSKLVPL 330
               RC+    E+R S KE++          LS L PL
Sbjct: 252 ----RCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPL 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 82.5 bits (203), Expect = 2e-17
 Identities = 78/278 (28%), Positives = 139/278 (50%), Gaps = 30/278 (10%)

Query: 63  LGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVNLLGFSN 119
           +G+G+ G+VY A  +  G++VA+K+ +  Q+  +E + NEI ++ +  +P +VN L    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+E+++ G+L DV+      ++ G+   +  +  +A++ LHS    +IHRDIK
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIK 142

Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S N+L+  + + +L DFG   +   +  + RST   GT  ++ P  VT      K D++S
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSK-RST-MVGTPYWMAPEVVTRKAYGPKVDIWS 200

Query: 240 FGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK--DPIVRKQLA 297
            GI+ +E++           PP + +   PL     I +   P +  P+    + R  L 
Sbjct: 201 LGIMAIEMVEGE--------PPYLNE--NPLRALYLIATNGTPELQNPERLSAVFRDFLN 250

Query: 298 VIAVRCVRSCRERRPSMKEIVD-----WLTGLSKLVPL 330
               RC+    +RR S KE++          LS L PL
Sbjct: 251 ----RCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPL 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 67/280 (23%), Positives = 127/280 (45%), Gaps = 41/280 (14%)

Query: 63  LGKGSHGSVYKAVL------RGRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           LG+ + G +YK  L        + VA+K  K   N +   E   E  +++++H P +V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVL-----HSN-----------NRPLNWGRRIRLALQ 158
           LG     +   ++ E+++ G L++ L     HS+              L+ G  + +A+Q
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRFRSTPPAGT 217
           +A  +E L S     +H+D+ + N+LI    + ++ D GL+      D +R +       
Sbjct: 133 IAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL-P 189

Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKIL 277
           I ++ P  +     S+ +D++SFG++L EI S       GFS   +++    +++K ++L
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE----MVRKRQLL 245

Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
                   PP+       +  +   C +    RRP  K+I
Sbjct: 246 PC--SEDCPPR-------MYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 69/263 (26%), Positives = 123/263 (46%), Gaps = 21/263 (7%)

Query: 63  LGKGSHGSVYKAVLRGRQ--VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           LG G+ G V K + R     +AVK  +   N+ I +++  E++IL K +SP +V   G  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
            ++ D  + +E+M  G+L  +L      +      ++A+ V K +  LH +   IIHRD+
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK-IIHRDV 127

Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVF 238
           K +N+L++     +L DFG++ +  V++         GT  Y+ P  +  ++ S K+D++
Sbjct: 128 KPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTF---VGTSSYMAPERIQGNDYSVKSDIW 183

Query: 239 SFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP--IVRKQL 296
           S G+ L+E+ + R        PP              I++      PPP+ P        
Sbjct: 184 SLGLSLIELATGRFPY-----PPENDPPDGIFELLQYIVNE-----PPPRLPSGKFSPDF 233

Query: 297 AVIAVRCVRSCRERRPSMKEIVD 319
                 C+      RPS KE+++
Sbjct: 234 QDFVNLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 57/192 (29%), Positives = 97/192 (50%), Gaps = 8/192 (4%)

Query: 61  KLLGKGSHGSVYKAVLRG-RQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           K LG G  G V+     G  +VA+K   +     +    E  ++ ++  PRLV L  ++ 
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL--YAV 69

Query: 120 DSKDRLLVV-EFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
            +++ + ++ E+M NG+L D L +     L   + I +A Q+A+ +  +  E    IHRD
Sbjct: 70  VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI--ERKNYIHRD 127

Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+      ++ DFGLA R   DN           I +  P  +     + K+DV
Sbjct: 128 LRAANILVSETLCCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186

Query: 238 FSFGILLLEIIS 249
           +SFGILL EI++
Sbjct: 187 WSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 74/291 (25%), Positives = 127/291 (43%), Gaps = 36/291 (12%)

Query: 55  NGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
               E   LG+G+ GSV K  L+    +   K      N ++ +++  E+EI     SP 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 111 LVNLLG-FSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRI------RLALQVAKA 162
           +V   G F ++S   + + +E+   G+L D ++   +    G RI      ++A  V K 
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKR--GGRIGEKVLGKIAESVLKG 117

Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL---ALRCGVDNFRFRSTPPAGTIG 219
           +  LHS    IIHRDIK +N+L+ R    +L DFG+    +      F        GT  
Sbjct: 118 LSYLHSR--KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF-------TGTSF 168

Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV 279
           Y+ P  +     S  +DV+S G+ LLE+   R        PP       P+     I+++
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF-----PPEGEPPLGPIELLSYIVNM 223

Query: 280 FDPRIP-PPKDPIV-RKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLSK 326
            +P +   P + I   ++      +C+     RRP+  ++++  W+    K
Sbjct: 224 PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 80.9 bits (199), Expect = 5e-17
 Identities = 70/266 (26%), Positives = 126/266 (47%), Gaps = 24/266 (9%)

Query: 57  FSEQKLLGKGSHGSVYKAV-LRGRQVAVKKPSKNQEISQEVDN---EIEILSKIHSPRLV 112
           F++ + +GKGS G V+K +  R ++V   K    +E   E+++   EI +LS+  SP + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
              G         +++E++  G+  D+L     PL+  +   +  ++ K ++ LHSE   
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKK- 122

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
            IHRDIK+ANVL+  +   +L DFG+A +  + + + +     GT  ++ P  +      
Sbjct: 123 -IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179

Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV 292
           +K D++S GI  +E+         G  P S +    P+    K+L +     PP  +   
Sbjct: 180 SKADIWSLGITAIELAK-------GEPPHSELH---PM----KVLFLIPKNNPPTLEGNY 225

Query: 293 RKQLAVIAVRCVRSCRERRPSMKEIV 318
            K L      C+      RP+ KE++
Sbjct: 226 SKPLKEFVEACLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 28/270 (10%)

Query: 61  KLLGKGSHGSVYKAVLRGR-QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           + +GKG+ G VYK VL+G  +VAVK  + +   ++ ++   E EIL +   P +V L+G 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
               +   +V+E +  G+L   L      L   + ++++L  A  +E L S+    IHRD
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRD 118

Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           + + N L+  N   ++ DFG++       +          I +  P  +     ++++DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178

Query: 238 FSFGILLLEIISCRKAIDIGFSP-PSIVDWAA-PLIKKGKILSVFDPRIPPPK---DPIV 292
           +S+GILL E  S      +G +P P + +      I+ G        R+P P+   + I 
Sbjct: 179 WSYGILLWETFS------LGDTPYPGMSNQQTRERIESGY-------RMPAPQLCPEEIY 225

Query: 293 RKQLAVIAVRCVRSCRERRPSMKEIVDWLT 322
           R     + ++C     E RPS  EI + L 
Sbjct: 226 R-----LMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 80.4 bits (199), Expect = 6e-17
 Identities = 77/275 (28%), Positives = 125/275 (45%), Gaps = 39/275 (14%)

Query: 61  KLLGKGSHGSVYKAVLR---GRQVAVKKPS----KNQEISQEVDNEIEILSKIHSPRLVN 113
           + +GKGS G+V K V R   G+ +  K+        +E  Q V +E+ IL ++  P +V 
Sbjct: 6   ETIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLV-SEVNILRELKHPNIVR 63

Query: 114 LLG-FSNDSKDRL-LVVEFMSNGTLYDVL---HSNNRPLNWGRRIRLALQVAKAVEILHS 168
                 + S   L +V+E+   G L  ++       + +      R+  Q+  A+   H+
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 169 EMPP---IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
              P   ++HRD+K AN+ +D N N +LGDFGLA   G D+  F  T   GT  Y+ P  
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS-FAKT-YVGTPYYMSPEQ 181

Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP---SIVDWAAPLIKKGKILSVFDP 282
           +   +   K+D++S G L+ E+ +         SPP         A  IK+GK       
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCA--------LSPPFTARNQLQLASKIKEGKF-----R 228

Query: 283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
           RIP      + +   VI    +    ++RPS +E+
Sbjct: 229 RIPYRYSSELNE---VIK-SMLNVDPDKRPSTEEL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 40/278 (14%)

Query: 61  KLLGKGSHGSVYKAVLR---GR--QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           K LG GS G V +       G+   VAVK  K  K  +I  +   E  I+  +    L+ 
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPP 172
           L G        ++V E    G+L D L  +             A+Q+A  +  L S+   
Sbjct: 61  LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR-- 117

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNFRF---RSTPPAGTIGYLDPCYVT 227
            IHRD+ + N+L+  +   ++GDFGL  AL    D++        P      +  P  + 
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP----FAWCAPESLR 173

Query: 228 PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP---RI 284
               S  +DV+ FG+ L E+ +       G  P     WA   +   +IL   D    R+
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFT------YGEEP-----WAG--LSGSQILKKIDKEGERL 220

Query: 285 PPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
             P+  P   + +  + ++C       RP+   + ++L
Sbjct: 221 ERPEACP---QDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 80.4 bits (198), Expect = 7e-17
 Identities = 69/274 (25%), Positives = 130/274 (47%), Gaps = 24/274 (8%)

Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKP--------SKNQEISQEVDNEIEILSKIHSPRLV 112
           K+LG G+ G+VYK +       VK P        + + + ++E+ +E  +++ + SP + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            LLG    S  +L V + M  G L D +  N   +     +   +Q+AK +  L  E   
Sbjct: 73  RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL--EEVR 129

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           ++HRD+ + NVL+    + ++ DFGLA    +D   + +      I ++    +     +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV 292
            ++DV+S+G+ + E+++       G     I D    L++KG+       R+P P  PI 
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD----LLEKGE-------RLPQP--PIC 236

Query: 293 RKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
              + +I V+C     E RP  +E+VD  + +++
Sbjct: 237 TIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 76/297 (25%), Positives = 136/297 (45%), Gaps = 53/297 (17%)

Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLR--GRQ---VAVK--KPSKNQEISQEVDNEIEIL 103
           E   +  ++QK++G G  G V++ +L+  GR+   VA+K  KP   ++  Q+  +E  I+
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60

Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
            +     ++ L G     K  +++ E+M NG L   L  ++   +  + + +   +A  +
Sbjct: 61  GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGM 120

Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG--YL 221
           + L S+M   +HRD+ + N+L++ N   ++ DFGL+ R   D+     T   G I   + 
Sbjct: 121 KYL-SDMN-YVHRDLAARNILVNSNLECKVSDFGLS-RVLEDDPEGTYTTSGGKIPIRWT 177

Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIIS-------------CRKAIDIGFSPPSIVDWAA 268
            P  +     ++ +DV+SFGI++ E++S               KAI+ GF          
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---------- 227

Query: 269 PLIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
                         R+P P D P    QL    ++C +  R RRP   +IV+ L  L
Sbjct: 228 --------------RLPAPMDCPSAVYQL---MLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 70/281 (24%), Positives = 134/281 (47%), Gaps = 45/281 (16%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKK-----------PSKNQEISQEVDNEIEILSKIH 107
           +L+GKG++G VY A  V  G  +AVK+            S+ +++ + + +EIE L  + 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGR----RIR-LALQVAKA 162
              +V  LGF    +   + +E++  G++   L        +GR     +R    QV + 
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR------TYGRFEEQLVRFFTEQVLEG 120

Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           +  LHS+   I+HRD+K+ N+L+D +   ++ DFG++ +        ++    G++ ++ 
Sbjct: 121 LAYLHSK--GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178

Query: 223 PCYVTPDN--LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF 280
           P  +   +   S K D++S G ++LE+ + R+       P S  +  A + K G      
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR-------PWSDEEAIAAMFKLGNK---- 227

Query: 281 DPRIPPPKDPIVRKQLAVIAVRCVRSC----RERRPSMKEI 317
             R  PP  P V   L+ +A+  + +C     + RP+ +E+
Sbjct: 228 --RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 10/195 (5%)

Query: 57  FSEQKLLGKGSHGSVYKAVL-RGRQVAVKKPSKNQEISQEVDN---EIEILSKIHSPRLV 112
           F++ + +GKGS G VYK +  R ++V   K    +E   E+++   EI +LS+  SP + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
              G         +++E++  G+  D+L     PL       +  ++ K ++ LHSE   
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLHSERK- 122

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
            IHRDIK+ANVL+    + +L DFG+A +  + + + +     GT  ++ P  +      
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179

Query: 233 TKTDVFSFGILLLEI 247
            K D++S GI  +E+
Sbjct: 180 FKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 63/202 (31%), Positives = 105/202 (51%), Gaps = 16/202 (7%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVD----NEIEILSKIHSPR 110
           F + ++LGKG  G V    +R  G+  A KK  K +   ++ +    NE +IL K++S R
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS-R 60

Query: 111 LVNLLGFSNDSKDRL-LVVEFMSNGTL-YDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
            V  L ++ ++KD L LV+  M+ G L + + H        GR +  A ++   +E LH 
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN-FRFRSTPPAGTIGYLDPCYVT 227
           E   I++RD+K  N+L+D + + R+ D GLA+        + R     GT+GY+ P  V 
Sbjct: 121 ER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVK 174

Query: 228 PDNLSTKTDVFSFGILLLEIIS 249
            +  +   D ++ G LL E+I+
Sbjct: 175 NERYTFSPDWWALGCLLYEMIA 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 25/201 (12%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPS------KNQEISQEVDNEIEILSKIHSPRLV 112
           +LLG GS GSVY+ +    G   AVK+ S        QE  ++++ EI +LSK+  P +V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLH---SNNRPL--NWGRRIRLALQVAKAVEILH 167
             LG   +  +  + +E +  G+L  +L    S   P+   + R+I L L      E LH
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGL------EYLH 119

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
                 +HRDIK AN+L+D N   +L DFG+A +  V  F F  +   G+  ++ P  + 
Sbjct: 120 DR--NTVHRDIKGANILVDTNGVVKLADFGMAKQ--VVEFSFAKS-FKGSPYWMAPEVIA 174

Query: 228 PDNL-STKTDVFSFGILLLEI 247
                    D++S G  +LE+
Sbjct: 175 QQGGYGLAADIWSLGCTVLEM 195

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 70/289 (24%), Positives = 133/289 (46%), Gaps = 47/289 (16%)

Query: 61  KLLGKGSHGSVYKAV---LRGR----QVAVKKPSKNQEISQEVD--NEIEILSKIHSPRL 111
           K LG+G  G V KA    L+GR     VAVK   +N   S+  D  +E  +L +++ P +
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVL-----------------------HSNNRPLN 148
           + L G  +     LL+VE+   G+L   L                       + + R L 
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 149 WGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR 208
            G  I  A Q+++ ++ L +EM  ++HRD+ + NVL+      ++ DFGL+     ++  
Sbjct: 126 MGDLISFAWQISRGMQYL-AEMK-LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA 268
            + +     + ++    +     +T++DV+SFG+LL EI++       G +P  + +   
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN--- 240

Query: 269 PLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
            L+K G        R+  P++    +++  + + C +   ++RP+  +I
Sbjct: 241 -LLKTGY-------RMERPEN--CSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 78.6 bits (193), Expect = 3e-16
 Identities = 55/195 (28%), Positives = 102/195 (52%), Gaps = 10/195 (5%)

Query: 57  FSEQKLLGKGSHGSVYKAV-LRGRQVAVKKPSKNQEISQEVDN---EIEILSKIHSPRLV 112
           F++ + +GKGS G V+K +  R +QV   K    +E   E+++   EI +LS+  SP + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
              G         +++E++  G+  D+L +   P +  +   +  ++ K ++ LHSE   
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKK- 122

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
            IHRDIK+ANVL+    + +L DFG+A +  + + + +     GT  ++ P  +      
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIQQSAYD 179

Query: 233 TKTDVFSFGILLLEI 247
           +K D++S GI  +E+
Sbjct: 180 SKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 77.7 bits (191), Expect = 3e-16
 Identities = 74/262 (28%), Positives = 117/262 (44%), Gaps = 23/262 (8%)

Query: 61  KLLGKGSHGSVYKAVLRGRQ-VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           +LLGKG+ G V+K  L+ +  VAVK  K    QE+  +  +E  IL +   P +V L+G 
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
               +   +V+E +  G     L      L   + ++ AL  A  +  L S+    IHRD
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK--NCIHRD 118

Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           + + N L+  N   ++ DFG++ R   D     S      I +  P  +     S+++DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMS-RQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177

Query: 238 FSFGILLLEIISCRKAIDIGFSP-PSIVDWAA-PLIKKGKILSVFDPRIPPPKDPIVRKQ 295
           +S+GILL E  S      +G  P P + +  A   ++KG  +S       P K P     
Sbjct: 178 WSYGILLWETFS------LGVCPYPGMTNQQAREQVEKGYRMSC------PQKCP---DD 222

Query: 296 LAVIAVRCVRSCRERRPSMKEI 317
           +  +  RC     E RP   E+
Sbjct: 223 VYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 18/198 (9%)

Query: 63  LGKGSHGSVYKAVLRGR-----QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           LG G+ GSV K V   +     +VAVK  K        +E   E  +++++  P +V L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
           G     +  +LV+E    G L   L    R +       LA QVA  +  L  E    +H
Sbjct: 63  GVC-KGEPLMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYL--ESKHFVH 118

Query: 176 RDIKSANVLIDRNFNARLGDFGL--ALRCGVDNFRFRSTPPAGT--IGYLDPCYVTPDNL 231
           RD+ + NVL+     A++ DFG+  AL  G D +R  +   AG   + +  P  +     
Sbjct: 119 RDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT---AGRWPLKWYAPECINYGKF 175

Query: 232 STKTDVFSFGILLLEIIS 249
           S+K+DV+S+G+ L E  S
Sbjct: 176 SSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 74/264 (28%), Positives = 122/264 (46%), Gaps = 21/264 (7%)

Query: 61  KLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           K LG G  G V+     G  +VAVK         +    E +I+ K+   +LV L    +
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
           + +   +V E+MS G+L D L     R L     + +A QVA  +  +  E    IHRD+
Sbjct: 72  E-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI--ERMNYIHRDL 128

Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVF 238
           +SAN+L+      ++ DFGLA R   DN           I +  P        + K+DV+
Sbjct: 129 RSANILVGDGLVCKIADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 239 SFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD-PIVRKQLA 297
           SFGILL E+++  +    G +   +++     +++G        R+P P+D PI    L 
Sbjct: 188 SFGILLTELVTKGRVPYPGMNNREVLEQ----VERGY-------RMPCPQDCPI---SLH 233

Query: 298 VIAVRCVRSCRERRPSMKEIVDWL 321
            + ++C +   E RP+ + +  +L
Sbjct: 234 ELMLQCWKKDPEERPTFEYLQSFL 257

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 7e-16
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 23/155 (14%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           +   + +G G++G VYKA     G  VA+K  K     +    +  EI +L +   P +V
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE-IIQQEISMLKECRHPNIV 63

Query: 113 NLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVA-------KAVE 164
              G S   +D+L +V+E+   G+L D+      PL+        LQ+A       K + 
Sbjct: 64  AYFG-SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS-------ELQIAYVCRETLKGLA 115

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
            LH      IHRDIK AN+L+  + + +L DFG++
Sbjct: 116 YLHETG--KIHRDIKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 47/143 (32%), Positives = 74/143 (51%), Gaps = 8/143 (5%)

Query: 62  LLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           L+G+GS+G V K   +  G+ VA+KK      ++ + +    EI +L ++    LVNL+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
                K   LV EF+ + T+ D L      L+  R  +   Q+ + +E  HS    IIHR
Sbjct: 68  VFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH--NIIHR 124

Query: 177 DIKSANVLIDRNFNARLGDFGLA 199
           DIK  N+L+ ++   +L DFG A
Sbjct: 125 DIKPENILVSQSGVVKLCDFGFA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 77.9 bits (192), Expect = 9e-16
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 23/210 (10%)

Query: 55  NGFSEQKLLGKGSHGSVYKAVLRGRQV----AVKKPSKNQEISQE----VDNEIEILSKI 106
             F  + L+G+G  G V   V+R +      A+K   K+  ++QE     + E +ILS  
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58

Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
           +SP +  L     D  +  LV+E+   G L  +L+      +     +  L  A+ V  +
Sbjct: 59  NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD-EDMAQFYL--AELVLAI 115

Query: 167 HS--EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
           HS  +M   +HRDIK  NVLIDR  + +L DFG A R   +     S  P GT  Y+ P 
Sbjct: 116 HSVHQMG-YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN-SKLPVGTPDYIAPE 173

Query: 225 YVTPDNLSTKT------DVFSFGILLLEII 248
            +T  N   K       D +S G++  E+I
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 77.4 bits (190), Expect = 9e-16
 Identities = 67/295 (22%), Positives = 131/295 (44%), Gaps = 38/295 (12%)

Query: 60  QKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVD--NEIEILSKIHSPRL 111
           ++ LG+G+ G V+ A        + + +   K  K+  ++   D   E E+L+ +    +
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSN---------------NRPLNWGRRIRLA 156
           V   G   D    ++V E+M +G L   L ++                  L   + + +A
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG 216
            Q+A  +  L S+    +HRD+ + N L+  N   ++GDFG++      ++         
Sbjct: 130 SQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 217 TIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI 276
            I ++ P  +     +T++DV+SFG++L EI +  K      S   +++     I +G++
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE----CITQGRV 243

Query: 277 LSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLH 331
           L    PR+ P       K++  I + C +   ++R ++KEI   L  L K  P++
Sbjct: 244 LE--RPRVCP-------KEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPIY 289

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 26/200 (13%)

Query: 61  KLLGKGSHGSVY--KAVLRGRQVAVK------KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           K + KG+ GSVY  K    G   A+K        +KNQ  + + +  I ++ +  SP + 
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESPYVA 60

Query: 113 NLLGFSNDSKDRL-LVVEFMSNG---TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
            L  +S  SKD L LV+E+++ G   +L   L     P +W ++     +V   VE LH 
Sbjct: 61  KLY-YSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQ--YIAEVVLGVEDLHQ 115

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               IIHRDIK  N+LID+  + +L DFGL+ R G++N +F  TP      YL P  +  
Sbjct: 116 R--GIIHRDIKPENLLIDQTGHLKLTDFGLS-RNGLENKKFVGTP-----DYLAPETILG 167

Query: 229 DNLSTKTDVFSFGILLLEII 248
                 +D +S G ++ E +
Sbjct: 168 VGDDKMSDWWSLGCVIFEFL 187

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 37/217 (17%)

Query: 60  QKLLGKGSHGSVYKAVLRG----RQVAVK--KPSKNQEISQEVDNEIEILSKI-HSPRLV 112
           Q ++G+G+ G V KA ++        A+K  K   +++  ++   E+E+L K+ H P ++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVL---------------HSNNRPLNWGRRIRLAL 157
           NLLG         L +E+  +G L D L               +S    L+  + +  A 
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 158 QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT 217
            VA+ ++ L  +    IHRD+ + N+L+  N+ A++ DFGL+        R +      T
Sbjct: 132 DVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLS--------RGQEVYVKKT 181

Query: 218 IGYLDPCYVTPDNL-----STKTDVFSFGILLLEIIS 249
           +G L   ++  ++L     +T +DV+S+G+LL EI+S
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 14/200 (7%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVD----NEIEILSKIHSPR 110
           F   ++LGKG  G V    +R  G+  A KK  K +   ++ +    NE +IL K++S  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 111 LVNLLGFSNDSKDRL-LVVEFMSNGTL-YDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           +V+L  ++ ++KD L LV+  M+ G L + + +  N   +  R +  A ++   +E LH 
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
           E   I++RD+K  N+L+D   + R+ D GLA+    +    R     GT+GY+ P  V  
Sbjct: 121 ER--IVYRDLKPENILLDDYGHIRISDLGLAVEIP-EGETIRGR--VGTVGYMAPEVVKN 175

Query: 229 DNLSTKTDVFSFGILLLEII 248
           +  +   D +  G L+ E+I
Sbjct: 176 ERYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 71/283 (25%), Positives = 135/283 (47%), Gaps = 34/283 (12%)

Query: 60  QKLLGKGSHGSVYKAVLR--------GRQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
            ++LG+G  G V  ++          G  VAVK  K    Q+ +     EI IL  ++  
Sbjct: 9   IRVLGEGHFGKV--SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66

Query: 110 RLVNLLGFSNDSKDR--LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
            +V   G  ++   +   L++E++  G+L D L  +   LN  + +  A Q+ + +  LH
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH 124

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDPCY 225
           S+    IHRD+ + NVL+D +   ++GDFGLA  +  G + +R R    +    Y   C 
Sbjct: 125 SQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC- 181

Query: 226 VTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPS----IVDWAAPLIKKGKILSVF 280
           +  +  S  +DV+SFG+ L E+++ C    D   SPP     ++      +   +++ + 
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHC----DSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237

Query: 281 D--PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           +   R+P PK+    +++ ++   C  +  + RP+ + ++  L
Sbjct: 238 ERGMRLPCPKN--CPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 14/158 (8%)

Query: 55  NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN----EIEILSKIHS 108
           N +    ++G+G++G V K   +  G  VA+KK  K  E  ++V      E+++L ++  
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKK-FKESEDDEDVKKTALREVKVLRQLRH 59

Query: 109 PRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
             +VNL       K RL LV E++   TL ++L ++   L          Q+ +A+   H
Sbjct: 60  ENIVNLKEAFR-RKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH 117

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCG 203
           S    IIHRDIK  N+L+  +   +L DFG A  LR  
Sbjct: 118 SH--NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 32/213 (15%)

Query: 63  LGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           LG+G+ G V+               VAVK  K + + +  ++ + E E+L+      +V 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-------------PLNWGRRIRLALQVA 160
             G   +    ++V E+M +G L   L S+                L   + +++A+Q+A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRF---RSTPPAG 216
             +  L S+    +HRD+ + N L+  +   ++GDFG++      D +R       P   
Sbjct: 133 SGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP--- 187

Query: 217 TIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
            I ++ P  +     +T++DV+SFG++L EI +
Sbjct: 188 -IRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 33/205 (16%)

Query: 61  KLLGKGSHGSVY--KAVLRGRQVAVKK------PSKNQEISQEVDNEIEILSKIHSPRLV 112
           K +G+GS G +Y  KA        +K+      P K +E S+    E+ +L+K+  P +V
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKMKHPNIV 62

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTL-------YDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
                  ++    +V+E+   G L         VL S ++ L+W  +I L L+       
Sbjct: 63  TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK------- 115

Query: 166 LHSEMPPIIHRDIKSANVLIDRN-FNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP- 223
            H     I+HRDIKS N+ + +N   A+LGDFG+A R   D+     T   GT  YL P 
Sbjct: 116 -HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA-RQLNDSMELAYT-CVGTPYYLSPE 172

Query: 224 -CYVTPDNLSTKTDVFSFGILLLEI 247
            C   P N   KTD++S G +L E+
Sbjct: 173 ICQNRPYN--NKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 49/178 (27%), Positives = 89/178 (50%), Gaps = 9/178 (5%)

Query: 78  GRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR--LLVVEFMSN 133
           G QVAVK  KP        ++  EIEIL  ++   +V   G   +       L++EF+ +
Sbjct: 33  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92

Query: 134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL 193
           G+L + L  N   +N  ++++ A+Q+ K ++ L S     +HRD+ + NVL++     ++
Sbjct: 93  GSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKI 150

Query: 194 GDFGL--ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
           GDFGL  A+    + +  +    +    Y   C +        +DV+SFG+ L E+++
Sbjct: 151 GDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 69/262 (26%), Positives = 121/262 (46%), Gaps = 21/262 (8%)

Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 72

Query: 122 KDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +   +V E+MS G+L D L     + L   + + +A Q+A  +   + E    +HRD+++
Sbjct: 73  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA--YVERMNYVHRDLRA 130

Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV+SF
Sbjct: 131 ANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189

Query: 241 GILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQLAVI 299
           GILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L  +
Sbjct: 190 GILLTELTTKGRVPYPGMVNREVLDQ----VERGY-------RMPCPPECP---ESLHDL 235

Query: 300 AVRCVRSCRERRPSMKEIVDWL 321
             +C R   E RP+ + +  +L
Sbjct: 236 MCQCWRKEPEERPTFEYLQAFL 257

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.0 bits (188), Expect = 4e-15
 Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 20/153 (13%)

Query: 60  QKLLGKGSHGSVYKAV--LRGRQVAVKKPSKNQEISQEVD-----NEIEILSKIHSPRLV 112
            K +G G++G V  AV    GR+VA+KK S        +D      EI++L  +    ++
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKISN--VFDDLIDAKRILREIKLLRHLRHENII 62

Query: 113 NLLGF-----SNDSKDRLLVVEFMSNGT-LYDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
            LL         D  D  +V E M   T L+ V+ S  +PL          Q+ + ++ L
Sbjct: 63  GLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYL 119

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
           HS    +IHRD+K +N+L++ N + ++ DFGLA
Sbjct: 120 HSA--NVIHRDLKPSNILVNSNCDLKICDFGLA 150

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 37/217 (17%)

Query: 60  QKLLGKGSHGSVYKAVLRGRQVAVKKPSKN-QEISQEVDN-----EIEILSKI-HSPRLV 112
           + ++G+G+ G V +A+++   + +    K  +E + E D+     E+E+L K+ H P ++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVL---------------HSNNRPLNWGRRIRLAL 157
           NLLG   +     + +E+   G L D L               H     L   + ++ A 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 158 QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT 217
            VA  ++ L  +    IHRD+ + NVL+  N  +++ DFGL+        R        T
Sbjct: 127 DVATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIADFGLS--------RGEEVYVKKT 176

Query: 218 IGYLDPCYVTPDNL-----STKTDVFSFGILLLEIIS 249
           +G L   ++  ++L     +TK+DV+SFG+LL EI+S
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 5/191 (2%)

Query: 61  KLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           K LG G  G V+        +VAVK         Q    E  ++  +   +LV L     
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 120 DSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
             +   ++ E+M+ G+L D L S+    +   + I  + Q+A+ +  +  E    IHRD+
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI--ERKNYIHRDL 129

Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVF 238
           ++ANVL+  +   ++ DFGLA R   DN           I +  P  +   + + K+DV+
Sbjct: 130 RAANVLVSESLMCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188

Query: 239 SFGILLLEIIS 249
           SFGILL EI++
Sbjct: 189 SFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 74.7 bits (183), Expect = 5e-15
 Identities = 56/189 (29%), Positives = 93/189 (49%), Gaps = 6/189 (3%)

Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K       + +    E +I+ K+   +LV L    ++ 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE- 72

Query: 122 KDRLLVVEFMSNGTLYDVL-HSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +   +V EFM  G+L D L   + + L   + + +A Q+A  +  +  E    IHRD+++
Sbjct: 73  EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI--ERMNYIHRDLRA 130

Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV+SF
Sbjct: 131 ANILVGDNLVCKIADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189

Query: 241 GILLLEIIS 249
           GILL E+++
Sbjct: 190 GILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 73/298 (24%), Positives = 130/298 (43%), Gaps = 61/298 (20%)

Query: 53  ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPR 110
            T  F   +++G+G++G VYKA  +  G+ VA+K     ++  +E+  E  IL K  +  
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHP 63

Query: 111 LVNLLGF---------SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---- 157
             N+  F           +     LV+E    G++ D++         G+R++       
Sbjct: 64  --NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKRLKEEWIAYI 118

Query: 158 --QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA 215
             +  + +  LH     +IHRDIK  N+L+ +N   +L DFG++ +  +D+   R     
Sbjct: 119 LRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQ--LDSTLGRRNTFI 174

Query: 216 GTIGYLDPCYVTPDNLS----------TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           GT     P ++ P+ ++           ++DV+S GI          AI++        D
Sbjct: 175 GT-----PYWMAPEVIACDEQPDASYDARSDVWSLGI---------TAIELA-------D 213

Query: 266 WAAPLIKKGKILSVFD-PRIPPP--KDPIV-RKQLAVIAVRCVRSCRERRPSMKEIVD 319
              PL     + ++F  PR PPP  K P    K+       C+    E+RP M+E+++
Sbjct: 214 GKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 58/215 (26%), Positives = 106/215 (49%), Gaps = 37/215 (17%)

Query: 62  LLGKGSHGSVYKAVLRGRQVAVKKPSKN-QEISQEVDN-----EIEILSKI-HSPRLVNL 114
           ++G+G+ G V KA ++   + +    K  +E + + D+     E+E+L K+ H P ++NL
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVL---------------HSNNRPLNWGRRIRLALQV 159
           LG         L +E+  +G L D L               +S    L+  + +  A  V
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG 219
           A+ ++ L  +    IHRD+ + N+L+  N+ A++ DFGL+        R +      T+G
Sbjct: 122 ARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLS--------RGQEVYVKKTMG 171

Query: 220 YLDPCYVTPDNL-----STKTDVFSFGILLLEIIS 249
            L   ++  ++L     +T +DV+S+G+LL EI+S
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 56/221 (25%), Positives = 110/221 (49%), Gaps = 32/221 (14%)

Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEISQEVD--NEIE 101
           E A    +  + LG+GS G VY+ + +G        +VA+K  ++   + + ++  NE  
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61

Query: 102 ILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS---------NNRPLNWGRR 152
           ++ + +   +V LLG  +  +  L+++E M+ G L   L S            P +  + 
Sbjct: 62  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121

Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG-VDNFRFRS 211
           I++A ++A  +  L++     +HRD+ + N ++  +F  ++GDFG+       D +R   
Sbjct: 122 IQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR--- 176

Query: 212 TPPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEI 247
               G  G L   +++P++L     +T +DV+SFG++L EI
Sbjct: 177 ---KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 74.4 bits (183), Expect = 8e-15
 Identities = 68/295 (23%), Positives = 132/295 (44%), Gaps = 45/295 (15%)

Query: 44  HFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ-------VAVK--KPSKNQEISQ 94
            F  S+L        E   LG+G  G V+ A  +G +       V VK  + +K++ +  
Sbjct: 1   AFPRSNL-------QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS 53

Query: 95  EVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN--------RP 146
           E   E+++  K+    +V LLG   +++   +++E+   G L   L +           P
Sbjct: 54  EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113

Query: 147 LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL-RCGVD 205
           L+  +++ L  Q+A  ++ L +     +HRD+ + N L+      ++    L+      +
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE 171

Query: 206 NFRFRST--PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSI 263
            ++ R+   P    + +L P  V  D+ STK+DV+SFG+L+ E+ +  +    G S   +
Sbjct: 172 YYKLRNALIP----LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227

Query: 264 VDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           ++     ++ GK+       +P P+      +L  +  RC     + RPS  E+V
Sbjct: 228 LN----RLQAGKL------ELPVPEG--CPSRLYKLMTRCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 74.4 bits (183), Expect = 9e-15
 Identities = 60/266 (22%), Positives = 116/266 (43%), Gaps = 38/266 (14%)

Query: 70  SVYKAVLRGRQVAV---KKPSKN-QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL 125
           S+YK +   ++V +   KK  K  + +    +NEI+ L +I S  ++ + GF  D  D L
Sbjct: 35  SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 126 ----LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH-SEMPPIIHRDIKS 180
               L++E+ + G L +VL    + L++  ++ +A+   K +  L+     P  ++++ S
Sbjct: 95  PRLSLILEYCTRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151

Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPP---AGTIGYLDPCYVTP--DNLSTKT 235
            + L+  N+  ++   GL         +  S+PP      + Y     +       + K 
Sbjct: 152 VSFLVTENYKLKIICHGL--------EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKD 203

Query: 236 DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQ 295
           D++S G++L EI +      I F   +  +    +I K   L +      P   P    +
Sbjct: 204 DIYSLGVVLWEIFTG----KIPFENLTTKEIYDLIINKNNSLKL------PLDCP---LE 250

Query: 296 LAVIAVRCVRSCRERRPSMKEIVDWL 321
           +  I   C      +RP++KEI+  L
Sbjct: 251 IKCIVEACTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 53/190 (27%), Positives = 91/190 (47%), Gaps = 4/190 (2%)

Query: 61  KLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           K LG G  G V+    R + +VA+K  ++     ++   E +++ K+  P+LV L G   
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
             K   +V EFM NG L + L      L+    + +   V + +E L  E    IHRD+ 
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL--ERNSFIHRDLA 127

Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           + N L+      ++ DFG+  R  +D+    S+     + +  P        S+K+DV+S
Sbjct: 128 ARNCLVSSTGVVKVSDFGMT-RYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186

Query: 240 FGILLLEIIS 249
           FG+L+ E+ +
Sbjct: 187 FGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 16/201 (7%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVD----NEIEILSKIHSPR 110
           F + ++LGKG  G V    +R  G+  A K+  K +   ++ +    NE +IL K++S  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 111 LVNLLGFSNDSKDRL-LVVEFMSNGTL-YDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           +VNL  ++ ++KD L LV+  M+ G L + + +  N      R +  A ++   +E LH 
Sbjct: 62  VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV-DNFRFRSTPPAGTIGYLDPCYVT 227
           E    ++RD+K  N+L+D   + R+ D GLA++    ++ R R     GT+GY+ P  + 
Sbjct: 121 E--NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLN 174

Query: 228 PDNLSTKTDVFSFGILLLEII 248
               +   D +  G L+ E+I
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 10/209 (4%)

Query: 60  QKLLGKGSHGSVYKAVL-RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           +K LG G  G V+ A   +  +VAVK         +    E  ++  +   +LV L    
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70

Query: 119 NDSKDRLLVVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   ++ EFM+ G+L D L S   + +PL   + I  + Q+A+ +  +  E    IH
Sbjct: 71  T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFI--EQRNYIH 125

Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKT 235
           RD+++AN+L+  +   ++ DFGLA R   DN           I +  P  +   + + K+
Sbjct: 126 RDLRAANILVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184

Query: 236 DVFSFGILLLEIISCRKAIDIGFSPPSIV 264
           DV+SFGILL+EI++  +    G S P ++
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVI 213

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 60/240 (25%), Positives = 96/240 (40%), Gaps = 76/240 (31%)

Query: 61  KLLGKGSHGSVYKAV--LRGRQVAVKKPSKNQEISQEVDN----------------EIEI 102
             LG+G++G V KA   L G+ VA+KK  K  EIS +V                  E++I
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKK-VKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 103 LSKIHSPRLVNLL------GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA 156
           +++I    ++ L+       F N      LV++ M+   L  V+          R+IRL 
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFIN------LVMDIMA-SDLKKVVD---------RKIRLT 117

Query: 157 --------LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF- 207
                   LQ+   + +LH      +HRD+  AN+ I+     ++ DFGLA R G   + 
Sbjct: 118 ESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175

Query: 208 -----------RFRSTPPAGTIGYLDP-------CYVTPDNLSTKTDVFSFGILLLEIIS 249
                      R   T    T+ Y  P        Y          D++S G +  E+++
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKY------HFAVDMWSVGCIFAELLT 229

Length = 335

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 20/203 (9%)

Query: 61  KLLGKGSHGSVYKAVL-----RGRQVAVKKPSKNQEISQEVDN---EIEILSKIHSPRLV 112
           +++GKG  G VY   L     +    AVK  ++  ++ +EV+    E  I+     P ++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL-EEVEQFLKEGIIMKDFSHPNVL 59

Query: 113 NLLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   LVV  +M +G L + + S          I   LQVAK +E L S+  
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK-- 117

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
             +HRD+ + N ++D +F  ++ DFGLA R   D   +  +    T   L   ++  ++L
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLA-RDIYDKEYY--SVHNHTGAKLPVKWMALESL 174

Query: 232 -----STKTDVFSFGILLLEIIS 249
                +TK+DV+SFG+LL E+++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 63/260 (24%), Positives = 119/260 (45%), Gaps = 27/260 (10%)

Query: 79  RQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTL 136
             VAVK  +P  +    ++   E++ILS++  P +  LLG         +++E+M NG L
Sbjct: 47  VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 137 YDVLHS----------NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID 186
              L            N++ L++   + +A Q+A  +  L   +   +HRD+ + N L+ 
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL-ESL-NFVHRDLATRNCLVG 164

Query: 187 RNFNARLGDFGL---ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGIL 243
           +N+  ++ DFG+         D +R +   P   I ++    V     +TK+DV++FG+ 
Sbjct: 165 KNYTIKIADFGMSRNLYSS--DYYRVQGRAPL-PIRWMAWESVLLGKFTTKSDVWAFGVT 221

Query: 244 LLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVR 302
           L EI++ CR+      +   +++ A    +          +I  P+ P   K +  + + 
Sbjct: 222 LWEILTLCREQPYEHLTDQQVIENAGHFFRDDGR------QIYLPRPPNCPKDIYELMLE 275

Query: 303 CVRSCRERRPSMKEIVDWLT 322
           C R   E RP+ +EI  +L 
Sbjct: 276 CWRRDEEDRPTFREIHLFLQ 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 21/206 (10%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS----QEVDNEIEILSKIHSPRLVNL 114
           K +G G+ G V+    R      A+K  +  + I     Q V NE  +L ++  P ++ L
Sbjct: 7   KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
               +D +   +++E++  G L+  L ++ R  N       A ++  A+E LHS+   I+
Sbjct: 67  FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLHSK--EIV 123

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           +RD+K  N+L+D+  + +L DFG A        R R+    GT  YL P  +     +  
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFA-----KKLRDRTWTLCGTPEYLAPEVIQSKGHNKA 178

Query: 235 TDVFSFGILLLEIISCRKAIDIGFSP 260
            D ++ GIL+ E++       +G+ P
Sbjct: 179 VDWWALGILIYEML-------VGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 45/142 (31%), Positives = 73/142 (51%), Gaps = 8/142 (5%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G+GS+G V+K   R  G+ VA+KK  ++++   I +    EI +L ++  P LVNL+  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
               +   LV E+  + T+ + L  N R +      ++  Q  +AV   H      IHRD
Sbjct: 69  FRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH--NCIHRD 125

Query: 178 IKSANVLIDRNFNARLGDFGLA 199
           +K  N+LI +    +L DFG A
Sbjct: 126 VKPENILITKQGQIKLCDFGFA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 43/217 (19%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN--EIEILSKIHS-PRL 111
           +   K LG G+ GSVY A  +  G  VA+KK  K     +E  N  E++ L K++  P +
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIR-LALQVAKAVEILHSE 169
           V L     ++ +   V E+M  G LY ++     +P +    IR +  Q+ + +  +H  
Sbjct: 61  VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESV-IRSIIYQILQGLAHIHKH 118

Query: 170 --MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR-FRSTPPAGTIGYLDPCYV 226
                  HRD+K  N+L+      ++ DFGLA        R  RS PP     Y D  YV
Sbjct: 119 GFF----HRDLKPENLLVSGPEVVKIADFGLA--------REIRSRPP-----YTD--YV 159

Query: 227 T------PDNL------STKTDVFSFGILLLEIISCR 251
           +      P+ L      S+  D+++ G ++ E+ + R
Sbjct: 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 67/265 (25%), Positives = 122/265 (46%), Gaps = 24/265 (9%)

Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKP--------SKNQEISQEVDNEIEILSKIHSPRLV 112
           K+LG G+ G+VYK +       VK P        +   + + E  +E  I++ +  P LV
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            LLG    S    LV + M +G L D +H +   +     +   +Q+AK   +++ E   
Sbjct: 73  RLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG--MMYLEERR 129

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           ++HRD+ + NVL+    + ++ DFGLA     D   + +      I ++    +     +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV 292
            ++DV+S+G+ + E+++       G     I D    L++KG+       R+P P  PI 
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD----LLEKGE-------RLPQP--PIC 236

Query: 293 RKQLAVIAVRCVRSCRERRPSMKEI 317
              + ++ V+C     + RP  KE+
Sbjct: 237 TIDVYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 15/199 (7%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLG 116
           LGKG  G V    +R  G+  A KK +K +    +  +    E  IL+K+HS  +V+L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 117 FSNDSKDRLLVVEFMSNGTL----YDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
                 D  LV+  M+ G L    Y+V    N      R      Q+   +E LH     
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNV-DEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           II+RD+K  NVL+D + N R+ D GLA+   + + + ++   AGT G++ P  +  +   
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVE--LKDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Query: 233 TKTDVFSFGILLLEIISCR 251
              D F+ G+ L E+I+ R
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 63/278 (22%), Positives = 131/278 (47%), Gaps = 24/278 (8%)

Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKP--------SKNQEISQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P        + + + ++E+ +E  +++ + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 69  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-- 125

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
           E   ++HRD+ + NVL+    + ++ DFGLA   G D   + +      I ++    +  
Sbjct: 126 EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185

Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 186 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 233

Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
            PI    + +I V+C     + RP  +E++   + +++
Sbjct: 234 -PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 71/264 (26%), Positives = 124/264 (46%), Gaps = 21/264 (7%)

Query: 60  QKLLGKGSHGSVYKA--VLRGRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           Q++LG G+ G+VYKA  +L  R +AVK        E+ +++ +E+EIL K  SP ++   
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
           G         +  EFM  G+L DV       +  GR   +A+ V K +  L S    I+H
Sbjct: 66  GAFFVENRISICTEFMDGGSL-DVYRKIPEHV-LGR---IAVAVVKGLTYLWSL--KILH 118

Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKT 235
           RD+K +N+L++     +L DFG++ +  V++    +    GT  Y+ P  ++ +     +
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSI---AKTYVGTNAYMAPERISGEQYGIHS 174

Query: 236 DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQ 295
           DV+S GI  +E+   R      F  P I      L+    +  + D   P        ++
Sbjct: 175 DVWSLGISFMELALGR------FPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK 228

Query: 296 LAVIAVRCVRSCRERRPSMKEIVD 319
                 +C+R   + RP+ + ++D
Sbjct: 229 FVHFITQCMRKQPKERPAPENLMD 252

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 16/201 (7%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVD----NEIEILSKIHSPR 110
           F   ++LGKG  G V    +R  G+  A KK  K +   ++ +    NE  IL K++S R
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-R 60

Query: 111 LVNLLGFSNDSKDRL-LVVEFMSNGTL-YDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
            V  L ++ ++KD L LV+  M+ G L + + +  N   +  R I  A ++   +E L  
Sbjct: 61  FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV-DNFRFRSTPPAGTIGYLDPCYVT 227
           E   I++RD+K  N+L+D   + R+ D GLA++    +  R R     GT+GY+ P  + 
Sbjct: 121 ER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVIN 174

Query: 228 PDNLSTKTDVFSFGILLLEII 248
            +  +   D +  G L+ E+I
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 71.9 bits (176), Expect = 5e-14
 Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 10/194 (5%)

Query: 63  LGKGSHGSVYKAV--LRGRQ--VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           LG G+ G V K V  +R +Q  VA+K  K    + +  E+  E EI+ ++ +P +V ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
              +++  +LV+E  S G L   L      +     + L  QV+  ++ L  E    +HR
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL--EGKNFVHR 119

Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS-TPPAGTIGYLDPCYVTPDNLSTKT 235
           D+ + NVL+     A++ DFGL+   G D+  +++ +     + +  P  +     S+++
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179

Query: 236 DVFSFGILLLEIIS 249
           DV+S+GI + E  S
Sbjct: 180 DVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 71.8 bits (176), Expect = 5e-14
 Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 29/209 (13%)

Query: 62  LLGKGSHGSVYKAV--LRGRQVAVKK---PS-------KNQEISQEVDNEIEILSKIHSP 109
           L+G GS GSVY  +    G  +AVK+   PS       + + +   +  EI +L ++   
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNG---TLYDVLHSNNRPL--NWGRRIRLALQVAKAVE 164
            +V  LG S D+    + +E++  G    L +   +    L  N+ R      Q+ K + 
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR------QILKGLN 120

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPA--GTIGY 220
            LH+    IIHRDIK AN+L+D     ++ DFG++  L     + +     P+  G++ +
Sbjct: 121 YLHNR--GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 221 LDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
           + P  V   + + K D++S G L++E+++
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLT 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 25/209 (11%)

Query: 54  TNGFSEQKLLGKGSHGSVYKAV--LRGRQVAVKKPS----KNQEISQEVDNEIEILSKIH 107
              F  +K +GKG    VYKA+  L GR VA+KK       + +  Q+   EI++L ++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVL---HSNNRPLNWGRRIRLALQVAKAVE 164
            P ++  L    ++ +  +V+E    G L  ++       R +      +  +Q+  A+E
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS--TPPA----GTI 218
            +HS+   I+HRDIK ANV I      +LGD GL         RF S  T  A    GT 
Sbjct: 121 HMHSKR--IMHRDIKPANVFITATGVVKLGDLGLG--------RFFSSKTTAAHSLVGTP 170

Query: 219 GYLDPCYVTPDNLSTKTDVFSFGILLLEI 247
            Y+ P  +  +  + K+D++S G LL E+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 71.0 bits (174), Expect = 8e-14
 Identities = 73/283 (25%), Positives = 128/283 (45%), Gaps = 52/283 (18%)

Query: 57  FSEQKLLGKGSHGSVYKAVL-----RGRQVAVKKPS----KNQEISQEVDNEIEILSKIH 107
           + + K +G+GS G   KA+L      G+Q  +K+ +      +E  +E   E+ +LS + 
Sbjct: 2   YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKE-REESRKEVAVLSNMK 57

Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYD-------VLHSNNRPLNWGRRIRLALQVA 160
            P +V       ++ +  +V+++   G LY        VL   ++ L+W  +I LAL+  
Sbjct: 58  HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK-- 115

Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTI 218
                 H     I+HRDIKS N+ + ++   +LGDFG+A  L   V+  R       GT 
Sbjct: 116 ------HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR----TCIGTP 165

Query: 219 GYLDP--CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI 276
            YL P  C   P N   K+D+++ G +L E+ + + A + G     ++          KI
Sbjct: 166 YYLSPEICENRPYN--NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL----------KI 213

Query: 277 LSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           +    P +       +R  ++ +  R  R     RPS+  I++
Sbjct: 214 IRGSYPPVSSHYSYDLRNLVSQLFKRNPRD----RPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 59/194 (30%), Positives = 91/194 (46%), Gaps = 18/194 (9%)

Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEI-----SQEVDNEIEILSKIHSPRLVNLL- 115
           LG GS G V  A  +G  +    K  K +EI      Q V  E  IL ++  P +VN++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 116 GFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
            F ++  +R+  ++EF+  G L+  L    R  N   +   A ++  A E LHS+   II
Sbjct: 86  SFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA-ELVLAFEYLHSK--DII 140

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           +RD+K  N+L+D   + ++ DFG A +     F    TP      YL P  +        
Sbjct: 141 YRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPE-----YLAPEVIQSKGHGKA 195

Query: 235 TDVFSFGILLLEII 248
            D ++ G+LL E I
Sbjct: 196 VDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 73.0 bits (179), Expect = 1e-13
 Identities = 68/282 (24%), Positives = 125/282 (44%), Gaps = 36/282 (12%)

Query: 59  EQKLLGKGSHGSVYK--AVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           E+ ++ +G  G+ YK  ++  G Q  VK+ +    I     +EI  + K+  P +V L+G
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS---SEIADMGKLQHPNIVKLIG 750

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP-IIH 175
                K   L+ E++    L +VL    R L+W RR ++A+ +AKA+  LH    P ++ 
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806

Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKT 235
            ++    ++ID      L    L      D   F S+       Y+ P      +++ K+
Sbjct: 807 GNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS------AYVAPETRETKDITEKS 859

Query: 236 DVFSFGILLLEIISCRKAIDIGFS-PPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRK 294
           D++ FG++L+E+++ +   D  F    SIV+WA             D  +    DP +R 
Sbjct: 860 DIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR--------YCYSDCHLDMWIDPSIRG 911

Query: 295 QLAV----------IAVRCVRSCRERRPSMKEIVDWLTGLSK 326
            ++V          +A+ C  +    RP   +++  L   S+
Sbjct: 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953

Length = 968

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 74/277 (26%), Positives = 131/277 (47%), Gaps = 43/277 (15%)

Query: 75  VLRGRQ--VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF 130
           V +GR   VAVK  +P  N+    +   E++ILS++  P ++ LLG   D     ++ E+
Sbjct: 41  VRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEY 100

Query: 131 MSNGTLYDVLHS--------NNRP----------LNWGRRIRLALQVAKAVEILHSEMPP 172
           M NG L   L S        N             +++   + +ALQ+A  ++ L S    
Sbjct: 101 MENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--N 158

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRF--RSTPPAGTIGYLDPCYVTP 228
            +HRD+ + N L+  N   ++ DFG++  L  G D +R   R+  P   I ++    +  
Sbjct: 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAG-DYYRIQGRAVLP---IRWMAWECILM 214

Query: 229 DNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIK-KGKILSVFDPRIPP 286
              +T +DV++FG+ L EI+  C++      +   +++ A    + +G+ + +F P    
Sbjct: 215 GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRP---- 270

Query: 287 PKDPIVRKQLAVIAVRC-VRSCRERRPSMKEIVDWLT 322
              P   + L  + ++C  R CRE RPS  +I  +LT
Sbjct: 271 ---PPCPQGLYELMLQCWSRDCRE-RPSFSDIHAFLT 303

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 52/189 (27%), Positives = 100/189 (52%), Gaps = 9/189 (4%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPS-KNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           +G+GS G V  A ++  G+ VAVKK   + Q+  + + NE+ I+       +V +     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+EF+  G L D++   +  +N  +   + L V KA+ +LH++   +IHRDIK
Sbjct: 88  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLHAQ--GVIHRDIK 143

Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S ++L+  +   +L DFG   +   +  R +S    GT  ++ P  ++      + D++S
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL--VGTPYWMAPELISRLPYGPEVDIWS 201

Query: 240 FGILLLEII 248
            GI+++E++
Sbjct: 202 LGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 54/189 (28%), Positives = 102/189 (53%), Gaps = 9/189 (4%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPS-KNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           +G+GS G V  A  +  G+QVAVKK   + Q+  + + NE+ I+   H   +V++     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+EF+  G L D++   +  +N  +   + L V +A+  LH++   +IHRDIK
Sbjct: 90  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLHNQ--GVIHRDIK 145

Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S ++L+  +   +L DFG   +   +  + +S    GT  ++ P  ++     T+ D++S
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL--VGTPYWMAPEVISRLPYGTEVDIWS 203

Query: 240 FGILLLEII 248
            GI+++E+I
Sbjct: 204 LGIMVIEMI 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 70/281 (24%), Positives = 132/281 (46%), Gaps = 43/281 (15%)

Query: 60  QKLLGKGSHGSVYKAVLR--GRQ---VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++++G G  G V +  L+  G++   VA+K  K    ++  ++  +E  I+ +   P ++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
           +L G    S+  +++ EFM NG L   L  N+      + + +   +A  ++ L SEM  
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL-SEMN- 126

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF---RSTPPAGT--------IGYL 221
            +HRD+ + N+L++ N   ++ DFGL+        RF    ++ P  T        I + 
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLS--------RFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD 281
            P  +     ++ +DV+S+GI++ E++S  +      S   +++     I++       D
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN----AIEQ-------D 227

Query: 282 PRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
            R+PPP D P    QL    + C +  R  RP   +IV  L
Sbjct: 228 YRLPPPMDCPTALHQL---MLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 25/206 (12%)

Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKKPS----KNQEISQEVDNEIEILSKIHSPR 110
           F  +K +G+G    VY+A   L  + VA+KK       + +  Q+   EI++L +++ P 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH--SNNRPLNWGRRI-RLALQVAKAVEILH 167
           ++  L    +  +  +V+E    G L  ++      + L   R + +  +Q+  AVE +H
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA------GTIGYL 221
           S    ++HRDIK ANV I      +LGD GL         RF S+         GT  Y+
Sbjct: 124 SRR--VMHRDIKPANVFITATGVVKLGDLGLG--------RFFSSKTTAAHSLVGTPYYM 173

Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEI 247
            P  +  +  + K+D++S G LL E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 62/194 (31%), Positives = 104/194 (53%), Gaps = 14/194 (7%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVNLLG-FS 118
           LG G+ G VYKA  +  G   A K   +K++E  ++   EIEIL+  + P +V LLG F 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
            D K   +++EF   G +  ++   +R L   +   +  Q+ +A++ LHS    IIHRD+
Sbjct: 80  WDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM--KIIHRDL 136

Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST----- 233
           K+ NVL+  + + +L DFG++ +  V   + R +   GT  ++ P  V  + +       
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAK-NVKTLQRRDS-FIGTPYWMAPEVVMCETMKDTPYDY 194

Query: 234 KTDVFSFGILLLEI 247
           K D++S GI L+E+
Sbjct: 195 KADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 11/196 (5%)

Query: 61  KLLGKGSHGSVYKAVLRGR-----QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           + +G+G  G VY+ V          VAVK  K   +  + ++   E  I+ +   P +V 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G   ++    +V+E    G L   L  N   L+    I  + Q++ A+  L S+    
Sbjct: 72  LIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--F 128

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDI + NVL+      +LGDFGL+ R   D   ++++     I ++ P  +     ++
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLS-RYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187

Query: 234 KTDVFSFGILLLEIIS 249
            +DV+ FG+ + EI+ 
Sbjct: 188 ASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 76/297 (25%), Positives = 133/297 (44%), Gaps = 51/297 (17%)

Query: 57  FSEQKL-----LGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEI 100
           FS  KL     LG+G  G V  A   G           VAVK  K    ++   ++ +E+
Sbjct: 12  FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 71

Query: 101 EILSKIHSPR-LVNLLGFSNDSKDRLLVVEFMSNGTL---------------YDVLHSNN 144
           E++  I   + ++NLLG         ++VE+ S G L               YD+    +
Sbjct: 72  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD 131

Query: 145 RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV 204
             + +   +    QVA+ +E L S+    IHRD+ + NVL+  N   ++ DFGLA     
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDVNN 189

Query: 205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI 263
            ++  ++T     + ++ P  +     + ++DV+SFG+L+ EI +      +G SP P I
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGI 243

Query: 264 -VDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
            V+    L+K+G        R+  P +     +L ++   C  +    RP+ K++V+
Sbjct: 244 PVEELFKLLKEGH-------RMDKPAN--CTNELYMMMRDCWHAIPSHRPTFKQLVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 69.9 bits (172), Expect = 4e-13
 Identities = 51/149 (34%), Positives = 83/149 (55%), Gaps = 15/149 (10%)

Query: 60  QKLLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKI-HSP---R 110
            + LGKG++G V+KA+ R     VA+KK     +N   +Q    EI  L ++   P   +
Sbjct: 12  LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVK 71

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           L+N++   ND KD  LV E+M    L+ V+ +N   L    +  +  Q+ KA++ +HS  
Sbjct: 72  LLNVIKAEND-KDIYLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG- 126

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLA 199
             +IHRD+K +N+L++ +   +L DFGLA
Sbjct: 127 -NVIHRDLKPSNILLNSDCRVKLADFGLA 154

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 49/155 (31%), Positives = 71/155 (45%), Gaps = 26/155 (16%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN---------EIEILSKIHSPRL 111
           LG+G+ G VYKA     GR VA+KK      I    +          EI+IL K+  P +
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKK------ILMHNEKDGFPITALREIKILKKLKHPNV 69

Query: 112 VNLLGF-----SNDSKDRLLV--VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           V L+           + R  V  V    +  L  +L + +  L   +     LQ+ + + 
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN 129

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
            LH     I+HRDIK+AN+LID     ++ DFGLA
Sbjct: 130 YLHENH--ILHRDIKAANILIDNQGILKIADFGLA 162

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 55/211 (26%), Positives = 105/211 (49%), Gaps = 28/211 (13%)

Query: 60  QKLLGKGSHGSVYKAVLRGRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
            + LG+G+     + VL    VAVK  +    +    +   EI+I+S++ +P ++ LLG 
Sbjct: 30  AEFLGEGAPEFDGQPVL----VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV 85

Query: 118 SNDSKDRLLVVEFMSNGTLYDVL----------HSNNRP-LNWGRRIRLALQVAKAVEIL 166
                   ++ E+M NG L   L          H+NN P ++    + +A+Q+A  ++ L
Sbjct: 86  CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL 145

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRF--RSTPPAGTIGYLD 222
            S     +HRD+ + N L+  ++  ++ DFG++  L  G D +R   R+  P   I ++ 
Sbjct: 146 ASL--NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG-DYYRIQGRAVLP---IRWMA 199

Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIIS-CRK 252
              +     +T +DV++FG+ L E+ + C++
Sbjct: 200 WESILLGKFTTASDVWAFGVTLWEMFTLCKE 230

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 42/224 (18%)

Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKK-PSKNQEISQ-----EV 96
           F   DL+       +   +G+G+ G+V K + +  G  +AVK+  S   E  Q     ++
Sbjct: 1   FTAEDLK-------DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53

Query: 97  DNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM--SNGTLYDVLHSNNRPLNWGRRI- 153
           D    ++     P +V   G      D  + +E M  S    Y  ++   +       I 
Sbjct: 54  D---VVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLK-----SVIP 105

Query: 154 -----RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG--VDN 206
                ++A+   KA+  L  E+  IIHRD+K +N+L+DRN N +L DFG+    G  VD+
Sbjct: 106 EEILGKIAVATVKALNYLKEELK-IIHRDVKPSNILLDRNGNIKLCDFGI---SGQLVDS 161

Query: 207 FRFRSTPPAGTIGYLDPCYVTP---DNLSTKTDVFSFGILLLEI 247
                T  AG   Y+ P  + P   D    ++DV+S GI L E+
Sbjct: 162 --IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 68.8 bits (168), Expect = 7e-13
 Identities = 62/254 (24%), Positives = 118/254 (46%), Gaps = 29/254 (11%)

Query: 81  VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYD 138
           VAVK  +   N+    +   EI+I+S++  P ++ LL     S    ++ E+M NG L  
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 139 VL----------HSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN 188
            L           ++   +++   I +A Q+A  ++ L S     +HRD+ + N L+ +N
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL--NFVHRDLATRNCLVGKN 166

Query: 189 FNARLGDFGLA--LRCGVDNFRF--RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILL 244
           +  ++ DFG++  L  G D +R   R+  P   I ++    +     +T +DV++FG+ L
Sbjct: 167 YTIKIADFGMSRNLYSG-DYYRIQGRAVLP---IRWMSWESILLGKFTTASDVWAFGVTL 222

Query: 245 LEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRC 303
            EI++ C++      S   +++        G+       ++  PK  +    L  + + C
Sbjct: 223 WEILTLCKEQPYSQLSDEQVIE------NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSC 276

Query: 304 VRSCRERRPSMKEI 317
            R   + RPS +EI
Sbjct: 277 WRRNAKERPSFQEI 290

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 69.5 bits (170), Expect = 8e-13
 Identities = 69/272 (25%), Positives = 116/272 (42%), Gaps = 58/272 (21%)

Query: 17  TNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVL 76
            +S+S ++  + +S ++    K         S+LE           +G G+ G+VYK + 
Sbjct: 50  PSSSSSSSSSSSASGSAPSAAKS-------LSELERV-------NRIGSGAGGTVYKVIH 95

Query: 77  R--GRQVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMS 132
           R  GR  A+K    N E  + +++  EIEIL  ++ P +V      + + +  +++EFM 
Sbjct: 96  RPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155

Query: 133 NGTLYDVLHSNNRPLNWGRRI-------RLALQVAKAVEILHSEMPPIIHRDIKSANVLI 185
            G+L             G  I        +A Q+   +  LH     I+HRDIK +N+LI
Sbjct: 156 GGSLE------------GTHIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLI 201

Query: 186 DRNFNARLGDFGLALRCGVDNFRFRSTPP----AGTIGYLDPCYVTPDNLSTK-----TD 236
           +   N ++ DF      GV     ++  P     GTI Y+ P  +  D           D
Sbjct: 202 NSAKNVKIADF------GVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGD 255

Query: 237 VFSFGILLLEIISCRKAIDIGFSPPSIVDWAA 268
           ++S G+ +LE    R    +G       DWA+
Sbjct: 256 IWSLGVSILEFYLGRFPFGVGRQG----DWAS 283

Length = 353

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 68.0 bits (166), Expect = 8e-13
 Identities = 48/218 (22%), Positives = 110/218 (50%), Gaps = 27/218 (12%)

Query: 61  KLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           +++G+G+ G V+    +        +Q+ V++ +K++       NE ++L  +  P ++ 
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER--LAAQNECQVLKLLSHPNIIE 63

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI-RLALQVAKAVEILHSEMPP 172
                 + K  ++V+E+   GTL + +      L     I    +Q+  A+  +H+++  
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL-- 121

Query: 173 IIHRDIKSANVLIDRNFN-ARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD-- 229
           I+HRD+K+ N+L+D++    ++GDFG++        +  S+          PCY++P+  
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGIS--------KILSSKSKAYTVVGTPCYISPELC 173

Query: 230 ---NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIV 264
                + K+D+++ G +L E+ S ++A +   + P++V
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFE-AANLPALV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 70/281 (24%), Positives = 125/281 (44%), Gaps = 47/281 (16%)

Query: 63  LGKGSHGSVYKAV---LRGRQ----VAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           LG+G+ G V+ A    L   Q    VAVK     ++   Q+   E E+L+ +    +V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR--------------PLNWGRRIRLALQVA 160
            G   + +  L+V E+M +G L   L S+                 L  G+ + +A Q+A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRF--RSTPPAGT 217
             +  L S     +HRD+ + N L+ +    ++GDFG++      D +R   R+  P   
Sbjct: 133 SGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP--- 187

Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKIL 277
           I ++ P  +     +T++D++SFG++L EI +  K      S    ++     I +G+ L
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE----CITQGREL 243

Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
               PR  PP+         V A+  ++ C +R P  + ++
Sbjct: 244 E--RPRTCPPE---------VYAI--MQGCWQREPQQRMVI 271

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 59/211 (27%), Positives = 110/211 (52%), Gaps = 32/211 (15%)

Query: 63  LGKGSHGSVY----KAVLRGR---QVAVKKPSKNQEISQEVD--NEIEILSKIHSPRLVN 113
           LG+GS G VY    + +++G    +VAVK  +++  + + ++  NE  ++       +V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NN--RPLNWGRR-IRLALQVAKAVE 164
           LLG  +  +  L+V+E M++G L   L S      NN  RP    +  I++A ++A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRFRSTPPAGTIGYLDP 223
            L+++    +HRD+ + N ++  +F  ++GDFG+       D +R       G  G L  
Sbjct: 134 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR------KGGKGLLPV 185

Query: 224 CYVTPDNL-----STKTDVFSFGILLLEIIS 249
            ++ P++L     +T +D++SFG++L EI S
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 68.0 bits (166), Expect = 9e-13
 Identities = 72/276 (26%), Positives = 129/276 (46%), Gaps = 29/276 (10%)

Query: 60  QKLLGKGSHGSVYKAVLR--GRQ---VAVKKPSKNQEISQEVD--NEIEILSKIHSPRLV 112
           +K++G G  G V    L+  G++   VA+K         Q  D  +E  I+ +   P ++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
           +L G    SK  ++V E+M NG+L   L  ++      + + +   +A  ++ L S+M  
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL-SDM-G 126

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG--YLDPCYVTPDN 230
            +HRD+ + N+L++ N   ++ DFGL+ R   D+     T   G I   +  P  +    
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLS-RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP-RIPPPKD 289
            ++ +DV+S+GI++ E++S       G  P     W   +  +  I ++ +  R+P P D
Sbjct: 186 FTSASDVWSYGIVMWEVMS------YGERPY----WE--MSNQDVIKAIEEGYRLPAPMD 233

Query: 290 -PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            P    QL    + C +  R  RP  ++IV  L  L
Sbjct: 234 CPAALHQL---MLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 67/231 (29%), Positives = 103/231 (44%), Gaps = 24/231 (10%)

Query: 26  QTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ---VA 82
           Q    K S   ++P +     Y D       F+  + LG GS G V  A  +      VA
Sbjct: 8   QLHKKKDSDSTKEPKRKNKMKYED-------FNFIRTLGTGSFGRVILATYKNEDFPPVA 60

Query: 83  VKKPSKNQEISQ-EVD---NEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYD 138
           +K+  K++ I Q +VD   +E +IL+ I+ P  VNL G   D     LV+EF+  G  + 
Sbjct: 61  IKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT 120

Query: 139 VLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFG 197
            L  N R P + G     A Q+    E L S    I++RD+K  N+L+D++   ++ DFG
Sbjct: 121 FLRRNKRFPNDVG--CFYAAQIVLIFEYLQSL--NIVYRDLKPENLLLDKDGFIKMTDFG 176

Query: 198 LALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEII 248
            A       +    TP      Y+ P  +         D ++ GI + EI+
Sbjct: 177 FAKVVDTRTYTLCGTPE-----YIAPEILLNVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 71/267 (26%), Positives = 126/267 (47%), Gaps = 29/267 (10%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE---VDNEIEILSKIHSPRLVNLL 115
           +++GKGS+G V     R  G+Q  +KK +      +E    + E ++LS++  P +V   
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AY 64

Query: 116 GFSNDSKDRLL--VVEFMSNGTLYDVLHSNNRPLNWGRRI-RLALQVAKAVEILHSEMPP 172
             S + +D LL  V+ F   G LY  L      L    ++    +Q+A A++ LH +   
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH-- 122

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           I+HRD+K+ NV + R    ++GD G+A R   +     ST   GT  Y+ P   +    +
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIA-RVLENQCDMAST-LIGTPYYMSPELFSNKPYN 180

Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP-PKDPI 291
            K+DV++ G  + E+ + + A    F+   +            +  + + ++PP PKD  
Sbjct: 181 YKSDVWALGCCVYEMATLKHA----FNAKDM---------NSLVYRIIEGKLPPMPKD-- 225

Query: 292 VRKQLAVIAVRCVRSCRERRPSMKEIV 318
              +L  +    +    E+RPS+K I+
Sbjct: 226 YSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 36/206 (17%)

Query: 62  LLGKGSHGSVYKAVLR--GRQVAVKK--PSKNQEISQEVDNEIEILSKIH-SPRLVNLLG 116
            +G G+ G VYK   +  G  +AVK+   + N+E ++ +  +++++ K H  P +V   G
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81

Query: 117 -FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI----------RLALQVAKAVEI 165
            F  DS D  + +E MS  T  D L          +RI          ++ + + KA+  
Sbjct: 82  YFITDS-DVFICMELMS--TCLDKLL---------KRIQGPIPEDILGKMTVAIVKALHY 129

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           L  E   +IHRD+K +N+L+D + N +L DFG++ R      + RS   AG   Y+ P  
Sbjct: 130 L-KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS---AGCAAYMAPER 185

Query: 226 VTPDNLSTK----TDVFSFGILLLEI 247
           + P + + K     DV+S GI L+E+
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVEL 211

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 55/203 (27%), Positives = 106/203 (52%), Gaps = 18/203 (8%)

Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVK---KPSKNQEISQEVDNEIEILSKIH---S 108
           +   +L+G+G++G+VY+   V  GR VA+K     + + ++S ++  E+ +LS++     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS-DIQREVALLSQLRQSQP 61

Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL-QVAKAVEILH 167
           P +    G         +++E+   G++  ++ +   P+   + I + + +V  A++ +H
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG--PIA-EKYISVIIREVLVALKYIH 118

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
                +IHRDIK+AN+L+    N +L DFG+A      N   RST   GT  ++ P  +T
Sbjct: 119 KV--GVIHRDIKAANILVTNTGNVKLCDFGVAALL-NQNSSKRST-FVGTPYWMAPEVIT 174

Query: 228 PDNL-STKTDVFSFGILLLEIIS 249
                 TK D++S GI + E+ +
Sbjct: 175 EGKYYDTKADIWSLGITIYEMAT 197

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 46/227 (20%)

Query: 61  KLLGKGSHGSVYKAVLRG--RQVAVKKPSKNQEI----SQEVDNEIEILSKIHSPRLVNL 114
           KLLGKG  G V+   L+G  +  A+K   K + I     + V  E EIL+ +  P L  L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIR------LALQVAKAVEILHS 168
                      LV+++   G L+ +L    +P   G+ +        A +V  A+E LH 
Sbjct: 67  YASFQTETYLCLVMDYCPGGELFRLL--QRQP---GKCLSEEVARFYAAEVLLALEYLH- 120

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV--------------------DNFR 208
            +  I++RD+K  N+L+  + +  L DF L+ +  V                        
Sbjct: 121 -LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179

Query: 209 FRSTPPA-------GTIGYLDPCYVTPDNLSTKTDVFSFGILLLEII 248
             S  P+       GT  Y+ P  ++ D   +  D ++ GILL E++
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 65/272 (23%), Positives = 123/272 (45%), Gaps = 34/272 (12%)

Query: 63  LGKGSHGSVYKAVLRGRQVAVKKPS----KNQEISQEVDNEIEILSKIHSPRLVNLLG-F 117
           LG G+ GSV K         + K          + +++  E++I+ +  SP +V+  G F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
            N++ +  + +EFM  G+L D ++    P+      ++A+ V + +  L++    I+HRD
Sbjct: 73  LNEN-NICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR-IMHRD 129

Query: 178 IKSANVLIDRNFNARLGDFGLA---LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           IK +N+L++     +L DFG++   +    D F        GT  Y+ P  +     + K
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSGELINSIADTF-------VGTSTYMSPERIQGGKYTVK 182

Query: 235 TDVFSFGILLLEIISCR-------KAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP 287
           +DV+S GI ++E+   +          D    P  I+D    L++  +I+    PR+P  
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD----LLQ--QIVQEPPPRLPSS 236

Query: 288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
             P   + L      C+      RP+ +++  
Sbjct: 237 DFP---EDLRDFVDACLLKDPTERPTPQQLCA 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 53/195 (27%), Positives = 97/195 (49%), Gaps = 12/195 (6%)

Query: 63  LGKGSHGSVYKAVLRGRQ----VAVK---KPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           LG G+ G+V K + + ++    VAVK     + +  +  E+  E  ++ ++ +P +V ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
           G   +++  +LV+E    G L   L   N+ +       L  QV+  ++ L  E    +H
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYL--EETNFVH 118

Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           RD+ + NVL+     A++ DFGL+   G D N+    T     + +  P  +     S+K
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178

Query: 235 TDVFSFGILLLEIIS 249
           +DV+SFG+L+ E  S
Sbjct: 179 SDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 16/195 (8%)

Query: 63  LGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN---EIEILSKIHSPRLVNLLGFSN 119
           LG G+ G VYKA  +   V       + +  +E+++   EI+IL+    P +V LL    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +++EF + G +  V+    RPL   +   +  Q  +A+  LH     IIHRD+K
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN--KIIHRDLK 130

Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRF--RSTPPAGTIGYLDP----CYVTPDN-LS 232
           + N+L   + + +L DFG++ +    N R   R     GT  ++ P    C  + D    
Sbjct: 131 AGNILFTLDGDIKLADFGVSAK----NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186

Query: 233 TKTDVFSFGILLLEI 247
            K DV+S GI L+E+
Sbjct: 187 YKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 39/211 (18%)

Query: 60  QKL--LGKGSHGSVYKA--VLRGRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLV 112
           +KL  +G+G++G VY+A     G  VA+KK   + E   I      EI +L  +  P +V
Sbjct: 10  EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV 69

Query: 113 NLL----GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
            L     G   DS    LV+E+     L  +L +   P +  +   L LQ+ + ++ LH 
Sbjct: 70  ELKEVVVGKHLDSI--FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE 126

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT- 227
               IIHRD+K +N+L+      ++ DFGLA   G          PA     + P  VT 
Sbjct: 127 NF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYG---------LPAKP---MTPKVVTL 172

Query: 228 ----P------DNLSTKTDVFSFGILLLEII 248
               P         +T  D+++ G +L E++
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELL 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 40/276 (14%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHS-PRLVNLLG--F 117
           +GKG++G V+K + +  G + AVK      +I +E++ E  IL  +   P +V   G  +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85

Query: 118 SNDSK--DRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIR---LALQVAKAVEIL-HSEM 170
             D K  D+L LV+E  + G++ D++      L  G R+    +A  + +A+  L H  +
Sbjct: 86  KKDVKNGDQLWLVLELCNGGSVTDLVKGF---LKRGERMEEPIIAYILHEALMGLQHLHV 142

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP----CYV 226
              IHRD+K  N+L+      +L DFG++ +  + + R R     GT  ++ P    C  
Sbjct: 143 NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTSVGTPFWMAPEVIACEQ 200

Query: 227 TPDN-LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP 285
             D+    + DV+S GI          AI++G   P + D   P+    KI     PR P
Sbjct: 201 QLDSTYDARCDVWSLGI---------TAIELGDGDPPLAD-LHPMRALFKI-----PRNP 245

Query: 286 PPK---DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           PP      +   +      +C+    E+RP++ +++
Sbjct: 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 78/295 (26%), Positives = 133/295 (45%), Gaps = 56/295 (18%)

Query: 61  KLLGKGSHGSVYKA----VLRGRQ-----VAVKKPSKNQEISQEVD--NEIEILSKIHSP 109
           K LG+G  G V +A    + + R      VAVK    N       D  +E+E++  I   
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTL---------------YDVLHSNNRPLNWGRRI 153
           + ++NLLG         ++VE+ + G L               +D+       L++   +
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
             A QVA+ +E L S     IHRD+ + NVL+  +   ++ DFGLA   GV +  +    
Sbjct: 138 SCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDYYKKT 193

Query: 214 PAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDW 266
              + G L   ++ P+ L     + ++DV+SFGIL+ EI +      +G SP P I V+ 
Sbjct: 194 ---SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT------LGGSPYPGIPVEE 244

Query: 267 AAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
              L+++G        R+  P       +L ++   C  +   +RP+ K++V+ L
Sbjct: 245 LFKLLREGH-------RMDKP--SNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 27/208 (12%)

Query: 57  FSEQKLLGKGSHGSVYKAVL--RGRQV-AVKKPSKNQEISQEVD----NEIEILSKIHSP 109
           F   K++G+G+ G V + V     +QV A+K  SK + I +        E +I++  +S 
Sbjct: 45  FDVIKVIGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSE 103

Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
            +V L     D K   +V+E+M  G L +++ + + P  W R      +V  A++ +HS 
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARF--YTAEVVLALDAIHSM 161

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
               IHRD+K  N+L+D++ + +L DFG  ++   +    R     GT     P Y++P+
Sbjct: 162 --GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGT-----PDYISPE 213

Query: 230 NLSTK---------TDVFSFGILLLEII 248
            L ++          D +S G+ L E++
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 65.3 bits (159), Expect = 7e-12
 Identities = 54/213 (25%), Positives = 106/213 (49%), Gaps = 23/213 (10%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKNQEISQEVDN---EIEILSKIHS 108
           F+  ++LGKG  GSV +A L+      ++VAVK    +   S +++    E   + +   
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 109 PRLVNLLGFS--NDSKDRL----LVVEFMSNGTLYDVLHSN---NRPLNWGRR--IRLAL 157
           P ++ L+G S  + +K RL    +++ FM +G L+  L  +     P     +  +R  +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 158 QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT 217
            +A  +E L S+    IHRD+ + N +++ N    + DFGL+ +    ++  +       
Sbjct: 121 DIASGMEYLSSK--NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178

Query: 218 IGYLDPCYVTPDNL-STKTDVFSFGILLLEIIS 249
           + +L       DN+ +T +DV++FG+ + EI++
Sbjct: 179 VKWL-ALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 40/261 (15%)

Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQEVDNEIEIL 103
           D S L      F   +++G G++G VYK   V  G+  A+K     ++  +E+  EI +L
Sbjct: 7   DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66

Query: 104 SKI-HSPRLVNLLG-FSNDS----KDRL-LVVEFMSNGTLYDVLHS---NNRPLNWGRRI 153
            K  H   +    G F   S     D+L LV+EF   G++ D++ +   N    +W   I
Sbjct: 67  KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126

Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
               ++ + +  LH+    +IHRDIK  NVL+  N   +L DFG++ +  +D    R   
Sbjct: 127 --CREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNT 180

Query: 214 PAGTIGYLDP----CYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA 268
             GT  ++ P    C   PD     ++D++S GI  +E                + + A 
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE----------------MAEGAP 224

Query: 269 PLIKKGKILSVF-DPRIPPPK 288
           PL     + ++F  PR PPPK
Sbjct: 225 PLCDMHPMRALFLIPRNPPPK 245

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 25/206 (12%)

Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPS----KNQEISQEVDNEIEILSKIHSPR 110
           F  +K +G+G    VY+A  +L G  VA+KK       + +   +   EI++L +++ P 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH--SNNRPLNWGRRI-RLALQVAKAVEILH 167
           ++       +  +  +V+E    G L  ++      + L   + + +  +Q+  A+E +H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA------GTIGYL 221
           S    ++HRDIK ANV I      +LGD GL         RF S+         GT  Y+
Sbjct: 124 SRR--VMHRDIKPANVFITATGVVKLGDLGLG--------RFFSSKTTAAHSLVGTPYYM 173

Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEI 247
            P  +  +  + K+D++S G LL E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 74/288 (25%), Positives = 134/288 (46%), Gaps = 46/288 (15%)

Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G  G V  A   G          +VAVK  K    ++   ++ +E+E++  I   
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               L++   +
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
             A QVA+ +E L S+    IHRD+ + NVL+  +   ++ DFGLA      ++  ++T 
Sbjct: 144 SCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+LL EI +      +G SP P + V+    L+
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVEELFKLL 255

Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+
Sbjct: 256 KEGH-------RMDKPSN--CTNELYMMMRDCWHAVPSQRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 19/208 (9%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA  +  G  VA+KK   + E   +      EI +L +++ P +
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 112 VNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLAL-QVAKAVEILHS 168
           V LL   +      LV EF+        D    +  PL     I+  L Q+ + +   HS
Sbjct: 62  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLP---LIKSYLFQLLQGLAFCHS 118

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS-TPPAGTIGYLDP-CYV 226
               ++HRD+K  N+LI+     +L DFGLA   GV     R+ T    T+ Y  P   +
Sbjct: 119 HR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEILL 173

Query: 227 TPDNLSTKTDVFSFGILLLEIISCRKAI 254
                ST  D++S G +  E+++ R+A+
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 77/289 (26%), Positives = 134/289 (46%), Gaps = 48/289 (16%)

Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK---KPSKNQEISQEVDNEIEILSKIHS 108
           K LG+G  G V  A   G           VAVK     + ++++S  V +E+E++  I  
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV-SEMEMMKMIGK 76

Query: 109 PR-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRR 152
            + ++NLLG         ++VE+ S G L + L +   P               L +   
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST 212
           +  A QVA+ +E L S+    IHRD+ + NVL+  +   ++ DFGLA      ++  ++T
Sbjct: 137 VSCAYQVARGMEYLASQ--KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPL 270
                + ++ P  +     + ++DV+SFG+LL EI +      +G SP P I V+    L
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT------LGGSPYPGIPVEELFKL 248

Query: 271 IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           +K+G        R+  P +     +L +I   C  +   +RP+ K++V+
Sbjct: 249 LKEGH-------RMDKPAN--CTHELYMIMRECWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 64/198 (32%), Positives = 98/198 (49%), Gaps = 16/198 (8%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVD-----NEIEILSKIHSPRLVN 113
           ++LGKGS G V  A L+  GR  AVK   K+  I Q+ D      E  ILS   +   + 
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDV-ILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 114 LLGFSNDSKDRLL-VVEFMSNGTLYDVLH-SNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
            L     + DRL  V+EF++ G L  + H   +R  +  R    A ++  A+  LH +  
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDK-- 115

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            II+RD+K  NVL+D   + +L DFG+  + G+ N +  ST   GT  Y+ P  +     
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMC-KEGIFNGKTTST-FCGTPDYIAPEILQEMLY 173

Query: 232 STKTDVFSFGILLLEIIS 249
               D ++ G+LL E++ 
Sbjct: 174 GPSVDWWAMGVLLYEMLC 191

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 61/277 (22%), Positives = 128/277 (46%), Gaps = 24/277 (8%)

Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKP--------SKNQEISQEVDNEIEILSKIHSPRLV 112
           KLLG G  G+V+K +      ++K P           ++  QE+ + +  +  +    +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            LLG    +  +L V +    G+L D +  +   L+  R +   +Q+AK +  L  E   
Sbjct: 73  RLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL--EEHR 129

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           ++HR++ + N+L+  +   ++ DFG+A     D+ ++  +     I ++    +     +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189

Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV 292
            ++DV+S+G+ + E++S       G  P  + D    L++KG+       R+  P+  I 
Sbjct: 190 HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD----LLEKGE-------RLAQPQ--IC 236

Query: 293 RKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
              + ++ V+C       RP+ KE+ +  T +++  P
Sbjct: 237 TIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPP 273

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 43/152 (28%), Positives = 79/152 (51%), Gaps = 11/152 (7%)

Query: 54  TNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHS 108
           TN + + + +G G+ G V  A   L G+ VA+KK   P     +++    E+++L  +  
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 109 PRLVNLLG-FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
             +++L   F +  +D   V E +    L+ +L S  RPL          Q+ + ++ +H
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTS--RPLEKQFIQYFLYQILRGLKYVH 125

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
           S    ++HRD+K +N+LI+ N + ++ DFGLA
Sbjct: 126 S--AGVVHRDLKPSNILINENCDLKICDFGLA 155

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 40/283 (14%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPS-KNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           +G+GS G V  A  +  GRQVAVK    + Q+  + + NE+ I+       +V +     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
             ++  +++EF+  G L D++ S  R LN  +   +   V +A+  LHS+   +IHRDIK
Sbjct: 89  VGEELWVLMEFLQGGALTDIV-SQTR-LNEEQIATVCESVLQALCYLHSQ--GVIHRDIK 144

Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S ++L+  +   +L DFG   +   D  + +S    GT  ++ P  ++     T+ D++S
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAPEVISRTPYGTEVDIWS 202

Query: 240 FGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK-------DPIV 292
            GI+++E++           PP   D     +K+ +         PPPK        P++
Sbjct: 203 LGIMVIEMVDGE--------PPYFSDSPVQAMKRLR-------DSPPPKLKNAHKISPVL 247

Query: 293 RKQLAVIAVRCVRSCRERRPSMKEIVD----WLTGLSK-LVPL 330
           R  L  +  R      + R + +E++D      TGL + LVPL
Sbjct: 248 RDFLERMLTR----EPQERATAQELLDHPFLLQTGLPECLVPL 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 32/207 (15%)

Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPS----KNQEISQEVDNEIEILSKIHSPR 110
           F++ + +G GS G+VY A  V     VA+KK S    ++ E  Q++  E+  L ++  P 
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS-E 169
            +   G         LV+E+   G+  D+L  + +PL       +     + +  LHS E
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE 135

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLA-LRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               IHRDIK+ N+L+      +L DFG A L    ++F        GT     P ++ P
Sbjct: 136 R---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-------VGT-----PYWMAP 180

Query: 229 D--------NLSTKTDVFSFGILLLEI 247
           +            K DV+S GI  +E+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 27/165 (16%)

Query: 56  GFSEQKLLGKGSHGSVYKAVL----RGRQVAVK--KPSKNQE--ISQEVDNEIEILSKIH 107
            +  +  +G+G++G VYKA       G++ A+K  K  K Q   ISQ    EI +L ++ 
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 108 SPRLVNLLGFSNDSKDRL--LVVEFMSNGTLYDVLH-------SNNRPLNWGRRIRLALQ 158
              +V+L+    +  D+   L+ ++      +D+         +    +       L  Q
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116

Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLIDRNFNAR----LGDFGLA 199
           +   V  LHS    ++HRD+K AN+L+      R    +GD GLA
Sbjct: 117 ILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLA 159

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 25/215 (11%)

Query: 49  DLEAATNGFSEQKLLGKGSHGSV--YKAVLRGRQVAVKKPSKNQEISQEVD----NEIEI 102
           DL      +   K++G+G+ G V   +     +  A+K  SK + I +        E +I
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 103 LSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
           ++  +SP +V L     D +   +V+E+M  G L +++ + + P  W R      +V  A
Sbjct: 97  MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF--YTAEVVLA 154

Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           ++ +HS     IHRD+K  N+L+D++ + +L DFG  ++   +    R     GT     
Sbjct: 155 LDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGT----- 206

Query: 223 PCYVTPDNLSTK---------TDVFSFGILLLEII 248
           P Y++P+ L ++          D +S G+ L E++
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 51/153 (33%), Positives = 77/153 (50%), Gaps = 11/153 (7%)

Query: 60  QKL--LGKGSHGSVYKA--VLRGRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLV 112
           QK+  +G+G++G VYKA   L G  VA+KK     E   +      EI +L +++ P +V
Sbjct: 2   QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIV 61

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL-QVAKAVEILHSEMP 171
            LL   +      LV EF+ +  L   + S+         I+  L Q+ + +   HS   
Sbjct: 62  RLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR- 119

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGV 204
            ++HRD+K  N+LIDR    +L DFGLA   GV
Sbjct: 120 -VLHRDLKPQNLLIDREGALKLADFGLARAFGV 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 31/204 (15%)

Query: 63  LGKGSHGSVYKAVLRGRQ----VAVKK--PSKNQEISQEVDNEIEI-LSKIHSPRLVNLL 115
           LG+G++G V K  +R       +AVK+   + N +  + +  +++I +  +  P  V   
Sbjct: 9   LGRGAYGVVDK--MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI------RLALQVAKAVEILHSE 169
           G      D  + +E M   T  D  +      + G  I      ++A+ + KA+E LHS+
Sbjct: 67  GALFREGDVWICMEVMD--TSLDKFYKK--VYDKGLTIPEDILGKIAVSIVKALEYLHSK 122

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG--VDNFRFRSTPPAGTIGYLDPCYVT 227
           +  +IHRD+K +NVLI+RN   +L DFG++   G  VD+     T  AG   Y+ P  + 
Sbjct: 123 LS-VIHRDVKPSNVLINRNGQVKLCDFGIS---GYLVDS--VAKTIDAGCKPYMAPERIN 176

Query: 228 PD----NLSTKTDVFSFGILLLEI 247
           P+        K+DV+S GI ++E+
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 26/204 (12%)

Query: 61  KLLGK---GSHGSVYKA--VLRGRQVAVKKPSKNQEISQEVDN--EIEILSKI-HSPRLV 112
           K+LGK   G+   V KA     G+  A+K   K+ +  ++V+N  EI+ L ++   P ++
Sbjct: 2   KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNIL 61

Query: 113 NLLGFSNDSKD-RL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            L+    D K  RL LV E M +  LY+++    RPL   R      Q+ K+++ +H   
Sbjct: 62  RLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN- 119

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPP----AGTIGYLDP-CY 225
             I HRDIK  N+LI  +   +L DFG     G+      S PP      T  Y  P C 
Sbjct: 120 -GIFHRDIKPENILIKDD-ILKLADFGSC--RGIY-----SKPPYTEYISTRWYRAPECL 170

Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +T      K D+++ G +  EI+S
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 55/214 (25%), Positives = 103/214 (48%), Gaps = 25/214 (11%)

Query: 50  LEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVD----NEIEIL 103
           L+     +   K++G+G+ G V     +  Q   A+K  SK + I +        E +I+
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
           +  +SP +V L     D K   +V+E+M  G L +++ + + P  W +      +V  A+
Sbjct: 98  AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF--YTAEVVLAL 155

Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           + +HS    +IHRD+K  N+L+D++ + +L DFG  ++   +    R     GT     P
Sbjct: 156 DAIHSM--GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD-ETGMVRCDTAVGT-----P 207

Query: 224 CYVTPDNLSTK---------TDVFSFGILLLEII 248
            Y++P+ L ++          D +S G+ L E++
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 32/217 (14%)

Query: 63  LGKGSHGSVYKA----VLRGRQ---VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           +G+G+ G V++A    +L       VAVK  K   + ++  +   E  ++++   P +V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR---------------------PLNWGRR 152
           LLG     K   L+ E+M+ G L + L   +                      PL+   +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST 212
           + +A QVA  +  L SE    +HRD+ + N L+  N   ++ DFGL+      ++   S 
Sbjct: 133 LCIAKQVAAGMAYL-SERK-FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE 190

Query: 213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
             A  I ++ P  +  +  +T++DV+++G++L EI S
Sbjct: 191 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 68/296 (22%), Positives = 127/296 (42%), Gaps = 47/296 (15%)

Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEIS--QEVDNE 99
           ++  +T  F E+  LG+   G VYK  L G       + VA+K      E    +E  +E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 100 IEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVL-----HSNNRPLNWGRRIR 154
             + S++  P +V LLG     +   ++  + S+  L++ L     HS+    +  + ++
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 155 LAL----------QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-G 203
             L          Q+A  +E L S    ++H+D+ + NVL+    N ++ D GL      
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 204 VDNFRF--RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP 261
            D ++    S  P   I ++ P  +     S  +D++S+G++L E+ S       G+S  
Sbjct: 177 ADYYKLMGNSLLP---IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 233

Query: 262 SIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
            +++    +I+  ++L       P P D      +  + + C      RRP  K+I
Sbjct: 234 DVIE----MIRNRQVL-------PCPDD--CPAWVYTLMLECWNEFPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 35/216 (16%)

Query: 61  KLLGKGSHGSVYKAVLRG--------RQVAVKKPSKNQEISQEVD--NEIEILSKIHSPR 110
             LG G+ G VY+              +VAVK   K     ++ +   E  ++S  + P 
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP------LNWGRRIRLALQVAKAVE 164
           +V LLG    ++ + +++E M  G L   L            L     + + L VAK   
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 165 ILHSEMPPIIHRDIKSANVLI-----DRNFNARLGDFGLALRC-GVDNFRFRSTPPAGTI 218
            L  E    IHRD+ + N L+     D +   ++GDFGLA      D +R          
Sbjct: 121 YL--EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE------ 172

Query: 219 GYLDPCYVTPDNL-----STKTDVFSFGILLLEIIS 249
           G L   ++ P++L     +T++DV+SFG+L+ EI++
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 62.8 bits (152), Expect = 7e-11
 Identities = 70/292 (23%), Positives = 131/292 (44%), Gaps = 35/292 (11%)

Query: 60  QKLLGKGSHGSVYKAV---LRGRQ----VAVKK-PSKNQEISQEVDNEIEILSKIHSPRL 111
           ++ LG+G+ G V+ A    L   Q    VAVK     +    ++   E E+L+ +    +
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSN----------NRP--LNWGRRIRLALQV 159
           V   G   +    ++V E+M +G L   L ++          NRP  L   + + +A Q+
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG 219
           A  +  L S+    +HRD+ + N L+  N   ++GDFG++      ++          I 
Sbjct: 130 AAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV 279
           ++ P  +     +T++DV+S G++L EI +  K      S   +++     I +G++L  
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE----CITQGRVLQ- 242

Query: 280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLH 331
             PR  P       K++  + + C +     R ++KEI   L  L+K  P++
Sbjct: 243 -RPRTCP-------KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVY 286

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 74/282 (26%), Positives = 123/282 (43%), Gaps = 42/282 (14%)

Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVN 113
           F   +L+G G++G VYK   V  G+  A+K      +  +E+  EI +L K  H   +  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 114 LLG-FSNDS----KDRL-LVVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVE 164
             G F   +     D+L LV+EF   G++ D++ +   N     W   I    ++ + + 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI--CREILRGLS 125

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP- 223
            LH     +IHRDIK  NVL+  N   +L DFG++ +  +D    R     GT  ++ P 
Sbjct: 126 HLHQH--KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPE 181

Query: 224 ---CYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV 279
              C   PD     K+D++S GI  +E                + + A PL     + ++
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIE----------------MAEGAPPLCDMHPMRAL 225

Query: 280 F-DPRIPPP--KDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           F  PR P P  K     K+       C+     +RP+ ++++
Sbjct: 226 FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLM 267

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 29/212 (13%)

Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIE-------ILS-KIHSPR 110
           K+LGKGS G V  A L+G+    AVK   K+  +   +D+++E       +L+    +P 
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL---IDDDVECTMVEKRVLALAWENPF 57

Query: 111 LVNLLGFSNDSKDRLL-VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           L +L   +  +K+ L  V+EF++ G L   +    R  +  R    A ++   ++ LHS+
Sbjct: 58  LTHLYC-TFQTKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSK 115

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF-RFRSTPPAGTIGYLDPCYVTP 228
              II+RD+K  NV++DR+ + ++ DFG+   C  + F   R++   GT  Y+ P  +  
Sbjct: 116 G--IIYRDLKLDNVMLDRDGHIKIADFGM---CKENVFGDNRASTFCGTPDYIAPEILQG 170

Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
              +   D +SFG+LL E++       IG SP
Sbjct: 171 LKYTFSVDWWSFGVLLYEML-------IGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 29/217 (13%)

Query: 61  KLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVD-----NEIEILSKIHS-PRLVN 113
           K+LGKGS G V  A L+G  ++   K  K   I Q+ D      E  +L+     P L  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 114 LLGFSN-DSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           L   S   +KDRL  V+E+++ G L   +  + R  +  R    A ++   ++ LH    
Sbjct: 61  L--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR-FDEPRARFYAAEIVLGLQFLHER-- 115

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLA---LRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
            II+RD+K  NVL+D   + ++ DFG+    +  GV    F  TP      Y+ P  ++ 
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP-----DYIAPEILSY 170

Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
                  D ++ G+LL E++        G SP    D
Sbjct: 171 QPYGPAVDWWALGVLLYEML-------AGQSPFEGDD 200

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.0 bits (153), Expect = 2e-10
 Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 43/221 (19%)

Query: 126 LVVEFMSNGTLYDVLHSN---NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSAN 182
           LV+++ + G L   + S    NR         L +QV  AV  +HS+   +IHRDIKSAN
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSAN 173

Query: 183 VLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL---DPCYVTPD-----NLSTK 234
           +L+  N   +LGDFG +        +  +   +  +G      P YV P+       S K
Sbjct: 174 ILLCSNGLVKLGDFGFS--------KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK 225

Query: 235 TDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILS-VFDPRIPPPKDPIVR 293
            D+FS G+LL E+++ ++  D G +   ++          K L+  +DP +PP   P   
Sbjct: 226 ADMFSLGVLLYELLTLKRPFD-GENMEEVMH---------KTLAGRYDP-LPPSISP--- 271

Query: 294 KQLAVIAVRCVRSCRERRPSMKEIVD------WLTGLSKLV 328
            ++  I    + S  +RRPS  ++++      +++GL ++V
Sbjct: 272 -EMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIV 311

Length = 496

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 46/157 (29%), Positives = 78/157 (49%), Gaps = 17/157 (10%)

Query: 55  NGFSEQKLLGKGSHGSVYKAVLRGRQ----VAVKKPSK----NQEISQEVDNEIEILSKI 106
           + F   K++G+G+ G V+  ++R +      A+K   K     +     V  E +IL+  
Sbjct: 1   DDFEVIKVIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA 58

Query: 107 HSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVL-HSNNRPLNWGRRIRLALQVAKAVE 164
            SP +V L  +S   ++ L LV+E+M  G L ++L   +  P    R      ++  A++
Sbjct: 59  DSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARF--YIAELVLALD 115

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR 201
            +H      IHRDIK  N+LID + + +L DFGL  +
Sbjct: 116 SVHKL--GFIHRDIKPDNILIDADGHIKLADFGLCKK 150

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 19/207 (9%)

Query: 61  KLLGKGSHGSVYKAVLRG-RQVAVKKPSKNQEISQEVDNEIEILSK------IHSPRLVN 113
           K+LGKGS G V+ A L+G  Q    K  K   +  + D E  ++ K         P L +
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L       ++   V+E+++ G L   + S ++  +  R    A ++   ++ LHS+   I
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQFLHSK--GI 117

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           ++RD+K  N+L+D + + ++ DFG+     + +   ++    GT  Y+ P  +     +T
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILLGQKYNT 175

Query: 234 KTDVFSFGILLLEIISCRKAIDIGFSP 260
             D +SFG+LL E++       IG SP
Sbjct: 176 SVDWWSFGVLLYEML-------IGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 51/206 (24%), Positives = 95/206 (46%), Gaps = 25/206 (12%)

Query: 61  KLLGKGSHGSVYKAVLRG-------------RQVAVKKPSKNQEISQEVDNEIEILSKIH 107
           ++LG G++G V+     G             ++  + + +K  E ++    E ++L  + 
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTR---TERQVLEAVR 62

Query: 108 -SPRLVNL-LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
             P LV L   F  D+K  L ++++++ G L+  L+          R+ +A ++  A++ 
Sbjct: 63  RCPFLVTLHYAFQTDTKLHL-ILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDH 120

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LH     II+RDIK  N+L+D   +  L DFGL+     +    R+    GTI Y+ P  
Sbjct: 121 LHQL--GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE-EERAYSFCGTIEYMAPEV 177

Query: 226 VT--PDNLSTKTDVFSFGILLLEIIS 249
           +           D +S G+L  E+++
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 20/203 (9%)

Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           + + K +G G+ G V  A   + G  VAVKK   P +NQ  ++    E+ +L  ++   +
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 112 VNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++LL      K      D  LV+E M +  L  V+H     L+  R   L  Q+   ++ 
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKH 138

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    IIHRD+K +N+++  +   ++ DFGLA R    NF    TP   T  Y  P  
Sbjct: 139 LHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTACTNFMM--TPYVVTRYYRAPEV 193

Query: 226 VTPDNLSTKTDVFSFGILLLEII 248
           +         D++S G ++ E++
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 19/200 (9%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G+G++G VYKA  R     +A+KK    QE   +      EI +L ++    +V L   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA----LQVAKAVEILHSEMPPI 173
            +  K   LV E++    L    H ++ P ++ +  RL      Q+ + +   HS    +
Sbjct: 70  VHSEKRLYLVFEYLD---LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR--V 123

Query: 174 IHRDIKSANVLIDRNFNA-RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTPDNL 231
           +HRD+K  N+LIDR  NA +L DFGLA   G+    F  T    T+ Y  P   +   + 
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF--THEVVTLWYRAPEILLGSRHY 181

Query: 232 STKTDVFSFGILLLEIISCR 251
           ST  D++S G +  E+++ +
Sbjct: 182 STPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 28/156 (17%)

Query: 63  LGKGSHGSVYKAV--LRGRQVAVKKPSKNQEISQEVDN---------EIEILSKIHSPRL 111
           +G G++G V  A+    G++VA+KK      I    D          E++IL       +
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKK------IPHAFDVPTLAKRTLRELKILRHFKHDNI 66

Query: 112 VNLLGF----SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL-QVAKAVEIL 166
           + +         D KD  +V++ M +  L+ ++HS+ +PL     IR  L Q+ + ++ +
Sbjct: 67  IAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSD-QPLT-EEHIRYFLYQLLRGLKYI 123

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC 202
           HS    +IHRD+K +N+L++ +   R+GDFG+A R 
Sbjct: 124 HSA--NVIHRDLKPSNLLVNEDCELRIGDFGMA-RG 156

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 13/198 (6%)

Query: 61  KLLGKGSHGSV--YKAVLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPRLVNL 114
           KLLGKG+ G V   +    G+  A+K   K   I+++       E  +L     P L +L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 115 LGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
             +S  +KDRL  V+E+++ G L+  L S  R  +  R      ++  A++ LHS    I
Sbjct: 61  -KYSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGAEIVSALDYLHSG--KI 116

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           ++RD+K  N+++D++ + ++ DFGL      D    ++    GT  YL P  +  ++   
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF--CGTPEYLAPEVLEDNDYGR 174

Query: 234 KTDVFSFGILLLEIISCR 251
             D +  G+++ E++  R
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 72/280 (25%), Positives = 125/280 (44%), Gaps = 46/280 (16%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSN 119
           +GKG++G VYK   +  G   AVK      ++ +E++ E  IL  + + P +V   G   
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89

Query: 120 DSKDRL------LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL----QVAKAVEILHSE 169
            + D+L      LV+E  + G++ +++      L  G+R+  A+         + + H  
Sbjct: 90  KA-DKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLGLQHLH 145

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP----CY 225
              IIHRD+K  N+L+      +L DFG++ +  + + R R     GT  ++ P    C 
Sbjct: 146 NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTSVGTPFWMAPEVIACE 203

Query: 226 VTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD-PR 283
              D +   + DV+S GI          AI++G   P       PL     + ++F  PR
Sbjct: 204 QQYDYSYDARCDVWSLGI---------TAIELGDGDP-------PLFDMHPVKTLFKIPR 247

Query: 284 IPPPK----DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
            PPP     +   R     I+ +C+    E RPS+  +++
Sbjct: 248 NPPPTLLHPEKWCRSFNHFIS-QCLIKDFEARPSVTHLLE 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 58/242 (23%), Positives = 107/242 (44%), Gaps = 22/242 (9%)

Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEI----EILSKIHSPRLV 112
           F +   LG G+ G V K + R   + + +   + EI   + N+I    ++L + +SP +V
Sbjct: 3   FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMP 171
              G      +  + +E M  G+L  VL    R P N   +I +A  V + +  L  +  
Sbjct: 63  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA--VLRGLTYLREKHK 120

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLA---LRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
            I+HRD+K +N+L++     +L DFG++   +    ++F        GT  Y+ P  +  
Sbjct: 121 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-------VGTRSYMSPERLQG 172

Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
            + + ++D++S G+ L+E+   R  I     PP   +  A   +        +   P   
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYPI----PPPDAKELEAMFGRPVSEGEAKESHRPVSG 228

Query: 289 DP 290
            P
Sbjct: 229 HP 230

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 16/196 (8%)

Query: 63  LGKGSHGSVYKAVLRGRQ--VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           +G+G+ G V+   LR     VAVK  + +   ++  +   E  IL +   P +V L+G  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
              +   +V+E +  G     L +    L     I++    A  +E L S+    IHRD+
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDL 120

Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL-----ST 233
            + N L+      ++ DFG++ R   D   + ST   G +  +   +  P+ L     S+
Sbjct: 121 AARNCLVTEKNVLKISDFGMS-REEEDGV-YAST---GGMKQIPVKWTAPEALNYGRYSS 175

Query: 234 KTDVFSFGILLLEIIS 249
           ++DV+SFGILL E  S
Sbjct: 176 ESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 60.3 bits (147), Expect = 5e-10
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 33/202 (16%)

Query: 66  GSHGSVYKAV--LRGRQVAVKKPSKNQEISQEVDN-------EIEILSKIHSPRLVNL-- 114
           G++G VY+A     G  VA+KK     ++ +E +        EI IL K+  P +V +  
Sbjct: 16  GTYGVVYRARDKKTGEIVALKK----LKMEKEKEGFPITSLREINILLKLQHPNIVTVKE 71

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
           +   ++     +V+E++ +  L  ++ +  +P        L LQ+   V  LH     I+
Sbjct: 72  VVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--IL 128

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-------CYVT 227
           HRD+K++N+L++     ++ DFGLA   G     +  T    T+ Y  P        Y  
Sbjct: 129 HRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLWYRAPELLLGAKEY-- 184

Query: 228 PDNLSTKTDVFSFGILLLEIIS 249
               ST  D++S G +  E+++
Sbjct: 185 ----STAIDMWSVGCIFAELLT 202

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 33/218 (15%)

Query: 62  LLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHS---PRLVN 113
            +G+G++G+VYKA  +  GR VA+KK   P   + I      EI +L ++ S   P +V 
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 114 LL----GFSNDSK-DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIR-LALQVAKAVEILH 167
           LL    G   D +    LV E +    L   L    +P      I+ L  Q+ + V+ LH
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH 124

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP---- 223
           S    I+HRD+K  N+L+  +   ++ DFGLA    + +F    T    T+ Y  P    
Sbjct: 125 SHR--IVHRDLKPQNILVTSDGQVKIADFGLA---RIYSFEMALTSVVVTLWYRAPEVLL 179

Query: 224 --CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFS 259
              Y TP       D++S G +  E+   R+ +  G S
Sbjct: 180 QSSYATP------VDMWSVGCIFAELFR-RRPLFRGTS 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 14/198 (7%)

Query: 59  EQKLLGKGSHGSVYKA--VLRGRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           E+ +LGKG++G VY A  +    ++A+K+ P ++    Q +  EI + S +    +V  L
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPL--NWGRRIRLALQVAKAVEILHSEMPPI 173
           G  +++    + +E +  G+L  +L S   PL  N    I    Q+ + ++ LH     I
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--I 129

Query: 174 IHRDIKSANVLIDRNFNA-RLGDFGLALR-CGVDNFRFRSTPPAGTIGYLDPCYVT--PD 229
           +HRDIK  NVL++      ++ DFG + R  G++      T   GT+ Y+ P  +   P 
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEVIDKGPR 186

Query: 230 NLSTKTDVFSFGILLLEI 247
                 D++S G  ++E+
Sbjct: 187 GYGAPADIWSLGCTIVEM 204

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 45/216 (20%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKN-----QEISQEVDNEIEILSKIHSPRLVNLL 115
           +G+G +G V+ A  +  G  VA+K+  K+      E+   V  E +IL+   S  LV LL
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRH-VLTERDILTTTKSEWLVKLL 67

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGR-RIRLALQVAKAVEILHSEMPPII 174
               D +   L +E++  G    +L +N   L+    R  +A     AV+ LH E+   I
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFE-AVDALH-ELG-YI 123

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD-----PCYVTPD 229
           HRD+K  N LID + + +L DFGL+                G + Y +     P Y+ P+
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLS---------------KGIVTYANSVVGSPDYMAPE 168

Query: 230 NLSTK-----TDVFSFGILLLEIISCRKAIDIGFSP 260
            L  K      D +S G +L E +        GF P
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLC-------GFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 44/144 (30%), Positives = 77/144 (53%), Gaps = 14/144 (9%)

Query: 63  LGKGSHGSVYKA--VLRGRQVAVK----KPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           +G G++G VYKA  V  G   A+K    +P ++  + Q+   EI ++       +V   G
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSNIVAYFG 73

Query: 117 FSNDSKDRLLV-VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
            S   +D+L + +EF   G+L D+ H    PL+  +   ++ +  + +  LHS+    +H
Sbjct: 74  -SYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGK--MH 129

Query: 176 RDIKSANVLIDRNFNARLGDFGLA 199
           RDIK AN+L+  N + +L DFG++
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 39/211 (18%)

Query: 61  KLLGKGSHGS--VYKAVLRGRQVAVK-----KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           +++G+GS G   + + V   ++ A+K     K S   E S++   E  +L+K+  P +V 
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVA 62

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDV-------LHSNNRPLNWGRRIRLALQVAKAVEIL 166
                       +V+E+   G L          L   +  L W  ++ L +Q        
Sbjct: 63  FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ-------- 114

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL-DPCY 225
           H     ++HRDIKS N+ + +N   +LGDFG A        R  ++P A    Y+  P Y
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSA--------RLLTSPGAYACTYVGTPYY 166

Query: 226 VTP---DNL--STKTDVFSFGILLLEIISCR 251
           V P   +N+  + K+D++S G +L E+ + +
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 60.1 bits (145), Expect = 7e-10
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 28/205 (13%)

Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPS----KNQEISQEVDNEIEILSKIHSPR 110
           F++ + +G GS G+VY A  V     VA+KK S    ++ E  Q++  E++ L +I  P 
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            +   G         LV+E+   G+  D+L  + +PL       +     + +  LHS  
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 145

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD- 229
             +IHRDIK+ N+L+      +L DFG A           ++P    +G   P ++ P+ 
Sbjct: 146 --MIHRDIKAGNILLTEPGQVKLADFGSA---------SIASPANSFVG--TPYWMAPEV 192

Query: 230 -------NLSTKTDVFSFGILLLEI 247
                      K DV+S GI  +E+
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 60.2 bits (146), Expect = 7e-10
 Identities = 54/194 (27%), Positives = 87/194 (44%), Gaps = 18/194 (9%)

Query: 61  KLLGKGSHGSVYKAVLRG----RQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL- 115
             L  GS G V+     G    ++V VK  +  +   +E+D    IL  I    ++NL+ 
Sbjct: 98  SSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREID----ILKTISHRAIINLIH 153

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNR--PLNWGRRIRLALQVAKAVEILHSEMPPI 173
            +   S     V   M      D+    +R  PL   + I +  ++ +A+  LH     I
Sbjct: 154 AYRWKS----TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR--GI 206

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           IHRD+K+ N+ +D   NA LGDFG A +        +    +GT+    P  +  D    
Sbjct: 207 IHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA 266

Query: 234 KTDVFSFGILLLEI 247
           KTD++S G++L E+
Sbjct: 267 KTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 60.1 bits (145), Expect = 7e-10
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)

Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y AVL  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77

Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           +++LL      K      D  LV+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 78  IISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 133

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 134 HLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 188

Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 59.9 bits (145), Expect = 7e-10
 Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 15/195 (7%)

Query: 63  LGKGSHGSVYKAVLRG--RQVAVKKPSKNQEISQ-EVDN---EIEILSKIHSPRLVNLLG 116
           +GKGS G V +   R   R  A+K   K   +S+ EV +   E  +L++++ P +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59

Query: 117 FSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
           FS  S ++L LV+ F++ G L+  L    R  +  R      ++  A+E LH     +I+
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLHKF--NVIY 116

Query: 176 RDIKSANVLIDRNFNARLGDFGLA-LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           RD+K  N+L+D   +  L DFGL  L    D+   ++    GT  YL P  +     +  
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLGHGYTKA 173

Query: 235 TDVFSFGILLLEIIS 249
            D ++ G+LL E+++
Sbjct: 174 VDWWTLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 60.3 bits (146), Expect = 8e-10
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 18/210 (8%)

Query: 50  LEAATN-GFSEQKLLGKGSHGSVYKAVLRGR--QVAVKKPSKNQEISQEVDNEIE--ILS 104
            E   + G++  K L  GS G V+ A   G+   V +K       I Q+    IE  +L 
Sbjct: 60  REVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLK-------IGQKGTTLIEAMLLQ 112

Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            ++ P ++ +           +V+    +  LY  L   +RPL   + + +  Q+ + + 
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLR 171

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LH++   IIHRD+K+ N+ I+      +GD G A +  V    F     AGT+    P 
Sbjct: 172 YLHAQR--IIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGL--AGTVETNAPE 226

Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAI 254
            +  D  ++K D++S GI+L E+++    I
Sbjct: 227 VLARDKYNSKADIWSAGIVLFEMLAYPSTI 256

Length = 357

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 59.7 bits (144), Expect = 9e-10
 Identities = 59/244 (24%), Positives = 111/244 (45%), Gaps = 31/244 (12%)

Query: 63  LGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN----EIEILSKIHSPRLVNLLGFS 118
           LG G+ G V K   +   + + +   + EI   + N    E+++L + +SP +V   G  
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI------RLALQVAKAVEILHSEMPP 172
               +  + +E M  G+L  VL          +RI      ++++ V + +  L  E   
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKE-------AKRIPEEILGKVSIAVLRGLAYLR-EKHQ 124

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           I+HRD+K +N+L++     +L DFG++ +  +D+    +    GT  Y+ P  +   + S
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSYMSPERLQGTHYS 180

Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA----PLIKKGKILS-VFDPRIPPP 287
            ++D++S G+ L+E+   R  I     PP   +  A    P++   +       PR  PP
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPI----PPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236

Query: 288 KDPI 291
             P+
Sbjct: 237 GRPV 240

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 59.7 bits (144), Expect = 9e-10
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 20/201 (9%)

Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPS----KNQEISQEVDNEIEILSKIHSPR 110
           FS+ + +G GS G+VY A  V     VA+KK S    ++ E  Q++  E+  L K+  P 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            +   G         LV+E+   G+  D+L  + +PL       +     + +  LHS  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH- 134

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP----PAGTIGYLDPCYV 226
             +IHRD+K+ N+L+      +LGDFG A      N  F  TP    P   +   +  Y 
Sbjct: 135 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-XFVGTPYWMAPEVILAMDEGQY- 191

Query: 227 TPDNLSTKTDVFSFGILLLEI 247
                  K DV+S GI  +E+
Sbjct: 192 -----DGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 16/150 (10%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLL-- 115
           +G+G+ G V+KA  +   + VA+KK     E          EI+IL  +    +VNL+  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 116 ------GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
                  ++       LV EF  +  L  +L + N         ++   +   +  +H  
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN 138

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
              I+HRD+K+AN+LI ++   +L DFGLA
Sbjct: 139 --KILHRDMKAANILITKDGILKLADFGLA 166

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 62/197 (31%), Positives = 94/197 (47%), Gaps = 19/197 (9%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKN-----QEISQEVDNEIEIL---SKIHSPRLV 112
           +GKG+ G VY+   +   R  A+K  SK      +E++  +  E  IL       SP +V
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTI-GERNILVRTLLDESPFIV 59

Query: 113 NL-LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
            L   F  DS D  LV ++MS G L+  L    R      +  +A ++  A+E LH    
Sbjct: 60  GLKFSFQTDS-DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKY-- 115

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            I++RD+K  N+L+D   +  L DFGL+     DN    +    GT  YL P  +  +  
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF--CGTTEYLAPEVLLDEKG 173

Query: 232 STK-TDVFSFGILLLEI 247
            TK  D +S G+L+ E+
Sbjct: 174 YTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 43/279 (15%)

Query: 61  KLLGKGSHGSVYKAVL-RGRQVAVKK---PSKNQEIS----QEVDNEIEILSKIHSPRLV 112
           ++LGKG++G+VY  +  +G+ +AVK+    + N   +    +++  E+++L  +    +V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR--PLNWGRRIRLALQVAKAVEILHSEM 170
             LG   D     + +EF+  G++  +L   NR  PL      +   Q+   V  LH+  
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRC------GVDNFRFRSTPPAGTIGYLDPC 224
             ++HRDIK  NV++  N   +L DFG A R       G  +   +S    GT  ++ P 
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM--HGTPYWMAPE 178

Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI 284
            +       K+D++S G  + E+ +       G  P + +D  A +   G    +  PR+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMAT-------GKPPLASMDRLAAMFYIGAHRGLM-PRL 230

Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRER----RPSMKEIVD 319
           P           +  A+  V SC  R    RPS  +++ 
Sbjct: 231 P--------DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 18/152 (11%)

Query: 63  LGKGSHGSVYKAV--LRGRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G+G++G VYKA     G  VA+KK   + E          EI+IL +++   +VNL   
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74

Query: 118 SNDSKDRL----------LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
             D +D L          LV E+M +  L  +L S     +         Q+ + +   H
Sbjct: 75  VTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH 133

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
            +    +HRDIK +N+L++     +L DFGLA
Sbjct: 134 KK--NFLHRDIKCSNILLNNKGQIKLADFGLA 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 47/212 (22%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN--------EIEILSKIHSPRLV 112
           LGKG++GSVYK + R  G  +A+K      EI  E+D         E++IL K  SP +V
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMK------EIRLELDESKFNQIIMELDILHKAVSPYIV 62

Query: 113 NLLGFSNDSKDRLLVVEFMSNGT---LYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHS 168
           +  G         + +E+M  G+   LY    +    P +  RRI     V K ++ L  
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRI--TYAVVKGLKFLKE 120

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLA---------LRCGVDNF----RFRSTPPA 215
           E   IIHRD+K  NVL++ N   +L DFG++            G  ++    R +S  P 
Sbjct: 121 EHN-IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPN 179

Query: 216 GTIGYLDPCYVTPDNLSTKTDVFSFGILLLEI 247
               Y           + ++DV+S G+ +LE+
Sbjct: 180 QNPTY-----------TVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 48/216 (22%), Positives = 96/216 (44%), Gaps = 37/216 (17%)

Query: 61  KLLGKGSHGSVYKAVLRGR-----QVAVKKPSKNQEISQEVD---NEIEILSKIHSPRLV 112
           K+LG+G  GSV +  L        +VAVK    +     E++   +E   +     P ++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 113 NLLGFSNDSKDR------LLVVEFMSNGTLYDVL-------HSNNRPLNWGRRIRLALQV 159
            L+G   ++         ++++ FM +G L+  L            PL     ++  + +
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQ--TLLKFMVDI 122

Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRFRSTPPAGTI 218
           A  +E L +     IHRD+ + N ++  +    + DFGL+ +    D +R       G I
Sbjct: 123 ALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR------QGRI 174

Query: 219 GYLDPCYVTPDNL-----STKTDVFSFGILLLEIIS 249
             +   ++  ++L     ++K+DV++FG+ + EI +
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 13/198 (6%)

Query: 61  KLLGKGSHGSV--YKAVLRGRQVAVKKPSKNQEISQ-EVDN---EIEILSKIHSPRLVNL 114
           KLLGKG+ G V   +    GR  A+K   K   I++ EV +   E  +L     P L  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 115 LGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
             ++  + DRL  V+E+ + G L+  L S  R     R      ++  A+E LHS    +
Sbjct: 61  -KYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLHSR--DV 116

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           ++RDIK  N+++D++ + ++ DFGL      D    ++    GT  YL P  +  ++   
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYLAPEVLEDNDYGR 174

Query: 234 KTDVFSFGILLLEIISCR 251
             D +  G+++ E++  R
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 40/115 (34%), Positives = 59/115 (51%), Gaps = 10/115 (8%)

Query: 136 LYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGD 195
           LY  L +  RPL   +   +A Q+  A++ +H E   IIHRDIK+ NVL++   +  LGD
Sbjct: 246 LYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE--GIIHRDIKTENVLVNGPEDICLGD 303

Query: 196 FGLALRCGVDNFRFRSTPP----AGTIGYLDPCYVTPDNLSTKTDVFSFGILLLE 246
           FG A  C        STP     AGT+    P  +  D  +   D++S G+++ E
Sbjct: 304 FGAA--CFARG--SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 20/199 (10%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           K +G G+ G V  A   + G+ VA+KK   P +N   ++    E+ ++  ++   ++ LL
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81

Query: 116 G-FSNDSK-----DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
             F+         D  LV+E M +  L  V+      L+  R   L  Q+   ++ LHS 
Sbjct: 82  NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSA 137

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
              IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P  +   
Sbjct: 138 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGM 192

Query: 230 NLSTKTDVFSFGILLLEII 248
                 D++S G ++ E+I
Sbjct: 193 GYKENVDIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 50/188 (26%), Positives = 91/188 (48%), Gaps = 22/188 (11%)

Query: 99  EIEILSKIHSPRLVNLLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGRRIRLAL 157
           E  + ++++ P +V LL         L  V E++   TL +VL + +  L  G   RL L
Sbjct: 28  ETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL-AADGALPAGETGRLML 86

Query: 158 QVAKAVEILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGL-ALRCGV-DNFRFRST 212
           QV  A+   H++   I+HRD+K  N+++       +A++ DFG+  L  GV D      T
Sbjct: 87  QVLDALACAHNQ--GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144

Query: 213 PPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCRKAI------DIGFSPP 261
                +G   P Y  P+ L     +  +D++++G++ LE ++ ++ +      +I +   
Sbjct: 145 RTTEVLG--TPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQL 202

Query: 262 SIVDWAAP 269
           S VD + P
Sbjct: 203 SPVDVSLP 210

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)

Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y A+L  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84

Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           ++ LL      K      D  +V+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 140

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 141 HLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 195

Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E+I
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMI 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 12/198 (6%)

Query: 61  KLLGKGSHGSV--YKAVLRGRQVAVKKPSKNQEISQ-EVDN---EIEILSKIHSPRLVNL 114
           KLLGKG+ G V   K    GR  A+K   K   +++ EV +   E  +L     P L  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 115 LGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
             +S  + DRL  V+E+ + G L+  L S  R  +  R      ++  A++ LHSE   +
Sbjct: 61  -KYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALDYLHSEKN-V 117

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           ++RD+K  N+++D++ + ++ DFGL      D    ++    GT  YL P  +  ++   
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF--CGTPEYLAPEVLEDNDYGR 175

Query: 234 KTDVFSFGILLLEIISCR 251
             D +  G+++ E++  R
Sbjct: 176 AVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 14/202 (6%)

Query: 56  GFSEQKLLGKGSHGSVYKAV-LRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           GFS  +    G+ G  +  +  +  +  V K  +    + E      IL  I+ P ++ L
Sbjct: 93  GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEA----HILRAINHPSIIQL 148

Query: 115 LG-FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
            G F+ +    L++  + ++  LY  L +  R +     + +   V +A++ LH     I
Sbjct: 149 KGTFTYNKFTCLILPRYKTD--LYCYL-AAKRNIAICDILAIERSVLRAIQYLHEN--RI 203

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           IHRDIK+ N+ I+   +  LGDFG A  C  VD    +    AGTI    P  +  D   
Sbjct: 204 IHRDIKAENIFINHPGDVCLGDFGAA--CFPVDINANKYYGWAGTIATNAPELLARDPYG 261

Query: 233 TKTDVFSFGILLLEIISCRKAI 254
              D++S GI+L E+ +C  ++
Sbjct: 262 PAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 32/206 (15%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN--------EIEILSKIHSPRLV 112
           LG+G++ +VYK   R  G  VA+K      EI  + +         EI ++ ++    +V
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALK------EIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 113 NLLGFSNDSKDRLLVVEFMSNG-TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
            L    +     +LV E+M      Y   H     L+         Q+ K +   H    
Sbjct: 62  RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR- 120

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            ++HRD+K  N+LI++    +L DFGLA   G+    F +         +   Y  PD L
Sbjct: 121 -VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE-------VVTLWYRAPDVL 172

Query: 232 ------STKTDVFSFGILLLEIISCR 251
                 ST  D++S G ++ E+I+ R
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 62/249 (24%), Positives = 113/249 (45%), Gaps = 19/249 (7%)

Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN----EIEILSKI 106
           E   + F +   LG G+ G V+K   +   + + +   + EI   + N    E+++L + 
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEI 165
           +SP +V   G      +  + +E M  G+L  VL    R P     ++ +A  V K +  
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTY 118

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           L  E   I+HRD+K +N+L++     +L DFG++ +  +D+    +    GT  Y+ P  
Sbjct: 119 LR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSYMSPER 173

Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL---IKKGKILSVFDP 282
           +   + S ++D++S G+ L+E+   R  I     PP   +        ++     S   P
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYPI----PPPDAKELELMFGCPVEGDPAESETSP 229

Query: 283 RIPPPKDPI 291
           R  PP  P+
Sbjct: 230 RPRPPGRPL 238

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 18/153 (11%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G+G++G VYK   +  G+ VA+KK    S+ + +      EI +L ++  P +V L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL------QVAKAVEILHSEMP 171
                   L+ EF+S   L   L S    L  G+ +   L      Q+ + +   HS   
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYLDS----LPKGQYMDAELVKSYLYQILQGILFCHSRR- 121

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGV 204
            ++HRD+K  N+LID     +L DFGLA   G+
Sbjct: 122 -VLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 5e-09
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 36/216 (16%)

Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           +     +G+G++G V  A     G +VA+KK  P ++Q   Q    EI+IL +     ++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 113 NLLGF----SNDS-KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
            +L      S +S  D  +V E M    LY ++ + +  L+         Q+ + ++ +H
Sbjct: 67  GILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH--LSNDHIQYFLYQILRGLKYIH 123

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG----------- 216
           S    ++HRD+K +N+L++ N + ++ DFGLA          R   P             
Sbjct: 124 S--ANVLHRDLKPSNLLLNTNCDLKICDFGLA----------RIADPEHDHTGFLTEYVA 171

Query: 217 TIGYLDP-CYVTPDNLSTKTDVFSFGILLLEIISCR 251
           T  Y  P   +     +   D++S G +L E++S R
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 17/199 (8%)

Query: 61  KLLGKGSHGSVY---------KAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL 111
           K+LG+GS G V+            L   +V +KK +           E +IL++++ P +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKV-LKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 112 VNL-LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           V L   F  + K   L+++F+  G L+  L           +  LA ++A A++ LHS  
Sbjct: 61  VKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHSL- 117

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             II+RD+K  N+L+D   + +L DFGL+ +  +D+ + ++    GT+ Y+ P  V    
Sbjct: 118 -GIIYRDLKPENILLDEEGHIKLTDFGLS-KESIDHEK-KAYSFCGTVEYMAPEVVNRRG 174

Query: 231 LSTKTDVFSFGILLLEIIS 249
            +   D +SFG+L+ E+++
Sbjct: 175 HTQSADWWSFGVLMFEMLT 193

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 25/210 (11%)

Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQE------VDNEIEILSKIHSPRLV 112
           K+LGKGS G V  A L+G     A+K   K+  +  +      V+  +  L+  H P L 
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEH-PFLT 59

Query: 113 NLLGFSNDSKDRLL-VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +L   +  +K+ L  V+E+++ G L   + S+ R  +  R    A ++   ++ LH +  
Sbjct: 60  HLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLHKKG- 116

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPP-AGTIGYLDPCYVTPDN 230
            II+RD+K  NVL+D++ + ++ DFG+   C  +           GT  Y+ P  +    
Sbjct: 117 -IIYRDLKLDNVLLDKDGHIKIADFGM---CKENMNGEGKASTFCGTPDYIAPEILKGQK 172

Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
            +   D +SFG+LL E++       IG SP
Sbjct: 173 YNESVDWWSFGVLLYEML-------IGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 41/147 (27%), Positives = 71/147 (48%), Gaps = 8/147 (5%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G+G++G+V+KA  R     VA+K+      ++ +      EI +L ++    +V L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
            +  K   LV E+  +  L     S N  ++         Q+ K +   HS    ++HRD
Sbjct: 68  LHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRD 124

Query: 178 IKSANVLIDRNFNARLGDFGLALRCGV 204
           +K  N+LI++N   +L DFGLA   G+
Sbjct: 125 LKPQNLLINKNGELKLADFGLARAFGI 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 56.8 bits (137), Expect = 8e-09
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 18/199 (9%)

Query: 61  KLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNE-------IEILSKIHSPRLV 112
           K+LGKGS G V  A L+G  +V   K  K   I Q+ D +       I  L+  H P L 
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH-PFLT 59

Query: 113 NLLGFSNDSKDRLL-VVEFMSNGTL-YDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            L      +KDRL  V+E+++ G L + +  S  R  +  R    A +V  A+  LH   
Sbjct: 60  ALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH- 115

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             +I+RD+K  N+L+D   + +L DFG+  + G+ N    +T   GT  Y+ P  +    
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMC-KEGILNGVTTTT-FCGTPDYIAPEILQELE 172

Query: 231 LSTKTDVFSFGILLLEIIS 249
                D ++ G+L+ E+++
Sbjct: 173 YGPSVDWWALGVLMYEMMA 191

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 65/241 (26%), Positives = 108/241 (44%), Gaps = 37/241 (15%)

Query: 61  KLLGKGSHGSVYKAVL-----RGRQVAVKKPSK-----NQEISQEVDNEIEILSKIHSPR 110
           K+LGKG +G V++         G+  A+K   K     NQ+ +     E  IL  +  P 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 111 LVNLL-GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           +V+L+  F    K   L++E++S G L+  L      +       L+ +++ A+E LH +
Sbjct: 62  IVDLIYAFQTGGK-LYLILEYLSGGELFMHLEREGIFMEDTACFYLS-EISLALEHLHQQ 119

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGL---ALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
              II+RD+K  N+L+D   + +L DFGL   ++  G     F      GTI Y+ P  +
Sbjct: 120 --GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF-----CGTIEYMAPEIL 172

Query: 227 TPDNLSTKTDVFSFGILLLEIISC---------RKAIDIGFS-----PPSIVDWAAPLIK 272
                    D +S G L+ ++++          +K ID         PP +   A  L+K
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLK 232

Query: 273 K 273
           K
Sbjct: 233 K 233

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 28/199 (14%)

Query: 63  LGKGSHGSVYKAV--LRGRQVAVKKPS----KNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           +G GS G+VY A        VAVKK S    +  E  Q++  E++ L ++  P  +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
                    LV+E+   G+  D+L  + +PL       +     + +  LHS    +IHR
Sbjct: 89  CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHR 145

Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD------- 229
           DIK+ N+L+      +L DFG A          +S+P    +G   P ++ P+       
Sbjct: 146 DIKAGNILLTEPGQVKLADFGSA---------SKSSPANSFVG--TPYWMAPEVILAMDE 194

Query: 230 -NLSTKTDVFSFGILLLEI 247
                K DV+S GI  +E+
Sbjct: 195 GQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 26/204 (12%)

Query: 60  QKLLGKGSHGSVY-----KA-------VLRGRQVAVKKPSKNQEISQEVDNEIEILSKIH 107
           Q+ LGKGS G+VY     KA       VL+   V    P++  + +QE     ++LSK+ 
Sbjct: 5   QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEA----QLLSKLD 60

Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVE 164
            P +V       +     ++ E+     L   L       + L+  +     +Q+   V 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA-LRCGVDNFRFRSTPPAGTIGYLDP 223
            +H     I+HRD+K+ N+ +  N   ++GDFG++ L  G  +    +T   GT  Y+ P
Sbjct: 121 YMHQRR--ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDL---ATTFTGTPYYMSP 174

Query: 224 CYVTPDNLSTKTDVFSFGILLLEI 247
             +      +K+D++S G +L E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 44/146 (30%), Positives = 78/146 (53%), Gaps = 14/146 (9%)

Query: 63  LGKGSHGSVYKA--VLRGRQVAVK----KPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           +G G++G VYKA  +  G   AVK    +P  +  + Q+   EI ++ +     +V   G
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCNIVAYFG 73

Query: 117 FSNDSKDRLLV-VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
            S  S+++L + +E+   G+L D+ H    PL+  +   +  +  + +  LHS+    +H
Sbjct: 74  -SYLSREKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSKGK--MH 129

Query: 176 RDIKSANVLIDRNFNARLGDFGLALR 201
           RDIK AN+L+  N + +L DFG+A +
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAK 155

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 32/211 (15%)

Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIE-------ILSKIHSPRLVN 113
           K LG+G  GSV +  L      +K   K  +I+    +E+E        + +   P ++ 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 114 LLGFSNDSKDR------LLVVEFMSNGTLYD-VLHS--NNRPLNWGRR--IRLALQVAKA 162
           L+G    + +       ++++ FM +G L+  +L+S   + P     +  ++    +A  
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRFRSTPPAGTIGYL 221
           +E L S+    IHRD+ + N +++ N N  + DFGL+ +    D +R       G I  +
Sbjct: 125 MEYLSSK--SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR------QGRIAKM 176

Query: 222 DPCYVTPDNL-----STKTDVFSFGILLLEI 247
              ++  ++L     +TK+DV+SFG+ + EI
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 18/155 (11%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           +     +G G++G V  A     GR+VA+KK   P ++   ++    E+ +L  +    +
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76

Query: 112 VNLLGF------SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIR-LALQVAKAVE 164
           + LL          D +D  LV   M    L +++    + L+    I+ L  Q+ + ++
Sbjct: 77  IGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLS-DDHIQFLVYQILRGLK 132

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
            +HS    IIHRD+K +N+ ++ +   ++ DFGLA
Sbjct: 133 YIHS--AGIIHRDLKPSNIAVNEDCELKILDFGLA 165

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 16/198 (8%)

Query: 61  KLLGKGSHGSVY--KAVLRGRQVAVKKPSK----NQEISQEVDNEIEILSK-IHSPRLVN 113
           K++GKGS G V   K    G+  AVK   K     ++  + +  E  +L K +  P LV 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 114 LLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRL-ALQVAKAVEILHSEMP 171
           L  +S  + D+L  V+++++ G L+  L           R R  A ++A A+  LHS   
Sbjct: 61  L-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPE--PRARFYAAEIASALGYLHSL-- 115

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            II+RD+K  N+L+D   +  L DFGL  + G+++ +  ST   GT  YL P  +     
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLC-KEGIEHSKTTST-FCGTPEYLAPEVLRKQPY 173

Query: 232 STKTDVFSFGILLLEIIS 249
               D +  G +L E++ 
Sbjct: 174 DRTVDWWCLGAVLYEMLY 191

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 53.7 bits (129), Expect = 8e-08
 Identities = 38/115 (33%), Positives = 57/115 (49%), Gaps = 8/115 (6%)

Query: 146 PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD 205
           PL     I  + QVA+ +E L S     IHRD+ + N+L+  N   ++ DFGLA     D
Sbjct: 169 PLTLEDLISYSFQVARGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKD 226

Query: 206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
               R       + ++ P  +     +T++DV+SFG+LL EI S      +G SP
Sbjct: 227 PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS------LGASP 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 20/207 (9%)

Query: 61  KLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQE-----VDNEIEILSKIHS-PRLVN 113
           +++G+GS+  V    L+   Q+   K  K + +  +     V  E  +  +  S P LV 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLH-SNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
           L      +    LV+E+++ G L  + H    R L        A ++  A+  LH     
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLHER--G 116

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGL---ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
           II+RD+K  NVL+D + + +L D+G+    L  G     F  TP      Y+ P  +  +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP-----NYIAPEILRGE 171

Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDI 256
                 D ++ G+L+ E+++ R   DI
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.7 bits (129), Expect = 9e-08
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 23/158 (14%)

Query: 55  NGFSEQKLLGKGSHGSVYKAVLR---GRQVAVKKPSKNQEISQE----VDNEIEILSKIH 107
             F   K++GKG+ G V + V +   G+  A+K   K++   ++    V  E ++L++  
Sbjct: 1   EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59

Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWG------RRIRLALQVAK 161
           SP +V+L     D++   L++EF+  G L  +L      + +        R  +A +   
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML------IKYDTFSEDVTRFYMA-ECVL 112

Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
           A+E +H      IHRDIK  N+LIDR  + +L DFGL+
Sbjct: 113 AIEAVHKL--GFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 52.9 bits (128), Expect = 9e-08
 Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 33/197 (16%)

Query: 66  GSHGSVYKAVLRGRQVAVKKPSKNQ----EISQEVDNEIEILSKIHS-----PRLVNLLG 116
           G  G V   VL+       KP++       I  +  N IE +  +H      P  + L  
Sbjct: 27  GKFGKVS--VLK------HKPTQKLFVQKIIKAKNFNAIEPM--VHQLMKDNPNFIKLYY 76

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
                K  +L+++++ +G L+D+L      L+     ++  Q+ +A+  LH     IIH 
Sbjct: 77  SVTTLKGHVLIMDYIKDGDLFDLLK-KEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHN 133

Query: 177 DIKSANVLIDRN-FNARLGDFGLALRCGVDNFRFRSTPPA--GTIGYLDPCYVTPDNLST 233
           DIK  NVL DR      L D+GL    G        TP    GT+ Y  P  +   N   
Sbjct: 134 DIKLENVLYDRAKDRIYLCDYGLCKIIG--------TPSCYDGTLDYFSPEKIKGHNYDV 185

Query: 234 KTDVFSFGILLLEIISC 250
             D ++ G+L  E+++ 
Sbjct: 186 SFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 23/209 (11%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSK-----NQEISQEVDNEIEILS 104
           F   K+LG G++G V+  ++R       G+  A+K   K       + ++    E ++L 
Sbjct: 2   FELLKVLGTGAYGKVF--LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59

Query: 105 KI-HSPRLVNL-LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
            I  SP LV L   F  D+K  L ++++++ G L+  L    R      +I    ++  A
Sbjct: 60  HIRQSPFLVTLHYAFQTDTKLHL-ILDYINGGELFTHLSQRERFKEQEVQIYSG-EIVLA 117

Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           +E LH     II+RDIK  N+L+D N +  L DFGL+     D    R+    GTI Y+ 
Sbjct: 118 LEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMA 174

Query: 223 PCYVTPDNL--STKTDVFSFGILLLEIIS 249
           P  V   +       D +S G+L+ E+++
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 13/198 (6%)

Query: 61  KLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEISQ-EVDN---EIEILSKIHSPRLVNL 114
           KLLGKG+ G V   +    G+  A+K   K   I++ EV +   E  +L     P L  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 115 LGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
             +S  + DRL  V+E+ + G L+  L S  R  +  R      ++  A+  LHS    +
Sbjct: 61  -KYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALGYLHSC--DV 116

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           ++RD+K  N+++D++ + ++ DFGL  + G+ +     T   GT  YL P  +  ++   
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLC-KEGISDGATMKT-FCGTPEYLAPEVLEDNDYGR 174

Query: 234 KTDVFSFGILLLEIISCR 251
             D +  G+++ E++  R
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 30/208 (14%)

Query: 63  LGKGSHGSVYKAVLRGR------------QVAVKKPSKNQEISQEVDNEIEILSKIHSPR 110
           LG+G+  ++YK VLR +             V +K    +   S        ++S++    
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           LV L G     ++ ++V E++  G L   LH     ++   ++ +A Q+A A+  L  E 
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL--ED 119

Query: 171 PPIIHRDIKSANVLIDRN-------FNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
             ++H ++   N+L+ R           +L D G+ +       R    P      ++ P
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP------WIAP 173

Query: 224 CYV--TPDNLSTKTDVFSFGILLLEIIS 249
             +     +L+   D +SFG  LLEI S
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEICS 201

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 22/208 (10%)

Query: 57  FSEQKLLGKGSHGSVY-------------KAVLRGRQVAVKKPSKNQEISQEVDNEIEIL 103
           F   K+LG G++G V+              A+   ++ A+ + +K  E ++   N +E +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 104 SKIHSPRLVNL-LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
            +  SP LV L   F  ++K  L +++++S G ++  L+  +       R     ++  A
Sbjct: 62  RQ--SPFLVTLHYAFQTEAKLHL-ILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILA 117

Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           +E LH     I++RDIK  N+L+D   +  L DFGL+ +  +   + R+    GTI Y+ 
Sbjct: 118 LEHLHKL--GIVYRDIKLENILLDSEGHVVLTDFGLS-KEFLSEEKERTYSFCGTIEYMA 174

Query: 223 PCYVTPDNLSTK-TDVFSFGILLLEIIS 249
           P  +       K  D +S GIL+ E+++
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLT 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 14/196 (7%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIE-----ILSKIHSPRLVN 113
           K++GKGS G V  A  +  G   AVK   K   + ++  N I      +L  +  P LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 114 LLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
           L  +S  + ++L  V+++++ G L+  L      L    R   A +VA A+  LHS    
Sbjct: 61  L-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHSL--N 116

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           II+RD+K  N+L+D   +  L DFGL  + GV+     ST   GT  YL P  +  +   
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLC-KEGVEPEETTST-FCGTPEYLAPEVLRKEPYD 174

Query: 233 TKTDVFSFGILLLEII 248
              D +  G +L E++
Sbjct: 175 RTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 63/241 (26%), Positives = 111/241 (46%), Gaps = 31/241 (12%)

Query: 63  LGKGSHGSVYKAV-LR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHS---PRLVN 113
           +G+G++G V+KA  L+  GR VA+K+    +  + +      E+ +L  + +   P +V 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 114 LLGF----SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIR-LALQVAKAVEILHS 168
           L         D + +L +V    +  L   L     P      I+ +  Q+ + ++ LHS
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+K  N+L+  +   +L DFGLA    + +F+   T    T+ Y  P  +  
Sbjct: 129 HR--VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAPEVLLQ 183

Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
            + +T  D++S G +  E+   RK +   F   S VD      + GKIL V    +P  +
Sbjct: 184 SSYATPVDLWSVGCIFAEMFR-RKPL---FRGSSDVD------QLGKILDVIG--LPGEE 231

Query: 289 D 289
           D
Sbjct: 232 D 232

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 18/203 (8%)

Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIE-------ILSKIH 107
           F+   +LGKGS G V  A  +G     A+K   K+  I    D+++E       +L+   
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALSG 58

Query: 108 SPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
            P  +  L     + DRL  V+E+++ G L   +    R       +  A ++A  +  L
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFL 117

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
           HS+   II+RD+K  NV++D   + ++ DFG+      D    ++    GT  Y+ P  +
Sbjct: 118 HSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF--CGTPDYIAPEII 173

Query: 227 TPDNLSTKTDVFSFGILLLEIIS 249
                    D ++FG+LL E+++
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 18/198 (9%)

Query: 61  KLLGKGSHGSVYKAVLRGRQV--AVKKPSKNQEISQEVDNEIE-----ILSKIHSPRLVN 113
           K++GKGS G V  A  +  +   AVK   K   + ++ +  I      +L  +  P LV 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 114 LLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
           L  FS  + D+L  V+++++ G L+  L      L    R   A ++A A+  LHS    
Sbjct: 61  L-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSL--N 116

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA--GTIGYLDPCYVTPDN 230
           I++RD+K  N+L+D   +  L DFGL      +N     T     GT  YL P  +    
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLC----KENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 231 LSTKTDVFSFGILLLEII 248
                D +  G +L E++
Sbjct: 173 YDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 17/151 (11%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKP---SKNQEISQEVDNEIEILSKI-HSPRLVNLLG 116
           +G+G++G VYKA  +  G+ VA+KK       + I      EI +L  +  S  +V LL 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 117 F----SNDSKDRL-LVVEFM-SNGTLYDVLH--SNNRPLNWGRRIRLALQVAKAVEILHS 168
                  + K  L LV E++ S+   +   +     RPL          Q+ K V   H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 169 EMPPIIHRDIKSANVLIDRNFNA-RLGDFGL 198
               ++HRD+K  N+L+D+     ++ D GL
Sbjct: 129 H--GVMHRDLKPQNLLVDKQKGLLKIADLGL 157

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 60/196 (30%), Positives = 95/196 (48%), Gaps = 14/196 (7%)

Query: 61  KLLGKGSHGSVY--KAVLRGRQVAVKKPSK----NQEISQEVDNEIEILSK-IHSPRLVN 113
           K++GKGS G V   K  L G+  AVK   K    N++  + +  E  +L K +  P LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 114 LLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
           L  +S  + ++L  V++F++ G L+  L    R     R    A ++A A+  LHS    
Sbjct: 61  L-HYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAAEIASALGYLHS--IN 116

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           I++RD+K  N+L+D   +  L DFGL  + G+      +T   GT  YL P  +      
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLC-KEGIAQSD-TTTTFCGTPEYLAPEVIRKQPYD 174

Query: 233 TKTDVFSFGILLLEII 248
              D +  G +L E++
Sbjct: 175 NTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 14/179 (7%)

Query: 146 PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD 205
           PL     I  + QVA+ +E L S     IHRD+ + N+L+  N   ++ DFGLA     D
Sbjct: 170 PLTMEDLICYSFQVARGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227

Query: 206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
               R       + ++ P  +     +T++DV+SFG+LL EI S      +G SP   V 
Sbjct: 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS------LGASPYPGVQ 281

Query: 266 WAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
                 ++ K  +    R P    P + +    I + C +   + RP+   +V+ L  L
Sbjct: 282 INEEFCQRLKDGTRM--RAPENATPEIYR----IMLACWQGDPKERPTFSALVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 37/116 (31%), Positives = 56/116 (48%), Gaps = 8/116 (6%)

Query: 145 RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV 204
           + L     I  + QVAK +E L S     IHRD+ + N+L+  N   ++ DFGLA     
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYK 231

Query: 205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
           D    R       + ++ P  +     + ++DV+SFG+LL EI S      +G SP
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 7/116 (6%)

Query: 136 LYD-VLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLG 194
           +YD      +RPL    R  +  Q+  AVE +H +   +IHRDIK  N+ ++ +    LG
Sbjct: 253 MYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCDGKIVLG 309

Query: 195 DFGLALRCGVDNFRF-RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
           DFG A+    +  R        GT+    P  +  D     TD++S G++LL+++S
Sbjct: 310 DFGTAMP--FEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 17/198 (8%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQ-EVDNE------IEILSKIHSPRLVN 113
           LG+G  G V  A  +  G   A+K   K   I++ EV++        E  +    P LVN
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L            V+E+ + G L   +H++       R +  A  V   ++ LH     I
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP--RAVFYAACVVLGLQYLHEN--KI 122

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           ++RD+K  N+L+D     ++ DFGL   C     F  R++   GT  +L P  +T  + +
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGL---CKEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179

Query: 233 TKTDVFSFGILLLEIISC 250
              D +  G+L+ E++  
Sbjct: 180 RAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.6 bits (121), Expect = 7e-07
 Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 32/218 (14%)

Query: 55  NGFSEQKLLGKGSHGSVYKAVLRGRQV----AVKKPSKNQEI----SQEVDNEIEILSKI 106
             F   KL+  G++G+VY  ++R ++     A+KK +K   I     Q+V  E +IL+  
Sbjct: 1   EDFETIKLISNGAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA 58

Query: 107 HSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVL-HSNNRPLNWGRRIRLALQVAKAVE 164
            +P +V++   S ++K  L +V+E++  G    +L +    P++  R +  A  V  A+E
Sbjct: 59  ENPFVVSMFC-SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMAR-MYFAETVL-ALE 115

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV--------------DNFRFR 210
            LH+    I+HRD+K  N+LI    + +L DFGL+ + G+              D   F 
Sbjct: 116 YLHNY--GIVHRDLKPDNLLITSMGHIKLTDFGLS-KIGLMSLTTNLYEGHIEKDTREFL 172

Query: 211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEII 248
                GT  Y+ P  +         D ++ GI+L E +
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 50.3 bits (120), Expect = 7e-07
 Identities = 66/259 (25%), Positives = 106/259 (40%), Gaps = 41/259 (15%)

Query: 63  LGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHS---PRLVNL 114
           +G G++G+VYKA     G  VA+K     +    +      E+ +L ++ +   P +V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 115 LGFSNDSK-DR----LLVVEFMSNG--TLYDVLHSNNRPLNWGRRIR-LALQVAKAVEIL 166
           +     S+ DR     LV E +     T  D +     P      I+ L  Q  + ++ L
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAE---TIKDLMRQFLRGLDFL 124

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
           H+    I+HRD+K  N+L+      +L DFGLA    + + +   TP   T+ Y  P  +
Sbjct: 125 HANC--IVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYRAPEVL 179

Query: 227 TPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-------------PSIVDWAAPLIKK 273
                +T  D++S G +  E+   RK +  G S              P   DW   +   
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238

Query: 274 GKILSVFDPRIPPPKDPIV 292
                 F PR P P   +V
Sbjct: 239 R---GAFSPRGPRPVQSVV 254

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 18/209 (8%)

Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIE-------ILSKIH 107
           F+   +LGKGS G V  A  +G     A+K   K+  I    D+++E       +L+   
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALQD 58

Query: 108 SPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
            P  +  L     + DRL  V+E+++ G L   +    +     + +  A +++  +  L
Sbjct: 59  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFL 117

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
           H     II+RD+K  NV++D   + ++ DFG+     VD    R+    GT  Y+ P  +
Sbjct: 118 HRR--GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF--CGTPDYIAPEII 173

Query: 227 TPDNLSTKTDVFSFGILLLEIISCRKAID 255
                    D +++G+LL E+++ +   D
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 45/154 (29%), Positives = 81/154 (52%), Gaps = 16/154 (10%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           + + K +G G++G+V  A+ R  G +VA+KK   P +++  ++    E+ +L  +    +
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76

Query: 112 VNLLG-FSNDSK-----DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           + LL  F+ D       D  LV+ FM  GT    L  + + L+  R   L  Q+ K ++ 
Sbjct: 77  IGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEK-LSEDRIQFLVYQMLKGLKY 133

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
           +H+    IIHRD+K  N+ ++ +   ++ DFGLA
Sbjct: 134 IHA--AGIIHRDLKPGNLAVNEDCELKILDFGLA 165

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 21/156 (13%)

Query: 55  NGFSEQKLLGKGSHGSV--YKAVLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHS 108
           + F   K++G+G+ G V   +    G   A+KK  K++ + +E    V  E +IL++  +
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNG---TL---YDVLHSNNRPLNWGRRIRLALQVAKA 162
           P +V L     D     L++E++  G   TL    D             R  +A +   A
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE------ETRFYIA-ETILA 113

Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
           ++ +H      IHRDIK  N+L+D   + +L DFGL
Sbjct: 114 IDSIHKL--GYIHRDIKPDNLLLDAKGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 65/294 (22%), Positives = 119/294 (40%), Gaps = 53/294 (18%)

Query: 56  GFSEQKLLGKGSHGSVYKAVLRG------RQVAVKKPSKNQEISQEVD---NEIEILSKI 106
             +   LL +G+ G ++  +L         +V VK    +    Q V     E  +L  +
Sbjct: 7   RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ-VTLLLQESCLLYGL 65

Query: 107 HSPRLVNLLGFSNDSKDRLLVVE-FMSNGTLYDVLHS-------NNRPLNWGRRIRLALQ 158
               ++ +L    +  +   V+  +M+ G L   L         N + L+  + + +A+Q
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA-------LRCGVDNFRFRS 211
           +A  +  LH     +IH+DI + N +ID     ++ D  L+         C  DN    +
Sbjct: 126 IACGMSYLHKR--GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN---EN 180

Query: 212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD--WAAP 269
            P    + ++    +     S+ +DV+SFG+LL E+++      +G +P   +D    A 
Sbjct: 181 RP----VKWMALESLVNKEYSSASDVWSFGVLLWELMT------LGQTPYVEIDPFEMAA 230

Query: 270 LIKKGKILSVFDPRIP-PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT 322
            +K G        R+  P   P    +L  +   C     E RPS  ++V  LT
Sbjct: 231 YLKDGY-------RLAQPINCP---DELFAVMACCWALDPEERPSFSQLVQCLT 274

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)

Query: 61  KLLGKGSHGSVYKAVLR------GRQVAVKKPSKNQEISQEVDNEIEILSKIHS-PRLVN 113
           +++G+GS+  V    L+        +V  K+   + E    V  E  +  +  + P LV 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L            V+E+++ G L   +    +      R   A +++ A+  LH     I
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHER--GI 117

Query: 174 IHRDIKSANVLIDRNFNARLGDFGL---ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
           I+RD+K  NVL+D   + +L D+G+    LR G     F  TP      Y+ P  +  ++
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP-----NYIAPEILRGED 172

Query: 231 LSTKTDVFSFGILLLEIISCRKAIDI 256
                D ++ G+L+ E+++ R   DI
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 65/277 (23%), Positives = 115/277 (41%), Gaps = 46/277 (16%)

Query: 63  LGKGSHGSVYKAV---------LRGRQVAVK-KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           LG+G+   ++K +         L   +V +K     ++  S+       ++S++    LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
              G      + ++V E++  G+L   L  N   +N   ++ +A Q+A A+  L  E   
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL--EDKG 120

Query: 173 IIHRDIKSANVLIDRNFNA--------RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP- 223
           + H ++ + NVL+ R  +         +L D G+++            P      ++ P 
Sbjct: 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP------WVPPE 174

Query: 224 CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR 283
           C   P NLS   D +SFG  L EI S       G  P S +D         K L  ++ R
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG------GDKPLSALDSQ-------KKLQFYEDR 221

Query: 284 --IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
             +P PK      +LA +  +C+    + RPS + I+
Sbjct: 222 HQLPAPK----WTELANLINQCMDYEPDFRPSFRAII 254

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 40/126 (31%), Positives = 65/126 (51%), Gaps = 21/126 (16%)

Query: 145 RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV 204
            PL+    +R + QVA+ ++ L S+    IHRD+ + NVL+     A++ DFGLA     
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASK--NCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264

Query: 205 D-NFRFRSTPPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGF 258
           D N+  +          L   ++ P+++     + ++DV+S+GILL EI S      +G 
Sbjct: 265 DSNYVVKGN------ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGK 312

Query: 259 SP-PSI 263
           SP P I
Sbjct: 313 SPYPGI 318

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 23/161 (14%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS-QEVDNEIEILSKIHSPRLVN 113
           + + + LG GS+G V+ AV     ++VAVKK       S +    EI+I+ ++    +V 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 114 LLGFSNDSKDRL--------------LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQV 159
           +      S   L              +V E+M    L +VL          R      Q+
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARL--FMYQL 123

Query: 160 AKAVEILHSEMPPIIHRDIKSANVLID-RNFNARLGDFGLA 199
            + ++ +HS    ++HRD+K ANV I+  +   ++GDFGLA
Sbjct: 124 LRGLKYIHS--ANVLHRDLKPANVFINTEDLVLKIGDFGLA 162

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 22/208 (10%)

Query: 61  KLLGKGSHGSVYKAVLRG-RQVAVKKPSKNQEISQE-----VDNEIEILSKIHS-PRLVN 113
           +++G+GS+  V    L+  R++   K  K + ++ +     V  E  +     + P LV 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 114 LLG-FSNDSKDRLLVVEFMSNGTL-YDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           L   F  +S+    V+EF+S G L + +      P    R    + +++ A+  LH    
Sbjct: 61  LHSCFQTESR-LFFVIEFVSGGDLMFHMQRQRKLPEEHARF--YSAEISLALNFLHER-- 115

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGL---ALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
            II+RD+K  NVL+D   + +L D+G+    +R G     F  TP      Y+ P  +  
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP-----NYIAPEILRG 170

Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDI 256
           ++     D ++ G+L+ E+++ R   DI
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 49/199 (24%), Positives = 98/199 (49%), Gaps = 21/199 (10%)

Query: 62  LLGKGSHGSVY--KAVLRGRQVAVK----KPSKNQEISQEVDNEIEILSKIHS---PRLV 112
           ++G+G  G VY  +    G+  A+K    K  K ++      NE  +LS + +   P +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 113 NLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRL-ALQVAKAVEILHSEM 170
             + ++  + D+L  +++ M+ G L+   H +   +   + +R  A ++   +E +H+  
Sbjct: 61  -CMTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFSEKEMRFYATEIILGLEHMHNRF 117

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             +++RD+K AN+L+D + + R+ D GLA     D  + +     GT GY+ P  +    
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGT 171

Query: 231 -LSTKTDVFSFGILLLEII 248
              +  D FS G +L +++
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 26/169 (15%)

Query: 60  QKLLGKGSHGSVYKAV--LRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL------ 111
           Q+++GKGS+G V  A+    G +VA+KK     ++ + V +   IL +I   RL      
Sbjct: 5   QEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 112 -----VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
                + L     + KD  +V E M +  L+ V+ +N+       +  L  Q+ +A++ +
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFL-YQLLRALKYI 119

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA 215
           H+    + HRD+K  N+L + +   ++ DFGLA         F  TP A
Sbjct: 120 HTA--NVFHRDLKPKNILANADCKLKICDFGLA------RVAFNDTPTA 160

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 60/275 (21%), Positives = 114/275 (41%), Gaps = 37/275 (13%)

Query: 62  LLGKGSHGSVYKA--------VLRGRQVAVKKPS---KNQEISQEVD---NEIEILSK-I 106
            LG G+ G VYK         +L  +++ V  P+     +E  + +    +E+ I+ + +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 107 HSPRLVNLLGFSNDSKDRLLVV----EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
             P +V       ++ DRL +V    E    G  ++ L    +     R   + +Q+  A
Sbjct: 67  RHPNIVRYYKTFLEN-DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           +  LH E   I+HRD+   N+++  +    + DFGLA +   ++   + T   GTI Y  
Sbjct: 126 LRYLHKE-KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSC 181

Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP 282
           P  V  +    K DV++FG +L ++ +          PP        L  K     + + 
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT--------LQPPFYSTNMLSLATK-----IVEA 228

Query: 283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
              P  + +  + +  +   C+    E RP + ++
Sbjct: 229 VYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 14/167 (8%)

Query: 158 QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT 217
           QVA+ +E L S+    +HRD+ + NVL+ +    ++ DFGLA     D+           
Sbjct: 245 QVARGMEFLASK--NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKIL 277
           + ++ P  +  +  +T +DV+S+GILL EI S          P  IVD         KI 
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP----YPGMIVDSTF----YNKIK 354

Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           S +  R+  P      +++  I V+C  S  E+RPS   + D +  L
Sbjct: 355 SGY--RMAKPDH--ATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 30/161 (18%)

Query: 55  NGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKK---PSKNQEISQEVDNEIEILSKIHSP 109
           N F    ++G+G++G V K   +  +  VA+KK     +N+E+ +    E+++L  +   
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 110 RLVNL-----------LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQ 158
            +V L           L F    K+ L ++E M NG   + + S               Q
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRS------------YIYQ 108

Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
           + KA+   H     I+HRDIK  N+LI  N   +L DFG A
Sbjct: 109 LIKAIHWCHKN--DIVHRDIKPENLLISHNDVLKLCDFGFA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 47.8 bits (114), Expect = 6e-06
 Identities = 49/210 (23%), Positives = 91/210 (43%), Gaps = 28/210 (13%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           K +G+G++G V  A       +VA+KK      I+   DN I+    +   +L+  L   
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKK------IANAFDNRIDAKRTLREIKLLRHLDHE 64

Query: 119 N--------------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N                 D  +V E M    L+ ++ S+ + L+         Q+ + ++
Sbjct: 65  NVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSS-QTLSDDHCQYFLYQLLRGLK 122

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            +HS    ++HRD+K +N+L++ N + ++ DFGLA R   +   F +             
Sbjct: 123 YIHS--ANVLHRDLKPSNLLLNANCDLKICDFGLA-RTTSEKGDFMTEYVVTRWYRAPEL 179

Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAI 254
            +     +T  DV+S G +  E++  RK +
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLG-RKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 28/208 (13%)

Query: 57  FSEQKLLGKGSHGSVYKAVLRG-RQVAVKKPSKNQEISQEVDNE---IE--ILSKIHSPR 110
           F+   +LGKGS G V  A  +G  ++   K  K   I Q+ D E   +E  +L+    P 
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61

Query: 111 LVNLLGFSNDSKDRL-LVVEFMSNGTL-YDVLHSNNRPLNWGRRIRLALQVAKAVEI--- 165
            +  L     + DRL  V+E+++ G L Y +            + +    V  A EI   
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--------KFKEPHAVFYAAEIAIG 113

Query: 166 ---LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPP-AGTIGYL 221
              LHS+   II+RD+K  NV++D   + ++ DFG+   C  + F  ++T    GT  Y+
Sbjct: 114 LFFLHSK--GIIYRDLKLDNVMLDAEGHIKIADFGM---CKENIFGGKTTRTFCGTPDYI 168

Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIIS 249
            P  +         D ++FG+LL E+++
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 47.2 bits (112), Expect = 8e-06
 Identities = 44/195 (22%), Positives = 87/195 (44%), Gaps = 12/195 (6%)

Query: 64  GKGSHGSVYKAVLRGRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           GK   G  ++ +    +V VK  + S   +       E++   +++ P ++  LG   +S
Sbjct: 9   GKVLLGEAHRGM-SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES 67

Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE--ILHSEMPPIIHRDIK 179
              LLV+EF   G L + L SN   +    +  +  ++A  V   +L       IH D+ 
Sbjct: 68  IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLA 127

Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT-------PDNLS 232
             N  +  + + ++GD+GLAL    +++       A  + +L P  V        P + +
Sbjct: 128 LRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQT 187

Query: 233 TKTDVFSFGILLLEI 247
            K++++S G+ + E+
Sbjct: 188 KKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 47.2 bits (112), Expect = 8e-06
 Identities = 59/289 (20%), Positives = 113/289 (39%), Gaps = 52/289 (17%)

Query: 60  QKLLGKGSHGSVYKAVLR--GRQ---VAVKKPSKNQEISQEVD--NEIEILSKIHSPRLV 112
           +++LG G  G + +  L+   ++   VA+          Q      E   L +     +V
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            L G        ++V E+MSNG L   L  +   L  G+ + +   +A  ++ L SEM  
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL-SEMG- 127

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
            +H+ + +  VL++ +   ++  F        +   + +      + +  P  +   + S
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFS 186

Query: 233 TKTDVFSFGILLLEIIS-------------CRKAIDIGFSPPSIVDWAAPLIKKGKILSV 279
           + +DV+SFGI++ E++S               KA++ GF                     
Sbjct: 187 SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF--------------------- 225

Query: 280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLV 328
              R+P P++      L  + + C +  R  RP   +I      LSK+V
Sbjct: 226 ---RLPAPRN--CPNLLHQLMLDCWQKERGERPRFSQIHS---ILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 23/50 (46%), Positives = 29/50 (58%), Gaps = 1/50 (2%)

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           +HRDIK  NVL+D+N + RL DFG  LR   D    +S    GT  Y+ P
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQSNVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 29/211 (13%)

Query: 52  AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE--ISQEVDNEIEILSKIH 107
           AAT+  + +KL G+GS+ +VYK + R  G+ VA+K  S   E  +      E  +L  + 
Sbjct: 3   AATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK 61

Query: 108 SPRLVNLLGFSNDSKDRLLVVEFM-SNGTLYDVLHSNN-RPLNWGRRIRLAL-QVAKAVE 164
              +V L    +  +    V E+M ++   Y + H     P N    +RL + Q+ + + 
Sbjct: 62  HANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYN----VRLFMFQLLRGLA 117

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG------TI 218
            +H +   I+HRD+K  N+LI      +L DFGLA        R +S P         T+
Sbjct: 118 YIHGQH--ILHRDLKPQNLLISYLGELKLADFGLA--------RAKSIPSQTYSSEVVTL 167

Query: 219 GYLDP-CYVTPDNLSTKTDVFSFGILLLEII 248
            Y  P   +   + S+  D++  G + +E++
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 40/154 (25%), Positives = 78/154 (50%), Gaps = 17/154 (11%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           ++  K +G G++GSV  A+ +  G +VA+KK   P +++  ++    E+ +L  +    +
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 112 VNLLGF------SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           + LL         ++ +D  LV+ +M      D+      PL+  +   L  Q+   ++ 
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQT----DLQKIMGHPLSEDKVQYLVYQMLCGLKY 132

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
           +HS    IIHRD+K  N+ ++ +   ++ DFGLA
Sbjct: 133 IHSA--GIIHRDLKPGNLAVNEDCELKILDFGLA 164

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 32/176 (18%)

Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRS 211
           +  + QVAK +  L S+    IHRD+ + N+L+      ++ DFGLA     D N+  + 
Sbjct: 217 LSFSYQVAKGMSFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274

Query: 212 TPPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-V 264
                    L   ++ P+++     + ++DV+S+GILL EI S      +G SP P + V
Sbjct: 275 N------ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS------LGSSPYPGMPV 322

Query: 265 DWA-APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           D     +IK+G    +  P   P        ++  I   C  +   +RP+ K+IV 
Sbjct: 323 DSKFYKMIKEG--YRMLSPECAPS-------EMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 51/225 (22%), Positives = 99/225 (44%), Gaps = 38/225 (16%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKP----SKNQEISQEVDNEIEILSKIHSPRLVNL 114
           +L+GKG  G VY A   +  R+VA+KK     S+N  + +    E +I + +  P +V +
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSN------NRPLNWGRRI----RLALQVAKAVE 164
               +D       + ++   TL  +L S       ++ L     +     +  ++   +E
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC------------GVDNFRFRS- 211
            +HS+   ++HRD+K  N+L+       + D+G A+                 N  + S 
Sbjct: 128 YVHSK--GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185

Query: 212 TPPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCR 251
           T P   +G  D  Y+ P+ L     S  TD+++ G++L ++++  
Sbjct: 186 TIPGKIVGTPD--YMAPERLLGVPASESTDIYALGVILYQMLTLS 228

Length = 932

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 35/116 (30%), Positives = 58/116 (50%), Gaps = 2/116 (1%)

Query: 134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL 193
            T  D L + +  L++   +  + QVA  +E L S+    +HRD+ + NVLI      ++
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK--NCVHRDLAARNVLICEGKLVKI 280

Query: 194 GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
            DFGLA     D+           + ++ P  +  +  +T +DV+SFGILL EI +
Sbjct: 281 CDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 11/155 (7%)

Query: 46  DYSDLEAATNG-FSEQKLLGKGSHGSVYK-AVLRGRQVAVKKPSKNQEISQEVDNEIEIL 103
           D+  L+    G F E +L+ K   G VY   +LR      K     +E    +  E +IL
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR------KADMLEKEQVGHIRAERDIL 55

Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
            +  S  +V +     D  +  L++EF+  G +  +L   +       +  +A +   A+
Sbjct: 56  VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAI 114

Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
           + +H      IHRDIK  N+L+D   + +L DFGL
Sbjct: 115 DSIHQL--GFIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.6 bits (108), Expect = 5e-05
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 17/153 (11%)

Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSK----NQEISQEVDNEIEILSKIHSPR 110
           F   K + +G+ G VY        +  AVK   K    N+ +  +V  E + L+   SP 
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65

Query: 111 LVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSN---NRPLNWGRRIRLALQVAKAVEIL 166
           +V+L  +S  S + + LV+E++  G +  +LH     +  +     ++   +VA A++ L
Sbjct: 66  IVHLY-YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA----VKYISEVALALDYL 120

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
           H     IIHRD+K  N+LI    + +L DFGL+
Sbjct: 121 HRH--GIIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 44.7 bits (105), Expect = 6e-05
 Identities = 50/220 (22%), Positives = 97/220 (44%), Gaps = 48/220 (21%)

Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSP------- 109
           F   K++G+G+ G V           VK  + ++  + ++ N+ E+L +  +        
Sbjct: 3   FEILKVIGRGAFGEV---------AVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 53

Query: 110 -------RLVNLLGFS-NDSKDRLLVVEFMSNGTLYDVLH--SNNRPLNWGRRIRLALQV 159
                  + +  L ++  D  +  LV+++   G L  +L    +  P +  R     + +
Sbjct: 54  VLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVI 113

Query: 160 A-KAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTI 218
           A  +V  LH      +HRDIK  N+L+D N + RL DFG  L+  +++   +S+   GT 
Sbjct: 114 AIDSVHQLH-----YVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGT- 166

Query: 219 GYLDPCYVTPDNLST----------KTDVFSFGILLLEII 248
               P Y++P+ L            + D +S G+ + E++
Sbjct: 167 ----PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 44.5 bits (105), Expect = 6e-05
 Identities = 49/198 (24%), Positives = 96/198 (48%), Gaps = 19/198 (9%)

Query: 62  LLGKGSHGSVY--KAVLRGRQVAVK----KPSKNQEISQEVDNEIEILSKIHS---PRLV 112
           ++G+G  G VY  +    G+  A+K    K  K ++      NE  +LS + +   P +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 113 NLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
             + ++  + D+L  +++ M+ G L+  L S +   +       A ++   +E +H+   
Sbjct: 61  -CMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILGLEHMHNRF- 117

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD-N 230
            +++RD+K AN+L+D + + R+ D GLA     D  + +     GT GY+ P  +     
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGVA 172

Query: 231 LSTKTDVFSFGILLLEII 248
             +  D FS G +L +++
Sbjct: 173 YDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 44.4 bits (105), Expect = 8e-05
 Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 41/164 (25%)

Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQV------AVKKPSKNQEISQE----VDNEIEILSKI 106
           F + K +G G+ G V       R+V      A+K   K   + +     V  E +IL++ 
Sbjct: 3   FVKIKTIGIGAFGEVCLV----RKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA 58

Query: 107 HSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL-------- 157
            +  +V L  +S   KD L  V++++  G +  +L            IRL +        
Sbjct: 59  DNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLL------------IRLGIFEEDLARF 105

Query: 158 ---QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
              ++  A+E +H      IHRDIK  N+LIDR+ + +L DFGL
Sbjct: 106 YIAELTCAIESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 57/235 (24%), Positives = 102/235 (43%), Gaps = 51/235 (21%)

Query: 63  LGKGSHGSVYKAVLRG----RQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           +G+G++G VYKA  +     ++ A+K+  +   IS     EI +L ++  P ++ L    
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQ-IEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 119 NDSKDRLLVVEFMSNGTLYDVLH---------SNNRPLNWGRRI--RLALQVAKAVEILH 167
               DR + + F  +   +D+ H         +N +P+   R +   L  Q+   +  LH
Sbjct: 68  LSHSDRKVWLLF--DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 168 SEMPPIIHRDIKSANVLI----DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           +    ++HRD+K AN+L+          ++ D G A         F S  P   +  LDP
Sbjct: 126 ANW--VLHRDLKPANILVMGEGPERGRVKIADMGFAR-------LFNS--PLKPLADLDP 174

Query: 224 CYVT-----PDNL------STKTDVFSFGILLLEIIS------CRKAIDIGFSPP 261
             VT     P+ L      +   D+++ G +  E+++      CR+  DI  S P
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-DIKTSNP 228

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 31/145 (21%), Positives = 56/145 (38%), Gaps = 12/145 (8%)

Query: 58  SEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHS-PRLV-NLL 115
           S  KLL  G    VY    +     +K    ++E   + + E+ IL  +      V  +L
Sbjct: 1   SSIKLLKGGLTNRVYLLGTKDEDYVLKINP-SREKGADREREVAILQLLARKGLPVPKVL 59

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS-EMPPII 174
                     L++E++   TL +V               +A Q+A+ +  LH   +  + 
Sbjct: 60  ASGESDGWSYLLMEWIEGETLDEVSEEEK--------EDIAEQLAELLAKLHQLPLLVLC 111

Query: 175 HRDIKSANVLIDRNFNARLGDFGLA 199
           H D+   N+L+D      + D+  A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 28/203 (13%)

Query: 63  LGKGSHGSVYK--AVLRGRQVAVKKPSKNQEISQEVD--NEIEILSKIHSPRLVNLLGFS 118
           LG+G++ +VYK  + L    VA+K+     E         E+ +L  +    +V L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
           +  K   LV E++ +  L   L      +N         Q+ + +   H     ++HRD+
Sbjct: 74  HTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR--KVLHRDL 130

Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC----YVTPDNL--- 231
           K  N+LI+     +L DFGLA        R +S P   T  Y +      Y  PD L   
Sbjct: 131 KPQNLLINERGELKLADFGLA--------RAKSIP---TKTYSNEVVTLWYRPPDILLGS 179

Query: 232 ---STKTDVFSFGILLLEIISCR 251
              ST+ D++  G +  E+ + R
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 11/155 (7%)

Query: 46  DYSDLEAATNG-FSEQKLLGKGSHGSVYK-AVLRGRQVAVKKPSKNQEISQEVDNEIEIL 103
           D+  L+    G F E +L+ K   G +Y   +LR      K     +E    +  E +IL
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR------KADMLEKEQVAHIRAERDIL 55

Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
            +     +V +     D ++  L++EF+  G +  +L   +       +  +A +   A+
Sbjct: 56  VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAI 114

Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
           + +H      IHRDIK  N+L+D   + +L DFGL
Sbjct: 115 DAIHQL--GFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 40/209 (19%)

Query: 63  LGKGSHGSVYK--AVLRGRQVAVKKPSKNQEISQEVDN--------EIEILSKIHSPRLV 112
           LG+G++ +V+K  + L    VA+K      EI  E +         E+ +L  +    +V
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALK------EIRLEHEEGAPCTAIREVSLLKNLKHANIV 66

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            L    +  +   LV E++ +     + +  N       +I    Q+ + +   H     
Sbjct: 67  TLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHKR--K 123

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC----YVTP 228
           I+HRD+K  N+LI+     +L DFGLA        R +S P   T  Y +      Y  P
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLA--------RAKSVP---TKTYSNEVVTLWYRPP 172

Query: 229 DNL------STKTDVFSFGILLLEIISCR 251
           D L      ST  D++  G +L E+ + R
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 51/235 (21%)

Query: 63  LGKGSHGSVYKAVLRG----RQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           +G+G++G VYKA  +     R  A+K+  +   IS     EI +L ++  P +++L    
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQ-IEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 119 NDSKDRLLVVEFMSNGTLYDVLH---------SNNRPLNWGRRI--RLALQVAKAVEILH 167
               DR + + F  +   +D+ H         +N +P+   R +   L  Q+   +  LH
Sbjct: 68  LSHADRKVWLLF--DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 168 SEMPPIIHRDIKSANVLI----DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           +    ++HRD+K AN+L+          ++ D G A         F S  P   +  LDP
Sbjct: 126 ANW--VLHRDLKPANILVMGEGPERGRVKIADMGFAR-------LFNS--PLKPLADLDP 174

Query: 224 CYVT-----PDNL------STKTDVFSFGILLLEIIS------CRKAIDIGFSPP 261
             VT     P+ L      +   D+++ G +  E+++      CR+  DI  S P
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-DIKTSNP 228

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 10/149 (6%)

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNR---PLNWGRRIRLALQVAKAVEILHSEMPPI 173
           F +D K  LL++E+ S G L   +    +   P        L  Q+  A++ +HS    +
Sbjct: 134 FKSDDK-LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--M 190

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRD+KSAN+ +      +LGDFG + +         ++   GT  YL P        S 
Sbjct: 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSK 250

Query: 234 KTDVFSFGILLLEIISCRKAIDIGFSPPS 262
           K D++S G++L E+++  +     F  PS
Sbjct: 251 KADMWSLGVILYELLTLHRP----FKGPS 275

Length = 478

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 54/222 (24%)

Query: 58  SEQKL--LGKGSHGSVYKAV--LRGRQVAVKKPSKNQE-------ISQEVDNEIEILSKI 106
           + +KL  LG+GS+ +VYK    L G+ VA+K+     E       I      E  +L  +
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-----REASLLKDL 60

Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFM-SNGTLY-----DVLHSNNRPLNWGRRIRLAL-QV 159
               +V L    +  K   LV E++ ++   Y       L  +N        +RL L Q+
Sbjct: 61  KHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHN--------VRLFLFQL 112

Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG 219
            + +   H     ++HRD+K  N+LI      +L DFGLA        R +S P   +  
Sbjct: 113 LRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLA--------RAKSVP---SKT 159

Query: 220 YLDPC----YVTPDNL------STKTDVFSFGILLLEIISCR 251
           Y +      Y  PD L      ST  D++  G +  E+ + R
Sbjct: 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 16/85 (18%)

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDIK  NVL+D N + RL DFG  L+   D    +S+   GT     P Y++P+ L  
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQSSVAVGT-----PDYISPEILQA 177

Query: 234 ----------KTDVFSFGILLLEII 248
                     + D +S G+ + E++
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 73/312 (23%), Positives = 118/312 (37%), Gaps = 92/312 (29%)

Query: 63  LGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN-----EIEILSKIHSP--RLVNLL 115
           LG+G+  ++Y   LR       +  + ++    V+      E+ ++ K+  P  R + L 
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 116 GFSNDS--------------------KDRLLVVEFMSNGTLYDVLHSNNR---PLNWGRR 152
            F   S                     + ++V EF+ +G L DV     +   P+ W  +
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAW--K 119

Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST 212
           I +A Q+A A+  L  E   ++H ++ + N+L+     ARLG     L  G   F   S 
Sbjct: 120 ITVAQQLASALSYL--EDKNLVHGNVCAKNILL-----ARLG-----LAEGTSPFIKLSD 167

Query: 213 PPAG-----------TIGYLDP-CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
           P               I ++ P C    ++LST  D +SFG  LLEI  C          
Sbjct: 168 PGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI--C---------- 215

Query: 261 PSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQ----------LAVIAVRCVRSCRER 310
               D   PL            R P  K+    K+          LA +  +C+     +
Sbjct: 216 ---FDGEVPL----------KERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQ 262

Query: 311 RPSMKEIVDWLT 322
           RPS + I+  LT
Sbjct: 263 RPSFRTILRDLT 274

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 42.0 bits (98), Expect = 4e-04
 Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 22/205 (10%)

Query: 55  NGFSEQKLLGKGSHGSVYK--AVLRGRQVAVKKPSKNQEISQEVD--NEIEILSKIHSPR 110
           + + + + LG+GS+ +VYK  + + G+ VA+K     +E         E  +L  +    
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDV------LHSNNRPLNWGRRIRLALQVAKAVE 164
           +V L    +  +   LV E++       +      LH  N  L          Q+ + + 
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-------FLFQLLRGLS 117

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP- 223
            +H     I+HRD+K  N+LI      +L DFGLA    V +  + +     T+ Y  P 
Sbjct: 118 YIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE--VVTLWYRPPD 173

Query: 224 CYVTPDNLSTKTDVFSFGILLLEII 248
             +     ST  D++  G + +E+I
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 26/203 (12%)

Query: 62  LLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL---- 115
           ++G GS G VY+A+      +VA+KK  ++    Q  + E+ I+  ++   ++ L     
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQYKNRELLIMKNLNHINIIFLKDYYY 129

Query: 116 --GFSNDSKDRLL--VVEFMSNGTLYDVLH--SNNRPLNWGRRIRLALQVAKAVEILHSE 169
              F  + K+  L  V+EF+       + H   NN  L        + Q+ +A+  +HS+
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189

Query: 170 MPPIIHRDIKSANVLID-RNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDP-CY 225
              I HRD+K  N+LID      +L DFG A  L  G      RS     +  Y  P   
Sbjct: 190 F--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-----RSVSYICSRFYRAPELM 242

Query: 226 VTPDNLSTKTDVFSFGILLLEII 248
           +   N +T  D++S G ++ E+I
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 48/162 (29%), Positives = 68/162 (41%), Gaps = 46/162 (28%)

Query: 56  GFSEQKLLGKGSHGSVY-------KAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHS 108
            F E  L  K    ++Y       K VL   QVA  K  +  +I  E DNE         
Sbjct: 13  AFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAER--DILAEADNE--------- 61

Query: 109 PRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---------- 157
              V  L +S   KD L  V++++  G +  +L            IR+ +          
Sbjct: 62  --WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL------------IRMGIFPEDLARFYI 107

Query: 158 -QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
            ++  AVE +H      IHRDIK  N+LIDR+ + +L DFGL
Sbjct: 108 AELTCAVESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 41.7 bits (98), Expect = 7e-04
 Identities = 59/220 (26%), Positives = 91/220 (41%), Gaps = 59/220 (26%)

Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQE---ISQEVD-NEIEILSKIHSPRLV 112
           F   K LG+G+ G VYKA L      V K SK +    + +  +   +EI       R  
Sbjct: 134 FVLGKKLGEGAFGVVYKASL------VNKQSKKEGKYVLKKATEYGAVEIWMNERVRRAC 187

Query: 113 N------LLGF----SNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLN------------- 148
                  + GF    S+  +D   LV  +    TL D++ S   P N             
Sbjct: 188 PNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247

Query: 149 -----WGRRIRLAL-QVAKAVEILHSEMPPIIHRDIKSANVLID---RNFNARLGDFGLA 199
                  + I+  + Q+  A++ LHS    I+HRD+K  N++      +F  ++ D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHST--GIVHRDVKPQNIIFSEGSGSF--KIIDLGAA 303

Query: 200 --LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN--LSTKT 235
             LR G+ N+      P   +  LDP Y  P+   +ST+T
Sbjct: 304 ADLRVGI-NYI-----PKEFL--LDPRYAAPEQYIMSTQT 335

Length = 566

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 41.1 bits (96), Expect = 8e-04
 Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 28/203 (13%)

Query: 63  LGKGSHGSVYK--AVLRGRQVAVKKPSKNQEISQEVD--NEIEILSKIHSPRLVNLLGFS 118
           LG+G++ +V+K  + L    VA+K+     E         E+ +L  +    +V L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
           +  K   LV E++ +  L   +      ++         Q+ + +   H     ++HRD+
Sbjct: 74  HTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR--KVLHRDL 130

Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC----YVTPDNL--- 231
           K  N+LI+     +L DFGLA        R +S P   T  Y +      Y  PD L   
Sbjct: 131 KPQNLLINERGELKLADFGLA--------RAKSVP---TKTYSNEVVTLWYRPPDVLLGS 179

Query: 232 ---STKTDVFSFGILLLEIISCR 251
              ST+ D++  G +  E+ S R
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 9/148 (6%)

Query: 57  FSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPR 110
           F + K LG G+ G V  A       L   +   KK   N+     V  E +IL++  +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           +V L     D  +   V++++  G +  +L           R  +A ++  A+E +H   
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHKM- 120

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGL 198
              IHRDIK  N+LID + + +L DFGL
Sbjct: 121 -GFIHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 18/42 (42%), Positives = 28/42 (66%), Gaps = 2/42 (4%)

Query: 158 QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
           Q+ + ++ LHS    I+HRDIK  N+L++ N   ++ DFGLA
Sbjct: 111 QILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLA 150

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 39.3 bits (91), Expect = 0.003
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 40/210 (19%)

Query: 63  LGKGSHGSVYKA--VLRGRQVAVKKPSKN-QEI--SQEVDNEIEILSKIHSPRLVNLLGF 117
           +G G++GSV  A     G +VAVKK S+  Q I  ++    E+ +L  +    ++ LL  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIR---------LALQVAKAVEILHS 168
              ++    + EF     +Y V H     LN   + +         L  Q+ + ++ +HS
Sbjct: 85  FTPARS---LEEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 138

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVT 227
               IIHRD+K +N+ ++ +   ++ DFGLA          R T    T GY+    Y  
Sbjct: 139 --ADIIHRDLKPSNLAVNEDCELKILDFGLA----------RHTDDEMT-GYVATRWYRA 185

Query: 228 PD------NLSTKTDVFSFGILLLEIISCR 251
           P+      + +   D++S G ++ E+++ R
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 38.9 bits (91), Expect = 0.004
 Identities = 45/208 (21%), Positives = 83/208 (39%), Gaps = 29/208 (13%)

Query: 61  KLLGKGSHGSV----YKAVLRGRQVAVKKPSKNQEISQEVDNEI-------EILSKIH-- 107
           K LG+G++G V             VA+KK      I+     +I       E+    H  
Sbjct: 6   KELGQGAYGIVCSARNAETSEEETVAIKK------ITNVFSKKILAKRALRELKLLRHFR 59

Query: 108 -SPRLVNLLGFSN---DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
               +  L         + + L + E +    L+ ++ S  +PL          Q+   +
Sbjct: 60  GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSG-QPLTDAHFQSFIYQILCGL 118

Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS--TPPAGTIGYL 221
           + +HS    ++HRD+K  N+L++ +   ++ DFGLA     +        T    T  Y 
Sbjct: 119 KYIHS--ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR 176

Query: 222 DP-CYVTPDNLSTKTDVFSFGILLLEII 248
            P   ++  + +   DV+S G +L E++
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELL 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	487
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.98
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.79
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
PRK10345	210	hypothetical protein; Provisional	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
smart00090	237	RIO RIO-like kinase.	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.64
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.63
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.51
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.48
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.34
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.3
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.26
KOG1243	690	consensus Protein kinase [General function predict	99.25
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.24
KOG3087	229	consensus Serine/threonine protein kinase [General	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.07
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.07
COG4248	637	Uncharacterized protein with protein kinase and he	98.99
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.99
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.98
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.83
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.74
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.72
PRK09902	216	hypothetical protein; Provisional	98.68
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.64
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.62
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.57
PF01636	239	APH: Phosphotransferase enzyme family This family	98.57
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.43
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.43
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.33
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.27
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.25
PLN02876	822	acyl-CoA dehydrogenase	98.2
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.19
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.16
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.11
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.11
PRK10593	297	hypothetical protein; Provisional	98.09
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.05
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.83
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.76
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.71
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.67
PRK05231	319	homoserine kinase; Provisional	97.64
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.61
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.54
PLN02756	418	S-methyl-5-thioribose kinase	97.34
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.31
PLN02236	344	choline kinase	97.31
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.15
KOG2270	520	consensus Serine/threonine protein kinase involved	97.09
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.02
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.01
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.88
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.86
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.76
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.65
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.63
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.54
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.49
PRK12396	409	5-methylribose kinase; Reviewed	96.47
COG2334	331	Putative homoserine kinase type II (protein kinase	96.12
PTZ00384	383	choline kinase; Provisional	96.08
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.69
PTZ00296	442	choline kinase; Provisional	95.56
PRK11768	325	serine/threonine protein kinase; Provisional	95.42
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.36
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.06

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-52  Score=427.63  Aligned_cols=283  Identities=45%  Similarity=0.778  Sum_probs=251.7

Q ss_pred             cccccchhhHHHhhcCcccceeecccCceEEEEEEECC-eEEEEEEcCCChhh-HHHHHHHHHHHHhCCCCCceeeEEEE
Q 011384           41 KIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-RQVAVKKPSKNQEI-SQEVDNEIEILSKIHSPRLVNLLGFS  118 (487)
Q Consensus        41 ~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~g-~~vAvK~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~  118 (487)
                      ....|++.++..+|++|....+||+|+||.||+|...+ ..||||++...... ..+|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            67789999999999999999999999999999999985 89999988876654 66799999999999999999999999


Q ss_pred             eCCCc-eEEEEEecCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC-CCeeeccCCCCcEEEccCCcEEEcc
Q 011384          119 NDSKD-RLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEM-PPIIHRDIKSANVLIDRNFNARLGD  195 (487)
Q Consensus       119 ~~~~~-~~lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~-~~ivH~DIkp~NILld~~~~vkL~D  195 (487)
                      .+.+. .+||||||++|+|.++|..... +++|..+++||.++|+||+|||... |.||||||||+|||+|.++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            99994 9999999999999999988665 8999999999999999999999974 4799999999999999999999999


Q ss_pred             cccceecCC-CCcccccCCC-CCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCC--CCchhhhhhhhhh
Q 011384          196 FGLALRCGV-DNFRFRSTPP-AGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGF--SPPSIVDWAAPLI  271 (487)
Q Consensus       196 FGla~~~~~-~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~--~~~~~~~~~~~~~  271 (487)
                      ||+++.... ...   .... .||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+...  ....+..|++..+
T Consensus       221 FGLa~~~~~~~~~---~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  221 FGLAKLGPEGDTS---VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             ccCcccCCccccc---eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            999966543 221   1112 89999999999999999999999999999999999999887543  3445889999999


Q ss_pred             hcCccccccCCCCC-CCCCh-HHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          272 KKGKILSVFDPRIP-PPKDP-IVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       272 ~~~~i~~~~~~~~~-~~~~~-~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ..+++.+++|+++. ...+. .....+..++.+|++.+|.+||+|.||++.|+.+..
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            99999999999987 55554 567779999999999999999999999999966543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-48  Score=401.51  Aligned_cols=245  Identities=28%  Similarity=0.444  Sum_probs=214.7

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCC----ChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSK----NQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~----~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      .+|...++||+|||+.||.+++.  |..||+|++.+    .....+.+.+||++.++|+|||||++++||++.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            67999999999999999999983  99999999886    4556678999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      |+|++++|..+++.. +++++.+++.++.||+.||.|||++  +|+|||||..|+|++.+.+|||+|||||..+..+.. 
T Consensus        98 ELC~~~sL~el~Krr-k~ltEpEary~l~QIv~GlkYLH~~--~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E-  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR-KPLTEPEARYFLRQIVEGLKYLHSL--GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE-  173 (592)
T ss_pred             EecCCccHHHHHHhc-CCCCcHHHHHHHHHHHHHHHHHHhc--CceecccchhheeecCcCcEEecccceeeeecCccc-
Confidence            999999999999854 5699999999999999999999999  999999999999999999999999999988765433 


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                       +..+.+|||.|.|||++.....+..+||||+|||||-||.|++||+...-     .-.+..++..+          ...
T Consensus       174 -rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-----kety~~Ik~~~----------Y~~  237 (592)
T KOG0575|consen  174 -RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-----KETYNKIKLNE----------YSM  237 (592)
T ss_pred             -ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-----HHHHHHHHhcC----------ccc
Confidence             45678999999999999999999999999999999999999999974211     11122222211          123


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      |..++.++++||.++|+.||.+|||+++|+.
T Consensus       238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  238 PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            3467889999999999999999999999997

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-48  Score=395.79  Aligned_cols=257  Identities=32%  Similarity=0.499  Sum_probs=217.1

Q ss_pred             CcccceeecccCceEEEEEEECCeE-EEEEEcCCChh---hHHHHHHHHHHHHhCCCCCceeeEEEEeCCC-ceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLRGRQ-VAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGFSNDSK-DRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~g~~-vAvK~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~~~lV~Ey  130 (487)
                      ++...+.||+|+||+||+|.|+|.. ||||++.....   ..+.|.+|+.+|++++|||||+++|+|.+.. .++|||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            3444566999999999999999998 99999886532   2568999999999999999999999999988 79999999


Q ss_pred             cCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-eeeccCCCCcEEEccCC-cEEEcccccceecCCCCc
Q 011384          131 MSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPP-IIHRDIKSANVLIDRNF-NARLGDFGLALRCGVDNF  207 (487)
Q Consensus       131 ~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~-ivH~DIkp~NILld~~~-~vkL~DFGla~~~~~~~~  207 (487)
                      +++|+|.+++.. ....+++..++.|+.||+.||.|||++  + ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~--~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE--GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC--CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            999999999988 466799999999999999999999999  7 99999999999999997 99999999998765432 


Q ss_pred             ccccCCCCCCCccCCccccC--CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVT--PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~--~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                       ...+...||+.|||||++.  ...|+.|+|||||||++|||+||+.||..-.. .++..   ....         ...+
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~---~v~~---------~~~R  264 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVAS---AVVV---------GGLR  264 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHH---HHHh---------cCCC
Confidence             2344578999999999999  56899999999999999999999999974322 22221   1111         1223


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCC
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP  329 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  329 (487)
                      ++.+..++..+..|+.+||+.||..||++.+|+..|+.+.....
T Consensus       265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            33444588899999999999999999999999999998866433

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=381.67  Aligned_cols=248  Identities=26%  Similarity=0.409  Sum_probs=211.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcC--CChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCc-eEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPS--KNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKD-RLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~--~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-~~lV~E  129 (487)
                      .+...++.||+|..|+||++.++  ++.+|+|++.  .+....+++.+|+++++..+||+||.+||.|..... ++|+||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            35667889999999999999998  8899999883  456667899999999999999999999999999884 999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||++|||.+++...++ +++.....++.++++||.|||+ .  +||||||||+||||+..|.|||||||.+..+...   
T Consensus       159 YMDgGSLd~~~k~~g~-i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKRVGR-IPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             hcCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            9999999999987754 9999999999999999999996 6  9999999999999999999999999999776543   


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCC-CchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFS-PPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                       ...+..||..|||||.+.++.|+.++||||||++++|+.+|+.|+..... +....+....         +++ ..++.
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~---------Iv~-~ppP~  301 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA---------IVD-EPPPR  301 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH---------Hhc-CCCCC
Confidence             34567899999999999999999999999999999999999999975411 2222222111         111 11223


Q ss_pred             CCh-HHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          288 KDP-IVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       288 ~~~-~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .|. .++++++.++..||++||.+||++.|+++
T Consensus       302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            333 48999999999999999999999999997

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-48  Score=383.11  Aligned_cols=253  Identities=29%  Similarity=0.436  Sum_probs=216.3

Q ss_pred             HHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhH--------HHHHHHHHHHHhCCCCCceeeEEEEeC
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS--------QEVDNEIEILSKIHSPRLVNLLGFSND  120 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~--------~~~~~Ei~~l~~l~hpnIv~l~~~~~~  120 (487)
                      +...+.|.+.+.||+|+||.|-+|..+  ++.||||++++.....        ..+.+|+++|++++|||||+++++|+.
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            345667899999999999999999876  8999999988653221        236799999999999999999999999


Q ss_pred             CCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC---CcEEEcccc
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN---FNARLGDFG  197 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~---~~vkL~DFG  197 (487)
                      .+..|+||||++||.|.+.+..++. +.+..-..++.|++.|+.|||+.  ||+||||||+|||+..+   ..+||+|||
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH~~--GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLHSQ--GIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHHHc--CcccccCCcceEEeccCCcceEEEecccc
Confidence            9999999999999999999987764 88888899999999999999999  99999999999999765   789999999


Q ss_pred             cceecCCCCcccccCCCCCCCccCCccccCCCCC---CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC
Q 011384          198 LALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL---STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG  274 (487)
Q Consensus       198 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  274 (487)
                      +|+..+...   .+.+.+|||.|.|||++.+..+   ..+.|+||+||+||-+|+|.+||.....+....+    .+.+|
T Consensus       325 lAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e----QI~~G  397 (475)
T KOG0615|consen  325 LAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE----QILKG  397 (475)
T ss_pred             hhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH----HHhcC
Confidence            999876433   4667899999999999987654   3478999999999999999999986666554333    34444


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       275 ~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +.      .+.++....++++..+||.+||..||++|||+.|+++
T Consensus       398 ~y------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  398 RY------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cc------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            43      2334566789999999999999999999999999996

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-47  Score=387.58  Aligned_cols=260  Identities=26%  Similarity=0.427  Sum_probs=223.7

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEECCe-EEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~g~-~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++.....+..++.||+|-||.||.|.|++. .||+|.++......+.|.+|+++|++|+|+|||+++++|..+..+||||
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            334445577789999999999999999976 9999999887777788999999999999999999999999988999999


Q ss_pred             EecCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          129 EFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       129 Ey~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+.|+|.++|.. .+..+...+.+.++.|||+|++||+++  ++|||||.++||||+++..+||+|||+++....+.+
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~--~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK--NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC--CccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence            99999999999987 566799999999999999999999999  999999999999999999999999999995444333


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                      . ......-...|+|||.+..+.++.|||||||||+||||+|-...+..+.+....             .+.++...+.+
T Consensus       359 ~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-------------~~~le~GyRlp  424 (468)
T KOG0197|consen  359 T-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-------------LELLERGYRLP  424 (468)
T ss_pred             e-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-------------HHHHhccCcCC
Confidence            2 334445567999999999999999999999999999999954444333333222             33455566677


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      .|..||.++.+|+..||+.+|++|||++.+...|+.+.
T Consensus       425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            88899999999999999999999999999999888764

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-47  Score=357.50  Aligned_cols=251  Identities=25%  Similarity=0.401  Sum_probs=208.1

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEE-EEeCCCc-eEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLG-FSNDSKD-RLLV  127 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~-~~~~~~~-~~lV  127 (487)
                      .+|.+.+.||+|.||+||++.+.  |..||.|.+...   ....+....|+.+|++|+|||||++++ -+.++.. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            46888999999999999999765  899999987743   445567899999999999999999999 4444444 8999


Q ss_pred             EEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--eeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          128 VEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPP--IIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~--ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                      ||||..|+|...++.   .++.++++.+|+++.|++.||..+|+.-++  |+||||||.||||+.+|.|||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999998863   556799999999999999999999995556  999999999999999999999999999987


Q ss_pred             CCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCC
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~  282 (487)
                      .....  ......|||.||+||.+....|+.+|||||+||++|||+.-..||...    .... .-..+.+|+       
T Consensus       179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~-L~~KI~qgd-------  244 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLS-LCKKIEQGD-------  244 (375)
T ss_pred             cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHH-HHHHHHcCC-------
Confidence            65432  345678999999999999999999999999999999999999999743    2211 112223322       


Q ss_pred             CCCCCCC-hHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          283 RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       283 ~~~~~~~-~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                       . ++.| ...+.++..||..|+..||+.||+.-.++..+
T Consensus       245 -~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  245 -Y-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             -C-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence             1 2234 67899999999999999999999855555443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7e-46  Score=365.20  Aligned_cols=248  Identities=26%  Similarity=0.423  Sum_probs=208.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ..+|...+.||.|+||+||+|+++  +..||||.+.+.   ....+.+..|+.+|+.++|||||.+++++..++.+||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            457888899999999999999987  789999987654   344567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC------CcEEEcccccceec
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN------FNARLGDFGLALRC  202 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~------~~vkL~DFGla~~~  202 (487)
                      |||.||+|.+++...+. +++..+..++.||+.||++||++  +||||||||+||||+..      -.+||+|||+++.+
T Consensus        89 EyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~~~--~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLHEN--NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHC--CeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            99999999999998764 99999999999999999999999  99999999999999764      56899999999988


Q ss_pred             CCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCC
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~  282 (487)
                      ....   ...+.+|+|-|||||++..+.|+.|+|+||+|++||++++|+.||..... .++..    .+++++       
T Consensus       166 ~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~-~eL~~----~~~k~~-------  230 (429)
T KOG0595|consen  166 QPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP-KELLL----YIKKGN-------  230 (429)
T ss_pred             Cchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH-HHHHH----HHhccc-------
Confidence            7543   34567999999999999999999999999999999999999999974322 22211    222221       


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       283 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+.+..+..++..+.+|+...++.+|.+|-++.+-..
T Consensus       231 ~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~  267 (429)
T KOG0595|consen  231 EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD  267 (429)
T ss_pred             cccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence            2233344456666778888999999999988766543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-47  Score=393.78  Aligned_cols=338  Identities=21%  Similarity=0.336  Sum_probs=276.3

Q ss_pred             ccccccchhhHHHhhcCc---------ccceeecccCceEEEEEEEC--C---eEEEEEEcCCC--hhhHHHHHHHHHHH
Q 011384           40 IKIQHFDYSDLEAATNGF---------SEQKLLGKGSHGSVYKAVLR--G---RQVAVKKPSKN--QEISQEVDNEIEIL  103 (487)
Q Consensus        40 ~~~~~~~~~~~~~~~~~y---------~~~~~LG~G~~g~Vy~~~~~--g---~~vAvK~~~~~--~~~~~~~~~Ei~~l  103 (487)
                      .-+..++|+|...+.+.|         .+.++||.|.||+|++|.++  +   ..||||.++..  .....+|+.|..||
T Consensus       605 ~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIM  684 (996)
T KOG0196|consen  605 TYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIM  684 (996)
T ss_pred             eecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhc
Confidence            345567788777666554         67899999999999999986  3   46999999865  44556899999999


Q ss_pred             HhCCCCCceeeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcE
Q 011384          104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANV  183 (487)
Q Consensus       104 ~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NI  183 (487)
                      -++.||||++|.|+.......+||.|||++|+|+.+|+.+...+++.++.-++++|+.|++||.+.  ++|||||..+||
T Consensus       685 GQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm--~YVHRDLAARNI  762 (996)
T KOG0196|consen  685 GQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM--NYVHRDLAARNI  762 (996)
T ss_pred             ccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc--Cchhhhhhhhhe
Confidence            999999999999999999999999999999999999998888899999999999999999999999  999999999999


Q ss_pred             EEccCCcEEEcccccceecCCCCcc-cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCc
Q 011384          184 LIDRNFNARLGDFGLALRCGVDNFR-FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPP  261 (487)
Q Consensus       184 Lld~~~~vkL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~  261 (487)
                      |++.+..+||+|||+++.+..+... .......-..+|.|||.+....+|.+||||||||||||.++ |..|+...... 
T Consensus       763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-  841 (996)
T KOG0196|consen  763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-  841 (996)
T ss_pred             eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH-
Confidence            9999999999999999977544322 11122233569999999999999999999999999999775 77777532111 


Q ss_pred             hhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCCCCCCCCCCCCcc
Q 011384          262 SIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFNNPCL  341 (487)
Q Consensus       262 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~p~~  341 (487)
                                   ++.+-++...+.|.|..|+..|.+|+.+||++|..+||.+.+|+..|.+|.+.           |..
T Consensus       842 -------------dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn-----------P~S  897 (996)
T KOG0196|consen  842 -------------DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN-----------PNS  897 (996)
T ss_pred             -------------HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC-----------chh
Confidence                         22334455566667788999999999999999999999999999999998753           111


Q ss_pred             eeecc--CCcccccccccCCcccchhhhhhcccccccccCccccccccchhhHHHHHhhcccccccc
Q 011384          342 MVETV--GRPVEVRKTQEGGIAGENLDLLDGKLSRMSMKDSRRVYSDLGLRSNLMELMAGMDEEHEF  406 (487)
Q Consensus       342 ~~e~~--~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (487)
                      +..+.  ......+.....+..+..+..+++|++.++|..|...|...||.+  ++..++|+.+|-.
T Consensus       898 Lk~~~~~~~r~s~~lld~~~~~~~~f~sv~~WL~aIkm~rY~~~F~~ag~~s--~~~V~q~s~eDl~  962 (996)
T KOG0196|consen  898 LKTIAPESPRPSQPLLDRSGSDFTPFRSVGDWLEAIKMGRYKEHFAAAGYTS--FEDVAQMSAEDLL  962 (996)
T ss_pred             hcccCCCCCCCcccccCCCCCCCcccCCHHHHHHHhhhhHHHHHHHhcCccc--HHHHHhhhHHHHH
Confidence            11111  011122233356677788999999999999999999999999999  8999999987744

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=357.76  Aligned_cols=247  Identities=26%  Similarity=0.369  Sum_probs=208.5

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++|.+.++||+|+||.||.++.+  ++.||+|++++..    ...+...+|..+|.+++||+||+++..|++.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467999999999999999999876  8889999887653    3346789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      +||+.||.|..+|.+.+. +++..+.-++.+|+.||.|||++  +||||||||+|||+|.+|+++|+|||+++..-..+.
T Consensus       104 ld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH~~--gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLHSK--GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHHhC--CeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            999999999999998765 99999999999999999999999  999999999999999999999999999975433322


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                        ...+.+||+.|||||++....|+..+|+|||||++|||++|.+||.....    ..+...+. .++         ...
T Consensus       181 --~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~----~~~~~~I~-~~k---------~~~  244 (357)
T KOG0598|consen  181 --ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV----KKMYDKIL-KGK---------LPL  244 (357)
T ss_pred             --ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH----HHHHHHHh-cCc---------CCC
Confidence              34457999999999999999999999999999999999999999974322    22222121 111         112


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCC----CHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRP----SMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RP----s~~eil~  319 (487)
                      .+...+.+.++++.++|..+|.+|.    ++.+|.+
T Consensus       245 ~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  245 PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence            3344778999999999999999995    4555543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=368.34  Aligned_cols=269  Identities=24%  Similarity=0.409  Sum_probs=219.5

Q ss_pred             cchhhHHHhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC
Q 011384           45 FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS  121 (487)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  121 (487)
                      ....++++..+++.+...||+|.||+||+|.|.| .||||+++.+   ....+.|++||.++++-+|.||+-+.|||..+
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            3335666777788899999999999999999987 7899988754   44567899999999999999999999999988


Q ss_pred             CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      .. .||+-+|+|-+|+.+|+-....|+....+.|++|+++|+.|||.+  +|||||||..|||+.++++|||+|||++..
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK--~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK--NIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh--hhhhhhccccceEEccCCcEEEecccceee
Confidence            77 999999999999999998777799999999999999999999999  999999999999999999999999999853


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCC---CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccc
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPD---NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILS  278 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~  278 (487)
                      -..-..........|...|||||+++.+   +|+..+||||||||+|||++|..||. ....+++. |.   +..|.   
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIi-fm---VGrG~---  609 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQII-FM---VGRGY---  609 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheE-EE---ecccc---
Confidence            2222222223345688899999999764   78999999999999999999999998 33333322 11   11111   


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       279 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                       +.++.. .....+++++++|+..||.+++++||.+.+|+..|+.+...
T Consensus       610 -l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  610 -LMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             -cCccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence             011111 12345788999999999999999999999999988877653

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-44  Score=361.10  Aligned_cols=251  Identities=23%  Similarity=0.305  Sum_probs=214.0

Q ss_pred             HHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCc
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKD  123 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  123 (487)
                      +....+|.+++.||+|+|++||+|+..  ++.||||++.+...    ..+.+..|-.+|.+| .||.|++||-.|.|...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            445578999999999999999999886  88999999887533    235678899999999 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      +|+|+||+++|.|.++|.+.+. |++.-.+.++.+|+.||+|||++  |||||||||+|||||.|+++||+|||.|+.+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH~~--GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLHSN--GIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHHhc--CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            9999999999999999998864 99999999999999999999999  99999999999999999999999999998776


Q ss_pred             CCCcc---------ccc--CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh
Q 011384          204 VDNFR---------FRS--TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK  272 (487)
Q Consensus       204 ~~~~~---------~~~--~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~  272 (487)
                      .....         ...  ....||..|.+||.+.....++.+|+|+|||+||+|+.|.+||.....-....        
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq--------  297 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ--------  297 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH--------
Confidence            43322         111  44789999999999999999999999999999999999999997543221111        


Q ss_pred             cCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          273 KGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       273 ~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        +|.     .+...+++.+++.+.+|+.++|..||.+|+|..+|.+
T Consensus       298 --kI~-----~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  298 --KIQ-----ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             --HHH-----HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence              111     1122345566688999999999999999999999987

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-44  Score=352.64  Aligned_cols=253  Identities=26%  Similarity=0.417  Sum_probs=206.8

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC--ceEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSK--DRLLVV  128 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~~~lV~  128 (487)
                      ..+|...+.||+|+||.||++...  |...|||...... ...+.+.+|+.+|++++|||||+++|......  .++++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            356888899999999999999887  6899999876542 22467899999999999999999999855444  589999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc-CCcEEEcccccceecCC-CC
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-NFNARLGDFGLALRCGV-DN  206 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla~~~~~-~~  206 (487)
                      ||+++|+|.+++.+.+..+++..+..+++|++.||+|||++  |||||||||+|||++. ++.+||+|||++..... ..
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~--g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK--GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999999998765799999999999999999999999  9999999999999999 79999999999876653 11


Q ss_pred             cccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      .........||+.|||||++..+ ....++|||||||++.||+||..||..-.   ....+...+...         ...
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~---~~~~~~~~ig~~---------~~~  241 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF---EEAEALLLIGRE---------DSL  241 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc---chHHHHHHHhcc---------CCC
Confidence            12234457899999999999963 33459999999999999999999986321   111111111111         112


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                      +..+..++.++.+++.+|+..+|.+|||++++++.
T Consensus       242 P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  242 PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            25666789999999999999999999999999983

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.7e-43  Score=357.60  Aligned_cols=258  Identities=27%  Similarity=0.376  Sum_probs=206.2

Q ss_pred             hhcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCC-
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKI-HSPRLVNLLGFSNDS-  121 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~-  121 (487)
                      ..++|.+.+.||+|+||.||+|.+.       ++.||||++....  .....+.+|+.++..+ +||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            3568999999999999999999752       4579999987542  3345789999999999 899999999988764 


Q ss_pred             CceEEEEEecCCCCHHHHHHhCC---------------------------------------------------------
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNN---------------------------------------------------------  144 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------  144 (487)
                      ..+++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            45789999999999999997531                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCcc
Q 011384          145 ----RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGY  220 (487)
Q Consensus       145 ----~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y  220 (487)
                          .++++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHC--CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence                3478888999999999999999999  9999999999999999999999999999765433222222334567899


Q ss_pred             CCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHH
Q 011384          221 LDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVI  299 (487)
Q Consensus       221 ~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~L  299 (487)
                      +|||++.+..++.++|||||||++|||++ |..||...........    ....+.         ....+..++..+.+|
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~----~~~~~~---------~~~~~~~~~~~l~~l  309 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ----RLKDGT---------RMRAPENATPEIYRI  309 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH----HHhcCC---------CCCCCCCCCHHHHHH
Confidence            99999998899999999999999999997 8888864322222111    111111         111233456789999


Q ss_pred             HHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          300 AVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       300 i~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      +.+||+.||.+|||+.+|++.|+.+.
T Consensus       310 i~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         310 MLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHH
Confidence            99999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.3e-44  Score=337.62  Aligned_cols=260  Identities=22%  Similarity=0.299  Sum_probs=209.4

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh---hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      +.|....++|+|+||+||+++++  |+.||||++..+..   ..+-..+|+++|++++|+|+|.++.+|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45778889999999999999887  89999999886543   34567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      ||+. ++.+.|......++.+.+.+++.|++.|+.|+|++  ++|||||||+||||+.++.+||||||+|+.+...+.  
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~--n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--  156 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN--NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--  156 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc--CeecccCChhheEEecCCcEEeccchhhHhhcCCcc--
Confidence            9955 77777777666699999999999999999999999  999999999999999999999999999998764332  


Q ss_pred             ccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhh----------hhhhcCcccc
Q 011384          210 RSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA----------PLIKKGKILS  278 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~----------~~~~~~~i~~  278 (487)
                      ..+....|.+|.|||.+.+ .+|....|||++||++.||++|.+.|....+-+++.....          .++..+....
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            3455678999999999988 6899999999999999999999988864333333222111          1222222211


Q ss_pred             cc-CCCCCC--C---CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          279 VF-DPRIPP--P---KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       279 ~~-~~~~~~--~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      -+ -|....  +   .-+.++.-+.++++.||+.||.+|++-++++.
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            11 111111  1   12345667899999999999999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=355.75  Aligned_cols=248  Identities=26%  Similarity=0.380  Sum_probs=210.2

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC-----h-hhHHHHHHHHHHHHhCC-CCCceeeEEEEeCCC
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN-----Q-EISQEVDNEIEILSKIH-SPRLVNLLGFSNDSK  122 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~-----~-~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~  122 (487)
                      .....|.+.+.||+|+||.|+.|.+.  +..||+|++.+.     . ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            44578999999999999999999875  899999976653     1 23456788999999998 999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC-CcEEEccccccee
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN-FNARLGDFGLALR  201 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~-~~vkL~DFGla~~  201 (487)
                      .+++||||+.+|.|.+++.+ ..++.+..+..++.|++.|++|+|++  +|+||||||+|||+|.+ +++||+|||++..
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~--gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR--GIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC--CEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            99999999999999999998 45699999999999999999999999  99999999999999999 9999999999987


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCCC-CC-cchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccc
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPDN-LS-TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV  279 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~  279 (487)
                      ..  .........+||+.|+|||++.+.. |+ .++|||||||+||.|++|+.||.....+..    .. .+..+.    
T Consensus       171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l----~~-ki~~~~----  239 (370)
T KOG0583|consen  171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL----YR-KIRKGE----  239 (370)
T ss_pred             cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH----HH-HHhcCC----
Confidence            63  1112456689999999999999977 84 789999999999999999999985222111    11 122222    


Q ss_pred             cCCCCCCCCChHH-HHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          280 FDPRIPPPKDPIV-RKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       280 ~~~~~~~~~~~~~-~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                            ..++..+ +.++..|+.+||..||.+|+|+.+|+.
T Consensus       240 ------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  240 ------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                  1234445 889999999999999999999999995

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.7e-42  Score=342.33  Aligned_cols=261  Identities=20%  Similarity=0.308  Sum_probs=210.0

Q ss_pred             ccccccchhhHHHhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCChhh----HHHHHHHHHHHHhCCCCCceeeE
Q 011384           40 IKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI----SQEVDNEIEILSKIHSPRLVNLL  115 (487)
Q Consensus        40 ~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~----~~~~~~Ei~~l~~l~hpnIv~l~  115 (487)
                      ..+..+++++++     ......||+|+++.||+|.+.|+.||||++......    .+.+.+|+.++++++||||++++
T Consensus        10 ~~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~   84 (283)
T PHA02988         10 NDIKCIESDDID-----KYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY   84 (283)
T ss_pred             CcceecCHHHcC-----CCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence            355556666652     233368999999999999999999999998764332    36678999999999999999999


Q ss_pred             EEEeC----CCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcE
Q 011384          116 GFSND----SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNA  191 (487)
Q Consensus       116 ~~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~v  191 (487)
                      +++.+    ....++||||+++|+|.+++.... .+++...+.++.+++.||.|||+.. +++||||||+|||++.++.+
T Consensus        85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~-~~~Hrdlkp~nill~~~~~~  162 (283)
T PHA02988         85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYT-NKPYKNLTSVSFLVTENYKL  162 (283)
T ss_pred             eeEEecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcC-CCCCCcCChhhEEECCCCcE
Confidence            99876    456899999999999999998754 5899999999999999999999732 78899999999999999999


Q ss_pred             EEcccccceecCCCCcccccCCCCCCCccCCccccCC--CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhh
Q 011384          192 RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP--DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP  269 (487)
Q Consensus       192 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~  269 (487)
                      ||+|||++..+...     .....|++.|+|||.+.+  ..++.++|||||||++|||++|+.||... ....+..   .
T Consensus       163 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~-~~~~~~~---~  233 (283)
T PHA02988        163 KIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL-TTKEIYD---L  233 (283)
T ss_pred             EEcccchHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC-CHHHHHH---H
Confidence            99999998755332     123468899999999976  67899999999999999999999999732 2222211   1


Q ss_pred             hhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       270 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      ....         ....+.+..++.++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       234 i~~~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        234 IINK---------NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHhc---------CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            1111         1112233356788999999999999999999999999998765

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-43  Score=330.29  Aligned_cols=235  Identities=26%  Similarity=0.367  Sum_probs=206.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      -++|.+.+.||.|+||.|.+++.+  |.-+|+|++++...    ..+...+|-.+|+.+.||+++++++.|.+.+.+++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            357899999999999999999887  88899999987643    346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||++||-|..+|++.++ +++..++.++.||+.||+|||++  +|++|||||+|||+|.+|.+||+|||.++.+...  
T Consensus       123 meyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH~~--~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLHSL--DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             EeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHHhc--CeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence            999999999999998765 99999999999999999999999  9999999999999999999999999999887543  


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                         ..+.+|||.|+|||.+....+..++|+|+|||++|||+.|.+||..... ..+    +..+..+++          .
T Consensus       198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~i----Y~KI~~~~v----------~  259 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQI----YEKILEGKV----------K  259 (355)
T ss_pred             ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHH----HHHHHhCcc----------c
Confidence               4457999999999999999999999999999999999999999985433 222    222233332          2


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCC
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERR  311 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~R  311 (487)
                      +|..++.++++|+..+|+.|-.+|
T Consensus       260 fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  260 FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             CCcccCHHHHHHHHHHHhhhhHhh
Confidence            456778899999999999999999

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-42  Score=341.21  Aligned_cols=265  Identities=22%  Similarity=0.334  Sum_probs=214.2

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCC--ChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSK--NQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ..+|.+...||.|..+.||+|++.  +..||||+++-  +......+.+|+..++.++||||++++..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            357888999999999999999886  88999999874  44556889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          130 FMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       130 y~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||.+||+.++++. ....+++..+..|+++++.||.|||.+  |.||||||+.||||+.+|.|||+|||.+..+...+.+
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~--G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R  182 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN--GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR  182 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc--CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence            9999999999976 334599999999999999999999999  9999999999999999999999999998666554422


Q ss_pred             c--ccCCCCCCCccCCccccCC--CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          209 F--RSTPPAGTIGYLDPCYVTP--DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       209 ~--~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      .  ......||+.|||||++..  ..|+.|+|||||||+..||.+|..||. .++|......    .-++......-..+
T Consensus       183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~-k~pPmkvLl~----tLqn~pp~~~t~~~  257 (516)
T KOG0582|consen  183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS-KYPPMKVLLL----TLQNDPPTLLTSGL  257 (516)
T ss_pred             eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc-cCChHHHHHH----HhcCCCCCcccccC
Confidence            1  1145689999999999654  378999999999999999999999996 2333322211    01111111111122


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLS  325 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l~  325 (487)
                      +.......+..+++++..||.+||.+|||++++++  +|+..+
T Consensus       258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            22334456778999999999999999999999997  565543

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9.2e-42  Score=341.09  Aligned_cols=260  Identities=23%  Similarity=0.390  Sum_probs=204.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC------------------CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCcee
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR------------------GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVN  113 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~------------------g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~  113 (487)
                      .++|.+.+.||+|+||.||+|.+.                  +..||+|.+...  ......+.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            357899999999999999999753                  236999988754  333467899999999999999999


Q ss_pred             eEEEEeCCCceEEEEEecCCCCHHHHHHhCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 011384          114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN------------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIH  175 (487)
Q Consensus       114 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH  175 (487)
                      +++++.+.+..++||||+++++|.+++....                  ..+++..++.++.|++.||.|||+.  +|+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--~ivH  161 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--NFVH  161 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--Cccc
Confidence            9999999999999999999999999986421                  2367888999999999999999999  9999


Q ss_pred             ccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhC--CcC
Q 011384          176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISC--RKA  253 (487)
Q Consensus       176 ~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG--~~p  253 (487)
                      |||||+|||++.++.+||+|||++..+.............++..|+|||++..+.++.++|||||||++|||+++  ..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999765433322223334567899999999888999999999999999999874  455


Q ss_pred             CCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          254 IDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       254 f~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      |.. ...................      ......++.++..+.+|+.+||+.+|.+|||+.+|.+.|+
T Consensus       242 ~~~-~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGE-LTDEQVIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCc-CCHHHHHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            542 2222222222221111100      0111122345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=9.7e-43  Score=352.91  Aligned_cols=244  Identities=23%  Similarity=0.369  Sum_probs=213.7

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ++|.+.+.||+|+||+||+|+.+  .+.||+|.+.+..   ...+.+.+|+++++.++|||||.++++|+....+|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57899999999999999999876  6789999877654   344668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |+.| +|..+|...+. ++++.+..++.+++.||.|||+.  +|+|||+||+|||++.++.+|+||||+++.+.....  
T Consensus        82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLhs~--rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~--  155 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLHSN--RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS--  155 (808)
T ss_pred             hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHhc--CcccccCCcceeeecCCCceeechhhhhhhcccCce--
Confidence            9976 99999988765 99999999999999999999999  999999999999999999999999999998776543  


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      ..+...|||.|||||.+.++.|+..+|+||+||++||+++|++||..    .++...+..+...           +..++
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a----~si~~Lv~~I~~d-----------~v~~p  220 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA----RSITQLVKSILKD-----------PVKPP  220 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH----HHHHHHHHHHhcC-----------CCCCc
Confidence            45667899999999999999999999999999999999999999963    3344333322221           22345


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...+..+..++..+|.+||.+|.|..+++.
T Consensus       221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  221 STASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            588899999999999999999999999986

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-41  Score=337.90  Aligned_cols=248  Identities=23%  Similarity=0.294  Sum_probs=203.1

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .|...+.||+|+||.||++.+.  ++.||||.+....    .....+.+|+.++++++|+||+.+++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3778899999999999999875  8899999876432    223457889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          130 FMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       130 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      |+++|+|.+++... ...+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.......  
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE--RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence            99999999888643 34589999999999999999999999  99999999999999999999999999997653222  


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............. ....          ......
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~-~~~~----------~~~~~~  224 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD-RRVK----------EDQEEY  224 (285)
T ss_pred             -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH-HHhh----------cccccC
Confidence             1234578999999999999999999999999999999999999997433322111111 1111          011123


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCC-----HHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPS-----MKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs-----~~eil~  319 (487)
                      +..++.++.+|+.+||+.||.+||+     ++++++
T Consensus       225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            4456788999999999999999997     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.2e-42  Score=350.33  Aligned_cols=252  Identities=24%  Similarity=0.326  Sum_probs=207.2

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ..++|..++.||+|+||.||+|+.+  |..+|+|++++..-    ..+.++.|-.+|....+|.||+||..|.+.+++||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            3468999999999999999999876  89999999998643    34678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC-
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-  205 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~-  205 (487)
                      ||||++||++..+|...+ .|++..+..++.+++.||..||+.  |+|||||||+|+|||..|++||+||||+.-+... 
T Consensus       219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~--gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQL--GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHc--CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            999999999999998876 499999999999999999999999  9999999999999999999999999998432110 


Q ss_pred             -------------------Cccc-------------------------ccCCCCCCCccCCccccCCCCCCcchhhhhHH
Q 011384          206 -------------------NFRF-------------------------RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFG  241 (487)
Q Consensus       206 -------------------~~~~-------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlG  241 (487)
                                         ....                         ......|||.|+|||++.+..|+..+|+||||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence                               0000                         01123699999999999999999999999999


Q ss_pred             HHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCC---HHHHH
Q 011384          242 ILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPS---MKEIV  318 (487)
Q Consensus       242 vvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs---~~eil  318 (487)
                      ||+||||.|.+||..+........     +..      +...+..|....++.++.+||.+||. ||++|.-   ++||.
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rk-----I~n------wr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRK-----IVN------WRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHH-----HHH------HhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence            999999999999974333222111     111      11123333444566899999999999 9999984   67776


Q ss_pred             H
Q 011384          319 D  319 (487)
Q Consensus       319 ~  319 (487)
                      +
T Consensus       444 ~  444 (550)
T KOG0605|consen  444 K  444 (550)
T ss_pred             c
Confidence            5

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-43  Score=355.47  Aligned_cols=247  Identities=25%  Similarity=0.409  Sum_probs=212.9

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhh-HHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEI-SQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ..|.....||+|+.|.||.+...  ++.||||++...... .+-+.+|+.+|+..+|+|||++++.|...+.+|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            35888899999999999999765  788999998866544 456899999999999999999999888889999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      +||+|.|.+....  +++.++..+++++++||+|||.+  +|+|||||.+|||++.+|.+||+|||+|..+.....  ..
T Consensus       353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~--gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR  426 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHAR--GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KR  426 (550)
T ss_pred             CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhc--ceeeeccccceeEeccCCcEEEeeeeeeeccccccC--cc
Confidence            9999999998765  99999999999999999999999  999999999999999999999999999987765543  34


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ....|||.|||||++....|.++.||||||+|++||+-|.+||..+.+-..+.    -+...|.        .....+..
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly----LIa~ng~--------P~lk~~~k  494 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----LIATNGT--------PKLKNPEK  494 (550)
T ss_pred             ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH----HHhhcCC--------CCcCCccc
Confidence            56789999999999999999999999999999999999999997533222221    1222222        12234567


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ++..+++++.+||+.|+++||++.|+|+
T Consensus       495 lS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  495 LSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            8899999999999999999999999998

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-43  Score=350.91  Aligned_cols=261  Identities=24%  Similarity=0.334  Sum_probs=211.5

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHH--HHHHHHHHHhCC-CCCceeeEEEEeCCC-ceE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE--VDNEIEILSKIH-SPRLVNLLGFSNDSK-DRL  125 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~--~~~Ei~~l~~l~-hpnIv~l~~~~~~~~-~~~  125 (487)
                      ...++|..++.||.|.||.||+|+..  +..||||++++.-...++  -.+|+..|++++ |||||++.+++.+.+ .++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            34578999999999999999999876  888999988866444443  467999999998 999999999998887 899


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +||||| ..+|+++++..++.+++..+..|+.||++||+|+|.+  |+.|||+||+|||+..+..+||+|||+|+.+...
T Consensus        87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~--GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH--GFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc--CcccccCChhheEecccceeEecccccccccccC
Confidence            999999 6699999999899999999999999999999999999  9999999999999998999999999999887655


Q ss_pred             CcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc---------Cc
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK---------GK  275 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~---------~~  275 (487)
                      .   ..+....|.+|.|||++.. +.|+.+.|+|++|||++|+.+-++.|....+-+++..... .+..         ..
T Consensus       164 p---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~-VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  164 P---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE-VLGTPDKDSWPEGYN  239 (538)
T ss_pred             C---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH-HhCCCccccchhHHH
Confidence            4   4556678999999998754 6789999999999999999999988864333333222110 0000         01


Q ss_pred             cccccCCCCCCC-------CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          276 ILSVFDPRIPPP-------KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       276 i~~~~~~~~~~~-------~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +...+.-+++..       .-+.++.++..|+.+||..||.+|||+.|.++
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            111122222211       11237889999999999999999999999998

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-41  Score=334.18  Aligned_cols=254  Identities=19%  Similarity=0.329  Sum_probs=207.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .++|++.+.||+|+||.||+|.+.     +..||+|++....  .....+.+|+.++++++||||+++++++......++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            457899999999999999999764     5689999887542  334578999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++++|.+++......+++..++.++.|++.||+|||+.  +++||||||+|||++.++.++++|||.+.......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~--~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM--GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999999999987656699999999999999999999999  99999999999999999999999999875432221


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      . .......++..|+|||.+.+..++.++|||||||++||+++ |..||... .......    .+..         ...
T Consensus       162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~-~~~~~~~----~~~~---------~~~  226 (266)
T cd05064         162 I-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM-SGQDVIK----AVED---------GFR  226 (266)
T ss_pred             h-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHH----HHHC---------CCC
Confidence            1 11222345678999999999999999999999999999775 99888632 2211111    1111         111


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      .+.+..++..+.+++.+||+.+|.+||++++|++.|.++
T Consensus       227 ~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            233455778899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-43  Score=354.64  Aligned_cols=246  Identities=27%  Similarity=0.421  Sum_probs=210.3

Q ss_pred             cCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCC
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNG  134 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~g  134 (487)
                      +....++.||+|+.|.||+|++.++.||||+++.-.      ..+|.-|++|+||||+.|.|+|.....+|||||||..|
T Consensus       124 e~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  124 EEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             HHhhhhhhhccCcccceeeeeccCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            344567899999999999999999999999875432      34788899999999999999999999999999999999


Q ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCC
Q 011384          135 TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPP  214 (487)
Q Consensus       135 sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  214 (487)
                      .|+..|+... ++.......|..+||.|+.|||.+  .|||||||.-||||..+..|||+|||-++......   .+..+
T Consensus       198 qL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~h--KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSF  271 (904)
T KOG4721|consen  198 QLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHLH--KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSF  271 (904)
T ss_pred             cHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHHh--hHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhh
Confidence            9999998765 488889999999999999999999  99999999999999999999999999987654431   33457


Q ss_pred             CCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHH
Q 011384          215 AGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRK  294 (487)
Q Consensus       215 ~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  294 (487)
                      +||..|||||+++.++.+.|.|||||||||||||||.-|+..-.+.    .++|.         +=...+..+.|..|++
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwG---------VGsNsL~LpvPstcP~  338 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWG---------VGSNSLHLPVPSTCPD  338 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEe---------ccCCcccccCcccCch
Confidence            8999999999999999999999999999999999999998632111    11111         1112344567778999


Q ss_pred             HHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          295 QLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       295 ~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      .++-|++.||+..|..||++.+|+.+|+...
T Consensus       339 GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  339 GFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             HHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            9999999999999999999999999887654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-42  Score=355.25  Aligned_cols=244  Identities=24%  Similarity=0.338  Sum_probs=210.7

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      .-|++++-||.|+.|.|-+|++.  |+.+|||++.+.    ......+.+||-+|+.+.|||++++|+++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45888999999999999999986  999999988765    233467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++|-|.++|-..+. +++.++.+++.||+.|+.|+|..  +|+|||+||+|+|||..+++||+|||+|..-....  
T Consensus        92 Eyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH~~--~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk--  166 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCHAF--NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK--  166 (786)
T ss_pred             EecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhhh--cceeccCCchhhhhhcccCEeeeccceeecccCCc--
Confidence            99999999999987764 99999999999999999999999  99999999999999999999999999986533222  


Q ss_pred             cccCCCCCCCccCCccccCCCCC-CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                       .-.+-||.|+|.|||++.+.+| ..++||||+|||||.||+|+.||+.+.    +. .....+..|..          .
T Consensus       167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN----ir-~LLlKV~~G~f----------~  230 (786)
T KOG0588|consen  167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN----IR-VLLLKVQRGVF----------E  230 (786)
T ss_pred             -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc----HH-HHHHHHHcCcc----------c
Confidence             2345699999999999999999 679999999999999999999998322    21 12222333332          2


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .|..++.++++|+.+||..||.+|.|++||++
T Consensus       231 MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  231 MPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             CCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence            45678899999999999999999999999998

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.9e-41  Score=328.49  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=205.2

Q ss_pred             cCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      ++|.+.+.||+|+||.||++.+. +..+|+|.+.........+.+|++++++++||||+++++++.+....++||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            45888999999999999999887 56899998876655567889999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      |+|.+++......+++..++.++.|++.||.|||+.  +++|+||||+||+++.++.+||+|||++........ .....
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~  160 (256)
T cd05114          84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN--SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSG  160 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC--CccccccCcceEEEcCCCeEEECCCCCccccCCCce-eccCC
Confidence            999999976545689999999999999999999999  999999999999999999999999999875433221 12223


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV  292 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  292 (487)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......    +..+.         ....+...
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-~~~~~~~----i~~~~---------~~~~~~~~  226 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-NYEVVEM----ISRGF---------RLYRPKLA  226 (256)
T ss_pred             CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH----HHCCC---------CCCCCCCC
Confidence            345678999999998889999999999999999999 888885322 1122111    11111         11112234


Q ss_pred             HHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          293 RKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       293 ~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                      +..+.+++.+||+.+|++||++.+|++.|
T Consensus       227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         227 SMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            56789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2e-41  Score=349.65  Aligned_cols=255  Identities=26%  Similarity=0.339  Sum_probs=204.6

Q ss_pred             hcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCc
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKD  123 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  123 (487)
                      .++|.+.+.||+|+||.||+|.+.       +..||||+++...  ...+.+.+|++++..+ +||||++++++|.+...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            457999999999999999999752       4579999987542  3345788999999999 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhCC-----------------------------------------------------------
Q 011384          124 RLLVVEFMSNGTLYDVLHSNN-----------------------------------------------------------  144 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------  144 (487)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986422                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          145 ---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       145 ---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                                     ..+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++..........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                           2478889999999999999999999  99999999999999999999999999997654433221


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..||...........    .+..+         .....
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~----~~~~~---------~~~~~  338 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK----MIKEG---------YRMLS  338 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHH----HHHhC---------ccCCC
Confidence            2223345678999999999999999999999999999998 7777753222222221    11111         11112


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhc
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG  323 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~  323 (487)
                      +...+.++.+|+.+||+.||++|||+.+|++.|+.
T Consensus       339 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         339 PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            22345789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2e-41  Score=334.34  Aligned_cols=253  Identities=26%  Similarity=0.473  Sum_probs=208.8

Q ss_pred             cCcccceeecccCceEEEEEEECC-------eEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~g-------~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      .+|++.+.||+|+||.||+|.+.+       ..||+|.+....  .....+.+|++++.+++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998752       569999886442  33467899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc
Q 011384          126 LVVEFMSNGTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN  190 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~  190 (487)
                      ++|||+++++|.+++....               ..+++..++.++.|++.||.|||+.  +++|+||||+|||+++++.
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~--~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH--HFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccccccceEEEcCCCc
Confidence            9999999999999997531               3488899999999999999999999  9999999999999999999


Q ss_pred             EEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhh
Q 011384          191 ARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAP  269 (487)
Q Consensus       191 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~  269 (487)
                      +||+|||++......+.........+++.|+|||.+....++.++|||||||++|||++ |..||.. ..+..+..    
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~~----  237 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVIE----  237 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHH----
Confidence            99999999976544332222334567889999999988889999999999999999998 9888863 22222221    


Q ss_pred             hhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhc
Q 011384          270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG  323 (487)
Q Consensus       270 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~  323 (487)
                      .+..         ....+.+..++.++.+|+.+||+.||.+||++.+|++.|+.
T Consensus       238 ~i~~---------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 MIRS---------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHc---------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            1111         11223345677899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.5e-41  Score=350.47  Aligned_cols=256  Identities=25%  Similarity=0.361  Sum_probs=205.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCc
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKD  123 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  123 (487)
                      .++|.+.+.||+|+||.||+|++.       +..||||++....  .....+.+|+++++.+ +|+||++++++|.+...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            457999999999999999999863       2479999987542  3345688999999999 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhCC-----------------------------------------------------------
Q 011384          124 RLLVVEFMSNGTLYDVLHSNN-----------------------------------------------------------  144 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------  144 (487)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999986421                                                           


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCC
Q 011384          145 ----------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPP  214 (487)
Q Consensus       145 ----------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  214 (487)
                                .++++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++...............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK--NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC--CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                      2478889999999999999999999  9999999999999999999999999998765433221122233


Q ss_pred             CCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          215 AGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       215 ~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      .+++.|+|||++....++.++|||||||++|||++ |+.||...........    ....         ......+..++
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~----~~~~---------~~~~~~~~~~~  341 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK----MVKR---------GYQMSRPDFAP  341 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH----HHHc---------ccCccCCCCCC
Confidence            45678999999998899999999999999999997 9999864322211111    1111         11112223356


Q ss_pred             HHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          294 KQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      .++.+++.+||+.+|++|||+.+|++.|+++
T Consensus       342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            7899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.3e-42  Score=367.41  Aligned_cols=261  Identities=26%  Similarity=0.447  Sum_probs=220.5

Q ss_pred             hcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  124 (487)
                      +.+....+.||+|+||.||+|...       ...||||.++...  +...+|++|++++..++|||||+|+|.|.+++.+
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            345666789999999999999864       3469999988653  3567899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhC---------CCC----CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcE
Q 011384          125 LLVVEFMSNGTLYDVLHSN---------NRP----LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNA  191 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~---------~~~----l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~v  191 (487)
                      |+|+|||..|+|.++|...         +.+    |+..+.+.||.|||.|+.||-++  .+|||||..+|+||.++..|
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~--~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH--HFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--cccccchhhhhceeccceEE
Confidence            9999999999999999742         123    88999999999999999999999  99999999999999999999


Q ss_pred             EEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhh
Q 011384          192 RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPL  270 (487)
Q Consensus       192 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~  270 (487)
                      ||+|||+++..-..++........-..+||+||.+..+.||.+||||||||||||+++ |+.|+. +.+..++.+    .
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~-glSn~EVIe----~  717 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY-GLSNQEVIE----C  717 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc-ccchHHHHH----H
Confidence            9999999987766554433334455679999999999999999999999999999997 666665 455544443    3


Q ss_pred             hhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCCC
Q 011384          271 IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPL  330 (487)
Q Consensus       271 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~  330 (487)
                      +..|++         -+.|..||.++..|+..||+.+|.+||+++||-..|+.+....+.
T Consensus       718 i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~  768 (774)
T KOG1026|consen  718 IRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK  768 (774)
T ss_pred             HHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence            334333         356778999999999999999999999999999999987765443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.2e-42  Score=343.13  Aligned_cols=261  Identities=23%  Similarity=0.304  Sum_probs=208.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCC--CceEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDS--KDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~l  126 (487)
                      .+.|..+++||+|.||.||+|++.  |+.||+|++..+.   .......+||.+|++|+||||++|.+...+.  ..+|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            356889999999999999999886  8899999877554   3345678999999999999999999988766  68999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      |+|||+. +|.-++...+-.|++.++..++.||+.||.|+|++  +|+|||||.+|||||.+|.+||+|||||+.+....
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~--gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR--GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc--CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            9999955 99999988777799999999999999999999999  99999999999999999999999999999776655


Q ss_pred             cccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhh--------hcCccc
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI--------KKGKIL  277 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~--------~~~~i~  277 (487)
                      .. ..+...-|++|.|||.+.+. .|+.+.|+||+||||.||+.|++.|.....-+++.. +..+.        ...++.
T Consensus       273 ~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~k-IfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  273 SA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHK-IFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             Cc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHH-HHHHhCCCChhccccccCC
Confidence            43 46677889999999999886 789999999999999999999988863322222111 11110        000111


Q ss_pred             --cccCCCCCC-----CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          278 --SVFDPRIPP-----PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       278 --~~~~~~~~~-----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        ..+.+..+.     +.-..++....+|+..+|..||.+|.|+.++++
T Consensus       351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence              111111110     011224567789999999999999999999997

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=338.37  Aligned_cols=242  Identities=23%  Similarity=0.330  Sum_probs=202.5

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||+|.+.  ++.||+|++....    ...+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46889999999999999999987  8899999876432    23456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++++|.+++...+ .+++..+..++.|++.||+|||++  +|+||||||+|||++.++.+||+|||++......   
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSK--EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence            9999999999997754 489999999999999999999999  9999999999999999999999999998755322   


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                        .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||.... ...+..    .+..++          ...
T Consensus       155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-~~~~~~----~i~~~~----------~~~  217 (291)
T cd05612         155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN-PFGIYE----KILAGK----------LEF  217 (291)
T ss_pred             --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHH----HHHhCC----------cCC
Confidence              223568999999999998889999999999999999999999996422 111111    111111          112


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCC-----HHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPS-----MKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs-----~~eil~  319 (487)
                      +..++..+.+|+.+||+.||.+||+     ++++++
T Consensus       218 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         218 PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            3345678999999999999999995     888875

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.2e-41  Score=316.53  Aligned_cols=260  Identities=23%  Similarity=0.279  Sum_probs=208.7

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhh---HHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEI---SQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~---~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .+|...++||+|.||.||+|++.  |+.||||+++..+..   .....+||..|+.++|+||+.++++|.+.+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46888899999999999999986  899999988765432   3568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |++. +|+..++.....+....+..|+.++++||+|||.+  .|+||||||.|+|++.+|.+||+|||+++.+...+.. 
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~--~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK--WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh--hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc-
Confidence            9965 99999999888899999999999999999999999  9999999999999999999999999999988876643 


Q ss_pred             ccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCc---c---------
Q 011384          210 RSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK---I---------  276 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~---i---------  276 (487)
                       .+...-|.+|.|||.+.+ ..|+...|+||.||++.||+-|.+.|. |.+.-+.....-..+..-+   +         
T Consensus       158 -~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp-G~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  158 -QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP-GDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             -cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC-CCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence             233477999999999876 478999999999999999999886655 3332221111111110000   0         


Q ss_pred             cccc-CCC-CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          277 LSVF-DPR-IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       277 ~~~~-~~~-~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                      .++- -|. .....-..++.++.+|+..||..||.+|+|+.|++++
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            0000 000 0001223456778999999999999999999999973

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-41  Score=341.86  Aligned_cols=250  Identities=23%  Similarity=0.279  Sum_probs=204.6

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||+|++.  ++.||||++....    .....+.+|++++..++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46899999999999999999986  7899999987542    23456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++++|.+++...+ .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.....    
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHEL--GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence            9999999999997654 489999999999999999999999  999999999999999999999999999865432    


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                       ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... +......   +...   ...+........
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-~~~~~~~---i~~~---~~~~~~~~~~~~  225 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST-PNETWEN---LKYW---KETLQRPVYDDP  225 (333)
T ss_pred             -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC-HHHHHHH---HHhc---cccccCCCCCcc
Confidence             2334579999999999999999999999999999999999999996322 2111111   1000   000111000001


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...++.++.+++.+||..+|.+||+++++++
T Consensus       226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             ccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence            1245788999999999999999999999997

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-41  Score=326.41  Aligned_cols=255  Identities=26%  Similarity=0.386  Sum_probs=209.6

Q ss_pred             hhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ..++|.+.+.||+|++|.||+|.+. ++.||+|.+.......+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            3567999999999999999999876 678999998876555678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          132 SNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       132 ~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      ++++|.+++.... ..+++..+..++.|++.||.|||+.  +++|+||||+||+++.++.+||+|||++......... .
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~  160 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ--NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-A  160 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-c
Confidence            9999999997643 4589999999999999999999999  9999999999999999999999999999876532211 1


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      ......+..|+|||++.+..++.++||||||+++|||++ |+.||... .......    .+..         ....+.+
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~----~~~~---------~~~~~~~  226 (261)
T cd05068         161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM-TNAEVLQ----QVDQ---------GYRMPCP  226 (261)
T ss_pred             cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHH----HHHc---------CCCCCCC
Confidence            111233468999999998899999999999999999999 88887532 2111111    1111         1112233


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ..++..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            45668899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.8e-41  Score=338.06  Aligned_cols=255  Identities=24%  Similarity=0.445  Sum_probs=207.6

Q ss_pred             cCcccceeecccCceEEEEEEEC--Ce----EEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GR----QVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~----~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .+|+..+.||+|+||.||+|++.  +.    .||||++...  ....+.+.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            56999999999999999999874  33    4899998643  33456789999999999999999999999875 5689


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      |++|+++|+|.+++......+++..++.++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||+++.+....
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE  163 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc--CeeccccchhheEecCCCcEEEccccccccccCCC
Confidence            9999999999999987666689999999999999999999999  99999999999999999999999999998665433


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      .........++..|+|||.+....++.++|||||||++|||++ |+.||.. .....+..    ....         ...
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~----~~~~---------~~~  229 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISS----ILEK---------GER  229 (316)
T ss_pred             cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHH----HHhC---------CCC
Confidence            2222223345678999999999999999999999999999997 8888853 22222111    1111         111


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .+.+..++.++..++.+||..+|.+||++.+|+..|..+..
T Consensus       230 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         230 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            22334466788999999999999999999999999887754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.4e-40  Score=337.32  Aligned_cols=259  Identities=21%  Similarity=0.329  Sum_probs=204.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .++|.+.+.||+|+||.||++.+.  +..||+|.+...  ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999987  778999987754  2344679999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |+++++|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++......    
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----  157 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCCCcEEEccCccccccccc----
Confidence            999999999997654 4899999999999999999999852 5999999999999999999999999998654322    


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCc--c-----------
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK--I-----------  276 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~--i-----------  276 (487)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ..+..........+.  .           
T Consensus       158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-KELEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhcccccccccCCccccCcccccc
Confidence            12345789999999999998999999999999999999999999963221 111111000000000  0           


Q ss_pred             --------------------c-cccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          277 --------------------L-SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       277 --------------------~-~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                                          . .......+......++.++.+|+.+||+.||++|||+++|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~  300 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN  300 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                                0 000000011111235678999999999999999999999997

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.3e-41  Score=342.84  Aligned_cols=242  Identities=24%  Similarity=0.326  Sum_probs=202.7

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||+|.+.  ++.||||++....    ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57899999999999999999986  7889999886542    23356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++++|.+++...+ .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.......  
T Consensus        98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSK--DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--  172 (329)
T ss_pred             cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence            9999999999998764 489999999999999999999999  99999999999999999999999999997654322  


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                         ....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.... +....    ..+..+.          ...
T Consensus       173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~----~~i~~~~----------~~~  234 (329)
T PTZ00263        173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-PFRIY----EKILAGR----------LKF  234 (329)
T ss_pred             ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC-HHHHH----HHHhcCC----------cCC
Confidence               23579999999999999999999999999999999999999996321 11111    1111111          112


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCC-----HHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPS-----MKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs-----~~eil~  319 (487)
                      +..++..+.+|+.+||+.||.+||+     +++++.
T Consensus       235 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        235 PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            3345678899999999999999997     677774

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.2e-41  Score=327.75  Aligned_cols=254  Identities=25%  Similarity=0.370  Sum_probs=209.6

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ..+|.+.+.||+|+||.||+|.+.  ++.||+|++..+......+.+|+++++.++||||+++++++......++||||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            356888999999999999999886  788999998877666678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          132 SNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       132 ~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      ++++|.+++... ...+++..++.++.|++.||+|||+.  +++|+||||+|||++.++.+||+|||++......... .
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~--~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~  161 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-A  161 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CEeecccCcceEEEcCCCcEEeCCCccccccccceee-c
Confidence            999999999753 34589999999999999999999999  9999999999999999999999999998765432211 1


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |..||... .......    ...         .....+.+
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~----~~~---------~~~~~~~~  227 (263)
T cd05052         162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYE----LLE---------KGYRMERP  227 (263)
T ss_pred             cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHH----HHH---------CCCCCCCC
Confidence            112234678999999998899999999999999999998 88887532 2111111    111         11122334


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ..++.++.+++.+||+.+|++||++.++++.|+.+
T Consensus       228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            45678899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.9e-41  Score=326.59  Aligned_cols=254  Identities=24%  Similarity=0.391  Sum_probs=209.2

Q ss_pred             hcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      .++|++.+.||+|+||.||+|... +..||+|.+.......+.+.+|+.+++.++|+||+++++++.+....++||||++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            467999999999999999999876 6789999887665556789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          133 NGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       133 ~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      +++|.+++... ...+++..++.++.|++.||+|||+.  +++|+||||+||+++.++.++|+|||++......... ..
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~--~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~  161 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK--NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AR  161 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccccchhhEEecCCCcEEECCCccceecCCCcee-cc
Confidence            99999999753 34588999999999999999999999  9999999999999999999999999999765432211 12


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      ....++..|+|||++....++.++|||||||++|+|++ |..||... ........    +..+         ...+...
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~----~~~~---------~~~~~~~  227 (261)
T cd05072         162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM-SNSDVMSA----LQRG---------YRMPRME  227 (261)
T ss_pred             CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC-CHHHHHHH----HHcC---------CCCCCCC
Confidence            23346778999999988889999999999999999998 88888532 11111111    1110         1112223


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      .++.++.+++.+||+.+|++||++++|++.|+.+
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            4667899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=343.68  Aligned_cols=250  Identities=28%  Similarity=0.424  Sum_probs=216.7

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ..|+..++||+|.||.||+|.+.  ++.||+|++..+.  ...+.+++|+.++.+++++||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            35777789999999999999987  8899999988654  3457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      |.||++.+.|+... .+++..+..++++++.||.|||..  +.+|||||+.|||+..+|.+||+|||.+.++.....  .
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~--~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--r  167 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSE--KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--R  167 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhc--ceecccccccceeEeccCcEEEEecceeeeeechhh--c
Confidence            99999999998765 358888888999999999999999  999999999999999999999999999977654432  3


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      ..+..|||.|||||++....|+.|+||||||++.+||.+|.+|+..- .|.             ++.-.+....++....
T Consensus       168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~-hPm-------------rvlflIpk~~PP~L~~  233 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL-HPM-------------RVLFLIPKSAPPRLDG  233 (467)
T ss_pred             cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc-Ccc-------------eEEEeccCCCCCcccc
Confidence            36679999999999999889999999999999999999999998632 221             2233445555666667


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhc
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG  323 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~  323 (487)
                      .+++.+++++..||.+||+.||++.++++  ++++
T Consensus       234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  234 DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence            88899999999999999999999999997  4554

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.7e-40  Score=331.92  Aligned_cols=261  Identities=20%  Similarity=0.242  Sum_probs=200.5

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .++|.+.+.||+|+||.||+|...  ++.||||++....  .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999986  7899999876543  223467889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |++ ++|.+++......+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  158 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR--YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--  158 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--
Confidence            995 688888877666699999999999999999999999  999999999999999999999999999865432221  


Q ss_pred             ccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCc---------cccc
Q 011384          210 RSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK---------ILSV  279 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~---------i~~~  279 (487)
                      ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.....................         ....
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            2234578999999999865 45788999999999999999999999743221111111100000000         0000


Q ss_pred             cCCCCCCCCCh---------HHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          280 FDPRIPPPKDP---------IVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       280 ~~~~~~~~~~~---------~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .........+.         ..+.++.+|+.+||+.||.+|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00000000000         12357889999999999999999999996

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=325.99  Aligned_cols=255  Identities=22%  Similarity=0.407  Sum_probs=208.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .++|++.+.||+|+||.||+|.+.     ...||||.+...  ......+.+|+.++++++||||+++++++.+....++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            357899999999999999999885     347999987654  2334578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++++|.+++......+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.++|+|||++..+....
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~--~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM--NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999987655799999999999999999999999  99999999999999999999999999998765322


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||... .......    .+..+         ..
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-~~~~~~~----~~~~~---------~~  226 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIK----AVEDG---------YR  226 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC-CHHHHHH----HHHcC---------CC
Confidence            2222223345678999999998899999999999999999998 88888532 1111111    11111         11


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      .+.+..++..+.+++.+||+.+|++||++.+|++.|..+
T Consensus       227 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            122334567899999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.7e-41  Score=340.32  Aligned_cols=239  Identities=22%  Similarity=0.291  Sum_probs=198.0

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNG  134 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~g  134 (487)
                      +.||+|+||.||++...  ++.||||++....    .....+.+|+.++++++||||+++++++...+..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999875  7899999887532    23356788999999999999999999999999999999999999


Q ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCC
Q 011384          135 TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPP  214 (487)
Q Consensus       135 sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  214 (487)
                      +|.+++...+ .+++..+..++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++.......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~--~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~  155 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSC--DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTF  155 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccce
Confidence            9999997654 589999999999999999999999  999999999999999999999999999864322211  23345


Q ss_pred             CCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHH
Q 011384          215 AGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRK  294 (487)
Q Consensus       215 ~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  294 (487)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ......    .+..+.          ...+..++.
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-~~~~~~----~~~~~~----------~~~p~~~~~  220 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFE----LILMEE----------IRFPRTLSP  220 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC-HHHHHH----HHHcCC----------CCCCCCCCH
Confidence            79999999999999999999999999999999999999996321 111111    111111          122345677


Q ss_pred             HHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          295 QLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       295 ~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      ++.+|+.+||+.||++||     ++.++++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            899999999999999999     7898885

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-41  Score=332.18  Aligned_cols=248  Identities=33%  Similarity=0.533  Sum_probs=197.6

Q ss_pred             ccceeecccCceEEEEEEEC------CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           58 SEQKLLGKGSHGSVYKAVLR------GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        58 ~~~~~LG~G~~g~Vy~~~~~------g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ...+.||.|.||.||+|.+.      +..|+||+++..  ......+.+|++.+++++||||++++|++.+....++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            35689999999999999988      678999999653  3345789999999999999999999999998888999999


Q ss_pred             ecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          130 FMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       130 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      |+++|+|.++|... ...+++..++.|+.|++.||.|||+.  +++|+||+++|||++.++.+||+|||++.........
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~--~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN--NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT--TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccc
Confidence            99999999999886 56699999999999999999999999  9999999999999999999999999999776333222


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                      ...........|+|||.+....++.++||||||+++|||++ |+.|+.. .....+.   ..+ ..+..         .+
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~-~~~~~~~---~~~-~~~~~---------~~  225 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD-YDNEEII---EKL-KQGQR---------LP  225 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT-SCHHHHH---HHH-HTTEE---------TT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccc---ccc-ccccc---------ce
Confidence            23344567789999999988889999999999999999999 5677642 2222211   111 22111         12


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                      .+..++..+.+++..||+.+|++|||+.+|++.|
T Consensus       226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            3345677899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.6e-41  Score=330.72  Aligned_cols=261  Identities=20%  Similarity=0.210  Sum_probs=201.4

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ++|.+.+.||+|+||.||+|+++  ++.||||++....   ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999986  7789999876542   234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |++++.|..+. .....+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++......... 
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  156 (287)
T cd07848          81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKN--DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-  156 (287)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-
Confidence            99887665544 3344599999999999999999999999  9999999999999999999999999999765432211 


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhh-----------hhhhhcCcccc
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA-----------APLIKKGKILS  278 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~-----------~~~~~~~~i~~  278 (487)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||.............           ...........
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            2234568999999999998889999999999999999999999986432211111000           00000000000


Q ss_pred             ccCCCCC------CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          279 VFDPRIP------PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       279 ~~~~~~~------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...+...      ......++.++.+|+.+||+.||.+|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000      0111235678999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=324.72  Aligned_cols=250  Identities=25%  Similarity=0.384  Sum_probs=205.3

Q ss_pred             cCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      .+|++.+.||+|+||.||++.+. +..+|+|.+.........+.+|+++++.++||||+++++++.+....++||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            35888899999999999999887 55799999876655556788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      ++|.+++......+++..++.++.|++.||+|||+.  +++|+||||+||+++.++.+||+|||+++........ ....
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~  160 (256)
T cd05059          84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN--GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQG  160 (256)
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CcccccccHhhEEECCCCcEEECCcccceeccccccc-ccCC
Confidence            999999987555689999999999999999999999  9999999999999999999999999998765422111 1112


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV  292 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  292 (487)
                      ..++..|+|||.+.+..++.++|||||||++|+|++ |+.||... .......    ....         ....+.+..+
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~----~~~~---------~~~~~~~~~~  226 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF-SNSEVVE----SVSA---------GYRLYRPKLA  226 (256)
T ss_pred             CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC-CHHHHHH----HHHc---------CCcCCCCCCC
Confidence            234568999999998899999999999999999999 78887532 2221111    1111         1112233346


Q ss_pred             HHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          293 RKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       293 ~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                      +.++.+++.+||+.+|++|||+.+|++.|
T Consensus       227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            77899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3e-41  Score=341.57  Aligned_cols=250  Identities=25%  Similarity=0.352  Sum_probs=205.4

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||++...  ++.||+|++.....    ....+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47899999999999999999886  78999999875432    4456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++++|.+++......+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++..+......
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM--GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            99999999999987656799999999999999999999999  9999999999999999999999999999765433222


Q ss_pred             cccCCCCCCCccCCccccC------CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCC
Q 011384          209 FRSTPPAGTIGYLDPCYVT------PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~  282 (487)
                       ......||+.|+|||.+.      ...++.++|||||||++|||++|+.||.........    ..+.....       
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~----~~i~~~~~-------  226 (330)
T cd05601         159 -NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY----NNIMNFQR-------  226 (330)
T ss_pred             -eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH----HHHHcCCC-------
Confidence             233457999999999986      456789999999999999999999999643221111    11111111       


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       283 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+..+....++.++.+|+.+||+ +|.+||++++++.
T Consensus       227 ~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         227 FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            11112233467789999999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.6e-40  Score=322.38  Aligned_cols=246  Identities=23%  Similarity=0.357  Sum_probs=198.9

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCCH
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTL  136 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  136 (487)
                      +.||+|+||.||+|.+.  ++.||+|.....  ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999885  888999987643  33446789999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCC
Q 011384          137 YDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG  216 (487)
Q Consensus       137 ~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~g  216 (487)
                      .+++...+..+++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++.................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK--HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            999977666689999999999999999999999  999999999999999999999999999865432211111111233


Q ss_pred             CCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHH
Q 011384          217 TIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQ  295 (487)
Q Consensus       217 t~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  295 (487)
                      +..|+|||.+.+..++.++|||||||++|||++ |..||... .......    ..         ......+.+..++..
T Consensus       159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~----~~---------~~~~~~~~~~~~~~~  224 (252)
T cd05084         159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTRE----AI---------EQGVRLPCPELCPDA  224 (252)
T ss_pred             ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHH----HH---------HcCCCCCCcccCCHH
Confidence            567999999998889999999999999999998 77777521 1111111    11         111222334456778


Q ss_pred             HHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          296 LAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       296 l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      +.+++.+||+.+|++|||+.+|++.|+
T Consensus       225 ~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         225 VYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.3e-40  Score=324.71  Aligned_cols=251  Identities=24%  Similarity=0.385  Sum_probs=206.0

Q ss_pred             cCcccceeecccCceEEEEEEECC-eEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLRG-RQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~g-~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      .+|.+.+.||+|+||.||++.+.+ ..||||.+.........+.+|+.++++++||||+++++++.+....++||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            468889999999999999998874 4699998876655567899999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      ++|.+++......+++..++.++.|++.||+|||+.  +++|+||||+|||++.++.+||+|||++......... ....
T Consensus        84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~  160 (256)
T cd05113          84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK--QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVG  160 (256)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCC
Confidence            999999987555699999999999999999999999  9999999999999999999999999998765433221 1222


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV  292 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  292 (487)
                      ..++..|++||.+.+..++.++|||||||++|+|++ |..||.... ......    .+..+.         ....+...
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-~~~~~~----~~~~~~---------~~~~~~~~  226 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-NSETVE----KVSQGL---------RLYRPHLA  226 (256)
T ss_pred             CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC-HHHHHH----HHhcCC---------CCCCCCCC
Confidence            346678999999988889999999999999999998 888875321 111111    111111         11122234


Q ss_pred             HHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          293 RKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       293 ~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      +..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         227 SEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            678999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2e-40  Score=344.72  Aligned_cols=259  Identities=27%  Similarity=0.355  Sum_probs=209.0

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCC-CCCceeeEEEEeCC
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKIH-SPRLVNLLGFSNDS  121 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~  121 (487)
                      ...++|.+.++||+|+||.||+|++.       +..||||++....  ...+.+.+|+++++++. ||||++++++|.+.
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            33568999999999999999999864       2469999987543  23467899999999996 99999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHHhCC---------------------------------------------------------
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNN---------------------------------------------------------  144 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------  144 (487)
                      ...|+|||||++|+|.+++....                                                         
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            99999999999999999886421                                                         


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc
Q 011384          145 --------------------------------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID  186 (487)
Q Consensus       145 --------------------------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld  186 (487)
                                                            ..+++..++.++.|++.||.|||+.  +|+|+||||+|||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivH~dikp~Nill~  271 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK--NCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChHhEEEe
Confidence                                                  2477888899999999999999999  999999999999999


Q ss_pred             cCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhh
Q 011384          187 RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVD  265 (487)
Q Consensus       187 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~  265 (487)
                      .++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||...........
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            999999999999976543332222233457788999999998889999999999999999997 8888863322211111


Q ss_pred             hhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          266 WAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       266 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                          ....         ....+.+..++.++.+++.+||+.+|++||++.+|.+.|+.+.
T Consensus       352 ----~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         352 ----KIKS---------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             ----HHhc---------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence                1111         1112233456788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-41  Score=343.97  Aligned_cols=248  Identities=22%  Similarity=0.374  Sum_probs=215.0

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCc-eEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKD-RLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-~~lV~  128 (487)
                      ++|..++.+|+|+||.++.++++  ++.|++|++....   ......++|+.++++++|||||.+.+.|.+++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57889999999999999998877  7789999876443   334568999999999999999999999998888 89999


Q ss_pred             EecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          129 EFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      +||+||+|.+.+.+.+ ..++++.+..|+.|++.|+.|||++  +|+|||||+.|||+.+++.|||+|||+++.+.....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~--~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN--RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh--hhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            9999999999998754 6799999999999999999999999  999999999999999999999999999998876652


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                        ......||+.||+||.+.+.+|..|+|||||||++|||++-+++|.......-+..    +          .+....+
T Consensus       162 --~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k----i----------~~~~~~P  225 (426)
T KOG0589|consen  162 --LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILK----I----------NRGLYSP  225 (426)
T ss_pred             --hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHH----H----------hhccCCC
Confidence              34557899999999999999999999999999999999999999975333322221    1          1122345


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                      .+...+.++..|+..||+.+|+.||++.+++..
T Consensus       226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            677788999999999999999999999999984

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-41  Score=343.22  Aligned_cols=250  Identities=22%  Similarity=0.332  Sum_probs=202.2

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|++.+.||+|+||.||+|.+.  ++.||||++....    .....+.+|+.++..++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999986  7899999987532    23356788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++|+|.+++...+ .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++..+......
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKL--GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            9999999999998755 499999999999999999999999  9999999999999999999999999998654321100


Q ss_pred             ------------------------------------cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCc
Q 011384          209 ------------------------------------FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRK  252 (487)
Q Consensus       209 ------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~  252 (487)
                                                          .......||+.|+|||++....++.++|||||||++|||++|..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence                                                01112469999999999999999999999999999999999999


Q ss_pred             CCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCC---HHHHHH
Q 011384          253 AIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPS---MKEIVD  319 (487)
Q Consensus       253 pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs---~~eil~  319 (487)
                      ||..... ....   .....       ....+..+....+++++.+|+.+|+. +|.+|++   +.++++
T Consensus       238 Pf~~~~~-~~~~---~~i~~-------~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         238 PFCSDNP-QETY---RKIIN-------WKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCH-HHHH---HHHHc-------CCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9964321 1111   11111       01111112222456788999999997 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-41  Score=342.37  Aligned_cols=250  Identities=26%  Similarity=0.367  Sum_probs=206.0

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||+|.+.  ++.||||++....    .....+.+|++++..++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999987  8899999987542    33467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC--
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN--  206 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~--  206 (487)
                      ||+++++|.+++... ..+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.......  
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~--giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKL--GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            999999999999876 4599999999999999999999999  99999999999999999999999999987654332  


Q ss_pred             -------------------------cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc
Q 011384          207 -------------------------FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP  261 (487)
Q Consensus       207 -------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~  261 (487)
                                               .........||+.|+|||.+.+..++.++|||||||++|||++|+.||...... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-  236 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ-  236 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH-
Confidence                                     001223457999999999999999999999999999999999999999743211 


Q ss_pred             hhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCC-HHHHHH
Q 011384          262 SIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPS-MKEIVD  319 (487)
Q Consensus       262 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-~~eil~  319 (487)
                      ..   ...+..       .......+....++.++.+|+.+||. +|.+||+ ++++++
T Consensus       237 ~~---~~~i~~-------~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         237 ET---YNKIIN-------WKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             HH---HHHHhc-------cCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            11   111111       00111122222367889999999997 9999999 999996

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.1e-40  Score=321.26  Aligned_cols=256  Identities=23%  Similarity=0.369  Sum_probs=208.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCC----ChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSK----NQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~----~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||+|++.  ++.||||.+..    .......+.+|+++++.++||||+++++++.+....++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999875  78999997653    2333456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          129 EFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       129 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      ||+++++|.+++..   ....+++..++.++.|++.||.|||++  +++|+||||+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC--CeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            99999999988853   334588999999999999999999999  9999999999999999999999999998765433


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      ..  ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||.......  ..+... +..        ...+
T Consensus       160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--~~~~~~-~~~--------~~~~  226 (267)
T cd08228         160 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--FSLCQK-IEQ--------CDYP  226 (267)
T ss_pred             hH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH--HHHHHH-Hhc--------CCCC
Confidence            21  1223468899999999988889999999999999999999999986432221  111111 110        0111


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      ......++..+.+++.+||+.+|++||++.+|++.|++++
T Consensus       227 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            1122346678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.7e-40  Score=328.35  Aligned_cols=259  Identities=19%  Similarity=0.249  Sum_probs=201.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ++|.+.+.||+|+||.||+|...  +..||+|++....  .....+.+|++++++++||||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56999999999999999999886  7889999876432  2335678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +++ +|.+++...+..+++..+..++.|++.||+|||++  +|+||||||+|||++.++.+||+|||++........  .
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~  159 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR--KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--T  159 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--c
Confidence            974 99999987666689999999999999999999999  999999999999999999999999999875433221  2


Q ss_pred             cCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh------------cCccc
Q 011384          211 STPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK------------KGKIL  277 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~------------~~~i~  277 (487)
                      .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||........+.. ......            .....
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL-IFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCChHHhhccccchhhh
Confidence            234568999999999875 4679999999999999999999999864322211111 100000            00000


Q ss_pred             cccCCCCCC----CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          278 SVFDPRIPP----PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       278 ~~~~~~~~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ....+....    ...+.++.++.+|+.+||+.||.+|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            011111000    011234677899999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.3e-40  Score=333.33  Aligned_cols=264  Identities=24%  Similarity=0.334  Sum_probs=198.8

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC-----CceE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS-----KDRL  125 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~~~  125 (487)
                      +|.+.+.||+|+||.||+|++.  +..||||++...   ......+.+|+++++.++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999876  789999987643   22335688999999999999999999988543     2479


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +||||+. ++|.+++.... .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            9999995 68999887654 499999999999999999999999  9999999999999999999999999998754322


Q ss_pred             Cc-ccccCCCCCCCccCCccccCC--CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhh-----------hh
Q 011384          206 NF-RFRSTPPAGTIGYLDPCYVTP--DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP-----------LI  271 (487)
Q Consensus       206 ~~-~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~-----------~~  271 (487)
                      .. ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||....... .......           .+
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHh
Confidence            21 112234579999999999876  578999999999999999999999986432111 0000000           00


Q ss_pred             hcCc---cccccCCCCCCCC---ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          272 KKGK---ILSVFDPRIPPPK---DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       272 ~~~~---i~~~~~~~~~~~~---~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                      ...+   ....+....+.+.   .+.++..+.+++.+||+.||++|||++++++  ++..+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL  296 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence            0000   0011111111111   1124567889999999999999999999997  45443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.1e-40  Score=326.32  Aligned_cols=253  Identities=22%  Similarity=0.401  Sum_probs=206.8

Q ss_pred             hcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCChh--hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  124 (487)
                      .++|.+.+.||+|+||.||+|.+.       +..||||.+.....  ..+.+.+|+++++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            356888999999999999999864       36799998875433  346899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcE
Q 011384          125 LLVVEFMSNGTLYDVLHSNN-------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNA  191 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~v  191 (487)
                      ++||||+++++|.+++...+             ..+++..+..++.|++.||.|||++  +++|+||||+||+++.++.+
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~--~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ--HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC--CeeccccccceEEEcCCCeE
Confidence            99999999999999997542             3478889999999999999999999  99999999999999999999


Q ss_pred             EEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhh
Q 011384          192 RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPL  270 (487)
Q Consensus       192 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~  270 (487)
                      ||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.... ......    .
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-~~~~~~----~  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-NEEVIE----C  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH----H
Confidence            9999999875533322212233456789999999999999999999999999999998 998886322 222211    1


Q ss_pred             hhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          271 IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       271 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      +..+.         ....+..++..+.+++.+||+.||++||++.||++.|+
T Consensus       237 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 ITQGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            11111         11122346678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-41  Score=347.80  Aligned_cols=263  Identities=29%  Similarity=0.425  Sum_probs=215.6

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEEC---C--eE-EEEEEcCC----ChhhHHHHHHHHHHHHhCCCCCceeeEEEEe
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLR---G--RQ-VAVKKPSK----NQEISQEVDNEIEILSKIHSPRLVNLLGFSN  119 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~---g--~~-vAvK~~~~----~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  119 (487)
                      ++..-++....++||+|+||.||+|.+.   +  .. ||||..+.    ......+|.+|.+++++++|||||++||++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            3344455666799999999999999875   2  23 89998774    2445678999999999999999999999999


Q ss_pred             CCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       120 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                      +...++||||+|.||+|.++|.+.+..++..++..++.+.+.||+|||++  ++|||||..+|+|++.++.+||+|||++
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k--~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK--NCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC--CCcchhHhHHHheecCCCeEEeCccccc
Confidence            99999999999999999999999887799999999999999999999999  9999999999999999999999999998


Q ss_pred             eecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCcccc
Q 011384          200 LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILS  278 (487)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~  278 (487)
                      +...  ..........-...|+|||.+....|+.++|||||||++||+++ |..|+. +....++..+            
T Consensus       310 ~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~-g~~~~~v~~k------------  374 (474)
T KOG0194|consen  310 RAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYP-GMKNYEVKAK------------  374 (474)
T ss_pred             cCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCC-CCCHHHHHHH------------
Confidence            6543  11111112245679999999999999999999999999999998 677664 3332222221            


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCC
Q 011384          279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP  329 (487)
Q Consensus       279 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  329 (487)
                      +.....+.+.+...+.++..++.+||..+|++||+|.++.+.|+.+.....
T Consensus       375 I~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  375 IVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             HHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            112233444555778899999999999999999999999999998876443

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-40  Score=335.94  Aligned_cols=239  Identities=23%  Similarity=0.308  Sum_probs=197.0

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNG  134 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~g  134 (487)
                      +.||+|+||.||++...  ++.||+|++....    .....+.+|+++++.++||||+++++++...+..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999875  7899999886532    23356778999999999999999999999999999999999999


Q ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCC
Q 011384          135 TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPP  214 (487)
Q Consensus       135 sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  214 (487)
                      +|.+++.... .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||++........  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~  155 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTF  155 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccc
Confidence            9999887654 589999999999999999999999  999999999999999999999999999864322211  22345


Q ss_pred             CCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHH
Q 011384          215 AGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRK  294 (487)
Q Consensus       215 ~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  294 (487)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ....    .+..+      ..    ..+..++.
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~----~~~~~------~~----~~p~~~~~  220 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFE----LILME------EI----RFPRTLSP  220 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HHHH----HHhcC------CC----CCCCCCCH
Confidence            7999999999999999999999999999999999999999632211 1111    01110      01    12335677


Q ss_pred             HHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          295 QLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       295 ~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      ++.+++.+||+.||.+||     ++.++++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            899999999999999998     8888886

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-40  Score=341.22  Aligned_cols=256  Identities=23%  Similarity=0.278  Sum_probs=198.0

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ..+|.+.+.||+|+||.||++.+.  ++.||+|....     ..+.+|++++++++||||+++++++......++|+|++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            357999999999999999999986  78899996532     35678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      . ++|.+++.... .+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........ ...
T Consensus       166 ~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~--~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~  240 (391)
T PHA03212        166 K-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHEN--RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKY  240 (391)
T ss_pred             C-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-ccc
Confidence            4 68988887654 489999999999999999999999  999999999999999999999999999864322211 123


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCC-------chhhhhhhhhh---------hcCc
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-------PSIVDWAAPLI---------KKGK  275 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~-------~~~~~~~~~~~---------~~~~  275 (487)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......       ..+........         ....
T Consensus       241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~  320 (391)
T PHA03212        241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN  320 (391)
T ss_pred             ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence            3467999999999999999999999999999999999999877532110       00000000000         0000


Q ss_pred             ccc---------ccCCCCCCCC--ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          276 ILS---------VFDPRIPPPK--DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       276 i~~---------~~~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..         ...+......  ...++.++.+|+.+||+.||.+|||++|+++
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000         0000000000  1235678999999999999999999999996

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.3e-40  Score=342.28  Aligned_cols=250  Identities=22%  Similarity=0.298  Sum_probs=199.0

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .|..++.||+|+||.||+|++.  ++.||||++....    .....+.+|++++..++||||+++++++.+...+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5889999999999999999886  7889999886532    334578999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc--
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF--  207 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~--  207 (487)
                      |+++|+|.+++.... .+++..+..++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++..+.....  
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~--givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKM--GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            999999999997654 489999999999999999999999  999999999999999999999999999753311000  


Q ss_pred             -------------------------------------------ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHH
Q 011384          208 -------------------------------------------RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILL  244 (487)
Q Consensus       208 -------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl  244 (487)
                                                                 ........||+.|+|||.+.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                       0011234699999999999988899999999999999


Q ss_pred             HHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHH--hhhhcCCCCCCHHHHHH
Q 011384          245 LEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVR--CVRSCRERRPSMKEIVD  319 (487)
Q Consensus       245 ~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~--cl~~dP~~RPs~~eil~  319 (487)
                      |||++|+.||...........    ...       .......+....++.++.+|+.+  |+..++..||++.+|+.
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~----i~~-------~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLK----VIN-------WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHH----HHc-------cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            999999999974322111111    110       01111112222456788889887  55566667999999996

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.5e-40  Score=335.14  Aligned_cols=249  Identities=24%  Similarity=0.349  Sum_probs=200.8

Q ss_pred             CcccceeecccCceEEEEEEE-----CCeEEEEEEcCCCh-----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCce
Q 011384           56 GFSEQKLLGKGSHGSVYKAVL-----RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~-----~g~~vAvK~~~~~~-----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  124 (487)
                      +|.+.+.||+|+||.||++..     .++.||+|++.+..     ...+.+..|+.++..+ +||||+.+++++.+....
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            588899999999999999876     36789999876432     2335678899999999 589999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||+++|+|.+++.... .+++..+..++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKL--GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            99999999999999997654 499999999999999999999999  999999999999999999999999999875433


Q ss_pred             CCcccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      .... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..................       .+  
T Consensus       158 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------~~--  227 (332)
T cd05614         158 EEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-------CD--  227 (332)
T ss_pred             cCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-------CC--
Confidence            2211 22345799999999999865 4788999999999999999999999643322222111111110       11  


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                        .+.+..++..+.+++.+||+.||++||     +++++++
T Consensus       228 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         228 --PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence              223345677899999999999999999     6778875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-40  Score=339.56  Aligned_cols=243  Identities=25%  Similarity=0.312  Sum_probs=202.0

Q ss_pred             hcCcccceeecccCceEEEEEEEC---CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR---GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~---g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .++|.+.+.||+|+||.||+|.+.   +..||+|++...    ......+.+|+.+++.++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            356999999999999999999865   357999987643    2234568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++|+|.+++.... .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++...... 
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSL--NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence            999999999999998765 499999999999999999999999  9999999999999999999999999999765432 


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||... .+.....    .+..+.          .
T Consensus       185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-~~~~~~~----~i~~~~----------~  245 (340)
T PTZ00426        185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN-EPLLIYQ----KILEGI----------I  245 (340)
T ss_pred             ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC-CHHHHHH----HHhcCC----------C
Confidence                23457999999999999888999999999999999999999999632 1111111    111111          1


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      ..+..++..+.+++.+||+.+|.+|+     +++++++
T Consensus       246 ~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        246 YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            12334567789999999999999995     7888875

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.2e-40  Score=336.93  Aligned_cols=257  Identities=29%  Similarity=0.393  Sum_probs=204.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhC-CCCCceeeEEEEeC-CC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKI-HSPRLVNLLGFSND-SK  122 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~-~~  122 (487)
                      .++|.+.+.||+|+||.||+|.+.       ++.||+|++....  ...+.+..|+.++.++ +|+||++++++|.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            457999999999999999999753       3679999887532  2335678899999999 89999999998764 45


Q ss_pred             ceEEEEEecCCCCHHHHHHhCC----------------------------------------------------------
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNN----------------------------------------------------------  144 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------  144 (487)
                      .++++|||+++++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6889999999999999986421                                                          


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCC
Q 011384          145 --RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD  222 (487)
Q Consensus       145 --~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~a  222 (487)
                        .++++..+..++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++..+.............++..|+|
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~--~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence              2589999999999999999999999  999999999999999999999999999976543332222334456788999


Q ss_pred             ccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHH
Q 011384          223 PCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAV  301 (487)
Q Consensus       223 PE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~  301 (487)
                      ||++.+..++.++|||||||++|||++ |..||......+...    ..+..+         .....+..++.++.+++.
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~----~~~~~~---------~~~~~~~~~~~~~~~l~~  310 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC----RRLKEG---------TRMRAPEYATPEIYSIML  310 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH----HHHhcc---------CCCCCCccCCHHHHHHHH
Confidence            999999999999999999999999998 888885322111111    111111         111122345678999999


Q ss_pred             HhhhhcCCCCCCHHHHHHHHhccc
Q 011384          302 RCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       302 ~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      +||+.+|++||++.||++.|+.+.
T Consensus       311 ~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         311 DCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHccCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.9e-40  Score=325.49  Aligned_cols=255  Identities=23%  Similarity=0.412  Sum_probs=204.5

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSK  122 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  122 (487)
                      ..+++|++.+.||+|+||.||+|.+.       +..||||++....  .....+.+|+.+++.++||||+++++++.+..
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35678999999999999999999864       3579999876432  23456889999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEE
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNN---------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL  193 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL  193 (487)
                      ..++||||+++++|.+++....         ..+++..+..++.|++.||.|||+.  +++|+||||+|||++.++.++|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCcchheEEEcCCCCEEE
Confidence            9999999999999999997532         2357788999999999999999999  9999999999999999999999


Q ss_pred             cccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhh
Q 011384          194 GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIK  272 (487)
Q Consensus       194 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~  272 (487)
                      +|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.. .........    ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~-~~~~~~~~~----~~  235 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQVLRF----VM  235 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHH----HH
Confidence            99999875543322222223456788999999998889999999999999999999 5777752 222222211    11


Q ss_pred             cCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          273 KGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       273 ~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      .+.         ....+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       236 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         236 EGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             cCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            111         01123345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3e-40  Score=327.59  Aligned_cols=258  Identities=23%  Similarity=0.395  Sum_probs=209.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      .++|.+.+.||+|+||.||++...       +..+|+|.+.... .....+.+|++++++++||||+++++++......+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            467999999999999999999752       3568999887543 34567999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEE
Q 011384          126 LVVEFMSNGTLYDVLHSNN------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL  193 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL  193 (487)
                      +||||+++++|.+++...+            ..+++..++.++.|++.||+|||++  +++||||||+|||++.++.+||
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~--~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ--HFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecccCcceEEEccCCcEEe
Confidence            9999999999999997532            2489999999999999999999999  9999999999999999999999


Q ss_pred             cccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhh
Q 011384          194 GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIK  272 (487)
Q Consensus       194 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~  272 (487)
                      +|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||... .......    .+.
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~-~~~~~~~----~i~  236 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIE----CIT  236 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHH----HHH
Confidence            99999876543332222333456789999999998889999999999999999998 88887532 2211111    111


Q ss_pred             cCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          273 KGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       273 ~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      .+..         ...+..++.++.+|+.+||+.+|.+|||+.+|++.|+.+...
T Consensus       237 ~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         237 QGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             cCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            1111         112234567899999999999999999999999999888653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.9e-40  Score=324.85  Aligned_cols=265  Identities=22%  Similarity=0.369  Sum_probs=204.9

Q ss_pred             cccceeecccCceEEEEEEE------CCeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCC--CceEE
Q 011384           57 FSEQKLLGKGSHGSVYKAVL------RGRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDS--KDRLL  126 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~l  126 (487)
                      |...+.||+|+||.||++..      .+..||+|.+....  .....+.+|+++++.++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            48899999999999988753      26789999887543  2456788999999999999999999988653  45789


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++++|.+++....  +++..++.++.|++.||.|||++  +++|+||||+|||++.++.+||+|||++.......
T Consensus        86 v~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          86 IMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQ--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             EecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHHHC--CeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            999999999999997653  99999999999999999999999  99999999999999999999999999987654332


Q ss_pred             cccc-cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc-hhhhhhhhhhhcCccccccCCCC
Q 011384          207 FRFR-STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP-SIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       207 ~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~-~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      .... .....++..|+|||.+....++.++|||||||++|||++|..|+....... ..............+....+...
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM  241 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence            2111 122345667999999988889999999999999999999999875322110 01110000001111111222222


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      ..+.+..++.++.+++.+||+.+|++|||+++|++.|+.+.
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            23344556789999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.3e-40  Score=325.18  Aligned_cols=255  Identities=23%  Similarity=0.386  Sum_probs=205.5

Q ss_pred             cCcccceeecccCceEEEEEEEC--Ce----EEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GR----QVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~----~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ++|.+.+.||+|+||.||+|.+.  +.    .|++|.+....  ....++..|+..+..+.||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46888899999999999999984  43    47888775432  233567888989999999999999999864 45789


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ++||+++|+|.+++......+++..+..++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||+++......
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH--RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            9999999999999987666799999999999999999999999  99999999999999999999999999998665443


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      .........++..|++||.+.+..++.++|||||||++||+++ |..||... .+....+    .+..+.         .
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~----~~~~~~---------~  229 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPD----LLEKGE---------R  229 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHH----HHHCCC---------c
Confidence            3223334567789999999998899999999999999999998 88888532 2222221    112211         1


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .+.+..++..+..++.+||..+|.+|||+.|+++.|..+..
T Consensus       230 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         230 LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            11122345678889999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=334.57  Aligned_cols=237  Identities=23%  Similarity=0.299  Sum_probs=195.1

Q ss_pred             ecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCCH
Q 011384           63 LGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTL  136 (487)
Q Consensus        63 LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  136 (487)
                      ||+|+||.||+|.+.  ++.||+|++...    ......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999986  778999987643    23345678899999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCC
Q 011384          137 YDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG  216 (487)
Q Consensus       137 ~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~g  216 (487)
                      .+++...+ .+++..+..++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++........  ......|
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g  155 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLHKF--NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCG  155 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccccC
Confidence            99997754 499999999999999999999999  999999999999999999999999999865332221  2334579


Q ss_pred             CCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHH
Q 011384          217 TIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQL  296 (487)
Q Consensus       217 t~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  296 (487)
                      |+.|+|||.+.+..++.++|||||||++|+|++|+.||.....    ......... +          +...+..++.++
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~----~~~~~~~~~-~----------~~~~~~~~~~~~  220 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV----NEMYRKILQ-E----------PLRFPDGFDRDA  220 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH----HHHHHHHHc-C----------CCCCCCcCCHHH
Confidence            9999999999999999999999999999999999999963211    111111111 1          112334567789


Q ss_pred             HHHHHHhhhhcCCCCCC---HHHHHH
Q 011384          297 AVIAVRCVRSCRERRPS---MKEIVD  319 (487)
Q Consensus       297 ~~Li~~cl~~dP~~RPs---~~eil~  319 (487)
                      .+++.+||+.||.+||+   +.+++.
T Consensus       221 ~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         221 KDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             HHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            99999999999999985   555554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.7e-40  Score=338.49  Aligned_cols=251  Identities=23%  Similarity=0.331  Sum_probs=197.6

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||++...  ++.||||++.+..    .....+.+|+.++.+++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999886  7899999987542    23356888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc-
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF-  207 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~-  207 (487)
                      ||+++|+|.+++...+ .+++..+..++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++..+..... 
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~--givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQL--GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            9999999999998754 599999999999999999999999  999999999999999999999999999865432110 


Q ss_pred             --------------------------------ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCC
Q 011384          208 --------------------------------RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAID  255 (487)
Q Consensus       208 --------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~  255 (487)
                                                      ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                            000123579999999999999999999999999999999999999996


Q ss_pred             CCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhh--hcCCCCCCHHHHHH
Q 011384          256 IGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVR--SCRERRPSMKEIVD  319 (487)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~--~dP~~RPs~~eil~  319 (487)
                      ... +.....   .... .+    ....++.  ...++.++.+++.+++.  .++..||+++||++
T Consensus       238 ~~~-~~~~~~---~i~~-~~----~~~~~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~  292 (363)
T cd05628         238 SET-PQETYK---KVMN-WK----ETLIFPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT  292 (363)
T ss_pred             CCC-HHHHHH---HHHc-Cc----CcccCCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence            322 111111   1111 00    0001111  12245677888877543  34446789999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.7e-40  Score=323.62  Aligned_cols=254  Identities=25%  Similarity=0.391  Sum_probs=210.5

Q ss_pred             hhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChh-hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQE-ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ...+|++.+.||.|+||.||+|.+. ++.+++|.+..... ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            3457999999999999999999987 68899999876654 456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          131 MSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       131 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      +++++|.+++... +..+++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++........  
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~--  159 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ--NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY--  159 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccccCcceEEEcCCceEEEccccchhhcCCccc--
Confidence            9999999999763 34589999999999999999999999  999999999999999999999999999876543221  


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                      ......++..|++||.+....++.++||||||+++|+|++ |+.||... .........    .         .....+.
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~-~~~~~~~~~----~---------~~~~~~~  225 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM-NNHEVYDQI----T---------AGYRMPC  225 (261)
T ss_pred             cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC-CHHHHHHHH----H---------hCCcCCC
Confidence            1223456778999999988889999999999999999998 78888532 221221111    1         1112223


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      +..++..+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus       226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            445677899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-41  Score=333.84  Aligned_cols=261  Identities=23%  Similarity=0.337  Sum_probs=209.0

Q ss_pred             ccchhhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh---------------hHHHHHHHHHHHHhC
Q 011384           44 HFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---------------ISQEVDNEIEILSKI  106 (487)
Q Consensus        44 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~---------------~~~~~~~Ei~~l~~l  106 (487)
                      .+.-.+-...-++|.+++.||+|.||.|-+|...  ++.||||++.+...               ..+...+||.+|+++
T Consensus        86 ~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl  165 (576)
T KOG0585|consen   86 RYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL  165 (576)
T ss_pred             eecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc
Confidence            3444445566788999999999999999999886  88999998875321               125789999999999


Q ss_pred             CCCCceeeEEEEeCC--CceEEEEEecCCCCHHHHHHhCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcE
Q 011384          107 HSPRLVNLLGFSNDS--KDRLLVVEFMSNGTLYDVLHSNNRP-LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANV  183 (487)
Q Consensus       107 ~hpnIv~l~~~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NI  183 (487)
                      +|||||+|+.+..+.  +.+|+|+|||..|.+...=  ...+ +++.++++++++++.||.|||.+  +||||||||+|+
T Consensus       166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Q--giiHRDIKPsNL  241 (576)
T KOG0585|consen  166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQ--GIIHRDIKPSNL  241 (576)
T ss_pred             CCcCeeEEEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhc--Ceeccccchhhe
Confidence            999999999998764  5789999999988776442  2233 89999999999999999999999  999999999999


Q ss_pred             EEccCCcEEEcccccceecCCC---CcccccCCCCCCCccCCccccCCCC---C-CcchhhhhHHHHHHHHHhCCcCCCC
Q 011384          184 LIDRNFNARLGDFGLALRCGVD---NFRFRSTPPAGTIGYLDPCYVTPDN---L-STKTDVFSFGILLLEIISCRKAIDI  256 (487)
Q Consensus       184 Lld~~~~vkL~DFGla~~~~~~---~~~~~~~~~~gt~~Y~aPE~~~~~~---~-s~ksDVwSlGvvl~eLltG~~pf~~  256 (487)
                      ||+.+|+|||+|||.+..+...   +....-....|||.|+|||.+.++.   + +.+.||||+||+||-|+.|+.||..
T Consensus       242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            9999999999999999765221   1111122368999999999998743   2 5689999999999999999999974


Q ss_pred             CCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          257 GFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                      +..-    +..         .+++...+..+..+++.+++++||++||++||+.|.+..+|..+.
T Consensus       322 ~~~~----~l~---------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  322 DFEL----ELF---------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             chHH----HHH---------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            3221    111         123334444455567889999999999999999999999998643

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.7e-40  Score=325.03  Aligned_cols=253  Identities=23%  Similarity=0.419  Sum_probs=204.5

Q ss_pred             cCcccceeecccCceEEEEEEE------CCeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVL------RGRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .+|++.+.||+|+||.||+|.+      .+..|++|.+....  .....+.+|+++++.++||||+++++++......|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4688889999999999999985      25789999887432  233578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc
Q 011384          127 VVEFMSNGTLYDVLHSN----------------NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN  190 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~----------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~  190 (487)
                      ||||+++++|.+++...                ...+++..+..++.|++.||.|||++  +++|+||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH--FFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc--CeehhccccceEEEcCCCc
Confidence            99999999999998532                12478889999999999999999999  9999999999999999999


Q ss_pred             EEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhh
Q 011384          191 ARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAP  269 (487)
Q Consensus       191 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~  269 (487)
                      +||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.. ..+..+..    
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~~~----  237 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVIE----  237 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHH----
Confidence            99999999976544332222333456778999999988889999999999999999998 8888752 22222211    


Q ss_pred             hhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhc
Q 011384          270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG  323 (487)
Q Consensus       270 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~  323 (487)
                      ....+         ...+.+..++.++.+++.+||+.+|.+||++.+|++.|..
T Consensus       238 ~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 MVRKR---------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11111         1112334466789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-40  Score=318.56  Aligned_cols=250  Identities=27%  Similarity=0.416  Sum_probs=209.3

Q ss_pred             hcCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      .++|++.+.||+|+||.||+|...++.||+|.+.......+.+.+|+.+++.++|+||+++++++.+....++||||+++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   84 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK   84 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence            35788999999999999999999999999999887766567899999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccC
Q 011384          134 GTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       134 gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      ++|.+++.... ..+++..+..++.|++.||.|||+.  +++|+||||+||+++.++.+||+|||++.......     .
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~--~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~  157 (256)
T cd05039          85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK--NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----D  157 (256)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccchhcccceEEEeCCCCEEEccccccccccccc-----c
Confidence            99999997644 3589999999999999999999999  99999999999999999999999999987653221     1


Q ss_pred             CCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ....+..|+|||.+....++.++||||||+++|++++ |..||... ....+..    ....         ......+..
T Consensus       158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~----~~~~---------~~~~~~~~~  223 (256)
T cd05039         158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVP----HVEK---------GYRMEAPEG  223 (256)
T ss_pred             cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHH----HHhc---------CCCCCCccC
Confidence            2345678999999988889999999999999999997 88887532 2111111    1111         111122334


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ++.++.+++.+||..+|++|||++++++.|+++
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            567899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.5e-40  Score=323.86  Aligned_cols=256  Identities=27%  Similarity=0.452  Sum_probs=207.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC--Ce----EEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GR----QVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~----~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      .++|...+.||+|+||.||+|.+.  +.    .||+|++...  ......+.+|+.++..++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            467899999999999999999874  33    4899987643  33456788999999999999999999999764 578


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      ++++|+++|+|.+++......+++..++.++.|++.||.|||+.  +++||||||+|||++.++.+||+|||+++.+...
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            99999999999999987656699999999999999999999999  9999999999999999999999999999876543


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ..........+++.|++||.+.+..++.++|||||||++|||++ |..||... ....+..+    +..+         .
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~----~~~~---------~  228 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDL----LEKG---------E  228 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHH----HHCC---------C
Confidence            32222223345678999999998899999999999999999998 88887532 22222111    1111         1


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ..+.+..++.++.+++.+||+.||++||++.++++.|..+..
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         229 RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            112233466789999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.4e-40  Score=326.29  Aligned_cols=257  Identities=24%  Similarity=0.407  Sum_probs=209.4

Q ss_pred             cCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCChh-hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQE-ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .+|.+.+.||+|+||.||+|.+.       +..+++|.+..... ..+.+.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46888999999999999999753       34689998875543 34578999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcE
Q 011384          127 VVEFMSNGTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNA  191 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~v  191 (487)
                      ||||+++++|.+++....               ..+++..++.++.|++.||+|||++  +++|+||||+|||++.++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--~i~H~dlkp~Nil~~~~~~~  162 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ--HFVHRDLATRNCLVGANLLV  162 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecccCcceEEEccCCcE
Confidence            999999999999996532               2488999999999999999999999  99999999999999999999


Q ss_pred             EEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhh
Q 011384          192 RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPL  270 (487)
Q Consensus       192 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~  270 (487)
                      +|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.... ......    .
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~~----~  237 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-NTEVIE----C  237 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHH----H
Confidence            9999999875544332222334557889999999998899999999999999999998 888875322 111111    1


Q ss_pred             hhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          271 IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       271 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      ...+..         ...+..++..+.+++.+||+.+|.+|||+.+|++.|..+...
T Consensus       238 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         238 ITQGRV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HhCCCC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            111111         112233567899999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.8e-40  Score=334.81  Aligned_cols=239  Identities=22%  Similarity=0.292  Sum_probs=197.8

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNG  134 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~g  134 (487)
                      +.||+|+||.||++...  ++.||||++....    .....+.+|+++++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999876  7899999887542    23456888999999999999999999999999999999999999


Q ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCC
Q 011384          135 TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPP  214 (487)
Q Consensus       135 sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  214 (487)
                      +|.+.+.... .+++..+..++.||+.||+|||++  +|+||||||+|||++.++.+||+|||++........  .....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~  155 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSG--KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTF  155 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--ccccc
Confidence            9999987654 599999999999999999999999  999999999999999999999999999865322211  22345


Q ss_pred             CCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHH
Q 011384          215 AGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRK  294 (487)
Q Consensus       215 ~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  294 (487)
                      .||+.|+|||.+.+..++.++|||||||++|+|++|+.||.... ......    .+..+          ....+..++.
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-~~~~~~----~~~~~----------~~~~p~~~~~  220 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFE----LILME----------DIKFPRTLSA  220 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-HHHHHH----HhccC----------CccCCCCCCH
Confidence            79999999999998899999999999999999999999996321 111111    11110          1123345677


Q ss_pred             HHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          295 QLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       295 ~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      ++.+|+.+||+.||.+||     ++.++++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            899999999999999997     8999886

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-41  Score=311.41  Aligned_cols=244  Identities=27%  Similarity=0.397  Sum_probs=210.1

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+++.||+|-||.||.|+.+  +..||+|++.+++-    ...++.+|+++-+.|+||||+++|+||.+....||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            56888999999999999999887  66899999887653    3467999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          129 EFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       129 Ey~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      ||.++|.|+..|.. ....+++...+.++.|+|.||.|+|.+  +||||||||+|+|++..+.+||+|||.+.... .+ 
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k--~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~-  177 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SN-  177 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC--CcccCCCCHHHhccCCCCCeeccCCCceeecC-CC-
Confidence            99999999999984 234599999999999999999999999  99999999999999999999999999986543 22 


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                        ...+.+||..|.+||...+..++...|+|++|++.||++.|.+||......+...     .+.+   .       ...
T Consensus       178 --kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk-----rI~k---~-------~~~  240 (281)
T KOG0580|consen  178 --KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK-----RIRK---V-------DLK  240 (281)
T ss_pred             --CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH-----HHHH---c-------ccc
Confidence              3456799999999999999999999999999999999999999998543222211     1111   1       112


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .|..++.+++++|.+|+..+|.+|.+..|+++
T Consensus       241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  241 FPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             CCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence            34578889999999999999999999999997

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.4e-40  Score=326.58  Aligned_cols=259  Identities=26%  Similarity=0.401  Sum_probs=208.8

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCC--hhhHHHHHHHHHHHHhC-CCCCceeeEEEEe
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKN--QEISQEVDNEIEILSKI-HSPRLVNLLGFSN  119 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~  119 (487)
                      ++...++|++.+.||+|+||.||++.+.       ...+|+|.....  ......+.+|++++.++ +||||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            3445567999999999999999999875       257999987754  23345688999999999 8999999999999


Q ss_pred             CCCceEEEEEecCCCCHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEE
Q 011384          120 DSKDRLLVVEFMSNGTLYDVLHSN---------------NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVL  184 (487)
Q Consensus       120 ~~~~~~lV~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NIL  184 (487)
                      .....+++|||+++++|.+++...               ...+++..++.++.|++.||.|||+.  +|+|+||||+|||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~ivH~dlkp~Nil  164 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK--KCIHRDLAARNVL  164 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC--CccccccceeeEE
Confidence            999999999999999999999642               24589999999999999999999999  9999999999999


Q ss_pred             EccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchh
Q 011384          185 IDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSI  263 (487)
Q Consensus       185 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~  263 (487)
                      ++.++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||.. ......
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~  243 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEEL  243 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-CCHHHH
Confidence            99999999999999976544332222233345678999999988889999999999999999997 8888752 222121


Q ss_pred             hhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          264 VDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       264 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ..    ....         ......+..++..+.+|+.+||..+|++|||+.++++.|+.+
T Consensus       244 ~~----~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         244 FK----LLKE---------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HH----HHHc---------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            11    1111         111123334567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.4e-40  Score=348.29  Aligned_cols=248  Identities=21%  Similarity=0.274  Sum_probs=203.2

Q ss_pred             CcccceeecccCceEEEEEEEC---CeEEEEEEcCCC-hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR---GRQVAVKKPSKN-QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~---g~~vAvK~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      .|.+.+.||+|+||.||+|...   +..||+|..... ......+.+|+.+++.++||||++++++|...+..||||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4999999999999999999865   567888876543 333456888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          132 SNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       132 ~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ++|+|.+++..   ...++++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++..+......
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR--KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            99999998864   234689999999999999999999999  9999999999999999999999999999866443222


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+   ..... .+.         ..+.
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-~~~~---~~~~~-~~~---------~~~~  291 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-QREI---MQQVL-YGK---------YDPF  291 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-HHHH---HHHHH-hCC---------CCCC
Confidence            22344579999999999999999999999999999999999999986321 1111   11111 111         1122


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..++.++.+|+.+||+.+|++||++.+++.
T Consensus       292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            3346678999999999999999999999975

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.4e-40  Score=340.94  Aligned_cols=252  Identities=23%  Similarity=0.329  Sum_probs=203.7

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      ...++|.+.+.||+|+||.||++...  ++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+....+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34568999999999999999999886  7899999886432    23345788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +||||+++|+|.+++...  .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++......
T Consensus       120 lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999998764  388899999999999999999999  9999999999999999999999999999765433


Q ss_pred             CcccccCCCCCCCccCCccccCCC----CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPD----NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      .. .......||+.|+|||.+...    .++.++|||||||++|||++|+.||...... ...   ..+... .      
T Consensus       196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~---~~i~~~-~------  263 (370)
T cd05596         196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTY---SKIMDH-K------  263 (370)
T ss_pred             Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHH---HHHHcC-C------
Confidence            21 122345799999999998653    3788999999999999999999999743221 111   111110 0      


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCC--CCCHHHHHH
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRER--RPSMKEIVD  319 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--RPs~~eil~  319 (487)
                      ..+..+....++.++.+|+.+||+.+|.+  ||++++++.
T Consensus       264 ~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         264 NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            01111222346788999999999999988  999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.9e-40  Score=326.21  Aligned_cols=254  Identities=24%  Similarity=0.409  Sum_probs=206.2

Q ss_pred             CcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      +|.+.+.||+|+||.||+|...       ...+++|.+....  .....+.+|+.+++.++||||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999864       2568988877543  234678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcE
Q 011384          127 VVEFMSNGTLYDVLHSN-----------------------NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANV  183 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NI  183 (487)
                      |+||+.+++|.+++...                       ...+++..++.++.|++.||.|||+.  +++||||||+||
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~ivH~dikp~ni  158 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM--KLVHRDLAARNV  158 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC--CeehhhhhhheE
Confidence            99999999999998642                       13478899999999999999999999  999999999999


Q ss_pred             EEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCch
Q 011384          184 LIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPS  262 (487)
Q Consensus       184 Lld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~  262 (487)
                      |+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||. +..+..
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~  237 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP-GIAPER  237 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC-CCCHHH
Confidence            999999999999999876543332222333456778999999988889999999999999999998 888875 233333


Q ss_pred             hhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          263 IVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       263 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      +...    ...         ....+.+..++.++.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus       238 ~~~~----~~~---------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         238 LFNL----LKT---------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HHHH----HhC---------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            2221    111         1112223446678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-40  Score=341.01  Aligned_cols=250  Identities=24%  Similarity=0.326  Sum_probs=198.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||++...  ++.||||++.+..    .....+.+|++++++++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47899999999999999999885  7899999876532    23456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc-
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF-  207 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~-  207 (487)
                      ||+++|+|.+++...+ .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++.+..... 
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~--givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKL--GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            9999999999997654 589999999999999999999999  999999999999999999999999999853211000 


Q ss_pred             -----------c---------------------------------cccCCCCCCCccCCccccCCCCCCcchhhhhHHHH
Q 011384          208 -----------R---------------------------------FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGIL  243 (487)
Q Consensus       208 -----------~---------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvv  243 (487)
                                 .                                 .......||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                       0                                 00012469999999999999899999999999999


Q ss_pred             HHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCC---CCHHHHHH
Q 011384          244 LLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERR---PSMKEIVD  319 (487)
Q Consensus       244 l~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R---Ps~~eil~  319 (487)
                      +|||++|+.||..... ....   ......       ...+..+....++.++.+|+.+||. +|.+|   +++.+++.
T Consensus       238 l~elltG~~Pf~~~~~-~~~~---~~i~~~-------~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         238 MFECLIGWPPFCSENS-HETY---RKIINW-------RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             hhhhhcCCCCCCCCCH-HHHH---HHHHcc-------CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence            9999999999964322 1111   111110       0111112222456789999999998 66665   59999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.9e-40  Score=324.31  Aligned_cols=260  Identities=24%  Similarity=0.427  Sum_probs=207.5

Q ss_pred             hcCcccceeecccCceEEEEEEECC------------------eEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCcee
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLRG------------------RQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVN  113 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~g------------------~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~  113 (487)
                      ..+|.+.+.||+|+||.||++.+..                  ..||+|.+....  ...+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578999999999999999987642                  458999887543  34567899999999999999999


Q ss_pred             eEEEEeCCCceEEEEEecCCCCHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcE
Q 011384          114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN----------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANV  183 (487)
Q Consensus       114 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NI  183 (487)
                      +++++..+...++||||+++++|.+++....          ..+++..++.++.|++.||+|||+.  +++|+||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~--~i~H~dlkp~Ni  161 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL--NFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc--Cccccccchhce
Confidence            9999999999999999999999999997643          2589999999999999999999999  999999999999


Q ss_pred             EEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh--CCcCCCCCCCCc
Q 011384          184 LIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS--CRKAIDIGFSPP  261 (487)
Q Consensus       184 Lld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt--G~~pf~~~~~~~  261 (487)
                      +++.++.++|+|||++................+++.|+|||.+....++.++|||||||++|||++  +..||.. ....
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~-~~~~  240 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH-LTDQ  240 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC-cChH
Confidence            999999999999999876544332223334567789999999988889999999999999999998  5566642 2222


Q ss_pred             hhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          262 SIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       262 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      .............      ......+.+..++.++.+++.+||+.+|.+|||+.+|+++|+
T Consensus       241 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 QVIENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            2222221111111      111111223345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-40  Score=324.48  Aligned_cols=248  Identities=24%  Similarity=0.301  Sum_probs=202.7

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .|+..+.||+|+||.||++.+.  ++.||||++....    .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999875  7899999886532    223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          130 FMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       130 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      |+++++|.+++... ...+++..+..++.|++.||.|||+.  +++|+||||+||++++++.++|+|||++.......  
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE--RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC--CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence            99999999988653 34599999999999999999999999  99999999999999999999999999987653222  


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                       ......|++.|+|||.+.+..++.++|||||||++|||++|+.||............ ...+.          ......
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~-~~~~~----------~~~~~~  224 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV-ERRVK----------EDQEEY  224 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH-HHHhh----------hccccc
Confidence             123347899999999999888999999999999999999999999743221111111 11111          111223


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      +..++..+.+|+.+||+.||.+||     +++++++
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            445778899999999999999999     8888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.6e-40  Score=337.14  Aligned_cols=245  Identities=24%  Similarity=0.393  Sum_probs=195.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      .+|...+.||+|+||.||+|++.  ++.||||++...  ......+.+|+++++.++|+||+++++++.+.+.+++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45777899999999999999986  789999988643  23346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +++++|.+.     ...++..+..++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++..+.....  .
T Consensus       154 ~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~  224 (353)
T PLN00034        154 MDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRR--HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--P  224 (353)
T ss_pred             CCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEcCCCCEEEcccccceecccccc--c
Confidence            999998653     2366778889999999999999999  999999999999999999999999999876543221  1


Q ss_pred             cCCCCCCCccCCccccCCC-----CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          211 STPPAGTIGYLDPCYVTPD-----NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~-----~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      .....||..|+|||.+...     ..+.++|||||||++|||++|+.||....... ........ .         ....
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~-~---------~~~~  293 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASLMCAI-C---------MSQP  293 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHH-h---------ccCC
Confidence            2345799999999987532     33568999999999999999999997332211 11100000 0         0111


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...+..++.++.+|+.+||+.||++|||+.||++
T Consensus       294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2233456788999999999999999999999997

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.3e-40  Score=341.00  Aligned_cols=249  Identities=23%  Similarity=0.296  Sum_probs=198.7

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      +|..++.||+|+||.||+|+..  ++.||+|++....    .....+.+|++++++++||||+++++++.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5889999999999999999886  7889999887542    234578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC---
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN---  206 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~---  206 (487)
                      |+++|+|.+++...+ .+++..+..++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++..+....   
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~--~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            999999999997654 489999999999999999999999  99999999999999999999999999974321000   


Q ss_pred             ------------------------------------------cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHH
Q 011384          207 ------------------------------------------FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILL  244 (487)
Q Consensus       207 ------------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl  244 (487)
                                                                .........||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                      00011234699999999999999999999999999999


Q ss_pred             HHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCC---HHHHHH
Q 011384          245 LEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPS---MKEIVD  319 (487)
Q Consensus       245 ~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs---~~eil~  319 (487)
                      |||++|+.||...........    ...       .......+....+++++.+++.+|+ .+|.+|++   +.+++.
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~----i~~-------~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMK----VIN-------WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHH----HHc-------cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999974321111111    100       1111222223346678888888876 59999997   888775

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-41  Score=310.96  Aligned_cols=265  Identities=23%  Similarity=0.328  Sum_probs=214.7

Q ss_pred             hHHHhhcCcccceeecccCceEEEEEEE--CCeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC---
Q 011384           49 DLEAATNGFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSK---  122 (487)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~--~g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---  122 (487)
                      ++....++|.+.+.||+|||+-||+++.  .++.||+|++.-.. ...+...+|++..++++|||+++++++.....   
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            3345567899999999999999999874  48899999877554 56678999999999999999999999875443   


Q ss_pred             --ceEEEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccc
Q 011384          123 --DRLLVVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFG  197 (487)
Q Consensus       123 --~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFG  197 (487)
                        ..||+++|+..|+|.+.+..   .+..+++.+++.|+.++++||.+||+..|.+.||||||.|||+.+.+.++|.|||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence              48999999999999999864   4456999999999999999999999996679999999999999999999999999


Q ss_pred             cceecCCCC--cc-----cccCCCCCCCccCCccccCCC---CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhh
Q 011384          198 LALRCGVDN--FR-----FRSTPPAGTIGYLDPCYVTPD---NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA  267 (487)
Q Consensus       198 la~~~~~~~--~~-----~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~  267 (487)
                      .+......-  ..     ........|..|.|||.+...   ..+.++|||||||+||+|++|..||+..........  
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla--  252 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA--  252 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE--
Confidence            986543211  00     111223579999999998654   568999999999999999999999974333211111  


Q ss_pred             hhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          268 APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       268 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                               ..+....+..|.....++.+.+|+++||+.||.+||++.+++..++.+
T Consensus       253 ---------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  253 ---------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ---------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                     233344444445555889999999999999999999999999988765

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2e-40  Score=341.85  Aligned_cols=250  Identities=22%  Similarity=0.311  Sum_probs=199.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      .+|.+.+.||+|+||.||++...  ++.||||++....    .....+.+|++++++++||||+++++.+.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36999999999999999999876  7899999886532    23356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC--
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN--  206 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~--  206 (487)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||++..+....  
T Consensus        81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            9999999999997764 489999999999999999999999  99999999999999999999999999974321000  


Q ss_pred             ---------------------------------------cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHH
Q 011384          207 ---------------------------------------FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEI  247 (487)
Q Consensus       207 ---------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eL  247 (487)
                                                             .........||+.|+|||++.+..++.++|||||||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                   00011234799999999999999999999999999999999


Q ss_pred             HhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCC---CHHHHHH
Q 011384          248 ISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRP---SMKEIVD  319 (487)
Q Consensus       248 ltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP---s~~eil~  319 (487)
                      ++|+.||...........    ...       .......+....++.++.+++.+|+ .+|.+|+   ++.+++.
T Consensus       238 l~G~~Pf~~~~~~~~~~~----i~~-------~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         238 LVGQPPFLADTPAETQLK----VIN-------WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             hhCCCCCCCCCHHHHHHH----Hhc-------cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            999999974322111111    100       0111111222345677888888876 5999999   8899885

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.6e-40  Score=319.29  Aligned_cols=253  Identities=24%  Similarity=0.410  Sum_probs=207.9

Q ss_pred             hhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ..++|.+.++||+|+||.||+|... ++.||+|.+.........+.+|+.++++++||||+++++++. ....+++|||+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            3567999999999999999999876 788999998876666678999999999999999999999875 45689999999


Q ss_pred             CCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          132 SNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       132 ~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      ++++|.+++.. .+..+++..+..++.|++.||+|||+.  +++|+||||+||+++.++.++|+|||++......... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~--~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~  159 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK--NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-A  159 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-c
Confidence            99999999865 334689999999999999999999999  9999999999999999999999999998765422211 1


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      .....++..|+|||.+....++.++||||||+++||+++ |+.||... ........    ..         .....+.+
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~----~~---------~~~~~~~~  225 (260)
T cd05067         160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQN----LE---------RGYRMPRP  225 (260)
T ss_pred             ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHH----HH---------cCCCCCCC
Confidence            223346778999999998889999999999999999999 89888632 22222211    11         11112233


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhc
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG  323 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~  323 (487)
                      ..++.++.+++.+||+.+|++||++++++.+|+.
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            3456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-41  Score=341.79  Aligned_cols=262  Identities=25%  Similarity=0.359  Sum_probs=224.6

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      +.++....+....++||-|-||.||.|+|+  .-.||||.++.+....++|+.|..+|+.++|||+|+|+|+|.....+|
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            566667778888999999999999999998  678999999999888899999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          126 LVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ||+|||.+|+|.++|...+ ..++.-..+.++.||..|+.||..+  ++|||||..+|+|+..+..|||+|||+++.+..
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk--nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh--hhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            9999999999999998743 4477788899999999999999999  999999999999999999999999999998876


Q ss_pred             CCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      +.+... ....-...|.|||-+....++.|+|||+|||+||||.|-......+....++..             +++..+
T Consensus       418 DTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~-------------LLEkgy  483 (1157)
T KOG4278|consen  418 DTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG-------------LLEKGY  483 (1157)
T ss_pred             Cceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH-------------HHhccc
Confidence            654322 122345689999999999999999999999999999884433333433333322             333445


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      +...|..|++.+.+|++.||+.+|.+||++.||.+.|+.|.
T Consensus       484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            55667789999999999999999999999999999998873

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-39  Score=317.94  Aligned_cols=252  Identities=25%  Similarity=0.395  Sum_probs=205.6

Q ss_pred             hcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      .++|.+.+.||+|+||.||+|.+. +..||+|.+.........+.+|+.++++++|||++++++++.+ ...+++|||++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS   83 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence            357899999999999999999876 6789999988765556789999999999999999999998854 56899999999


Q ss_pred             CCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          133 NGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       133 ~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      +++|.+++... ...+++..+..++.+++.||.|||+.  +++|+||||+||+++.++.++|+|||++..+...... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~--~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~  160 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM--NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-AR  160 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cc
Confidence            99999999763 34589999999999999999999999  9999999999999999999999999999765432211 11


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |..||... ........   +          ......+.+.
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~---~----------~~~~~~~~~~  226 (260)
T cd05070         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQ---V----------ERGYRMPCPQ  226 (260)
T ss_pred             cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHH---H----------HcCCCCCCCC
Confidence            22345678999999988889999999999999999999 78887532 22111111   1          1111223344


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhc
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG  323 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~  323 (487)
                      ..+..+.+|+.+||..+|++|||+.++.++|+.
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.3e-39  Score=318.61  Aligned_cols=253  Identities=24%  Similarity=0.400  Sum_probs=206.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      ..+|.+.+.||+|+||.||+|.+. ...||+|++.......+.+.+|+++++.++||||+++++++.+ ...++||||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            457999999999999999999886 4579999988755556788999999999999999999998754 56799999999


Q ss_pred             CCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          133 NGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       133 ~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      +++|.+++... +..+++..+..++.|++.||+|||+.  +++|+||||+||+++.++.++|+|||++..+...... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~--~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~  160 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-AR  160 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC--CccccccCcccEEEcCCCcEEeccCCceeeccccccc-cc
Confidence            99999999763 34589999999999999999999999  9999999999999999999999999999765433221 12


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      ....++..|+|||+..+..++.++|||||||++|+|++ |..||.... ......    ....         ....+.+.
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-~~~~~~----~~~~---------~~~~~~~~  226 (262)
T cd05071         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLD----QVER---------GYRMPCPP  226 (262)
T ss_pred             cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-hHHHHH----HHhc---------CCCCCCcc
Confidence            23346778999999988889999999999999999999 777775322 111111    1111         11122344


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      .++..+.+|+.+||+.+|++||++.++++.|+..
T Consensus       227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            5678899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.9e-41  Score=327.50  Aligned_cols=247  Identities=25%  Similarity=0.385  Sum_probs=210.6

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      ....+|.+.+.||+|.||.|-++...  |+.||||-+.++    .+..-.+++||++|+.|+||||+.+|.+|+..+.+.
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            44578999999999999999999875  999999987755    334456899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      |||||..+|.|+|++...+. |++.++.++++||..|+.|+|.+  +++|||||.+|||+|.++++||+|||++-.+...
T Consensus       130 ivMEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCHkn--rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCHKN--RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EEEEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHhhc--cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            99999999999999988764 99999999999999999999999  9999999999999999999999999999776655


Q ss_pred             CcccccCCCCCCCccCCccccCCCCC-CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      .   .-.+.+|+|.|.+||++.+.+| .+..|.|||||+||-|+.|..||+. .....    ....+..|...       
T Consensus       207 k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~----lvrQIs~GaYr-------  271 (668)
T KOG0611|consen  207 K---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKR----LVRQISRGAYR-------  271 (668)
T ss_pred             c---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHH----HHHHhhccccc-------
Confidence            4   3456899999999999999988 6899999999999999999999973 22111    11222232221       


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                          .+..+.+..-||++||..||++|.|+++|...
T Consensus       272 ----EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  272 ----EPETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ----CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                12334567889999999999999999999873

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.4e-40  Score=322.02  Aligned_cols=258  Identities=26%  Similarity=0.349  Sum_probs=215.7

Q ss_pred             HhhcCcccceeecccCceEEEEEEECC--eEEEEEEcCCChhh----HHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLRG--RQVAVKKPSKNQEI----SQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~g--~~vAvK~~~~~~~~----~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      ..-++|..++.||.|..|.||++...+  ..+|+|++.+....    ..+...|-+||+.+.||.++.||..|+.+...|
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence            334679999999999999999999985  78999999876433    356788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          126 LVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      +|||||+||+|..++++ .++.+++..+..++.+++.||+|||..  |||+|||||+||||-++|++-|+||.|+..+..
T Consensus       154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml--GivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML--GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh--ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            99999999999999986 345699999999999999999999999  999999999999999999999999999754321


Q ss_pred             CC---------------------------------c---------------------ccccCCCCCCCccCCccccCCCC
Q 011384          205 DN---------------------------------F---------------------RFRSTPPAGTIGYLDPCYVTPDN  230 (487)
Q Consensus       205 ~~---------------------------------~---------------------~~~~~~~~gt~~Y~aPE~~~~~~  230 (487)
                      ..                                 .                     ..++....||-.|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence            00                                 0                     01122336999999999999999


Q ss_pred             CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCC
Q 011384          231 LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRER  310 (487)
Q Consensus       231 ~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~  310 (487)
                      .+.++|+|+|||++|||+.|..||........+.             +++......+..+.++..+++||+++|.+||.+
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~-------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR-------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH-------------HHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence            9999999999999999999999998554444433             233334444455578899999999999999999


Q ss_pred             CCC----HHHHHH--HHhcc
Q 011384          311 RPS----MKEIVD--WLTGL  324 (487)
Q Consensus       311 RPs----~~eil~--~L~~l  324 (487)
                      |.-    +.||.+  +++++
T Consensus       379 Rlg~~rGA~eIK~HpFF~gV  398 (459)
T KOG0610|consen  379 RLGSKRGAAEIKRHPFFEGV  398 (459)
T ss_pred             hhccccchHHhhcCccccCC
Confidence            997    888876  45544

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=344.60  Aligned_cols=243  Identities=24%  Similarity=0.342  Sum_probs=204.6

Q ss_pred             HHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCc
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKD  123 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  123 (487)
                      ....++|.+.++||+|.||.|+++..+  ++.+|||++++..    ...+....|-+++... +||.+++++.+|...+.
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            344578999999999999999999887  6789999998763    3446778888888877 59999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      +|+||||+.||++..+.+.  +.+++..+..++..++.||+|||++  +|||||||.+|||+|.+|.+||+|||+++..-
T Consensus       444 l~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~~--~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHEN--GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHhc--CceeeecchhheEEcccCcEEecccccccccC
Confidence            9999999999994433332  3499999999999999999999999  99999999999999999999999999997543


Q ss_pred             CCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ..+  ..+.+.+|||.|||||++.+..|+.+.|+|||||+|||||.|..||..+... ++-+   .++           .
T Consensus       520 ~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-e~Fd---sI~-----------~  582 (694)
T KOG0694|consen  520 GQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-EVFD---SIV-----------N  582 (694)
T ss_pred             CCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHH---HHh-----------c
Confidence            222  2567789999999999999999999999999999999999999999743332 2221   111           1


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSM  314 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~  314 (487)
                      ....+|..++.+...+++++|.++|++|.-+
T Consensus       583 d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            1234667889999999999999999999854

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.3e-39  Score=328.84  Aligned_cols=258  Identities=21%  Similarity=0.320  Sum_probs=202.6

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .++|.+.+.||+|+||.||++.+.  +..+|+|++...  ......+.+|+++++.++||||++++++|.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999986  778999987654  2334678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |+++++|.+++...+ .+++..+..++.+++.||.|||+.. +++|+||||+|||++.++.+||+|||++......    
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----  157 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcC-CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----
Confidence            999999999997654 4899999999999999999999742 6999999999999999999999999998654322    


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccc------------
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKIL------------  277 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~------------  277 (487)
                      ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||..... ..... .......+...            
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  235 (333)
T cd06650         158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA-KELEL-MFGCPVEGDPAESETSPRPRPPG  235 (333)
T ss_pred             ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch-hHHHH-HhcCcccCCccccccCcccCCcc
Confidence            12334689999999999988899999999999999999999999864221 11100 00000000000            


Q ss_pred             --------------------c-ccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          278 --------------------S-VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       278 --------------------~-~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                                          . ......+.......+.++.+|+.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                                0 00000000001124577999999999999999999999986

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.2e-40  Score=331.43  Aligned_cols=240  Identities=23%  Similarity=0.327  Sum_probs=196.6

Q ss_pred             ceeecccCceEEEEEEE-----CCeEEEEEEcCCCh-----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           60 QKLLGKGSHGSVYKAVL-----RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~-----~g~~vAvK~~~~~~-----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ++.||+|+||.||++..     .++.||||++....     .....+.+|+++++.++||||+++++++.+++..|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            36899999999999976     36789999876532     233567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |+++++|.+.+...+ .+.+..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (323)
T cd05584          81 YLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQ--GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--  155 (323)
T ss_pred             CCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence            999999999997765 488889999999999999999999  999999999999999999999999999875432221  


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .   ... .+..+.          ...+
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-~---~~~-~~~~~~----------~~~~  220 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-K---TID-KILKGK----------LNLP  220 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-H---HHH-HHHcCC----------CCCC
Confidence            223457999999999999888999999999999999999999999642211 1   111 111111          1233


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      ..++.++.+++.+||+.+|++||     ++.++++
T Consensus       221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            44667899999999999999999     7888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.5e-40  Score=322.76  Aligned_cols=254  Identities=26%  Similarity=0.373  Sum_probs=203.3

Q ss_pred             hhcCcccceeecccCceEEEEEEECC-------eEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCc
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKD  123 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~g-------~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  123 (487)
                      .+++|.+.+.||+|++|.||+|.+.+       ..|++|.....  ......+.+|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35679999999999999999998853       67899987644  3334568999999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC---cEEEc
Q 011384          124 RLLVVEFMSNGTLYDVLHSNN------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF---NARLG  194 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~---~vkL~  194 (487)
                      .++||||+++++|.+++....      ..+++..++.++.||+.||.|||+.  +++|+||||+|||++.++   .+||+
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN--HFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccchheEEEeccCCCcceEec
Confidence            999999999999999997643      2489999999999999999999999  999999999999998654   69999


Q ss_pred             ccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhc
Q 011384          195 DFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKK  273 (487)
Q Consensus       195 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~  273 (487)
                      |||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |..||... ....+...   ....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-~~~~~~~~---~~~~  237 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-TNQEVMEF---VTGG  237 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHH---HHcC
Confidence            9999876533222111222344578999999998899999999999999999997 88888632 22222111   1111


Q ss_pred             CccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          274 GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       274 ~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                                .....+..++..+.+++.+||+.+|++||++.+|++.|.
T Consensus       238 ----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         238 ----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                      111223445678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-39  Score=322.48  Aligned_cols=259  Identities=19%  Similarity=0.263  Sum_probs=196.0

Q ss_pred             cCcccceeecccCceEEEEEEEC---CeEEEEEEcCCCh---hhHHHHHHHHHHHHhC---CCCCceeeEEEEe-----C
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR---GRQVAVKKPSKNQ---EISQEVDNEIEILSKI---HSPRLVNLLGFSN-----D  120 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~---g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~-----~  120 (487)
                      ++|.+.+.||+|+||.||+|.+.   ++.||||++....   .....+.+|+.+++.+   +||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            46899999999999999999873   5789999876432   2234566788777766   6999999999885     3


Q ss_pred             CCceEEEEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                      ....++||||++ ++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            456899999996 6999998753 34589999999999999999999999  9999999999999999999999999999


Q ss_pred             eecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh--cCcc-
Q 011384          200 LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK--KGKI-  276 (487)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~--~~~i-  276 (487)
                      .......   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........+.........  .... 
T Consensus       158 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         158 RIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             EeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            7654331   234457899999999998888999999999999999999999998743322221111110000  0000 


Q ss_pred             ------ccccCCCCCC---CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          277 ------LSVFDPRIPP---PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       277 ------~~~~~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                            ...+.+....   ...+.++..+.+|+.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                  0000000000   011235677899999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.2e-40  Score=348.99  Aligned_cols=256  Identities=26%  Similarity=0.318  Sum_probs=207.6

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK  122 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  122 (487)
                      .+.+...++|.+.+.||+|+||.||+|.+.  ++.||||++...   ......+.+|+.++..++|+||+++++.+....
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            444555679999999999999999999875  889999987643   334457889999999999999999988765332


Q ss_pred             --------ceEEEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcE
Q 011384          123 --------DRLLVVEFMSNGTLYDVLHSN---NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNA  191 (487)
Q Consensus       123 --------~~~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~v  191 (487)
                              .+++||||+++|+|.+++...   ...+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~--~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK--HMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEeCCCCE
Confidence                    368999999999999998642   34689999999999999999999999  99999999999999999999


Q ss_pred             EEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhh
Q 011384          192 RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI  271 (487)
Q Consensus       192 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~  271 (487)
                      ||+|||+++.+.............||+.|+|||.+.+..++.++|||||||++|||++|+.||....    .........
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~----~~~~~~~~~  258 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN----MEEVMHKTL  258 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHh
Confidence            9999999976544322223345679999999999999999999999999999999999999996321    111111111


Q ss_pred             hcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       272 ~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                       .+         ...+.+..++.++.+|+.+||+.+|.+||++.+++.
T Consensus       259 -~~---------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        259 -AG---------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             -cC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence             11         111234456788999999999999999999999986

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=318.30  Aligned_cols=252  Identities=20%  Similarity=0.358  Sum_probs=201.7

Q ss_pred             cccceeecccCceEEEEEEEC-----CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCc-----
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKD-----  123 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-----  123 (487)
                      |.+.+.||+|+||.||+|.+.     +..||+|++....   .....+.+|++.++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567889999999999999874     2679999877542   334578999999999999999999998866554     


Q ss_pred             -eEEEEEecCCCCHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccc
Q 011384          124 -RLLVVEFMSNGTLYDVLHSN-----NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFG  197 (487)
Q Consensus       124 -~~lV~Ey~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFG  197 (487)
                       .++|+||+++++|..++...     ...+++..+..++.|++.||.|||+.  +++|+||||+||++++++.+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR--NFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC--CeeccccchheEEECCCCeEEECCcc
Confidence             79999999999999998542     23589999999999999999999999  99999999999999999999999999


Q ss_pred             cceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCcc
Q 011384          198 LALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKI  276 (487)
Q Consensus       198 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i  276 (487)
                      +++...............++..|+|||.+....++.++|||||||++|||++ |..||.. ..........    ..+. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~-~~~~~~~~~~----~~~~-  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDYL----RHGN-  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHH----HcCC-
Confidence            9976644332212222345678999999988889999999999999999999 7777753 2222222211    1111 


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          277 LSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                              ....+..++.++.+++.+||+.||++||++.+|++.|+.+
T Consensus       233 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         233 --------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             --------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    1122345677899999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-40  Score=321.59  Aligned_cols=254  Identities=23%  Similarity=0.411  Sum_probs=206.5

Q ss_pred             hhcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCc
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKD  123 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  123 (487)
                      ..++|.+.+.||+|+||.||+|.+.       +..||+|.+....  .....+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            3468999999999999999999875       2679999987553  334578899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEc
Q 011384          124 RLLVVEFMSNGTLYDVLHSNN---------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLG  194 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~  194 (487)
                      .++||||+++++|.+++....         ..+++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK--KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccccChheEEEcCCCCEEEC
Confidence            999999999999999996422         2378889999999999999999999  99999999999999999999999


Q ss_pred             ccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhc
Q 011384          195 DFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKK  273 (487)
Q Consensus       195 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~  273 (487)
                      |||+++.+.............++..|+|||.+....++.++|||||||++||+++ |..||.. .........    ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~----~~~  236 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKF----VID  236 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHH----Hhc
Confidence            9999876544332222334457889999999988889999999999999999998 8877752 222222221    111


Q ss_pred             CccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          274 GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       274 ~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      +.         ....+..++.++.+++.+||+.+|++|||+.+|++.|+
T Consensus       237 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         237 GG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            11         11223345788999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-39  Score=316.30  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=209.6

Q ss_pred             hhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ..++|.+.+.||+|+||.||++.+. +..||||.+.......+.+.+|+.++++++||||+++++++......++||||+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            4578999999999999999999877 577999998876666678999999999999999999999999989999999999


Q ss_pred             CCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          132 SNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       132 ~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      ++++|.+++.... ..+++..+..++.+++.||.|||++  +++|+||||+||+++.++.+||+|||++..+...... .
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~--~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~  160 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR--NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-A  160 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCcchheEEEcCCCCEEECccccceeccchhhh-h
Confidence            9999999997643 4589999999999999999999999  9999999999999999999999999998765432211 1


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      .....++..|+|||.+.+..++.++|||||||++|++++ |+.||... ........   . .         .....+.+
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~---~-~---------~~~~~~~~  226 (261)
T cd05034         161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQ---V-E---------RGYRMPRP  226 (261)
T ss_pred             hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHH---H-H---------cCCCCCCC
Confidence            122235678999999998889999999999999999998 88887532 22111111   1 0         01112223


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhc
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG  323 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~  323 (487)
                      ..++.++.+++.+||+.+|++||+++++++.|+.
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            3456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2e-39  Score=324.45  Aligned_cols=258  Identities=26%  Similarity=0.320  Sum_probs=208.0

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCC
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKI-HSPRLVNLLGFSNDS  121 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~  121 (487)
                      ...++|.+.+.||+|+||.||++.+.       +..||||++....  ...+.+.+|+++++++ +||||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            34467999999999999999999752       4579999887542  3345789999999999 899999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      +..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.  +++|+||||+|||++.++.++|+|||++.
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeehhhhccceEEEcCCCeEEECCCcccc
Confidence            99999999999999999997533 3489999999999999999999999  99999999999999999999999999987


Q ss_pred             ecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccc
Q 011384          201 RCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSV  279 (487)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~  279 (487)
                      ...............++..|+|||.+....++.++|||||||++|||++ |..||...........    ....      
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~----~~~~------  259 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK----LIKE------  259 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH----HHHc------
Confidence            5543322112223456788999999998889999999999999999998 8888864322221111    1111      


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       280 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                         ......+...+.++.+++.+||..+|++|||+.+|++.|..+
T Consensus       260 ---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         260 ---GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ---CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence               111122334567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1e-39  Score=330.83  Aligned_cols=244  Identities=22%  Similarity=0.295  Sum_probs=196.9

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      ++||+|+||.||++.+.  ++.||||++.+..    .....+..|..++..+ +||||+++++++.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999986  7889999887532    2335678899999998 799999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      ++|.+++...+ .+++..+..++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++........  ....
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~~  155 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHER--GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTST  155 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEECCCCCEEECcCccccccccCCC--cccc
Confidence            99999887654 599999999999999999999999  999999999999999999999999999864222111  2334


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc----hhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~----~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.......    ....+....+..+.          ...+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~p  225 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ----------IRIP  225 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC----------CCCC
Confidence            579999999999999999999999999999999999999996321111    11122222222111          1123


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCC------HHHHHH
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPS------MKEIVD  319 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs------~~eil~  319 (487)
                      ..++.++.+++.+||+.||.+||+      ++++++
T Consensus       226 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         226 RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            346678999999999999999997      566664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-39  Score=318.85  Aligned_cols=255  Identities=22%  Similarity=0.391  Sum_probs=207.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC--C---eEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--G---RQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g---~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .++|+..+.||+|+||.||+|+..  +   ..+++|.....  ....+.+.+|++++++++||||+++++++.+....++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            457888999999999999999875  3   36999987654  3344678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++++|.+++......+++..+..++.|++.||+|||+.  +++|+||||+||+++.++.+||+|||++.......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~--~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM--NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            9999999999999987656699999999999999999999999  99999999999999999999999999987654322


Q ss_pred             ccc-ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          207 FRF-RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       207 ~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ... .......++.|+|||.+....++.++|||||||++|||++ |+.||.... ......    .+..         ..
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~-~~~~~~----~i~~---------~~  227 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS-NHEVMK----AIND---------GF  227 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC-HHHHHH----HHhc---------CC
Confidence            111 1112234567999999988889999999999999999997 999985322 111111    1111         11


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ..+.+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            2223334667899999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.5e-40  Score=327.52  Aligned_cols=257  Identities=25%  Similarity=0.376  Sum_probs=206.8

Q ss_pred             hcCcccceeecccCceEEEEEEEC---------CeEEEEEEcCCC--hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR---------GRQVAVKKPSKN--QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDS  121 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~---------g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~  121 (487)
                      .++|.+.+.||+|+||.||++.+.         ...||+|.+...  ......+.+|+++++.+ +||||+++++++.+.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            467999999999999999999863         246999988754  23345788899999999 799999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID  186 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld  186 (487)
                      ...++||||+++++|.+++....               ..+++..++.++.|++.||+|||+.  +++|+||||+|||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--gi~H~dlkp~Nill~  174 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVLVT  174 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC--CcccccccHHheEEc
Confidence            99999999999999999997532               2488999999999999999999999  999999999999999


Q ss_pred             cCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhh
Q 011384          187 RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVD  265 (487)
Q Consensus       187 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~  265 (487)
                      .++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.. ........
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~~~~~~~~  253 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFK  253 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHH
Confidence            999999999999875543222111222345578999999998889999999999999999998 7777742 22211111


Q ss_pred             hhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          266 WAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       266 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                          ....         ....+.+..++.++.+|+.+||+.+|.+|||+.+|++.|+.+..
T Consensus       254 ----~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         254 ----LLKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             ----HHHc---------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence                1111         11122334567789999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.7e-40  Score=322.53  Aligned_cols=253  Identities=22%  Similarity=0.365  Sum_probs=204.5

Q ss_pred             cCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      .+|.+.+.||+|+||.||+|.+.       +..||+|++....  .....+.+|+.++..++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            35778899999999999999864       3679999987543  23466889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc
Q 011384          126 LVVEFMSNGTLYDVLHSN---------------NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN  190 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~  190 (487)
                      +++||+++++|.+++...               ...+++..++.++.|++.||.|||+.  +++||||||+|||++.++.
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~--gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH--HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc--CccccccchhheEecCCCc
Confidence            999999999999998531               13478888999999999999999999  9999999999999999999


Q ss_pred             EEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhh
Q 011384          191 ARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAP  269 (487)
Q Consensus       191 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~  269 (487)
                      +||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.. .....+..    
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~----  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVIE----  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHH----
Confidence            99999999876543332222233456789999999988889999999999999999998 6667642 22222211    


Q ss_pred             hhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhc
Q 011384          270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG  323 (487)
Q Consensus       270 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~  323 (487)
                      .+..+.         ..+.+..++..+.+|+..||+.+|.+||++.+|+..|++
T Consensus       238 ~i~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 MIRNRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHcCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            111111         122344577889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.5e-40  Score=337.72  Aligned_cols=252  Identities=22%  Similarity=0.329  Sum_probs=202.1

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      ...++|.+.+.||+|+||.||++.+.  ++.||+|++.+.    ......+.+|+.+++.++||||+++++++.++...|
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999986  778999987642    223356788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +||||+++|+|.+++...  .+++..+..++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||++......
T Consensus       120 lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~--~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSM--GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            999999999999999754  389999999999999999999999  9999999999999999999999999999765433


Q ss_pred             CcccccCCCCCCCccCCccccCCC----CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPD----NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      .. .......||+.|+|||.+...    .++.++|||||||++|||++|+.||......    .....+....       
T Consensus       196 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~----~~~~~i~~~~-------  263 (370)
T cd05621         196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV----GTYSKIMDHK-------  263 (370)
T ss_pred             Cc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH----HHHHHHHhCC-------
Confidence            22 123456799999999998764    3788999999999999999999999643211    1111111110       


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCC--CCCHHHHHH
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRER--RPSMKEIVD  319 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--RPs~~eil~  319 (487)
                      ..+..+....++..+.+++.+||..++.+  ||++.++++
T Consensus       264 ~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         264 NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            01112223346788999999999865543  889999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.5e-39  Score=316.90  Aligned_cols=244  Identities=23%  Similarity=0.367  Sum_probs=197.5

Q ss_pred             eecccCceEEEEEEEC----CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCC
Q 011384           62 LLGKGSHGSVYKAVLR----GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNG  134 (487)
Q Consensus        62 ~LG~G~~g~Vy~~~~~----g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~g  134 (487)
                      .||+|+||.||+|.+.    +..||+|++....   ...+.+.+|+.+++.+.||||+++++++.. ...++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999763    6789999876442   334678999999999999999999999864 4678999999999


Q ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc-ccCC
Q 011384          135 TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF-RSTP  213 (487)
Q Consensus       135 sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~-~~~~  213 (487)
                      +|.+++.... .+++..+..++.|++.||.|||++  +++|+||||+|||++.++.+||+|||++..+....... ....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~--~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEET--NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            9999997654 589999999999999999999999  99999999999999999999999999987654432211 1222


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV  292 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  292 (487)
                      ..+++.|+|||.+....++.++|||||||++|||++ |..||... .......    .+..         ....+.+..+
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~----~i~~---------~~~~~~~~~~  223 (257)
T cd05116         158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM-KGNEVTQ----MIES---------GERMECPQRC  223 (257)
T ss_pred             CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHH----HHHC---------CCCCCCCCCC
Confidence            345679999999988888999999999999999998 88888632 1222111    1111         1112234456


Q ss_pred             HHHHHHHHHHhhhhcCCCCCCHHHHHHHHhc
Q 011384          293 RKQLAVIAVRCVRSCRERRPSMKEIVDWLTG  323 (487)
Q Consensus       293 ~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~  323 (487)
                      +.++.+++.+||+.||++||++.+|++.|++
T Consensus       224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         224 PPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            7889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.5e-39  Score=316.48  Aligned_cols=248  Identities=27%  Similarity=0.391  Sum_probs=204.0

Q ss_pred             cCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEe-CCCceEEEEEecCC
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN-DSKDRLLVVEFMSN  133 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~lV~Ey~~~  133 (487)
                      .+|.+.+.||+|+||.||++...+..||+|....... .+.+.+|+.++++++|+|++++++++. +....++||||+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   84 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch-HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence            5788999999999999999999999999998875543 467899999999999999999999764 55678999999999


Q ss_pred             CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccC
Q 011384          134 GTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       134 gsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      ++|.+++..... .+++..++.++.|++.||+|||++  +++|+||||+||+++.++.+||+|||++......     ..
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-----~~  157 (256)
T cd05082          85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QD  157 (256)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CEeccccchheEEEcCCCcEEecCCccceecccc-----CC
Confidence            999999976443 488999999999999999999999  9999999999999999999999999998654322     12


Q ss_pred             CCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ...++..|+|||++....++.++|||||||++|+|++ |+.||... .......    .+..         ......+..
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-~~~~~~~----~~~~---------~~~~~~~~~  223 (256)
T cd05082         158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVP----RVEK---------GYKMDAPDG  223 (256)
T ss_pred             CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHH----HHhc---------CCCCCCCCC
Confidence            3345678999999998889999999999999999997 88887532 1111111    1111         111223345


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            677899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-39  Score=322.70  Aligned_cols=260  Identities=21%  Similarity=0.387  Sum_probs=202.4

Q ss_pred             hcCcccceeecccCceEEEEEEECC----------------eEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLRG----------------RQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLL  115 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~g----------------~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~  115 (487)
                      .++|.+.+.||+|+||.||++.+.+                ..||+|.+...  ......+.+|++++++++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4679999999999999999987642                25899988754  33345789999999999999999999


Q ss_pred             EEEeCCCceEEEEEecCCCCHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEE
Q 011384          116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNN-----------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVL  184 (487)
Q Consensus       116 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NIL  184 (487)
                      +++......++||||+++++|.+++....           ..+++..++.++.|++.||+|||+.  +++|+||||+|||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--~i~H~dlkp~Nil  161 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL--NFVHRDLATRNCL  161 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc--CeeccccChhhEE
Confidence            99999999999999999999999986432           1368889999999999999999999  9999999999999


Q ss_pred             EccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh--CCcCCCCCCCCch
Q 011384          185 IDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS--CRKAIDIGFSPPS  262 (487)
Q Consensus       185 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt--G~~pf~~~~~~~~  262 (487)
                      ++.++.+||+|||++..+.............+++.|+|||.+....++.++|||||||++|+|++  +..||... ....
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~-~~~~  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL-SDEQ  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc-ChHH
Confidence            99999999999999876543322222233345778999999988889999999999999999998  44555421 2222


Q ss_pred             hhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          263 IVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       263 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      ............      ........+..++..+.+|+.+||+.+|++||++++|++.|+
T Consensus       241 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            211111111110      001111122335678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.9e-39  Score=317.17  Aligned_cols=255  Identities=23%  Similarity=0.368  Sum_probs=207.6

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|++.+.||+|+||.||++.+.  ++.|+||.+...    ......+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888999999999999999974  889999976542    233457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          129 EFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       129 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      ||+++++|.+++..   ....+++..++.++.|++.||.|||+.  +++|+||||+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            99999999998864   234589999999999999999999999  9999999999999999999999999998655433


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      ..  ......++..|+|||.+.+..++.++||||||+++|+|++|..||......  ........      ...   ..+
T Consensus       160 ~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~------~~~---~~~  226 (267)
T cd08229         160 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKI------EQC---DYP  226 (267)
T ss_pred             Cc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhh------hcC---CCC
Confidence            21  122346889999999998888999999999999999999999998632211  11111100      111   111


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ......++.++.+++.+||+.+|++|||+.+|++.++++
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            112234778899999999999999999999999998775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.8e-40  Score=330.70  Aligned_cols=242  Identities=23%  Similarity=0.328  Sum_probs=195.1

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHH---HhCCCCCceeeEEEEeCCCceEEE
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEIL---SKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l---~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      |.+.+.||+|+||.||+|.+.  ++.||||++....    ...+.+.+|++++   +.++||||+++++++.+....|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999886  7899999987532    2234566676655   566899999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+++++|...+...  .+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++....... 
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~--~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHEN--KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-  155 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence            9999999999888653  499999999999999999999999  99999999999999999999999999986432221 


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                       .......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ...   ..... .+.          ..
T Consensus       156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-~~~---~~~i~-~~~----------~~  219 (324)
T cd05589         156 -DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-EEV---FDSIV-NDE----------VR  219 (324)
T ss_pred             -CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-HHH---HHHHH-hCC----------CC
Confidence             123346799999999999998999999999999999999999999863221 111   11111 111          11


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      .+..++..+.+++.+||+.||.+||     ++.++++
T Consensus       220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         220 YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            2334667889999999999999999     4666665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.2e-39  Score=329.36  Aligned_cols=239  Identities=22%  Similarity=0.276  Sum_probs=195.5

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCC-CceeeEEEEeCCCceEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSP-RLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hp-nIv~l~~~~~~~~~~~lV~  128 (487)
                      +|.+.+.||+|+||.||+|.+.  ++.||||++.+.    ....+.+..|++++..+.|+ +|+.+++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5888999999999999999987  678999988753    23345678899999999765 5888999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++|+|.+++.... .+++..+..++.||+.||.|||++  +|+||||||+|||++.++.+||+|||++........ 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-  156 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSK--GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-  156 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-
Confidence            9999999999997654 489999999999999999999999  999999999999999999999999999864322211 


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .....   . +...          ....
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~---~-i~~~----------~~~~  220 (324)
T cd05587         157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQ---S-IMEH----------NVSY  220 (324)
T ss_pred             -ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHH---H-HHcC----------CCCC
Confidence             22345799999999999999999999999999999999999999963321 11111   1 1111          1123


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSM  314 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~  314 (487)
                      +..++.++.+++.+||+.||.+||+.
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         221 PKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            33466789999999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.8e-39  Score=318.21  Aligned_cols=252  Identities=22%  Similarity=0.337  Sum_probs=198.8

Q ss_pred             cccceeecccCceEEEEEEEC--C--eEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC------Cc
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--G--RQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS------KD  123 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g--~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~  123 (487)
                      |.+.+.||+|+||.||+|.+.  +  ..||+|.+...   ....+.+.+|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            456789999999999999886  2  26899987653   34456788999999999999999999987532      24


Q ss_pred             eEEEEEecCCCCHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccc
Q 011384          124 RLLVVEFMSNGTLYDVLHS-----NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL  198 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~-----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGl  198 (487)
                      .++||||+++|+|.+++..     ....+++..+..++.|++.||+|||++  +|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK--SFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC--CeeccccchhheEEcCCCCEEECCCCc
Confidence            6899999999999998743     223589999999999999999999999  999999999999999999999999999


Q ss_pred             ceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccc
Q 011384          199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKIL  277 (487)
Q Consensus       199 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~  277 (487)
                      +..+.............+++.|++||.+....++.++|||||||++|||++ |+.||.. .....+..    .+..+.. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~----~~~~~~~-  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYD----YLRQGNR-  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHH----HHHcCCC-
Confidence            976543322111223356778999999999899999999999999999999 7777753 22222211    1222111 


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                              .+.+..++..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       233 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 --------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                    112234567799999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.9e-39  Score=320.62  Aligned_cols=253  Identities=23%  Similarity=0.377  Sum_probs=204.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCC-hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKN-QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      .++|...+.||+|+||.||++...       +..+|+|.+... ......+.+|+++++.++|+||+++++++.+....+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            357888999999999999999642       457899987654 344567999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcE
Q 011384          126 LVVEFMSNGTLYDVLHSNN--------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNA  191 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~v  191 (487)
                      +||||+++++|.+++....              ..+++..++.++.|++.||+|||+.  +++|+||||+|||+++++.+
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL--HFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC--CeecccccHhhEEEcCCCCE
Confidence            9999999999999997542              2488999999999999999999999  99999999999999999999


Q ss_pred             EEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhh
Q 011384          192 RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPL  270 (487)
Q Consensus       192 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~  270 (487)
                      ||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .....    .
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~----~  236 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-TEAIE----C  236 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-HHHHH----H
Confidence            9999999876543322112223345788999999998899999999999999999998 8888753211 11111    0


Q ss_pred             hhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          271 IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       271 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      ...+         .....+..++..+.+|+.+||+.+|.+||++.+|++.|+
T Consensus       237 ~~~~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         237 ITQG---------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHcC---------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            1111         111223346678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.1e-40  Score=332.89  Aligned_cols=239  Identities=22%  Similarity=0.299  Sum_probs=196.4

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNG  134 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~g  134 (487)
                      +.||+|+||.||++...  ++.||+|++....    .....+.+|++++..++||||+++++++.+....|+||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999875  7899999887532    23456788999999999999999999999999999999999999


Q ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          135 TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       135 sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      +|.+++.... .+++..+..++.||+.||.|||+ .  +|+||||||+|||++.++.+||+|||++........  ....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~--~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~  155 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKT  155 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cccc
Confidence            9999887654 49999999999999999999997 7  999999999999999999999999999865332221  2234


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ......    .+..+      .    ...+..++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-~~~~~~----~i~~~------~----~~~p~~~~  220 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFE----LILME------E----IRFPRTLS  220 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC-HHHHHH----HHhcC------C----CCCCCCCC
Confidence            579999999999999899999999999999999999999996321 111111    11111      1    11233456


Q ss_pred             HHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          294 KQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      .++.+|+.+||+.||++|+     ++.++++
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            7899999999999999996     8999886

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=315.02  Aligned_cols=246  Identities=29%  Similarity=0.493  Sum_probs=205.6

Q ss_pred             eeecccCceEEEEEEEC-----CeEEEEEEcCCChhh--HHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR-----GRQVAVKKPSKNQEI--SQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~~~~--~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|+||.||+|.+.     +..|++|.+......  ...+.+|+++++.++|+||+++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            47999999999999886     678999998765443  57889999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          134 GTLYDVLHSN--------NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       134 gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      ++|.+++...        ...+++..++.++.|++.||.|||++  +++|+||+|+||+++.++.+||+|||.+......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~--~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK--KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC--CcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            9999999875        46699999999999999999999999  9999999999999999999999999999776544


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ..........+++.|+|||.+....++.++|||||||++|+|++ |..||... ....+...    ...         ..
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~----~~~---------~~  224 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEY----LRK---------GY  224 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHH----HHc---------CC
Confidence            32223344567889999999988889999999999999999999 58888643 22222111    111         11


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      ....+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            12234456788999999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2e-39  Score=320.79  Aligned_cols=242  Identities=25%  Similarity=0.309  Sum_probs=196.3

Q ss_pred             ecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCCH
Q 011384           63 LGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTL  136 (487)
Q Consensus        63 LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  136 (487)
                      ||+|+||.||++.+.  ++.||+|.+.....    ..+.+..|+++++.++||||+++++++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999876  78999998765422    224577899999999999999999999999999999999999999


Q ss_pred             HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          137 YDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       137 ~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      .+.+..   ....+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++..+.....  ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccc
Confidence            988753   334589999999999999999999999  999999999999999999999999999876543322  2234


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...............         ....  ....+..++
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~---------~~~~--~~~~~~~~~  225 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---------ILND--SVTYPDKFS  225 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh---------hccc--CCCCcccCC
Confidence            57899999999999999999999999999999999999999643222111111100         1111  112334567


Q ss_pred             HHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          294 KQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      ..+.+++.+||+.||++||     +++++++
T Consensus       226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            8899999999999999999     6777776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.4e-39  Score=314.88  Aligned_cols=251  Identities=24%  Similarity=0.391  Sum_probs=204.7

Q ss_pred             cCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      ++|.+...||+|++|.||+|.+. +..+|+|.+.......+.+.+|+++++.++|||++++++++.. ...++||||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence            56889999999999999999887 4579999887665556778999999999999999999998864 567999999999


Q ss_pred             CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccC
Q 011384          134 GTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       134 gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      ++|.+++... ...+++..+..++.|++.||.|||+.  +++|+||||+||++++++.++|+|||++......... ...
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~--~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~  161 (260)
T cd05069          85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM--NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQ  161 (260)
T ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CEeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccC
Confidence            9999999763 34589999999999999999999999  9999999999999999999999999999765433211 112


Q ss_pred             CCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ...++..|+|||...+..++.++|||||||++|+|++ |..||.... .......    ...         ....+.+..
T Consensus       162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~----~~~---------~~~~~~~~~  227 (260)
T cd05069         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-NREVLEQ----VER---------GYRMPCPQG  227 (260)
T ss_pred             CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHH----HHc---------CCCCCCCcc
Confidence            2346778999999988889999999999999999999 888875322 2121111    111         111223345


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhc
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG  323 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~  323 (487)
                      .+..+.+++.+||+.+|++||++++|+++|+.
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            67889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.4e-39  Score=329.85  Aligned_cols=239  Identities=22%  Similarity=0.296  Sum_probs=193.0

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|+||.||++.+.  ++.||+|++.+.    ......+..|+.++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999886  678999988753    23345678899988877 899999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      ++|..++...+ .+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++........  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~  155 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTST  155 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--cccc
Confidence            99999887654 499999999999999999999999  999999999999999999999999999864322211  2234


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCC----chhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP----PSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||......    .....+....+..+.          ...+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~p  225 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IRIP  225 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CCCC
Confidence            57999999999999999999999999999999999999999532111    111122222221111          1133


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCH
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSM  314 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~  314 (487)
                      ..++.++.+|+.+||+.||.+||++
T Consensus       226 ~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         226 RSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            4566788999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.7e-39  Score=337.65  Aligned_cols=260  Identities=27%  Similarity=0.360  Sum_probs=207.2

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCC-CCCceeeEEEEe
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKIH-SPRLVNLLGFSN  119 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~  119 (487)
                      ++...++|.+.+.||+|+||.||+|++.       ++.||||++....  ...+.+.+|++++.++. ||||++++++|.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3444567888999999999999999874       3579999987542  22356889999999997 999999999999


Q ss_pred             CCCceEEEEEecCCCCHHHHHHhCC-------------------------------------------------------
Q 011384          120 DSKDRLLVVEFMSNGTLYDVLHSNN-------------------------------------------------------  144 (487)
Q Consensus       120 ~~~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------------------------  144 (487)
                      .....++||||+++|+|.+++....                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999996532                                                       


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCc
Q 011384          145 ------------------------------------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSAN  182 (487)
Q Consensus       145 ------------------------------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~N  182 (487)
                                                                ..+++..++.++.|++.||.|||+.  +++||||||+|
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrdlkp~N  269 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK--NCVHRDLAARN  269 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--CcCcccCCcce
Confidence                                                      1367778889999999999999999  99999999999


Q ss_pred             EEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCc
Q 011384          183 VLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPP  261 (487)
Q Consensus       183 ILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~  261 (487)
                      ||++.++.+||+|||+++...............+++.|+|||.+....++.++|||||||++|||++ |+.||.......
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999876533222112223457789999999998889999999999999999998 788875322111


Q ss_pred             hhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          262 SIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       262 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ...    ..+..+         ...+.+..++.++.+|+.+||+.+|.+||++++|++.|+.+
T Consensus       350 ~~~----~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         350 QFY----NAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HHH----HHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            111    111111         11223344678899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.7e-39  Score=320.22  Aligned_cols=258  Identities=20%  Similarity=0.315  Sum_probs=209.0

Q ss_pred             hhcCcccceeecccCceEEEEEEECC------eEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC-CCc
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLRG------RQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSND-SKD  123 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~g------~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~  123 (487)
                      ..++|.+.+.||+|+||.||+|.+..      ..|++|++...  ......+.+|+.+++.++||||+++++++.+ ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45789999999999999999998753      77999987654  3334678899999999999999999998766 567


Q ss_pred             eEEEEEecCCCCHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccc
Q 011384          124 RLLVVEFMSNGTLYDVLHSNN-------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDF  196 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~-------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DF  196 (487)
                      .+++++|+++++|.+++....       ..+++..++.++.|++.||+|||+.  +++|+||||+||+++.++.+||+||
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR--GVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccCHhhEEEcCCCcEEECCC
Confidence            899999999999999996532       3589999999999999999999999  9999999999999999999999999


Q ss_pred             ccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCc
Q 011384          197 GLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGK  275 (487)
Q Consensus       197 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~  275 (487)
                      |+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |+.||... .+..+..+.    ..+ 
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~----~~~-  235 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-DPFEMAAYL----KDG-  235 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC-CHHHHHHHH----HcC-
Confidence            99976544333222233456778999999988889999999999999999999 99888632 222222211    111 


Q ss_pred             cccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          276 ILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       276 i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                              .....+..++.++.+++.+||+.+|++|||+.++++.|..+..
T Consensus       236 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         236 --------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             --------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                    1111223456789999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.8e-39  Score=318.30  Aligned_cols=254  Identities=22%  Similarity=0.368  Sum_probs=205.0

Q ss_pred             cCcccceeecccCceEEEEEEEC--C---eEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--G---RQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g---~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .+|++.+.||+|+||.||+|.+.  +   ..||||.+...  ......+..|+.+++.++||||+++++++.+....++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            45888999999999999999875  2   35999998753  33456899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+++++|.+++......+++..++.++.|++.||.|||++  +++|+||||+||+++.++.+||+|||++........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~--g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM--NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            999999999999987656689999999999999999999999  999999999999999999999999999865543221


Q ss_pred             ccccCC-C--CCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          208 RFRSTP-P--AGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       208 ~~~~~~-~--~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ...... .  ..+..|+|||.+.+..++.++|||||||++||+++ |..||... .......+.    .         ..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-~~~~~~~~i----~---------~~  227 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVINAI----E---------QD  227 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC-CHHHHHHHH----H---------cC
Confidence            111111 1  12457999999998899999999999999999886 88888532 221221111    1         01


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ...+.+..++..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11222345667889999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.2e-39  Score=322.97  Aligned_cols=253  Identities=24%  Similarity=0.395  Sum_probs=203.0

Q ss_pred             cCcccceeecccCceEEEEEEEC--C--eEEEEEEcCCC--hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--G--RQVAVKKPSKN--QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g--~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      ++|++.+.||+|+||.||+|.+.  +  ..+++|.++..  ....+.+.+|++++.++ +||||+++++++.+....++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            57899999999999999999875  2  24788877642  33446789999999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEE
Q 011384          128 VEFMSNGTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNAR  192 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vk  192 (487)
                      +||+++++|.+++....               ..+++..++.++.|++.||+|||+.  +++||||||+|||++.++.+|
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~--~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK--QFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCcCCcceEEECCCCeEE
Confidence            99999999999997532               2488999999999999999999999  999999999999999999999


Q ss_pred             EcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhh
Q 011384          193 LGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLI  271 (487)
Q Consensus       193 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~  271 (487)
                      |+|||++......   ........+..|+|||.+.+..++.++|||||||++|||++ |..||... .......    ..
T Consensus       160 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~-~~~~~~~----~~  231 (297)
T cd05089         160 IADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM-TCAELYE----KL  231 (297)
T ss_pred             ECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHH----HH
Confidence            9999998532211   11122233567999999998889999999999999999997 98888632 2111111    01


Q ss_pred             hcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       272 ~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                               ......+.+..++..+.+|+.+||+.+|.+||++++|++.|..+..
T Consensus       232 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         232 ---------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             ---------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                     1111222334466789999999999999999999999999887754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-39  Score=324.50  Aligned_cols=259  Identities=25%  Similarity=0.387  Sum_probs=208.2

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC---------CeEEEEEEcCCC--hhhHHHHHHHHHHHHhC-CCCCceeeEEEEe
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR---------GRQVAVKKPSKN--QEISQEVDNEIEILSKI-HSPRLVNLLGFSN  119 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~---------g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~  119 (487)
                      ...++|.+.+.||+|+||.||++.+.         +..||+|.....  ......+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            33567889999999999999999752         346999988654  23346789999999999 8999999999999


Q ss_pred             CCCceEEEEEecCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEE
Q 011384          120 DSKDRLLVVEFMSNGTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVL  184 (487)
Q Consensus       120 ~~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NIL  184 (487)
                      .....++||||+++++|.+++....               ..+++..+..++.|++.||.|||+.  +++|+||||+|||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--givH~dlkp~Nil  169 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ--KCIHRDLAARNVL  169 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC--CeeecccccceEE
Confidence            9999999999999999999997532               2478888999999999999999999  9999999999999


Q ss_pred             EccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchh
Q 011384          185 IDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSI  263 (487)
Q Consensus       185 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~  263 (487)
                      ++.++.+||+|||++..+.............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.. ......
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~  248 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEEL  248 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-CCHHHH
Confidence            99999999999999977654333222333456788999999988889999999999999999998 6666642 222121


Q ss_pred             hhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          264 VDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       264 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ..    .+..+         .....+..++..+..|+.+||+.+|.+|||+.+|++.|+++..
T Consensus       249 ~~----~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         249 FK----LLKEG---------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             HH----HHHcC---------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            11    11111         1111233567889999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-39  Score=313.14  Aligned_cols=249  Identities=27%  Similarity=0.382  Sum_probs=203.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh------hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ------EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ++|...+.||+|++|.||++...  ++.||+|.+....      .....+.+|++++++++||||+++++++.+....++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46889999999999999999875  7899999876432      123568889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      |+||+++++|.+.+...+ .+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~--~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence            999999999999997654 489999999999999999999999  99999999999999999999999999987654322


Q ss_pred             cccc-cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          207 FRFR-STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       207 ~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      .... .....++..|+|||.+.+..++.++|||||||++|||++|+.||...........    .         ......
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~---------~~~~~~  225 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----I---------ATQPTN  225 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH----H---------hccCCC
Confidence            1111 1234678899999999998899999999999999999999999863211111110    0         011112


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...+..++..+.+++.+||..+|.+|||+.++++
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence            2334456778999999999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.7e-39  Score=314.20  Aligned_cols=250  Identities=24%  Similarity=0.400  Sum_probs=205.7

Q ss_pred             cCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      .+|++.+.||+|+||.||++.+. +..+|+|.+.........+.+|++++++++|||++++++++......++||||+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            46888999999999999999886 78899999887665567899999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      ++|.+++......+++..++.++.+++.||+|||+.  +++|+||||+||+++.++.+||+|||++......... ....
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~  160 (256)
T cd05112          84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS--NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTG  160 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC--CccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCC
Confidence            999999987655689999999999999999999999  9999999999999999999999999998765433211 1122


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV  292 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  292 (487)
                      ..++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ...   .... ..+         .....+...
T Consensus       161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~---~~~~-~~~---------~~~~~~~~~  226 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEV---VETI-NAG---------FRLYKPRLA  226 (256)
T ss_pred             CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHH---HHHH-hCC---------CCCCCCCCC
Confidence            345678999999998889999999999999999998 8888853221 111   1111 110         011112224


Q ss_pred             HHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          293 RKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       293 ~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                      +..+.+|+.+||+.+|++|||+.++++.|
T Consensus       227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         227 SQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            57899999999999999999999999877

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-40  Score=360.20  Aligned_cols=258  Identities=27%  Similarity=0.425  Sum_probs=213.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC---C----eEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR---G----RQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~---g----~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  124 (487)
                      ....+....||+|.||+||.|...   +    ..||||.+.+.  .....+|.+|..+|+.++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            345677899999999999999875   3    24999988865  45567899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccc
Q 011384          125 LLVVEFMSNGTLYDVLHSN------NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL  198 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGl  198 (487)
                      +|++|||++|+|..+|++.      ...++....+.++.|||+|+.||+++  ++|||||..+|+||+....|||+|||+
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~--~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK--HFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC--CCcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999999986      56699999999999999999999999  999999999999999999999999999


Q ss_pred             ceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccc
Q 011384          199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILS  278 (487)
Q Consensus       199 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~  278 (487)
                      |+.+...++........-...|||||.+..+.++.|+|||||||+|||++|...+.+.+....++..   .....|    
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~---~~~~gg----  921 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL---DVLEGG----  921 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH---HHHhCC----
Confidence            9855444332222222445699999999999999999999999999999995544433333333322   122222    


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       279 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                            +.+.|..|+..+.+||..||+.+|++||++..|++.+..+..
T Consensus       922 ------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  922 ------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             ------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence                  234566789999999999999999999999999998777654

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8.6e-39  Score=312.06  Aligned_cols=255  Identities=26%  Similarity=0.396  Sum_probs=209.1

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|++.+.||+|+||.||+|...  ++.||+|.+...    ....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999986  889999977532    223467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          129 EFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       129 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      ||+++++|.+++..   ....+++..++.++.+++.||.|||+.  +++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK--RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC--CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            99999999999864   234589999999999999999999999  9999999999999999999999999998765433


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      ..  ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||......  ...... ....         ...
T Consensus       160 ~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~-~~~~---------~~~  225 (267)
T cd08224         160 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCK-KIEK---------CDY  225 (267)
T ss_pred             Cc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHh-hhhc---------CCC
Confidence            21  123346889999999999888999999999999999999999998643211  111111 0111         111


Q ss_pred             CCCCh-HHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          286 PPKDP-IVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       286 ~~~~~-~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      .+.+. .++..+.+++.+||..+|++|||+.+|++.|+.+.
T Consensus       226 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         226 PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            12222 56678999999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.5e-39  Score=311.48  Aligned_cols=246  Identities=27%  Similarity=0.416  Sum_probs=205.1

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +|.+.+.||+|++|.||+|.+.  ++.|++|.+...   ......+.+|+++++.++||||+++++++.+....++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4788899999999999999885  789999987643   34456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          131 MSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       131 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      +++++|.+++... +..+++..++.++.|++.||.|||+.  +++|+||||+||+++.++.++|+|||++........  
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~--~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK--KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCcceEEEeCCCCEEEcccccceeccCccc--
Confidence            9999999999764 45689999999999999999999999  999999999999999999999999999876554322  


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.... ......    ....         ....+.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~----~~~~---------~~~~~~~  222 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-QGALIL----KIIR---------GVFPPVS  222 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHH----HHHc---------CCCCCCc
Confidence            1233468899999999999889999999999999999999999986432 111111    1111         1111223


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..++..+.+++.+||+.+|++||++.++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            356678999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.5e-39  Score=316.03  Aligned_cols=254  Identities=22%  Similarity=0.373  Sum_probs=206.7

Q ss_pred             cCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .+|++.+.||+|+||.||+|.+.     +..+|+|.+...  ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57889999999999999999874     337999987654  23346789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+++++|.+++......+++..+..++.|++.||.|||+.  +++|+||||+|||++.++.++|+|||++..+.....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence            999999999999987666689999999999999999999999  999999999999999999999999999976543322


Q ss_pred             cc-ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          208 RF-RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       208 ~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      .. ......++..|++||.+.+..++.++|||||||++||+++ |..||... .........    ..+         ..
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~----~~~---------~~  227 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAI----EEG---------YR  227 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHH----hCC---------Cc
Confidence            11 1122234568999999998889999999999999999886 99888532 222221111    111         11


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      .+.+..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            122334567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1e-39  Score=329.50  Aligned_cols=234  Identities=24%  Similarity=0.318  Sum_probs=192.4

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|+||.||+|++.  ++.||||++.+..    .....+..|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999986  7889999886532    2335677888888876 799999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      |+|.+++.... .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........  ....
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~--~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~~  155 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDK--GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTST  155 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cccc
Confidence            99999987664 499999999999999999999999  999999999999999999999999999865332221  2334


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      ..||+.|+|||.+.+..++.++|||||||++|+|++|+.||.... ...+..    .+..+.          ...+..++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-~~~~~~----~i~~~~----------~~~~~~~~  220 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFE----AILNDE----------VVYPTWLS  220 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-HHHHHH----HHhcCC----------CCCCCCCC
Confidence            579999999999998899999999999999999999999996322 111111    111111          11233466


Q ss_pred             HHHHHHHHHhhhhcCCCCCCH
Q 011384          294 KQLAVIAVRCVRSCRERRPSM  314 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RPs~  314 (487)
                      .++.+++.+||+.||.+||++
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         221 QDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHHHHHHHHHcccCHHHCCCC
Confidence            789999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.2e-39  Score=329.01  Aligned_cols=239  Identities=22%  Similarity=0.306  Sum_probs=195.4

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      ++||+|+||.||+|.+.  ++.||||++....    .....+..|.+++..+ +||||+++++++.+....|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999986  6789999887542    2334577889998866 899999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      ++|.+.+.... .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~  155 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRH--GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTT  155 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccc
Confidence            99999987654 489999999999999999999999  999999999999999999999999999875432221  2334


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .....   .. ..+.          ...+..++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-~~~~~---~i-~~~~----------~~~p~~~~  220 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFE---SI-LHDD----------VLYPVWLS  220 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-HHHHH---HH-HcCC----------CCCCCCCC
Confidence            5799999999999988999999999999999999999999974321 11111   11 1111          11233456


Q ss_pred             HHHHHHHHHhhhhcCCCCC-------CHHHHHH
Q 011384          294 KQLAVIAVRCVRSCRERRP-------SMKEIVD  319 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RP-------s~~eil~  319 (487)
                      .++.+++.+||+.+|++||       +++++++
T Consensus       221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            7899999999999999999       7777775

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.4e-39  Score=318.82  Aligned_cols=266  Identities=25%  Similarity=0.385  Sum_probs=204.5

Q ss_pred             cCcccceeecccCceEEEEEEEC------CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeC--CCceE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR------GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSND--SKDRL  125 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~------g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~  125 (487)
                      .+|.+.+.||+|+||.||++...      +..||+|.+.... ...+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            57889999999999999999752      6789999987543 334678999999999999999999998754  35689


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +||||+++++|.+++......+++..++.++.|++.||.|||+.  +++|+||||+||+++.++.+||+|||++..+...
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~--~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK--RYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            99999999999999987655699999999999999999999999  9999999999999999999999999999765433


Q ss_pred             Ccccc-cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh----cCcccccc
Q 011384          206 NFRFR-STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK----KGKILSVF  280 (487)
Q Consensus       206 ~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~----~~~i~~~~  280 (487)
                      ..... .....++..|+|||.+.+..++.++|||||||++|||++|..++....  ............    ...+...+
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPP--AEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcc--hhhhhhcccccccccchHHHHHHH
Confidence            22111 112234456999999998889999999999999999999876653211  110000000000    00001111


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ......+.+..++.++.+|+.+||..+|++|||+.+|++.|+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            11222233445678899999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.3e-39  Score=321.23  Aligned_cols=258  Identities=23%  Similarity=0.393  Sum_probs=204.8

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSK  122 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  122 (487)
                      ...++|++.+.||+|+||.||+|.++       +..||+|.+....  .....+.+|+.+++.++||||+++++++.+..
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34678999999999999999999753       3479999876543  22346788999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEE
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNN---------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL  193 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL  193 (487)
                      ..++||||+++|+|.+++....         ..+++..+..++.|++.||.|||++  +++||||||+|||++.++.++|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK--KFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999997522         2356778889999999999999999  9999999999999999999999


Q ss_pred             cccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhh
Q 011384          194 GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIK  272 (487)
Q Consensus       194 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~  272 (487)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.. ........   ... 
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~---~~~-  235 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLK---FVM-  235 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHH---HHH-
Confidence            99999875543332222223345778999999998889999999999999999998 6777742 22222211   111 


Q ss_pred             cCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          273 KGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       273 ~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      .+..         .+.+..++..+.+++.+||+.+|++|||+.++++.|+...
T Consensus       236 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         236 DGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             cCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            1110         1122334678999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.3e-39  Score=315.04  Aligned_cols=246  Identities=24%  Similarity=0.413  Sum_probs=198.2

Q ss_pred             eecccCceEEEEEEEC----CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCC
Q 011384           62 LLGKGSHGSVYKAVLR----GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGT  135 (487)
Q Consensus        62 ~LG~G~~g~Vy~~~~~----g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gs  135 (487)
                      .||+|+||.||+|++.    +..||+|+.....  ...+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999874    4569999887543  234678999999999999999999998864 57899999999999


Q ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc-ccCCC
Q 011384          136 LYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF-RSTPP  214 (487)
Q Consensus       136 L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~-~~~~~  214 (487)
                      |.+++......+++..++.++.|++.||.|||++  +++|+||||+|||++.++.+||+|||++.......... .....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK--NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc--CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            9999986556699999999999999999999999  99999999999999999999999999987554332211 12223


Q ss_pred             CCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          215 AGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       215 ~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      .+++.|+|||.+....++.++|||||||++||+++ |..||... ....+.    ..+..+         .....+..++
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~----~~~~~~---------~~~~~~~~~~  224 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVM----SFIEQG---------KRLDCPAECP  224 (257)
T ss_pred             CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHH----HHHHCC---------CCCCCCCCCC
Confidence            34678999999988889999999999999999996 88888632 211111    111111         1122344567


Q ss_pred             HHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          294 KQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      .++.+++.+||..+|++||++.+|.+.|+..
T Consensus       225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            8899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.9e-39  Score=334.45  Aligned_cols=257  Identities=23%  Similarity=0.336  Sum_probs=204.1

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCC
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDS  121 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  121 (487)
                      .++....++|.+.+.||+|+||.||++.+.  ++.||+|++....    .....+.+|+.+++.++||||+++++++.+.
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344555689999999999999999999986  7889999876422    2335578899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      ...++||||+++|+|.+++....  +++..+..++.||+.||.|||++  +|+||||||+|||++.++.+||+|||++..
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHC--CEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            99999999999999999997643  88999999999999999999999  999999999999999999999999999976


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCC----CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccc
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPD----NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKIL  277 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~  277 (487)
                      ....... ......||+.|+|||.+...    .++.++|||||||++|||++|+.||.....    ......+....   
T Consensus       192 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~---  263 (371)
T cd05622         192 MNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIMNHK---  263 (371)
T ss_pred             cCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----HHHHHHHHcCC---
Confidence            6433221 23356799999999998754    378899999999999999999999963221    11111111110   


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHHHhhhhcCCC--CCCHHHHHHH
Q 011384          278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRER--RPSMKEIVDW  320 (487)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--RPs~~eil~~  320 (487)
                          ..+..+....++.++.+++.+||..++.+  ||++++|++.
T Consensus       264 ----~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         264 ----NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             ----CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                11112223356788999999999844433  7899999873

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.7e-39  Score=313.32  Aligned_cols=253  Identities=25%  Similarity=0.420  Sum_probs=207.0

Q ss_pred             hhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ...+|.+.+.||+|+||.||++.+. +..+|+|.+.........+.+|+++++.++|+||+++++++.+ ...+++|||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            4568999999999999999999876 6679999888766556788999999999999999999999887 7789999999


Q ss_pred             CCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          132 SNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       132 ~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      ++++|.+++... +..+++..+..++.|++.||.|||+.  +++|+||||+||+++.++.+||+|||++......... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~--~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~  159 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-A  159 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC--CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-c
Confidence            999999999763 34588899999999999999999999  9999999999999999999999999998765432211 1


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      .....++..|+|||++....++.++|+|||||++|++++ |+.||... ........    +..         ....+.+
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~----~~~---------~~~~~~~  225 (260)
T cd05073         160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRA----LER---------GYRMPRP  225 (260)
T ss_pred             ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-CHHHHHHH----HhC---------CCCCCCc
Confidence            222345678999999998889999999999999999999 88888632 22222111    111         1112233


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhc
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG  323 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~  323 (487)
                      ...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            4566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.4e-39  Score=326.19  Aligned_cols=239  Identities=23%  Similarity=0.313  Sum_probs=192.8

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHh-CCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSK-IHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|+||.||+|.+.  ++.||||++....    ...+.+..|..++.. .+||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999986  6789999887542    223445667777765 4899999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      |+|.+++...+ .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.......  .....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~--~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~  155 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKK--GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAST  155 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccccc
Confidence            99999997654 499999999999999999999999  99999999999999999999999999987543222  12334


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .....   ... ..          .....+..++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-~~~~~---~~i-~~----------~~~~~~~~~~  220 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-EDELF---DSI-LN----------DRPHFPRWIS  220 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-HHHHH---HHH-Hc----------CCCCCCCCCC
Confidence            579999999999999899999999999999999999999996322 11111   111 10          0112334567


Q ss_pred             HHHHHHHHHhhhhcCCCCCCHH-HHHH
Q 011384          294 KQLAVIAVRCVRSCRERRPSMK-EIVD  319 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RPs~~-eil~  319 (487)
                      .++.+++.+||+.+|.+||++. ++++
T Consensus       221 ~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         221 KEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            7889999999999999999875 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.4e-39  Score=341.48  Aligned_cols=266  Identities=19%  Similarity=0.281  Sum_probs=198.0

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCC------CCceeeEEEEe
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHS------PRLVNLLGFSN  119 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~h------pnIv~l~~~~~  119 (487)
                      +++...+++|.+.++||+|+||.||+|.+.  ++.||||++.........+..|++++..++|      ++++.++++|.
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            344456789999999999999999999885  7789999987654445566778888877765      45888999887


Q ss_pred             CC-CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCC--------
Q 011384          120 DS-KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNF--------  189 (487)
Q Consensus       120 ~~-~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~--------  189 (487)
                      .. ..+|+||+++ +++|.+++.+.+ .+++..+..++.||+.||.|||+ .  +||||||||+|||++.++        
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccccc
Confidence            64 4678999988 779999887654 59999999999999999999997 6  999999999999998765        


Q ss_pred             --------cEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc
Q 011384          190 --------NARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP  261 (487)
Q Consensus       190 --------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~  261 (487)
                              .+||+|||++.....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             cccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                    499999998753221     2345679999999999999999999999999999999999999996432211


Q ss_pred             hhhhhhhhhhh--------c---C---ccc---cccCCCCCC-----------CCChHHHHHHHHHHHHhhhhcCCCCCC
Q 011384          262 SIVDWAAPLIK--------K---G---KIL---SVFDPRIPP-----------PKDPIVRKQLAVIAVRCVRSCRERRPS  313 (487)
Q Consensus       262 ~~~~~~~~~~~--------~---~---~i~---~~~~~~~~~-----------~~~~~~~~~l~~Li~~cl~~dP~~RPs  313 (487)
                      .+. .......        .   .   .+.   ..+.+....           .........+.+||.+||+.||.+|||
T Consensus       353 ~~~-~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        353 HLH-LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHH-HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            111 0000000        0   0   000   000000000           000112456789999999999999999


Q ss_pred             HHHHHH--HHhc
Q 011384          314 MKEIVD--WLTG  323 (487)
Q Consensus       314 ~~eil~--~L~~  323 (487)
                      ++|+++  ||..
T Consensus       432 a~e~L~Hp~~~~  443 (467)
T PTZ00284        432 ARQMTTHPYVLK  443 (467)
T ss_pred             HHHHhcCccccc
Confidence            999997  4544

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.1e-39  Score=327.44  Aligned_cols=239  Identities=21%  Similarity=0.284  Sum_probs=195.7

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      +|.+.+.||+|+||.||+|.+.  ++.||||++.+..    .....+..|..++..+ +|++|+.+++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5888999999999999999887  6789999877542    2234567788888877 5899999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++|+|.+.+...+ .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........ 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~-  156 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-  156 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-
Confidence            9999999999987654 489999999999999999999999  999999999999999999999999999875432221 


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+..   .+ ....          ...
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~---~i-~~~~----------~~~  220 (323)
T cd05616         157 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQ---SI-MEHN----------VAY  220 (323)
T ss_pred             -ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC-HHHHHH---HH-HhCC----------CCC
Confidence             2334579999999999999999999999999999999999999996322 111111   11 1111          122


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSM  314 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~  314 (487)
                      +..++.++.+++.+||+.+|.+|++.
T Consensus       221 p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         221 PKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            33567789999999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.9e-39  Score=310.24  Aligned_cols=245  Identities=26%  Similarity=0.386  Sum_probs=199.0

Q ss_pred             eeecccCceEEEEEEEC-CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCCHH
Q 011384           61 KLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLY  137 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~  137 (487)
                      ++||+|+||.||+|... ++.||+|.+....  .....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36999999999999876 6789999877543  33456889999999999999999999999999999999999999999


Q ss_pred             HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCC
Q 011384          138 DVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT  217 (487)
Q Consensus       138 ~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt  217 (487)
                      +++......+++..+..++.+++.+|.|||+.  +++|+||||+||+++.++.+||+|||++......... ......++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~  157 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESK--NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIP  157 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCc
Confidence            99977655689999999999999999999999  9999999999999999999999999998654322111 11223446


Q ss_pred             CccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHH
Q 011384          218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQL  296 (487)
Q Consensus       218 ~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  296 (487)
                      +.|+|||++....++.++||||||+++|++++ |..||... .......    ....+         .....+..++..+
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~----~~~~~---------~~~~~~~~~~~~~  223 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQARE----QVEKG---------YRMSCPQKCPDDV  223 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHH----HHHcC---------CCCCCCCCCCHHH
Confidence            78999999998889999999999999999998 88888532 1111111    11111         1112233466789


Q ss_pred             HHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          297 AVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       297 ~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      .+++.+||+.+|++||++.++++.|.
T Consensus       224 ~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         224 YKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHcccCcccCCCHHHHHHHhc
Confidence            99999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.6e-39  Score=318.41  Aligned_cols=260  Identities=23%  Similarity=0.392  Sum_probs=203.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC------------------CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCcee
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR------------------GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVN  113 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~------------------g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~  113 (487)
                      .++|++.+.||+|+||.||++.+.                  ...||+|++...  ......+.+|+++++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356999999999999999998543                  236899988754  334467899999999999999999


Q ss_pred             eEEEEeCCCceEEEEEecCCCCHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcE
Q 011384          114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN----------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANV  183 (487)
Q Consensus       114 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NI  183 (487)
                      +++++.+....++||||+++++|.+++....          ..+++..+..++.|++.||+|||+.  +++|+||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--~i~H~dlkp~Ni  161 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL--NFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC--CeecccCChheE
Confidence            9999999999999999999999999997532          2367788999999999999999999  999999999999


Q ss_pred             EEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh--CCcCCCCCCCCc
Q 011384          184 LIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS--CRKAIDIGFSPP  261 (487)
Q Consensus       184 Lld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt--G~~pf~~~~~~~  261 (487)
                      |++.++.++|+|||++..+.............+++.|++||....+.++.++|||||||++|||++  |..||.. ....
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~-~~~~  240 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ-LSDE  240 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc-cChH
Confidence            999999999999999876543322112223345678999999888889999999999999999998  5667642 2222


Q ss_pred             hhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          262 SIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       262 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      ..............      .....+.+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       241 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QVIENTGEFFRDQG------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHHHHhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            22221111111110      01111223345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.3e-40  Score=314.04  Aligned_cols=261  Identities=21%  Similarity=0.262  Sum_probs=206.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhH---HHHHHHHHHHHhCCCCCceeeEEEEe--CCCceEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS---QEVDNEIEILSKIHSPRLVNLLGFSN--DSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~---~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~~l  126 (487)
                      .++|..+..|++|.||.||+|+++  +..||+|+++.+....   -.-.+||.+|.+++|||||.+-.+..  +-+.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            346888999999999999999987  7889999988664322   24678999999999999999988764  4467999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      |||||+. +|..++..-+.++...++..+..|++.|++|||..  .|+||||||+|+|++..|.+||+|||+|+.++..-
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~--wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN--WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc--eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            9999955 99999998888899999999999999999999999  99999999999999999999999999999887552


Q ss_pred             cccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhh----------hhcCc
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL----------IKKGK  275 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~----------~~~~~  275 (487)
                        ...+...-|.+|.|||.+.+. .|+.+.|+||+|||+.||+++++.|.......++.....-+          +..-.
T Consensus       232 --k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  232 --KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             --ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence              245667789999999998875 78999999999999999999998876443333332221111          00000


Q ss_pred             ccc------ccCCCCCCCCChH-HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          276 ILS------VFDPRIPPPKDPI-VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       276 i~~------~~~~~~~~~~~~~-~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...      .....+...+... +++.-.+|+..+|..||.+|.|+++.++
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            000      0000000111111 5577889999999999999999999997

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4e-39  Score=317.23  Aligned_cols=266  Identities=24%  Similarity=0.380  Sum_probs=209.2

Q ss_pred             cCcccceeecccCceEEEEEEEC------CeEEEEEEcCCChh--hHHHHHHHHHHHHhCCCCCceeeEEEEeC--CCce
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR------GRQVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVNLLGFSND--SKDR  124 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~------g~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~  124 (487)
                      ++|...+.||+|+||.||++.+.      +..||||.+.....  ....+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46788899999999999999864      57899999886655  36789999999999999999999999887  5678


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||+++++|.+++......+++..+..++.|++.||.|||+.  +++|+||||+|||++.++.++|+|||++.....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ--RYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            999999999999999987665699999999999999999999999  999999999999999999999999999976653


Q ss_pred             CCccc-ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhh---hhcCcccccc
Q 011384          205 DNFRF-RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL---IKKGKILSVF  280 (487)
Q Consensus       205 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~---~~~~~i~~~~  280 (487)
                      ..... ......++..|++||.+....++.++||||||+++|||++|..|+.......  ..+....   .....+...+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF--LRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh--ccccccccccccHHHHHHHH
Confidence            22111 1122345667999999988889999999999999999999998875322111  0000000   0000001111


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ......+.+..++.++.+|+.+||+.+|++|||+.+|+++|+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11222223445667899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-39  Score=312.31  Aligned_cols=246  Identities=26%  Similarity=0.401  Sum_probs=200.2

Q ss_pred             eeecccCceEEEEEEEC--C---eEEEEEEcCCChh--hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR--G---RQVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g---~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|+||.||+|++.  +   ..||+|.+.....  ..+.+.+|+.+++.+.||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            47999999999999874  2   6799998876544  45678999999999999999999998764 467999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc-cC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR-ST  212 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~-~~  212 (487)
                      ++|.+++.... .+++..+..++.|++.||.|||..  +++|+||||+|||++.++.+||+|||++..+........ ..
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~--~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~  156 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESK--HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT  156 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhc--CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence            99999998765 599999999999999999999999  999999999999999999999999999976644332211 11


Q ss_pred             CCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ...++..|+|||.+....++.++|||||||++|+|++ |..||... ........    +..+         ...+.+..
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~----~~~~---------~~~~~~~~  222 (257)
T cd05060         157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAM----LESG---------ERLPRPEE  222 (257)
T ss_pred             CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHH----HHcC---------CcCCCCCC
Confidence            2234568999999998889999999999999999998 88888632 22222221    1111         11223445


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ++..+.+++.+||..+|++||++.+|++.|+.+
T Consensus       223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            667899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.3e-39  Score=340.92  Aligned_cols=264  Identities=22%  Similarity=0.262  Sum_probs=197.2

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC--------C
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS--------K  122 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--------~  122 (487)
                      ...+|.+.+.||+|+||.||+|++.  ++.||||++....   ....+|+.+++.++||||+++++++...        .
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            3467999999999999999999885  7899999876543   2345799999999999999999876432        2


Q ss_pred             ceEEEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC-cEEEccccc
Q 011384          123 DRLLVVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF-NARLGDFGL  198 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~-~vkL~DFGl  198 (487)
                      .+++||||+++ +|.+++..   ....+++..++.++.||+.||+|||+.  +|+||||||+|||++.++ .+||+|||+
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~--~IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK--FICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCcCHHHEEEcCCCCceeeecccc
Confidence            46799999975 78777653   345699999999999999999999999  999999999999998664 799999999


Q ss_pred             ceecCCCCcccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh-----
Q 011384          199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK-----  272 (487)
Q Consensus       199 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~-----  272 (487)
                      ++.+....   ......||+.|+|||++.+. .++.++|||||||++|||++|..||........+......+..     
T Consensus       218 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~  294 (440)
T PTZ00036        218 AKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ  294 (440)
T ss_pred             chhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            97654322   22345789999999998764 6899999999999999999999998643322222211110000     


Q ss_pred             ----cCccccccCCC-----CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhccc
Q 011384          273 ----KGKILSVFDPR-----IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLS  325 (487)
Q Consensus       273 ----~~~i~~~~~~~-----~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l~  325 (487)
                          ........-+.     +....+...+.++.+|+.+||+.+|.+|||+.|++.  ++..+.
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                00000000000     011122235678999999999999999999999996  555543

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.9e-39  Score=319.24  Aligned_cols=254  Identities=24%  Similarity=0.385  Sum_probs=204.6

Q ss_pred             hcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  124 (487)
                      .++|+..+.||+|+||.||+|.+.       +..||+|++....  .....+.+|+.++++++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999863       5689999887542  3346789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcE
Q 011384          125 LLVVEFMSNGTLYDVLHSNN---------------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANV  183 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NI  183 (487)
                      ++||||+++++|.+++....                     ..+++..++.++.|++.||.|||..  +++|+||||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~--~i~H~dl~p~ni  161 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER--KFVHRDLATRNC  161 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC--CeecccccHhhe
Confidence            99999999999999997421                     2478888999999999999999999  999999999999


Q ss_pred             EEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCch
Q 011384          184 LIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPS  262 (487)
Q Consensus       184 Lld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~  262 (487)
                      |++.++.++|+|||++..+..............++.|+|||.+.+..++.++|||||||++|||++ |..||.. .....
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~-~~~~~  240 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG-MAHEE  240 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHH
Confidence            999999999999999875543322112223345678999999988899999999999999999997 7777752 22222


Q ss_pred             hhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhc
Q 011384          263 IVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG  323 (487)
Q Consensus       263 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~  323 (487)
                      ...    .+..+..         .+.+..++.++.+|+.+||+.+|++|||+.||++.|++
T Consensus       241 ~~~----~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 VIY----YVRDGNV---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHH----HHhcCCC---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            111    1112211         11233456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=346.38  Aligned_cols=259  Identities=22%  Similarity=0.354  Sum_probs=211.4

Q ss_pred             HHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcC-CChhhHHHHHHHHHHHHhCC-CCCceeeEE-EEeC-----
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPS-KNQEISQEVDNEIEILSKIH-SPRLVNLLG-FSND-----  120 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~-~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~-~~~~-----  120 (487)
                      .....++++.+.|.+|||+.||.|...  +..||+|+.. .+....+.+++||++|++|+ |+|||.+++ ....     
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            445678899999999999999999987  4899999755 45666788999999999996 999999999 3221     


Q ss_pred             -CCceEEEEEecCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccc
Q 011384          121 -SKDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL  198 (487)
Q Consensus       121 -~~~~~lV~Ey~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGl  198 (487)
                       ...++|+||||.+|+|.|++.. -...|++.++++|+.++++|+++||...|.|||||||-+||||+.++..||||||.
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence             1346899999999999999974 22339999999999999999999999988899999999999999999999999999


Q ss_pred             ceecCCCC--cc-----cccCCCCCCCccCCcccc---CCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhh
Q 011384          199 ALRCGVDN--FR-----FRSTPPAGTIGYLDPCYV---TPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA  268 (487)
Q Consensus       199 a~~~~~~~--~~-----~~~~~~~gt~~Y~aPE~~---~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~  268 (487)
                      +.-....-  ..     ...-...-|+.|.|||.+   .+..++.|+|||+|||+||-|++...||+.+..         
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------  263 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------  263 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------
Confidence            84321111  00     001122468999999975   567889999999999999999999999974311         


Q ss_pred             hhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          269 PLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       269 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                              ..+++-.+..|..+..+..++.||..||+.||++||++-+|+..+..|..
T Consensus       264 --------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  264 --------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             --------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                    33444445555556899999999999999999999999999998887764

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-39  Score=316.26  Aligned_cols=255  Identities=25%  Similarity=0.449  Sum_probs=208.2

Q ss_pred             cCcccceeecccCceEEEEEEEC--C----eEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--G----RQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g----~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .+|.+.+.||+|+||.||+|.+.  +    ..||+|......  .....+.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            57888999999999999999874  2    258999877653  334678899999999999999999999987 78899


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++|+|.+++......+++..+..++.|++.||+|||+.  +++|+||||+||+++.++.+||+|||++..+....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--CEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence            9999999999999988666699999999999999999999999  99999999999999999999999999997665433


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      .........++..|+|||.+....++.++|||||||++||+++ |+.||... ....+..    .+..+         ..
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~----~~~~~---------~~  229 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPD----LLEKG---------ER  229 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-CHHHHHH----HHhCC---------CC
Confidence            2222222334678999999988889999999999999999998 99988632 2222221    11111         11


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .+.+..++..+.+++.+||..+|.+||++.++++.|..+.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            12233455678999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-38  Score=331.14  Aligned_cols=258  Identities=23%  Similarity=0.307  Sum_probs=200.7

Q ss_pred             hhcCcccceeecccCceEEEEEEEC----CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR----GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~----g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ...+|.+.+.||+|+||.||++...    +..||||.+...    ..+.+|++++++++||||+++++++......|+||
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            3457999999999999999999764    467999987654    34568999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      |++. ++|.+++... ..+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++.........
T Consensus       166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~--givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHGR--GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            9995 6898888544 4599999999999999999999999  9999999999999999999999999998765544332


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc---C-----------
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK---G-----------  274 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~---~-----------  274 (487)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... .......   .           
T Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~-l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQ-LRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHH-HHHHHHHhccCccccCCccchh
Confidence            233356799999999999999999999999999999999999999964332211110 0000000   0           


Q ss_pred             ------ccccccCCCCCCCC---ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          275 ------KILSVFDPRIPPPK---DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       275 ------~i~~~~~~~~~~~~---~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                            .......+....+.   ....+.++.+++.+||+.+|++|||+.|++.
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence                  00000001000000   0123567889999999999999999999997

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.2e-39  Score=326.52  Aligned_cols=238  Identities=26%  Similarity=0.351  Sum_probs=193.3

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|+||.||+|.+.  ++.||+|++....    .....+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999986  7789999887542    2334567788888754 899999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      ++|.+++.... .+++..+..++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||++.......  .....
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSK--GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAST  155 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cceec
Confidence            99999997654 489999999999999999999999  99999999999999999999999999986432211  12334


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ......    .+..+      .    ...+..++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-~~~~~~----~~~~~------~----~~~~~~~~  220 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-EDELFE----SIRVD------T----PHYPRWIT  220 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-HHHHHH----HHHhC------C----CCCCCCCC
Confidence            679999999999999999999999999999999999999996322 111111    11110      1    11233466


Q ss_pred             HHHHHHHHHhhhhcCCCCCCH-HHHH
Q 011384          294 KQLAVIAVRCVRSCRERRPSM-KEIV  318 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RPs~-~eil  318 (487)
                      .++.+++.+||+.||.+||++ ++++
T Consensus       221 ~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         221 KESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCChHHHH
Confidence            789999999999999999997 4565

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.7e-39  Score=313.60  Aligned_cols=253  Identities=20%  Similarity=0.296  Sum_probs=201.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      .++|.+.+.||+|+||.||+|+..  ++.||+|++.... .....+.+|+.++++++||||+++++++......++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            357999999999999999999975  7889999876443 2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +++++|.+++...+ ++++..+..++.|++.||.|||+.  +|+|+||+|+||+++.++.+||+|||++..+.....  .
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~  162 (267)
T cd06646          88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSK--GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K  162 (267)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence            99999999987654 589999999999999999999999  999999999999999999999999999976543221  1


Q ss_pred             cCCCCCCCccCCccccC---CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          211 STPPAGTIGYLDPCYVT---PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                      .....+++.|+|||.+.   ...++.++|||||||++|||++|+.||...........+     ....   ...+..  .
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-----~~~~---~~~~~~--~  232 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-----SKSN---FQPPKL--K  232 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-----ecCC---CCCCCC--c
Confidence            23346889999999875   345788999999999999999999998532211111100     0000   000111  1


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                      ....++..+.+++.+||+.+|++||++++|++.|
T Consensus       233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1224567899999999999999999999998743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.6e-39  Score=328.12  Aligned_cols=256  Identities=23%  Similarity=0.304  Sum_probs=195.8

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ...+|.+.+.||+|+||.||+|.+.  +..||+|+....     ....|+.++++++||||+++++++.+....++|+||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            3467999999999999999999986  568999975443     235699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      + .++|.+++......+++..++.|+.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++.......   .
T Consensus       139 ~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~  212 (357)
T PHA03209        139 Y-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ--RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---A  212 (357)
T ss_pred             c-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEEecCccccccccCc---c
Confidence            9 5699999987667799999999999999999999999  99999999999999999999999999986432221   2


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc--hhh----hhhhhhhhc-Ccccc-----
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP--SIV----DWAAPLIKK-GKILS-----  278 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~--~~~----~~~~~~~~~-~~i~~-----  278 (487)
                      .....||+.|+|||++.+..++.++|||||||++|||+++..++.......  ...    ......+.. +....     
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            234568999999999999999999999999999999998766653221111  000    000000000 00000     


Q ss_pred             --------ccC--CCCCCC-------CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          279 --------VFD--PRIPPP-------KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       279 --------~~~--~~~~~~-------~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                              .++  .....+       ....++.++..||.+||+.||.+|||+.|++.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence                    000  000000       01123456778999999999999999999996

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.3e-39  Score=328.04  Aligned_cols=257  Identities=28%  Similarity=0.370  Sum_probs=202.3

Q ss_pred             hcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhC-CCCCceeeEEEEeC-CC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKI-HSPRLVNLLGFSND-SK  122 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~-~~  122 (487)
                      .++|.+.+.||+|+||.||+|.+.       ++.||||++....  .....+.+|+.++.++ +||||+++++++.. +.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            457999999999999999999742       5789999987532  2345688999999999 78999999998765 45


Q ss_pred             ceEEEEEecCCCCHHHHHHhCC----------------------------------------------------------
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNN----------------------------------------------------------  144 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------  144 (487)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999986421                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCC
Q 011384          145 --------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG  216 (487)
Q Consensus       145 --------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~g  216 (487)
                              ..+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++................+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                    2367888899999999999999999  999999999999999999999999999876543322222233456


Q ss_pred             CCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHH
Q 011384          217 TIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQ  295 (487)
Q Consensus       217 t~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  295 (487)
                      ++.|+|||.+.+..++.++|||||||++|+|++ |..||...........    ....+.         ..+.+...+.+
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~~~---------~~~~~~~~~~~  310 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR----RLKEGT---------RMRAPDYTTPE  310 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH----HHhccC---------CCCCCCCCCHH
Confidence            778999999988889999999999999999997 8888753222211111    111111         11112234567


Q ss_pred             HHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          296 LAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       296 l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      +.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus       311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.4e-39  Score=323.54  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=206.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC---------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR---------GRQVAVKKPSKNQ--EISQEVDNEIEILSKI-HSPRLVNLLGFSNDS  121 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~---------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~  121 (487)
                      ..+|.+.+.||+|+||.||++...         ...||+|.+....  .....+.+|+++++++ +||||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            457889999999999999999752         3569999877542  3345788999999999 699999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID  186 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld  186 (487)
                      ...++||||+++++|.+++....               ..+++..+..++.|++.||.|||++  +++|+||||+|||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--gi~H~dlkp~Nill~  168 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR--RCIHRDLAARNVLVT  168 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC--CeeeccccceeEEEc
Confidence            99999999999999999996532               3488999999999999999999999  999999999999999


Q ss_pred             cCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhh
Q 011384          187 RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVD  265 (487)
Q Consensus       187 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~  265 (487)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.. ........
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-~~~~~~~~  247 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-IPVEELFK  247 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC-CCHHHHHH
Confidence            999999999999976543222111222334568999999998889999999999999999999 7777742 22222221


Q ss_pred             hhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          266 WAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       266 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                          ....+.         ....+..++.++.+++.+||+.+|++|||+.++++.|..+..
T Consensus       248 ----~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         248 ----LLREGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ----HHHcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                111111         112234556789999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.2e-39  Score=317.90  Aligned_cols=259  Identities=22%  Similarity=0.396  Sum_probs=204.8

Q ss_pred             cCcccceeecccCceEEEEEEEC------CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC--Cce
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR------GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS--KDR  124 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~------g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~  124 (487)
                      ..|++.+.||+|+||.||++.+.      +..||+|.+...  ......+.+|+++++.++||||+++++++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            45788999999999999999742      678999988744  23346789999999999999999999998775  568


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||+++++|.+++......+++..++.++.|++.||+|||++  +++||||||+||+++.++.++|+|||++.....
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~--gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR--QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999999977655689999999999999999999999  999999999999999999999999999876543


Q ss_pred             CCccc-ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCC----------chhhhhhhhhhhc
Q 011384          205 DNFRF-RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP----------PSIVDWAAPLIKK  273 (487)
Q Consensus       205 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~----------~~~~~~~~~~~~~  273 (487)
                      ..... ......++..|+|||.+.+..++.++|||||||++|||++++.|.......          .............
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            32211 122345677899999998888999999999999999999987664321110          0000000011111


Q ss_pred             CccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          274 GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       274 ~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                               ....+.+..++..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus       242 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         242 ---------GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ---------CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence                     111222345678899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5e-39  Score=315.14  Aligned_cols=251  Identities=24%  Similarity=0.356  Sum_probs=201.9

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCC------C
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSNDS------K  122 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~------~  122 (487)
                      ..++.|...+.||+|+||.||+|.+.  ++.||+|++.........+.+|+.+++++ +||||+++++++...      .
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            34677899999999999999999885  78899999876665567789999999998 799999999998753      4


Q ss_pred             ceEEEEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          123 DRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      ..++||||+++++|.+++... ...+++..+..++.|++.||+|||+.  +|+|+||||+||+++.++.++|+|||++..
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~--~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH--KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            578999999999999999863 34689999999999999999999999  999999999999999999999999999876


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCC-----CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcc
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTP-----DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI  276 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i  276 (487)
                      .....  .......|++.|+|||++..     ..++.++|||||||++|||++|+.||..... .....    ....   
T Consensus       161 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-~~~~~----~~~~---  230 (272)
T cd06637         161 LDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-MRALF----LIPR---  230 (272)
T ss_pred             ccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-HHHHH----HHhc---
Confidence            43221  12334578999999999863     3578899999999999999999999853211 11110    0000   


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          277 LSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                           .......+..++.++.+|+.+||..+|.+|||+.+|++
T Consensus       231 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 -----NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -----CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                 00111122345678999999999999999999999986

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-38  Score=309.38  Aligned_cols=248  Identities=27%  Similarity=0.398  Sum_probs=207.3

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecC
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      ++|...+.||+|+||.||+|.+.  ++.|++|.+..... .+.+.+|++++++++||||+++++++.+....|+++||++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            57899999999999999999987  68899999876544 6789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccC
Q 011384          133 NGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       133 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      +++|.+++......+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++........  ...
T Consensus        82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~--~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~  157 (256)
T cd06612          82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN--KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRN  157 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccc
Confidence            9999999987667799999999999999999999999  999999999999999999999999999876543321  223


Q ss_pred             CCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHH
Q 011384          213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV  292 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  292 (487)
                      ...++..|+|||.+.+..++.++|||||||++|+|++|+.||...........     ..     .  ........+..+
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-----~~-----~--~~~~~~~~~~~~  225 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----IP-----N--KPPPTLSDPEKW  225 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-----hc-----c--CCCCCCCchhhc
Confidence            34588999999999988899999999999999999999999864222111110     00     0  001111223456


Q ss_pred             HHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          293 RKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       293 ~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +.++.+++.+||+.+|++|||+++|++
T Consensus       226 ~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         226 SPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            678999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.5e-39  Score=324.35  Aligned_cols=239  Identities=25%  Similarity=0.360  Sum_probs=193.2

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHh-CCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSK-IHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|+||.||+|.+.  ++.||||++....    .....+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999986  6789999877542    223456678888876 4999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      |+|.+++.... .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~~--~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~  155 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSK--GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCT  155 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceee
Confidence            99999997654 489999999999999999999999  999999999999999999999999999865322211  2234


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ......    .+..      ..+    ..+..++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-~~~~~~----~i~~------~~~----~~~~~~~  220 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-EEELFQ----SIRM------DNP----CYPRWLT  220 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-HHHHHH----HHHh------CCC----CCCccCC
Confidence            578999999999998899999999999999999999999996322 111111    1111      111    1233466


Q ss_pred             HHHHHHHHHhhhhcCCCCCCHH-HHHH
Q 011384          294 KQLAVIAVRCVRSCRERRPSMK-EIVD  319 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RPs~~-eil~  319 (487)
                      .++.+++.+||+.+|++||++. ++++
T Consensus       221 ~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         221 REAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            7899999999999999999986 5653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.3e-39  Score=315.86  Aligned_cols=244  Identities=27%  Similarity=0.313  Sum_probs=195.3

Q ss_pred             ecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCCH
Q 011384           63 LGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTL  136 (487)
Q Consensus        63 LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  136 (487)
                      ||+|+||.||++...  ++.||+|.+.....    ....+..|++++++++||||+++++++.+....++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999876  88999998864321    223456799999999999999999999999999999999999999


Q ss_pred             HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCC
Q 011384          137 YDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA  215 (487)
Q Consensus       137 ~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~  215 (487)
                      .+++.... ..+++..+..++.|++.||+|||+.  +++||||||+|||++.++.++|+|||++.......   ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM--DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC--CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccC
Confidence            98886533 4589999999999999999999999  99999999999999999999999999987654322   223457


Q ss_pred             CCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHH
Q 011384          216 GTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQ  295 (487)
Q Consensus       216 gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  295 (487)
                      |++.|+|||++.+..++.++|||||||++|||++|+.||................         +...+.. ....++.+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~~-~~~~~~~~  225 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT---------LEDEVKF-EHQNFTEE  225 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHh---------hcccccc-ccccCCHH
Confidence            8999999999998889999999999999999999999986432211111111111         1111111 11245678


Q ss_pred             HHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          296 LAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       296 l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                      +.+|+.+||+.||++||++.|+++.+
T Consensus       226 ~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         226 SKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             HHHHHHHHhccCHhhCCCCccchhhh
Confidence            99999999999999999998776533

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.7e-39  Score=326.07  Aligned_cols=239  Identities=23%  Similarity=0.313  Sum_probs=195.8

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|+||.||+|.+.  ++.||||++.+..    .....+..|.+++..+ +||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999986  6789999887542    2335677899999888 799999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      ++|.+++...+ .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~  155 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHER--GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTST  155 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccc
Confidence            99999987664 499999999999999999999999  999999999999999999999999999864322221  2233


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      ..|++.|+|||.+.+..++.++|||||||++|+|++|+.||.... ......    .+..+.          ...+..++
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-~~~~~~----~i~~~~----------~~~~~~~~  220 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-EDELFQ----SILEDE----------VRYPRWLS  220 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-HHHHHH----HHHcCC----------CCCCCcCC
Confidence            568999999999999999999999999999999999999996322 111111    111111          11233466


Q ss_pred             HHHHHHHHHhhhhcCCCCCCH-----HHHHH
Q 011384          294 KQLAVIAVRCVRSCRERRPSM-----KEIVD  319 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RPs~-----~eil~  319 (487)
                      .++.+|+.+||+.||.+||++     .++++
T Consensus       221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             HHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            789999999999999999999     77775

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.4e-39  Score=317.64  Aligned_cols=247  Identities=25%  Similarity=0.343  Sum_probs=201.0

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      |+..+.||+|+||.||++.+.  ++.||||.+....    .....+.+|+.++++++|+||+.+++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677899999999999999886  7899999876432    2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          131 MSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       131 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      +++++|.+++... ...+++..+..++.|++.||.|||+.  +|+|+||||+||+++.++.++|+|||++.......   
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---
Confidence            9999999998653 23589999999999999999999999  99999999999999999999999999986543222   


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||........... ......          ......+
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~-~~~~~~----------~~~~~~~  225 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-VERLVK----------EVQEEYS  225 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH-HHhhhh----------hhhhhcC
Confidence            12234789999999999998999999999999999999999999974322211111 111111          0111123


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCC-----HHHHHH
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPS-----MKEIVD  319 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs-----~~eil~  319 (487)
                      ..++.++.+|+.+||+.||++|||     ++|+++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            345678999999999999999999     889886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.1e-39  Score=332.41  Aligned_cols=250  Identities=21%  Similarity=0.324  Sum_probs=198.0

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|...+.||+|+||.||++...  ++.||+|++...    ......+.+|+.++..++||||+++++.+.+...+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999886  789999988643    223456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc-
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF-  207 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~-  207 (487)
                      ||+++|+|.+++...+ .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++..+..... 
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~--givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQL--GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            9999999999997654 499999999999999999999999  999999999999999999999999999864422110 


Q ss_pred             --------------------------------ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCC
Q 011384          208 --------------------------------RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAID  255 (487)
Q Consensus       208 --------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~  255 (487)
                                                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                            001123479999999999999999999999999999999999999996


Q ss_pred             CCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCC---HHHHHH
Q 011384          256 IGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPS---MKEIVD  319 (487)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs---~~eil~  319 (487)
                      .... .....   .....       ...+..+....++.++.+|+.+|+ .+|.+|++   +.++++
T Consensus       238 ~~~~-~~~~~---~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         238 SETP-QETYR---KVMNW-------KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCH-HHHHH---HHHcC-------CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            3222 11111   11110       011111111235678888988876 49999995   566664

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5e-39  Score=321.64  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=201.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--Ce--EEEEEEcCCC--hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GR--QVAVKKPSKN--QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~--~vAvK~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .++|++.+.||+|+||.||+|.+.  +.  .+++|.+...  ......+.+|++++.++ +||||+++++++.+....++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            457899999999999999999875  43  4677776542  33446788999999999 89999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcE
Q 011384          127 VVEFMSNGTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNA  191 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~v  191 (487)
                      ||||+++++|.+++...+               ..+++..++.++.|++.||+|||+.  +++||||||+|||++.++.+
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC--CccccccchheEEecCCCcE
Confidence            999999999999997532               2478999999999999999999999  99999999999999999999


Q ss_pred             EEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhh
Q 011384          192 RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPL  270 (487)
Q Consensus       192 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~  270 (487)
                      ||+|||++......   .......++..|+|||.+.+..++.++|||||||++|||++ |..||... ........    
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~----  235 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEK----  235 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC-ChHHHHHH----
Confidence            99999998532111   11122234678999999988888999999999999999998 88888532 11111110    


Q ss_pred             hhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          271 IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       271 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      ..         .......+..++.++.+|+.+||+.+|++||++.+++..|..+.
T Consensus       236 ~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         236 LP---------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             Hh---------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11         01111122335678899999999999999999999999887764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9.3e-39  Score=315.75  Aligned_cols=259  Identities=20%  Similarity=0.365  Sum_probs=205.9

Q ss_pred             chhhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEe---
Q 011384           46 DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSN---  119 (487)
Q Consensus        46 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~---  119 (487)
                      .++.+....++|.+.+.||+|+||.||++...  ++.||+|++.........+.+|+.+++.+ +||||+++++++.   
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            34555667889999999999999999999885  78999998876555556788999999999 6999999999874   


Q ss_pred             --CCCceEEEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEc
Q 011384          120 --DSKDRLLVVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLG  194 (487)
Q Consensus       120 --~~~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~  194 (487)
                        .+...++||||+++++|.+++..   ....+++..+..++.|++.||.|||+.  +++||||||+||+++.++.+||+
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN--KTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC--CccccCCCHHhEEECCCCCEEEc
Confidence              34568999999999999998753   334588999999999999999999999  99999999999999999999999


Q ss_pred             ccccceecCCCCcccccCCCCCCCccCCccccCC-----CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhh
Q 011384          195 DFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP-----DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP  269 (487)
Q Consensus       195 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~  269 (487)
                      |||++........  ......|++.|+|||++..     ..++.++|||||||++|||++|+.||............   
T Consensus       167 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~---  241 (286)
T cd06638         167 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI---  241 (286)
T ss_pred             cCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc---
Confidence            9999876543221  2334568999999998753     34788999999999999999999998643221111110   


Q ss_pred             hhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       270 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                        ..     ...+.  ...+..++.++.+|+.+||+.+|++|||+.||++.
T Consensus       242 --~~-----~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         242 --PR-----NPPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             --cc-----cCCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence              00     00011  11122345679999999999999999999999974

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-39  Score=327.54  Aligned_cols=250  Identities=23%  Similarity=0.305  Sum_probs=215.0

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCC-CCCceeeEEEEeCCCce
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIH-SPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~  124 (487)
                      .....|.+.+.||+|.||.||+++.+  |+.+|+|.+.+...    ....+.+|+++|+++. |||||.+++.|++...+
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            34567999999999999999999987  88999998876533    3468999999999998 99999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC----CcEEEcccccce
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN----FNARLGDFGLAL  200 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~----~~vkL~DFGla~  200 (487)
                      ++|||++.||.|.+.+... . +++..+..++.|++.++.|||+.  ||+||||||+|+|+...    +.+|++|||++.
T Consensus       112 ~lvmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH~~--gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLHSL--GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHHhC--CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            9999999999999999877 3 99999999999999999999999  99999999999999543    579999999998


Q ss_pred             ecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccccc
Q 011384          201 RCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF  280 (487)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~  280 (487)
                      ....   .......+||+.|+|||++....|+..+||||+||++|.|++|..||..........     .+..++.    
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~i~~~~~----  255 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----AILRGDF----  255 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----HHHcCCC----
Confidence            7765   224566799999999999999999999999999999999999999998543332222     1222222    


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        .+..+.-+.++..+.+++..||..||.+|+|+.++++
T Consensus       256 --~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 --DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             --CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence              4444555678999999999999999999999999997

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.6e-39  Score=313.59  Aligned_cols=254  Identities=24%  Similarity=0.404  Sum_probs=206.1

Q ss_pred             hcCcccceeecccCceEEEEEEECC-----eEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLRG-----RQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~g-----~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ..+|.+.+.||+|+||.||+|.+..     ..|+||......  ...+.+.+|+.++++++||||+++++++.+. ..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEE
Confidence            4568899999999999999998752     368999877543  3446799999999999999999999998764 5789


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++++|.+++......+++..++.++.+++.||.|||+.  +++|+||||+|||++.++.+||+|||++.......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK--RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            9999999999999987666689999999999999999999999  99999999999999999999999999987654332


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      . .......+++.|+|||.+....++.++|||||||++||+++ |..||...... .....    +..+.         .
T Consensus       162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~----~~~~~---------~  226 (270)
T cd05056         162 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DVIGR----IENGE---------R  226 (270)
T ss_pred             c-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHH----HHcCC---------c
Confidence            1 12223345678999999988889999999999999999986 99998633221 11111    11111         1


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      .+.+..++..+.+++.+||..+|.+|||+.++++.|..+.
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         227 LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1223456778999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.3e-38  Score=315.71  Aligned_cols=247  Identities=23%  Similarity=0.297  Sum_probs=200.6

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      |...+.||+|+||.||++.+.  ++.||+|.+....    .....+.+|+++++.++|+||+.+++++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            677889999999999999886  7899999876542    2234578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          131 MSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       131 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      +++++|.+++... ...+++..+..++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++.......   
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~--~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE--NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC---
Confidence            9999999888653 34599999999999999999999999  99999999999999999999999999986543322   


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      ......|++.|+|||.+.+..++.++|||||||++|+|++|..||...........+.. .....          ....+
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~-~~~~~----------~~~~~  225 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR-RVLET----------EEVYS  225 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-hhhcc----------ccccC
Confidence            12345789999999999988999999999999999999999999974322211111111 11110          11123


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCC-----HHHHHH
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPS-----MKEIVD  319 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs-----~~eil~  319 (487)
                      ..++.++.+|+.+||+.||++||+     +.+++.
T Consensus       226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            345677899999999999999999     667776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=332.22  Aligned_cols=256  Identities=25%  Similarity=0.408  Sum_probs=219.9

Q ss_pred             HHhhcCcccceeecccCceEEEEEEEC----C--eEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLR----G--RQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK  122 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~----g--~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  122 (487)
                      +.........++||.|-||.||+|++.    |  -.||||..+.+  ....+.|..|.-+|++++||||++++|+|.+. 
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence            344455667789999999999999875    2  25999988764  34467899999999999999999999999876 


Q ss_pred             ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                      ..+||||.++.|-|..+|+.++..|+......++.||+.||+|||+.  ++|||||..+|||+.....|||+|||+++.+
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk--rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK--RFVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh--chhhhhhhhhheeecCcceeeecccchhhhc
Confidence            47999999999999999999888899999999999999999999999  9999999999999999999999999999988


Q ss_pred             CCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      ..+... ..+...-...|||||.+....++.+||||.|||++||++. |.+||..              +++.++...++
T Consensus       542 ed~~yY-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg--------------vkNsDVI~~iE  606 (974)
T KOG4257|consen  542 EDDAYY-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG--------------VKNSDVIGHIE  606 (974)
T ss_pred             cccchh-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc--------------ccccceEEEec
Confidence            765543 3445566779999999999999999999999999999875 7888862              22333344555


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ..-+.|.|+.|++.+..|+.+||.++|.+||.+.||...|..+
T Consensus       607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence            5666778899999999999999999999999999998876654

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=308.61  Aligned_cols=246  Identities=26%  Similarity=0.411  Sum_probs=200.5

Q ss_pred             eeecccCceEEEEEEEC-CeEEEEEEcCCChh--hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCCHH
Q 011384           61 KLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLY  137 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~  137 (487)
                      ++||+|+||.||++.+. ++.|++|.......  ....+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            47999999999999887 88999998765432  4467899999999999999999999999999999999999999999


Q ss_pred             HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCC
Q 011384          138 DVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT  217 (487)
Q Consensus       138 ~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt  217 (487)
                      +++......+++..+..++.+++.+|.|||++  +++|+||+|+|||++.++.+||+|||++................++
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~--~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK--NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP  158 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence            99977655689999999999999999999999  9999999999999999999999999998755422221111223346


Q ss_pred             CccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHH
Q 011384          218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQL  296 (487)
Q Consensus       218 ~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  296 (487)
                      ..|+|||.+.+..++.++|||||||++|||++ |..||... ........    +         ......+.+..++.++
T Consensus       159 ~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~----~---------~~~~~~~~~~~~~~~~  224 (251)
T cd05041         159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRER----I---------ESGYRMPAPQLCPEEI  224 (251)
T ss_pred             eccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHH----H---------hcCCCCCCCccCCHHH
Confidence            67999999988889999999999999999999 77777432 21111111    1         1111122334567789


Q ss_pred             HHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          297 AVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       297 ~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      .+++.+||+.+|++|||+.||++.|+
T Consensus       225 ~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         225 YRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHhccChhhCcCHHHHHHHhh
Confidence            99999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.1e-38  Score=309.97  Aligned_cols=247  Identities=20%  Similarity=0.306  Sum_probs=203.7

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCC--ChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSK--NQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      +|.+.+.||+|+||.||++.+.  ++.||+|.+..  .....+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5788999999999999999886  78899998753  2334467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          132 SNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       132 ~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      ++++|.+++.. .+..+++..++.++.|++.||.|||+.  +++|+||||+||+++.++.++|+|||++........  .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK--RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--Y  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC--CcccCCCCcceEEECCCCcEEEcccCcceeeccccc--c
Confidence            99999998865 334589999999999999999999999  999999999999999999999999999876543221  1


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ....   .. ....+.         ..+.+.
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-~~~~---~~-~~~~~~---------~~~~~~  222 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-WKNL---IL-KVCQGS---------YKPLPS  222 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-HHHH---HH-HHhcCC---------CCCCCc
Confidence            233568899999999998889999999999999999999999986321 1111   11 111111         112334


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                      .++..+.+++.+||+.||++||++.+|+..
T Consensus       223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         223 HYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            566789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-39  Score=324.27  Aligned_cols=252  Identities=23%  Similarity=0.321  Sum_probs=199.2

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||++...  ++.||+|++.+.    ....+.+.+|+.++..++|+||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999986  789999998642    223356888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++++|.+++......+++..+..++.|++.||+|||++  +|+||||||+|||++.++.+||+|||++..+..... 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL--GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-
Confidence            99999999999987555699999999999999999999999  999999999999999999999999999876543322 


Q ss_pred             cccCCCCCCCccCCccccCC-----CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTP-----DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      .......||+.|+|||++..     ..++.++|||||||++|+|++|+.||.....    .............     ..
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~----~~~~~~i~~~~~~-----~~  228 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHKEH-----FQ  228 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH----HHHHHHHHcCCCc-----cc
Confidence            12233469999999999863     4568899999999999999999999963221    1111111111100     01


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCC--CCCCHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRE--RRPSMKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~--~RPs~~eil~  319 (487)
                      ++. ....++.++.+++.+||..++.  .||+++++++
T Consensus       229 ~~~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         229 FPP-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             CCC-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            111 1223677889999998865443  4789999986

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-39  Score=327.99  Aligned_cols=236  Identities=23%  Similarity=0.297  Sum_probs=193.7

Q ss_pred             eeecccCceEEEEEEE-----CCeEEEEEEcCCChh---hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecC
Q 011384           61 KLLGKGSHGSVYKAVL-----RGRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~-----~g~~vAvK~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      +.||+|+||.||++..     .++.||+|++.....   ....+.+|++++++++||||+++++++.+....|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999875     378899998875432   23457789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccC
Q 011384          133 NGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       133 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      +++|.+++.+.. .+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........  ...
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~  156 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAY  156 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--cee
Confidence            999999997654 499999999999999999999999  999999999999999999999999999875433211  233


Q ss_pred             CCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHH
Q 011384          213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV  292 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  292 (487)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ......   . +....          ...+..+
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-~~~~~~---~-i~~~~----------~~~p~~~  221 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-RKETMT---M-ILKAK----------LGMPQFL  221 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC-HHHHHH---H-HHcCC----------CCCCCCC
Confidence            4579999999999998889999999999999999999999996322 111111   1 11111          1123346


Q ss_pred             HHHHHHHHHHhhhhcCCCCCCHHH
Q 011384          293 RKQLAVIAVRCVRSCRERRPSMKE  316 (487)
Q Consensus       293 ~~~l~~Li~~cl~~dP~~RPs~~e  316 (487)
                      +.++.+|+.+||+.||.+||++.+
T Consensus       222 ~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         222 SPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CHHHHHHHHHHhhcCHhHcCCCCC
Confidence            678999999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-38  Score=335.95  Aligned_cols=258  Identities=24%  Similarity=0.302  Sum_probs=198.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ...|.+.+.||+|+||.||++.+.  ++.||||....     ..+.+|++++++++|+||+++++++......++|||++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            347999999999999999999987  67899996332     34578999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                       .++|.+++......+++..++.|+.|++.||.|||++  +|+||||||+|||++.++.+||+|||+++.+.........
T Consensus       243 -~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        243 -RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE--GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence             5799999877656799999999999999999999999  9999999999999999999999999999765433222122


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc---hhhhhhhhhhhcCccc-cc--------
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP---SIVDWAAPLIKKGKIL-SV--------  279 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~---~~~~~~~~~~~~~~i~-~~--------  279 (487)
                      ....||+.|+|||++.+..++.++|||||||+||||++|..++.......   .........+...... ..        
T Consensus       320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~  399 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR  399 (461)
T ss_pred             cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence            34579999999999999999999999999999999999887654322110   0000011111111100 00        


Q ss_pred             ------------cCCCCCCC-CC--hHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          280 ------------FDPRIPPP-KD--PIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       280 ------------~~~~~~~~-~~--~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                                  ..+....+ +.  ...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence                        00000000 00  123457889999999999999999999997

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1e-38  Score=319.93  Aligned_cols=260  Identities=19%  Similarity=0.265  Sum_probs=200.9

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ++|.+.+.||+|+||.||+|.+.  ++.||+|.+....  .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56999999999999999999886  7789999876432  2234678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +++ +|.+++...+..+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........  .
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~  160 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR--KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--T  160 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEECccccceecCCCcc--c
Confidence            965 89888877666689999999999999999999999  999999999999999999999999999865433221  1


Q ss_pred             cCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhh----------hhhhcC-cccc
Q 011384          211 STPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA----------PLIKKG-KILS  278 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~----------~~~~~~-~i~~  278 (487)
                      .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..............          +.+... ....
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            233467899999998865 4578999999999999999999999964322111111000          000000 0000


Q ss_pred             ccCCCCC----CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          279 VFDPRIP----PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       279 ~~~~~~~----~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .-.+...    ....+.++.++.+|+.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000000    0011235678899999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.1e-38  Score=310.88  Aligned_cols=250  Identities=21%  Similarity=0.304  Sum_probs=192.1

Q ss_pred             eeecccCceEEEEEEEC----CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCC
Q 011384           61 KLLGKGSHGSVYKAVLR----GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNG  134 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~----g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~g  134 (487)
                      +.||+|+||.||+|.+.    +..+|+|.+....  .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36899999999999865    3579999876543  23357888999999999999999999999999999999999999


Q ss_pred             CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          135 TLYDVLHSNN----RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       135 sL~~~l~~~~----~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +|.+++....    ..+++..+..++.|++.||.|||+.  +++|+||||+||+++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC--CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            9999997522    2467778889999999999999999  999999999999999999999999999865433322222


Q ss_pred             cCCCCCCCccCCccccCCC-------CCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCC
Q 011384          211 STPPAGTIGYLDPCYVTPD-------NLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~-------~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~  282 (487)
                      .....++..|+|||++...       .++.++|||||||++|||++ |+.||..... .......    ..+.......+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-~~~~~~~----~~~~~~~~~~~  233 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-EQVLTYT----VREQQLKLPKP  233 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHH----hhcccCCCCCC
Confidence            2334678899999998642       35789999999999999996 9989864322 1211110    11111111112


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       283 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      .+    ....++.+.+++..|| .+|++|||+++|+..|+
T Consensus       234 ~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         234 RL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11    2234567888999999 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.9e-39  Score=325.45  Aligned_cols=235  Identities=24%  Similarity=0.296  Sum_probs=189.4

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHH-HHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIE-ILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|+||.||+|.+.  ++.||||++....    .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999986  7899999886532    12234555554 56789999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      ++|.+++...+ .+++..+..++.||+.||.|||++  +|+||||||+|||++.++.+||+|||++.......  .....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTST  155 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccccc
Confidence            99999997654 589999999999999999999999  99999999999999999999999999986432221  12334


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...   ...... .+.          ...++.++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-~~~---~~~~i~-~~~----------~~~~~~~~  220 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAE---MYDNIL-NKP----------LRLKPNIS  220 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-HHH---HHHHHH-cCC----------CCCCCCCC
Confidence            579999999999999999999999999999999999999996321 111   111111 110          11223456


Q ss_pred             HHHHHHHHHhhhhcCCCCCCHH
Q 011384          294 KQLAVIAVRCVRSCRERRPSMK  315 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RPs~~  315 (487)
                      ..+.+++.+||+.||.+||++.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         221 VSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHHHHHhhcCHHhCCCCC
Confidence            7899999999999999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.7e-38  Score=313.52  Aligned_cols=248  Identities=25%  Similarity=0.355  Sum_probs=198.2

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ++|.+.++||+|+||.||+|++.  ++.||+|++...  ......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36788899999999999999875  788999987654  33346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +++++|..+.     .+++..+..++.|++.||.|||+.  +|+|+||||+|||++.++.++|+|||++......    .
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~  149 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSL--KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----I  149 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC--CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----c
Confidence            9999996552     378889999999999999999999  9999999999999999999999999998755332    2


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||............. ...     ....+...+.....
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~  223 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL-QLL-----QCIVDEDPPVLPVG  223 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH-HHH-----HHHhccCCCCCCCC
Confidence            234578999999999998889999999999999999999999986422111100000 000     00000000111112


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+.++.+++.+||+.+|++||+++++++
T Consensus       224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         224 QFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            35567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-41  Score=309.08  Aligned_cols=250  Identities=23%  Similarity=0.328  Sum_probs=209.9

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++.|++.+.||+|.|+.||++.+.  |+.+|+|+++..   ....+.+.+|+++.+.++||||+++.+.+.+....|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4567888999999999999999876  889999977643   33457899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc---CCcEEEcccccceecCC
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR---NFNARLGDFGLALRCGV  204 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~~~~~  204 (487)
                      +|+|.|+.|-.-+-.. .-+++..+-++++||+.+|.|+|.+  +|||||+||.|+|+-.   .--+||+|||++..+..
T Consensus        89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n--~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSN--GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhc--CceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            9999999996655443 2378889999999999999999999  9999999999999943   34599999999988772


Q ss_pred             CCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      .   .......|||+|||||+++..+|+..+|||++||+||-||.|..||......     .....+..|..      .+
T Consensus       166 g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-----rlye~I~~g~y------d~  231 (355)
T KOG0033|consen  166 G---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYEQIKAGAY------DY  231 (355)
T ss_pred             c---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-----HHHHHHhcccc------CC
Confidence            2   2455678999999999999999999999999999999999999999742221     22223333332      34


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +.+.-+.++++.++|+++||..||.+|.|+.|.+.
T Consensus       232 ~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  232 PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            55566788999999999999999999999999985

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9.9e-39  Score=323.28  Aligned_cols=239  Identities=22%  Similarity=0.311  Sum_probs=193.5

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|+||.||+|...  ++.||+|++....    .....+.+|+.++.++ +||||+.+++++.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999886  6889999987542    2345688899999888 699999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      ++|.+++...+ .+++..+..++.|++.||+|||++  +|+||||||+|||++.++.+||+|||++........  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~  155 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHER--GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTST  155 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ceec
Confidence            99999887654 499999999999999999999999  999999999999999999999999999864322211  2234


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc--hhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP--SIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~--~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ....+........          +...+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~p~~  225 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK----------PIRIPRF  225 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC----------CCCCCCC
Confidence            579999999999999999999999999999999999999996322111  1111111111111          1123344


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCH
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSM  314 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~  314 (487)
                      ++..+.+++.+||+.||.+||++
T Consensus       226 ~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         226 LSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCC
Confidence            66788999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.3e-38  Score=308.77  Aligned_cols=250  Identities=25%  Similarity=0.400  Sum_probs=195.7

Q ss_pred             eeecccCceEEEEEEEC-----CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEe-CCCceEEEEEecC
Q 011384           61 KLLGKGSHGSVYKAVLR-----GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSN-DSKDRLLVVEFMS  132 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~lV~Ey~~  132 (487)
                      +.||+|+||.||+|.+.     ...||+|.+...  ......+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999863     357999987543  334567889999999999999999999775 4556899999999


Q ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc--cc
Q 011384          133 NGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR--FR  210 (487)
Q Consensus       133 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~--~~  210 (487)
                      +++|.+++......+++..+..++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++..+......  ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK--KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            9999999987555578888899999999999999999  9999999999999999999999999998754332111  11


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      .....++..|+|||.+.+..++.++|||||||++|||++|..|+............    ...+         .....+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~----~~~~---------~~~~~~~  225 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY----LLQG---------RRLLQPE  225 (262)
T ss_pred             cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HhcC---------CCCCCCC
Confidence            12335677899999998888999999999999999999965444322222222211    1111         1111223


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      .++..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus       226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            35678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8.8e-39  Score=312.86  Aligned_cols=246  Identities=24%  Similarity=0.389  Sum_probs=197.8

Q ss_pred             eeecccCceEEEEEEECC--------eEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           61 KLLGKGSHGSVYKAVLRG--------RQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~g--------~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +.||+|+||.||+|.+..        ..+|+|.+....  .....+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998752        579999876543  3456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC-----cEEEcccccc
Q 011384          131 MSNGTLYDVLHSN------NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF-----NARLGDFGLA  199 (487)
Q Consensus       131 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~-----~vkL~DFGla  199 (487)
                      +++++|.+++...      ...+++..+..++.|++.||.|||+.  +++|+||||+||+++.++     .++|+|||++
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM--HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC--CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999999642      23478899999999999999999999  999999999999999877     8999999998


Q ss_pred             eecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCcccc
Q 011384          200 LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILS  278 (487)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~  278 (487)
                      ..+.............++..|+|||++.+..++.++|||||||++|||++ |..||..... ......    +..     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-~~~~~~----~~~-----  228 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQH----VTA-----  228 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-HHHHHH----Hhc-----
Confidence            75543322212223456788999999999999999999999999999998 8888853211 111111    111     


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       279 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                          ......+..++..+.+++.+||..+|.+||++.+|++.|+
T Consensus       229 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 ----GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ----CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                1111223456788999999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1e-38  Score=323.81  Aligned_cols=252  Identities=21%  Similarity=0.297  Sum_probs=199.5

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||++++.  ++.||+|++.+..    .....+.+|+.++..++|+||+++++++.+...+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47899999999999999999987  6789999886432    22345888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++|+|.+++......+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........ 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~--~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL--HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHEEECCCCCEEEeecchheecccCCc-
Confidence            99999999999987656699999999999999999999999  999999999999999999999999999865433222 


Q ss_pred             cccCCCCCCCccCCccccC-----CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVT-----PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.....    ............     ...
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~----~~~~~~i~~~~~-----~~~  228 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHKE-----RFQ  228 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH----HHHHHHHhCCCc-----ccc
Confidence            1223457999999999986     34678999999999999999999999964321    111111111100     001


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCC--CCCHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRER--RPSMKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~--RPs~~eil~  319 (487)
                      ++ .....++.++.+|+.+||..++.+  |++++++++
T Consensus       229 ~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~  265 (332)
T cd05623         229 FP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ  265 (332)
T ss_pred             CC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence            11 112346788999999988655444  789999986

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.7e-39  Score=311.28  Aligned_cols=250  Identities=30%  Similarity=0.479  Sum_probs=200.4

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHH---HHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQ---EVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~---~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      |++.+.||+|+||.||+++..  ++.||+|++........   ...+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            678899999999999999997  56899999887754433   3355999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      ++++|.+++.... .+++..++.++.|++.||.+||+.  +++|+||||+||+++.++.++|+|||.+......  ....
T Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh~~--~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~~  155 (260)
T PF00069_consen   81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLHSK--GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NENF  155 (260)
T ss_dssp             TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHHHT--TEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSEB
T ss_pred             ccccccccccccc-cccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc--cccc
Confidence            9999999998433 489999999999999999999999  9999999999999999999999999998754211  2234


Q ss_pred             CCCCCCCccCCccccC-CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          212 TPPAGTIGYLDPCYVT-PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~-~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      ....++..|+|||.+. +..++.++||||||+++|+|++|..||...... ............ ......      ....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-~~~~~~~~~~~~-~~~~~~------~~~~  227 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-DQLEIIEKILKR-PLPSSS------QQSR  227 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-HHHHHHHHHHHT-HHHHHT------TSHT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccch-hhhhhhhhcccc-cccccc------cccc
Confidence            4567899999999998 778899999999999999999999999743111 111111100000 000000      0001


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .....+.+++.+||+.||++||++.++++
T Consensus       228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  228 EKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            12378999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.3e-39  Score=325.47  Aligned_cols=241  Identities=24%  Similarity=0.296  Sum_probs=191.8

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHH-HHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIE-ILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|+||.||+|++.  ++.||+|++....    .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999986  6789999876532    12234444444 56788999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      ++|.+++.... .+++..+..++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++........  ....
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~--giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~  155 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTST  155 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Cccc
Confidence            99999997754 488888999999999999999999  999999999999999999999999999865332221  2334


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ......   .... .          +...++.++
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~---~i~~-~----------~~~~~~~~~  220 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYD---NILN-K----------PLQLKPNIT  220 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC-HHHHHH---HHHh-C----------CcCCCCCCC
Confidence            579999999999999999999999999999999999999996322 111111   1111 0          111233466


Q ss_pred             HHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          294 KQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                      ..+.+++.+||+.+|.+||++.+.+..+
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~~~~~~i  248 (325)
T cd05602         221 NSARHLLEGLLQKDRTKRLGAKDDFMEI  248 (325)
T ss_pred             HHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence            7899999999999999999977554433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.9e-38  Score=325.16  Aligned_cols=258  Identities=24%  Similarity=0.310  Sum_probs=196.8

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC-----
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK-----  122 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----  122 (487)
                      ..++|.+.+.||+|+||.||++.+.  +..||||++...   ......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3578999999999999999999875  789999988643   233467889999999999999999999986543     


Q ss_pred             -ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          123 -DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       123 -~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                       ..|+||||+++ +|.+.+..   .+++..+..++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++..
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~--~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~  172 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART  172 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence             46999999965 67666643   388899999999999999999999  999999999999999999999999999865


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhh--------------hh
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD--------------WA  267 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~--------------~~  267 (487)
                      .....   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........              ..
T Consensus       173 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         173 ACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             cccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            43221   23445789999999999999999999999999999999999999964321111000              00


Q ss_pred             ----hhhhhcC-cc-----ccccCCC-C--CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          268 ----APLIKKG-KI-----LSVFDPR-I--PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       268 ----~~~~~~~-~i-----~~~~~~~-~--~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                          ....... ..     ...+... .  ....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                0000000 00     0000000 0  00111224567899999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1e-38  Score=323.75  Aligned_cols=258  Identities=26%  Similarity=0.379  Sum_probs=206.5

Q ss_pred             hhcCcccceeecccCceEEEEEEEC---------CeEEEEEEcCCC--hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeC
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR---------GRQVAVKKPSKN--QEISQEVDNEIEILSKI-HSPRLVNLLGFSND  120 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~---------g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~  120 (487)
                      ...+|.+.+.||+|+||.||++.+.         ...||+|.....  ....+.+.+|+++++++ +||||++++++|.+
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            3457999999999999999999753         236899987753  23346789999999999 89999999999999


Q ss_pred             CCceEEEEEecCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI  185 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl  185 (487)
                      ....++++||+++++|.+++....               ..+++..+..++.|++.||.|||++  +++||||||+|||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--givH~dlkp~Nill  167 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ--KCIHRDLAARNVLV  167 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC--CeeccccccceEEE
Confidence            999999999999999999997532               2478889999999999999999999  99999999999999


Q ss_pred             ccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhh
Q 011384          186 DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIV  264 (487)
Q Consensus       186 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~  264 (487)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.. .......
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~  246 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELF  246 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-CCHHHHH
Confidence            9999999999999876543322212223345678999999999999999999999999999998 7777752 2211111


Q ss_pred             hhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          265 DWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       265 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .    .+..         ....+.+..++.++.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus       247 ~----~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         247 K----LLKE---------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             H----HHHc---------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            1    1111         11112233456789999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.6e-38  Score=316.17  Aligned_cols=254  Identities=22%  Similarity=0.372  Sum_probs=201.5

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ++|.+.+.||+|+||.||++.+.  +..||+|.+...  ......+.+|++++++++||||++++++|.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999886  678999987654  23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      +++++|.+++...+ .+++..+..++.|++.||.|||+ .  +++|+||||+|||++.++.+||+|||++......    
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----  153 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----  153 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc----
Confidence            99999999998764 58999999999999999999997 5  8999999999999999999999999998654322    


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCc--------------
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK--------------  275 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~--------------  275 (487)
                      ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||..... .....+.........              
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCccccccccCCcccccCCCCC
Confidence            12335788999999999888899999999999999999999999863321 111111100000000              


Q ss_pred             -------------cccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          276 -------------ILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       276 -------------i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                                   +.....+..+   ...++.++.+++.+||..+|++|||+.+|+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  286 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPKERADLKELTK  286 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCc---CcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                         0000000110   1125678999999999999999999999997

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1e-38  Score=323.79  Aligned_cols=252  Identities=21%  Similarity=0.285  Sum_probs=199.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||++++.  ++.||+|++.+..    .....+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999886  7789999886532    23345788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++|+|.+++......+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~--~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL--HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            99999999999987555699999999999999999999999  9999999999999999999999999999765433221


Q ss_pred             cccCCCCCCCccCCccccCC-----CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTP-----DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                       ......||+.|+|||++.+     +.++.++|||||||++|+|++|+.||........    .........     ...
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~----~~~i~~~~~-----~~~  228 (331)
T cd05624         159 -QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET----YGKIMNHEE-----RFQ  228 (331)
T ss_pred             -eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH----HHHHHcCCC-----ccc
Confidence             2234579999999999875     4678899999999999999999999964321111    111111000     001


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCC--CCCHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRER--RPSMKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~--RPs~~eil~  319 (487)
                      ++. ....+++++.+++.+||...+.+  |++++++++
T Consensus       229 ~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         229 FPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             CCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            111 11235678999999999876544  467888875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.5e-38  Score=315.61  Aligned_cols=247  Identities=25%  Similarity=0.385  Sum_probs=203.6

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      .+|...+.||+|+||.||+|+..  ++.|++|.+.... .....+.+|+.+++.+.||||+++++++......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57999999999999999999875  7899999876543 33467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      ++++|.+++...  .+++..+..++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||++........  ..
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~--gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~  173 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR  173 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEcCCCCEEECccccchhcccccc--cc
Confidence            999999998654  489999999999999999999999  999999999999999999999999999865433221  12


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...........    ....        .....+.+..
T Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~----~~~~--------~~~~~~~~~~  241 (296)
T cd06654         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL----IATN--------GTPELQNPEK  241 (296)
T ss_pred             CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH----HhcC--------CCCCCCCccc
Confidence            334688999999999988889999999999999999999999964322111111    1000        1111122345


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ++..+.+++.+||..+|++||++.+|++
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             cCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            6678999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.2e-38  Score=328.25  Aligned_cols=258  Identities=21%  Similarity=0.305  Sum_probs=198.4

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC-----ceE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK-----DRL  125 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~~~  125 (487)
                      +|+..+.||+|+||.||++.+.  ++.||||++...   ....+.+.+|+++++.++||||+++++++....     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999975  889999987643   233467889999999999999999999998776     789


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +|+||+. ++|.+.+.... .+++..+..++.|++.||.|||+.  +++||||||+|||++.++.+||+|||++......
T Consensus        81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            9999996 58888886554 599999999999999999999999  9999999999999999999999999999765433


Q ss_pred             CcccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcc--------
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI--------  276 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i--------  276 (487)
                      ... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... ...............        
T Consensus       157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         157 ESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             ccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHhhH
Confidence            221 23345688999999998874 4789999999999999999999999643221 111111000000000        


Q ss_pred             --c-cccCCCCCC-------CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          277 --L-SVFDPRIPP-------PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       277 --~-~~~~~~~~~-------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        . .........       ......++++.+|+.+||+.||.+|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence              0 000000000       112234678899999999999999999999997

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2e-38  Score=311.36  Aligned_cols=245  Identities=25%  Similarity=0.421  Sum_probs=195.4

Q ss_pred             eeecccCceEEEEEEEC--Ce--EEEEEEcCCC--hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GR--QVAVKKPSKN--QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~--~vAvK~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|+||.||+|.+.  +.  .+++|.+...  ......+.+|++++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999886  32  5788887743  33446788999999999 899999999999999999999999999


Q ss_pred             CCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccc
Q 011384          134 GTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL  198 (487)
Q Consensus       134 gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGl  198 (487)
                      ++|.+++....               ..+++..+..++.|++.||+|||+.  +++|+||||+|||++.++.+||+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~--~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccccceEEEcCCCeEEECCCCC
Confidence            99999997532               2478999999999999999999999  999999999999999999999999999


Q ss_pred             ceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccc
Q 011384          199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKIL  277 (487)
Q Consensus       199 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~  277 (487)
                      +......   ........+..|+|||++....++.++|||||||++|||++ |..||... .......    .+.     
T Consensus       159 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~-~~~~~~~----~~~-----  225 (270)
T cd05047         159 SRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYE----KLP-----  225 (270)
T ss_pred             ccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc-CHHHHHH----HHh-----
Confidence            7532211   11122234668999999988889999999999999999997 88888532 1111111    011     


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                          .....+.+..++.++.+|+.+||+.+|.+|||+.+++..|..+
T Consensus       226 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         226 ----QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             ----CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                1111122334567889999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2e-38  Score=313.74  Aligned_cols=257  Identities=23%  Similarity=0.305  Sum_probs=194.3

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhC---CCCCceeeEEEEeC-----CC
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKI---HSPRLVNLLGFSND-----SK  122 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~-----~~  122 (487)
                      +|.+.+.||+|+||.||+|.+.  ++.||+|.+....   .....+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4888999999999999999886  7889999876432   2223566777777665   79999999998864     24


Q ss_pred             ceEEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      ..++||||++ ++|.+++.... ..+++..+..++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++..
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence            5799999997 48988887633 3489999999999999999999999  999999999999999999999999999876


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh---cCccc-
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK---KGKIL-  277 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~---~~~i~-  277 (487)
                      .....   ......||+.|+|||.+.+..++.++|||||||++|+|++|++||............. ....   ..... 
T Consensus       158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~-~~~~~~~~~~~~~  233 (288)
T cd07863         158 YSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF-DLIGLPPEDDWPR  233 (288)
T ss_pred             ccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHH-HHhCCCChhhCcc
Confidence            54322   2234568999999999998889999999999999999999999886432221111111 0000   00000 


Q ss_pred             ------cccCCCCC---CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          278 ------SVFDPRIP---PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       278 ------~~~~~~~~---~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                            ..+.+...   ....+.++.++.+|+.+||+.||++|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                  00000000   0111245678899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.3e-38  Score=312.58  Aligned_cols=259  Identities=22%  Similarity=0.255  Sum_probs=198.7

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +|.+.+.||+|++|.||+|++.  +..||||++....   .....+.+|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5888999999999999999985  7889999876432   2336788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          131 MSNGTLYDVLHSNN--RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       131 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ++ ++|.+++....  ..+++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR--RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC--CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence            97 68988886532  4689999999999999999999999  999999999999999999999999999876543321 


Q ss_pred             cccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc-----------Ccc
Q 011384          209 FRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK-----------GKI  276 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~-----------~~i  276 (487)
                       ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...................           ...
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence             12334678999999988654 46889999999999999999999986432211111110000000           000


Q ss_pred             cc---ccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          277 LS---VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       277 ~~---~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..   .............++.++.+++.+||+.||.+|||+.+|+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00   00000000111235678899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-39  Score=326.87  Aligned_cols=264  Identities=23%  Similarity=0.394  Sum_probs=217.8

Q ss_pred             HhhcCcccceeecccCceEEEEEEECC-eEEEEEEcCCChh--hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLRG-RQVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~g-~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      .......++++||+|-||+|.++...+ ..||||+++....  ...+|.+|+++|.+++||||+.++|+|..++.+|+|+
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            334567788999999999999999885 8999999986643  3478999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          129 EFMSNGTLYDVLHSNNRPL-NWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l-~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||++|+|.+++.++..+. ....-..|+.||+.|++||.+.  ++|||||.++|+|+|.++++||+|||+++-+...++
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~--nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL--NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh--chhhccccccceeecCcccEEecCcccccccccCCc
Confidence            9999999999998764333 5556678999999999999999  999999999999999999999999999987665555


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh--CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS--CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt--G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      ........-..+|||+|.+..+.++.+||||+||+++||+++  ...||. ....+++.+-...+...+.      ....
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~-~lt~e~vven~~~~~~~~~------~~~~  765 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYS-QLTDEQVVENAGEFFRDQG------RQVV  765 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchh-hhhHHHHHHhhhhhcCCCC------ccee
Confidence            444455566789999999999999999999999999999864  567765 2333444443333332221      1222


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ...|+.|+.++.+++..||..+-.+||+++++...|+..
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            345667889999999999999999999999999988764

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.3e-38  Score=321.92  Aligned_cols=239  Identities=21%  Similarity=0.288  Sum_probs=194.7

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCC-CCCceeeEEEEeCCCceEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIH-SPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      +|...+.||+|+||.||+|.+.  ++.||+|++.+..    ...+.+..|+.++..+. |++|+++++++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999886  7899999887542    23356778999998885 577888999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++|+|.+++...+ .+++..+..++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++........ 
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~--~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-  156 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRR--GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-  156 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence            9999999999997654 499999999999999999999999  999999999999999999999999999865332221 


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ......   .. ....          ...
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-~~~~~~---~i-~~~~----------~~~  220 (323)
T cd05615         157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-EDELFQ---SI-MEHN----------VSY  220 (323)
T ss_pred             -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHH---HH-HhCC----------CCC
Confidence             2234569999999999999899999999999999999999999996322 111111   11 1111          112


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSM  314 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~  314 (487)
                      +..++.++.+++.+||+.+|.+|++.
T Consensus       221 p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         221 PKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CccCCHHHHHHHHHHcccCHhhCCCC
Confidence            33456788999999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.3e-38  Score=308.30  Aligned_cols=254  Identities=24%  Similarity=0.341  Sum_probs=203.5

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ++..++.+.....||+|+||.||+|.+.  +..|++|.+.... ...+.+.+|+.+++.++|+||+++++++...+..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3455677777789999999999999876  6789999876543 345678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc-CCcEEEcccccceecC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPL--NWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-NFNARLGDFGLALRCG  203 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l--~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla~~~~  203 (487)
                      |+||+++++|.+++......+  ++..+..++.|++.||.|||+.  +|+|+||||+||+++. ++.++|+|||++....
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN--QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            999999999999998654445  8888999999999999999999  9999999999999976 6799999999986553


Q ss_pred             CCCcccccCCCCCCCccCCccccCCCC--CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTPDN--LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      ..+.  ......+++.|+|||++....  ++.++||||||+++|+|++|+.||........ ..+...           .
T Consensus       161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-~~~~~~-----------~  226 (268)
T cd06624         161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-AMFKVG-----------M  226 (268)
T ss_pred             cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-hHhhhh-----------h
Confidence            3221  122346889999999986643  78899999999999999999999863221111 111000           0


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .......+..++.++.+++.+||+.+|.+|||+.+|++
T Consensus       227 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         227 FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            01112234456788999999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.9e-38  Score=306.00  Aligned_cols=247  Identities=23%  Similarity=0.385  Sum_probs=204.8

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +|+..+.||.|+||.||.+...  +..+++|.+...   ......+.+|++++++++|+||+++++++.+....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5889999999999999988775  788999986643   33446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          131 MSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       131 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      +++++|.+++... ...+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.+||+|||++........  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA--GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCChHhEEEeCCCCEEECcCcceEEcccccc--
Confidence            9999999999764 44589999999999999999999999  999999999999999999999999999876544331  


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..........    .. ..+.         ..+.+
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~----~~-~~~~---------~~~~~  222 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV----KI-VQGN---------YTPVV  222 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH----HH-HcCC---------CCCCc
Confidence            2234568999999999988888999999999999999999999986432211111    11 1111         11223


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                      ..++.++.+++.+||+.+|.+||+++++++.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            4567789999999999999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.8e-38  Score=308.00  Aligned_cols=247  Identities=22%  Similarity=0.381  Sum_probs=201.3

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----------hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCc
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----------ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKD  123 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  123 (487)
                      +|.+...||+|++|.||+|...  ++.||+|.+.....          ..+.+.+|+.++++++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999875  78899997754311          22568899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      .++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||+++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH~~--~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHNR--GIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHhc--CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            999999999999999997654 489999999999999999999999  99999999999999999999999999987654


Q ss_pred             CCCcc----cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccc
Q 011384          204 VDNFR----FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV  279 (487)
Q Consensus       204 ~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~  279 (487)
                      .....    .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||........+..    .      ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~------~~~  227 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK----I------GEN  227 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHH----H------hcc
Confidence            32111    011223588899999999988899999999999999999999999963221111110    0      011


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       280 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                          .....+..++..+.+++.+||+.+|.+||++.+|++
T Consensus       228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 ----ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ----CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                112233456788999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-38  Score=313.20  Aligned_cols=248  Identities=24%  Similarity=0.379  Sum_probs=201.5

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ++|++.+.||+|+||.||++.+.  +..||+|.+...  ......+.+|++++++++||||+++++++......++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888999999999999999986  889999987643  33346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          131 MSNGTLYDVLHSN--NRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       131 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      +++++|..++...  ...+++..+..++.+++.||.|||+ .  +++|+||||+||+++.++.+||+|||++......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            9999999988763  2358999999999999999999996 5  8999999999999999999999999998654322  


Q ss_pred             ccccCCCCCCCccCCccccCCCC------CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDN------LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~------~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                        ......+++.|+|||.+.+..      ++.++|||||||++|+|++|+.||...... ........         .. 
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~---------~~-  223 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-NIFAQLSA---------IV-  223 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-hHHHHHHH---------Hh-
Confidence              223346888999999985543      478999999999999999999998643211 11110000         00 


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...+...+..++.++.+++.+||+.+|++||++.+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         224 DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            11122344457888999999999999999999999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4e-38  Score=311.05  Aligned_cols=247  Identities=24%  Similarity=0.336  Sum_probs=200.2

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCC-hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN-QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      |++.+.||+|+||.||+|.+.  +..+++|.+... ....+.+.+|+++++.++||||+++++++......++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            677889999999999999986  678899987654 34456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      ++|..++.....++++..+..++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++........  ....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~--~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~  162 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDS  162 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCcccEEEccCCCEEEcccccccccccccc--cccc
Confidence            999998876556799999999999999999999999  999999999999999999999999999865432211  2234


Q ss_pred             CCCCCccCCccccC-----CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          214 PAGTIGYLDPCYVT-----PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                      ..+++.|+|||.+.     ...++.++|||||||++|+|++|+.||...........    ... +     ..+.  ...
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----~~~-~-----~~~~--~~~  230 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK----IAK-S-----EPPT--LAQ  230 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH----Hhh-c-----CCCC--CCC
Confidence            56899999999984     34567899999999999999999999863221111111    100 0     0111  112


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..++.++.+++.+||+.+|.+||++.++++
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            3346678999999999999999999999985

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-38  Score=305.29  Aligned_cols=252  Identities=22%  Similarity=0.340  Sum_probs=205.6

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.+++|.+.... ...+.+.+|++++++++||||+++++++.+....+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367999999999999999999885  6789999877543 2456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +++++|.+++......+++..++.++.|++.||.|||+.  +++|+||+|+||+++.++.+||+|||++........  .
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~--~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~  157 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET--GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--K  157 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCChhhEEECCCCCEEECccccchhhhhhhh--c
Confidence            999999999987655699999999999999999999999  999999999999999999999999999865443221  2


Q ss_pred             cCCCCCCCccCCccccCCC---CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          211 STPPAGTIGYLDPCYVTPD---NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~---~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                      .....++..|+|||.+...   .++.++|||||||++|+|++|+.||...........     .....    +.+ ....
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-----~~~~~----~~~-~~~~  227 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-----ISKSN----FPP-PKLK  227 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhcc----CCC-cccc
Confidence            2335688899999999776   789999999999999999999999863221111111     01100    010 1111


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .....+.++.+++.+||..+|.+|||+.+|+.
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            23456788999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.9e-38  Score=308.33  Aligned_cols=246  Identities=25%  Similarity=0.411  Sum_probs=201.4

Q ss_pred             cCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCC
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNG  134 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~g  134 (487)
                      ++|.+.+.||+|+||.||++...++.||+|+..... ....+.+|+.+++.++|||++++++++... ..++||||++++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~   83 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG   83 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence            468899999999999999999889999999886543 346788999999999999999999998765 479999999999


Q ss_pred             CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          135 TLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       135 sL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      +|.+++.... ..+++..++.++.|++.||.|||+.  +++||||||+||+++.++.+||+|||++......     ...
T Consensus        84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~  156 (254)
T cd05083          84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK--KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDN  156 (254)
T ss_pred             CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccccCcceEEEcCCCcEEECCCccceecccc-----CCC
Confidence            9999997643 3589999999999999999999999  9999999999999999999999999998654321     122


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV  292 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  292 (487)
                      ...+..|+|||.+.+..++.++|+|||||++|+|++ |+.||... .......    ....         ......+..+
T Consensus       157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~----~~~~---------~~~~~~~~~~  222 (254)
T cd05083         157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM-SLKEVKE----CVEK---------GYRMEPPEGC  222 (254)
T ss_pred             CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC-CHHHHHH----HHhC---------CCCCCCCCcC
Confidence            344678999999988889999999999999999998 88887532 1111111    1111         1111223346


Q ss_pred             HHHHHHHHHHhhhhcCCCCCCHHHHHHHHhc
Q 011384          293 RKQLAVIAVRCVRSCRERRPSMKEIVDWLTG  323 (487)
Q Consensus       293 ~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~  323 (487)
                      +..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            6789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.4e-38  Score=306.61  Aligned_cols=246  Identities=23%  Similarity=0.353  Sum_probs=199.9

Q ss_pred             eeecccCceEEEEEEEC---C--eEEEEEEcCCChh--hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR---G--RQVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~---g--~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|++|.||+|.+.   +  ..||||.+.....  ..+.+.+|+.++++++||||+++++++.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            46899999999999874   2  3699998876544  45689999999999999999999999988 889999999999


Q ss_pred             CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc-cc
Q 011384          134 GTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF-RS  211 (487)
Q Consensus       134 gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~-~~  211 (487)
                      ++|.+.+.... ..+++..++.++.|++.||.|||+.  +++|+||||+||+++.++.+||+|||++..+....... ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK--RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC--CccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            99999998755 5689999999999999999999999  99999999999999999999999999997665432211 12


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      ....++..|+|||.+....++.++|||||||++|+|++ |..||... .......   ......         .....+.
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~---~~~~~~---------~~~~~~~  224 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILK---KIDKEG---------ERLERPE  224 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHH---HHHhcC---------CcCCCCc
Confidence            23457789999999998889999999999999999998 99988532 1111111   111110         1111223


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      .++..+.+++.+||+.+|.+||++.+|++.|.
T Consensus       225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            45678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.2e-38  Score=323.98  Aligned_cols=259  Identities=22%  Similarity=0.296  Sum_probs=197.9

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC-----
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS-----  121 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----  121 (487)
                      ...++|.+.+.||+|+||.||++.+.  ++.||||++...   ......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999875  789999988753   23346778899999999999999999988643     


Q ss_pred             -CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          122 -KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       122 -~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                       ...++||||+++ +|.+.+..   .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~--givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChHHEEECCCCCEEEeeCcccc
Confidence             346999999965 77777653   388999999999999999999999  99999999999999999999999999997


Q ss_pred             ecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhh------------
Q 011384          201 RCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA------------  268 (487)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~------------  268 (487)
                      ......   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..............            
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             cCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            543321   23345789999999999998999999999999999999999999964321111000000            


Q ss_pred             ------hhhhc-CccccccCC-----C-C--CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          269 ------PLIKK-GKILSVFDP-----R-I--PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       269 ------~~~~~-~~i~~~~~~-----~-~--~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                            ..... ........+     . .  ........+.++.+|+.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence                  00000 000000000     0 0  01112234567899999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4e-38  Score=308.68  Aligned_cols=248  Identities=22%  Similarity=0.338  Sum_probs=189.1

Q ss_pred             eecccCceEEEEEEEC----CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCC
Q 011384           62 LLGKGSHGSVYKAVLR----GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGT  135 (487)
Q Consensus        62 ~LG~G~~g~Vy~~~~~----g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gs  135 (487)
                      .||+|+||.||+|...    ...+++|.+....  .....+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            5899999999999753    3568888766432  334568899999999999999999999999999999999999999


Q ss_pred             HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          136 LYDVLHSNN----RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       136 L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      |.+++....    ...++..+..++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc--CEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence            999997643    2246778889999999999999999  9999999999999999999999999998654332221122


Q ss_pred             CCCCCCCccCCccccCC-------CCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          212 TPPAGTIGYLDPCYVTP-------DNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~-------~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ....+++.|+|||++..       ..++.++|||||||++|||++ |..||... ......   ......+. .....+ 
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~---~~~~~~~~-~~~~~~-  233 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL-SDEQVL---KQVVREQD-IKLPKP-  233 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHH---HHHhhccC-ccCCCC-
Confidence            33456778999998643       356889999999999999999 66776532 111111   11111111 111111 


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                         ..+..++..+.+++..|| .+|++|||+++|++.|
T Consensus       234 ---~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         234 ---QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             ---cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence               223356677888999999 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.5e-38  Score=317.99  Aligned_cols=256  Identities=26%  Similarity=0.444  Sum_probs=204.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC--Ce----EEEEEEcCCChh--hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GR----QVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~----~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      ..+|...+.||+|+||.||+|.+.  +.    .||+|.+.....  ....+.+|+.+++.++||||++++++|... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356888999999999999999874  33    578898775432  234688999999999999999999998764 467


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +++||+++|+|.+++......+++..++.++.|++.||.|||++  +|+|+||||+|||++.++.+||+|||++..+...
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc--CeeccccccceeeecCCCceEEccccccccccCc
Confidence            99999999999999987666689999999999999999999999  9999999999999999999999999999765433


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ..........++..|++||.+.+..++.++|||||||++|||++ |..||... .......    ....+.         
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~----~~~~~~---------  228 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPD----LLEKGE---------  228 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHH----HHHCCC---------
Confidence            32222233456779999999998899999999999999999997 88887522 1122211    111111         


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ..+.+..++..+.+++.+||..+|++||++.++++.|..+..
T Consensus       229 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         229 RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            111223355678999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5e-38  Score=307.09  Aligned_cols=249  Identities=22%  Similarity=0.343  Sum_probs=201.4

Q ss_pred             CcccceeecccCceEEEEEEEC-CeEEEEEEcCCCh-------hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQ-------EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~-------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      +|...+.||+|+||.||+|... ++.+|||.+....       .....+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4788899999999999999875 7889999876331       1235688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC-
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN-  206 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~-  206 (487)
                      +||+++++|.+++.... ++++..+..++.|++.||+|||+.  +++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNN--CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence            99999999999997654 489999999999999999999999  99999999999999999999999999986543211 


Q ss_pred             ---cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          207 ---FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       207 ---~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                         .........++..|+|||.+.+..++.++|||||||++|+|++|..||...........    ....    .    .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~----~~~~----~----~  225 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY----IGAH----R----G  225 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH----hhhc----c----C
Confidence               11112234689999999999988899999999999999999999999963221111100    0000    0    1


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..++.+..++.++.+++.+||+.+|.+||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111233456778999999999999999999999985

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.7e-38  Score=324.60  Aligned_cols=258  Identities=22%  Similarity=0.297  Sum_probs=197.1

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC------
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS------  121 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------  121 (487)
                      ..++|.+.+.||+|+||.||++.+.  ++.||||++...   ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999876  788999988753   23346788899999999999999999987543      


Q ss_pred             CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      ...|+||||+++ +|.+.+..   .+++..+..++.|++.||+|||++  +|+||||||+|||++.++.+||+|||+++.
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhC--CeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence            357999999964 78777753   388899999999999999999999  999999999999999999999999999975


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhh-------------
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA-------------  268 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~-------------  268 (487)
                      .....   ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||..............             
T Consensus       176 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (364)
T cd07875         176 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  252 (364)
T ss_pred             cCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            43321   23345789999999999999999999999999999999999999964321111100000             


Q ss_pred             -----hhhhcC-ccc----cccCCCC----CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          269 -----PLIKKG-KIL----SVFDPRI----PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       269 -----~~~~~~-~i~----~~~~~~~----~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                           ...... ...    ..+.+..    ........+.++.+|+.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                 000000 000    0000000    01111223467899999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2e-38  Score=313.10  Aligned_cols=259  Identities=23%  Similarity=0.296  Sum_probs=200.4

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +|...+.||+|+||.||+|++.  |+.||+|.+....   .....+.+|++++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999986  8899999876432   2235678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      ++ ++|.+++......+++..++.++.||+.||.|||+.  +++|+||||+||+++.++.+||+|||++........  .
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~  155 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH--NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--C  155 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--C
Confidence            96 588888876556699999999999999999999999  999999999999999999999999999875543221  1


Q ss_pred             cCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCc------cccccC--
Q 011384          211 STPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK------ILSVFD--  281 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~------i~~~~~--  281 (487)
                      .....+++.|+|||.+.+. .++.++|||||||++|+|++|..|+..+..................      +....+  
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            2334678999999998765 4689999999999999999999887644432221111100000000      000000  


Q ss_pred             --CCCC-----CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          282 --PRIP-----PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       282 --~~~~-----~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        +...     ....+.++.++.+++.+||+.||.+|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence              0000     0112345678999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.4e-38  Score=311.53  Aligned_cols=259  Identities=21%  Similarity=0.366  Sum_probs=206.6

Q ss_pred             cchhhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCC
Q 011384           45 FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSNDS  121 (487)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~  121 (487)
                      +...++...+++|.+.+.||+|+||.||++...  ++.+|+|.+.........+.+|+.++.++ +|||++++++++...
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            444566667889999999999999999999885  78899999876655557788999999999 899999999998653


Q ss_pred             -----CceEEEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEE
Q 011384          122 -----KDRLLVVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL  193 (487)
Q Consensus       122 -----~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL  193 (487)
                           ...++||||+++++|.+++..   .+..+++..++.++.|++.||.|||+.  +++|+||||+||+++.++.+||
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN--RIIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEEcCCCCEEE
Confidence                 357999999999999998863   345689999999999999999999999  9999999999999999999999


Q ss_pred             cccccceecCCCCcccccCCCCCCCccCCccccCCC-----CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhh
Q 011384          194 GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD-----NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA  268 (487)
Q Consensus       194 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~  268 (487)
                      +|||++........  ......|+..|+|||.+...     .++.++|||||||++|||++|+.||........+..+  
T Consensus       170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~--  245 (291)
T cd06639         170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI--  245 (291)
T ss_pred             eecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH--
Confidence            99999875543221  22335688999999997654     2588999999999999999999998643221121111  


Q ss_pred             hhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          269 PLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       269 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                         ..+.     .+.+  ..+......+.+++.+||+.+|++||++.+|++
T Consensus       246 ---~~~~-----~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         246 ---PRNP-----PPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             ---hcCC-----CCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence               0000     0111  112335567999999999999999999999996

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6e-38  Score=304.71  Aligned_cols=236  Identities=24%  Similarity=0.380  Sum_probs=190.7

Q ss_pred             eeecccCceEEEEEEECCe------------EEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           61 KLLGKGSHGSVYKAVLRGR------------QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~g~------------~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      +.||+|+||.||+|.+...            .|++|.+.........+.+|+.+++.++||||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            4699999999999998632            47888877655446788999999999999999999999988 7789999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC-------cEEEccccccee
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF-------NARLGDFGLALR  201 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~-------~vkL~DFGla~~  201 (487)
                      ||+++++|.+++......+++..+..++.|++.||+|||+.  +|+|+||||+|||++.++       .+||+|||++..
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~  157 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK--KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT  157 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC--CeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence            99999999999987665699999999999999999999999  999999999999999887       799999999865


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCC--CCCcchhhhhHHHHHHHHHhC-CcCCCCCCCCchhhhhhhhhhhcCcccc
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPD--NLSTKTDVFSFGILLLEIISC-RKAIDIGFSPPSIVDWAAPLIKKGKILS  278 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVwSlGvvl~eLltG-~~pf~~~~~~~~~~~~~~~~~~~~~i~~  278 (487)
                      ...      .....++..|+|||++...  .++.++|||||||++|+|++| ..||.... ......+.    ..     
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~----~~-----  221 (259)
T cd05037         158 VLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFY----QD-----  221 (259)
T ss_pred             ccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHH----hc-----
Confidence            433      1223567789999999876  789999999999999999995 55554321 21111110    00     


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       279 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                        ....+.+    ....+.+++.+||..+|.+|||+.+|++.|
T Consensus       222 --~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         222 --QHRLPMP----DCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             --CCCCCCC----CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence              0011111    126889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.6e-38  Score=311.18  Aligned_cols=258  Identities=23%  Similarity=0.339  Sum_probs=206.0

Q ss_pred             cchhhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEeC-
Q 011384           45 FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSND-  120 (487)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~-  120 (487)
                      .++.++....+.|++.+.||+|+||.||+|.+.  ++.||+|+..........+..|+.+++++ +||||+++++++.. 
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            355566667788999999999999999999985  78899999877666667789999999998 79999999999853 


Q ss_pred             -----CCceEEEEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEc
Q 011384          121 -----SKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLG  194 (487)
Q Consensus       121 -----~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~  194 (487)
                           ....+++|||+++++|.+++... ...+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--~ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH--KVIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEe
Confidence                 45679999999999999999763 34588888999999999999999999  99999999999999999999999


Q ss_pred             ccccceecCCCCcccccCCCCCCCccCCccccC-----CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhh
Q 011384          195 DFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT-----PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP  269 (487)
Q Consensus       195 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~  269 (487)
                      |||++........  ......|++.|+|||.+.     ...++.++|||||||++|||++|..||........+..    
T Consensus       164 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----  237 (282)
T cd06636         164 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL----  237 (282)
T ss_pred             eCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh----
Confidence            9999865432211  223456899999999976     34578899999999999999999999863221111110    


Q ss_pred             hhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       270 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                               .............++.++.+++.+||+.||.+||++.||++
T Consensus       238 ---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 ---------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ---------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                     00001111112346678999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.5e-38  Score=320.88  Aligned_cols=235  Identities=25%  Similarity=0.285  Sum_probs=188.6

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHH-HHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIE-ILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      ++||+|+||.||+|++.  ++.||+|++.+..    .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999986  7889999876532    22234555554 57889999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      ++|...+.... .+++..+..++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++.......  .....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTST  155 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccccc
Confidence            99999887654 488999999999999999999999  99999999999999999999999999986432211  12334


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|..||....    ......... .        .  +...+...+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~-~--------~--~~~~~~~~~  220 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD----VSQMYDNIL-H--------K--PLQLPGGKT  220 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC----HHHHHHHHh-c--------C--CCCCCCCCC
Confidence            578999999999998899999999999999999999999996421    111111111 1        1  112333456


Q ss_pred             HHHHHHHHHhhhhcCCCCCCHH
Q 011384          294 KQLAVIAVRCVRSCRERRPSMK  315 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RPs~~  315 (487)
                      .++.+++.+||+.+|.+||++.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         221 VAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHHHHHHHccCCHhhcCCCC
Confidence            7889999999999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.4e-38  Score=305.64  Aligned_cols=248  Identities=31%  Similarity=0.532  Sum_probs=202.8

Q ss_pred             cccceeecccCceEEEEEEECC------eEEEEEEcCCChh--hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           57 FSEQKLLGKGSHGSVYKAVLRG------RQVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~g------~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      |.+.+.||.|+||.||++.+..      ..||+|++.....  ..+.+..|++++..++|+||+++++++.+....+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567899999999999999874      7899999876543  4578999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          129 EFMSNGTLYDVLHSNNRP-LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      ||+++++|.+++...... +++..+..++.|++.||+|||+.  +++|+||||+||+++.++.++|+|||++........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~--~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC--CeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            999999999999765444 89999999999999999999999  999999999999999999999999999976654322


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                      . ......+++.|+|||.+....++.++|||||||++|+|++ |..||.. ........    ....+.         ..
T Consensus       159 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~----~~~~~~---------~~  223 (258)
T smart00219      159 Y-KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLE----YLKKGY---------RL  223 (258)
T ss_pred             c-ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHH----HHhcCC---------CC
Confidence            1 1112347789999999988889999999999999999998 6777653 22222211    111111         11


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                      ..+..++.++.+++.+||..+|++|||+.++++.|
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            22333677899999999999999999999999764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.9e-39  Score=323.93  Aligned_cols=239  Identities=25%  Similarity=0.291  Sum_probs=190.7

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHH-HHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIE-ILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|+||.||+|...  ++.||+|++....    .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999886  7899999886532    22344555655 46779999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      ++|...+.... .+++..+..++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++.......  .....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~--givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~  155 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTT  155 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCccc
Confidence            99999887654 599999999999999999999999  99999999999999999999999999986432211  12334


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|..||.... .....   ..... +.          ...++..+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-~~~~~---~~~~~-~~----------~~~~~~~~  220 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-VAEMY---DNILH-KP----------LVLRPGAS  220 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-HHHHH---HHHHc-CC----------ccCCCCCC
Confidence            579999999999999999999999999999999999999996422 11111   11111 10          01122356


Q ss_pred             HHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          294 KQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+.+++.+||+.+|.+||++.+.++
T Consensus       221 ~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         221 LTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             HHHHHHHHHHhccCHHhcCCCCCCHH
Confidence            77889999999999999998764433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.8e-38  Score=317.34  Aligned_cols=264  Identities=16%  Similarity=0.246  Sum_probs=197.4

Q ss_pred             cceeeccc--CceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           59 EQKLLGKG--SHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        59 ~~~~LG~G--~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      +.++||+|  +|+.||++..+  ++.||+|++...   ......+.+|+++++.++||||++++++|..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  78999999886  789999998754   233457888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc-
Q 011384          132 SNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF-  209 (487)
Q Consensus       132 ~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~-  209 (487)
                      ++++|.+++... ...+++..++.++.|++.||.|||++  +|+||||||+|||++.++.++++||+............ 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            999999999753 34589999999999999999999999  99999999999999999999999998654332111100 


Q ss_pred             ----ccCCCCCCCccCCccccCC--CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhh----h-------
Q 011384          210 ----RSTPPAGTIGYLDPCYVTP--DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI----K-------  272 (487)
Q Consensus       210 ----~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~----~-------  272 (487)
                          ......++..|+|||++.+  ..++.++|||||||++|||++|+.||.................    .       
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE  239 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence                1122356778999999876  4588999999999999999999999963221111111000000    0       


Q ss_pred             ----------------cCccc----cccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          273 ----------------KGKIL----SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       273 ----------------~~~i~----~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                                      .+...    .........+....++..+.+|+.+||+.||++|||++++++  ++..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                            00000    000000011123345678999999999999999999999997  45443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-38  Score=308.80  Aligned_cols=245  Identities=27%  Similarity=0.403  Sum_probs=203.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ++|...+.||.|++|.||+|.+.  ++.||+|.+....  .....+.+|+++++.++||||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888999999999999999986  7899999876543  3345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +++++|.+++...  ++++..++.++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++........  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~--~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~  154 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE--GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--K  154 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEEcccccceeeccccc--c
Confidence            9999999999765  589999999999999999999999  999999999999999999999999999977654321  2


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||.... +.....    .+..     .    .....+.
T Consensus       155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-~~~~~~----~~~~-----~----~~~~~~~  220 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-PMRVLF----LIPK-----N----NPPSLEG  220 (274)
T ss_pred             cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-hHHHHH----Hhhh-----c----CCCCCcc
Confidence            334568889999999998889999999999999999999999986322 111110    0011     1    1111111


Q ss_pred             H-HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          291 I-VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       291 ~-~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      . ++.++.+++.+||..+|++|||++++++
T Consensus       221 ~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         221 NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            2 5678999999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.3e-37  Score=302.33  Aligned_cols=246  Identities=25%  Similarity=0.383  Sum_probs=201.5

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC-CCceEEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSND-SKDRLLVVE  129 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~lV~E  129 (487)
                      +|.+.+.||+|++|.||++...  ++.||+|.+...   ....+.+.+|++++++++|+|++++++.+.. ...+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4889999999999999999876  678999987643   2334568899999999999999999998764 446799999


Q ss_pred             ecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          130 FMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       130 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      |+++++|.+++... ...+++..++.++.+++.||.+||+.  +++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~--~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK--HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence            99999999999763 34589999999999999999999999  999999999999999999999999999876543221 


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                       ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....    ........ ..+.         ..+.
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~----~~~~~~~~-~~~~---------~~~~  222 (257)
T cd08223         158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD----MNSLVYRI-IEGK---------LPPM  222 (257)
T ss_pred             -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----HHHHHHHH-HhcC---------CCCC
Confidence             2334568999999999999889999999999999999999999986321    11111111 1111         1123


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..++..+.+++.+||+.+|++||++.++++
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         223 PKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            3456788999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.1e-38  Score=310.60  Aligned_cols=249  Identities=26%  Similarity=0.327  Sum_probs=201.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      +.|++.+.||+|+||.||+|.+.  +..|++|.+.... .....+.+|+.+++.++||||+++++++..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56899999999999999999886  7889999876543 34567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      ++++|..++......+++..+..++.|++.+|.|||+.  +++|+||||+||+++.++.+||+|||++.......  ...
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~  167 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM--KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRR  167 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC--CeeecCCCcceEEEcCCCCEEEccCccceeccccc--ccc
Confidence            99999998876556699999999999999999999999  99999999999999999999999999986533221  122


Q ss_pred             CCCCCCCccCCccccCC-----CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          212 TPPAGTIGYLDPCYVTP-----DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                      ....+++.|+|||++.+     ..++.++|||||||++|+|++|+.||.... +....   .... .     ...+.  .
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~---~~~~-~-----~~~~~--~  235 (292)
T cd06644         168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVL---LKIA-K-----SEPPT--L  235 (292)
T ss_pred             ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-HHHHH---HHHh-c-----CCCcc--C
Confidence            34468899999999853     456789999999999999999999986322 11111   1010 0     00111  1


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+..++.++.+++.+||+.+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            123356678999999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.8e-38  Score=308.31  Aligned_cols=250  Identities=21%  Similarity=0.310  Sum_probs=200.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ++|.+.+.||+|+||.||+|.+.  ++.||+|.+.... .....+.+|+.+++.++||||+++++++......++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            57888999999999999999885  7889999876543 23356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      ++++|.+++...+ .+++..++.++.|++.||.|||+.  +++|+||||+||+++.++.++|+|||++........  ..
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~  163 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSK--GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KR  163 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--cc
Confidence            9999999997655 599999999999999999999999  999999999999999999999999999876543211  22


Q ss_pred             CCCCCCCccCCccccC---CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          212 TPPAGTIGYLDPCYVT---PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                      ....|++.|+|||.+.   ...++.++|||||||++|+|++|..||............     ....   ...+...  .
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~-----~~~~---~~~~~~~--~  233 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-----TKSN---FQPPKLK--D  233 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh-----hccC---CCCCccc--c
Confidence            3457899999999874   456788999999999999999999998643221111110     0000   0011111  1


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...++..+.+++.+||+.+|++||++++|++
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            1134567899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-39  Score=311.80  Aligned_cols=263  Identities=21%  Similarity=0.237  Sum_probs=205.4

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcC---CChhhHHHHHHHHHHHHhCCCCCceeeEEEEeC-----CC
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPS---KNQEISQEVDNEIEILSKIHSPRLVNLLGFSND-----SK  122 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~---~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----~~  122 (487)
                      ....|...+.||+|+||.|..++++  |..||||++.   ......++..+|+.+|+.++|+||+.+++.+..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3456777899999999999999887  8899999876   344456788999999999999999999998865     35


Q ss_pred             ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                      .+|+|+|+| +-+|...++.+. .|+...+..++.|++.||.|+|+.  +|+||||||+|+|++.+..+||+|||+|+..
T Consensus       100 DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSA--nViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSA--NVIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcc--cccccccchhheeeccCCCEEeccccceeec
Confidence            679999999 568999887764 499999999999999999999999  9999999999999999999999999999987


Q ss_pred             CCCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhh----------hhhh
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA----------APLI  271 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~----------~~~~  271 (487)
                      .........+....|.+|.|||.+.. ..|+.+.||||+||++.||++|++.|.....-.++....          ...+
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i  255 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI  255 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence            65433334566788999999999765 589999999999999999999998886432221111100          0011


Q ss_pred             hcCcccc---ccCCCCCCC---CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          272 KKGKILS---VFDPRIPPP---KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       272 ~~~~i~~---~~~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...+...   .+...-+.+   .-+..++++.+|+.+||..||.+|+|++|.++
T Consensus       256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            1101111   011111111   11346778999999999999999999999997

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.2e-38  Score=313.52  Aligned_cols=259  Identities=20%  Similarity=0.289  Sum_probs=201.0

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ++|.+.+.||+|+||.||+|.+.  ++.||+|.+....  .....+.+|+.+++.++||||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57999999999999999999886  7889999876432  2335678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      ++ ++|.+++......+++..+..++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++........  .
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~  160 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR--KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--T  160 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--c
Confidence            96 599999887666799999999999999999999999  999999999999999999999999999865433221  1


Q ss_pred             cCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhh------------hhcCccc
Q 011384          211 STPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL------------IKKGKIL  277 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~------------~~~~~i~  277 (487)
                      .....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||........ .......            .......
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhchhhhcccccc
Confidence            2234678999999988654 578899999999999999999999864322111 1110000            0000000


Q ss_pred             cccCCCCCC----CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          278 SVFDPRIPP----PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       278 ~~~~~~~~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..-.+....    .....++.++.+|+.+||+.||.+|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000011100    111245678899999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.2e-38  Score=311.44  Aligned_cols=252  Identities=22%  Similarity=0.334  Sum_probs=204.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .++|++.+.||+|+||.||++.+.  ++.||+|+....  ....+.+.+|+++++.++||||+++++++.....+++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            357888999999999999999986  888999976643  3345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      |+++++|.+++...+ .+++..+..++.+++.+|.|||+ .  +++|+||+|+||+++.++.++|+|||++......   
T Consensus        84 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---  157 (284)
T cd06620          84 FMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---  157 (284)
T ss_pred             cCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence            999999999987654 58999999999999999999997 5  8999999999999999999999999997544221   


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc-------hhhhhhhhhhhcCccccccC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP-------SIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~-------~~~~~~~~~~~~~~i~~~~~  281 (487)
                       ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.......       .+..+.....         .
T Consensus       158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~  227 (284)
T cd06620         158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV---------Q  227 (284)
T ss_pred             -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh---------h
Confidence             1223578999999999988889999999999999999999999997433221       1111111111         1


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                      ...+......++.++.+|+.+||+.||++|||+.|+++..
T Consensus       228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            1111111123667899999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.3e-38  Score=309.12  Aligned_cols=261  Identities=24%  Similarity=0.308  Sum_probs=203.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh---hHHHHHHHHHHHHhCCCCC-ceeeEEEEeCCC-----
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPR-LVNLLGFSNDSK-----  122 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~---~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~-----  122 (487)
                      ...|...++||+|.||+||+|+..  |+.||+|++..+..   ......+|+.+++.++|+| |+.+++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            345777788999999999999886  88999998775533   4466789999999999999 999999998777     


Q ss_pred             -ceEEEEEecCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccc
Q 011384          123 -DRLLVVEFMSNGTLYDVLHSNN---RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL  198 (487)
Q Consensus       123 -~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGl  198 (487)
                       .+++|+||+ .-+|.+++....   ..++...+..+..||+.||+|||++  +|+||||||+||||+++|.+||+|||+
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~--~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH--GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC--CeecccCCcceEEECCCCcEeeeccch
Confidence             789999999 559999998755   3588889999999999999999999  999999999999999999999999999


Q ss_pred             ceecCCCCcccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc---C
Q 011384          199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK---G  274 (487)
Q Consensus       199 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~---~  274 (487)
                      |+.......  ..++..+|..|.|||++.+. .|+...||||+||++.||+++++.|..+....++..... .+..   .
T Consensus       167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~-~lGtP~e~  243 (323)
T KOG0594|consen  167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR-LLGTPNEK  243 (323)
T ss_pred             HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH-HcCCCCcc
Confidence            986653332  24567899999999999887 789999999999999999998888764433222211111 1100   0


Q ss_pred             cccc-----ccCCCCCC-----CCChHH---HHHHHHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          275 KILS-----VFDPRIPP-----PKDPIV---RKQLAVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       275 ~i~~-----~~~~~~~~-----~~~~~~---~~~l~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                      .+..     -.+..++.     ......   .....+++.+||+.+|.+|.|++.++.+
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            0000     00111111     111111   2478899999999999999999999974

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=8.6e-38  Score=311.84  Aligned_cols=247  Identities=24%  Similarity=0.389  Sum_probs=203.7

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      .+|.+.+.||+|+||.||+++..  ++.||+|.+.... ...+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            67999999999999999999874  8899999876543 33466889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      ++++|.+++.+.  .+++..+..++.|++.||.|||+.  +++|+||||+|||++.++.++|+|||++........  ..
T Consensus        99 ~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~--~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~  172 (297)
T cd06656          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR  172 (297)
T ss_pred             CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--Cc
Confidence            999999998754  389999999999999999999999  999999999999999999999999999876543321  12


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ....+++.|+|||.+.+..++.++|||||||++|++++|..||...........    ...        ........+..
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~----~~~--------~~~~~~~~~~~  240 (297)
T cd06656         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IAT--------NGTPELQNPER  240 (297)
T ss_pred             CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee----ecc--------CCCCCCCCccc
Confidence            335688999999999988899999999999999999999999964221111100    000        00111112344


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ++..+.+++.+||+.+|++||++++|++
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         241 LSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            6677899999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.1e-39  Score=312.97  Aligned_cols=263  Identities=25%  Similarity=0.318  Sum_probs=202.1

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC-----ceEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK-----DRLLV  127 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~~~lV  127 (487)
                      -.|...+++|.|+||.||+|+..  +..||||+.-.+...   --+|+++|+.+.|||||++.-+|....     ...+|
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            35777899999999999999987  689999987766432   245999999999999999998875322     34689


Q ss_pred             EEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC-CcEEEcccccceecC
Q 011384          128 VEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN-FNARLGDFGLALRCG  203 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~-~~vkL~DFGla~~~~  203 (487)
                      |||||. +|++.++.   .+..++...+.-+..||++||.|||+.  +|+||||||+|+|+|.+ |.+||||||.|+.+.
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~--~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH--GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc--CcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            999976 99999974   345588888889999999999999998  99999999999999976 899999999998876


Q ss_pred             CCCcccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhh-------hc--
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI-------KK--  273 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~-------~~--  273 (487)
                      ....+   .....|..|.|||.+.+. .|+.+.||||.|||+.||+-|++.|.......++.....-+-       ..  
T Consensus       178 ~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  178 KGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             cCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence            54422   334678999999998874 789999999999999999999988875433333333221110       00  


Q ss_pred             CccccccCCCCCCC-----CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcccc
Q 011384          274 GKILSVFDPRIPPP-----KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLSK  326 (487)
Q Consensus       274 ~~i~~~~~~~~~~~-----~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l~~  326 (487)
                      .+..+...+.+...     .....+.++.+|+.++|..+|.+|.++.|++.  ++..+..
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence            00011111222111     23446788999999999999999999999996  5655543

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-38  Score=306.64  Aligned_cols=252  Identities=24%  Similarity=0.374  Sum_probs=203.7

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCC------
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSK------  122 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~------  122 (487)
                      ..+++|.+.+.||+|++|.||+|.+.  ++.|++|++.........+.+|+.+++++ .|+||+++++++.+..      
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            34688999999999999999999985  67899999887766667899999999999 7999999999997644      


Q ss_pred             ceEEEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          123 DRLLVVEFMSNGTLYDVLHSN---NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                      ..++||||+++++|.+++...   +..+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~--~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN--KVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCHHHEEEccCCeEEECCCccc
Confidence            489999999999999998652   35699999999999999999999999  9999999999999999999999999998


Q ss_pred             eecCCCCcccccCCCCCCCccCCccccCCC-----CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC
Q 011384          200 LRCGVDNFRFRSTPPAGTIGYLDPCYVTPD-----NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG  274 (487)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  274 (487)
                      ........  ......+++.|+|||.+...     .++.++|||||||++|+|++|..||...........    . .. 
T Consensus       161 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~-~~-  232 (275)
T cd06608         161 AQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK----I-PR-  232 (275)
T ss_pred             eecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH----h-hc-
Confidence            75543221  22345689999999987543     467899999999999999999999963221111111    0 00 


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       275 ~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                          ...+.  ...+..++.++.+|+.+||..||++|||+.+|++
T Consensus       233 ----~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         233 ----NPPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ----cCCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                00111  1122346778999999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-38  Score=310.45  Aligned_cols=249  Identities=24%  Similarity=0.341  Sum_probs=203.2

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ++|.+.+.||.|+||.||++.+.  +..||+|...... ...+.+.+|++++++++||||+++++++......++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            56899999999999999999885  7889999876543 34467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      ++++|.+++......+++..+..++.|++.||.|||+.  +|+|+||+|+||+++.++.++|+|||++........  ..
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~--~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~  160 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH--KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KR  160 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChhhEEECCCCCEEEccCccchhhccccc--cc
Confidence            99999999987666799999999999999999999999  999999999999999999999999998765433221  22


Q ss_pred             CCCCCCCccCCccccC-----CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          212 TPPAGTIGYLDPCYVT-----PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                      ....+++.|++||.+.     ...++.++|||||||++|+|++|+.||...........    . ..+.     .+.+  
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~----~-~~~~-----~~~~--  228 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK----I-LKSE-----PPTL--  228 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH----H-hcCC-----CCCc--
Confidence            3456899999999875     34567899999999999999999999863211111111    1 1110     0111  


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+..++.++.+++.+||+.+|.+||++.+|++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            123346678999999999999999999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.3e-37  Score=306.76  Aligned_cols=245  Identities=25%  Similarity=0.406  Sum_probs=204.5

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ..|+..+.||.|+||.||+|.+.  +..||+|.+...  ......+.+|+.+++.+.||||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35778899999999999999875  789999987644  33446789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +++++|.+++...  ++++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++..+.....  .
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~--~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSE--KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K  157 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--c
Confidence            9999999998753  489999999999999999999999  999999999999999999999999999876543321  2


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      .....++..|+|||.+.+..++.++|+|||||++|||++|..||.... +.....             ......+...+.
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~-------------~~~~~~~~~~~~  223 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLF-------------LIPKNNPPTLTG  223 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhh-------------hhhcCCCCCCch
Confidence            233468889999999988889999999999999999999999986322 111110             111111233455


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .++..+.+++.+||+.+|++||++.+++.
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06640         224 EFSKPFKEFIDACLNKDPSFRPTAKELLK  252 (277)
T ss_pred             hhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence            67889999999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.6e-38  Score=349.52  Aligned_cols=260  Identities=19%  Similarity=0.333  Sum_probs=203.2

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC--
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSND--  120 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--  120 (487)
                      .+.....++|.+++.||+|+||.||++.+.  +..||+|.+...   ......+..|+.++++++||||++++++|.+  
T Consensus         6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            334455678999999999999999999986  678999987643   3344678999999999999999999998854  


Q ss_pred             CCceEEEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCeeeccCCCCcEEEcc-----
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSN---NRPLNWGRRIRLALQVAKAVEILHSEM-----PPIIHRDIKSANVLIDR-----  187 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~-----~~ivH~DIkp~NILld~-----  187 (487)
                      ...+||||||+++++|.++|...   ...+++..++.|+.||+.||.|||...     .+|||+||||+||||+.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            45689999999999999999752   245999999999999999999999851     15999999999999964     


Q ss_pred             ------------CCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCC--CCCCcchhhhhHHHHHHHHHhCCcC
Q 011384          188 ------------NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP--DNLSTKTDVFSFGILLLEIISCRKA  253 (487)
Q Consensus       188 ------------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVwSlGvvl~eLltG~~p  253 (487)
                                  .+.+||+|||++..+....   ......||+.|+|||++.+  ..++.++||||||||||||++|..|
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                        2458999999997654332   2234579999999999864  4578999999999999999999999


Q ss_pred             CCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          254 IDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       254 f~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                      |........+..    .+..+       +.++   ....+.++.+||..||+.+|.+||++.+++.  ++..+
T Consensus       243 F~~~~~~~qli~----~lk~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        243 FHKANNFSQLIS----ELKRG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             CCcCCcHHHHHH----HHhcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            964322221111    11110       1111   1234678999999999999999999999995  55444

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.4e-38  Score=310.69  Aligned_cols=244  Identities=25%  Similarity=0.401  Sum_probs=201.7

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      .|+..+.||+|+||.||+|.+.  +..||+|.+...  ....+.+.+|+.++++++||||+++++++......++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4677789999999999999875  778999987643  234467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      ++++|.+++...  .+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++..+.....  ..
T Consensus        85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~--~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~  158 (277)
T cd06642          85 GGGSALDLLKPG--PLEETYIATILREILKGLDYLHSE--RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KR  158 (277)
T ss_pred             CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcC--CeeccCCChheEEEeCCCCEEEccccccccccCcch--hh
Confidence            999999998653  489999999999999999999999  999999999999999999999999999876543221  22


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ....++..|+|||.+.+..++.++|||||||++|||++|+.|+..... .....             .+........+..
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~-------------~~~~~~~~~~~~~  224 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP-MRVLF-------------LIPKNSPPTLEGQ  224 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch-hhHHh-------------hhhcCCCCCCCcc
Confidence            234688999999999988899999999999999999999999863221 11110             0111111223334


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ++..+.+++.+||+.+|.+||++.+|+.
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         225 YSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            6678999999999999999999999998

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.3e-38  Score=346.23  Aligned_cols=258  Identities=21%  Similarity=0.285  Sum_probs=204.1

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.++||+|+||.||+|.+.  ++.||||++...    ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999886  789999988643    233467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccc
Q 011384          129 EFMSNGTLYDVLHSN----------NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL  198 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~----------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGl  198 (487)
                      ||+++++|.+++...          ...+++..++.++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||+
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~--GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK--GVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC--CccccCCchheEEEcCCCCEEEEecCc
Confidence            999999999998641          12356677889999999999999999  999999999999999999999999999


Q ss_pred             ceecCCCCc----------------ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCch
Q 011384          199 ALRCGVDNF----------------RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS  262 (487)
Q Consensus       199 a~~~~~~~~----------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~  262 (487)
                      +........                ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-k  238 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-K  238 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-h
Confidence            976521110                00112346999999999999999999999999999999999999999642111 1


Q ss_pred             hhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCC-HHHHHHHHhcccc
Q 011384          263 IVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPS-MKEIVDWLTGLSK  326 (487)
Q Consensus       263 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-~~eil~~L~~l~~  326 (487)
                      ...       ...   ...+.. ......++..+.+++.+||+.||++||+ ++++++.|+....
T Consensus       239 i~~-------~~~---i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 ISY-------RDV---ILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhh-------hhh---ccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            110       000   001100 0011245678899999999999999975 7778777776543

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.6e-38  Score=306.61  Aligned_cols=252  Identities=23%  Similarity=0.378  Sum_probs=201.2

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-----------hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-----------EISQEVDNEIEILSKIHSPRLVNLLGFSNDSK  122 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-----------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  122 (487)
                      +|...+.||+|+||.||+|...  ++.||+|.+....           ...+.+.+|+.+++.++|||++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5778899999999999999875  7889999765321           11246788999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                      ..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++...
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSK--GILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC--CeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            9999999999999999998764 589999999999999999999999  9999999999999999999999999998654


Q ss_pred             CCCCcccccCCCCCCCccCCccccCCCC--CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccccc
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTPDN--LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF  280 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~  280 (487)
                      .............++..|+|||.+....  ++.++|+||||+++|++++|..||..........    .....     ..
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~-----~~  229 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF----KLGNK-----RS  229 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH----Hhhcc-----cc
Confidence            3222121223456889999999987654  7899999999999999999999985322111111    11100     11


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...++......++.++.+++.+||+.+|++||++++|++
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            112222223346788999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.7e-38  Score=305.72  Aligned_cols=237  Identities=22%  Similarity=0.332  Sum_probs=188.1

Q ss_pred             eeecccCceEEEEEEEC--------------CeEEEEEEcCCChh-hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           61 KLLGKGSHGSVYKAVLR--------------GRQVAVKKPSKNQE-ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--------------g~~vAvK~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      +.||+|+||.||+|++.              ...|++|.+..... ....+..|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            36899999999999853              23588898765433 3457888999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc-------EEEccccc
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN-------ARLGDFGL  198 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~-------vkL~DFGl  198 (487)
                      +||||+++++|..++......+++..++.++.|++.||+|||+.  +|+||||||+|||++.++.       ++++|||+
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK--DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC--CeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            99999999999999877666699999999999999999999999  9999999999999987654       89999999


Q ss_pred             ceecCCCCcccccCCCCCCCccCCccccC-CCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCcc
Q 011384          199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVT-PDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKI  276 (487)
Q Consensus       199 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i  276 (487)
                      +......      ....++..|+|||.+. +..++.++|||||||++|||++ |..|+... .......    . ..+. 
T Consensus       159 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~~----~-~~~~-  225 (262)
T cd05077         159 PITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKER----F-YEGQ-  225 (262)
T ss_pred             CccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-chhHHHH----H-HhcC-
Confidence            8654322      2245788999999887 4678999999999999999984 77666421 1111110    0 0100 


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          277 LSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                           ....    .....++.+|+.+||+.||.+||++.+|++.|
T Consensus       226 -----~~~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         226 -----CMLV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -----ccCC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                 0111    12346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.6e-37  Score=304.18  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=197.7

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC------hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC--CCce
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN------QEISQEVDNEIEILSKIHSPRLVNLLGFSND--SKDR  124 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~------~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~  124 (487)
                      .+|...+.||+|+||.||+|...  ++.|++|++...      ......+.+|+.++++++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47889999999999999999875  789999987533      1233568899999999999999999998875  3567


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++++||+++++|.+.+...+ .+++..++.++.|++.||.|||+.  +++|+||+|+||+++.++.+||+|||++..+..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~--~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            89999999999999997654 489999999999999999999999  999999999999999999999999999875432


Q ss_pred             CCc-ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          205 DNF-RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       205 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ... ........++..|+|||.+.+..++.++|||||||++|||++|+.||........+..    ..         ...
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~---------~~~  225 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IA---------TQP  225 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH----Hh---------cCC
Confidence            111 1111234588999999999988899999999999999999999999863221111110    00         001


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+..+..+++.+..++ .||..+|++||++++|++
T Consensus       226 ~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            11223445667788888 688899999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.4e-38  Score=308.83  Aligned_cols=238  Identities=23%  Similarity=0.326  Sum_probs=190.1

Q ss_pred             eeecccCceEEEEEEEC---------CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           61 KLLGKGSHGSVYKAVLR---------GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~---------g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +.||+|+||.||+|.+.         ...|++|.+.... ...+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            36999999999999874         2348888876543 3346788999999999999999999999998899999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc--------EEEcccccceec
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN--------ARLGDFGLALRC  202 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~--------vkL~DFGla~~~  202 (487)
                      +++|+|.+++...+..+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.        ++++|||++...
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK--GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            999999999987666789999999999999999999999  9999999999999987765        699999987543


Q ss_pred             CCCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      ..      .....+++.|+|||++.+ ..++.++|||||||++|+|++|..++.....+.....    ....       .
T Consensus       159 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~----~~~~-------~  221 (258)
T cd05078         159 LP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ----FYED-------R  221 (258)
T ss_pred             CC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH----HHHc-------c
Confidence            32      123467889999999986 4579999999999999999999644432222211111    0000       0


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                          ...+.....++.+|+.+||+.+|++|||+++|++.|
T Consensus       222 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         222 ----HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ----ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                112223446789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.1e-37  Score=306.44  Aligned_cols=252  Identities=24%  Similarity=0.439  Sum_probs=203.0

Q ss_pred             cCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCChh--hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      .+|...+.||+|+||.||+|+..       .+.|++|.+.....  ....+.+|++++++++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57889999999999999999864       35799998775433  3467999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccc
Q 011384          126 LVVEFMSNGTLYDVLHSNN--------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFG  197 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~--------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFG  197 (487)
                      +||||+++++|.+++....        ..+++..+..++.|++.||+|||+.  +|+|+||||+|||++.++.++|+|||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~--~i~H~dlkp~Nili~~~~~~~l~~~~  162 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA--RFVHRDLAARNCLVSSQREVKVSLLS  162 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc--CcccCcCccceEEEeCCCcEEEcccc
Confidence            9999999999999997643        1589999999999999999999999  99999999999999999999999999


Q ss_pred             cceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCcc
Q 011384          198 LALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKI  276 (487)
Q Consensus       198 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i  276 (487)
                      ++........ .......+++.|++||.+.+..++.++||||||+++|+|++ |..||.. ........    ....+.+
T Consensus       163 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~-~~~~~~~~----~~~~~~~  236 (275)
T cd05046         163 LSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG-LSDEEVLN----RLQAGKL  236 (275)
T ss_pred             cccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cchHHHHH----HHHcCCc
Confidence            9864432221 12223356778999999988888999999999999999999 6777742 22222111    1111111


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          277 LSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                              ..+.+..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus       237 --------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         237 --------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                    11122345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.3e-39  Score=300.67  Aligned_cols=251  Identities=24%  Similarity=0.398  Sum_probs=210.1

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---------hhhHHHHHHHHHHHHhC-CCCCceeeEEEEe
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---------QEISQEVDNEIEILSKI-HSPRLVNLLGFSN  119 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---------~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~  119 (487)
                      ..-+.|...+.||.|..+.|.++.++  ++.+|+|++...         ....+.-.+|+.+|+++ .||+|+.+.++|+
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34456888899999999999999876  888999976532         11234567799999998 6999999999999


Q ss_pred             CCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       120 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                      .+...++|+|.|+.|.|.|+|...- .++++....|.+|++.|+.|||.+  +||||||||+|||+|++.++||+|||++
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~--~IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHAR--NIVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHh--hhhhcccChhheeeccccceEEecccee
Confidence            9999999999999999999997654 499999999999999999999999  9999999999999999999999999999


Q ss_pred             eecCCCCcccccCCCCCCCccCCccccCCC------CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc
Q 011384          200 LRCGVDNFRFRSTPPAGTIGYLDPCYVTPD------NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK  273 (487)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~  273 (487)
                      +.+....   .-...+|||+|+|||.+.+.      .|+...|+|++||++|.|+.|.+||....   +  .....++..
T Consensus       171 ~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---Q--mlMLR~Ime  242 (411)
T KOG0599|consen  171 CQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---Q--MLMLRMIME  242 (411)
T ss_pred             eccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---H--HHHHHHHHh
Confidence            8876543   33457999999999998764      56788999999999999999999996321   1  122233344


Q ss_pred             CccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          274 GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       274 ~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      |+.      .+..+.-..++...++||.+||+.||.+|.|++|.+.
T Consensus       243 Gky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  243 GKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            443      3444555678889999999999999999999999997

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.5e-38  Score=308.67  Aligned_cols=236  Identities=25%  Similarity=0.383  Sum_probs=187.6

Q ss_pred             eecccCceEEEEEEEC--------------------------CeEEEEEEcCCChh-hHHHHHHHHHHHHhCCCCCceee
Q 011384           62 LLGKGSHGSVYKAVLR--------------------------GRQVAVKKPSKNQE-ISQEVDNEIEILSKIHSPRLVNL  114 (487)
Q Consensus        62 ~LG~G~~g~Vy~~~~~--------------------------g~~vAvK~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l  114 (487)
                      +||+|+||.||+|.+.                          ...|++|++..... ....+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            6999999999998752                          13588998875433 23568889999999999999999


Q ss_pred             EEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC-----
Q 011384          115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF-----  189 (487)
Q Consensus       115 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~-----  189 (487)
                      +++|.+....++||||+++++|..++......+++..+..++.|++.||+|||++  +|+||||||+|||++..+     
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK--NLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC--CccCCCCCcccEEEeccCcccCc
Confidence            9999999999999999999999999977555689999999999999999999999  999999999999997643     


Q ss_pred             --cEEEcccccceecCCCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHH-hCCcCCCCCCCCchhhh
Q 011384          190 --NARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEII-SCRKAIDIGFSPPSIVD  265 (487)
Q Consensus       190 --~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLl-tG~~pf~~~~~~~~~~~  265 (487)
                        .+|++|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||... .+.....
T Consensus       160 ~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~  232 (274)
T cd05076         160 SPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER-TPSEKER  232 (274)
T ss_pred             cceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc-ChHHHHH
Confidence              4899999987543221      22357788999998875 56799999999999999995 688887532 2222111


Q ss_pred             hhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          266 WAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       266 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                      +    ...       ...++.    ....++.+++.+||+.+|++|||+.+|++.|
T Consensus       233 ~----~~~-------~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         233 F----YEK-------KHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             H----HHh-------ccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            1    110       011111    1235688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.2e-37  Score=310.83  Aligned_cols=247  Identities=24%  Similarity=0.398  Sum_probs=203.3

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      .+|.+.+.||.|++|.||+|+..  ++.|++|.+.... ...+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46999999999999999999874  7899999876433 33467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      ++++|.+++...  .+++..+..++.+++.||.|||+.  +++|+||||+||+++.++.+||+|||++........  ..
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~--~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~  172 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHAN--QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KR  172 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cC
Confidence            999999998754  489999999999999999999999  999999999999999999999999999865543322  12


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...........    .....        ......+..
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~----~~~~~--------~~~~~~~~~  240 (296)
T cd06655         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNG--------TPELQNPEK  240 (296)
T ss_pred             CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcC--------CcccCCccc
Confidence            334688999999999988899999999999999999999999864322111110    00000        001112334


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ++..+.+++.+||..+|.+||++.+|+.
T Consensus       241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         241 LSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            5678999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=318.68  Aligned_cols=250  Identities=22%  Similarity=0.347  Sum_probs=215.8

Q ss_pred             cCcccceeecccCceEEEEEEE--CCeEEEEEEcCCChh---hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~--~g~~vAvK~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .-|.+.+-||+|.|++|-++++  .|..||||++.+..-   ....+..|++.|+.++|||||+||.+......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4588899999999999999976  499999999887643   34678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE-ccCCcEEEcccccceecCCCCcc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI-DRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl-d~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      .=.+|+|+|++.+....+.+..+.+++.||+.|+.|+|..  .+|||||||+|+.+ .+-|.|||.|||++-.+.+..  
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL--HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--  173 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL--HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--  173 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh--hhhcccCCcceeEEeeecCceEeeeccccccCCCcc--
Confidence            9999999999998777899999999999999999999999  99999999999765 567999999999986655443  


Q ss_pred             cccCCCCCCCccCCccccCCCCC-CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                       .-++.+|.+.|-|||++.+..| -++.|||||||+||-|++|+.||.-....+.+...+             |  ....
T Consensus       174 -kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm-------------D--CKYt  237 (864)
T KOG4717|consen  174 -KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM-------------D--CKYT  237 (864)
T ss_pred             -hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh-------------c--cccc
Confidence             3456799999999999999998 478999999999999999999998554444433211             1  1234


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                      .|..++.+.++||..||..||.+|.+.+||+.  ||+..
T Consensus       238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence            67789999999999999999999999999986  66554

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2e-37  Score=300.45  Aligned_cols=245  Identities=20%  Similarity=0.408  Sum_probs=201.9

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +|...+.||+|+||.||++...  ++.+|||.+...   ......+.+|+++++.++||||+++++.+......++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5888999999999999999875  788999987643   23346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC-CcEEEcccccceecCCCCcc
Q 011384          131 MSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN-FNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       131 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~-~~vkL~DFGla~~~~~~~~~  208 (487)
                      +++++|.+++... +..+++..+..++.+++.+|.|||++  +++|+||+|+||+++.+ +.+||+|||++.......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK--LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence            9999999999764 34589999999999999999999999  99999999999999854 568999999987654332  


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                       ......++..|+|||.+....++.++||||||+++|+|++|+.||.....+.....    ...          ....+.
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~----~~~----------~~~~~~  221 (256)
T cd08220         157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK----IMS----------GTFAPI  221 (256)
T ss_pred             -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH----HHh----------cCCCCC
Confidence             22235688999999999988889999999999999999999999864322211111    110          111122


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..++.++.+++.+||+.+|.+|||+.+++.
T Consensus       222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            3346778999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-38  Score=322.42  Aligned_cols=252  Identities=23%  Similarity=0.308  Sum_probs=205.9

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCC---ChhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSK---NQEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~---~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .....|.+.+.||+||.+.||++... .+.||+|++..   +......|.+|+..|.+| .|.+||+||+|-..++.+|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            34567999999999999999999876 46688886553   455667899999999999 58999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||= +.+|...|.+....++.-.+..++.||+.++.++|..  ||||.||||.|+|+- .|.+||+|||+|..+..+.
T Consensus       438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~--gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH--GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh--ceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence            99975 6799999988765555447888999999999999999  999999999999984 5699999999999988888


Q ss_pred             cccccCCCCCCCccCCccccCCCC-----------CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCc
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDN-----------LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK  275 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~-----------~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~  275 (487)
                      ........+||+.||+||.+....           .+.+||||||||+||+|+.|+.||.      ++.....      +
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~------~~~n~~a------K  581 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG------QIINQIA------K  581 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH------HHHHHHH------H
Confidence            777777889999999999986543           3578999999999999999999996      2221111      2


Q ss_pred             cccccCCCCCCCCChHHH-HHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          276 ILSVFDPRIPPPKDPIVR-KQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       276 i~~~~~~~~~~~~~~~~~-~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..+.+|...-+++..-+ .++.++++.||..||.+||++.|+|+
T Consensus       582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            234445533222322222 23999999999999999999999996

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3e-37  Score=301.86  Aligned_cols=248  Identities=27%  Similarity=0.376  Sum_probs=198.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC------hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC--Cce
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN------QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS--KDR  124 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~------~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~  124 (487)
                      .+|.+.+.||+|+||.||+|.+.  ++.||||.+...      ....+.+.+|++++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57899999999999999999875  789999986532      12345788899999999999999999998764  467


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||+++++|.+++.... .+++..+..++.|++.||.|||++  +++|+||||+|||++.++.++|+|||++.....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSN--MIVHRDIKGANILRDSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence            89999999999999997654 488999999999999999999999  999999999999999999999999999875432


Q ss_pred             CCcc-cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          205 DNFR-FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       205 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      .... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||........+.    ..         ....
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~---------~~~~  225 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF----KI---------ATQP  225 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH----HH---------hcCC
Confidence            2111 11223468899999999988889999999999999999999999986321111110    00         0011


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .....+...+..+.+++.+||. +|++||++++|++
T Consensus       226 ~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            1222445677788899999995 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.4e-38  Score=305.85  Aligned_cols=249  Identities=26%  Similarity=0.411  Sum_probs=205.1

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ++|...+.||+|++|.||++.+.  ++.|++|.+...  ......+.+|++++++++||||+++++++......++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788899999999999999987  788999987654  33446789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      +++++|.+++......+++..+..++.|++.||.|||+ .  +++|+||||+||+++.++.++|+|||.+.......   
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---  155 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---  155 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC--CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence            99999999998765679999999999999999999999 8  99999999999999999999999999986543221   


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCC-CchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFS-PPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                       .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... +............         .. ....
T Consensus       156 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------~~-~~~~  224 (265)
T cd06605         156 -AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---------EP-PPRL  224 (265)
T ss_pred             -hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---------CC-CCCC
Confidence             1125788999999999988999999999999999999999999864322 1222221111111         00 1111


Q ss_pred             ChH-HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPI-VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~-~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +.. ++.++.+++.+||..+|.+|||+.+++.
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            222 6788999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.6e-37  Score=301.67  Aligned_cols=246  Identities=23%  Similarity=0.399  Sum_probs=203.5

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +|+..+.||+|+||.||++...  ++.||+|.+...   ......+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888999999999999999875  789999987643   33446789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          131 MSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       131 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      +++++|.+++... ...+++..++.++.|++.||.|||+.  +++|+||+|+|||++.++.++|+|||++........  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR--KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--
Confidence            9999999999764 33588999999999999999999999  999999999999999999999999999876543221  


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||.......    ....... +         ...+.+
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----~~~~~~~-~---------~~~~~~  222 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN----LVLKIIR-G---------SYPPVS  222 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH----HHHHHhc-C---------CCCCCc
Confidence            1223468889999999998889999999999999999999999986432211    1111111 1         111233


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..++.++.+++.+||+.+|.+||++.+|++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            456778999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-37  Score=301.40  Aligned_cols=245  Identities=24%  Similarity=0.391  Sum_probs=202.2

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh------hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ------EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      +|+..+.||+|++|.||+|...  ++.|++|.+....      ...+.+.+|+.+++.++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999999885  7899999865432      2346789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      +||+++++|.+++.... .+++..+..++.|++.||+|||+.  +++|+||+|+||+++.++.+||+|||++....... 
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDR--NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence            99999999999997654 489999999999999999999999  99999999999999999999999999987654332 


Q ss_pred             ccccCCCCCCCccCCccccCCCC-CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDN-LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                        ......++..|++||.+.... ++.++|+|||||++|+|++|+.||.........    .......         ...
T Consensus       157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~---------~~~  221 (258)
T cd06632         157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV----FKIGRSK---------ELP  221 (258)
T ss_pred             --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH----HHHHhcc---------cCC
Confidence              223456889999999987776 899999999999999999999998643211111    1111100         111


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+..++..+.+++.+||+.+|.+||++.+++.
T Consensus       222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            233456788999999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.2e-37  Score=313.10  Aligned_cols=193  Identities=21%  Similarity=0.346  Sum_probs=159.6

Q ss_pred             ceeecccCceEEEEEEEC----CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeC--CCceEEEEEecCC
Q 011384           60 QKLLGKGSHGSVYKAVLR----GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND--SKDRLLVVEFMSN  133 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~----g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lV~Ey~~~  133 (487)
                      .+.||+|+||.||+|.+.    ++.||+|.+..... ...+.+|++++++++||||+++++++..  ....++||||+. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            468999999999999864    46899998875432 3457889999999999999999998854  456789999995 


Q ss_pred             CCHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE----ccCCcEEEccccccee
Q 011384          134 GTLYDVLHSN--------NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI----DRNFNARLGDFGLALR  201 (487)
Q Consensus       134 gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl----d~~~~vkL~DFGla~~  201 (487)
                      ++|.+++...        ...+++..+..++.|++.||.|||+.  +|+||||||+|||+    +.++.+||+|||+++.
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC--CEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            5888887532        12489999999999999999999999  99999999999999    4567899999999976


Q ss_pred             cCCCCcc-cccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCC
Q 011384          202 CGVDNFR-FRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDI  256 (487)
Q Consensus       202 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~  256 (487)
                      ....... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            5432211 122345789999999998764 579999999999999999999999963

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.9e-37  Score=302.99  Aligned_cols=249  Identities=20%  Similarity=0.327  Sum_probs=189.5

Q ss_pred             eecccCceEEEEEEEC-C---eEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCC
Q 011384           62 LLGKGSHGSVYKAVLR-G---RQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGT  135 (487)
Q Consensus        62 ~LG~G~~g~Vy~~~~~-g---~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gs  135 (487)
                      .||+|+||.||++... +   ..+++|.+....  ...+.+.+|+.+++.++||||++++++|.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            5999999999999754 2   346677665442  345689999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccC
Q 011384          136 LYDVLHSNN---RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       136 L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      |.+++....   ..+++..++.++.|++.||+|||+.  +++|+||||+|||++.++.+||+|||++.............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH--NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC--CeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence            999997532   3467777889999999999999999  99999999999999999999999999975432222111223


Q ss_pred             CCCCCCccCCccccCC-------CCCCcchhhhhHHHHHHHHHhC-CcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          213 PPAGTIGYLDPCYVTP-------DNLSTKTDVFSFGILLLEIISC-RKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~-------~~~s~ksDVwSlGvvl~eLltG-~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ...++..|+|||++..       ..++.++|||||||++|||+++ ..||.. .......   ..... +......++.+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~-~~~~~~~---~~~~~-~~~~~~~~~~~  234 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH-LSDREVL---NHVIK-DQQVKLFKPQL  234 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC-CCHHHHH---HHHHh-hcccccCCCcc
Confidence            4568899999998753       2357899999999999999975 456542 2222211   11111 12223333333


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      ..    ..+..+.+++..|| .+|++||++++|++.|.
T Consensus       235 ~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         235 EL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            33    35567888999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.8e-37  Score=310.31  Aligned_cols=252  Identities=23%  Similarity=0.294  Sum_probs=200.0

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||++.+.  ++.|++|.+....    .....+.+|+++++.++||||+++++.+......++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47899999999999999999987  6789999877543    23356789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC--
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN--  206 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~--  206 (487)
                      ||+++++|.+++...+ .+++..+..++.|++.||.|||+.  +++|+||||+||+++.++.+||+|||+++......  
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNY--GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            9999999999997764 589999999999999999999999  99999999999999999999999999886321110  


Q ss_pred             -----------cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCc
Q 011384          207 -----------FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK  275 (487)
Q Consensus       207 -----------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~  275 (487)
                                 .........++..|+|||.+....++.++|||||||++|||++|..||... .+.....   . ...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-~~~~~~~---~-~~~~~  232 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-TPEELFG---Q-VISDD  232 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHH---H-HHhcc
Confidence                       001112345788999999998888999999999999999999999998632 2222111   1 11110


Q ss_pred             cccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          276 ILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       276 i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                      +      ..+ .....++.++.+++.+||+.+|++||++.++.+.|
T Consensus       233 ~------~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll  271 (305)
T cd05609         233 I------EWP-EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK  271 (305)
T ss_pred             c------CCC-CccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence            0      001 11124667899999999999999999965555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=308.82  Aligned_cols=248  Identities=26%  Similarity=0.341  Sum_probs=212.5

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      -|.++.+||+|+||.||++.++  |..+|||.+..+.. .+++.+|+.++.++..|++|++||.|.....++||||||.-
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            4888999999999999999887  89999999876644 57889999999999999999999998888899999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      |++.+.+....++|.+.++..+++..+.||+|||..  .-||||||..|||++.+|.+||+|||.+-.+...  .....+
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~--~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRNT  188 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL--KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRNT  188 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH--HHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhCc
Confidence            999999999888999999999999999999999999  8899999999999999999999999999665432  223456


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      +.|||-|||||++..-.|..++||||||++..||..|++|+..-.+-..+.            .-...|.-....|..++
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------------MIPT~PPPTF~KPE~WS  256 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------------MIPTKPPPTFKKPEEWS  256 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------------eccCCCCCCCCChHhhh
Confidence            789999999999998899999999999999999999999986311111100            00111222234567899


Q ss_pred             HHHHHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          294 KQLAVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                      .++.++++.||-++|++|-|+.++++.
T Consensus       257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  257 SEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            999999999999999999999999873

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.6e-37  Score=306.41  Aligned_cols=260  Identities=23%  Similarity=0.301  Sum_probs=200.2

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ++|+..+.||+|++|.||+|++.  ++.||+|++....   ...+.+.+|+.++++++||||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46889999999999999999986  7899999876432   233567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |++++.|..++.... .+++..++.++.|++.||.|||+.  +++|+||||+||+++.++.++|+|||++........  
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--  155 (286)
T cd07847          81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKH--NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--  155 (286)
T ss_pred             ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHC--CceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence            999988877765543 499999999999999999999999  999999999999999999999999999976544321  


Q ss_pred             ccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhh----------hhcCccc-
Q 011384          210 RSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL----------IKKGKIL-  277 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~----------~~~~~i~-  277 (487)
                      ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||................          ....... 
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            1223457889999999876 457899999999999999999999986433222211111000          0000000 


Q ss_pred             cccCCCCCC--C---CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          278 SVFDPRIPP--P---KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       278 ~~~~~~~~~--~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ....+....  +   ....++..+.+|+.+||+.+|++||++.|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            000000000  0   01234678899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.7e-37  Score=301.76  Aligned_cols=246  Identities=24%  Similarity=0.357  Sum_probs=201.8

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC--CCceEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSND--SKDRLLVV  128 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lV~  128 (487)
                      +|.+.+.||.|+||.||++.+.  +..||+|++...   ....+.+.+|+++++.++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999875  788999987643   3344678899999999999999999998754  45678999


Q ss_pred             EecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          129 EFMSNGTLYDVLHSN---NRPLNWGRRIRLALQVAKAVEILH-----SEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH-----~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      ||+++++|.+++...   ..++++..++.++.|++.||.|||     +.  +++|+||+|+||+++.++.+||+|||++.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~--~i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN--TVLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC--cceecCCCHHHEEEecCCCEEEecccccc
Confidence            999999999999753   456999999999999999999999     77  99999999999999999999999999987


Q ss_pred             ecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccccc
Q 011384          201 RCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF  280 (487)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~  280 (487)
                      .......  ......+++.|++||.+.+..++.++||||||+++|+|++|..||.... ......    ....       
T Consensus       159 ~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~----~~~~-------  224 (265)
T cd08217         159 ILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLAS----KIKE-------  224 (265)
T ss_pred             cccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HHHHHH----HHhc-------
Confidence            6544321  1233568999999999998889999999999999999999999987432 111111    1111       


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        ......+...+.++.+++.+||+.+|.+||++.+|++
T Consensus       225 --~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         225 --GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             --CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence              1112234456788999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-37  Score=301.67  Aligned_cols=251  Identities=24%  Similarity=0.412  Sum_probs=203.0

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-------hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-------EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      +|+..+.||+|++|.||++...  ++.||+|++....       ...+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4788899999999999999874  7899999876432       134678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC-cEEEcccccceecCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF-NARLGDFGLALRCGVD  205 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~~~~  205 (487)
                      |+||+++++|.+++...+ ++++..++.++.|++.||.|||++  +++|+||+|+||+++.++ .+||+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~--~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHEN--QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            999999999999997654 589999999999999999999999  999999999999998765 6999999998765433


Q ss_pred             Ccc--cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          206 NFR--FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       206 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ...  .......++..|+|||.+.+..++.++|||||||++|+|++|..||.......... ....         .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~---------~~~~~  227 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA-LIFK---------IASAT  227 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH-HHHH---------HhccC
Confidence            111  01123467889999999988889999999999999999999999986332211111 1100         00111


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .....+..++.++.+++.+||..+|.+||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            123345567788999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.5e-37  Score=302.84  Aligned_cols=249  Identities=20%  Similarity=0.368  Sum_probs=200.4

Q ss_pred             CcccceeecccCceEEEEEEEC---CeEEEEEEcCCC-----------hhhHHHHHHHHHHHHh-CCCCCceeeEEEEeC
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR---GRQVAVKKPSKN-----------QEISQEVDNEIEILSK-IHSPRLVNLLGFSND  120 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~---g~~vAvK~~~~~-----------~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~  120 (487)
                      +|++.+.||+|+||.||+|.+.   ++.+|+|.+...           ......+.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4788899999999999999986   478999976422           2233557788888875 799999999999999


Q ss_pred             CCceEEEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCCcEEEccc
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDF  196 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~~vkL~DF  196 (487)
                      ++..++||||+++++|.+++..   ....+++..++.++.|++.||.|||. .  +++|+||+|+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999998843   34568999999999999999999996 6  8999999999999999999999999


Q ss_pred             ccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcc
Q 011384          197 GLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI  276 (487)
Q Consensus       197 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i  276 (487)
                      |++.......   ......|+..|++||.+.+..++.++||||||+++|+|++|+.||...... ..   .... ..   
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-~~---~~~~-~~---  227 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-SL---ATKI-VE---  227 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-HH---HHHH-hh---
Confidence            9987654332   234457899999999999888999999999999999999999998632211 11   1111 11   


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          277 LSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                           ....+.....++..+.+++.+||+.||++||++.|+...+.
T Consensus       228 -----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         228 -----AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -----ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                 11111112245678999999999999999999999998774

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-38  Score=319.75  Aligned_cols=238  Identities=26%  Similarity=0.333  Sum_probs=188.0

Q ss_pred             ecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhC---CCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           63 LGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKI---HSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        63 LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      ||+|+||.||+|.+.  ++.||||++.+...    ....+..|..++...   .||||+++++++.+....|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999886  78999998865321    223455677777665   699999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      |+|.+++...+ .+++..+..++.||+.||+|||++  +|+||||||+|||++.++.+||+|||++........  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~--~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~  155 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKY--DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNT  155 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccC
Confidence            99999997654 499999999999999999999999  999999999999999999999999999865332221  2334


Q ss_pred             CCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHH
Q 011384          214 PAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV  292 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  292 (487)
                      ..||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...... ..    ...+..+.      ..++.   ..+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-~~----~~~i~~~~------~~~~~---~~~  221 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-QM----YRNIAFGK------VRFPK---NVL  221 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-HH----HHHHHcCC------CCCCC---ccC
Confidence            5799999999998764 4799999999999999999999999642211 11    11111111      11111   235


Q ss_pred             HHHHHHHHHHhhhhcCCCCC----CHHHHHH
Q 011384          293 RKQLAVIAVRCVRSCRERRP----SMKEIVD  319 (487)
Q Consensus       293 ~~~l~~Li~~cl~~dP~~RP----s~~eil~  319 (487)
                      +.++.+++.+||+.||.+||    ++.++++
T Consensus       222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            67889999999999999998    4666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.5e-37  Score=304.79  Aligned_cols=252  Identities=24%  Similarity=0.398  Sum_probs=198.3

Q ss_pred             cccceeecccCceEEEEEEEC-----CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC------
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK------  122 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------  122 (487)
                      |.+.+.||+|+||.||+|.+.     +..||||++...   ....+.+.+|+++++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999863     578999988754   234467889999999999999999999886532      


Q ss_pred             ceEEEEEecCCCCHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccc
Q 011384          123 DRLLVVEFMSNGTLYDVLHSN-----NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFG  197 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFG  197 (487)
                      ..+++++|+.+++|.+++...     ...+++..++.++.|++.||+|||+.  +|+|+||||+||+++.++.+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK--NFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CEeecccchhhEEEcCCCCEEECccc
Confidence            247899999999999887532     12478899999999999999999999  99999999999999999999999999


Q ss_pred             cceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCcc
Q 011384          198 LALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKI  276 (487)
Q Consensus       198 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i  276 (487)
                      +++...............+++.|++||.+....++.++|||||||++|||++ |+.||.. ........+    ...+. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~----~~~~~-  232 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNY----LIKGN-  232 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHH----HHcCC-
Confidence            9876543322212223345678999999998889999999999999999999 7777752 222222111    11111 


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          277 LSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                              ....+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       233 --------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 --------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             --------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    0111234567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8e-38  Score=308.84  Aligned_cols=260  Identities=25%  Similarity=0.368  Sum_probs=200.2

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh---hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ++|...+.||+|+||.||+|.+.  ++.||+|++.....   ..+.+.+|+++++.++||||+++++++......++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999986  78999998764322   34568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |+++++|.++..... .+++..++.++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++........  
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~--~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--  155 (286)
T cd07846          81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--  155 (286)
T ss_pred             cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--
Confidence            999988888765543 489999999999999999999999  999999999999999999999999999876543321  


Q ss_pred             ccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhh---h-------hhhcCccc-
Q 011384          210 RSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA---P-------LIKKGKIL-  277 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~---~-------~~~~~~i~-  277 (487)
                      ......++..|+|||++.+. .++.++|||||||++|||++|+.||..............   .       ......+. 
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            22334678999999998753 468899999999999999999988864322111111000   0       00000000 


Q ss_pred             cccCCCCCC-----CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          278 SVFDPRIPP-----PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       278 ~~~~~~~~~-----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ....+....     ...+.++..+.+|+.+||+.+|++||++.+|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000000000     012245678999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.4e-37  Score=305.97  Aligned_cols=242  Identities=29%  Similarity=0.365  Sum_probs=201.9

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||++.+.  ++.||+|++....    .....+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47899999999999999999986  7899999876532    23466889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++++|.+++...+ .+++..+..++.|++.||.|||+.  +++|+||+|+|||++.++.+||+|||++......   
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~~--~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSL--DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence            9999999999998764 599999999999999999999999  9999999999999999999999999998765433   


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                        .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.... ......    ....+.          .+.
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~----~~~~~~----------~~~  217 (290)
T cd05580         155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYE----KILEGK----------VRF  217 (290)
T ss_pred             --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-HHHHHH----HHhcCC----------ccC
Confidence              233468999999999988888999999999999999999999986432 111111    111111          122


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      +..++..+.+++.+||..+|.+||     ++++++.
T Consensus       218 ~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            334567899999999999999999     6677764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.4e-37  Score=305.16  Aligned_cols=259  Identities=23%  Similarity=0.269  Sum_probs=201.7

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +|.+.+.||+|++|.||+|.+.  ++.|+||++....   .....+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5888999999999999999985  7899999876543   3346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      + +++|.+++.....++++..++.++.|++.||.|||+.  +++|+||||+||+++.++.++|+|||++........ ..
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~  156 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN--GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RL  156 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cc
Confidence            9 9999999987667799999999999999999999999  999999999999999999999999999876544321 12


Q ss_pred             cCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC------------ccc
Q 011384          211 STPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG------------KIL  277 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~------------~i~  277 (487)
                      .....++..|+|||.+.+. .++.++|||||||++|+|++|..+|.... ...............            ...
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-DIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-HHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            3345789999999998654 46899999999999999999977664322 111111111100000            000


Q ss_pred             cccCCCCC----CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          278 SVFDPRIP----PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       278 ~~~~~~~~----~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ....+...    ....+..+..+.+++.+||+.+|.+||++++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00000000    0011234588999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.5e-37  Score=305.72  Aligned_cols=258  Identities=24%  Similarity=0.300  Sum_probs=199.9

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh------hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE------ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      +|...+.||+|++|.||+|.+.  ++.||||.+.....      ....+..|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999985  78999998875432      234677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+ +++|.+++......+++..++.++.|++.||.|||++  +++|+||+|+|||++.++.++|+|||++........
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN--WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            9999 8999999987654699999999999999999999999  999999999999999999999999999976544321


Q ss_pred             ccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc---------Cccc
Q 011384          208 RFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK---------GKIL  277 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~---------~~i~  277 (487)
                        ......+++.|+|||.+.+ ..++.++|||||||++|||++|..+|............. .....         ....
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         158 --KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIF-EALGTPTEENWPGVTSLP  234 (298)
T ss_pred             --cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHH-HHcCCCchhhhhhccccc
Confidence              2233456889999998865 457899999999999999999977665322211111100 00000         0000


Q ss_pred             cccCCCCCC-----CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          278 SVFDPRIPP-----PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       278 ~~~~~~~~~-----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .........     ......+.++.+++.+||+.+|++|||+.+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            000000000     111335678999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-37  Score=306.57  Aligned_cols=260  Identities=20%  Similarity=0.269  Sum_probs=198.1

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ++|.+.+.||+|++|.||+|...  ++.||||.+....  .....+.+|++++++++||||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67999999999999999999886  7899999876432  2234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +++ +|.+++......+++..+..++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||+++.......  .
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~  159 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR--RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--T  159 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecccCCHHHEEEcCCCCEEECccccccccCCCCc--c
Confidence            975 99999987666789999999999999999999999  999999999999999999999999999865432221  1


Q ss_pred             cCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCc------------cc
Q 011384          211 STPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK------------IL  277 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~------------i~  277 (487)
                      .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.....................            ..
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK  239 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence            222356889999999875 45789999999999999999999998643322111111111100000            00


Q ss_pred             cccCCCCC-C---CCChHHH--HHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          278 SVFDPRIP-P---PKDPIVR--KQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       278 ~~~~~~~~-~---~~~~~~~--~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ....+... .   .....+.  .++.+++.+||+.+|++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00000000 0   0001122  67889999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=326.12  Aligned_cols=280  Identities=24%  Similarity=0.334  Sum_probs=222.2

Q ss_pred             cccceeecccCceEEEEEEEC---C--eEEEEEEcCCChh--hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR---G--RQVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~---g--~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ..+.++||+|.||.|++|.|+   |  -.||||.+..+..  ....|++|+.+|.+|+|+|+++|||+..+ ....+|+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            345689999999999999997   3  3699998876533  45789999999999999999999999987 67889999


Q ss_pred             ecCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          130 FMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       130 y~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      .++.|||.+.|.+ ....|.....-.++.|||.||.||.++  ++|||||..+|+|+-....|||+||||.+.++.....
T Consensus       191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk--rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK--RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh--hhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            9999999999988 445688888899999999999999999  9999999999999999999999999999988876655


Q ss_pred             cccCCC-CCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCC-cCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          209 FRSTPP-AGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCR-KAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       209 ~~~~~~-~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~-~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                      +.+... .-...|+|||.++...++.+||||+|||+||||+++. .||. +....++             ++.+|.+...
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~-G~~g~qI-------------L~~iD~~erL  334 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV-GCRGIQI-------------LKNIDAGERL  334 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC-CCCHHHH-------------HHhccccccC
Confidence            544433 3456899999999999999999999999999999854 5553 4444443             3344555555


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHH-HhcccccCCCCCCCCCCCCcceeeccCCccccc
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDW-LTGLSKLVPLHSWNGFNNPCLMVETVGRPVEVR  353 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~-L~~l~~~~~~~~~~~~~~p~~~~e~~~~~~~~~  353 (487)
                      +.+..|++++.++++.||..+|.+||||..|.+. +.........--...+.+|..+.-+.+..+.+-
T Consensus       335 pRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp~~a~~~~d~~ep~aLh~~kgD~IvVI  402 (1039)
T KOG0199|consen  335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAVARETYDSIEPGALHLTKGDEIVVI  402 (1039)
T ss_pred             CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCceeeeeccccCCCceeeccCCeEEEE
Confidence            6778899999999999999999999999999843 222211111111223345555555555554433

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.9e-37  Score=295.12  Aligned_cols=249  Identities=27%  Similarity=0.400  Sum_probs=208.3

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCC--CceEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDS--KDRLLVV  128 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lV~  128 (487)
                      +|+..+.||+|++|.||+|...  ++.|++|+.....   ...+.+.+|+.++++++||||+++++++.+.  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4788899999999999999987  8899999887654   3457889999999999999999999999988  8899999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++++|.+++.... .+++..++.++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~--~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSN--GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            9999999999998765 699999999999999999999999  9999999999999999999999999998766544321


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                      .......++..|++||.+.....+.++||||||+++|+|++|..||........   ....         ..........
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~---------~~~~~~~~~~  225 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---ALYK---------IGSSGEPPEI  225 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHh---------ccccCCCcCC
Confidence            113345788999999999888899999999999999999999999974331111   1111         1111122233


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..++..+.+++.+||+.+|.+||++.+++.
T Consensus       226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            4455789999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.4e-37  Score=299.08  Aligned_cols=253  Identities=22%  Similarity=0.336  Sum_probs=204.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ++|++.+.||.|+||.||+|.+.  +..+++|++....  .....+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999875  7789999886432  3456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          131 MSNGTLYDVLHSN--NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       131 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      +++++|.+++...  ...+++..+..++.|++.||.|||+.  +++|+||+|+||++++++.++|+|||++..+......
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~--~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN--GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            9999999999763  23589999999999999999999999  9999999999999999999999999998665443322


Q ss_pred             c--ccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          209 F--RSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       209 ~--~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      .  ......|+..|++||.+... .++.++|+|||||++|+|++|+.||.............    ..      ..+...
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~----~~------~~~~~~  228 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL----QN------DPPSLE  228 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHh----cC------CCCCcC
Confidence            1  12334688999999998877 78999999999999999999999986432221111111    00      011111


Q ss_pred             CCC-ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          286 PPK-DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       286 ~~~-~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ... ...++..+.+++.+||+.||++||++.+|++
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111 1356788999999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=8e-38  Score=324.82  Aligned_cols=192  Identities=26%  Similarity=0.345  Sum_probs=172.1

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCC-C-----CCceeeEEEEeCCCceEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIH-S-----PRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~-h-----pnIv~l~~~~~~~~~~~lV  127 (487)
                      +|.+.++||+|.||.|.+|.+.  ++.||||++++......+...|+.+|..|+ |     -|+|++++||...+.+|||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            5889999999999999999886  789999999999888888899999999997 4     4899999999999999999


Q ss_pred             EEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc--CCcEEEcccccceecCC
Q 011384          128 VEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR--NFNARLGDFGLALRCGV  204 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~--~~~vkL~DFGla~~~~~  204 (487)
                      +|.+ .-+|+++|+.++ .+++...++.++.||+.||.+||+.  +|||+||||+||||.+  ...+||+|||.++....
T Consensus       267 fELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l--~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  267 FELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL--GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             ehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence            9999 569999998754 5699999999999999999999999  9999999999999964  34799999999976543


Q ss_pred             CCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAID  255 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~  255 (487)
                      .-     .....+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.
T Consensus       344 ~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  344 RV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             cc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence            21     24567889999999999999999999999999999999976665

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-37  Score=316.62  Aligned_cols=258  Identities=21%  Similarity=0.269  Sum_probs=195.8

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCC-----
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDS-----  121 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----  121 (487)
                      ...++|.+.+.||+|+||.||+|.+.  ++.||||++....   .....+.+|++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34678999999999999999999875  7789999887542   2235677899999999999999999987543     


Q ss_pred             -CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          122 -KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       122 -~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                       ...|++++++ +++|.+++...  .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~--~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  166 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLAR  166 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeecccCChhhEEECCCCCEEEcCCccce
Confidence             3468999988 78998887643  499999999999999999999999  99999999999999999999999999997


Q ss_pred             ecCCCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhh---------
Q 011384          201 RCGVDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL---------  270 (487)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~---------  270 (487)
                      .....     .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||........+..+....         
T Consensus       167 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07878         167 QADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK  241 (343)
T ss_pred             ecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            65432     234578999999999876 468999999999999999999999986432111111100000         


Q ss_pred             -hhcCccccccC--CCCCCC----CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          271 -IKKGKILSVFD--PRIPPP----KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       271 -~~~~~i~~~~~--~~~~~~----~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                       +........+.  +..+..    .....++.+.+|+.+||+.||.+|||+.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             00000000000  000000    00113456789999999999999999999996

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.5e-37  Score=298.52  Aligned_cols=249  Identities=27%  Similarity=0.408  Sum_probs=206.9

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ++|.+.+.||+|++|.||++.+.  ++.|+||++....  .....+.+|+..+.+++|+||+++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46888999999999999999886  7899999887654  3457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      +++++|.+++... .++++..++.++.|++.||.|||+ .  +++|+||+|+||+++.++.++|+|||++......... 
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-  156 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-  156 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccC--CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence            9999999999865 459999999999999999999999 8  9999999999999999999999999998765433321 


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                       .....++..|+|||.+....++.++||||||+++|+|++|+.||...... ..........         . ......+
T Consensus       157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~---------~-~~~~~~~  224 (264)
T cd06623         157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAIC---------D-GPPPSLP  224 (264)
T ss_pred             -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHh---------c-CCCCCCC
Confidence             22446889999999999888999999999999999999999998643321 1111111111         1 1111223


Q ss_pred             hH-HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          290 PI-VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       290 ~~-~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .. ++..+.+++.+||+.+|.+||++.++++
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            33 6788999999999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-36  Score=301.93  Aligned_cols=255  Identities=25%  Similarity=0.354  Sum_probs=200.9

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCC--CceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDS--KDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lV~  128 (487)
                      ++|...+.||.|++|.||++.+.  ++.||+|.+....  .....+.+|++++++++||||++++++|.+.  ..+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888999999999999999985  7889999877543  2446789999999999999999999988653  4689999


Q ss_pred             EecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          129 EFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       129 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~--~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR--KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            99999999988753   334589999999999999999999999  9999999999999999999999999998654322


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc-hhhhhhhhhhhcCccccccCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP-SIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~-~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      .    .....++..|++||.+.+..++.++|||||||++|+|++|..||.....+. ...+... ......... +..  
T Consensus       159 ~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~--  230 (287)
T cd06621         159 L----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS-YIVNMPNPE-LKD--  230 (287)
T ss_pred             c----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH-HHhcCCchh-hcc--
Confidence            1    123457889999999998899999999999999999999999997543211 1111111 111101000 000  


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ........++.+.+++.+||+.+|.+|||+.||++
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            01111235678999999999999999999999997

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.3e-37  Score=304.43  Aligned_cols=262  Identities=20%  Similarity=0.239  Sum_probs=198.0

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++++|.+.+.||+|+||.||+|...  ++.||+|++....  .....+.+|+++++.++|+||+++++++.+....++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3578999999999999999999875  7899999876442  22346788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+. ++|.+.+......+++..+..++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++........ 
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ--HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence            9995 688777766545688889999999999999999999  999999999999999999999999999865433221 


Q ss_pred             cccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc------------Cc
Q 011384          209 FRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK------------GK  275 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~------------~~  275 (487)
                       ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.............+.....            ..
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence             12234578999999998754 57889999999999999999999986432211111111100000            00


Q ss_pred             cc-cccCCCCCCCC-----ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          276 IL-SVFDPRIPPPK-----DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       276 i~-~~~~~~~~~~~-----~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .. .......+...     ....+..+.+++.+||..||.+|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00 00000000000     0012467889999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.4e-37  Score=298.33  Aligned_cols=250  Identities=27%  Similarity=0.415  Sum_probs=202.8

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh---hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +|...+.||+|+||.||+|...  ++.|++|.+.....   ....+.+|+++++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888999999999999999875  78999998775533   456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +++++|.+++.... .+++..+..++.+++.||.|||+.  +++|+||+|+||+++.++.+||+|||++...........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~--~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSH--GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            99999999997654 488999999999999999999999  999999999999999999999999999876544332111


Q ss_pred             --cCCCCCCCccCCccccCCCC---CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          211 --STPPAGTIGYLDPCYVTPDN---LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       211 --~~~~~gt~~Y~aPE~~~~~~---~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                        .....+++.|++||.+....   ++.++||||||+++|++++|+.||...........   ...      ....+.++
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~---~~~------~~~~~~~~  228 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF---HVG------AGHKPPIP  228 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH---HHh------cCCCCCCC
Confidence              11246788999999998766   78999999999999999999999963221111111   000      00111111


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        ....++..+.+++.+||+.+|.+||++.+++.
T Consensus       229 --~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         229 --DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              12234778899999999999999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-37  Score=309.04  Aligned_cols=250  Identities=26%  Similarity=0.360  Sum_probs=202.7

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|...+.||+|++|.||+|...  ++.||+|.+.....    ..+.+..|+++++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            46889999999999999999886  68999998875432    3456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          129 EFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      ||+.+++|.+++... +..+++..+..++.|++.||+|||+.  +++|+||||+||+++.++.++|+|||++........
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL--GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC--CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            999999999999753 34699999999999999999999999  999999999999999999999999999865432211


Q ss_pred             c---------------------------cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCC
Q 011384          208 R---------------------------FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP  260 (487)
Q Consensus       208 ~---------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~  260 (487)
                      .                           .......|+..|+|||.+.+..++.++|||||||++|+|++|..||......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence            0                           0111235788999999999888999999999999999999999998633221


Q ss_pred             chhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCC----HHHHHH
Q 011384          261 PSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPS----MKEIVD  319 (487)
Q Consensus       261 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs----~~eil~  319 (487)
                      .....             ........+.....+..+.+++.+||+.+|++|||    +++++.
T Consensus       239 ~~~~~-------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         239 ETFSN-------------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHHH-------------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            11111             11111112222236788999999999999999999    777775

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.4e-37  Score=304.50  Aligned_cols=247  Identities=25%  Similarity=0.389  Sum_probs=202.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC-hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN-QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ++|.+.+.||+|+||.||++...  ++.||+|.+... ....+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67999999999999999999864  788999987643 333467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      ++++|.+++.+..  +++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++........  ..
T Consensus        99 ~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH~~--gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~  172 (293)
T cd06647          99 AGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR  172 (293)
T ss_pred             CCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHhC--CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--cc
Confidence            9999999997643  88999999999999999999999  999999999999999999999999998865543322  12


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ....+++.|++||.+....++.++|||||||++|++++|+.||...........    ...        ........+..
T Consensus       173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~----~~~--------~~~~~~~~~~~  240 (293)
T cd06647         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IAT--------NGTPELQNPEK  240 (293)
T ss_pred             ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee----hhc--------CCCCCCCCccc
Confidence            334688999999999888899999999999999999999999964322111110    000        00111112334


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ++..+.+++.+||..+|++||++.+++.
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~  268 (293)
T cd06647         241 LSAIFRDFLNRCLEMDVEKRGSAKELLQ  268 (293)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            5678999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.7e-37  Score=302.15  Aligned_cols=245  Identities=25%  Similarity=0.305  Sum_probs=203.9

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      +|.+.+.||.|+||.||+|.+.  ++.||+|.+....    ...+.+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5888999999999999999986  8899999887542    344678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |+.+++|.+++... .++++..+..++.|++.||.|||..  +++|+||+|+||+++.++.++|+|||++.......   
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~--~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSK--GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence            99999999999776 4599999999999999999999999  99999999999999999999999999987654332   


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      ......|+..|+|||.+....++.++|+||||+++|+|++|..||......  ...........          .....+
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~----------~~~~~~  222 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET----------ADVLYP  222 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc----------ccccCc
Confidence            223456889999999999888999999999999999999999998744321  11111111110          112233


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCH--HHHH
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSM--KEIV  318 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~--~eil  318 (487)
                      ..++..+.+++.+||+.+|.+||++  ++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            4566889999999999999999999  6655

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.1e-37  Score=308.04  Aligned_cols=193  Identities=20%  Similarity=0.330  Sum_probs=158.9

Q ss_pred             ceeecccCceEEEEEEEC----CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeC--CCceEEEEEecCC
Q 011384           60 QKLLGKGSHGSVYKAVLR----GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND--SKDRLLVVEFMSN  133 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~----g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lV~Ey~~~  133 (487)
                      ...||+|+||.||+|...    +..||+|.+..... ...+.+|+++++.++||||+++++++..  ....++|+||++ 
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence            468999999999999874    46799998875533 3467889999999999999999998853  556799999996 


Q ss_pred             CCHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE----ccCCcEEEccccccee
Q 011384          134 GTLYDVLHSN--------NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI----DRNFNARLGDFGLALR  201 (487)
Q Consensus       134 gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl----d~~~~vkL~DFGla~~  201 (487)
                      ++|.+++...        ...+++..++.++.|++.||.|||+.  +|+||||||+|||+    +.++.+||+|||+++.
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC--CEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            5888777521        12488999999999999999999999  99999999999999    5667899999999976


Q ss_pred             cCCCCcc-cccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCC
Q 011384          202 CGVDNFR-FRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDI  256 (487)
Q Consensus       202 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~  256 (487)
                      ....... .......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            5433211 122345689999999998764 579999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-37  Score=301.19  Aligned_cols=245  Identities=24%  Similarity=0.374  Sum_probs=199.4

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCC---CCCceeeEEEEeCCCceEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIH---SPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      .|+..+.||+|+||.||+|.+.  ++.||+|.+...  ......+.+|+.++++++   |||++++++++.+....++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4778899999999999999985  789999987653  233467889999999997   999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++++|.+++...  .+++..++.++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++........ 
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~--~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-  156 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhC--CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence            999999999998654  589999999999999999999999  999999999999999999999999999876654331 


Q ss_pred             cccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                       ......|+..|+|||.+..+ .++.++|||||||++|+|++|..||...... ....    ..     .....+.+.. 
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~----~~-----~~~~~~~~~~-  224 (277)
T cd06917         157 -KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-RAMM----LI-----PKSKPPRLED-  224 (277)
T ss_pred             -ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-hhhh----cc-----ccCCCCCCCc-
Confidence             22344689999999988754 5689999999999999999999998632211 1110    00     0000111111 


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        ..++.++.+++.+||+.+|++||++.+++.
T Consensus       225 --~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         225 --NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             --ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence              125678999999999999999999999987

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.1e-37  Score=301.52  Aligned_cols=244  Identities=27%  Similarity=0.435  Sum_probs=201.6

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      -|...+.||+|+||.||+|.+.  +..||||......  .....+.+|+.++++++||||+++++++.++...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4778899999999999999875  7899999876432  33467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      ++++|.+++...  .+++..+..++.|++.++.|||+.  +++|+||+|+||+++.++.++|+|||++..+.....  ..
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~  158 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KR  158 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccC--CeecCCCCHHhEEECCCCCEEEeecccceecccchh--hh
Confidence            999999998754  489999999999999999999999  999999999999999999999999999876543321  22


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ....++..|+|||.+.+..++.++|||||||++|+|++|..||.... +.....    ....         ......+..
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-~~~~~~----~~~~---------~~~~~~~~~  224 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-PMKVLF----LIPK---------NNPPTLEGN  224 (277)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc-hHHHHH----HHhc---------CCCCCCCcc
Confidence            33468889999999988888999999999999999999999986321 111111    0111         111223345


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ++.++.+++.+||+.+|.+||++.+++.
T Consensus       225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         225 YSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            6678999999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.1e-36  Score=292.82  Aligned_cols=247  Identities=27%  Similarity=0.418  Sum_probs=205.0

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh-hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecC
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE-ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      +|...+.||+|++|.||++.+.  +..|++|+...... ....+.+|+++++.++|||++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4788899999999999999986  78899999876643 55789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccC
Q 011384          133 NGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       133 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      +++|.+++......+++..+..++.|++.||.+||..  +++|+||+|+||+++.++.++|+|||.+........   ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~  155 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN--GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RN  155 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC--CEecCCCCHHHEEEccCCeEEEeecccccccccccc---cc
Confidence            9999999987655699999999999999999999999  999999999999999999999999999876544321   23


Q ss_pred             CCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHH
Q 011384          213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV  292 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  292 (487)
                      ...++..|++||.+....++.++||||||+++|+|++|+.||...........    . ..     ...+..  ..+..+
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~-~~-----~~~~~~--~~~~~~  223 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK----I-AT-----NGPPGL--RNPEKW  223 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH----H-Hh-----cCCCCc--Cccccc
Confidence            45688999999999888899999999999999999999999863221111111    0 00     000111  112224


Q ss_pred             HHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          293 RKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       293 ~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..+.+++.+||+.+|.+|||+.++++
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         224 SDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            678999999999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.5e-37  Score=301.42  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=194.5

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHH-HHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEI-LSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ++|.+.+.||+|+||.||++++.  ++.||+|++....  .....+..|+.+ ++.++||||+++++++......++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47899999999999999999986  8899999877542  233455566665 566799999999999999999999999


Q ss_pred             ecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          130 FMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       130 y~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      |++ ++|.+++..   .+..+++..++.++.|++.||.|||++. +++||||||+|||++.++.+||+|||++.......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL-SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC-CeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            996 688888754   2346899999999999999999999742 79999999999999999999999999987553221


Q ss_pred             cccccCCCCCCCccCCccccCC----CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTP----DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~  282 (487)
                         ......++..|+|||.+.+    ..++.++|+|||||++|+|++|+.||...........   ...      ....+
T Consensus       159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~------~~~~~  226 (283)
T cd06617         159 ---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK---QVV------EEPSP  226 (283)
T ss_pred             ---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH---HHH------hcCCC
Confidence               2233568899999998865    4568899999999999999999999863222211110   000      01111


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       283 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .++   ...++.++.+++.+||..+|++||++.+|++
T Consensus       227 ~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         227 QLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111   1235678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-38  Score=322.44  Aligned_cols=248  Identities=26%  Similarity=0.390  Sum_probs=207.7

Q ss_pred             ceeecccCceEEEEEEEC--CeEEEEEEcC-CChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCCH
Q 011384           60 QKLLGKGSHGSVYKAVLR--GRQVAVKKPS-KNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTL  136 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~-~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  136 (487)
                      .-+||+|.||+||-|++.  ...+|||.+. ++....+-++.||.+.++++|.|||+++|.|.+++.+-|.||-++||||
T Consensus       580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            358999999999999987  4567889665 4445556789999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc-CCcEEEcccccceecCCCCcccccCC
Q 011384          137 YDVLHSNNRPL--NWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-NFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       137 ~~~l~~~~~~l--~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      .++|...-+++  ++..+-.+..||++||.|||.+  .|||||||-+|+||+. .|.+||+|||-++.+..-+.  ...+
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen--~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TET  735 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN--KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTET  735 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc--ceeeccccCCcEEEeeccceEEecccccchhhccCCc--cccc
Confidence            99999877778  7888899999999999999999  9999999999999975 68999999999987654332  3456


Q ss_pred             CCCCCccCCccccCCC--CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          214 PAGTIGYLDPCYVTPD--NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~--~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ..||..|||||++-.+  .|..++|||||||++.||.||++||.--.+| +...+...++           ..-++.|.+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-qAAMFkVGmy-----------KvHP~iPee  803 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-QAAMFKVGMY-----------KVHPPIPEE  803 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-hHhhhhhcce-----------ecCCCCcHH
Confidence            7899999999999765  5788999999999999999999999632222 2222211111           223567889


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhc
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG  323 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~  323 (487)
                      ++.+.+.+|.+|+.++|.+||++.+++.  +|+-
T Consensus       804 lsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~  837 (1226)
T KOG4279|consen  804 LSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQH  837 (1226)
T ss_pred             HHHHHHHHHHHHcCCCcccCccHHHhccCccccc
Confidence            9999999999999999999999999997  5543

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-37  Score=328.70  Aligned_cols=263  Identities=19%  Similarity=0.244  Sum_probs=190.3

Q ss_pred             HhhcCcccceeecccCceEEEEEEECC---eEEE------------------EEEcCCChhhHHHHHHHHHHHHhCCCCC
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLRG---RQVA------------------VKKPSKNQEISQEVDNEIEILSKIHSPR  110 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~g---~~vA------------------vK~~~~~~~~~~~~~~Ei~~l~~l~hpn  110 (487)
                      ...++|.+++.||+|+||.||++.++.   ..++                  .|...........+.+|+.++++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            445789999999999999999987541   1111                  1222233334467889999999999999


Q ss_pred             ceeeEEEEeCCCceEEEEEecCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc
Q 011384          111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN----RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID  186 (487)
Q Consensus       111 Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld  186 (487)
                      |+++++++.+.+..|+|++++ +++|.+++....    .......+..++.||+.||.|||++  +||||||||+|||++
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~--gIiHrDLKP~NILl~  301 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK--KLIHRDIKLENIFLN  301 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEC
Confidence            999999999999999999999 457877775422    2234566788999999999999999  999999999999999


Q ss_pred             cCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhh
Q 011384          187 RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDW  266 (487)
Q Consensus       187 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~  266 (487)
                      .++.+||+|||++..+...... ......||+.|+|||++.+..++.++|||||||++|||++|..++............
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            9999999999999776533221 233467999999999999999999999999999999999998654322221111110


Q ss_pred             hhhhhhc-----C-------ccccccCC----CCCCCCC-----hHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          267 AAPLIKK-----G-------KILSVFDP----RIPPPKD-----PIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       267 ~~~~~~~-----~-------~i~~~~~~----~~~~~~~-----~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      . ..+..     .       ++...++.    ..+...+     ..++.++.+++.+||+.||.+|||+.|++.
T Consensus       381 ~-~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        381 L-KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             H-HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0 00000     0       00000000    0000000     113456778899999999999999999996

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.3e-36  Score=304.48  Aligned_cols=243  Identities=24%  Similarity=0.350  Sum_probs=197.5

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ..|...+.||+|+||.||+|...  ++.||+|.+...    ......+.+|+++++.++||||++++++|.+....++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45889999999999999999875  789999987533    223356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||++ |+|.+++......+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++......   
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~--~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH--ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence            9996 688888766555699999999999999999999999  9999999999999999999999999998654322   


Q ss_pred             cccCCCCCCCccCCccccC---CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVT---PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                         ....+++.|+|||.+.   ...++.++||||||+++|||++|..||..........    .....         ..+
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~----~~~~~---------~~~  232 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----HIAQN---------DSP  232 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH----HHhcC---------CCC
Confidence               2346788999999874   3567899999999999999999999986321111110    01000         001


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ......++..+.+++.+||+.+|++||++.+|+.
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            1112346778999999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-37  Score=302.42  Aligned_cols=261  Identities=22%  Similarity=0.263  Sum_probs=201.3

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ++|++.+.||+|++|.||+|.+.  ++.||||++...   ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36899999999999999999986  778999987643   2234678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |++++.|..+.... ..+++..++.++.|++.||.|||..  +++|+||+|+||+++.++.+||+|||++......... 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-  156 (288)
T cd07833          81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSH--NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-  156 (288)
T ss_pred             cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-
Confidence            99886666555443 4599999999999999999999999  9999999999999999999999999998765543321 


Q ss_pred             ccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhh----------hh-hcCccc
Q 011384          210 RSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP----------LI-KKGKIL  277 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~----------~~-~~~~i~  277 (487)
                      ......++..|+|||++... .++.++||||||+++|+|++|+.||...............          .. ......
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            22345678899999999888 7899999999999999999999888643221111110000          00 000000


Q ss_pred             --cccCCC----CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          278 --SVFDPR----IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       278 --~~~~~~----~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        ......    .....+..++.++.+|+.+||..+|++||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence              000000    000122335788999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1e-36  Score=297.39  Aligned_cols=240  Identities=25%  Similarity=0.324  Sum_probs=198.1

Q ss_pred             ecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCCH
Q 011384           63 LGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTL  136 (487)
Q Consensus        63 LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  136 (487)
                      ||.|++|.||+++..  ++.||+|++....    ...+.+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999997  8899999876532    3346789999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCC
Q 011384          137 YDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG  216 (487)
Q Consensus       137 ~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~g  216 (487)
                      .+++.+.. .+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++.......   ......+
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~--~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~  154 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLHNR--GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCG  154 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC--CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccC
Confidence            99997754 489999999999999999999999  99999999999999999999999999987654332   2233468


Q ss_pred             CCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHH
Q 011384          217 TIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQL  296 (487)
Q Consensus       217 t~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  296 (487)
                      ++.|++||.+....++.++|+||||+++|+|++|..||.......  ........         ........+..++.++
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~---------~~~~~~~~~~~~~~~~  223 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDIL---------KGNGKLEFPNYIDKAA  223 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHHh---------ccCCCCCCCcccCHHH
Confidence            899999999988889999999999999999999999997433211  11111111         1111122334457889


Q ss_pred             HHHHHHhhhhcCCCCCC-----HHHHHH
Q 011384          297 AVIAVRCVRSCRERRPS-----MKEIVD  319 (487)
Q Consensus       297 ~~Li~~cl~~dP~~RPs-----~~eil~  319 (487)
                      .+++.+||+.+|++||+     ++|+++
T Consensus       224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         224 KDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            99999999999999999     788776

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.9e-37  Score=303.88  Aligned_cols=260  Identities=22%  Similarity=0.273  Sum_probs=200.1

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh---hHHHHHHHHHHHHhCCCCCceeeEEEEeCC--CceEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGFSNDS--KDRLLV  127 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lV  127 (487)
                      ++|.+.+.||+|+||.||+|.+.  ++.+++|.+.....   ....+.+|+.++.+++||||+++++++...  ...|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888999999999999999986  78899998764432   224567899999999999999999998877  889999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||++ ++|.+++......+++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++........
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN--WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            99996 599999987655699999999999999999999999  999999999999999999999999999876654321


Q ss_pred             ccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhh----------hhhh-----
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA----------APLI-----  271 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~----------~~~~-----  271 (487)
                        ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||.............          +...     
T Consensus       162 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
T cd07843         162 --PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG  239 (293)
T ss_pred             --ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence              22334678899999998764 46899999999999999999999986432211110000          0000     


Q ss_pred             -hcCccccccCCCCCCCCChH-HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          272 -KKGKILSVFDPRIPPPKDPI-VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       272 -~~~~i~~~~~~~~~~~~~~~-~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                       ............+....+.. +++.+.+++.+||+.+|++|||+.|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence             00000000011111112222 4778899999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5e-37  Score=303.10  Aligned_cols=258  Identities=23%  Similarity=0.293  Sum_probs=197.7

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh---hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +|+..+.||.|++|.||+|++.  ++.||||++.....   ....+.+|++++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4888999999999999999885  78999998764322   235788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          131 MSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       131 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      +. ++|.+++... ...+++..++.++.|++.||+|||+.  +++|+||+|+||+++.++.+||+|||++........  
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~--~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--
Confidence            95 6898888653 34589999999999999999999999  999999999999999999999999999865543221  


Q ss_pred             ccCCCCCCCccCCccccCCCC-CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc---------------
Q 011384          210 RSTPPAGTIGYLDPCYVTPDN-LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK---------------  273 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~---------------  273 (487)
                      ......+++.|+|||.+.+.. ++.++|||||||++|+|+||+.||...................               
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            123345788999999887644 5889999999999999999999986433221111111000000               


Q ss_pred             CccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          274 GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       274 ~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ....... ........+.++.++.+++.+||+.||.+|||+++++.
T Consensus       236 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         236 PSFPKWA-RQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhccccc-ccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0000000 00000011234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1e-36  Score=301.59  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=207.8

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ..++.|...+.||+|++|.||+|.+.  +..|++|++.........+.+|+++++.++|+|++++++++......++|+|
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            34567899999999999999999987  8889999987665556778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |+++++|.+++......+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++........  
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~--gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ--NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--
Confidence            9999999999987654699999999999999999999999  999999999999999999999999998754432221  


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      ......++..|++||.+.+..++.++|||||||++|+|++|+.||... .+.....   ..... .       ......+
T Consensus       172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~---~~~~~-~-------~~~~~~~  239 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALF---LITTK-G-------IPPLKNP  239 (286)
T ss_pred             hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHH---HHHhc-C-------CCCCcch
Confidence            123345788999999998888999999999999999999999998632 1111111   00000 0       0011112


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..++..+.+++.+||+.+|.+||++.+|++
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            236678999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.2e-37  Score=296.77  Aligned_cols=246  Identities=22%  Similarity=0.385  Sum_probs=200.8

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +|+..+.||+|+||.||+|..+  +..||+|.+....   .....+.+|+++++.++|+||+++++++.+....++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5888999999999999999986  7889999876532   2345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC-cEEEcccccceecCCCCcc
Q 011384          131 MSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF-NARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       131 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~~~~~~~  208 (487)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+.  +++|+||||+||+++.++ .+||+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR--KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-
Confidence            99999999997643 3589999999999999999999999  999999999999998875 579999999876543221 


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                       ......|++.|+|||++....++.++|+|||||++|+|++|..||.....    ..+...... +        . ..+.
T Consensus       158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-~--------~-~~~~  222 (257)
T cd08225         158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL----HQLVLKICQ-G--------Y-FAPI  222 (257)
T ss_pred             -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHhc-c--------c-CCCC
Confidence             12234689999999999888899999999999999999999999863221    111111111 0        1 1112


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+.++.++.+++.+||..+|++|||+.+|++
T Consensus       223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         223 SPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            2345678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4e-37  Score=306.43  Aligned_cols=246  Identities=24%  Similarity=0.345  Sum_probs=198.8

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecC
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      .|.....||+|+||.||++...  +..||||.+.... ...+.+.+|+.+++.++||||+++++.+...+..++||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            3444577999999999999875  7889999876543 334578899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccC
Q 011384          133 NGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       133 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      +++|.+++...  .+++..++.++.|++.||.|||+.  +++||||||+||+++.++.++|+|||++........  ...
T Consensus       103 ~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  176 (292)
T cd06658         103 GGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQ--GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK  176 (292)
T ss_pred             CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence            99999988643  489999999999999999999999  999999999999999999999999999865432221  122


Q ss_pred             CCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHH
Q 011384          213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV  292 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  292 (487)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .....    .+     ...+.+...  ....+
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~----~~-----~~~~~~~~~--~~~~~  244 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP-LQAMR----RI-----RDNLPPRVK--DSHKV  244 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHH----HH-----HhcCCCccc--ccccc
Confidence            34688999999999888899999999999999999999999863221 11111    00     011111111  12235


Q ss_pred             HHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          293 RKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       293 ~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..+..++.+||..+|.+|||++++++
T Consensus       245 ~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         245 SSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            667899999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.1e-36  Score=303.08  Aligned_cols=260  Identities=25%  Similarity=0.348  Sum_probs=197.8

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh---hHHHHHHHHHHHHhCCCCCceeeEEEEeCC--CceEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGFSNDS--KDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~l  126 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||+|.+.....   ....+.+|+.++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999986  78999998764322   223567899999999999999999998755  46899


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+. ++|.+++......+++..++.++.|++.||.|||+.  +++|+||||+||+++.++.+||+|||++.......
T Consensus        86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN--FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999996 589998887656799999999999999999999999  99999999999999999999999999997664332


Q ss_pred             cccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc--Ccc-------
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK--GKI-------  276 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~--~~i-------  276 (487)
                      .  ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||........... .......  ...       
T Consensus       163 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         163 K--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL-IIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             C--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCCCChhhchhhhcc
Confidence            1  1223356788999999865 4578999999999999999999999864322111111 1000000  000       


Q ss_pred             --ccccC-CCCCCC----CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          277 --LSVFD-PRIPPP----KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       277 --~~~~~-~~~~~~----~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        ...+. +.....    .....++++.+++.+||+.||++|||+++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              00000 000000    01124677899999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-38  Score=319.79  Aligned_cols=242  Identities=24%  Similarity=0.347  Sum_probs=203.3

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .|.-.+.||.|+||.||-+.+.  ...||||+...+.    ..-..+.+||.+|.+++|||+|.+-|||......|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3677788999999999999876  7789999887542    233679999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      || -||-.|++.-..+++-+..+..|..+.+.||+|||+.  +.||||||..|||+.+.|.|||+|||.+..+.+.    
T Consensus       107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~--~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----  179 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH--NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----  179 (948)
T ss_pred             HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh--hHHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence            99 5688899887778899999999999999999999999  9999999999999999999999999998765543    


Q ss_pred             ccCCCCCCCccCCccccCC---CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTP---DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                        ..+.|||.|||||++..   +.|+-++|||||||+..||.-.++|+.....-..+..    +..+         .-+.
T Consensus       180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH----IAQN---------esPt  244 (948)
T KOG0577|consen  180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQN---------ESPT  244 (948)
T ss_pred             --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH----HHhc---------CCCC
Confidence              34689999999999764   5899999999999999999999988763221111111    1111         1111


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      --..+++..+..++..||++-|.+|||.+++++
T Consensus       245 Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  245 LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            224678999999999999999999999999986

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9.5e-37  Score=301.92  Aligned_cols=250  Identities=23%  Similarity=0.358  Sum_probs=195.7

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCC-CCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIH-SPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +|...+.||+|+||.||++.+.  ++.||+|.+....  .....+.+|+.++.++. ||||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            5666789999999999999986  7899999876542  33457889999999996 99999999999999999999999


Q ss_pred             cCCCCHHHHHH---h-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          131 MSNGTLYDVLH---S-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       131 ~~~gsL~~~l~---~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      +. ++|.++..   . ....+++..+..++.+++.||+|||+.. +++||||||+|||++.++.+||+|||++..+....
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL-KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC-CeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            85 46655432   1 2346999999999999999999999632 89999999999999999999999999986543322


Q ss_pred             cccccCCCCCCCccCCccccCCC---CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPD---NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                         ......|++.|+|||.+.+.   .++.++|||||||++|+|++|+.||....   .........      .....+.
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~------~~~~~~~  230 (288)
T cd06616         163 ---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQV------VKGDPPI  230 (288)
T ss_pred             ---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhh------cCCCCCc
Confidence               12334688999999998776   68999999999999999999999986332   111111111      0111122


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +.......++.++.+|+.+||+.+|++|||+++|+.
T Consensus       231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            222223457788999999999999999999999997

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.2e-36  Score=309.15  Aligned_cols=258  Identities=22%  Similarity=0.310  Sum_probs=198.6

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC------
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS------  121 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------  121 (487)
                      ..++|...+.||+|+||.||+|...  ++.||+|++...   ......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999875  889999987643   23345677899999999999999999988643      


Q ss_pred             CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      ...|+||||+. ++|.+.+...   ++...+..++.|++.||+|||+.  +|+|+||||+|||++.++.+||+|||++..
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~--gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  167 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART  167 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence            35699999995 5888887643   88999999999999999999999  999999999999999999999999999976


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhh--------------
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA--------------  267 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~--------------  267 (487)
                      .....   ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.............              
T Consensus       168 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
T cd07850         168 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL  244 (353)
T ss_pred             CCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            54322   2334568899999999999999999999999999999999999986432111100000              


Q ss_pred             ----hhhhhcCc------cccccC----CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          268 ----APLIKKGK------ILSVFD----PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       268 ----~~~~~~~~------i~~~~~----~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                          ........      +...+.    +......+...+.++.+++.+||+.||.+|||+.|++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                00000000      000000    00000112245677899999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5.7e-37  Score=306.05  Aligned_cols=246  Identities=23%  Similarity=0.324  Sum_probs=198.8

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC-hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecC
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN-QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      .|.....||+|+||.||++...  ++.||+|.+... ....+.+.+|+.++..++||||+++++++..++..++|+||++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            3445568999999999999875  789999987643 2334578899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccC
Q 011384          133 NGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       133 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      +++|.+++...  .+++..++.++.|++.||.|||+.  +++|+||||+||+++.++.+||+|||++........  ...
T Consensus       102 ~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~--~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  175 (297)
T cd06659         102 GGALTDIVSQT--RLNEEQIATVCESVLQALCYLHSQ--GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK  175 (297)
T ss_pred             CCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence            99999987653  489999999999999999999999  999999999999999999999999999865433221  123


Q ss_pred             CCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHH
Q 011384          213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV  292 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  292 (487)
                      ...|+..|+|||.+.+..++.++|||||||++|||++|+.||...... .....    +....       .........+
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~----~~~~~-------~~~~~~~~~~  243 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAMKR----LRDSP-------PPKLKNAHKI  243 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH----HhccC-------CCCccccCCC
Confidence            356899999999999888999999999999999999999998642211 11111    11000       0001112235


Q ss_pred             HHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          293 RKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       293 ~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..+.+++.+||+.+|.+||++++|++
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            567899999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2e-36  Score=299.29  Aligned_cols=239  Identities=20%  Similarity=0.287  Sum_probs=188.4

Q ss_pred             eecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHH---hCCCCCceeeEEEEeCCCceEEEEEecC
Q 011384           62 LLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILS---KIHSPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        62 ~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~---~l~hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      +||+|+||.||++...  ++.||+|.+....    .....+.+|..++.   ..+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999885  7899999876432    11233444544433   3479999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccC
Q 011384          133 NGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       133 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      +++|.+++...+ .+++..+..++.|++.||.|||+.  +++|+||||+|||++.++.++|+|||++.......    ..
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~--~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~  153 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH  153 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----cc
Confidence            999999987654 499999999999999999999999  99999999999999999999999999986543221    22


Q ss_pred             CCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          213 PPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ...|++.|+|||.+.. ..++.++|||||||++|+|++|..||......... . ....          ........+..
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~-~~~~----------~~~~~~~~~~~  221 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-E-IDRM----------TLTVNVELPDS  221 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-H-HHHH----------hhcCCcCCccc
Confidence            3468999999999864 56789999999999999999999999643222111 1 0000          00112223445


Q ss_pred             HHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          292 VRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      ++.++.+++.+||+.||.+||     ++.++++
T Consensus       222 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         222 FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            678899999999999999999     5999887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.5e-36  Score=297.32  Aligned_cols=255  Identities=22%  Similarity=0.259  Sum_probs=194.4

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCC-CCCceeeEEEEeCC--CceEEEEE
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIH-SPRLVNLLGFSNDS--KDRLLVVE  129 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~--~~~~lV~E  129 (487)
                      |++.+.||+|+||.||+|...  ++.||+|++....  .......+|+.++.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            677899999999999999875  7889999877532  22234557899999885 99999999999887  88999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |++ ++|.+.+......+++..++.++.|++.||.|||+.  +++|+||+|+||+++. +.+||+|||++.......   
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~---  153 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN--GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP---  153 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--CceecccCHHHEEEcC-CCeEEEecccccccccCC---
Confidence            996 588888876555699999999999999999999999  9999999999999999 999999999987654322   


Q ss_pred             ccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhh-----------hcCccc
Q 011384          210 RSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI-----------KKGKIL  277 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~-----------~~~~i~  277 (487)
                      ......++..|+|||.+.. ..++.++|||||||++|||++|..||..... ...........           ......
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-LDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-HHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence            1223457899999997654 4568899999999999999999999864322 11111111100           000000


Q ss_pred             cccCCCCCC----CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          278 SVFDPRIPP----PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       278 ~~~~~~~~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ....+....    .....++..+.+++.+||+++|++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000000000    011245789999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.3e-36  Score=303.18  Aligned_cols=245  Identities=24%  Similarity=0.361  Sum_probs=199.0

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .|...+.||+|+||.||++++.  +..||+|++...    ......+.+|+++++.++|||++++++++.+....++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3778899999999999999875  788999987643    2234578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |++ |+|.+.+.....++++..+..++.+++.||.|||+.  +++|+||+|+||+++.++.+||+|||++.....     
T Consensus       106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----  177 (317)
T cd06635         106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH--NMIHRDIKAGNILLTEPGQVKLADFGSASIASP-----  177 (317)
T ss_pred             CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence            996 588888876666799999999999999999999999  999999999999999999999999998754332     


Q ss_pred             ccCCCCCCCccCCccccC---CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVT---PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                       .....+++.|+|||++.   .+.++.++|||||||++|+|++|+.||...........    ....         ....
T Consensus       178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----~~~~---------~~~~  243 (317)
T cd06635         178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQN---------ESPT  243 (317)
T ss_pred             -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH----HHhc---------cCCC
Confidence             22346889999999974   45678999999999999999999999863211111111    1111         1111


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      .....++..+.+++.+||+.+|.+||++.+|++.+.
T Consensus       244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence            122346678999999999999999999999998543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=298.92  Aligned_cols=258  Identities=22%  Similarity=0.303  Sum_probs=198.8

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCC--CceEEEEE
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDS--KDRLLVVE  129 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lV~E  129 (487)
                      |.+.+.||+|++|.||+|++.  ++.||+|++....   .....+.+|+++++.++|||++++++++.+.  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            677899999999999999986  6899999987652   3345688999999999999999999999888  88999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |+++ +|.+++......+++..++.++.|++.||+|||+.  +++|+||+|+||+++.++.+||+|||++......... 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~--~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-  156 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN--GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-  156 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-
Confidence            9975 89999877655699999999999999999999999  9999999999999999999999999998765443211 


Q ss_pred             ccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc---Cc---ccc----
Q 011384          210 RSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK---GK---ILS----  278 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~---~~---i~~----  278 (487)
                      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........... .......   ..   +..    
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK-IFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCchhhccccccchhh
Confidence            1233467889999998765 4578999999999999999999999864332211111 1000000   00   000    


Q ss_pred             -ccCCC------CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          279 -VFDPR------IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       279 -~~~~~------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                       ...+.      +.......++..+.+++.+||+.+|.+||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             00000      000001113678899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-36  Score=292.87  Aligned_cols=248  Identities=26%  Similarity=0.366  Sum_probs=199.9

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC------hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC--Cce
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN------QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS--KDR  124 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~------~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~  124 (487)
                      .+|.+.+.||+|+||.||+|.+.  ++.||+|.+...      ......+.+|++++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47899999999999999999875  789999986432      22345788999999999999999999998764  457


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++|+||+++++|.+++...+ .+++..+..++.|++.||.|||+.  +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~--~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            89999999999999997654 489999999999999999999999  999999999999999999999999999875432


Q ss_pred             CCc-ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          205 DNF-RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       205 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ... ........++..|+|||.+.+..++.++|||||||++|+|++|+.||........+..             .....
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~  225 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK-------------IATQP  225 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH-------------HHcCC
Confidence            111 1112234688999999999988889999999999999999999999863211111111             11111


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .....+..+++++.+++.+||. +|..||++.+++.
T Consensus       226 ~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         226 TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            2223455677889999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3e-36  Score=346.40  Aligned_cols=259  Identities=24%  Similarity=0.456  Sum_probs=209.2

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ...|...++||+|+||.||+|++.  +..||||++......   ...|++++++++|||||+++++|.+....++||||+
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            356788899999999999999974  889999988754332   235688999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE-MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      ++|+|.+++..    ++|..+..++.|++.||+|||.. .++|+||||||+||+++.++.+++. ||.......      
T Consensus       766 ~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------  834 (968)
T PLN00113        766 EGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------  834 (968)
T ss_pred             CCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------
Confidence            99999999953    89999999999999999999943 3399999999999999998888775 555432211      


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCC-CchhhhhhhhhhhcCccccccCCCCCC--C
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFS-PPSIVDWAAPLIKKGKILSVFDPRIPP--P  287 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~--~  287 (487)
                      .....+|+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..|.............+++.+..  +
T Consensus       835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (968)
T PLN00113        835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS  914 (968)
T ss_pred             CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC
Confidence            1223688999999999999999999999999999999999999864332 334555655444444444455555533  2


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .+.....++.+++.+||+.+|++||||.||++.|+.+..
T Consensus       915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            344566678899999999999999999999999988754

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.2e-36  Score=298.63  Aligned_cols=246  Identities=25%  Similarity=0.383  Sum_probs=199.4

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecC
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      .|...+.||+|++|.||++.+.  ++.|++|++.... ...+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            4556689999999999999875  7889999876433 234568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccC
Q 011384          133 NGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       133 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      +++|.+++..  ..+++..+..++.|++.||+|||+.  +++||||+|+||+++.++.++|+|||++........  ...
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~  173 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQ--GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRK  173 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccc
Confidence            9999999977  3489999999999999999999999  999999999999999999999999998765432211  122


Q ss_pred             CCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHH
Q 011384          213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV  292 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  292 (487)
                      ...|++.|+|||.+.+..++.++|||||||++|+|++|+.||.... +.....    ....+     ..+..  ..+..+
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-~~~~~~----~~~~~-----~~~~~--~~~~~~  241 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-PLQAMK----RIRDN-----LPPKL--KNLHKV  241 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-HHHHHH----HHHhc-----CCCCC--cccccC
Confidence            3468999999999998889999999999999999999999986321 111111    11111     01111  112235


Q ss_pred             HHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          293 RKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       293 ~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..+.+++.+||+.+|++||++.++++
T Consensus       242 ~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         242 SPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            678999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-36  Score=289.64  Aligned_cols=245  Identities=24%  Similarity=0.421  Sum_probs=204.3

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +|.+.+.||+|++|.||++...  ++.|++|.+....   .....+.+|++++++++|||++++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788999999999999999876  7789999887654   3456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +++++|.+++... ..+++..++.++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++.........  
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQ--GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhC--CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence            9999999999876 4599999999999999999999999  9999999999999999999999999999766543321  


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      .....++..|++||.+.+..++.++||||||+++|+|++|+.||.........  +  ....          ......+.
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~--~--~~~~----------~~~~~~~~  221 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL--F--RIVQ----------DDHPPLPE  221 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH--H--HHhc----------cCCCCCCC
Confidence            23356889999999998888899999999999999999999998632211111  1  0100          11112334


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .++..+.+++.+||..+|++|||+.+++.
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         222 GISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            56778999999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.5e-36  Score=299.93  Aligned_cols=257  Identities=17%  Similarity=0.189  Sum_probs=188.3

Q ss_pred             hhcCcccceeecccCceEEEEEEECC-----eEEEEEEcCCChhh--H----------HHHHHHHHHHHhCCCCCceeeE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLRG-----RQVAVKKPSKNQEI--S----------QEVDNEIEILSKIHSPRLVNLL  115 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~g-----~~vAvK~~~~~~~~--~----------~~~~~Ei~~l~~l~hpnIv~l~  115 (487)
                      ..++|.+.++||+|+||.||+|.+.+     ..+|+|+.......  .          .....+...+..+.|+|+++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            34689999999999999999998763     35677754322111  0          1122344455677899999999


Q ss_pred             EEEeCCC----ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcE
Q 011384          116 GFSNDSK----DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNA  191 (487)
Q Consensus       116 ~~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~v  191 (487)
                      +++....    ..+++++++. .++.+.+.... ..++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~--~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIHEH--GISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCcE
Confidence            9765543    3468888874 47777776542 367888999999999999999999  99999999999999999999


Q ss_pred             EEcccccceecCCCCcc-----cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhh
Q 011384          192 RLGDFGLALRCGVDNFR-----FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDW  266 (487)
Q Consensus       192 kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~  266 (487)
                      +|+|||+++.+......     .......||+.|+|||.+.+..++.++|||||||++|||++|..||............
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999999766432211     1122346999999999999999999999999999999999999999743222222111


Q ss_pred             hh-hhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          267 AA-PLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       267 ~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                      .. ....     .+....+   ....+++++.+++..||+.+|++||++.+|++.|
T Consensus       246 ~~~~~~~-----~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        246 AKCDFIK-----RLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hHHHHHH-----Hhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            11 0100     0001111   1123467899999999999999999999999876

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4e-36  Score=290.54  Aligned_cols=246  Identities=24%  Similarity=0.385  Sum_probs=205.9

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +|.+.+.||.|+||.||++.+.  +..|++|++....   .....+.+|+++++.++|||++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5888999999999999999987  8899999887542   3456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          131 MSNGTLYDVLHSN---NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       131 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      +++++|.+++...   +..+++..+..++.+++.||.|||+.  +++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC--CEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence            9999999999764   36699999999999999999999999  99999999999999999999999999987654432 


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                       .......|++.|+|||.+....++.++|+||||+++|+|++|..||.... ...+..   ... .         ....+
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~---~~~-~---------~~~~~  222 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL---KIL-K---------GQYPP  222 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-HHHHHH---HHh-c---------CCCCC
Confidence             12233468899999999988889999999999999999999999986432 111111   111 1         11122


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+..++..+.+++.+||..+|++|||+.++++
T Consensus       223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            33356678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3e-36  Score=297.06  Aligned_cols=241  Identities=27%  Similarity=0.329  Sum_probs=193.7

Q ss_pred             ecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCCH
Q 011384           63 LGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTL  136 (487)
Q Consensus        63 LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  136 (487)
                      ||+|+||.||++.+.  ++.||+|.+....    .....+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999876  8899999876432    2234567899999999999999999999999999999999999999


Q ss_pred             HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCC
Q 011384          137 YDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA  215 (487)
Q Consensus       137 ~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~  215 (487)
                      .+++.... ..+++..++.++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++.......   ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~--~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccccc
Confidence            99997644 3589999999999999999999999  99999999999999999999999999986543211   223346


Q ss_pred             CCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHH
Q 011384          216 GTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQ  295 (487)
Q Consensus       216 gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  295 (487)
                      ++..|++||.+.+..++.++|||||||++|+|++|+.||............     ...    ..  ..+...+..++..
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~----~~--~~~~~~~~~~~~~  224 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL-----KRR----TL--EMAVEYPDKFSPE  224 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH-----Hhc----cc--cccccCCccCCHH
Confidence            788999999998888999999999999999999999998643221111110     000    00  1112233445778


Q ss_pred             HHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          296 LAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       296 l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      +.+++.+||+.+|.+||     ++.+++.
T Consensus       225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         225 AKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            99999999999999999     6666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.7e-36  Score=300.48  Aligned_cols=249  Identities=24%  Similarity=0.442  Sum_probs=197.0

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCC-CCCceeeEEEEeCCCceEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIH-SPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||.+....  .....+..|+.++.+.. ||||+++++++.+....++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            367888999999999999999997  8899999987542  23455677887777775 999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      ||+. ++|.+++......+++..+..++.|++.||+|||+ .  +|+|+||+|+||+++.++.+||+|||++..+.... 
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~-  169 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK-  169 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence            9984 58888887655579999999999999999999997 6  89999999999999999999999999986553322 


Q ss_pred             ccccCCCCCCCccCCccccCCCC----CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDN----LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                        ......+++.|+|||.+.+..    ++.++||||||+++|+|++|+.||..........   ...... .     .+.
T Consensus       170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~-~-----~~~  238 (296)
T cd06618         170 --AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL---TKILQE-E-----PPS  238 (296)
T ss_pred             --cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH---HHHhcC-C-----CCC
Confidence              122345788999999987653    7889999999999999999999986422211111   111111 0     011


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+  ....++.++.+|+.+||+.+|++||+++++++
T Consensus       239 ~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         239 LP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11  11235678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=298.47  Aligned_cols=258  Identities=24%  Similarity=0.305  Sum_probs=197.5

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      |+..+.||.|++|.||+|.+.  +..||+|++....   .....+.+|+++++.++|||++++++++.+....++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            667899999999999999875  8899999876543   22356888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          132 SNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       132 ~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      + ++|.+++.... ..+++..++.++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++........  .
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~--~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~  155 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH--RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--T  155 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--c
Confidence            5 69999987644 3589999999999999999999999  999999999999999999999999999865543221  1


Q ss_pred             cCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC-----------cccc
Q 011384          211 STPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG-----------KILS  278 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~-----------~i~~  278 (487)
                      .....+++.|+|||++.+. .++.++|||||||++|+|++|..||....................           ....
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP  235 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence            2234568899999988664 568899999999999999999999864322111111100000000           0000


Q ss_pred             cc---CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          279 VF---DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       279 ~~---~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+   ...........++..+.+++.+||+.+|.+|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00   000001112335578899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.5e-36  Score=299.72  Aligned_cols=260  Identities=23%  Similarity=0.306  Sum_probs=195.5

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh---hHHHHHHHHHHHHhCC-CCCceeeEEEEeCCCc-----
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIH-SPRLVNLLGFSNDSKD-----  123 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~---~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~-----  123 (487)
                      ++|++.+.||+|+||.||+|.+.  ++.||||.......   ....+.+|+.+++.+. ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46899999999999999999986  78999998764422   2356888999999995 6999999999887665     


Q ss_pred             eEEEEEecCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc-CCcEEEccccc
Q 011384          124 RLLVVEFMSNGTLYDVLHSN----NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-NFNARLGDFGL  198 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~-~~~vkL~DFGl  198 (487)
                      .|+||||+++ +|.+++...    ...+++..++.++.||+.||.|||+.  +++|+||+|+||+++. ++.+||+|||+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH--GVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCChHHEEEecCCCeEEEeeccc
Confidence            7999999975 898888643    24589999999999999999999999  9999999999999998 88999999999


Q ss_pred             ceecCCCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCc-c
Q 011384          199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK-I  276 (487)
Q Consensus       199 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~-i  276 (487)
                      +........  ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||..................... .
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         158 GRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             ceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            875533221  1223457889999998865 45789999999999999999999998643222211111100000000 0


Q ss_pred             ----cccc----CCCCCC----CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          277 ----LSVF----DPRIPP----PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       277 ----~~~~----~~~~~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                          ....    .+....    ...+.++.++.++|.+||..||.+||++++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                0000    000000    011235678999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.5e-36  Score=300.32  Aligned_cols=261  Identities=20%  Similarity=0.285  Sum_probs=194.5

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC-------
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSK-------  122 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-------  122 (487)
                      ++|...+.||+|+||.||+|...  ++.||||.+....   .....+.+|++++++++||||+++++++....       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            57999999999999999999986  7899999875432   22345678999999999999999999987654       


Q ss_pred             -ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          123 -DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       123 -~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                       ..++||||+. ++|.+.+......+++..++.++.|++.||.|||+.  +++|+||||+||+++.++.+||+|||++..
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN--KILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence             3499999996 589888877655699999999999999999999999  999999999999999999999999999876


Q ss_pred             cCCCCcc--cccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh------
Q 011384          202 CGVDNFR--FRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK------  272 (487)
Q Consensus       202 ~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~------  272 (487)
                      .......  .......++..|+|||.+.+. .++.++||||||+++|||++|+.||..... .........+..      
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  247 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-QHQLTLISQLCGSITPEV  247 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhh
Confidence            5432211  112234578899999988664 468899999999999999999988864322 111111111000      


Q ss_pred             --cCccccccCC-CCCCCC---------ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          273 --KGKILSVFDP-RIPPPK---------DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       273 --~~~i~~~~~~-~~~~~~---------~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        ...-....+. ..+...         +...+..+.+|+.+||+.||.+|||++++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence              0000000000 000000         0012356778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.9e-36  Score=296.49  Aligned_cols=259  Identities=22%  Similarity=0.317  Sum_probs=199.0

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      +|+..+.||.|++|.||+|++.  +..||||++....  .....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999986  7889999876543  23456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          132 SNGTLYDVLHSNN--RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       132 ~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      ++ +|.+++....  ..+++..+..++.|++.||.|||+.  +++|+||||+||+++.++.++|+|||++........  
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN--RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence            75 8988887543  4589999999999999999999999  999999999999999999999999999865433211  


Q ss_pred             ccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhh-------hhcCccccccC
Q 011384          210 RSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL-------IKKGKILSVFD  281 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~-------~~~~~i~~~~~  281 (487)
                      ......+++.|++||.+.+. .++.++|||||||++|+|++|+.||................       .........+.
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            12234578899999988664 56889999999999999999999986433222111110000       00000000000


Q ss_pred             CCCCC-------CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          282 PRIPP-------PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       282 ~~~~~-------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..++.       ...+.++..+.+++.+||+.+|.+||++.+|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            11110       011234678899999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.2e-36  Score=296.58  Aligned_cols=249  Identities=26%  Similarity=0.351  Sum_probs=199.5

Q ss_pred             CcccceeecccCceEEEEEEE-----CCeEEEEEEcCCCh-----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCce
Q 011384           56 GFSEQKLLGKGSHGSVYKAVL-----RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~-----~g~~vAvK~~~~~~-----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  124 (487)
                      +|++.+.||+|+||.||++..     .|..||+|++....     ...+.+.+|++++.++ +|+||+.+++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999986     47889999886532     2335688899999999 689999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||+++++|.+++.... .+++..+..++.|++.||.|||+.  +++|+||+|+|||++.++.+||+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            99999999999999997654 489999999999999999999999  999999999999999999999999999876543


Q ss_pred             CCcccccCCCCCCCccCCccccCCC--CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPD--NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~  282 (487)
                      .... ......|+..|+|||.+...  .++.++||||||+++|+|++|..||...........+......          
T Consensus       158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~----------  226 (290)
T cd05613         158 DEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK----------  226 (290)
T ss_pred             cccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc----------
Confidence            3221 22335688999999998753  4678999999999999999999998643222222222111111          


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       283 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                       ...+.+..++..+.+++.+||+.+|++||     ++++++.
T Consensus       227 -~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         227 -SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence             01123445667889999999999999997     6677765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-37  Score=317.61  Aligned_cols=247  Identities=24%  Similarity=0.432  Sum_probs=202.2

Q ss_pred             ccceeecccCceEEEEEEEC--CeEEE---EE--EcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCc--eEEEE
Q 011384           58 SEQKLLGKGSHGSVYKAVLR--GRQVA---VK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKD--RLLVV  128 (487)
Q Consensus        58 ~~~~~LG~G~~g~Vy~~~~~--g~~vA---vK--~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~--~~lV~  128 (487)
                      +...+||+|+|-+||+|.+.  |..||   ||  .+.+.....++|..|+++|+.|+||||+++|+++.+...  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44568999999999999987  54554   22  233455556889999999999999999999999987765  67999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc-CCcEEEcccccceecCCCCc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-NFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla~~~~~~~~  207 (487)
                      |.+..|+|..++++.++ ++.+.+..|++||+.||.|||++.|.|||||||-+||||+. -|.|||+|+|||..+.... 
T Consensus       123 EL~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-  200 (632)
T ss_pred             ecccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence            99999999999998765 99999999999999999999999999999999999999975 5899999999997765442 


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                         .....|||.|||||.+. +.|....||||||++++||+|+..|+.--..+.+++..+.    .|....-+.      
T Consensus       201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~----SGiKP~sl~------  266 (632)
T KOG0584|consen  201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT----SGIKPAALS------  266 (632)
T ss_pred             ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH----cCCCHHHhh------
Confidence               33479999999999987 8899999999999999999999999976666666554322    221111111      


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhc
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG  323 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~  323 (487)
                        ..-.++++++|.+||.. ..+|||+.|+|.  +|..
T Consensus       267 --kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  267 --KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             --ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence              11135789999999999 999999999997  4543

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-36  Score=292.71  Aligned_cols=239  Identities=25%  Similarity=0.284  Sum_probs=188.7

Q ss_pred             eeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHH-HhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEIL-SKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l-~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|+||.||+|...  ++.||||++.+...    ....+..|..++ ...+|||++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999885  78999998875432    122344555444 455899999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      ++|.+++...+ .+++..+..++.|++.||.|||+.  +++|+||+|+|||++.++.+||+|||++.....      ...
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~  152 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQR--GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKK  152 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCcEEEeecccceeccc------ccc
Confidence            99999997654 489999999999999999999999  999999999999999999999999999865432      223


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      ..+++.|++||.+.+..++.++||||||+++|+|++|..||..... ....   . ....+..      ..+......++
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~---~-~~~~~~~------~~~~~~~~~~~  221 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-DAVF---D-NILSRRI------NWPEEVKEFCS  221 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-HHHH---H-HHHhccc------CCCCcccccCC
Confidence            4688999999999888889999999999999999999999863221 1111   1 1111111      11122223467


Q ss_pred             HHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          294 KQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .++.+++.+||+.+|++||++.++.+
T Consensus       222 ~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         222 PEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             HHHHHHHHHHccCCHHHccCCCcHHH
Confidence            88999999999999999997654433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-36  Score=299.90  Aligned_cols=261  Identities=20%  Similarity=0.262  Sum_probs=195.0

Q ss_pred             CcccceeecccCceEEEEEEEC----CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCC--CceE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR----GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDS--KDRL  125 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~----g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~  125 (487)
                      +|.+.+.||+|+||.||+|.+.    ++.||+|.+....    .....+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999984    5889999887632    2335678899999999999999999999988  7899


Q ss_pred             EEEEecCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc----CCcEEEcccc
Q 011384          126 LVVEFMSNGTLYDVLHSN----NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR----NFNARLGDFG  197 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~----~~~vkL~DFG  197 (487)
                      +||||+++ +|.+.+...    ...+++..++.++.|++.||.|||+.  +++||||||+|||++.    ++.+||+|||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC--CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            99999965 777766431    23589999999999999999999999  9999999999999999    8999999999


Q ss_pred             cceecCCCCc-ccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc---------hhhhh
Q 011384          198 LALRCGVDNF-RFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPP---------SIVDW  266 (487)
Q Consensus       198 la~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~---------~~~~~  266 (487)
                      ++..+..... ........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.......         .+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9876543322 1122344678999999988764 57899999999999999999999986432211         00000


Q ss_pred             hhhh-----------hhcCccccccCCCCCCCCC-----------hHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          267 AAPL-----------IKKGKILSVFDPRIPPPKD-----------PIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       267 ~~~~-----------~~~~~i~~~~~~~~~~~~~-----------~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...+           ..........+.......+           ...+.++.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000           0000000000000000011           034457889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.3e-36  Score=290.87  Aligned_cols=244  Identities=26%  Similarity=0.375  Sum_probs=202.9

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +|++.+.||+|++|.||++.+.  +..+++|.+...   ......+.+|+++++.++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788999999999999999875  778999987653   23345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          131 MSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       131 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      +++++|.+++..   .+..+++..++.++.|++.||.|||+.  +++|+||+|.||+++.++.+||+|||++......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~--~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ--KILHRDLKSANILLVANDLVKIGDLGISKVLKKN--  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC--CcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence            999999999865   234589999999999999999999999  9999999999999999999999999998765443  


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                        ......+++.|++||.+.+..++.++|+||||+++|+|++|+.||.... ......    ...         .....+
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-~~~~~~----~~~---------~~~~~~  220 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLRY----KVQ---------RGKYPP  220 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHH----HHh---------cCCCCC
Confidence              1223468899999999998889999999999999999999999986322 111111    111         111122


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+..++.++.+++.+||+.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            33467788999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.7e-36  Score=296.57  Aligned_cols=252  Identities=21%  Similarity=0.308  Sum_probs=201.2

Q ss_pred             CcccceeecccCceEEEEEEEC-----CeEEEEEEcCCCh-----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCce
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKNQ-----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~~-----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  124 (487)
                      +|.+.+.||+|++|.||++...     ++.||||.+....     .....+.+|++++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788899999999999998753     5789999876432     2335688999999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||+++++|.+++.... .+++..+..++.|++.+|.|||+.  +++|+||+|+||+++.++.++|+|||++..+..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~--~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQL--GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            99999999999999987654 489999999999999999999999  999999999999999999999999999876543


Q ss_pred             CCcccccCCCCCCCccCCccccCCCC--CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPDN--LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~  282 (487)
                      .... ......|+..|++||.+.+..  .+.++||||||+++|+|++|..||..................         .
T Consensus       158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---------~  227 (288)
T cd05583         158 EEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK---------S  227 (288)
T ss_pred             cccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc---------c
Confidence            3211 222346889999999987654  688999999999999999999998643222221111111111         0


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       283 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                        ..+.+..++..+.+++.+||+.+|++|||+.++.+.|.
T Consensus       228 --~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         228 --KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             --CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence              11233446678899999999999999999888877654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-37  Score=288.25  Aligned_cols=248  Identities=23%  Similarity=0.396  Sum_probs=203.9

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCC-CCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIH-SPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +.+.+..||.|..|.||++..+  |...|||....+.  ...++++..+.++..-+ +|.||+.+|||..+...++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            4556788999999999999987  6899999877653  34467888888887765 89999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      | ...+..+|..-..++++..+-++...++.||.||..++ +|+|||+||+|||+|..|++||||||++-.+....   .
T Consensus       173 M-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---A  247 (391)
T KOG0983|consen  173 M-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---A  247 (391)
T ss_pred             H-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccccceeeccc---c
Confidence            9 55788888887788999999999999999999999875 99999999999999999999999999996655433   3


Q ss_pred             cCCCCCCCccCCccccCCC---CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          211 STPPAGTIGYLDPCYVTPD---NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~---~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                      .+...|-+.|||||.+...   .|+.++||||||+.|+||.||..||.......+....+         ..-..|.++..
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv---------ln~ePP~L~~~  318 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV---------LNEEPPLLPGH  318 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH---------HhcCCCCCCcc
Confidence            3456799999999999765   67889999999999999999999998544443333211         11112333322


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        ..++.++.+++..||++|+.+||...++++
T Consensus       319 --~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  319 --MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             --cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence              237889999999999999999999999997

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.6e-36  Score=297.51  Aligned_cols=258  Identities=23%  Similarity=0.313  Sum_probs=196.4

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ++|...+.||+|++|.||+|.+.  ++.||+|.+....   .....+.+|++++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            47899999999999999999886  7889999876432   233568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc-CCcEEEcccccceecCCCCc
Q 011384          130 FMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-NFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       130 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla~~~~~~~~  207 (487)
                      |++ ++|.+++.... ..+++..++.++.||+.||.|||++  +++|+||+|+||+++. ++.+||+|||++........
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH--RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            995 58888876533 3368888899999999999999999  9999999999999985 56799999999865443211


Q ss_pred             ccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccc-------
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV-------  279 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~-------  279 (487)
                        ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||........+..... ..... ....       
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~  234 (294)
T PLN00009        159 --TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFR-ILGTP-NEETWPGVTSL  234 (294)
T ss_pred             --ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HhCCC-Chhhccccccc
Confidence              12334678899999988664 578999999999999999999999864322211111100 00000 0000       


Q ss_pred             -----cCCCCCC----CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          280 -----FDPRIPP----PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       280 -----~~~~~~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                           ..+....    ...+.++.++.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 0000000    011235677899999999999999999999996

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7.9e-36  Score=299.23  Aligned_cols=244  Identities=24%  Similarity=0.353  Sum_probs=197.7

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      +.|...+.||+|+||.||+|++.  +..||+|.+...    ......+.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            44777889999999999999985  778999987532    233456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+. ++|.+.+.....++++..+..++.|++.||.|||+.  +++|+||+|+|||++.++.++|+|||++......   
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            9996 688888876566699999999999999999999999  9999999999999999999999999998654322   


Q ss_pred             cccCCCCCCCccCCccccC---CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVT---PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                         ....+++.|+|||.+.   ...++.++|||||||++|+|++|..||...........    .. .        ...+
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~-~--------~~~~  232 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IA-Q--------NESP  232 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH----Hh-h--------cCCC
Confidence               2346889999999974   34678899999999999999999999853211111111    00 0        0111


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                      ......++..+.+|+.+||+.+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            11233567789999999999999999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-36  Score=294.95  Aligned_cols=257  Identities=25%  Similarity=0.312  Sum_probs=200.9

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCChh---hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      |...+.||+|++|.||++...  ++.+++|++.....   ....+.+|++++++++|+||+++++++.+....++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999885  78899998765432   3467888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      ++ +|.+++......+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||.+........  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~  155 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH--GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PY  155 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC--CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cc
Confidence            75 89888877656799999999999999999999999  999999999999999999999999999876654331  12


Q ss_pred             CCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC---ccccccC------
Q 011384          212 TPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG---KILSVFD------  281 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~---~i~~~~~------  281 (487)
                      ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||........+.... ......   .......      
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF-RTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHcCCCchHhcccchhhhhhhh
Confidence            334678899999998876 78999999999999999999998885432211111100 000000   0000000      


Q ss_pred             CCC----C---CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          282 PRI----P---PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       282 ~~~----~---~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+    .   ....+.++.++.+++.+||+.+|.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            000    0   0112346788999999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6e-36  Score=297.99  Aligned_cols=263  Identities=22%  Similarity=0.291  Sum_probs=199.8

Q ss_pred             HHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC---
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSK---  122 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---  122 (487)
                      +...++|++.+.||+|+||.||+|.+.  ++.||+|++....   .....+.+|+++++.++||||+++++++.+..   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            345678999999999999999999986  7889999876432   23356788999999999999999999987654   


Q ss_pred             -------ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcc
Q 011384          123 -------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGD  195 (487)
Q Consensus       123 -------~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~D  195 (487)
                             ..++|+||+++ +|.+.+......+++..+..++.|++.||+|||+.  +|+|+||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK--NFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCcEEeCc
Confidence                   78999999975 78888876555699999999999999999999999  999999999999999999999999


Q ss_pred             cccceecCCCCcccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC
Q 011384          196 FGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG  274 (487)
Q Consensus       196 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  274 (487)
                      ||++......... ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||........... ........
T Consensus       160 fg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~-~~~~~~~~  237 (302)
T cd07864         160 FGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL-ISRLCGSP  237 (302)
T ss_pred             ccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCC
Confidence            9998765433211 12223567889999988654 568999999999999999999999864322111111 10000000


Q ss_pred             c---cccc--------cC------CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          275 K---ILSV--------FD------PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       275 ~---i~~~--------~~------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .   ....        .+      ..... ....++..+.+++.+||+.+|.+||++++|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             Chhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0   0000        00      00000 11134678999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.1e-36  Score=292.81  Aligned_cols=243  Identities=29%  Similarity=0.354  Sum_probs=195.7

Q ss_pred             ecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCCH
Q 011384           63 LGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTL  136 (487)
Q Consensus        63 LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  136 (487)
                      ||+|+||.||++++.  ++.|++|.+.....    ....+.+|++++++++||||+++++.+......|+|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999987  88999998875533    346788999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc------ccc
Q 011384          137 YDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF------RFR  210 (487)
Q Consensus       137 ~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~------~~~  210 (487)
                      .+++...+ .+++..++.++.|++.||+|||+.  +++|+||+|+||+++.++.++|+|||++........      ...
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~--~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSN--GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHc--CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence            99998755 599999999999999999999999  999999999999999999999999999865433211      112


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      .....++..|++||.+.....+.++||||||+++|+|++|..||.... +.....   .. ..+.        ...+...
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~---~~-~~~~--------~~~~~~~  224 (265)
T cd05579         158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-PEEIFQ---NI-LNGK--------IEWPEDV  224 (265)
T ss_pred             ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHH---HH-hcCC--------cCCCccc
Confidence            233467889999999988888999999999999999999999986432 111111   11 1111        1111111


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                      ..+..+.+++.+||+.+|.+|||+.++.+.|
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            2378899999999999999999995555444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.8e-36  Score=295.16  Aligned_cols=247  Identities=21%  Similarity=0.332  Sum_probs=203.4

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCC-CCCceeeEEEEeCCCceEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIH-SPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV  127 (487)
                      ++|.+.+.||+|+||.||++...  +..||+|++...    ......+.+|++++++++ ||||+++++++.+....++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47899999999999999999885  889999988753    233467889999999998 99999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+++++|.+++.+.+ .+++..++.++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~--~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            99999999999998765 599999999999999999999999  999999999999999999999999999875543321


Q ss_pred             c------------------cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhh
Q 011384          208 R------------------FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP  269 (487)
Q Consensus       208 ~------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~  269 (487)
                      .                  .......++..|++||.+....++.++||||||++++++++|+.||...... ..   ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~---~~~  233 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-LT---FQK  233 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-HH---HHH
Confidence            1                  1222345788999999998888999999999999999999999998743211 10   000


Q ss_pred             hhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCH----HHHHH
Q 011384          270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSM----KEIVD  319 (487)
Q Consensus       270 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~----~eil~  319 (487)
                      ..           ......+..+++.+.+++.+||+.+|.+||++    ++++.
T Consensus       234 ~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         234 IL-----------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HH-----------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            00           01112333457789999999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9.6e-36  Score=298.58  Aligned_cols=261  Identities=16%  Similarity=0.183  Sum_probs=198.3

Q ss_pred             cccceeecccCceEEEEEEECCeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           57 FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      |.+.+.+|.|+++.||++...++.||||++...   ......+.+|+++++.++||||+++++++.+.+..+++|||+++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            344556677777777777777999999987654   34456799999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc-----
Q 011384          134 GTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF-----  207 (487)
Q Consensus       134 gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~-----  207 (487)
                      ++|.+++... ...+++..+..++.|++.||.|||++  +|+|+||||+|||++.++.+||+|||.+........     
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~--~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK--GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            9999999763 34589999999999999999999999  999999999999999999999999998865432221     


Q ss_pred             ccccCCCCCCCccCCccccCCC--CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhh----hhcC-------
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPD--NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL----IKKG-------  274 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~----~~~~-------  274 (487)
                      ........++..|+|||.+...  .++.++|||||||++|||++|..||................    +...       
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence            1112234577889999998763  57899999999999999999999997432221111110000    0000       


Q ss_pred             cccc----ccC----CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          275 KILS----VFD----PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       275 ~i~~----~~~----~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ....    ...    ..........++.++.+++.+||+.||++|||++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            0000    000    01112233456778999999999999999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-36  Score=305.45  Aligned_cols=260  Identities=21%  Similarity=0.304  Sum_probs=195.8

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC-----ce
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK-----DR  124 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~~  124 (487)
                      +++|.+.+.||+|+||.||+|++.  ++.||||.+...  ......+.+|+.++++++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            578999999999999999999875  789999988642  233456888999999999999999999876543     47


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++|+||+. ++|.+.+...  .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~--~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            99999996 4888887543  499999999999999999999999  999999999999999999999999999876543


Q ss_pred             CCcc-cccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC---cc---
Q 011384          205 DNFR-FRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG---KI---  276 (487)
Q Consensus       205 ~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~---~i---  276 (487)
                      .... .......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ..........   .+   
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL-NLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCCHHHHHHh
Confidence            2211 11123468999999998754 46789999999999999999999998632211111 0000000000   00   


Q ss_pred             --------ccccCCCCCCC---CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          277 --------LSVFDPRIPPP---KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       277 --------~~~~~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                              ..........+   ..+..+.++.+++.+||+.+|++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~  291 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA  291 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                    00000000000   01234677899999999999999999999997

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.4e-35  Score=300.10  Aligned_cols=263  Identities=17%  Similarity=0.264  Sum_probs=196.7

Q ss_pred             eeeccc--CceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKG--SHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G--~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      ..||+|  +||.||++.+.  ++.||+|+....   ....+.+.+|+.+++.++||||++++++|......++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999884  899999987643   23346789999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc---
Q 011384          134 GTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF---  209 (487)
Q Consensus       134 gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~---  209 (487)
                      ++|.+++.... ..+++..+..++.|++.||.|||+.  +++||||||+|||++.++.++++||+.+..........   
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN--GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            99999987642 3589999999999999999999999  99999999999999999999999998653222111000   


Q ss_pred             --ccCCCCCCCccCCccccCCC--CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhh---------------
Q 011384          210 --RSTPPAGTIGYLDPCYVTPD--NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL---------------  270 (487)
Q Consensus       210 --~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~---------------  270 (487)
                        ......++..|+|||++.+.  .++.++|||||||++|+|++|+.||................               
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence              01112346679999999764  46899999999999999999999996433221111110000               


Q ss_pred             -----------------hhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhccc
Q 011384          271 -----------------IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLS  325 (487)
Q Consensus       271 -----------------~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l~  325 (487)
                                       ...+............+....++..+.+|+.+||+.||++|||++++++  ++..+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                             0000000111112222334557888999999999999999999999986  555543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-35  Score=301.71  Aligned_cols=267  Identities=24%  Similarity=0.289  Sum_probs=199.9

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCC--Cce
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDS--KDR  124 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~--~~~  124 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++...   ......+.+|+.+++++ +||||++++++|...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4578999999999999999999885  788999987542   22335677899999999 999999999998653  367


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||++ ++|..++...  .+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||++.....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~--~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG--NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            99999996 5999988765  589999999999999999999999  999999999999999999999999999876543


Q ss_pred             CCcc---cccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhh----------
Q 011384          205 DNFR---FRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL----------  270 (487)
Q Consensus       205 ~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~----------  270 (487)
                      ....   .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||................          
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            3221   12223468899999998765 457889999999999999999999986322211111000000          


Q ss_pred             h---hcCccccccCC---CCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          271 I---KKGKILSVFDP---RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       271 ~---~~~~i~~~~~~---~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                      +   ....+...+..   .......+.++.++.+++.+||+.+|++|||+.++++  ++..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence            0   00000000000   0001111225678999999999999999999999997  45554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.4e-35  Score=292.88  Aligned_cols=239  Identities=20%  Similarity=0.286  Sum_probs=188.2

Q ss_pred             eecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHH---HHHHhCCCCCceeeEEEEeCCCceEEEEEecC
Q 011384           62 LLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEI---EILSKIHSPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        62 ~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei---~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      .||+|+||.||++...  ++.||+|.+.+...    ....+..|.   ..++...||||+.+++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999875  78999998765321    112233443   34445689999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccC
Q 011384          133 NGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       133 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      +++|.+++...+ .+++..+..++.|++.||.|||+.  +++|+||||+||+++.++.+||+|||++.......    ..
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~--~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~  153 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH  153 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----Cc
Confidence            999999887654 599999999999999999999999  99999999999999999999999999986543221    22


Q ss_pred             CCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          213 PPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ...|+..|+|||.+.++ .++.++|||||||++|+|++|+.||......... .. .....          ......+..
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-~~-~~~~~----------~~~~~~~~~  221 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EI-DRMTL----------TMAVELPDS  221 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-HH-HHHhh----------ccCCCCCCc
Confidence            34689999999998754 6899999999999999999999999643221111 10 00000          111223334


Q ss_pred             HHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          292 VRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      ++.++.+++.+||..+|.+||     ++.++++
T Consensus       222 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         222 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            578899999999999999999     9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=290.43  Aligned_cols=257  Identities=25%  Similarity=0.291  Sum_probs=195.8

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhC---CCCCceeeEEEEeCCCc-----
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKI---HSPRLVNLLGFSNDSKD-----  123 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~-----  123 (487)
                      |++.+.||+|+||.||+|+++  ++.||+|++....   .....+.+|+.+++++   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            677899999999999999986  7899999886432   2234566788877766   59999999999988776     


Q ss_pred             eEEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          124 RLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                      .+++|||+. ++|.+++.... ..+++..++.++.|++.||.|||+.  +++|+||+|+||+++.++.+||+|||++...
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~--~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH--RIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence            899999996 48999887643 3589999999999999999999999  9999999999999999999999999998765


Q ss_pred             CCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcc------
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI------  276 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i------  276 (487)
                      ....   ......++..|+|||.+.+..++.++|||||||++|+|++|..||...........+.......+..      
T Consensus       158 ~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         158 SFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             cCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence            4332   1223357889999999998889999999999999999999998886432222111111100000000      


Q ss_pred             ---ccccCCCCC---CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          277 ---LSVFDPRIP---PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       277 ---~~~~~~~~~---~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                         ...+.....   ....+.++..+.+++.+||+.||.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence               000000000   1112345678899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.3e-35  Score=289.85  Aligned_cols=244  Identities=21%  Similarity=0.263  Sum_probs=192.8

Q ss_pred             HHhhcCcccceee--cccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceE
Q 011384           51 EAATNGFSEQKLL--GKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        51 ~~~~~~y~~~~~L--G~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~  125 (487)
                      ....++|.+.+.+  |+|+||.||++...  +..+|+|..........    |+.....+ +||||+++++++...+..+
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            3444567776666  99999999999876  78899998765432211    22222222 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC-cEEEcccccceecCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF-NARLGDFGLALRCGV  204 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~~~  204 (487)
                      +||||+++++|.+++.... ++++..++.++.|++.||.|||+.  +++|+||||+||+++.++ .++|+|||++.....
T Consensus        86 iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKH--NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            9999999999999998765 699999999999999999999999  999999999999999988 999999999876542


Q ss_pred             CCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc-hhhhhhhhhhhcCccccccCCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP-SIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~-~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      .      ....++..|+|||++.+..++.++|||||||++|+|++|+.||....... ....+....          .  
T Consensus       163 ~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------~--  224 (267)
T PHA03390        163 P------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ----------Q--  224 (267)
T ss_pred             C------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh----------c--
Confidence            2      22468899999999998889999999999999999999999997332211 111111100          0  


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCC-HHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPS-MKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-~~eil~  319 (487)
                      ...+....++..+.+++.+||+.+|.+||+ ++++++
T Consensus       225 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            111223357788999999999999999996 699985

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=315.79  Aligned_cols=249  Identities=26%  Similarity=0.386  Sum_probs=203.4

Q ss_pred             cCcccceeecccCceEEEEEEECCe--EEEEEEcC-CChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLRGR--QVAVKKPS-KNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~g~--~vAvK~~~-~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      +.|.++..||.|+||.||+++.+..  ..|.|++. +.....+.+.-||+||..+.||+||+|++.|...+.++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            4578888999999999999988733  34556655 44556678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      .||.+...+-.-+..|++.++.-++.|++.||.|||++  +|||||||..|||+.-+|.++|+|||.+....  ......
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~--~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkR  187 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ--NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKR  187 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc--chhhhhccccceEEEecCcEeeecccccccch--hHHhhh
Confidence            99999999988888899999999999999999999999  99999999999999999999999999974322  222345


Q ss_pred             CCCCCCCccCCccccCC-----CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          212 TPPAGTIGYLDPCYVTP-----DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                      ....|||.|||||+..+     .+|++++|||||||+|.||..+.+|-. ...+   ......+.+. .     .|.+  
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh-elnp---MRVllKiaKS-e-----PPTL--  255 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH-ELNP---MRVLLKIAKS-E-----PPTL--  255 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc-ccch---HHHHHHHhhc-C-----CCcc--
Confidence            56799999999998765     478999999999999999999987643 2221   1111111111 0     1111  


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      -.|..++..+.+++.+||.+||..||++.+|++
T Consensus       256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            134568889999999999999999999999986

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-37  Score=330.35  Aligned_cols=255  Identities=24%  Similarity=0.336  Sum_probs=213.6

Q ss_pred             hHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC
Q 011384           49 DLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK  122 (487)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  122 (487)
                      ++....++|.++++||+|+||.|..++++  ++.||+|++++-    ......|..|-.+|..-+.+-|++++-.|.++.
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            44455679999999999999999999987  788999998873    334467999999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                      ++|+|||||+||+|..++.+.. .++++.+..++..|+-||.-||+.  |+|||||||+|||||..|++||+|||.|..+
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~m--gyVHRDiKPDNvLld~~GHikLADFGsClkm  225 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSM--GYVHRDIKPDNVLLDKSGHIKLADFGSCLKM  225 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhc--cceeccCCcceeEecccCcEeeccchhHHhc
Confidence            9999999999999999999887 699999999999999999999999  9999999999999999999999999999877


Q ss_pred             CCCCcccccCCCCCCCccCCccccCC-----CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccc
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTP-----DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKIL  277 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~  277 (487)
                      ..++.. .+....|||.|.+||++..     +.|+..+|+||+||++|||+.|..||+.+    .++.....++...   
T Consensus       226 ~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad----slveTY~KIm~hk---  297 (1317)
T KOG0612|consen  226 DADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD----SLVETYGKIMNHK---  297 (1317)
T ss_pred             CCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH----HHHHHHHHHhchh---
Confidence            655543 5667899999999999853     46889999999999999999999999742    2332222222211   


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCC---HHHHHH
Q 011384          278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPS---MKEIVD  319 (487)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs---~~eil~  319 (487)
                          ..+..|-...+++++++||.+.+. +|+.|..   ++++..
T Consensus       298 ----~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  298 ----ESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             ----hhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence                123333335589999999988775 6777776   888876

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.6e-35  Score=295.26  Aligned_cols=241  Identities=24%  Similarity=0.370  Sum_probs=195.2

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      |...+.||+|+||.||+|+..  +..|++|++...    ......+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666788999999999999875  789999987643    22335688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +. ++|.+++.....++++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.+||+|||++.....      
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~--gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH--NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCChhhEEECCCCCEEEeecCCCcccCC------
Confidence            95 588888877666799999999999999999999999  999999999999999999999999998753221      


Q ss_pred             cCCCCCCCccCCccccC---CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          211 STPPAGTIGYLDPCYVT---PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                      .....|+..|+|||.+.   ...++.++|||||||++|+|++|..||...........    ....         ..+..
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~----~~~~---------~~~~~  240 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQN---------DSPTL  240 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhc---------CCCCC
Confidence            22356889999999984   35678899999999999999999999864322111111    1100         01111


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ....++..+.+++.+||+.+|.+||++.+++.
T Consensus       241 ~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         241 QSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            12234567899999999999999999999995

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.6e-36  Score=330.42  Aligned_cols=248  Identities=27%  Similarity=0.455  Sum_probs=193.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC--------
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS--------  121 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--------  121 (487)
                      ..+|...++||+||||.||+++.+  |+.||||++.-.  ......+.+|+.++++|+|||||++|..+.+.        
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            457889999999999999999876  999999987765  34446789999999999999999988432100        


Q ss_pred             --------------------------------------------------------------------------------
Q 011384          122 --------------------------------------------------------------------------------  121 (487)
Q Consensus       122 --------------------------------------------------------------------------------  121 (487)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             -------------------------------CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 011384          122 -------------------------------KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM  170 (487)
Q Consensus       122 -------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~  170 (487)
                                                     ..+||-||||+.-.|.+++..+...-.....|+++++|+.||+|+|+. 
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~-  716 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ-  716 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC-
Confidence                                           115889999999888888877653124778999999999999999999 


Q ss_pred             CCeeeccCCCCcEEEccCCcEEEcccccceecC----------C------CCcccccCCCCCCCccCCccccCCCC---C
Q 011384          171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCG----------V------DNFRFRSTPPAGTIGYLDPCYVTPDN---L  231 (487)
Q Consensus       171 ~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~----------~------~~~~~~~~~~~gt~~Y~aPE~~~~~~---~  231 (487)
                       |||||||||.|||+|.++.|||+|||++....          .      .......+...||.-|+|||.+.+..   |
T Consensus       717 -giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  717 -GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             -ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence             99999999999999999999999999996521          0      00111345568999999999997764   9


Q ss_pred             CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC---CChHHHHHHHHHHHHhhhhcC
Q 011384          232 STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP---KDPIVRKQLAVIAVRCVRSCR  308 (487)
Q Consensus       232 s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---~~~~~~~~l~~Li~~cl~~dP  308 (487)
                      +.|+|+||||||++||+.   ||........+..    .++++        .++.+   ..+..+. -..+|.+|++.||
T Consensus       796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~----~LR~g--------~iP~~~~f~~~~~~~-e~slI~~Ll~hdP  859 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILT----NLRKG--------SIPEPADFFDPEHPE-EASLIRWLLSHDP  859 (1351)
T ss_pred             cchhhhHHHHHHHHHHhc---cCCchHHHHHHHH----hcccC--------CCCCCcccccccchH-HHHHHHHHhcCCC
Confidence            999999999999999998   7765444333222    22232        33333   3333443 4558999999999


Q ss_pred             CCCCCHHHHHH
Q 011384          309 ERRPSMKEIVD  319 (487)
Q Consensus       309 ~~RPs~~eil~  319 (487)
                      .+|||+.|++.
T Consensus       860 ~kRPtA~eLL~  870 (1351)
T KOG1035|consen  860 SKRPTATELLN  870 (1351)
T ss_pred             ccCCCHHHHhh
Confidence            99999999996

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1e-35  Score=297.08  Aligned_cols=262  Identities=22%  Similarity=0.254  Sum_probs=194.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC------
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSK------  122 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------  122 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++....   .....+.+|+++++.++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999986  7889999875332   12345778999999999999999999875433      


Q ss_pred             --ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          123 --DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       123 --~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                        ..++|+||+. ++|...+......+++..+..++.|++.||.|||+.  +++|+||||+|||++.++.++|+|||++.
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN--HILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEECcCccch
Confidence              4699999995 478888776555699999999999999999999999  99999999999999999999999999986


Q ss_pred             ecCCCCccc---------ccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhh
Q 011384          201 RCGVDNFRF---------RSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL  270 (487)
Q Consensus       201 ~~~~~~~~~---------~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~  270 (487)
                      .........         ..+...+++.|+|||.+.+. .++.++|||||||++|||++|+.||........... ....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~-~~~~  242 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL-IFKL  242 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHH
Confidence            543322110         11233568889999987654 578999999999999999999998863222111111 0000


Q ss_pred             hhc---------CccccccCCCCCCCCC-------hHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          271 IKK---------GKILSVFDPRIPPPKD-------PIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       271 ~~~---------~~i~~~~~~~~~~~~~-------~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...         ..+....+.......+       ......+.+++.+||+.+|.+|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            000         0000000000000011       123367889999999999999999999985

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.4e-36  Score=302.41  Aligned_cols=262  Identities=21%  Similarity=0.323  Sum_probs=199.3

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeC----CCce
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSND----SKDR  124 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~  124 (487)
                      .++|.+.+.||+|+||.||+|...  +..||+|++....   .....+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            378999999999999999999876  8899999877542   234567889999999999999999998753    3567


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||+. ++|.+++.... .+++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++.....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSA--NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            99999995 68999887654 499999999999999999999999  999999999999999999999999999876543


Q ss_pred             CCcc--cccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhh----------hh
Q 011384          205 DNFR--FRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP----------LI  271 (487)
Q Consensus       205 ~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~----------~~  271 (487)
                      ....  .......++..|+|||.+.. ..++.++|||||||++|||++|+.||........+......          ..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence            3211  11234578899999999865 45789999999999999999999999643221111100000          00


Q ss_pred             hcCcccc---ccCCCCCCC---CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          272 KKGKILS---VFDPRIPPP---KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       272 ~~~~i~~---~~~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ....+..   ........+   ..+..+.++.+++.+||+.+|.+||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            0000000   011111111   11235788999999999999999999999997

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-35  Score=289.83  Aligned_cols=257  Identities=23%  Similarity=0.335  Sum_probs=195.8

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCChh--hHHHHHHHHHHHHhCC-CCCceeeEEEEeCCCceEEEEEec
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE--ISQEVDNEIEILSKIH-SPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      |++.+.||+|++|.||+|+..  ++.|+||++.....  ......+|+..+++++ ||||+++++++.+....++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            677899999999999999985  67899998765432  2234567999999999 999999999999999999999999


Q ss_pred             CCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          132 SNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       132 ~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                       +++|.+++.... ..+++..+..++.|++.+|.|||++  +++|+||+|+||+++.++.++|+|||++.......   .
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~--~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---~  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH--GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---P  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChhhEEEcCCCCEEEeecccceeccCCC---C
Confidence             889999987654 4689999999999999999999999  99999999999999999999999999987654322   1


Q ss_pred             cCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhh------------hhhhhhhcCccc
Q 011384          211 STPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD------------WAAPLIKKGKIL  277 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~------------~~~~~~~~~~i~  277 (487)
                      .....++..|+|||.+.. ..++.++|+||||+++|+|++|+.||...........            |.........+.
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            223467889999998754 4578999999999999999999988854322111110            100000000000


Q ss_pred             cccCCCCCC---CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          278 SVFDPRIPP---PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       278 ~~~~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+......   ......+.++.+++.+||+.+|++|||++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000000000   000112567999999999999999999999985

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3e-35  Score=293.02  Aligned_cols=244  Identities=23%  Similarity=0.361  Sum_probs=196.8

Q ss_pred             ccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCC
Q 011384           58 SEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNG  134 (487)
Q Consensus        58 ~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~g  134 (487)
                      .....||+|+||.||++...  +..||||++.... .....+.+|+.+++.++|+||+++++++...+..++||||++++
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            33468999999999999885  7899999876433 33456899999999999999999999999999999999999999


Q ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCC
Q 011384          135 TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPP  214 (487)
Q Consensus       135 sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  214 (487)
                      +|.+++...  .+++..+..++.|++.||+|||+.  +++|+||+|+||+++.++.++|+|||++........  .....
T Consensus       103 ~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~--givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~  176 (292)
T cd06657         103 ALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL  176 (292)
T ss_pred             cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence            999987543  489999999999999999999999  999999999999999999999999998865543221  12234


Q ss_pred             CCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHH
Q 011384          215 AGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRK  294 (487)
Q Consensus       215 ~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  294 (487)
                      .+++.|++||.+....++.++|||||||++|+|++|..||.... ........    ..     ...+.+.  ....++.
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~-~~~~~~~~----~~-----~~~~~~~--~~~~~~~  244 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-PLKAMKMI----RD-----NLPPKLK--NLHKVSP  244 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH----Hh-----hCCcccC--CcccCCH
Confidence            68899999999988888999999999999999999999986321 11111111    00     0111111  1123566


Q ss_pred             HHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          295 QLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       295 ~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+.+++.+||+.+|.+||++.++++
T Consensus       245 ~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         245 SLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHhCCcccCcCHHHHhc
Confidence            7889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.2e-35  Score=287.60  Aligned_cols=245  Identities=22%  Similarity=0.308  Sum_probs=195.2

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCC------ChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSK------NQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~------~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      +|.+.+.||+|+||.||++.+.  +..+++|..+.      .......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5888999999999999999886  34455555432      122334577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          128 VEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      +||+++++|.+++..   ....+++..++.++.|++.||.|||+.  +++|+||+|+||+++. +.++|+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR--RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc--CccccCCChhheEeec-CCEeecccCceeecCC
Confidence            999999999998864   335699999999999999999999999  9999999999999975 5699999999876543


Q ss_pred             CCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ...  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....    ........ ..         ..
T Consensus       158 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----~~~~~~~~-~~---------~~  221 (260)
T cd08222         158 SCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVLRI-VE---------GP  221 (260)
T ss_pred             Ccc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHH-Hc---------CC
Confidence            221  2223468889999999988888999999999999999999999985321    11111111 00         11


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ....+..++.++.+++.+||+.+|++||++.++++
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            12234466788999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.6e-35  Score=300.91  Aligned_cols=263  Identities=20%  Similarity=0.268  Sum_probs=199.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC-----Cc
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS-----KD  123 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~  123 (487)
                      .++|.+.+.||+|+||.||+|...  ++.||||.+...   ......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            467999999999999999999876  789999987643   22345677899999999999999999988654     34


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      .++|+||+. ++|.+++...+ .+++..+..++.|++.||.|||+.  +++|+||||+||+++.++.+||+|||++....
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~--~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            799999995 68999887654 599999999999999999999999  99999999999999999999999999987654


Q ss_pred             CCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhh-----------hh
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP-----------LI  271 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~-----------~~  271 (487)
                      ...  .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..... .........           ..
T Consensus       160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         160 EKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             CCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhhhc
Confidence            322  12234467889999998765 4688999999999999999999999853211 110000000           00


Q ss_pred             hcCcccccc-------CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          272 KKGKILSVF-------DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       272 ~~~~i~~~~-------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                      ........+       ..... ...+.++.++.+++.+||+.+|++|||++++++  +|..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             CchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            000000000       00000 112246778999999999999999999999997  35443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.4e-35  Score=297.77  Aligned_cols=260  Identities=22%  Similarity=0.276  Sum_probs=195.8

Q ss_pred             cCcc-cceeecccCceEEEEEEEC--CeEEEEEEcCCChhhH---------------HHHHHHHHHHHhCCCCCceeeEE
Q 011384           55 NGFS-EQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS---------------QEVDNEIEILSKIHSPRLVNLLG  116 (487)
Q Consensus        55 ~~y~-~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~---------------~~~~~Ei~~l~~l~hpnIv~l~~  116 (487)
                      ++|. +.+.||+|+||.||+|.+.  ++.||||++.......               ..+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 4578999999999999875  7899999876432211               24778999999999999999999


Q ss_pred             EEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccc
Q 011384          117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDF  196 (487)
Q Consensus       117 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DF  196 (487)
                      ++......++||||+. ++|.+++.... .+++..+..++.|++.||.|||+.  +++|+||+|+|||++.++.++|+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~--~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKW--YFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeecccccHHHeEECCCCCEEECCc
Confidence            9999999999999996 69999987644 489999999999999999999999  9999999999999999999999999


Q ss_pred             ccceecCCCC------------cccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchh
Q 011384          197 GLALRCGVDN------------FRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSI  263 (487)
Q Consensus       197 Gla~~~~~~~------------~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~  263 (487)
                      |++.......            .........+++.|+|||.+.+. .++.++|||||||++|+|++|..||.........
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~  243 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL  243 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9987654111            01112233568899999998764 4689999999999999999999998643322111


Q ss_pred             hhhhhhhhhcCcc-----------ccccCCCCCC---CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          264 VDWAAPLIKKGKI-----------LSVFDPRIPP---PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       264 ~~~~~~~~~~~~i-----------~~~~~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                       ............           ........+.   ......+.++.+++.+||+.+|++|||+++++.
T Consensus       244 -~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        244 -GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             -HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence             111111100000           0000000000   011234677899999999999999999999996

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.8e-35  Score=296.53  Aligned_cols=260  Identities=21%  Similarity=0.282  Sum_probs=197.5

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC-CCc
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSND-SKD  123 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~  123 (487)
                      +...+++|.+.+.||.|+||.||++...  ++.||||++...   ....+.+.+|+++++.++||||++++++|.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3446789999999999999999999876  788999987542   2234678889999999999999999998865 567


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      .++|+||+ +++|.+++...  ++++..+..++.|++.||.|||+.  +++|+||+|+|||++.++.++|+|||++....
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~--~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSA--GVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            89999999 56898888643  488888999999999999999999  99999999999999999999999999986533


Q ss_pred             CCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhh-----------hhhhhh
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD-----------WAAPLI  271 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~-----------~~~~~~  271 (487)
                      ..     .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........           +.....
T Consensus       160 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd07856         160 PQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC  234 (328)
T ss_pred             CC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            21     223457889999998766 5689999999999999999999999864321111000           000000


Q ss_pred             hcCc--cccccCCCCCCC---CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          272 KKGK--ILSVFDPRIPPP---KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       272 ~~~~--i~~~~~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ....  .........+.+   ..+.++..+.+++.+||+.+|++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000  000000000111   11235678999999999999999999999986

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.4e-36  Score=307.46  Aligned_cols=247  Identities=23%  Similarity=0.326  Sum_probs=210.0

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhh---HHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEI---SQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~---~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .....|.+.+.||+|.|+.|.++++.  +..||+|.++++...   ...+.+|+++|+.++|||||+++.+......+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            34567999999999999999999986  899999998876432   3458899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+.+|.+.+++.+.+. +.+..+..++.|+..|++|||++  .|||||||++||||+.+.++||+|||++..+....
T Consensus       133 V~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k--~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSK--NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             EEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhc--ceeccccchhhcccccccceeeeccccceeecccc
Confidence            9999999999999999886 66688999999999999999999  99999999999999999999999999997765332


Q ss_pred             cccccCCCCCCCccCCccccCCCCC-CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                         ....++|++.|.|||++.+..| ++++|+||+|++||-|+.|..||+.+.-...-.             ..+...+ 
T Consensus       210 ---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~-------------rvl~gk~-  272 (596)
T KOG0586|consen  210 ---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP-------------RVLRGKY-  272 (596)
T ss_pred             ---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc-------------hheeeee-
Confidence               4556899999999999999877 789999999999999999999998432211100             0111111 


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                       ..+.-++.+..+|++++|-.+|.+|+++++|.+
T Consensus       273 -rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  273 -RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             -cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence             123345667888999999999999999999987

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-35  Score=298.15  Aligned_cols=264  Identities=20%  Similarity=0.301  Sum_probs=199.4

Q ss_pred             HHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC---
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK---  122 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~---  122 (487)
                      ....++|++.+.||+|+||.||++...  +..||||++...   ......+.+|+++++.++||||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            345678999999999999999999875  789999987643   223356889999999999999999999987654   


Q ss_pred             ---ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          123 ---DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       123 ---~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                         ..++||||+ +++|.+++...  .+++..++.++.|++.||.|||+.  +|+|+||||+||+++.++.++|+|||++
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH~~--gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence               358999999 77998888643  499999999999999999999999  9999999999999999999999999998


Q ss_pred             eecCCCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhh----------
Q 011384          200 LRCGVDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA----------  268 (487)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~----------  268 (487)
                      ......     .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..............          
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         166 RQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             cccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            654322     223467889999999876 4578999999999999999999999864322111111000          


Q ss_pred             hhhhcCccccccC--CCCC----CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          269 PLIKKGKILSVFD--PRIP----PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       269 ~~~~~~~i~~~~~--~~~~----~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                      ..+..........  +...    ......++.++.+++.+||+.||.+|||+.+++.  +++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            0000000000000  0000    0011235567899999999999999999999995  44443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=299.80  Aligned_cols=244  Identities=25%  Similarity=0.314  Sum_probs=202.8

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .+.|+.-++||+||||.||-+..+  |+-||.|.+.+..    ....-..+|-.+|.+++.+.||.+--.|+..+.+|+|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356888999999999999987654  8899999766432    2234578899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          128 VEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      +..|.||+|.-+|.+.+ ..+++..++.++.+|+.||.+||+.  +||+||+||+|||+|+.|+++|+|+|+|..+....
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~--~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR--RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc--ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            99999999999887644 4599999999999999999999999  99999999999999999999999999998766543


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                         ......||.+|||||++.++.|+...|+|||||+||||+.|+.||........-.+... .        .  ...+.
T Consensus       342 ---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr-r--------~--~~~~~  407 (591)
T KOG0986|consen  342 ---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR-R--------T--LEDPE  407 (591)
T ss_pred             ---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH-H--------H--hcchh
Confidence               23344899999999999999999999999999999999999999974322111100000 0        0  01233


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCC
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPS  313 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs  313 (487)
                      .++...++++++|...+|++||.+|.-
T Consensus       408 ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  408 EYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             hcccccCHHHHHHHHHHHccCHHHhcc
Confidence            466788999999999999999999974

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-35  Score=287.88  Aligned_cols=258  Identities=26%  Similarity=0.348  Sum_probs=199.2

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      |+..+.||+|++|.||+|+..  ++.||+|++...   ....+.+..|+.+++.++|+||+++++++.+....++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566789999999999999986  789999988764   333467788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      + ++|.+++......+++..+..++.+++.||.|||+.  +|+|+||+|+||+++.++.++|+|||++........  ..
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~  155 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH--RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TY  155 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--cc
Confidence            7 599999987645699999999999999999999999  999999999999999999999999999876543321  22


Q ss_pred             CCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhh----------hhhhhcCcccccc
Q 011384          212 TPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA----------APLIKKGKILSVF  280 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~----------~~~~~~~~i~~~~  280 (487)
                      ....++..|+|||.+... .++.++|||||||++|||++|+.||.............          +.....-......
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            234567889999998776 78999999999999999999998886432211111000          0000000000000


Q ss_pred             CCCCCC----CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          281 DPRIPP----PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       281 ~~~~~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      -+....    ...+..+..+.+++.+||..+|++||++++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000    011123678999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=289.68  Aligned_cols=246  Identities=22%  Similarity=0.256  Sum_probs=206.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++|...++||+|.||.|-+++.+  ++.||+|++++.-.    ....-..|-++|...+||.+..+--.|...+.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            467889999999999999999876  88999999887633    234456789999999999999998889999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||..||.|.-+|.... .+++.....+...|+.||.|||++  +||+||||.+|+|+|++|++||+|||+++.--... 
T Consensus       247 MeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~--~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g-  322 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSR--NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG-  322 (516)
T ss_pred             EEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhC--CeeeeechhhhheeccCCceEeeecccchhccccc-
Confidence            99999999999997754 499999999999999999999999  99999999999999999999999999997533322 


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                       ..+.+.+|||.|+|||++....|..+.|+|.+|||+|||++|+.||........     -.++..+.      -    .
T Consensus       323 -~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-----FeLIl~ed------~----k  386 (516)
T KOG0690|consen  323 -DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-----FELILMED------L----K  386 (516)
T ss_pred             -ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH-----HHHHHhhh------c----c
Confidence             245678999999999999999999999999999999999999999974322211     11111111      1    2


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      +|..++++.+.|+.-+|.+||.+|.     .+.||.+
T Consensus       387 FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  387 FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence            4556788999999999999999995     3777765

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.4e-35  Score=297.11  Aligned_cols=261  Identities=21%  Similarity=0.335  Sum_probs=195.5

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC------
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK------  122 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------  122 (487)
                      .++|...+.||+|+||.||+|++.  ++.||||++...   ......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999875  789999987653   223356789999999999999999999987543      


Q ss_pred             ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                      ..++|+||+.. +|..++.   ..+++..+..++.|++.||+|||+.  +++||||||+|||++.++.+||+|||++...
T Consensus        94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~--~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSA--GIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            45899999964 7776652   3489999999999999999999999  9999999999999999999999999998654


Q ss_pred             CCCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhh----------hh
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP----------LI  271 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~----------~~  271 (487)
                      ...     .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...............          ..
T Consensus       168 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07879         168 DAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL  242 (342)
T ss_pred             CCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            321     223467889999999876 46789999999999999999999999743211111110000          00


Q ss_pred             hcCccccccC--CCCCC-C---CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhccc
Q 011384          272 KKGKILSVFD--PRIPP-P---KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLS  325 (487)
Q Consensus       272 ~~~~i~~~~~--~~~~~-~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l~  325 (487)
                      ..........  +..+. .   ..+..+.++.+|+.+||+.||.+||++.+++.  +++...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            0000000000  00000 0   01124567889999999999999999999995  465554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-34  Score=294.82  Aligned_cols=261  Identities=20%  Similarity=0.255  Sum_probs=198.0

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCC-
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDS-  121 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-  121 (487)
                      .++...+++|.+.+.||+|+||.||+|...  ++.||+|++....   ...+.+.+|++++++++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            455667899999999999999999999865  7899999887532   2245678899999999999999999987543 


Q ss_pred             -----CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccc
Q 011384          122 -----KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDF  196 (487)
Q Consensus       122 -----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DF  196 (487)
                           ...+++++++ +++|.+++...  .+++..++.++.|++.||+|||+.  +|+|+||||+||+++.++.+||+||
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIll~~~~~~kl~df  164 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDF  164 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCChHHEEEcCCCCEEEecc
Confidence                 3467888887 78998888654  489999999999999999999999  9999999999999999999999999


Q ss_pred             ccceecCCCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhh-----
Q 011384          197 GLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL-----  270 (487)
Q Consensus       197 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~-----  270 (487)
                      |++.....     ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||................     
T Consensus       165 g~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (345)
T cd07877         165 GLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  239 (345)
T ss_pred             cccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99865432     1233568899999999866 467889999999999999999999986332211111000000     


Q ss_pred             -----hhcC---ccccccCCCCCCC----CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          271 -----IKKG---KILSVFDPRIPPP----KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       271 -----~~~~---~i~~~~~~~~~~~----~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                           +...   .....+ +.++..    .....+.++.+++.+||+.+|.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         240 ELLKKISSESARNYIQSL-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HHHhhcccHhHHHHHHHh-cccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence                 0000   000000 000000    00123567899999999999999999999997

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-35  Score=295.50  Aligned_cols=265  Identities=23%  Similarity=0.289  Sum_probs=203.2

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC-----ceE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK-----DRL  125 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~~~  125 (487)
                      +|.+.+.||+|++|.||+|+..  +..||||++...   ....+.+.+|+.+++.++||||+++++++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999986  789999987754   233467899999999999999999999988775     789


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +||||++ ++|.+++.... .+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.++|+|||++......
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~--gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSA--NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            9999997 58998887654 699999999999999999999999  9999999999999999999999999999765443


Q ss_pred             Ccc-cccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhh-----------h
Q 011384          206 NFR-FRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI-----------K  272 (487)
Q Consensus       206 ~~~-~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~-----------~  272 (487)
                      ... .......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||........... .....           .
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL-IVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH-HHHhcCCCChhHhhhcc
Confidence            210 112334678899999999887 789999999999999999999999863321111000 00000           0


Q ss_pred             cCccccc---cCCCCCC---CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhccc
Q 011384          273 KGKILSV---FDPRIPP---PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLS  325 (487)
Q Consensus       273 ~~~i~~~---~~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l~  325 (487)
                      .......   .......   ...+.++.++.+++.+||+.+|.+||++++++.  +|+.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            0000000   0000000   011235678899999999999999999999997  455543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-37  Score=333.50  Aligned_cols=253  Identities=22%  Similarity=0.304  Sum_probs=205.1

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ..+.+|....+||.|.||.||.|+..  |...|+|-+.-.   ....+.+.+|..++..++|||+|++||+-.+.+..+|
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            33557888999999999999999875  788899965432   3334668899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      .||||.+|+|.+++...+ -.++.....+..|++.|++|||++  |||||||||.|||++.+|.+|++|||.|..+....
T Consensus      1312 FMEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH~~--gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHEH--GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHhc--CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            999999999999997654 377777778889999999999999  99999999999999999999999999998765442


Q ss_pred             cc--cccCCCCCCCccCCccccCCCC---CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          207 FR--FRSTPPAGTIGYLDPCYVTPDN---LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       207 ~~--~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      ..  .......||+.|||||++.+..   -..+.||||||||++||+||+.||..-...-.+..             .+.
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy-------------~V~ 1455 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY-------------HVA 1455 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh-------------HHh
Confidence            11  1112347999999999998753   45689999999999999999999962211111111             111


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                      -.-.++.|..++.+-.+++..||..||.+|.++.||++.
T Consensus      1456 ~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            122344566799999999999999999999999988873

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=280.76  Aligned_cols=251  Identities=23%  Similarity=0.357  Sum_probs=206.7

Q ss_pred             hhcCccc-ceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEeC----CCce
Q 011384           53 ATNGFSE-QKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSND----SKDR  124 (487)
Q Consensus        53 ~~~~y~~-~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~----~~~~  124 (487)
                      .+++|.+ .++||-|-.|.|-.+.++  +..+|+|++..+.    ..++|+++.-.. .|||||.++++|..    ...+
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            4566655 378999999999999887  8899999988774    457789888777 69999999998764    3456


Q ss_pred             EEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc---CCcEEEcccccce
Q 011384          125 LLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR---NFNARLGDFGLAL  200 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~  200 (487)
                      .+|||.|+||.|...+...+ ..+++.++..|..||+.|+.|||+.  +|.||||||+|+|...   |-.+||+|||+++
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~--nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK  212 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM--NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK  212 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc--chhhccCChhheeeecCCCCcceEeccccccc
Confidence            79999999999999998754 4699999999999999999999999  9999999999999953   5679999999998


Q ss_pred             ecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccccc
Q 011384          201 RCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF  280 (487)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~  280 (487)
                      .....+   ...+.+.||.|.|||++..+.|+...|+||+||++|-|++|.+||..... ..+.-.....+..|..    
T Consensus       213 ~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~aispgMk~rI~~gqy----  284 (400)
T KOG0604|consen  213 ETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKRRIRTGQY----  284 (400)
T ss_pred             ccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccCChhHHhHhhccCc----
Confidence            654322   34567899999999999999999999999999999999999999974332 1121112222233222    


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        .++.+.-..+++..+++|+.+|..+|.+|.|+.++++
T Consensus       285 --~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  285 --EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             --cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence              4556666789999999999999999999999999996

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-35  Score=288.47  Aligned_cols=266  Identities=28%  Similarity=0.438  Sum_probs=203.2

Q ss_pred             HhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHH--hCCCCCceeeEEEEeCC----CceE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILS--KIHSPRLVNLLGFSNDS----KDRL  125 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~--~l~hpnIv~l~~~~~~~----~~~~  125 (487)
                      ...++..+.+.||+|.||+||+|.|+|..||||++...++  ..+.+|.+++.  .|+|+||+.+++.-..+    .+++
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hhhheeEEEEEecCccccceeeccccCCceEEEEecccch--hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            4456788899999999999999999999999999987655  44555666655  56999999999875433    3679


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE------MPPIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~------~~~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                      ||++|.+.|||+|+|..+  .++.+..++++..+|.||++||..      +|.|.|||||..||||.+++.+.|+|+|||
T Consensus       286 LvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             EeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            999999999999999874  499999999999999999999964      578999999999999999999999999999


Q ss_pred             eecCCCC--cccccCCCCCCCccCCccccCCCC----C-C-cchhhhhHHHHHHHHHhC----------CcCCCCCC-CC
Q 011384          200 LRCGVDN--FRFRSTPPAGTIGYLDPCYVTPDN----L-S-TKTDVFSFGILLLEIISC----------RKAIDIGF-SP  260 (487)
Q Consensus       200 ~~~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~~----~-s-~ksDVwSlGvvl~eLltG----------~~pf~~~~-~~  260 (487)
                      .......  .........||.+|||||++...-    + + ..+||||||.|+||+.-.          ..||..-. ..
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D  443 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD  443 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence            7655442  223334568999999999986531    2 2 358999999999999742          34443211 11


Q ss_pred             chhhhhhhhhhhcCccccccCCCCCCCC-ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          261 PSIVDWAAPLIKKGKILSVFDPRIPPPK-DPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       261 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ++..+ ....+.    ...+.|.++..+ ...+...+..|++.||..||.-|-|+-.|.+.|.++..
T Consensus       444 Ps~ee-MrkVVC----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  444 PSFEE-MRKVVC----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCHHH-Hhccee----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            22211 111111    122334444433 34567788999999999999999999999998888763

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.9e-34  Score=289.99  Aligned_cols=260  Identities=20%  Similarity=0.246  Sum_probs=192.1

Q ss_pred             CcccceeecccCceEEEEEEEC----CeEEEEEEcCCC---hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeC----CCc
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR----GRQVAVKKPSKN---QEISQEVDNEIEILSKI-HSPRLVNLLGFSND----SKD  123 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~----g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~----~~~  123 (487)
                      +|.+.+.||+|+||.||++.+.    +..||+|++...   ....+.+.+|+++++++ +||||+++++++..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788999999999999999986    458999987643   22345678899999999 59999999997543    245


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      .+++++|+. ++|.+.+.... .+++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++..+.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIHSA--NVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            788899885 68999886543 599999999999999999999999  99999999999999999999999999997654


Q ss_pred             CCCcc--cccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhh-----------hhhh
Q 011384          204 VDNFR--FRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD-----------WAAP  269 (487)
Q Consensus       204 ~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~-----------~~~~  269 (487)
                      .....  .......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........           +...
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            32211  11223468999999998765 4679999999999999999999998864321110000           0000


Q ss_pred             hhhcC--ccccccC--CCCC-CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          270 LIKKG--KILSVFD--PRIP-PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       270 ~~~~~--~i~~~~~--~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .....  .......  +... ....+.++..+.+++.+||+.||.+|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000  0000000  0000 0011123578999999999999999999999986

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=278.53  Aligned_cols=234  Identities=26%  Similarity=0.339  Sum_probs=194.0

Q ss_pred             ecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCCH
Q 011384           63 LGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTL  136 (487)
Q Consensus        63 LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  136 (487)
                      ||+|+||.||++.+.  ++.|++|++.....    ....+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999986  78999998775432    345789999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCC
Q 011384          137 YDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG  216 (487)
Q Consensus       137 ~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~g  216 (487)
                      .+++.... .+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|||++........  ......+
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~--~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSL--GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCG  155 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCcC
Confidence            99998764 489999999999999999999999  999999999999999999999999999876543321  2334578


Q ss_pred             CCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHH
Q 011384          217 TIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQL  296 (487)
Q Consensus       217 t~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  296 (487)
                      +..|++||...+...+.++|+||||+++|++++|..||..... .....   ...         .  ...+.+...+..+
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~---~~~---------~--~~~~~~~~~~~~l  220 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYE---KIL---------K--DPLRFPEFLSPEA  220 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHH---HHh---------c--CCCCCCCCCCHHH
Confidence            8999999999888889999999999999999999999863221 11111   110         0  1112333446788


Q ss_pred             HHHHHHhhhhcCCCCCCHHH
Q 011384          297 AVIAVRCVRSCRERRPSMKE  316 (487)
Q Consensus       297 ~~Li~~cl~~dP~~RPs~~e  316 (487)
                      .+++.+||..||++||++.+
T Consensus       221 ~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         221 RDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHhcCCHhhCCCccc
Confidence            99999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=307.52  Aligned_cols=263  Identities=25%  Similarity=0.311  Sum_probs=202.3

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC------ceEE
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSK------DRLL  126 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------~~~l  126 (487)
                      |...+.||+||||.||+|+.+  |+.||||.+.+..  ...+..-+|+++|++++|||||++++.-++..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            455678999999999999976  9999999988743  23466788999999999999999998765443      4589


Q ss_pred             EEEecCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc--CC--cEEEcccccce
Q 011384          127 VVEFMSNGTLYDVLHS--NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR--NF--NARLGDFGLAL  200 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~--~~--~vkL~DFGla~  200 (487)
                      |||||.+|+|...|..  +...|++.+.+.++.+++.||.|||.+  +|+||||||.||++..  +|  ..||+|||.|+
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn--~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN--GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc--CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            9999999999999975  445699999999999999999999999  9999999999999842  23  47999999999


Q ss_pred             ecCCCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcc--c
Q 011384          201 RCGVDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI--L  277 (487)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i--~  277 (487)
                      .+..+.   ......||+.|++||.+.. ..|+..+|.|||||++|+..||..||.....+......++....+..-  .
T Consensus       173 el~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  173 ELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             cCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            876544   4566789999999999984 788999999999999999999999998766665444444443332210  0


Q ss_pred             cccCC------------CCCCCCChHHHHHHHHHHHHhhhhcCCCCC--CHHHHHHHHhcc
Q 011384          278 SVFDP------------RIPPPKDPIVRKQLAVIAVRCVRSCRERRP--SMKEIVDWLTGL  324 (487)
Q Consensus       278 ~~~~~------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP--s~~eil~~L~~l  324 (487)
                      ....+            ..+..........+-..+..+|..+|.+|-  .+.+....+..+
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            00111            112222333445566677788999999998  555554444443

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=293.36  Aligned_cols=265  Identities=29%  Similarity=0.453  Sum_probs=204.6

Q ss_pred             cCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHh--CCCCCceeeEEEEeCCC----ceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSK--IHSPRLVNLLGFSNDSK----DRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~~----~~~lV~  128 (487)
                      ......++||+|.||.||+|.+.++.||||++...+.  +.|.+|-++++.  ++|+||++++++-....    .++||+
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~k--qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEK--QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             CchhhHHHhhcCccceeehhhccCceeEEEecCHHHH--HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            3456678999999999999999999999999876544  667777777764  58999999999876555    789999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE-------MPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-------~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      +|.+.|+|.++|..+-  ++|....+|+..|++||+|||..       +|.|+|||||..||||..|+++.|+|||+|..
T Consensus       288 ~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             eeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence            9999999999998875  99999999999999999999974       46899999999999999999999999999988


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCCC-CC-----cchhhhhHHHHHHHHHhCCcCCCCCCCCc-------------h
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPDN-LS-----TKTDVFSFGILLLEIISCRKAIDIGFSPP-------------S  262 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-----~ksDVwSlGvvl~eLltG~~pf~~~~~~~-------------~  262 (487)
                      +.............||.+|||||++.+.. +.     .+.||||+|.|||||++.-..++.+..++             .
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            77554443444578999999999997752 22     25899999999999998765554322111             1


Q ss_pred             hhhhhhhhhhcCccccccCCCCCCCCC-hHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccC
Q 011384          263 IVDWAAPLIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLV  328 (487)
Q Consensus       263 ~~~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~  328 (487)
                      +.+ .+..+..    +-..|.++..+- ..-...+.+.+..||..||+.|.|+.=+.+.+..+....
T Consensus       446 ~e~-mq~~VV~----kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  446 LEE-MQELVVR----KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HHH-HHHHHHh----hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            111 1111111    111222222111 123456889999999999999999998988888776543

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=294.22  Aligned_cols=256  Identities=27%  Similarity=0.397  Sum_probs=207.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcC--CChhh------HHHHHHHHHHHHhCCCCCceeeEEEEe-CCC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPS--KNQEI------SQEVDNEIEILSKIHSPRLVNLLGFSN-DSK  122 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~--~~~~~------~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~  122 (487)
                      .++|-.+.+||+|||++||++.+-  .+-||||+-.  ++...      .+..-+|.++.+.|.||.||++|+||. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            346888999999999999999875  7789999743  33222      234677999999999999999999985 567


Q ss_pred             ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc---cCCcEEEcccccc
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID---RNFNARLGDFGLA  199 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld---~~~~vkL~DFGla  199 (487)
                      .+|-|+|||+|.+|.-+|+... .++++++..|+.||+.||.||....|.|||-||||.|||+-   ..|.+||.|||++
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            7899999999999999997664 59999999999999999999999999999999999999994   4578999999999


Q ss_pred             eecCCCCcc-----cccCCCCCCCccCCccccCCC----CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhh
Q 011384          200 LRCGVDNFR-----FRSTPPAGTIGYLDPCYVTPD----NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL  270 (487)
Q Consensus       200 ~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~  270 (487)
                      +.+..+...     .......||.+|++||.+.-+    ..+.|.||||+||++|..+.|+.||....+...+...    
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe----  696 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE----  696 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh----
Confidence            988765433     233456899999999987544    4588999999999999999999999877665554432    


Q ss_pred             hhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          271 IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       271 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                         +.|...-+-.+  |..+.++.+...+|++||++.-++|....++..
T Consensus       697 ---NTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  697 ---NTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             ---hchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence               22222222222  334568889999999999999999988777653

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=315.20  Aligned_cols=259  Identities=27%  Similarity=0.418  Sum_probs=211.4

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEEC---------CeEEEEEEcCCChh--hHHHHHHHHHHHHhC-CCCCceeeEEE
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLR---------GRQVAVKKPSKNQE--ISQEVDNEIEILSKI-HSPRLVNLLGF  117 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~---------g~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l-~hpnIv~l~~~  117 (487)
                      ++...++..+.+.||+|.||.||+|...         ...||||+++....  ..+.+..|+++|+.+ .||||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            4444555667779999999999999754         34699999886543  456799999999999 69999999999


Q ss_pred             EeCCCceEEEEEecCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCc
Q 011384          118 SNDSKDRLLVVEFMSNGTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSAN  182 (487)
Q Consensus       118 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~N  182 (487)
                      |.....+++|+||+..|+|.++|....               ..++....+.++.||+.|++||++.  ++|||||..+|
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~--~~vHRDLAaRN  448 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV--PCVHRDLAARN  448 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC--Cccchhhhhhh
Confidence            999999999999999999999998766               3489999999999999999999999  99999999999


Q ss_pred             EEEccCCcEEEcccccceecCCCCcccccCCCC--CCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCC-
Q 011384          183 VLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA--GTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFS-  259 (487)
Q Consensus       183 ILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~--gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~-  259 (487)
                      ||+..+..+||+|||+++......... .....  -...|||||.+....|+.++|||||||+||||+|...+...+.. 
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            999999999999999998654443221 11122  34469999999999999999999999999999996544443322 


Q ss_pred             CchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          260 PPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       260 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ...+    ...++.         ..+...|..|+.++..+++.||+.+|++||++.++++.|..+
T Consensus       528 ~~~l----~~~l~~---------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  528 TEEL----LEFLKE---------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHH----HHHHhc---------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            1122    123333         333456677889999999999999999999999999999874

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-34  Score=294.81  Aligned_cols=261  Identities=23%  Similarity=0.302  Sum_probs=193.3

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCC---------
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDS---------  121 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~---------  121 (487)
                      ..+|.+.+.||.|+||.||+|...  ++.||+|++.... ...+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            468999999999999999999886  7899999876443 3346788999999999999999999876543         


Q ss_pred             -----CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc-CCcEEEcc
Q 011384          122 -----KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-NFNARLGD  195 (487)
Q Consensus       122 -----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~-~~~vkL~D  195 (487)
                           ...++||||++ ++|.+++...  .+++..++.++.|++.||.|||+.  +++||||||+||+++. ++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~--givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEEcCCCceEEECC
Confidence                 35789999996 5898888643  489999999999999999999999  9999999999999974 56789999


Q ss_pred             cccceecCCCCcc-cccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh-
Q 011384          196 FGLALRCGVDNFR-FRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK-  272 (487)
Q Consensus       196 FGla~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~-  272 (487)
                      ||++..+...... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.................. 
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9998765322111 11122357889999998654 56788999999999999999999999643221111111000000 


Q ss_pred             ----cCccc----c-----ccCCCCC-CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          273 ----KGKIL----S-----VFDPRIP-PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       273 ----~~~i~----~-----~~~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                          .....    .     ...+..+ ......++.++.+++.+||+.||.+|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                00000    0     0000000 0011235578899999999999999999999995

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.5e-35  Score=296.74  Aligned_cols=257  Identities=19%  Similarity=0.261  Sum_probs=196.8

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCc---
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKD---  123 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~---  123 (487)
                      ...++|.+.+.||+|++|.||+|.+.  +..||||++...   ......+.+|+.++++++||||+++++++.....   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999986  788999987643   2233567789999999999999999998766554   


Q ss_pred             ---eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          124 ---RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       124 ---~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                         .++|+||+ +++|.+++...  .+++..++.++.|++.||.|||+.  +|+|+||||+||+++.++.++|+|||++.
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~~--gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSA--GIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCCEEEccccccc
Confidence               89999999 67999998753  499999999999999999999999  99999999999999999999999999986


Q ss_pred             ecCCCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh-------
Q 011384          201 RCGVDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK-------  272 (487)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~-------  272 (487)
                      .....     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||............ .....       
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i-~~~~~~~~~~~~  240 (343)
T cd07851         167 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI-MNLVGTPDEELL  240 (343)
T ss_pred             ccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHhcCCCCHHHH
Confidence            54322     233467889999999865 36789999999999999999999998643221111100 00000       


Q ss_pred             ----c---CccccccCCCCCCC---CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          273 ----K---GKILSVFDPRIPPP---KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       273 ----~---~~i~~~~~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                          .   +.....+.......   ....++.++.+++.+||+.+|++|||+.+|+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                0   00000000000000   01123678999999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=309.24  Aligned_cols=254  Identities=24%  Similarity=0.409  Sum_probs=218.4

Q ss_pred             cccceeecccCceEEEEEEEC------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR------GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ....++||+|+||.||+|.|-      .-+||+|++....  ....++..|+-+|.++.|||+++++++|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            455789999999999999984      3479999877543  34578999999999999999999999998776 88999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      +|++.|+|.++++.+...+-.+..+.|..||++||.|||.+  ++|||||..+||||..-..+||.|||+++.+..+...
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q--rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ--RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc--chhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            99999999999998888899999999999999999999999  9999999999999999999999999999988877766


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                      +......-.+.|||-|.+....|+.++|||||||++||++| |..|++ +.+..++.+             +++...+.+
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~-gi~~~eI~d-------------lle~geRLs  920 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYD-GIPAEEIPD-------------LLEKGERLS  920 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccC-CCCHHHhhH-------------HHhccccCC
Confidence            65555666779999999999999999999999999999998 556654 444444433             222233345


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      .|+.++.++..++.+||..|+..||+++++...+.++.+.
T Consensus       921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            6788999999999999999999999999999988887654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.7e-34  Score=276.17  Aligned_cols=218  Identities=18%  Similarity=0.174  Sum_probs=178.8

Q ss_pred             cCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCCHHHHHHhC
Q 011384           66 GSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSN  143 (487)
Q Consensus        66 G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~  143 (487)
                      |.+|.||++.+.  ++.||+|++.....    +..|...+....||||+++++++.+....++||||+++++|.+++...
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            899999999986  78899999876532    334555566678999999999999999999999999999999999765


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCc
Q 011384          144 NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP  223 (487)
Q Consensus       144 ~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  223 (487)
                      . .+++..+..++.|++.||.|||+.  +++|+||||+||+++.++.++|+|||.+..+...     .....++..|+||
T Consensus        80 ~-~l~~~~~~~~~~ql~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aP  151 (237)
T cd05576          80 L-NIPEECVKRWAAEMVVALDALHRE--GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAP  151 (237)
T ss_pred             c-CCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCC
Confidence            4 499999999999999999999999  9999999999999999999999999987554322     1233567789999


Q ss_pred             cccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHh
Q 011384          224 CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRC  303 (487)
Q Consensus       224 E~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~c  303 (487)
                      |.+....++.++||||+||++|||++|+.|+.....  ..             .    .......+..++..+.+++.+|
T Consensus       152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~--~~-------------~----~~~~~~~~~~~~~~~~~li~~~  212 (237)
T cd05576         152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPS--GI-------------N----THTTLNIPEWVSEEARSLLQQL  212 (237)
T ss_pred             cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch--hc-------------c----cccccCCcccCCHHHHHHHHHH
Confidence            999888899999999999999999999987652111  00             0    0001112344667899999999


Q ss_pred             hhhcCCCCCCH
Q 011384          304 VRSCRERRPSM  314 (487)
Q Consensus       304 l~~dP~~RPs~  314 (487)
                      |+.||++||++
T Consensus       213 l~~dp~~R~~~  223 (237)
T cd05576         213 LQFNPTERLGA  223 (237)
T ss_pred             ccCCHHHhcCC
Confidence            99999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=7.4e-34  Score=313.23  Aligned_cols=143  Identities=29%  Similarity=0.435  Sum_probs=131.1

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||+|.+.  ++.||||++....    .....+..|+.++..++||||+++++++.....+|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            67999999999999999999997  8899999886532    23467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      ||+.+++|.+++...+ .+++..++.|+.||+.||.|||..  +|+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~--gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRH--GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999997654 489999999999999999999999  99999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-35  Score=293.15  Aligned_cols=242  Identities=26%  Similarity=0.361  Sum_probs=202.0

Q ss_pred             ceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCC
Q 011384           60 QKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNG  134 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~g  134 (487)
                      .++||+|-||+||-|+++  |+.||||++.+.   ......+++|+.+|.++.||.||.+...|+..+.+++|||-+.|-
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            589999999999999887  999999987764   234478999999999999999999999999999999999999554


Q ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC---CcEEEcccccceecCCCCccccc
Q 011384          135 TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN---FNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       135 sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~---~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      =|.-.|......|++.....++.||+.||.|||.+  +|+|+||||+|||+...   ..+||||||+++..+....+   
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k--nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR---  723 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK--NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR---  723 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc--ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh---
Confidence            44555555666799999999999999999999999  99999999999999643   56999999999998877643   


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ..+.|||.|+|||+++...|...-|+||.||++|--|+|..||.-+..-.+..+       +   ..++   .++.-..+
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ-------N---AaFM---yPp~PW~e  790 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ-------N---AAFM---YPPNPWSE  790 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhh-------c---cccc---cCCCchhh
Confidence            357899999999999999999999999999999999999999974332211111       0   1111   12223356


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ++.+..+||..+|+..-.+|.|.++-+.
T Consensus       791 is~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  791 ISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             cCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            8889999999999999999999988876

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=299.51  Aligned_cols=250  Identities=24%  Similarity=0.397  Sum_probs=210.8

Q ss_pred             HHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEe-----CCC
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSN-----DSK  122 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~-----~~~  122 (487)
                      ..-++-|.+.+.||.|.+|.||+++..  ++.+|||+...+....+++..|.++++.. .|||++.+||+|.     .++
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            334567999999999999999998765  88999999999988889999999999988 7999999999885     357


Q ss_pred             ceEEEEEecCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          123 DRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      ++|||||||.+||.-|++++ .+..+.|+.+..|++.++.||.+||..  .++|||||-.|||++.++.|||+|||++.+
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n--kviHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN--KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc--ceeeecccCceEEEeccCcEEEeeeeeeee
Confidence            89999999999999999976 345699999999999999999999999  999999999999999999999999999977


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCC-----CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcc
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPD-----NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI  276 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i  276 (487)
                      +...-  .+..+..|||.|||||++...     .|+.++|+||||++..||--|.+|+-....-..+             
T Consensus       173 ldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-------------  237 (953)
T KOG0587|consen  173 LDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------------  237 (953)
T ss_pred             eeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-------------
Confidence            65433  244567899999999999765     4678899999999999999999888532211110             


Q ss_pred             ccccCCCCCC---CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          277 LSVFDPRIPP---PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       277 ~~~~~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        +.-++-++   ..+...+.++.++|..||.+|-++||++.++++
T Consensus       238 --F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 --FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             --ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence              11122222   235678999999999999999999999999986

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-34  Score=270.83  Aligned_cols=250  Identities=22%  Similarity=0.313  Sum_probs=196.3

Q ss_pred             eeecccCceEEEEEEE--CCeEEEEEEcCCChh-hHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEEecCCCCH
Q 011384           61 KLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQE-ISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSNGTL  136 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~--~g~~vAvK~~~~~~~-~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  136 (487)
                      ++||+|+++.|-.++.  .+..||||++.+... ...++.+|++++.+. .|+||++|++||+++...|||||-|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            6899999999998865  489999999887644 446789999999999 599999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC---cEEEcccccceecCCCCcc-----
Q 011384          137 YDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF---NARLGDFGLALRCGVDNFR-----  208 (487)
Q Consensus       137 ~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~---~vkL~DFGla~~~~~~~~~-----  208 (487)
                      ..++.+.. .+++.++.+++.+|+.||.|||.+  ||.|||+||+|||..+..   -+|||||.+.......+.-     
T Consensus       164 LshI~~~~-~F~E~EAs~vvkdia~aLdFlH~k--gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast  240 (463)
T KOG0607|consen  164 LSHIQKRK-HFNEREASRVVKDIASALDFLHTK--GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST  240 (463)
T ss_pred             HHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhc--CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence            99998765 499999999999999999999999  999999999999996544   3899999886432221111     


Q ss_pred             cccCCCCCCCccCCccccC---C--CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc----------hhhhhhhhhhhc
Q 011384          209 FRSTPPAGTIGYLDPCYVT---P--DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----------SIVDWAAPLIKK  273 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~---~--~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~----------~~~~~~~~~~~~  273 (487)
                      -.-.+++|+..|||||+..   +  ..|+.+.|.||||||||-||+|.+||...-...          .-....-+-+..
T Consensus       241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE  320 (463)
T KOG0607|consen  241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE  320 (463)
T ss_pred             ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence            1122457888999999752   2  257889999999999999999999996322110          011111112222


Q ss_pred             CccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          274 GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       274 ~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      |+.      .++......++.+.++|+..+|..++.+|.++.+++.
T Consensus       321 GkY------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  321 GKY------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cCC------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            222      2333344568999999999999999999999887764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-34  Score=296.52  Aligned_cols=239  Identities=24%  Similarity=0.318  Sum_probs=200.0

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .+..|.+...+|.|+|+.|-.+.+.  ++..+||++.+..   ....+|+.++... +||||+++.+.+.+....|+|||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            3567888889999999999999886  7889999988762   2345577666655 79999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE-ccCCcEEEcccccceecCCCCcc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI-DRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl-d~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      .+.++-|.+.+.....  ....+.+|+.+|+.|+.|||.+  |+|||||||+|||+ +..++++|+|||.++.....   
T Consensus       397 ~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH~~--gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLHEQ--GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---  469 (612)
T ss_pred             hccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHHhc--CeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence            9999988888876553  3377888999999999999999  99999999999999 68899999999999765443   


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                        ....+-|..|.|||++....|+.++||||||++||+||+|+.||........+..    .+.            .+++
T Consensus       470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~----~i~------------~~~~  531 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT----RIQ------------MPKF  531 (612)
T ss_pred             --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH----hhc------------CCcc
Confidence              3456789999999999999999999999999999999999999975444322221    111            1223


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...++.++++|+.+||+.||.+||++.++..
T Consensus       532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  532 SECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            3678999999999999999999999999986

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=281.28  Aligned_cols=267  Identities=24%  Similarity=0.327  Sum_probs=210.1

Q ss_pred             cchhhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCC--C----CceeeEE
Q 011384           45 FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHS--P----RLVNLLG  116 (487)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~h--p----nIv~l~~  116 (487)
                      +-+......+++|.+...+|+|.||.|-.+.++  +..||||+++.-....+..+-|++++.++.+  |    -+|++.+
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~  158 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRD  158 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence            444445566899999999999999999999887  6789999998877777788889999999943  3    3788889


Q ss_pred             EEeCCCceEEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc---------
Q 011384          117 FSNDSKDRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID---------  186 (487)
Q Consensus       117 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld---------  186 (487)
                      ||...+..|||+|.+ |.|+.++|..++ .+++...+..++.|++.+++|||+.  +++|.||||+|||+-         
T Consensus       159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~--kl~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL--KLTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc--ceeecCCChheEEEeccceEEEec
Confidence            999999999999999 779999998744 6799999999999999999999999  999999999999982         


Q ss_pred             -----------cCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCC
Q 011384          187 -----------RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAID  255 (487)
Q Consensus       187 -----------~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~  255 (487)
                                 ++..++|+|||.+.......     .....|..|.|||++.+-.++..+||||+||||+|+.+|...|.
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq  310 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ  310 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence                       13458999999986543322     44678999999999999999999999999999999999999998


Q ss_pred             CCCCCchhhhh----------------hhhhhhcCccc-----------cccCCCCCC----CCChHHHHHHHHHHHHhh
Q 011384          256 IGFSPPSIVDW----------------AAPLIKKGKIL-----------SVFDPRIPP----PKDPIVRKQLAVIAVRCV  304 (487)
Q Consensus       256 ~~~~~~~~~~~----------------~~~~~~~~~i~-----------~~~~~~~~~----~~~~~~~~~l~~Li~~cl  304 (487)
                      .....+.+..+                ....+..+++.           .+.++..+.    ........+|.+|+.+||
T Consensus       311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL  390 (415)
T KOG0671|consen  311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML  390 (415)
T ss_pred             cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence            65533322110                11122222211           111111100    112334567999999999


Q ss_pred             hhcCCCCCCHHHHHH
Q 011384          305 RSCRERRPSMKEIVD  319 (487)
Q Consensus       305 ~~dP~~RPs~~eil~  319 (487)
                      ..||.+|+|+.|++.
T Consensus       391 ~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  391 EFDPARRITLREALS  405 (415)
T ss_pred             ccCccccccHHHHhc
Confidence            999999999999996

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.6e-34  Score=275.36  Aligned_cols=266  Identities=20%  Similarity=0.250  Sum_probs=197.1

Q ss_pred             cCcccceeecccCceEEEEEEEC------CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeC-CCce
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR------GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSND-SKDR  124 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~------g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~  124 (487)
                      ..|.....||+|.||.||+++..      .+.+|+|+++...   ......-+|+.+++.++|||++.+..+|.. +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46888999999999999999653      2369999887652   233567889999999999999999998876 7789


Q ss_pred             EEEEEecCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC----CcEEEccc
Q 011384          125 LLVVEFMSNGTLYDVLHS----NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN----FNARLGDF  196 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~----~~vkL~DF  196 (487)
                      ++++||.+. +|+..++-    ..+.++...+..|+.||+.|+.|||++  -|+||||||.||||..+    |.|||+||
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N--WvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN--WVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh--heeeccCCcceEEEeccCCccCeeEeecc
Confidence            999999965 89988863    235699999999999999999999999  99999999999999776    99999999


Q ss_pred             ccceecCCCCcc-cccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCC------CCchhhhhhh
Q 011384          197 GLALRCGVDNFR-FRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGF------SPPSIVDWAA  268 (487)
Q Consensus       197 Gla~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~------~~~~~~~~~~  268 (487)
                      |+++.+...-.. .....+.-|..|.|||.+.+. .||.+.|||++||++.||++-.+.|....      .|....+...
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            999876543222 133456678999999999875 78999999999999999999887775321      1211111111


Q ss_pred             hhhhcCc-----------------cccccCCCCCCCC-ChH-------HHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhc
Q 011384          269 PLIKKGK-----------------ILSVFDPRIPPPK-DPI-------VRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG  323 (487)
Q Consensus       269 ~~~~~~~-----------------i~~~~~~~~~~~~-~~~-------~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~  323 (487)
                      -+.-.|.                 ...-+........ -..       -++...+|+.++|+.||-+|.|+++.++...-
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            0000000                 0000000000000 000       12236789999999999999999999985433

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=282.70  Aligned_cols=240  Identities=23%  Similarity=0.300  Sum_probs=199.8

Q ss_pred             hhcCcccceeecccCceEEEEEEECC--eEEEEEEcCCChhh----HHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLRG--RQVAVKKPSKNQEI----SQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~g--~~vAvK~~~~~~~~----~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~  125 (487)
                      ...+|..+.+||+|+||.|-++..+|  ..||||+++++...    .+--..|-++|... +-|.+++++.+|..-+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            34579999999999999999998874  56999998876322    23344566677665 5689999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +||||+.||+|.-+++.-++ +.+..+..++.+|+.||-+||++  |||+||||.+|||+|.+|++||+|||+++.--..
T Consensus       427 FVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~k--gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             eEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcC--CeeeeeccccceEeccCCceEeeecccccccccC
Confidence            99999999999999988765 89999999999999999999999  9999999999999999999999999998753333


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      +.  ...+.+|||.|+|||++..++|+..+|+|||||+||||+.|.+||+.....+....    +..         .  .
T Consensus       504 ~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a----I~e---------h--n  566 (683)
T KOG0696|consen  504 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA----IME---------H--N  566 (683)
T ss_pred             Cc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHH---------c--c
Confidence            22  34567999999999999999999999999999999999999999985433322221    111         1  1


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCC
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRP  312 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RP  312 (487)
                      ..+|...+.+...+.+..|.++|.+|.
T Consensus       567 vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             CcCcccccHHHHHHHHHHhhcCCcccc
Confidence            235667889999999999999999995

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-35  Score=273.62  Aligned_cols=250  Identities=22%  Similarity=0.336  Sum_probs=196.9

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +.+.+..||.|+||.|++-.++  |+..|||++...  ....++++.|++...+- +.||||++||.+..++..|+.||.
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            3445678999999999999887  899999987644  34557788898877655 789999999999888899999999


Q ss_pred             cCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          131 MSNGTLYDVLHS----NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       131 ~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      | .-||..+.+.    ....+++..+-+|....+.||.||.... .|||||+||+|||+|..|.+||||||++-.+..  
T Consensus       145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--  220 (361)
T KOG1006|consen  145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--  220 (361)
T ss_pred             H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEecCCCEeeecccchHhHHH--
Confidence            9 5688776643    3345999999999999999999998754 899999999999999999999999999865432  


Q ss_pred             cccccCCCCCCCccCCccccCCC--CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPD--NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                       ....+...|-..|||||.+...  .|+.+|||||||++|||+.||+.|+..-.+   +.+.. ..+..|..     |.+
T Consensus       221 -SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql-~~Vv~gdp-----p~l  290 (361)
T KOG1006|consen  221 -SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQL-CQVVIGDP-----PIL  290 (361)
T ss_pred             -HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHH-HHHHcCCC-----Cee
Confidence             2345667889999999999764  589999999999999999999999863211   11111 11112221     111


Q ss_pred             CC-CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          285 PP-PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       285 ~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .. ......+..+..+|.-||.+|-..||...++++
T Consensus       291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            11 123457788999999999999999999999986

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.6e-32  Score=261.76  Aligned_cols=236  Identities=29%  Similarity=0.403  Sum_probs=194.3

Q ss_pred             CceEEEEEEEC--CeEEEEEEcCCChhh--HHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCCHHHHHHh
Q 011384           67 SHGSVYKAVLR--GRQVAVKKPSKNQEI--SQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS  142 (487)
Q Consensus        67 ~~g~Vy~~~~~--g~~vAvK~~~~~~~~--~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~  142 (487)
                      +||.||+|++.  ++.+++|++......  .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            68999999986  589999998765432  47899999999999999999999999999999999999999999999976


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCC
Q 011384          143 NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD  222 (487)
Q Consensus       143 ~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~a  222 (487)
                      ... +++..++.++.+++.+|.+||+.  +++|+||+|+||+++.++.++|+|||.+.......   ......++..|++
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh~~--~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~  154 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLHSN--GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMA  154 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHHHc--CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCC
Confidence            544 89999999999999999999999  99999999999999999999999999997665432   2334568889999


Q ss_pred             ccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHH
Q 011384          223 PCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVR  302 (487)
Q Consensus       223 PE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~  302 (487)
                      ||.+....++.++||||||+++|+|++|..||.............    ..+..      . .......++.++.+++.+
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~----~~~~~------~-~~~~~~~~~~~~~~~i~~  223 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI----GKPKP------P-FPPPEWKISPEAKDLIRK  223 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH----hccCC------C-CccccccCCHHHHHHHHH
Confidence            999988888999999999999999999999987533322222211    11000      0 000001156789999999


Q ss_pred             hhhhcCCCCCCHHHHHH
Q 011384          303 CVRSCRERRPSMKEIVD  319 (487)
Q Consensus       303 cl~~dP~~RPs~~eil~  319 (487)
                      ||..+|++||++.++++
T Consensus       224 ~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      224 LLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HccCCchhccCHHHHhh
Confidence            99999999999999996

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-34  Score=286.65  Aligned_cols=250  Identities=24%  Similarity=0.332  Sum_probs=209.6

Q ss_pred             cCcccceeecccCceEEEEEEECCeE--EEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~g~~--vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      .++..+.-||-||||.|-++..++..  +|+|++++.    ....+.+..|-++|...+.|.||++|-.|.+..++|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45677888999999999999988555  888887754    334467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      |-|-||.|+..|.+.+. ++......++..++.|+.|||++  +||+|||||+|.++|.+|.+||.|||+++.+....  
T Consensus       500 EaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH~k--~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--  574 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLHRK--GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--  574 (732)
T ss_pred             HhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHHhc--CceeccCChhheeeccCCceEEeehhhHHHhccCC--
Confidence            99999999999988764 99999999999999999999999  99999999999999999999999999998876554  


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                       .+.+.+|||.|.|||++.+...+.++|.||||+++|||++|.+||... .|-....    ++-+|     ++.   ..+
T Consensus       575 -KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~-dpmktYn----~ILkG-----id~---i~~  640 (732)
T KOG0614|consen  575 -KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV-DPMKTYN----LILKG-----IDK---IEF  640 (732)
T ss_pred             -ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC-chHHHHH----HHHhh-----hhh---hhc
Confidence             456789999999999999999999999999999999999999999732 2222221    11111     110   124


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCC-----HHHHHH--HHhc
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPS-----MKEIVD--WLTG  323 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs-----~~eil~--~L~~  323 (487)
                      |..+.+...+|+++++..+|.+|.-     +.+|.+  |+++
T Consensus       641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  641 PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            5667888999999999999999975     666665  4444

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=4e-33  Score=272.75  Aligned_cols=263  Identities=22%  Similarity=0.325  Sum_probs=219.3

Q ss_pred             hhhHHHhhcCcccceeecccCceEEEEEEECC-------eEEEEEEcCCChh--hHHHHHHHHHHHHhCCCCCceeeEEE
Q 011384           47 YSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVNLLGF  117 (487)
Q Consensus        47 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~g-------~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~  117 (487)
                      ..++.....+++...++-+|.||.||+|.|..       +.|.||.++....  ....+..|-..+..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            35666677889999999999999999998862       3577787765533  34578889999999999999999998


Q ss_pred             EeC-CCceEEEEEecCCCCHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC
Q 011384          118 SND-SKDRLLVVEFMSNGTLYDVLHS-------NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF  189 (487)
Q Consensus       118 ~~~-~~~~~lV~Ey~~~gsL~~~l~~-------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~  189 (487)
                      +.+ ....++++.++..|+|..+|..       ..+.++..+...++.|++.|++|||+.  ++||.||..+|++||+..
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~--~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH--GVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc--Ccccchhhhhcceehhhe
Confidence            765 4567999999999999999982       224577788889999999999999999  999999999999999999


Q ss_pred             cEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhh
Q 011384          190 NARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP  269 (487)
Q Consensus       190 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~  269 (487)
                      .+||+|=.+++.+.+.++.+..........||+||.+....|+.++|||||||+||||+|-......+.+|.+...+   
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y---  510 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY---  510 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH---
Confidence            99999999999998888888777778889999999999999999999999999999999854444445555554432   


Q ss_pred             hhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       270 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                       ++.|         .+...|..|++++..++..||...|++||++++++.-|...
T Consensus       511 -lkdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  511 -LKDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             -Hhcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence             2222         22234567999999999999999999999999999988764

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-33  Score=284.13  Aligned_cols=242  Identities=21%  Similarity=0.273  Sum_probs=190.5

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      -|..++.||-|+||+|.++...  ...||.|.+.+...    ....++.|-.||.....+-||+||-.|.+.+.+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            3778899999999999998654  56799998765432    23567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec-------
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-------  202 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~-------  202 (487)
                      |++||++..+|.+-+- +++..+..++.++.+|+++.|+.  |+|||||||+|||||.+|++||.|||||.-+       
T Consensus       710 YIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVHkm--GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk  786 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  786 (1034)
T ss_pred             ccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHHhc--cceecccCccceEEccCCceeeeeccccccceeccccc
Confidence            9999999999988764 99999999999999999999999  9999999999999999999999999998422       


Q ss_pred             --CCCCc-------------------------------ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh
Q 011384          203 --GVDNF-------------------------------RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS  249 (487)
Q Consensus       203 --~~~~~-------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt  249 (487)
                        ...+.                               +.......||+.|+|||++....|+.-+|+||.|||||||+.
T Consensus       787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV  866 (1034)
T ss_pred             cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence              10000                               011122369999999999999999999999999999999999


Q ss_pred             CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCC
Q 011384          250 CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRP  312 (487)
Q Consensus       250 G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP  312 (487)
                      |+.||..+........           +.-+..-+..++...++++..+||.+++ -+++.|.
T Consensus       867 g~~pf~~~tp~~tq~k-----------v~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL  917 (1034)
T KOG0608|consen  867 GQPPFLADTPGETQYK-----------VINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL  917 (1034)
T ss_pred             CCCCccCCCCCcceee-----------eeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence            9999975443322111           0111122233445566777777775533 3456665

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.9e-32  Score=293.20  Aligned_cols=256  Identities=21%  Similarity=0.254  Sum_probs=168.4

Q ss_pred             hhcCcccceeecccCceEEEEEEEC------CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEE------EeC
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF------SND  120 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~------g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~------~~~  120 (487)
                      ..++|.+.+.||+|+||.||+|++.      +..||||++...... +....|  .+....+.++..++..      +..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence            5678999999999999999999885      468999987654322 111111  1122222222222211      245


Q ss_pred             CCceEEEEEecCCCCHHHHHHhCCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCC
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSNNRP-------------------LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSA  181 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~  181 (487)
                      ....++||||+++++|.+++.....+                   .....+..++.|++.||.|||+.  +|+||||||+
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~--gIiHRDLKP~  284 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST--GIVHRDVKPQ  284 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC--CEEeCcCCHH
Confidence            66789999999999999998754311                   12334567999999999999999  9999999999


Q ss_pred             cEEEcc-CCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCC----------------------CCCcchhhh
Q 011384          182 NVLIDR-NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD----------------------NLSTKTDVF  238 (487)
Q Consensus       182 NILld~-~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~s~ksDVw  238 (487)
                      |||++. ++.+||+|||+++.+.... ........+++.|+|||.+...                      .++.++|||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            999986 5799999999997553322 2233456789999999965432                      234467999


Q ss_pred             hHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCc----cccccCCCCCCC------CChHHHHHHHHHHHHhhhhcC
Q 011384          239 SFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK----ILSVFDPRIPPP------KDPIVRKQLAVIAVRCVRSCR  308 (487)
Q Consensus       239 SlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~----i~~~~~~~~~~~------~~~~~~~~l~~Li~~cl~~dP  308 (487)
                      ||||+||||+++..++..     ....+...+...+.    +.....+.....      ..........+|+.+||+.||
T Consensus       364 SlGviL~el~~~~~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDS-----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             HHHHHHHHHHhCcCCCch-----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            999999999997654331     11111100000000    001111111000      001112345589999999999


Q ss_pred             CCCCCHHHHHH
Q 011384          309 ERRPSMKEIVD  319 (487)
Q Consensus       309 ~~RPs~~eil~  319 (487)
                      .+|||+.++++
T Consensus       439 ~kR~ta~e~L~  449 (566)
T PLN03225        439 RQRISAKAALA  449 (566)
T ss_pred             ccCCCHHHHhC
Confidence            99999999996

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.1e-32  Score=261.80  Aligned_cols=244  Identities=21%  Similarity=0.290  Sum_probs=199.5

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .++|.+.++||+|+|+.|-.+.+.  .+.||+|++++.    .....-.+.|-.++.+. +||.+|.++.+|.....+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            468999999999999999999876  778999987753    33445577788888776 79999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      |.||++||+|.-+++...+ |+++.+..+-..|+-||.|||++  |||+||||.+|+|+|..|++||.|+|+++.--...
T Consensus       329 vieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh~r--giiyrdlkldnvlldaeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLHER--GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHhhc--CeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence            9999999999999887654 99999999999999999999999  99999999999999999999999999987532222


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCC---CchhhhhhhhhhhcCccccccCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFS---PPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~---~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      .  ...+.+|||.|.|||.+++..|....|+|+|||+++||+.|+.||++-..   .....++....+-.        ..
T Consensus       406 d--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile--------kq  475 (593)
T KOG0695|consen  406 D--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE--------KQ  475 (593)
T ss_pred             c--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh--------hc
Confidence            1  35678999999999999999999999999999999999999999985321   22222232222221        22


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCC
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRP  312 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RP  312 (487)
                      ++  .|...+-....+++..|.+||.+|.
T Consensus       476 ir--iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  476 IR--IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             cc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence            22  2334555677888999999999985

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.98  E-value=6.7e-32  Score=239.73  Aligned_cols=259  Identities=23%  Similarity=0.289  Sum_probs=199.8

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +|...++||+|.||+||+++..  +..||+|.+..+   +.......+|+-+++.++|.|||++++..-.+..+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4667789999999999999876  778999987643   33456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      | ...|..+...-++.++.+.+..++.|++.||.++|++  +++|||+||+|.||+.+|.+||+|||+++.++..-.-  
T Consensus        83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh--nvlhrdlkpqnllin~ngelkladfglarafgipvrc--  157 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH--NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC--  157 (292)
T ss_pred             h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh--hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe--
Confidence            9 5699999988666799999999999999999999999  9999999999999999999999999999877654321  


Q ss_pred             cCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc-hhhhhhhhh--hhcCccc---cccCCC
Q 011384          211 STPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPP-SIVDWAAPL--IKKGKIL---SVFDPR  283 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~-~~~~~~~~~--~~~~~i~---~~~~~~  283 (487)
                      .....-|..|.+|.++.+. -|+...|+||-||++.|+.....|...+.... ++....+-+  ..+..+.   .+-|-.
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            1223568999999998875 56899999999999999987665655444322 222211111  1111111   111111


Q ss_pred             CCCCCC---------hHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          284 IPPPKD---------PIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       284 ~~~~~~---------~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+-++         +.....-++|+.++|.-+|.+|.++++.++
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            111111         223344578999999999999999999886

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2.7e-31  Score=280.90  Aligned_cols=261  Identities=18%  Similarity=0.212  Sum_probs=181.9

Q ss_pred             hhcCcccceeecccCceEEEEEEE------------------CCeEEEEEEcCCChh-hHH--------------HHHHH
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVL------------------RGRQVAVKKPSKNQE-ISQ--------------EVDNE   99 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~------------------~g~~vAvK~~~~~~~-~~~--------------~~~~E   99 (487)
                      ..++|.+.++||+|+||.||+|.+                  .++.||||++..... ..+              ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                  246799998765422 112              23346


Q ss_pred             HHHHHhCCCCCc-----eeeEEEEeC--------CCceEEEEEecCCCCHHHHHHhCC----------------------
Q 011384          100 IEILSKIHSPRL-----VNLLGFSND--------SKDRLLVVEFMSNGTLYDVLHSNN----------------------  144 (487)
Q Consensus       100 i~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~----------------------  144 (487)
                      +.++.+++|.++     ++++++|..        ....+|||||+++++|.+++....                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777776554     677777753        356799999999999999986421                      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCc
Q 011384          145 -RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP  223 (487)
Q Consensus       145 -~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  223 (487)
                       ..+++..++.++.|++.+|.|||+.  +|+||||||+|||++.++.+||+|||++..+.... ........+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~--~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI--GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeCh
Confidence             1246678889999999999999999  99999999999999999999999999986543321 1122233458899999


Q ss_pred             cccCCCCC----------------------CcchhhhhHHHHHHHHHhCCc-CCCCCCC-CchhhhhhhhhhhcCccccc
Q 011384          224 CYVTPDNL----------------------STKTDVFSFGILLLEIISCRK-AIDIGFS-PPSIVDWAAPLIKKGKILSV  279 (487)
Q Consensus       224 E~~~~~~~----------------------s~ksDVwSlGvvl~eLltG~~-pf~~~~~-~~~~~~~~~~~~~~~~i~~~  279 (487)
                      |.+.....                      ..+.||||+||++|+|++|.. |+..... ......+.. ...  .+...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~-~~~--~~r~~  456 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDN-DLN--RWRMY  456 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccc-hHH--HHHhh
Confidence            98764321                      234799999999999999875 4431100 001100000 000  00000


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhhhcC---CCCCCHHHHHH
Q 011384          280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCR---ERRPSMKEIVD  319 (487)
Q Consensus       280 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP---~~RPs~~eil~  319 (487)
                      .......+..+.++....+|+.+||..+|   .+|+|++|+++
T Consensus       457 ~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        457 KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11111222334567889999999999876   68999999996

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.3e-33  Score=258.93  Aligned_cols=263  Identities=20%  Similarity=0.292  Sum_probs=197.1

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC--------C
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSND--------S  121 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--------~  121 (487)
                      ..|....+||+|.||+||+|+.+  ++.||+|+...+   ........+|+.+|..++|+|++.++..|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45777889999999999999876  778999865432   2334567889999999999999999988753        2


Q ss_pred             CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      ..+|+|+++|+. +|.-+|.+....++...+.++..++..||.|+|..  .|+|||+||.|+||+.++.+||+|||+++.
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~--kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN--KILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh--hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            347999999965 99999988766799999999999999999999999  999999999999999999999999999976


Q ss_pred             cCCCCcc--cccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhh----------hhh
Q 011384          202 CGVDNFR--FRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD----------WAA  268 (487)
Q Consensus       202 ~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~----------~~~  268 (487)
                      +......  -..+...-|..|.+||.+.+. .|+++.|||.-||++.||.++.+.+.......++..          -+|
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            6543321  123344569999999998874 789999999999999999999877763322222111          111


Q ss_pred             hhhhcCccccccC-CCCCCC---------CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          269 PLIKKGKILSVFD-PRIPPP---------KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       269 ~~~~~~~i~~~~~-~~~~~~---------~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                      +...+-.+...+. +.++..         .+..-.++..+|+.++|..||.+|+++++++..
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            1111111111110 001110         001113467899999999999999999999974

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=6.9e-32  Score=285.26  Aligned_cols=245  Identities=25%  Similarity=0.410  Sum_probs=191.5

Q ss_pred             CcccceeecccCce-EEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           56 GFSEQKLLGKGSHG-SVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        56 ~y~~~~~LG~G~~g-~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      -|.-.+++|.|+.| .||+|...++.||||++-.+..  ....+||..|+.- .|||||++|+.-.+.+.+||..|.| .
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~--~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~  586 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFF--DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A  586 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhH--HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence            35566789999887 6899999999999998765433  4568899999888 7999999999999999999999999 6


Q ss_pred             CCHHHHHHhCCCCC---CHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc---C--CcEEEcccccceecCCC
Q 011384          134 GTLYDVLHSNNRPL---NWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR---N--FNARLGDFGLALRCGVD  205 (487)
Q Consensus       134 gsL~~~l~~~~~~l---~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~---~--~~vkL~DFGla~~~~~~  205 (487)
                      .+|.+++......+   .-...+.++.|++.||++||+.  +||||||||+||||+.   +  ..++|+|||+++.+...
T Consensus       587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl--~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL--KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc--ccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            69999998732111   1133467889999999999999  9999999999999975   3  46899999999988766


Q ss_pred             Cccc-ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhC-CcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          206 NFRF-RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISC-RKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       206 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG-~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      .... ......||-+|+|||.+.....+.+.||||||||+|..++| ..||+.......      +++....-...+.  
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~------NIl~~~~~L~~L~--  736 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA------NILTGNYTLVHLE--  736 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh------hhhcCccceeeec--
Confidence            5432 23456899999999999998888899999999999999987 789874332211      1111111011111  


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                         +. ..+  +..+||.+|++++|..||++.+|+.
T Consensus       737 ---~~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  737 ---PL-PDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ---cC-chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence               11 122  8899999999999999999999984

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=241.04  Aligned_cols=209  Identities=25%  Similarity=0.379  Sum_probs=173.7

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCce
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  124 (487)
                      ++...++...+..||+|++|.|-+-++.  |...|+|.+...  .+..++...|+.+..+. .+|.+|.+||...+....
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            3344456667789999999988777665  899999987643  44556788899887665 789999999999888999


Q ss_pred             EEEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          125 LLVVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      +|.||.| .-||..+..+   .+..+++..+-+|+..+..||.|||++. .+||||+||+||||+.+|.||+||||++-.
T Consensus       121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~  198 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICDFGISGY  198 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEccccccee
Confidence            9999999 5588776653   5667999999999999999999999975 899999999999999999999999999866


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCC----CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchh
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPD----NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSI  263 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~  263 (487)
                      +...   ...+...|-..|||||.+..+    .|+.+|||||||+++.||.+++.|++....+.+.
T Consensus       199 L~dS---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~q  261 (282)
T KOG0984|consen  199 LVDS---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQ  261 (282)
T ss_pred             ehhh---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHH
Confidence            5432   133445788899999998654    6889999999999999999999999877666544

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=7.7e-30  Score=236.81  Aligned_cols=208  Identities=36%  Similarity=0.578  Sum_probs=184.7

Q ss_pred             ecccCceEEEEEEEC--CeEEEEEEcCCChh--hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCCHHH
Q 011384           63 LGKGSHGSVYKAVLR--GRQVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYD  138 (487)
Q Consensus        63 LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~  138 (487)
                      ||+|++|.||++...  ++.+++|++.....  ....+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999998  88999999887654  35779999999999999999999999999999999999999999999


Q ss_pred             HHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc-CCcEEEcccccceecCCCCcccccCCCCCC
Q 011384          139 VLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-NFNARLGDFGLALRCGVDNFRFRSTPPAGT  217 (487)
Q Consensus       139 ~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~~~~gt  217 (487)
                      ++......+++..++.++.+++.+|.+||+.  +++|+||+|.||+++. ++.++|+|||.+........  ......+.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~  156 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSN--GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT  156 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence            9987644589999999999999999999999  9999999999999999 89999999999876544321  12335678


Q ss_pred             CccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHH
Q 011384          218 IGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQL  296 (487)
Q Consensus       218 ~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  296 (487)
                      ..|++||.+... ..+.++|+|+||+++++|                                              ..+
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------~~~  190 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------PEL  190 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------HHH
Confidence            899999999877 788999999999999988                                              457


Q ss_pred             HHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          297 AVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       297 ~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                      .+++.+|++.+|.+||++.++++.
T Consensus       191 ~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         191 KDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHhhCCcccCcCHHHHhhC
Confidence            889999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=3.5e-31  Score=243.18  Aligned_cols=253  Identities=21%  Similarity=0.329  Sum_probs=197.1

Q ss_pred             hcCcccceeecccCceEEEEEEE--CCeEEEEEEcCCChhhHHHHHHHHHHHHhCC-CCCceeeEEEEeCCC--ceEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIH-SPRLVNLLGFSNDSK--DRLLVV  128 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~--~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~--~~~lV~  128 (487)
                      .++|.+.+++|+|.+++||.|..  ....++||+++.-..  +.+.+|+.+|..+. ||||+.+++...+..  ...||+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk--kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK--KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH--HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            56899999999999999999984  478899999886543  67899999999997 999999999987754  457999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC-CcEEEcccccceecCCCCc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN-FNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~-~~vkL~DFGla~~~~~~~~  207 (487)
                      ||+.+.+...+..    .|+...+..++.+++.||.|+|+.  ||.|||+||.|++||.. -.++|+|+|+|....+.. 
T Consensus       115 E~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~--GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~-  187 (338)
T KOG0668|consen  115 EYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSM--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  187 (338)
T ss_pred             hhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhc--CcccccCCcceeeechhhceeeeeecchHhhcCCCc-
Confidence            9999988877764    377788899999999999999999  99999999999999964 579999999998765442 


Q ss_pred             ccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc-hhhhhhhh--------hhhcCccc
Q 011384          208 RFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP-SIVDWAAP--------LIKKGKIL  277 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~-~~~~~~~~--------~~~~~~i~  277 (487)
                        .......+..|-.||.+.. ..|+..-|+|||||+|..|++.+.||..|.+.. +++..+.-        .+.+-.+ 
T Consensus       188 --eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i-  264 (338)
T KOG0668|consen  188 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI-  264 (338)
T ss_pred             --eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc-
Confidence              1122345667788998865 467999999999999999999999998776533 33222110        0111000 


Q ss_pred             cccCCC----------------CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          278 SVFDPR----------------IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       278 ~~~~~~----------------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                       .+++.                +......-+++++.+|+.++|..|.++|||+.|.+.
T Consensus       265 -~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  265 -DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             -CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence             11111                111222234588999999999999999999999986

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.2e-29  Score=249.41  Aligned_cols=129  Identities=28%  Similarity=0.386  Sum_probs=115.0

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCC-----C---CCceeeEEEEeC----
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIH-----S---PRLVNLLGFSND----  120 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~-----h---pnIv~l~~~~~~----  120 (487)
                      .+|.+.++||.|-|++||++.+.  .+.||+|+.+..+...+....||++|++++     |   ..||+|+++|..    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            68999999999999999999886  678999999888777788899999999984     3   369999999974    


Q ss_pred             CCceEEEEEecCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI  185 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl  185 (487)
                      +..+|+|+|++ |.+|..++.. +.+.++...+.+|+.||+.||.|||..+ +|||.||||+|||+
T Consensus       158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL  221 (590)
T ss_pred             CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence            56789999999 7799998876 3456999999999999999999999976 99999999999998

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=1.3e-30  Score=262.59  Aligned_cols=266  Identities=22%  Similarity=0.275  Sum_probs=210.2

Q ss_pred             cchhhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCC------CCceeeEE
Q 011384           45 FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHS------PRLVNLLG  116 (487)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~h------pnIv~l~~  116 (487)
                      |.+.-.+....+|.+.-..|+|-|++|.+|.+.  |..||||++.++....+.=+.|+++|++|+.      .|+++|+-
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            444556677889999999999999999999986  8899999999999888888999999999963      48999999


Q ss_pred             EEeCCCceEEEEEecCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC-CcEEE
Q 011384          117 FSNDSKDRLLVVEFMSNGTLYDVLHSNN--RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN-FNARL  193 (487)
Q Consensus       117 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~-~~vkL  193 (487)
                      .|...+.+|||+|.+ ..+|.++|++.+  ..|....+..++.|+.-||..|..+  +|+|.||||+|||++.. ..+||
T Consensus       502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c--~vlHaDIKPDNiLVNE~k~iLKL  578 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC--GVLHADIKPDNILVNESKNILKL  578 (752)
T ss_pred             HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc--CeeecccCccceEeccCcceeee
Confidence            999999999999998 679999998754  3588889999999999999999999  99999999999999864 56899


Q ss_pred             cccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhh------
Q 011384          194 GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA------  267 (487)
Q Consensus       194 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~------  267 (487)
                      ||||.|.......    .++..-+.-|.|||++.+-+|+...|+||.||+||||.||+-.|.. ........+.      
T Consensus       579 CDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG-~TNN~MLrl~me~KGk  653 (752)
T KOG0670|consen  579 CDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG-RTNNQMLRLFMELKGK  653 (752)
T ss_pred             ccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC-CCcHHHHHHHHHhcCC
Confidence            9999986554332    2333445579999999999999999999999999999999988863 2211111110      


Q ss_pred             --hhhhhcCc---------------------------cccccCC------------CCCCCCChHHHHHHHHHHHHhhhh
Q 011384          268 --APLIKKGK---------------------------ILSVFDP------------RIPPPKDPIVRKQLAVIAVRCVRS  306 (487)
Q Consensus       268 --~~~~~~~~---------------------------i~~~~~~------------~~~~~~~~~~~~~l~~Li~~cl~~  306 (487)
                        ..++.+|.                           ++..+.|            ++ +...+.+...+.+|+..||..
T Consensus       654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~-~deq~~~~~~~rdLLdkml~L  732 (752)
T KOG0670|consen  654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRL-PDEQPKIVQQLRDLLDKMLIL  732 (752)
T ss_pred             CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCC-CchhHHHHHHHHHHHHHHhcc
Confidence              01111111                           0111111            01 112244566789999999999


Q ss_pred             cCCCCCCHHHHHH
Q 011384          307 CRERRPSMKEIVD  319 (487)
Q Consensus       307 dP~~RPs~~eil~  319 (487)
                      ||++|.|..+.|.
T Consensus       733 dP~KRit~nqAL~  745 (752)
T KOG0670|consen  733 DPEKRITVNQALK  745 (752)
T ss_pred             ChhhcCCHHHHhc
Confidence            9999999999986

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1e-29  Score=259.06  Aligned_cols=194  Identities=26%  Similarity=0.381  Sum_probs=168.7

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhH---------HHHHHHHHHHHhCC---CCCceeeEEEEeC
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS---------QEVDNEIEILSKIH---SPRLVNLLGFSND  120 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~---------~~~~~Ei~~l~~l~---hpnIv~l~~~~~~  120 (487)
                      .+|..++.+|.|+||.|++++++  ...|+||.+.++..-.         ..+-.||++|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46899999999999999999997  5679999887764322         23566999999997   9999999999999


Q ss_pred             CCceEEEEEec-CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          121 SKDRLLVVEFM-SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       121 ~~~~~lV~Ey~-~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                      ++++||+||-. ++-+|.+++.... .+++.++.-|+.|++.|+++||+.  +|||||||-+|+.++.+|.+||+|||.+
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~--~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQ--GIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccccc--CceecccccccEEEecCCeEEEeeccch
Confidence            99999999986 3558899987654 499999999999999999999999  9999999999999999999999999998


Q ss_pred             eecCCCCcccccCCCCCCCccCCccccCCCCC-CcchhhhhHHHHHHHHHhCCcCCC
Q 011384          200 LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAID  255 (487)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvvl~eLltG~~pf~  255 (487)
                      ......    ......||..|.|||++.+..| ...-|||++|++||.++....||.
T Consensus       718 a~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  718 AYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            654332    2334689999999999999988 566899999999999999988875

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=245.27  Aligned_cols=262  Identities=20%  Similarity=0.290  Sum_probs=196.5

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC-----ce
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSK-----DR  124 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----~~  124 (487)
                      .+..-.+.||-|+||.||.+.+.  |+.||+|++..-.   ..-+.+.+|+.+|+-++|.|++..+++..-.+     .+
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            34555689999999999999886  8999999876543   33467889999999999999999888765432     35


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      |+|+|.|. .+|...+-.. ..++.+.+.-++.||++||+|||+.  +|+||||||.|.|++.+..+||||||+++.-..
T Consensus       133 YV~TELmQ-SDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA--~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  133 YVLTELMQ-SDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTA--NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHHH-hhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhc--chhhccCCCccEEeccCceEEecccccccccch
Confidence            78888884 4777777654 3588899999999999999999999  999999999999999999999999999986554


Q ss_pred             CCcccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhh-----------h
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI-----------K  272 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~-----------~  272 (487)
                      +... .++...-|-.|.|||.+.+. .|+.+.||||.||++.||+..+-.|..... -+..+.+..++           .
T Consensus       209 d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P-iqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  209 RDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP-IEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             hhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh-HHHHHHHHHHhCCCcHHHHHHHh
Confidence            4333 45555678899999999875 789999999999999999988877764332 22222222221           1


Q ss_pred             cCccccccCCCCCCC---------CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          273 KGKILSVFDPRIPPP---------KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       273 ~~~i~~~~~~~~~~~---------~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      .|...+++......+         -+..-..+...+...++..+|++|.+..+.+..+.
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            122222222221111         11223446677888999999999999998887543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=7.4e-28  Score=227.82  Aligned_cols=197  Identities=32%  Similarity=0.436  Sum_probs=172.3

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCChh--hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecC
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      |.+.+.||+|++|.||++...  ++.+++|.......  ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            567889999999999999986  58899999876543  45789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccC
Q 011384          133 NGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       133 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      +++|.+++......+++..+..++.+++.+|.+||..  +++|+||+|.||+++.++.++|+|||++......... ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~  157 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL--GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLK  157 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-ccc
Confidence            9999999987543388999999999999999999999  9999999999999999999999999998766543211 123


Q ss_pred             CCCCCCccCCcccc-CCCCCCcchhhhhHHHHHHHHHhCCcCCCC
Q 011384          213 PPAGTIGYLDPCYV-TPDNLSTKTDVFSFGILLLEIISCRKAIDI  256 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~-~~~~~s~ksDVwSlGvvl~eLltG~~pf~~  256 (487)
                      ...++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            34678899999998 666778899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-29  Score=261.13  Aligned_cols=251  Identities=22%  Similarity=0.342  Sum_probs=202.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh-hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE-ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      .++|.....+|+|.+|.||++++.  ++..|||+++.... ...-+..|+-+++..+||||+.++|-+.....+++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            467899999999999999999886  88999999886543 346678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      |.+|+|++..+-.+ ++++.++....+..++||+|||+.  +=+|||||-.|||+++.|.+|++|||.+..+...  ...
T Consensus        94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs~--gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~K  168 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHSQ--GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAK  168 (829)
T ss_pred             cCCCcccceeeecc-cchhHHHHHHHhhhhccchhhhcC--CcccccccccceeecccCceeecccCchhhhhhh--hhh
Confidence            99999999887665 599999999999999999999999  9899999999999999999999999998655432  223


Q ss_pred             cCCCCCCCccCCcccc---CCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          211 STPPAGTIGYLDPCYV---TPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~---~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                      .....||+.|||||+.   +.+.|...+|||++|+...|+---.+|... ..|....    .+..+    ..+++. ...
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd-lhpmr~l----~LmTk----S~~qpp-~lk  238 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD-LHPMRAL----FLMTK----SGFQPP-TLK  238 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc-cchHHHH----HHhhc----cCCCCC-ccc
Confidence            4457899999999986   345788999999999999999876666542 2221111    11111    111211 112


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      -.....+.+.++++.||.++|++||+++.++.
T Consensus       239 Dk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            23467888999999999999999999998875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=236.64  Aligned_cols=253  Identities=23%  Similarity=0.325  Sum_probs=194.3

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC------C
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS------K  122 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~  122 (487)
                      ..+|.-.+.+|.|.- .|--+.+.  +++||+|+....   ....++..+|+.++..++|+||++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            357888889999988 66666665  899999976533   33346788899999999999999999998644      3


Q ss_pred             ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                      ..|+|||+| ..+|...+.-   .++-+.+..|+.|++.|++|||+.  +|+||||||+||++..+..+||.|||+++.-
T Consensus        95 e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~--~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHSA--GIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhc--ceeecccCcccceecchhheeeccchhhccc
Confidence            468999999 5699888872   277788899999999999999999  9999999999999999999999999999765


Q ss_pred             CCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhh--------------
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA--------------  268 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~--------------  268 (487)
                      +..   ...+....|..|.|||++.+..+...+||||+||++.||++|.-.|....   .+.+|..              
T Consensus       169 ~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d---~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  169 DTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD---HIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             Ccc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch---HHHHHHHHHHHhcCCCHHHHH
Confidence            443   46777889999999999999999999999999999999999998886321   1111111              


Q ss_pred             -------hhhhcC-c-----ccc-ccCCCCCC--CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          269 -------PLIKKG-K-----ILS-VFDPRIPP--PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       269 -------~~~~~~-~-----i~~-~~~~~~~~--~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                             ...... +     ..+ +-|..++.  +.++.-...+.+++.+||-.||++|.+++++|+
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                   000000 0     000 00111111  112233456889999999999999999999997

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-27  Score=224.88  Aligned_cols=249  Identities=19%  Similarity=0.277  Sum_probs=191.1

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEE-EEeCCCceEEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLG-FSNDSKDRLLVV  128 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~-~~~~~~~~~lV~  128 (487)
                      ..+.|.+.+.||+|.||.+-++.++  .+.+++|-+.......++|.+|+.---.| .|.||+..|+ .|...+.+++++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            3467999999999999999999998  56799999999988899999998876666 5889998887 467777888999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc--cCCcEEEcccccceecCCCC
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID--RNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld--~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||++.|+|..-+...+  +-+..-..++.|+++||.|+|++  ++||||||.+||||-  +...+||||||+.+..+.. 
T Consensus       102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsk--nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-  176 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSK--NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-  176 (378)
T ss_pred             ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhcc--chhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence            9999999999988766  88888899999999999999999  999999999999993  3357999999998654432 


Q ss_pred             cccccCCCCCCCccCCccccCCC---C--CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPD---N--LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~---~--~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                          ......+..|.+||.+...   .  ..+.+|||.||+++|..+||..||...... ....|-+....+++.     
T Consensus       177 ----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~w~~rk~-----  246 (378)
T KOG1345|consen  177 ----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQWLKRKN-----  246 (378)
T ss_pred             ----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHHHhcccC-----
Confidence                2233467789999876432   2  267899999999999999999999732221 111222222222222     


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHH
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI  317 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ei  317 (487)
                      ++.+..+. ..++.+..+.++-|..++++|=-..++
T Consensus       247 ~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  247 PALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             ccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHH
Confidence            12222121 245677788899999999999433333

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=7.7e-28  Score=270.97  Aligned_cols=197  Identities=16%  Similarity=0.218  Sum_probs=141.1

Q ss_pred             HhCCC-CCceeeEEEE-------eCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 011384          104 SKIHS-PRLVNLLGFS-------NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH  175 (487)
Q Consensus       104 ~~l~h-pnIv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH  175 (487)
                      +.++| .||++++++|       .+...+++++||+ +++|.++|......+++..++.++.||+.||.|||++  +|+|
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--gIvH  103 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ--GIVV  103 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC--Ceee
Confidence            34556 5888888887       2334567889988 6699999987666699999999999999999999999  9999


Q ss_pred             ccCCCCcEEEcc-------------------CCcEEEcccccceecCCCCc--------------ccccCCCCCCCccCC
Q 011384          176 RDIKSANVLIDR-------------------NFNARLGDFGLALRCGVDNF--------------RFRSTPPAGTIGYLD  222 (487)
Q Consensus       176 ~DIkp~NILld~-------------------~~~vkL~DFGla~~~~~~~~--------------~~~~~~~~gt~~Y~a  222 (487)
                      |||||+||||+.                   ++.+|++|||+++.......              ........||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999965                   34556666666643211000              000112358899999


Q ss_pred             ccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHH
Q 011384          223 PCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVR  302 (487)
Q Consensus       223 PE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~  302 (487)
                      ||++.+..++.++|||||||+||||++|..|+....      ...... ..    ..+.+.    . .........++.+
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~-~~----~~~~~~----~-~~~~~~~~~~~~~  247 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSL-RH----RVLPPQ----I-LLNWPKEASFCLW  247 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHH-HH----hhcChh----h-hhcCHHHHHHHHH
Confidence            999999999999999999999999999887754110      000000 00    001111    1 1112345678899


Q ss_pred             hhhhcCCCCCCHHHHHH
Q 011384          303 CVRSCRERRPSMKEIVD  319 (487)
Q Consensus       303 cl~~dP~~RPs~~eil~  319 (487)
                      ||+++|.+||++.||++
T Consensus       248 ~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        248 LLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             hCCCChhhCcChHHHhh
Confidence            99999999999999986

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=1.9e-26  Score=211.66  Aligned_cols=167  Identities=22%  Similarity=0.269  Sum_probs=129.4

Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      |+|.+++...+.++++..++.++.|++.||.|||+.  +      ||+|||++.++.+|+  ||++.......       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~--~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ--A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc--C------CcccEeEcCccceee--ccceEeecccc-------
Confidence            689999987667799999999999999999999999  6      999999999999999  99987654321       


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||............   .....  . ...+. ....+..+.
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~---~~~~~--~-~~~~~-~~~~~~~~~  136 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEI---LLNGM--P-ADDPR-DRSNLESVS  136 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHH---HHHHh--c-cCCcc-ccccHHHHH
Confidence            26899999999999999999999999999999999999998643322222111   11100  0 00000 011223344


Q ss_pred             H--HHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          294 K--QLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       294 ~--~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      .  ++.+++.+||..+|.+||++.++++.+..+
T Consensus       137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      137 AARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             hhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            4  699999999999999999999999977554

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=6e-27  Score=232.31  Aligned_cols=264  Identities=24%  Similarity=0.334  Sum_probs=197.6

Q ss_pred             hHHHhhcCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCC
Q 011384           49 DLEAATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSK  122 (487)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~  122 (487)
                      .+....+.|..+++||.|.|+.||++++.     .+.||+|.+...... ..+.+|+++|..+ -+.||+++.+++..++
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            34455678999999999999999999764     568999988765443 5689999999999 5899999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc-CCcEEEccccccee
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-NFNARLGDFGLALR  201 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla~~  201 (487)
                      ..++|+||++.....+++..    ++...+..+++.++.||.++|..  |||||||||+|+|.+. .+.-.|+|||++..
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~--GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKN--GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhcc--CccccCCCccccccccccCCceEEechhHHH
Confidence            99999999999999999864    67889999999999999999999  9999999999999985 46789999999851


Q ss_pred             cCCC----------------------------------Cccc--------ccCCCCCCCccCCccccCC-CCCCcchhhh
Q 011384          202 CGVD----------------------------------NFRF--------RSTPPAGTIGYLDPCYVTP-DNLSTKTDVF  238 (487)
Q Consensus       202 ~~~~----------------------------------~~~~--------~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVw  238 (487)
                      ....                                  +...        ......||++|.|||++.. ...+++.|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            1000                                  0000        0012259999999999765 4568999999


Q ss_pred             hHHHHHHHHHhCCcCCCCCCCCch-hhhhhh---------hhhhcCc--cc--------------------cccCC----
Q 011384          239 SFGILLLEIISCRKAIDIGFSPPS-IVDWAA---------PLIKKGK--IL--------------------SVFDP----  282 (487)
Q Consensus       239 SlGvvl~eLltG~~pf~~~~~~~~-~~~~~~---------~~~~~~~--i~--------------------~~~~~----  282 (487)
                      |.||+++-+++++.||........ +.+.+.         -....|+  +.                    +.+.+    
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence            999999999999999974432211 111000         0000111  00                    00000    


Q ss_pred             -CCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          283 -RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       283 -~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                       -.........+..+.+|+.+||..||.+|.|+++.|+
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence             0011122334557889999999999999999999996

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.6e-24  Score=216.58  Aligned_cols=258  Identities=22%  Similarity=0.244  Sum_probs=198.2

Q ss_pred             CcccceeecccCceEEEEEEECC---eEEEEEEcCCChhh-HHHHHHHHHHHHhCCC----CCceeeEEEE-eCCCceEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLRG---RQVAVKKPSKNQEI-SQEVDNEIEILSKIHS----PRLVNLLGFS-NDSKDRLL  126 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~g---~~vAvK~~~~~~~~-~~~~~~Ei~~l~~l~h----pnIv~l~~~~-~~~~~~~l  126 (487)
                      +|.+.+.||+|+||.||.|....   ..+|+|........ ...+..|+.++..+..    +++..+++.+ ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            89999999999999999999864   46999987664322 2267889999998873    6899999999 57788899


Q ss_pred             EEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC-----CcEEEcccccce
Q 011384          127 VVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN-----FNARLGDFGLAL  200 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~-----~~vkL~DFGla~  200 (487)
                      ||+.+ |.+|.++..... ..++...+..++.|++.+|.+||+.  |++||||||+|+++...     ..+.|.|||+++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~--G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK--GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc--CcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            99998 889999986554 6799999999999999999999999  99999999999999754     469999999998


Q ss_pred             --ecCCCCcc---cc---cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh
Q 011384          201 --RCGVDNFR---FR---STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK  272 (487)
Q Consensus       201 --~~~~~~~~---~~---~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~  272 (487)
                        ........   ..   .....||..|+++....+...+.+.|+||++.++.+++.|..||................ .
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~-~  254 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP-R  254 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh-h
Confidence              33222211   01   223459999999999999999999999999999999999999996433222221111100 0


Q ss_pred             cCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          273 KGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       273 ~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .    .....     .....+.++..+...+-..+...+|....+...|.....
T Consensus       255 ~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  255 K----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             h----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            0    00000     122345667777777777999999999999988776644

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=9.8e-26  Score=211.96  Aligned_cols=248  Identities=22%  Similarity=0.378  Sum_probs=197.4

Q ss_pred             ccceeecccCceEEEEEEECCeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCC
Q 011384           58 SEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNG  134 (487)
Q Consensus        58 ~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~g  134 (487)
                      .+..+|.+...|+.|+|+|+|..+++|+++..+   .....|..|.-.|+-+.||||+.+++.|.....+.++..||+.|
T Consensus       193 nl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            345678899999999999999999999887543   23367999999999999999999999999999999999999999


Q ss_pred             CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          135 TLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       135 sL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      ||+..|+... --.+..++.+++.+++.|++|||+..|-|.---|....++||++.+.+|.       +......+....
T Consensus       273 slynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-------mad~kfsfqe~g  345 (448)
T KOG0195|consen  273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-------MADTKFSFQEVG  345 (448)
T ss_pred             HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-------cccceeeeeccc
Confidence            9999998643 34677788999999999999999987655566788999999999887764       111122223333


Q ss_pred             CCCCCccCCccccCCCCC---CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          214 PAGTIGYLDPCYVTPDNL---STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~---s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      ..-.|.||+||.+...+-   -.++|+|||.+++|||.|..-||. +.++-+...            ++.-+.++...|+
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfa-dlspmecgm------------kialeglrv~ipp  412 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFA-DLSPMECGM------------KIALEGLRVHIPP  412 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccc-cCCchhhhh------------hhhhccccccCCC
Confidence            456889999999976643   357999999999999999999996 233333221            1222334445666


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      .++..+..|+.-|+..||.+||.+..|+-.|+++.
T Consensus       413 gis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            78888999999999999999999999999998764

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=9.1e-23  Score=200.24  Aligned_cols=256  Identities=28%  Similarity=0.395  Sum_probs=198.9

Q ss_pred             cccceeecccCceEEEEEEECCeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCC-CceeeEEEEeCCCceEEEEEec
Q 011384           57 FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSP-RLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hp-nIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      |...+.||.|+|+.||++.+. ..+++|.+.....    ....+.+|+.++..+.|+ +++.+++++......+++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            677899999999999999988 7888898775432    356799999999999988 7999999997777789999999


Q ss_pred             CCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC-cEEEcccccceecCCCCcc
Q 011384          132 SNGTLYDVLHSNN--RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF-NARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       132 ~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~~~~~~~  208 (487)
                      .+++|.+++....  ..++......++.|++.++.|+|..  +++||||||+||+++..+ .++++|||++..+......
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~--~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            9999997776654  2589999999999999999999999  999999999999999988 7999999999755544322


Q ss_pred             c----ccCCCCCCCccCCccccCC---CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCC---chhhhhhhhhhhcCcccc
Q 011384          209 F----RSTPPAGTIGYLDPCYVTP---DNLSTKTDVFSFGILLLEIISCRKAIDIGFSP---PSIVDWAAPLIKKGKILS  278 (487)
Q Consensus       209 ~----~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~---~~~~~~~~~~~~~~~i~~  278 (487)
                      .    ......|+..|++||.+.+   ..++...|+||+|++++++++|..||......   .............     
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----  233 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-----  233 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-----
Confidence            1    2456789999999999987   57789999999999999999999997543321   1211111111000     


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       279 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                      .................+.+++..|+..+|..|.+..+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            000001100002234678899999999999999998877763

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=5.2e-24  Score=216.77  Aligned_cols=166  Identities=21%  Similarity=0.190  Sum_probs=130.5

Q ss_pred             HHhhcCcccceeecccCceEEEEEEEC---CeEEEEEEcCCC------hhhHHHHHHHHHHHHhCCCCCcee-eEEEEeC
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLR---GRQVAVKKPSKN------QEISQEVDNEIEILSKIHSPRLVN-LLGFSND  120 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~---g~~vAvK~~~~~------~~~~~~~~~Ei~~l~~l~hpnIv~-l~~~~~~  120 (487)
                      ....++|.+.+.||+|+||.||+|.+.   +..||||+....      ......+.+|++++++++|+|++. ++++   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            345678999999999999999999874   667899986532      223456999999999999999985 4432   


Q ss_pred             CCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccC-CCCcEEEccCCcEEEcccccc
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI-KSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DI-kp~NILld~~~~vkL~DFGla  199 (487)
                       ...++||||++|++|... ..    ..   ...++.+++.+|.|||+.  +|+|||| ||+|||++.++.+||+|||++
T Consensus        91 -~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~--gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRA--GITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             -CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHC--CCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence             357999999999999632 11    11   146788999999999999  9999999 999999999999999999999


Q ss_pred             eecCCCCcccc------cCCCCCCCccCCccccCCCC
Q 011384          200 LRCGVDNFRFR------STPPAGTIGYLDPCYVTPDN  230 (487)
Q Consensus       200 ~~~~~~~~~~~------~~~~~gt~~Y~aPE~~~~~~  230 (487)
                      +.+........      .+...+++.|+|||.+....
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~  196 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE  196 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence            87654432211      13457888999999987653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.8e-24  Score=199.25  Aligned_cols=274  Identities=19%  Similarity=0.190  Sum_probs=209.7

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCC-CCceeeEEEEeCCCceEEEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHS-PRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ....|.+++.||+|+||.+|.|..-  |..||||+....... .++.-|..+...+++ +.|..+..|+.+..+..+||+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            3468999999999999999999764  899999987665432 567779999999976 778888889999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc---CCcEEEcccccceecCCCC
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR---NFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~~~~~~~  206 (487)
                      .+ |.||.+++.-..+.++.+.++-++.|++.-++|+|.+  ++|||||||+|+|..-   ...+.|+|||+++......
T Consensus        92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r--~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~  168 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR--NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR  168 (341)
T ss_pred             cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh--ccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence            99 8999999987667799999999999999999999999  9999999999999964   3568999999997654332


Q ss_pred             cc-----cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          207 FR-----FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       207 ~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      ..     .......||..|.+--...+-..+.+.|+-|+|.+|..+.-|..||.. ..+..-.+-.. .+...++...  
T Consensus       169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg-lka~tk~QKyE-kI~EkK~s~~--  244 (341)
T KOG1163|consen  169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG-LKAATKKQKYE-KISEKKMSTP--  244 (341)
T ss_pred             ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc-cchhhHHHHHH-HHHHhhcCCC--
Confidence            11     122345799999998888888889999999999999999999999973 22222111111 1111111100  


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCCCCCCCCCC
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFN  337 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~  337 (487)
                         ........|.++...+.-|-..--++-|...-+.+.+.-|...+......-++
T Consensus       245 ---ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyD  297 (341)
T KOG1163|consen  245 ---IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYD  297 (341)
T ss_pred             ---HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEee
Confidence               01122345678888999999999999999888888777666555444333333

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1.6e-23  Score=202.14  Aligned_cols=261  Identities=16%  Similarity=0.197  Sum_probs=204.9

Q ss_pred             cCcccceeecccCceEEEEEEE--CCeEEEEEEcCCChhhHHHHHHHHHHHHhCC-CCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIH-SPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~--~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      -+|.++++||+|+||+.|.|+.  ++..||||....... ..+++.|.+..+.|. .++|...|-|..++-+..||+|.+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC-cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            4689999999999999999975  599999997654433 367888999999985 599999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc-----CCcEEEcccccceecCCCC
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-----NFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~-----~~~vkL~DFGla~~~~~~~  206 (487)
                       |.||.|++.-.++.++.+.+..+|.|++.-++|+|++  .+|.|||||+|+||..     ...+.|+|||+++......
T Consensus       107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k--~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~  183 (449)
T KOG1165|consen  107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK--DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK  183 (449)
T ss_pred             -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc--ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence             8999999998888899999999999999999999999  9999999999999953     3468999999998764432


Q ss_pred             ccc-----ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          207 FRF-----RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       207 ~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      ...     ......||.+||+--...+.+.+.+.|+-|||-|++.+|-|..||.. ...+........+-...+...   
T Consensus       184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG-LKA~tnK~kYeKIGe~Kr~T~---  259 (449)
T KOG1165|consen  184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG-LKADTNKEKYEKIGETKRSTP---  259 (449)
T ss_pred             ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc-ccCcchHHHHHHhccccccCC---
Confidence            110     11234699999999999999999999999999999999999999973 333332222221111111100   


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                         .......++.++..-+.-.-..+-.+-|..+-+...+..+..
T Consensus       260 ---i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  260 ---IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             ---HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence               011223467788888888888899999998887776555543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=9e-24  Score=228.22  Aligned_cols=251  Identities=22%  Similarity=0.244  Sum_probs=189.6

Q ss_pred             ccceeecccCceEEEEEEEC--CeEEEEEEcC----CChh---hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           58 SEQKLLGKGSHGSVYKAVLR--GRQVAVKKPS----KNQE---ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        58 ~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~----~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ....++|.|++|.|+.....  .+.++.|.+.    ....   ....+..|+-+-..+.|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45789999999988877654  3334444322    1111   1123677888889999999988888777766666669


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      |||++ +|..++...+ .+....+-.++.|++.|+.|+|..  ||.|||+|++|+++..++.+||+|||.+..+......
T Consensus       401 E~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~--GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSM--GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             hcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhc--CceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            99999 9999998764 388899999999999999999999  9999999999999999999999999998655444332


Q ss_pred             --cccCCCCCCCccCCccccCCCCCCc-chhhhhHHHHHHHHHhCCcCCCCCCCCchhh-hhhhhhhhcCccccccCCCC
Q 011384          209 --FRSTPPAGTIGYLDPCYVTPDNLST-KTDVFSFGILLLEIISCRKAIDIGFSPPSIV-DWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       209 --~~~~~~~gt~~Y~aPE~~~~~~~s~-ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~-~~~~~~~~~~~i~~~~~~~~  284 (487)
                        .......|...|+|||.+.+..|.+ ..||||.|+++..|++|+.||.......... +..    ..   ...-...-
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~----~~---~~~~~~~~  549 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN----YS---DQRNIFEG  549 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc----cc---cccccccC
Confidence              4566778999999999999999965 5899999999999999999997543322210 000    00   00000011


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +......++...+.++.+||+.+|.+|.|+++|++
T Consensus       550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            11223446778899999999999999999999997

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=2.2e-22  Score=191.58  Aligned_cols=171  Identities=14%  Similarity=0.139  Sum_probs=134.7

Q ss_pred             HhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhH----H------HHHHHHHHHHhCCCCCceeeEEEEeCC
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEIS----Q------EVDNEIEILSKIHSPRLVNLLGFSNDS  121 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~----~------~~~~Ei~~l~~l~hpnIv~l~~~~~~~  121 (487)
                      ...++|...++||.|+||.||++...+..+|||.+.......    .      .+.+|++.+.+++||+|..+.+++...
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            457899999999999999999987778899999987543221    2      268999999999999999999986643


Q ss_pred             --------CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEE
Q 011384          122 --------KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL  193 (487)
Q Consensus       122 --------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL  193 (487)
                              ...+|||||++|.+|.+...     ++.    ....+++.+|..+|..  |++||||+|+||+++.++ ++|
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~--gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQH--GMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHc--CCccCCCChHHEEEeCCC-EEE
Confidence                    35789999999999988732     333    2456899999999999  999999999999999888 999


Q ss_pred             cccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHH
Q 011384          194 GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEII  248 (487)
Q Consensus       194 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLl  248 (487)
                      +|||...........              ..+.....+..++|+||||+++..+.
T Consensus       176 iDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        176 IDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999987544222111              11344455677999999999987544

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=8.8e-21  Score=177.27  Aligned_cols=185  Identities=18%  Similarity=0.152  Sum_probs=143.2

Q ss_pred             cccceeecccCceEEEEEEECCeEEEEEEcCCChhhHH-----HHHHHHHHHHhCC-CCCceeeEEEEeCCCceEEEEEe
Q 011384           57 FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQ-----EVDNEIEILSKIH-SPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~-----~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +.+...|++|+||+||.+...+.+++.+.+........     .+.+|+++|+++. |+++++++++    ...+++|||
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             cccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            34567999999999998887888999887776654333     5889999999995 5889999886    346999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccC-CCCcEEEccCCcEEEcccccceecCCCCcc-
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI-KSANVLIDRNFNARLGDFGLALRCGVDNFR-  208 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DI-kp~NILld~~~~vkL~DFGla~~~~~~~~~-  208 (487)
                      +.|.+|...+..       . ...++.|++.+|.++|..  ||+|||| ||+|||++.++.++|+|||++......... 
T Consensus        80 I~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~--GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         80 LAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRC--GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             ecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHC--cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            999998755421       1 135778999999999999  9999999 799999999999999999999754432210 


Q ss_pred             ---c-------ccCCCCCCCccCCccccCCC-CCC-cchhhhhHHHHHHHHHhCCcCCC
Q 011384          209 ---F-------RSTPPAGTIGYLDPCYVTPD-NLS-TKTDVFSFGILLLEIISCRKAID  255 (487)
Q Consensus       209 ---~-------~~~~~~gt~~Y~aPE~~~~~-~~s-~ksDVwSlGvvl~eLltG~~pf~  255 (487)
                         .       .......++.|++|+...-. ..+ .+.++++.|+.+|.++|++.+..
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence               0       01122467888888764432 223 67899999999999999997765

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=2.8e-21  Score=200.60  Aligned_cols=218  Identities=25%  Similarity=0.379  Sum_probs=168.7

Q ss_pred             HHhCCCCCceeeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCe-eeccCCCC
Q 011384          103 LSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI-IHRDIKSA  181 (487)
Q Consensus       103 l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~i-vH~DIkp~  181 (487)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+......+++.....++++++.||.|||..  .| .|+.+++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence            3578999999999999999999999999999999999998777799999999999999999999998  45 99999999


Q ss_pred             cEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCC-------CCcchhhhhHHHHHHHHHhCCcCC
Q 011384          182 NVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN-------LSTKTDVFSFGILLLEIISCRKAI  254 (487)
Q Consensus       182 NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-------~s~ksDVwSlGvvl~eLltG~~pf  254 (487)
                      |+++|....+||.|||+.................-...|.|||.+....       .+.+.||||||++++|+++...||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9999999999999999976543211111111223455799999987741       467799999999999999999999


Q ss_pred             CCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          255 DIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ..........+.+..+..  .....+.|.+....  +.++++..++..||..+|.+||++++|-..++.+..
T Consensus       159 ~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccCChHHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            865443332222222111  11223333333221  455689999999999999999999999988877654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=3.6e-21  Score=179.89  Aligned_cols=137  Identities=19%  Similarity=0.239  Sum_probs=107.5

Q ss_pred             ceeecccCceEEEEEEEC-CeEEEEEEcCCChh---h------------------------HHHHHHHHHHHHhCCCCCc
Q 011384           60 QKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQE---I------------------------SQEVDNEIEILSKIHSPRL  111 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~---~------------------------~~~~~~Ei~~l~~l~hpnI  111 (487)
                      ...||+|+||.||+|... |+.||||++.....   .                        ......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            467999999999999886 89999998764421   0                        1123459999999988776


Q ss_pred             eeeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeeeccCCCCcEEEccCCc
Q 011384          112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL-HSEMPPIIHRDIKSANVLIDRNFN  190 (487)
Q Consensus       112 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~~~ivH~DIkp~NILld~~~~  190 (487)
                      .....+...  ..+|||||+++++|...+... .+++...+..++.|++.+|.+| |+.  +|+||||||+|||++ ++.
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~--giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDC--RLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEEE-CCc
Confidence            444333222  238999999988776554333 3589999999999999999999 688  999999999999998 478


Q ss_pred             EEEcccccceec
Q 011384          191 ARLGDFGLALRC  202 (487)
Q Consensus       191 vkL~DFGla~~~  202 (487)
                      ++|+|||++...
T Consensus       156 v~LiDFG~a~~~  167 (190)
T cd05147         156 LYIIDVSQSVEH  167 (190)
T ss_pred             EEEEEccccccC
Confidence            999999998543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=2.4e-20  Score=174.36  Aligned_cols=138  Identities=19%  Similarity=0.190  Sum_probs=110.1

Q ss_pred             ceeecccCceEEEEEEEC-CeEEEEEEcCCChhh---------------------------HHHHHHHHHHHHhCCCCCc
Q 011384           60 QKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEI---------------------------SQEVDNEIEILSKIHSPRL  111 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~---------------------------~~~~~~Ei~~l~~l~hpnI  111 (487)
                      ...||+|++|.||+|.+. |+.||||+.......                           ...+..|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            468999999999999986 999999987654210                           1234679999999999987


Q ss_pred             eeeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCCc
Q 011384          112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFN  190 (487)
Q Consensus       112 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~~  190 (487)
                      .....+....  .++||||++++++....... ..++...+..++.|++.++.++|+ .  ||+||||||+|||++ ++.
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~--givHrDlkP~NIll~-~~~  155 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEA--GLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCChhhEEEE-CCC
Confidence            5544443332  48999999988654432222 347888999999999999999999 8  999999999999999 889


Q ss_pred             EEEcccccceecC
Q 011384          191 ARLGDFGLALRCG  203 (487)
Q Consensus       191 vkL~DFGla~~~~  203 (487)
                      ++|+|||++....
T Consensus       156 ~~liDFG~a~~~~  168 (190)
T cd05145         156 PYIIDVSQAVELD  168 (190)
T ss_pred             EEEEEcccceecC
Confidence            9999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=1e-19  Score=178.34  Aligned_cols=230  Identities=21%  Similarity=0.328  Sum_probs=147.2

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCC----------CCceeeEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHS----------PRLVNLLGFS  118 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~h----------pnIv~l~~~~  118 (487)
                      ..+.....||.|+++.||.+++.  +..+|||++....    ...+.+++|.-....+.+          -.++-.++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            34667899999999999999997  6999999765322    233566666655544332          1222222221


Q ss_pred             ---------eCC---C-----ceEEEEEecCCCCHHHHHHh---CCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 011384          119 ---------NDS---K-----DRLLVVEFMSNGTLYDVLHS---NNR---PLNWGRRIRLALQVAKAVEILHSEMPPIIH  175 (487)
Q Consensus       119 ---------~~~---~-----~~~lV~Ey~~~gsL~~~l~~---~~~---~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH  175 (487)
                               ...   .     ..+++|+-+ -++|.+++..   ...   .+....+..+..|+++.+++||+.  |++|
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~--GlVH  168 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY--GLVH  168 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT--TEEE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc--ceEe
Confidence                     111   1     236788888 5588887652   211   234455567778999999999999  9999


Q ss_pred             ccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCC--------CCCcchhhhhHHHHHHHH
Q 011384          176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD--------NLSTKTDVFSFGILLLEI  247 (487)
Q Consensus       176 ~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--------~~s~ksDVwSlGvvl~eL  247 (487)
                      +||+|+|+|++.+|.++|+||+.....+.....     ...+..|.+||.....        .++.+.|.|+||+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            999999999999999999999987665432211     2345778899876432        468899999999999999


Q ss_pred             HhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCC
Q 011384          248 ISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERR  311 (487)
Q Consensus       248 ltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R  311 (487)
                      .+++.||..... .....+                .+. .+. .+++.++.||..+|+.||.+|
T Consensus       244 WC~~lPf~~~~~-~~~~~~----------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSP-EADPEW----------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGG-GSTSGG----------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCc-cccccc----------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999974311 111111                011 122 788999999999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=1e-20  Score=205.50  Aligned_cols=249  Identities=22%  Similarity=0.231  Sum_probs=179.2

Q ss_pred             CcccceeecccCceEEEEEEECCeEEEEEEcCCChh--hHHH---HHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQE--ISQE---VDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~--~~~~---~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +|...+.||++.|=.|.+++++...|+||++.+...  ....   ...|++ ...++|||.+++.-+-..+...|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            678889999999999999999977799998765432  2233   334555 5567999999987776667777888899


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec--CCCC--
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDN--  206 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~--~~~~--  206 (487)
                      . ..+|+|.|....- +..-+...|+.|++.||.-+|..  ||+|||||.+||||+.-+.+.|+||...+..  ..++  
T Consensus       103 v-khnLyDRlSTRPF-L~~iEKkWiaFQLL~al~qcH~~--gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  103 V-KHNLYDRLSTRPF-LVLIEKKWIAFQLLKALSQCHKL--GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             H-hhhhhhhhccchH-HHHHHHHHHHHHHHHHHHHHHHc--CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            8 4599999976543 66677778999999999999999  9999999999999999999999999876432  2222  


Q ss_pred             -cccccCCCCCCCccCCccccCCC----------C-CCcchhhhhHHHHHHHHHhC-CcCCCCCCCCchhhhhhhhhhhc
Q 011384          207 -FRFRSTPPAGTIGYLDPCYVTPD----------N-LSTKTDVFSFGILLLEIISC-RKAIDIGFSPPSIVDWAAPLIKK  273 (487)
Q Consensus       207 -~~~~~~~~~gt~~Y~aPE~~~~~----------~-~s~ksDVwSlGvvl~eLltG-~~pf~~~~~~~~~~~~~~~~~~~  273 (487)
                       +.+.-.+-..-..|.|||.+...          . ++++-||||+||++.||++- +++|..    .++..+-..  ..
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~--~~  252 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSG--NA  252 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhcc--Cc
Confidence             22222223344579999987552          2 57788999999999999875 666652    111111100  00


Q ss_pred             CccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhc
Q 011384          274 GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG  323 (487)
Q Consensus       274 ~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~  323 (487)
                       ...+.+-..+.       ...++.|+..|++.||.+|.++++.++.-.+
T Consensus       253 -~~~e~~Le~Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  253 -DDPEQLLEKIE-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             -cCHHHHHHhCc-------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence             00001111111       1258889999999999999999999986443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=9.6e-21  Score=196.97  Aligned_cols=223  Identities=23%  Similarity=0.271  Sum_probs=181.5

Q ss_pred             eecccCceEEEEEE-----ECCeEEEEEEcCCChh---hHHHHHHHHHHHHhCC-CCCceeeEEEEeCCCceEEEEEecC
Q 011384           62 LLGKGSHGSVYKAV-----LRGRQVAVKKPSKNQE---ISQEVDNEIEILSKIH-SPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        62 ~LG~G~~g~Vy~~~-----~~g~~vAvK~~~~~~~---~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      .+|+|.||.|+++.     +.+.-+|+|.+++...   .......|-.++..++ ||.++++...+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999753     3367788887665321   1124455777888886 9999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccC
Q 011384          133 NGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       133 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      +|.|...+.+... +++.....+...++-++.++|+.  +++|+|+|++||+++.+|++++.|||+++..-...      
T Consensus        81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh~l--~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------  151 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLHKL--GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------  151 (612)
T ss_pred             cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcchh--HHHHhcccccceeecccCccccCCchhhhHhHhhh------
Confidence            9999999877654 77777888889999999999999  99999999999999999999999999987654332      


Q ss_pred             CCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHH
Q 011384          213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV  292 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  292 (487)
                      ..+||..|||||++.  ....++|.||||++++||++|..||..     .+   ...+.           ....+.|...
T Consensus       152 ~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~---~~~Il-----------~~~~~~p~~l  210 (612)
T KOG0603|consen  152 IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DT---MKRIL-----------KAELEMPREL  210 (612)
T ss_pred             hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HH---HHHHh-----------hhccCCchhh
Confidence            128999999999998  567899999999999999999999973     11   11111           1223467788


Q ss_pred             HHHHHHHHHHhhhhcCCCCCCH
Q 011384          293 RKQLAVIAVRCVRSCRERRPSM  314 (487)
Q Consensus       293 ~~~l~~Li~~cl~~dP~~RPs~  314 (487)
                      ...+..++..++..+|..|--.
T Consensus       211 ~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  211 SAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hHHHHHHHHHHHhhCHHHHhcc
Confidence            8899999999999999999754

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=2.7e-19  Score=197.76  Aligned_cols=199  Identities=23%  Similarity=0.255  Sum_probs=157.4

Q ss_pred             hHHHhhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCC---CCCceeeEEEEeCCCce
Q 011384           49 DLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIH---SPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~  124 (487)
                      +.+.....|.+.+.||+|+||.||+|... |+.||+|+-+.....  +|.--.+++.+|+   -+-|..+...+.-.+.-
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            34444567999999999999999999876 899999987765442  2222334444554   13344444555556667


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc-------cCCcEEEcccc
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID-------RNFNARLGDFG  197 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld-------~~~~vkL~DFG  197 (487)
                      +||+||.+.|+|.+++...+ .+++..+..++.||+..+..||..  +|||+||||+|+||.       ....++|+|||
T Consensus       770 ~lv~ey~~~Gtlld~~N~~~-~m~e~lv~~~~~qml~ive~lH~~--~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTNK-VMDEYLVMFFSCQMLRIVEHLHAM--GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             eeeeeccccccHHHhhccCC-CCCchhhhHHHHHHHHHHHHHHhc--ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            89999999999999998544 599999999999999999999999  999999999999993       23469999999


Q ss_pred             cceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCc
Q 011384          198 LALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRK  252 (487)
Q Consensus       198 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~  252 (487)
                      .+..+..-.....-....+|-.+-++|...+..+++..|.|.|..+++-||+|+.
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9965543322223445678999999999999999999999999999999999974

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=5.7e-19  Score=174.21  Aligned_cols=195  Identities=21%  Similarity=0.244  Sum_probs=142.7

Q ss_pred             CCCCceeeEEEEeC---------------------------CCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHH
Q 011384          107 HSPRLVNLLGFSND---------------------------SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQV  159 (487)
Q Consensus       107 ~hpnIv~l~~~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi  159 (487)
                      +|||||++.++|.+                           +..+|+||..++ .+|..++..+.  .+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC--CchHHHHHHHHHH
Confidence            59999999987653                           234689999984 59999998765  6777777899999


Q ss_pred             HHHHHHHHhCCCCeeeccCCCCcEEE--ccC--CcEEEcccccceecCCCCccc----ccCCCCCCCccCCccccCCCC-
Q 011384          160 AKAVEILHSEMPPIIHRDIKSANVLI--DRN--FNARLGDFGLALRCGVDNFRF----RSTPPAGTIGYLDPCYVTPDN-  230 (487)
Q Consensus       160 ~~gL~yLH~~~~~ivH~DIkp~NILl--d~~--~~vkL~DFGla~~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~-  230 (487)
                      ++|+.|||.+  ||.|||+|.+|||+  |+|  ..+.|+|||++......+-..    .....-|.-..||||+....+ 
T Consensus       351 LEav~hL~~h--gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG  428 (598)
T KOG4158|consen  351 LEAVTHLHKH--GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG  428 (598)
T ss_pred             HHHHHHHHHc--cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence            9999999999  99999999999999  333  457899999985433322111    111235777899999976532 


Q ss_pred             -C----CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhh
Q 011384          231 -L----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVR  305 (487)
Q Consensus       231 -~----s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~  305 (487)
                       .    -.|+|.|+.|.+.||++....||.....-  ..+           .....+..-+..+..++..+.+|+..+|+
T Consensus       429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem--~L~-----------~r~Yqe~qLPalp~~vpp~~rqlV~~lL~  495 (598)
T KOG4158|consen  429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM--LLD-----------TRTYQESQLPALPSRVPPVARQLVFDLLK  495 (598)
T ss_pred             CceeeccchhhhhhhhhhHHHHhccCCcccccchh--eec-----------hhhhhhhhCCCCcccCChHHHHHHHHHhc
Confidence             1    24899999999999999999999741110  000           00111222334566788899999999999


Q ss_pred             hcCCCCCCHHHHHH
Q 011384          306 SCRERRPSMKEIVD  319 (487)
Q Consensus       306 ~dP~~RPs~~eil~  319 (487)
                      .||.+|++..-...
T Consensus       496 r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  496 RDPSKRVSPNIAAN  509 (598)
T ss_pred             CCccccCCccHHHh
Confidence            99999999654433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2e-18  Score=163.42  Aligned_cols=133  Identities=24%  Similarity=0.382  Sum_probs=114.3

Q ss_pred             eeecccCceEEEEEEECCeEEEEEEcCCChh---------hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           61 KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQE---------ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~---------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      +.||+|++|.||+|.+.+..|+||+......         ....+.+|++++..+.|+++.....++.+....++||||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            5799999999999999999999997553211         1245788999999999999988887777777889999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      +|++|.+.+....    . .+..++.+++.+|.+||..  +++|+|++|.|||++ ++.++|+|||++..
T Consensus        82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~--~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA--GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC--CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999986532    2 7788999999999999999  999999999999999 78999999998743

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=2.5e-18  Score=162.74  Aligned_cols=135  Identities=19%  Similarity=0.214  Sum_probs=105.1

Q ss_pred             cccceeecccCceEEEEEEEC-CeEEEEEEcCCC-hhhHHHHHHHHHHHHhC-----CCCCceeeEEEEeCCC---ceE-
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKN-QEISQEVDNEIEILSKI-----HSPRLVNLLGFSNDSK---DRL-  125 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~-~~~~~~~~~Ei~~l~~l-----~hpnIv~l~~~~~~~~---~~~-  125 (487)
                      +...++||+|+||.||.  +. ....+||+.... ....+.+.+|+.+++.+     .||||++++|++.++.   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34467999999999996  43 333468877653 23446799999999999     5799999999998874   333 


Q ss_pred             EEEEe--cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCeeeccCCCCcEEEcc----CCcEEEccccc
Q 011384          126 LVVEF--MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV-EILHSEMPPIIHRDIKSANVLIDR----NFNARLGDFGL  198 (487)
Q Consensus       126 lV~Ey--~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL-~yLH~~~~~ivH~DIkp~NILld~----~~~vkL~DFGl  198 (487)
                      +|+||  +.+++|.+++....  +++.  ..++.+++.++ +|||++  +|+||||||+|||++.    ++.++|+||+.
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh~~--~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLLDN--RIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            78999  55799999997642  6655  35677888777 999999  9999999999999974    34799999543


Q ss_pred             c
Q 011384          199 A  199 (487)
Q Consensus       199 a  199 (487)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=3.8e-18  Score=160.06  Aligned_cols=129  Identities=24%  Similarity=0.432  Sum_probs=107.9

Q ss_pred             eecccCceEEEEEEECCeEEEEEEcCCCh----h-----hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecC
Q 011384           62 LLGKGSHGSVYKAVLRGRQVAVKKPSKNQ----E-----ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        62 ~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~----~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      +||+|+||.||+|.+.+..|++|......    .     ....+.+|++++..+.|+++.....++......++||||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            48999999999999999999999854321    1     12567889999999998876665556666667799999999


Q ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          133 NGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       133 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      |++|.+.+.....        .++.+++.+|.+||+.  +++|+|++|.||+++ ++.++++|||++..
T Consensus        81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~--gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKA--GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CccHHHHHhhcHH--------HHHHHHHHHHHHHHHC--CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998764321        6899999999999999  999999999999999 88999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.76  E-value=3.4e-18  Score=165.27  Aligned_cols=139  Identities=17%  Similarity=0.227  Sum_probs=110.2

Q ss_pred             cCcccceeecccCceEEEEEE-E--CCeEEEEEEcCCChh-------------------------hHHHHHHHHHHHHhC
Q 011384           55 NGFSEQKLLGKGSHGSVYKAV-L--RGRQVAVKKPSKNQE-------------------------ISQEVDNEIEILSKI  106 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~-~--~g~~vAvK~~~~~~~-------------------------~~~~~~~Ei~~l~~l  106 (487)
                      ..|.+.+.||+|++|.||+|. .  .|+.||||++.....                         ....+..|++++.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            358899999999999999998 3  489999998764321                         112357899999999


Q ss_pred             CCC--CceeeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-eeeccCCCCcE
Q 011384          107 HSP--RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP-IIHRDIKSANV  183 (487)
Q Consensus       107 ~hp--nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~-ivH~DIkp~NI  183 (487)
                      .+.  .+..++++    ...++||||+++.+|........ .+....+..++.|++.+|.+||..  + ++|+||||+||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~--g~iiH~Dikp~NI  180 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLYKE--GELVHGDLSEYNI  180 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHHhc--CCEEeCCCChhhE
Confidence            753  34455543    23489999999988876553332 366667788999999999999999  9 99999999999


Q ss_pred             EEccCCcEEEccccccee
Q 011384          184 LIDRNFNARLGDFGLALR  201 (487)
Q Consensus       184 Lld~~~~vkL~DFGla~~  201 (487)
                      +++ ++.++|+|||.+..
T Consensus       181 li~-~~~i~LiDFg~a~~  197 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             EEE-CCCEEEEEChhhhc
Confidence            999 88999999998754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.76  E-value=7e-19  Score=191.32  Aligned_cols=208  Identities=27%  Similarity=0.361  Sum_probs=149.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ..+|..+++|-.|++|.||.++++  .+.+|+|+-+++ ...+   +   ++.....|.+|                   
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-lilR---n---ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-LILR---N---ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc-hhhh---c---cccccCCccee-------------------
Confidence            357999999999999999999887  778888543332 2111   1   22233334333                   


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC-------
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV-------  204 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~-------  204 (487)
                        |+-.+.++..+ +++..        ++.+++|||+.  +|+|||+||+|.+|..-|++|+.|||+++....       
T Consensus       136 --gDc~tllk~~g-~lPvd--------mvla~Eylh~y--givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  136 --GDCATLLKNIG-PLPVD--------MVLAVEYLHSY--GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             --chhhhhcccCC-CCcch--------hhHHhHhhccC--CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence              45555555433 35443        37789999999  999999999999999999999999999753211       


Q ss_pred             ------CCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccc
Q 011384          205 ------DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILS  278 (487)
Q Consensus       205 ------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~  278 (487)
                            ....+....++|||.|.|||++..+.|...+|+|++|+++||.+-|..||+. ..++++...+..         
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~vis---------  272 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVIS---------  272 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhh---------
Confidence                  1112334456899999999999999999999999999999999999999974 334433321110         


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCC
Q 011384          279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRP  312 (487)
Q Consensus       279 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP  312 (487)
                        +...-++.+...+.++++++.++|+.+|..|-
T Consensus       273 --d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  273 --DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             --hhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence              11111222445667899999999999999996

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=9.7e-18  Score=180.99  Aligned_cols=139  Identities=24%  Similarity=0.386  Sum_probs=116.0

Q ss_pred             HHhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCC----h-----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCC
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKN----Q-----EISQEVDNEIEILSKIHSPRLVNLLGFSNDS  121 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~----~-----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  121 (487)
                      ......|...+.||+|+||.||+|.+.+..+++|+....    .     ...+.+.+|++++..++|++++..+.++.+.
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            333455677899999999999999998777766643211    1     1225688999999999999999888888877


Q ss_pred             CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      ...++||||+++++|.+++.         ....++.+++.+|.+||+.  +++||||||+|||+ .++.++|+|||+++.
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~--giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA--GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC--CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            78899999999999999885         3467899999999999999  99999999999999 677999999999854

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.74  E-value=7.1e-19  Score=179.92  Aligned_cols=173  Identities=25%  Similarity=0.364  Sum_probs=129.7

Q ss_pred             ceEEEEEecCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          123 DRLLVVEFMSNGTLYDVLHS--NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      ++||.|++|...+|.+.|..  .....++...+.++.|++.|+.|   +  +.+|+|+||.||+...+..+||+|||+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k--~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K--GLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c--cchhhhccccccccccchhhhhhhhhhee
Confidence            46899999999999999963  44557888899999999999999   6  89999999999999999999999999986


Q ss_pred             ecCCCC----cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcc
Q 011384          201 RCGVDN----FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI  276 (487)
Q Consensus       201 ~~~~~~----~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i  276 (487)
                      ......    .....+...||..||+||.+.+..|+.++||||||++|+||+.   +|.......    -+...+..|  
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~----~t~~d~r~g--  475 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERI----ATLTDIRDG--  475 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHH----HhhhhhhcC--
Confidence            654433    2234556789999999999999999999999999999999998   333211110    011111111  


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHH
Q 011384          277 LSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKE  316 (487)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e  316 (487)
                            .+++..-... ++-..|+.+++...|.+||++.+
T Consensus       476 ------~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  476 ------IIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             ------CCChHHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence                  1221111112 23456899999999999994433

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=2.5e-17  Score=154.79  Aligned_cols=137  Identities=18%  Similarity=0.211  Sum_probs=108.7

Q ss_pred             cCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChh-----------------------hHHHHHHHHHHHHhCCCC-
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQE-----------------------ISQEVDNEIEILSKIHSP-  109 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~-----------------------~~~~~~~Ei~~l~~l~hp-  109 (487)
                      ..|.+.+.||+|+||.||++... |+.||||+......                       ....+..|+.++..+.|+ 
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            34888899999999999999885 89999997554320                       112367789999999877 


Q ss_pred             -CceeeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC
Q 011384          110 -RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN  188 (487)
Q Consensus       110 -nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~  188 (487)
                       .++..++.    ...++||||+++++|......       .....++.+++.++.++|..  +++|+||||+||+++.+
T Consensus        95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~--gi~H~Dl~p~Nill~~~  161 (198)
T cd05144          95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKH--GIIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHC--CCCcCCCCcccEEEcCC
Confidence             44555442    345899999999998765431       23467889999999999999  99999999999999999


Q ss_pred             CcEEEcccccceecCC
Q 011384          189 FNARLGDFGLALRCGV  204 (487)
Q Consensus       189 ~~vkL~DFGla~~~~~  204 (487)
                      +.++|+|||++..+..
T Consensus       162 ~~~~liDfg~~~~~~~  177 (198)
T cd05144         162 EKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcEEEEECCccccCCC
Confidence            9999999999855443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=3.6e-16  Score=138.02  Aligned_cols=134  Identities=21%  Similarity=0.250  Sum_probs=115.2

Q ss_pred             cceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCC--CCceeeEEEEeCCCceEEEEEecCCCCH
Q 011384           59 EQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHS--PRLVNLLGFSNDSKDRLLVVEFMSNGTL  136 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~lV~Ey~~~gsL  136 (487)
                      +.+.||+|.++.||++...+..+++|....... ...+.+|+.++..++|  .+++++++++...+..+++|||++++.+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            457899999999999999889999999876544 5678999999999976  5899999998888889999999988777


Q ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          137 YDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM-PPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       137 ~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      ..+        +......++.+++.+|++||... .+++|+|++|+||+++..+.++++|||.+..
T Consensus        81 ~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          81 DEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            644        45566778999999999999852 2699999999999999989999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=1.4e-15  Score=147.36  Aligned_cols=134  Identities=15%  Similarity=0.212  Sum_probs=106.5

Q ss_pred             ceeec-ccCceEEEEEEECCeEEEEEEcCCCh--------------hhHHHHHHHHHHHHhCCCCCc--eeeEEEEeCCC
Q 011384           60 QKLLG-KGSHGSVYKAVLRGRQVAVKKPSKNQ--------------EISQEVDNEIEILSKIHSPRL--VNLLGFSNDSK  122 (487)
Q Consensus        60 ~~~LG-~G~~g~Vy~~~~~g~~vAvK~~~~~~--------------~~~~~~~~Ei~~l~~l~hpnI--v~l~~~~~~~~  122 (487)
                      ...|| .||.|.||.+...+..++||++....              .....+.+|++++.+++|++|  +..+++.....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            35787 89999999999989999999764311              122467889999999998775  67777654332


Q ss_pred             c----eEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccc
Q 011384          123 D----RLLVVEFMSN-GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFG  197 (487)
Q Consensus       123 ~----~~lV~Ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFG  197 (487)
                      .    .++|||++++ .+|.+++...  .++..    .+.+++.+|.+||..  ||+|+||||.|||++.++.++|+|||
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~--GI~HrDlkp~NILv~~~~~v~LIDfg  187 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDA--GVYHADLNAHNILLDPDGKFWLIDFD  187 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHC--CCCCCCCCchhEEEcCCCCEEEEECC
Confidence            2    2599999997 6899888653  35554    356899999999999  99999999999999998899999999


Q ss_pred             ccee
Q 011384          198 LALR  201 (487)
Q Consensus       198 la~~  201 (487)
                      .+..
T Consensus       188 ~~~~  191 (239)
T PRK01723        188 RGEL  191 (239)
T ss_pred             Cccc
Confidence            8743

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.64  E-value=4.6e-16  Score=144.34  Aligned_cols=133  Identities=21%  Similarity=0.269  Sum_probs=97.2

Q ss_pred             ceeecccCceEEEEEEEC-CeEEEEEEcCCChhhH----HH---------------------HHHHHHHHHhCCCC--Cc
Q 011384           60 QKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEIS----QE---------------------VDNEIEILSKIHSP--RL  111 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~----~~---------------------~~~Ei~~l~~l~hp--nI  111 (487)
                      .+.||+|+||.||+|.+. ++.||||+........    ..                     ...|.+.+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            468999999999999987 8999999876532111    11                     13566666666443  34


Q ss_pred             eeeEEEEeCCCceEEEEEecCCCCHHH-HHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCC
Q 011384          112 VNLLGFSNDSKDRLLVVEFMSNGTLYD-VLHSNNRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNF  189 (487)
Q Consensus       112 v~l~~~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~  189 (487)
                      .+++++    ...++||||++++.+.. .+....  .. ..+..++.+++.++.++|. .  +|+|+||||+||+++ ++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~--~ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREA--GLVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhcc--CcCcCCCChhhEEEE-CC
Confidence            455543    23589999999854321 122111  11 5678899999999999999 8  999999999999999 88


Q ss_pred             cEEEcccccceec
Q 011384          190 NARLGDFGLALRC  202 (487)
Q Consensus       190 ~vkL~DFGla~~~  202 (487)
                      .++|+|||.+...
T Consensus       152 ~~~liDfg~a~~~  164 (187)
T cd05119         152 KVYIIDVPQAVEI  164 (187)
T ss_pred             cEEEEECcccccc
Confidence            9999999998544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=3.6e-17  Score=177.07  Aligned_cols=250  Identities=21%  Similarity=0.271  Sum_probs=193.2

Q ss_pred             CcccceeecccCceEEEEEEEC---CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCC-CCCceeeEEEEeCCCceEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR---GRQVAVKKPSKN---QEISQEVDNEIEILSKIH-SPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~---g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      .|.+.+.||+|+|+.|-.....   ...+|+|.....   .........|..+-+.+. |+|++.+++...+.+..++++
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            4556667999999999987664   345666655433   233345666888888887 999999999999999999999


Q ss_pred             EecCCCCHHHHH-HhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeeeccCCCCcEEEccCC-cEEEcccccceecCC-
Q 011384          129 EFMSNGTLYDVL-HSNNRPLNWGRRIRLALQVAKAVEILH-SEMPPIIHRDIKSANVLIDRNF-NARLGDFGLALRCGV-  204 (487)
Q Consensus       129 Ey~~~gsL~~~l-~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~~~-  204 (487)
                      +|..++++.+.+ .......+......++.|+..++.|+| ..  ++.|+||||+|.+++..+ .++++|||++..... 
T Consensus       101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~--~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN--GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc--ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            999999999988 544435777778889999999999999 88  999999999999999999 999999999977665 


Q ss_pred             CCcccccCCCCC-CCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCC
Q 011384          205 DNFRFRSTPPAG-TIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       205 ~~~~~~~~~~~g-t~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~  282 (487)
                      .+........+| ++.|+|||...+. ......|+||+|+++.-+++|..||.........            ...+...
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~------------~~~~~~~  246 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR------------YSSWKSN  246 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc------------ceeeccc
Confidence            444444455678 9999999999885 4477899999999999999999998743322211            1111111


Q ss_pred             C--CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          283 R--IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       283 ~--~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .  ...............++.+++..+|..|.+.+++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  247 KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence            1  011122345567788899999999999999998875

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.51  E-value=1.8e-14  Score=139.81  Aligned_cols=205  Identities=19%  Similarity=0.263  Sum_probs=143.8

Q ss_pred             HHHHHHhCCCCCceeeEEEEeCC-----CceEEEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 011384           99 EIEILSKIHSPRLVNLLGFSNDS-----KDRLLVVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEM  170 (487)
Q Consensus        99 Ei~~l~~l~hpnIv~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~  170 (487)
                      -+.-+-++-|.|||+++.|+.+.     ....++.|||..|+|..+|++   +...+......+|+.||+.||.|||+..
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            34556667799999999998654     346899999999999999975   4456888888999999999999999999


Q ss_pred             CCeeeccCCCCcEEEccCCcEEEccccc--ceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHH
Q 011384          171 PPIIHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEII  248 (487)
Q Consensus       171 ~~ivH~DIkp~NILld~~~~vkL~DFGl--a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLl  248 (487)
                      |.|+|+++..+.|++..++-+|++----  .................+.++|.+||+-.....+.++|||+||+..+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            9999999999999999999999853110  00000001111223345788999999987778889999999999999998


Q ss_pred             hCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          249 SCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       249 tG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                      -+.--...+.+......     .....+...-+            ..-+.++.+|++..|..||+|++++.+
T Consensus       277 ilEiq~tnseS~~~~ee-----~ia~~i~~len------------~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEE-----NIANVIIGLEN------------GLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HheeccCCCcceeehhh-----hhhhheeeccC------------ccccCcCcccccCCCCCCcchhhhhcC
Confidence            76532211111000000     00000010111            112456789999999999999998864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=4.8e-14  Score=147.09  Aligned_cols=246  Identities=23%  Similarity=0.198  Sum_probs=190.2

Q ss_pred             hcCcccceeecc--cCceEEEEEEE--C--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCc
Q 011384           54 TNGFSEQKLLGK--GSHGSVYKAVL--R--GRQVAVKKPSKN---QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKD  123 (487)
Q Consensus        54 ~~~y~~~~~LG~--G~~g~Vy~~~~--~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  123 (487)
                      ...|...+.+|.  |.+|.||.+..  .  +..+|+|.-+..   ......-.+|+.....+ .|+|.++.+..+...+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            345778899999  99999999877  3  778999874422   22233445677777777 58999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCeeeccCCCCcEEEccC-CcEEEccccc
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK----AVEILHSEMPPIIHRDIKSANVLIDRN-FNARLGDFGL  198 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~----gL~yLH~~~~~ivH~DIkp~NILld~~-~~vkL~DFGl  198 (487)
                      +++-+|+| +.+|.++.......++...++..+.+...    ||.++|+.  +++|-|+||.||+...+ ...+++|||+
T Consensus       193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~--~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN--NIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC--cccccccchhheecccccceeecCCcce
Confidence            99999999 57998888876666899999999999999    99999999  99999999999999998 8899999999


Q ss_pred             ceecCCCCccc---ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCC--CCchhhhhhhhhhhc
Q 011384          199 ALRCGVDNFRF---RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGF--SPPSIVDWAAPLIKK  273 (487)
Q Consensus       199 a~~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~--~~~~~~~~~~~~~~~  273 (487)
                      ...+...+...   ......|...|++||... .-++..+|+|++|.++.+..++......++  .+..+..+       
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~-------  341 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG-------  341 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc-------
Confidence            98877655321   112236888999999886 457889999999999999999877765442  11111110       


Q ss_pred             CccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          274 GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       274 ~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                               .++.++....+..+..++..+++.+|..|++...+..
T Consensus       342 ---------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  342 ---------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ---------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                     1233333344556666899999999999999887765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=3.5e-13  Score=141.56  Aligned_cols=139  Identities=23%  Similarity=0.304  Sum_probs=97.9

Q ss_pred             ceeecccCceEEEEEEEC-CeEEEEEEcCCChhhH-----------------------------------------HHHH
Q 011384           60 QKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEIS-----------------------------------------QEVD   97 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~-----------------------------------------~~~~   97 (487)
                      .+.||.|++|.||+|++. |+.||||+........                                         -.|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            478999999999999986 8999999876531100                                         0144


Q ss_pred             HHHHHHHhCC-----CCCceeeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 011384           98 NEIEILSKIH-----SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK-AVEILHSEMP  171 (487)
Q Consensus        98 ~Ei~~l~~l~-----hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~-gL~yLH~~~~  171 (487)
                      +|.+.+.++.     ++++.-..-|.......+|||||++|++|.+.........+   ...++..++. .+..+|..  
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~--  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD--  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC--
Confidence            4555555552     33332222222334456999999999999887754221232   3446666655 47888999  


Q ss_pred             CeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       172 ~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      |++|+|++|.||+++.++.++|+|||++..+.
T Consensus       277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            99999999999999999999999999986654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=3e-13  Score=123.08  Aligned_cols=129  Identities=22%  Similarity=0.258  Sum_probs=98.6

Q ss_pred             ceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCc-eeeEEEEeCCCceEEEEEecCCCCHHH
Q 011384           60 QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL-VNLLGFSNDSKDRLLVVEFMSNGTLYD  138 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~Ey~~~gsL~~  138 (487)
                      .+.|+.|.++.||++...++.|++|+..........+.+|+.+++.+.+.++ .+++.+..  ...++||||++|.++.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLT   80 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccc
Confidence            4678999999999999999999999976654333456889999999866554 44555443  23589999999988764


Q ss_pred             HHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          139 VLHSNNRPLNWGRRIRLALQVAKAVEILHSEM---PPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       139 ~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~---~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      .     . ..   ...++.+++.+|+.||...   .+++|+|++|.||+++ ++.++++|||.+.
T Consensus        81 ~-----~-~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          81 E-----D-FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             c-----c-cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            3     0 11   1235678999999999981   1259999999999999 6689999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.34  E-value=3.6e-12  Score=135.91  Aligned_cols=141  Identities=21%  Similarity=0.195  Sum_probs=92.0

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh-----------------------------------hHHH-
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE-----------------------------------ISQE-   95 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~-----------------------------------~~~~-   95 (487)
                      ...|.. +.||+|++|.||+|+++  |+.||||+..+...                                   ..+. 
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 89999999999999985  79999998765410                                   0111 


Q ss_pred             -----HHHHHHHHHhCC----CCCceeeEEEEe-CCCceEEEEEecCCCCHHHH--HHhCCC---CCCHHHHHHHHHHHH
Q 011384           96 -----VDNEIEILSKIH----SPRLVNLLGFSN-DSKDRLLVVEFMSNGTLYDV--LHSNNR---PLNWGRRIRLALQVA  160 (487)
Q Consensus        96 -----~~~Ei~~l~~l~----hpnIv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~--l~~~~~---~l~~~~~~~i~~qi~  160 (487)
                           +.+|+..+.+++    +.+.+.+-.++. .....+|||||+.|+.|.+.  +...+.   .+....+..++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence                 333444444442    333333222222 23456899999999999874  333321   12222233333333 


Q ss_pred             HHHHHHHhCCCCeeeccCCCCcEEEccCC----cEEEcccccceecCC
Q 011384          161 KAVEILHSEMPPIIHRDIKSANVLIDRNF----NARLGDFGLALRCGV  204 (487)
Q Consensus       161 ~gL~yLH~~~~~ivH~DIkp~NILld~~~----~vkL~DFGla~~~~~  204 (487)
                            +..  |++|+|+||.||+++.++    .++++|||++..+..
T Consensus       277 ------f~~--GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ------FRD--GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------HhC--CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  446  999999999999999887    999999999876644

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.30  E-value=4.8e-11  Score=111.43  Aligned_cols=134  Identities=16%  Similarity=0.185  Sum_probs=98.7

Q ss_pred             eeecccCceEEEEEEEC--------CeEEEEEEcCCC-----------------------hhhHHHH----HHHHHHHHh
Q 011384           61 KLLGKGSHGSVYKAVLR--------GRQVAVKKPSKN-----------------------QEISQEV----DNEIEILSK  105 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~--------g~~vAvK~~~~~-----------------------~~~~~~~----~~Ei~~l~~  105 (487)
                      ..||.|--+.||.|...        +..+|||+....                       ......+    .+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            46899999999999765        368999964321                       0011223    489999999


Q ss_pred             CCC--CCceeeEEEEeCCCceEEEEEecCCCCHHH-HHHhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeeeccCCCC
Q 011384          106 IHS--PRLVNLLGFSNDSKDRLLVVEFMSNGTLYD-VLHSNNRPLNWGRRIRLALQVAKAVEIL-HSEMPPIIHRDIKSA  181 (487)
Q Consensus       106 l~h--pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~~~ivH~DIkp~  181 (487)
                      +..  .++..++++    ...+|||||+.+..+.. .+...  .++......+..+++.+|..| |..  ++||+||++.
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H~~--glVHGDLs~~  154 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYKEC--NLVHADLSEY  154 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHH
Confidence            953  567777765    34589999997654422 23222  255566777889999999999 888  9999999999


Q ss_pred             cEEEccCCcEEEcccccceecC
Q 011384          182 NVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       182 NILld~~~~vkL~DFGla~~~~  203 (487)
                      |||++ ++.+.|+|||.+....
T Consensus       155 NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         155 NMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HEEEE-CCcEEEEECCCceeCC
Confidence            99997 4689999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.26  E-value=6.2e-12  Score=131.43  Aligned_cols=244  Identities=22%  Similarity=0.247  Sum_probs=176.2

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC---CeEEEEEEcCCChhhH---HHHHHHHHHHHhC-CCCCceeeEEEEeCCCce
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR---GRQVAVKKPSKNQEIS---QEVDNEIEILSKI-HSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~---g~~vAvK~~~~~~~~~---~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  124 (487)
                      -.+.+|..+..||.|.|+.|+.+..+   +..|++|.+.+.....   ..-..|+-+...+ .|.++++++..+......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34568999999999999999998755   6789999776543221   1224466666555 688888888877777778


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC-CcEEEcccccceecC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN-FNARLGDFGLALRCG  203 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~-~~vkL~DFGla~~~~  203 (487)
                      |+-.|||.++++.....-. ..+++..++.+..|++.++.++|+.  .++|+|+||+||++..+ +..+++|||+...+.
T Consensus       342 ~ip~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~s~--~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~  418 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIHSK--LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA  418 (524)
T ss_pred             cCchhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhccccccch--hhhcccccccceeeccchhhhhccccccccccc
Confidence            8999999999887766332 2388888999999999999999999  99999999999999876 888999999885433


Q ss_pred             CCCcccccCCCCCCCccC--CccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          204 VDNFRFRSTPPAGTIGYL--DPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~--aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      ...     ....+.-++.  ++.......+-.+.|++|||.-+.+.+++......+      ..|.           .+.
T Consensus       419 ~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~------~~~~-----------~i~  476 (524)
T KOG0601|consen  419 FSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG------VQSL-----------TIR  476 (524)
T ss_pred             eec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccc------ccce-----------eee
Confidence            221     1122333444  454555567788999999999999999987443211      1111           011


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                      .... +..+....++..+.+.++..++..||.+.++....
T Consensus       477 ~~~~-p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  477 SGDT-PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             cccc-cCCCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence            1111 11223337888899999999999999998887643

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.25  E-value=1.8e-10  Score=121.88  Aligned_cols=162  Identities=17%  Similarity=0.250  Sum_probs=122.1

Q ss_pred             CeEEEEEEcCCChh-hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHH
Q 011384           78 GRQVAVKKPSKNQE-ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA  156 (487)
Q Consensus        78 g~~vAvK~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~  156 (487)
                      +.+|.|...+.... ......+-++.|+.++||||+++++.++....+|||+|-+  ..|..+++..+    ...+.--+
T Consensus        37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v~~Gl  110 (690)
T KOG1243|consen   37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEVCLGL  110 (690)
T ss_pred             CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHHHHHH
Confidence            66777776654443 2345777889999999999999999999999999999988  36777776543    45556678


Q ss_pred             HHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchh
Q 011384          157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTD  236 (487)
Q Consensus       157 ~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksD  236 (487)
                      .||+.||.|||..+ +++|++|.-+.|+|+..|..||++|.++......+.  ......---.|..|+.+....  -..|
T Consensus       111 ~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D  185 (690)
T KOG1243|consen  111 FQILAALSFLNDDC-NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSID  185 (690)
T ss_pred             HHHHHHHHHHhccC-CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchh
Confidence            89999999998654 899999999999999999999999998754332221  011111222456666554332  3579


Q ss_pred             hhhHHHHHHHHHhC
Q 011384          237 VFSFGILLLEIISC  250 (487)
Q Consensus       237 VwSlGvvl~eLltG  250 (487)
                      .|-|||+++|++.|
T Consensus       186 ~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  186 SWGLGCLIEELFNG  199 (690)
T ss_pred             hhhHHHHHHHHhCc
Confidence            99999999999998

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.24  E-value=1.1e-10  Score=106.14  Aligned_cols=129  Identities=26%  Similarity=0.405  Sum_probs=102.6

Q ss_pred             eeecccCceEEEEEEECCeEEEEEEc-CCC---hh-----hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           61 KLLGKGSHGSVYKAVLRGRQVAVKKP-SKN---QE-----ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~g~~vAvK~~-~~~---~~-----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ..+++|+-+.+|.+.+.|.++++|.- .+.   ..     ....-.+|+.++.++.--.|.-.+-|..+...-.|+|||+
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            46889999999999998888888842 222   11     1245678999999997666666666677777778999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      +|..|.+.+...        ...++..+-.-+.-||..  +|+|+||.++||++..+. +.++|||++.
T Consensus        82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~--givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKA--GIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             CChhHHHHHHhc--------chHHHHHHHHHHHHHHhc--CeecCCCccceEEEeCCc-EEEEECCccc
Confidence            999999898765        134666777777889999  999999999999997664 9999999985

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.24  E-value=1.2e-10  Score=105.48  Aligned_cols=140  Identities=22%  Similarity=0.296  Sum_probs=109.8

Q ss_pred             cceeecccCceEEEEEEECCeEEEEEE-cCCC--------hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           59 EQKLLGKGSHGSVYKAVLRGRQVAVKK-PSKN--------QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~g~~vAvK~-~~~~--------~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ...+|-+|+-+.|+++.+.|+..+||. +.+.        .-..++..+|++++.++.--.|.-..-++.+...-+|+||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            567899999999999999999999984 3322        1223567889999999976677666667778778899999


Q ss_pred             ecCC-CCHHHHHHhCCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC---cEEEcccccce
Q 011384          130 FMSN-GTLYDVLHSNNRPL-NWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF---NARLGDFGLAL  200 (487)
Q Consensus       130 y~~~-gsL~~~l~~~~~~l-~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~---~vkL~DFGla~  200 (487)
                      |++| .++.+++......- ..+....++..+-..+.-||..  +|||+||..+||++..++   .+.++|||++.
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n--diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN--DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC--CeecccccccceEEecCCCcCceEEEeecchh
Confidence            9976 47888887633322 3333377889999999999999  999999999999996543   46899999974

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=8.1e-11  Score=111.53  Aligned_cols=139  Identities=24%  Similarity=0.334  Sum_probs=108.8

Q ss_pred             ceeecccCceEEEEEEECC-eEEEEEEcCCChh--hHHHHHHHHHHHHhCCC--CCceeeEEEEeCCC---ceEEEEEec
Q 011384           60 QKLLGKGSHGSVYKAVLRG-RQVAVKKPSKNQE--ISQEVDNEIEILSKIHS--PRLVNLLGFSNDSK---DRLLVVEFM  131 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~g-~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~---~~~lV~Ey~  131 (487)
                      .+.|+.|.++.||++...+ ..+++|+......  ....+.+|++++..+.+  .++.+++.+.....   ..++||||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            3678999999999998875 8999998765443  34678999999999976  44677888776643   568999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE------------------------------------------  169 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~------------------------------------------  169 (487)
                      +|.+|.+.+..  ..++......++.+++..|..||+.                                          
T Consensus        83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            99888776532  2367777777888888888888842                                          


Q ss_pred             ------------CCCeeeccCCCCcEEEcc--CCcEEEcccccce
Q 011384          170 ------------MPPIIHRDIKSANVLIDR--NFNARLGDFGLAL  200 (487)
Q Consensus       170 ------------~~~ivH~DIkp~NILld~--~~~vkL~DFGla~  200 (487)
                                  ...++|+|+.|.|||++.  ++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                        124799999999999988  6678999999764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.07  E-value=4e-09  Score=103.67  Aligned_cols=138  Identities=17%  Similarity=0.167  Sum_probs=104.2

Q ss_pred             eeecccCceEEEEEEECCeEEEEEEcCCChhh--H----------HHHHHHHHHHHhCCCC--CceeeEEEEeC-----C
Q 011384           61 KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--S----------QEVDNEIEILSKIHSP--RLVNLLGFSND-----S  121 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~--~----------~~~~~Ei~~l~~l~hp--nIv~l~~~~~~-----~  121 (487)
                      +.+-......|+++.+.|+.|.||........  .          ..+.+|.+.+.++..-  ..+.++++++.     .
T Consensus        28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            55555566668888889999999976433211  1          1477899999888543  34555666643     2


Q ss_pred             CceEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc-------CCcEE
Q 011384          122 KDRLLVVEFMSNG-TLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-------NFNAR  192 (487)
Q Consensus       122 ~~~~lV~Ey~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~-------~~~vk  192 (487)
                      ..-+||+|++++- +|.+++... ..+.+......++.+++..+.-||..  ||+|+|+++.|||++.       ++.+.
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~--Gi~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA--GINHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC--cCccCCCChhhEEEeccccCCCCCceEE
Confidence            3468999999886 899998642 23456677888999999999999999  9999999999999975       46899


Q ss_pred             Ecccccce
Q 011384          193 LGDFGLAL  200 (487)
Q Consensus       193 L~DFGla~  200 (487)
                      |+||+.+.
T Consensus       186 LIDl~r~~  193 (268)
T PRK15123        186 VIDLHRAQ  193 (268)
T ss_pred             EEECCccc
Confidence            99999774

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.07  E-value=4.8e-11  Score=131.00  Aligned_cols=246  Identities=22%  Similarity=0.250  Sum_probs=173.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .+.|.+.+-+-+|.++.++.+.-.  +...+.|.......    ..+....+-.++-..++|-++....-+.-....+|+
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            355677778889999999987654  33344443222211    112233333333334556666555555566778999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC--
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD--  205 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~--  205 (487)
                      ++|+.+++|...|++.+ ..+.+.....+..+..++.|||..  .++|+|++|.|+|+..++..++.|||.....+.-  
T Consensus       883 ~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~--~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSS--LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             hHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccc--hhhcccccccchhhcccCCcccCccccccccccccC
Confidence            99999999999998766 467677777888899999999999  8999999999999999999999999843211100  


Q ss_pred             -----------------------C----cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCC
Q 011384          206 -----------------------N----FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGF  258 (487)
Q Consensus       206 -----------------------~----~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~  258 (487)
                                             .    .........||+.|.+||...+......+|+|++|++++|.++|..||....
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence                                   0    0011234568999999999999999999999999999999999999997433


Q ss_pred             CCchhhhhhhhhhhcCccccccCCCCC-CCCChHHHHHHHHHHHHhhhhcCCCCCCHH
Q 011384          259 SPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQLAVIAVRCVRSCRERRPSMK  315 (487)
Q Consensus       259 ~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~  315 (487)
                      ..... +            .+....++ +..+...+.+..+++...+..+|.+|-.+.
T Consensus      1040 pq~~f-~------------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1040 PQQIF-E------------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhh-h------------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            22111 1            11111111 223455677889999999999999998765

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.99  E-value=1.9e-08  Score=101.45  Aligned_cols=260  Identities=17%  Similarity=0.186  Sum_probs=162.7

Q ss_pred             ccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEE------EeCCCc-eEEEEE
Q 011384           58 SEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGF------SNDSKD-RLLVVE  129 (487)
Q Consensus        58 ~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~------~~~~~~-~~lV~E  129 (487)
                      .....||+|+-+.+|..-.-+..|| |+........+.  ..+..|... .||-+-.-+.|      .-+... .-++|.
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQA--QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CCCccccCCccceeeecchhhchhh-eeecCCCchHHH--HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            4567899999999997655556666 776654332221  123333333 55543321221      122222 567888


Q ss_pred             ecCCCC-HHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          130 FMSNGT-LYDVLHS-----NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       130 y~~~gs-L~~~l~~-----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      .+++.- +..++..     .-....|...++.++.++.+.+.||..  |.+-+|+.++|+|+++++.|.|.|-...... 
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~--Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~-  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH--GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN-  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc--CCcccccCccceeeecCceEEEEcccceeec-
Confidence            887652 3333321     123478999999999999999999999  9999999999999999999999885432221 


Q ss_pred             CCCcccccCCCCCCCccCCccccCC-----CCCCcchhhhhHHHHHHHHHhC-CcCCCCC----CCCc-hhhhhhhhhhh
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTP-----DNLSTKTDVFSFGILLLEIISC-RKAIDIG----FSPP-SIVDWAAPLIK  272 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvvl~eLltG-~~pf~~~----~~~~-~~~~~~~~~~~  272 (487)
                      ..+.  ..-...|...|++||...-     -..+..+|.|.||+++++++.| +.||..-    ..+. ...+++...+.
T Consensus       168 ~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         168 ANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             cCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence            1111  2234578999999998652     2447789999999999999987 8888521    1111 11122211111


Q ss_pred             cCccccccCCCCCCC--CC-hHHHHHHHHHHHHhhhhc--CCCCCCHHHHHHHHhccccc
Q 011384          273 KGKILSVFDPRIPPP--KD-PIVRKQLAVIAVRCVRSC--RERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       273 ~~~i~~~~~~~~~~~--~~-~~~~~~l~~Li~~cl~~d--P~~RPs~~eil~~L~~l~~~  327 (487)
                      ...  ..-....+.+  .| ...+..+..|..+|+...  +.-|||++..+..|..+...
T Consensus       246 ya~--~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         246 YAS--DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             ech--hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            100  0000111111  11 235677888888898765  56899999999888776543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.99  E-value=1.6e-08  Score=104.24  Aligned_cols=212  Identities=16%  Similarity=0.187  Sum_probs=153.0

Q ss_pred             CceEEEEEEEC--CeEEEEEEcCCChhh-HHHHHHHHHHHHhCCCCCceeeEEEEe----CCCceEEEEEecCC-CCHHH
Q 011384           67 SHGSVYKAVLR--GRQVAVKKPSKNQEI-SQEVDNEIEILSKIHSPRLVNLLGFSN----DSKDRLLVVEFMSN-GTLYD  138 (487)
Q Consensus        67 ~~g~Vy~~~~~--g~~vAvK~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~----~~~~~~lV~Ey~~~-gsL~~  138 (487)
                      -..+.|++...  |..|++|+++-+... ......-++.++++.|+|+|++.++|.    .+..+++||+|+++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            45678898876  889999998533221 123345688999999999999998775    45678999999986 58888


Q ss_pred             HHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          139 VLHS--------------NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       139 ~l~~--------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      +...              .+...++..+|.++.|+..||.++|+.  |+.-+-|.|.+||++.+.+++|...|+...+..
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss--GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS--GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc--CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            7753              223478899999999999999999999  998899999999999988999988887655443


Q ss_pred             CCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      +.              .+|  +..   -.+-|.=.||.+++.|.||...-.......+.   .                 
T Consensus       446 d~--------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s---~-----------------  486 (655)
T KOG3741|consen  446 DP--------------TEP--LES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSS---H-----------------  486 (655)
T ss_pred             CC--------------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccccccccchHHH---H-----------------
Confidence            32              111  111   23579999999999999986431111111000   0                 


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                      .......++.++..++.-....++++ -++.+++..
T Consensus       487 ~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  487 LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            00123457788888998888888886 567777763

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.98  E-value=6.7e-09  Score=96.57  Aligned_cols=123  Identities=23%  Similarity=0.339  Sum_probs=81.7

Q ss_pred             EEEEEEEC-CeEEEEEEcCCC---------------------------hhhHHHHHHHHHHHHhCCCC--CceeeEEEEe
Q 011384           70 SVYKAVLR-GRQVAVKKPSKN---------------------------QEISQEVDNEIEILSKIHSP--RLVNLLGFSN  119 (487)
Q Consensus        70 ~Vy~~~~~-g~~vAvK~~~~~---------------------------~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~~~  119 (487)
                      .||.|... |..+|||+....                           ........+|++.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999885 889999964321                           01123478899999999765  567777553 


Q ss_pred             CCCceEEEEEecC--CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCeeeccCCCCcEEEccCCcEEEccc
Q 011384          120 DSKDRLLVVEFMS--NGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI-LHSEMPPIIHRDIKSANVLIDRNFNARLGDF  196 (487)
Q Consensus       120 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~y-LH~~~~~ivH~DIkp~NILld~~~~vkL~DF  196 (487)
                         ..+|||||++  |..+..+....   ++......++.+++..+.. +|..  ||+|+|+.+.|||++.+ .+.|+||
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~--givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKA--GIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCT--TEEESS-STTSEEEETT-CEEE--G
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhc--CceecCCChhhEEeecc-eEEEEec
Confidence               3489999998  55554443322   2234456677788875555 5788  99999999999999887 9999999


Q ss_pred             ccceec
Q 011384          197 GLALRC  202 (487)
Q Consensus       197 Gla~~~  202 (487)
                      |.+...
T Consensus       151 ~qav~~  156 (188)
T PF01163_consen  151 GQAVDS  156 (188)
T ss_dssp             TTEEET
T ss_pred             Ccceec
Confidence            988554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.83  E-value=1.9e-09  Score=114.64  Aligned_cols=152  Identities=17%  Similarity=0.275  Sum_probs=106.3

Q ss_pred             HHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC-ccccc------CCCCCCCccCCccccCCC
Q 011384          157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN-FRFRS------TPPAGTIGYLDPCYVTPD  229 (487)
Q Consensus       157 ~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~-~~~~~------~~~~gt~~Y~aPE~~~~~  229 (487)
                      .+++.|+.|+|... ++||++|.|++|.++.++.+||+.|+.+....... ..+..      ........|.|||++.+.
T Consensus       106 ~~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hcccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            34558999999875 89999999999999999999999999874332211 10000      011345689999999998


Q ss_pred             CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCC
Q 011384          230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRE  309 (487)
Q Consensus       230 ~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~  309 (487)
                      ..+.++|+|||||++|.+..|+.+..................          ..-...+...++.++.+=+.+++..++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~----------~~~~~~~s~~~p~el~~~l~k~l~~~~~  254 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL----------NAGAFGYSNNLPSELRESLKKLLNGDSA  254 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc----------ccccccccccCcHHHHHHHHHHhcCCcc
Confidence            889999999999999999965555433332222221111111          1111123356778899999999999999


Q ss_pred             CCCCHHHHHH
Q 011384          310 RRPSMKEIVD  319 (487)
Q Consensus       310 ~RPs~~eil~  319 (487)
                      -||++.++..
T Consensus       255 ~rp~~~~l~~  264 (700)
T KOG2137|consen  255 VRPTLDLLLS  264 (700)
T ss_pred             cCcchhhhhc
Confidence            9998877764

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.74  E-value=4.8e-08  Score=94.08  Aligned_cols=131  Identities=21%  Similarity=0.308  Sum_probs=98.1

Q ss_pred             cccceeecccCceEEEEEEEC-CeEEEEEEcC----------CC-------------hhhHHHHHHHHHHHHhCCCC--C
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPS----------KN-------------QEISQEVDNEIEILSKIHSP--R  110 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~----------~~-------------~~~~~~~~~Ei~~l~~l~hp--n  110 (487)
                      +.+...||-|--+.||.|... |.++|||.-.          ..             .......++|+++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            667899999999999999997 9999999311          10             11123468899999999654  6


Q ss_pred             ceeeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc
Q 011384          111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN  190 (487)
Q Consensus       111 Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~  190 (487)
                      +.+.+++    +..++||||++|--|...-      ++.+..-.++..|+.-+.-+-..  ||||+|+.+-|||++.+|.
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~--GiVHGDlSefNIlV~~dg~  240 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRR--GIVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHc--CccccCCchheEEEecCCC
Confidence            7777654    4558999999886665432      22333445566666666666677  9999999999999999999


Q ss_pred             EEEcccccc
Q 011384          191 ARLGDFGLA  199 (487)
Q Consensus       191 vkL~DFGla  199 (487)
                      +.++||--+
T Consensus       241 ~~vIDwPQ~  249 (304)
T COG0478         241 IVVIDWPQA  249 (304)
T ss_pred             EEEEeCccc
Confidence            999999655

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.72  E-value=1.3e-07  Score=89.42  Aligned_cols=105  Identities=21%  Similarity=0.285  Sum_probs=84.8

Q ss_pred             HHHHHHHHHHHhCCC--CCceeeEEEEeCCC----ceEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Q 011384           94 QEVDNEIEILSKIHS--PRLVNLLGFSNDSK----DRLLVVEFMSNG-TLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL  166 (487)
Q Consensus        94 ~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yL  166 (487)
                      ....+|...+..+..  -..+..+++.....    ..+||+|++++. +|.+++..... ++......++.+++..++-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            467888888888743  34566777766532    348999999884 89999986443 66777888999999999999


Q ss_pred             HhCCCCeeeccCCCCcEEEccCC---cEEEccccccee
Q 011384          167 HSEMPPIIHRDIKSANVLIDRNF---NARLGDFGLALR  201 (487)
Q Consensus       167 H~~~~~ivH~DIkp~NILld~~~---~vkL~DFGla~~  201 (487)
                      |..  ||+|+|+++.|||++.+.   .+.|+||+-++.
T Consensus       135 H~~--gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 HDA--GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHC--cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999  999999999999998886   899999997754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.68  E-value=5.4e-07  Score=84.71  Aligned_cols=142  Identities=16%  Similarity=0.150  Sum_probs=107.1

Q ss_pred             CcccceeecccCceEEEEEEECCeEEEEEEcCCC-------hhhHHHHHHHHHHHHhCCC--CCceeeEEEEe-C--C--
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKN-------QEISQEVDNEIEILSKIHS--PRLVNLLGFSN-D--S--  121 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~-------~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~-~--~--  121 (487)
                      ++-..---|+||.+-|++....|..+-+|+....       ......|.+|+..+.++..  ..+.+++ ++. .  +  
T Consensus        19 ~wve~pN~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~   97 (216)
T PRK09902         19 DWVEEPNYRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGE   97 (216)
T ss_pred             ceecCCCcCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCc
Confidence            3333444578999999999988888999975421       2234679999999999853  3355555 332 1  1  


Q ss_pred             CceEEEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc--EEEcccc
Q 011384          122 KDRLLVVEFMSN-GTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN--ARLGDFG  197 (487)
Q Consensus       122 ~~~~lV~Ey~~~-gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~--vkL~DFG  197 (487)
                      ..-+||+|-++| .+|.+++.... .+.+......++.+++..++-||..  |+.|+|+-+.|||++.++.  ++++||.
T Consensus        98 ~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~--Gv~Hgdly~khIll~~~g~~~v~lIDlE  175 (216)
T PRK09902         98 WRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV--NRQHGCCYVRHIYVKTEGKAEAGFLDLE  175 (216)
T ss_pred             eEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC--CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence            234799997754 58988886532 2467778889999999999999999  9999999999999986667  9999998


Q ss_pred             cce
Q 011384          198 LAL  200 (487)
Q Consensus       198 la~  200 (487)
                      -++
T Consensus       176 k~r  178 (216)
T PRK09902        176 KSR  178 (216)
T ss_pred             ccc
Confidence            664

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.64  E-value=4e-07  Score=87.46  Aligned_cols=135  Identities=14%  Similarity=0.193  Sum_probs=86.2

Q ss_pred             eeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCC--ceeeEEEEeCCCceEEEEEecCCCC-HH
Q 011384           61 KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPR--LVNLLGFSNDSKDRLLVVEFMSNGT-LY  137 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~~~~~lV~Ey~~~gs-L~  137 (487)
                      ..||+|..+.||+.  .+..+++|...... ......+|.++++.+..-.  +.+.++++.+.+...+|||+++|.. +.
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~   83 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS   83 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence            67999999999984  36677889876533 3355788999999986443  5777888888878889999998863 21


Q ss_pred             HHH---------------------HhCC-CCCCHHHHH-HHHH----------HHHH-HHHHHHhC--CCCeeeccCCCC
Q 011384          138 DVL---------------------HSNN-RPLNWGRRI-RLAL----------QVAK-AVEILHSE--MPPIIHRDIKSA  181 (487)
Q Consensus       138 ~~l---------------------~~~~-~~l~~~~~~-~i~~----------qi~~-gL~yLH~~--~~~ivH~DIkp~  181 (487)
                      ..+                     +.-. ...+..... .+..          .+.. ...+|...  .+.++|+|+.|.
T Consensus        84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~  163 (226)
T TIGR02172        84 RIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIG  163 (226)
T ss_pred             hhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCC
Confidence            111                     1100 011111111 0100          0111 12222221  236789999999


Q ss_pred             cEEEccCCcEEEcccccc
Q 011384          182 NVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       182 NILld~~~~vkL~DFGla  199 (487)
                      ||+++.++ +.|+||+.+
T Consensus       164 Nii~~~~~-~~iIDwe~a  180 (226)
T TIGR02172       164 NLITSGKG-TYWIDLGDF  180 (226)
T ss_pred             cEEEcCCC-cEEEechhc
Confidence            99999887 999999876

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.62  E-value=1.7e-07  Score=99.77  Aligned_cols=144  Identities=19%  Similarity=0.278  Sum_probs=96.0

Q ss_pred             CcccceeecccCceEEEEEEEC-CeEEEEEEcCCChh-------------------------------h----HH-----
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQE-------------------------------I----SQ-----   94 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~-------------------------------~----~~-----   94 (487)
                      .|. .+.|+.++-|.||+|++. |+.||||+...+-.                               .    .+     
T Consensus       127 eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E  205 (517)
T COG0661         127 EFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE  205 (517)
T ss_pred             HcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence            344 378999999999999998 99999997654200                               0    01     


Q ss_pred             -HHHHHHHHHHhCC-----CCCceeeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 011384           95 -EVDNEIEILSKIH-----SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS  168 (487)
Q Consensus        95 -~~~~Ei~~l~~l~-----hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~  168 (487)
                       .+.+|...+.+++     .|++.-.-=|++-.....|+|||++|-.+.+........++.+.+.....++.  +..+-.
T Consensus       206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~  283 (517)
T COG0661         206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLR  283 (517)
T ss_pred             hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHh
Confidence             1344555555542     24433323334445567899999999999888533223366555444433332  222223


Q ss_pred             CCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       169 ~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      .  |++|.|..|.||+++.++.+.+.|||+...+..
T Consensus       284 d--gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 D--GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             c--CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            4  899999999999999999999999999865543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.57  E-value=9e-07  Score=83.62  Aligned_cols=137  Identities=19%  Similarity=0.254  Sum_probs=96.4

Q ss_pred             HhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHH----------HHHHHHHHHHhCCC---CCceeeEEEE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQ----------EVDNEIEILSKIHS---PRLVNLLGFS  118 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~----------~~~~Ei~~l~~l~h---pnIv~l~~~~  118 (487)
                      ....+|...+++-......|.+....++.+++|.+.......+          ...+++..+.+++.   .....++.+.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            4567899999999999999999999999999998775432221          12334444444432   2222322222


Q ss_pred             -----eCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEE
Q 011384          119 -----NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL  193 (487)
Q Consensus       119 -----~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL  193 (487)
                           .-....++||||++|..|.+...     +++    .++..+..++.-||..  |++|+|+.|.|++++.+ .+++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~--G~~HGD~hpgNFlv~~~-~i~i  175 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKH--GFYHGDPHPGNFLVSNN-GIRI  175 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHc--CCccCCCCcCcEEEECC-cEEE
Confidence                 22344578999999988876642     333    2456677789999999  99999999999999855 5999


Q ss_pred             cccccce
Q 011384          194 GDFGLAL  200 (487)
Q Consensus       194 ~DFGla~  200 (487)
                      +||+..+
T Consensus       176 ID~~~k~  182 (229)
T PF06176_consen  176 IDTQGKR  182 (229)
T ss_pred             EECcccc
Confidence            9998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.57  E-value=1.1e-06  Score=83.50  Aligned_cols=140  Identities=19%  Similarity=0.252  Sum_probs=86.2

Q ss_pred             ceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCC--CceeeEEEEeC---CCceEEEEEecCCC
Q 011384           60 QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSP--RLVNLLGFSND---SKDRLLVVEFMSNG  134 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~~~~---~~~~~lV~Ey~~~g  134 (487)
                      ++.|+.|..+.||++...+..+++|..... .....+.+|+.++..+...  .+.+++.++..   ....+++|+++++.
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            478999999999999998889999997766 4557788899999888533  35666664432   33468999999998


Q ss_pred             CHHH----------------HHH---hC---CCCCCHHHH---------HHH------------HHHHHH-HHHHHHh--
Q 011384          135 TLYD----------------VLH---SN---NRPLNWGRR---------IRL------------ALQVAK-AVEILHS--  168 (487)
Q Consensus       135 sL~~----------------~l~---~~---~~~l~~~~~---------~~i------------~~qi~~-gL~yLH~--  168 (487)
                      .+..                .+.   ..   ..++.....         ...            ...+.. .+..++.  
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (239)
T PF01636_consen   81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL  160 (239)
T ss_dssp             EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence            8877                111   11   011111100         000            111222 3333332  


Q ss_pred             ---CCCCeeeccCCCCcEEEc-cCCcEEEcccccce
Q 011384          169 ---EMPPIIHRDIKSANVLID-RNFNARLGDFGLAL  200 (487)
Q Consensus       169 ---~~~~ivH~DIkp~NILld-~~~~vkL~DFGla~  200 (487)
                         ....++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus       161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               122699999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.43  E-value=2.6e-06  Score=82.46  Aligned_cols=136  Identities=16%  Similarity=0.208  Sum_probs=86.5

Q ss_pred             eecccCc-eEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCC-CCCceeeEEEEeCCCceEEEEEecCCCCHHHH
Q 011384           62 LLGKGSH-GSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIH-SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDV  139 (487)
Q Consensus        62 ~LG~G~~-g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~  139 (487)
                      .|-.|.+ +.||+....+..+.||+.....  ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|...
T Consensus         5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             ecCCCCCcCeEEEEcCCCCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            3445555 7899987777788889876553  345778999988883 34566788888777778999999999877643


Q ss_pred             HH-------------------hC---CCCCCHH--HHHHHHHH--------------------HHHHHHHHHh-----CC
Q 011384          140 LH-------------------SN---NRPLNWG--RRIRLALQ--------------------VAKAVEILHS-----EM  170 (487)
Q Consensus       140 l~-------------------~~---~~~l~~~--~~~~i~~q--------------------i~~gL~yLH~-----~~  170 (487)
                      ..                   .-   ..++...  ........                    +...+..|-.     ..
T Consensus        83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  162 (244)
T cd05150          83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED  162 (244)
T ss_pred             hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence            21                   00   0011100  00000000                    1111222211     12


Q ss_pred             CCeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          171 PPIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       171 ~~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                      +.++|+|+.|.|||++.+..+.|+||+.+
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a  191 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRL  191 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEcccc
Confidence            36899999999999999877889999876

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.43  E-value=2.7e-06  Score=81.38  Aligned_cols=150  Identities=23%  Similarity=0.262  Sum_probs=103.2

Q ss_pred             ccchhhHHHhhcCcccceeec---ccCceEEEEEEEC-CeEEEEEEcCCChhh--------------------H-----H
Q 011384           44 HFDYSDLEAATNGFSEQKLLG---KGSHGSVYKAVLR-GRQVAVKKPSKNQEI--------------------S-----Q   94 (487)
Q Consensus        44 ~~~~~~~~~~~~~y~~~~~LG---~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~--------------------~-----~   94 (487)
                      ..+.+.+....++..+....|   .|--+.||+|... +..+|||+.......                    .     .
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            445556666666666655555   5666789998765 889999976542110                    0     1


Q ss_pred             HHHHHHHHHHhCC--CCCceeeEEEEeCCCceEEEEEecCCCC-HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 011384           95 EVDNEIEILSKIH--SPRLVNLLGFSNDSKDRLLVVEFMSNGT-LYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS-EM  170 (487)
Q Consensus        95 ~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~~~~lV~Ey~~~gs-L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~  170 (487)
                      -..+|+.-|+++.  +-.+.+.+++...    .|||||+.... -.-.|..-  +++......+..++++.+.-|-. . 
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~n----VLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~~a-  186 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFRNN----VLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYKEA-  186 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeecCC----eEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHHhc-
Confidence            2456888888873  5566666666543    79999996541 11122221  24444677788888888888877 6 


Q ss_pred             CCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       171 ~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                       ++||+||+.=|||+. ++.+.++|||-+...
T Consensus       187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             -CcccccchhhheEEE-CCeEEEEECcccccc
Confidence             999999999999999 889999999987443

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.33  E-value=2.8e-06  Score=90.37  Aligned_cols=138  Identities=19%  Similarity=0.212  Sum_probs=88.3

Q ss_pred             ceeecccCceEEEEEEEC-CeEEEEEEcCCChh--------------------------------hHHH------HHHHH
Q 011384           60 QKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQE--------------------------------ISQE------VDNEI  100 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~--------------------------------~~~~------~~~Ei  100 (487)
                      .+.||.-+.|.||+|+.+ |..||||+.+..-.                                ..+.      |.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            378999999999999998 88899997654210                                0111      33343


Q ss_pred             HHHHh----CCCCC------ceeeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 011384          101 EILSK----IHSPR------LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM  170 (487)
Q Consensus       101 ~~l~~----l~hpn------Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~  170 (487)
                      +-..+    +.|-+      |.++|  +.-.....|+||||+|..+.|.-.-....++...+..-+.+...-+-+-  . 
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~--~-  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFK--T-  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHh--c-
Confidence            33322    23444      33332  2333456899999999877655432222366665544444433222222  3 


Q ss_pred             CCeeeccCCCCcEEEcc----CCcEEEcccccceecC
Q 011384          171 PPIIHRDIKSANVLIDR----NFNARLGDFGLALRCG  203 (487)
Q Consensus       171 ~~ivH~DIkp~NILld~----~~~vkL~DFGla~~~~  203 (487)
                       |++|+|-.|.||++..    ++.+.+-|||+.....
T Consensus       321 -GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  321 -GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             -CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence             8999999999999984    6789999999986544

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.27  E-value=1.6e-05  Score=74.26  Aligned_cols=135  Identities=26%  Similarity=0.381  Sum_probs=97.9

Q ss_pred             CccccccchhhHHHhhcCcccceeecccCc-eEEEEEEECCeEEEEEEcCC---Ch-------------------hhHHH
Q 011384           39 PIKIQHFDYSDLEAATNGFSEQKLLGKGSH-GSVYKAVLRGRQVAVKKPSK---NQ-------------------EISQE   95 (487)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~-g~Vy~~~~~g~~vAvK~~~~---~~-------------------~~~~~   95 (487)
                      ..++..|+.     .+.+++.++.||.|.- |.||++...|+.||+|++..   ..                   ....-
T Consensus        26 gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P  100 (207)
T PF13095_consen   26 GPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADP  100 (207)
T ss_pred             CCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcCh
Confidence            345666666     2378999999999999 99999999999999998221   10                   01124


Q ss_pred             HHHHHHHHHhCCC---CCc--eeeEEEEeCC------------------CceEEEEEecCCCCHHHHHHhCCCCCCHHHH
Q 011384           96 VDNEIEILSKIHS---PRL--VNLLGFSNDS------------------KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRR  152 (487)
Q Consensus        96 ~~~Ei~~l~~l~h---pnI--v~l~~~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~  152 (487)
                      |..|.+...+|+.   .++  |+++||..-.                  ....||.||++...          .+...  
T Consensus       101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~--  168 (207)
T PF13095_consen  101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR--  168 (207)
T ss_pred             HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh--
Confidence            7788888888853   455  8999987322                  12368888886643          13333  


Q ss_pred             HHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       153 ~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                        -+.+|.+-|..+|..  ||+-+|+++.|..     .-||+|||.+
T Consensus       169 --~~~~~~~dl~~~~k~--gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  169 --DIPQMLRDLKILHKL--GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             --HHHHHHHHHHHHHHC--CeeeccCcccccc-----CCEEEecccC
Confidence              345666677889999  9999999999987     4589999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.25  E-value=6.7e-06  Score=74.70  Aligned_cols=128  Identities=22%  Similarity=0.332  Sum_probs=92.2

Q ss_pred             cccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCce-eeEEEEeCCCceEEEEEecCCCC
Q 011384           57 FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLV-NLLGFSNDSKDRLLVVEFMSNGT  135 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv-~l~~~~~~~~~~~lV~Ey~~~gs  135 (487)
                      ....+.|++|.+|.||+|.|.+..+|+|+-..+.. ...+..|+++|..++--++- ++|.|..+    ++.|||+.|..
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~-r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~   98 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP-RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhhcccccEEEEeeccCceEEEEEecCCcc-hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence            34568899999999999999999999998765544 46789999999999876664 45555443    45699999988


Q ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCC-C-cEEEccCCcEEEcccccce
Q 011384          136 LYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS-A-NVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       136 L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp-~-NILld~~~~vkL~DFGla~  200 (487)
                      |.+.-...    +.+.    +..++..---|-..  ||-|+.|.- . ||++. +..+.|+||.-|.
T Consensus        99 L~~~~~~~----~rk~----l~~vlE~a~~LD~~--GI~H~El~~~~k~vlv~-~~~~~iIDFd~At  154 (201)
T COG2112          99 LGKLEIGG----DRKH----LLRVLEKAYKLDRL--GIEHGELSRPWKNVLVN-DRDVYIIDFDSAT  154 (201)
T ss_pred             hhhhhhcc----cHHH----HHHHHHHHHHHHHh--ccchhhhcCCceeEEec-CCcEEEEEccchh
Confidence            88775431    2222    33444444445556  898998864 4 55554 4489999998775

>PLN02876 acyl-CoA dehydrogenase

Probab=98.20  E-value=1.6e-05  Score=90.51  Aligned_cols=143  Identities=17%  Similarity=0.338  Sum_probs=92.1

Q ss_pred             cceeecccCceEEEEEEECC----eEEEEEEcCCCh--hhHHHHHHHHHHHHhCC-CCCc--eeeEEEEeCC---CceEE
Q 011384           59 EQKLLGKGSHGSVYKAVLRG----RQVAVKKPSKNQ--EISQEVDNEIEILSKIH-SPRL--VNLLGFSNDS---KDRLL  126 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~g----~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~-hpnI--v~l~~~~~~~---~~~~l  126 (487)
                      ..+.|+.|.+..+|+....+    ..+++|+.....  .....+.+|+++++.+. |+++  .+++.+|.+.   +..|+
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            36788999999999987764    467888765432  22356889999999995 6654  7888888764   45789


Q ss_pred             EEEecCCCCHHH--------------------HHH---hC----------CCCCCH--HHHHHHHH--------------
Q 011384          127 VVEFMSNGTLYD--------------------VLH---SN----------NRPLNW--GRRIRLAL--------------  157 (487)
Q Consensus       127 V~Ey~~~gsL~~--------------------~l~---~~----------~~~l~~--~~~~~i~~--------------  157 (487)
                      ||||++|..+.+                    .|.   .-          +.+..+  .++..|..              
T Consensus       122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~  201 (822)
T PLN02876        122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN  201 (822)
T ss_pred             EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence            999998864321                    111   10          001111  11212111              


Q ss_pred             -HHHHHHHHHHhCCC---------CeeeccCCCCcEEEcc-CCc-EEEccccccee
Q 011384          158 -QVAKAVEILHSEMP---------PIIHRDIKSANVLIDR-NFN-ARLGDFGLALR  201 (487)
Q Consensus       158 -qi~~gL~yLH~~~~---------~ivH~DIkp~NILld~-~~~-vkL~DFGla~~  201 (487)
                       .+...+.+|..+.|         .+||+|+++.|||++. ++. +-|.||+++..
T Consensus       202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence             12334567755422         4999999999999975 333 57999988743

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.19  E-value=3.7e-05  Score=72.19  Aligned_cols=127  Identities=20%  Similarity=0.281  Sum_probs=93.1

Q ss_pred             cceeecccCceEEEEEEEC-CeEEEEEEcCCCh-----------------hhHHHHHHHHHHHHhCC------CCCceee
Q 011384           59 EQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQ-----------------EISQEVDNEIEILSKIH------SPRLVNL  114 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~-----------------~~~~~~~~Ei~~l~~l~------hpnIv~l  114 (487)
                      ...+||+|+.-.||.  +. +....||+.....                 ....+..+|+.-...+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            346899999999995  43 4556678766554                 22356677777776666      7889999


Q ss_pred             EEEEeCCCceEEEEEecCC------CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC
Q 011384          115 LGFSNDSKDRLLVVEFMSN------GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN  188 (487)
Q Consensus       115 ~~~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~  188 (487)
                      +|+.+.+-..-+|+|.+.+      .+|.+++....  ++. ...+.+   -.-..||-..  +|+.+|++|.||++..+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~~~L---~~f~~~l~~~--~Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELRQAL---DEFKRYLLDH--HIVIRDLNPHNIVVQRR  154 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHHHHH---HHHHHHHHHc--CCeecCCCcccEEEEec
Confidence            9999999999999998754      27888886554  665 333333   4445677888  89999999999999543


Q ss_pred             ---C-cEEEcc
Q 011384          189 ---F-NARLGD  195 (487)
Q Consensus       189 ---~-~vkL~D  195 (487)
                         . .+.|+|
T Consensus       155 ~~~~~~lvlID  165 (199)
T PF10707_consen  155 DSGEFRLVLID  165 (199)
T ss_pred             CCCceEEEEEe
Confidence               2 577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.16  E-value=1.4e-05  Score=77.14  Aligned_cols=74  Identities=16%  Similarity=0.254  Sum_probs=49.2

Q ss_pred             ceeecccCce-EEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCC---CceeeEEEEeCCC---ceEEEEEecC
Q 011384           60 QKLLGKGSHG-SVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSP---RLVNLLGFSNDSK---DRLLVVEFMS  132 (487)
Q Consensus        60 ~~~LG~G~~g-~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~l~~~~~~~~---~~~lV~Ey~~  132 (487)
                      ++.|+.||.. .||+.   +..+++|..... .....+.+|.+++..+...   -+..+++.....+   ..+++|++++
T Consensus         2 ~~~~~~gG~~n~vy~~---~~~~VlR~~~~~-~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           2 IEPVDSGGTDNATFRL---GDDMSVRLPSAA-GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             ceeccCCCcccceEEc---CCceEEEcCCcc-chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            3567877777 49975   346778876653 2345788999999888532   3455555544322   3488999999


Q ss_pred             CCCHH
Q 011384          133 NGTLY  137 (487)
Q Consensus       133 ~gsL~  137 (487)
                      |.++.
T Consensus        78 G~~l~   82 (235)
T cd05155          78 GETAT   82 (235)
T ss_pred             CCCCC
Confidence            87663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.11  E-value=3.9e-07  Score=96.37  Aligned_cols=186  Identities=17%  Similarity=0.124  Sum_probs=131.5

Q ss_pred             hcCcccceeecccCceEEEEEEECC-eEEEEEEcCCChhhHHHHHHHHHHHHhCCCCC-ceeeEEEEeCCCceEEEEEec
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLRG-RQVAVKKPSKNQEISQEVDNEIEILSKIHSPR-LVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~g-~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      +.-+...+-+++|+++.+++.+... +...++.+...    ....-++++|.+++||| .+..++-+..+...+++++++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            3444555678899999999986552 22223333332    34556899999999999 666666677778889999999


Q ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          132 SNG-TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       132 ~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      .++ +-..........+..-+...+.+.-+.++++||+.  .=+|+|    ||+... +..+..||+....+....   .
T Consensus       317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~--~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~  386 (829)
T KOG0576|consen  317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS--YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---K  386 (829)
T ss_pred             cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccc--cccCcc----cccccc-cccccccccCCcccCccc---c
Confidence            887 32222211112244444556677778899999988  558888    777654 689999999886654432   3


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcC
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKA  253 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~p  253 (487)
                      .....+++.+++||+.....+....|+|++|+-..++--|-+|
T Consensus       387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence            4456899999999999999999999999999866666555444

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.11  E-value=7e-05  Score=69.80  Aligned_cols=99  Identities=24%  Similarity=0.360  Sum_probs=79.9

Q ss_pred             HHHHHHHHhCCC-CCceeeEEEEeCCCceEEEEEecCCCCHHHH---HHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-
Q 011384           97 DNEIEILSKIHS-PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDV---LHSNNRPLNWGRRIRLALQVAKAVEILHSEMP-  171 (487)
Q Consensus        97 ~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~---l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~-  171 (487)
                      .+|.-+++.+++ +++++++|+|-+    ++|.||.+.+++...   +... ...+|..+.+|+.+++..+.+|+.... 
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            458888888876 699999999954    789999987766432   1111 237899999999999999999998522 


Q ss_pred             CeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          172 PIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       172 ~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      .+.-.|++|+|+-+++++.+|++|...+.
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcc
Confidence            47778999999999999999999998763

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=98.09  E-value=4.8e-05  Score=76.18  Aligned_cols=80  Identities=10%  Similarity=0.075  Sum_probs=60.3

Q ss_pred             CcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCC---CCceeeEEEEeCC---CceEEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHS---PRLVNLLGFSNDS---KDRLLVVE  129 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~h---pnIv~l~~~~~~~---~~~~lV~E  129 (487)
                      .....+.||.|..+.||+....+..+.+|..+. ......+..|.+.++.+..   ..+.+++++|...   +..+||||
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQGNPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCCCCEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            344567899999999999877666677787433 2233578999999998853   4688889887643   56799999


Q ss_pred             ecCCCCH
Q 011384          130 FMSNGTL  136 (487)
Q Consensus       130 y~~~gsL  136 (487)
                      ++++.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998754

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.05  E-value=4e-05  Score=73.59  Aligned_cols=73  Identities=21%  Similarity=0.225  Sum_probs=49.9

Q ss_pred             ceeecccCceEEEEEEEC---CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCc-eeeEEEEeCCCceEEEEEecCCCC
Q 011384           60 QKLLGKGSHGSVYKAVLR---GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL-VNLLGFSNDSKDRLLVVEFMSNGT  135 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~---g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~Ey~~~gs  135 (487)
                      ++.|..|-...+|++...   ++.|++|+........-...+|+.+++.+...++ +++++.+. .   .+||||++|.+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~   78 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT   78 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence            467888889999998876   4789999876543322234578888888854333 44444433 2   47999999876


Q ss_pred             H
Q 011384          136 L  136 (487)
Q Consensus       136 L  136 (487)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.00  E-value=2.9e-05  Score=75.78  Aligned_cols=134  Identities=18%  Similarity=0.214  Sum_probs=80.6

Q ss_pred             eecccCceEEEEEEECCeEEEEEEcCCChhhH-HHHHHHHHHHHhCCCCCc-eeeEEEEeCCCceEEEEEecCCCCHHH-
Q 011384           62 LLGKGSHGSVYKAVLRGRQVAVKKPSKNQEIS-QEVDNEIEILSKIHSPRL-VNLLGFSNDSKDRLLVVEFMSNGTLYD-  138 (487)
Q Consensus        62 ~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~-~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~Ey~~~gsL~~-  138 (487)
                      .+..|-.+.+|+....++.+++|+........ -...+|.++++.+....+ .+++.++.    -++||||++|..+.. 
T Consensus         3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             cCCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            35568888999998778899999866543221 235779999998864433 34444432    268999999866531 


Q ss_pred             -------------HHHh---C---CCCCCHHH-HHHHHHHH---------HHHHHHHHhC------CCCeeeccCCCCcE
Q 011384          139 -------------VLHS---N---NRPLNWGR-RIRLALQV---------AKAVEILHSE------MPPIIHRDIKSANV  183 (487)
Q Consensus       139 -------------~l~~---~---~~~l~~~~-~~~i~~qi---------~~gL~yLH~~------~~~ivH~DIkp~NI  183 (487)
                                   .+.+   .   +.+++... +..+..++         ...+..+-..      .+.++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                         1111   1   11122221 12222111         1112222111      12589999999999


Q ss_pred             EEccCCcEEEcccccce
Q 011384          184 LIDRNFNARLGDFGLAL  200 (487)
Q Consensus       184 Lld~~~~vkL~DFGla~  200 (487)
                      +++.++ +.|+||+.+.
T Consensus       159 l~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEeCCC-CEEEeccccC
Confidence            999876 7899998763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.83  E-value=8.8e-05  Score=83.76  Aligned_cols=197  Identities=19%  Similarity=0.171  Sum_probs=139.6

Q ss_pred             HHHHHHHHHHHhCCCCCceeeEEEEeCCCc----eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 011384           94 QEVDNEIEILSKIHSPRLVNLLGFSNDSKD----RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE  169 (487)
Q Consensus        94 ~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~----~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~  169 (487)
                      ....-|+..+.++.|+|++.++.|..+...    ..+..++|..-++...+..-+ .++....+.+..++..||.|+|+.
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHHHh
Confidence            344557888889999999999998765432    245678888888888887655 488899999999999999999998


Q ss_pred             CCCeeeccCCCC---cEEEccCCcEEEc--ccccceecCCCCcccccCCCCCCCccCCccccCCCCCCc--chhhhhHHH
Q 011384          170 MPPIIHRDIKSA---NVLIDRNFNARLG--DFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST--KTDVFSFGI  242 (487)
Q Consensus       170 ~~~ivH~DIkp~---NILld~~~~vkL~--DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~--ksDVwSlGv  242 (487)
                        ...|.-+..+   +--.+..+.+.++  ||+.+..+.....   ......+..+.+||.........  ..|+|.+|.
T Consensus       306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             --ccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHH
Confidence              5656555555   4444566677777  8888765544332   22334556777888776665544  479999999


Q ss_pred             HHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHH
Q 011384          243 LLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDW  320 (487)
Q Consensus       243 vl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~  320 (487)
                      .+..+..|..+......+..+.                        +......+.+...+|+..++++|+++.+++..
T Consensus       381 l~~~~~~~~~i~~~~~~~~~~l------------------------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAVPVSLL------------------------DVLSTSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HHhhhhhcCcccccccchhhhh------------------------ccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence            9999998876543221111111                        01111256778889999999999999999973

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.76  E-value=0.00028  Score=70.24  Aligned_cols=139  Identities=19%  Similarity=0.193  Sum_probs=86.6

Q ss_pred             cceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCC--CceeeEEE------EeCCCceEEEEEe
Q 011384           59 EQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSP--RLVNLLGF------SNDSKDRLLVVEF  130 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~------~~~~~~~~lV~Ey  130 (487)
                      ..+.|..|....+|+....+..+++|+...  .....+..|++++..+.+.  .+.+++..      ....+..++|++|
T Consensus        18 ~i~~i~~G~~n~~y~v~~~~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~   95 (296)
T cd05153          18 SFEGISAGIENTNYFVTTDSGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF   95 (296)
T ss_pred             heecccCccccceEEEEeCCCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence            356788888899999887777899998765  2345677788888888433  24444432      2234556899999


Q ss_pred             cCCCCHHH-----------HH---Hh--CC--C------CCCHHHHH----------HHHHHHHHHHHHHHhC-----CC
Q 011384          131 MSNGTLYD-----------VL---HS--NN--R------PLNWGRRI----------RLALQVAKAVEILHSE-----MP  171 (487)
Q Consensus       131 ~~~gsL~~-----------~l---~~--~~--~------~l~~~~~~----------~i~~qi~~gL~yLH~~-----~~  171 (487)
                      ++|..+..           .+   +.  ..  .      ...|....          .....+..++.++...     ..
T Consensus        96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~  175 (296)
T cd05153          96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR  175 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence            99866421           11   11  00  0      01111100          0111223344455431     12


Q ss_pred             CeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          172 PIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       172 ~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                      +++|+|+.|.|||++.+..+.|+||+.+
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a  203 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFA  203 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhh
Confidence            7999999999999998877889999876

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.71  E-value=0.0002  Score=71.61  Aligned_cols=74  Identities=22%  Similarity=0.352  Sum_probs=50.9

Q ss_pred             ceeecccCceEEEEEEECC--------eEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCc-eeeEEEEeCCCceEEEEEe
Q 011384           60 QKLLGKGSHGSVYKAVLRG--------RQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL-VNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~g--------~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~Ey  130 (487)
                      ++.|..|-...||+....+        +.+++|+............+|++++..+...++ .++++++..    .+|+||
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            3566777788999987653        789999977654444556788888888854333 455555542    358999


Q ss_pred             cCCCCHH
Q 011384          131 MSNGTLY  137 (487)
Q Consensus       131 ~~~gsL~  137 (487)
                      ++|..+.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            9887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.67  E-value=0.0012  Score=68.62  Aligned_cols=74  Identities=18%  Similarity=0.191  Sum_probs=53.2

Q ss_pred             ceeecccCceEEEEEEECC--eEEEEEEcCCC--------hhhHHHHHHHHHHHHhCC---CCCceeeEEEEeCCCceEE
Q 011384           60 QKLLGKGSHGSVYKAVLRG--RQVAVKKPSKN--------QEISQEVDNEIEILSKIH---SPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~g--~~vAvK~~~~~--------~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~l  126 (487)
                      .+.||.|.+..||++...+  +.|+||.-...        .....+...|.+.|..+.   ..++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4679999999999999874  48999974311        123456777888888763   2456777766  3355689


Q ss_pred             EEEecCCCC
Q 011384          127 VVEFMSNGT  135 (487)
Q Consensus       127 V~Ey~~~gs  135 (487)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998744

>PRK05231 homoserine kinase; Provisional

Probab=97.64  E-value=0.00076  Score=67.98  Aligned_cols=138  Identities=16%  Similarity=0.185  Sum_probs=77.9

Q ss_pred             ceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCC--CceeeEE------EEeCCCceEEEEEec
Q 011384           60 QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSP--RLVNLLG------FSNDSKDRLLVVEFM  131 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~------~~~~~~~~~lV~Ey~  131 (487)
                      .+.|+.|....+|+....+..+++|+...  .....+..|+.++..+...  .+.+.+.      +....+..+++++|+
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l  104 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQGEYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL  104 (319)
T ss_pred             cchhccccccceEEEEeCCCcEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence            45677788889999887767899998752  2234444566666665321  2334332      122345678999999


Q ss_pred             CCCCHH-----------HHHH---hCCC----------CCCH-HHHHH------------HHHH-HHHHHHHHHh-----
Q 011384          132 SNGTLY-----------DVLH---SNNR----------PLNW-GRRIR------------LALQ-VAKAVEILHS-----  168 (487)
Q Consensus       132 ~~gsL~-----------~~l~---~~~~----------~l~~-~~~~~------------i~~q-i~~gL~yLH~-----  168 (487)
                      +|..+.           ..|.   ....          .+.+ .....            .+.+ +...+..+..     
T Consensus       105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  184 (319)
T PRK05231        105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA  184 (319)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence            886431           1111   1000          0111 11111            1111 1112233321     


Q ss_pred             CCCCeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       169 ~~~~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                      ...++||+|+.|.|||++.+...-|+||+.+
T Consensus       185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~  215 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFA  215 (319)
T ss_pred             CCcccCCCCCCCCcEEEECCceEEEEecccc
Confidence            1128999999999999997766689999876

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.61  E-value=0.00044  Score=69.47  Aligned_cols=139  Identities=18%  Similarity=0.201  Sum_probs=83.2

Q ss_pred             ceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCC--CceeeEEEE------eCCCceEEEEEec
Q 011384           60 QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSP--RLVNLLGFS------NDSKDRLLVVEFM  131 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~~------~~~~~~~lV~Ey~  131 (487)
                      .+.++.|-...+|+....+..+++|+..... ....+..|++++..|...  .+.+++...      ...+..+++++|+
T Consensus        27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i  105 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL  105 (307)
T ss_pred             ccccCCccccceEEEEeCCCcEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence            5677888888999987776678889865532 124456677777777432  244444321      2245678999999


Q ss_pred             CCCCHH-----------HHH---HhCCCCC-----------CHHHHH------------HHHHHHHHHHHHHHhC-----
Q 011384          132 SNGTLY-----------DVL---HSNNRPL-----------NWGRRI------------RLALQVAKAVEILHSE-----  169 (487)
Q Consensus       132 ~~gsL~-----------~~l---~~~~~~l-----------~~~~~~------------~i~~qi~~gL~yLH~~-----  169 (487)
                      +|..+.           ..+   +.....+           .|....            .....+...+.++...     
T Consensus       106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~  185 (307)
T TIGR00938       106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL  185 (307)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            885431           111   1100001           011000            0011233445555431     


Q ss_pred             CCCeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          170 MPPIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       170 ~~~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                      ..+++|+|+.+.||+++.++.+.|+||+.+
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~  215 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFA  215 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeecccc
Confidence            238999999999999998877789999876

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.54  E-value=0.00015  Score=71.90  Aligned_cols=146  Identities=16%  Similarity=0.217  Sum_probs=102.7

Q ss_pred             cccccchhhHHHhhcC---cccceeecccCceEEEEEEEC-CeEEEEEEcC----------CCh--------h-----hH
Q 011384           41 KIQHFDYSDLEAATNG---FSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPS----------KNQ--------E-----IS   93 (487)
Q Consensus        41 ~~~~~~~~~~~~~~~~---y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~----------~~~--------~-----~~   93 (487)
                      ....++|-.++...++   +.+++.||-|.-+.||.+... |++.++|.-.          ...        .     ..
T Consensus        75 Ty~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSR  154 (465)
T KOG2268|consen   75 TYAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSR  154 (465)
T ss_pred             eeccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHH
Confidence            3445666666666553   788999999999999999887 8999988311          000        0     01


Q ss_pred             HHHHHHHHHHHhCCC--CCceeeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 011384           94 QEVDNEIEILSKIHS--PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP  171 (487)
Q Consensus        94 ~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~  171 (487)
                      -...+|+..|+.|..  --+.+.+++    +..|+|||++.+-.|...-+-    .+..   .+...+..-+.-|-.+  
T Consensus       155 laa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~d~~---~ly~~lm~~Iv~la~~--  221 (465)
T KOG2268|consen  155 LAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV----EDPP---TLYDDLMGLIVRLANH--  221 (465)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec----CChH---HHHHHHHHHHHHHHHc--
Confidence            135678999988843  335555544    445899999988777654321    2222   3445555556677778  


Q ss_pred             CeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          172 PIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       172 ~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                      |+||+|..-=||++++++.++++||--.
T Consensus       222 GlIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  222 GLIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             CceecccchheeEEecCCCEEEeechHh
Confidence            9999999999999999999999999654

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.34  E-value=0.0028  Score=65.74  Aligned_cols=80  Identities=16%  Similarity=0.183  Sum_probs=55.3

Q ss_pred             cceeecccCceEEEEEEECCeEEEEEEcC-----CCh---hhHHHHHHHHHHHHhCC---CCCceeeEEEEeCCCceEEE
Q 011384           59 EQKLLGKGSHGSVYKAVLRGRQVAVKKPS-----KNQ---EISQEVDNEIEILSKIH---SPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~-----~~~---~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~lV  127 (487)
                      ..+.||.|....||+....++.|+||+-.     ...   ....+-..|.+.|+.+.   ..++.+++.++.+.  .+++
T Consensus        36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlv  113 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIG  113 (418)
T ss_pred             eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEE
Confidence            35788999999999998877789999755     111   12334455677776653   35788888888844  5789


Q ss_pred             EEecCC--CCHHHHH
Q 011384          128 VEFMSN--GTLYDVL  140 (487)
Q Consensus       128 ~Ey~~~--gsL~~~l  140 (487)
                      ||++++  ..+.+.+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999977  2444433

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.31  E-value=0.0019  Score=64.28  Aligned_cols=76  Identities=20%  Similarity=0.308  Sum_probs=50.4

Q ss_pred             cccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCC---CCCceeeEEEEeCCCceEEEEEecCC
Q 011384           57 FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIH---SPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      ....+.|+.|....+|+....++.+.||+-.  ......|..|.+-|+.|.   --.+.+++++....+..+||+||++.
T Consensus        19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             --EEEEE--SSSSEEEEEETTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeeeEecCCCChhheEEEECCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            4456789999999999988778999999866  333356788888888883   45678899988877777999999977


Q ss_pred             C
Q 011384          134 G  134 (487)
Q Consensus       134 g  134 (487)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=97.31  E-value=0.0015  Score=66.76  Aligned_cols=138  Identities=22%  Similarity=0.291  Sum_probs=82.4

Q ss_pred             cceeecccCceEEEEEEEC------CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCc-eeeEEEEeCCCceEEEEEec
Q 011384           59 EQKLLGKGSHGSVYKAVLR------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL-VNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~------g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ..+.|-.|-...+|++.+.      ++.|++|+........-.-.+|+.+++.+..-++ .++++++..+    .|++|+
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            3456666889999998753      2679999877653322223678888888865444 3556665433    589999


Q ss_pred             CCCCHHHH--------------HH---hCC-----CCCCHHHHHHHHHHH-----------------HHHHHHHHh----
Q 011384          132 SNGTLYDV--------------LH---SNN-----RPLNWGRRIRLALQV-----------------AKAVEILHS----  168 (487)
Q Consensus       132 ~~gsL~~~--------------l~---~~~-----~~l~~~~~~~i~~qi-----------------~~gL~yLH~----  168 (487)
                      ++.+|...              +.   ...     .+..+..+..+..++                 ...+..|..    
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87665321              11   111     011123333333221                 111222221    


Q ss_pred             C--CCCeeeccCCCCcEEEcc-CCcEEEcccccce
Q 011384          169 E--MPPIIHRDIKSANVLIDR-NFNARLGDFGLAL  200 (487)
Q Consensus       169 ~--~~~ivH~DIkp~NILld~-~~~vkL~DFGla~  200 (487)
                      .  ...++|+|+++.|||+++ ++.+.|+||..+.
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            1  126899999999999986 4689999998763

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.15  E-value=0.0037  Score=62.84  Aligned_cols=139  Identities=17%  Similarity=0.316  Sum_probs=86.7

Q ss_pred             cccceeecccCceEEEEEEECCeEEEEEEcC--CChhhHHHHHHHHHHHHhCCC--CCceeeEEEEeCCC--ceEEEEEe
Q 011384           57 FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPS--KNQEISQEVDNEIEILSKIHS--PRLVNLLGFSNDSK--DRLLVVEF  130 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~--~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~--~~~lV~Ey  130 (487)
                      ..+.+.+..|-...+|.....++.+++.+..  ..........+|+++++.+.-  .-+...+++|.++.  ..+.||+|
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~  106 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDTGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW  106 (321)
T ss_pred             CceeeeccCCcccceEEEecCCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence            3444555555566777777778888888442  223344567788888888753  33455667777665  66999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHH-HHHHHH-----------------------------------------------
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLA-LQVAKA-----------------------------------------------  162 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~-~qi~~g-----------------------------------------------  162 (487)
                      ++|..+.+.+....  ..    .+++ ..++..                                               
T Consensus       107 veGe~~~~~~~~~~--~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         107 VEGEVVWSALPPES--LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             ecceeccCcCCccc--ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            98843322211100  00    0111 123333                                               


Q ss_pred             ---HHHHHhCC------CCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          163 ---VEILHSEM------PPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       163 ---L~yLH~~~------~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                         ..+|+...      +.++|+|+.+.|++++.+.-+-|.||+++..
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence               34444432      2489999999999999988899999998754

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.09  E-value=0.0027  Score=64.26  Aligned_cols=134  Identities=18%  Similarity=0.259  Sum_probs=91.8

Q ss_pred             eeecccCceEEEEEEEC-CeEEEEEEcCCC--------------------------hhhH-HHHHHHHHHHHhCCCCCce
Q 011384           61 KLLGKGSHGSVYKAVLR-GRQVAVKKPSKN--------------------------QEIS-QEVDNEIEILSKIHSPRLV  112 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~--------------------------~~~~-~~~~~Ei~~l~~l~hpnIv  112 (487)
                      -.|..|--+.||.+.-. |..+|||+.+.+                          .... --...|++-|++++...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            45677888899998876 888999975531                          0111 1246688888888765543


Q ss_pred             eeEEEEeCCCceEEEEEecCCCCH-HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcE
Q 011384          113 NLLGFSNDSKDRLLVVEFMSNGTL-YDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNA  191 (487)
Q Consensus       113 ~l~~~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~v  191 (487)
                      -.--+..  ....|||+|+..... .-.|+.  -.++...+..+-.+++.-+.-|...+ ++||.||.--|+|+. +|.+
T Consensus       230 ~PePIlL--k~hVLVM~FlGrdgw~aPkLKd--~~ls~~ka~~~Y~~~v~~MR~lY~~c-~LVHADLSEfN~Lyh-dG~l  303 (520)
T KOG2270|consen  230 CPEPILL--KNHVLVMEFLGRDGWAAPKLKD--ASLSTSKARELYQQCVRIMRRLYQKC-RLVHADLSEFNLLYH-DGKL  303 (520)
T ss_pred             CCCceee--ecceEeeeeccCCCCcCccccc--ccCChHHHHHHHHHHHHHHHHHHHHh-ceeccchhhhhheEE-CCEE
Confidence            2222221  123799999953222 222322  23777788888899999888887654 999999999999984 6689


Q ss_pred             EEcccccce
Q 011384          192 RLGDFGLAL  200 (487)
Q Consensus       192 kL~DFGla~  200 (487)
                      .|+|.+-+.
T Consensus       304 yiIDVSQSV  312 (520)
T KOG2270|consen  304 YIIDVSQSV  312 (520)
T ss_pred             EEEEccccc
Confidence            999987653

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.02  E-value=0.0036  Score=63.68  Aligned_cols=136  Identities=16%  Similarity=0.267  Sum_probs=80.1

Q ss_pred             ceeecccCceEEEEEEECC-----eEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCc-eeeEEEEeCCCceEEEEEecCC
Q 011384           60 QKLLGKGSHGSVYKAVLRG-----RQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL-VNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~g-----~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      .+.|..|=...+|+....+     ..|++|+........-.-.+|..+++.+..-++ .++++++.. +   +|.+|+++
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g   94 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA   94 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence            3556558888999987653     279999877643322234678888888865555 455666532 2   58999977


Q ss_pred             CCHHH--------------HHH---hCC-----CCCCHHHHHHHHHHH----------------------HHHHHHHHh-
Q 011384          134 GTLYD--------------VLH---SNN-----RPLNWGRRIRLALQV----------------------AKAVEILHS-  168 (487)
Q Consensus       134 gsL~~--------------~l~---~~~-----~~l~~~~~~~i~~qi----------------------~~gL~yLH~-  168 (487)
                      ..|..              .+.   ...     .+-.+..+.++..++                      ..-+..+.. 
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            65421              111   111     011233333333222                      111222211 


Q ss_pred             ---C--CCCeeeccCCCCcEEEcc-CCcEEEcccccc
Q 011384          169 ---E--MPPIIHRDIKSANVLIDR-NFNARLGDFGLA  199 (487)
Q Consensus       169 ---~--~~~ivH~DIkp~NILld~-~~~vkL~DFGla  199 (487)
                         .  ..-++|+|+.+.|||+++ ++.++++||..+
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa  211 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG  211 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence               1  114799999999999975 578999999987

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.01  E-value=0.0064  Score=60.21  Aligned_cols=45  Identities=20%  Similarity=0.228  Sum_probs=30.6

Q ss_pred             eecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCC
Q 011384           62 LLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIH  107 (487)
Q Consensus        62 ~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~  107 (487)
                      ..++|-...||..... |+.+++|..... .....+.+|+++++.+.
T Consensus        18 ~~~~g~~~~v~~i~~~~g~~~VlR~p~~~-~~~~~l~rE~~vL~~L~   63 (276)
T cd05152          18 LNESGLDFQVVFAKDTDGVPWVLRIPRRP-DVSERAAAEKRVLALVR   63 (276)
T ss_pred             ecCCcceeEEEEEEcCCCCeEEEEecCCH-HHHHHHHHHHHHHHHHH
Confidence            3455555566666443 788999987643 33466889999999885

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.88  E-value=0.0044  Score=58.60  Aligned_cols=90  Identities=16%  Similarity=0.120  Sum_probs=64.1

Q ss_pred             hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 011384           92 ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP  171 (487)
Q Consensus        92 ~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~  171 (487)
                      ....|.++.+++.+++  .|+++..  .+...+-++.|+|-....          ..   . .++.--+..|.-+|+..+
T Consensus       101 ~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i----------~~---~-N~i~agi~~L~~fH~~~~  162 (308)
T PF07387_consen  101 NDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI----------NF---S-NFITAGIKDLMDFHSENQ  162 (308)
T ss_pred             chhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc----------ch---h-HHHHHhHHHHHHhhccCC
Confidence            3466788999998885  6777762  234455689999843111          11   1 122223567888998777


Q ss_pred             CeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          172 PIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       172 ~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                      +.+|+|..|+||+-|+.|.+||.|-+..
T Consensus       163 ~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  163 HCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             CeecCCCChhheeecCCCCEEecChhhh
Confidence            9999999999999999999999997653

The function of this family is unknown.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.86  E-value=0.0016  Score=61.67  Aligned_cols=119  Identities=25%  Similarity=0.346  Sum_probs=61.1

Q ss_pred             CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCc-eeeEEEEeCCCceEEEEEecCCCCHHH-------HH-------H-
Q 011384           78 GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL-VNLLGFSNDSKDRLLVVEFMSNGTLYD-------VL-------H-  141 (487)
Q Consensus        78 g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~Ey~~~gsL~~-------~l-------~-  141 (487)
                      .+.|+|++........-.-..|..+++.+..-++ .++++++.++    .|++|+++..|..       .+       . 
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~   77 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK   77 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence            4678889888775555566778888888865444 4556655442    5779996654311       11       0 


Q ss_pred             --h--C----CCCCCHHHHHHH----------------------HHHHHHHHHHHHh---C--C-CCeeeccCCCCcEEE
Q 011384          142 --S--N----NRPLNWGRRIRL----------------------ALQVAKAVEILHS---E--M-PPIIHRDIKSANVLI  185 (487)
Q Consensus       142 --~--~----~~~l~~~~~~~i----------------------~~qi~~gL~yLH~---~--~-~~ivH~DIkp~NILl  185 (487)
                        .  .    ...--+..+..+                      +..+..-+..+.+   .  . ..++|+|+.|.|||+
T Consensus        78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~  157 (211)
T PF01633_consen   78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI  157 (211)
T ss_dssp             HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred             HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence              0  0    000011222222                      1112222222221   1  1 157999999999999


Q ss_pred             -ccCCcEEEcccccce
Q 011384          186 -DRNFNARLGDFGLAL  200 (487)
Q Consensus       186 -d~~~~vkL~DFGla~  200 (487)
                       +.++.++|+||..+.
T Consensus       158 ~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  158 NNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             TSSSSCEEE--GTT-E
T ss_pred             ccCCCeEEEecHHHHh
Confidence             888999999999874

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.76  E-value=0.032  Score=55.71  Aligned_cols=64  Identities=13%  Similarity=0.145  Sum_probs=40.2

Q ss_pred             EEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCC--CceeeEEE------EeCCCceEEEEEecCCCCH
Q 011384           70 SVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSP--RLVNLLGF------SNDSKDRLLVVEFMSNGTL  136 (487)
Q Consensus        70 ~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~~~------~~~~~~~~lV~Ey~~~gsL  136 (487)
                      .||++...+..+++|+.....   ..+..|+.++..+...  .+++++..      ...++..++|++|++|..+
T Consensus        11 ~v~~v~t~~g~~~LK~~~~~~---~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~   82 (313)
T TIGR02906        11 NVYKVETDSGNKCLKKINYPP---ERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC   82 (313)
T ss_pred             cEEEEEeCCCCeEEEEcCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence            489888776689999876432   3345566666666322  33444432      2234567899999988543

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.65  E-value=0.016  Score=58.20  Aligned_cols=29  Identities=17%  Similarity=0.251  Sum_probs=26.7

Q ss_pred             CeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          172 PIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       172 ~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      +++|+|+.+.|||++.++.+.|+||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999899999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.63  E-value=0.023  Score=58.08  Aligned_cols=71  Identities=20%  Similarity=0.231  Sum_probs=46.8

Q ss_pred             eecccCceEEEEEEECC--eEEEEEEcCC-------C-hhhHHHHHHHHHHHHhCC--CC-CceeeEEEEeCCCceEEEE
Q 011384           62 LLGKGSHGSVYKAVLRG--RQVAVKKPSK-------N-QEISQEVDNEIEILSKIH--SP-RLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        62 ~LG~G~~g~Vy~~~~~g--~~vAvK~~~~-------~-~~~~~~~~~Ei~~l~~l~--hp-nIv~l~~~~~~~~~~~lV~  128 (487)
                      .||.|....||++...+  +.|+||.-..       + .....+..-|.+.|+...  -| .++++|.|  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            47999999999998874  5899995321       1 223345566778887663  24 34444433  445567999


Q ss_pred             EecCCC
Q 011384          129 EFMSNG  134 (487)
Q Consensus       129 Ey~~~g  134 (487)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            999654

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.54  E-value=0.00034  Score=80.95  Aligned_cols=158  Identities=11%  Similarity=-0.010  Sum_probs=112.8

Q ss_pred             HHHHHHHHHhCCCCCceeeEEEEeC--CCceEEEEEecCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 011384           96 VDNEIEILSKIHSPRLVNLLGFSND--SKDRLLVVEFMSNGTLYDVLHSNN---RPLNWGRRIRLALQVAKAVEILHSEM  170 (487)
Q Consensus        96 ~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~  170 (487)
                      ...|...++...|+++...+.=...  ....+.+++|+.+|.+.+.+-+.-   .+++...+...-.+.+.+..-.|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            4556666677789988776654433  334589999999999999997633   23443334433334355555556542


Q ss_pred             ---CCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHH
Q 011384          171 ---PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEI  247 (487)
Q Consensus       171 ---~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eL  247 (487)
                         --.+|+++|+-|.+|..+..+|++++|+.+.....  ........+++.|+.|+....-.++.++|+|..|+-+|+.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence               13589999999999999999999999998732221  1123345678889999988887888889999999999999


Q ss_pred             HhCCcCCC
Q 011384          248 ISCRKAID  255 (487)
Q Consensus       248 ltG~~pf~  255 (487)
                      .-|..+|.
T Consensus      1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred             hcccHHHH
Confidence            88876663

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.49  E-value=0.0023  Score=67.10  Aligned_cols=50  Identities=22%  Similarity=0.385  Sum_probs=39.9

Q ss_pred             HHHHHHHHHHHhCCCCCceeeEEEEeCC-CceEEEEEecCCCCHHHHHHhCC
Q 011384           94 QEVDNEIEILSKIHSPRLVNLLGFSNDS-KDRLLVVEFMSNGTLYDVLHSNN  144 (487)
Q Consensus        94 ~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~  144 (487)
                      .++...+++++.+.|+|+..++++-... ....+|+|++ +.||++.+....
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~   77 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN   77 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence            4566678899999999999999887643 3467899999 789999987643

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.47  E-value=0.017  Score=59.80  Aligned_cols=73  Identities=22%  Similarity=0.258  Sum_probs=49.9

Q ss_pred             ceeecccCceEEEEEEEC--CeEEEEEEcC------CC-hhhHHHHHHHHHHHHhCC--CC-CceeeEEEEeCCCceEEE
Q 011384           60 QKLLGKGSHGSVYKAVLR--GRQVAVKKPS------KN-QEISQEVDNEIEILSKIH--SP-RLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~------~~-~~~~~~~~~Ei~~l~~l~--hp-nIv~l~~~~~~~~~~~lV  127 (487)
                      .+.||.|.-..||++...  ++.|+||.-.      .+ .-...+..-|.+.|+...  .| +++++|.|  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            568999999999999975  6789999522      11 223456677888887763  34 44555543  44556789


Q ss_pred             EEecCCC
Q 011384          128 VEFMSNG  134 (487)
Q Consensus       128 ~Ey~~~g  134 (487)
                      ||+++..
T Consensus       112 MEdL~~~  118 (409)
T PRK12396        112 MEDLSDH  118 (409)
T ss_pred             HHhCccc
Confidence            9999653

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.12  E-value=0.023  Score=57.64  Aligned_cols=137  Identities=23%  Similarity=0.318  Sum_probs=87.1

Q ss_pred             eeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCC------ceeeEE----EEeCCCceEEEEEe
Q 011384           61 KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPR------LVNLLG----FSNDSKDRLLVVEF  130 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpn------Iv~l~~----~~~~~~~~~lV~Ey  130 (487)
                      ..|.+ .-..||+....++.+++|+.... ....++..|+..+..+.-..      +..+=|    ........+-|++|
T Consensus        32 ~~l~s-~eN~~f~~~~~~g~~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          32 RGLNS-EENSNFRVQTEDGRYILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             ccccc-ccCceEEEEecCCCeEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            34444 56789999888777799998887 56677888888888874222      222222    11222377899999


Q ss_pred             cCCCCHHH------------HH---Hh--CC---------CCCCHHH----H---------HHHHHHHHHHHHHHHhC--
Q 011384          131 MSNGTLYD------------VL---HS--NN---------RPLNWGR----R---------IRLALQVAKAVEILHSE--  169 (487)
Q Consensus       131 ~~~gsL~~------------~l---~~--~~---------~~l~~~~----~---------~~i~~qi~~gL~yLH~~--  169 (487)
                      ++|..+..            .|   +.  .+         ....|..    .         .....++...+..+.+.  
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99987762            11   11  00         0122321    0         12334555566666654  


Q ss_pred             --CC--C--eeeccCCCCcEEEccCCc-EEEcccccc
Q 011384          170 --MP--P--IIHRDIKSANVLIDRNFN-ARLGDFGLA  199 (487)
Q Consensus       170 --~~--~--ivH~DIkp~NILld~~~~-vkL~DFGla  199 (487)
                        .|  +  +||+|+.|.|||++.+.. +.++||+-+
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa  226 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDA  226 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEcccc
Confidence              12  3  899999999999998874 899999876

>PTZ00384 choline kinase; Provisional

Probab=96.08  E-value=0.04  Score=57.20  Aligned_cols=75  Identities=23%  Similarity=0.338  Sum_probs=47.5

Q ss_pred             cceeecccCceEEEEEEECCe--------EEEEEEcCCChhhHHHHHHHHHHHHhCCCCCc-eeeEEEEeCCCceEEEEE
Q 011384           59 EQKLLGKGSHGSVYKAVLRGR--------QVAVKKPSKNQEISQEVDNEIEILSKIHSPRL-VNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~g~--------~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~E  129 (487)
                      ..+.|..|-...+|++...+.        .|.++.........-.-.+|+++++.+...++ .++++.+..    .+|+|
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e  129 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE  129 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence            345666688999999876421        25555433222211233568999999976555 455666543    59999


Q ss_pred             ecCCCCHH
Q 011384          130 FMSNGTLY  137 (487)
Q Consensus       130 y~~~gsL~  137 (487)
                      |++|..|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99987653

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.69  E-value=0.11  Score=49.60  Aligned_cols=77  Identities=14%  Similarity=0.210  Sum_probs=58.2

Q ss_pred             cceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhC---CCCCceeeEEEEeCCCceEEEEEecCCCC
Q 011384           59 EQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKI---HSPRLVNLLGFSNDSKDRLLVVEFMSNGT  135 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~~~~~~lV~Ey~~~gs  135 (487)
                      ..+.+--|..-..|...+...++.||.-...  ....|..|+.-|..|   +--++.+++.+..+....|+|+||++-+.
T Consensus        20 er~~v~gG~inea~~v~dg~~~~FvK~n~~~--~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          20 EREEVSGGDINEAWRLRDGTDPFFVKCNQRE--QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccccCCccccceeEeecCCcceEEEecchh--hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            3456666778888888888889999974333  335677787777666   34568888999999999999999999866


Q ss_pred             HH
Q 011384          136 LY  137 (487)
Q Consensus       136 L~  137 (487)
                      +.
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            54

>PTZ00296 choline kinase; Provisional

Probab=95.56  E-value=0.096  Score=55.41  Aligned_cols=74  Identities=16%  Similarity=0.218  Sum_probs=49.5

Q ss_pred             cceeecccCceEEEEEEEC----------CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCce-eeEEEEeCCCceEEE
Q 011384           59 EQKLLGKGSHGSVYKAVLR----------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLV-NLLGFSNDSKDRLLV  127 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~----------g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv-~l~~~~~~~~~~~lV  127 (487)
                      ..+.|..|-.-.+|++...          ++.|.+++........-.-.+|..+++.+...+|- ++++.+. +   ..|
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g---g~I  184 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS-G---GRI  184 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC-C---CEE
Confidence            4577777888899998754          45799998776543322345688888887654543 4555543 2   468


Q ss_pred             EEecCCCCH
Q 011384          128 VEFMSNGTL  136 (487)
Q Consensus       128 ~Ey~~~gsL  136 (487)
                      .+|++|..|
T Consensus       185 ~efi~g~~l  193 (442)
T PTZ00296        185 EEWLYGDPL  193 (442)
T ss_pred             EEeeCCccC
Confidence            999988644

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.42  E-value=0.37  Score=48.83  Aligned_cols=70  Identities=16%  Similarity=0.138  Sum_probs=44.9

Q ss_pred             cCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCC--CceeeE---E--EEeCCCceEEEEEecCCCC
Q 011384           66 GSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSP--RLVNLL---G--FSNDSKDRLLVVEFMSNGT  135 (487)
Q Consensus        66 G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~l~---~--~~~~~~~~~lV~Ey~~~gs  135 (487)
                      +.-..||+.... +..+++|+..........+..|++.+..+...  .++...   |  +...++..+.|+++++|..
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            456679988775 66899998765444556677888888777321  222222   1  1222456788999998764

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.36  E-value=0.05  Score=56.01  Aligned_cols=62  Identities=18%  Similarity=0.128  Sum_probs=44.6

Q ss_pred             ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR  187 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~  187 (487)
                      ...++-+|.+|.++..+++..+  .+++...+++.-.+.||--+--.. +++|.|+.|.||++-.
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~vD-NFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLIVD-NFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHHhh-cceecccCCCcEEEEe
Confidence            3467888899999999997655  455566666666666554433222 7999999999999943

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.06  E-value=0.061  Score=54.67  Aligned_cols=73  Identities=21%  Similarity=0.242  Sum_probs=55.3

Q ss_pred             CCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      ..+.|++|++- |++|.-.     .--.++++..++.+.+..++-+..+. ..=|||+.-.||||+ +|+|.|+||-+++
T Consensus       298 ~~y~yl~~kdh-gt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf-~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII-----KADRSEEELSFFWSCISILDILEKKF-PFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             ceEEEEEEecC-Cceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcC-Ccccccccccceeee-cCceEEEEeeeee
Confidence            33456777765 5455322     12467788888888888777777654 678999999999999 9999999999998


Q ss_pred             e
Q 011384          201 R  201 (487)
Q Consensus       201 ~  201 (487)
                      .
T Consensus       370 l  370 (488)
T COG5072         370 L  370 (488)
T ss_pred             c
Confidence            4

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	487
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-40
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-39
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-38
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-38
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-34
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-34
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-34
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-31
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-27
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-26
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-23
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-23
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-16
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-16
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-16
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-16
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-16
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-16
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-16
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-16
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		8e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		8e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-14
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-14
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-14
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-13
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-11
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-11
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-11
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-11
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		9e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		7e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		8e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		8e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-06
3soa_A	444	Full-Length Human Camkii Length = 444		3e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		8e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-04
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		6e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-04
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-04
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		6e-04
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-04
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		7e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		7e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		7e-04
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 101/294 (34%), Positives = 159/294 (54%), Gaps = 12/294 (4%)
Query: 41  KIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVK--KPSKNQEISQEVD 97
           +++ F   +L+ A++ FS + +LG+G  G VYK  L  G  VAVK  K  + Q    +  
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 98  NEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS---NNRPLNWGRRIR 154
            E+E++S      L+ L GF     +RLLV  +M+NG++   L     +  PL+W +R R
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 155 LALQVAKAVEILHSEM-PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
           +AL  A+ +  LH    P IIHRD+K+AN+L+D  F A +GDFGLA      +       
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA- 202
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGF----SPPSIVDWAAP 269
             GTIG++ P Y++    S KTDVF +G++LLE+I+ ++A D+          ++DW   
Sbjct: 203 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 262
Query: 270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG 323
           L+K+ K+ ++ D  +         +QL  +A+ C +S    RP M E+V  L G
Sbjct: 263 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 161/296 (54%), Gaps = 16/296 (5%)
Query: 41  KIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVK--KPSKNQEISQEVD 97
           +++ F   +L+ A++ F  + +LG+G  G VYK  L  G  VAVK  K  + Q    +  
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 98  NEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS---NNRPLNWGRRIR 154
            E+E++S      L+ L GF     +RLLV  +M+NG++   L     +  PL+W +R R
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 155 LALQVAKAVEILHSEM-PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
           +AL  A+ +  LH    P IIHRD+K+AN+L+D  F A +GDFGLA    + +++     
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---KLMDYKDXHVX 192
Query: 214 PA--GTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGF----SPPSIVDWA 267
            A  G IG++ P Y++    S KTDVF +G++LLE+I+ ++A D+          ++DW 
Sbjct: 193 XAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 268 APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG 323
             L+K+ K+ ++ D  +         +QL  +A+ C +S    RP M E+V  L G
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 98/280 (35%), Positives = 158/280 (56%), Gaps = 15/280 (5%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQ---EVDNEIEILS 104
           DLE ATN F  + L+G G  G VYK VLR G +VA+K+  +  E SQ   E + EIE LS
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR--RTPESSQGIEEFETEIETLS 90
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---LNWGRRIRLALQVAK 161
               P LV+L+GF ++  + +L+ ++M NG L   L+ ++ P   ++W +R+ + +  A+
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
            +  LH+    IIHRD+KS N+L+D NF  ++ DFG++ +    +         GT+GY+
Sbjct: 151 GLHYLHTR--AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIV---DWAAPLIKKGKILS 278
           DP Y     L+ K+DV+SFG++L E++  R AI +   P  +V   +WA      G++  
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           + DP +     P   ++    AV+C+    E RPSM +++
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 98/280 (35%), Positives = 157/280 (56%), Gaps = 15/280 (5%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQ---EVDNEIEILS 104
           DLE ATN F  + L+G G  G VYK VLR G +VA+K+  +  E SQ   E + EIE LS
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR--RTPESSQGIEEFETEIETLS 90
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---LNWGRRIRLALQVAK 161
               P LV+L+GF ++  + +L+ ++M NG L   L+ ++ P   ++W +R+ + +  A+
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
            +  LH+    IIHRD+KS N+L+D NF  ++ DFG++ +              GT+GY+
Sbjct: 151 GLHYLHTR--AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIV---DWAAPLIKKGKILS 278
           DP Y     L+ K+DV+SFG++L E++  R AI +   P  +V   +WA      G++  
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           + DP +     P   ++    AV+C+    E RPSM +++
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 92/298 (30%), Positives = 152/298 (51%), Gaps = 16/298 (5%)
Query: 41  KIQHFDYSDLEAATNGFSEQKL------LGKGSHGSVYKAVLRGRQVAVKKPS-----KN 89
           +   F + +L+  TN F E+ +      +G+G  G VYK  +    VAVKK +       
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 70
Query: 90  QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH--SNNRPL 147
           +E+ Q+ D EI++++K     LV LLGFS+D  D  LV  +M NG+L D L       PL
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 148 NWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF 207
           +W  R ++A   A  +  LH      IHRDIKSAN+L+D  F A++ DFGLA        
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA 267
               +   GT  Y+ P  +  + ++ K+D++SFG++LLEII+   A+D    P  ++D  
Sbjct: 189 TVMXSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 268 APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS 325
             +  + K +  +  +     D    + +  +A +C+   + +RP +K++   L  ++
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 92/298 (30%), Positives = 151/298 (50%), Gaps = 16/298 (5%)
Query: 41  KIQHFDYSDLEAATNGFSEQKL------LGKGSHGSVYKAVLRGRQVAVKKPS-----KN 89
           +   F + +L+  TN F E+ +      +G+G  G VYK  +    VAVKK +       
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 70
Query: 90  QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH--SNNRPL 147
           +E+ Q+ D EI++++K     LV LLGFS+D  D  LV  +M NG+L D L       PL
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 148 NWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF 207
           +W  R ++A   A  +  LH      IHRDIKSAN+L+D  F A++ DFGLA        
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA 267
                   GT  Y+ P  +  + ++ K+D++SFG++LLEII+   A+D    P  ++D  
Sbjct: 189 TVMXXRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 268 APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS 325
             +  + K +  +  +     D    + +  +A +C+   + +RP +K++   L  ++
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  141 bits (355), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 92/298 (30%), Positives = 151/298 (50%), Gaps = 16/298 (5%)
Query: 41  KIQHFDYSDLEAATNGFSEQKL------LGKGSHGSVYKAVLRGRQVAVKKPS-----KN 89
           +   F + +L+  TN F E+ +      +G+G  G VYK  +    VAVKK +       
Sbjct: 5   RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 64
Query: 90  QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH--SNNRPL 147
           +E+ Q+ D EI++++K     LV LLGFS+D  D  LV  +M NG+L D L       PL
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 124
Query: 148 NWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF 207
           +W  R ++A   A  +  LH      IHRDIKSAN+L+D  F A++ DFGLA        
Sbjct: 125 SWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA 267
                   GT  Y+ P  +  + ++ K+D++SFG++LLEII+   A+D    P  ++D  
Sbjct: 183 XVMXXRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 241
Query: 268 APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS 325
             +  + K +  +  +     D    + +  +A +C+   + +RP +K++   L  ++
Sbjct: 242 EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 299

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 145/294 (49%), Gaps = 16/294 (5%)
Query: 41  KIQHFDYSDLEAATNGFSEQKL------LGKGSHGSVYKAVLRGRQVAVKKPS-----KN 89
           +   F + +L+  TN F E+ +       G+G  G VYK  +    VAVKK +       
Sbjct: 2   RFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 61
Query: 90  QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH--SNNRPL 147
           +E+ Q+ D EI++ +K     LV LLGFS+D  D  LV  +  NG+L D L       PL
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPL 121
Query: 148 NWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF 207
           +W  R ++A   A  +  LH      IHRDIKSAN+L+D  F A++ DFGLA        
Sbjct: 122 SWHXRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA 267
               +   GT  Y  P  +  + ++ K+D++SFG++LLEII+   A+D    P  ++D  
Sbjct: 180 XVXXSRIVGTTAYXAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 238
Query: 268 APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
             +  + K +  +  +     D    +    +A +C+   + +RP +K++   L
Sbjct: 239 EEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 144/287 (50%), Gaps = 20/287 (6%)
Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVK---KPSKNQEISQEVDNEIE 101
            D  D++      + ++ +G GS G+V++A   G  VAVK   +   + E   E   E+ 
Sbjct: 27  MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVA 86
Query: 102 ILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN--RPLNWGRRIRLALQV 159
           I+ ++  P +V  +G      +  +V E++S G+LY +LH +     L+  RR+ +A  V
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG 219
           AK +  LH+  PPI+HRD+KS N+L+D+ +  ++ DFGL+ R     F   S   AGT  
Sbjct: 147 AKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKASXF-LXSKXAAGTPE 204
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV 279
           ++ P  +  +  + K+DV+SFG++L E+ + ++      +P  +V       K+ +I   
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG-NLNPAQVVAAVGFKCKRLEIPRN 263
Query: 280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
            +P            Q+A I   C  +   +RPS   I+D L  L K
Sbjct: 264 LNP------------QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 144/287 (50%), Gaps = 20/287 (6%)
Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVK---KPSKNQEISQEVDNEIE 101
            D  D++      + ++ +G GS G+V++A   G  VAVK   +   + E   E   E+ 
Sbjct: 27  MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVA 86
Query: 102 ILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN--RPLNWGRRIRLALQV 159
           I+ ++  P +V  +G      +  +V E++S G+LY +LH +     L+  RR+ +A  V
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG 219
           AK +  LH+  PPI+HR++KS N+L+D+ +  ++ DFGL+ R     F   S   AGT  
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS-RLKASTF-LSSKSAAGTPE 204
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV 279
           ++ P  +  +  + K+DV+SFG++L E+ + ++      +P  +V       K+ +I   
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG-NLNPAQVVAAVGFKCKRLEIPRN 263
Query: 280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
            +P            Q+A I   C  +   +RPS   I+D L  L K
Sbjct: 264 LNP------------QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 140/299 (46%), Gaps = 45/299 (15%)
Query: 42  IQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIE 101
           +   DY ++E        ++++G+G+ G V KA  R + VA+K+     E  +    E+ 
Sbjct: 2   LHMIDYKEIEV-------EEVVGRGAFGVVCKAKWRAKDVAIKQIESESE-RKAFIVELR 53
Query: 102 ILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNW---GRRIRLALQ 158
            LS+++ P +V L G   +     LV+E+   G+LY+VLH    PL +      +   LQ
Sbjct: 54  QLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLH-GAEPLPYYTAAHAMSWCLQ 110
Query: 159 VAKAVEILHSEMP-PIIHRDIKSANVLIDRNFNA-RLGDFGLALRCGVDNFRFRSTPPAG 216
            ++ V  LHS  P  +IHRD+K  N+L+       ++ DFG A      + +   T   G
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKG 165
Query: 217 TIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA------PL 270
           +  ++ P      N S K DVFS+GI+L E+I+ RK  D    P   + WA       PL
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL 225
Query: 271 IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
           IK           +P P + ++         RC      +RPSM+EIV  +T L +  P
Sbjct: 226 IKN----------LPKPIESLM--------TRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 140/299 (46%), Gaps = 45/299 (15%)
Query: 42  IQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIE 101
           +   DY ++E        ++++G+G+ G V KA  R + VA+K+     E  +    E+ 
Sbjct: 3   LHMIDYKEIEV-------EEVVGRGAFGVVCKAKWRAKDVAIKQIESESE-RKAFIVELR 54
Query: 102 ILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNW---GRRIRLALQ 158
            LS+++ P +V L G   +     LV+E+   G+LY+VLH    PL +      +   LQ
Sbjct: 55  QLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLH-GAEPLPYYTAAHAMSWCLQ 111
Query: 159 VAKAVEILHSEMP-PIIHRDIKSANVLIDRNFNA-RLGDFGLALRCGVDNFRFRSTPPAG 216
            ++ V  LHS  P  +IHRD+K  N+L+       ++ DFG A      + +   T   G
Sbjct: 112 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKG 166
Query: 217 TIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA------PL 270
           +  ++ P      N S K DVFS+GI+L E+I+ RK  D    P   + WA       PL
Sbjct: 167 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL 226
Query: 271 IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
           IK           +P P + ++         RC      +RPSM+EIV  +T L +  P
Sbjct: 227 IKN----------LPKPIESLM--------TRCWSKDPSQRPSMEEIVKIMTHLMRYFP 267

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 107/226 (47%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 65
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         ++ EFM+ G L D L   NR  +N    + +A Q++ A
Sbjct: 66  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 125
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D +    T PAG    I 
Sbjct: 126 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAPAGAKFPIK 179
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 219

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 107/226 (47%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 64
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         ++ EFM+ G L D L   NR  +N    + +A Q++ A
Sbjct: 65  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 124
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D +    T PAG    I 
Sbjct: 125 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAPAGAKFPIK 178
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 218

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 107/226 (47%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 68
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         +++EFM+ G L D L   NR  +N    + +A Q++ A
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 128
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D +    T  AG    I 
Sbjct: 129 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIK 182
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 222

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 65
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         ++ EFM+ G L D L   NR  +N    + +A Q++ A
Sbjct: 66  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 125
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D +    T  AG    I 
Sbjct: 126 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIK 179
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 219

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 68
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         ++ EFM+ G L D L   NR  +N    + +A Q++ A
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 128
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D +    T  AG    I 
Sbjct: 129 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIK 182
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 222

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 65
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         ++ EFM+ G L D L   NR  +N    + +A Q++ A
Sbjct: 66  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 125
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D +    T  AG    I 
Sbjct: 126 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIK 179
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 219

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 76
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         ++ EFM+ G L D L   NR  +N    + +A Q++ A
Sbjct: 77  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 136
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D +    T  AG    I 
Sbjct: 137 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIK 190
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 191 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 230

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         ++ EFM+ G L D L   NR  +N    + +A Q++ A
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 123
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D +    T  AG    I 
Sbjct: 124 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIK 177
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 217

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 67
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         ++ EFM+ G L D L   NR  +N    + +A Q++ A
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 127
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D +    T  AG    I 
Sbjct: 128 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIK 181
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 221

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         ++ EFM+ G L D L   NR  +N    + +A Q++ A
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 123
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D +    T  AG    I 
Sbjct: 124 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIK 177
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 217

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 68
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         ++ EFM+ G L D L   NR  +N    + +A Q++ A
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 128
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D +    T  AG    I 
Sbjct: 129 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIK 182
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 222

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 64
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         +++EFM+ G L D L   NR  +N    + +A Q++ A
Sbjct: 65  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 124
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D      T  AG    I 
Sbjct: 125 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----XTAHAGAKFPIK 178
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 218

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         +++EFM+ G L D L   NR  ++    + +A Q++ A
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D +    T  AG    I 
Sbjct: 124 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIK 177
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 217

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 130/286 (45%), Gaps = 43/286 (15%)
Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSK-NQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           ++LGKG  G   K   R  G  + +K+  + ++E  +    E++++  +  P ++  +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
               K    + E++  GTL  ++ S +    W +R+  A  +A  +  LHS    IIHRD
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRD 133
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG--------------TIGYLDP 223
           + S N L+  N N  + DFGLA R  VD      T P G               +G  +P
Sbjct: 134 LNSHNCLVRENKNVVVADFGLA-RLMVDE----KTQPEGLRSLKKPDRKKRYTVVG--NP 186
Query: 224 CYVTPDNLS-----TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILS 278
            ++ P+ ++      K DVFSFGI+L EII  R   D  + P ++ D+   L  +G +  
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIG-RVNADPDYLPRTM-DFG--LNVRGFLDR 242
Query: 279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
              P  PP   P        I VRC     E+RPS  ++  WL  L
Sbjct: 243 YCPPNCPPSFFP--------ITVRCCDLDPEKRPSFVKLEHWLETL 280

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         +++EFM+ G L D L   NR  ++    + +A Q++ A
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D +    T  AG    I 
Sbjct: 124 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIK 177
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 217

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 110/218 (50%), Gaps = 28/218 (12%)
Query: 50  LEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVK--KPSKNQEISQEVDN---EIEILS 104
           LE      + ++++G G  G VY+A   G +VAVK  +   +++ISQ ++N   E ++ +
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP----LNWGRRIRLALQVA 160
            +  P ++ L G      +  LV+EF   G L  VL     P    +NW      A+Q+A
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIA 115
Query: 161 KAVEILHSE-MPPIIHRDIKSANVLIDR--------NFNARLGDFGLALRCGVDNFRFRS 211
           + +  LH E + PIIHRD+KS+N+LI +        N   ++ DFGLA        R   
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTK 171
Query: 212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
              AG   ++ P  +     S  +DV+S+G+LL E+++
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT 209

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 63  LGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND 120
           LG G +G VY+ V +     VAVK   ++    +E   E  ++ +I  P LV LLG    
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 121 SKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
                ++ EFM+ G L D L   NR  ++    + +A Q++ A+E L  E    IHRD+ 
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKNFIHRDLA 136
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTPDNLSTKTD 236
           + N L+  N   ++ DFGL+     D F    T  AG    I +  P  +  +  S K+D
Sbjct: 137 ARNCLVGENHLVKVADFGLSRLMTGDTF----TAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 237 VFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           V++FG+LL EI +   +   G  P  + +
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         ++ EFM+ G L D L   NR  ++    + +A Q++ A
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D +    T  AG    I 
Sbjct: 124 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIK 177
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 217

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 105/226 (46%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 68
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         ++ EFM+ G L D L   NR  +N    + +A Q++ A
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 128
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D      T  AG    I 
Sbjct: 129 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----XTAHAGAKFPIK 182
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 222

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         ++ EFM+ G L D L   NR  ++    + +A Q++ A
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D +    T  AG    I 
Sbjct: 124 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIK 177
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 217

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 68
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         ++ EFM+ G L D L   NR  ++    + +A Q++ A
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 128
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHRD+ + N L+  N   ++ DFGL+     D +    T  AG    I 
Sbjct: 129 MEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIK 182
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 222

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 309
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         ++ EFM+ G L D L   NR  +N    + +A Q++ A
Sbjct: 310 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 369
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHR++ + N L+  N   ++ DFGL+     D +    T  AG    I 
Sbjct: 370 MEYL--EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIK 423
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 424 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 463

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 140/295 (47%), Gaps = 33/295 (11%)
Query: 47  YSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVK-----KPSKNQEISQEVDNEIE 101
           Y ++EA+    S +  +G GS G+VYK    G  VAVK      P+  Q   Q   NE+ 
Sbjct: 30  YWEIEASEVMLSTR--IGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQ--FQAFRNEVA 84
Query: 102 ILSKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVA 160
           +L K     ++  +G+   +KD L +V ++    +LY  LH         + I +A Q A
Sbjct: 85  VLRKTRHVNILLFMGYM--TKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTA 142
Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGY 220
           + ++ LH++   IIHRD+KS N+ +      ++GDFGLA      +   +   P G++ +
Sbjct: 143 QGMDYLHAK--NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLW 200
Query: 221 LDPCYV-TPDN--LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI- 276
           + P  +   DN   S ++DV+S+GI+L E+++     ++ +S  +  D    ++ +G   
Sbjct: 201 MAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG----ELPYSHINNRDQIIFMVGRGYAS 256
Query: 277 --LSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
             LS      P        K +  +   CV+  +E RP   +I+  +  L   +P
Sbjct: 257 PDLSKLYKNCP--------KAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 63  LGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND 120
           LG G +G VY+ V +     VAVK   ++    +E   E  ++ +I  P LV LLG    
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 121 SKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
                +++EFM+ G L D L   NR  ++    + +A Q++ A+E L  E    IHRD+ 
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKNFIHRDLA 136
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTPDNLSTKTD 236
           + N L+  N   ++ DFGL+     D      T  AG    I +  P  +  +  S K+D
Sbjct: 137 ARNCLVGENHLVKVADFGLSRLMTGDT----XTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 237 VFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           V++FG+LL EI +   +   G  P  + +
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/193 (34%), Positives = 99/193 (51%), Gaps = 14/193 (7%)
Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND 120
           + +GKG  G V     RG +VAVK   KN   +Q    E  +++++    LV LLG   +
Sbjct: 27  QTIGKGEFGDVMLGDYRGNKVAVK-CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 121 SKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGR-RIRLALQVAKAVEILHSEMPPIIHRDI 178
            K  L +V E+M+ G+L D L S  R +  G   ++ +L V +A+E L  E    +HRD+
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFVHRDL 143
Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT--IGYLDPCYVTPDNLSTKTD 236
            + NVL+  +  A++ DFGL            ST   G   + +  P  +     STK+D
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREKKFSTKSD 196
Query: 237 VFSFGILLLEIIS 249
           V+SFGILL EI S
Sbjct: 197 VWSFGILLWEIYS 209

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 136/275 (49%), Gaps = 29/275 (10%)
Query: 63  LGKGSHGSVYKAVLRG----RQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           +G GS G+VYK    G    + + V  P+  Q   Q   NE+ +L K     ++  +G+S
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 119 NDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
             +K +L +V ++    +LY  LH++       + I +A Q A+ ++ LH++   IIHRD
Sbjct: 90  --TKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK--SIIHRD 145
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN---LSTK 234
           +KS N+ +  +   ++GDFGLA      +   +    +G+I ++ P  +   +    S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 235 TDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI---LSVFDPRIPPPKDPI 291
           +DV++FGI+L E+++ +    + +S  +  D    ++ +G +   LS      P      
Sbjct: 206 SDVYAFGIVLYELMTGQ----LPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP------ 255
Query: 292 VRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
             K++  +   C++  R+ RPS   I+  +  L++
Sbjct: 256 --KRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/193 (34%), Positives = 99/193 (51%), Gaps = 14/193 (7%)
Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND 120
           + +GKG  G V     RG +VAVK   KN   +Q    E  +++++    LV LLG   +
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAVK-CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 121 SKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGR-RIRLALQVAKAVEILHSEMPPIIHRDI 178
            K  L +V E+M+ G+L D L S  R +  G   ++ +L V +A+E L  E    +HRD+
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFVHRDL 315
Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT--IGYLDPCYVTPDNLSTKTD 236
            + NVL+  +  A++ DFGL            ST   G   + +  P  +     STK+D
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 237 VFSFGILLLEIIS 249
           V+SFGILL EI S
Sbjct: 369 VWSFGILLWEIYS 381

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 133/274 (48%), Gaps = 27/274 (9%)
Query: 63  LGKGSHGSVYKAVLRG----RQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           +G GS G+VYK    G    + + V  P+  Q   Q   NE+ +L K     ++  +G+S
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
             +    +V ++    +LY  LH++       + I +A Q A+ ++ LH++   IIHRD+
Sbjct: 90  T-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK--SIIHRDL 146
Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN---LSTKT 235
           KS N+ +  +   ++GDFGLA      +   +    +G+I ++ P  +   +    S ++
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206
Query: 236 DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI---LSVFDPRIPPPKDPIV 292
           DV++FGI+L E+++ +    + +S  +  D    ++ +G +   LS      P       
Sbjct: 207 DVYAFGIVLYELMTGQ----LPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP------- 255
Query: 293 RKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
            K++  +   C++  R+ RPS   I+  +  L++
Sbjct: 256 -KRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/193 (34%), Positives = 99/193 (51%), Gaps = 14/193 (7%)
Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND 120
           + +GKG  G V     RG +VAVK   KN   +Q    E  +++++    LV LLG   +
Sbjct: 12  QTIGKGEFGDVMLGDYRGNKVAVK-CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 121 SKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGR-RIRLALQVAKAVEILHSEMPPIIHRDI 178
            K  L +V E+M+ G+L D L S  R +  G   ++ +L V +A+E L  E    +HRD+
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFVHRDL 128
Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT--IGYLDPCYVTPDNLSTKTD 236
            + NVL+  +  A++ DFGL            ST   G   + +  P  +     STK+D
Sbjct: 129 AARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 237 VFSFGILLLEIIS 249
           V+SFGILL EI S
Sbjct: 182 VWSFGILLWEIYS 194

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEIL 103
           +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E  ++
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 270
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKA 162
            +I  P LV LLG         ++ EFM+ G L D L   NR  ++    + +A Q++ A
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IG 219
           +E L  E    IHR++ + N L+  N   ++ DFGL+     D +    T  AG    I 
Sbjct: 331 MEYL--EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIK 384
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           +  P  +  +  S K+DV++FG+LL EI +       G SP   +D
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID 424

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 116/259 (44%), Gaps = 33/259 (12%)
Query: 63  LGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND 120
           LG G +G VY  V +     VAVK   ++    +E   E  ++ +I  P LV LLG    
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTL 99
Query: 121 SKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
                +V E+M  G L D L   NR  +     + +A Q++ A+E L  E    IHRD+ 
Sbjct: 100 EPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYL--EKKNFIHRDLA 157
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTPDNLSTKTD 236
           + N L+  N   ++ DFGL+     D +    T  AG    I +  P  +  +  S K+D
Sbjct: 158 ARNCLVGENHVVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNTFSIKSD 213
Query: 237 VFSFGILLLEIISCRKAIDIGFSPPSIVDWAA--PLIKKGKILSVFDPRIPPPKDPIVRK 294
           V++FG+LL EI +       G SP   +D +    L++KG  +    P   PPK      
Sbjct: 214 VWAFGVLLWEIAT------YGMSPYPGIDLSQVYDLLEKGYRME--QPEGCPPK------ 259
Query: 295 QLAVIAVRCVRSCRERRPS 313
                    +R+C +  P+
Sbjct: 260 -----VYELMRACWKWSPA 273

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/193 (34%), Positives = 99/193 (51%), Gaps = 14/193 (7%)
Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND 120
           + +GKG  G V     RG +VAVK   KN   +Q    E  +++++    LV LLG   +
Sbjct: 18  QTIGKGEFGDVMLGDYRGNKVAVK-CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 121 SKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGR-RIRLALQVAKAVEILHSEMPPIIHRDI 178
            K  L +V E+M+ G+L D L S  R +  G   ++ +L V +A+E L  E    +HRD+
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFVHRDL 134
Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT--IGYLDPCYVTPDNLSTKTD 236
            + NVL+  +  A++ DFGL            ST   G   + +  P  +     STK+D
Sbjct: 135 AARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREAAFSTKSD 187
Query: 237 VFSFGILLLEIIS 249
           V+SFGILL EI S
Sbjct: 188 VWSFGILLWEIYS 200

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 110/224 (49%), Gaps = 32/224 (14%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKK--------PSKNQEISQEVDNEIEI 102
           A N    +K +GKG  G V+K  L   +  VA+K          ++  E  QE   E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 103 LSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
           +S ++ P +V L G  ++     +V+EF+  G LY  L     P+ W  ++RL L +A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 163 VEILHSEMPPIIHRDIKSANVL---IDRN--FNARLGDFGLALRCG------VDNFRFRS 211
           +E + ++ PPI+HRD++S N+    +D N    A++ DFGL+ +        + NF++ +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMA 194
Query: 212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAID 255
                TIG  +  Y      + K D +SF ++L  I++     D
Sbjct: 195 ---PETIGAEEESY------TEKADTYSFAMILYTILTGEGPFD 229

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 10/205 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVK----KPSKNQEISQEVDNEIEILSKIHSPR 110
           F    LLGKGS   VY+A  +  G +VA+K    K      + Q V NE++I  ++  P 
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           ++ L  +  DS    LV+E   NG +   L +  +P +         Q+   +  LHS  
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH- 131
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             I+HRD+  +N+L+ RN N ++ DFGLA +  + + +  +    GT  Y+ P   T   
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIATRSA 188
Query: 231 LSTKTDVFSFGILLLEIISCRKAID 255
              ++DV+S G +   ++  R   D
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 63  LGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND 120
           LG G  G VY+ V +     VAVK   ++    +E   E  ++ +I  P LV LLG    
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 121 SKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
                ++ EFM+ G L D L   NR  ++    + +A Q++ A+E L  E    IHRD+ 
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKNFIHRDLA 136
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTPDNLSTKTD 236
           + N L+  N   ++ DFGL+     D      T  AG    I +  P  +  +  S K+D
Sbjct: 137 ARNCLVGENHLVKVADFGLSRLMTGDT----XTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 237 VFSFGILLLEIISCRKAIDIGFSPPSIVD 265
           V++FG+LL EI +   +   G  P  + +
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 118/259 (45%), Gaps = 17/259 (6%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ-VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           K LG G  G V     +G+  VAVK   +      E   E + + K+  P+LV   G  +
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
                 +V E++SNG L + L S+ + L   + + +   V + +  L S     IHRD+ 
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLA 131
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           + N L+DR+   ++ DFG+  R  +D+    S      + +  P        S+K+DV++
Sbjct: 132 ARNCLVDRDLCVKVSDFGMT-RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 240 FGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVI 299
           FGIL+ E+ S      +G  P  +   +  ++K  +   ++ P +    D I +     I
Sbjct: 191 FGILMWEVFS------LGKMPYDLYTNSEVVLKVSQGHRLYRPHL--ASDTIYQ-----I 237
Query: 300 AVRCVRSCRERRPSMKEIV 318
              C     E+RP+ ++++
Sbjct: 238 MYSCWHELPEKRPTFQQLL 256

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 140/289 (48%), Gaps = 29/289 (10%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG----RQVAVKKPSKNQEISQEVDNEIEILS 104
           D E      +  + +G GS G+VYK    G    + + V  P+  Q   Q   NE+ +L 
Sbjct: 6   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLR 63
Query: 105 KIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
           K     ++  +G+S  +K +L +V ++    +LY  LH++       + I +A Q A+ +
Sbjct: 64  KTRHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 121
Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           + LH++   IIHRD+KS N+ +  +   ++GDFGLA      +   +    +G+I ++ P
Sbjct: 122 DYLHAK--SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 179
Query: 224 CYVTPDN---LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI---L 277
             +   +    S ++DV++FGI+L E+++ +    + +S  +  D    ++ +G +   L
Sbjct: 180 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ----LPYSNINNRDQIIEMVGRGSLSPDL 235
Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
           S      P        K++  +   C++  R+ RPS   I+  +  L++
Sbjct: 236 SKVRSNCP--------KRMKRLMAECLKKKRDERPSFPRILAEIEELAR 276

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 108/189 (57%), Gaps = 9/189 (4%)
Query: 63  LGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVNLLGFSN 119
           +G+G+ G+VY A  V  G++VA+++ +  Q+  +E + NEI ++ +  +P +VN L    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+E+++ G+L DV+      ++ G+   +  +  +A+E LHS    +IHRDIK
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIK 143
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S N+L+  + + +L DFG   +   +  + RST   GT  ++ P  VT      K D++S
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSK-RST-MVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 240 FGILLLEII 248
            GI+ +E+I
Sbjct: 202 LGIMAIEMI 210

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 127/262 (48%), Gaps = 23/262 (8%)
Query: 60  QKLLGKGSHGSVYKAVL-RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           +K LG G  G V+ A   +  +VAVK         +    E  ++  +   +LV L    
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNN---RPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   ++ EFM+ G+L D L S+    +PL   + I  + Q+A+ +  +  E    IH
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFI--EQRNYIH 307
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKT 235
           RD+++AN+L+  +   ++ DFGLA R   DN           I +  P  +   + + K+
Sbjct: 308 RDLRAANILVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 236 DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQ 295
           DV+SFGILL+EI++  +    G S P ++      +++G        R+P P++    ++
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPEVIR----ALERGY-------RMPRPEN--CPEE 413
Query: 296 LAVIAVRCVRSCRERRPSMKEI 317
           L  I +RC ++  E RP+ + I
Sbjct: 414 LYNIMMRCWKNRPEERPTFEYI 435

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 32/224 (14%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKK--------PSKNQEISQEVDNEIEI 102
           A N    +K +GKG  G V+K  L   +  VA+K          ++  E  QE   E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 103 LSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
           +S ++ P +V L G  ++     +V+EF+  G LY  L     P+ W  ++RL L +A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 163 VEILHSEMPPIIHRDIKSANVL---IDRN--FNARLGDFGLALRCG------VDNFRFRS 211
           +E + ++ PPI+HRD++S N+    +D N    A++ DFG + +        + NF++ +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLGNFQWMA 194
Query: 212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAID 255
                TIG  +  Y      + K D +SF ++L  I++     D
Sbjct: 195 ---PETIGAEEESY------TEKADTYSFAMILYTILTGEGPFD 229

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 138/278 (49%), Gaps = 30/278 (10%)
Query: 63  LGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVNLLGFSN 119
           +G+G+ G+VY A  V  G++VA+++ +  Q+  +E + NEI ++ +  +P +VN L    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+E+++ G+L DV+      ++ G+   +  +  +A+E LHS    +IHRDIK
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIK 144
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S N+L+  + + +L DFG   +   +  + + +   GT  ++ P  VT      K D++S
Sbjct: 145 SDNILLGMDGSVKLTDFGFCAQITPE--QSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWS 202
Query: 240 FGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK--DPIVRKQLA 297
            GI+ +E+I           PP + +   PL     I +   P +  P+    I R  L 
Sbjct: 203 LGIMAIEMIEGE--------PPYLNE--NPLRALYLIATNGTPELQNPEKLSAIFRDFLN 252
Query: 298 VIAVRCVRSCRERRPSMKEIVDW-----LTGLSKLVPL 330
               RC+    E+R S KE++          LS L PL
Sbjct: 253 ----RCLEMDVEKRGSAKELIQHQFLKIAKPLSSLTPL 286

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 107/189 (56%), Gaps = 9/189 (4%)
Query: 63  LGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVNLLGFSN 119
           +G+G+ G+VY A  V  G++VA+++ +  Q+  +E + NEI ++ +  +P +VN L    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+E+++ G+L DV+      ++ G+   +  +  +A+E LHS    +IHRDIK
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIK 143
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S N+L+  + + +L DFG   +   +  + + +   GT  ++ P  VT      K D++S
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPE--QSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 240 FGILLLEII 248
            GI+ +E+I
Sbjct: 202 LGIMAIEMI 210

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 127/262 (48%), Gaps = 23/262 (8%)
Query: 60  QKLLGKGSHGSVYKAVL-RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           +K LG G  G V+ A   +  +VAVK         +    E  ++  +   +LV L    
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 79
Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNN---RPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   ++ EFM+ G+L D L S+    +PL   + I  + Q+A+ +  +  E    IH
Sbjct: 80  T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFI--EQRNYIH 134
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKT 235
           RD+++AN+L+  +   ++ DFGLA R   DN           I +  P  +   + + K+
Sbjct: 135 RDLRAANILVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 193
Query: 236 DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQ 295
           DV+SFGILL+EI++  +    G S P ++      +++G        R+P P++    ++
Sbjct: 194 DVWSFGILLMEIVTYGRIPYPGMSNPEVIR----ALERGY-------RMPRPEN--CPEE 240
Query: 296 LAVIAVRCVRSCRERRPSMKEI 317
           L  I +RC ++  E RP+ + I
Sbjct: 241 LYNIMMRCWKNRPEERPTFEYI 262

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 32/224 (14%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKK--------PSKNQEISQEVDNEIEI 102
           A N    +K +GKG  G V+K  L   +  VA+K          ++  E  QE   E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 103 LSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
           +S ++ P +V L G  ++     +V+EF+  G LY  L     P+ W  ++RL L +A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 163 VEILHSEMPPIIHRDIKSANVL---IDRN--FNARLGDFGLALRCG------VDNFRFRS 211
           +E + ++ PPI+HRD++S N+    +D N    A++ DF L+ +        + NF++ +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLGNFQWMA 194
Query: 212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAID 255
                TIG  +  Y      + K D +SF ++L  I++     D
Sbjct: 195 ---PETIGAEEESY------TEKADTYSFAMILYTILTGEGPFD 229

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 107/189 (56%), Gaps = 9/189 (4%)
Query: 63  LGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVNLLGFSN 119
           +G+G+ G+VY A  V  G++VA+++ +  Q+  +E + NEI ++ +  +P +VN L    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+E+++ G+L DV+      ++ G+   +  +  +A+E LHS    +IHRDIK
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIK 143
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S N+L+  + + +L DFG   +   +  + + +   GT  ++ P  VT      K D++S
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPE--QSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 240 FGILLLEII 248
            GI+ +E+I
Sbjct: 202 LGIMAIEMI 210

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 134/262 (51%), Gaps = 25/262 (9%)
Query: 63  LGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVNLLGFSN 119
           +G+G+ G+VY A  V  G++VA+++ +  Q+  +E + NEI ++ +  +P +VN L    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+E+++ G+L DV+      ++ G+   +  +  +A+E LHS    +IHR+IK
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ--VIHRNIK 144
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S N+L+  + + +L DFG   +   +  + RST   GT  ++ P  VT      K D++S
Sbjct: 145 SDNILLGMDGSVKLTDFGFCAQITPEQSK-RST-MVGTPYWMAPEVVTRKAYGPKVDIWS 202
Query: 240 FGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK--DPIVRKQLA 297
            GI+ +E+I           PP + +   PL     I +   P +  P+    I R  L 
Sbjct: 203 LGIMAIEMIEGE--------PPYLNE--NPLRALYLIATNGTPELQNPEKLSAIFRDFLN 252
Query: 298 VIAVRCVRSCRERRPSMKEIVD 319
               RC+    E+R S KE++ 
Sbjct: 253 ----RCLEMDVEKRGSAKELIQ 270

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 127/262 (48%), Gaps = 33/262 (12%)
Query: 60  QKLLGKGSHGSVYKAVL-RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           +K LG G  G V+ A   +  +VAVK         +    E  ++  +   +LV L    
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 246
Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNN---RPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   ++ EFM+ G+L D L S+    +PL   + I  + Q+A+ +  +  E    IH
Sbjct: 247 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFI--EQRNYIH 301
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKT 235
           RD+++AN+L+  +   ++ DFGLA R G   F  + T P           +   + + K+
Sbjct: 302 RDLRAANILVSASLVCKIADFGLA-RVGA-KFPIKWTAPEA---------INFGSFTIKS 350
Query: 236 DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQ 295
           DV+SFGILL+EI++  +    G S P ++      +++G        R+P P++    ++
Sbjct: 351 DVWSFGILLMEIVTYGRIPYPGMSNPEVIR----ALERGY-------RMPRPEN--CPEE 397
Query: 296 LAVIAVRCVRSCRERRPSMKEI 317
           L  I +RC ++  E RP+ + I
Sbjct: 398 LYNIMMRCWKNRPEERPTFEYI 419

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 99/187 (52%), Gaps = 7/187 (3%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND 120
           LG+GS+GSVYKA+ +  G+ VA+K+     ++ QE+  EI I+ +  SP +V   G    
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-QEIIKEISIMQQCDSPHVVKYYGSYFK 95
Query: 121 SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           + D  +V+E+   G++ D++   N+ L       +     K +E LH      IHRDIK+
Sbjct: 96  NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK--IHRDIKA 153
Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
            N+L++   +A+L DFG+A +  + +   +     GT  ++ P  +     +   D++S 
Sbjct: 154 GNILLNTEGHAKLADFGVAGQ--LTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSL 211
Query: 241 GILLLEI 247
           GI  +E+
Sbjct: 212 GITAIEM 218

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 139/291 (47%), Gaps = 28/291 (9%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSV----YKAVL--RGRQVAVKK-PSKNQEISQEVDN 98
           D +  E     F +Q  LGKG+ GSV    Y  +    G  VAVKK     +E  ++ + 
Sbjct: 3   DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 99  EIEILSKIHSPRLVNLLG--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA 156
           EIEIL  +    +V   G  +S   ++  L++E++  G+L D L  +   ++  + ++  
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG 216
            Q+ K +E L ++    IHRD+ + N+L++     ++GDFGL      D   F+   P  
Sbjct: 121 SQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 217 T-IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK 275
           + I +  P  +T    S  +DV+SFG++L E+ +    I+   SPP+         K+G+
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQ 235
Query: 276 ILSVF--------DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           ++ VF        + R+P P       ++ +I   C  +   +RPS +++ 
Sbjct: 236 MI-VFHLIELLKNNGRLPRPDG--CPDEIYMIMTECWNNNVNQRPSFRDLA 283

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 139/292 (47%), Gaps = 29/292 (9%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG----RQVAVKKPSKNQEISQEVDNEIEILS 104
           D E      +  + +G GS G+VYK    G    + + V  P+  Q   Q   NE+ +L 
Sbjct: 30  DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLR 87
Query: 105 KIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
           K     ++  +G+S  +K +L +V ++    +LY  LH         + I +A Q A+ +
Sbjct: 88  KTRHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 145
Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           + LH++   IIHRD+KS N+ +  +   ++GDFGLA      +   +    +G+I ++ P
Sbjct: 146 DYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 203
Query: 224 CYVTPDN---LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI---L 277
             +   +    S ++DV++FGI+L E+++ +    + +S  +  D    ++ +G +   L
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ----LPYSNINNRDQIIFMVGRGYLSPDL 259
Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
           S      P        K +  +   C++  R+ RP   +I+  +  L++ +P
Sbjct: 260 SKVRSNCP--------KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 303

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           F E  +LG+G+ G V KA   L  R  A+KK    +E    + +E+ +L+ ++   +V  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 115 LG------------FSNDSKDRLLV-VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK 161
                          +   K  L + +E+  NGTLYD++HS N         RL  Q+ +
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA---------LRCGVDNFRFRST 212
           A+  +HS+   IIHRD+K  N+ ID + N ++GDFGLA         L+    N    S 
Sbjct: 128 ALSYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 213 PPAGTIGYLDPCYVTPDNL------STKTDVFSFGILLLEII 248
                IG     YV  + L      + K D++S GI+  E+I
Sbjct: 186 NLTSAIG--TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 139/292 (47%), Gaps = 29/292 (9%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG----RQVAVKKPSKNQEISQEVDNEIEILS 104
           D E      +  + +G GS G+VYK    G    + + V  P+  Q   Q   NE+ +L 
Sbjct: 22  DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLR 79
Query: 105 KIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
           K     ++  +G+S  +K +L +V ++    +LY  LH         + I +A Q A+ +
Sbjct: 80  KTRHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 137
Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           + LH++   IIHRD+KS N+ +  +   ++GDFGLA      +   +    +G+I ++ P
Sbjct: 138 DYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 195
Query: 224 CYVTPDN---LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI---L 277
             +   +    S ++DV++FGI+L E+++ +    + +S  +  D    ++ +G +   L
Sbjct: 196 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ----LPYSNINNRDQIIFMVGRGYLSPDL 251
Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
           S      P        K +  +   C++  R+ RP   +I+  +  L++ +P
Sbjct: 252 SKVRSNCP--------KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 295

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 48  SDLEAATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVK---KPSKNQEISQEVDNEIEI 102
           +D +     +  QK +GKG+   V  A  VL GR+VAVK   K   N    Q++  E+ I
Sbjct: 8   TDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRI 67
Query: 103 LSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
           +  ++ P +V L       K   LV+E+ S G ++D L ++ R      R +   Q+  A
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSA 126
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF--RFRSTPPAGTIGY 220
           V+  H +   I+HRD+K+ N+L+D + N ++ DFG +    V N    F  +PP      
Sbjct: 127 VQYCHQKY--IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPP------ 178
Query: 221 LDPCYVTPDNLSTK------TDVFSFGILLLEIIS 249
               Y  P+    K       DV+S G++L  ++S
Sbjct: 179 ----YAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 139/292 (47%), Gaps = 29/292 (9%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG----RQVAVKKPSKNQEISQEVDNEIEILS 104
           D E      +  + +G GS G+VYK    G    + + V  P+  Q   Q   NE+ +L 
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLR 59
Query: 105 KIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
           K     ++  +G+S  +K +L +V ++    +LY  LH         + I +A Q A+ +
Sbjct: 60  KTRHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           + LH++   IIHRD+KS N+ +  +   ++GDFGLA      +   +    +G+I ++ P
Sbjct: 118 DYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 175
Query: 224 CYVTPDN---LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI---L 277
             +   +    S ++DV++FGI+L E+++ +    + +S  +  D    ++ +G +   L
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ----LPYSNINNRDQIIFMVGRGYLSPDL 231
Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
           S      P        K +  +   C++  R+ RP   +I+  +  L++ +P
Sbjct: 232 SKVRSNCP--------KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 139/292 (47%), Gaps = 29/292 (9%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG----RQVAVKKPSKNQEISQEVDNEIEILS 104
           D E      +  + +G GS G+VYK    G    + + V  P+  Q   Q   NE+ +L 
Sbjct: 30  DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLR 87
Query: 105 KIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
           K     ++  +G+S  +K +L +V ++    +LY  LH         + I +A Q A+ +
Sbjct: 88  KTRHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 145
Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           + LH++   IIHRD+KS N+ +  +   ++GDFGLA      +   +    +G+I ++ P
Sbjct: 146 DYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 203
Query: 224 CYVTPDN---LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI---L 277
             +   +    S ++DV++FGI+L E+++ +    + +S  +  D    ++ +G +   L
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ----LPYSNINNRDQIIFMVGRGYLSPDL 259
Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
           S      P        K +  +   C++  R+ RP   +I+  +  L++ +P
Sbjct: 260 SKVRSNCP--------KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 303

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 139/292 (47%), Gaps = 29/292 (9%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG----RQVAVKKPSKNQEISQEVDNEIEILS 104
           D E      +  + +G GS G+VYK    G    + + V  P+  Q   Q   NE+ +L 
Sbjct: 29  DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLR 86
Query: 105 KIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
           K     ++  +G+S  +K +L +V ++    +LY  LH         + I +A Q A+ +
Sbjct: 87  KTRHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 144
Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           + LH++   IIHRD+KS N+ +  +   ++GDFGLA      +   +    +G+I ++ P
Sbjct: 145 DYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 202
Query: 224 CYVTPDN---LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI---L 277
             +   +    S ++DV++FGI+L E+++ +    + +S  +  D    ++ +G +   L
Sbjct: 203 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ----LPYSNINNRDQIIFMVGRGYLSPDL 258
Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
           S      P        K +  +   C++  R+ RP   +I+  +  L++ +P
Sbjct: 259 SKVRSNCP--------KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 302

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 139/292 (47%), Gaps = 29/292 (9%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG----RQVAVKKPSKNQEISQEVDNEIEILS 104
           D E      +  + +G GS G+VYK    G    + + V  P+  Q   Q   NE+ +L 
Sbjct: 7   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLR 64
Query: 105 KIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
           K     ++  +G+S  +K +L +V ++    +LY  LH         + I +A Q A+ +
Sbjct: 65  KTRHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           + LH++   IIHRD+KS N+ +  +   ++GDFGLA      +   +    +G+I ++ P
Sbjct: 123 DYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180
Query: 224 CYVTPDN---LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI---L 277
             +   +    S ++DV++FGI+L E+++ +    + +S  +  D    ++ +G +   L
Sbjct: 181 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ----LPYSNINNRDQIIFMVGRGYLSPDL 236
Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
           S      P        K +  +   C++  R+ RP   +I+  +  L++ +P
Sbjct: 237 SKVRSNCP--------KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 280

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 28/210 (13%)
Query: 60  QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF-S 118
           Q+ +GKG  G V++   RG +VAVK  S  +E S   + EI     +   R  N+LGF +
Sbjct: 14  QESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIA 70
Query: 119 NDSKDR------LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM-- 170
            D+KD        LV ++  +G+L+D L  N   +     I+LAL  A  +  LH E+  
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 128
Query: 171 ----PPIIHRDIKSANVLIDRNFNARLGDFGLALR--CGVDNFRFRSTPPAGTIGYLDPC 224
               P I HRD+KS N+L+ +N    + D GLA+R     D          GT  Y+ P 
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP- 187
Query: 225 YVTPDNLSTK-------TDVFSFGILLLEI 247
            V  D+++ K        D+++ G++  EI
Sbjct: 188 EVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF--- 117
           + +GKG +G V++ +  G  VAVK  S   E  Q    E EI + +   R  N+LGF   
Sbjct: 14  ECVGKGRYGEVWRGLWHGESVAVKIFSSRDE--QSWFRETEIYNTV-LLRHDNILGFIAS 70
Query: 118 ----SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM--- 170
                N S    L+  +  +G+LYD L    + L     +RLA+  A  +  LH E+   
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFL--QRQTLEPHLALRLAVSAACGLAHLHVEIFGT 128
Query: 171 ---PPIIHRDIKSANVLIDRNFNARLGDFGLAL--RCGVDNFRFRSTPPAGTIGYLDPCY 225
              P I HRD KS NVL+  N    + D GLA+    G D     + P  GT  Y+ P  
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP-E 187
Query: 226 VTPDNLSTK-------TDVFSFGILLLEI 247
           V  + + T        TD+++FG++L EI
Sbjct: 188 VLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 139/292 (47%), Gaps = 29/292 (9%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG----RQVAVKKPSKNQEISQEVDNEIEILS 104
           D E      +  + +G GS G+VYK    G    + + V  P+  Q   Q   NE+ +L 
Sbjct: 7   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLR 64
Query: 105 KIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
           K     ++  +G+S  +K +L +V ++    +LY  LH         + I +A Q A+ +
Sbjct: 65  KTRHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           + LH++   IIHRD+KS N+ +  +   ++GDFGLA      +   +    +G+I ++ P
Sbjct: 123 DYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180
Query: 224 CYVTPDN---LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI---L 277
             +   +    S ++DV++FGI+L E+++ +    + +S  +  D    ++ +G +   L
Sbjct: 181 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ----LPYSNINNRDQIIFMVGRGYLSPDL 236
Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
           S      P        K +  +   C++  R+ RP   +I+  +  L++ +P
Sbjct: 237 SKVRSNCP--------KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 280

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 28/210 (13%)
Query: 60  QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF-S 118
           Q+ +GKG  G V++   RG +VAVK  S  +E S   + EI     +   R  N+LGF +
Sbjct: 11  QESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIA 67
Query: 119 NDSKDR------LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM-- 170
            D+KD        LV ++  +G+L+D L  N   +     I+LAL  A  +  LH E+  
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 125
Query: 171 ----PPIIHRDIKSANVLIDRNFNARLGDFGLALR--CGVDNFRFRSTPPAGTIGYLDPC 224
               P I HRD+KS N+L+ +N    + D GLA+R     D          GT  Y+ P 
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP- 184
Query: 225 YVTPDNLSTK-------TDVFSFGILLLEI 247
            V  D+++ K        D+++ G++  EI
Sbjct: 185 EVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 28/210 (13%)
Query: 60  QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF-S 118
           Q+ +GKG  G V++   RG +VAVK  S  +E S   + EI     +   R  N+LGF +
Sbjct: 9   QESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIA 65
Query: 119 NDSKDR------LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM-- 170
            D+KD        LV ++  +G+L+D L  N   +     I+LAL  A  +  LH E+  
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 123
Query: 171 ----PPIIHRDIKSANVLIDRNFNARLGDFGLALR--CGVDNFRFRSTPPAGTIGYLDPC 224
               P I HRD+KS N+L+ +N    + D GLA+R     D          GT  Y+ P 
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP- 182
Query: 225 YVTPDNLSTK-------TDVFSFGILLLEI 247
            V  D+++ K        D+++ G++  EI
Sbjct: 183 EVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 139/292 (47%), Gaps = 29/292 (9%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG----RQVAVKKPSKNQEISQEVDNEIEILS 104
           D E      +  + +G GS G+VYK    G    + + V  P+  Q   Q   NE+ +L 
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLR 59
Query: 105 KIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
           K     ++  +G+S  +K +L +V ++    +LY  LH         + I +A Q A+ +
Sbjct: 60  KTRHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           + LH++   IIHRD+KS N+ +  +   ++GDFGLA      +   +    +G+I ++ P
Sbjct: 118 DYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 224 CYVTPDN---LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI---L 277
             +   +    S ++DV++FGI+L E+++ +    + +S  +  D    ++ +G +   L
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ----LPYSNINNRDQIIFMVGRGYLSPDL 231
Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
           S      P        K +  +   C++  R+ RP   +I+  +  L++ +P
Sbjct: 232 SKVRSNCP--------KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 139/292 (47%), Gaps = 29/292 (9%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG----RQVAVKKPSKNQEISQEVDNEIEILS 104
           D E      +  + +G GS G+VYK    G    + + V  P+  Q   Q   NE+ +L 
Sbjct: 4   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLR 61
Query: 105 KIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
           K     ++  +G+S  +K +L +V ++    +LY  LH         + I +A Q A+ +
Sbjct: 62  KTRHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 119
Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           + LH++   IIHRD+KS N+ +  +   ++GDFGLA      +   +    +G+I ++ P
Sbjct: 120 DYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 177
Query: 224 CYVTPDN---LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI---L 277
             +   +    S ++DV++FGI+L E+++ +    + +S  +  D    ++ +G +   L
Sbjct: 178 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ----LPYSNINNRDQIIFMVGRGYLSPDL 233
Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
           S      P        K +  +   C++  R+ RP   +I+  +  L++ +P
Sbjct: 234 SKVRSNCP--------KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 277

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 28/210 (13%)
Query: 60  QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF-S 118
           Q+ +GKG  G V++   RG +VAVK  S  +E S   + EI     +   R  N+LGF +
Sbjct: 8   QESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIA 64
Query: 119 NDSKDR------LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM-- 170
            D+KD        LV ++  +G+L+D L  N   +     I+LAL  A  +  LH E+  
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 171 ----PPIIHRDIKSANVLIDRNFNARLGDFGLALR--CGVDNFRFRSTPPAGTIGYLDPC 224
               P I HRD+KS N+L+ +N    + D GLA+R     D          GT  Y+ P 
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP- 181
Query: 225 YVTPDNLSTK-------TDVFSFGILLLEI 247
            V  D+++ K        D+++ G++  EI
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 132/274 (48%), Gaps = 26/274 (9%)
Query: 63  LGKGSHGSV----YKAVL--RGRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           LGKG+ GSV    Y  +    G  VAVKK     +E  ++ + EIEIL  +    +V   
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 116 G--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           G  +S   ++  L++E++  G+L D L  +   ++  + ++   Q+ K +E L ++    
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--Y 142
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT-IGYLDPCYVTPDNLS 232
           IHRD+ + N+L++     ++GDFGL      D    +   P  + I +  P  +T    S
Sbjct: 143 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 202
Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF--------DPRI 284
             +DV+SFG++L E+ +    I+   SPP+         K+G+++ VF        + R+
Sbjct: 203 VASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMI-VFHLIELLKNNGRL 258
Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           P P       ++ +I   C  +   +RPS +++ 
Sbjct: 259 PRPDG--CPDEIYMIMTECWNNNVNQRPSFRDLA 290

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 139/291 (47%), Gaps = 28/291 (9%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSV----YKAVL--RGRQVAVKK-PSKNQEISQEVDN 98
           D +  E     F +Q  LGKG+ GSV    Y  +    G  VAVKK     +E  ++ + 
Sbjct: 4   DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 61
Query: 99  EIEILSKIHSPRLVNLLG--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA 156
           EIEIL  +    +V   G  +S   ++  L++E++  G+L D L  +   ++  + ++  
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 121
Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG 216
            Q+ K +E L ++    IHR++ + N+L++     ++GDFGL      D   ++   P  
Sbjct: 122 SQICKGMEYLGTKR--YIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 179
Query: 217 T-IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK 275
           + I +  P  +T    S  +DV+SFG++L E+ +    I+   SPP+         K+G+
Sbjct: 180 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQ 236
Query: 276 ILSVF--------DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           ++ VF        + R+P P       ++ +I   C  +   +RPS +++ 
Sbjct: 237 MI-VFHLIELLKNNGRLPRPDG--CPDEIYMIMTECWNNNVNQRPSFRDLA 284

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 28/210 (13%)
Query: 60  QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF-S 118
           Q+ +GKG  G V++   RG +VAVK  S  +E S   + EI     +   R  N+LGF +
Sbjct: 47  QESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIA 103
Query: 119 NDSKDR------LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM-- 170
            D+KD        LV ++  +G+L+D L  N   +     I+LAL  A  +  LH E+  
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 171 ----PPIIHRDIKSANVLIDRNFNARLGDFGLALR--CGVDNFRFRSTPPAGTIGYLDPC 224
               P I HRD+KS N+L+ +N    + D GLA+R     D          GT  Y+ P 
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP- 220
Query: 225 YVTPDNLSTK-------TDVFSFGILLLEI 247
            V  D+++ K        D+++ G++  EI
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 132/274 (48%), Gaps = 26/274 (9%)
Query: 63  LGKGSHGSV----YKAVL--RGRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           LGKG+ GSV    Y  +    G  VAVKK     +E  ++ + EIEIL  +    +V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 116 G--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           G  +S   ++  L++E++  G+L D L  +   ++  + ++   Q+ K +E L ++    
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--Y 153
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT-IGYLDPCYVTPDNLS 232
           IHRD+ + N+L++     ++GDFGL      D    +   P  + I +  P  +T    S
Sbjct: 154 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 213
Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF--------DPRI 284
             +DV+SFG++L E+ +    I+   SPP+         K+G+++ VF        + R+
Sbjct: 214 VASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMI-VFHLIELLKNNGRL 269
Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           P P       ++ +I   C  +   +RPS +++ 
Sbjct: 270 PRPDG--CPDEIYMIMTECWNNNVNQRPSFRDLA 301

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 28/210 (13%)
Query: 60  QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF-S 118
           Q+ +GKG  G V++   RG +VAVK  S  +E S   + EI     +   R  N+LGF +
Sbjct: 34  QESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIA 90
Query: 119 NDSKDR------LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM-- 170
            D+KD        LV ++  +G+L+D L  N   +     I+LAL  A  +  LH E+  
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 148
Query: 171 ----PPIIHRDIKSANVLIDRNFNARLGDFGLALR--CGVDNFRFRSTPPAGTIGYLDPC 224
               P I HRD+KS N+L+ +N    + D GLA+R     D          GT  Y+ P 
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP- 207
Query: 225 YVTPDNLSTK-------TDVFSFGILLLEI 247
            V  D+++ K        D+++ G++  EI
Sbjct: 208 EVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 138/291 (47%), Gaps = 28/291 (9%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSV----YKAVL--RGRQVAVKK-PSKNQEISQEVDN 98
           D +  E     F +Q  LGKG+ GSV    Y  +    G  VAVKK     +E  ++ + 
Sbjct: 8   DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 65
Query: 99  EIEILSKIHSPRLVNLLG--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA 156
           EIEIL  +    +V   G  +S   ++  L++E++  G+L D L  +   ++  + ++  
Sbjct: 66  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 125
Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG 216
            Q+ K +E L ++    IHRD+ + N+L++     ++GDFGL      D    +   P  
Sbjct: 126 SQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 183
Query: 217 T-IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK 275
           + I +  P  +T    S  +DV+SFG++L E+ +    I+   SPP+         K+G+
Sbjct: 184 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQ 240
Query: 276 ILSVF--------DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           ++ VF        + R+P P       ++ +I   C  +   +RPS +++ 
Sbjct: 241 MI-VFHLIELLKNNGRLPRPDG--CPDEIYMIMTECWNNNVNQRPSFRDLA 288

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 138/291 (47%), Gaps = 28/291 (9%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSV----YKAVL--RGRQVAVKK-PSKNQEISQEVDN 98
           D +  E     F +Q  LGKG+ GSV    Y  +    G  VAVKK     +E  ++ + 
Sbjct: 6   DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 63
Query: 99  EIEILSKIHSPRLVNLLG--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA 156
           EIEIL  +    +V   G  +S   ++  L++E++  G+L D L  +   ++  + ++  
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 123
Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG 216
            Q+ K +E L ++    IHRD+ + N+L++     ++GDFGL      D    +   P  
Sbjct: 124 SQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 217 T-IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK 275
           + I +  P  +T    S  +DV+SFG++L E+ +    I+   SPP+         K+G+
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQ 238
Query: 276 ILSVF--------DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           ++ VF        + R+P P       ++ +I   C  +   +RPS +++ 
Sbjct: 239 MI-VFHLIELLKNNGRLPRPDG--CPDEIYMIMTECWNNNVNQRPSFRDLA 286

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 132/274 (48%), Gaps = 26/274 (9%)
Query: 63  LGKGSHGSV----YKAVL--RGRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           LGKG+ GSV    Y  +    G  VAVKK     +E  ++ + EIEIL  +    +V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 116 G--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           G  +S   ++  L++E++  G+L D L  +   ++  + ++   Q+ K +E L ++    
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--Y 166
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT-IGYLDPCYVTPDNLS 232
           IHRD+ + N+L++     ++GDFGL      D    +   P  + I +  P  +T    S
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 226
Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF--------DPRI 284
             +DV+SFG++L E+ +    I+   SPP+         K+G+++ VF        + R+
Sbjct: 227 VASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMI-VFHLIELLKNNGRL 282
Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           P P       ++ +I   C  +   +RPS +++ 
Sbjct: 283 PRPDG--CPDEIYMIMTECWNNNVNQRPSFRDLA 314

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 138/291 (47%), Gaps = 28/291 (9%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSV----YKAVL--RGRQVAVKK-PSKNQEISQEVDN 98
           D +  E     F +Q  LGKG+ GSV    Y  +    G  VAVKK     +E  ++ + 
Sbjct: 3   DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 99  EIEILSKIHSPRLVNLLG--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA 156
           EIEIL  +    +V   G  +S   ++  L++E++  G+L D L  +   ++  + ++  
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG 216
            Q+ K +E L ++    IHRD+ + N+L++     ++GDFGL      D    +   P  
Sbjct: 121 SQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 217 T-IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK 275
           + I +  P  +T    S  +DV+SFG++L E+ +    I+   SPP+         K+G+
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQ 235
Query: 276 ILSVF--------DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           ++ VF        + R+P P       ++ +I   C  +   +RPS +++ 
Sbjct: 236 MI-VFHLIELLKNNGRLPRPDG--CPDEIYMIMTECWNNNVNQRPSFRDLA 283

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 136/291 (46%), Gaps = 27/291 (9%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG----RQVAVKKPSKNQEISQEVDNEIEILS 104
           D E      +  + +G GS G+VYK    G    + + V  P+  Q   Q   NE+ +L 
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLR 59
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           K     ++  +G+S  +    +V ++    +LY  LH         + I +A Q A+ ++
Sbjct: 60  KTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LH++   IIHRD+KS N+ +  +   ++GDFGLA      +   +    +G+I ++ P 
Sbjct: 119 YLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 225 YVTPDN---LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI---LS 278
            +   +    S ++DV++FGI+L E+++ +    + +S  +  D    ++ +G +   LS
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQ----LPYSNINNRDQIIFMVGRGYLSPDLS 232
Query: 279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
                 P        K +  +   C++  R+ RP   +I+  +  L++ +P
Sbjct: 233 KVRSNCP--------KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 138/291 (47%), Gaps = 28/291 (9%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSV----YKAVL--RGRQVAVKK-PSKNQEISQEVDN 98
           D +  E     F +Q  LGKG+ GSV    Y  +    G  VAVKK     +E  ++ + 
Sbjct: 9   DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 66
Query: 99  EIEILSKIHSPRLVNLLG--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA 156
           EIEIL  +    +V   G  +S   ++  L++E++  G+L D L  +   ++  + ++  
Sbjct: 67  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 126
Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG 216
            Q+ K +E L ++    IHRD+ + N+L++     ++GDFGL      D    +   P  
Sbjct: 127 SQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 184
Query: 217 T-IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK 275
           + I +  P  +T    S  +DV+SFG++L E+ +    I+   SPP+         K+G+
Sbjct: 185 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQ 241
Query: 276 ILSVF--------DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           ++ VF        + R+P P       ++ +I   C  +   +RPS +++ 
Sbjct: 242 MI-VFHLIELLKNNGRLPRPDG--CPDEIYMIMTECWNNNVNQRPSFRDLA 289

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 132/273 (48%), Gaps = 26/273 (9%)
Query: 63  LGKGSHGSV----YKAVL--RGRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           LGKG+ GSV    Y  +    G  VAVKK     +E  ++ + EIEIL  +    +V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 116 G--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           G  +S   ++  L++E++  G+L D L  +   ++  + ++   Q+ K +E L ++    
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--Y 153
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT-IGYLDPCYVTPDNLS 232
           IHRD+ + N+L++     ++GDFGL      D    +   P  + I +  P  +T    S
Sbjct: 154 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 213
Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF--------DPRI 284
             +DV+SFG++L E+ +    I+   SPP+         K+G+++ VF        + R+
Sbjct: 214 VASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMI-VFHLIELLKNNGRL 269
Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
           P P       ++ +I   C  +   +RPS +++
Sbjct: 270 PRPDG--CPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 138/290 (47%), Gaps = 28/290 (9%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSV----YKAVL--RGRQVAVKK-PSKNQEISQEVDN 98
           D +  E     F +Q  LGKG+ GSV    Y  +    G  VAVKK     +E  ++ + 
Sbjct: 3   DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 99  EIEILSKIHSPRLVNLLG--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA 156
           EIEIL  +    +V   G  +S   ++  L++E++  G+L D L  +   ++  + ++  
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG 216
            Q+ K +E L ++    IHRD+ + N+L++     ++GDFGL      D    +   P  
Sbjct: 121 SQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 217 T-IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK 275
           + I +  P  +T    S  +DV+SFG++L E+ +    I+   SPP+         K+G+
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQ 235
Query: 276 ILSVF--------DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
           ++ VF        + R+P P       ++ +I   C  +   +RPS +++
Sbjct: 236 MI-VFHLIELLKNNGRLPRPDG--CPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 138/290 (47%), Gaps = 28/290 (9%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSV----YKAVL--RGRQVAVKK-PSKNQEISQEVDN 98
           D +  E     F +Q  LGKG+ GSV    Y  +    G  VAVKK     +E  ++ + 
Sbjct: 1   DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 58
Query: 99  EIEILSKIHSPRLVNLLG--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA 156
           EIEIL  +    +V   G  +S   ++  L++E++  G+L D L  +   ++  + ++  
Sbjct: 59  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 118
Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG 216
            Q+ K +E L ++    IHRD+ + N+L++     ++GDFGL      D    +   P  
Sbjct: 119 SQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 176
Query: 217 T-IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK 275
           + I +  P  +T    S  +DV+SFG++L E+ +    I+   SPP+         K+G+
Sbjct: 177 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQ 233
Query: 276 ILSVF--------DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
           ++ VF        + R+P P       ++ +I   C  +   +RPS +++
Sbjct: 234 MI-VFHLIELLKNNGRLPRPDG--CPDEIYMIMTECWNNNVNQRPSFRDL 280

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 146/306 (47%), Gaps = 32/306 (10%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSV----YKAVL--RGRQVAVKK-PSKNQEISQEVDN 98
           D +  E     F +Q  LGKG+ GSV    Y  +    G  VAVKK     +E  ++ + 
Sbjct: 7   DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 64
Query: 99  EIEILSKIHSPRLVNLLG--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA 156
           EIEIL  +    +V   G  +S   ++  L++E++  G+L D L  +   ++  + ++  
Sbjct: 65  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 124
Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG 216
            Q+ K +E L ++    IHRD+ + N+L++     ++GDFGL      D    +   P  
Sbjct: 125 SQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 182
Query: 217 T-IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK 275
           + I +  P  +T    S  +DV+SFG++L E+ +    I+   SPP+         K+G+
Sbjct: 183 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQ 239
Query: 276 ILSVF--------DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI---VDWL-TG 323
           ++ VF        + R+P P       ++ +I   C  +   +RPS +++   VD +   
Sbjct: 240 MI-VFHLIELLKNNGRLPRPDG--CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 296
Query: 324 LSKLVP 329
           ++ LVP
Sbjct: 297 MAGLVP 302

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 138/290 (47%), Gaps = 28/290 (9%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSV----YKAVL--RGRQVAVKK-PSKNQEISQEVDN 98
           D +  E     F +Q  LGKG+ GSV    Y  +    G  VAVKK     +E  ++ + 
Sbjct: 2   DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 59
Query: 99  EIEILSKIHSPRLVNLLG--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA 156
           EIEIL  +    +V   G  +S   ++  L++E++  G+L D L  +   ++  + ++  
Sbjct: 60  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 119
Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG 216
            Q+ K +E L ++    IHRD+ + N+L++     ++GDFGL      D    +   P  
Sbjct: 120 SQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 177
Query: 217 T-IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK 275
           + I +  P  +T    S  +DV+SFG++L E+ +    I+   SPP+         K+G+
Sbjct: 178 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQ 234
Query: 276 ILSVF--------DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
           ++ VF        + R+P P       ++ +I   C  +   +RPS +++
Sbjct: 235 MI-VFHLIELLKNNGRLPRPDG--CPDEIYMIMTECWNNNVNQRPSFRDL 281

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 63  LGKGSHGSV----YKAVL--RGRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           LGKG+ GSV    Y  +    G  VAVKK     +E  ++ + EIEIL  +    +V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 116 G--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           G  +S   ++  L++E++  G+L D L ++   ++  + ++   Q+ K +E L ++    
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKR--Y 138
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT-IGYLDPCYVTPDNLS 232
           IHRD+ + N+L++     ++GDFGL      D    +   P  + I +  P  +T    S
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 198
Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF--------DPRI 284
             +DV+SFG++L E+ +    I+   SPP+         K+G+++ VF        + R+
Sbjct: 199 VASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMI-VFHLIELLKNNGRL 254
Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           P P       ++ +I   C  +   +RPS +++ 
Sbjct: 255 PRPDG--CPDEIYMIMTECWNNNVNQRPSFRDLA 286

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 96/194 (49%), Gaps = 17/194 (8%)
Query: 63  LGKGSHGSVYKAVLRGRQ----VAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNL 114
           LGKG  G+VY A  R RQ    +A+K   K Q     +  ++  E+EI S +  P ++ L
Sbjct: 20  LGKGKFGNVYLA--RERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
            G+ +D+    L++E+   GT+Y  L   +R  +  R      ++A A+   HS+   +I
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCHSKR--VI 134
Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           HRDIK  N+L+  N   ++ DFG ++         R T   GT+ YL P  +       K
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEK 190
Query: 235 TDVFSFGILLLEII 248
            D++S G+L  E +
Sbjct: 191 VDLWSLGVLCYEFL 204

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 132/274 (48%), Gaps = 26/274 (9%)
Query: 63  LGKGSHGSV----YKAVL--RGRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           LGKG+ GSV    Y  +    G  VAVKK     +E  ++ + EIEIL  +    +V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 116 G--FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           G  +S   ++  L++EF+  G+L + L  +   ++  + ++   Q+ K +E L ++    
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--Y 138
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT-IGYLDPCYVTPDNLS 232
           IHRD+ + N+L++     ++GDFGL      D    +   P  + I +  P  +T    S
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 198
Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF--------DPRI 284
             +DV+SFG++L E+ +    I+   SPP+         K+G+++ VF        + R+
Sbjct: 199 VASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQGQMI-VFHLIELLKNNGRL 254
Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           P P       ++ +I   C  +   +RPS +++ 
Sbjct: 255 PRPDG--CPDEIYMIMTECWNNNVNQRPSFRDLA 286

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           F E  +LG+G+ G V KA   L  R  A+KK    +E    + +E+ +L+ ++   +V  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 115 LG------------FSNDSKDRLLV-VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK 161
                          +   K  L + +E+  N TLYD++HS N         RL  Q+ +
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA---------LRCGVDNFRFRST 212
           A+  +HS+   IIHRD+K  N+ ID + N ++GDFGLA         L+    N    S 
Sbjct: 128 ALSYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 213 PPAGTIGYLDPCYVTPDNL------STKTDVFSFGILLLEII 248
                IG     YV  + L      + K D++S GI+  E+I
Sbjct: 186 NLTSAIG--TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 119/240 (49%), Gaps = 32/240 (13%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEISQEVD--NE 99
           + E A    +  + LG+GS G VY+ V +G        +VA+K  ++   + + ++  NE
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 100 IEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NN---RPLNWG 150
             ++ + +   +V LLG  +  +  L+++E M+ G L   L S      NN    P +  
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRF 209
           + I++A ++A  +  L++     +HRD+ + N ++  +F  ++GDFG+       D +R 
Sbjct: 133 KMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR- 189
Query: 210 RSTPPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIV 264
                 G  G L   +++P++L     +T +DV+SFG++L EI +  +    G S   ++
Sbjct: 190 -----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 244

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 117/235 (49%), Gaps = 32/235 (13%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEISQEVD--NE 99
           + E A    +  + LG+GS G VY+ V +G        +VA+K  ++   + + ++  NE
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 100 IEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NN---RPLNWG 150
             ++ + +   +V LLG  +  +  L+++E M+ G L   L S      NN    P +  
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRF 209
           + I++A ++A  +  L++     +HRD+ + N ++  +F  ++GDFG+       D +R 
Sbjct: 139 KMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR- 195
Query: 210 RSTPPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFS 259
                 G  G L   +++P++L     +T +DV+SFG++L EI +  +    G S
Sbjct: 196 -----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 119/240 (49%), Gaps = 32/240 (13%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEISQEVD--NE 99
           + E A    +  + LG+GS G VY+ V +G        +VA+K  ++   + + ++  NE
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 100 IEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NN---RPLNWG 150
             ++ + +   +V LLG  +  +  L+++E M+ G L   L S      NN    P +  
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 129
Query: 151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRF 209
           + I++A ++A  +  L++     +HRD+ + N ++  +F  ++GDFG+       D +R 
Sbjct: 130 KMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR- 186
Query: 210 RSTPPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIV 264
                 G  G L   +++P++L     +T +DV+SFG++L EI +  +    G S   ++
Sbjct: 187 -----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 241

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 119/240 (49%), Gaps = 32/240 (13%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEISQEVD--NE 99
           + E A    +  + LG+GS G VY+ V +G        +VA+K  ++   + + ++  NE
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 100 IEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NN---RPLNWG 150
             ++ + +   +V LLG  +  +  L+++E M+ G L   L S      NN    P +  
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRF 209
           + I++A ++A  +  L++     +HRD+ + N ++  +F  ++GDFG+       D +R 
Sbjct: 132 KMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR- 188
Query: 210 RSTPPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIV 264
                 G  G L   +++P++L     +T +DV+SFG++L EI +  +    G S   ++
Sbjct: 189 -----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 243

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 119/240 (49%), Gaps = 32/240 (13%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEISQEVD--NE 99
           + E A    +  + LG+GS G VY+ V +G        +VA+K  ++   + + ++  NE
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 100 IEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NN---RPLNWG 150
             ++ + +   +V LLG  +  +  L+++E M+ G L   L S      NN    P +  
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRF 209
           + I++A ++A  +  L++     +HRD+ + N ++  +F  ++GDFG+       D +R 
Sbjct: 126 KMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR- 182
Query: 210 RSTPPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIV 264
                 G  G L   +++P++L     +T +DV+SFG++L EI +  +    G S   ++
Sbjct: 183 -----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 237

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 119/240 (49%), Gaps = 32/240 (13%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEISQEVD--NE 99
           + E A    +  + LG+GS G VY+ V +G        +VA+K  ++   + + ++  NE
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 100 IEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NN---RPLNWG 150
             ++ + +   +V LLG  +  +  L+++E M+ G L   L S      NN    P +  
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 128
Query: 151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRF 209
           + I++A ++A  +  L++     +HRD+ + N ++  +F  ++GDFG+       D +R 
Sbjct: 129 KMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR- 185
Query: 210 RSTPPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIV 264
                 G  G L   +++P++L     +T +DV+SFG++L EI +  +    G S   ++
Sbjct: 186 -----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 240

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 119/240 (49%), Gaps = 32/240 (13%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEISQEVD--NE 99
           + E A    +  + LG+GS G VY+ V +G        +VA+K  ++   + + ++  NE
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 100 IEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NN---RPLNWG 150
             ++ + +   +V LLG  +  +  L+++E M+ G L   L S      NN    P +  
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRF 209
           + I++A ++A  +  L++     +HRD+ + N ++  +F  ++GDFG+       D +R 
Sbjct: 132 KMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR- 188
Query: 210 RSTPPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIV 264
                 G  G L   +++P++L     +T +DV+SFG++L EI +  +    G S   ++
Sbjct: 189 -----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 243

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 117/235 (49%), Gaps = 32/235 (13%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEISQEVD--NE 99
           + E A    +  + LG+GS G VY+ V +G        +VA+K  ++   + + ++  NE
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 100 IEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NN---RPLNWG 150
             ++ + +   +V LLG  +  +  L+++E M+ G L   L S      NN    P +  
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 138
Query: 151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRF 209
           + I++A ++A  +  L++     +HRD+ + N ++  +F  ++GDFG+       D +R 
Sbjct: 139 KMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR- 195
Query: 210 RSTPPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFS 259
                 G  G L   +++P++L     +T +DV+SFG++L EI +  +    G S
Sbjct: 196 -----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKP--------SKNQEISQEVDNEIEILSKIHSPRLV 112
           K+LG G+ G+VYK +       VK P        + + + ++E+ +E  +++ + SP + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            LLG    S  +L V + M  G L D +  N   L     +   +Q+AK +  L  E   
Sbjct: 83  RLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYL--EDVR 139
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           ++HRD+ + NVL+    + ++ DFGLA    +D   + +      I ++    +     +
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFT 199
Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV 292
            ++DV+S+G+ + E+++       G     I D    L++KG+       R+P P  PI 
Sbjct: 200 HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD----LLEKGE-------RLPQP--PIC 246
Query: 293 RKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
              + +I V+C     E RP  +E+V   + +++
Sbjct: 247 TIDVYMIMVKCWMIDSECRPRFRELVSEFSRMAR 280

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 119/240 (49%), Gaps = 32/240 (13%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEISQEVD--NE 99
           + E A    +  + LG+GS G VY+ V +G        +VA+K  ++   + + ++  NE
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 100
Query: 100 IEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NN---RPLNWG 150
             ++ + +   +V LLG  +  +  L+++E M+ G L   L S      NN    P +  
Sbjct: 101 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 160
Query: 151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRF 209
           + I++A ++A  +  L++     +HRD+ + N ++  +F  ++GDFG+       D +R 
Sbjct: 161 KMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR- 217
Query: 210 RSTPPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIV 264
                 G  G L   +++P++L     +T +DV+SFG++L EI +  +    G S   ++
Sbjct: 218 -----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 272

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 90/188 (47%), Gaps = 4/188 (2%)
Query: 63  LGKGSHGSVYKAV-LRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           +G G  G V+    L   +VA+K   +     ++   E E++ K+  P+LV L G   + 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSA 181
               LV EFM +G L D L +          + + L V + +  L  E   +IHRD+ + 
Sbjct: 78  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL--EEACVIHRDLAAR 135
Query: 182 NVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFG 241
           N L+  N   ++ DFG+  R  +D+    ST     + +  P   +    S+K+DV+SFG
Sbjct: 136 NCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFG 194
Query: 242 ILLLEIIS 249
           +L+ E+ S
Sbjct: 195 VLMWEVFS 202

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 90/188 (47%), Gaps = 4/188 (2%)
Query: 63  LGKGSHGSVYKAV-LRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           +G G  G V+    L   +VA+K   +     ++   E E++ K+  P+LV L G   + 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSA 181
               LV EFM +G L D L +          + + L V + +  L  E   +IHRD+ + 
Sbjct: 75  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL--EEASVIHRDLAAR 132
Query: 182 NVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFG 241
           N L+  N   ++ DFG+  R  +D+    ST     + +  P   +    S+K+DV+SFG
Sbjct: 133 NCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFG 191
Query: 242 ILLLEIIS 249
           +L+ E+ S
Sbjct: 192 VLMWEVFS 199

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 21/264 (7%)
Query: 61  KLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           K LG G  G V+     G  +VA+K         +    E +I+ K+   +LV L    +
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
           + +   +V E+M+ G+L D L     R L     + +A QVA  +  +  E    IHRD+
Sbjct: 75  E-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI--ERMNYIHRDL 131
Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVF 238
           +SAN+L+      ++ DFGLA R   DN           I +  P        + K+DV+
Sbjct: 132 RSANILVGNGLICKIADFGLA-RLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 239 SFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD-PIVRKQLA 297
           SFGILL E+++  +    G +   +++     +++G        R+P P+D PI    L 
Sbjct: 191 SFGILLTELVTKGRVPYPGMNNREVLE----QVERGY-------RMPCPQDCPI---SLH 236
Query: 298 VIAVRCVRSCRERRPSMKEIVDWL 321
            + + C +   E RP+ + +  +L
Sbjct: 237 ELMIHCWKKDPEERPTFEYLQSFL 260

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 90/188 (47%), Gaps = 4/188 (2%)
Query: 63  LGKGSHGSVYKAV-LRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           +G G  G V+    L   +VA+K   +     ++   E E++ K+  P+LV L G   + 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSA 181
               LV EFM +G L D L +          + + L V + +  L  E   +IHRD+ + 
Sbjct: 76  APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL--EEACVIHRDLAAR 133
Query: 182 NVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFG 241
           N L+  N   ++ DFG+  R  +D+    ST     + +  P   +    S+K+DV+SFG
Sbjct: 134 NCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFG 192
Query: 242 ILLLEIIS 249
           +L+ E+ S
Sbjct: 193 VLMWEVFS 200

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEIS---QEVDNEIEILSKIHSPRLVNLL 115
           K +GKG+   V  A  +L G++VAVK   K Q  S   Q++  E+ I+  ++ P +V L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
                 K   LV+E+ S G ++D L ++ R      R +   Q+  AV+  H +   I+H
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF--IVH 136
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RD+K+ N+L+D + N ++ DFG +     + F F +   A       P Y  P+    K 
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFS-----NEFTFGNKLDAFCGA---PPYAAPELFQGKK 188
Query: 235 -----TDVFSFGILLLEIIS 249
                 DV+S G++L  ++S
Sbjct: 189 YDGPEVDVWSLGVILYTLVS 208

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 120/265 (45%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ KI   +LV L    ++ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE- 84
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V E+MS G+L D L         G+ +RL   V  A +I     + E    +HRD
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEM-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 140 LRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 244
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 120/265 (45%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V E+MS G+L D L         G+ +RL   V  A +I     + E    +HRD
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 306 LRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 410
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFL 435

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 120/265 (45%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V E+MS G+L D L         G+ +RL   V  A +I     + E    +HRD
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 306 LRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 410
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFL 435

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 90/188 (47%), Gaps = 4/188 (2%)
Query: 63  LGKGSHGSVYKAV-LRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           +G G  G V+    L   +VA+K   +     ++   E E++ K+  P+LV L G   + 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSA 181
               LV EFM +G L D L +          + + L V + +  L  E   +IHRD+ + 
Sbjct: 73  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL--EEACVIHRDLAAR 130
Query: 182 NVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFG 241
           N L+  N   ++ DFG+  R  +D+    ST     + +  P   +    S+K+DV+SFG
Sbjct: 131 NCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFG 189
Query: 242 ILLLEIIS 249
           +L+ E+ S
Sbjct: 190 VLMWEVFS 197

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 90/188 (47%), Gaps = 4/188 (2%)
Query: 63  LGKGSHGSVYKAV-LRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           +G G  G V+    L   +VA+K   +     ++   E E++ K+  P+LV L G   + 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSA 181
               LV EFM +G L D L +          + + L V + +  L  E   +IHRD+ + 
Sbjct: 75  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL--EEACVIHRDLAAR 132
Query: 182 NVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFG 241
           N L+  N   ++ DFG+  R  +D+    ST     + +  P   +    S+K+DV+SFG
Sbjct: 133 NCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFG 191
Query: 242 ILLLEIIS 249
           +L+ E+ S
Sbjct: 192 VLMWEVFS 199

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 120/265 (45%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V E+MS G+L D L         G+ +RL   V  A +I     + E    +HRD
Sbjct: 334 EPIYIVTEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 389 LRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 493
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFL 518

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 121/265 (45%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 84
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V+E+MS G+L D L         G+ +RL   V  A +I     + E    +HRD
Sbjct: 85  EPIYIVIEYMSKGSLLDFLKGEM-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 140 LRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 244
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 121/265 (45%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 84
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V+E+MS G+L D L         G+ +RL   V  A +I     + E    +HRD
Sbjct: 85  EPIYIVIEYMSKGSLLDFLKGEM-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 140 LRAANILVGENLVCKVADFGLA-RLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 244
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 26/202 (12%)
Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEIS---QEVDNEIEILSKIHSPRLVNLL 115
           K +GKG+   V  A  +L G++VAVK   K Q  S   Q++  E+ I+  ++ P +V L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
                 K   LV+E+ S G ++D L ++ R      R +   Q+  AV+  H +   I+H
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF--IVH 136
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNF--RFRSTPPAGTIGYLDPCYVTPDNLST 233
           RD+K+ N+L+D + N ++ DFG +      N    F  +PP          Y  P+    
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP----------YAAPELFQG 186
Query: 234 K------TDVFSFGILLLEIIS 249
           K       DV+S G++L  ++S
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVS 208

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 51/298 (17%)
Query: 63  LGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEIS-QEVDNEIEILSKIHSPRLVNL 114
           LG+G+ G V+ A             VAVK   +  E + Q+   E E+L+ +    +V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNN--------------RPLNWGRRIRLALQVA 160
            G   + +  L+V E+M +G L   L S+                PL  G+ + +A QVA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRF--RSTPPAGT 217
             +  L       +HRD+ + N L+ +    ++GDFG++      D +R   R+  P   
Sbjct: 169 AGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP--- 223
Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKIL 277
           I ++ P  +     +T++DV+SFG++L EI +  K      S    +D     I +G+ L
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID----CITQGREL 279
Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRP----SMKEIVDWLTGLSKLVPLH 331
               PR  PP+         V A+  +R C +R P    S+K++   L  L++  P++
Sbjct: 280 E--RPRACPPE---------VYAI--MRGCWQREPQQRHSIKDVHARLQALAQAPPVY 324

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 120/265 (45%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 77
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V E+MS G+L D L         G+ +RL   V  A +I     + E    +HRD
Sbjct: 78  EPIYIVTEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 132
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 133 LRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 192 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 237
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 238 HDLMCQCWRKEPEERPTFEYLQAFL 262

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 89/188 (47%), Gaps = 4/188 (2%)
Query: 63  LGKGSHGSVYKAV-LRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           +G G  G V+    L   +VA+K   +      +   E E++ K+  P+LV L G   + 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQ 94
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSA 181
               LV EFM +G L D L +          + + L V + +  L  E   +IHRD+ + 
Sbjct: 95  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL--EEACVIHRDLAAR 152
Query: 182 NVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFG 241
           N L+  N   ++ DFG+  R  +D+    ST     + +  P   +    S+K+DV+SFG
Sbjct: 153 NCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFG 211
Query: 242 ILLLEIIS 249
           +L+ E+ S
Sbjct: 212 VLMWEVFS 219

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 26/202 (12%)
Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEIS---QEVDNEIEILSKIHSPRLVNLL 115
           K +GKG+   V  A  +L G++VAVK   K Q  S   Q++  E+ I+  ++ P +V L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
                 K   LV+E+ S G ++D L ++ R      R +   Q+  AV+  H +   I+H
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF--IVH 136
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNF--RFRSTPPAGTIGYLDPCYVTPDNLST 233
           RD+K+ N+L+D + N ++ DFG +      N    F  +PP          Y  P+    
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP----------YAAPELFQG 186
Query: 234 K------TDVFSFGILLLEIIS 249
           K       DV+S G++L  ++S
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVS 208

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 120/265 (45%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 74
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V E+MS G+L D L         G+ +RL   V  A +I     + E    +HRD
Sbjct: 75  EPIXIVTEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 129
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 130 LRAANILVGENLVCKVADFGLA-RLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 188
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 189 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 234
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 235 HDLMCQCWRKEPEERPTFEYLQAFL 259

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 95/194 (48%), Gaps = 17/194 (8%)
Query: 63  LGKGSHGSVYKAVLRGRQ----VAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNL 114
           LGKG  G+VY A  R RQ    +A+K   K Q     +  ++  E+EI S +  P ++ L
Sbjct: 20  LGKGKFGNVYLA--RERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
            G+ +D+    L++E+   GT+Y  L   +R  +  R      ++A A+   HS+   +I
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCHSKR--VI 134
Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           HRDIK  N+L+  N   ++ DFG ++         R     GT+ YL P  +       K
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSVHAPSS----RRDTLCGTLDYLPPEMIEGRMHDEK 190
Query: 235 TDVFSFGILLLEII 248
            D++S G+L  E +
Sbjct: 191 VDLWSLGVLCYEFL 204

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 118/240 (49%), Gaps = 32/240 (13%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEISQEVD--NE 99
           + E A    +  + LG+GS G VY+ V +G        +VA+K  ++   + + ++  NE
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 100 IEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NN---RPLNWG 150
             ++ + +   +V LLG  +  +  L+++E M+ G L   L S      NN    P +  
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRF 209
           + I++A ++A  +  L++     +HRD+ + N  +  +F  ++GDFG+       D +R 
Sbjct: 126 KMIQMAGEIADGMAYLNAN--KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYR- 182
Query: 210 RSTPPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIV 264
                 G  G L   +++P++L     +T +DV+SFG++L EI +  +    G S   ++
Sbjct: 183 -----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 237

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 127/270 (47%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L +++ M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 79  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 138 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 243
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 244 -PICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 118/240 (49%), Gaps = 32/240 (13%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEISQEVD--NE 99
           + E A    +  + LG+GS G VY+ V +G        +VA+K  ++   + + ++  NE
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 100 IEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NN---RPLNWG 150
             ++ + +   +V LLG  +  +  L+++E M+ G L   L S      NN    P +  
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 123
Query: 151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG-VDNFRF 209
           + I++A ++A  +  L++     +HRD+ + N ++  +F  ++GDFG+       D  R 
Sbjct: 124 KMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR- 180
Query: 210 RSTPPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIV 264
                 G  G L   +++P++L     +T +DV+SFG++L EI +  +    G S   ++
Sbjct: 181 -----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 235

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 118/240 (49%), Gaps = 32/240 (13%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEISQEVD--NE 99
           + E A    +  + LG+GS G VY+ V +G        +VA+K  ++   + + ++  NE
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 100 IEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NN---RPLNWG 150
             ++ + +   +V LLG  +  +  L+++E M+ G L   L S      NN    P +  
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG-VDNFRF 209
           + I++A ++A  +  L++     +HRD+ + N ++  +F  ++GDFG+       D  R 
Sbjct: 133 KMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR- 189
Query: 210 RSTPPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIV 264
                 G  G L   +++P++L     +T +DV+SFG++L EI +  +    G S   ++
Sbjct: 190 -----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 244

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 127/270 (47%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L +++ M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 80  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 139 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 244
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 245 -PICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 127/270 (47%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L +++ M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 81  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 139
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 140 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 197
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 198 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 245
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 246 -PICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 51/298 (17%)
Query: 63  LGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEIS-QEVDNEIEILSKIHSPRLVNL 114
           LG+G+ G V+ A             VAVK   +  E + Q+   E E+L+ +    +V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNN--------------RPLNWGRRIRLALQVA 160
            G   + +  L+V E+M +G L   L S+                PL  G+ + +A QVA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRF--RSTPPAGT 217
             +  L       +HRD+ + N L+ +    ++GDFG++      D +R   R+  P   
Sbjct: 140 AGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP--- 194
Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKIL 277
           I ++ P  +     +T++DV+SFG++L EI +  K      S    +D     I +G+ L
Sbjct: 195 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID----CITQGREL 250
Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRP----SMKEIVDWLTGLSKLVPLH 331
               PR  PP+         V A+  +R C +R P    S+K++   L  L++  P++
Sbjct: 251 E--RPRACPPE---------VYAI--MRGCWQREPQQRHSIKDVHARLQALAQAPPVY 295

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 120/265 (45%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 84
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V E+MS G+L D L         G+ +RL   V  A +I     + E    +HRD
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEM-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 140 LRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 244
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 127/270 (47%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L +++ M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 77  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 136 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 241
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 242 -PICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 127/270 (47%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L +++ M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 78  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 136
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 137 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 194
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 195 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 242
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 243 -PICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 127/270 (47%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L +++ M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 78  PHVCRLLGICLTSTVQL-IMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 136
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 137 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 194
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 195 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 242
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 243 -PICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 26/202 (12%)
Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEIS---QEVDNEIEILSKIHSPRLVNLL 115
           K +GKG+   V  A  +L G++VAV+   K Q  S   Q++  E+ I+  ++ P +V L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
                 K   LV+E+ S G ++D L ++ R      R +   Q+  AV+  H +   I+H
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF--IVH 136
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNF--RFRSTPPAGTIGYLDPCYVTPDNLST 233
           RD+K+ N+L+D + N ++ DFG +      N    F  +PP          Y  P+    
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPP----------YAAPELFQG 186
Query: 234 K------TDVFSFGILLLEIIS 249
           K       DV+S G++L  ++S
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVS 208

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 6/205 (2%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG G  G V+     G  +VAVK   +          E  ++ ++   RLV L       
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 87
Query: 122 KDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +   ++ E+M NG+L D L + +   L   + + +A Q+A+ +  +       IHRD+++
Sbjct: 88  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRA 145
Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           AN+L+    + ++ DFGLA R   DN           I +  P  +     + K+DV+SF
Sbjct: 146 ANILVSDTLSCKIADFGLA-RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 204
Query: 241 GILLLEIISCRKAIDIGFSPPSIVD 265
           GILL EI++  +    G + P ++ 
Sbjct: 205 GILLTEIVTHGRIPYPGMTNPEVIQ 229

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 126/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 102 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 160
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 161 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 218
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 219 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 266
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 267 -PICTIDVYMIMVKCWMIDADSRPKFRELI 295

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 126/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 84  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 143 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 248
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 249 -PICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 123/266 (46%), Gaps = 29/266 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L  ++  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 249
Query: 122 KDRLLVV-EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHR 176
           ++ + +V E+MS G+L D L         G+ +RL   V  A +I     + E    +HR
Sbjct: 250 EEPIYIVGEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTD 236
           D+++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+D
Sbjct: 305 DLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 237 VFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQ 295
           V+SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + 
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ES 409
Query: 296 LAVIAVRCVRSCRERRPSMKEIVDWL 321
           L  +  +C R   E RP+ + +  +L
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYLQAFL 435

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 6/204 (2%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG G  G V+     G  +VAVK   +          E  ++ ++   RLV L       
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 74
Query: 122 KDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +   ++ E+M NG+L D L + +   L   + + +A Q+A+ +  +  E    IHRD+++
Sbjct: 75  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRA 132
Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           AN+L+    + ++ DFGLA R   DN           I +  P  +     + K+DV+SF
Sbjct: 133 ANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 191
Query: 241 GILLLEIISCRKAIDIGFSPPSIV 264
           GILL EI++  +    G + P ++
Sbjct: 192 GILLTEIVTHGRIPYPGMTNPEVI 215

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 126/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 80  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 139 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 244
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 245 -PICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 6/204 (2%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG G  G V+     G  +VAVK   +          E  ++ ++   RLV L       
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 80
Query: 122 KDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +   ++ E+M NG+L D L + +   L   + + +A Q+A+ +  +  E    IHRD+++
Sbjct: 81  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRA 138
Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           AN+L+    + ++ DFGLA R   DN           I +  P  +     + K+DV+SF
Sbjct: 139 ANILVSDTLSCKIADFGLA-RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 197
Query: 241 GILLLEIISCRKAIDIGFSPPSIV 264
           GILL EI++  +    G + P ++
Sbjct: 198 GILLTEIVTHGRIPYPGMTNPEVI 221

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 120/265 (45%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 84
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V E+MS G+L D L         G+ +RL   V  A +I     + E    +HRD
Sbjct: 85  EPIYIVCEYMSKGSLLDFLKGEM-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 140 LRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 244
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 6/205 (2%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG G  G V+     G  +VAVK   +          E  ++ ++   RLV L       
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 89
Query: 122 KDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +   ++ E+M NG+L D L + +   L   + + +A Q+A+ +  +  E    IHRD+++
Sbjct: 90  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRA 147
Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           AN+L+    + ++ DFGLA R   DN           I +  P  +     + K+DV+SF
Sbjct: 148 ANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 206
Query: 241 GILLLEIISCRKAIDIGFSPPSIVD 265
           GILL EI++  +    G + P ++ 
Sbjct: 207 GILLTEIVTHGRIPYPGMTNPEVIQ 231

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 126/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 80  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 139 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 244
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 245 -PICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 126/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 79  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 138 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 243
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 244 -PICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 114/270 (42%), Gaps = 17/270 (6%)
Query: 47  YSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSK 105
           Y   E      +  K LG G  G V     RG+  VA+K   +      E   E +++  
Sbjct: 16  YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 75
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           +   +LV L G     +   ++ E+M+NG L + L          + + +   V +A+E 
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           L S+    +HRD+ + N L++     ++ DFGL+ R  +D+    S      + +  P  
Sbjct: 136 LESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLS-RYVLDDEETSSVGSKFPVRWSPPEV 192
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP 285
           +     S+K+D+++FG+L+ EI S  K     F+        A  I +G  L ++ P + 
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAEHIAQG--LRLYRPHLA 246
Query: 286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMK 315
             K       +  I   C     + RP+ K
Sbjct: 247 SEK-------VYTIMYSCWHEKADERPTFK 269

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 126/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 83  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 141
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 142 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 199
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 200 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 247
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 248 -PICTIDVYMIMVKCWMIDADSRPKFRELI 276

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 51/298 (17%)
Query: 63  LGKGSHGSVYKAVLRG-------RQVAVKKPSKNQEIS-QEVDNEIEILSKIHSPRLVNL 114
           LG+G+ G V+ A             VAVK   +  E + Q+   E E+L+ +    +V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNN--------------RPLNWGRRIRLALQVA 160
            G   + +  L+V E+M +G L   L S+                PL  G+ + +A QVA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRF--RSTPPAGT 217
             +  L       +HRD+ + N L+ +    ++GDFG++      D +R   R+  P   
Sbjct: 146 AGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP--- 200
Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKIL 277
           I ++ P  +     +T++DV+SFG++L EI +  K      S    +D     I +G+ L
Sbjct: 201 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID----CITQGREL 256
Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRP----SMKEIVDWLTGLSKLVPLH 331
               PR  PP+         V A+  +R C +R P    S+K++   L  L++  P++
Sbjct: 257 E--RPRACPPE---------VYAI--MRGCWQREPQQRHSIKDVHARLQALAQAPPVY 301

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 6/205 (2%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG G  G V+     G  +VAVK   +          E  ++ ++   RLV L       
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 85
Query: 122 KDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +   ++ E+M NG+L D L + +   L   + + +A Q+A+ +  +       IHRD+++
Sbjct: 86  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRA 143
Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           AN+L+    + ++ DFGLA R   DN           I +  P  +     + K+DV+SF
Sbjct: 144 ANILVSDTLSCKIADFGLA-RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 202
Query: 241 GILLLEIISCRKAIDIGFSPPSIVD 265
           GILL EI++  +    G + P ++ 
Sbjct: 203 GILLTEIVTHGRIPYPGMTNPEVIQ 227

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 6/205 (2%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG G  G V+     G  +VAVK   +          E  ++ ++   RLV L       
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 81
Query: 122 KDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +   ++ E+M NG+L D L + +   L   + + +A Q+A+ +  +  E    IHRD+++
Sbjct: 82  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRA 139
Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           AN+L+    + ++ DFGLA R   DN           I +  P  +     + K+DV+SF
Sbjct: 140 ANILVSDTLSCKIADFGLA-RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 198
Query: 241 GILLLEIISCRKAIDIGFSPPSIVD 265
           GILL EI++  +    G + P ++ 
Sbjct: 199 GILLTEIVTHGRIPYPGMTNPEVIQ 223

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 120/265 (45%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 84
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V+E+MS G L D L         G+ +RL   V  A +I     + E    +HRD
Sbjct: 85  EPIYIVMEYMSKGCLLDFLKGEM-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 140 LRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 244
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 6/204 (2%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG G  G V+     G  +VAVK   +          E  ++ ++   RLV L       
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79
Query: 122 KDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +   ++ E+M NG+L D L + +   L   + + +A Q+A+ +  +  E    IHRD+++
Sbjct: 80  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRA 137
Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           AN+L+    + ++ DFGLA R   DN           I +  P  +     + K+DV+SF
Sbjct: 138 ANILVSDTLSCKIADFGLA-RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196
Query: 241 GILLLEIISCRKAIDIGFSPPSIV 264
           GILL EI++  +    G + P ++
Sbjct: 197 GILLTEIVTHGRIPYPGMTNPEVI 220

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 6/205 (2%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG G  G V+     G  +VAVK   +          E  ++ ++   RLV L       
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 85
Query: 122 KDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +   ++ E+M NG+L D L + +   L   + + +A Q+A+ +  +  E    IHRD+++
Sbjct: 86  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRA 143
Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           AN+L+    + ++ DFGLA R   DN           I +  P  +     + K+DV+SF
Sbjct: 144 ANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 202
Query: 241 GILLLEIISCRKAIDIGFSPPSIVD 265
           GILL EI++  +    G + P ++ 
Sbjct: 203 GILLTEIVTHGRIPYPGMTNPEVIQ 227

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 6/205 (2%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG G  G V+     G  +VAVK   +          E  ++ ++   RLV L       
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 84
Query: 122 KDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +   ++ E+M NG+L D L + +   L   + + +A Q+A+ +  +  E    IHRD+++
Sbjct: 85  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRA 142
Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           AN+L+    + ++ DFGLA R   DN           I +  P  +     + K+DV+SF
Sbjct: 143 ANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 201
Query: 241 GILLLEIISCRKAIDIGFSPPSIVD 265
           GILL EI++  +    G + P ++ 
Sbjct: 202 GILLTEIVTHGRIPYPGMTNPEVIQ 226

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 6/205 (2%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG G  G V+     G  +VAVK   +          E  ++ ++   RLV L       
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79
Query: 122 KDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +   ++ E+M NG+L D L + +   L   + + +A Q+A+ +  +       IHRD+++
Sbjct: 80  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRA 137
Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           AN+L+    + ++ DFGLA R   DN           I +  P  +     + K+DV+SF
Sbjct: 138 ANILVSDTLSCKIADFGLA-RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196
Query: 241 GILLLEIISCRKAIDIGFSPPSIVD 265
           GILL EI++  +    G + P ++ 
Sbjct: 197 GILLTEIVTHGRIPYPGMTNPEVIQ 221

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 120/265 (45%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 73
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V E+MS G+L D L         G+ +RL   V  A +I     + E    +HRD
Sbjct: 74  EPIYIVTEYMSKGSLLDFLKGEM-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 128
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 129 LRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 188 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 233
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 234 HDLMCQCWRKDPEERPTFEYLQAFL 258

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 126/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 77  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 136 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 241
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 242 -PICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 6/205 (2%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG G  G V+     G  +VAVK   +          E  ++ ++   RLV L       
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 88
Query: 122 KDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +   ++ E+M NG+L D L + +   L   + + +A Q+A+ +  +       IHRD+++
Sbjct: 89  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRA 146
Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           AN+L+    + ++ DFGLA R   DN           I +  P  +     + K+DV+SF
Sbjct: 147 ANILVSDTLSCKIADFGLA-RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 205
Query: 241 GILLLEIISCRKAIDIGFSPPSIVD 265
           GILL EI++  +    G + P ++ 
Sbjct: 206 GILLTEIVTHGRIPYPGMTNPEVIQ 230

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRGRQ------VAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A  + R+      V  K   +   +  ++  E+EI S
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 119
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL P 
Sbjct: 120 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPE 173
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 174 MIEGRMHDEKVDLWSLGVLCYEFL 197

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 6/204 (2%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG G  G V+     G  +VAVK   +          E  ++ ++   RLV L       
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79
Query: 122 KDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +   ++ E+M NG+L D L + +   L   + + +A Q+A+ +  +  E    IHRD+++
Sbjct: 80  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRA 137
Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           AN+L+    + ++ DFGLA R   DN           I +  P  +     + K+DV+SF
Sbjct: 138 ANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196
Query: 241 GILLLEIISCRKAIDIGFSPPSIV 264
           GILL EI++  +    G + P ++
Sbjct: 197 GILLTEIVTHGRIPYPGMTNPEVI 220

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 120/265 (45%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 75
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V E+MS G+L D L         G+ +RL   V  A +I     + E    +HRD
Sbjct: 76  EPIYIVTEYMSKGSLLDFLKGEM-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 130
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 131 LRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 190 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 235
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 236 HDLMCQCWRKDPEERPTFEYLQAFL 260

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 126/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 71  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 130 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 235
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 236 -PICTIDVYMIMVKCWMIDADSRPKFRELI 264

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 26/202 (12%)
Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEIS---QEVDNEIEILSKIHSPRLVNLL 115
           K +GKG+   V  A  +L G++VAV+   K Q  S   Q++  E+ I+  ++ P +V L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
                 K   LV+E+ S G ++D L ++ R      R +   Q+  AV+  H +   I+H
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF--IVH 136
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNF--RFRSTPPAGTIGYLDPCYVTPDNLST 233
           RD+K+ N+L+D + N ++ DFG +      N    F  +PP          Y  P+    
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP----------YAAPELFQG 186
Query: 234 K------TDVFSFGILLLEIIS 249
           K       DV+S G++L  ++S
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVS 208

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 126/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 77  PHVCRLLGICLTSTVQL-ITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 136 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 241
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 242 -PICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 114/270 (42%), Gaps = 17/270 (6%)
Query: 47  YSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSK 105
           Y   E      +  K LG G  G V     RG+  VA+K   +      E   E +++  
Sbjct: 16  YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 75
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           +   +LV L G     +   ++ E+M+NG L + L          + + +   V +A+E 
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           L S+    +HRD+ + N L++     ++ DFGL+ R  +D+    S      + +  P  
Sbjct: 136 LESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEV 192
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP 285
           +     S+K+D+++FG+L+ EI S  K     F+        A  I +G  L ++ P + 
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAEHIAQG--LRLYRPHLA 246
Query: 286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMK 315
             K       +  I   C     + RP+ K
Sbjct: 247 SEK-------VYTIMYSCWHEKADERPTFK 269

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 13/211 (6%)
Query: 44  HFDYSDLEAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVD 97
           H +    + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++ 
Sbjct: 2   HXESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 98  NEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL 157
            E+EI S +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYIT 120
Query: 158 QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT 217
           ++A A+   HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT
Sbjct: 121 ELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGT 174
Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEII 248
           + YL P  +       K D++S G+L  E +
Sbjct: 175 LDYLPPEXIEGRXHDEKVDLWSLGVLCYEFL 205

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 114/270 (42%), Gaps = 17/270 (6%)
Query: 47  YSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSK 105
           Y   E      +  K LG G  G V     RG+  VA+K   +      E   E +++  
Sbjct: 7   YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 66
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           +   +LV L G     +   ++ E+M+NG L + L          + + +   V +A+E 
Sbjct: 67  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 126
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           L S+    +HRD+ + N L++     ++ DFGL+ R  +D+    S      + +  P  
Sbjct: 127 LESK--QFLHRDLAARNCLVNDQGVVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEV 183
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP 285
           +     S+K+D+++FG+L+ EI S  K     F+        A  I +G  L ++ P + 
Sbjct: 184 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAEHIAQG--LRLYRPHLA 237
Query: 286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMK 315
             K       +  I   C     + RP+ K
Sbjct: 238 SEK-------VYTIMYSCWHEKADERPTFK 260

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/313 (22%), Positives = 138/313 (44%), Gaps = 45/313 (14%)
Query: 40  IKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVL------RGRQVAVKKPSKNQEIS 93
           I +QH    D+         ++ LG+G+ G V+ A        + + +   K  K+  ++
Sbjct: 7   IHVQHIKRRDIVL-------KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA 59
Query: 94  --QEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS--------- 142
             ++   E E+L+ +    +V   G   D    ++V E+M +G L   L +         
Sbjct: 60  ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 143 NNRP------LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDF 196
           + +P      L   + + +A Q+A  +  L S+    +HRD+ + N L+  N   ++GDF
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDF 177
Query: 197 GLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDI 256
           G++      ++          I ++ P  +     +T++DV+SFG++L EI +  K    
Sbjct: 178 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 237
Query: 257 GFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKE 316
             S   +++     I +G++L    PR+ P       K++  + + C +   ++R ++KE
Sbjct: 238 QLSNTEVIE----CITQGRVLE--RPRVCP-------KEVYDVMLGCWQREPQQRLNIKE 284
Query: 317 IVDWLTGLSKLVP 329
           I   L  L K  P
Sbjct: 285 IYKILHALGKATP 297

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 84
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V E+MS G L D L         G+ +RL   V  A +I     + E    +HRD
Sbjct: 85  EPIYIVTEYMSKGCLLDFLKGEM-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 140 LRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 244
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 48  SDLEAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIE 101
           S  + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+E
Sbjct: 5   SKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 64
Query: 102 ILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK 161
           I S +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A 
Sbjct: 65  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 123
Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
           A+   HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL
Sbjct: 124 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYL 177
Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEII 248
            P  +       K D++S G+L  E +
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFL 204

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 17/256 (6%)
Query: 61  KLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           K LG G  G V     RG+  VA+K   +      E   E +++  +   +LV L G   
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
             +   ++ E+M+NG L + L          + + +   V +A+E L S+    +HRD+ 
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLA 132
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           + N L++     ++ DFGL+ R  +D+    S      + +  P  +     S+K+D+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 240 FGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVI 299
           FG+L+ EI S  K     F+        A  I +G  L ++ P +   K       +  I
Sbjct: 192 FGVLMWEIYSLGKMPYERFTNSE----TAEHIAQG--LRLYRPHLASEK-------VYTI 238
Query: 300 AVRCVRSCRERRPSMK 315
              C     + RP+ K
Sbjct: 239 MYSCWHEKADERPTFK 254

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 48  SDLEAATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVK---KPSKNQEISQEVDNEIEI 102
           SD +     +   K +GKG+   V  A  +L GR+VA+K   K   N    Q++  E+ I
Sbjct: 5   SDEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRI 64
Query: 103 LSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
           +  ++ P +V L       K   L++E+ S G ++D L ++ R      R +   Q+  A
Sbjct: 65  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSA 123
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGY 220
           V+  H +   I+HRD+K+ N+L+D + N ++ DFG +     G     F  +PP      
Sbjct: 124 VQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPP------ 175
Query: 221 LDPCYVTPDNLSTK------TDVFSFGILLLEIIS 249
               Y  P+    K       DV+S G++L  ++S
Sbjct: 176 ----YAAPELFQGKKYDGPEVDVWSLGVILYTLVS 206

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 84
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V E+MS G+L D L         G+ +RL   V  A +I     + E    +HRD
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEM-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           + +AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 140 LAAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 244
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 17/256 (6%)
Query: 61  KLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           K LG G  G V     RG+  VA+K   +      E   E +++  +   +LV L G   
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
             +   ++ E+M+NG L + L          + + +   V +A+E L S+    +HRD+ 
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLA 131
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           + N L++     ++ DFGL+ R  +D+    S      + +  P  +     S+K+D+++
Sbjct: 132 ARNCLVNDQGVVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 190
Query: 240 FGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVI 299
           FG+L+ EI S  K     F+        A  I +G  L ++ P +   K       +  I
Sbjct: 191 FGVLMWEIYSLGKMPYERFTNSE----TAEHIAQG--LRLYRPHLASEK-------VYTI 237
Query: 300 AVRCVRSCRERRPSMK 315
              C     + RP+ K
Sbjct: 238 MYSCWHEKADERPTFK 253

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 63  LGKGSHGSVYKAVL------RGRQVAVKKPSKNQEISQ-EVDNEIEILSKIHSPRLVNLL 115
           LGKG+ GSV            G  VAVK+   +    Q +   EI+IL  +HS  +V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 116 GFSNDS--KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           G S     +   LV+E++ +G L D L  +   L+  R +  + Q+ K +E L S     
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--C 148
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           +HRD+ + N+L++   + ++ DFGLA    +D ++     P    I +  P  ++ +  S
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 208
Query: 233 TKTDVFSFGILLLEIIS-CRKAI 254
            ++DV+SFG++L E+ + C K+ 
Sbjct: 209 RQSDVWSFGVVLYELFTYCDKSC 231

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 123/265 (46%), Gaps = 24/265 (9%)
Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQ--------EVDNEIEILSKIHSPRLV 112
           K+LG G+ G+VYK +       VK P   + +++        E  +E  I++ +  P LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            LLG    S    LV + M +G L + +H +   +     +   +Q+AK   +++ E   
Sbjct: 81  RLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKG--MMYLEERR 137
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           ++HRD+ + NVL+    + ++ DFGLA     D   + +      I ++    +     +
Sbjct: 138 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 197
Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV 292
            ++DV+S+G+ + E+++       G     I D    L++KG+       R+P P  PI 
Sbjct: 198 HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD----LLEKGE-------RLPQP--PIC 244
Query: 293 RKQLAVIAVRCVRSCRERRPSMKEI 317
              + ++ V+C     + RP  KE+
Sbjct: 245 TIDVYMVMVKCWMIDADSRPKFKEL 269

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 63  LGKGSHGSVYKAVL------RGRQVAVKKPSKNQEISQ-EVDNEIEILSKIHSPRLVNLL 115
           LGKG+ GSV            G  VAVK+   +    Q +   EI+IL  +HS  +V   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 116 GFSNDS--KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           G S     +   LV+E++ +G L D L  +   L+  R +  + Q+ K +E L S     
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--C 136
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           +HRD+ + N+L++   + ++ DFGLA    +D ++     P    I +  P  ++ +  S
Sbjct: 137 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 196
Query: 233 TKTDVFSFGILLLEIIS-CRKAI 254
            ++DV+SFG++L E+ + C K+ 
Sbjct: 197 RQSDVWSFGVVLYELFTYCDKSC 219

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 122
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL P 
Sbjct: 123 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTXLCGTLDYLPPE 176
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFL 200

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 122
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL P 
Sbjct: 123 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPE 176
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFL 200

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 63  LGKGSHGSVYKAVL------RGRQVAVKKPSKNQEISQ-EVDNEIEILSKIHSPRLVNLL 115
           LGKG+ GSV            G  VAVK+   +    Q +   EI+IL  +HS  +V   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 116 GFSNDS--KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           G S     +   LV+E++ +G L D L  +   L+  R +  + Q+ K +E L S     
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--C 135
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           +HRD+ + N+L++   + ++ DFGLA    +D ++     P    I +  P  ++ +  S
Sbjct: 136 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 195
Query: 233 TKTDVFSFGILLLEIIS-CRKAI 254
            ++DV+SFG++L E+ + C K+ 
Sbjct: 196 RQSDVWSFGVVLYELFTYCDKSC 218

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 125
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL P 
Sbjct: 126 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPE 179
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFL 203

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 119/265 (44%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 251
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V E+MS G+L D L         G+ +RL   V  A +I     + E    +HRD
Sbjct: 252 EPIYIVTEYMSKGSLLDFLKGEM-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 306
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGL  R   DN           I +  P        + K+DV
Sbjct: 307 LRAANILVGENLVCKVADFGLG-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 366 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 411
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 412 HDLMCQCWRKDPEERPTFEYLQAFL 436

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 17/256 (6%)
Query: 61  KLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           K LG G  G V     RG+  VA+K   +      E   E +++  +   +LV L G   
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
             +   ++ E+M+NG L + L          + + +   V +A+E L S+    +HRD+ 
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLA 132
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           + N L++     ++ DFGL+ R  +D+    S      + +  P  +     S+K+D+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLS-RYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 240 FGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVI 299
           FG+L+ EI S  K     F+        A  I +G  L ++ P +   K       +  I
Sbjct: 192 FGVLMWEIYSLGKMPYERFTNSE----TAEHIAQG--LRLYRPHLASEK-------VYTI 238
Query: 300 AVRCVRSCRERRPSMK 315
              C     + RP+ K
Sbjct: 239 MYSCWHEKADERPTFK 254

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 122
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL P 
Sbjct: 123 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTELCGTLDYLPPE 176
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFL 200

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF--- 117
           K +GKG +G V+    RG +VAVK     +E S   + EI    +    R  N+LGF   
Sbjct: 43  KQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEI---YQTVLMRHENILGFIAA 99
Query: 118 ----SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM--- 170
               +       L+ ++  NG+LYD L S    L+    ++LA      +  LH+E+   
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 171 ---PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPP---AGTIGYLDPC 224
              P I HRD+KS N+L+ +N    + D GLA++   D       PP    GT  Y+ P 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV-DIPPNTRVGTKRYMPP- 215
Query: 225 YVTPDNLS-------TKTDVFSFGILLLEI 247
            V  ++L+          D++SFG++L E+
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 121
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL P 
Sbjct: 122 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPE 175
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 176 MIEGRMHDEKVDLWSLGVLCYEFL 199

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 127/291 (43%), Gaps = 54/291 (18%)
Query: 58  SEQKLLGKGSHGSVYKAVLR---GRQ---VAVKKPSKNQEISQEVD--NEIEILSKIHSP 109
           + QK++G G  G VYK +L+   G++   VA+K         Q VD   E  I+ +    
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
            ++ L G  +  K  +++ E+M NG L   L   +   +  + + +   +A  ++ L + 
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG--YLDPCYVT 227
               +HRD+ + N+L++ N   ++ DFGL+ R   D+     T   G I   +  P  ++
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLS-RVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 228 PDNLSTKTDVFSFGILLLEIIS-------------CRKAIDIGFSPPSIVDWAAPLIKKG 274
               ++ +DV+SFGI++ E+++               KAI+ GF                
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---------------- 267
Query: 275 KILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
                   R+P P D P    QL    ++C +  R RRP   +IV  L  L
Sbjct: 268 --------RLPTPMDCPSAIYQL---MMQCWQQERARRPKFADIVSILDKL 307

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 127
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL P 
Sbjct: 128 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPE 181
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFL 205

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 17/256 (6%)
Query: 61  KLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           K LG G  G V     RG+  VA+K   +      E   E +++  +   +LV L G   
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
             +   ++ E+M+NG L + L          + + +   V +A+E L S+    +HRD+ 
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLA 127
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           + N L++     ++ DFGL+ R  +D+    S      + +  P  +     S+K+D+++
Sbjct: 128 ARNCLVNDQGVVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 186
Query: 240 FGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVI 299
           FG+L+ EI S  K     F+        A  I +G  L ++ P +   K       +  I
Sbjct: 187 FGVLMWEIYSLGKMPYERFTNSE----TAEHIAQG--LRLYRPHLASEK-------VYTI 233
Query: 300 AVRCVRSCRERRPSMK 315
              C     + RP+ K
Sbjct: 234 MYSCWHEKADERPTFK 249

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 22/200 (11%)
Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEIS---QEVDNEIEILSKIHSPRLVNLL 115
           K +GKG+   V  A  +L G++VAVK   K Q  S   Q++  E+ I   ++ P +V L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF 79
Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
                 K   LV E+ S G ++D L ++ R      R +   Q+  AV+  H +   I+H
Sbjct: 80  EVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKF--IVH 136
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RD+K+ N+L+D + N ++ DFG +     + F F +   A       P Y  P+    K 
Sbjct: 137 RDLKAENLLLDADXNIKIADFGFS-----NEFTFGNKLDAFCGA---PPYAAPELFQGKK 188
Query: 235 -----TDVFSFGILLLEIIS 249
                 DV+S G++L  ++S
Sbjct: 189 YDGPEVDVWSLGVILYTLVS 208

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 125
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL P 
Sbjct: 126 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPE 179
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFL 203

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 126/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+A+ +  L  
Sbjct: 74  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLED 132
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 133 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 190
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 191 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 238
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 239 -PICTIDVYMIMVKCWMIDADSRPKFRELI 267

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILSKI 106
           A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
             P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+   
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 150
Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
           HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL P  +
Sbjct: 151 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMI 204
Query: 227 TPDNLSTKTDVFSFGILLLEII 248
                  K D++S G+L  E +
Sbjct: 205 EGRMHDEKVDLWSLGVLCYEFL 226

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 123
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL P 
Sbjct: 124 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPE 177
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFL 201

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 122
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL P 
Sbjct: 123 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPE 176
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFL 200

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P    E+        ++E+ +E  +++ + +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 111 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 169
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 170 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 227
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 228 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 275
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 276 -PICTIDVYMIMVKCWMIDADSRPKFRELI 304

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 123/265 (46%), Gaps = 24/265 (9%)
Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQ--------EVDNEIEILSKIHSPRLV 112
           K+LG G+ G+VYK +       VK P   + +++        E  +E  I++ +  P LV
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            LLG    S    LV + M +G L + +H +    N G ++ L   V  A  +++ E   
Sbjct: 104 RLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR 160
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           ++HRD+ + NVL+    + ++ DFGLA     D   + +      I ++    +     +
Sbjct: 161 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 220
Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV 292
            ++DV+S+G+ + E+++       G     I D    L++KG+       R+P P  PI 
Sbjct: 221 HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD----LLEKGE-------RLPQP--PIC 267
Query: 293 RKQLAVIAVRCVRSCRERRPSMKEI 317
              + ++ V+C     + RP  KE+
Sbjct: 268 TIDVYMVMVKCWMIDADSRPKFKEL 292

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 127
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL P 
Sbjct: 128 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPE 181
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFL 205

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 122
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL P 
Sbjct: 123 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPE 176
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFL 200

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 123
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG +          R T  +GT+ YL P 
Sbjct: 124 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSCHAPSS----RRTTLSGTLDYLPPE 177
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFL 201

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 120/265 (45%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 81
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V E+M+ G+L D L         G+ +RL   V  + +I     + E    +HRD
Sbjct: 82  EPIYIVTEYMNKGSLLDFLKGET-----GKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 137 LRAANILVGENLVCKVADFGLA-RLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 196 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 241
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 242 HDLMCQCWRKEPEERPTFEYLQAFL 266

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 27/231 (11%)
Query: 63  LGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           LGKG  G+VY A       +   +V  K   + + +  ++  EIEI S +  P ++ +  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
           + +D K   L++EF   G LY  L  + R  +  R      ++A A+   H     +IHR
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCHERK--VIHR 139
Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTD 236
           DIK  N+L+      ++ DFG ++         R     GT+ YL P  +       K D
Sbjct: 140 DIKPENLLMGYKGELKIADFGWSVHAP----SLRRRXMCGTLDYLPPEMIEGKTHDEKVD 195
Query: 237 VFSFGILLLEII-------------SCRKAIDIGFS-PPSIVDWAAPLIKK 273
           ++  G+L  E +             + R+ +++    PP + D +  LI K
Sbjct: 196 LWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 246

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +DS    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 122
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R     GT+ YL P 
Sbjct: 123 YCHSKK--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLDYLPPE 176
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFL 200

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 37/280 (13%)
Query: 61  KLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 92
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-- 150
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTP 228
             +HRD+ + N ++D  F  ++ DFGLA R   D   +      G    + ++    +  
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRI 284
              +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P  
Sbjct: 210 QKFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLLQ---PEY 259
Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 260 CP--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 126/266 (47%), Gaps = 24/266 (9%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQ--VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           F++ + +GKGS G V+K +    Q  VA+K     + ++  +++  EI +LS+  SP + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
              G         +++E++  G+  D+L     PL+  +   +  ++ K ++ LHSE   
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKK- 140
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
            IHRDIK+ANVL+  +   +L DFG+A +  + + + +     GT  ++ P  +      
Sbjct: 141 -IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNXFVGTPFWMAPEVIKQSAYD 197
Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV 292
           +K D++S GI  +E+         G  P S +    P+    K+L +     PP  +   
Sbjct: 198 SKADIWSLGITAIELAR-------GEPPHSELH---PM----KVLFLIPKNNPPTLEGNY 243
Query: 293 RKQLAVIAVRCVRSCRERRPSMKEIV 318
            K L      C+      RP+ KE++
Sbjct: 244 SKPLKEFVEACLNKEPSFRPTAKELL 269

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 120/265 (45%), Gaps = 27/265 (10%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    ++ 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 81
Query: 122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL----HSEMPPIIHRD 177
           +   +V E+M+ G+L D L         G+ +RL   V  + +I     + E    +HRD
Sbjct: 82  EPIYIVTEYMNKGSLLDFLKGET-----GKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 137 LRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-PPKDPIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P PP+ P   + L
Sbjct: 196 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 241
Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 242 HDLMCQCWRKEPEERPTFEYLQAFL 266

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 37/280 (13%)
Query: 61  KLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 112
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-- 170
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTP 228
             +HRD+ + N ++D  F  ++ DFGLA R   D   +      G    + ++    +  
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRI 284
              +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P  
Sbjct: 230 QKFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLLQ---PEY 279
Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 280 CP--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 37/280 (13%)
Query: 61  KLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 89
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-- 147
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTP 228
             +HRD+ + N ++D  F  ++ DFGLA R   D   +      G    + ++    +  
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRI 284
              +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P  
Sbjct: 207 QKFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLLQ---PEY 256
Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 257 CP--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           F E  +LG+G+ G V KA   L  R  A+KK    +E    + +E+ +L+ ++   +V  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRY 67
Query: 115 LG------------FSNDSKDRLLV-VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK 161
                          +   K  L +  E+  N TLYD++HS N         RL  Q+ +
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIG 219
           A+  +HS+   IIHR++K  N+ ID + N ++GDFGLA  +   +D  +  S    G+  
Sbjct: 128 ALSYIHSQ--GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 220 YLDPCYVTPDNLST-----------KTDVFSFGILLLEII 248
            L     T   ++T           K D +S GI+  E I
Sbjct: 186 NLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 37/280 (13%)
Query: 61  KLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 94
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-- 152
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTP 228
             +HRD+ + N ++D  F  ++ DFGLA R   D   +      G    + ++    +  
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRI 284
              +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P  
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLLQ---PEY 261
Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 262 CP--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 26/202 (12%)
Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVK---KPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           K +GKG+   V  A  +L GR+VA+K   K   N    Q++  E+ I+  ++ P +V L 
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
                 K   L++E+ S G ++D L ++ R      R +   Q+  AV+  H +   I+H
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCHQKR--IVH 137
Query: 176 RDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           RD+K+ N+L+D + N ++ DFG +     G     F   PP          Y  P+    
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP----------YAAPELFQG 187
Query: 234 K------TDVFSFGILLLEIIS 249
           K       DV+S G++L  ++S
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVS 209

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 55  NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVD----NEIEILSKIHS 108
           N F + ++LGKG  G V    +R  G+  A KK  K +   ++ +    NE +IL K++S
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 109 PRLVNLLGFSNDSKDRL-LVVEFMSNGTL-YDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
            R V  L ++ ++KD L LV+  M+ G L + + H         R +  A ++   +E L
Sbjct: 244 -RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV-DNFRFRSTPPAGTIGYLDPCY 225
           H E   I++RD+K  N+L+D + + R+ D GLA+        + R     GT+GY+ P  
Sbjct: 303 HRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEV 356
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           V  +  +   D ++ G LL E+I+
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIA 380

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 26/202 (12%)
Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEIS---QEVDNEIEILSKIHSPRLVNLL 115
           K +GKG+   V  A  +L G++VAVK   K Q  S   Q++  E+ I+  ++ P +V L 
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 72
Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
                 K   LV+E+ S G ++D L ++        R +   Q+  AV+  H +   I+H
Sbjct: 73  EVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF--IVH 129
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNF--RFRSTPPAGTIGYLDPCYVTPDNLST 233
           RD+K+ N+L+D + N ++ DFG +      N    F  +PP          Y  P+    
Sbjct: 130 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPP----------YAAPELFQG 179
Query: 234 K------TDVFSFGILLLEIIS 249
           K       DV+S G++L  ++S
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVS 201

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 126/266 (47%), Gaps = 24/266 (9%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQ--VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           F++ + +GKGS G V+K +    Q  VA+K     + ++  +++  EI +LS+  SP + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
              G         +++E++  G+  D+L     PL+  +   +  ++ K ++ LHSE   
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKK- 145
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
            IHRDIK+ANVL+  +   +L DFG+A +  + + + +     GT  ++ P  +      
Sbjct: 146 -IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIKQSAYD 202
Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV 292
           +K D++S GI  +E+         G  P S +    P+    K+L +     PP  +   
Sbjct: 203 SKADIWSLGITAIELAR-------GEPPHSELH---PM----KVLFLIPKNNPPTLEGNY 248
Query: 293 RKQLAVIAVRCVRSCRERRPSMKEIV 318
            K L      C+      RP+ KE++
Sbjct: 249 SKPLKEFVEACLNKEPSFRPTAKELL 274

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILSKI 106
           A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
             P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+   
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 141
Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
           HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL P  +
Sbjct: 142 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMI 195
Query: 227 TPDNLSTKTDVFSFGILLLEII 248
                  K D++S G+L  E +
Sbjct: 196 EGRMHDEKVDLWSLGVLCYEFL 217

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   G +Y  L   ++  +  R      ++A A+ 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALS 127
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL P 
Sbjct: 128 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPE 181
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFL 205

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 6/205 (2%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG G  G V+     G  +VAVK   +          E  ++ ++   RLV L       
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 75
Query: 122 KDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +   ++ E+M NG+L D L + +   L   + + +A Q+A+ +  +  E    IHR++++
Sbjct: 76  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRNLRA 133
Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           AN+L+    + ++ DFGLA R   DN           I +  P  +     + K+DV+SF
Sbjct: 134 ANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 192
Query: 241 GILLLEIISCRKAIDIGFSPPSIVD 265
           GILL EI++  +    G + P ++ 
Sbjct: 193 GILLTEIVTHGRIPYPGMTNPEVIQ 217

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 27/231 (11%)
Query: 63  LGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           LGKG  G+VY A       +   +V  K   + + +  ++  EIEI S +  P ++ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
           + +D K   L++EF   G LY  L  + R  +  R      ++A A+   H     +IHR
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCHERK--VIHR 138
Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTD 236
           DIK  N+L+      ++ DFG ++         R     GT+ YL P  +       K D
Sbjct: 139 DIKPENLLMGYKGELKIADFGWSVHAP----SLRRRXMCGTLDYLPPEMIEGKTHDEKVD 194
Query: 237 VFSFGILLLEII-------------SCRKAIDIGFS-PPSIVDWAAPLIKK 273
           ++  G+L  E +             + R+ +++    PP + D +  LI K
Sbjct: 195 LWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 126/266 (47%), Gaps = 24/266 (9%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQ--VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           F++ + +GKGS G V+K +    Q  VA+K     + ++  +++  EI +LS+  SP + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
              G         +++E++  G+  D+L     PL+  +   +  ++ K ++ LHSE   
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKK- 125
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
            IHRDIK+ANVL+  +   +L DFG+A +  + + + +     GT  ++ P  +      
Sbjct: 126 -IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNXFVGTPFWMAPEVIKQSAYD 182
Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV 292
           +K D++S GI  +E+         G  P S +    P+    K+L +     PP  +   
Sbjct: 183 SKADIWSLGITAIELAR-------GEPPHSELH---PM----KVLFLIPKNNPPTLEGNY 228
Query: 293 RKQLAVIAVRCVRSCRERRPSMKEIV 318
            K L      C+      RP+ KE++
Sbjct: 229 SKPLKEFVEACLNKEPSFRPTAKELL 254

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 126/266 (47%), Gaps = 24/266 (9%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQ--VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           F++ + +GKGS G V+K +    Q  VA+K     + ++  +++  EI +LS+  SP + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
              G         +++E++  G+  D+L     PL+  +   +  ++ K ++ LHSE   
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKK- 125
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
            IHRDIK+ANVL+  +   +L DFG+A +  + + + +     GT  ++ P  +      
Sbjct: 126 -IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIKQSAYD 182
Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV 292
           +K D++S GI  +E+         G  P S +    P+    K+L +     PP  +   
Sbjct: 183 SKADIWSLGITAIELAR-------GEPPHSELH---PM----KVLFLIPKNNPPTLEGNY 228
Query: 293 RKQLAVIAVRCVRSCRERRPSMKEIV 318
            K L      C+      RP+ KE++
Sbjct: 229 SKPLKEFVEACLNKEPSFRPTAKELL 254

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 37/280 (13%)
Query: 61  KLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 94
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-- 152
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTP 228
             +HRD+ + N ++D  F  ++ DFGLA R   D   +      G    + ++    +  
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRI 284
              +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P  
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLLQ---PEY 261
Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 262 CP--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 37/280 (13%)
Query: 61  KLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 91
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-- 149
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTP 228
             +HRD+ + N ++D  F  ++ DFGLA R   D   +      G    + ++    +  
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRI 284
              +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P  
Sbjct: 209 QKFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLLQ---PEY 258
Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 259 CP--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 55  NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVD----NEIEILSKIHS 108
           N F + ++LGKG  G V    +R  G+  A KK  K +   ++ +    NE +IL K++S
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 109 PRLVNLLGFSNDSKDRL-LVVEFMSNGTL-YDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
            R V  L ++ ++KD L LV+  M+ G L + + H         R +  A ++   +E L
Sbjct: 244 -RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV-DNFRFRSTPPAGTIGYLDPCY 225
           H E   I++RD+K  N+L+D + + R+ D GLA+        + R     GT+GY+ P  
Sbjct: 303 HRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEV 356
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           V  +  +   D ++ G LL E+I+
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIA 380

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 37/280 (13%)
Query: 61  KLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 93
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-- 151
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTP 228
             +HRD+ + N ++D  F  ++ DFGLA R   D   +      G    + ++    +  
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRI 284
              +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P  
Sbjct: 211 QKFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLLQ---PEY 260
Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 261 CP--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 126/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+L  G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L +++ M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 84  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 143 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 248
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 249 -PICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 37/280 (13%)
Query: 61  KLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 86
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-- 144
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTP 228
             +HRD+ + N ++D  F  ++ DFGLA R   D   +      G    + ++    +  
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRI 284
              +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P  
Sbjct: 204 QKFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLLQ---PEY 253
Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 254 CP--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 126/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L +++ M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 79  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFG A   G +   + +      I ++    +  
Sbjct: 138 RR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 243
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 244 -PICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 37/280 (13%)
Query: 61  KLLGKGSHGSVYKAVLR---GRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 113
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-- 171
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTP 228
             +HRD+ + N ++D  F  ++ DFGLA R   D   +      G    + ++    +  
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRI 284
              +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P  
Sbjct: 231 QKFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLLQ---PEY 280
Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 281 CP--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+L  G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 84  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 143 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 248
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 249 -PICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 84  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFG A   G +   + +      I ++    +  
Sbjct: 143 RR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 201 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 248
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 249 -PICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 37/222 (16%)
Query: 55  NGFSEQKLLGKGSHGSVYKAVLRG----RQVAVK--KPSKNQEISQEVDNEIEILSKI-H 107
           N    Q ++G+G+ G V KA ++        A+K  K   +++  ++   E+E+L K+ H
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVL---------------HSNNRPLNWGRR 152
            P ++NLLG         L +E+  +G L D L               +S    L+  + 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST 212
           +  A  VA+ ++ L  +    IHRD+ + N+L+  N+ A++ DFGL+        R +  
Sbjct: 145 LHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLS--------RGQEV 194
Query: 213 PPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIIS 249
               T+G L   ++  ++L     +T +DV+S+G+LL EI+S
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 37/222 (16%)
Query: 55  NGFSEQKLLGKGSHGSVYKAVLRG----RQVAVK--KPSKNQEISQEVDNEIEILSKI-H 107
           N    Q ++G+G+ G V KA ++        A+K  K   +++  ++   E+E+L K+ H
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVL---------------HSNNRPLNWGRR 152
            P ++NLLG         L +E+  +G L D L               +S    L+  + 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST 212
           +  A  VA+ ++ L  +    IHRD+ + N+L+  N+ A++ DFGL+        R +  
Sbjct: 135 LHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLS--------RGQEV 184
Query: 213 PPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIIS 249
               T+G L   ++  ++L     +T +DV+S+G+LL EI+S
Sbjct: 185 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+L  G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 77  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 136 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 241
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 242 -PICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 35/279 (12%)
Query: 61  KLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 95
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-- 153
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR--FRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + N ++D  F  ++ DFGLA       F      T     + ++    +   
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRIP 285
             +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P   
Sbjct: 214 KFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLLQ---PEYC 263
Query: 286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 264 P--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 35/279 (12%)
Query: 61  KLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 153
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-- 211
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR--FRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + N ++D  F  ++ DFGLA       F      T     + ++    +   
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRIP 285
             +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P   
Sbjct: 272 KFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLL---QPEYC 321
Query: 286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 322 P--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 80  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 139 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 244
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I  +C     + RP  +E++
Sbjct: 245 -PICTIDVYMIMRKCWMIDADSRPKFRELI 273

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 35/279 (12%)
Query: 61  KLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 94
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-- 152
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR--FRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + N ++D  F  ++ DFGLA       F      T     + ++    +   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRIP 285
             +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P   
Sbjct: 213 KFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLLQ---PEYC 262
Query: 286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 263 P--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 122
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R     GT+ YL P 
Sbjct: 123 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLDYLPPE 176
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFL 200

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 35/279 (12%)
Query: 61  KLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 99
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-- 157
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR--FRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + N ++D  F  ++ DFGLA       F      T     + ++    +   
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 217
Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRIP 285
             +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P   
Sbjct: 218 KFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLLQ---PEYC 267
Query: 286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 268 P--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 131/289 (45%), Gaps = 47/289 (16%)
Query: 61  KLLGKGSHGSVYKAV---LRGR----QVAVKKPSKNQEISQEVD--NEIEILSKIHSPRL 111
           K LG+G  G V KA    L+GR     VAVK   +N   S+  D  +E  +L +++ P +
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVL-----------------------HSNNRPLN 148
           + L G  +     LL+VE+   G+L   L                       H + R L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 149 WGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR 208
            G  I  A Q+++ ++ L +EM  ++HRD+ + N+L+      ++ DFGL+     ++  
Sbjct: 149 MGDLISFAWQISQGMQYL-AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA 268
            + +     + ++    +     +T++DV+SFG+LL EI++       G  P  + +   
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN--- 263
Query: 269 PLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
            L+K G        R+  P +    +++  + ++C +   ++RP   +I
Sbjct: 264 -LLKTGH-------RMERPDN--CSEEMYRLMLQCWKQEPDKRPVFADI 302

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 35/279 (12%)
Query: 61  KLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 94
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-- 152
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR--FRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + N ++D  F  ++ DFGLA       F      T     + ++    +   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRIP 285
             +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P   
Sbjct: 213 KFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLLQ---PEYC 262
Query: 286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 263 P--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 126/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L +++ M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 81  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 139
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFG A   G +   + +      I ++    +  
Sbjct: 140 RR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 197
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 198 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 245
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 246 -PICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 133/281 (47%), Gaps = 39/281 (13%)
Query: 61  KLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 95
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-- 153
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS----TPPAGTIGYLDPCYVT 227
             +HRD+ + N ++D  F  ++ DFGLA R  +D   F S    T     + ++    + 
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLA-RDMLDK-EFDSVHNKTGAKLPVKWMALESLQ 211
Query: 228 PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPR 283
               +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P 
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLLQ---PE 261
Query: 284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
             P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 262 YCP--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 77  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFG A   G +   + +      I ++    +  
Sbjct: 136 RR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 241
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I V+C     + RP  +E++
Sbjct: 242 -PICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 131/289 (45%), Gaps = 47/289 (16%)
Query: 61  KLLGKGSHGSVYKAV---LRGR----QVAVKKPSKNQEISQEVD--NEIEILSKIHSPRL 111
           K LG+G  G V KA    L+GR     VAVK   +N   S+  D  +E  +L +++ P +
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVL-----------------------HSNNRPLN 148
           + L G  +     LL+VE+   G+L   L                       H + R L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 149 WGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR 208
            G  I  A Q+++ ++ L +EM  ++HRD+ + N+L+      ++ DFGL+     ++  
Sbjct: 149 MGDLISFAWQISQGMQYL-AEM-SLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA 268
            + +     + ++    +     +T++DV+SFG+LL EI++       G  P  + +   
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN--- 263
Query: 269 PLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
            L+K G        R+  P +    +++  + ++C +   ++RP   +I
Sbjct: 264 -LLKTGH-------RMERPDN--CSEEMYRLMLQCWKQEPDKRPVFADI 302

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 35/279 (12%)
Query: 61  KLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 92
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-- 150
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR--FRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + N ++D  F  ++ DFGLA       F      T     + ++    +   
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 210
Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRIP 285
             +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P   
Sbjct: 211 KFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLLQ---PEYC 260
Query: 286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 261 P--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 125
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R     GT+ YL P 
Sbjct: 126 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLDYLPPE 179
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFL 203

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 77  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 136 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 241
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I  +C     + RP  +E++
Sbjct: 242 -PICTIDVYMIMRKCWMIDADSRPKFRELI 270

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 125
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ +FG ++         R T   GT+ YL P 
Sbjct: 126 YCHSKR--VIHRDIKPENLLLGSAGELKIANFGWSVHAPSS----RRTTLCGTLDYLPPE 179
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFL 203

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 131/289 (45%), Gaps = 47/289 (16%)
Query: 61  KLLGKGSHGSVYKAV---LRGR----QVAVKKPSKNQEISQEVD--NEIEILSKIHSPRL 111
           K LG+G  G V KA    L+GR     VAVK   +N   S+  D  +E  +L +++ P +
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVL-----------------------HSNNRPLN 148
           + L G  +     LL+VE+   G+L   L                       H + R L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 149 WGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR 208
            G  I  A Q+++ ++ L +EM  ++HRD+ + N+L+      ++ DFGL+     ++  
Sbjct: 149 MGDLISFAWQISQGMQYL-AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA 268
            + +     + ++    +     +T++DV+SFG+LL EI++       G  P  + +   
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN--- 263
Query: 269 PLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
            L+K G        R+  P +    +++  + ++C +   ++RP   +I
Sbjct: 264 -LLKTGH-------RMERPDN--CSEEMYRLMLQCWKQEPDKRPVFADI 302

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 6/205 (2%)
Query: 63  LGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS 121
           LG G  G V+     G  +VAVK   +          E  ++ ++   RLV L       
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79
Query: 122 KDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           +   ++ E+M NG+L D L + +   L   + + +A Q+A+ +  +       IHRD+++
Sbjct: 80  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRA 137
Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           AN+L+    + ++ DFGLA R   D            I +  P  +     + K+DV+SF
Sbjct: 138 ANILVSDTLSCKIADFGLA-RLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196
Query: 241 GILLLEIISCRKAIDIGFSPPSIVD 265
           GILL EI++  +    G + P ++ 
Sbjct: 197 GILLTEIVTHGRIPYPGMTNPEVIQ 221

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 133/298 (44%), Gaps = 33/298 (11%)
Query: 39  PIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVK--KPSKNQE 91
           P +  H    +L+A     S  K++G G  G V    L+        VA+K  K    ++
Sbjct: 31  PTQTVHEFAKELDATN--ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 92  ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGR 151
             ++   E  I+ +   P ++ L G    SK  ++V E+M NG+L   L  ++      +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ 148
Query: 152 RIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
            + +   +A  ++ L S+M   +HRD+ + N+LI+ N   ++ DFGLA R   D+     
Sbjct: 149 LVGMLRGIASGMKYL-SDMG-YVHRDLAARNILINSNLVCKVSDFGLA-RVLEDDPEAAY 205
Query: 212 TPPAGTIG--YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP 269
           T   G I   +  P  +     ++ +DV+S+GI+L E++S       G  P     W   
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPY----WE-- 253
Query: 270 LIKKGKILSVFDP--RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            +    ++   D   R+PPP D P    QL    + C +  R  RP  ++IV  L  L
Sbjct: 254 -MSNQDVIKAVDEGYRLPPPMDCPAALYQL---MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 63  LGKGSHGSVYKAVL------RGRQVAVKKPSKNQEISQ-EVDNEIEILSKIHSPRLVNLL 115
           LGKG+ GSV            G  VAVK+   +    Q +   EI+IL  +HS  +V   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 116 GFSNDS--KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           G S      +  LV+E++ +G L D L  +   L+  R +  + Q+ K +E L S     
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--C 132
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           +HRD+ + N+L++   + ++ DFGLA    +D +      P    I +  P  ++ +  S
Sbjct: 133 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFS 192
Query: 233 TKTDVFSFGILLLEIIS-CRKAI 254
            ++DV+SFG++L E+ + C K+ 
Sbjct: 193 RQSDVWSFGVVLYELFTYCDKSC 215

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 87  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 145
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 146 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 203
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 204 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 251
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I  +C     + RP  +E++
Sbjct: 252 -PICTIDVYMIMRKCWMIDADSRPKFRELI 280

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 112/220 (50%), Gaps = 30/220 (13%)
Query: 63  LGKGSHGSVYKA----VLRGR---QVAVKKPSKNQEISQEVD--NEIEILSKIHSPRLVN 113
           LG+GS G VY+     +++G    +VAVK  +++  + + ++  NE  ++       +V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NNR---PLNWGRRIRLALQVAKAVE 164
           LLG  +  +  L+V+E M++G L   L S      NN    P      I++A ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            L+++    +HRD+ + N ++  +F  ++GDFG+  R   +   +R     G  G L   
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMT-RDIYETAYYRK----GGKGLLPVR 197
Query: 225 YVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFS 259
           ++ P++L     +T +D++SFG++L EI S  +    G S
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 114/228 (50%), Gaps = 32/228 (14%)
Query: 63  LGKGSHGSVYKA----VLRGR---QVAVKKPSKNQEISQEVD--NEIEILSKIHSPRLVN 113
           LG+GS G VY+     +++G    +VAVK  +++  + + ++  NE  ++       +V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NNR---PLNWGRRIRLALQVAKAVE 164
           LLG  +  +  L+V+E M++G L   L S      NN    P      I++A ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRFRSTPPAGTIGYLDP 223
            L+++    +HRD+ + N ++  +F  ++GDFG+       D +R       G  G L  
Sbjct: 144 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR------KGGKGLLPV 195
Query: 224 CYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDW 266
            ++ P++L     +T +D++SFG++L EI S  +    G S   ++ +
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 243

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 122
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R     GT+ YL P 
Sbjct: 123 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLDYLPPE 176
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFL 200

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 124
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ +FG ++         R T   GT+ YL P 
Sbjct: 125 YCHSKR--VIHRDIKPENLLLGSAGELKIANFGWSVHAPSS----RRTTLCGTLDYLPPE 178
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFL 202

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 88/178 (49%), Gaps = 9/178 (5%)
Query: 78  GRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR--LLVVEFMSN 133
           G QVAVK  KP        ++  EIEIL  ++   +V   G   +       L++EF+ +
Sbjct: 50  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL 193
           G+L + L  N   +N  ++++ A+Q+ K ++ L S     +HRD+ + NVL++     ++
Sbjct: 110 GSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKI 167
Query: 194 GDFGL--ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
           GDFGL  A+    +    +    +    Y   C +        +DV+SFG+ L E+++
Sbjct: 168 GDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLT 224

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 125
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R     GT+ YL P 
Sbjct: 126 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRDDLCGTLDYLPPE 179
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFL 203

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 88/178 (49%), Gaps = 9/178 (5%)
Query: 78  GRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR--LLVVEFMSN 133
           G QVAVK  KP        ++  EIEIL  ++   +V   G   +       L++EF+ +
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL 193
           G+L + L  N   +N  ++++ A+Q+ K ++ L S     +HRD+ + NVL++     ++
Sbjct: 98  GSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKI 155
Query: 194 GDFGL--ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
           GDFGL  A+    +    +    +    Y   C +        +DV+SFG+ L E+++
Sbjct: 156 GDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC-LMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 125
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R     GT+ YL P 
Sbjct: 126 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLDYLPPE 179
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFL 203

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 123
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R     GT+ YL P 
Sbjct: 124 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRDTLCGTLDYLPPE 177
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFL 201

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 57  FSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSKIHSPR 110
           F   + LG GS G V+  ++   GR  A+K   K   +     +  ++E  +LS +  P 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           ++ + G   D++   ++++++  G L+ +L  + R  N   +   A +V  A+E LHS+ 
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLHSK- 125
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             II+RD+K  N+L+D+N + ++ DFG A       +    TP      Y+ P  V+   
Sbjct: 126 -DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTP-----DYIAPEVVSTKP 179
Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
            +   D +SFGIL+ E+++       G++P
Sbjct: 180 YNKSIDWWSFGILIYEMLA-------GYTP 202

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 111/221 (50%), Gaps = 32/221 (14%)
Query: 63  LGKGSHGSVYKA----VLRGR---QVAVKKPSKNQEISQEVD--NEIEILSKIHSPRLVN 113
           LG+GS G VY+     +++G    +VAVK  +++  + + ++  NE  ++       +V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NNR---PLNWGRRIRLALQVAKAVE 164
           LLG  +  +  L+V+E M++G L   L S      NN    P      I++A ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRFRSTPPAGTIGYLDP 223
            L+++    +HRD+ + N ++  +F  ++GDFG+       D +R       G  G L  
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR------KGGKGLLPV 196
Query: 224 CYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFS 259
            ++ P++L     +T +D++SFG++L EI S  +    G S
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+ 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALS 124
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R     GT+ YL P 
Sbjct: 125 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLDYLPPE 178
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFL 202

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 54  TNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEISQEVDNE-----IEILSKI 106
           ++ +  Q++LGKGS G V   K  + G++ AVK  SK Q + Q+ D E     +++L ++
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQL 89
Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR--PLNWGRRIRLALQVAKAVE 164
             P ++ L  F  D     LV E  + G L+D + S  R   ++  R IR   QV   + 
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR---QVLSGIT 146
Query: 165 ILHSEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
            +H     I+HRD+K  N+L++   ++ N R+ DFGL+          +     GT  Y+
Sbjct: 147 YMHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYI 201
Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIIS 249
            P  V       K DV+S G++L  ++S
Sbjct: 202 AP-EVLHGTYDEKCDVWSTGVILYILLS 228

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 23/198 (11%)
Query: 63  LGKGSHGSVY--KAVLRGRQVAVK----KPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           LG G+ G V   K  L G +VAVK    +  ++ ++  ++  EI+ L     P ++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
             +   D  +V+E++S G L+D +  N R L+     RL  Q+   V+  H  M  ++HR
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGR-LDEKESRRLFQQILSGVDYCHRHM--VVHR 140
Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK-- 234
           D+K  NVL+D + NA++ DFGL+       F   S    G+     P Y  P+ +S +  
Sbjct: 141 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGS-----PNYAAPEVISGRLY 192
Query: 235 ----TDVFSFGILLLEII 248
                D++S G++L  ++
Sbjct: 193 AGPEVDIWSSGVILYALL 210

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 33/298 (11%)
Query: 39  PIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVK--KPSKNQE 91
           P +  H    +L+A     S  K++G G  G V    L+        VA+K  K    ++
Sbjct: 31  PTQTVHEFAKELDATN--ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 92  ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGR 151
             ++   E  I+ +   P ++ L G    SK  ++V E+M NG+L   L  ++      +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ 148
Query: 152 RIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
            + +   +A  ++ L S+M   +HRD+ + N+LI+ N   ++ DFGL+ R   D+     
Sbjct: 149 LVGMLRGIASGMKYL-SDM-GYVHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAAY 205
Query: 212 TPPAGTIG--YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP 269
           T   G I   +  P  +     ++ +DV+S+GI+L E++S       G  P     W   
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPY----WE-- 253
Query: 270 LIKKGKILSVFDP--RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            +    ++   D   R+PPP D P    QL    + C +  R  RP  ++IV  L  L
Sbjct: 254 -MSNQDVIKAVDEGYRLPPPMDCPAALYQL---MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 33/298 (11%)
Query: 39  PIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVK--KPSKNQE 91
           P +  H    +L+A     S  K++G G  G V    L+        VA+K  K    ++
Sbjct: 31  PTQTVHEFAKELDATN--ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 92  ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGR 151
             ++   E  I+ +   P ++ L G    SK  ++V E+M NG+L   L  ++      +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ 148
Query: 152 RIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
            + +   +A  ++ L S+M   +HRD+ + N+LI+ N   ++ DFGL+ R   D+     
Sbjct: 149 LVGMLRGIASGMKYL-SDM-GYVHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAAY 205
Query: 212 TPPAGTIG--YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP 269
           T   G I   +  P  +     ++ +DV+S+GI+L E++S       G  P     W   
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPY----WE-- 253
Query: 270 LIKKGKILSVFDP--RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            +    ++   D   R+PPP D P    QL    + C +  R  RP  ++IV  L  L
Sbjct: 254 -MSNQDVIKAVDEGYRLPPPMDCPAALYQL---MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 33/298 (11%)
Query: 39  PIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVK--KPSKNQE 91
           P +  H    +L+A     S  K++G G  G V    L+        VA+K  K    ++
Sbjct: 31  PTQTVHEFAKELDATN--ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 92  ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGR 151
             ++   E  I+ +   P ++ L G    SK  ++V E+M NG+L   L  ++      +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ 148
Query: 152 RIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
            + +   +A  ++ L S+M   +HRD+ + N+LI+ N   ++ DFGL+ R   D+     
Sbjct: 149 LVGMLRGIASGMKYL-SDM-GYVHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAAY 205
Query: 212 TPPAGTIG--YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP 269
           T   G I   +  P  +     ++ +DV+S+GI+L E++S       G  P     W   
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPY----WE-- 253
Query: 270 LIKKGKILSVFDP--RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            +    ++   D   R+PPP D P    QL    + C +  R  RP  ++IV  L  L
Sbjct: 254 -MSNQDVIKAVDEGYRLPPPMDCPAALYQL---MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 33/298 (11%)
Query: 39  PIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVK--KPSKNQE 91
           P +  H    +L+A     S  K++G G  G V    L+        VA+K  K    ++
Sbjct: 31  PTQTVHEFAKELDATN--ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 92  ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGR 151
             ++   E  I+ +   P ++ L G    SK  ++V E+M NG+L   L  ++      +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ 148
Query: 152 RIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
            + +   +A  ++ L S+M   +HRD+ + N+LI+ N   ++ DFGL+ R   D+     
Sbjct: 149 LVGMLRGIASGMKYL-SDM-GFVHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAAY 205
Query: 212 TPPAGTIG--YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP 269
           T   G I   +  P  +     ++ +DV+S+GI+L E++S       G  P     W   
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPY----WE-- 253
Query: 270 LIKKGKILSVFDP--RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            +    ++   D   R+PPP D P    QL    + C +  R  RP  ++IV  L  L
Sbjct: 254 -MSNQDVIKAVDEGYRLPPPMDCPAALYQL---MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 57  FSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEISQEVDNE-----IEILSKIHSP 109
           +  Q++LGKGS G V   K  + G++ AVK  SK Q + Q+ D E     +++L ++  P
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHP 109
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR--PLNWGRRIRLALQVAKAVEILH 167
            ++ L  F  D     LV E  + G L+D + S  R   ++  R IR   QV   +  +H
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR---QVLSGITYMH 166
Query: 168 SEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
                I+HRD+K  N+L++   ++ N R+ DFGL+          +     GT  Y+ P 
Sbjct: 167 KN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAP- 220
Query: 225 YVTPDNLSTKTDVFSFGILLLEIIS 249
            V       K DV+S G++L  ++S
Sbjct: 221 EVLHGTYDEKCDVWSTGVILYILLS 245

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILSKI 106
           A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
             P ++ L G+ +D+    L++E+   GT+Y  L   ++  +  R      ++A A+   
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 150
Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
           HS+   +IHRDIK  N+L+      ++ DFG ++         R     GT+ YL P  +
Sbjct: 151 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRDDLCGTLDYLPPEMI 204
Query: 227 TPDNLSTKTDVFSFGILLLEII 248
                  K D++S G+L  E +
Sbjct: 205 EGRMHDEKVDLWSLGVLCYEFL 226

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 57  FSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEISQEVDNE-----IEILSKIHSP 109
           +  Q++LGKGS G V   K  + G++ AVK  SK Q + Q+ D E     +++L ++  P
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHP 110
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR--PLNWGRRIRLALQVAKAVEILH 167
            ++ L  F  D     LV E  + G L+D + S  R   ++  R IR   QV   +  +H
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR---QVLSGITYMH 167
Query: 168 SEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
                I+HRD+K  N+L++   ++ N R+ DFGL+          +     GT  Y+ P 
Sbjct: 168 KN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAP- 221
Query: 225 YVTPDNLSTKTDVFSFGILLLEIIS 249
            V       K DV+S G++L  ++S
Sbjct: 222 EVLHGTYDEKCDVWSTGVILYILLS 246

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 61  KLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLV 112
           +++G+G  G VY   L    G+++     S N+     E+SQ +   I I+     P ++
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVL 93
Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-- 151
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT---IGYLDPCYVTP 228
             +HRD+ + N ++D  F  ++ DFGLA R   D          G    + ++    +  
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP----SIVDWAAPLIKKGKILSVFDPRI 284
              +TK+DV+SFG+LL E+++ R A      PP    +  D    L++  ++L    P  
Sbjct: 211 QKFTTKSDVWSFGVLLWELMT-RGA------PPYPDVNTFDITVYLLQGRRLLQ---PEY 260
Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            P  DP+       + ++C     E RPS  E+V  ++ +
Sbjct: 261 CP--DPLYE-----VMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 136/302 (45%), Gaps = 36/302 (11%)
Query: 42  IQHFDYSDLEAATNGFSEQ---------KLLGKGSHGSVYKAVLR--GRQ---VAVKKPS 87
           +  F + D   A   F+++         K++G G  G V    L+  G++   VA+K   
Sbjct: 7   VDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLK 66
Query: 88  KNQEISQEVD--NEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR 145
                 Q  D  +E  I+ +   P +++L G     K  +++ E+M NG+L   L  N+ 
Sbjct: 67  AGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG 126
Query: 146 PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD 205
                + + +   +   ++ L S+M   +HRD+ + N+L++ N   ++ DFG++ R   D
Sbjct: 127 RFTVIQLVGMLRGIGSGMKYL-SDMSA-VHRDLAARNILVNSNLVCKVSDFGMS-RVLED 183
Query: 206 NFRFRSTPPAGTIG--YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSI 263
           +     T   G I   +  P  +     ++ +DV+S+GI++ E++S  +      S   +
Sbjct: 184 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 243
Query: 264 VDWAAPLIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT 322
           +      I++G        R+PPP D PI   QL    + C +  R  RP   +IV+ L 
Sbjct: 244 IK----AIEEGY-------RLPPPMDCPIALHQL---MLDCWQKERSDRPKFGQIVNMLD 289
Query: 323 GL 324
            L
Sbjct: 290 KL 291

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 129/284 (45%), Gaps = 32/284 (11%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVK--KPSKNQEISQEVDNEIEILSK 105
           ATN  S  K++G G  G V    L+        VA+K  K    ++  ++   E  I+ +
Sbjct: 32  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 90
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
              P ++ L G    SK  ++V E+M NG+L   L  ++      + + +   +A  ++ 
Sbjct: 91  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 150
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG--YLDP 223
           L S+M   +HRD+ + N+LI+ N   ++ DFGL+ R   D+     T   G I   +  P
Sbjct: 151 L-SDM-GYVHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 224 CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP- 282
             +     ++ +DV+S+GI+L E++S       G  P     W    +    ++   D  
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMS------YGERPY----WE---MSNQDVIKAVDEG 254
Query: 283 -RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            R+PPP D P    QL    + C +  R  RP  ++IV  L  L
Sbjct: 255 YRLPPPMDCPAALYQL---MLDCWQKDRNNRPKFEQIVSILDKL 295

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 54  TNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEISQEVDNE-----IEILSKI 106
           ++ +  Q++LGKGS G V   K  + G++ AVK  SK Q + Q+ D E     +++L ++
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQL 83
Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR--PLNWGRRIRLALQVAKAVE 164
             P ++ L  F  D     LV E  + G L+D + S  R   ++  R IR   QV   + 
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR---QVLSGIT 140
Query: 165 ILHSEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
            +H     I+HRD+K  N+L++   ++ N R+ DFGL+          +     GT  Y+
Sbjct: 141 YMHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYI 195
Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIIS 249
            P  V       K DV+S G++L  ++S
Sbjct: 196 AP-EVLHGTYDEKCDVWSTGVILYILLS 222

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 33/298 (11%)
Query: 39  PIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVK--KPSKNQE 91
           P +  H    +L+A     S  K++G G  G V    L+        VA+K  K    ++
Sbjct: 29  PTQTVHEFAKELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 86
Query: 92  ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGR 151
             ++   E  I+ +   P ++ L G    SK  ++V E+M NG+L   L  ++      +
Sbjct: 87  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ 146
Query: 152 RIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
            + +   +A  ++ L S+M   +HRD+ + N+LI+ N   ++ DFGL+ R   D+     
Sbjct: 147 LVGMLRGIASGMKYL-SDM-GYVHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAAY 203
Query: 212 TPPAGTIG--YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP 269
           T   G I   +  P  +     ++ +DV+S+GI+L E++S       G  P     W   
Sbjct: 204 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPY----WE-- 251
Query: 270 LIKKGKILSVFDP--RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            +    ++   D   R+PPP D P    QL    + C +  R  RP  ++IV  L  L
Sbjct: 252 -MSNQDVIKAVDEGYRLPPPMDCPAALYQL---MLDCWQKDRNNRPKFEQIVSILDKL 305

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 33/298 (11%)
Query: 39  PIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVK--KPSKNQE 91
           P +  H    +L+A     S  K++G G  G V    L+        VA+K  K    ++
Sbjct: 31  PTQTVHEFAKELDATN--ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 92  ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGR 151
             ++   E  I+ +   P ++ L G    SK  ++V E+M NG+L   L  ++      +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ 148
Query: 152 RIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
            + +   +A  ++ L S+M   +HRD+ + N+LI+ N   ++ DFGL+ R   D+     
Sbjct: 149 LVGMLRGIASGMKYL-SDM-GYVHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAAY 205
Query: 212 TPPAGTIG--YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP 269
           T   G I   +  P  +     ++ +DV+S+GI+L E++S       G  P     W   
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPY----WE-- 253
Query: 270 LIKKGKILSVFDP--RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            +    ++   D   R+PPP D P    QL    + C +  R  RP  ++IV  L  L
Sbjct: 254 -MSNQDVIKAVDEGYRLPPPMDCPAALYQL---MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 5/194 (2%)
Query: 61  KLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           K LG G  G V+        +VAVK         Q    E  ++  +   +LV L     
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
             +   ++ E+M+ G+L D L S+    +   + I  + Q+A+ +  +  E    IHRD+
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI--ERKNYIHRDL 136
Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVF 238
           ++ANVL+  +   ++ DFGLA R   DN           I +  P  +     + K+DV+
Sbjct: 137 RAANVLVSESLMCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVW 195
Query: 239 SFGILLLEIISCRK 252
           SFGILL EI++  K
Sbjct: 196 SFGILLYEIVTYGK 209

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 13/204 (6%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEISQEVDNEIEILS 104
           + A   F   + LGKG  G+VY A       +   +V  K   +   +  ++  E+EI S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            +  P ++ L G+ +D+    L++E+   G +Y  L   ++  +  R      ++A A+ 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALS 127
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
             HS+   +IHRDIK  N+L+      ++ DFG ++         R     GT+ YL P 
Sbjct: 128 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLXGTLDYLPPE 181
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +       K D++S G+L  E +
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFL 205

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 5/194 (2%)
Query: 61  KLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           K LG G  G V+        +VAVK         Q    E  ++  +   +LV L     
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
             +   ++ EFM+ G+L D L S+    +   + I  + Q+A+ +  +  E    IHRD+
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI--ERKNYIHRDL 135
Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVF 238
           ++ANVL+  +   ++ DFGLA R   DN           I +  P  +     + K++V+
Sbjct: 136 RAANVLVSESLMCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVW 194
Query: 239 SFGILLLEIISCRK 252
           SFGILL EI++  K
Sbjct: 195 SFGILLYEIVTYGK 208

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 60  QKL--LGKGSHGSVYKAV-LRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVN 113
           QKL  +G+G++G VYKA   +GR VA+K+    ++++ I      EI +L ++H P +V+
Sbjct: 24  QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL-QVAKAVEILHSEMPP 172
           L+   +  +   LV EFM    L  VL  N   L    +I++ L Q+ + V   H     
Sbjct: 84  LIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQ-DSQIKIYLYQLLRGVA--HCHQHR 139
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTPDNL 231
           I+HRD+K  N+LI+ +   +L DFGLA   G+    +  T    T+ Y  P   +     
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKY 197
Query: 232 STKTDVFSFGILLLEIIS 249
           ST  D++S G +  E+I+
Sbjct: 198 STSVDIWSIGCIFAEMIT 215

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 99/198 (50%), Gaps = 23/198 (11%)
Query: 63  LGKGSHGSVY--KAVLRGRQVAVK----KPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           LG G+ G V   +  L G +VAVK    +  ++ ++  ++  EI+ L     P ++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
             +   D  +V+E++S G L+D +  + R      R RL  Q+  AV+  H  M  ++HR
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM--VVHR 135
Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK-- 234
           D+K  NVL+D + NA++ DFGL+       F  R++  +       P Y  P+ +S +  
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTSCGS-------PNYAAPEVISGRLY 187
Query: 235 ----TDVFSFGILLLEII 248
                D++S G++L  ++
Sbjct: 188 AGPEVDIWSCGVILYALL 205

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQ--VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           F++   +GKGS G VYK +    +  VA+K     + ++  +++  EI +LS+  SP + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
              G    S    +++E++  G+  D+L     PL       +  ++ K ++ LHSE   
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLHSERK- 137
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
            IHRDIK+ANVL+    + +L DFG+A    + + + +     GT  ++ P  +      
Sbjct: 138 -IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 194
Query: 233 TKTDVFSFGILLLEI 247
            K D++S GI  +E+
Sbjct: 195 FKADIWSLGITAIEL 209

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 129/284 (45%), Gaps = 32/284 (11%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVK--KPSKNQEISQEVDNEIEILSK 105
           ATN  S  K++G G  G V    L+        VA+K  K    ++  ++   E  I+ +
Sbjct: 15  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
              P ++ L G    SK  ++V E+M NG+L   L  ++      + + +   +A  ++ 
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG--YLDP 223
           L S+M   +HRD+ + N+LI+ N   ++ DFGL+ R   D+     T   G I   +  P
Sbjct: 134 L-SDM-GYVHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 224 CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP- 282
             +     ++ +DV+S+GI+L E++S       G  P     W    +    ++   D  
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMS------YGERPY----WE---MSNQDVIKAVDEG 237
Query: 283 -RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            R+PPP D P    QL    + C +  R  RP  ++IV  L  L
Sbjct: 238 YRLPPPMDCPAALYQL---MLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 125/285 (43%), Gaps = 46/285 (16%)
Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           F E +L+G G  G V+KA  R  G+   +K+   N E   + + E++ L+K+    +V+ 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAKLDHVNIVHY 69
Query: 115 LG----FSND----------SKDRLLVV--EFMSNGTLYDVLHSN-NRPLNWGRRIRLAL 157
            G    F  D          SK + L +  EF   GTL   +       L+    + L  
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129
Query: 158 QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT 217
           Q+ K V+ +HS+   +I+RD+K +N+ +      ++GDFGL      D  R RS    GT
Sbjct: 130 QITKGVDYIHSK--KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS---KGT 184
Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKIL 277
           + Y+ P  ++  +   + D+++ G++L E++      D  F            ++ G I 
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLH---VCDTAFETSKFF----TDLRDGIIS 237
Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT 322
            +FD            K+   +  + +    E RP+  EI+  LT
Sbjct: 238 DIFD------------KKEKTLLQKLLSKKPEDRPNTSEILRTLT 270

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 60  QKL--LGKGSHGSVYKAV-LRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVN 113
           QKL  +G+G++G VYKA   +GR VA+K+    ++++ I      EI +L ++H P +V+
Sbjct: 24  QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL-QVAKAVEILHSEMPP 172
           L+   +  +   LV EFM    L  VL  N   L    +I++ L Q+ + V   H     
Sbjct: 84  LIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQ-DSQIKIYLYQLLRGVA--HCHQHR 139
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTPDNL 231
           I+HRD+K  N+LI+ +   +L DFGLA   G+    +  T    T+ Y  P   +     
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKY 197
Query: 232 STKTDVFSFGILLLEIIS 249
           ST  D++S G +  E+I+
Sbjct: 198 STSVDIWSIGCIFAEMIT 215

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 37/222 (16%)
Query: 55  NGFSEQKLLGKGSHGSVYKAVLRG----RQVAVK--KPSKNQEISQEVDNEIEILSKI-H 107
           N    Q ++G+G+ G V KA ++        A+K  K   +++  ++   E+E+L K+ H
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVL---------------HSNNRPLNWGRR 152
            P ++NLLG         L +E+  +G L D L               +S    L+  + 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST 212
           +  A  VA+ ++ L  +    IHR++ + N+L+  N+ A++ DFGL+        R +  
Sbjct: 142 LHFAADVARGMDYLSQKQ--FIHRNLAARNILVGENYVAKIADFGLS--------RGQEV 191
Query: 213 PPAGTIGYLDPCYVTPDNL-----STKTDVFSFGILLLEIIS 249
               T+G L   ++  ++L     +T +DV+S+G+LL EI+S
Sbjct: 192 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 33/298 (11%)
Query: 39  PIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVK--KPSKNQE 91
           P +  H    +L+A     S  K++G G  G V    L+        VA+K  K    ++
Sbjct: 31  PTQTVHEFAKELDATN--ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 92  ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGR 151
             ++   E  I+ +   P ++ L G    SK  ++V E+M NG+L   L  ++      +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ 148
Query: 152 RIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
            + +   +A  ++ L S+M   +HRD+ + N+LI+ N   ++ DFGL  R   D+     
Sbjct: 149 LVGMLRGIASGMKYL-SDM-GYVHRDLAARNILINSNLVCKVSDFGLG-RVLEDDPEAAY 205
Query: 212 TPPAGTIG--YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP 269
           T   G I   +  P  +     ++ +DV+S+GI+L E++S       G  P     W   
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPY----WE-- 253
Query: 270 LIKKGKILSVFDP--RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            +    ++   D   R+PPP D P    QL    + C +  R  RP  ++IV  L  L
Sbjct: 254 -MSNQDVIKAVDEGYRLPPPMDCPAALYQL---MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 128/275 (46%), Gaps = 27/275 (9%)
Query: 60  QKLLGKGSHGSVYKAVLR--GRQ---VAVKKPSKNQEISQEVD--NEIEILSKIHSPRLV 112
           +K++G G  G V    L+  G++   VA+K         Q  D  +E  I+ +   P ++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
           +L G     K  +++ E+M NG+L   L  N+      + + +   +   ++ L S+M  
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL-SDM-S 130
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG--YLDPCYVTPDN 230
            +HRD+ + N+L++ N   ++ DFG++ R   D+     T   G I   +  P  +    
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMS-RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD- 289
            ++ +DV+S+GI++ E++S  +      S   ++      I++G        R+PPP D 
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK----AIEEGY-------RLPPPMDC 238
Query: 290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           PI   QL    + C +  R  RP   +IV+ L  L
Sbjct: 239 PIALHQL---MLDCWQKERSDRPKFGQIVNMLDKL 270

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 23/198 (11%)
Query: 63  LGKGSHGSVY--KAVLRGRQVAVK----KPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           LG G+ G V   +  L G +VAVK    +  ++ ++  ++  EI+ L     P ++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
             +   D  +V+E++S G L+D +  + R      R RL  Q+  AV+  H  M  ++HR
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM--VVHR 135
Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK-- 234
           D+K  NVL+D + NA++ DFGL+       F   S           P Y  P+ +S +  
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCG--------SPNYAAPEVISGRLY 187
Query: 235 ----TDVFSFGILLLEII 248
                D++S G++L  ++
Sbjct: 188 AGPEVDIWSCGVILYALL 205

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 128/275 (46%), Gaps = 27/275 (9%)
Query: 60  QKLLGKGSHGSVYKAVLR--GRQ---VAVKKPSKNQEISQEVD--NEIEILSKIHSPRLV 112
           +K++G G  G V    L+  G++   VA+K         Q  D  +E  I+ +   P ++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
           +L G     K  +++ E+M NG+L   L  N+      + + +   +   ++ L S+M  
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL-SDM-S 136
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG--YLDPCYVTPDN 230
            +HRD+ + N+L++ N   ++ DFG++ R   D+     T   G I   +  P  +    
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGMS-RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD- 289
            ++ +DV+S+GI++ E++S  +      S   ++      I++G        R+PPP D 
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK----AIEEGY-------RLPPPMDC 244
Query: 290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           PI   QL    + C +  R  RP   +IV+ L  L
Sbjct: 245 PIALHQL---MLDCWQKERSDRPKFGQIVNMLDKL 276

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/270 (22%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L +++ M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 79  PHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFG A   G +   + +      I ++    +  
Sbjct: 138 RR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 243
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I  +C     + RP  +E++
Sbjct: 244 -PICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/320 (23%), Positives = 143/320 (44%), Gaps = 43/320 (13%)
Query: 40  IKIQHFDYSDLEAATNGFSEQ---------KLLGKGSHGSVYKAVLR--GRQ---VAVK- 84
           I I  F + D   A   F+++         +++G G  G V    L+  G++   VA+K 
Sbjct: 9   IFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT 68
Query: 85  -KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSN 143
            K    ++  ++  +E  I+ +   P +++L G    S   +++ EFM NG+L   L  N
Sbjct: 69  LKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN 128
Query: 144 NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG 203
           +      + + +   +A  ++ L ++M   +HRD+ + N+L++ N   ++ DFGL+    
Sbjct: 129 DGQFTVIQLVGMLRGIAAGMKYL-ADM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 186
Query: 204 VDNFRFRSTPPAG---TIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
            D      T   G    I +  P  +     ++ +DV+S+GI++ E++S  +      + 
Sbjct: 187 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 246
Query: 261 PSIVDWAAPLIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
             +++     I++       D R+PPP D P    QL    + C +  R  RP   +IV+
Sbjct: 247 QDVIN----AIEQ-------DYRLPPPMDCPSALHQL---MLDCWQKDRNHRPKFGQIVN 292
Query: 320 WL-------TGLSKLVPLHS 332
            L         L  + PL S
Sbjct: 293 TLDKMIRNPNSLKAMAPLSS 312

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 18/223 (8%)
Query: 42  IQHFDYSDLEAATNG---FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS--- 93
           ++   +  LEA   G   F + ++LG+G  G V+   ++  G+  A KK +K +      
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG 228
Query: 94  -QEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTL----YDVLHSNNRPLN 148
            Q    E +IL+K+HS  +V+L        D  LV+  M+ G +    Y+V   +N    
Sbjct: 229 YQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNV-DEDNPGFQ 287
Query: 149 WGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR 208
             R I    Q+   +E LH     II+RD+K  NVL+D + N R+ D GLA+       +
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345
Query: 209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCR 251
            +    AGT G++ P  +  +      D F+ G+ L E+I+ R
Sbjct: 346 TKGY--AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 32/226 (14%)
Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF--- 117
           + +GKG +G V++   +G  VAVK  S   E S   + E   L      R  N+LGF   
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETE---LYNTVMLRHENILGFIAS 70
Query: 118 ----SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM--- 170
                + S    L+  +   G+LYD L      L+    +R+ L +A  +  LH E+   
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 171 ---PPIIHRDIKSANVLIDRNFNARLGDFGLAL--RCGVDNFRFRSTPPAGTIGYLDP-- 223
              P I HRD+KS N+L+ +N    + D GLA+      +     + P  GT  Y+ P  
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 224 ----CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIG----FSPP 261
                 V   +   + D+++FG++L E+   R+ +  G    + PP
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIVEDYKPP 232

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 110/221 (49%), Gaps = 32/221 (14%)
Query: 63  LGKGSHGSVYKA----VLRGR---QVAVKKPSKNQEISQEVD--NEIEILSKIHSPRLVN 113
           LG+GS G VY+     +++G    +VAVK  +++  + + ++  NE  ++       +V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NNR---PLNWGRRIRLALQVAKAVE 164
           LLG  +  +  L+V+E M++G L   L S      NN    P      I++A ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG-VDNFRFRSTPPAGTIGYLDP 223
            L+++    +HRD+ + N ++  +F  ++GDFG+       D  R       G  G L  
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR------KGGKGLLPV 196
Query: 224 CYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFS 259
            ++ P++L     +T +D++SFG++L EI S  +    G S
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 64  GKGSHGSVYKAVLRGRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK 122
            +G  G V+KA L    VAVK  P ++++  Q   NE E+ S +   +  N+L F    K
Sbjct: 33  ARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQ---NEYEVYS-LPGMKHENILQFIGAEK 88
Query: 123 -------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP---- 171
                  D  L+  F   G+L D L +N   ++W     +A  +A+ +  LH ++P    
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 172 ----PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
                I HRDIKS NVL+  N  A + DFGLAL+         +    GT  Y+ P  + 
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLE 206
Query: 228 -----PDNLSTKTDVFSFGILLLEIISCRKAID 255
                  +   + D+++ G++L E+ S   A D
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 112/232 (48%), Gaps = 17/232 (7%)
Query: 63  LGKGSHGSVYKAVLRGRQ----VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           LG G+ GSV + V R R+    VA+K  K    +  ++E+  E +I+ ++ +P +V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
               ++  +LV+E    G L+  L      +       L  QV+  ++ L  E    +HR
Sbjct: 78  VCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL--EEKNFVHR 134
Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT--IGYLDPCYVTPDNLSTK 234
           D+ + NVL+     A++ DFGL+   G D+  + +   AG   + +  P  +     S++
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 235 TDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP 286
           +DV+S+G+ + E +S  +        P ++      I++GK +    P  PP
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMKGPEVM----AFIEQGKRMEC-PPECPP 240

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 32/226 (14%)
Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF--- 117
           + +GKG +G V++   +G  VAVK  S   E S   + E   L      R  N+LGF   
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETE---LYNTVMLRHENILGFIAS 70
Query: 118 ----SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM--- 170
                + S    L+  +   G+LYD L      L+    +R+ L +A  +  LH E+   
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 171 ---PPIIHRDIKSANVLIDRNFNARLGDFGLAL--RCGVDNFRFRSTPPAGTIGYLDP-- 223
              P I HRD+KS N+L+ +N    + D GLA+      +     + P  GT  Y+ P  
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 224 ----CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIG----FSPP 261
                 V   +   + D+++FG++L E+   R+ +  G    + PP
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIVEDYKPP 232

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 112/226 (49%), Gaps = 32/226 (14%)
Query: 63  LGKGSHGSVYKA----VLRGR---QVAVKKPSKNQEISQEVD--NEIEILSKIHSPRLVN 113
           LG+GS G VY+     +++G    +VAVK  +++  + + ++  NE  ++       +V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NNR---PLNWGRRIRLALQVAKAVE 164
           LLG  +  +  L+V+E M++G L   L S      NN    P      I++A ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG-VDNFRFRSTPPAGTIGYLDP 223
            L+++    +HRD+ + N ++  +F  ++GDFG+       D  R       G  G L  
Sbjct: 142 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR------KGGKGLLPV 193
Query: 224 CYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIV 264
            ++ P++L     +T +D++SFG++L EI S  +    G S   ++
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 239

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 110/221 (49%), Gaps = 32/221 (14%)
Query: 63  LGKGSHGSVYKA----VLRGR---QVAVKKPSKNQEISQEVD--NEIEILSKIHSPRLVN 113
           LG+GS G VY+     +++G    +VAVK  +++  + + ++  NE  ++       +V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NNR---PLNWGRRIRLALQVAKAVE 164
           LLG  +  +  L+V+E M++G L   L S      NN    P      I++A ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG-VDNFRFRSTPPAGTIGYLDP 223
            L+++    +HRD+ + N ++  +F  ++GDFG+       D  R       G  G L  
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR------KGGKGLLPV 196
Query: 224 CYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFS 259
            ++ P++L     +T +D++SFG++L EI S  +    G S
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 32/226 (14%)
Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF--- 117
           + +GKG +G V++   +G  VAVK  S   E S   + E   L      R  N+LGF   
Sbjct: 43  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETE---LYNTVMLRHENILGFIAS 99
Query: 118 ----SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM--- 170
                + S    L+  +   G+LYD L      L+    +R+ L +A  +  LH E+   
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 171 ---PPIIHRDIKSANVLIDRNFNARLGDFGLAL--RCGVDNFRFRSTPPAGTIGYLDP-- 223
              P I HRD+KS N+L+ +N    + D GLA+      +     + P  GT  Y+ P  
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 217
Query: 224 ----CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIG----FSPP 261
                 V   +   + D+++FG++L E+   R+ +  G    + PP
Sbjct: 218 LDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIVEDYKPP 261

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 18/223 (8%)
Query: 42  IQHFDYSDLEAATNG---FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS--- 93
           ++   +  LEA   G   F + ++LG+G  G V+   ++  G+  A KK +K +      
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG 228
Query: 94  -QEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTL----YDVLHSNNRPLN 148
            Q    E +IL+K+HS  +V+L        D  LV+  M+ G +    Y+V   +N    
Sbjct: 229 YQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNV-DEDNPGFQ 287
Query: 149 WGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR 208
             R I    Q+   +E LH     II+RD+K  NVL+D + N R+ D GLA+       +
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345
Query: 209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCR 251
            +    AGT G++ P  +  +      D F+ G+ L E+I+ R
Sbjct: 346 TKGY--AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 20/224 (8%)
Query: 42  IQHFDYSDLEAATNG---FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS--- 93
           ++   +  LEA   G   F + ++LG+G  G V+   ++  G+  A KK +K +      
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG 228
Query: 94  -QEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNG-----TLYDVLHSNNRPL 147
            Q    E +IL+K+HS R +  L ++ ++K  L +V  + NG      +Y+V   +N   
Sbjct: 229 YQGAMVEKKILAKVHS-RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNV-DEDNPGF 286
Query: 148 NWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF 207
              R I    Q+   +E LH     II+RD+K  NVL+D + N R+ D GLA+       
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344
Query: 208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCR 251
           + +    AGT G++ P  +  +      D F+ G+ L E+I+ R
Sbjct: 345 KTKGY--AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 18/223 (8%)
Query: 42  IQHFDYSDLEAATNG---FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS--- 93
           ++   +  LEA   G   F + ++LG+G  G V+   ++  G+  A KK +K +      
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG 228
Query: 94  -QEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTL----YDVLHSNNRPLN 148
            Q    E +IL+K+HS  +V+L        D  LV+  M+ G +    Y+V   +N    
Sbjct: 229 YQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNV-DEDNPGFQ 287
Query: 149 WGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR 208
             R I    Q+   +E LH     II+RD+K  NVL+D + N R+ D GLA+       +
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345
Query: 209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCR 251
            +    AGT G++ P  +  +      D F+ G+ L E+I+ R
Sbjct: 346 TKGY--AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/270 (22%), Positives = 124/270 (45%), Gaps = 24/270 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +       VK P   +E+        ++E+ +E  +++ + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S  +L + + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 79  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFG A   G +   + +      I ++    +  
Sbjct: 138 RR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I    + +++KG+       R+P P 
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSILEKGE-------RLPQP- 243
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            PI    + +I  +C     + RP  +E++
Sbjct: 244 -PICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 111/221 (50%), Gaps = 32/221 (14%)
Query: 63  LGKGSHGSVYKA----VLRGR---QVAVKKPSKNQEISQEVD--NEIEILSKIHSPRLVN 113
           LG+GS G VY+     +++G    +VAVK  +++  + + ++  NE  ++       +V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NNR---PLNWGRRIRLALQVAKAVE 164
           LLG  +  +  L+V+E M++G L   L S      NN    P      I++A ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRFRSTPPAGTIGYLDP 223
            L+++    +HR++ + N ++  +F  ++GDFG+       D +R       G  G L  
Sbjct: 145 YLNAK--KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR------KGGKGLLPV 196
Query: 224 CYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFS 259
            ++ P++L     +T +D++SFG++L EI S  +    G S
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 111/221 (50%), Gaps = 32/221 (14%)
Query: 63  LGKGSHGSVYKA----VLRGR---QVAVKKPSKNQEISQEVD--NEIEILSKIHSPRLVN 113
           LG+GS G VY+     +++G    +VAVK  +++  + + ++  NE  ++       +V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHS------NNR---PLNWGRRIRLALQVAKAVE 164
           LLG  +  +  L+V+E M++G L   L S      NN    P      I++A ++A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC-GVDNFRFRSTPPAGTIGYLDP 223
            L+++    +HR++ + N ++  +F  ++GDFG+       D +R       G  G L  
Sbjct: 146 YLNAK--KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR------KGGKGLLPV 197
Query: 224 CYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFS 259
            ++ P++L     +T +D++SFG++L EI S  +    G S
Sbjct: 198 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 238

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 128/293 (43%), Gaps = 39/293 (13%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRGR-------QVAVK--KPSKNQEISQEVDNEIE 101
           E   N     K LG G+ G V +A   G        +VAVK  K + + +  + + +E++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 102 ILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH---------SNNRPLNWGR 151
           I+S +     +VNLLG        L++ E+   G L + L           + RPL    
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 161
Query: 152 RIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
            +  + QVA+ +  L S+    IHRD+ + NVL+     A++GDFGLA     D+     
Sbjct: 162 LLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 219
Query: 212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSIV--DWAA 268
                 + ++ P  +     + ++DV+S+GILL EI S      +G +P P I+      
Sbjct: 220 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYPGILVNSKFY 273
Query: 269 PLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
            L+K G  ++   P   P       K +  I   C       RP+ ++I  +L
Sbjct: 274 KLVKDGYQMA--QPAFAP-------KNIYSIMQACWALEPTHRPTFQQICSFL 317

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 128/293 (43%), Gaps = 39/293 (13%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRGR-------QVAVK--KPSKNQEISQEVDNEIE 101
           E   N     K LG G+ G V +A   G        +VAVK  K + + +  + + +E++
Sbjct: 34  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 102 ILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH---------SNNRPLNWGR 151
           I+S +     +VNLLG        L++ E+   G L + L           + RPL    
Sbjct: 94  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 153
Query: 152 RIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
            +  + QVA+ +  L S+    IHRD+ + NVL+     A++GDFGLA     D+     
Sbjct: 154 LLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 211
Query: 212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSIV--DWAA 268
                 + ++ P  +     + ++DV+S+GILL EI S      +G +P P I+      
Sbjct: 212 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYPGILVNSKFY 265
Query: 269 PLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
            L+K G  ++   P   P       K +  I   C       RP+ ++I  +L
Sbjct: 266 KLVKDGYQMA--QPAFAP-------KNIYSIMQACWALEPTHRPTFQQICSFL 309

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 57  FSEQKLLGKGSHGSVYKAV-LRGRQVAVKKP---SKNQEISQEVDNEIEILSKIHSPRLV 112
           F++ + +GKGS G V+K +  R +QV   K     + ++  +++  EI +LS+  S  + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
              G         +++E++  G+  D+L +   P +  +   +  ++ K ++ LHSE   
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKK- 141
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
            IHRDIK+ANVL+    + +L DFG+A +  + + + +     GT  ++ P  +      
Sbjct: 142 -IHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIQQSAYD 198
Query: 233 TKTDVFSFGILLLEI 247
           +K D++S GI  +E+
Sbjct: 199 SKADIWSLGITAIEL 213

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 33/298 (11%)
Query: 39  PIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVK--KPSKNQE 91
           P +  H    +L+A     S  K++G G  G V    L+        VA+K  K    ++
Sbjct: 31  PTQTVHEFAKELDATN--ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 92  ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGR 151
             ++   E  I+ +   P ++ L G    SK  ++V E M NG+L   L  ++      +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ 148
Query: 152 RIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
            + +   +A  ++ L S+M   +HRD+ + N+LI+ N   ++ DFGL+ R   D+     
Sbjct: 149 LVGMLRGIASGMKYL-SDMG-YVHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAAY 205
Query: 212 TPPAGTIG--YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP 269
           T   G I   +  P  +     ++ +DV+S+GI+L E++S       G  P     W   
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPY----WE-- 253
Query: 270 LIKKGKILSVFDP--RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            +    ++   D   R+PPP D P    QL    + C +  R  RP  ++IV  L  L
Sbjct: 254 -MSNQDVIKAVDEGYRLPPPMDCPAALYQL---MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 103/189 (54%), Gaps = 9/189 (4%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPS-KNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           +G+GS G V  A  +  G+QVAVKK   + Q+  + + NE+ I+   H   +V++     
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+EF+  G L D++ ++ R +N  +   + L V +A+  LH++   +IHRDIK
Sbjct: 113 VGDELWVVMEFLEGGALTDIV-THTR-MNEEQIATVCLSVLRALSYLHNQ--GVIHRDIK 168
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S ++L+  +   +L DFG   +   +  + +     GT  ++ P  ++     T+ D++S
Sbjct: 169 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXL--VGTPYWMAPEVISRLPYGTEVDIWS 226
Query: 240 FGILLLEII 248
            GI+++E+I
Sbjct: 227 LGIMVIEMI 235

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 98/192 (51%), Gaps = 10/192 (5%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQ-EVDNEIEILSKIHSPRLVNLLGFSN 119
           LG G+ G V++ V +  GR    K  +    + +  V NEI I++++H P+L+NL     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
           D  + +L++EF+S G L+D + + +  ++    I    Q  + ++ +H     I+H DIK
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH--SIVHLDIK 176
Query: 180 SANVLID--RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
             N++ +  +  + ++ DFGLA +   D     +T    T  +  P  V  + +   TD+
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYTDM 233
Query: 238 FSFGILLLEIIS 249
           ++ G+L   ++S
Sbjct: 234 WAIGVLGYVLLS 245

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 98/193 (50%), Gaps = 12/193 (6%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           LG G+ G VYKA  +  G   A K   +K++E  ++   EIEIL+    P +V LLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
                 +++EF   G +  ++   +R L   +   +  Q+ +A+  LHS+   IIHRD+K
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLK 144
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP----CYVTPDN-LSTK 234
           + NVL+    + RL DFG++ +  +   + R +   GT  ++ P    C    D     K
Sbjct: 145 AGNVLMTLEGDIRLADFGVSAK-NLKTLQKRDS-FIGTPYWMAPEVVMCETMKDTPYDYK 202
Query: 235 TDVFSFGILLLEI 247
            D++S GI L+E+
Sbjct: 203 ADIWSLGITLIEM 215

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 33/298 (11%)
Query: 39  PIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVK--KPSKNQE 91
           P +  H    +L+A     S  K++G G  G V    L+        VA+K  K    ++
Sbjct: 31  PTQTVHEFAKELDATN--ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 92  ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGR 151
             ++   E  I+ +   P ++ L G    SK  ++V E M NG+L   L  ++      +
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ 148
Query: 152 RIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
            + +   +A  ++ L S+M  + HRD+ + N+LI+ N   ++ DFGL+ R   D+     
Sbjct: 149 LVGMLRGIASGMKYL-SDMGAV-HRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAAY 205
Query: 212 TPPAGTIG--YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP 269
           T   G I   +  P  +     ++ +DV+S+GI+L E++S       G  P     W   
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPY----WE-- 253
Query: 270 LIKKGKILSVFDP--RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            +    ++   D   R+PPP D P    QL    + C +  R  RP  ++IV  L  L
Sbjct: 254 -MSNQDVIKAVDEGYRLPPPMDCPAALYQL---MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 98/193 (50%), Gaps = 12/193 (6%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           LG G+ G VYKA  +  G   A K   +K++E  ++   EIEIL+    P +V LLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
                 +++EF   G +  ++   +R L   +   +  Q+ +A+  LHS+   IIHRD+K
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLK 136
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP----CYVTPDN-LSTK 234
           + NVL+    + RL DFG++ +  +   + R +   GT  ++ P    C    D     K
Sbjct: 137 AGNVLMTLEGDIRLADFGVSAK-NLKTLQKRDS-FIGTPYWMAPEVVMCETMKDTPYDYK 194
Query: 235 TDVFSFGILLLEI 247
            D++S GI L+E+
Sbjct: 195 ADIWSLGITLIEM 207

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 128/284 (45%), Gaps = 32/284 (11%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVK--KPSKNQEISQEVDNEIEILSK 105
           ATN  S  K++G G  G V    L+        VA+K  K    ++  ++   E  I+ +
Sbjct: 15  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
              P ++ L G    SK  ++V E M NG+L   L  ++      + + +   +A  ++ 
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG--YLDP 223
           L S+M   +HRD+ + N+LI+ N   ++ DFGL+ R   D+     T   G I   +  P
Sbjct: 134 L-SDMG-YVHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 224 CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP- 282
             +     ++ +DV+S+GI+L E++S       G  P     W    +    ++   D  
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMS------YGERPY----WE---MSNQDVIKAVDEG 237
Query: 283 -RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            R+PPP D P    QL    + C +  R  RP  ++IV  L  L
Sbjct: 238 YRLPPPMDCPAALYQL---MLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 54  TNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEISQEVDNE-----IEILSKI 106
           ++ +  Q++LGKGS G V   K  + G++ AVK  SK Q + Q+ D E     +++L ++
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQL 83
Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR--PLNWGRRIRLALQVAKAVE 164
             P +  L  F  D     LV E  + G L+D + S  R   ++  R IR   QV   + 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR---QVLSGIT 140
Query: 165 ILHSEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
             H     I+HRD+K  N+L++   ++ N R+ DFGL+          +     GT  Y+
Sbjct: 141 YXHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KXKDKIGTAYYI 195
Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIIS 249
            P  V       K DV+S G++L  ++S
Sbjct: 196 AP-EVLHGTYDEKCDVWSTGVILYILLS 222

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 132/288 (45%), Gaps = 46/288 (15%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G           VAVK  K    +E   ++ +E+E++  I   
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
               Q+A+ +E L S+    IHRD+ + NVL+  N   ++ DFGLA      ++  ++T 
Sbjct: 161 SCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+L+ EI +      +G SP P I V+    L+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 272
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+
Sbjct: 273 KEGH-------RMDKPAN--CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 137/297 (46%), Gaps = 36/297 (12%)
Query: 47  YSDLEAATNGFSEQ---------KLLGKGSHGSVYKAVLR--GRQ---VAVK--KPSKNQ 90
           Y D   A + F+++         +++G G  G V    L+  G++   VA+K  K    +
Sbjct: 5   YEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTE 64
Query: 91  EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWG 150
           +  ++   E  I+ +   P +++L G    SK  ++V E+M NG+L   L  N+      
Sbjct: 65  KQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVI 124
Query: 151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR 210
           + + +   ++  ++ L S+M   +HRD+ + N+LI+ N   ++ DFGL+ R   D+    
Sbjct: 125 QLVGMLRGISAGMKYL-SDM-GYVHRDLAARNILINSNLVCKVSDFGLS-RVLEDDPEAA 181
Query: 211 STPPAGTIG--YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA 268
            T   G I   +  P  +     ++ +DV+S+GI++ E++S  +      +   ++    
Sbjct: 182 YTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIK--- 238
Query: 269 PLIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
             +++G        R+P P D P    QL    + C +  R  RP   EIV+ L  L
Sbjct: 239 -AVEEGY-------RLPSPMDCPAALYQL---MLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 140/301 (46%), Gaps = 49/301 (16%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G          +VAVK  K    ++   ++ +E+E++  I   
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               L+    +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
             A QVA+ +E L S+    IHRD+ + NVL+  +   ++ DFGLA      ++  ++T 
Sbjct: 154 SCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+LL EI +      +G SP P + V+    L+
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVEELFKLL 265
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLH 331
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+    L ++V L 
Sbjct: 266 KEGH-------RMDKPSN--CTNELYMMMRDCWHAVPSQRPTFKQLVE---DLDRIVALT 313
Query: 332 S 332
           S
Sbjct: 314 S 314

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 132/288 (45%), Gaps = 46/288 (15%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G           VAVK  K    ++   ++ +E+E++  I   
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
               Q+A+ +E L S+    IHRD+ + NVL+  N   R+ DFGLA      ++  ++T 
Sbjct: 161 SCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+L+ EI +      +G SP P I V+    L+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 272
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+
Sbjct: 273 KEGH-------RMDKPAN--CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 140/301 (46%), Gaps = 49/301 (16%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G          +VAVK  K    ++   ++ +E+E++  I   
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTL---------------YDVLHSNNRPLNWGRRI 153
           + ++NLLG         ++VE+ S G L               Y+  H+    L+    +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
             A QVA+ +E L S+    IHRD+ + NVL+  +   ++ DFGLA      ++  ++T 
Sbjct: 195 SCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+LL EI +      +G SP P + V+    L+
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVEELFKLL 306
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLH 331
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+    L ++V L 
Sbjct: 307 KEGH-------RMDKPSN--CTNELYMMMRDCWHAVPSQRPTFKQLVE---DLDRIVALT 354
Query: 332 S 332
           S
Sbjct: 355 S 355

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 140/301 (46%), Gaps = 49/301 (16%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G          +VAVK  K    ++   ++ +E+E++  I   
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               L+    +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
             A QVA+ +E L S+    IHRD+ + NVL+  +   ++ DFGLA      ++  ++T 
Sbjct: 154 SCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+LL EI +      +G SP P + V+    L+
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVEELFKLL 265
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLH 331
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+    L ++V L 
Sbjct: 266 KEGH-------RMDKPSN--CTNELYMMMRDCWHAVPSQRPTFKQLVE---DLDRIVALT 313
Query: 332 S 332
           S
Sbjct: 314 S 314

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 140/301 (46%), Gaps = 49/301 (16%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G          +VAVK  K    ++   ++ +E+E++  I   
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               L+    +
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
             A QVA+ +E L S+    IHRD+ + NVL+  +   ++ DFGLA      ++  ++T 
Sbjct: 146 SCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 203
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+LL EI +      +G SP P + V+    L+
Sbjct: 204 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVEELFKLL 257
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLH 331
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+    L ++V L 
Sbjct: 258 KEGH-------RMDKPSN--CTNELYMMMRDCWHAVPSQRPTFKQLVE---DLDRIVALT 305
Query: 332 S 332
           S
Sbjct: 306 S 306

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 30/211 (14%)
Query: 63  LGKGSHGS--VYKAVLRGRQVAVKKPSKNQEISQEVDN---EIEILSKIHSPRLVNLLGF 117
           +G+GS G   + K+   GRQ  +K+ + ++  S+E +    E+ +L+ +  P +V     
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 118 SNDSKDRLLVVEFMSNGTLYD-------VLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
             ++    +V+++   G L+        VL   ++ L+W  +I LAL+        H   
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK--------HVHD 143
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDP--CYV 226
             I+HRDIKS N+ + ++   +LGDFG+A  L   V+  R       GT  YL P  C  
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR----ACIGTPYYLSPEICEN 199
Query: 227 TPDNLSTKTDVFSFGILLLEIISCRKAIDIG 257
            P N   K+D+++ G +L E+ + + A + G
Sbjct: 200 KPYN--NKSDIWALGCVLYELCTLKHAFEAG 228

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 140/301 (46%), Gaps = 49/301 (16%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G          +VAVK  K    ++   ++ +E+E++  I   
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               L+    +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
             A QVA+ +E L S+    IHRD+ + NVL+  +   ++ DFGLA      ++  ++T 
Sbjct: 154 SCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+LL EI +      +G SP P + V+    L+
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVEELFKLL 265
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLH 331
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+    L ++V L 
Sbjct: 266 KEGH-------RMDKPSN--CTNELYMMMRDCWHAVPSQRPTFKQLVE---DLDRIVALT 313
Query: 332 S 332
           S
Sbjct: 314 S 314

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 140/301 (46%), Gaps = 49/301 (16%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G          +VAVK  K    ++   ++ +E+E++  I   
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               L+    +
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
             A QVA+ +E L S+    IHRD+ + NVL+  +   ++ DFGLA      ++  ++T 
Sbjct: 143 SCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 200
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+LL EI +      +G SP P + V+    L+
Sbjct: 201 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVEELFKLL 254
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLH 331
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+    L ++V L 
Sbjct: 255 KEGH-------RMDKPSN--CTNELYMMMRDCWHAVPSQRPTFKQLVE---DLDRIVALT 302
Query: 332 S 332
           S
Sbjct: 303 S 303

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 140/301 (46%), Gaps = 49/301 (16%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G          +VAVK  K    ++   ++ +E+E++  I   
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               L+    +
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
             A QVA+ +E L S+    IHRD+ + NVL+  +   ++ DFGLA      ++  ++T 
Sbjct: 147 SCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 204
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+LL EI +      +G SP P + V+    L+
Sbjct: 205 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVEELFKLL 258
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLH 331
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+    L ++V L 
Sbjct: 259 KEGH-------RMDKPSN--CTNELYMMMRDCWHAVPSQRPTFKQLVE---DLDRIVALT 306
Query: 332 S 332
           S
Sbjct: 307 S 307

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 16/195 (8%)
Query: 63  LGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN---EIEILSKIHSPRLVNLLGFSN 119
           LG G+ G VYKA  +   V       + +  +E+++   EI+IL+    P +V LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +++EF + G +  V+    RPL   +   +  Q   A+  LH     IIHRD+K
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--KIIHRDLK 162
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRF--RSTPPAGTIGYLDP----CYVTPDN-LS 232
           + N+L   + + +L DFG++ +    N R   R     GT  ++ P    C  + D    
Sbjct: 163 AGNILFTLDGDIKLADFGVSAK----NTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 233 TKTDVFSFGILLLEI 247
            K DV+S GI L+E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/303 (22%), Positives = 128/303 (42%), Gaps = 39/303 (12%)
Query: 39  PIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQE 91
           P+  QH      E + +     + LG+   G VYK  L G       + VA+K      E
Sbjct: 10  PLINQHKQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE 69
Query: 92  --ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVL-----HSNN 144
             + +E  +E  + +++  P +V LLG     +   ++  + S+G L++ L     HS+ 
Sbjct: 70  GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV 129
Query: 145 RPLNWGRRIRLAL----------QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLG 194
              +  R ++ AL          Q+A  +E L S    ++H+D+ + NVL+    N ++ 
Sbjct: 130 GSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKIS 187
Query: 195 DFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAI 254
           D GL       ++          I ++ P  +     S  +D++S+G++L E+ S     
Sbjct: 188 DLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247
Query: 255 DIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSM 314
             G+S   +V+    +I+  ++L       P P D      +  + + C      RRP  
Sbjct: 248 YCGYSNQDVVE----MIRNRQVL-------PCPDD--CPAWVYALMIECWNEFPSRRPRF 294
Query: 315 KEI 317
           K+I
Sbjct: 295 KDI 297

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 16/195 (8%)
Query: 63  LGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN---EIEILSKIHSPRLVNLLGFSN 119
           LG G+ G VYKA  +   V       + +  +E+++   EI+IL+    P +V LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +++EF + G +  V+    RPL   +   +  Q   A+  LH     IIHRD+K
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--KIIHRDLK 162
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRF--RSTPPAGTIGYLDP----CYVTPDN-LS 232
           + N+L   + + +L DFG++ +    N R   R     GT  ++ P    C  + D    
Sbjct: 163 AGNILFTLDGDIKLADFGVSAK----NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 233 TKTDVFSFGILLLEI 247
            K DV+S GI L+E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           F E +L+G G  G V+KA  R  G+   +++   N E   + + E++ L+K+    +V+ 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNE---KAEREVKALAKLDHVNIVHY 70
Query: 115 ----LGFSND-----------------------SKDRLLVV--EFMSNGTLYDVLHSNN- 144
                GF  D                       SK + L +  EF   GTL   +     
Sbjct: 71  NGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 130
Query: 145 RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV 204
             L+    + L  Q+ K V+ +HS+   +IHRD+K +N+ +      ++GDFGL      
Sbjct: 131 EKLDKVLALELFEQITKGVDYIHSK--KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 188
Query: 205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIV 264
           D  R RS    GT+ Y+ P  ++  +   + D+++ G++L E++      D  F      
Sbjct: 189 DGKRTRS---KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH---VCDTAFETSKFF 242
Query: 265 DWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
                 ++ G I  +FD            K+   +  + +    E RP+  EI+  LT  
Sbjct: 243 ----TDLRDGIISDIFD------------KKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 286
Query: 325 SK 326
            K
Sbjct: 287 KK 288

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 121/274 (44%), Gaps = 24/274 (8%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ-----VAVKKPSKNQEI--SQEVDNEIEILSKIHSPRLVN 113
           ++LG+G  G VY+ V    +     VAVK   K+  +   ++  +E  I+  +  P +V 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G   + +   +++E    G L   L  N   L     +  +LQ+ KA+  L S     
Sbjct: 78  LIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES--INC 134
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDI   N+L+      +LGDFGL+ R   D   ++++     I ++ P  +     +T
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLS-RYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 193
Query: 234 KTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR 293
            +DV+ F + + EI+S  K          ++     +++KG  L    P + PP      
Sbjct: 194 ASDVWMFAVCMWEILSFGKQPFFWLENKDVIG----VLEKGDRLP--KPDLCPP------ 241
Query: 294 KQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL 327
             L  +  RC       RP   E+V  L+ + ++
Sbjct: 242 -VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 16/195 (8%)
Query: 63  LGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN---EIEILSKIHSPRLVNLLGFSN 119
           LG G+ G VYKA  +   V       + +  +E+++   EI+IL+    P +V LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +++EF + G +  V+    RPL   +   +  Q   A+  LH     IIHRD+K
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--KIIHRDLK 162
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRF--RSTPPAGTIGYLDP----CYVTPDN-LS 232
           + N+L   + + +L DFG++ +    N R   R     GT  ++ P    C  + D    
Sbjct: 163 AGNILFTLDGDIKLADFGVSAK----NTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 233 TKTDVFSFGILLLEI 247
            K DV+S GI L+E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 140/301 (46%), Gaps = 49/301 (16%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G          +VAVK  K    ++   ++ +E+E++  I   
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               L+    +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
             A QVA+ +E L S+    IHRD+ + NVL+  +   ++ DFGLA      ++  ++T 
Sbjct: 139 SCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+LL EI +      +G SP P + V+    L+
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVEELFKLL 250
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLH 331
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+    L ++V L 
Sbjct: 251 KEGH-------RMDKPSN--CTNELYMMMRDCWHAVPSQRPTFKQLVE---DLDRIVALT 298
Query: 332 S 332
           S
Sbjct: 299 S 299

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 26/214 (12%)
Query: 60  QKLLGKGSHGSVYKAVLRGRQ--VAVKKPS----KNQEISQEVDNEIEILSKIHSPRLVN 113
           ++ LG+GS G V  A     Q  VA+K  S    K  ++   V+ EI  L  +  P ++ 
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPL-NWGRRIRLALQVAKAVEILHSEMPP 172
           L        D ++V+E+ + G L+D +    R   + GRR     Q+  A+E  H     
Sbjct: 74  LYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRR--FFQQIICAIEYCHRH--K 128
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           I+HRD+K  N+L+D N N ++ DFGL+      NF   S    G+     P Y  P+ ++
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGS-----PNYAAPEVIN 180
Query: 233 TK------TDVFSFGILLLEIISCRKAIDIGFSP 260
            K       DV+S GI+L  ++  R   D  F P
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP 214

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 120/279 (43%), Gaps = 39/279 (13%)
Query: 63  LGKGSHGSVYKAVLRG-------RQVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVN 113
           LG+   G VYK  L G       + VA+K      E  + +E  +E  + +++  P +V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVL-----HSNNRPLNWGRRIRLAL----------Q 158
           LLG     +   ++  + S+G L++ L     HS+    +  R ++ AL          Q
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTI 218
           +A  +E L S    ++H+D+ + NVL+    N ++ D GL       ++          I
Sbjct: 137 IAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 194
Query: 219 GYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILS 278
            ++ P  +     S  +D++S+G++L E+ S       G+S   +V+    +I+  ++L 
Sbjct: 195 RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE----MIRNRQVL- 249
Query: 279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
                 P P D      +  + + C      RRP  K+I
Sbjct: 250 ------PCPDD--CPAWVYALMIECWNEFPSRRPRFKDI 280

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 98/189 (51%), Gaps = 9/189 (4%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPS-KNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           +G+GS G V  A +R  G+ VAVKK   + Q+  + + NE+ I+       +V +     
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+EF+  G L D++      +N  +   + L V +A+ +LH++   +IHRDIK
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQG--VIHRDIK 274
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S ++L+  +   +L DFG   +   +  R +     GT  ++ P  ++      + D++S
Sbjct: 275 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISRLPYGPEVDIWS 332
Query: 240 FGILLLEII 248
            GI+++E++
Sbjct: 333 LGIMVIEMV 341

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 63  LGKGSHGSVYKA--VLRGRQVAVKK--PSKNQEISQEVDNEIEI-LSKIHSPRLVNLLGF 117
           LG+G++G V K   V  G+ +AVK+   + N +  + +  +++I +  +  P  V   G 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 118 SNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
                D  + +E M       Y  +    + +      ++A+ + KA+E LHS++  +IH
Sbjct: 119 LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-VIH 177
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD----NL 231
           RD+K +NVLI+     ++ DFG++   G        T  AG   Y+ P  + P+      
Sbjct: 178 RDVKPSNVLINALGQVKMCDFGIS---GYLVDSVAKTIDAGCKPYMAPERINPELNQKGY 234
Query: 232 STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI 291
           S K+D++S GI ++E+   R   D          W  P  +  +++    P++P  K   
Sbjct: 235 SVKSDIWSLGITMIELAILRFPYD---------SWGTPFQQLKQVVEEPSPQLPADK--- 282
Query: 292 VRKQLAVIAVRCVRSCRERRPSMKEIV 318
              +      +C++   + RP+  E++
Sbjct: 283 FSAEFVDFTSQCLKKNSKERPTYPELM 309

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 121/274 (44%), Gaps = 24/274 (8%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ-----VAVKKPSKNQEI--SQEVDNEIEILSKIHSPRLVN 113
           ++LG+G  G VY+ V    +     VAVK   K+  +   ++  +E  I+  +  P +V 
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 89
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G   + +   +++E    G L   L  N   L     +  +LQ+ KA+  L S     
Sbjct: 90  LIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES--INC 146
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDI   N+L+      +LGDFGL+ R   D   ++++     I ++ P  +     +T
Sbjct: 147 VHRDIAVRNILVASPECVKLGDFGLS-RYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 205
Query: 234 KTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR 293
            +DV+ F + + EI+S  K          ++     +++KG  L    P + PP      
Sbjct: 206 ASDVWMFAVCMWEILSFGKQPFFWLENKDVIG----VLEKGDRLP--KPDLCPP------ 253
Query: 294 KQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL 327
             L  +  RC       RP   E+V  L+ + ++
Sbjct: 254 -VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 286

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 98/189 (51%), Gaps = 9/189 (4%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPS-KNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           +G+GS G V  A +R  G+ VAVKK   + Q+  + + NE+ I+       +V +     
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+EF+  G L D++      +N  +   + L V +A+ +LH++   +IHRDIK
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQG--VIHRDIK 197
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S ++L+  +   +L DFG   +   +  R +     GT  ++ P  ++      + D++S
Sbjct: 198 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISRLPYGPEVDIWS 255
Query: 240 FGILLLEII 248
            GI+++E++
Sbjct: 256 LGIMVIEMV 264

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 40  IKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKA------VLRGRQVAVKKPSKNQEIS 93
           I  +HF   D E         + LGKG  G+VY A       +   +V  K   + + + 
Sbjct: 15  ILTRHFTIDDFEIG-------RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVE 67
Query: 94  QEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI 153
            ++  EIEI + +H P ++ L  +  D +   L++E+   G LY  L  +    +  R  
Sbjct: 68  HQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT-FDEQRTA 126
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
            +  ++A A+   H +   +IHRDIK  N+L+      ++ DFG ++         R   
Sbjct: 127 TIMEELADALMYCHGKK--VIHRDIKPENLLLGLKGELKIADFGWSVHAP----SLRRKT 180
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEII 248
             GT+ YL P  +     + K D++  G+L  E++
Sbjct: 181 MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELL 215

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 121/274 (44%), Gaps = 24/274 (8%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ-----VAVKKPSKNQEI--SQEVDNEIEILSKIHSPRLVN 113
           ++LG+G  G VY+ V    +     VAVK   K+  +   ++  +E  I+  +  P +V 
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G   + +   +++E    G L   L  N   L     +  +LQ+ KA+  L S     
Sbjct: 74  LIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES--INC 130
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDI   N+L+      +LGDFGL+ R   D   ++++     I ++ P  +     +T
Sbjct: 131 VHRDIAVRNILVASPECVKLGDFGLS-RYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 189
Query: 234 KTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR 293
            +DV+ F + + EI+S  K          ++     +++KG  L    P + PP      
Sbjct: 190 ASDVWMFAVCMWEILSFGKQPFFWLENKDVIG----VLEKGDRLP--KPDLCPP------ 237
Query: 294 KQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL 327
             L  +  RC       RP   E+V  L+ + ++
Sbjct: 238 -VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 270

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 98/189 (51%), Gaps = 9/189 (4%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPS-KNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           +G+GS G V  A +R  G+ VAVKK   + Q+  + + NE+ I+       +V +     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+EF+  G L D++      +N  +   + L V +A+ +LH++   +IHRDIK
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQ--GVIHRDIK 154
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S ++L+  +   +L DFG   +   +  R +     GT  ++ P  ++      + D++S
Sbjct: 155 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISRLPYGPEVDIWS 212
Query: 240 FGILLLEII 248
            GI+++E++
Sbjct: 213 LGIMVIEMV 221

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 19/198 (9%)
Query: 61  KLLGKGSHGSVY-------KAVLRGRQVA---VKKPSKNQEISQEVDNEIEILSKIHSPR 110
           + LGKG     Y       K V  G+ V    + KP + +++S     EI I   + +P 
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS----TEIAIHKSLDNPH 103
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           +V   GF  D     +V+E     +L + LH   + +          Q  + V+ LH+  
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             +IHRD+K  N+ ++ + + ++GDFGLA +   D  R ++    GT  Y+ P  +    
Sbjct: 163 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL--CGTPNYIAPEVLCKKG 218
Query: 231 LSTKTDVFSFGILLLEII 248
            S + D++S G +L  ++
Sbjct: 219 HSFEVDIWSLGCILYTLL 236

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 112/232 (48%), Gaps = 17/232 (7%)
Query: 63  LGKGSHGSVYKAVLRGRQ----VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           LG G+ GSV + V R R+    VA+K  K    +  ++E+  E +I+ ++ +P +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
               ++  +LV+E    G L+  L      +       L  QV+  ++ L  E    +HR
Sbjct: 404 VCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL--EEKNFVHR 460
Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT--IGYLDPCYVTPDNLSTK 234
           ++ + NVL+     A++ DFGL+   G D+  + +   AG   + +  P  +     S++
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 235 TDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP 286
           +DV+S+G+ + E +S  +        P ++      I++GK +    P  PP
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMKGPEVM----AFIEQGKRMEC-PPECPP 566

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 94/192 (48%), Gaps = 10/192 (5%)
Query: 63  LGKGSHGSVYKA--VLRGRQVAVKK----PSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           LG G   +VY A   +   +VA+K     P + +E  +  + E+   S++    +V+++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
              +     LV+E++   TL + + S+  PL+    I    Q+   ++  H+    I+HR
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIK--HAHDMRIVHR 135
Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTD 236
           DIK  N+LID N   ++ DFG+A +   +    ++    GT+ Y  P     +     TD
Sbjct: 136 DIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTD 194
Query: 237 VFSFGILLLEII 248
           ++S GI+L E++
Sbjct: 195 IYSIGIVLYEML 206

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 98/189 (51%), Gaps = 9/189 (4%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPS-KNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           +G+GS G V  A +R  G+ VAVKK   + Q+  + + NE+ I+       +V +     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+EF+  G L D++      +N  +   + L V +A+ +LH++   +IHRDIK
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQ--GVIHRDIK 152
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S ++L+  +   +L DFG   +   +  R +     GT  ++ P  ++      + D++S
Sbjct: 153 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISRLPYGPEVDIWS 210
Query: 240 FGILLLEII 248
            GI+++E++
Sbjct: 211 LGIMVIEMV 219

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 101/189 (53%), Gaps = 9/189 (4%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPS-KNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           +G+GS G V  A +R  G+ VAVKK   + Q+  + + NE+ I+       +V +     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+EF+  G L D++ ++ R +N  +   + L V +A+ +LH++   +IHRDIK
Sbjct: 92  VGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLQALSVLHAQ--GVIHRDIK 147
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S ++L+  +   +L DFG   +   +  R +     GT  ++ P  ++      + D++S
Sbjct: 148 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISRLPYGPEVDIWS 205
Query: 240 FGILLLEII 248
            GI+++E++
Sbjct: 206 LGIMVIEMV 214

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 102/231 (44%), Gaps = 34/231 (14%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIE 101
           E   N     + +G+G+ G V++A   G         VAVK  K   + ++  +   E  
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 102 ILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN----------------- 144
           ++++  +P +V LLG     K   L+ E+M+ G L + L S +                 
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 145 ------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
                  PL+   ++ +A QVA  +  L       +HRD+ + N L+  N   ++ DFGL
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGL 220
Query: 199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
           +      ++       A  I ++ P  +  +  +T++DV+++G++L EI S
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 98/189 (51%), Gaps = 9/189 (4%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPS-KNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           +G+GS G V  A +R  G+ VAVKK   + Q+  + + NE+ I+       +V +     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
              +  +V+EF+  G L D++      +N  +   + L V +A+ +LH++   +IHRDIK
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQ--GVIHRDIK 143
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S ++L+  +   +L DFG   +   +  R +     GT  ++ P  ++      + D++S
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISRLPYGPEVDIWS 201
Query: 240 FGILLLEII 248
            GI+++E++
Sbjct: 202 LGIMVIEMV 210

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 59  EQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL 111
           E K LG G+ G+V K   +            +K  + +  +  E+  E  ++ ++ +P +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V ++G   +++  +LV+E    G L   L  N R +     I L  QV+  ++ L  E  
Sbjct: 69  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYL--EES 124
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + NVL+     A++ DFGL  ALR   +N+    T     + +  P  +   
Sbjct: 125 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYY 183
Query: 230 NLSTKTDVFSFGILLLEIIS 249
             S+K+DV+SFG+L+ E  S
Sbjct: 184 KFSSKSDVWSFGVLMWEAFS 203

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 59  EQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL 111
           E K LG G+ G+V K   +            +K  + +  +  E+  E  ++ ++ +P +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V ++G   +++  +LV+E    G L   L  N R +     I L  QV+  ++ L  E  
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYL--EES 130
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + NVL+     A++ DFGL  ALR   +N+    T     + +  P  +   
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYY 189
Query: 230 NLSTKTDVFSFGILLLEIIS 249
             S+K+DV+SFG+L+ E  S
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G  G V  A   G           VAVK  K    ++   ++ +E+E++  I   
Sbjct: 30  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               + +   +
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
               Q+A+ +E L S+    IHRD+ + NVL+  N   ++ DFGLA      ++  ++T 
Sbjct: 150 SCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+L+ EI +      +G SP P I V+    L+
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 261
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+
Sbjct: 262 KEGH-------RMDKPAN--CTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G  G V  A   G           VAVK  K    ++   ++ +E+E++  I   
Sbjct: 33  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               + +   +
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
               Q+A+ +E L S+    IHRD+ + NVL+  N   ++ DFGLA      ++  ++T 
Sbjct: 153 SCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+L+ EI +      +G SP P I V+    L+
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 264
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+
Sbjct: 265 KEGH-------RMDKPAN--CTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 59  EQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL 111
           E K LG G+ G+V K   +            +K  + +  +  E+  E  ++ ++ +P +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V ++G   +++  +LV+E    G L   L  N R +     I L  QV+  ++ L  E  
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYL--EES 146
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + NVL+     A++ DFGL  ALR   +N+    T     + +  P  +   
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYY 205
Query: 230 NLSTKTDVFSFGILLLEIIS 249
             S+K+DV+SFG+L+ E  S
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 59  EQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL 111
           E K LG G+ G+V K   +            +K  + +  +  E+  E  ++ ++ +P +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V ++G   +++  +LV+E    G L   L  N R +     I L  QV+  ++ L  E  
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYL--EES 146
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + NVL+     A++ DFGL  ALR   +N+    T     + +  P  +   
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYY 205
Query: 230 NLSTKTDVFSFGILLLEIIS 249
             S+K+DV+SFG+L+ E  S
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS 225

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 59  EQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL 111
           E K LG G+ G+V K   +            +K  + +  +  E+  E  ++ ++ +P +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V ++G   +++  +LV+E    G L   L  N R +     I L  QV+  ++ L  E  
Sbjct: 89  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYL--EES 144
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + NVL+     A++ DFGL  ALR   +N+    T     + +  P  +   
Sbjct: 145 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYY 203
Query: 230 NLSTKTDVFSFGILLLEIIS 249
             S+K+DV+SFG+L+ E  S
Sbjct: 204 KFSSKSDVWSFGVLMWEAFS 223

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 59  EQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL 111
           E K LG G+ G+V K   +            +K  + +  +  E+  E  ++ ++ +P +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V ++G   +++  +LV+E    G L   L  N R +     I L  QV+  ++ L  E  
Sbjct: 81  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYL--EES 136
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + NVL+     A++ DFGL  ALR   +N+    T     + +  P  +   
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYY 195
Query: 230 NLSTKTDVFSFGILLLEIIS 249
             S+K+DV+SFG+L+ E  S
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS 215

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 60  QKLLGKGSHGSVYKAVLR--GRQ---VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++++G G  G V +  L+  G++   VA+K  K    +   +E  +E  I+ +   P ++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            L G   +S   +++ EFM NG L   L  N+      + + +   +A  +  L +EM  
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL-AEM-S 138
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG---TIGYLDPCYVTPD 229
            +HRD+ + N+L++ N   ++ DFGL+     ++     T   G    I +  P  +   
Sbjct: 139 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD 289
             ++ +D +S+GI++ E++S  +      S   +++     I++       D R+PPP D
Sbjct: 199 KFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVIN----AIEQ-------DYRLPPPPD 247
Query: 290 -PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLV 328
            P    QL    + C +  R  RP   ++V   + L K++
Sbjct: 248 CPTSLHQL---MLDCWQKDRNARPRFPQVV---SALDKMI 281

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 133/285 (46%), Gaps = 40/285 (14%)
Query: 60  QKLLGKGSHGSVYKAVLR--GRQ---VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++++G G  G V +  L+  G++   VA+K  K    +   +E  +E  I+ +   P ++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            L G   +S   +++ EFM NG L   L  N+      + + +   +A  +  L +EM  
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL-AEM-S 136
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT--------IGYLDPC 224
            +HRD+ + N+L++ N   ++ DFGL+ R   +N    S+ P  T        I +  P 
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGLS-RFLEEN----SSDPTYTSSLGGKIPIRWTAPE 191
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI 284
            +     ++ +D +S+GI++ E++S  +      S   +++     I++       D R+
Sbjct: 192 AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVIN----AIEQ-------DYRL 240
Query: 285 PPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLV 328
           PPP D P    QL    + C +  R  RP   ++V   + L K++
Sbjct: 241 PPPPDCPTSLHQL---MLDCWQKDRNARPRFPQVV---SALDKMI 279

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G  G V  A   G           VAVK  K    ++   ++ +E+E++  I   
Sbjct: 28  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               + +   +
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
               Q+A+ +E L S+    IHRD+ + NVL+  N   ++ DFGLA      ++  ++T 
Sbjct: 148 SCTYQLARGMEYLASQ--KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+L+ EI +      +G SP P I V+    L+
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 259
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+
Sbjct: 260 KEGH-------RMDKPAN--CTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 59  EQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL 111
           E K LG G+ G+V K   +            +K  + +  +  E+  E  ++ ++ +P +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V ++G   +++  +LV+E    G L   L   NR +     I L  QV+  ++ L  E  
Sbjct: 433 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYL--EES 488
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + NVL+     A++ DFGL  ALR   +N+    T     + +  P  +   
Sbjct: 489 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYY 547
Query: 230 NLSTKTDVFSFGILLLEIIS 249
             S+K+DV+SFG+L+ E  S
Sbjct: 548 KFSSKSDVWSFGVLMWEAFS 567

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 59  EQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL 111
           E K LG G+ G+V K   +            +K  + +  +  E+  E  ++ ++ +P +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V ++G   +++  +LV+E    G L   L  N R +     I L  QV+  ++ L  E  
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYL--EES 126
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + NVL+     A++ DFGL  ALR   +N+    T     + +  P  +   
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYY 185
Query: 230 NLSTKTDVFSFGILLLEIIS 249
             S+K+DV+SFG+L+ E  S
Sbjct: 186 KFSSKSDVWSFGVLMWEAFS 205

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 59  EQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL 111
           E K LG G+ G+V K   +            +K  + +  +  E+  E  ++ ++ +P +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V ++G   +++  +LV+E    G L   L   NR +     I L  QV+  ++ L  E  
Sbjct: 434 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYL--EES 489
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + NVL+     A++ DFGL  ALR   +N+    T     + +  P  +   
Sbjct: 490 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYY 548
Query: 230 NLSTKTDVFSFGILLLEIIS 249
             S+K+DV+SFG+L+ E  S
Sbjct: 549 KFSSKSDVWSFGVLMWEAFS 568

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 19/198 (9%)
Query: 61  KLLGKGSHGSVY-------KAVLRGRQVA---VKKPSKNQEISQEVDNEIEILSKIHSPR 110
           + LGKG     Y       K V  G+ V    + KP + +++S     EI I   + +P 
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS----TEIAIHKSLDNPH 103
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           +V   GF  D     +V+E     +L + LH   + +          Q  + V+ LH+  
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             +IHRD+K  N+ ++ + + ++GDFGLA +   D  R +     GT  Y+ P  +    
Sbjct: 163 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXL--CGTPNYIAPEVLCKKG 218
Query: 231 LSTKTDVFSFGILLLEII 248
            S + D++S G +L  ++
Sbjct: 219 HSFEVDIWSLGCILYTLL 236

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 19/198 (9%)
Query: 61  KLLGKGSHGSVY-------KAVLRGRQVA---VKKPSKNQEISQEVDNEIEILSKIHSPR 110
           + LGKG     Y       K V  G+ V    + KP + +++S     EI I   + +P 
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS----TEIAIHKSLDNPH 103
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           +V   GF  D     +V+E     +L + LH   + +          Q  + V+ LH+  
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             +IHRD+K  N+ ++ + + ++GDFGLA +   D  R +     GT  Y+ P  +    
Sbjct: 163 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL--CGTPNYIAPEVLCKKG 218
Query: 231 LSTKTDVFSFGILLLEII 248
            S + D++S G +L  ++
Sbjct: 219 HSFEVDIWSLGCILYTLL 236

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 19/198 (9%)
Query: 61  KLLGKGSHGSVY-------KAVLRGRQVA---VKKPSKNQEISQEVDNEIEILSKIHSPR 110
           + LGKG     Y       K V  G+ V    + KP + +++S     EI I   + +P 
Sbjct: 32  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS----TEIAIHKSLDNPH 87
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           +V   GF  D     +V+E     +L + LH   + +          Q  + V+ LH+  
Sbjct: 88  VVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 146
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             +IHRD+K  N+ ++ + + ++GDFGLA +   D  R +     GT  Y+ P  +    
Sbjct: 147 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL--CGTPNYIAPEVLCKKG 202
Query: 231 LSTKTDVFSFGILLLEII 248
            S + D++S G +L  ++
Sbjct: 203 HSFEVDIWSLGCILYTLL 220

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G           VAVK  K    ++   ++ +E+E++  I   
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
               Q+A+ +E L S+    IHRD+ + NVL+  N   ++ DFGLA      ++   +T 
Sbjct: 161 SCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+L+ EI +      +G SP P I V+    L+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 272
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+
Sbjct: 273 KEGH-------RMDKPAN--CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 46/223 (20%)
Query: 64  GKGSHGSVYKAVLRGRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLV--NLLGF--- 117
            +G  G V+KA L    VAVK  P ++++  Q   +E EI S   +P +   NLL F   
Sbjct: 24  ARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQ---SEREIFS---TPGMKHENLLQFIAA 77
Query: 118 ----SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP-- 171
               SN   +  L+  F   G+L D L  N   + W     +A  +++ +  LH ++P  
Sbjct: 78  EKRGSNLEVELWLITAFHDKGSLTDYLKGN--IITWNELCHVAETMSRGLSYLHEDVPWC 135
Query: 172 -------PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR-STPPAGTIGYLDP 223
                   I HRD KS NVL+  +  A L DFGLA+       RF    PP  T G +  
Sbjct: 136 RGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAV-------RFEPGKPPGDTHGQVGT 188
Query: 224 -CYVTPDNLS----------TKTDVFSFGILLLEIISCRKAID 255
             Y+ P+ L            + D+++ G++L E++S  KA D
Sbjct: 189 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG-RQVAVKKPSKNQEISQEVDN-----EIEI 102
           DL      +   K++G+G+ G V     +  R+V   K     E+ +  D+     E +I
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 103 LSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
           ++  +SP +V L     D +   +V+E+M  G L +++ + + P  W R      +V  A
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF--YTAEVVLA 185
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           ++ +HS     IHRD+K  N+L+D++ + +L DFG  ++   +    R     GT     
Sbjct: 186 LDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGT----- 237
Query: 223 PCYVTPDNLSTK---------TDVFSFGILLLEII 248
           P Y++P+ L ++          D +S G+ L E++
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG-RQVAVKKPSKNQEISQEVDN-----EIEI 102
           DL      +   K++G+G+ G V     +  R+V   K     E+ +  D+     E +I
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 103 LSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
           ++  +SP +V L     D +   +V+E+M  G L +++ + + P  W R      +V  A
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF--YTAEVVLA 185
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           ++ +HS     IHRD+K  N+L+D++ + +L DFG  ++   +    R     GT     
Sbjct: 186 LDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGT----- 237
Query: 223 PCYVTPDNLSTK---------TDVFSFGILLLEII 248
           P Y++P+ L ++          D +S G+ L E++
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 59  EQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL 111
           E K LG G+ G+V K   +            +K  + +  +  E+  E  ++ ++ +P +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V ++G   +++  +LV+E    G L   L  N R +     I L  QV+  ++ L  E  
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYL--EES 130
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + NVL+     A++ DFGL  ALR   + ++ ++        Y   C +   
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPEC-INYY 189
Query: 230 NLSTKTDVFSFGILLLEIIS 249
             S+K+DV+SFG+L+ E  S
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 127/295 (43%), Gaps = 39/295 (13%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRGR-------QVAVK--KPSKNQEISQEVDNEIE 101
           E   N     K LG G+ G V +A   G        +VAVK  K + + +  + + +E++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 102 ILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVA 160
           I+S +     +VNLLG        L++ E+   G L + L   +R L       +A   A
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 161 KAVEILH--SEMPP---------IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF 209
              ++LH  S++            IHRD+ + NVL+     A++GDFGLA     D+   
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSIV--DW 266
                   + ++ P  +     + ++DV+S+GILL EI S      +G +P P I+    
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYPGILVNSK 275
Query: 267 AAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
              L+K G  ++   P   P       K +  I   C       RP+ ++I  +L
Sbjct: 276 FYKLVKDGYQMA--QPAFAP-------KNIYSIMQACWALEPTHRPTFQQICSFL 321

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRG-RQVAVKKPSKNQEISQEVDN-----EIEI 102
           DL      +   K++G+G+ G V     +  R+V   K     E+ +  D+     E +I
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 103 LSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
           ++  +SP +V L     D +   +V+E+M  G L +++ + + P  W R      +V  A
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF--YTAEVVLA 180
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           ++ +HS     IHRD+K  N+L+D++ + +L DFG  ++   +    R     GT     
Sbjct: 181 LDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGT----- 232
Query: 223 PCYVTPDNLSTK---------TDVFSFGILLLEII 248
           P Y++P+ L ++          D +S G+ L E++
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 52  AATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKN----QEISQEVDNEIEILSK 105
           A    +   K LG+GS G V  A     G++VA+K  +K      ++   ++ EI  L  
Sbjct: 11  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 70
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           +  P ++ L        + ++V+E+  N  L+D +   ++      R R   Q+  AVE 
Sbjct: 71  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEY 128
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
            H     I+HRD+K  N+L+D + N ++ DFGL+      NF   S           P Y
Sbjct: 129 CHRH--KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG--------SPNY 178
Query: 226 VTPDNLSTK------TDVFSFGILLLEIISCRK 252
             P+ +S K       DV+S G++L  ++ CR+
Sbjct: 179 AAPEVISGKLYAGPEVDVWSCGVILY-VMLCRR 210

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 125/305 (40%), Gaps = 42/305 (13%)
Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQE 95
           +D S  E   +  +  K LG+G+ G V +A   G       R VAVK  K        + 
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 96  VDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLV-VEFMSNGTLYDVLHSNNRP------- 146
           + +E++IL  I H   +VNLLG        L+V VEF   G L   L S           
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 147 ----LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC 202
               L     I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGLA   
Sbjct: 137 YKDFLTLEHLIXYSFQVAKGMEFLASR--KXIHRDLAARNILLSEKNVVKIXDFGLARDI 194
Query: 203 GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS 262
             D    R       + ++ P  +     + ++DV+SFG+LL EI S      +G SP  
Sbjct: 195 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYP 248
Query: 263 IVDWAAPL---IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
            V         +K+G  +   D   P         ++    + C      +RP+  E+V+
Sbjct: 249 GVKIDEEFXRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVE 299
Query: 320 WLTGL 324
            L  L
Sbjct: 300 HLGNL 304

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 133/291 (45%), Gaps = 34/291 (11%)
Query: 60  QKLLGKGSHGSVYKAVLR--GRQ---VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++++G G  G V    L+  G++   VA+K  K    ++  ++  +E  I+ +   P ++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
           +L G    S   +++ EFM NG+L   L  N+      + + +   +A  ++ L ++M  
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL-ADM-N 129
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG---TIGYLDPCYVTPD 229
            +HR + + N+L++ N   ++ DFGL+     D      T   G    I +  P  +   
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD 289
             ++ +DV+S+GI++ E++S  +      +   +++     I++       D R+PPP D
Sbjct: 190 KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN----AIEQ-------DYRLPPPMD 238
Query: 290 -PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL-------TGLSKLVPLHS 332
            P    QL    + C +  R  RP   +IV+ L         L  + PL S
Sbjct: 239 CPSALHQL---MLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAPLSS 286

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 139/301 (46%), Gaps = 49/301 (16%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G          +VAVK  K    ++   ++ +E+E++  I   
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               L+    +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
             A QVA+ +E L S+    IHRD+ + NVL+  +   ++ DFGLA      +   ++T 
Sbjct: 154 SCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+LL EI +      +G SP P + V+    L+
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVEELFKLL 265
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLH 331
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+    L ++V L 
Sbjct: 266 KEGH-------RMDKPSN--CTNELYMMMRDCWHAVPSQRPTFKQLVE---DLDRIVALT 313
Query: 332 S 332
           S
Sbjct: 314 S 314

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 52  AATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKN----QEISQEVDNEIEILSK 105
           A    +   K LG+GS G V  A     G++VA+K  +K      ++   ++ EI  L  
Sbjct: 10  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 69
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           +  P ++ L        + ++V+E+  N  L+D +   ++      R R   Q+  AVE 
Sbjct: 70  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEY 127
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
            H     I+HRD+K  N+L+D + N ++ DFGL+      NF   S           P Y
Sbjct: 128 CHRH--KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG--------SPNY 177
Query: 226 VTPDNLSTK------TDVFSFGILLLEIISCRK 252
             P+ +S K       DV+S G++L  ++ CR+
Sbjct: 178 AAPEVISGKLYAGPEVDVWSCGVILY-VMLCRR 209

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 52  AATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKN----QEISQEVDNEIEILSK 105
           A    +   K LG+GS G V  A     G++VA+K  +K      ++   ++ EI  L  
Sbjct: 5   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 64
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           +  P ++ L        + ++V+E+  N  L+D +   ++      R R   Q+  AVE 
Sbjct: 65  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEY 122
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
            H     I+HRD+K  N+L+D + N ++ DFGL+      NF   S    G+     P Y
Sbjct: 123 CHRH--KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGS-----PNY 172
Query: 226 VTPDNLSTK------TDVFSFGILLLEIISCRK 252
             P+ +S K       DV+S G++L  ++ CR+
Sbjct: 173 AAPEVISGKLYAGPEVDVWSCGVILY-VMLCRR 204

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 52  AATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKN----QEISQEVDNEIEILSK 105
           A    +   K LG+GS G V  A     G++VA+K  +K      ++   ++ EI  L  
Sbjct: 1   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 60
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           +  P ++ L        + ++V+E+  N  L+D +   ++      R R   Q+  AVE 
Sbjct: 61  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEY 118
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
            H     I+HRD+K  N+L+D + N ++ DFGL+      NF   S    G+     P Y
Sbjct: 119 CHRH--KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGS-----PNY 168
Query: 226 VTPDNLSTK------TDVFSFGILLLEIISCRK 252
             P+ +S K       DV+S G++L  ++ CR+
Sbjct: 169 AAPEVISGKLYAGPEVDVWSCGVILY-VMLCRR 200

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVK--KPSKNQEISQEVDNEIEILSKI 106
           +A  N       +G G+ G V+K   R  G  +AVK  + S N+E ++ +  +++++ K 
Sbjct: 21  QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKS 80
Query: 107 H-SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVE 164
           H  P +V   G    + D  + +E M  GT  + L    + P+      ++ + + KA+ 
Sbjct: 81  HDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALY 138
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            L  E   +IHRD+K +N+L+D     +L DFG++ R   D  + RS   AG   Y+ P 
Sbjct: 139 YL-KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS---AGCAAYMAPE 194
Query: 225 YVTP-----DNLSTKTDVFSFGILLLEIIS 249
            + P      +   + DV+S GI L+E+ +
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELAT 224

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G  G V  A   G           VAVK  K    ++   ++ +E+E++  I   
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               + +   +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
               Q+A+ +E L S+    IHRD+ + NVL+  N   ++ DFGLA      ++  ++T 
Sbjct: 207 SCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+L+ EI +      +G SP P I V+    L+
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 318
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+
Sbjct: 319 KEGH-------RMDKPAN--CTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 126/307 (41%), Gaps = 44/307 (14%)
Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQE 95
           +D S  E   +     K LG+G+ G V +A   G       R VAVK  K        + 
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 78
Query: 96  VDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLV-VEFMSNGTLYDVLHSNN------RP- 146
           + +E++IL  I H   +VNLLG        L+V VEF   G L   L S        +P 
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPE 138
Query: 147 ------LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL 200
                 L     I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGLA 
Sbjct: 139 DLYKDFLTLEHLIXYSFQVAKGMEFLASR--KXIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 201 RCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
               D    R       + ++ P  +     + ++DV+SFG+LL EI S      +G SP
Sbjct: 197 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP 250
Query: 261 PSIVDWAAPL---IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
              V         +K+G  +   D   P         ++    + C      +RP+  E+
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSEL 301
Query: 318 VDWLTGL 324
           V+ L  L
Sbjct: 302 VEHLGNL 308

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 132/288 (45%), Gaps = 46/288 (15%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G           VAVK  K    ++   ++ +E+E++  I   
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + +++LLG         ++VE+ S G L + L +   P               + +   +
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
               Q+A+ +E L S+    IHRD+ + NVL+  N   ++ DFGLA      ++  ++T 
Sbjct: 161 SCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+L+ EI +      +G SP P I V+    L+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 272
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+
Sbjct: 273 KEGH-------RMDKPAN--CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRGR-------QVAVK--KPSKNQEISQEVDNEIE 101
           E   N     K LG G+ G V +A   G        +VAVK  K + + +  + + +E++
Sbjct: 27  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 86
Query: 102 ILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH------------------- 141
           I+S +     +VNLLG        L++ E+   G L + L                    
Sbjct: 87  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEG 146
Query: 142 ---SNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
               + RPL     +  + QVA+ +  L S+    IHRD+ + NVL+     A++GDFGL
Sbjct: 147 LDKEDGRPLELRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGF 258
           A     D+           + ++ P  +     + ++DV+S+GILL EI S      +G 
Sbjct: 205 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGL 258
Query: 259 SP-PSIV--DWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMK 315
           +P P I+       L+K G  ++   P   P       K +  I   C       RP+ +
Sbjct: 259 NPYPGILVNSKFYKLVKDGYQMA--QPAFAP-------KNIYSIMQACWALEPTHRPTFQ 309
Query: 316 EIVDWL 321
           +I  +L
Sbjct: 310 QICSFL 315

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 151
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 152 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 210
Query: 231 LSTKTDVFSFGILLLEIIS 249
            S  +D+++ G ++ ++++
Sbjct: 211 ASKSSDLWALGCIIYQLVA 229

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 50  LEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEI----SQEVDNEIEIL 103
           L+     +   K++G+G+ G V     +  Q   A+K  SK + I    S     E +I+
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
           +  +SP +V L     D K   +V+E+M  G L +++ + + P  W +      +V  A+
Sbjct: 130 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF--YTAEVVLAL 187
Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           + +HS    +IHRD+K  N+L+D++ + +L DFG  ++          T   GT     P
Sbjct: 188 DAIHSM--GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDT-AVGT-----P 239
Query: 224 CYVTPDNLSTK---------TDVFSFGILLLEII 248
            Y++P+ L ++          D +S G+ L E++
Sbjct: 240 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 273

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G           VAVK  K    ++   ++ +E+E++  I   
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++ LLG         ++VE+ S G L + L +   P               + +   +
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
               Q+A+ +E L S+    IHRD+ + NVL+  N   ++ DFGLA      ++  ++T 
Sbjct: 161 SCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+L+ EI +      +G SP P I V+    L+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 272
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+
Sbjct: 273 KEGH-------RMDKPAN--CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 126/305 (41%), Gaps = 42/305 (13%)
Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQE 95
           +D S  E   +  +  K LG+G+ G V +A   G       R VAVK  K        + 
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 96  VDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLV-VEFMSNGTLYDVLHSNNRP------- 146
           + +E++IL  I H   +VNLLG        L+V VEF   G L   L S           
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 147 ----LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC 202
               L     I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGLA   
Sbjct: 137 YKDFLTLEHLICYSFQVAKGMEFLASR--KXIHRDLAARNILLSEKNVVKICDFGLARDI 194
Query: 203 GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP- 261
             D    R       + ++ P  +     + ++DV+SFG+LL EI S      +G SP  
Sbjct: 195 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYP 248
Query: 262 --SIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
              I +     +K+G  +   D   P         ++    + C      +RP+  E+V+
Sbjct: 249 GVKIDEEFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVE 299
Query: 320 WLTGL 324
            L  L
Sbjct: 300 HLGNL 304

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 123/267 (46%), Gaps = 27/267 (10%)
Query: 63  LGKGSHGSVYKA--VLRGRQVAVKK--PSKNQEISQEVDNEIEI-LSKIHSPRLVNLLGF 117
           LG+G++G V K   V  G+ +AVK+   + N +  + +  +++I +  +  P  V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 118 SNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
                D  + +E M       Y  +    + +      ++A+ + KA+E LHS++  +IH
Sbjct: 75  LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-VIH 133
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD----NL 231
           RD+K +NVLI+     ++ DFG++    VD+        AG   Y+ P  + P+      
Sbjct: 134 RDVKPSNVLINALGQVKMCDFGISGYL-VDD--VAKDIDAGCKPYMAPERINPELNQKGY 190
Query: 232 STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI 291
           S K+D++S GI ++E+   R   D          W  P  +  +++    P++P  K   
Sbjct: 191 SVKSDIWSLGITMIELAILRFPYD---------SWGTPFQQLKQVVEEPSPQLPADK--- 238
Query: 292 VRKQLAVIAVRCVRSCRERRPSMKEIV 318
              +      +C++   + RP+  E++
Sbjct: 239 FSAEFVDFTSQCLKKNSKERPTYPELM 265

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ-----VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           + +G+G  G V++ +    +     VA+K  K   +  + ++   E   + +   P +V 
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G   ++    +++E  + G L   L      L+    I  A Q++ A+  L S+    
Sbjct: 79  LIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--F 135
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDI + NVL+  N   +LGDFGL+ R   D+  ++++     I ++ P  +     ++
Sbjct: 136 VHRDIAARNVLVSSNDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 194
Query: 234 KTDVFSFGILLLEII 248
            +DV+ FG+ + EI+
Sbjct: 195 ASDVWMFGVCMWEIL 209

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ-----VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           + +G+G  G V++ +    +     VA+K  K   +  + ++   E   + +   P +V 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G   ++    +++E  + G L   L      L+    I  A Q++ A+  L S+    
Sbjct: 81  LIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--F 137
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDI + NVL+  N   +LGDFGL+ R   D+  ++++     I ++ P  +     ++
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 196
Query: 234 KTDVFSFGILLLEII 248
            +DV+ FG+ + EI+
Sbjct: 197 ASDVWMFGVCMWEIL 211

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G           VAVK  K    ++   ++ +E+E++  I   
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
               Q+A+ +E L S+    IHRD+ + NVL+  N   ++ DFGLA      +   ++T 
Sbjct: 161 SCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+L+ EI +      +G SP P I V+    L+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 272
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+
Sbjct: 273 KEGH-------RMDKPAN--CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G           VAVK  K    ++   ++ +E+E++  I   
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++VE+ S G L + L +   P               + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
               Q+A+ +E L S+    IHRD+ + NVL+  N   ++ DFGLA      +   ++T 
Sbjct: 161 SCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+L+ EI +      +G SP P I V+    L+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 272
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+
Sbjct: 273 KEGH-------RMDKPAN--CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G           VAVK  K    ++   ++ +E+E++  I   
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++V + S G L + L +   P               + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
               Q+A+ +E L S+    IHRD+ + NVL+  N   ++ DFGLA      ++  ++T 
Sbjct: 161 SCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+L+ EI +      +G SP P I V+    L+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 272
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+
Sbjct: 273 KEGH-------RMDKPAN--CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 62  LLGKGSHGSVYKAVLRGRQ------VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           +LGKGS G V K   R  Q      V  K  +KN++ S  +  E+E+L K+  P ++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDHPNIMKLF 87
Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
               DS    +V E  + G L+D +    R  +     R+  QV   +  +H     I+H
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKH--NIVH 144
Query: 176 RDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           RD+K  N+L+   +++ + ++ DFGL+  C   N + +     GT  Y+ P  V      
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKMKDR--IGTAYYIAP-EVLRGTYD 200
Query: 233 TKTDVFSFGILLLEIIS 249
            K DV+S G++L  ++S
Sbjct: 201 EKCDVWSAGVILYILLS 217

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K +G GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+M  G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ-----VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           + +G+G  G V++ +    +     VA+K  K   +  + ++   E   + +   P +V 
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G   ++    +++E  + G L   L      L+    I  A Q++ A+  L S+    
Sbjct: 104 LIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--F 160
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDI + NVL+  N   +LGDFGL+ R   D+  ++++     I ++ P  +     ++
Sbjct: 161 VHRDIAARNVLVSSNDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 219
Query: 234 KTDVFSFGILLLEII 248
            +DV+ FG+ + EI+
Sbjct: 220 ASDVWMFGVCMWEIL 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K +G GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+M  G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 127/297 (42%), Gaps = 43/297 (14%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRGR-------QVAVK--KPSKNQEISQEVDNEIE 101
           E   N     K LG G+ G V +A   G        +VAVK  K + + +  + + +E++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 102 ILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA---- 156
           I+S +     +VNLLG        L++ E+   G L + L   +R L       +A    
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTL 161
Query: 157 ---------LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF 207
                     QVA+ +  L S+    IHRD+ + NVL+     A++GDFGLA     D+ 
Sbjct: 162 STRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSIV-- 264
                     + ++ P  +     + ++DV+S+GILL EI S      +G +P P I+  
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYPGILVN 273
Query: 265 DWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
                L+K G  ++   P   P       K +  I   C       RP+ ++I  +L
Sbjct: 274 SKFYKLVKDGYQMA--QPAFAP-------KNIYSIMQACWALEPTHRPTFQQICSFL 321

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ-----VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           + +G+G  G V++ +    +     VA+K  K   +  + ++   E   + +   P +V 
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G   ++    +++E  + G L   L      L+    I  A Q++ A+  L S+    
Sbjct: 78  LIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--F 134
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDI + NVL+  N   +LGDFGL+ R   D+  ++++     I ++ P  +     ++
Sbjct: 135 VHRDIAARNVLVSSNDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 193
Query: 234 KTDVFSFGILLLEII 248
            +DV+ FG+ + EI+
Sbjct: 194 ASDVWMFGVCMWEIL 208

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 123/269 (45%), Gaps = 27/269 (10%)
Query: 60  QKLLGKGSHGSVYKAVLR---GRQVAVK----KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++++G G  G V    L+    R VAV     K    ++  ++   E  I+ +   P +V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
           +L G     K  ++V+EFM NG L   L  ++      + + +   +A  +  L ++M  
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYL-ADM-G 165
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG--YLDPCYVTPDN 230
            +HRD+ + N+L++ N   ++ DFGL+ R   D+     T   G I   +  P  +    
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLS-RVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRK 224
Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD- 289
            ++ +DV+S+GI++ E++S  +      S   ++      I++G        R+P P D 
Sbjct: 225 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK----AIEEGY-------RLPAPMDC 273
Query: 290 PIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           P    QL    + C +  R  RP  ++IV
Sbjct: 274 PAGLHQL---MLDCWQKERAERPKFEQIV 299

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ-----VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           + +G+G  G V++ +    +     VA+K  K   +  + ++   E   + +   P +V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G   ++    +++E  + G L   L      L+    I  A Q++ A+  L S+    
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--F 132
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDI + NVL+  N   +LGDFGL+ R   D+  ++++     I ++ P  +     ++
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 234 KTDVFSFGILLLEII 248
            +DV+ FG+ + EI+
Sbjct: 192 ASDVWMFGVCMWEIL 206

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 62  LLGKGSHGSVYKAVLRGRQ------VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           +LGKGS G V K   R  Q      V  K  +KN++ S  +  E+E+L K+  P ++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDHPNIMKLF 87
Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
               DS    +V E  + G L+D +    R  +     R+  QV   +  +H     I+H
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKH--NIVH 144
Query: 176 RDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           RD+K  N+L+   +++ + ++ DFGL+  C   N + +     GT  Y+ P  V      
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKMKDR--IGTAYYIAP-EVLRGTYD 200
Query: 233 TKTDVFSFGILLLEIIS 249
            K DV+S G++L  ++S
Sbjct: 201 EKCDVWSAGVILYILLS 217

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 135/283 (47%), Gaps = 40/283 (14%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPS-KNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           +G+GS G V  A  +  GRQVAVK    + Q+  + + NE+ I+       +V +     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK 179
             ++  +++EF+  G L D++ S  R LN  +   +   V +A+  LH++   +IHRDIK
Sbjct: 113 VGEELWVLMEFLQGGALTDIV-SQVR-LNEEQIATVCEAVLQALAYLHAQ--GVIHRDIK 168
Query: 180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
           S ++L+  +   +L DFG   +   D  + +     GT  ++ P  ++    +T+ D++S
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKXL--VGTPYWMAPEVISRSLYATEVDIWS 226
Query: 240 FGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK-------DPIV 292
            GI+++E++           PP   D     +K+ +         PPPK        P++
Sbjct: 227 LGIMVIEMVDG--------EPPYFSDSPVQAMKRLR-------DSPPPKLKNSHKVSPVL 271
Query: 293 RKQLAVIAVRCVRSCRERRPSMKEIVD----WLTGLSK-LVPL 330
           R  L  + VR      + R + +E++D      TGL + LVPL
Sbjct: 272 RDFLERMLVR----DPQERATAQELLDHPFLLQTGLPECLVPL 310

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ-----VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           + +G+G  G V++ +    +     VA+K  K   +  + ++   E   + +   P +V 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G   ++    +++E  + G L   L      L+    I  A Q++ A+  L S+    
Sbjct: 73  LIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--F 129
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDI + NVL+  N   +LGDFGL+ R   D+  ++++     I ++ P  +     ++
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 234 KTDVFSFGILLLEII 248
            +DV+ FG+ + EI+
Sbjct: 189 ASDVWMFGVCMWEIL 203

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 126/308 (40%), Gaps = 45/308 (14%)
Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQE 95
           +D S  E   +  +  K LG+G+ G V +A   G       R VAVK  K        + 
Sbjct: 18  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 77
Query: 96  VDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLV-VEFMSNGTLYDVLHSNNRP------- 146
           + +E++IL  I H   +VNLLG        L+V VEF   G L   L S           
Sbjct: 78  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTP 137
Query: 147 -------LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
                  L     I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGLA
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 200 LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFS 259
                D    R       + ++ P  +     + ++DV+SFG+LL EI S      +G S
Sbjct: 196 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGAS 249
Query: 260 P---PSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKE 316
           P     I +     +K+G  +   D   P         ++    + C      +RP+  E
Sbjct: 250 PYPGVKIDEEFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSE 300
Query: 317 IVDWLTGL 324
           +V+ L  L
Sbjct: 301 LVEHLGNL 308

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ-----VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           + +G+G  G V++ +    +     VA+K  K   +  + ++   E   + +   P +V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G   ++    +++E  + G L   L      L+    I  A Q++ A+  L S+    
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--F 132
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDI + NVL+  N   +LGDFGL+ R   D+  ++++     I ++ P  +     ++
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 234 KTDVFSFGILLLEII 248
            +DV+ FG+ + EI+
Sbjct: 192 ASDVWMFGVCMWEIL 206

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+   AGT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLAGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG+G+ G V  A   G           VAVK  K    ++   ++ +E+E++  I   
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 110 R-LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNWGRRI 153
           + ++NLLG         ++V + S G L + L +   P               + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
               Q+A+ +E L S+    IHRD+ + NVL+  N   ++ DFGLA      ++  ++T 
Sbjct: 161 SCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLI 271
               + ++ P  +     + ++DV+SFG+L+ EI +      +G SP P I V+    L+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVEELFKLL 272
Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           K+G        R+  P +     +L ++   C  +   +RP+ K++V+
Sbjct: 273 KEGH-------RMDKPAN--CTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 63  LGKGSHGSVYKAVL------RGRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           LG+G  G V            G  VAVK  K     +       EI+IL  ++   ++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 115 LGFSNDSKDR--LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            G   D  ++   LV+E++  G+L D L  ++  +   + +  A Q+ + +  LHS+   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHSQH-- 137
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
            IHR++ + NVL+D +   ++GDFGLA     G + +R R    +    Y   C +    
Sbjct: 138 YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC-LKEYK 196
Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIGFSPPS 262
               +DV+SFG+ L E+++     D   SPP+
Sbjct: 197 FYYASDVWSFGVTLYELLT---HCDSSQSPPT 225

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 43/280 (15%)
Query: 63  LGKGSHGSVYKAVLRGR-------QVAVKKPSKNQEISQEVDNEIE--ILSKIHSPRLVN 113
           LG G+ G VY+  + G        QVAVK   +      E+D  +E  I+SK +   +V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVL-HSNNRP-----LNWGRRIRLALQVAKAVEILH 167
            +G S  S  R +++E M+ G L   L  +  RP     L     + +A  +A   + L 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 168 SEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
                 IHRDI + N L+        A++GDFG+A      ++  +       + ++ P 
Sbjct: 173 ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP-- 282
                  ++KTD +SFG+LL EI S      +G+ P        P     ++L       
Sbjct: 231 AFMEGIFTSKTDTWSFGVLLWEIFS------LGYMP-------YPSKSNQEVLEFVTSGG 277
Query: 283 RIPPPKD---PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           R+ PPK+   P+ R     I  +C +   E RP+   I++
Sbjct: 278 RMDPPKNCPGPVYR-----IMTQCWQHQPEDRPNFAIILE 312

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 128/299 (42%), Gaps = 45/299 (15%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRGR-------QVAVK--KPSKNQEISQEVDNEIE 101
           E   N     K LG G+ G V +A   G        +VAVK  K + + +  + + +E++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 102 ILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVL---------------HSNNR 145
           I+S +     +VNLLG        L++ E+   G L + L               H+   
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE 161
Query: 146 PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD 205
            L+    +  + QVA+ +  L S+    IHRD+ + NVL+     A++GDFGLA     D
Sbjct: 162 QLSSRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 219
Query: 206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSIV 264
           +           + ++ P  +     + ++DV+S+GILL EI S      +G +P P I+
Sbjct: 220 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYPGIL 273
Query: 265 --DWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
                  L+K G  ++   P   P       K +  I   C       RP+ ++I  +L
Sbjct: 274 VNSKFYKLVKDGYQMA--QPAFAP-------KNIYSIMQACWALEPTHRPTFQQICSFL 323

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 43/280 (15%)
Query: 63  LGKGSHGSVYKAVLRGR-------QVAVKKPSKNQEISQEVDNEIE--ILSKIHSPRLVN 113
           LG G+ G VY+  + G        QVAVK   +      E+D  +E  I+SK++   +V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVL-HSNNRP-----LNWGRRIRLALQVAKAVEILH 167
            +G S  S  R +++E M+ G L   L  +  RP     L     + +A  +A   + L 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 168 SEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
                 IHRDI + N L+        A++GDFG+A      ++  +       + ++ P 
Sbjct: 173 ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP-- 282
                  ++KTD +SFG+LL EI S      +G+ P        P     ++L       
Sbjct: 231 AFMEGIFTSKTDTWSFGVLLWEIFS------LGYMP-------YPSKSNQEVLEFVTSGG 277
Query: 283 RIPPPKD---PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           R+ PPK+   P+ R     I  +C +   E RP+   I++
Sbjct: 278 RMDPPKNCPGPVYR-----IMTQCWQHQPEDRPNFAIILE 312

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 43/280 (15%)
Query: 63  LGKGSHGSVYKAVLRGR-------QVAVKKPSKNQEISQEVDNEIE--ILSKIHSPRLVN 113
           LG G+ G VY+  + G        QVAVK   +      E+D  +E  I+SK++   +V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVL-HSNNRP-----LNWGRRIRLALQVAKAVEILH 167
            +G S  S  R +++E M+ G L   L  +  RP     L     + +A  +A   + L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 168 SEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
                 IHRDI + N L+        A++GDFG+A      ++  +       + ++ P 
Sbjct: 159 ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 216
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP-- 282
                  ++KTD +SFG+LL EI S      +G+ P        P     ++L       
Sbjct: 217 AFMEGIFTSKTDTWSFGVLLWEIFS------LGYMP-------YPSKSNQEVLEFVTSGG 263
Query: 283 RIPPPKD---PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           R+ PPK+   P+ R     I  +C +   E RP+   I++
Sbjct: 264 RMDPPKNCPGPVYR-----IMTQCWQHQPEDRPNFAIILE 298

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 37/218 (16%)
Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKPS---KNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           +L+G+G +G+VYK  L  R VAVK  S   +   I+++    + ++   +  R +  +G 
Sbjct: 19  ELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFI--VGD 76
Query: 118 SNDSKD----RLLVVEFMSNGTL--YDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
              + D     LLV+E+  NG+L  Y  LH+++    W    RLA  V + +  LH+E+P
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD----WVSSCRLAHSVTRGLAYLHTELP 132
Query: 172 -------PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR-------STPPAGT 217
                   I HRD+ S NVL+  +    + DFGL++R    N   R       +    GT
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL-TGNRLVRPGEEDNAAISEVGT 191
Query: 218 IGYLDPCYVT-------PDNLSTKTDVFSFGILLLEII 248
           I Y+ P  +         ++   + D+++ G++  EI 
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPAI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 91/191 (47%), Gaps = 14/191 (7%)
Query: 78  GRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS--KDRLLVVEFMSN 133
           G  VAVK  K     +       EI+IL  ++   ++   G   D+      LV+E++  
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL 193
           G+L D L  ++  +   + +  A Q+ + +  LH++    IHRD+ + NVL+D +   ++
Sbjct: 120 GSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKI 175
Query: 194 GDFGLALRC--GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCR 251
           GDFGLA     G + +R R    +    Y   C +        +DV+SFG+ L E+++  
Sbjct: 176 GDFGLAKAVPEGHEXYRVREDGDSPVFWYAPEC-LKEYKFYYASDVWSFGVTLYELLT-- 232
Query: 252 KAIDIGFSPPS 262
              D   SPP+
Sbjct: 233 -HCDSSQSPPT 242

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQE 95
           +D S  E   +     K LG+G+ G V +A   G       R VAVK  K        + 
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 96  VDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLV-VEFMSNGTLYDVLHSNNRP------- 146
           + +E++IL  I H   +VNLLG        L+V VEF   G L   L S           
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 147 --------LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
                   L     I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGL
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
           A     D    R       + ++ P  +     + ++DV+SFG+LL EI S
Sbjct: 195 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+     T  D       PL   +      Q+ + +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSY--LFQLLQGLAF 121
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 122 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 177
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 60  QKLLGKGSHGSVYKAVLR--GRQ---VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           +K++G G  G V    LR  G++   VA+K  K    +   ++  +E  I+ +   P ++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            L G     +  ++V E+M NG+L   L +++      + + +   V   +  L S++  
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL-SDLG- 171
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG--YLDPCYVTPDN 230
            +HRD+ + NVL+D N   ++ DFGL+ R   D+     T   G I   +  P  +    
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLS-RVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRT 230
Query: 231 LSTKTDVFSFGILLLEIIS 249
            S+ +DV+SFG+++ E+++
Sbjct: 231 FSSASDVWSFGVVMWEVLA 249

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQE 95
           +D S  E   +     K LG+G+ G V +A   G       R VAVK  K        + 
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 96  VDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLV-VEFMSNGTLYDVLHSNNRP------- 146
           + +E++IL  I H   +VNLLG        L+V VEF   G L   L S           
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 147 --------LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
                   L     I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGL
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGL 185
Query: 199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
           A     D    R       + ++ P  +     + ++DV+SFG+LL EI S
Sbjct: 186 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVK-----KPSKNQEISQEVDNEIEILS 104
           A  + F   K LG GS G V   K +  G   A+K     K  K +EI   + NE  IL 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL-NEKRILQ 96
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            ++ P LV L     D+ +  +V+E+   G ++  L    R      R   A Q+    E
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    +I+RD+K  N++ID+    ++ DFGLA R      + R+    GT  YL P 
Sbjct: 156 YLHS--LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV-----KGRTWXLCGTPEYLAPE 208
Query: 225 YVTPDNLSTKTDVFSFGILLLEIIS 249
            +     +   D ++ G+L+ E+ +
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 43/280 (15%)
Query: 63  LGKGSHGSVYKAVLRGR-------QVAVKKPSKNQEISQEVDNEIE--ILSKIHSPRLVN 113
           LG G+ G VY+  + G        QVAVK   +      E+D  +E  I+SK +   +V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVL-HSNNRP-----LNWGRRIRLALQVAKAVEILH 167
            +G S  S  R +++E M+ G L   L  +  RP     L     + +A  +A   + L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 168 SEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
                 IHRDI + N L+        A++GDFG+A      ++  +       + ++ P 
Sbjct: 159 ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPE 216
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP-- 282
                  ++KTD +SFG+LL EI S      +G+ P        P     ++L       
Sbjct: 217 AFMEGIFTSKTDTWSFGVLLWEIFS------LGYMP-------YPSKSNQEVLEFVTSGG 263
Query: 283 RIPPPKD---PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           R+ PPK+   P+ R     I  +C +   E RP+   I++
Sbjct: 264 RMDPPKNCPGPVYR-----IMTQCWQHQPEDRPNFAIILE 298

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 62  LLGKGSHGSVYKAVLRGRQ------VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           +LGKGS G V K   R  Q      V  K  +KN++ S  +  E+E+L K+  P ++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDHPNIMKLF 87
Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
               DS    +V E  + G L+D +    R  +     R+  QV   +  +H     I+H
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKH--NIVH 144
Query: 176 RDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           RD+K  N+L+   +++ + ++ DFGL+  C   N + +     GT  Y+ P  V      
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKMKDR--IGTAYYIAP-EVLRGTYD 200
Query: 233 TKTDVFSFGILLLEIIS 249
            K DV+S G++L  ++S
Sbjct: 201 EKCDVWSAGVILYILLS 217

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 43/280 (15%)
Query: 63  LGKGSHGSVYKAVLRGR-------QVAVKKPSKNQEISQEVDNEIE--ILSKIHSPRLVN 113
           LG G+ G VY+  + G        QVAVK   +      E+D  +E  I+SK +   +V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVL-HSNNRP-----LNWGRRIRLALQVAKAVEILH 167
            +G S  S  R +++E M+ G L   L  +  RP     L     + +A  +A   + L 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 168 SEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
                 IHRDI + N L+        A++GDFG+A      ++  +       + ++ P 
Sbjct: 173 ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP-- 282
                  ++KTD +SFG+LL EI S      +G+ P        P     ++L       
Sbjct: 231 AFMEGIFTSKTDTWSFGVLLWEIFS------LGYMP-------YPSKSNQEVLEFVTSGG 277
Query: 283 RIPPPKD---PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           R+ PPK+   P+ R     I  +C +   E RP+   I++
Sbjct: 278 RMDPPKNCPGPVYR-----IMTQCWQHQPEDRPNFAIILE 312

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 59  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEY 177
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 178 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 230
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAA 254

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 84/309 (27%), Positives = 125/309 (40%), Gaps = 46/309 (14%)
Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQE 95
           +D S  E   +     K LG+G+ G V +A   G       R VAVK  K        + 
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 78
Query: 96  VDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLV-VEFMSNGTLYDVLHSNNRP------- 146
           + +E++IL  I H   +VNLLG        L+V VEF   G L   L S           
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEA 138
Query: 147 --------LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
                   L     I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGL
Sbjct: 139 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGL 196
Query: 199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGF 258
           A     D    R       + ++ P  +     + ++DV+SFG+LL EI S      +G 
Sbjct: 197 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGA 250
Query: 259 SP---PSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMK 315
           SP     I +     +K+G  +   D   P         ++    + C      +RP+  
Sbjct: 251 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFS 301
Query: 316 EIVDWLTGL 324
           E+V+ L  L
Sbjct: 302 ELVEHLGNL 310

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 84/309 (27%), Positives = 125/309 (40%), Gaps = 46/309 (14%)
Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQE 95
           +D S  E   +     K LG+G+ G V +A   G       R VAVK  K        + 
Sbjct: 54  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 113
Query: 96  VDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLV-VEFMSNGTLYDVLHSNNRP------- 146
           + +E++IL  I H   +VNLLG        L+V VEF   G L   L S           
Sbjct: 114 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 173
Query: 147 --------LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
                   L     I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGL
Sbjct: 174 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGL 231
Query: 199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGF 258
           A     D    R       + ++ P  +     + ++DV+SFG+LL EI S      +G 
Sbjct: 232 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGA 285
Query: 259 SP---PSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMK 315
           SP     I +     +K+G  +   D   P         ++    + C      +RP+  
Sbjct: 286 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFS 336
Query: 316 EIVDWLTGL 324
           E+V+ L  L
Sbjct: 337 ELVEHLGNL 345

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 43/280 (15%)
Query: 63  LGKGSHGSVYKAVLRGR-------QVAVKKPSKNQEISQEVDNEIE--ILSKIHSPRLVN 113
           LG G+ G VY+  + G        QVAVK   +      E+D  +E  I+SK +   +V 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVL-HSNNRP-----LNWGRRIRLALQVAKAVEILH 167
            +G S  S  R +++E M+ G L   L  +  RP     L     + +A  +A   + L 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 168 SEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
                 IHRDI + N L+        A++GDFG+A      ++  +       + ++ P 
Sbjct: 175 ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 232
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP-- 282
                  ++KTD +SFG+LL EI S      +G+ P        P     ++L       
Sbjct: 233 AFMEGIFTSKTDTWSFGVLLWEIFS------LGYMP-------YPSKSNQEVLEFVTSGG 279
Query: 283 RIPPPKD---PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           R+ PPK+   P+ R     I  +C +   E RP+   I++
Sbjct: 280 RMDPPKNCPGPVYR-----IMTQCWQHQPEDRPNFAIILE 314

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 26/223 (11%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVK---------KPSKNQEISQ 94
           D++  +     +  + ++G+G    V + V R  G + AVK          P + +E+ +
Sbjct: 85  DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVRE 144
Query: 95  EVDNEIEILSKIH-SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI 153
               E  IL ++   P ++ L+     S    LV + M  G L+D L +    L+     
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETR 203
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRST 212
            +   + +AV  LH+    I+HRD+K  N+L+D N   RL DFG +  C ++   + R  
Sbjct: 204 SIMRSLLEAVSFLHAN--NIVHRDLKPENILLDDNMQIRLSDFGFS--CHLEPGEKLREL 259
Query: 213 PPAGTIGYLDP----CYV--TPDNLSTKTDVFSFGILLLEIIS 249
              GT GYL P    C +  T      + D+++ G++L  +++
Sbjct: 260 --CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 43/280 (15%)
Query: 63  LGKGSHGSVYKAVLRGR-------QVAVKKPSKNQEISQEVDNEIE--ILSKIHSPRLVN 113
           LG G+ G VY+  + G        QVAVK   +      E+D  +E  I+SK +   +V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVL-HSNNRP-----LNWGRRIRLALQVAKAVEILH 167
            +G S  S  R +++E M+ G L   L  +  RP     L     + +A  +A   + L 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 168 SEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
                 IHRDI + N L+        A++GDFG+A      ++  +       + ++ P 
Sbjct: 158 ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP-- 282
                  ++KTD +SFG+LL EI S      +G+ P        P     ++L       
Sbjct: 216 AFMEGIFTSKTDTWSFGVLLWEIFS------LGYMP-------YPSKSNQEVLEFVTSGG 262
Query: 283 RIPPPKD---PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           R+ PPK+   P+ R     I  +C +   E RP+   I++
Sbjct: 263 RMDPPKNCPGPVYR-----IMTQCWQHQPEDRPNFAIILE 297

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 43/280 (15%)
Query: 63  LGKGSHGSVYKAVLRGR-------QVAVKKPSKNQEISQEVDNEIE--ILSKIHSPRLVN 113
           LG G+ G VY+  + G        QVAVK   +      E+D  +E  I+SK +   +V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVL-HSNNRP-----LNWGRRIRLALQVAKAVEILH 167
            +G S  S  R +++E M+ G L   L  +  RP     L     + +A  +A   + L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 168 SEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
                 IHRDI + N L+        A++GDFG+A      ++  +       + ++ P 
Sbjct: 159 ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 216
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP-- 282
                  ++KTD +SFG+LL EI S      +G+ P        P     ++L       
Sbjct: 217 AFMEGIFTSKTDTWSFGVLLWEIFS------LGYMP-------YPSKSNQEVLEFVTSGG 263
Query: 283 RIPPPKD---PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           R+ PPK+   P+ R     I  +C +   E RP+   I++
Sbjct: 264 RMDPPKNCPGPVYR-----IMTQCWQHQPEDRPNFAIILE 298

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 43/280 (15%)
Query: 63  LGKGSHGSVYKAVLRGR-------QVAVKKPSKNQEISQEVDNEIE--ILSKIHSPRLVN 113
           LG G+ G VY+  + G        QVAVK   +      E+D  +E  I+SK +   +V 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVL-HSNNRP-----LNWGRRIRLALQVAKAVEILH 167
            +G S  S  R +++E M+ G L   L  +  RP     L     + +A  +A   + L 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 168 SEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
                 IHRDI + N L+        A++GDFG+A      ++  +       + ++ P 
Sbjct: 185 ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 242
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP-- 282
                  ++KTD +SFG+LL EI S      +G+ P        P     ++L       
Sbjct: 243 AFMEGIFTSKTDTWSFGVLLWEIFS------LGYMP-------YPSKSNQEVLEFVTSGG 289
Query: 283 RIPPPKD---PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           R+ PPK+   P+ R     I  +C +   E RP+   I++
Sbjct: 290 RMDPPKNCPGPVYR-----IMTQCWQHQPEDRPNFAIILE 324

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 43/280 (15%)
Query: 63  LGKGSHGSVYKAVLRGR-------QVAVKKPSKNQEISQEVDNEIE--ILSKIHSPRLVN 113
           LG G+ G VY+  + G        QVAVK   +      E+D  +E  I+SK +   +V 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVL-HSNNRP-----LNWGRRIRLALQVAKAVEILH 167
            +G S  S  R +++E M+ G L   L  +  RP     L     + +A  +A   + L 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 168 SEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
                 IHRDI + N L+        A++GDFG+A      ++  +       + ++ P 
Sbjct: 150 ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 207
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP-- 282
                  ++KTD +SFG+LL EI S      +G+ P        P     ++L       
Sbjct: 208 AFMEGIFTSKTDTWSFGVLLWEIFS------LGYMP-------YPSKSNQEVLEFVTSGG 254
Query: 283 RIPPPKD---PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           R+ PPK+   P+ R     I  +C +   E RP+   I++
Sbjct: 255 RMDPPKNCPGPVYR-----IMTQCWQHQPEDRPNFAIILE 289

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 43/280 (15%)
Query: 63  LGKGSHGSVYKAVLRGR-------QVAVKKPSKNQEISQEVDNEIE--ILSKIHSPRLVN 113
           LG G+ G VY+  + G        QVAVK   +      E+D  +E  I+SK +   +V 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVL-HSNNRP-----LNWGRRIRLALQVAKAVEILH 167
            +G S  S  R +++E M+ G L   L  +  RP     L     + +A  +A   + L 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 168 SEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
                 IHRDI + N L+        A++GDFG+A      ++  +       + ++ P 
Sbjct: 165 ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 222
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP-- 282
                  ++KTD +SFG+LL EI S      +G+ P        P     ++L       
Sbjct: 223 AFMEGIFTSKTDTWSFGVLLWEIFS------LGYMP-------YPSKSNQEVLEFVTSGG 269
Query: 283 RIPPPKD---PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           R+ PPK+   P+ R     I  +C +   E RP+   I++
Sbjct: 270 RMDPPKNCPGPVYR-----IMTQCWQHQPEDRPNFAIILE 304

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 20/230 (8%)
Query: 39  PIKIQHFDYSDLEAATNGF---SEQKLLGKGSHGSVYKA--VLRGRQVAVKK-PSKNQEI 92
           P    H   +  + A N F   S+ ++LG G  G V+K      G ++A K   ++  + 
Sbjct: 70  PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129
Query: 93  SQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRR 152
            +EV NEI +++++    L+ L        D +LV+E++  G L+D +   +  L     
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189
Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVL-IDRNFNA-RLGDFGLALRCGVDNFRFR 210
           I    Q+ + +  +H     I+H D+K  N+L ++R+    ++ DFGLA R      R +
Sbjct: 190 ILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP---REK 244
Query: 211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
                GT  +L P  V  D +S  TD++S G++   ++S       G SP
Sbjct: 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS-------GLSP 287

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 55  NGFSEQKLLGKGSHGSV--YKAVLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHS 108
           N F   KLLGKG+ G V   K    GR  A+K   K   ++++       E  +L     
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 109 PRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
           P  +  L +S  + DRL  V+E+ + G L+  L S  R  +  R      ++  A++ LH
Sbjct: 208 P-FLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALDYLH 265
Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
           SE   +++RD+K  N+++D++ + ++ DFGL      D    ++    GT  YL P  + 
Sbjct: 266 SE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF--CGTPEYLAPEVLE 322
Query: 228 PDNLSTKTDVFSFGILLLEIISCR 251
            ++     D +  G+++ E++  R
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 43/280 (15%)
Query: 63  LGKGSHGSVYKAVLRGR-------QVAVKKPSKNQEISQEVDNEIE--ILSKIHSPRLVN 113
           LG G+ G VY+  + G        QVAVK   +      E+D  +E  I+SK +   +V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVL-HSNNRP-----LNWGRRIRLALQVAKAVEILH 167
            +G S  S  R +++E M+ G L   L  +  RP     L     + +A  +A   + L 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 168 SEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
                 IHRDI + N L+        A++GDFG+A      ++  +       + ++ P 
Sbjct: 158 ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP-- 282
                  ++KTD +SFG+LL EI S      +G+ P        P     ++L       
Sbjct: 216 AFMEGIFTSKTDTWSFGVLLWEIFS------LGYMP-------YPSKSNQEVLEFVTSGG 262
Query: 283 RIPPPKD---PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           R+ PPK+   P+ R     I  +C +   E RP+   I++
Sbjct: 263 RMDPPKNCPGPVYR-----IMTQCWQHQPEDRPNFAIILE 297

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 149
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 150 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKS 208
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 209 ACKSSDLWALGCIIYQLVA 227

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 60  QKLLGKGSHGSVYKAVLR--GRQ---VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           +K++G G  G V    LR  G++   VA+K  K    +   ++  +E  I+ +   P ++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            L G     +  ++V E+M NG+L   L +++      + + +   V   +  L S++  
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL-SDLG- 171
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG--YLDPCYVTPDN 230
            +HRD+ + NVL+D N   ++ DFGL+ R   D+     T   G I   +  P  +    
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLS-RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 231 LSTKTDVFSFGILLLEIIS 249
            S+ +DV+SFG+++ E+++
Sbjct: 231 FSSASDVWSFGVVMWEVLA 249

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQE 95
           +D S  E   +     K LG+G+ G V +A   G       R VAVK  K        + 
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 96  VDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLV-VEFMSNGTLYDVLHSNNRP------- 146
           + +E++IL  I H   +VNLLG        L+V VEF   G L   L S           
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 147 --------LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
                   L     I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGL
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
           A     D    R       + ++ P  +     + ++DV+SFG+LL EI S
Sbjct: 195 ARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVK-----KPSKNQEISQEVDNEIEILS 104
           A  + F   K LG GS G V   K +  G   A+K     K  K +EI   + NE  IL 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL-NEKRILQ 96
Query: 105 KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
            ++ P LV L     D+ +  +V+E+   G ++  L    R      R   A Q+    E
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFE 155
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    +I+RD+K  N++ID+    ++ DFGLA R      + R+    GT  YL P 
Sbjct: 156 YLHS--LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV-----KGRTWXLCGTPEYLAPE 208
Query: 225 YVTPDNLSTKTDVFSFGILLLEIIS 249
            +     +   D ++ G+L+ E+ +
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/289 (22%), Positives = 125/289 (43%), Gaps = 35/289 (12%)
Query: 63  LGKGSHGSVYKAVLRGR-------QVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           LG+G+ G V+ A             VAVK     +    ++   E E+L+ +    +V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSN----------NRP--LNWGRRIRLALQVAKA 162
            G   +    ++V E+M +G L   L ++          N P  L   + + +A Q+A  
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           +  L S+    +HRD+ + N L+  N   ++GDFG++      ++          I ++ 
Sbjct: 141 MVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 198
Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP 282
           P  +     +T++DV+S G++L EI +  K      S   +++     I +G++L    P
Sbjct: 199 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE----CITQGRVLQ--RP 252
Query: 283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLH 331
           R  P       +++  + + C +     R ++K I   L  L+K  P++
Sbjct: 253 RTCP-------QEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVY 294

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 156
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 157 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 215
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 216 ACKSSDLWALGCIIYQLVA 234

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 55  NGFSEQKLLGKGSHGSV--YKAVLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHS 108
           N F   KLLGKG+ G V   K    GR  A+K   K   ++++       E  +L     
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 109 PRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
           P  +  L +S  + DRL  V+E+ + G L+  L S  R  +  R      ++  A++ LH
Sbjct: 211 P-FLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALDYLH 268
Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
           SE   +++RD+K  N+++D++ + ++ DFGL      D    ++    GT  YL P  + 
Sbjct: 269 SE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF--CGTPEYLAPEVLE 325
Query: 228 PDNLSTKTDVFSFGILLLEIISCR 251
            ++     D +  G+++ E++  R
Sbjct: 326 DNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEY 157
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 158 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 210
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 151
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 152 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 211 ACKSSDLWALGCIIYQLVA 229

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ-----VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           + +G+G  G V++ +    +     VA+K  K   +  + ++   E   + +   P +V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G   ++    +++E  + G L   L      L+    I  A Q++ A+  L S+    
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--F 512
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDI + NVL+  N   +LGDFGL+ R   D+  ++++     I ++ P  +     ++
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 234 KTDVFSFGILLLEII 248
            +DV+ FG+ + EI+
Sbjct: 572 ASDVWMFGVCMWEIL 586

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 33  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 92
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEY 151
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 152 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 204
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 205 ILSKGYNKAVDWWALGVLIYEMAA 228

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQE 95
           +D S  E   +     K LG+G+ G V +A   G       R VAVK  K        + 
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 96  VDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLV-VEFMSNGTLYDVLHSNNRP------- 146
           + +E++IL  I H   +VNLLG        L+V VEF   G L   L S           
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 147 --------LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
                   L     I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGL
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
           A     D    R       + ++ P  +     + ++DV+SFG+LL EI S
Sbjct: 195 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 120/280 (42%), Gaps = 43/280 (15%)
Query: 63  LGKGSHGSVYKAVLRGR-------QVAVKKPSKNQEISQEVDNEIE--ILSKIHSPRLVN 113
           LG G+ G VY+  + G        QVAVK   +      E+D  +E  I+SK +   +V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVL-HSNNRP-----LNWGRRIRLALQVAKAVEILH 167
            +G S  S  R +++E M+ G L   L  +  RP     L     + +A  +A   + L 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 168 SEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
                 IHRDI + N L+        A++GDFG+A       +  +       + ++ P 
Sbjct: 199 ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 256
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP-- 282
                  ++KTD +SFG+LL EI S      +G+ P        P     ++L       
Sbjct: 257 AFMEGIFTSKTDTWSFGVLLWEIFS------LGYMP-------YPSKSNQEVLEFVTSGG 303
Query: 283 RIPPPKD---PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           R+ PPK+   P+ R     I  +C +   E RP+   I++
Sbjct: 304 RMDPPKNCPGPVYR-----IMTQCWQHQPEDRPNFAIILE 338

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 152
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 153 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 211
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 212 ACKSSDLWALGCIIYQLVA 230

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 120/280 (42%), Gaps = 43/280 (15%)
Query: 63  LGKGSHGSVYKAVLRGR-------QVAVKKPSKNQEISQEVDNEIE--ILSKIHSPRLVN 113
           LG G+ G VY+  + G        QVAVK   +      E+D  +E  I+SK +   +V 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVL-HSNNRP-----LNWGRRIRLALQVAKAVEILH 167
            +G S  S  R +++E M+ G L   L  +  RP     L     + +A  +A   + L 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 168 SEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
                 IHRDI + N L+        A++GDFG+A       +  +       + ++ P 
Sbjct: 176 ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 233
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP-- 282
                  ++KTD +SFG+LL EI S      +G+ P        P     ++L       
Sbjct: 234 AFMEGIFTSKTDTWSFGVLLWEIFS------LGYMP-------YPSKSNQEVLEFVTSGG 280
Query: 283 RIPPPKD---PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           R+ PPK+   P+ R     I  +C +   E RP+   I++
Sbjct: 281 RMDPPKNCPGPVYR-----IMTQCWQHQPEDRPNFAIILE 315

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 15/211 (7%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSV--YKAVLRGRQVAVKKPSKN-----QEISQEVDNEIE 101
           D +   N F   KLLGKG+ G V   +    GR  A+K   K       E++  V  E  
Sbjct: 4   DPKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESR 62
Query: 102 ILSKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVA 160
           +L     P  +  L ++  + DRL  V+E+ + G L+  L S  R     R      ++ 
Sbjct: 63  VLQNTRHP-FLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIV 120
Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGY 220
            A+E LHS    +++RDIK  N+++D++ + ++ DFGL      D    +     GT  Y
Sbjct: 121 SALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF--CGTPEY 176
Query: 221 LDPCYVTPDNLSTKTDVFSFGILLLEIISCR 251
           L P  +  ++     D +  G+++ E++  R
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 124/275 (45%), Gaps = 25/275 (9%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN----EIEILSKI 106
           E   + F +   LG G+ G V+K   +   + + +   + EI   + N    E+++L + 
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 80
Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEI 165
           +SP +V   G      +  + +E M  G+L  VL    R P     ++ +A  V K +  
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTY 138
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           L  E   I+HRD+K +N+L++     +L DFG++ +  +D+    +    GT  Y+ P  
Sbjct: 139 LR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSYMSPER 193
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP 285
           +   + S ++D++S G+ L+E+   R  I  G    +I +    ++ +           P
Sbjct: 194 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNE-----------P 242
Query: 286 PPKDP--IVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           PPK P  +   +      +C+      R  +K+++
Sbjct: 243 PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 277

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQE 95
           +D S  E   +     K LG+G+ G V +A   G       R VAVK  K        + 
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 96  VDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRP------- 146
           + +E++IL  I H   +VNLLG        L+V+ EF   G L   L S           
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 147 --------LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
                   L     I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGL
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGL 185
Query: 199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
           A     D    R       + ++ P  +     + ++DV+SFG+LL EI S
Sbjct: 186 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 151
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 152 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 211 AXKSSDLWALGCIIYQLVA 229

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 154
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 155 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 213
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 214 ACKSSDLWALGCIIYQLVA 232

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 151
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 152 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 211 ACKSSDLWALGCIIYQLVA 229

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 63  LGKGSHGSVYKAVL------RGRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           LG+G  G V            G  VAVK  K     +       EI+IL  ++   ++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 115 LGFSNDSKDR--LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            G   D  ++   LV+E++  G+L D L  ++  +   + +  A Q+ + +  LH++   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH-- 137
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
            IHR++ + NVL+D +   ++GDFGLA     G + +R R    +    Y   C +    
Sbjct: 138 YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC-LKEYK 196
Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIGFSPPS 262
               +DV+SFG+ L E+++     D   SPP+
Sbjct: 197 FYYASDVWSFGVTLYELLT---HCDSSQSPPT 225

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 152
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 153 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 211
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 212 ACKSSDLWALGCIIYQLVA 230

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 128/276 (46%), Gaps = 19/276 (6%)
Query: 50  LEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN----EIEILSK 105
           +E   + F +   LG G+ G V+K   +   + + +   + EI   + N    E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVE 164
            +SP +V   G      +  + +E M  G+L  VL    R P     ++ +A  V K + 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLT 118
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            L  E   I+HRD+K +N+L++     +L DFG++ +  +D+    +    GT  Y+ P 
Sbjct: 119 YLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSYMSPE 173
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI 284
            +   + S ++D++S G+ L+E+   R  I     PP   + + P +   ++L  +    
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKEDSRPPMAIFELLD-YIVNE 228
Query: 285 PPPKDP--IVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           PPPK P  +   +      +C+      R  +K+++
Sbjct: 229 PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 264

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 51  EAATNGFSEQKLLGKGSHGSV--YKAVLRGRQVAVKKPSKN-----QEISQEVDNEIEIL 103
           +   N F   KLLGKG+ G V   +    GR  A+K   K       E++  V  E  +L
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVL 59
Query: 104 SKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
                P  +  L ++  + DRL  V+E+ + G L+  L S  R     R      ++  A
Sbjct: 60  QNTRHP-FLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSA 117
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           +E LHS    +++RDIK  N+++D++ + ++ DFGL      D    ++    GT  YL 
Sbjct: 118 LEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYLA 173
Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIISCR 251
           P  +  ++     D +  G+++ E++  R
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 149
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 150 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 209 ACKSSDLWALGCIIYQLVA 227

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 149
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 150 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 209 ACKSSDLWALGCIIYQLVA 227

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 24  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 83
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 84  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 142
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 143 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEYLAPEI 195
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAA 219

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 151
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 152 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 211 ACKSSDLWALGCIIYQLVA 229

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 51  EAATNGFSEQKLLGKGSHGSV--YKAVLRGRQVAVKKPSKN-----QEISQEVDNEIEIL 103
           +   N F   KLLGKG+ G V   +    GR  A+K   K       E++  V  E  +L
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVL 62
Query: 104 SKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
                P  +  L ++  + DRL  V+E+ + G L+  L S  R     R      ++  A
Sbjct: 63  QNTRHP-FLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSA 120
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           +E LHS    +++RDIK  N+++D++ + ++ DFGL      D    ++    GT  YL 
Sbjct: 121 LEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYLA 176
Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIISCR 251
           P  +  ++     D +  G+++ E++  R
Sbjct: 177 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K +G GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 151
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 152 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 211 ACKSSDLWALGCIIYQLVA 229

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 157
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 158 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEYLAPEI 210
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++ P +
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 112 VNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V LL   +      LV EF+        D       PL   +      Q+ + +   HS 
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCHSH 129
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTP 228
              ++HRD+K  N+LI+     +L DFGLA   GV    +  T    T+ Y  P   +  
Sbjct: 130 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGX 185
Query: 229 DNLSTKTDVFSFGILLLEIISCR 251
              ST  D++S G +  E+++ R
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 63  LGKGSHGSVYKAVL------RGRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           LG+G  G V            G  VAVK  K     ++      EIEIL  ++   +V  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 115 LGFSNDSKDR--LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            G   D  ++   LV+E++  G+L D L  +   L   + +  A Q+ + +  LH++   
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL--AQLLLFAQQICEGMAYLHAQH-- 131
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
            IHR + + NVL+D +   ++GDFGLA     G + +R R    +    Y   C +    
Sbjct: 132 YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC-LKECK 190
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +DV+SFG+ L E+++
Sbjct: 191 FYYASDVWSFGVTLYELLT 209

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 125/309 (40%), Gaps = 46/309 (14%)
Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQE 95
           +D S  E   +     K LG+G+ G V +A   G       R VAVK  K        + 
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 96  VDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRP------- 146
           + +E++IL  I H   +VNLLG        L+V+ EF   G L   L S           
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 147 --------LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
                   L     I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGL
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGL 185
Query: 199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGF 258
           A     D    R       + ++ P  +     + ++DV+SFG+LL EI S      +G 
Sbjct: 186 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGA 239
Query: 259 SP---PSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMK 315
           SP     I +     +K+G  +   D   P         ++    + C      +RP+  
Sbjct: 240 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFS 290
Query: 316 EIVDWLTGL 324
           E+V+ L  L
Sbjct: 291 ELVEHLGNL 299

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 51  EAATNGFSEQKLLGKGSHGSV--YKAVLRGRQVAVKKPSKN-----QEISQEVDNEIEIL 103
           +   N F   KLLGKG+ G V   +    GR  A+K   K       E++  V  E  +L
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVL 59
Query: 104 SKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
                P  +  L ++  + DRL  V+E+ + G L+  L S  R     R      ++  A
Sbjct: 60  QNTRHP-FLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSA 117
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           +E LHS    +++RDIK  N+++D++ + ++ DFGL      D    ++    GT  YL 
Sbjct: 118 LEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYLA 173
Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIISCR 251
           P  +  ++     D +  G+++ E++  R
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 63  LGKGSHGSVYKAVL------RGRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           LG+G  G V            G  VAVK  K     ++      EIEIL  ++   +V  
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 115 LGFSNDSKDR--LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            G   D  ++   LV+E++  G+L D L  +   L   + +  A Q+ + +  LH++   
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL--AQLLLFAQQICEGMAYLHAQH-- 132
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
            IHR + + NVL+D +   ++GDFGLA     G + +R R    +    Y   C +    
Sbjct: 133 YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC-LKECK 191
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +DV+SFG+ L E+++
Sbjct: 192 FYYASDVWSFGVTLYELLT 210

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 57  FSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSK------IHSP 109
           F   K+LGKGS G V+ A  +   Q    K  K   +  + D E  ++ K         P
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
            L ++       ++   V+E+++ G L   + S ++  +  R    A ++   ++ LHS+
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSK 138
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
              I++RD+K  N+L+D++ + ++ DFG+     + +   ++    GT  Y+ P  +   
Sbjct: 139 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNEFCGTPDYIAPEILLGQ 194
Query: 230 NLSTKTDVFSFGILLLEII 248
             +   D +SFG+LL E++
Sbjct: 195 KYNHSVDWWSFGVLLYEML 213

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 128
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 129 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 187
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 188 ACKSSDLWALGCIIYQLVA 206

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++ P +
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 112 VNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V LL   +      LV EF+        D       PL   +      Q+ + +   HS 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCHSH 122
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTP 228
              ++HRD+K  N+LI+     +L DFGLA   GV    +  T    T+ Y  P   +  
Sbjct: 123 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGX 178
Query: 229 DNLSTKTDVFSFGILLLEIISCR 251
              ST  D++S G +  E+++ R
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 157
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 158 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 210
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 126
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 127 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 185
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 186 ACKSSDLWALGCIIYQLVA 204

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQE 95
           +D S  E   +     K LG+G+ G V +A   G       R VAVK  K        + 
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 96  VDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRP------- 146
           + +E++IL  I H   +VNLLG        L+V+ EF   G L   L S           
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 147 --------LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
                   L     I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGL
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGL 185
Query: 199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
           A     D    R       + ++ P  +     + ++DV+SFG+LL EI S
Sbjct: 186 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 127/297 (42%), Gaps = 42/297 (14%)
Query: 42  IQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQEVDNE 99
           +   D S L      F   +L+G G++G VYK   V  G+  A+K      +  +E+  E
Sbjct: 11  LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE 70
Query: 100 IEILSKI-HSPRLVNLLG-FSNDS----KDRL-LVVEFMSNGTLYDVLHS---NNRPLNW 149
           I +L K  H   +    G F   +     D+L LV+EF   G++ D++ +   N     W
Sbjct: 71  INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW 130
Query: 150 GRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF 209
              I    ++ + +  LH     +IHRDIK  NVL+  N   +L DFG++ +  +D    
Sbjct: 131 IAYI--CREILRGLSHLHQH--KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVG 184
Query: 210 RSTPPAGTIGYLDP----CYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIV 264
           R     GT  ++ P    C   PD     K+D++S GI  +E                + 
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE----------------MA 228
Query: 265 DWAAPLIKKGKILSVF-DPRIPPP--KDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
           + A PL     + ++F  PR P P  K     K+       C+     +RP+ ++++
Sbjct: 229 EGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLM 285

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 39  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 157
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 158 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 210
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 148
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 149 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 207
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 208 ACKSSDLWALGCIIYQLVA 226

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 15/208 (7%)
Query: 51  EAATNGFSEQKLLGKGSHGSVY--KAVLR---GRQVAVKKPSK-NQEISQEVDNEIE--I 102
           +A  + F   K+LG+GS G V+  + V R   G   A+K   K   ++   V  ++E  I
Sbjct: 24  KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI 83
Query: 103 LSKIHSPRLVNL-LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK 161
           L+ ++ P +V L   F  + K   L+++F+  G L+  L           +  LA ++A 
Sbjct: 84  LADVNHPFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELAL 141
Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
            ++ LHS    II+RD+K  N+L+D   + +L DFGL+ +  +D+ + ++    GT+ Y+
Sbjct: 142 GLDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLS-KEAIDHEK-KAYSFCGTVEYM 197
Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIIS 249
            P  V     S   D +S+G+L+ E+++
Sbjct: 198 APEVVNRQGHSHSADWWSYGVLMFEMLT 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 15/208 (7%)
Query: 51  EAATNGFSEQKLLGKGSHGSVY--KAVL--RGRQVAVKKPSKNQ--EISQEVDNEIE--I 102
           +A  + F   K+LG+GS G V+  K +     RQ+   K  K    ++   V  ++E  I
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 103 LSKIHSPRLVNL-LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK 161
           L +++ P +V L   F  + K   L+++F+  G L+  L           +  LA ++A 
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELAL 138
Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
           A++ LHS    II+RD+K  N+L+D   + +L DFGL+ +  +D+ + ++    GT+ Y+
Sbjct: 139 ALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLS-KESIDHEK-KAYSFCGTVEYM 194
Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIIS 249
            P  V     +   D +SFG+L+ E+++
Sbjct: 195 APEVVNRRGHTQSADWWSFGVLMFEMLT 222

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG 130
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 131 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 188
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 189 ACKSSDLWALGCIIYQLVA 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 127
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 128 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 186
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 187 ACKSSDLWALGCIIYQLVA 205

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+   G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N++ID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 12/210 (5%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSV--YKAVLRGRQVAVKKPSKNQEISQE----VDNEIEI 102
           D     N F   KLLGKG+ G V   K    GR  A+K   K   ++++       E  +
Sbjct: 4   DPRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 63
Query: 103 LSKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK 161
           L     P  +  L +S  + DRL  V+E+ + G L+  L S  R  +  R      ++  
Sbjct: 64  LQNSRHP-FLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVS 121
Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
           A++ LHSE   +++RD+K  N+++D++ + ++ DFGL      D    +     GT  YL
Sbjct: 122 ALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF--CGTPEYL 178
Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIISCR 251
            P  +  ++     D +  G+++ E++  R
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 133
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 134 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 192
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 193 ACKSSDLWALGCIIYQLVA 211

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 15/208 (7%)
Query: 51  EAATNGFSEQKLLGKGSHGSVY--KAVL--RGRQVAVKKPSKNQ--EISQEVDNEIE--I 102
           +A  + F   K+LG+GS G V+  K +     RQ+   K  K    ++   V  ++E  I
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 103 LSKIHSPRLVNL-LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK 161
           L +++ P +V L   F  + K   L+++F+  G L+  L           +  LA ++A 
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELAL 137
Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
           A++ LHS    II+RD+K  N+L+D   + +L DFGL+ +  +D+ + ++    GT+ Y+
Sbjct: 138 ALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLS-KESIDHEK-KAYSFCGTVEYM 193
Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIIS 249
            P  V     +   D +SFG+L+ E+++
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++ P +
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 112 VNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V LL   +      LV EF+        D       PL   +      Q+ + +   HS 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLSFCHSH 122
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTP 228
              ++HRD+K  N+LI+     +L DFGLA   GV    +  T    T+ Y  P   +  
Sbjct: 123 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGC 178
Query: 229 DNLSTKTDVFSFGILLLEIISCR 251
              ST  D++S G +  E+++ R
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 15/208 (7%)
Query: 51  EAATNGFSEQKLLGKGSHGSVY--KAVL--RGRQVAVKKPSKNQ--EISQEVDNEIE--I 102
           +A  + F   K+LG+GS G V+  K +     RQ+   K  K    ++   V  ++E  I
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 103 LSKIHSPRLVNL-LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK 161
           L +++ P +V L   F  + K   L+++F+  G L+  L           +  LA ++A 
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELAL 137
Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
           A++ LHS    II+RD+K  N+L+D   + +L DFGL+ +  +D+ + ++    GT+ Y+
Sbjct: 138 ALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLS-KESIDHEK-KAYSFCGTVEYM 193
Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIIS 249
            P  V     +   D +SFG+L+ E+++
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++ P +
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 112 VNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V LL   +      LV EF+        D       PL   +      Q+ + +   HS 
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCHSH 129
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTP 228
              ++HRD+K  N+LI+     +L DFGLA   GV    +  T    T+ Y  P   +  
Sbjct: 130 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGC 185
Query: 229 DNLSTKTDVFSFGILLLEIISCR 251
              ST  D++S G +  E+++ R
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+        D       PL   +      Q+ + +  
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAF 119
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +  T    T+ Y  P  
Sbjct: 120 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEI 175
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++ P +
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 112 VNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V LL   +      LV EF+        D       PL   +      Q+ + +   HS 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAFCHSH 122
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTP 228
              ++HRD+K  N+LI+     +L DFGLA   GV    +  T    T+ Y  P   +  
Sbjct: 123 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGC 178
Query: 229 DNLSTKTDVFSFGILLLEIISCR 251
              ST  D++S G +  E+++ R
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++ P +
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 112 VNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V LL   +      LV EF+        D       PL   +      Q+ + +   HS 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAFCHSH 121
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTP 228
              ++HRD+K  N+LI+     +L DFGLA   GV    +  T    T+ Y  P   +  
Sbjct: 122 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGC 177
Query: 229 DNLSTKTDVFSFGILLLEIISCR 251
              ST  D++S G +  E+++ R
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGT--LYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+S       D       PL   +      Q+ + +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 121
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 122 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 177
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           + + K +G G+ G V  A   + G  VAVKK   P +NQ  ++    E+ +L  ++   +
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 112 VNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++LL      K      D  LV+E M +  L  V+H     L+  R   L  Q+   ++ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKH 141
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    IIHRD+K +N+++  +   ++ DFGLA R    NF    TP   T  Y  P  
Sbjct: 142 LHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTACTNFMM--TPYVVTRYYRAPEV 196
Query: 226 VTPDNLSTKTDVFSFGILLLEII 248
           +     +   D++S G ++ E++
Sbjct: 197 ILGMGYAANVDIWSVGCIMGELV 219

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLXGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++ P +
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 112 VNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V LL   +      LV EF+        D       PL   +      Q+ + +   HS 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCHSH 122
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTP 228
              ++HRD+K  N+LI+     +L DFGLA   GV    +  T    T+ Y  P   +  
Sbjct: 123 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGC 178
Query: 229 DNLSTKTDVFSFGILLLEIISCR 251
              ST  D++S G +  E+++ R
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 7/140 (5%)
Query: 126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI 185
           +V+E++   TL D++H+   P+   R I +     +A+   H     IIHRD+K AN+LI
Sbjct: 93  IVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANILI 149
Query: 186 DRNFNARLGDFGLALRCGVD--NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGIL 243
                 ++ DFG+A R   D  N   ++    GT  YL P     D++  ++DV+S G +
Sbjct: 150 SATNAVKVVDFGIA-RAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 244 LLEIISCRKAIDIGFSPPSI 263
           L E+++       G SP S+
Sbjct: 209 LYEVLTGEPPF-TGDSPVSV 227

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+S       D       PL   +      Q+ + +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAF 121
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 122 CHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 177
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++ P +
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 112 VNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V LL   +      LV EF+        D       PL   +      Q+ + +   HS 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAFCHSH 121
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTP 228
              ++HRD+K  N+LI+     +L DFGLA   GV    +  T    T+ Y  P   +  
Sbjct: 122 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGC 177
Query: 229 DNLSTKTDVFSFGILLLEIISCR 251
              ST  D++S G +  E+++ R
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 148
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 149 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 207
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 208 ACKSSDLWALGCIIYQLVA 226

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++ P +
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 112 VNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V LL   +      LV EF+        D       PL   +      Q+ + +   HS 
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAFCHSH 126
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTP 228
              ++HRD+K  N+LI+     +L DFGLA   GV    +  T    T+ Y  P   +  
Sbjct: 127 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGC 182
Query: 229 DNLSTKTDVFSFGILLLEIISCR 251
              ST  D++S G +  E+++ R
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 55  NGFSEQKLLGKGSHGSV--YKAVLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHS 108
           N F   KLLGKG+ G V   K    GR  A+K   K   ++++       E  +L     
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 109 PRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
           P  +  L +S  + DRL  V+E+ + G L+  L S  R  +  R      ++  A++ LH
Sbjct: 69  P-FLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALDYLH 126
Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
           SE   +++RD+K  N+++D++ + ++ DFGL      D    +     GT  YL P  + 
Sbjct: 127 SE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF--CGTPEYLAPEVLE 183
Query: 228 PDNLSTKTDVFSFGILLLEIISCR 251
            ++     D +  G+++ E++  R
Sbjct: 184 DNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+S       D       PL   +      Q+ + +  
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAF 119
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 120 CHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 175
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGT--LYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+S       D       PL   +      Q+ + +  
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 120
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 121 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 176
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 51  EAATNGFSEQKLLGKGSHGSV--YKAVLRGRQVAVKKPSKN-----QEISQEVDNEIEIL 103
           +   N F   KLLGKG+ G V   +    GR  A+K   K       E++  V  E  +L
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVL 59
Query: 104 SKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
                P  +  L ++  + DRL  V+E+ + G L+  L S  R     R      ++  A
Sbjct: 60  QNTRHP-FLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSA 117
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           +E LHS    +++RDIK  N+++D++ + ++ DFGL      D    +     GT  YL 
Sbjct: 118 LEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF--CGTPEYLA 173
Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIISCR 251
           P  +  ++     D +  G+++ E++  R
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 31  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEY 149
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 150 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 202
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAA 226

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ-----VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           + +G+G  G V++ +    +     VA+K  K   +  + ++   E   + +   P +V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G   ++    +++E  + G L   L      L+    I  A Q++ A+  L S+    
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--F 132
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDI + NVL+  N   +LGDFGL+ R   D+   +++     I ++ P  +     ++
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLS-RYMEDSTXXKASKGKLPIKWMAPESINFRRFTS 191
Query: 234 KTDVFSFGILLLEII 248
            +DV+ FG+ + EI+
Sbjct: 192 ASDVWMFGVCMWEIL 206

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 25  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 84
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 143
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID     ++ DFG A R      + R+    GT  YL P  
Sbjct: 144 LHS--LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 196
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 197 ILSKGYNKAVDWWALGVLIYEMAA 220

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 55  NGFSEQKLLGKGSHGSV--YKAVLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHS 108
           N F   KLLGKG+ G V   K    GR  A+K   K   ++++       E  +L     
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 109 PRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
           P  +  L +S  + DRL  V+E+ + G L+  L S  R  +  R      ++  A++ LH
Sbjct: 68  P-FLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALDYLH 125
Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
           SE   +++RD+K  N+++D++ + ++ DFGL      D    +     GT  YL P  + 
Sbjct: 126 SE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF--CGTPEYLAPEVLE 182
Query: 228 PDNLSTKTDVFSFGILLLEIISCR 251
            ++     D +  G+++ E++  R
Sbjct: 183 DNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 51  EAATNGFSEQKLLGKGSHGSV--YKAVLRGRQVAVKKPSKN-----QEISQEVDNEIEIL 103
           +   N F   KLLGKG+ G V   +    GR  A+K   K       E++  V  E  +L
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVL 59
Query: 104 SKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
                P  +  L ++  + DRL  V+E+ + G L+  L S  R     R      ++  A
Sbjct: 60  QNTRHP-FLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSA 117
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           +E LHS    +++RDIK  N+++D++ + ++ DFGL      D    +     GT  YL 
Sbjct: 118 LEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF--CGTPEYLA 173
Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIISCR 251
           P  +  ++     D +  G+++ E++  R
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 72/141 (51%), Gaps = 7/141 (4%)
Query: 126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI 185
           +V+E++   TL D++H+   P+   R I +     +A+   H     IIHRD+K AN++I
Sbjct: 93  IVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI 149
Query: 186 DRNFNARLGDFGLALRCGVD--NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGIL 243
                 ++ DFG+A R   D  N   ++    GT  YL P     D++  ++DV+S G +
Sbjct: 150 SATNAVKVMDFGIA-RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 244 LLEIISCRKAIDIGFSPPSIV 264
           L E+++       G SP S+ 
Sbjct: 209 LYEVLTGEPPF-TGDSPDSVA 228

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 51  EAATNGFSEQKLLGKGSHGSV--YKAVLRGRQVAVKKPSKN-----QEISQEVDNEIEIL 103
           +   N F   KLLGKG+ G V   +    GR  A+K   K       E++  V  E  +L
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVL 59
Query: 104 SKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
                P  +  L ++  + DRL  V+E+ + G L+  L S  R     R      ++  A
Sbjct: 60  QNTRHP-FLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSA 117
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           +E LHS    +++RDIK  N+++D++ + ++ DFGL      D    +     GT  YL 
Sbjct: 118 LEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF--CGTPEYLA 173
Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIISCR 251
           P  +  ++     D +  G+++ E++  R
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ-----VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           + +G+G  G V++ +    +     VA+K  K   +  + ++   E   + +   P +V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G   ++    +++E  + G L   L      L+    I  A Q++ A+  L S+    
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--F 132
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDI + NVL+      +LGDFGL+ R   D+  ++++     I ++ P  +     ++
Sbjct: 133 VHRDIAARNVLVSATDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 234 KTDVFSFGILLLEII 248
            +DV+ FG+ + EI+
Sbjct: 192 ASDVWMFGVCMWEIL 206

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 57  FSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSK------IHSP 109
           F   K+LGKGS G V+ A  +   Q    K  K   +  + D E  ++ K         P
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
            L ++       ++   V+E+++ G L   + S ++  +  R    A ++   ++ LHS+
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSK 137
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
              I++RD+K  N+L+D++ + ++ DFG+     + +   ++    GT  Y+ P  +   
Sbjct: 138 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNXFCGTPDYIAPEILLGQ 193
Query: 230 NLSTKTDVFSFGILLLEII 248
             +   D +SFG+LL E++
Sbjct: 194 KYNHSVDWWSFGVLLYEML 212

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 72/140 (51%), Gaps = 7/140 (5%)
Query: 126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI 185
           +V+E++   TL D++H+   P+   R I +     +A+   H     IIHRD+K AN++I
Sbjct: 93  IVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI 149
Query: 186 DRNFNARLGDFGLALRCGVD--NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGIL 243
                 ++ DFG+A R   D  N   ++    GT  YL P     D++  ++DV+S G +
Sbjct: 150 SATNAVKVMDFGIA-RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 244 LLEIISCRKAIDIGFSPPSI 263
           L E+++       G SP S+
Sbjct: 209 LYEVLTGEPPF-TGDSPVSV 227

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N++ID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 IISKGYNKAVDWWALGVLIYEMAA 233

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 130/305 (42%), Gaps = 51/305 (16%)
Query: 52  AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE--ISQEVDNEIEILSKIH 107
           ++++ F + + LG G++ +VYK + +  G  VA+K+   + E         EI ++ ++ 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLAL------QV 159
              +V L    +      LV EFM N      D     N P    R + L L      Q+
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTP----RGLELNLVKYFQWQL 117
Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG 219
            + +   H     I+HRD+K  N+LI++    +LGDFGLA   G+    F S     T+ 
Sbjct: 118 LQGLAFCHEN--KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE--VVTLW 173
Query: 220 YLDP-CYVTPDNLSTKTDVFSFGILLLEIISCR------------KAIDIGFSPPSIVDW 266
           Y  P   +     ST  D++S G +L E+I+ +            K I      P+   W
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233
Query: 267 AAPLIKKGKILSVFDPRIP--PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
             P + K   L  ++P I   PP+D           +R V     + P    ++D+L GL
Sbjct: 234 --PSVTK---LPKYNPNIQQRPPRD-----------LRQVLQPHTKEPLDGNLMDFLHGL 277
Query: 325 SKLVP 329
            +L P
Sbjct: 278 LQLNP 282

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+   G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N++ID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 59  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 177
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 178 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 230
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAA 254

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+        D       PL   +      Q+ + +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAF 121
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 122 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 177
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 72/140 (51%), Gaps = 7/140 (5%)
Query: 126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI 185
           +V+E++   TL D++H+   P+   R I +     +A+   H     IIHRD+K AN++I
Sbjct: 93  IVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI 149
Query: 186 DRNFNARLGDFGLALRCGVD--NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGIL 243
                 ++ DFG+A R   D  N   ++    GT  YL P     D++  ++DV+S G +
Sbjct: 150 SATNAVKVMDFGIA-RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 244 LLEIISCRKAIDIGFSPPSI 263
           L E+++       G SP S+
Sbjct: 209 LYEVLTGEPPF-TGDSPVSV 227

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 72/140 (51%), Gaps = 7/140 (5%)
Query: 126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI 185
           +V+E++   TL D++H+   P+   R I +     +A+   H     IIHRD+K AN++I
Sbjct: 93  IVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI 149
Query: 186 DRNFNARLGDFGLALRCGVD--NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGIL 243
                 ++ DFG+A R   D  N   ++    GT  YL P     D++  ++DV+S G +
Sbjct: 150 SATNAVKVMDFGIA-RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 244 LLEIISCRKAIDIGFSPPSI 263
           L E+++       G SP S+
Sbjct: 209 LYEVLTGEPPF-TGDSPVSV 227

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 157
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 158 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 210
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+        D       PL   +      Q+ + +  
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAF 120
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 121 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 176
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +   A  +   R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +           R   A ++  A+E LH + 
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 149
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 150 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 231 LSTKTDVFSFGILLLEIIS 249
               +D+++ G ++ ++++
Sbjct: 209 ACKSSDLWALGCIIYQLVA 227

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+        D       PL   +      Q+ + +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAF 121
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 122 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 177
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+        D       PL   +      Q+ + +  
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAF 120
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 121 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 176
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 157
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 158 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 210
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+        D       PL   +      Q+ + +  
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAF 120
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 121 CHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 176
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+        D       PL   +      Q+ + +  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAF 118
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 119 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 174
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+        D       PL   +      Q+ + +  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAF 118
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 119 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 174
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+        D       PL   +      Q+ + +  
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAF 119
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 120 CHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 175
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+        D       PL   +      Q+ + +  
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAF 119
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 120 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 175
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 72/140 (51%), Gaps = 7/140 (5%)
Query: 126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI 185
           +V+E++   TL D++H+   P+   R I +     +A+   H     IIHRD+K AN++I
Sbjct: 110 IVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI 166
Query: 186 DRNFNARLGDFGLALRCGVD--NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGIL 243
                 ++ DFG+A R   D  N   ++    GT  YL P     D++  ++DV+S G +
Sbjct: 167 SATNAVKVMDFGIA-RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 225
Query: 244 LLEIISCRKAIDIGFSPPSI 263
           L E+++       G SP S+
Sbjct: 226 LYEVLTGEPPF-TGDSPVSV 244

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+   G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N++ID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+        D       PL   +      Q+ + +  
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAF 122
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 123 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 178
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 31  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 149
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 150 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 202
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAA 226

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E++  G ++  L    R      R   A Q+    E 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 157
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 158 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 210
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+        D       PL   +      Q+ + +  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAF 118
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 119 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 174
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 59  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 177
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R     +    TP      YL P  
Sbjct: 178 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPE-----YLAPEI 230
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAA 254

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ ++ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYQMAA 233

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++ P +
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 112 VNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V LL   +      LV EF+        D       PL   +      Q+ + +   HS 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAFCHSH 121
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTP 228
              ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P   +  
Sbjct: 122 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEILLGC 177
Query: 229 DNLSTKTDVFSFGILLLEIISCR 251
              ST  D++S G +  E+++ R
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++ P +
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 112 VNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V LL   +      LV EF+        D       PL   +      Q+ + +   HS 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAFCHSH 123
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTP 228
              ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P   +  
Sbjct: 124 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEILLGC 179
Query: 229 DNLSTKTDVFSFGILLLEIISCR 251
              ST  D++S G +  E+++ R
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGT--LYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+        D       PL   +      Q+ + +  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKS--YLFQLLQGLAF 118
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 119 CHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 174
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV EF+        D       PL   +      Q+ + +  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAF 118
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 119 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 174
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 36/222 (16%)
Query: 61  KLLGKGSHGSVYKAVLRGR-------QVAVK--KPSKNQEISQEVDNEIEILSKIHS-PR 110
           K+LG G+ G V  A   G        QVAVK  K   +    + + +E+++++++ S   
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP----------------------LN 148
           +VNLLG    S    L+ E+   G L + L S                          L 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 149 WGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NF 207
           +   +  A QVAK +E L  E    +HRD+ + NVL+      ++ DFGLA     D N+
Sbjct: 171 FEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
             R       + ++ P  +     + K+DV+S+GILL EI S
Sbjct: 229 VVRGNARL-PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++ P +
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 112 VNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V LL   +      LV EF+        D       PL   +      Q+ + +   HS 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAFCHSH 121
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTP 228
              ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P   +  
Sbjct: 122 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEILLGC 177
Query: 229 DNLSTKTDVFSFGILLLEIISCR 251
              ST  D++S G +  E+++ R
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ-----VAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           + +G+G  G V++ +    +     VA+K  K   +  + ++   E   + +   P +V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G   ++    +++E  + G L   L      L+    I  A Q++ A+  L S+    
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--F 512
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDI + NVL+      +LGDFGL+ R   D+  ++++     I ++ P  +     ++
Sbjct: 513 VHRDIAARNVLVSATDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 234 KTDVFSFGILLLEII 248
            +DV+ FG+ + EI+
Sbjct: 572 ASDVWMFGVCMWEIL 586

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPS----KNQEISQEVDNEIEILSKIHSPR 110
           FS+ + +G GS G+VY A  V     VA+KK S    ++ E  Q++  E+  L K+  P 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            +   G         LV+E+   G+  D+L  + +PL       +     + +  LHS  
Sbjct: 116 TIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH- 173
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLA-LRCGVDNFRFRSTPPAGTIGYLDPCYVTP- 228
             +IHRD+K+ N+L+      +LGDFG A +    + F        GT  ++ P  +   
Sbjct: 174 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-------VGTPYWMAPEVILAM 225
Query: 229 --DNLSTKTDVFSFGILLLEI 247
                  K DV+S GI  +E+
Sbjct: 226 DEGQYDGKVDVWSLGITCIEL 246

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P L  L     D+ +  +V+E+   G ++  L    R      R   A Q+    E 
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEY 157
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N++ID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 158 LHS--LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 210
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++ P +
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 112 VNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V LL   +      LV E +     T  D       PL   +      Q+ + +   HS 
Sbjct: 64  VKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKS--YLFQLLQGLAFCHSH 121
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTP 228
              ++HRD+K  N+LI+     +L DFGLA   GV    +  T    T+ Y  P   +  
Sbjct: 122 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGC 177
Query: 229 DNLSTKTDVFSFGILLLEIISCR 251
              ST  D++S G +  E+++ R
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y AVL  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           +++LL      K      D  LV+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLXGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 141 HLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+   G ++  L    R      R   A Q+    E 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 157
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N++ID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 158 LHS--LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 210
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 50  LEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN----EIEILSK 105
           +E   + F +   LG G+ G V+K   +   + + +   + EI   + N    E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVE 164
            +SP +V   G      +  + +E M  G+L  VL    R P     ++ +A  V K + 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLT 118
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            L  E   I+HRD+K +N+L++     +L DFG++ +  +D+    +    GT  Y+ P 
Sbjct: 119 YLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSYMSPE 173
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAI 254
            +   + S ++D++S G+ L+E+   R  I
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           + + K +G G+ G V  A   + G  VAVKK   P +NQ  ++    E+ +L  ++   +
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 112 VNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++LL      K      D  LV+E M +  L  V+H     L+  R   L  Q+   ++ 
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKH 139
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    IIHRD+K +N+++  +   ++ DFGLA R    NF    TP   T  Y  P  
Sbjct: 140 LHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTASTNFMM--TPYVVTRYYRAPEV 194
Query: 226 VTPDNLSTKTDVFSFGILLLEII 248
           +         D++S G ++ E++
Sbjct: 195 ILGMGYKENVDIWSVGCIMGELV 217

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 50  LEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN----EIEILSK 105
           +E   + F +   LG G+ G V+K   +   + + +   + EI   + N    E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVE 164
            +SP +V   G      +  + +E M  G+L  VL    R P     ++ +A  V K + 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLT 118
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            L  E   I+HRD+K +N+L++     +L DFG++ +  +D+    +    GT  Y+ P 
Sbjct: 119 YLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSYMSPE 173
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAI 254
            +   + S ++D++S G+ L+E+   R  I
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 50  LEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN----EIEILSK 105
           +E   + F +   LG G+ G V+K   +   + + +   + EI   + N    E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVE 164
            +SP +V   G      +  + +E M  G+L  VL    R P     ++ +A  V K + 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLT 118
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            L  E   I+HRD+K +N+L++     +L DFG++ +  +D+    +    GT  Y+ P 
Sbjct: 119 YLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSYMSPE 173
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAI 254
            +   + S ++D++S G+ L+E+   R  I
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 50  LEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN----EIEILSK 105
           +E   + F +   LG G+ G V+K   +   + + +   + EI   + N    E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVE 164
            +SP +V   G      +  + +E M  G+L  VL    R P     ++ +A  V K + 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLT 118
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            L  E   I+HRD+K +N+L++     +L DFG++ +  +D+    +    GT  Y+ P 
Sbjct: 119 YLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSYMSPE 173
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAI 254
            +   + S ++D++S G+ L+E+   R  I
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 61  KLLGKGSHGSVYKAVLRG--RQVAVKKPSKNQ---------EISQEVDNEIEILSKIHSP 109
           K LG G+ G V  A  R   ++VA+K  SK +         + +  V+ EIEIL K++ P
Sbjct: 22  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 81
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
            ++ +  F  D++D  +V+E M  G L+D +  N R      ++    Q+  AV+ LH  
Sbjct: 82  CIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHEN 139
Query: 170 MPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP--- 223
              IIHRD+K  NVL+   + +   ++ DFG +   G  +   R+    GT  YL P   
Sbjct: 140 --GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL--CGTPTYLAPEVL 194
Query: 224 CYVTPDNLSTKTDVFSFGILLLEIIS 249
             V     +   D +S G++L   +S
Sbjct: 195 VSVGTAGYNRAVDCWSLGVILFICLS 220

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 61  KLLGKGSHGSVYKAVLRG--RQVAVKKPSKNQ---------EISQEVDNEIEILSKIHSP 109
           K LG G+ G V  A  R   ++VA+K  SK +         + +  V+ EIEIL K++ P
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
            ++ +  F  D++D  +V+E M  G L+D +  N R      ++    Q+  AV+ LH  
Sbjct: 76  CIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHEN 133
Query: 170 MPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP--- 223
              IIHRD+K  NVL+   + +   ++ DFG +   G  +   R+    GT  YL P   
Sbjct: 134 --GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL--CGTPTYLAPEVL 188
Query: 224 CYVTPDNLSTKTDVFSFGILLLEIIS 249
             V     +   D +S G++L   +S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 61  KLLGKGSHGSVYKAVLRG--RQVAVKKPSKNQ---------EISQEVDNEIEILSKIHSP 109
           K LG G+ G V  A  R   ++VA+K  SK +         + +  V+ EIEIL K++ P
Sbjct: 15  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 74
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
            ++ +  F  D++D  +V+E M  G L+D +  N R      ++    Q+  AV+ LH  
Sbjct: 75  CIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHEN 132
Query: 170 MPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP--- 223
              IIHRD+K  NVL+   + +   ++ DFG +   G  +   R+    GT  YL P   
Sbjct: 133 --GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL--CGTPTYLAPEVL 187
Query: 224 CYVTPDNLSTKTDVFSFGILLLEIIS 249
             V     +   D +S G++L   +S
Sbjct: 188 VSVGTAGYNRAVDCWSLGVILFICLS 213

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPS----KNQEISQEVDNEIEILSKIHSPR 110
           FS+ + +G GS G+VY A  V     VA+KK S    ++ E  Q++  E+  L K+  P 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            +   G         LV+E+   G+  D+L  + +PL       +     + +  LHS  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH- 134
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLA-LRCGVDNFRFRSTPPAGTIGYLDPCYVTP- 228
             +IHRD+K+ N+L+      +LGDFG A +    + F        GT  ++ P  +   
Sbjct: 135 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-------VGTPYWMAPEVILAM 186
Query: 229 --DNLSTKTDVFSFGILLLEI 247
                  K DV+S GI  +E+
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 61  KLLGKGSHGSVYKAVLRG--RQVAVKKPSKNQ---------EISQEVDNEIEILSKIHSP 109
           K LG G+ G V  A  R   ++VA+K  SK +         + +  V+ EIEIL K++ P
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
            ++ +  F  D++D  +V+E M  G L+D +  N R      ++    Q+  AV+ LH  
Sbjct: 76  CIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHEN 133
Query: 170 MPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP--- 223
              IIHRD+K  NVL+   + +   ++ DFG +   G  +   R+    GT  YL P   
Sbjct: 134 --GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL--CGTPTYLAPEVL 188
Query: 224 CYVTPDNLSTKTDVFSFGILLLEIIS 249
             V     +   D +S G++L   +S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 61  KLLGKGSHGSVYKAVLRG--RQVAVKKPSKNQ---------EISQEVDNEIEILSKIHSP 109
           K LG G+ G V  A  R   ++VA+K  SK +         + +  V+ EIEIL K++ P
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
            ++ +  F  D++D  +V+E M  G L+D +  N R      ++    Q+  AV+ LH  
Sbjct: 76  CIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHEN 133
Query: 170 MPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP--- 223
              IIHRD+K  NVL+   + +   ++ DFG +   G  +   R+    GT  YL P   
Sbjct: 134 --GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL--CGTPTYLAPEVL 188
Query: 224 CYVTPDNLSTKTDVFSFGILLLEIIS 249
             V     +   D +S G++L   +S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P L  L     D+ +  +V+E+   G ++  L    R      R   A Q+    E 
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 157
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N++ID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 158 LHS--LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 210
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K +  G   A+K   K + +     +   NE  IL  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P L  L     D+ +  +V+E+   G ++  L    R      R   A Q+    E 
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 157
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N++ID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 158 LHS--LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEI 210
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA   L G  VA+ K    ++ + +      EI +L +++ P +
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 112 VNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V LL   +      LV EF+        D       PL   +      Q+ + +   HS 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCHSH 122
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTP 228
              ++HRD+K  N+LI+     +L DFGLA   GV    +  T    T+ Y  P   +  
Sbjct: 123 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGC 178
Query: 229 DNLSTKTDVFSFGILLLEIISCR 251
              ST  D++S G +  E+++ R
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA   L G  VA+ K    ++ + +      EI +L +++ P +
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 112 VNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V LL   +      LV EF+        D       PL   +      Q+ + +   HS 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCHSH 121
Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTP 228
              ++HRD+K  N+LI+     +L DFGLA   GV    +  T    T+ Y  P   +  
Sbjct: 122 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGC 177
Query: 229 DNLSTKTDVFSFGILLLEIISCR 251
              ST  D++S G +  E+++ R
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 61  KLLGKGSHGSVYKAVLRGR-----QVAVKKPSKNQEISQ--EVDNEIEILSKIHSPRLVN 113
           +++GKG  G VY      +     Q A+K  S+  E+ Q      E  ++  ++ P ++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 114 LLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
           L+G     +    +++ +M +G L   + S  R       I   LQVA+ +E L  +   
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ--K 144
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLAL------RCGVDNFRFRSTPPAGTIGYLDPCYV 226
            +HRD+ + N ++D +F  ++ DFGLA          V   R    P   T       Y 
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY- 203
Query: 227 TPDNLSTKTDVFSFGILLLEIIS 249
                +TK+DV+SFG+LL E+++
Sbjct: 204 ---RFTTKSDVWSFGVLLWELLT 223

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAVLRGR--QVAVKKPSKNQEISQEVDNEIEILSKI-HSPR 110
           ++G+  ++ +G GS+    + V +    + AVK   K++    E   EIEIL +    P 
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE---EIEILLRYGQHPN 82
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQ-VAKAVEILHSE 169
           ++ L    +D K   LV E M  G L D +    +     R     L  + K VE LHS+
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKIL--RQKFFSEREASFVLHTIGKTVEYLHSQ 140
Query: 170 MPPIIHRDIKSANVL-IDRNFNA---RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
              ++HRD+K +N+L +D + N    R+ DFG A +   +N    +  P  T  ++ P  
Sbjct: 141 --GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT--PCYTANFVAPEV 196
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
           +         D++S GILL  +++       G++P
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLA-------GYTP 224

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y AVL  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           +++LL      K      D  LV+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLCGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 141 HLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 104/213 (48%), Gaps = 23/213 (10%)
Query: 55  NGFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPS--KNQEISQEVDNEIEILSKIHSPR 110
           + +  Q+++G G+   V  A    +  +VA+K+ +  K Q    E+  EI+ +S+ H P 
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 111 LVNLLGFSNDSKDRL-LVVEFMSNGTLYDVL-------HSNNRPLNWGRRIRLALQVAKA 162
           +V+    S   KD L LV++ +S G++ D++          +  L+      +  +V + 
Sbjct: 70  IVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 128
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           +E LH      IHRD+K+ N+L+  + + ++ DFG++          R+      +G   
Sbjct: 129 LEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG--T 184
Query: 223 PCYVTPDNLST------KTDVFSFGILLLEIIS 249
           PC++ P+ +        K D++SFGI  +E+ +
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 217

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAVLRGR--QVAVKKPSKNQEISQEVDNEIEILSKI-HSPR 110
           ++G+  ++ +G GS+    + V +    + AVK   K++    E   EIEIL +    P 
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE---EIEILLRYGQHPN 82
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQ-VAKAVEILHSE 169
           ++ L    +D K   LV E M  G L D +    +     R     L  + K VE LHS+
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKIL--RQKFFSEREASFVLHTIGKTVEYLHSQ 140
Query: 170 MPPIIHRDIKSANVL-IDRNFNA---RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
              ++HRD+K +N+L +D + N    R+ DFG A +   +N    +  P  T  ++ P  
Sbjct: 141 --GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT--PCYTANFVAPEV 196
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
           +         D++S GILL  +++       G++P
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLA-------GYTP 224

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 104/213 (48%), Gaps = 23/213 (10%)
Query: 55  NGFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPS--KNQEISQEVDNEIEILSKIHSPR 110
           + +  Q+++G G+   V  A    +  +VA+K+ +  K Q    E+  EI+ +S+ H P 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 111 LVNLLGFSNDSKDRL-LVVEFMSNGTLYDVL-------HSNNRPLNWGRRIRLALQVAKA 162
           +V+    S   KD L LV++ +S G++ D++          +  L+      +  +V + 
Sbjct: 75  IVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           +E LH      IHRD+K+ N+L+  + + ++ DFG++          R+      +G   
Sbjct: 134 LEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG--T 189
Query: 223 PCYVTPDNLST------KTDVFSFGILLLEIIS 249
           PC++ P+ +        K D++SFGI  +E+ +
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   K LG GS G V   K    G   A+K   K + +     +   NE  IL  
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+++ G ++  L    R      R   A Q+    E 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 156
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R     +    TP A     L P  
Sbjct: 157 LHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEA-----LAPEI 209
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y AVL  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           +++LL      K      D  LV+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLXGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 141 HLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y AVL  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           +++LL      K      D  LV+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLXGIK 133
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 134 HLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 188
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y A+L  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           ++ LL      K      D  +V+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERMSYLLYQMLVGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 141 HLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G+++ E+I
Sbjct: 196 VILGMGYKENVDIWSVGVIMGEMI 219

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y A+L  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           ++ LL      K      D  +V+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERMSYLLYQMLVGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 141 HLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G+++ E+I
Sbjct: 196 VILGMGYKENVDIWSVGVIMGEMI 219

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y AVL  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           +++LL      K      D  LV+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 141 HLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPS----KNQEISQEVDNEIEILSKIHSPR 110
           F  +K +G+G    VY+A  +L G  VA+KK       + +   +   EI++L +++ P 
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVL--HSNNRPLNWGRRI-RLALQVAKAVEILH 167
           ++       +  +  +V+E    G L  ++      + L   R + +  +Q+  A+E +H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA------GTIGYL 221
           S    ++HRDIK ANV I      +LGD GL         RF S+         GT  Y+
Sbjct: 154 SRR--VMHRDIKPANVFITATGVVKLGDLGLG--------RFFSSKTTAAHSLVGTPYYM 203
Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIIS 249
            P  +  +  + K+D++S G LL E+ +
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAA 231

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN----EIEILSKI 106
           E   + F +   LG G+ G V+K   +   + + +   + EI   + N    E+++L + 
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEI 165
           +SP +V   G      +  + +E M  G+L  VL    R P     ++ +A  V K +  
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTY 146
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           L  E   I+HRD+K +N+L++     +L DFG++ +  +D+    +    GT  Y+ P  
Sbjct: 147 LR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSYMSPER 201
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAI 254
           +   + S ++D++S G+ L+E+   R  I
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 73/143 (51%), Gaps = 8/143 (5%)
Query: 62  LLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           L+G+GS+G V K   +  GR VA+KK      ++ + +    EI++L ++    LVNLL 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
                K   LV EF+ + T+ D L      L++    +   Q+   +   HS    IIHR
Sbjct: 92  VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH--NIIHR 148
Query: 177 DIKSANVLIDRNFNARLGDFGLA 199
           DIK  N+L+ ++   +L DFG A
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFA 171

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 125/278 (44%), Gaps = 26/278 (9%)
Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKP---------SKNQEISQEVDNEIEILSKIHSPRL 111
           K+LG G  G+V+K V      ++K P         S  Q      D+ + I S  H+  +
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA-HI 95
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V LLG    S  +L V +++  G+L D +  +   L     +   +Q+AK +  L  E  
Sbjct: 96  VRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL--EEH 152
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            ++HR++ + NVL+      ++ DFG+A     D+ +   +     I ++    +     
Sbjct: 153 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 212
Query: 232 STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI 291
           + ++DV+S+G+ + E+++       G     + D    L++KG+       R+  P+  I
Sbjct: 213 THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD----LLEKGE-------RLAQPQ--I 259
Query: 292 VRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
               + ++ V+C       RP+ KE+ +  T +++  P
Sbjct: 260 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 297

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 124/275 (45%), Gaps = 26/275 (9%)
Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKKP---------SKNQEISQEVDNEIEILSKIHSPRL 111
           K+LG G  G+V+K V      ++K P         S  Q      D+ + I S  H+  +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA-HI 77
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V LLG    S  +L V +++  G+L D +  +   L     +   +Q+AK +  L  E  
Sbjct: 78  VRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL--EEH 134
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            ++HR++ + NVL+      ++ DFG+A     D+ +   +     I ++    +     
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 232 STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI 291
           + ++DV+S+G+ + E+++       G     + D    L++KG+       R+  P+  I
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD----LLEKGE-------RLAQPQ--I 241
Query: 292 VRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
               + ++ V+C       RP+ KE+ +  T +++
Sbjct: 242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN----EIEILSKI 106
           E   + F +   LG G+ G V+K   +   + + +   + EI   + N    E+++L + 
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 123
Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEI 165
           +SP +V   G      +  + +E M  G+L  VL    R P     ++ +A  V K +  
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTY 181
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           L  E   I+HRD+K +N+L++     +L DFG++ +  +D+    +    GT  Y+ P  
Sbjct: 182 LR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSYMSPER 236
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAI 254
           +   + S ++D++S G+ L+E+   R  I
Sbjct: 237 LQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y AVL  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           +++LL      K      D  LV+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 178
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 179 HLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 233
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E++
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 119/279 (42%), Gaps = 52/279 (18%)
Query: 63  LGKGSHGSVYKAVLRGRQVAV-------KKPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           +G+GS  +VYK +     V V       +K +K++   Q    E E L  +  P +V   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE--RQRFKEEAEXLKGLQHPNIVRFY 91
Query: 116 -GFSNDSKDR---LLVVEFMSNGTLYDVLHSNNRPL-----NWGRRIRLALQVAKAVEIL 166
             + +  K +   +LV E  ++GTL   L            +W R      Q+ K ++ L
Sbjct: 92  DSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCR------QILKGLQFL 145
Query: 167 HSEMPPIIHRDIKSANVLIDR-NFNARLGDFGLA-LRCGVDNFRFRSTPPAGTIGYLDPC 224
           H+  PPIIHRD+K  N+ I     + ++GD GLA L+        R++     IG   P 
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--------RASFAKAVIG--TPE 195
Query: 225 YVTPDNLSTK----TDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF 280
           +  P+    K     DV++FG   LE  +          P S    AA + ++     V 
Sbjct: 196 FXAPEXYEEKYDESVDVYAFGXCXLEXATSE-------YPYSECQNAAQIYRR-----VT 243
Query: 281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
               P   D +   ++  I   C+R  ++ R S+K++++
Sbjct: 244 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y AVL  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           +++LL      K      D  LV+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 178
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 179 HLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 233
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E++
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 19/197 (9%)
Query: 62  LLGKGSHGSVY-------KAVLRGRQVA---VKKPSKNQEISQEVDNEIEILSKIHSPRL 111
            LGKG     +       K V  G+ V    + KP + +++S E    I I   +    +
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME----ISIHRSLAHQHV 83
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V   GF  D+    +V+E     +L + LH   + L          Q+    + LH    
Sbjct: 84  VGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR- 141
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            +IHRD+K  N+ ++ +   ++GDFGLA +   D  R ++    GT  Y+ P  ++    
Sbjct: 142 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL--CGTPNYIAPEVLSKKGH 198
Query: 232 STKTDVFSFGILLLEII 248
           S + DV+S G ++  ++
Sbjct: 199 SFEVDVWSIGCIMYTLL 215

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 16/216 (7%)
Query: 39  PIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE- 95
           P++I+H      +   + +   + LG G+ G V++   R  G   A K      E  +E 
Sbjct: 147 PVEIKH------DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET 200
Query: 96  VDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRL 155
           V  EI+ +S +  P LVNL     D  + +++ EFMS G L++ +   +  ++    +  
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 260
Query: 156 ALQVAKAVEILHSEMPPIIHRDIKSANVLI--DRNFNARLGDFGLALRCGVDNFRFRSTP 213
             QV K +  +H      +H D+K  N++    R+   +L DFGL            +T 
Sbjct: 261 MRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT- 317
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
             GT  +  P       +   TD++S G+L   ++S
Sbjct: 318 --GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y AVL  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           +++LL      K      D  LV+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 86  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 141
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 142 HLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 196
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E++
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 19/197 (9%)
Query: 62  LLGKGSHGSVY-------KAVLRGRQVA---VKKPSKNQEISQEVDNEIEILSKIHSPRL 111
            LGKG     +       K V  G+ V    + KP + +++S E    I I   +    +
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME----ISIHRSLAHQHV 79
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V   GF  D+    +V+E     +L + LH   + L          Q+    + LH    
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR- 137
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            +IHRD+K  N+ ++ +   ++GDFGLA +   D  R ++    GT  Y+ P  ++    
Sbjct: 138 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL--CGTPNYIAPEVLSKKGH 194
Query: 232 STKTDVFSFGILLLEII 248
           S + DV+S G ++  ++
Sbjct: 195 SFEVDVWSIGCIMYTLL 211

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y AVL  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           +++LL      K      D  LV+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 86  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 141
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 142 HLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 196
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E++
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 19/197 (9%)
Query: 62  LLGKGSHGSVY-------KAVLRGRQVA---VKKPSKNQEISQEVDNEIEILSKIHSPRL 111
            LGKG     +       K V  G+ V    + KP + +++S E    I I   +    +
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME----ISIHRSLAHQHV 79
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V   GF  D+    +V+E     +L + LH   + L          Q+    + LH    
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR- 137
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            +IHRD+K  N+ ++ +   ++GDFGLA +   D  R ++    GT  Y+ P  ++    
Sbjct: 138 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL--CGTPNYIAPEVLSKKGH 194
Query: 232 STKTDVFSFGILLLEII 248
           S + DV+S G ++  ++
Sbjct: 195 SFEVDVWSIGCIMYTLL 211

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y AVL  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           +++LL      K      D  LV+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 141 HLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y AVL  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           +++LL      K      D  LV+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 133
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 134 HLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 188
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y AVL  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           +++LL      K      D  LV+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 134
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 135 HLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 189
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E++
Sbjct: 190 VILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y AVL  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           +++LL      K      D  LV+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 141 HLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y AVL  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           +++LL      K      D  LV+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 134
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 135 HLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 189
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E++
Sbjct: 190 VILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y AVL  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 83
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           +++LL      K      D  LV+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 84  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 139
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 140 HLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 194
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E++
Sbjct: 195 VILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y A+L  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           ++ LL      K      D  +V+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 141 HLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPEVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E+I
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMI 219

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN----EIEILSKI 106
           E   + F +   LG G+ G V+K   +   + + +   + EI   + N    E+++L + 
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEI 165
           +SP +V   G      +  + +E M  G+L  VL    R P     ++ +A  V K +  
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTY 122
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           L  E   I+HRD+K +N+L++     +L DFG++ +  +D     +    GT  Y+ P  
Sbjct: 123 LR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDEM---ANEFVGTRSYMSPER 177
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCR 251
           +   + S ++D++S G+ L+E+   R
Sbjct: 178 LQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 16/216 (7%)
Query: 39  PIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE- 95
           P++I+H      +   + +   + LG G+ G V++   R  G   A K      E  +E 
Sbjct: 41  PVEIKH------DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET 94
Query: 96  VDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRL 155
           V  EI+ +S +  P LVNL     D  + +++ EFMS G L++ +   +  ++    +  
Sbjct: 95  VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 154
Query: 156 ALQVAKAVEILHSEMPPIIHRDIKSANVLI--DRNFNARLGDFGLALRCGVDNFRFRSTP 213
             QV K +  +H      +H D+K  N++    R+   +L DFGL            +T 
Sbjct: 155 MRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT- 211
Query: 214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
             GT  +  P       +   TD++S G+L   ++S
Sbjct: 212 --GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 245

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 14/204 (6%)
Query: 52  AATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEIS----QEVDNEIEILSK 105
           A  + F   + LG GS G V   K    G   A+K   K + +     +   NE  I   
Sbjct: 39  AHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++ P LV L     D+ +  +V+E+   G ++  L    R      R   A Q+    E 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEY 157
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    +I+RD+K  N+LID+    ++ DFG A R      + R+    GT  YL P  
Sbjct: 158 LHS--LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEI 210
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +     +   D ++ G+L+ E+ +
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y A+L  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           ++ LL      K      D  +V+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 141
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 142 HLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 196
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E+I
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMI 220

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 25/223 (11%)
Query: 43  QHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVD 97
           QH+D++  +    G      +G+G++GSV K V +  G+ +AVK+       +E  Q + 
Sbjct: 15  QHWDFTAEDLKDLG-----EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLM 69
Query: 98  NEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHS---NNRPLNWGRR 152
           +   ++     P +V   G      D  + +E MS      Y  ++S   +  P     +
Sbjct: 70  DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129
Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST 212
           I LA    KA+  L   +  IIHRDIK +N+L+DR+ N +L DFG++ +  VD+     T
Sbjct: 130 ITLA--TVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDS--IAKT 183
Query: 213 PPAGTIGYLDPCYVTP----DNLSTKTDVFSFGILLLEIISCR 251
             AG   Y+ P  + P         ++DV+S GI L E+ + R
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 84/196 (42%), Gaps = 16/196 (8%)
Query: 63  LGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVD----NEIEILSKIHSPRLVNLLGFS 118
           +G+G+ G V+   LR     V   S  + +  ++      E  IL +   P +V L+G  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
              +   +V+E +  G     L +    L     +++    A  +E L S+    IHRD+
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDL 239
Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFR-----FRSTPPAGTIGYLDPCYVTPDNLST 233
            + N L+      ++ DFG++ R   D         R  P    + +  P  +     S+
Sbjct: 240 AARNCLVTEKNVLKISDFGMS-REEADGVXAASGGLRQVP----VKWTAPEALNYGRYSS 294
Query: 234 KTDVFSFGILLLEIIS 249
           ++DV+SFGILL E  S
Sbjct: 295 ESDVWSFGILLWETFS 310

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y A+L  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           ++ LL      K      D  +V+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERMSYLLYQMLVGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 141 HLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E+I
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMI 219

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 30/220 (13%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKKPS-KNQEISQE-VDNEIEILSKIHSPRLV 112
           F   + LG+G  G V++A   +     A+K+    N+E+++E V  E++ L+K+  P +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 113 NLLG--FSNDSKDRL----------LVVEFMSNGTLYDVLHSNNRPLNWGRRI--RLALQ 158
                    ++ ++L          + ++      L D ++         R +   + LQ
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR---------- 208
           +A+AVE LHS+   ++HRD+K +N+    +   ++GDFGL      D             
Sbjct: 127 IAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEII 248
            R T   GT  Y+ P  +  ++ S K D+FS G++L E++
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y A+L  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           ++ LL      K      D  +V+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 141 HLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E+I
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y A+L  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           ++ LL      K      D  +V+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 141 HLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E+I
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 61  KLLGKGSHGSVYKAVLRG--RQVAVKKPSKNQ---------EISQEVDNEIEILSKIHSP 109
           K LG G+ G V  A  R   ++VA++  SK +         + +  V+ EIEIL K++ P
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
            ++ +  F  D++D  +V+E M  G L+D +  N R      ++    Q+  AV+ LH  
Sbjct: 201 CIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHEN 258
Query: 170 MPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP--- 223
              IIHRD+K  NVL+   + +   ++ DFG +   G  +   R+    GT  YL P   
Sbjct: 259 --GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL--CGTPTYLAPEVL 313
Query: 224 CYVTPDNLSTKTDVFSFGILLLEIIS 249
             V     +   D +S G++L   +S
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLS 339

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y A+L  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 89
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           ++ LL      K      D  +V+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 90  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 145
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 146 HLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 200
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAI 254
            +         D++S G ++ E++ C K +
Sbjct: 201 VILGMGYKENVDLWSVGCIMGEMV-CHKIL 229

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 84/196 (42%), Gaps = 16/196 (8%)
Query: 63  LGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVD----NEIEILSKIHSPRLVNLLGFS 118
           +G+G+ G V+   LR     V   S  + +  ++      E  IL +   P +V L+G  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
              +   +V+E +  G     L +    L     +++    A  +E L S+    IHRD+
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDL 239
Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFR-----FRSTPPAGTIGYLDPCYVTPDNLST 233
            + N L+      ++ DFG++ R   D         R  P    + +  P  +     S+
Sbjct: 240 AARNCLVTEKNVLKISDFGMS-REEADGVYAASGGLRQVP----VKWTAPEALNYGRYSS 294
Query: 234 KTDVFSFGILLLEIIS 249
           ++DV+SFGILL E  S
Sbjct: 295 ESDVWSFGILLWETFS 310

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 61  KLLGKGSHGSVYKAVLRG--RQVAVKKPSKNQ---------EISQEVDNEIEILSKIHSP 109
           K LG G+ G V  A  R   ++VA++  SK +         + +  V+ EIEIL K++ P
Sbjct: 155 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 214
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
            ++ +  F  D++D  +V+E M  G L+D +  N R      ++    Q+  AV+ LH  
Sbjct: 215 CIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHEN 272
Query: 170 MPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP--- 223
              IIHRD+K  NVL+   + +   ++ DFG +   G  +   R+    GT  YL P   
Sbjct: 273 --GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL--CGTPTYLAPEVL 327
Query: 224 CYVTPDNLSTKTDVFSFGILLLEIIS 249
             V     +   D +S G++L   +S
Sbjct: 328 VSVGTAGYNRAVDCWSLGVILFICLS 353

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           +   F + + +G+G++G VYKA   L G  VA+KK    ++ + +      EI +L +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            P +V LL   +      LV E +        D       PL   +      Q+ + +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAF 121
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-C 224
            HS    ++HRD+K  N+LI+     +L DFGLA   GV    +       T+ Y  P  
Sbjct: 122 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEI 177
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCR 251
            +     ST  D++S G +  E+++ R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 19/197 (9%)
Query: 62  LLGKGSHGSVY-------KAVLRGRQVA---VKKPSKNQEISQEVDNEIEILSKIHSPRL 111
            LGKG     +       K V  G+ V    + KP + +++S E    I I   +    +
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME----ISIHRSLAHQHV 103
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V   GF  D+    +V+E     +L + LH   + L          Q+    + LH    
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR- 161
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            +IHRD+K  N+ ++ +   ++GDFGLA +   D  R +     GT  Y+ P  ++    
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGH 218
Query: 232 STKTDVFSFGILLLEII 248
           S + DV+S G ++  ++
Sbjct: 219 SFEVDVWSIGCIMYTLL 235

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y A+L  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           ++ LL      K      D  +V+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERMSYLLYQMLCGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 141 HLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E+I
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y A+L  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           ++ LL      K      D  +V+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 79  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 134
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 135 HLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 189
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAI 254
            +         D++S G ++ E++ C K +
Sbjct: 190 VILGMGYKENVDLWSVGCIMGEMV-CHKIL 218

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y A+L  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           ++ LL      K      D  +V+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERMSYLLYQMLCGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 141 HLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E+I
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y A+L  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           ++ LL      K      D  +V+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERMSYLLYQMLCGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P 
Sbjct: 141 HLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E+I
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAVLRGR--QVAVKKPSKNQEISQEVDNEIEILSKI-HSPR 110
           T+G+  ++ +G GS+    + + +    + AVK   K++    E   EIEIL +    P 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPN 77
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           ++ L    +D K   +V E M  G L D +    +  +      +   + K VE LH++ 
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKI-LRQKFFSEREASAVLFTITKTVEYLHAQ- 135
Query: 171 PPIIHRDIKSANVL-IDRNFN---ARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
             ++HRD+K +N+L +D + N    R+ DFG A +   +N    +  P  T  ++ P  +
Sbjct: 136 -GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPEVL 192
Query: 227 TPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
                    D++S G+LL  +++       G++P
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLT-------GYTP 219

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 115/270 (42%), Gaps = 39/270 (14%)
Query: 63  LGKGSHGSVYKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF-- 117
           L +   G ++K   +G  + VK       +   S++ + E   L     P ++ +LG   
Sbjct: 18  LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
           S  +    L+  +M  G+LY+VLH   N  ++  + ++ AL +A+ +  LH+  P I   
Sbjct: 78  SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRH 137
Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK-- 234
            + S +V+ID +  AR+          + + +F    P        P +V P+ L  K  
Sbjct: 138 ALNSRSVMIDEDMTARI---------SMADVKFSFQSPGRMYA---PAWVAPEALQKKPE 185
Query: 235 ------TDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
                  D++SF +LL E+++     ++ F+  S ++     I     L    P IPP  
Sbjct: 186 DTNRRSADMWSFAVLLWELVTR----EVPFADLSNME-----IGMKVALEGLRPTIPPGI 236
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            P V K + +    C+     +RP    IV
Sbjct: 237 SPHVSKLMKI----CMNEDPAKRPKFDMIV 262

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 19/197 (9%)
Query: 62  LLGKGSHGSVY-------KAVLRGRQVA---VKKPSKNQEISQEVDNEIEILSKIHSPRL 111
            LGKG     +       K V  G+ V    + KP + +++S E    I I   +    +
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME----ISIHRSLAHQHV 101
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V   GF  D+    +V+E     +L + LH   + L          Q+    + LH    
Sbjct: 102 VGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR- 159
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            +IHRD+K  N+ ++ +   ++GDFGLA +   D  R +     GT  Y+ P  ++    
Sbjct: 160 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGH 216
Query: 232 STKTDVFSFGILLLEII 248
           S + DV+S G ++  ++
Sbjct: 217 SFEVDVWSIGCIMYTLL 233

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQV--AVKK-PSKNQEISQEVDNEIEILSK 105
           D E   NG  ++ +LGKG++G VY       QV  A+K+ P ++   SQ +  EI +   
Sbjct: 18  DYEYDENG--DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKH 75
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI--RLALQVAKAV 163
           +    +V  LG  +++    + +E +  G+L  +L S   PL    +       Q+ + +
Sbjct: 76  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLALR-CGVDNFRFRSTPPAGTIGYL 221
           + LH     I+HRDIK  NVLI+      ++ DFG + R  G++      T   GT+ Y+
Sbjct: 136 KYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT---GTLQYM 190
Query: 222 DPCYVT--PDNLSTKTDVFSFGILLLEIISCR 251
            P  +   P       D++S G  ++E+ + +
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 19/197 (9%)
Query: 62  LLGKGSHGSVY-------KAVLRGRQVA---VKKPSKNQEISQEVDNEIEILSKIHSPRL 111
            LGKG     +       K V  G+ V    + KP + +++S E    I I   +    +
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME----ISIHRSLAHQHV 77
Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V   GF  D+    +V+E     +L + LH   + L          Q+    + LH    
Sbjct: 78  VGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR- 135
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            +IHRD+K  N+ ++ +   ++GDFGLA +   D  R +     GT  Y+ P  ++    
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGH 192
Query: 232 STKTDVFSFGILLLEII 248
           S + DV+S G ++  ++
Sbjct: 193 SFEVDVWSIGCIMYTLL 209

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 99/193 (51%), Gaps = 15/193 (7%)
Query: 61  KLLGKGSHGSVYKAVLR--GRQVA---VKKPSKNQEISQEVDNEIEILSKIHS-PRLVNL 114
           K LG+G    V + + +  G++ A   +KK  + Q+   E+ +EI +L    S PR++NL
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDV-LHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
                ++ + +L++E+ + G ++ + L      ++    IRL  Q+ + V  LH     I
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN--NI 152
Query: 174 IHRDIKSANVLIDRNF---NARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
           +H D+K  N+L+   +   + ++ DFG++ + G      R     GT  YL P  +  D 
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREI--MGTPEYLAPEILNYDP 209
Query: 231 LSTKTDVFSFGIL 243
           ++T TD+++ GI+
Sbjct: 210 ITTATDMWNIGII 222

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 111/227 (48%), Gaps = 34/227 (14%)
Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIH-SPRLVNL 114
           K LGKG++G V+K++ R  G  VAVKK     +N   +Q    EI IL+++     +VNL
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 115 LGF--SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
           L    +++ +D  LV ++M    L+ V+ +N   L    +  +  Q+ K ++ LHS    
Sbjct: 75  LNVLRADNDRDVYLVFDYMETD-LHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHS--GG 129
Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLA--------------LRCGVDNFRFRSTPPAGTI 218
           ++HRD+K +N+L++   + ++ DFGL+              L    +   F    P  T 
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 219 GYLDPCYVTPDNL--STK----TDVFSFGILLLEIISCRKAIDIGFS 259
                 Y  P+ L  STK     D++S G +L EI+ C K I  G S
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPIFPGSS 235

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 18/172 (10%)
Query: 46  DYSDLEAATNGFSEQKL-----LGKGSHGSVYKA--VLRGRQVAVKKP-SKNQEISQEVD 97
           D SD    T    E +L     L +G    VY+A  V  GR+ A+K+  S  +E ++ + 
Sbjct: 14  DQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII 73
Query: 98  NEIEILSKIHS-PRLVNLLGFSNDSKDR-------LLVVEFMSNGTLYDVLH--SNNRPL 147
            E+  + K+   P +V     ++  K+         L++  +  G L + L    +  PL
Sbjct: 74  QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL 133
Query: 148 NWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
           +    +++  Q  +AV+ +H + PPIIHRD+K  N+L+      +L DFG A
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQV--AVKK-PSKNQEISQEVDNEIEILSK 105
           D E   NG  ++ +LGKG++G VY       QV  A+K+ P ++   SQ +  EI +   
Sbjct: 4   DYEYDENG--DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKH 61
Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI--RLALQVAKAV 163
           +    +V  LG  +++    + +E +  G+L  +L S   PL    +       Q+ + +
Sbjct: 62  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 121
Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLALR-CGVDNFRFRSTPPAGTIGYL 221
           + LH     I+HRDIK  NVLI+      ++ DFG + R  G++      T   GT+ Y+
Sbjct: 122 KYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT---GTLQYM 176
Query: 222 DPCYVT--PDNLSTKTDVFSFGILLLEIISCR 251
            P  +   P       D++S G  ++E+ + +
Sbjct: 177 APEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 33/226 (14%)
Query: 51  EAATNGFSEQKLLGKGSHGSV-YKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHS- 108
           ++  N    +K+LG GS G+V ++   +GR VAVK+     +       EI++L++    
Sbjct: 29  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML--IDFCDIALMEIKLLTESDDH 86
Query: 109 PRLVNLLGFSNDSKDRLLVVEF-MSNGTLYDVLHSNN---RPLNWGRR---IRLALQVAK 161
           P ++    + +++ DR L +   + N  L D++ S N     L   +    I L  Q+A 
Sbjct: 87  PNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 162 AVEILHSEMPPIIHRDIKSANVLID-------------RNFNARLGDFGLA--LRCGVDN 206
            V  LHS    IIHRD+K  N+L+               N    + DFGL   L  G   
Sbjct: 145 GVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 207 FRFRSTPPAGTIGYLDPCYV---TPDNLSTKTDVFSFGILLLEIIS 249
           FR     P+GT G+  P  +   T   L+   D+FS G +   I+S
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 57  FSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSK-----NQEISQEVDNEIEILS 104
           F   K+LG G++G V+  ++R       G+  A+K   K       + ++    E ++L 
Sbjct: 56  FELLKVLGTGAYGKVF--LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 105 KI-HSPRLVNL-LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
            I  SP LV L   F  ++K  L ++++++ G L+  L    R      +I +  ++  A
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHL-ILDYINGGELFTHLSQRERFTEHEVQIYVG-EIVLA 171
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           +E LH     II+RDIK  N+L+D N +  L DFGL+     D    R+    GTI Y+ 
Sbjct: 172 LEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMA 228
Query: 223 PCYVTPDN--LSTKTDVFSFGILLLEIIS 249
           P  V   +       D +S G+L+ E+++
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLT 257

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 37/230 (16%)
Query: 51  EAATNGFSEQKLLGKGSHGSV-YKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHS- 108
           ++  N    +K+LG GS G+V ++   +GR VAVK+     +       EI++L++    
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI--DFCDIALMEIKLLTESDDH 68
Query: 109 PRLVNLLGFSNDSKDRLLVVEF-MSNGTLYDVLHSNN---RPLNWGRR---IRLALQVAK 161
           P ++    + +++ DR L +   + N  L D++ S N     L   +    I L  Q+A 
Sbjct: 69  PNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 162 AVEILHSEMPPIIHRDIKSANVLID-------------RNFNARLGDFGLA--LRCGVDN 206
            V  LHS    IIHRD+K  N+L+               N    + DFGL   L  G  +
Sbjct: 127 GVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 207 FRFRSTPPAGTIGYLDPCYV-TPDNLSTK------TDVFSFGILLLEIIS 249
           FR     P+GT G+  P  +   +NL TK       D+FS G +   I+S
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 33/226 (14%)
Query: 51  EAATNGFSEQKLLGKGSHGSV-YKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHS- 108
           ++  N    +K+LG GS G+V ++   +GR VAVK+     +       EI++L++    
Sbjct: 29  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML--IDFCDIALMEIKLLTESDDH 86
Query: 109 PRLVNLLGFSNDSKDRLLVVEF-MSNGTLYDVLHSNN---RPLNWGRR---IRLALQVAK 161
           P ++    + +++ DR L +   + N  L D++ S N     L   +    I L  Q+A 
Sbjct: 87  PNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 162 AVEILHSEMPPIIHRDIKSANVLID-------------RNFNARLGDFGLA--LRCGVDN 206
            V  LHS    IIHRD+K  N+L+               N    + DFGL   L  G   
Sbjct: 145 GVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 207 FRFRSTPPAGTIGYLDPCYV---TPDNLSTKTDVFSFGILLLEIIS 249
           FR     P+GT G+  P  +   T   L+   D+FS G +   I+S
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 62  LLGKGSHGSVYKA--VLRGRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLL 115
           LL K  +G   KA  V++  Q    + S +    ++  +E+ NEI +L  +  P ++ L 
Sbjct: 53  LLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112
Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
               D K   LV EF   G L++ +  N    +      +  Q+   +  LH     I+H
Sbjct: 113 DVFEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAANIMKQILSGICYLHKH--NIVH 169
Query: 176 RDIKSANVLIDRN---FNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           RDIK  N+L++      N ++ DFGL+     D   ++     GT  Y+ P  V     +
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAP-EVLKKKYN 225
Query: 233 TKTDVFSFGILLLEIISC 250
            K DV+S G+++  I+ C
Sbjct: 226 EKCDVWSCGVIMY-ILLC 242

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGR-----QVAVKKPSKNQEISQEVDN---EIEILSKIHS 108
           F+  ++LGKG  GSV +A L+       +VAVK    +   S +++    E   + +   
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 109 PRLVNLLGFSNDSKDR------LLVVEFMSNGTLYDVLHSN-------NRPLNWGRRIRL 155
           P +  L+G S  S+ +      ++++ FM +G L+  L ++       N PL     +R 
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ--TLVRF 142
Query: 156 ALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA 215
            + +A  +E L S     IHRD+ + N ++  +    + DFGL+ +    ++  +     
Sbjct: 143 MVDIACGMEYLSSR--NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 216 GTIGYLDPCYVTPDNLST-KTDVFSFGILLLEIIS 249
             + +L       DNL T  +DV++FG+ + EI++
Sbjct: 201 LPVKWL-ALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y A+L  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           ++ LL      K      D  +V+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F   P   T  Y  P 
Sbjct: 141 HLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMEPEVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAI 254
            +         D++S G ++ E++ C K +
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMV-CHKIL 224

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 57  FSEQKLLGKGSHGS-VYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNL 114
           F  + +LG G+ G+ VY+ +   R VAVK+     E     D E+++L +    P ++  
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVIRY 83
Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
                D + + + +E +   TL + +   +        I L  Q    +  LHS    I+
Sbjct: 84  FCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS--LNIV 140
Query: 175 HRDIKSANVLIDR-----NFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
           HRD+K  N+LI          A + DFGL   L  G  +F  RS  P GT G++ P  ++
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWIAPEMLS 199
Query: 228 PD---NLSTKTDVFSFGILLLEIIS 249
            D   N +   D+FS G +   +IS
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 104/230 (45%), Gaps = 37/230 (16%)
Query: 51  EAATNGFSEQKLLGKGSHGSV-YKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHS- 108
           ++  N    +K+LG GS G+V ++   +GR VAVK+     +       EI++L++    
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI--DFCDIALMEIKLLTESDDH 68
Query: 109 PRLVNLLGFSNDSKDRLLVVEF-MSNGTLYDVLHSNN---RPLNWGRR---IRLALQVAK 161
           P ++    + +++ DR L +   + N  L D++ S N     L   +    I L  Q+A 
Sbjct: 69  PNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 162 AVEILHSEMPPIIHRDIKSANVLID-------------RNFNARLGDFGLA--LRCGVDN 206
            V  LHS    IIHRD+K  N+L+               N    + DFGL   L  G   
Sbjct: 127 GVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 184
Query: 207 FRFRSTPPAGTIGYLDPCYV-TPDNLSTK------TDVFSFGILLLEIIS 249
           FR     P+GT G+  P  +   +NL TK       D+FS G +   I+S
Sbjct: 185 FRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 80/148 (54%), Gaps = 13/148 (8%)
Query: 94  QEVDNEIEILSKIHSPRLVNLLGFSND-SKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGR 151
           ++V  EI IL K+  P +V L+   +D ++D L +V E ++ G + +V     +PL+  +
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV--PTLKPLSEDQ 138
Query: 152 RIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
                  + K +E LH +   IIHRDIK +N+L+  + + ++ DFG++     + F+   
Sbjct: 139 ARFYFQDLIKGIEYLHYQ--KIIHRDIKPSNLLVGEDGHIKIADFGVS-----NEFKGSD 191
Query: 212 TPPAGTIGYLDPCYVTPDNLSTKTDVFS 239
              + T+G   P ++ P++LS    +FS
Sbjct: 192 ALLSNTVG--TPAFMAPESLSETRKIFS 217

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 91/194 (46%), Gaps = 13/194 (6%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G+GS+G V+K   R  G+ VA+KK  ++++   I +    EI +L ++  P LVNLL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
               +   LV E+  +  L++ L    R +       +  Q  +AV   H      IHRD
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHE-LDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRD 127
Query: 178 IKSANVLIDRNFNARLGDFGLA-LRCGVDNFRFRSTPPAGTIGYLDPCYVTPD-NLSTKT 235
           +K  N+LI ++   +L DFG A L  G  ++         T  Y  P  +  D       
Sbjct: 128 VKPENILITKHSVIKLCDFGFARLLTGPSDY---YDDEVATRWYRSPELLVGDTQYGPPV 184
Query: 236 DVFSFGILLLEIIS 249
           DV++ G +  E++S
Sbjct: 185 DVWAIGCVFAELLS 198

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 116/266 (43%), Gaps = 27/266 (10%)
Query: 63  LGKGSHGSVYKA--VLRGRQVAVKK--PSKNQEISQEVDNEIEILSK-IHSPRLVNLLGF 117
           LG+G++G V K   V  G+  AVK+   + N +  + +  +++I  + +  P  V   G 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 118 SNDSKDRLLVVEFMSNG--TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
                D  +  E         Y  +    + +      ++A+ + KA+E LHS++  +IH
Sbjct: 102 LFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-VIH 160
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD----NL 231
           RD+K +NVLI+     +  DFG++    VD+        AG   Y  P  + P+      
Sbjct: 161 RDVKPSNVLINALGQVKXCDFGISGYL-VDD--VAKDIDAGCKPYXAPERINPELNQKGY 217
Query: 232 STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI 291
           S K+D++S GI  +E+   R   D          W  P  +  +++    P++P  K   
Sbjct: 218 SVKSDIWSLGITXIELAILRFPYD---------SWGTPFQQLKQVVEEPSPQLPADK--- 265
Query: 292 VRKQLAVIAVRCVRSCRERRPSMKEI 317
              +      +C++   + RP+  E+
Sbjct: 266 FSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y A+L  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           ++ LL      K      D  +V+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F   P   T  Y  P 
Sbjct: 141 HLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMEPEVVTRYYRAPE 195
Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAI 254
            +         D++S G ++ E++ C K +
Sbjct: 196 VILGMGYKENVDLWSVGCIMGEMV-CHKIL 224

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 121/270 (44%), Gaps = 29/270 (10%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G GS+G   K   +  G+ +  K+    S  +   Q + +E+ +L ++  P +V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 118 SNDSKDRLL--VVEFMSNGTLYDVLHSNNRP---LNWGRRIRLALQVAKAVEILHSEMP- 171
             D  +  L  V+E+   G L  V+    +    L+    +R+  Q+  A++  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 172 --PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
              ++HRD+K ANV +D   N +LGDFGLA R    +  F  T   GT  Y+ P  +   
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLA-RILNHDTSFAKT-FVGTPYYMSPEQMNRM 191
Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD 289
           + + K+D++S G LL E+ +        FS   +    A  I++GK       RIP    
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPF-TAFSQKEL----AGKIREGKF-----RRIPYR-- 239
Query: 290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
                +L  I  R +      RPS++EI++
Sbjct: 240 --YSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN----EIEILSKI 106
           E   + F     LG G+ G V K   R   + + +   + EI   + N    E+++L + 
Sbjct: 12  ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 71
Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEI 165
           +SP +V   G      +  + +E M  G+L  VL    R P     ++ +A  V + +  
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAY 129
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           L  E   I+HRD+K +N+L++     +L DFG++ +  +D+    +    GT  Y+ P  
Sbjct: 130 LR-EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSM---ANSFVGTRSYMAPER 184
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAI 254
           +   + S ++D++S G+ L+E+   R  I
Sbjct: 185 LQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 57  FSEQKLLGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPR 110
           +   K +G G+ G V   Y A+L  R VA+KK   P +NQ  ++    E+ ++  ++   
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 86
Query: 111 LVNLLGFSNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           ++ LL      K      D  +V+E M +  L  V+      L+  R   L  Q+   ++
Sbjct: 87  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIK 142
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
            LHS    IIHRD+K +N+++  +   ++ DFGLA   G     F   P   T  Y  P 
Sbjct: 143 HLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMVPFVVTRYYRAPE 197
Query: 225 YVTPDNLSTKTDVFSFGILLLEII 248
            +         D++S G ++ E+I
Sbjct: 198 VILGMGYKENVDIWSVGCIMGEMI 221

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 35/223 (15%)
Query: 53  ATNGFSE----QKLLGKGSHGSVYKAVLR--GRQVAVK----------KPSKNQEISQEV 96
           +T+GF E    +++LG+G    V + + +   ++ AVK             + QE+ +  
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 97  DNEIEILSKIH-SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRR--I 153
             E++IL K+   P ++ L      +    LV + M  G L+D L           R  +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRST 212
           R  L+V  A+  L+     I+HRD+K  N+L+D + N +L DFG +  C +D   + RS 
Sbjct: 131 RALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLRSV 183
Query: 213 PPAGTIGYLDP----CYVTPDN--LSTKTDVFSFGILLLEIIS 249
              GT  YL P    C +  ++     + D++S G+++  +++
Sbjct: 184 --CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 12/109 (11%)
Query: 150 GRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF 209
           G  + + +Q+A+AVE LHS+   ++HRD+K +N+    +   ++GDFGL      D    
Sbjct: 164 GVCLHIFIQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 210 RSTPP----------AGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEII 248
               P           GT  Y+ P  +  +N S K D+FS G++L E++
Sbjct: 222 TVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 127
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 188 VDVWSCGIVLTAMLA 202

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I + ++   +V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 128
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 189 VDVWSCGIVLTAMLA 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 127
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 188 VDVWSCGIVLTAMLA 202

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 29/270 (10%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G GS+G   K   +  G+ +  K+    S  +   Q + +E+ +L ++  P +V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 118 SNDSKDRLL--VVEFMSNGTLYDVLHSNNRP---LNWGRRIRLALQVAKAVEILHSEMP- 171
             D  +  L  V+E+   G L  V+    +    L+    +R+  Q+  A++  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 172 --PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
              ++HRD+K ANV +D   N +LGDFGLA     D    ++    GT  Y+ P  +   
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF--VGTPYYMSPEQMNRM 191
Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD 289
           + + K+D++S G LL E+ +        FS   +    A  I++GK       RIP    
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPF-TAFSQKEL----AGKIREGKF-----RRIPYR-- 239
Query: 290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
                +L  I  R +      RPS++EI++
Sbjct: 240 --YSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKK------PSKNQEISQEVDNEI 100
           D+++    + +   LG+G   +VYKA  +     VA+KK            I++    EI
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 101 EILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVA 160
           ++L ++  P ++ LL       +  LV +FM    L  ++  N+  L         L   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN 206
           + +E LH     I+HRD+K  N+L+D N   +L DFGLA   G  N
Sbjct: 123 QGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 128
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 188
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 189 VDVWSCGIVLTAMLA 203

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 128
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 189 VDVWSCGIVLTAMLA 203

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 128
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 189 VDVWSCGIVLTAMLA 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 128
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 189 VDVWSCGIVLTAMLA 203

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 121/271 (44%), Gaps = 31/271 (11%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G GS+G   K   +  G+ +  K+    S  +   Q + +E+ +L ++  P +V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 118 SNDSKDRLL--VVEFMSNGTLYDVLHSNNRP---LNWGRRIRLALQVAKAVEILHSEMP- 171
             D  +  L  V+E+   G L  V+    +    L+    +R+  Q+  A++  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 172 --PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDPCYVTP 228
              ++HRD+K ANV +D   N +LGDFGLA     D +F   +    GT  Y+ P  +  
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDF---AKEFVGTPYYMSPEQMNR 190
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
            + + K+D++S G LL E+ +        FS   +    A  I++GK       RIP   
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKEL----AGKIREGKF-----RRIPYR- 239
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
                 +L  I  R +      RPS++EI++
Sbjct: 240 ---YSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG--ITH 128
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 189 VDVWSCGIVLTAMLA 203

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 48  SDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQV--AVKKPSKNQEISQEVDNEIE---- 101
           S+  A  + F   K++GKGS G V  A  +  +V  AVK   K   + ++ +  I     
Sbjct: 31  SNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERN 90
Query: 102 -ILSKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQV 159
            +L  +  P LV L  FS  + D+L  V+++++ G L+  L      L    R   A ++
Sbjct: 91  VLLKNVKHPFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEI 148
Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA--GT 217
           A A+  LHS    I++RD+K  N+L+D   +  L DFGL   C  +N    ST     GT
Sbjct: 149 ASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGL---CK-ENIEHNSTTSTFCGT 202
Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEII 248
             YL P  +         D +  G +L E++
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG--ITH 127
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 188 VDVWSCGIVLTAMLA 202

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 126
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 187 VDVWSCGIVLTAMLA 201

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 128
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 189 VDVWSCGIVLTAMLA 203

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 127
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 188 VDVWSCGIVLTAMLA 202

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 128
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 189 VDVWSCGIVLTAMLA 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 127
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 188 VDVWSCGIVLTAMLA 202

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 127
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 188 VDVWSCGIVLTAMLA 202

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 127
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 188 VDVWSCGIVLTAMLA 202

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 127
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 188 VDVWSCGIVLTAMLA 202

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 107/244 (43%), Gaps = 35/244 (14%)
Query: 57  FSEQKLLGKGSHGSVYK-----AVLRGRQVAVKKPSK-----NQEISQEVDNEIEILSKI 106
           F   ++LGKG +G V++         G+  A+K   K     N + +     E  IL ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
             P +V+L+          L++E++S G L+  L      +       LA +++ A+  L
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-EISMALGHL 137
Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGL---ALRCGVDNFRFRSTPPAGTIGYLDP 223
           H +   II+RD+K  N++++   + +L DFGL   ++  G     F      GTI Y+ P
Sbjct: 138 HQK--GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXF-----CGTIEYMAP 190
Query: 224 CYVTPDNLSTKTDVFSFGILLLEIISC---------RKAIDIGFS-----PPSIVDWAAP 269
             +     +   D +S G L+ ++++          +K ID         PP +   A  
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 250
Query: 270 LIKK 273
           L+KK
Sbjct: 251 LLKK 254

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 107/244 (43%), Gaps = 35/244 (14%)
Query: 57  FSEQKLLGKGSHGSVYK-----AVLRGRQVAVKKPSK-----NQEISQEVDNEIEILSKI 106
           F   ++LGKG +G V++         G+  A+K   K     N + +     E  IL ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
             P +V+L+          L++E++S G L+  L      +       LA +++ A+  L
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-EISMALGHL 137
Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGL---ALRCGVDNFRFRSTPPAGTIGYLDP 223
           H +   II+RD+K  N++++   + +L DFGL   ++  G     F      GTI Y+ P
Sbjct: 138 HQK--GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF-----CGTIEYMAP 190
Query: 224 CYVTPDNLSTKTDVFSFGILLLEIISC---------RKAIDIGFS-----PPSIVDWAAP 269
             +     +   D +S G L+ ++++          +K ID         PP +   A  
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 250
Query: 270 LIKK 273
           L+KK
Sbjct: 251 LLKK 254

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 15/194 (7%)
Query: 57  FSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEI-SQEVDNEIEILSKIHSPRLVN 113
           F   ++LG G+   V+  K  L G+  A+K   K+       ++NEI +L KI    +V 
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL-QVAKAVEILHSEMPP 172
           L      +    LV++ +S G L+D +    R +   +   L + QV  AV+ LH     
Sbjct: 71  LEDIYESTTHYYLVMQLVSGGELFDRIL--ERGVYTEKDASLVIQQVLSAVKYLHEN--G 126
Query: 173 IIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
           I+HRD+K  N+L    + N    + DFGL+    ++     ST   GT GY+ P  +   
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLS---KMEQNGIMST-ACGTPGYVAPEVLAQK 182
Query: 230 NLSTKTDVFSFGIL 243
             S   D +S G++
Sbjct: 183 PYSKAVDCWSIGVI 196

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 127
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 188 VDVWSCGIVLTAMLA 202

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 127
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 188 VDVWSCGIVLTAMLA 202

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 35/223 (15%)
Query: 53  ATNGFSE----QKLLGKGSHGSVYKAVLR--GRQVAVK----------KPSKNQEISQEV 96
           +T+GF E    +++LG+G    V + + +   ++ AVK             + QE+ +  
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 97  DNEIEILSKIH-SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRR--I 153
             E++IL K+   P ++ L      +    LV + M  G L+D L           R  +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRST 212
           R  L+V  A+  L+     I+HRD+K  N+L+D + N +L DFG +  C +D   + R  
Sbjct: 131 RALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLREV 183
Query: 213 PPAGTIGYLDP----CYVTPDN--LSTKTDVFSFGILLLEIIS 249
              GT  YL P    C +  ++     + D++S G+++  +++
Sbjct: 184 --CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 127
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 188 VDVWSCGIVLTAMLA 202

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 125/278 (44%), Gaps = 43/278 (15%)
Query: 63  LGKGSHGSVYKAVL---RGRQVAVK-KPSKNQEISQ--EVDNEIEILSKIHS---PRLVN 113
           LG GS G V +       G+ V+V  K  K   +SQ   +D+ I  ++ +HS     L+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L G       ++ V E    G+L D L  +      G   R A+QVA+ +  L S+    
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--F 142
Query: 174 IHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNF---RFRSTPPAGTIGYLDPCYVTP 228
           IHRD+ + N+L+      ++GDFGL  AL    D++     R  P A         +  P
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA---------WCAP 193
Query: 229 DNLSTKT-----DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR 283
           ++L T+T     D + FG+ L E+ +  +   IG +   I+     + K+G+       R
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH---KIDKEGE-------R 243
Query: 284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           +P P+D    + +  + V+C     E RP+   + D+L
Sbjct: 244 LPRPED--CPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIE-------ILSKIH 107
           F+   +LGKGS G V  A  +G +   A+K   K+  I    D+++E       +L+ + 
Sbjct: 21  FNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQ---DDDVECTMVEKRVLALLD 77
Query: 108 SPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
            P  +  L     + DRL  V+E+++ G L   +    +     + +  A +++  +  L
Sbjct: 78  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISIGLFFL 136
Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
           H     II+RD+K  NV++D   + ++ DFG+     +D    R     GT  Y+ P  +
Sbjct: 137 HKR--GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREF--CGTPDYIAPEII 192
Query: 227 TPDNLSTKTDVFSFGILLLEIISCRKAID 255
                    D +++G+LL E+++ +   D
Sbjct: 193 AYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAVLRGR--QVAVKKPSKNQEISQEVDNEIEILSKI-HSPR 110
           T+G+  ++ +G GS+    + + +    + AVK   K++    E   EIEIL +    P 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTE---EIEILLRYGQHPN 77
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           ++ L    +D K   +V E    G L D +    +  +      +   + K VE LH++ 
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKI-LRQKFFSEREASAVLFTITKTVEYLHAQ- 135
Query: 171 PPIIHRDIKSANVL-IDRNFNA---RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
             ++HRD+K +N+L +D + N    R+ DFG A +   +N    +  P  T  ++ P  +
Sbjct: 136 -GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXT--PCYTANFVAPEVL 192
Query: 227 TPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
                    D++S G+LL   ++       G++P
Sbjct: 193 ERQGYDAACDIWSLGVLLYTXLT-------GYTP 219

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 125/278 (44%), Gaps = 43/278 (15%)
Query: 63  LGKGSHGSVYKAVL---RGRQVAVK-KPSKNQEISQ--EVDNEIEILSKIHS---PRLVN 113
           LG GS G V +       G+ V+V  K  K   +SQ   +D+ I  ++ +HS     L+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L G       ++ V E    G+L D L  +      G   R A+QVA+ +  L S+    
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--F 136
Query: 174 IHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNF---RFRSTPPAGTIGYLDPCYVTP 228
           IHRD+ + N+L+      ++GDFGL  AL    D++     R  P A         +  P
Sbjct: 137 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA---------WCAP 187
Query: 229 DNLSTKT-----DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR 283
           ++L T+T     D + FG+ L E+ +  +   IG +   I+     + K+G+       R
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH---KIDKEGE-------R 237
Query: 284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           +P P+D    + +  + V+C     E RP+   + D+L
Sbjct: 238 LPRPED--CPQDIYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 55  NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVD-----NEIEILSKIH 107
           + F   ++LGKGS G V  A ++  G   AVK   K+  I Q+ D      E  ILS   
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV-ILQDDDVECTMTEKRILSLAR 81
Query: 108 SPRLVNLLGFSNDSKDRLL-VVEFMSNGTLYDVLH-SNNRPLNWGRRIRLALQVAKAVEI 165
           +   +  L     + DRL  V+EF++ G L  + H   +R  +  R    A ++  A+  
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LH +   II+RD+K  NVL+D   + +L DFG+  + G+ N    +T   GT  Y+ P  
Sbjct: 140 LHDK--GIIYRDLKLDNVLLDHEGHCKLADFGMC-KEGICNGVTTAT-FCGTPDYIAPEI 195
Query: 226 VTPDNLSTKTDVFSFGILLLEIIS 249
           +         D ++ G+LL E++ 
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLC 219

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 13/189 (6%)
Query: 62  LLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQE--VDNEIEILSKIHSPRLVNLLGF 117
           +LG G+   V  A  +  Q  VA+K  +K     +E  ++NEI +L KI  P +V L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
                   L+++ +S G L+D +             RL  QV  AV+ LH     I+HRD
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-RLIFQVLDAVKYLHD--LGIVHRD 141
Query: 178 IKSANVL---IDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           +K  N+L   +D +    + DFGL+    +++     +   GT GY+ P  +     S  
Sbjct: 142 LKPENLLYYSLDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 198
Query: 235 TDVFSFGIL 243
            D +S G++
Sbjct: 199 VDCWSIGVI 207

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 125/278 (44%), Gaps = 43/278 (15%)
Query: 63  LGKGSHGSVYKAVL---RGRQVAVK-KPSKNQEISQ--EVDNEIEILSKIHS---PRLVN 113
           LG GS G V +       G+ V+V  K  K   +SQ   +D+ I  ++ +HS     L+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L G       ++ V E    G+L D L  +      G   R A+QVA+ +  L S+    
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--F 136
Query: 174 IHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNF---RFRSTPPAGTIGYLDPCYVTP 228
           IHRD+ + N+L+      ++GDFGL  AL    D++     R  P A         +  P
Sbjct: 137 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA---------WCAP 187
Query: 229 DNLSTKT-----DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR 283
           ++L T+T     D + FG+ L E+ +  +   IG +   I+     + K+G+       R
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH---KIDKEGE-------R 237
Query: 284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           +P P+D    + +  + V+C     E RP+   + D+L
Sbjct: 238 LPRPED--CPQDIYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 10/192 (5%)
Query: 63  LGKGSHGSVYKAVLR-GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           +G+G++G VYKA    G   A+KK     +++ I      EI IL ++    +V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
           +  K  +LV E +    L  +L      L         LQ+   +   H     ++HRD+
Sbjct: 70  HTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDL 126
Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTPDNLSTKTDV 237
           K  N+LI+R    ++ DFGLA   G+   ++  T    T+ Y  P   +     ST  D+
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 238 FSFGILLLEIIS 249
           +S G +  E+++
Sbjct: 185 WSVGCIFAEMVN 196

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 10/192 (5%)
Query: 63  LGKGSHGSVYKAVLR-GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           +G+G++G VYKA    G   A+KK     +++ I      EI IL ++    +V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
           +  K  +LV E +    L  +L      L         LQ+   +   H     ++HRD+
Sbjct: 70  HTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDL 126
Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTPDNLSTKTDV 237
           K  N+LI+R    ++ DFGLA   G+   ++  T    T+ Y  P   +     ST  D+
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 238 FSFGILLLEIIS 249
           +S G +  E+++
Sbjct: 185 WSVGCIFAEMVN 196

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 14/196 (7%)
Query: 62  LLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQE--VDNEIEILSKIHSPRLVNLLGF 117
           +LG G+   V  A  +  Q  VA+K  +K     +E  ++NEI +L KI  P +V L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
                   L+++ +S G L+D +             RL  QV  AV+ LH     I+HRD
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-RLIFQVLDAVKYLHD--LGIVHRD 141
Query: 178 IKSANVL---IDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           +K  N+L   +D +    + DFGL+    +++     +   GT GY+ P  +     S  
Sbjct: 142 LKPENLLYYSLDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 198
Query: 235 TDVFSFGILLLEIISC 250
            D +S G++   I+ C
Sbjct: 199 VDCWSIGVIAY-ILLC 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 125/278 (44%), Gaps = 43/278 (15%)
Query: 63  LGKGSHGSVYKAVL---RGRQVAVK-KPSKNQEISQ--EVDNEIEILSKIHS---PRLVN 113
           LG GS G V +       G+ V+V  K  K   +SQ   +D+ I  ++ +HS     L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L G       ++ V E    G+L D L  +      G   R A+QVA+ +  L S+    
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--F 132
Query: 174 IHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNF---RFRSTPPAGTIGYLDPCYVTP 228
           IHRD+ + N+L+      ++GDFGL  AL    D++     R  P A         +  P
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA---------WCAP 183
Query: 229 DNLSTKT-----DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR 283
           ++L T+T     D + FG+ L E+ +  +   IG +   I+     + K+G+       R
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH---KIDKEGE-------R 233
Query: 284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           +P P+D    + +  + V+C     E RP+   + D+L
Sbjct: 234 LPRPED--CPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 47/299 (15%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIE 101
           E   N  S  K LG G+ G V +A   G         VAVK  KPS +    + + +E++
Sbjct: 42  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 101
Query: 102 ILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH--------SNNRP------ 146
           +LS + +   +VNLLG        L++ E+   G L + L         S   P      
Sbjct: 102 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 147 ---LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG 203
              L+    +  + QVAK +  L S+    IHRD+ + N+L+      ++ DFGLA    
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARHIK 219
Query: 204 VDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PS 262
            D+           + ++ P  +     + ++DV+S+GI L E+ S      +G SP P 
Sbjct: 220 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS------LGSSPYPG 273
Query: 263 I-VDWA-APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           + VD     +IK+G    +  P   P        ++  I   C  +   +RP+ K+IV 
Sbjct: 274 MPVDSKFYKMIKEG--FRMLSPEHAP-------AEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           +++ + +G+G++G V  A   +R  +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRF---RHE 101
Query: 113 NLLGFSN-------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           N++G  +       ++   + +V+ +    LY +L S    L+         Q+ + ++ 
Sbjct: 102 NVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ--LSNDHICYFLYQILRGLKY 159
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV--DNFRFRSTPPAGTIGYLDP 223
           +HS    ++HRD+K +N+LI+   + ++ DFGLA       D+  F  T    T  Y  P
Sbjct: 160 IHSAN--VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFL-TEXVATRWYRAP 216
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 13/189 (6%)
Query: 62  LLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQE--VDNEIEILSKIHSPRLVNLLGF 117
           +LG G+   V  A  +  Q  VA+K  +K     +E  ++NEI +L KI  P +V L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
                   L+++ +S G L+D +             RL  QV  AV+ LH     I+HRD
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-RLIFQVLDAVKYLHD--LGIVHRD 141
Query: 178 IKSANVL---IDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           +K  N+L   +D +    + DFGL+    +++     +   GT GY+ P  +     S  
Sbjct: 142 LKPENLLYYSLDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 198
Query: 235 TDVFSFGIL 243
            D +S G++
Sbjct: 199 VDCWSIGVI 207

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 125/278 (44%), Gaps = 43/278 (15%)
Query: 63  LGKGSHGSVYKAVL---RGRQVAVK-KPSKNQEISQ--EVDNEIEILSKIHS---PRLVN 113
           LG GS G V +       G+ V+V  K  K   +SQ   +D+ I  ++ +HS     L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L G       ++ V E    G+L D L  +      G   R A+QVA+ +  L S+    
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--F 132
Query: 174 IHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNF---RFRSTPPAGTIGYLDPCYVTP 228
           IHRD+ + N+L+      ++GDFGL  AL    D++     R  P A         +  P
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA---------WCAP 183
Query: 229 DNLSTKT-----DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR 283
           ++L T+T     D + FG+ L E+ +  +   IG +   I+     + K+G+       R
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH---KIDKEGE-------R 233
Query: 284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           +P P+D    + +  + V+C     E RP+   + D+L
Sbjct: 234 LPRPED--CPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 89/195 (45%), Gaps = 10/195 (5%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G+ G V  AV R  +  VAVK     + +   + +  EI I   ++   +V   G
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +   + L +E+ S G L+D +  +   P    +R     Q+   V  LH     I H
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG--IGITH 127
Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           RDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +       + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 235 TDVFSFGILLLEIIS 249
            DV+S GI+L  +++
Sbjct: 188 VDVWSCGIVLTAMLA 202

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 50  LEAATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEI----SQEVDNEIEIL 103
            +  ++ +   K LG G++G V   K  L G + A+K   K+       S  + +E+ +L
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVL 75
Query: 104 SKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYD--VLHSNNRPLNWGRRIRLALQVAK 161
            ++  P ++ L  F  D ++  LV+E    G L+D  +L      ++    ++   QV  
Sbjct: 76  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---QVLS 132
Query: 162 AVEILHSEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTI 218
               LH     I+HRD+K  N+L++   R+   ++ DFGL+    V     +     GT 
Sbjct: 133 GTTYLHKH--NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG---KMKERLGTA 187
Query: 219 GYLDPCYVTPDNLSTKTDVFSFGILLLEIISC 250
            Y+ P  V       K DV+S G++L  I+ C
Sbjct: 188 YYIAP-EVLRKKYDEKCDVWSCGVILY-ILLC 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 13/189 (6%)
Query: 62  LLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQE--VDNEIEILSKIHSPRLVNLLGF 117
           +LG G+   V  A  +  Q  VA+K  +K     +E  ++NEI +L KI  P +V L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
                   L+++ +S G L+D +             RL  QV  AV+ LH     I+HRD
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-RLIFQVLDAVKYLHD--LGIVHRD 141
Query: 178 IKSANVL---IDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           +K  N+L   +D +    + DFGL+    +++     +   GT GY+ P  +     S  
Sbjct: 142 LKPENLLYYSLDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 198
Query: 235 TDVFSFGIL 243
            D +S G++
Sbjct: 199 VDCWSIGVI 207

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 96/193 (49%), Gaps = 13/193 (6%)
Query: 63  LGKGSHGSVYKAV-LRGRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVNLLGFSND 120
           LG+G  G V++ V    ++  + K  K +   Q  V  EI IL+      +++L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 121 SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKS 180
            ++ +++ EF+S   +++ ++++   LN    +    QV +A++ LHS    I H DI+ 
Sbjct: 73  MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH--NIGHFDIRP 130
Query: 181 ANVLID--RNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTD 236
            N++    R+   ++ +FG A  L+ G DNFR   T P     Y  P     D +ST TD
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPE----YYAPEVHQHDVVSTATD 185
Query: 237 VFSFGILLLEIIS 249
           ++S G L+  ++S
Sbjct: 186 MWSLGTLVYVLLS 198

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 10/192 (5%)
Query: 63  LGKGSHGSVYKAVLR-GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           +G+G++G VYKA    G   A+KK     +++ I      EI IL ++    +V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
           +  K  +LV E +    L  +L      L         LQ+   +   H     ++HRD+
Sbjct: 70  HTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDL 126
Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTPDNLSTKTDV 237
           K  N+LI+R    ++ DFGLA   G+   ++  T    T+ Y  P   +     ST  D+
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 238 FSFGILLLEIIS 249
           +S G +  E+++
Sbjct: 185 WSVGCIFAEMVN 196

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 47/299 (15%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIE 101
           E   N  S  K LG G+ G V +A   G         VAVK  KPS +    + + +E++
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 102 ILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH--------SNNRP------ 146
           +LS + +   +VNLLG        L++ E+   G L + L         S   P      
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 147 ---LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG 203
              L+    +  + QVAK +  L S+    IHRD+ + N+L+      ++ DFGLA    
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 204 VDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PS 262
            D+           + ++ P  +     + ++DV+S+GI L E+ S      +G SP P 
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS------LGSSPYPG 250
Query: 263 I-VDWA-APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           + VD     +IK+G    +  P   P        ++  I   C  +   +RP+ K+IV 
Sbjct: 251 MPVDSKFYKMIKEG--FRMLSPEHAP-------AEMYDIMKTCWDADPLKRPTFKQIVQ 300

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 63  LGKGSHGSVYKAV--LRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND 120
           +G G++G V  A   L G+QVA+KK     ++       +  L  +   +  N++   + 
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 121 SKDRLLVVEFMSNGTLYDVLHSN-------NRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
            +  +   EF S   + D++ S+       ++PL          Q+ + ++ +HS    +
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--V 180
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDP-CYVTPDN 230
           IHRD+K +N+L++ N   ++GDFG+A  L       ++  T    T  Y  P   ++   
Sbjct: 181 IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE 240
Query: 231 LSTKTDVFSFGILLLEIISCRK 252
            +   D++S G +  E+++ R+
Sbjct: 241 YTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 47/299 (15%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIE 101
           E   N  S  K LG G+ G V +A   G         VAVK  KPS +    + + +E++
Sbjct: 42  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 101
Query: 102 ILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH--------SNNRP------ 146
           +LS + +   +VNLLG        L++ E+   G L + L         S   P      
Sbjct: 102 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 147 ---LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG 203
              L+    +  + QVAK +  L S+    IHRD+ + N+L+      ++ DFGLA    
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIK 219
Query: 204 VDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PS 262
            D+           + ++ P  +     + ++DV+S+GI L E+ S      +G SP P 
Sbjct: 220 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS------LGSSPYPG 273
Query: 263 I-VDWA-APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           + VD     +IK+G    +  P   P        ++  I   C  +   +RP+ K+IV 
Sbjct: 274 MPVDSKFYKMIKEG--FRMLSPEHAP-------AEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 130 FMSNGTLYDVLHSNN------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANV 183
           F  + +L DV    +       P+     I  + QVA+ +E L S     IHRD+ + N+
Sbjct: 173 FQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVARGMEFLSSR--KCIHRDLAARNI 230
Query: 184 LIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGIL 243
           L+  N   ++ DFGLA     +    R       + ++ P  +     STK+DV+S+G+L
Sbjct: 231 LLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVL 290
Query: 244 LLEIIS 249
           L EI S
Sbjct: 291 LWEIFS 296

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 47/299 (15%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIE 101
           E   N  S  K LG G+ G V +A   G         VAVK  KPS +    + + +E++
Sbjct: 37  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 96
Query: 102 ILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH--------SNNRP------ 146
           +LS + +   +VNLLG        L++ E+   G L + L         S   P      
Sbjct: 97  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 156
Query: 147 ---LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG 203
              L+    +  + QVAK +  L S+    IHRD+ + N+L+      ++ DFGLA    
Sbjct: 157 ELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIK 214
Query: 204 VDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PS 262
            D+           + ++ P  +     + ++DV+S+GI L E+ S      +G SP P 
Sbjct: 215 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS------LGSSPYPG 268
Query: 263 I-VDWA-APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           + VD     +IK+G    +  P   P        ++  I   C  +   +RP+ K+IV 
Sbjct: 269 MPVDSKFYKMIKEG--FRMLSPEHAP-------AEMYDIMKTCWDADPLKRPTFKQIVQ 318

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 122/292 (41%), Gaps = 52/292 (17%)
Query: 63  LGKGSHGSVYKAV---------LRGRQVAVKKPSK-NQEISQEVDNEIEILSKIHSPRLV 112
           LG+G+   ++K V         L   +V +K   K ++  S+       ++SK+    LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
              G      + +LV EF+  G+L   L  N   +N   ++ +A Q+A A+  L  E   
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL--EENT 133
Query: 173 IIHRDIKSANVLIDRNFNARLG--------DFGLALRC---GVDNFRFRSTPPAGTIGYL 221
           +IH ++ + N+L+ R  + + G        D G+++      +   R    PP       
Sbjct: 134 LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPE------ 187
Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD 281
             C   P NL+  TD +SFG  L EI S       G  P S +D         + L  ++
Sbjct: 188 --CIENPKNLNLATDKWSFGTTLWEICSG------GDKPLSALD-------SQRKLQFYE 232
Query: 282 PR--IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL--SKLVP 329
            R  +P PK      +LA +   C+    + RPS + I+  L  L    LVP
Sbjct: 233 DRHQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 47/299 (15%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIE 101
           E   N  S  K LG G+ G V +A   G         VAVK  KPS +    + + +E++
Sbjct: 35  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 94
Query: 102 ILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH--------SNNRP------ 146
           +LS + +   +VNLLG        L++ E+   G L + L         S   P      
Sbjct: 95  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 154
Query: 147 ---LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG 203
              L+    +  + QVAK +  L S+    IHRD+ + N+L+      ++ DFGLA    
Sbjct: 155 ELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIK 212
Query: 204 VDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PS 262
            D+           + ++ P  +     + ++DV+S+GI L E+ S      +G SP P 
Sbjct: 213 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS------LGSSPYPG 266
Query: 263 I-VDWA-APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           + VD     +IK+G    +  P   P        ++  I   C  +   +RP+ K+IV 
Sbjct: 267 MPVDSKFYKMIKEG--FRMLSPEHAP-------AEMYDIMKTCWDADPLKRPTFKQIVQ 316

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 19/220 (8%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           AT+ +     +G G++G+VYKA     G  VA+K    P+  + +      E+ +L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 108 S---PRLVNLLGFSNDSK-DRLLVVEFMSNGTLYDV---LHSNNRPLNWGRRIR-LALQV 159
           +   P +V L+     S+ DR + V  +      D+   L     P      I+ L  Q 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG 219
            + ++ LH+    I+HRD+K  N+L+      +L DFGLA    + +++    P   T+ 
Sbjct: 122 LRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLA---RIYSYQMALAPVVVTLW 176
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFS 259
           Y  P  +     +T  D++S G +  E+   RK +  G S
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNS 215

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 63  LGKGSHGSVYKAV--LRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND 120
           +G G++G V  A   L G+QVA+KK     ++       +  L  +   +  N++   + 
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 121 SKDRLLVVEFMSNGTLYDVLHSN-------NRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
            +  +   EF S   + D++ S+       ++PL          Q+ + ++ +HS    +
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--V 179
Query: 174 IHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDP-CYVTPDN 230
           IHRD+K +N+L++ N   ++GDFG+A  L       ++  T    T  Y  P   ++   
Sbjct: 180 IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE 239
Query: 231 LSTKTDVFSFGILLLEIISCRK 252
            +   D++S G +  E+++ R+
Sbjct: 240 YTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 122/292 (41%), Gaps = 52/292 (17%)
Query: 63  LGKGSHGSVYKAV---------LRGRQVAVKKPSK-NQEISQEVDNEIEILSKIHSPRLV 112
           LG+G+   ++K V         L   +V +K   K ++  S+       ++SK+    LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
              G      + +LV EF+  G+L   L  N   +N   ++ +A Q+A A+  L  E   
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFL--EENT 133
Query: 173 IIHRDIKSANVLIDRNFNARLG--------DFGLALRC---GVDNFRFRSTPPAGTIGYL 221
           +IH ++ + N+L+ R  + + G        D G+++      +   R    PP       
Sbjct: 134 LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPE------ 187
Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD 281
             C   P NL+  TD +SFG  L EI S       G  P S +D         + L  ++
Sbjct: 188 --CIENPKNLNLATDKWSFGTTLWEICSG------GDKPLSALD-------SQRKLQFYE 232
Query: 282 PR--IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL--SKLVP 329
            R  +P PK      +LA +   C+    + RPS + I+  L  L    LVP
Sbjct: 233 DRHQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVK-----KPSKNQEISQE-VDNEIEILSKIHSPRLV 112
           +++GKG+   V + + R  G+Q AVK     K + +  +S E +  E  I   +  P +V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 113 NLLGFSNDSKDRLLVVEFMSNGTL-YDVLHSNNRPLNWGRRI--RLALQVAKAVEILHSE 169
            LL   +      +V EFM    L ++++   +    +   +      Q+ +A+   H  
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 170 MPPIIHRDIKSANVLIDRNFNA---RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
              IIHRD+K  NVL+    N+   +LGDFG+A++ G       +    GT  ++ P  V
Sbjct: 150 --NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG--LVAGGRVGTPHFMAPEVV 205
Query: 227 TPDNLSTKTDVFSFGILLLEIIS 249
             +      DV+  G++L  ++S
Sbjct: 206 KREPYGKPVDVWGCGVILFILLS 228

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRG---RQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           ++ +  +G+GS G V  AV +G   R+ A K P    E       EIEI+  +  P ++ 
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYD-VLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
           L     D+ D  LV+E  + G L++ V+H   R        R+   V  AV   H     
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLN-- 126
Query: 173 IIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
           + HRD+K  N L      +   +L DFGLA R        R+    GT     P YV+P 
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTK--VGT-----PYYVSPQ 178
Query: 230 NLS----TKTDVFSFGILLLEII 248
            L      + D +S G+++  ++
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLL 201

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  + +      + E++I+ K+    +V 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---NRELQIMRKLDHCNIVR 77
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLA--LRCGVDNFRFRST----PPAGT 217
            +HS    I HRDIK  N+L+D +    +L DFG A  L  G  N  +  +     P   
Sbjct: 137 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194
Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            G  D         ++  DV+S G +L E++                + I +  +P    
Sbjct: 195 FGATD--------YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++A P IK      VF PR PP
Sbjct: 247 IREMNPNYTEFAFPQIKAHPWTKVFRPRTPP 277

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 133/312 (42%), Gaps = 52/312 (16%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEI-------SQEVDNE 99
           D EA    +    LLGKG  G+V+    +    QVA+K   +N+ +       S     E
Sbjct: 25  DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE 84
Query: 100 IEILSKIHS----PRLVNLLGFSNDSKDRLLVVEF-MSNGTLYDVLHSNNRPLNWGRRIR 154
           + +L K+ +    P ++ LL +    +  +LV+E  +    L+D + +   PL  G    
Sbjct: 85  VALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKGPLGEGPSRC 143
Query: 155 LALQVAKAVEILHSEMPPIIHRDIKSANVLID-RNFNARLGDFGLALRCGVDNFRFRSTP 213
              QV  A++  HS    ++HRDIK  N+LID R   A+L DFG       + +    T 
Sbjct: 144 FFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TD 197
Query: 214 PAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK 272
             GT  Y  P +++     +    V+S GILL +++      DI F             +
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG----DIPFE------------R 241
Query: 273 KGKILSV---FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV--DWLTGLSKL 327
             +IL     F   + P    ++R        RC+      RPS++EI+   W+   ++ 
Sbjct: 242 DQEILEAELHFPAHVSPDCCALIR--------RCLAPKPSSRPSLEEILLDPWMQTPAED 293
Query: 328 VPLHSWNGFNNP 339
           VPL+   G   P
Sbjct: 294 VPLNPSKGGPAP 305

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 124/278 (44%), Gaps = 43/278 (15%)
Query: 63  LGKGSHGSVYKAVL---RGRQVAVK-KPSKNQEISQ--EVDNEIEILSKIHS---PRLVN 113
           LG GS G V +       G+ V+V  K  K   +SQ   +D+ I  ++ +HS     L+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L G       ++ V E    G+L D L  +      G   R A+QVA+ +  L S+    
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--F 142
Query: 174 IHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNF---RFRSTPPAGTIGYLDPCYVTP 228
           IHRD+ + N+L+      ++GDFGL  AL    D+      R  P A         +  P
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA---------WCAP 193
Query: 229 DNLSTKT-----DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR 283
           ++L T+T     D + FG+ L E+ +  +   IG +   I+     + K+G+       R
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH---KIDKEGE-------R 243
Query: 284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           +P P+D    + +  + V+C     E RP+   + D+L
Sbjct: 244 LPRPED--CPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 11/201 (5%)
Query: 63  LGKGSHGSVYKAVLRGRQ--VAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G+G++G+V+KA  R     VA+K+      ++ +      EI +L ++    +V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
            +  K   LV EF  +  L     S N  L+         Q+ K +   HS    ++HRD
Sbjct: 70  LHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRD 126
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL-STKTD 236
           +K  N+LI+RN   +L DFGLA   G+    + +     T+ Y  P  +    L ST  D
Sbjct: 127 LKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE--VVTLWYRPPDVLFGAKLYSTSID 184
Query: 237 VFSFGILLLEIISCRKAIDIG 257
           ++S G +  E+ +  + +  G
Sbjct: 185 MWSAGCIFAELANAARPLFPG 205

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 61  KLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEI----SQEVDNEIEILSKIHSPRLVNL 114
           K LG G++G V   K  L G + A+K   K+       S  + +E+ +L ++  P ++ L
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 115 LGFSNDSKDRLLVVEFMSNGTLYD--VLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
             F  D ++  LV+E    G L+D  +L      ++    ++   QV      LH     
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---QVLSGTTYLHKH--N 124
Query: 173 IIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
           I+HRD+K  N+L++   R+   ++ DFGL+    V     +     GT  Y+ P  V   
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG---KMKERLGTAYYIAP-EVLRK 180
Query: 230 NLSTKTDVFSFGILLLEIISC 250
               K DV+S G++L  I+ C
Sbjct: 181 KYDEKCDVWSCGVILY-ILLC 200

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRG---RQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           ++ +  +G+GS G V  AV +G   R+ A K P    E       EIEI+  +  P ++ 
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYD-VLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
           L     D+ D  LV+E  + G L++ V+H   R        R+   V  AV   H     
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLN-- 143
Query: 173 IIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
           + HRD+K  N L      +   +L DFGLA R        R+    GT     P YV+P 
Sbjct: 144 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTK--VGT-----PYYVSPQ 195
Query: 230 NLS----TKTDVFSFGILLLEII 248
            L      + D +S G+++  ++
Sbjct: 196 VLEGLYGPECDEWSAGVMMYVLL 218

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  + +      + E++I+ K+    +V 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---NRELQIMRKLDHCNIVR 77
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
            +HS    I HRDIK  N+L+D +    +L DFG A +        R  P    I     
Sbjct: 137 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL------VRGEPNVSXI--CSR 186
Query: 224 CYVTPD------NLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            Y  P+      + ++  DV+S G +L E++                + I +  +P    
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++A P IK      VF PR PP
Sbjct: 247 IREMNPNYTEFAFPQIKAHPWTKVFRPRTPP 277

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 15/217 (6%)
Query: 55  NGFSEQKLLGKGSHGSV--YKAVLRGRQVAVKKPSKNQEISQ-EVDN---EIEILSKIHS 108
           + F   + +GKGS G V   +     +  A+K  +K + + + EV N   E++I+  +  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P LVNL     D +D  +VV+ +  G L   L  N        ++ +  ++  A++ L +
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQN 133
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
           +   IIHRD+K  N+L+D + +  + DF +A     +    + T  AGT  Y+ P   + 
Sbjct: 134 QR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSS 188
Query: 229 DN---LSTKTDVFSFGILLLEIISCRKAIDIGFSPPS 262
                 S   D +S G+   E++  R+   I  S  S
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 19/220 (8%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           AT+ +     +G G++G+VYKA     G  VA+K    P+  + +      E+ +L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 108 S---PRLVNLLGFSNDSK-DRLLVVEFMSNGTLYDV---LHSNNRPLNWGRRIR-LALQV 159
           +   P +V L+     S+ DR + V  +      D+   L     P      I+ L  Q 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG 219
            + ++ LH+    I+HRD+K  N+L+      +L DFGLA    + +++    P   T+ 
Sbjct: 122 LRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLA---RIYSYQMALDPVVVTLW 176
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFS 259
           Y  P  +     +T  D++S G +  E+   RK +  G S
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNS 215

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 19/220 (8%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIH 107
           AT+ +     +G G++G+VYKA     G  VA+K    P+  + +      E+ +L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 108 S---PRLVNLLGFSNDSK-DRLLVVEFMSNGTLYDV---LHSNNRPLNWGRRIR-LALQV 159
           +   P +V L+     S+ DR + V  +      D+   L     P      I+ L  Q 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG 219
            + ++ LH+    I+HRD+K  N+L+      +L DFGLA    + +++    P   T+ 
Sbjct: 122 LRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLA---RIYSYQMALFPVVVTLW 176
Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFS 259
           Y  P  +     +T  D++S G +  E+   RK +  G S
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNS 215

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 35/220 (15%)
Query: 56  GFSE----QKLLGKGSHGSVYKAVLR--GRQVAVK----------KPSKNQEISQEVDNE 99
           GF E    +++LG+G    V + + +   ++ AVK             + QE+ +    E
Sbjct: 1   GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 60
Query: 100 IEILSKIH-SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRR--IRLA 156
           ++IL K+   P ++ L      +    LV + M  G L+D L           R  +R  
Sbjct: 61  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 120
Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPA 215
           L+V  A+  L+     I+HRD+K  N+L+D + N +L DFG +  C +D   + R     
Sbjct: 121 LEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLREV--C 171
Query: 216 GTIGYLDP----CYVTPDN--LSTKTDVFSFGILLLEIIS 249
           GT  YL P    C +  ++     + D++S G+++  +++
Sbjct: 172 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 211

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 124/278 (44%), Gaps = 43/278 (15%)
Query: 63  LGKGSHGSVYKAVL---RGRQVAVK-KPSKNQEISQ--EVDNEIEILSKIHS---PRLVN 113
           LG GS G V +       G+ V+V  K  K   +SQ   +D+ I  ++ +HS     L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L G       ++ V E    G+L D L  +      G   R A+QVA+ +  L S+    
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--F 132
Query: 174 IHRDIKSANVLIDRNFNARLGDFGL--ALRCGVDNF---RFRSTPPAGTIGYLDPCYVTP 228
           IHRD+ + N+L+      ++GDFGL  AL    D+      R  P A         +  P
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA---------WCAP 183
Query: 229 DNLSTKT-----DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR 283
           ++L T+T     D + FG+ L E+ +  +   IG +   I+     + K+G+       R
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH---KIDKEGE-------R 233
Query: 284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           +P P+D    + +  + V+C     E RP+   + D+L
Sbjct: 234 LPRPED--CPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 54/270 (20%)
Query: 57  FSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V L
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 157
Query: 115 LGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVEI 165
             F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++  
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLA--LRCGVDNFRFRST----PPAGTI 218
           +HS    I HRDIK  N+L+D +    +L DFG A  L  G  N  +  +     P    
Sbjct: 217 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 274
Query: 219 GYLDPCYVTPDNLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP----- 260
           G  D         ++  DV+S G +L E++                + I +  +P     
Sbjct: 275 GATD--------YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 326
Query: 261 ----PSIVDWAAPLIKKGKILSVFDPRIPP 286
               P+  ++  P IK      VF PR PP
Sbjct: 327 REMNPNYTEFKFPQIKAHPWTKVFRPRTPP 356

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V 
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 105
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLA--LRCGVDNFRFRST----PPAGT 217
            +HS    I HRDIK  N+L+D +    +L DFG A  L  G  N  +  +     P   
Sbjct: 165 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 222
Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            G  D         ++  DV+S G +L E++                + I +  +P    
Sbjct: 223 FGATD--------YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 274
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++  P IK      VF PR PP
Sbjct: 275 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 305

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 54/270 (20%)
Query: 57  FSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V L
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 114
Query: 115 LGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVEI 165
             F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++  
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLA--LRCGVDNFRFRST----PPAGTI 218
           +HS    I HRDIK  N+L+D +    +L DFG A  L  G  N  +  +     P    
Sbjct: 174 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 231
Query: 219 GYLDPCYVTPDNLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP----- 260
           G  D         ++  DV+S G +L E++                + I +  +P     
Sbjct: 232 GATD--------YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 283
Query: 261 ----PSIVDWAAPLIKKGKILSVFDPRIPP 286
               P+  ++  P IK      VF PR PP
Sbjct: 284 REMNPNYTEFKFPQIKAHPWTKVFRPRTPP 313

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 111
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLA--LRCGVDNFRFRST----PPAGT 217
            +HS    I HRDIK  N+L+D +    +L DFG A  L  G  N  +  +     P   
Sbjct: 171 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 228
Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            G  D         ++  DV+S G +L E++                + I +  +P    
Sbjct: 229 FGATD--------YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++  P IK      VF PR PP
Sbjct: 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 311

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V 
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 82
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 141
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLA--LRCGVDNFRFRST----PPAGT 217
            +HS    I HRDIK  N+L+D +    +L DFG A  L  G  N  +  +     P   
Sbjct: 142 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 199
Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            G  D         ++  DV+S G +L E++                + I +  +P    
Sbjct: 200 FGATD--------YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 251
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++  P IK      VF PR PP
Sbjct: 252 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 282

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVK----KPSKNQEISQEVDNEIEI 102
           ++    N FS  +++G+G  G VY  +    G+  A+K    K  K ++      NE  +
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 103 LSKIHS---PRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQ 158
           LS + +   P +V  + ++  + D+L  +++ M+ G L+  L  +        R   A +
Sbjct: 243 LSLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAE 300
Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTI 218
           +   +E +H+    +++RD+K AN+L+D + + R+ D GLA     D  + +     GT 
Sbjct: 301 IILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTH 354
Query: 219 GYLDPCYVTPD-NLSTKTDVFSFGILLLEII 248
           GY+ P  +       +  D FS G +L +++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVK----KPSKNQEISQEVDNEIEI 102
           ++    N FS  +++G+G  G VY  +    G+  A+K    K  K ++      NE  +
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 103 LSKIHS---PRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQ 158
           LS + +   P +V  + ++  + D+L  +++ M+ G L+  L  +        R   A +
Sbjct: 243 LSLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAE 300
Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTI 218
           +   +E +H+    +++RD+K AN+L+D + + R+ D GLA     D  + +     GT 
Sbjct: 301 IILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTH 354
Query: 219 GYLDPCYVTPD-NLSTKTDVFSFGILLLEII 248
           GY+ P  +       +  D FS G +L +++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 111
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
            +HS    I HRDIK  N+L+D +    +L DFG A +        R  P    I     
Sbjct: 171 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL------VRGEPNVSXI--CSR 220
Query: 224 CYVTPD------NLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            Y  P+      + ++  DV+S G +L E++                + I +  +P    
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++  P IK      VF PR PP
Sbjct: 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 311

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVK----KPSKNQEISQEVDNEIEI 102
           ++    N FS  +++G+G  G VY  +    G+  A+K    K  K ++      NE  +
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 103 LSKIHS---PRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQ 158
           LS + +   P +V  + ++  + D+L  +++ M+ G L+  L  +        R   A +
Sbjct: 243 LSLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAE 300
Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTI 218
           +   +E +H+    +++RD+K AN+L+D + + R+ D GLA     D  + +     GT 
Sbjct: 301 IILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTH 354
Query: 219 GYLDPCYVTPD-NLSTKTDVFSFGILLLEII 248
           GY+ P  +       +  D FS G +L +++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 54/270 (20%)
Query: 57  FSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V L
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 116
Query: 115 LGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVEI 165
             F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++  
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLA--LRCGVDNFRFRST----PPAGTI 218
           +HS    I HRDIK  N+L+D +    +L DFG A  L  G  N  +  +     P    
Sbjct: 176 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 233
Query: 219 GYLDPCYVTPDNLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP----- 260
           G  D         ++  DV+S G +L E++                + I +  +P     
Sbjct: 234 GATD--------YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 285
Query: 261 ----PSIVDWAAPLIKKGKILSVFDPRIPP 286
               P+  ++  P IK      VF PR PP
Sbjct: 286 REMNPNYTEFKFPQIKAHPWTKVFRPRTPP 315

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V 
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 89
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
            +HS    I HRDIK  N+L+D +    +L DFG A +        R  P    I     
Sbjct: 149 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL------VRGEPNVSXI--CSR 198
Query: 224 CYVTPD------NLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            Y  P+      + ++  DV+S G +L E++                + I +  +P    
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 258
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++  P IK      VF PR PP
Sbjct: 259 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 289

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVY--KAVLRGRQVAVK----KPSKNQEISQEVDNEIEI 102
           ++    N FS  +++G+G  G VY  +    G+  A+K    K  K ++      NE  +
Sbjct: 182 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 241
Query: 103 LSKIHS---PRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQ 158
           LS + +   P +V  + ++  + D+L  +++ M+ G L+  L  +        R   A +
Sbjct: 242 LSLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAE 299
Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTI 218
           +   +E +H+    +++RD+K AN+L+D + + R+ D GLA     D  + +     GT 
Sbjct: 300 IILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTH 353
Query: 219 GYLDPCYVTPD-NLSTKTDVFSFGILLLEII 248
           GY+ P  +       +  D FS G +L +++
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V 
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 90
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLA--LRCGVDNFRFRST----PPAGT 217
            +HS    I HRDIK  N+L+D +    +L DFG A  L  G  N  +  +     P   
Sbjct: 150 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 207
Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            G  D         ++  DV+S G +L E++                + I +  +P    
Sbjct: 208 FGATD--------YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 259
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++  P IK      VF PR PP
Sbjct: 260 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 290

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 117/285 (41%), Gaps = 40/285 (14%)
Query: 61  KLLGKGSHGSVYKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           +L+GKG  G VY     G +VA++       N++  +    E+    +     +V  +G 
Sbjct: 39  ELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
                   ++       TLY V+      L+  +  ++A ++ K +  LH++   I+H+D
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKD 155
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGV-------DNFRFRSTPPAGTIGYLDPCYV---T 227
           +KS NV  D N    + DFGL    GV       D  R ++    G + +L P  +   +
Sbjct: 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN----GWLCHLAPEIIRQLS 210
Query: 228 PDN------LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD 281
           PD        S  +DVF+ G +  E+ +  +       P   + W      K  +  +  
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHA--REWPFKTQPAEAIIWQMGTGMKPNLSQIG- 267
Query: 282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
                     + K+++ I + C    +E RP+  +++D L  L K
Sbjct: 268 ----------MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 77
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLA--LRCGVDNFRFRST----PPAGT 217
            +HS    I HRDIK  N+L+D +    +L DFG A  L  G  N  +  +     P   
Sbjct: 137 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194
Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            G  D         ++  DV+S G +L E++                + I +  +P    
Sbjct: 195 FGATD--------YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++  P IK      VF PR PP
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 277

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V 
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 89
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
            +HS    I HRDIK  N+L+D +    +L DFG A +        R  P    I     
Sbjct: 149 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL------VRGEPNVSXI--CSR 198
Query: 224 CYVTPD------NLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            Y  P+      + ++  DV+S G +L E++                + I +  +P    
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 258
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++  P IK      VF PR PP
Sbjct: 259 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 289

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V 
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 81
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
            +HS    I HRDIK  N+L+D +    +L DFG A +        R  P    I     
Sbjct: 141 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL------VRGEPNVSXI--CSR 190
Query: 224 CYVTPD------NLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            Y  P+      + ++  DV+S G +L E++                + I +  +P    
Sbjct: 191 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 250
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++  P IK      VF PR PP
Sbjct: 251 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 281

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V 
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 85
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
            +HS    I HRDIK  N+L+D +    +L DFG A +        R  P    I     
Sbjct: 145 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL------VRGEPNVSXI--CSR 194
Query: 224 CYVTPD------NLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            Y  P+      + ++  DV+S G +L E++                + I +  +P    
Sbjct: 195 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 254
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++  P IK      VF PR PP
Sbjct: 255 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 285

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V 
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 96
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
            +HS    I HRDIK  N+L+D +    +L DFG A +        R  P    I     
Sbjct: 156 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL------VRGEPNVSXI--CSR 205
Query: 224 CYVTPD------NLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            Y  P+      + ++  DV+S G +L E++                + I +  +P    
Sbjct: 206 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 265
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++  P IK      VF PR PP
Sbjct: 266 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 296

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 77
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
            +HS    I HRDIK  N+L+D +    +L DFG A +        R  P    I     
Sbjct: 137 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL------VRGEPNVSXI--CSR 186
Query: 224 CYVTPD------NLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            Y  P+      + ++  DV+S G +L E++                + I +  +P    
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++  P IK      VF PR PP
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 277

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 77
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
            +HS    I HRDIK  N+L+D +    +L DFG A +        R  P    I     
Sbjct: 137 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL------VRGEPNVSXI--CSR 186
Query: 224 CYVTPD------NLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            Y  P+      + ++  DV+S G +L E++                + I +  +P    
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++  P IK      VF PR PP
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 277

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V 
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 78
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
            +HS    I HRDIK  N+L+D +    +L DFG A +        R  P    I     
Sbjct: 138 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL------VRGEPNVSXI--CSR 187
Query: 224 CYVTPD------NLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            Y  P+      + ++  DV+S G +L E++                + I +  +P    
Sbjct: 188 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 247
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++  P IK      VF PR PP
Sbjct: 248 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 278

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 61  KLLGKGSHGSVY----KAVLRGRQVAV-KKPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           K LG G++G V     K     R + + +K S +   + ++  E+ +L  +  P ++ L 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 116 GFSNDSKDRLLVVEFMSNGTLYD-VLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
            F  D ++  LV+E    G L+D ++H      N      +  QV   V  LH     I+
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKH--NIV 158
Query: 175 HRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
           HRD+K  N+L+   +++   ++ DFGL+    V   + +     GT  Y+ P  V     
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLS---AVFENQKKMKERLGTAYYIAP-EVLRKKY 214
Query: 232 STKTDVFSFGILLLEIIS 249
             K DV+S G++L  +++
Sbjct: 215 DEKCDVWSIGVILFILLA 232

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKK--PSKNQEISQEVDNEIEILSKIHSP 109
           ++ F  + LLG+G++G V  A  +  G  VA+KK  P      +     EI+IL      
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 110 RLVNLLGF----SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            ++ +       S ++ + + +++ +    L+ V+  + + L+         Q  +AV++
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI--STQMLSDDHIQYFIYQTLRAVKV 127
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG--------- 216
           LH     +IHRD+K +N+LI+ N + ++ DFGLA    +D     ++ P G         
Sbjct: 128 LHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLAR--IIDESAADNSEPTGQQSGMTEXV 183
Query: 217 -TIGYLDP-CYVTPDNLSTKTDVFSFGILLLEII 248
            T  Y  P   +T    S   DV+S G +L E+ 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   +   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 101
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  LV   M    LY +L + +  L+         Q+ + ++
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQH--LSNDHICYFLYQILRGLK 158
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 159 YIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 11/191 (5%)
Query: 63  LGKGSHGSVYKAVLRGRQ--VAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G+G++G+V+KA  R     VA+K+      ++ +      EI +L ++    +V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
            +  K   LV EF  +  L     S N  L+         Q+ K +   HS    ++HRD
Sbjct: 70  LHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRD 126
Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL-STKTD 236
           +K  N+LI+RN   +L +FGLA   G+    + +     T+ Y  P  +    L ST  D
Sbjct: 127 LKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE--VVTLWYRPPDVLFGAKLYSTSID 184
Query: 237 VFSFGILLLEI 247
           ++S G +  E+
Sbjct: 185 MWSAGCIFAEL 195

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKK--PSKNQEISQEVDNEIEILSKIHSP 109
           ++ F  + LLG+G++G V  A  +  G  VA+KK  P      +     EI+IL      
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 110 RLVNLLGF----SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            ++ +       S ++ + + +++ +    L+ V+  + + L+         Q  +AV++
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI--STQMLSDDHIQYFIYQTLRAVKV 127
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG--------- 216
           LH     +IHRD+K +N+LI+ N + ++ DFGLA    +D     ++ P G         
Sbjct: 128 LHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLAR--IIDESAADNSEPTGQQSGMVEFV 183
Query: 217 -TIGYLDP-CYVTPDNLSTKTDVFSFGILLLEII 248
            T  Y  P   +T    S   DV+S G +L E+ 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKK--PSKNQEISQEVDNEIEILSKIHSP 109
           ++ F  + LLG+G++G V  A  +  G  VA+KK  P      +     EI+IL      
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 110 RLVNLLGF----SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            ++ +       S ++ + + +++ +    L+ V+  + + L+         Q  +AV++
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI--STQMLSDDHIQYFIYQTLRAVKV 127
Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG--------- 216
           LH     +IHRD+K +N+LI+ N + ++ DFGLA    +D     ++ P G         
Sbjct: 128 LHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLAR--IIDESAADNSEPTGQQSGMTEYV 183
Query: 217 -TIGYLDP-CYVTPDNLSTKTDVFSFGILLLEII 248
            T  Y  P   +T    S   DV+S G +L E+ 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 119/271 (43%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  + +      + E++I+ K+    +V 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---NRELQIMRKLDHCNIVR 77
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLA--LRCGVDNFRFRST----PPAGT 217
            +HS    I HRDIK  N+L+D +    +L DFG A  L  G  N  +  +     P   
Sbjct: 137 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194
Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            G  D         ++  DV+S G +L E++                + I +  +P    
Sbjct: 195 FGATD--------YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++  P IK      VF PR PP
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 277

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   L   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 85
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 142
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   L   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 79
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 136
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 137 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   L   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 79
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 136
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 137 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   L   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRF---RHE 85
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 142
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 57  FSEQKLLGKGSHGSVYKAVLR------GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSP 109
           F   +++G+GS+  V    L+        +V  K+   + E    V  E  +  +  + P
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH-SNNRPLNWGRRIRLALQVAKAVEILHS 168
            LV L            V+E+++ G L  + H    R L        + +++ A+  LH 
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGL---ALRCGVDNFRFRSTPPAGTIGYLDPCY 225
               II+RD+K  NVL+D   + +L D+G+    LR G     F  TP      Y+ P  
Sbjct: 129 R--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTP-----NYIAPEI 181
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDI 256
           +  ++     D ++ G+L+ E+++ R   DI
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 20/218 (9%)
Query: 41  KIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEV-- 96
           K++  DY   E   +  + Q  LG+GS G V++   +  G Q AVKK      +  EV  
Sbjct: 80  KLKPVDYEYREE-VHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKK------VRLEVFR 132
Query: 97  DNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA 156
             E+   + + SPR+V L G   +     + +E +  G+L  ++      L   R +   
Sbjct: 133 AEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC-LPEDRALYYL 191
Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRN-FNARLGDFGLALRC----GVDNFRFRS 211
            Q  + +E LHS    I+H D+K+ NVL+  +  +A L DFG A+ C    G+       
Sbjct: 192 GQALEGLEYLHSRR--ILHGDVKADNVLLSSDGSHAALCDFGHAV-CLQPDGLGKSLLTG 248
Query: 212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
               GT  ++ P  V   +   K DV+S   ++L +++
Sbjct: 249 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLN 286

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   L   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 86
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 143
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 144 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 201
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   L   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 87
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 88  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 144
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 145 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 202
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 203 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   L   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 78
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 79  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 135
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 136 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 193
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 194 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   L   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 85
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 142
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 57  FSEQKLLGKGSHGSVYKAVLR------GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSP 109
           F   +++G+GS+  V    L+        +V  K+   + E    V  E  +  +  + P
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH-SNNRPLNWGRRIRLALQVAKAVEILHS 168
            LV L            V+E+++ G L  + H    R L        + +++ A+  LH 
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHE 139
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLA---LRCGVDNFRFRSTPPAGTIGYLDPCY 225
               II+RD+K  NVL+D   + +L D+G+    LR G     F  TP      Y+ P  
Sbjct: 140 R--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTP-----NYIAPEI 192
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDI 256
           +  ++     D ++ G+L+ E+++ R   DI
Sbjct: 193 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 223

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 57  FSEQKLLGKGSHGSVYKAVLR------GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSP 109
           F   +++G+GS+  V    L+        +V  K+   + E    V  E  +  +  + P
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH-SNNRPLNWGRRIRLALQVAKAVEILHS 168
            LV L            V+E+++ G L  + H    R L        + +++ A+  LH 
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHE 124
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLA---LRCGVDNFRFRSTPPAGTIGYLDPCY 225
               II+RD+K  NVL+D   + +L D+G+    LR G     F  TP      Y+ P  
Sbjct: 125 R--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTP-----NYIAPEI 177
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDI 256
           +  ++     D ++ G+L+ E+++ R   DI
Sbjct: 178 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 208

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 41  KIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEV-- 96
           K++  DY   E   +  + Q  LG+GS G V++   +  G Q AVKK      +  EV  
Sbjct: 61  KLKPVDYEYREE-VHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKK------VRLEVFR 113
Query: 97  DNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA 156
             E+   + + SPR+V L G   +     + +E +  G+L  ++      L   R +   
Sbjct: 114 AEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC-LPEDRALYYL 172
Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRN-FNARLGDFGLALRC------GVDNFRF 209
            Q  + +E LHS    I+H D+K+ NVL+  +  +A L DFG A+ C      G D    
Sbjct: 173 GQALEGLEYLHSRR--ILHGDVKADNVLLSSDGSHAALCDFGHAV-CLQPDGLGKDLLTG 229
Query: 210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
              P  GT  ++ P  V   +   K DV+S   ++L +++
Sbjct: 230 DYIP--GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLN 267

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 29/231 (12%)
Query: 63  LGKGSHGSVYKAV-LR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHS---PRLVN 113
           +G+G++G V+KA  L+  GR VA+K+    +  + +      E+ +L  + +   P +V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 114 LLGFSN----DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIR-LALQVAKAVEILHS 168
           L         D + +L +V    +  L   L     P      I+ +  Q+ + ++ LHS
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+K  N+L+  +   +L DFGLA    + +F+   T    T+ Y  P  +  
Sbjct: 139 HR--VVHRDLKPQNILVTSSGQIKLADFGLA---RIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV 279
            + +T  D++S G +  E+   RK +   F   S VD      + GKIL V
Sbjct: 194 SSYATPVDLWSVGCIFAEMFR-RKPL---FRGSSDVD------QLGKILDV 234

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 57  FSEQKLLGKGSHGSVYKAVLR------GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSP 109
           F   +++G+GS+  V    L+        +V  K+   + E    V  E  +  +  + P
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH-SNNRPLNWGRRIRLALQVAKAVEILHS 168
            LV L            V+E+++ G L  + H    R L        + +++ A+  LH 
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHE 171
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGL---ALRCGVDNFRFRSTPPAGTIGYLDPCY 225
               II+RD+K  NVL+D   + +L D+G+    LR G     F  TP      Y+ P  
Sbjct: 172 R--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP-----NYIAPEI 224
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDI 256
           +  ++     D ++ G+L+ E+++ R   DI
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 89/208 (42%), Gaps = 28/208 (13%)
Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVK----KPSKNQEISQEVDNEIEILSKIHSPR 110
           F  ++ LG G+   V  A  +  G+  AVK    K  K +E S  ++NEI +L KI    
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESS--IENEIAVLRKIKHEN 81
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIR-----LALQVAKAVEI 165
           +V L           LV++ +S G L+D      R +  G         L  QV  AV  
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFD------RIVEKGFYTEKDASTLIRQVLDAVYY 135
Query: 166 LHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           LH     I+HRD+K  N+L    D      + DFGL+   G  +     +   GT GY+ 
Sbjct: 136 LHR--MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVM---STACGTPGYVA 190
Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIISC 250
           P  +     S   D +S G++   I+ C
Sbjct: 191 PEVLAQKPYSKAVDCWSIGVIAY-ILLC 217

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 18/198 (9%)
Query: 62  LLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSK-----IHSPRLVNLL 115
           +LGKGS G V  +  +G  ++   K  K   + Q+ D E  ++ K        P  +  L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 116 GFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
                + DRL  V+E+++ G L   +    R       +  A ++A  +  L S+   II
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKG--II 464
Query: 175 HRDIKSANVLIDRNFNARLGDFGLA---LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
           +RD+K  NV++D   + ++ DFG+    +  GV    F  TP      Y+ P  +     
Sbjct: 465 YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTP-----DYIAPEIIAYQPY 519
Query: 232 STKTDVFSFGILLLEIIS 249
               D ++FG+LL E+++
Sbjct: 520 GKSVDWWAFGVLLYEMLA 537

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVD-----NEI 100
           D S+ +A ++ F  +  LG+G+   VY    R +Q   +KP   + + + VD      EI
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVY----RCKQKGTQKPYALKVLKKTVDKKIVRTEI 99
Query: 101 EILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRR--IRLALQ 158
            +L ++  P ++ L        +  LV+E ++ G L+D +        +  R       Q
Sbjct: 100 GVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQ 156
Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLIDR---NFNARLGDFGLALRCGVDNFRFRSTPPA 215
           + +AV  LH     I+HRD+K  N+L      +   ++ DFGL+    +   +       
Sbjct: 157 ILEAVAYLHEN--GIVHRDLKPENLLYATPAPDAPLKIADFGLS---KIVEHQVLMKTVC 211
Query: 216 GTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
           GT GY  P  +       + D++S GI+   I+ C      GF P
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITY-ILLC------GFEP 249

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 108/270 (40%), Gaps = 39/270 (14%)
Query: 63  LGKGSHGSVYKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF-- 117
           L +   G ++K   +G  + VK       +   S++ + E   L     P ++ +LG   
Sbjct: 18  LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
           S  +    L+  +   G+LY+VLH   N  ++  + ++ AL  A+    LH+  P I   
Sbjct: 78  SPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRH 137
Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK-- 234
            + S +V ID +  AR+    +        F F+S  P        P +V P+ L  K  
Sbjct: 138 ALNSRSVXIDEDXTARISXADV-------KFSFQS--PGRXYA---PAWVAPEALQKKPE 185
Query: 235 ------TDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
                  D +SF +LL E+++     ++ F+     D +   I     L    P IPP  
Sbjct: 186 DTNRRSADXWSFAVLLWELVTR----EVPFA-----DLSNXEIGXKVALEGLRPTIPPGI 236
Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            P V K   +    C      +RP    IV
Sbjct: 237 SPHVSKLXKI----CXNEDPAKRPKFDXIV 262

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 56  GFSEQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVR 77
Query: 114 LLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL---QVAKAVE 164
           L  F   S + KD +   LV++++   T+Y V    +R       I + L   Q+ +++ 
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
            +HS    I HRDIK  N+L+D +    +L DFG A +        R  P    I     
Sbjct: 137 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL------VRGEPNVSXI--CSR 186
Query: 224 CYVTPD------NLSTKTDVFSFGILLLEII-------------SCRKAIDIGFSP---- 260
            Y  P+      + ++  DV+S G +L E++                + I +  +P    
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 261 -----PSIVDWAAPLIKKGKILSVFDPRIPP 286
                P+  ++  P IK      VF PR PP
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 277

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 63  LGKGSHGSVYKAV--LRGRQVAVKKPSKNQEIS---QEVDNEIEILSKIHSPRLVNLLGF 117
           LGKG+   V + V  L G++ A K  +  +  +   Q+++ E  I   +  P +V L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 118 SNDSKDRLLVVEFMSNGTLYD--VLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
            ++     L+ + ++ G L++  V        +    I+  L+      +LH     ++H
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA-----VLHCHQMGVVH 144
Query: 176 RDIKSANVLIDRNFN---ARLGDFGLALRCGVDN---FRFRSTPPAGTIGYLDPCYVTPD 229
           RD+K  N+L+         +L DFGLA+    +    F F     AGT GYL P  +  D
Sbjct: 145 RDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-----AGTPGYLSPEVLRKD 199
Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
                 D+++ G++L  ++       +G+ P
Sbjct: 200 PYGKPVDLWACGVILYILL-------VGYPP 223

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 18/198 (9%)
Query: 62  LLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSK-----IHSPRLVNLL 115
           +LGKGS G V  +  +G  ++   K  K   + Q+ D E  ++ K        P  +  L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 116 GFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
                + DRL  V+E+++ G L   +    R       +  A ++A  +  L S+   II
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSK--GII 143
Query: 175 HRDIKSANVLIDRNFNARLGDFGLA---LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
           +RD+K  NV++D   + ++ DFG+    +  GV    F  TP      Y+ P  +     
Sbjct: 144 YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTP-----DYIAPEIIAYQPY 198
Query: 232 STKTDVFSFGILLLEIIS 249
               D ++FG+LL E+++
Sbjct: 199 GKSVDWWAFGVLLYEMLA 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 29/231 (12%)
Query: 63  LGKGSHGSVYKAV-LR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHS---PRLVN 113
           +G+G++G V+KA  L+  GR VA+K+    +  + +      E+ +L  + +   P +V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 114 LLGFSN----DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIR-LALQVAKAVEILHS 168
           L         D + +L +V    +  L   L     P      I+ +  Q+ + ++ LHS
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+K  N+L+  +   +L DFGLA    + +F+   T    T+ Y  P  +  
Sbjct: 139 HR--VVHRDLKPQNILVTSSGQIKLADFGLA---RIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV 279
            + +T  D++S G +  E+   RK +   F   S VD      + GKIL V
Sbjct: 194 SSYATPVDLWSVGCIFAEMFR-RKPL---FRGSSDVD------QLGKILDV 234

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 29/231 (12%)
Query: 63  LGKGSHGSVYKAV-LR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHS---PRLVN 113
           +G+G++G V+KA  L+  GR VA+K+    +  + +      E+ +L  + +   P +V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 114 LLGFSN----DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIR-LALQVAKAVEILHS 168
           L         D + +L +V    +  L   L     P      I+ +  Q+ + ++ LHS
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+K  N+L+  +   +L DFGLA    + +F+   T    T+ Y  P  +  
Sbjct: 139 HR--VVHRDLKPQNILVTSSGQIKLADFGLA---RIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV 279
            + +T  D++S G +  E+   RK +   F   S VD      + GKIL V
Sbjct: 194 SSYATPVDLWSVGCIFAEMFR-RKPL---FRGSSDVD------QLGKILDV 234

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   L   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 85
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L   +  L+         Q+ + ++
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKCQH--LSNDHICYFLYQILRGLK 142
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 12/214 (5%)
Query: 41  KIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEI 100
           K++  DY   E   +  + Q  LG+GS G V++  ++ +Q   +   K   +      E+
Sbjct: 59  KLKPVDYEYREE-VHWMTHQPRLGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFRVEEL 115
Query: 101 EILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVA 160
              + + SPR+V L G   +     + +E +  G+L  ++      L   R +    Q  
Sbjct: 116 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQAL 174
Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDRNFN-ARLGDFGLALRC----GVDNFRFRSTPPA 215
           + +E LH+    I+H D+K+ NVL+  + + A L DFG AL C    G+           
Sbjct: 175 EGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHAL-CLQPDGLGKSLLTGDYIP 231
Query: 216 GTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
           GT  ++ P  V       K D++S   ++L +++
Sbjct: 232 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 265

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 53  ATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKK------PSKNQEISQEVDNEIEILS 104
           AT+ +     +G G++G+VYKA     G  VA+K             +      E+ +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 105 KIHS---PRLVNLLGFSNDSK-DRLLVVEFMSNGTLYDV---LHSNNRPLNWGRRIR-LA 156
           ++ +   P +V L+     S+ DR + V  +      D+   L     P      I+ L 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG 216
            Q  + ++ LH+    I+HRD+K  N+L+      +L DFGLA    + +++   TP   
Sbjct: 127 RQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLA---RIYSYQMALTPVVV 181
Query: 217 TIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFS 259
           T+ Y  P  +     +T  D++S G +  E+   RK +  G S
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNS 223

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS---QEVDNEIEILSKIHS 108
           ++ +  ++ LGKG+   V + V +  G + A K  +  +  +   Q+++ E  I  K+  
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +V L     +     LV + ++ G L++ + +     +         Q+ +++   HS
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCHS 122
Query: 169 EMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
               I+HR++K  N+L+    +    +L DFGLA+    D+  +     AGT GYL P  
Sbjct: 123 N--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGF--AGTPGYLSPEV 177
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
           +  D  S   D+++ G++L  ++       +G+ P
Sbjct: 178 LKKDPYSKPVDIWACGVILYILL-------VGYPP 205

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   +   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 101
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 158
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 159 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 14/90 (15%)
Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
           A+  LHS+   ++H D+K AN+ +      +LGDFGL +  G        T  AG +   
Sbjct: 169 ALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELG--------TAGAGEVQEG 218
Query: 222 DPCYVTPDNLS----TKTDVFSFGILLLEI 247
           DP Y+ P+ L     T  DVFS G+ +LE+
Sbjct: 219 DPRYMAPELLQGSYGTAADVFSLGLTILEV 248

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   +   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 83
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 141 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 57  FSEQKLLGKGSHG---SVYKAVLRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRL 111
           ++    +G+G++G   S Y  V + R VA+KK  P ++Q   Q    EI+IL +    R 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRF---RH 80
Query: 112 VNLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
            N++G ++          KD  +V + M    LY +L + +  L+         Q+ + +
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGL 137
Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLD 222
           + +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  
Sbjct: 138 KYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 223 PCYVTPDNLSTKT-DVFSFGILLLEIISCR 251
           P  +      TK+ D++S G +L E++S R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   L   +VA++K  P ++Q   Q    EI+IL +    R  
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRF---RHE 85
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 142
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 57  FSEQKLLGKGSHG---SVYKAVLRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRL 111
           ++    +G+G++G   S Y  V + R VA+KK  P ++Q   Q    EI+IL +    R 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRF---RH 80
Query: 112 VNLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
            N++G ++          KD  +V + M    LY +L + +  L+         Q+ + +
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGL 137
Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLD 222
           + +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  
Sbjct: 138 KYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 223 PCYVTPDNLSTKT-DVFSFGILLLEIISCR 251
           P  +      TK+ D++S G +L E++S R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   +   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 81
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 138
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 139 YIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS---QEVDNEIEILSKIHS 108
           ++ +  ++ LGKG+   V + V +  G + A K  +  +  +   Q+++ E  I  K+  
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +V L     +     LV + ++ G L++ + +     +         Q+ +++   HS
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCHS 123
Query: 169 EMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
               I+HR++K  N+L+    +    +L DFGLA+    D+  +     AGT GYL P  
Sbjct: 124 N--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGF--AGTPGYLSPEV 178
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
           +  D  S   D+++ G++L  ++       +G+ P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILL-------VGYPP 206

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS---QEVDNEIEILSKIHS 108
           ++ +  ++ LGKG+   V + V +  G + A K  +  +  +   Q+++ E  I  K+  
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +V L     +     LV + ++ G L++ + +     +         Q+ +++   HS
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCHS 123
Query: 169 EMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
               I+HR++K  N+L+    +    +L DFGLA+    D+  +     AGT GYL P  
Sbjct: 124 N--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGF--AGTPGYLSPEV 178
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
           +  D  S   D+++ G++L  ++       +G+ P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILL-------VGYPP 206

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   +   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 89
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 90  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 146
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 147 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 204
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 205 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   +   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 81
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 138
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 139 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   +   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 81
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 138
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 139 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 59  EQKLLGKGSHGSVYKAV--LRGRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLL 115
           ++ +LG+G+H  V   +  +  ++ AVK   K    I   V  E+E+L +    R V  L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 116 GFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
               + +DR  LV E M  G++   +H   R  N      +   VA A++ LH++   I 
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEASVVVQDVASALDFLHNK--GIA 133
Query: 175 HRDIKSANVLIDRNFN---ARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC----YVT 227
           HRD+K  N+L +        ++ DFGL     ++        P  T   L PC    Y+ 
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNG----DCSPISTPELLTPCGSAEYMA 189
Query: 228 PDNLST----------KTDVFSFGILLLEIIS 249
           P+ +            + D++S G++L  ++S
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS---QEVDNEIEILSKIHS 108
           ++ +  ++ LGKG+   V + V +  G + A K  +  +  +   Q+++ E  I  K+  
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +V L     +     LV + ++ G L++ + +     +         Q+ +++   HS
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCHS 146
Query: 169 EMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
               I+HR++K  N+L+    +    +L DFGLA+    D+  +     AGT GYL P  
Sbjct: 147 N--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGF--AGTPGYLSPEV 201
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
           +  D  S   D+++ G++L  ++       +G+ P
Sbjct: 202 LKKDPYSKPVDIWACGVILYILL-------VGYPP 229

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 98/240 (40%), Gaps = 65/240 (27%)
Query: 63  LGKGSHGSVYKAVLRG----RQVAVKKPSKNQEIS----QEVDNEIEILSKIHSPRLVNL 114
           +G+GS+G V  A+       R + +   +K ++I+    + +  E+ ++ K+H P +  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVL---------------------------------- 140
                D +   LV+E    G L D L                                  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 141 -HSNNRPLNWGRRIRL----ALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN--FNARL 193
            H     L++ +R +L      Q+  A+  LH++   I HRDIK  N L   N  F  +L
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ--GICHRDIKPENFLFSTNKSFEIKL 211
Query: 194 GDFGLALR-CGVDNFRFRS-TPPAGTIGYLDPCYVTPDNLST-------KTDVFSFGILL 244
            DFGL+     ++N  +   T  AGT     P +V P+ L+T       K D +S G+LL
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGT-----PYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   L   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 85
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 142
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +          T  Y  P
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 200
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 43  QHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEI 100
           QH+D  DL+         K LG+GS     K V +   +  AVK  SK  E + + +   
Sbjct: 8   QHYDL-DLK--------DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITA 58
Query: 101 EILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVA 160
             L + H P +V L    +D     LV+E ++ G L++ +    +  +      +  ++ 
Sbjct: 59  LKLCEGH-PNIVKLHEVFHDQLHTFLVMELLNGGELFERI-KKKKHFSETEASYIMRKLV 116
Query: 161 KAVEILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGT 217
            AV  +H     ++HRD+K  N+L    + N   ++ DFG A     DN   ++  P  T
Sbjct: 117 SAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFT 172
Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
           + Y  P  +  +      D++S G++L  ++S
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLS 204

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   L   +VA+KK  P ++Q   Q    EI+IL +    R  
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF---RHE 86
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 143
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +          T  Y  P
Sbjct: 144 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 201
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 33/231 (14%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN----EIEILSKIHSPRLVNLLG 116
           LG G  G V + + +  G QVA+K+    QE+S +       EI+I+ K++ P +V+   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 117 FSNDSKDR------LLVVEFMSNGTLYDVLHS--NNRPLNWGRRIRLALQVAKAVEILHS 168
             +  +        LL +E+   G L   L+   N   L  G    L   ++ A+  LH 
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 169 EMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
               IIHRD+K  N+++    +    ++ D G A            T   GT+ YL P  
Sbjct: 140 NR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPEL 194
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI 276
           +     +   D +SFG L  E I+       GF  P + +W  P+   GK+
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECIT-------GFR-PFLPNW-QPVQWHGKV 236

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 12/214 (5%)
Query: 41  KIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEI 100
           K++  DY   E   +  + Q  +G+GS G V++  ++ +Q   +   K   +      E+
Sbjct: 45  KLKPVDYEYREE-VHWMTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFRVEEL 101
Query: 101 EILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVA 160
              + + SPR+V L G   +     + +E +  G+L  ++      L   R +    Q  
Sbjct: 102 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQAL 160
Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDRNFN-ARLGDFGLALRC----GVDNFRFRSTPPA 215
           + +E LH+    I+H D+K+ NVL+  + + A L DFG AL C    G+           
Sbjct: 161 EGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHAL-CLQPDGLGKSLLTGDYIP 217
Query: 216 GTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
           GT  ++ P  V       K D++S   ++L +++
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 251

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 33/231 (14%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN----EIEILSKIHSPRLVNLLG 116
           LG G  G V + + +  G QVA+K+    QE+S +       EI+I+ K++ P +V+   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKLNHPNVVSARE 80
Query: 117 FSNDSKDR------LLVVEFMSNGTLYDVLHS--NNRPLNWGRRIRLALQVAKAVEILHS 168
             +  +        LL +E+   G L   L+   N   L  G    L   ++ A+  LH 
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 140
Query: 169 EMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
               IIHRD+K  N+++    +    ++ D G A            T   GT+ YL P  
Sbjct: 141 NR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPEL 195
Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI 276
           +     +   D +SFG L  E I+       GF  P + +W  P+   GK+
Sbjct: 196 LEQKKYTVTVDYWSFGTLAFECIT-------GFR-PFLPNW-QPVQWHGKV 237

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 105/240 (43%), Gaps = 35/240 (14%)
Query: 52  AATNGFSEQKL-----LGKGSHGSVYKAV--LRGRQVAVKKPSKNQEISQ---------E 95
           AA  G   QK      LG G+ G V+ AV   + ++V VK   K + +           +
Sbjct: 16  AACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 96  VDNEIEILSKIHSPRLVNLLG-FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIR 154
           V  EI ILS++    ++ +L  F N    +L++ +  S   L+  +  + R L+      
Sbjct: 76  VTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASY 134
Query: 155 LALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRST 212
           +  Q+  AV  L   +  IIHRDIK  N++I  +F  +L DFG A  L  G   + F   
Sbjct: 135 IFRQLVSAVGYLR--LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--- 189
Query: 213 PPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEII-------SCRKAIDIGFSPPSIV 264
              GTI Y  P  +  +     + +++S G+ L  ++          + ++    PP +V
Sbjct: 190 --CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV 247

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 12/214 (5%)
Query: 41  KIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEI 100
           K++  DY   E   +  + Q  +G+GS G V++  ++ +Q   +   K   +      E+
Sbjct: 61  KLKPVDYEYREE-VHWMTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFRVEEL 117
Query: 101 EILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVA 160
              + + SPR+V L G   +     + +E +  G+L  ++      L   R +    Q  
Sbjct: 118 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQAL 176
Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDRNFN-ARLGDFGLALRC----GVDNFRFRSTPPA 215
           + +E LH+    I+H D+K+ NVL+  + + A L DFG AL C    G+           
Sbjct: 177 EGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHAL-CLQPDGLGKSLLTGDYIP 233
Query: 216 GTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS 249
           GT  ++ P  V       K D++S   ++L +++
Sbjct: 234 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 267

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   +   +VA+KK  P ++Q   Q    EI+IL      R  
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAF---RHE 83
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 141 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 87/191 (45%), Gaps = 18/191 (9%)
Query: 61  KLLGKGSHGSVYKAV--LRGRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPR-LVNLLG 116
           +LLG+G++  V  AV    G++ AVK   K    S+  V  E+E L +    + ++ L+ 
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
           F  D     LV E +  G++   +    +  N     R+   VA A++ LH++   I HR
Sbjct: 79  FFEDDTRFYLVFEKLQGGSILAHIQ-KQKHFNEREASRVVRDVAAALDFLHTK--GIAHR 135
Query: 177 DIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC----YVTPD 229
           D+K  N+L    ++    ++ DF L     ++N    S  P  T     PC    Y+ P+
Sbjct: 136 DLKPENILCESPEKVSPVKICDFDLGSGMKLNN----SCTPITTPELTTPCGSAEYMAPE 191
Query: 230 NLSTKTDVFSF 240
            +   TD  +F
Sbjct: 192 VVEVFTDQATF 202

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           ++    +G+G++G V  A   +   +VA+KK  P ++Q   Q    EI+IL      R  
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAF---RHE 83
Query: 113 NLLGFSN--------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           N++G ++          KD  +V + M    LY +L + +  L+         Q+ + ++
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQH--LSNDHICYFLYQILRGLK 140
Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLDP 223
            +HS    ++HRD+K +N+L++   + ++ DFGLA     D +     T    T  Y  P
Sbjct: 141 YIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 224 CYVTPDNLSTKT-DVFSFGILLLEIISCR 251
             +      TK+ D++S G +L E++S R
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 20/175 (11%)
Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST 212
           I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGLA     D    R  
Sbjct: 194 ICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 251
Query: 213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP---PSIVDWAAP 269
                + ++ P  +     + ++DV+SFG+LL EI S      +G SP     I +    
Sbjct: 252 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCR 305
Query: 270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            +K+G  +   D   P         ++    + C      +RP+  E+V+ L  L
Sbjct: 306 RLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 351

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 20/175 (11%)
Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST 212
           I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGLA     D    R  
Sbjct: 203 ICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 260
Query: 213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP---PSIVDWAAP 269
                + ++ P  +     + ++DV+SFG+LL EI S      +G SP     I +    
Sbjct: 261 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCR 314
Query: 270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            +K+G  +   D   P         ++    + C      +RP+  E+V+ L  L
Sbjct: 315 RLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 360

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 20/175 (11%)
Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST 212
           I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGLA     D    R  
Sbjct: 201 ICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 258
Query: 213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP---PSIVDWAAP 269
                + ++ P  +     + ++DV+SFG+LL EI S      +G SP     I +    
Sbjct: 259 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCR 312
Query: 270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            +K+G  +   D   P         ++    + C      +RP+  E+V+ L  L
Sbjct: 313 RLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 358

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 20/175 (11%)
Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST 212
           I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGLA     D    R  
Sbjct: 196 ICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP---PSIVDWAAP 269
                + ++ P  +     + ++DV+SFG+LL EI S      +G SP     I +    
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCR 307
Query: 270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            +K+G  +   D   P         ++    + C      +RP+  E+V+ L  L
Sbjct: 308 RLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/212 (21%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 61  KLLGKGSHGSVYKAVLRGR-----QVAVKKPSKNQEISQEVD---NEIEILSKIHSPRLV 112
           K+LG+G  GSV +  L+       +VAVK    +    +E++   +E   +     P ++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 113 NLLGFSNDSKDR-----LLVVEFMSNG-----TLYDVLHSNNRPLNWGRRIRLALQVAKA 162
            LLG   +   +     ++++ FM  G      LY  L +  + +     ++  + +A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           +E L +     +HRD+ + N ++  +    + DFGL+ +    ++ +R     G I  + 
Sbjct: 160 MEYLSNR--NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY-YRQ----GRIAKMP 212
Query: 223 PCYVTPDNL-----STKTDVFSFGILLLEIIS 249
             ++  ++L     ++K+DV++FG+ + EI +
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 34/213 (15%)
Query: 63  LGKGSHGSVYKAV--LRGRQVA-----VKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           LGKG+   V + V  L G++ A      KK S      Q+++ E  I   +  P +V L 
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH--QKLEREARICRLLKHPNIVRLH 76
Query: 116 GFSNDSKDRLLVVEFMSNGTLYD--VLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
              ++     L+ + ++ G L++  V        +    I+  L+      +LH     +
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA-----VLHCHQMGV 131
Query: 174 IHRDIKSANVLIDRNFN---ARLGDFGLALRCGVDN---FRFRSTPPAGTIGYLDPCYVT 227
           +HR++K  N+L+         +L DFGLA+    +    F F     AGT GYL P  + 
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-----AGTPGYLSPEVLR 186
Query: 228 PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
            D      D+++ G++L  ++       +G+ P
Sbjct: 187 KDPYGKPVDLWACGVILYILL-------VGYPP 212

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 22/201 (10%)
Query: 63  LGKGSHGSVYKAV--LRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLG- 116
           +G G++G+V  AV    G +VA+KK   P +++  ++    E+ +L  +    ++ LL  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 117 FS-----NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           F+     +D  D  LV+ FM  GT    L  + + L   R   L  Q+ K +  +H+   
Sbjct: 93  FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIHA--A 147
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            IIHRD+K  N+ ++ +   ++ DFGLA +   +           T  Y  P  +     
Sbjct: 148 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MXGXVVTRWYRAPEVILNWMR 202
Query: 232 STKT-DVFSFGILLLEIISCR 251
            T+T D++S G ++ E+I+ +
Sbjct: 203 YTQTVDIWSVGCIMAEMITGK 223

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 54  TNGFSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEIS---QEVDNEIEILSKIHS 108
           T+ +   + LGKG+   V +   +  G++ A K  +  +  +   Q+++ E  I   +  
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +V L    ++     LV + ++ G L++ + +     +         Q+ ++V   H 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY-YSEADASHCIQQILESVN--HC 119
Query: 169 EMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDN---FRFRSTPPAGTIGYLD 222
            +  I+HRD+K  N+L+    +    +L DFGLA+    D    F F     AGT GYL 
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGF-----AGTPGYLS 174
Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
           P  +  D      D+++ G++L  ++       +G+ P
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILL-------VGYPP 205

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 28/212 (13%)
Query: 59  EQKLLGKGSHGSVYKAV--LRGRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLL 115
           ++ +LG+G+H  V   +  +  ++ AVK   K    I   V  E+E+L +    R V  L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 116 GFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
               + +DR  LV E M  G++   +H   R  N      +   VA A++ LH++   I 
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEASVVVQDVASALDFLHNK--GIA 133
Query: 175 HRDIKSANVLIDRNFN---ARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC----YVT 227
           HRD+K  N+L +        ++ DF L     ++        P  T   L PC    Y+ 
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG----DCSPISTPELLTPCGSAEYMA 189
Query: 228 PDNLST----------KTDVFSFGILLLEIIS 249
           P+ +            + D++S G++L  ++S
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 83/360 (23%), Positives = 149/360 (41%), Gaps = 84/360 (23%)
Query: 40  IKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKA-VLRGRQVAVKKPSKNQEISQEVDN 98
           IK+   D    E     ++  K++G GS G V++A ++   +VA+KK  +++      + 
Sbjct: 25  IKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK---NR 81
Query: 99  EIEILSKIHSPRLVNLLGF---SNDSKDRL---LVVEFMSNGTLYDVLH----SNNRPLN 148
           E++I+  +  P +V+L  F   + D KD +   LV+E++         H        P+ 
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML 141
Query: 149 WGRRIRLAL-QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLA--LRCGV 204
               I+L + Q+ +++  +HS    I HRDIK  N+L+D      +L DFG A  L  G 
Sbjct: 142 L---IKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196
Query: 205 DNF-----RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCR-------- 251
            N      R+   P                N +T  D++S G ++ E++  +        
Sbjct: 197 PNVSXICSRYYRAP---------ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247
Query: 252 -----KAIDIGFSP---------PSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRK--- 294
                + I +  +P         P+ ++   P I+      VF PR PP    ++ +   
Sbjct: 248 IDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLE 307
Query: 295 -----QLAVIAVRC------VRSCRERRPSMKE---IVDWLTG--------LSKLVPLHS 332
                +L  I   C      +R+   R P+ +E   + +W           +S+LVP H+
Sbjct: 308 YTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHA 367

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 63  LGKGSHGSVYKA--VLRGRQVAVKKPSKNQEIS---QEVDNEIEILSKIHSPRLVNLLGF 117
           LGKG+   V +   +  G++ A K  +  +  +   Q+++ E  I   +  P +V L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
            ++     LV + ++ G L++ + +     +         Q+ ++V   H  +  I+HRD
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY-YSEADASHCIQQILESVN--HCHLNGIVHRD 128
Query: 178 IKSANVLI---DRNFNARLGDFGLALRCGVDN---FRFRSTPPAGTIGYLDPCYVTPDNL 231
           +K  N+L+    +    +L DFGLA+    D    F F     AGT GYL P  +  D  
Sbjct: 129 LKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGF-----AGTPGYLSPEVLRKDPY 183
Query: 232 STKTDVFSFGILLLEIISCRKAIDIGFSP 260
               D+++ G++L  ++       +G+ P
Sbjct: 184 GKPVDMWACGVILYILL-------VGYPP 205

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 42/218 (19%)
Query: 57  FSEQKLLGKGSHGSVY--KAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           F  +++ G+G+ G+V   K    G  VA+KK  ++          ++ L+ +H P +V L
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 115 LGF-----SNDSKDRLL--VVEFMSNGTLYDVLHSNNRPLNWGRR--------IRLAL-Q 158
             +       D +D  L  V+E++      D LH   R  N+ RR        I++ L Q
Sbjct: 85  QSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCR--NYYRRQVAPPPILIKVFLFQ 137
Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLIDR-NFNARLGDFGLALRCGVDNFRFRSTPPAGT 217
           + +++  LH     + HRDIK  NVL++  +   +L DFG A +          +P    
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL---------SPSEPN 188
Query: 218 IGYLDPCYVTPDNL-------STKTDVFSFGILLLEII 248
           + Y+   Y     L       +T  D++S G +  E++
Sbjct: 189 VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAVLRG-RQVAVKKPSKNQEIS----QEVDNEIEILSKIHS 108
           T+ +   + LGKG+   V + V +   Q    K    +++S    Q+++ E  I   +  
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +V L    ++     LV + ++ G L++ + +     +         Q+ ++V  +H 
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY-YSEADASHCIHQILESVNHIHQ 148
Query: 169 EMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDN---FRFRSTPPAGTIGYLD 222
               I+HRD+K  N+L+    +    +L DFGLA+    +    F F     AGT GYL 
Sbjct: 149 H--DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGF-----AGTPGYLS 201
Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
           P  +  D      D+++ G++L  ++       +G+ P
Sbjct: 202 PEVLRKDPYGKPVDIWACGVILYILL-------VGYPP 232

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 30/211 (14%)
Query: 57  FSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDN-----EIEILSKIHSPR 110
           F   K++G+G+ G V    L+   +V   K     E+ +  +      E ++L    S  
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVL--HSNNRPLNWGRRIRLALQVA-KAVEILH 167
           +  L     D  +  LV+++   G L  +L    +  P    R     + +A  +V  LH
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
                 +HRDIK  N+L+D N + RL DFG  L+   D    +S+   GT     P Y++
Sbjct: 196 -----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGT-----PDYIS 244
Query: 228 PDNLST----------KTDVFSFGILLLEII 248
           P+ L            + D +S G+ + E++
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEML 275

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 78/158 (49%), Gaps = 20/158 (12%)
Query: 55  NGFSEQKLLGKGSHGSVYKAVLRG--RQVAVKKPSKNQEI---SQEVDNEIEILSKIHSP 109
           + +  + L+G+GS+G VY A  +   + VA+KK ++  E     + +  EI IL+++ S 
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
            ++ L        D ++  + +    LY VL   +  L    +  + L       IL++ 
Sbjct: 88  YIIRL-------HDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNL 140
Query: 170 M--------PPIIHRDIKSANVLIDRNFNARLGDFGLA 199
           +          IIHRD+K AN L++++ + ++ DFGLA
Sbjct: 141 LLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLA 178

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 85/200 (42%), Gaps = 22/200 (11%)
Query: 63  LGKGSHGSVYK--AVLRGRQVAVKKPSKNQEISQEVD--NEIEILSKIHSPRLVNLLGFS 118
           LG+G++ +VYK  + L    VA+K+     E         E+ +L  +    +V L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
           +  K   LV E++ +  L   L      +N         Q+ + +   H +   ++HRD+
Sbjct: 70  HTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ--KVLHRDL 126
Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG------TIGYLDP-CYVTPDNL 231
           K  N+LI+     +L DFGLA        R +S P         T+ Y  P   +   + 
Sbjct: 127 KPQNLLINERGELKLADFGLA--------RAKSIPTKTYDNEVVTLWYRPPDILLGSTDY 178
Query: 232 STKTDVFSFGILLLEIISCR 251
           ST+ D++  G +  E+ + R
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 30/220 (13%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAV--LRGRQVAVKKPSKNQEIS---QEVDNEIEILSKIHS 108
           T+ +   + +GKG+   V + V    G + A K  +  +  +   Q+++ E  I   +  
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYD--VLHSNNRPLNWGRRIRLALQVAKAVEIL 166
             +V L    ++     LV + ++ G L++  V        +    I+  L+      +L
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEA-----VL 117
Query: 167 HSEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDN---FRFRSTPPAGTIGY 220
           H     ++HRD+K  N+L+    +    +L DFGLA+    D    F F     AGT GY
Sbjct: 118 HCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGF-----AGTPGY 172
Query: 221 LDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
           L P  +  +      D+++ G++L  ++       +G+ P
Sbjct: 173 LSPEVLRKEAYGKPVDIWACGVILYILL-------VGYPP 205

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 23/192 (11%)
Query: 40  IKIQHFDYSDLEAATNG-FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDN 98
           +++Q  D+  L+    G FSE  ++     G VY   +  +   +K+     E+S     
Sbjct: 56  VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR----GEVSC-FRE 110
Query: 99  EIEILSKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRI---- 153
           E ++L      R +  L F+   ++ L LV+E+   G L  +L        +G RI    
Sbjct: 111 ERDVLVN-GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLS------KFGERIPAEM 163
Query: 154 -RLAL-QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
            R  L ++  A++ +H      +HRDIK  N+L+DR  + RL DFG  L+   D    RS
Sbjct: 164 ARFYLAEIVMAIDSVHRL--GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVRS 220
Query: 212 TPPAGTIGYLDP 223
               GT  YL P
Sbjct: 221 LVAVGTPDYLSP 232

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 15/146 (10%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEI-EILSKI---- 106
           T  F E + +G G  GSV+K V R  G   A+K+  K    S +  N + E+ +      
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 107 HSPRLVNLLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGRRIRLA---LQVAKA 162
           HS  +     ++ D  D +L+  E+ + G+L D +  N R +++ +   L    LQV + 
Sbjct: 70  HSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRN 188
           +  +HS    ++H DIK +N+ I R 
Sbjct: 128 LRYIHS--MSLVHMDIKPSNIFISRT 151

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 15/146 (10%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEI-EILSKI---- 106
           T  F E + +G G  GSV+K V R  G   A+K+  K    S +  N + E+ +      
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 107 HSPRLVNLLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGRRIRLA---LQVAKA 162
           HS  +     ++ D  D +L+  E+ + G+L D +  N R +++ +   L    LQV + 
Sbjct: 68  HSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRN 188
           +  +HS    ++H DIK +N+ I R 
Sbjct: 126 LRYIHS--MSLVHMDIKPSNIFISRT 149

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 15/146 (10%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEI-EILSKI---- 106
           T  F E + +G G  GSV+K V R  G   A+K+  K    S +  N + E+ +      
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 107 HSPRLVNLLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGRRIRLA---LQVAKA 162
           HS  +     ++ D  D +L+  E+ + G+L D +  N R +++ +   L    LQV + 
Sbjct: 68  HSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRN 188
           +  +HS    ++H DIK +N+ I R 
Sbjct: 126 LRYIHS--MSLVHMDIKPSNIFISRT 149

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/204 (22%), Positives = 95/204 (46%), Gaps = 29/204 (14%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLG- 116
           +G G++GSV  A+ +  G +VA+KK   P +++  ++    E+ +L  +    ++ LL  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 117 FSNDSK-----DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           F+  S      D  LV+ FM      D+        +  +   L  Q+ K ++ +HS   
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQT----DLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS--A 163
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST----PPAGTIGYLDPCYVT 227
            ++HRD+K  N+ ++ +   ++ DFGLA     +   +  T     P   + ++      
Sbjct: 164 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWM------ 217
Query: 228 PDNLSTKTDVFSFGILLLEIISCR 251
             + +   D++S G ++ E+++ +
Sbjct: 218 --HYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 14/149 (9%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G+G+ G V+KA  R  G++VA+KK    ++ +        EI+IL  +    +VNL+  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 118 S-------NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
                   N  K  + +V       L  +L +           R+   +   +  +H   
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 143
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLA 199
             I+HRD+K+ANVLI R+   +L DFGLA
Sbjct: 144 -KILHRDMKAANVLITRDGVLKLADFGLA 171

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 14/149 (9%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G+G+ G V+KA  R  G++VA+KK    ++ +        EI+IL  +    +VNL+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 118 S-------NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
                   N  K  + +V       L  +L +           R+   +   +  +H   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLA 199
             I+HRD+K+ANVLI R+   +L DFGLA
Sbjct: 145 -KILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 14/149 (9%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G+G+ G V+KA  R  G++VA+KK    ++ +        EI+IL  +    +VNL+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 118 S-------NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
                   N  K  + +V       L  +L +           R+   +   +  +H   
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLA 199
             I+HRD+K+ANVLI R+   +L DFGLA
Sbjct: 145 -KILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 15/146 (10%)
Query: 54  TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEI-EILSKI---- 106
           T  F E + +G G  GSV+K V R  G   A+K+  K    S +  N + E+ +      
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 65
Query: 107 HSPRLVNLLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGRRIRLA---LQVAKA 162
           HS  +     ++ D  D +L+  E+ + G+L D +  N R +++ +   L    LQV + 
Sbjct: 66  HSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 123
Query: 163 VEILHSEMPPIIHRDIKSANVLIDRN 188
           +  +HS    ++H DIK +N+ I R 
Sbjct: 124 LRYIHS--MSLVHMDIKPSNIFISRT 147

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 14/149 (9%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           +G+G+ G V+KA  R  G++VA+KK    ++ +        EI+IL  +    +VNL+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 118 S-------NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
                   N  K  + +V       L  +L +           R+   +   +  +H   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLA 199
             I+HRD+K+ANVLI R+   +L DFGLA
Sbjct: 145 -KILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 89/186 (47%), Gaps = 21/186 (11%)
Query: 73  KAVLRGRQVAVKKPSKNQEIS-----QEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV 127
           K++L  ++   K  S N +IS      +  NE++I++ I +   +   G   +  +  ++
Sbjct: 64  KSLLEKKRDFTK--SNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYII 121
Query: 128 VEFMSNGTL------YDVLHSNNRPLNWGRRIRLALQ-VAKAVEILHSEMPPIIHRDIKS 180
            E+M N ++      + VL  N       + I+  ++ V  +   +H+E   I HRD+K 
Sbjct: 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE-KNICHRDVKP 180
Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST--KTDVF 238
           +N+L+D+N   +L DFG +    VD    +     GT  ++ P + + ++     K D++
Sbjct: 181 SNILMDKNGRVKLSDFGES-EYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIW 236
Query: 239 SFGILL 244
           S GI L
Sbjct: 237 SLGICL 242

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/204 (22%), Positives = 95/204 (46%), Gaps = 29/204 (14%)
Query: 63  LGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLG- 116
           +G G++GSV  A+ +  G +VA+KK   P +++  ++    E+ +L  +    ++ LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 117 FSNDSK-----DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           F+  S      D  LV+ FM      D+        +  +   L  Q+ K ++ +HS   
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQT----DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS--A 145
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST----PPAGTIGYLDPCYVT 227
            ++HRD+K  N+ ++ +   ++ DFGLA     +   +  T     P   + ++      
Sbjct: 146 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWM------ 199
Query: 228 PDNLSTKTDVFSFGILLLEIISCR 251
             + +   D++S G ++ E+++ +
Sbjct: 200 --HYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 11/173 (6%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQV-AVKKPSKNQEISQEVD---NEIEILSKI--HSPR 110
           +S  K +G G    V++ +   +Q+ A+K  +  +  +Q +D   NEI  L+K+  HS +
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           ++ L  +    +   +V+E   N  L   L        W R+      + +AV  +H   
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWK-NMLEAVHTIHQH- 174
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
             I+H D+K AN LI      +L DFG+A +   D          GT+ Y+ P
Sbjct: 175 -GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 225

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 11/173 (6%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQV-AVKKPSKNQEISQEVD---NEIEILSKI--HSPR 110
           +S  K +G G    V++ +   +Q+ A+K  +  +  +Q +D   NEI  L+K+  HS +
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           ++ L  +    +   +V+E   N  L   L        W R+      + +AV  +H   
Sbjct: 90  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWK-NMLEAVHTIHQH- 146
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
             I+H D+K AN LI      +L DFG+A +   D          GT+ Y+ P
Sbjct: 147 -GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 11/173 (6%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQV-AVKKPSKNQEISQEVD---NEIEILSKI--HSPR 110
           +S  K +G G    V++ +   +Q+ A+K  +  +  +Q +D   NEI  L+K+  HS +
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 73
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           ++ L  +    +   +V+E   N  L   L        W R+      + +AV  +H   
Sbjct: 74  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWK-NMLEAVHTIHQH- 130
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
             I+H D+K AN LI      +L DFG+A +   D          GT+ Y+ P
Sbjct: 131 -GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 181

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 11/173 (6%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQV-AVKKPSKNQEISQEVD---NEIEILSKI--HSPR 110
           +S  K +G G    V++ +   +Q+ A+K  +  +  +Q +D   NEI  L+K+  HS +
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 69
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           ++ L  +    +   +V+E   N  L   L        W R+      + +AV  +H   
Sbjct: 70  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWK-NMLEAVHTIHQH- 126
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
             I+H D+K AN LI      +L DFG+A +   D          GT+ Y+ P
Sbjct: 127 -GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 177

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 11/173 (6%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQV-AVKKPSKNQEISQEVD---NEIEILSKI--HSPR 110
           +S  K +G G    V++ +   +Q+ A+K  +  +  +Q +D   NEI  L+K+  HS +
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           ++ L  +    +   +V+E   N  L   L        W R+      + +AV  +H   
Sbjct: 90  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWK-NMLEAVHTIHQH- 146
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
             I+H D+K AN LI      +L DFG+A +   D          GT+ Y+ P
Sbjct: 147 -GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPP 197

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 20/153 (13%)
Query: 60  QKLLGKGSHGSVYKAVLRG--RQVAVKKPSKNQEI---SQEVDNEIEILSKIHSPRLVNL 114
           + L+G+GS+G VY A  +   + VA+KK ++  E     + +  EI IL+++ S  ++ L
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM---- 170
                   D ++  + +    LY VL   +  L    +  + L       IL++ +    
Sbjct: 91  Y-------DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 171 ----PPIIHRDIKSANVLIDRNFNARLGDFGLA 199
                 IIHRD+K AN L++++ + ++ DFGLA
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 11/173 (6%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQV-AVKKPSKNQEISQEVD---NEIEILSKI--HSPR 110
           +S  K +G G    V++ +   +Q+ A+K  +  +  +Q +D   NEI  L+K+  HS +
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           ++ L  +    +   +V+E   N  L   L        W R+      + +AV  +H   
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWK-NMLEAVHTIHQH- 174
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
             I+H D+K AN LI      +L DFG+A +   D          GT+ Y+ P
Sbjct: 175 -GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 225

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 26/149 (17%)
Query: 63  LGKGSHGSVYKAV--LRGRQVAVK--KPSKNQEISQEVDNEIEILSKIHS-PRLVNLLGF 117
           LG+G +  V++A+      +V VK  KP K  +I +E    I+IL  +   P ++ L   
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKRE----IKILENLRGGPNIITLADI 100
Query: 118 SND--SKDRLLVVEFMSNG---TLYDVLHSNNRPLNWGRRIRLAL-QVAKAVEILHSEMP 171
             D  S+   LV E ++N     LY  L   +        IR  + ++ KA++  HS   
Sbjct: 101 VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD--------IRFYMYEILKALDYCHSM-- 150
Query: 172 PIIHRDIKSANVLIDRNFNA-RLGDFGLA 199
            I+HRD+K  NV+ID      RL D+GLA
Sbjct: 151 GIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 11/173 (6%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQV-AVKKPSKNQEISQEVD---NEIEILSKI--HSPR 110
           +S  K +G G    V++ +   +Q+ A+K  +  +  +Q +D   NEI  L+K+  HS +
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           ++ L  +    +   +V+E   N  L   L        W R+      + +AV  +H   
Sbjct: 71  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWK-NMLEAVHTIHQH- 127
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
             I+H D+K AN LI      +L DFG+A +   D          GT+ Y+ P
Sbjct: 128 -GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 98/226 (43%), Gaps = 44/226 (19%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI-SQEVDNEIEILSKIH 107
           +++     F   K++G+G+ G          +VAV K    + I + ++ N+ E+L +  
Sbjct: 68  EMQLHREDFEIIKVIGRGAFG----------EVAVVKMKNTERIYAMKILNKWEMLKRAE 117
Query: 108 SP--------------RLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRR 152
           +               + +  L ++   ++ L LV+++   G L  +L      L     
Sbjct: 118 TACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMA 177
Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST 212
                ++  A++ +H      +HRDIK  NVL+D N + RL DFG  L+   D+   +S+
Sbjct: 178 RFYIGEMVLAIDSIHQ--LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMN-DDGTVQSS 234
Query: 213 PPAGTIGYLDPCYVTPDNLST----------KTDVFSFGILLLEII 248
              GT     P Y++P+ L            + D +S G+ + E++
Sbjct: 235 VAVGT-----PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 275

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 96/225 (42%), Gaps = 42/225 (18%)
Query: 49  DLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHS 108
           +++     F   K++G+G+ G V           VK  +  +  + ++ N+ E+L +  +
Sbjct: 84  EMQLHREDFEIIKVIGRGAFGEV---------AVVKMKNTERIYAMKILNKWEMLKRAET 134
Query: 109 P--------------RLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRI 153
                          + +  L ++   ++ L LV+++   G L  +L      L      
Sbjct: 135 ACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMAR 194
Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP 213
               ++  A++ +H      +HRDIK  NVL+D N + RL DFG  L+   D+   +S+ 
Sbjct: 195 FYIGEMVLAIDSIHQ--LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMN-DDGTVQSSV 251
Query: 214 PAGTIGYLDPCYVTPDNLST----------KTDVFSFGILLLEII 248
             GT     P Y++P+ L            + D +S G+ + E++
Sbjct: 252 AVGT-----PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 291

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 89/199 (44%), Gaps = 21/199 (10%)
Query: 63  LGKGSHGSVYKAV--LRGRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGF 117
           LG+G++G VYKA+  +    VA+K+     E   +      E+ +L ++    ++ L   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI--RLALQVAKAVEILHSEMPPIIH 175
            + +    L+ E+  N    D+    ++  +   R+      Q+   V   HS     +H
Sbjct: 102 IHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLH 155
Query: 176 RDIKSANVLIDRNFNA-----RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVTPD 229
           RD+K  N+L+  +  +     ++GDFGLA   G+   +F  T    T+ Y  P   +   
Sbjct: 156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIITLWYRPPEILLGSR 213
Query: 230 NLSTKTDVFSFGILLLEII 248
           + ST  D++S   +  E++
Sbjct: 214 HYSTSVDIWSIACIWAEML 232

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/169 (21%), Positives = 73/169 (43%), Gaps = 19/169 (11%)
Query: 48  SDLEAATNGFSEQKLLGKGSHGSVYKAV-LRGRQVAVKKPSK------------NQEISQ 94
           ++L A  + ++ Q+ +  GS+G+V   V   G  VA+K+               +  + +
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 95  EVDNEIEILSKIHSPRLVNL----LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWG 150
            V  EI +L+  H P ++ L    + F   +  +L +V  +    L  V+H     ++  
Sbjct: 75  RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ 134
Query: 151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
                   +   + +LH     ++HRD+   N+L+  N +  + DF LA
Sbjct: 135 HIQYFMYHILLGLHVLHE--AGVVHRDLHPGNILLADNNDITICDFNLA 181

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/169 (21%), Positives = 73/169 (43%), Gaps = 19/169 (11%)
Query: 48  SDLEAATNGFSEQKLLGKGSHGSVYKAV-LRGRQVAVKKPSK------------NQEISQ 94
           ++L A  + ++ Q+ +  GS+G+V   V   G  VA+K+               +  + +
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 95  EVDNEIEILSKIHSPRLVNL----LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWG 150
            V  EI +L+  H P ++ L    + F   +  +L +V  +    L  V+H     ++  
Sbjct: 75  RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ 134
Query: 151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
                   +   + +LH     ++HRD+   N+L+  N +  + DF LA
Sbjct: 135 HIQYFMYHILLGLHVLHE--AGVVHRDLHPGNILLADNNDITICDFNLA 181

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 98/204 (48%), Gaps = 28/204 (13%)
Query: 63  LGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLL- 115
           +G G++GSV   Y A LR ++VAVKK   P ++   ++    E+ +L  +    ++ LL 
Sbjct: 36  VGSGAYGSVCSAYDARLR-QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLD 94
Query: 116 ----GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
                 S +    + +V  +    L +++ S  + L+      L  Q+ + ++ +HS   
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKS--QALSDEHVQFLVYQLLRGLKYIHS--A 150
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST----PPAGTIGYLDPCYVT 227
            IIHRD+K +NV ++ +   R+ DFGLA +   +   + +T     P   + ++      
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWM------ 204
Query: 228 PDNLSTKTDVFSFGILLLEIISCR 251
             + +   D++S G ++ E++  +
Sbjct: 205 --HYNQTVDIWSVGCIMAELLQGK 226

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 11/173 (6%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQV-AVKKPSKNQEISQEVD---NEIEILSKI--HSPR 110
           +S  K +G G    V++ +   +Q+ A+K  +  +  +Q +D   NEI  L+K+  HS +
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           ++ L  +    +   +V+E   N  L   L        W R+      + +AV  +H   
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWK-NMLEAVHTIHQH- 174
Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
             I+H D+K AN LI      +L DFG+A +   D          G + Y+ P
Sbjct: 175 -GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 33/216 (15%)
Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEILS---- 104
           E   + +    L+GKGS G V KA  R  Q  VA+K     +    +   E+ +L     
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK 109
Query: 105 -----KIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQ 158
                K +   L     F N     L +V  M +  LYD+L + N R ++     + A Q
Sbjct: 110 HDTEMKYYIVHLKRHFMFRN----HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLI--DRNFNARLGDFGLALRCGVDNF-----RFRS 211
           +  A+  L +    IIH D+K  N+L+   +    ++ DFG + + G   +     RF  
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXIQSRFYR 225
Query: 212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEI 247
           +P    +G        P +L+   D++S G +L+E+
Sbjct: 226 SPEV-LLG-------MPYDLA--IDMWSLGCILVEM 251

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 96/202 (47%), Gaps = 28/202 (13%)
Query: 63  LGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLL- 115
           +G G++GSV   Y A LR ++VAVKK   P ++   ++    E+ +L  +    ++ LL 
Sbjct: 28  VGSGAYGSVCSAYDARLR-QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLD 86
Query: 116 ----GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
                 S +    + +V  +    L +++    + L+      L  Q+ + ++ +HS   
Sbjct: 87  VFTPATSIEDFSEVYLVTTLMGADLNNIVKC--QALSDEHVQFLVYQLLRGLKYIHS--A 142
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST----PPAGTIGYLDPCYVT 227
            IIHRD+K +NV ++ +   R+ DFGLA +   +   + +T     P   + ++      
Sbjct: 143 GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWM------ 196
Query: 228 PDNLSTKTDVFSFGILLLEIIS 249
             + +   D++S G ++ E++ 
Sbjct: 197 --HYNQTVDIWSVGCIMAELLQ 216

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL-GF 117
           ++LG G +G V +   +  Q   A+K      +  +EV+         H  R+V++    
Sbjct: 38  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL 97
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
               K  L+V+E +  G L+  +    ++         +   + +A++ LHS    I HR
Sbjct: 98  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHR 155
Query: 177 DIKSANVLIDR---NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           D+K  N+L      N   +L DFG A      N     T P  T  Y+ P  + P+    
Sbjct: 156 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDK 212
Query: 234 KTDVFSFGILLLEIISC 250
             D++S G+++  I+ C
Sbjct: 213 SCDMWSLGVIMY-ILLC 228

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 96/202 (47%), Gaps = 28/202 (13%)
Query: 63  LGKGSHGSV---YKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLL- 115
           +G G++GSV   Y A LR ++VAVKK   P ++   ++    E+ +L  +    ++ LL 
Sbjct: 36  VGSGAYGSVCSAYDARLR-QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLD 94
Query: 116 ----GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
                 S +    + +V  +    L +++    + L+      L  Q+ + ++ +HS   
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKC--QALSDEHVQFLVYQLLRGLKYIHS--A 150
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST----PPAGTIGYLDPCYVT 227
            IIHRD+K +NV ++ +   R+ DFGLA +   +   + +T     P   + ++      
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWM------ 204
Query: 228 PDNLSTKTDVFSFGILLLEIIS 249
             + +   D++S G ++ E++ 
Sbjct: 205 --HYNQTVDIWSVGCIMAELLQ 224

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 105/240 (43%), Gaps = 43/240 (17%)
Query: 47  YSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKI 106
           Y  +   +N F  +  +G+G+  SVY A  + +    +K +    I     + I I +++
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIP--TSHPIRIAAEL 70
Query: 107 HSPRLV----NLLG--FSNDSKDRLLV-VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQV 159
               +     N++G  +     D +++ + ++ + +  D+L+S    L++       L +
Sbjct: 71  QCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS----LSFQEVREYMLNL 126
Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRNFNAR-LGDFGLAL------------------ 200
            KA++ +H     I+HRD+K +N L +R      L DFGLA                   
Sbjct: 127 FKALKRIHQF--GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQ 184
Query: 201 --RCGVDNF------RFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCR 251
             RC  +        R +  P AGT G+  P  +T   N +T  D++S G++ L ++S R
Sbjct: 185 QERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL-GF 117
           ++LG G +G V +   +  Q   A+K      +  +EV+         H  R+V++    
Sbjct: 23  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL 82
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
               K  L+V+E +  G L+  +    ++         +   + +A++ LHS    I HR
Sbjct: 83  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHR 140
Query: 177 DIKSANVLIDR---NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           D+K  N+L      N   +L DFG A      N     T P  T  Y+ P  + P+    
Sbjct: 141 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDK 197
Query: 234 KTDVFSFGILLLEIISC 250
             D++S G+++  I+ C
Sbjct: 198 SCDMWSLGVIMY-ILLC 213

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 33/205 (16%)
Query: 62  LLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEILS---------KIHSPR 110
           L+GKGS G V KA  R  Q  VA+K     +    +   E+ +L          K +   
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSE 169
           L     F N     L +V  M +  LYD+L + N R ++     + A Q+  A+  L + 
Sbjct: 121 LKRHFMFRN----HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176
Query: 170 MPPIIHRDIKSANVLI--DRNFNARLGDFGLALRCGVDNF-----RFRSTPPAGTIGYLD 222
              IIH D+K  N+L+   +    ++ DFG + + G   +     RF  +P    +G   
Sbjct: 177 ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRFYRSPEV-LLG--- 232
Query: 223 PCYVTPDNLSTKTDVFSFGILLLEI 247
                P +L+   D++S G +L+E+
Sbjct: 233 ----MPYDLA--IDMWSLGCILVEM 251

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL-GF 117
           ++LG G +G V +   +  Q   A+K      +  +EV+         H  R+V++    
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL 81
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
               K  L+V+E +  G L+  +    ++         +   + +A++ LHS    I HR
Sbjct: 82  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHR 139
Query: 177 DIKSANVLIDR---NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           D+K  N+L      N   +L DFG A      N     T P  T  Y+ P  + P+    
Sbjct: 140 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTEPCYTPYYVAPEVLGPEKYDK 196
Query: 234 KTDVFSFGILLLEIISC 250
             D++S G+++  I+ C
Sbjct: 197 SCDMWSLGVIMY-ILLC 212

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 33/205 (16%)
Query: 62  LLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEILS---------KIHSPR 110
           L+GKGS G V KA  R  Q  VA+K     +    +   E+ +L          K +   
Sbjct: 42  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 101
Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSE 169
           L     F N     L +V  M +  LYD+L + N R ++     + A Q+  A+  L + 
Sbjct: 102 LKRHFMFRN----HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 157
Query: 170 MPPIIHRDIKSANVLI--DRNFNARLGDFGLALRCGVDNF-----RFRSTPPAGTIGYLD 222
              IIH D+K  N+L+   +    ++ DFG + + G   +     RF  +P    +G   
Sbjct: 158 ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRFYRSPEV-LLG--- 213
Query: 223 PCYVTPDNLSTKTDVFSFGILLLEI 247
                P +L+   D++S G +L+E+
Sbjct: 214 ----MPYDLA--IDMWSLGCILVEM 232

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 63  LGKGSHGSVYKA--VLRGRQVAVKKPSKN-QEI--SQEVDNEIEILSKIHSPRLVNLLGF 117
           +G G++GSV  A     G +VAVKK S+  Q I  ++    E+ +L  +    ++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 118 SNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
              ++      D  LV   M    L +++      L       L  Q+ + ++ +HS   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHS--A 144
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST----PPAGTIGYLDPCYVT 227
            IIHRD+K +N+ ++ +   ++ DFGLA     +   F +T     P   + ++      
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWM------ 198
Query: 228 PDNLSTKTDVFSFGILLLEIISCR 251
             + +   D++S G ++ E+++ R
Sbjct: 199 --HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL-GF 117
           ++LG G +G V +   +  Q   A+K      +  +EV+         H  R+V++    
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL 81
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
               K  L+V+E +  G L+  +    ++         +   + +A++ LHS    I HR
Sbjct: 82  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHR 139
Query: 177 DIKSANVLIDR---NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           D+K  N+L      N   +L DFG A      N     T P  T  Y+ P  + P+    
Sbjct: 140 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDK 196
Query: 234 KTDVFSFGILLLEIISC 250
             D++S G+++  I+ C
Sbjct: 197 SCDMWSLGVIMY-ILLC 212

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 58/130 (44%), Gaps = 10/130 (7%)
Query: 125 LLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANV 183
           L+V+E +  G L+  +    ++         +   + +A++ LHS    I HRD+K  N+
Sbjct: 141 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENL 198
Query: 184 LIDR---NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           L      N   +L DFG A      N     T P  T  Y+ P  + P+      D++S 
Sbjct: 199 LYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 255
Query: 241 GILLLEIISC 250
           G+++  I+ C
Sbjct: 256 GVIMY-ILLC 264

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 63  LGKGSHGSVYKA--VLRGRQVAVKKPSKN-QEI--SQEVDNEIEILSKIHSPRLVNLLGF 117
           +G G++GSV  A     G +VAVKK S+  Q I  ++    E+ +L  +    ++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 118 SNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
              ++      D  LV   M    L +++      L       L  Q+ + ++ +HS   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHS--A 144
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST----PPAGTIGYLDPCYVT 227
            IIHRD+K +N+ ++ +   ++ DFGLA     +   F +T     P   + ++      
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWM------ 198
Query: 228 PDNLSTKTDVFSFGILLLEIISCR 251
             + +   D++S G ++ E+++ R
Sbjct: 199 --HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL-GF 117
           ++LG G +G V +   +  Q   A+K      +  +EV+         H  R+V++    
Sbjct: 30  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL 89
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
               K  L+V+E +  G L+  +    ++         +   + +A++ LHS    I HR
Sbjct: 90  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHR 147
Query: 177 DIKSANVLIDR---NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           D+K  N+L      N   +L DFG A      N     T P  T  Y+ P  + P+    
Sbjct: 148 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDK 204
Query: 234 KTDVFSFGILLLEIISC 250
             D++S G+++  I+ C
Sbjct: 205 SCDMWSLGVIMY-ILLC 220

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL-GF 117
           ++LG G +G V +   +  Q   A+K      +  +EV+         H  R+V++    
Sbjct: 28  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL 87
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
               K  L+V+E +  G L+  +    ++         +   + +A++ LHS    I HR
Sbjct: 88  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHR 145
Query: 177 DIKSANVLIDR---NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           D+K  N+L      N   +L DFG A      N     T P  T  Y+ P  + P+    
Sbjct: 146 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDK 202
Query: 234 KTDVFSFGILLLEIISC 250
             D++S G+++  I+ C
Sbjct: 203 SCDMWSLGVIMY-ILLC 218

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL-GF 117
           ++LG G +G V +   +  Q   A+K      +  +EV+         H  R+V++    
Sbjct: 29  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL 88
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
               K  L+V+E +  G L+  +    ++         +   + +A++ LHS    I HR
Sbjct: 89  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHR 146
Query: 177 DIKSANVLIDR---NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           D+K  N+L      N   +L DFG A      N     T P  T  Y+ P  + P+    
Sbjct: 147 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDK 203
Query: 234 KTDVFSFGILLLEIISC 250
             D++S G+++  I+ C
Sbjct: 204 SCDMWSLGVIMY-ILLC 219

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 58/130 (44%), Gaps = 10/130 (7%)
Query: 125 LLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANV 183
           L+V+E +  G L+  +    ++         +   + +A++ LHS    I HRD+K  N+
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENL 192
Query: 184 LIDR---NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSF 240
           L      N   +L DFG A      N     T P  T  Y+ P  + P+      D++S 
Sbjct: 193 LYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249
Query: 241 GILLLEIISC 250
           G+++  I+ C
Sbjct: 250 GVIMY-ILLC 258

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL-GF 117
           ++LG G +G V +   +  Q   A+K      +  +EV+         H  R+V++    
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL 83
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
               K  L+V+E +  G L+  +    ++         +   + +A++ LHS    I HR
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHR 141
Query: 177 DIKSANVLIDR---NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           D+K  N+L      N   +L DFG A      N     T P  T  Y+ P  + P+    
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDK 198
Query: 234 KTDVFSFGILLLEIISC 250
             D++S G+++  I+ C
Sbjct: 199 SCDMWSLGVIMY-ILLC 214

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ--VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL-GF 117
           ++LG G +G V +   +  Q   A+K      +  +EV+         H  R+V++    
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL 83
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
               K  L+V+E +  G L+  +    ++         +   + +A++ LHS    I HR
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHR 141
Query: 177 DIKSANVLIDR---NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           D+K  N+L      N   +L DFG A      N     T P  T  Y+ P  + P+    
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDK 198
Query: 234 KTDVFSFGILLLEIISC 250
             D++S G+++  I+ C
Sbjct: 199 SCDMWSLGVIMY-ILLC 214

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 63  LGKGSHGSVYKA--VLRGRQVAVKKPSKN-QEI--SQEVDNEIEILSKIHSPRLVNLLGF 117
           +G G++GSV  A     G +VAVKK S+  Q I  ++    E+ +L  +    ++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 118 SNDSK------DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
              ++      D  LV   M    L +++      L       L  Q+ + ++ +HS   
Sbjct: 86  FTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHS--A 140
Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST----PPAGTIGYLDPCYVT 227
            IIHRD+K +N+ ++ +   ++ DFGLA     +   F +T     P   + ++      
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWM------ 194
Query: 228 PDNLSTKTDVFSFGILLLEIISCR 251
             + +   D++S G ++ E+++ R
Sbjct: 195 --HYNQTVDIWSVGCIMAELLTGR 216

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 83/196 (42%), Gaps = 25/196 (12%)
Query: 61  KLLGKGSHGSVYKAVLRGRQ----VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           K +G G+ G     ++R +Q    VAVK   + ++I + V  EI     +  P +V    
Sbjct: 24  KDIGSGNFGVA--RLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKE 81
Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
                    +V+E+ S G L++ + +  R      R     Q+   V   H+    + HR
Sbjct: 82  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ-QLISGVSYCHAMQ--VCHR 138
Query: 177 DIKSANVLIDRNFNARLG--DFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           D+K  N L+D +   RL   DFG +    +       + P  T+G   P Y+ P+ L  K
Sbjct: 139 DLKLENTLLDGSPAPRLKICDFGYSKSSVL------HSQPKSTVG--TPAYIAPEVLLKK 190
Query: 235 ------TDVFSFGILL 244
                  DV+S G+ L
Sbjct: 191 EYDGKVADVWSCGVTL 206

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 57  FSEQKLLGKGSHGSVYKAVLRG--RQVAVKKP--SKNQEISQEVDNEIEILSKIHSPRLV 112
           + + K LG G +G V+ AV     ++VA+KK   +  Q +   +  EI+I+ ++    +V
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIV 71
Query: 113 NLLGFSNDSKDRL--------------LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQ 158
            +      S  +L              +V E+M    L +VL     PL          Q
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVLEQG--PLLEEHARLFMYQ 128
Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLID-RNFNARLGDFGLALRCGVDNFRFRSTPPAGT 217
           + + ++ +HS    ++HRD+K AN+ I+  +   ++GDFGLA R    ++  +     G 
Sbjct: 129 LLRGLKYIHS--ANVLHRDLKPANLFINTEDLVLKIGDFGLA-RIMDPHYSHKGHLSEGL 185
Query: 218 IG--YLDP-CYVTPDNLSTKTDVFSFGILLLEIISCR 251
           +   Y  P   ++P+N +   D+++ G +  E+++ +
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 40/210 (19%)
Query: 63  LGKGSHGSVYKA--VLRGRQVAVKKPSKN-QEI--SQEVDNEIEILSKIHSPRLVNLLGF 117
           +G G++GSV  A     G +VAVKK SK  Q I  ++    E+ +L  +    ++ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIR---------LALQVAKAVEILHS 168
              ++    + EF     +Y V H     LN   + +         L  Q+ + ++ +HS
Sbjct: 102 FTPARS---LEEF---NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-CYVT 227
               IIHRD+K +N+ ++ +   ++ DFGLA          R T    T GY+    Y  
Sbjct: 156 --ADIIHRDLKPSNLAVNEDCELKILDFGLA----------RHTDDEMT-GYVATRWYRA 202
Query: 228 PD------NLSTKTDVFSFGILLLEIISCR 251
           P+      + +   D++S G ++ E+++ R
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	487
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-99
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-98
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	9e-94
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-74
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-65
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-61
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-59
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-59
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-57
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-55
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-55
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-54
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-52
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-38
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-36
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-34
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-32
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-32
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-32
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-32
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-32
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-32
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-32
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-31
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-31
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-31
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-31
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-31
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-30
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-30
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-30
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-30
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-30
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-30
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-30
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-29
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-29
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-29
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-29
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-29
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-28
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-28
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-28
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-28
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-28
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-28
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-28
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-27
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-27
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-27
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-27
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-27
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-27
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-27
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-27
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-26
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-26
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-26
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-26
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-26
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-26
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-25
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-25
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-25
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-24
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-05
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-22
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-20
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-20
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-20
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-20
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-20
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-20
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-20
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-20
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-19
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-19
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-19
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-19
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-18
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-16
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-14
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-08
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-06

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  301 bits (772), Expect = 2e-99
 Identities = 101/293 (34%), Positives = 160/293 (54%), Gaps = 12/293 (4%)

Query: 42  IQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKN--QEISQEVDN 98
           ++ F   +L+ A++ FS + +LG+G  G VYK  L  G  VAVK+  +   Q    +   
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 99  EIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH---SNNRPLNWGRRIRL 155
           E+E++S      L+ L GF     +RLLV  +M+NG++   L     +  PL+W +R R+
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 156 ALQVAKAVEILHSEM-PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPP 214
           AL  A+ +  LH    P IIHRD+K+AN+L+D  F A +GDFGLA +         +T  
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAV 195

Query: 215 AGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS----IVDWAAPL 270
            GTIG++ P Y++    S KTDVF +G++LLE+I+ ++A D+          ++DW   L
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255

Query: 271 IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG 323
           +K+ K+ ++ D  +         +QL  +A+ C +S    RP M E+V  L G
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  298 bits (765), Expect = 2e-98
 Identities = 102/317 (32%), Positives = 164/317 (51%), Gaps = 11/317 (3%)

Query: 19  SNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR- 77
           S       + +   S     P +       DLE ATN F  + L+G G  G VYK VLR 
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 78  GRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGT 135
           G +VA+K   P  +Q I +E + EIE LS    P LV+L+GF ++  + +L+ ++M NG 
Sbjct: 63  GAKVALKRRTPESSQGI-EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121

Query: 136 LYDVLH---SNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNAR 192
           L   L+        ++W +R+ + +  A+ +  LH+    IIHRD+KS N+L+D NF  +
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPK 179

Query: 193 LGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRK 252
           + DFG++ +    +    ST   GT+GY+DP Y     L+ K+DV+SFG++L E++  R 
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

Query: 253 AIDIGFSP--PSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRER 310
           AI         ++ +WA      G++  + DP +     P   ++    AV+C+    E 
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299

Query: 311 RPSMKEIVDWLTGLSKL 327
           RPSM +++  L    +L
Sbjct: 300 RPSMGDVLWKLEYALRL 316

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  285 bits (733), Expect = 9e-94
 Identities = 92/306 (30%), Positives = 151/306 (49%), Gaps = 22/306 (7%)

Query: 36  QEKPIKIQHFDYSDLEAATNGFSEQK------LLGKGSHGSVYKAVLRGRQVAVKKPSKN 89
           +    +   F + +L+  TN F E+        +G+G  G VYK  +    VAVKK +  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAM 65

Query: 90  QEIS-----QEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH--S 142
            +I+     Q+ D EI++++K     LV LLGFS+D  D  LV  +M NG+L D L    
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125

Query: 143 NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC 202
              PL+W  R ++A   A  +  LH      IHRDIKSAN+L+D  F A++ DFGLA   
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISDFGLARAS 183

Query: 203 GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS 262
                   ++   GT  Y+ P  +    ++ K+D++SFG++LLEII+   A+D    P  
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242

Query: 263 IVDWAAPLIK-KGKILSVFDPRIP--PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           ++D    +   +  I    D ++           + +  +A +C+   + +RP +K++  
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSV---EAMYSVASQCLHEKKNKRPDIKKVQQ 299

Query: 320 WLTGLS 325
            L  ++
Sbjct: 300 LLQEMT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  236 bits (603), Expect = 3e-74
 Identities = 72/315 (22%), Positives = 122/315 (38%), Gaps = 39/315 (12%)

Query: 44  HFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEIL 103
                +L   +      ++  +G  G V+KA L    VAVK      + S + + E+  L
Sbjct: 13  DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSL 72

Query: 104 SKIHSPRLVNLLGFS----NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQV 159
             +    ++  +G      +   D  L+  F   G+L D L +N   ++W     +A  +
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETM 130

Query: 160 AKAVEILHSEM--------PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS 211
           A+ +  LH ++        P I HRDIKS NVL+  N  A + DFGLAL+         +
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190

Query: 212 TPPAGTIGYLDPCYV-----TPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP------ 260
               GT  Y+ P  +        +   + D+++ G++L E+ S   A D           
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250

Query: 261 ------PSIVDWAAPLIKKGKILSVFDPRIPP--PKDPIVRKQLAVIAVRCVRSCRERRP 312
                 PS+ D    ++ K K      P +     K   +   L      C     E R 
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKK-----RPVLRDYWQKHAGMAM-LCETIEECWDHDAEARL 304

Query: 313 SMKEIVDWLTGLSKL 327
           S   + + +T + +L
Sbjct: 305 SAGCVGERITQMQRL 319

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  211 bits (539), Expect = 6e-65
 Identities = 86/307 (28%), Positives = 145/307 (47%), Gaps = 20/307 (6%)

Query: 25  HQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVK 84
           H   S       E        D  D++      + ++ +G GS G+V++A   G  VAVK
Sbjct: 7   HHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVK 66

Query: 85  K---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH 141
                  + E   E   E+ I+ ++  P +V  +G      +  +V E++S G+LY +LH
Sbjct: 67  ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH 126

Query: 142 SNN--RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
            +     L+  RR+ +A  VAK +  LH+  PPI+HR++KS N+L+D+ +  ++ DFGL+
Sbjct: 127 KSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186

Query: 200 LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFS 259
                 +    S   AGT  ++ P  +  +  + K+DV+SFG++L E+ + ++      +
Sbjct: 187 --RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG-NLN 243

Query: 260 PPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
           P  +V        K K        IP   +P    Q+A I   C  +   +RPS   I+D
Sbjct: 244 PAQVVAAVG---FKCK-----RLEIPRNLNP----QVAAIIEGCWTNEPWKRPSFATIMD 291

Query: 320 WLTGLSK 326
            L  L K
Sbjct: 292 LLRPLIK 298

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  202 bits (515), Expect = 9e-62
 Identities = 58/290 (20%), Positives = 107/290 (36%), Gaps = 36/290 (12%)

Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKK---PSKNQEISQEVDNEIEI 102
           D+  L            L +   G ++K   +G  + VK       +   S++ + E   
Sbjct: 8   DFKQLN-------FLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPR 60

Query: 103 LSKIHSPRLVNLLGFSNDSKDRLL--VVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQV 159
           L     P ++ +LG            +  +M  G+LY+VLH   N  ++  + ++ AL +
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120

Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG 219
           A+ +  LH+  P I    + S +V+ID +  AR+    +        F F+S        
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPA 173

Query: 220 YLDP---CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI 276
           ++ P        D      D++SF +LL E+++         S   I    A    +G  
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA-DLSNMEIGMKVA---LEGL- 228

Query: 277 LSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
                 R   P    +   ++ +   C+     +RP    IV  L  +  
Sbjct: 229 ------RPTIPPG--ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  202 bits (516), Expect = 1e-61
 Identities = 86/288 (29%), Positives = 137/288 (47%), Gaps = 31/288 (10%)

Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSK 105
           DY ++E        ++++G+G+ G V KA  R + VA+K+  +++   +    E+  LS+
Sbjct: 6   DYKEIE-------VEEVVGRGAFGVVCKAKWRAKDVAIKQI-ESESERKAFIVELRQLSR 57

Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP--LNWGRRIRLALQVAKAV 163
           ++ P +V L G         LV+E+   G+LY+VLH             +   LQ ++ V
Sbjct: 58  VNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115

Query: 164 EILHSEMP-PIIHRDIKSANVLIDRNFN-ARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
             LHS  P  +IHRD+K  N+L+       ++ DFG A  C +       T   G+  ++
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA--CDIQT---HMTNNKGSAAWM 170

Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD 281
            P      N S K DVFS+GI+L E+I+ RK  D    P   + WA   +  G       
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA---VHNGT------ 221

Query: 282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
            R P  K+  + K +  +  RC      +RPSM+EIV  +T L +  P
Sbjct: 222 -RPPLIKN--LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  199 bits (507), Expect = 7e-60
 Identities = 69/323 (21%), Positives = 124/323 (38%), Gaps = 42/323 (13%)

Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEI-- 102
              S+     +     +L+G+G +G+VYK  L  R VAVK  S      Q   NE  I  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR--QNFINEKNIYR 60

Query: 103 LSKIHSPRLVNLLGFS-----NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL 157
           +  +    +   +        +   + LLV+E+  NG+L   L  +    +W    RLA 
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAH 118

Query: 158 QVAKAVEILHSEM-------PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR 210
            V + +  LH+E+       P I HRD+ S NVL+  +    + DFGL++R   +     
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178

Query: 211 ------STPPAGTIGYLDP-------CYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDI 256
                 +    GTI Y+ P            ++   + D+++ G++  EI   C      
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238

Query: 257 GFSPPSIVDWAA-----PLIKKGKILSVFD---PRIPP--PKDPIVRKQLAVIAVRCVRS 306
              P   + +       P  +  ++L   +   P+ P    ++ +  + L      C   
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298

Query: 307 CRERRPSMKEIVDWLTGLSKLVP 329
             E R + +   + +  L  +  
Sbjct: 299 DAEARLTAQXAEERMAELMMIWE 321

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  196 bits (500), Expect = 2e-59
 Identities = 75/302 (24%), Positives = 131/302 (43%), Gaps = 54/302 (17%)

Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVL--RGRQVAVKK--------PSKNQEISQE 95
             +++E        +K +GKG  G V+K  L      VA+K          ++  E  QE
Sbjct: 17  ADNEIE-------YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE 69

Query: 96  VDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRL 155
              E+ I+S ++ P +V L G  ++     +V+EF+  G LY  L     P+ W  ++RL
Sbjct: 70  FQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL 127

Query: 156 ALQVAKAVEILHSEMPPIIHRDIKSANVLID-----RNFNARLGDFGLALRCGVDNFRFR 210
            L +A  +E + ++ PPI+HRD++S N+ +          A++ DFGL+ +  V +    
Sbjct: 128 MLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-QQSVHS---- 182

Query: 211 STPPAGTIGYLDP--------CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS 262
            +   G   ++ P         Y      + K D +SF ++L  I++     D  +S   
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESY------TEKADTYSFAMILYTILTGEGPFD-EYSYGK 235

Query: 263 IVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT 322
           I  +   + ++G       P IP    P    +L  +   C     ++RP    IV  L+
Sbjct: 236 I-KFINMIREEGL-----RPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELS 285

Query: 323 GL 324
            L
Sbjct: 286 EL 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  196 bits (500), Expect = 4e-59
 Identities = 74/345 (21%), Positives = 133/345 (38%), Gaps = 53/345 (15%)

Query: 9   ESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSH 68
           E  +S++S  + S     +Q+S   Q+ +    I    +  LE         +L+GKG  
Sbjct: 3   EMNLSLLS--ARSFPRKASQTSIFLQEWD----I---PFEQLE-------IGELIGKGRF 46

Query: 69  GSVYKAVLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL 125
           G VY     G +VA++       N++  +    E+    +     +V  +G         
Sbjct: 47  GQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105

Query: 126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI 185
           ++       TLY V+      L+  +  ++A ++ K +  LH+    I+H+D+KS NV  
Sbjct: 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFY 163

Query: 186 DRNFNARLGDFGLA---LRCGVDNFRFRSTPPAGTIGYLDP---CYVTPDNL------ST 233
           D N    + DFGL              +     G + +L P     ++PD        S 
Sbjct: 164 D-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSK 222

Query: 234 KTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR 293
            +DVF+ G +  E+ +            +I+ W    +  G       P +         
Sbjct: 223 HSDVFALGTIWYELHAREWPFK-TQPAEAII-WQ---MGTGM-----KPNLSQIGMG--- 269

Query: 294 KQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLV-----PLHSW 333
           K+++ I + C    +E RP+  +++D L  L K       P H W
Sbjct: 270 KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  192 bits (491), Expect = 4e-58
 Identities = 66/288 (22%), Positives = 130/288 (45%), Gaps = 28/288 (9%)

Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKK---PSKNQEISQEVDNEIEI 102
               +          + +G GS G+VYK    G  VAVK     +   +  Q   NE+ +
Sbjct: 22  PDGQIT-------VGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGV 73

Query: 103 LSKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK 161
           L K     ++  +G+S  +  +L +V ++    +LY  LH++       + I +A Q A+
Sbjct: 74  LRKTRHVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131

Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
            ++ LH+    IIHRD+KS N+ +  +   ++GDFGLA      +   +    +G+I ++
Sbjct: 132 GMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189

Query: 222 DP---CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILS 278
            P        +  S ++DV++FGI+L E+++ +       +    +      + +G  LS
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEM---VGRGS-LS 244

Query: 279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
               ++          ++  +   C++  R+ RPS   I+  +  L++
Sbjct: 245 PDLSKVRSNCPK----RMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  183 bits (467), Expect = 8e-55
 Identities = 77/293 (26%), Positives = 128/293 (43%), Gaps = 40/293 (13%)

Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVK--KPSKNQEISQ---EVDNEI 100
           D+++L         ++++G G  G VY+A   G +VAVK  +   +++ISQ    V  E 
Sbjct: 5   DFAELT-------LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEA 57

Query: 101 EILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVA 160
           ++ + +  P ++ L G      +  LV+EF   G L  VL    + +     +  A+Q+A
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIA 115

Query: 161 KAVEILHSEMP-PIIHRDIKSANVLIDR--------NFNARLGDFGLALRCGVDNFRFRS 211
           + +  LH E   PIIHRD+KS+N+LI +        N   ++ DFGLA           S
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA--REWHRTTKMS 173

Query: 212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI 271
              AG   ++ P  +     S  +DV+S+G+LL E+++       G    ++    A   
Sbjct: 174 A--AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR-GIDGLAVAYGVA--- 227

Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
                       +P P      +  A +   C       RPS   I+D LT +
Sbjct: 228 MNKL-------ALPIPST--CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  185 bits (471), Expect = 1e-54
 Identities = 70/324 (21%), Positives = 121/324 (37%), Gaps = 34/324 (10%)

Query: 28  QSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPS 87
           QS  +      P+ +Q      ++         K +GKG +G V+    RG +VAVK   
Sbjct: 17  QSQSSGSGSGLPLLVQRTIAKQIQ-------MVKQIGKGRYGEVWMGKWRGEKVAVKVFF 69

Query: 88  KNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR----LLVVEFMSNGTLYDVLHSN 143
             +E S   + EI     +    ++  +              L+ ++  NG+LYD L S 
Sbjct: 70  TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST 129

Query: 144 NRPLNWGRRIRLALQVAKAVEILHSEM------PPIIHRDIKSANVLIDRNFNARLGDFG 197
              L+    ++LA      +  LH+E+      P I HRD+KS N+L+ +N    + D G
Sbjct: 130 --TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187

Query: 198 LALRC--GVDNFRFRSTPPAGTIGY-----LDPCYVTPDNLST-KTDVFSFGILLLEIIS 249
           LA++     +          GT  Y     LD         S    D++SFG++L E+  
Sbjct: 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR 247

Query: 250 CRKAIDIGFS---PPSIVDWAAPLIKKGKILSVFD---PRIPP-PKDPIVRKQLAVIAVR 302
              +  I      P   +  + P  +  + +       P  P         +Q+  +   
Sbjct: 248 RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE 307

Query: 303 CVRSCRERRPSMKEIVDWLTGLSK 326
           C       R +   +   L  +S+
Sbjct: 308 CWAHNPASRLTALRVKKTLAKMSE 331

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  180 bits (460), Expect = 3e-53
 Identities = 78/299 (26%), Positives = 119/299 (39%), Gaps = 40/299 (13%)

Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSK-NQEISQEVDNEIE 101
           F  SDL          ++LGKG  G   K   R  G  + +K+  + ++E  +    E++
Sbjct: 7   FRPSDLI-------HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVK 59

Query: 102 ILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK 161
           ++  +  P ++  +G     K    + E++  GTL  ++ S +    W +R+  A  +A 
Sbjct: 60  VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119

Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
            +  LHS    IIHRD+ S N L+  N N  + DFGLA R  VD         +      
Sbjct: 120 GMAYLHSM--NIIHRDLNSHNCLVRENKNVVVADFGLA-RLMVDEKTQPEGLRSLKKPDR 176

Query: 222 DPCYVTPDNL-------------STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA 268
              Y    N                K DVFSFGI+L EII  R   D  + P ++     
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG-RVNADPDYLPRTMD--FG 233

Query: 269 PLIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
             ++              P + P        I VRC     E+RPS  ++  WL  L  
Sbjct: 234 LNVRGFL-------DRYCPPNCP---PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  180 bits (458), Expect = 4e-53
 Identities = 70/291 (24%), Positives = 117/291 (40%), Gaps = 29/291 (9%)

Query: 60  QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLG--- 116
            + +GKG +G V++   +G  VAVK  S   E S   + E+     +    ++  +    
Sbjct: 13  LECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72

Query: 117 -FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM----- 170
              + S    L+  +   G+LYD L      L+    +R+ L +A  +  LH E+     
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130

Query: 171 -PPIIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDNFRFRSTPPAGTIGYLDP---- 223
            P I HRD+KS N+L+ +N    + D GLA+      +     + P  GT  Y+ P    
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190

Query: 224 --CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFS---PPSIVDWAAPLIKKGKILS 278
               V   +   + D+++FG++L E+     +  I      P   V    P  +  + + 
Sbjct: 191 ETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV 250

Query: 279 VFD---PRIPP--PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
             D   P IP     DP +   LA +   C       R +   I   LT +
Sbjct: 251 CVDQQRPNIPNRWFSDPTLTS-LAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  179 bits (456), Expect = 2e-52
 Identities = 71/292 (24%), Positives = 118/292 (40%), Gaps = 27/292 (9%)

Query: 60  QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLG--- 116
           Q+ +GKG  G V++   RG +VAVK  S  +E S   + EI     +    ++  +    
Sbjct: 47  QESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106

Query: 117 -FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM----- 170
             +       LV ++  +G+L+D L+     +     I+LAL  A  +  LH E+     
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQG 164

Query: 171 -PPIIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDNFRFRSTPPAGTIGY-----LD 222
            P I HRD+KS N+L+ +N    + D GLA+R     D          GT  Y     LD
Sbjct: 165 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 224

Query: 223 PCYVTPDNLST-KTDVFSFGILLLEIISCRKAIDIGFS---PPSIVDWAAPLIKKGKILS 278
                    S  + D+++ G++  EI        I      P   +  + P +++ + + 
Sbjct: 225 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 284

Query: 279 VFD---PRIPPPKDPI-VRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
                 P IP         + +A I   C  +    R +   I   L+ LS+
Sbjct: 285 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  139 bits (352), Expect = 7e-38
 Identities = 74/291 (25%), Positives = 125/291 (42%), Gaps = 47/291 (16%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           F E  +LG+G+ G V KA      R  A+KK    +E    + +E+ +L+ ++   +V  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67

Query: 115 LGFSNDSKDRL-------------LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK 161
                + ++ +             + +E+  NGTLYD++HS N         RL  Q+ +
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127

Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIG 219
           A+  +HS+   IIHRD+K  N+ ID + N ++GDFGLA  +   +D  +  S    G+  
Sbjct: 128 ALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185

Query: 220 YLD-----PCYVTPDNLS------TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA 268
            L        YV  + L        K D++S GI+  E+I         FS     +   
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-------PFSTGM--ERVN 236

Query: 269 PL--IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
            L  ++   I   F P     K  + +K   +I    +     +RP  + +
Sbjct: 237 ILKKLRSVSI--EFPPDFDDNKMKVEKK---IIR-LLIDHDPNKRPGARTL 281

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  138 bits (349), Expect = 1e-36
 Identities = 64/281 (22%), Positives = 113/281 (40%), Gaps = 39/281 (13%)

Query: 60  QKLLGKGSHGSVYKAVLRGR--QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
            + +G+G+ G V+   LR     VAVK  + +   ++  +   E  IL +   P +V L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
           G     +   +V+E +  G     L +    L     +++    A  +E L S+    IH
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK--CCIH 236

Query: 176 RDIKSANVLIDRNFNARLGDFGLA---------LRCGVDNFRFRSTPPAGTIGYLDPCYV 226
           RD+ + N L+      ++ DFG++            G+     + T P   + Y      
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE-ALNY------ 289

Query: 227 TPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP 286
                S+++DV+SFGILL E  S   +     S     ++    ++KG        R+P 
Sbjct: 290 --GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF----VEKGG-------RLPC 336

Query: 287 PKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
           P+  P     +  +  +C      +RPS   I   L  + K
Sbjct: 337 PELCP---DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  135 bits (342), Expect = 2e-36
 Identities = 64/266 (24%), Positives = 112/266 (42%), Gaps = 28/266 (10%)

Query: 61  KLLGKGSHGSVYKAV--LRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
             +G+GS  +VYK +      +VA  +       +   Q    E E+L  +  P +V   
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 116 GF---SNDSKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
                +   K  +++V E M++GTL   L    + +          Q+ K ++ LH+  P
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTP 150

Query: 172 PIIHRDIKSANVLID-RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
           PIIHRD+K  N+ I     + ++GD GLA    +    F      GT  ++ P     + 
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKA-VIGTPEFMAPEMYE-EK 205

Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP 290
                DV++FG+ +LE+ +          P S    AA + ++     V     P   D 
Sbjct: 206 YDESVDVYAFGMCMLEMATSEY-------PYSECQNAAQIYRR-----VTSGVKPASFDK 253

Query: 291 IVRKQLAVIAVRCVRSCRERRPSMKE 316
           +   ++  I   C+R  ++ R S+K+
Sbjct: 254 VAIPEVKEIIEGCIRQNKDERYSIKD 279

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  130 bits (329), Expect = 1e-34
 Identities = 61/280 (21%), Positives = 116/280 (41%), Gaps = 46/280 (16%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           F E +L+G G  G V+KA  R  G+   +K+   N   +++ + E++ L+K+    +V+ 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKAEREVKALAKLDHVNIVHY 69

Query: 115 LGFSNDSKDRL----------------LVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLAL 157
            G  +                      + +EF   GTL   +       L+    + L  
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129

Query: 158 QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGT 217
           Q+ K V+ +HS+   +I+RD+K +N+ +      ++GDFGL      D  R RS    GT
Sbjct: 130 QITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK---GT 184

Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKIL 277
           + Y+ P  ++  +   + D+++ G++L E++                      ++ G I 
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLH-------VCDTAFETSKFFTDLRDGIIS 237

Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
            +FD             +   +  + +    E RP+  EI
Sbjct: 238 DIFDK------------KEKTLLQKLLSKKPEDRPNTSEI 265

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  128 bits (324), Expect = 7e-34
 Identities = 59/289 (20%), Positives = 106/289 (36%), Gaps = 46/289 (15%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           F   + LG+G  G V++A  +      A+K+      +   ++V  E++ L+K+  P +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 113 ----------NLLGFSNDSKDRLL--VVEFMSNGTLYDVLHSNNR--PLNWGRRIRLALQ 158
                             S    L   ++      L D ++             + + LQ
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126

Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTI 218
           +A+AVE LHS+   ++HRD+K +N+    +   ++GDFGL      D        P    
Sbjct: 127 IAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184

Query: 219 GYLD-----PCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA 268
                      Y++P+ +     S K D+FS G++L E++         FS         
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-------YPFSTQMERVRTL 237

Query: 269 PLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
             ++  K      P +   K P       ++    +      RP    I
Sbjct: 238 TDVRNLKF-----PPLFTQKYPCEYV---MVQ-DMLSPSPMERPEAINI 277

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  128 bits (324), Expect = 1e-33
 Identities = 65/316 (20%), Positives = 107/316 (33%), Gaps = 42/316 (13%)

Query: 16  STNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNG---FSEQKLLGKGSHGSVY 72
           + N    + HQ Q  + S + E    +Q   Y      +     F     LG GS+G V+
Sbjct: 15  TENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVF 74

Query: 73  KAVLR--GRQVAVKKPSKNQEISQEVD---NEIEILSKI-HSPRLVNLLGFSNDSKDRL- 125
           K   +  GR  AVK+        ++      E+    K+   P  V L   + +    L 
Sbjct: 75  KVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ-AWEEGGILY 133

Query: 126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI 185
           L  E     +L     +    L   +          A+  LHS+   ++H D+K AN+ +
Sbjct: 134 LQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ--GLVHLDVKPANIFL 190

Query: 186 DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP----DNLSTKTDVFSFG 241
                 +LGDFGL +   +              G  DP Y+ P     +  T  DVFS G
Sbjct: 191 GPRGRCKLGDFGLLVE--LGTAGAGEV----QEG--DPRYMAPELLQGSYGTAADVFSLG 242

Query: 242 ILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAV 301
           + +LE+             P   +    L +         P         +R  L     
Sbjct: 243 LTILEVAC-------NMELPHGGEGWQQLRQG-----YLPPEFTAGLSSELRSVLV---- 286

Query: 302 RCVRSCRERRPSMKEI 317
             +    + R + + +
Sbjct: 287 MMLEPDPKLRATAEAL 302

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  127 bits (321), Expect = 3e-33
 Identities = 60/335 (17%), Positives = 114/335 (34%), Gaps = 50/335 (14%)

Query: 18  NSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKA--V 75
            S+    H +   +    Q   + I +  Y             + LG+G    V     +
Sbjct: 2   GSSHHHHHHSSGRENLYFQGHMVIIDNKHYL----------FIQKLGEGGFSYVDLVEGL 51

Query: 76  LRGRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR----LLVVEF 130
             G   A+K+     Q+  +E   E ++    + P ++ L+ +    +       L++ F
Sbjct: 52  HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF 111

Query: 131 MSNGTLYDVLHSNNRPLNWGRRI------RLALQVAKAVEILHSEMPPIIHRDIKSANVL 184
              GTL++ +    R  + G  +       L L + + +E +H+      HRD+K  N+L
Sbjct: 112 FKRGTLWNEI---ERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNIL 166

Query: 185 IDRNFNARLGDFGLA--LRCGVDNFRFRSTPPA-----GTIGYLDP--CYVTP-DNLSTK 234
           +       L D G        V+  R   T         TI Y  P    V     +  +
Sbjct: 167 LGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER 226

Query: 235 TDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRK 294
           TDV+S G +L  ++         +        +  L  + +        +  P+ P    
Sbjct: 227 TDVWSLGCVLYAMMFGEGP----YDMVFQKGDSVALAVQNQ--------LSIPQSPRHSS 274

Query: 295 QLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
            L  +    +     +RP +  ++  L  L    P
Sbjct: 275 ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (325), Expect = 5e-33
 Identities = 69/313 (22%), Positives = 123/313 (39%), Gaps = 36/313 (11%)

Query: 28  QSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKA-VLRGRQVAVKKP 86
            SS + ++ +   +        +      F  + +LG G+ G++    +   R VAVK+ 
Sbjct: 2   GSSPSLEQDDGDEETSVVIVGKIS-----FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI 56

Query: 87  SKNQEISQEVDNEIEILSKI--HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN 144
                     D E+++L +   H P ++       D + + + +E  +  TL + +   +
Sbjct: 57  LPECF--SFADREVQLLRESDEH-PNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKD 112

Query: 145 RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI-----DRNFNARLGDFGLA 199
                   I L  Q    +  LHS    I+HRD+K  N+LI          A + DFGL 
Sbjct: 113 FAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170

Query: 200 LRCGVDNFRF-RSTPPAGTIGYLDPCYVTPD---NLSTKTDVFSFGILLLEIISCRKAID 255
            +  V    F R +   GT G++ P  ++ D   N +   D+FS G +   +IS      
Sbjct: 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS------ 224

Query: 256 IGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMK 315
            G  P          I  G      D   P   + ++ ++L  I  + +    ++RPS K
Sbjct: 225 EGSHPFGKSLQRQANILLGA--CSLDCLHPEKHEDVIAREL--IE-KMIAMDPQKRPSAK 279

Query: 316 EIVD--WLTGLSK 326
            ++   +   L K
Sbjct: 280 HVLKHPFFWSLEK 292

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  124 bits (314), Expect = 1e-32
 Identities = 70/274 (25%), Positives = 119/274 (43%), Gaps = 29/274 (10%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           +     +G GS+G   K   +  G+ +  K+    S  +   Q + +E+ +L ++  P +
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 112 VNLLG-FSNDSKDRLLVV-EFMSNGTLYDVL---HSNNRPLNWGRRIRLALQVAKAVEIL 166
           V       + +   L +V E+   G L  V+       + L+    +R+  Q+  A++  
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127

Query: 167 HSEMPP---IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           H        ++HRD+K ANV +D   N +LGDFGLA R    +  F  T   GT  Y+ P
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA-RILNHDTSFAKT-FVGTPYYMSP 185

Query: 224 CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR 283
             +   + + K+D++S G LL E+ +        FS   +       I++GK       R
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAG----KIREGKF-----RR 235

Query: 284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
           IP         +L  I  R +      RPS++EI
Sbjct: 236 IP----YRYSDELNEIITRMLNLKDYHRPSVEEI 265

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  124 bits (314), Expect = 2e-32
 Identities = 63/298 (21%), Positives = 118/298 (39%), Gaps = 52/298 (17%)

Query: 60  QKLLGKGSHGSVYKAVLRGRQ------VAVK--KPSKNQEISQEVDNEIEILSKIHSPRL 111
            + LG+G  G V               VAVK  KP        ++  EIEIL  ++   +
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 112 VNLLGFSNDSKDR--LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V   G   +       L++EF+ +G+L + L  N   +N  ++++ A+Q+ K ++ L S 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRS--------TPPAGTIG 219
               +HRD+ + NVL++     ++GDFGL   +    + +  +           P   + 
Sbjct: 146 Q--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC-LM 202

Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAP--------- 269
                          +DV+SFG+ L E+++ C            ++              
Sbjct: 203 Q--------SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254

Query: 270 LIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
            +K+GK       R+P P + P    ++  +  +C       R S + +++    L K
Sbjct: 255 TLKEGK-------RLPCPPNCP---DEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  125 bits (316), Expect = 2e-32
 Identities = 55/274 (20%), Positives = 113/274 (41%), Gaps = 34/274 (12%)

Query: 55  NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSP 109
             +   + +G+GS G          GRQ  +K+      + +  +E   E+ +L+ +  P
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVL-HSNNRPLNWGRRIRLALQVAKAVEILHS 168
            +V       ++    +V+++   G L+  +           + +   +Q+  A++ +H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               I+HRDIKS N+ + ++   +LGDFG+A R              GT     P Y++P
Sbjct: 144 RK--ILHRDIKSQNIFLTKDGTVQLGDFGIA-RVLNSTVELARA-CIGT-----PYYLSP 194

Query: 229 DNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR 283
           +       + K+D+++ G +L E+ + + A +   S  ++V      I  G       P 
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHAFE-AGSMKNLVL----KIISGSF-----PP 244

Query: 284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
           +       +R  ++    +  +     RPS+  I
Sbjct: 245 VSLHYSYDLRSLVS----QLFKRNPRDRPSVNSI 274

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  123 bits (312), Expect = 3e-32
 Identities = 64/296 (21%), Positives = 121/296 (40%), Gaps = 52/296 (17%)

Query: 60  QKLLGKGSHGSVYKAVLRGRQ------VAVK--KPSKNQEISQEVDNEIEILSKIHSPRL 111
            + LGKG+ GSV        Q      VAVK  + S  + + ++ + EIEIL  +    +
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL-RDFEREIEILKSLQHDNI 73

Query: 112 VNLLGFSNDSKDR--LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V   G    +  R   L++E++  G+L D L  +   ++  + ++   Q+ K +E L ++
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG---------TIGY 220
               IHRD+ + N+L++     ++GDFGL      D   F+   P           ++  
Sbjct: 134 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191

Query: 221 LDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP----------- 269
                      S  +DV+SFG++L E+ +  +      +    +                
Sbjct: 192 --------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243

Query: 270 LIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           L+K          R+P P   P    ++ +I   C  +   +RPS +++   +  +
Sbjct: 244 LLKNNG-------RLPRPDGCP---DEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  126 bits (319), Expect = 5e-32
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 21/265 (7%)

Query: 60  QKLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           +  LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRP-LNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
           ++ +   +V E+MS G+L D L       L   + + +A Q+A  +  +       +HRD
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRD 305

Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 306 LRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364

Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD-PIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P P + P   + L
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 410

Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFL 435

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  127 bits (320), Expect = 6e-32
 Identities = 73/295 (24%), Positives = 126/295 (42%), Gaps = 25/295 (8%)

Query: 33  SQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ--VAVK--KPSK 88
            ++ +  I     +Y   E      + +  LG G +G VY+ V +     VAVK  K   
Sbjct: 198 PKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT 257

Query: 89  NQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PL 147
            +   +E   E  ++ +I  P LV LLG         ++ EFM+ G L D L   NR  +
Sbjct: 258 MEV--EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 315

Query: 148 NWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF 207
           +    + +A Q++ A+E L  +    IHR++ + N L+  N   ++ DFGL+ R    + 
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLS-RLMTGDT 372

Query: 208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA 267
                     I +  P  +  +  S K+DV++FG+LL EI +   +   G     + +  
Sbjct: 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-- 430

Query: 268 APLIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
             L++K         R+  P+  P   +++  +   C +     RPS  EI    
Sbjct: 431 --LLEKDY-------RMERPEGCP---EKVYELMRACWQWNPSDRPSFAEIHQAF 473

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  126 bits (318), Expect = 6e-32
 Identities = 78/302 (25%), Positives = 123/302 (40%), Gaps = 33/302 (10%)

Query: 27  TQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKP 86
           T+  K    +        F  S            + +GKG  G V     RG +VAVK  
Sbjct: 165 TRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKC- 223

Query: 87  SKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNR 145
            KN   +Q    E  +++++    LV LLG   + K  L +V E+M+ G+L D L S  R
Sbjct: 224 IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 283

Query: 146 -PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRC 202
             L     ++ +L V +A+E L       +HRD+ + NVL+  +  A++ DFGL      
Sbjct: 284 SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341

Query: 203 GVDNFRF--RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP 260
             D  +   + T P   +             STK+DV+SFGILL EI S  +        
Sbjct: 342 TQDTGKLPVKWTAPEA-LRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392

Query: 261 PSIVDWAAPLIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
             +V      ++KG        ++  P   P     +  +   C       RP+  ++ +
Sbjct: 393 KDVVP----RVEKGY-------KMDAPDGCP---PAVYDVMKNCWHLDAATRPTFLQLRE 438

Query: 320 WL 321
            L
Sbjct: 439 QL 440

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  123 bits (311), Expect = 8e-32
 Identities = 63/296 (21%), Positives = 121/296 (40%), Gaps = 52/296 (17%)

Query: 60  QKLLGKGSHGSVYKAVLRGRQ------VAVK--KPSKNQEISQEVDNEIEILSKIHSPRL 111
            + LGKG+ GSV        Q      VAVK  + S  + + ++ + EIEIL  +    +
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL-RDFEREIEILKSLQHDNI 104

Query: 112 VNLLGFSNDSKDR--LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V   G    +  R   L++E++  G+L D L  +   ++  + ++   Q+ K +E L ++
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAG---------TIGY 220
               IHRD+ + N+L++     ++GDFGL      D   ++   P           ++  
Sbjct: 165 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 222

Query: 221 LDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP----------- 269
                      S  +DV+SFG++L E+ +  +      +    +                
Sbjct: 223 --------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274

Query: 270 LIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           L+K          R+P P   P    ++ +I   C  +   +RPS +++   +  +
Sbjct: 275 LLKNNG-------RLPRPDGCP---DEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  123 bits (310), Expect = 2e-31
 Identities = 42/262 (16%), Positives = 93/262 (35%), Gaps = 54/262 (20%)

Query: 15  ISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKA 74
           + +  + ++ +          +EK   I  +               + L +G    +   
Sbjct: 3   LGSMKDILSNYSNLIYLNKYVKEKDKYINDYRI------------IRTLNQGKFNKIILC 50

Query: 75  VLRGRQVAVKKPSKNQ------------------EISQEVDNEIEILSKIHSPRLVNLLG 116
               +  A+KK  K+                       +  NE++I++ I +   +   G
Sbjct: 51  EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRR-------IRLALQVAKAVEILHSE 169
              +  +  ++ E+M N ++                         +   V  +   +H+E
Sbjct: 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
              I HRD+K +N+L+D+N   +L DFG +    + + + + +   GT       ++ P+
Sbjct: 171 KN-ICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDKKIKGS--RGT-----YEFMPPE 220

Query: 230 NLSTKT-------DVFSFGILL 244
             S ++       D++S GI L
Sbjct: 221 FFSNESSYNGAKVDIWSLGICL 242

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  119 bits (302), Expect = 5e-31
 Identities = 69/280 (24%), Positives = 118/280 (42%), Gaps = 41/280 (14%)

Query: 60  QKLLGKGSHGSVYKAVLRGR-QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
            K LG G  G V     +G+  VAVK  K     E   E   E + + K+  P+LV   G
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE--DEFFQEAQTMMKLSHPKLVKFYG 70

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
             +      +V E++SNG L + L S+ + L   + + +   V + +  L  E    IHR
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL--ESHQFIHR 128

Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS---------TPPAGTIGYLDPCYVT 227
           D+ + N L+DR+   ++ DFG+  R  +D+    S         + P     Y       
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMT-RYVLDDQYVSSVGTKFPVKWSAPEV-FHY------- 179

Query: 228 PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP 287
               S+K+DV++FGIL+ E+ S  K     ++   +V      + +G        R+  P
Sbjct: 180 -FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL----KVSQGH-------RLYRP 227

Query: 288 KD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
                    +  I   C     E+RP+ ++++  +  L +
Sbjct: 228 HLAS---DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  120 bits (302), Expect = 6e-31
 Identities = 66/299 (22%), Positives = 117/299 (39%), Gaps = 38/299 (12%)

Query: 34  QKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-RQVAVKKPSKNQEI 92
             +  P       Y   E      +  K LG G  G V     RG   VA+K   +    
Sbjct: 4   GSKNAPS-TAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS 62

Query: 93  SQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRR 152
             E   E +++  +   +LV L G     +   ++ E+M+NG L + L          + 
Sbjct: 63  EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL 122

Query: 153 IRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS- 211
           + +   V +A+E L  E    +HRD+ + N L++     ++ DFGL+ R  +D+    S 
Sbjct: 123 LEMCKDVCEAMEYL--ESKQFLHRDLAARNCLVNDQGVVKVSDFGLS-RYVLDDEYTSSV 179

Query: 212 --------TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSI 263
                   +PP   + Y           S+K+D+++FG+L+ EI S  K     F+    
Sbjct: 180 GSKFPVRWSPPEV-LMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 230

Query: 264 VDWAAPLIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
            +     I +G        R+  P       +++  I   C     + RP+ K ++  +
Sbjct: 231 AE----HIAQGL-------RLYRPHLAS---EKVYTIMYSCWHEKADERPTFKILLSNI 275

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  124 bits (313), Expect = 7e-31
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 21/265 (7%)

Query: 60  QKLLGKGSHGSVYKAVLRG-RQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           +  LG+G  G V+     G  +VA+K         +    E +++ K+   +LV L    
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRP-LNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
           ++ +   +V E+MS G+L D L       L   + + +A Q+A  +  +       +HRD
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRD 388

Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDV 237
           +++AN+L+  N   ++ DFGLA R   DN           I +  P        + K+DV
Sbjct: 389 LRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447

Query: 238 FSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD-PIVRKQL 296
           +SFGILL E+ +  +    G     ++D     +++G        R+P P + P   + L
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY-------RMPCPPECP---ESL 493

Query: 297 AVIAVRCVRSCRERRPSMKEIVDWL 321
             +  +C R   E RP+ + +  +L
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFL 518

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  119 bits (300), Expect = 9e-31
 Identities = 75/269 (27%), Positives = 118/269 (43%), Gaps = 33/269 (12%)

Query: 60  QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
            + +GKG  G V     RG +VAVK   KN   +Q    E  +++++    LV LLG   
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84

Query: 120 DSKDRL-LVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
           + K  L +V E+M+ G+L D L S  R  L     ++ +L V +A+E L       +HRD
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRD 142

Query: 178 IKSANVLIDRNFNARLGDFGLA--LRCGVDNFRF--RSTPPAGTIGYLDPCYVTPDNLST 233
           + + NVL+  +  A++ DFGL        D  +   + T P       +  +      ST
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPE---ALREKKF------ST 193

Query: 234 KTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD-PIV 292
           K+DV+SFGILL EI S  +          +V      ++KG        ++  P   P  
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP----RVEKGY-------KMDAPDGCP-- 240

Query: 293 RKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
              +  +   C       RPS  ++ + L
Sbjct: 241 -PAVYEVMKNCWHLDAAMRPSFLQLREQL 268

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  120 bits (302), Expect = 1e-30
 Identities = 62/289 (21%), Positives = 119/289 (41%), Gaps = 40/289 (13%)

Query: 60  QKLLGKGSHGSVYKAVLRGR------QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRL 111
            + LG+G  G V               VAVK  K     +       EI+IL  ++   +
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 112 VNLLGFSNDSKDR--LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           +   G   D+      LV+E++  G+L D L  ++  +   + +  A Q+ + +  LH++
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQ 153

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRS--------TPPAGTIG 219
               IHRD+ + NVL+D +   ++GDFGLA  +  G + +R R           P   + 
Sbjct: 154 H--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE-CLK 210

Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILS 278
                          +DV+SFG+ L E+++ C  +         ++  A   +   ++  
Sbjct: 211 EY--------KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262

Query: 279 VFDP--RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           + +   R+P P   P    ++  +   C  +    RP+ + ++  L  +
Sbjct: 263 LLERGERLPRPDKCP---AEVYHLMKNCWETEASFRPTFENLIPILKTV 308

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  120 bits (302), Expect = 1e-30
 Identities = 72/296 (24%), Positives = 122/296 (41%), Gaps = 53/296 (17%)

Query: 60  QKLLGKGSHGSVYKAVLRGR------QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRL 111
              LGKG+ GSV               VAVK  + S   +  ++   EI+IL  +HS  +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFI 86

Query: 112 VNLLGFSNDSKDR--LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           V   G S     +   LV+E++ +G L D L  +   L+  R +  + Q+ K +E L S 
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRS--------TPPAGTIG 219
               +HRD+ + N+L++   + ++ DFGLA  L    D +  R           P     
Sbjct: 147 R--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE---S 201

Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAP--------- 269
             D  +      S ++DV+SFG++L E+ + C K+         ++              
Sbjct: 202 LSDNIF------SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255

Query: 270 LIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           L+++G+       R+P P   P    ++  +   C     + RPS   +   L  L
Sbjct: 256 LLEEGQ-------RLPAPPACPA---EVHELMKLCWAPSPQDRPSFSALGPQLDML 301

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  118 bits (298), Expect = 1e-30
 Identities = 67/280 (23%), Positives = 114/280 (40%), Gaps = 41/280 (14%)

Query: 60  QKLLGKGSHGSVYKAVLRGR-QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
            + +G G  G V+      + +VA+K  +     E  ++   E E++ K+  P+LV L G
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYG 70

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
              +     LV EFM +G L D L +          + + L V + +  L  E   +IHR
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL--EEACVIHR 128

Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS---------TPPAGTIGYLDPCYVT 227
           D+ + N L+  N   ++ DFG+  R  +D+    S           P     +       
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWASPEV-FSF------- 179

Query: 228 PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP 287
               S+K+DV+SFG+L+ E+ S  K      S   +V+     I  G        R+  P
Sbjct: 180 -SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTGF-------RLYKP 227

Query: 288 KD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
           +        +  I   C R   E RP+   ++  L  +++
Sbjct: 228 RLAS---THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  119 bits (300), Expect = 2e-30
 Identities = 64/287 (22%), Positives = 117/287 (40%), Gaps = 53/287 (18%)

Query: 59  EQKLLGKGSHGSVYKAVLRGR-----QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRL 111
             +++GKG  G VY      +     Q A+K        +  +    E  ++  ++ P +
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 112 VNLLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           + L+G     +    V+  +M +G L   + S  R       I   LQVA+ +E L  + 
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN--FRFRSTPPAGTIGYLDPCYVTP 228
              +HRD+ + N ++D +F  ++ DFGLA R  +D   +  +          L      P
Sbjct: 145 --FVHRDLAARNCMLDESFTVKVADFGLA-RDILDREYYSVQ----QHRHARL------P 191

Query: 229 ----------DNL-STKTDVFSFGILLLEIISCRKAIDIGFSP-PSIVDWAAP-LIKKGK 275
                         +TK+DV+SFG+LL E+++       G  P   I  +     + +G+
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTR------GAPPYRHIDPFDLTHFLAQGR 245

Query: 276 ILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
                  R+P P+  P     L  +  +C  +    RP+ + +V  +
Sbjct: 246 -------RLPQPEYCP---DSLYQVMQQCWEADPAVRPTFRVLVGEV 282

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  118 bits (298), Expect = 2e-30
 Identities = 57/190 (30%), Positives = 93/190 (48%), Gaps = 10/190 (5%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNL 114
            LLGKGS   VY+A  +  G +VA+K   K       + Q V NE++I  ++  P ++ L
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
             +  DS    LV+E   NG +   L +  +P +         Q+   +  LHS    I+
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--IL 134

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           HRD+  +N+L+ RN N ++ DFGLA +  + + +  +    GT  Y+ P   T      +
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIATRSAHGLE 192

Query: 235 TDVFSFGILL 244
           +DV+S G + 
Sbjct: 193 SDVWSLGCMF 202

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  118 bits (299), Expect = 3e-30
 Identities = 62/321 (19%), Positives = 120/321 (37%), Gaps = 51/321 (15%)

Query: 15  ISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKA 74
           +   S  +        +  +     +                F  +K +G+G    VY+A
Sbjct: 1   MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLA---------NFRIEKKIGRGQFSEVYRA 51

Query: 75  VLR--GRQVAVKK-----PSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV 127
                G  VA+KK         +    +   EI++L +++ P ++       +  +  +V
Sbjct: 52  ACLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110

Query: 128 VEFMSNGTLYDVL---HSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVL 184
           +E    G L  ++       R +      +  +Q+  A+E +HS    ++HRDIK ANV 
Sbjct: 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVF 168

Query: 185 IDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL-----STKTDV 237
           I      +LGD GL               +   GT     P Y++P+ +     + K+D+
Sbjct: 169 ITATGVVKLGDLGLGRFFSSKTT---AAHS-LVGT-----PYYMSPERIHENGYNFKSDI 219

Query: 238 FSFGILLLEIISCRKA-IDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQL 296
           +S G LL E+ + +        +  S+       I++        P +P        ++L
Sbjct: 220 WSLGCLLYEMAALQSPFYGDKMNLYSLC----KKIEQCDY-----PPLPSDHYS---EEL 267

Query: 297 AVIAVRCVRSCRERRPSMKEI 317
             +   C+    E+RP +  +
Sbjct: 268 RQLVNMCINPDPEKRPDVTYV 288

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  118 bits (298), Expect = 3e-30
 Identities = 61/319 (19%), Positives = 116/319 (36%), Gaps = 52/319 (16%)

Query: 26  QTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVK 84
                 T     + + ++   YS L          K +G G    V++ +    +  A+K
Sbjct: 9   SGVDLGTENLYFQSMSVKGRIYSIL----------KQIGSGGSSKVFQVLNEKKQIYAIK 58

Query: 85  ---KPSKNQEISQEVDNEIEILSKI--HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDV 139
                  + +      NEI  L+K+  HS +++ L  +    +   +V+E   N  L   
Sbjct: 59  YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSW 117

Query: 140 LHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
           L           +       + +AV  +H     I+H D+K AN LI      +L DFG+
Sbjct: 118 LKKKKSIDPWERKSY--WKNMLEAVHTIHQHG--IVHSDLKPANFLIVDG-MLKLIDFGI 172

Query: 199 ALRCGVDNFRFRSTPPAGTIGYLDP-----------CYVTPDNLSTKTDVFSFGILLLEI 247
           A +   D          GT+ Y+ P              +   +S K+DV+S G +L  +
Sbjct: 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232

Query: 248 ISCRKAIDIGFSPP--SIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVR 305
              +         P   I++  + L     I    +   P   +  ++  L      C++
Sbjct: 233 TYGK--------TPFQQIINQISKLHA--IIDPNHEIEFPDIPEKDLQDVLK----CCLK 278

Query: 306 SCRERRPSMKEIVD--WLT 322
              ++R S+ E++   ++ 
Sbjct: 279 RDPKQRISIPELLAHPYVQ 297

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  119 bits (301), Expect = 5e-30
 Identities = 65/340 (19%), Positives = 122/340 (35%), Gaps = 52/340 (15%)

Query: 5   SCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLG 64
             K  +A      + +S         K S    + I ++   YS L          K +G
Sbjct: 16  GMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL----------KQIG 65

Query: 65  KGSHGSVYKAVLR-GRQVAVK---KPSKNQEISQEVDNEIEILSKI--HSPRLVNLLGFS 118
            G    V++ +    +  A+K       + +      NEI  L+K+  HS +++ L  + 
Sbjct: 66  SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125

Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
              +   +V+E   N  L   L           +       + +AV  +H     I+H D
Sbjct: 126 ITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSY--WKNMLEAVHTIHQHG--IVHSD 180

Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP-----------CYV 226
           +K AN LI      +L DFG+A +   D          G + Y+ P              
Sbjct: 181 LKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGK 239

Query: 227 TPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP--SIVDWAAPLIKKGKILSVFDPRI 284
           +   +S K+DV+S G +L  +   +         P   I++  + L     I    +   
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGK--------TPFQQIINQISKLHA--IIDPNHEIEF 289

Query: 285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLT 322
           P   +  ++  L      C++   ++R S+ E++   ++ 
Sbjct: 290 PDIPEKDLQDVLK----CCLKRDPKQRISIPELLAHPYVQ 325

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  117 bits (296), Expect = 6e-30
 Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 39/282 (13%)

Query: 60  QKLLGKGSHGSVYKAVLRGR-----QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
            +++G+G  G VY   L          AVK      +     +   E  I+     P ++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 113 NLLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   LVV  +M +G L + + +          I   LQVAK ++ L S+  
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK- 148

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP--- 228
             +HRD+ + N ++D  F  ++ DFGLA R   D +           G   P        
Sbjct: 149 -FVHRDLAARNCMLDEKFTVKVADFGLA-R---DMYDKEYYSVHNKTGAKLPVKWMALES 203

Query: 229 --DNL-STKTDVFSFGILLLEIISCRKAIDIGFSP-PSIVDW-AAPLIKKGKILSVFDPR 283
                 +TK+DV+SFG+LL E+++       G  P P +  +     + +G+       R
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGR-------R 250

Query: 284 IPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           +  P+  P     L  + ++C     E RPS  E+V  ++ +
Sbjct: 251 LLQPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  116 bits (294), Expect = 2e-29
 Identities = 76/297 (25%), Positives = 124/297 (41%), Gaps = 63/297 (21%)

Query: 61  KLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIEILSKIHS-PR 110
           K LG G+ G V +A   G        +VAVK  K + + +  + + +E++I+S +     
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSN-------------NRPLNWGRRIRLAL 157
           +VNLLG        L++ E+   G L + L                N   +    +  + 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 158 QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDNFRFRS---- 211
           QVA+ +  L S+    IHRD+ + NVL+     A++GDFGLA R      N+  +     
Sbjct: 172 QVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLA-RDIMNDSNYIVKGNARL 228

Query: 212 ----TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSIVDW 266
                 P       D  Y      + ++DV+S+GILL EI S      +G +P P I+  
Sbjct: 229 PVKWMAPE---SIFDCVY------TVQSDVWSYGILLWEIFS------LGLNPYPGILVN 273

Query: 267 A--APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           +    L+K G        ++  P      K +  I   C       RP+ ++I  +L
Sbjct: 274 SKFYKLVKDGY-------QMAQPAF--APKNIYSIMQACWALEPTHRPTFQQICSFL 321

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  115 bits (290), Expect = 2e-29
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 23/199 (11%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNL 114
           + LGKG  G+VY A  +     +A+K   K Q     +  ++  E+EI S +  P ++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
            G+ +D+    L++E+   GT+Y  L   ++            ++A A+   HS+   +I
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKR--VI 131

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           HRDIK  N+L+      ++ DFG ++         R+    GT       Y+ P+ +  +
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTD-LCGT-----LDYLPPEMIEGR 182

Query: 235 T-----DVFSFGILLLEII 248
                 D++S G+L  E +
Sbjct: 183 MHDEKVDLWSLGVLCYEFL 201

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  116 bits (293), Expect = 2e-29
 Identities = 57/253 (22%), Positives = 104/253 (41%), Gaps = 15/253 (5%)

Query: 2   GYLSCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLE--AATNGFSE 59
           G +S     +++ ++   +S +    +    ++  E  +  +     D E     +  + 
Sbjct: 3   GSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTH 62

Query: 60  QKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
           Q  +G+GS G V++   +  G Q AVKK      +      E+   + + SPR+V L G 
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQCAVKK----VRLEVFRVEELVACAGLSSPRIVPLYGA 118

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
             +     + +E +  G+L  ++      L   R +    Q  + +E LH+    I+H D
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGD 175

Query: 178 IKSANVLIDRN-FNARLGDFGLALRCGVDNFRFRSTPPA---GTIGYLDPCYVTPDNLST 233
           +K+ NVL+  +   A L DFG AL    D             GT  ++ P  V       
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235

Query: 234 KTDVFSFGILLLE 246
           K D++S   ++L 
Sbjct: 236 KVDIWSSCCMMLH 248

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  116 bits (293), Expect = 3e-29
 Identities = 62/305 (20%), Positives = 116/305 (38%), Gaps = 48/305 (15%)

Query: 38  KPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVK---KPSKNQEIS 93
           + I ++   YS L          K +G G    V++ +    +  A+K       + +  
Sbjct: 2   ECISVKGRIYSIL----------KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 51

Query: 94  QEVDNEIEILSKI--HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWG 150
               NEI  L+K+  HS +++ L  +    +   +V+E   N  L   L           
Sbjct: 52  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWER 110

Query: 151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR 210
           +       + +AV  +H     I+H D+K AN LI      +L DFG+A +   D     
Sbjct: 111 KSY--WKNMLEAVHTIHQHG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVV 165

Query: 211 STPPAGTIGYLDP-----------CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFS 259
                GT+ Y+ P              +   +S K+DV+S G +L  +   +        
Sbjct: 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-------- 217

Query: 260 PPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
            P    +   + +  K+ ++ DP        I  K L  +   C++   ++R S+ E++ 
Sbjct: 218 TP----FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273

Query: 320 --WLT 322
             ++ 
Sbjct: 274 HPYVQ 278

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  118 bits (297), Expect = 4e-29
 Identities = 75/275 (27%), Positives = 130/275 (47%), Gaps = 41/275 (14%)

Query: 60  QKLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           +K LG G  G V+ A      +VAVK         +    E  ++  +   +LV L    
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 119 NDSKDRLLVV-EFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
             +K+ + ++ EFM+ G+L D L S+        + I  + Q+A+ +  +  E    IHR
Sbjct: 253 --TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRNYIHR 308

Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDN---------FRFRSTPPAGTIGYLDPCYVT 227
           D+++AN+L+  +   ++ DFGLA R   DN         F  + T P   I +       
Sbjct: 309 DLRAANILVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEA-INF------- 359

Query: 228 PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP 287
             + + K+DV+SFGILL+EI++  +    G S P ++      +++G        R+P P
Sbjct: 360 -GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR----ALERGY-------RMPRP 407

Query: 288 KD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           ++ P   ++L  I +RC ++  E RP+ + I   L
Sbjct: 408 ENCP---EELYNIMMRCWKNRPEERPTFEYIQSVL 439

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  115 bits (290), Expect = 6e-29
 Identities = 59/291 (20%), Positives = 126/291 (43%), Gaps = 62/291 (21%)

Query: 61  KLLGKGSHGSVYKAVLRGR------QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           K+LG G+ G+VYK +           VA+K  + + + + ++E+ +E  +++ + +P + 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            LLG    S    L+ + M  G L D +  +   +     +   +Q+AK +  L  +   
Sbjct: 81  RLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRR- 137

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT----- 227
           ++HRD+ + NVL+    + ++ DFGLA        +         +G  +  Y       
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLA--------KL--------LGAEEKEYHAEGGKV 181

Query: 228 ------PDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSP-PSIVDWAAP-LIKKG 274
                  +++     + ++DV+S+G+ + E+++       G  P   I       +++KG
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTF------GSKPYDGIPASEISSILEKG 235

Query: 275 KILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           +       R+P P    I    + +I  +C     + RP  +E++   + +
Sbjct: 236 E-------RLPQPPICTI---DVYMIMRKCWMIDADSRPKFRELIIEFSKM 276

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  114 bits (288), Expect = 6e-29
 Identities = 72/275 (26%), Positives = 118/275 (42%), Gaps = 41/275 (14%)

Query: 61  KLLGKGSHGSVYKAVLRGR--QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
             LG G +G VY+ V +     VAVK  K    +   +E   E  ++ +I  P LV LLG
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLG 76

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
                    ++ EFM+ G L D L   NR  ++    + +A Q++ A+E L  +    IH
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIH 134

Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS--------TPPAGTIGYLDPCYVT 227
           RD+ + N L+  N   ++ DFGL+     D +   +        T P   + Y       
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES-LAY------- 186

Query: 228 PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP 287
            +  S K+DV++FG+LL EI +   +   G     + +    L++K         R+  P
Sbjct: 187 -NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE----LLEKDY-------RMERP 234

Query: 288 KD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           +  P   +++  +   C +     RPS  EI    
Sbjct: 235 EGCP---EKVYELMRACWQWNPSDRPSFAEIHQAF 266

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  113 bits (286), Expect = 1e-28
 Identities = 67/293 (22%), Positives = 114/293 (38%), Gaps = 62/293 (21%)

Query: 61  KLLGKGSHGSVYKAVLRGR---------QVAVK--KPSKNQEISQEVDNEIEILSKIHSP 109
           + LG+G+   ++K V R           +V +K    + ++  S+       ++SK+   
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHK 72

Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
            LV   G      + +LV EF+  G+L   L  N   +N   ++ +A Q+A A+  L  E
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL--E 130

Query: 170 MPPIIHRDIKSANVLIDRNFNAR--------LGDFGLALRCGVDN----FRFRSTPPAGT 217
              +IH ++ + N+L+ R  + +        L D G++    +       R    PP   
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITVLPKDILQERIPWVPPE-- 187

Query: 218 IGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP------PSIVDWAAPLI 271
                 C   P NL+  TD +SFG  L EI S       G  P         +       
Sbjct: 188 ------CIENPKNLNLATDKWSFGTTLWEICSG------GDKPLSALDSQRKLQ----FY 231

Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           +          ++P PK      +LA +   C+    + RPS + I+  L  L
Sbjct: 232 EDRH-------QLPAPKAA----ELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  115 bits (289), Expect = 1e-28
 Identities = 76/347 (21%), Positives = 134/347 (38%), Gaps = 53/347 (15%)

Query: 2   GYLSCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQK 61
           G  S +  S        S ++      +         P  +Q   +  +  ++      +
Sbjct: 36  GICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNE 95

Query: 62  LLGKGSHGSVYKAVLRGR-----QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           ++G+G  G VY   L          AVK      +     +   E  I+     P +++L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155

Query: 115 LGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           LG    S+   LVV  +M +G L + + +          I   LQVAK ++ L S+    
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--F 213

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRC--GVDNFRFRSTPPAGTIGYLDPCYVTP--- 228
           +HRD+ + N ++D  F  ++ DFGLA R     +     +     T   L      P   
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEFDSVHNK----TGAKL------PVKW 262

Query: 229 -------DNL-STKTDVFSFGILLLEIISCRKAIDIGFSP-PSIVDWAAP-LIKKGKILS 278
                      +TK+DV+SFG+LL E+++       G  P P +  +     + +G+   
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGR--- 313

Query: 279 VFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
               R+  P+  P     L  + ++C     E RPS  E+V  ++ +
Sbjct: 314 ----RLLQPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  113 bits (284), Expect = 2e-28
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 23/197 (11%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVD----NEIEILSKIHSPRLVNL 114
           + LGKG  G+VY A  +     +A+K   K+Q   + V+     EIEI S +  P ++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
             + +D K   L++EF   G LY  L  + R  +  R      ++A A+   H     +I
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCHERK--VI 136

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           HRDIK  N+L+      ++ DFG ++     + R R T   GT       Y+ P+ +  K
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVH--APSLR-RRT-MCGT-----LDYLPPEMIEGK 187

Query: 235 T-----DVFSFGILLLE 246
           T     D++  G+L  E
Sbjct: 188 THDEKVDLWCAGVLCYE 204

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  113 bits (286), Expect = 2e-28
 Identities = 73/300 (24%), Positives = 124/300 (41%), Gaps = 65/300 (21%)

Query: 61  KLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIEILSKIHS-PR 110
           K LG G+ G V +A   G         VAVK  KPS +    + + +E+++LS + +   
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVL-----------------HSNNRPLNWGRRI 153
           +VNLLG        L++ E+   G L + L                   +   L+    +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA---------LRCGV 204
             + QVAK +  L S+    IHRD+ + N+L+      ++ DFGLA         +  G 
Sbjct: 149 SFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI 263
                +   P       +  Y      + ++DV+S+GI L E+ S      +G SP P +
Sbjct: 207 ARLPVKWMAPE---SIFNCVY------TFESDVWSYGIFLWELFS------LGSSPYPGM 251

Query: 264 VDWA--APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
              +    +IK+G        R+  P+      ++  I   C  +   +RP+ K+IV  +
Sbjct: 252 PVDSKFYKMIKEGF-------RMLSPEH--APAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  112 bits (283), Expect = 2e-28
 Identities = 68/275 (24%), Positives = 123/275 (44%), Gaps = 41/275 (14%)

Query: 60  QKLLGKGSHGSVYKAVLRGR-QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
            + LG G  G V+     G  +VAVK   +          E  ++ ++   RLV L    
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 119 NDSKDRLLVV-EFMSNGTLYDVLHSNNRP-LNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
             +++ + ++ E+M NG+L D L + +   L   + + +A Q+A+ +  +  E    IHR
Sbjct: 78  --TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHR 133

Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDN---------FRFRSTPPAGTIGYLDPCYVT 227
           D+++AN+L+    + ++ DFGLA R   DN         F  + T P          +  
Sbjct: 134 DLRAANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPE---AINYGTF-- 187

Query: 228 PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP 287
               + K+DV+SFGILL EI++  +    G + P ++      +++G        R+  P
Sbjct: 188 ----TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ----NLERGY-------RMVRP 232

Query: 288 KD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
            + P   ++L  +   C +   E RP+   +   L
Sbjct: 233 DNCP---EELYQLMRLCWKERPEDRPTFDYLRSVL 264

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  113 bits (284), Expect = 2e-28
 Identities = 53/226 (23%), Positives = 105/226 (46%), Gaps = 17/226 (7%)

Query: 29  SSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKK- 85
           S +++++ +    +  +DY + +   +      +LGKG++G VY         ++A+K+ 
Sbjct: 1   SMRSTEEGDCESDLLEYDY-EYDENGDR----VVLGKGTYGIVYAGRDLSNQVRIAIKEI 55

Query: 86  PSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR 145
           P ++   SQ +  EI +   +    +V  LG  +++    + +E +  G+L  +L S   
Sbjct: 56  PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 115

Query: 146 PLNWGRR-IRL-ALQVAKAVEILHSEMPPIIHRDIKSANVLID-RNFNARLGDFGLALRC 202
           PL    + I     Q+ + ++ LH     I+HRDIK  NVLI+  +   ++ DFG + R 
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKR- 172

Query: 203 GVDNFRFRSTPPAGTIGYLDPCYVTPDNL--STKTDVFSFGILLLE 246
            +      +    GT+ Y+ P  +           D++S G  ++E
Sbjct: 173 -LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 217

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  113 bits (285), Expect = 3e-28
 Identities = 67/294 (22%), Positives = 124/294 (42%), Gaps = 63/294 (21%)

Query: 61  KLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRL 111
           + LG+GS G VY+ V +G        +VA+K    + +     E  NE  ++ + +   +
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSN---------NRPLNWGRRIRLALQVAKA 162
           V LLG  +  +  L+++E M+ G L   L S            P +  + I++A ++A  
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDNFRFRSTPPAGTIGY 220
           +  L++     +HRD+ + N ++  +F  ++GDFG+  R     D +R       G  G 
Sbjct: 151 MAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMT-RDIYETDYYR------KGGKGL 201

Query: 221 LDPCYVTP----------DNL-STKTDVFSFGILLLEIISCRKAIDIGFSP-PSIVDW-A 267
           L      P          D + +T +DV+SFG++L EI +      +   P   + +   
Sbjct: 202 L------PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQV 249

Query: 268 APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
              + +G         +  P +      L  +   C +   + RPS  EI+  +
Sbjct: 250 LRFVMEGG-------LLDKPDN--CPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  113 bits (285), Expect = 3e-28
 Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 47/291 (16%)

Query: 61  KLLGKGSHGSVYKAVLRGR-------QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRL 111
           + LG G+ G VY+  + G        QVAVK      +++   +   E  I+SK +   +
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVL------HSNNRPLNWGRRIRLALQVAKAVEI 165
           V  +G S  S  R +++E M+ G L   L       S    L     + +A  +A   + 
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 166 LHSEMPPIIHRDIKSANVLIDR---NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           L  E    IHRDI + N L+        A++GDFG+A R       +R     G    L 
Sbjct: 156 L-EEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRK----GGCAMLP 208

Query: 223 PCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSP-PSIVDW-AAPLIKKGK 275
             ++ P+       ++KTD +SFG+LL EI S       G+ P PS  +      +  G 
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL------GYMPYPSKSNQEVLEFVTSGG 262

Query: 276 ILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
                  R+ PPK+      +  I  +C +   E RP+   I++ +   ++
Sbjct: 263 -------RMDPPKN--CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  112 bits (282), Expect = 4e-28
 Identities = 61/196 (31%), Positives = 110/196 (56%), Gaps = 11/196 (5%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVN 113
           ++  + +G+G+ G+VY A+    G++VA+++   + Q   + + NEI ++ +  +P +VN
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 114 LLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            L  S    D L VV E+++ G+L DV+      ++ G+   +  +  +A+E LHS    
Sbjct: 82  YLD-SYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN--Q 136

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           +IHRDIKS N+L+  + + +L DFG   +   +  + RST   GT  ++ P  VT     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST-MVGTPYWMAPEVVTRKAYG 194

Query: 233 TKTDVFSFGILLLEII 248
            K D++S GI+ +E+I
Sbjct: 195 PKVDIWSLGIMAIEMI 210

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  112 bits (283), Expect = 4e-28
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 11/196 (5%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVN 113
                 +G+GS G V  A  +  GRQVAVK    + Q+  + + NE+ I+       +V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 114 LLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
           +   S    + L V+ EF+  G L D++      LN  +   +   V +A+  LH++   
Sbjct: 107 MYK-SYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQG-- 161

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           +IHRDIKS ++L+  +   +L DFG   +   D  + R +   GT  ++ P  ++    +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKS-LVGTPYWMAPEVISRSLYA 219

Query: 233 TKTDVFSFGILLLEII 248
           T+ D++S GI+++E++
Sbjct: 220 TEVDIWSLGIMVIEMV 235

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  112 bits (283), Expect = 6e-28
 Identities = 70/290 (24%), Positives = 125/290 (43%), Gaps = 62/290 (21%)

Query: 60  QKLLGKGSHGSVYKAVLRGR------QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRL 111
           QK++G G  G VYK +L+         VA+K  K    ++   +   E  I+ +     +
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           + L G  +  K  +++ E+M NG L   L   +   +  + + +   +A  ++ L + M 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL-ANM- 166

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT-PDN 230
             +HRD+ + N+L++ N   ++ DFGL+ R   D+     T   G I    P   T P+ 
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLS-RVLEDDPEATYTTSGGKI----PIRWTAPEA 221

Query: 231 L-----STKTDVFSFGILLLEIIS-------------CRKAIDIGFSPPSIVDWAAPLIK 272
           +     ++ +DV+SFGI++ E+++               KAI+ GF              
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-------------- 267

Query: 273 KGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
                     R+P P D P     +  + ++C +  R RRP   +IV  L
Sbjct: 268 ----------RLPTPMDCP---SAIYQLMMQCWQQERARRPKFADIVSIL 304

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  112 bits (282), Expect = 8e-28
 Identities = 75/303 (24%), Positives = 130/303 (42%), Gaps = 66/303 (21%)

Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHS- 108
           K LG+G+ G V  A   G           VAVK  K    ++   ++ +E+E++  I   
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVL---------------HSNNRPLNWGRRI 153
             ++NLLG         ++VE+ S G L + L                     + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDNFRFRS 211
               Q+A+ +E L S+    IHRD+ + NVL+  N   ++ DFGLA R    +D ++  +
Sbjct: 161 SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLA-RDINNIDYYKKTT 217

Query: 212 --------TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PS 262
                     P       D  Y      + ++DV+SFG+L+ EI +      +G SP P 
Sbjct: 218 NGRLPVKWMAPE---ALFDRVY------THQSDVWSFGVLMWEIFT------LGGSPYPG 262

Query: 263 I-VDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           I V+    L+K+G        R+  P +     +L ++   C  +   +RP+ K++V+ L
Sbjct: 263 IPVEELFKLLKEGH-------RMDKPAN--CTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

Query: 322 TGL 324
             +
Sbjct: 314 DRI 316

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  112 bits (281), Expect = 1e-27
 Identities = 66/297 (22%), Positives = 122/297 (41%), Gaps = 60/297 (20%)

Query: 60  QKLLGKGSHGSVYKAVLRGR-----QVAVKKPSKNQEISQEVD---NEIEILSKIHSPRL 111
            ++LGKG  GSV +A L+       +VAVK    +   S +++    E   + +   P +
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 112 VNLLGFSNDSKDR------LLVVEFMSNGTLYDVL-----HSNNRPLNWGRRIRLALQVA 160
             L+G S  S+ +      ++++ FM +G L+  L       N   L     +R  + +A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGY 220
             +E L S     IHRD+ + N ++  +    + DFGL+ R       +R     G    
Sbjct: 148 CGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLS-RKIYSGDYYR----QGCASK 200

Query: 221 LDPCYVTP----------DNL-STKTDVFSFGILLLEIISCRKAIDIGFSP-PSIVDW-A 267
           L      P          DNL +  +DV++FG+ + EI++       G +P   I +   
Sbjct: 201 L------PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT------RGQTPYAGIENAEI 248

Query: 268 APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
              +  G        R+  P +    +++  +  +C  +  ++RPS   +   L  +
Sbjct: 249 YNYLIGGN-------RLKQPPE--CMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  111 bits (280), Expect = 1e-27
 Identities = 63/302 (20%), Positives = 123/302 (40%), Gaps = 61/302 (20%)

Query: 60  QKLLGKGSHGSVYKAVLRGR-----QVAVK---KPSKNQEISQEVDNEIEILSKIHSPRL 111
            K+LG+G  GSV +  L+       +VAVK     + +Q   +E  +E   +     P +
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 112 VNLLGFSNDSKDR-----LLVVEFMSNGTLYDVL-----HSNNRPLNWGRRIRLALQVAK 161
           + LLG   +   +     ++++ FM  G L+  L      +  + +     ++  + +A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 162 AVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
            +E L +     +HRD+ + N ++  +    + DFGL+ +       +R     G I  +
Sbjct: 159 GMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLS-KKIYSGDYYR----QGRIAKM 211

Query: 222 DPCYVTP----------DNL-STKTDVFSFGILLLEIISCRKAIDIGFSP-PSIVDW-AA 268
                 P          D + ++K+DV++FG+ + EI +       G +P P + +    
Sbjct: 212 ------PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR------GMTPYPGVQNHEMY 259

Query: 269 PLIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL 327
             +  G        R+  P+D      +L  I   C R+    RP+   +   L  L + 
Sbjct: 260 DYLLHGH-------RLKQPEDCL---DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309

Query: 328 VP 329
           +P
Sbjct: 310 LP 311

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  111 bits (281), Expect = 1e-27
 Identities = 75/331 (22%), Positives = 139/331 (41%), Gaps = 75/331 (22%)

Query: 27  TQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQ----VA 82
                  +    P      D++D++        Q ++G+G+ G V KA ++        A
Sbjct: 4   HHHHHHGKNNPDPTIYPVLDWNDIKF-------QDVIGEGNFGQVLKARIKKDGLRMDAA 56

Query: 83  VK--KPSKNQEISQEVDNEIEILSKIHS-PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDV 139
           +K  K   +++  ++   E+E+L K+   P ++NLLG         L +E+  +G L D 
Sbjct: 57  IKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116

Query: 140 L---------------HSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVL 184
           L               +S    L+  + +  A  VA+ ++ L S+    IHRD+ + N+L
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL-SQKQ-FIHRDLAARNIL 174

Query: 185 IDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP----------DNL-ST 233
           +  N+ A++ DFGL+ R G + +         T+G L      P           ++ +T
Sbjct: 175 VGENYVAKIADFGLS-R-GQEVYV------KKTMGRL------PVRWMAIESLNYSVYTT 220

Query: 234 KTDVFSFGILLLEIISCRKAIDIGFSP-PSI-VDWAAPLIKKGKILSVFDPRIPPPKD-P 290
            +DV+S+G+LL EI+S       G +P   +        + +G        R+  P +  
Sbjct: 221 NSDVWSYGVLLWEIVSL------GGTPYCGMTCAELYEKLPQGY-------RLEKPLNCD 267

Query: 291 IVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
               ++  +  +C R     RPS  +I+  L
Sbjct: 268 ---DEVYDLMRQCWREKPYERPSFAQILVSL 295

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  111 bits (279), Expect = 2e-27
 Identities = 64/296 (21%), Positives = 117/296 (39%), Gaps = 69/296 (23%)

Query: 60  QKLLGKGSHGSVYKAVLRGR-----QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           +K++G G  G V    LR        VA+K  K    +   ++  +E  I+ +   P ++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            L G     +  ++V E+M NG+L   L +++      + + +   V   +  L S++  
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL-SDL-G 171

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRS--------TPPAGTIGYLD 222
            +HRD+ + NVL+D N   ++ DFGL+  L    D     +        T P   I +  
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE-AIAF-- 228

Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIIS-------------CRKAIDIGFSPPSIVDWAAP 269
                    S+ +DV+SFG+++ E+++                +++ G+           
Sbjct: 229 ------RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY----------- 271

Query: 270 LIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
                        R+P P   P     L  + + C    R +RP   +IV  L  L
Sbjct: 272 -------------RLPAPMGCP---HALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  110 bits (278), Expect = 2e-27
 Identities = 47/195 (24%), Positives = 79/195 (40%), Gaps = 21/195 (10%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNL 114
           + LGKG     ++          A K   K+        +++  EI I   +    +V  
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
            GF  D+    +V+E     +L ++       L          Q+    + LH     +I
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHRNR--VI 137

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           HRD+K  N+ ++ +   ++GDFGLA +   D  R +     GT     P Y+ P+ LS K
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGT-----PNYIAPEVLSKK 190

Query: 235 T-----DVFSFGILL 244
                 DV+S G ++
Sbjct: 191 GHSFEVDVWSIGCIM 205

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  111 bits (279), Expect = 2e-27
 Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 28/214 (13%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKK-PSKNQEISQEVDNEIEILSKI-HSPRLVNLLG 116
           ++L +G    VY+A  V  GR+ A+K+  S  +E ++ +  E+  + K+   P +V    
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 117 F-------SNDSKDRLLVVEFMSNGTLYDVL--HSNNRPLNWGRRIRLALQVAKAVEILH 167
                   S+  +   L++  +  G L + L    +  PL+    +++  Q  +AV+ +H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD----- 222
            + PPIIHRD+K  N+L+      +L DFG A         +  +     +   +     
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA-TTISHYPDYSWSAQRRALVEEEITRNT 212

Query: 223 -PCYVTP---DNLS-----TKTDVFSFGILLLEI 247
            P Y TP   D  S      K D+++ G +L  +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  112 bits (281), Expect = 2e-27
 Identities = 75/303 (24%), Positives = 129/303 (42%), Gaps = 66/303 (21%)

Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHS- 108
           K LG+G  G V  A   G           VAVK  K    ++   ++ +E+E++  I   
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVL---------------HSNNRPLNWGRRI 153
             ++NLLG         ++VE+ S G L + L                     + +   +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDNFRFRS 211
               Q+A+ +E L S+    IHRD+ + NVL+  N   ++ DFGLA R    +D ++  +
Sbjct: 207 SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLA-RDINNIDYYKKTT 263

Query: 212 --------TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PS 262
                     P       D  Y      + ++DV+SFG+L+ EI +      +G SP P 
Sbjct: 264 NGRLPVKWMAPE---ALFDRVY------THQSDVWSFGVLMWEIFT------LGGSPYPG 308

Query: 263 I-VDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           I V+    L+K+G        R+  P +     +L ++   C  +   +RP+ K++V+ L
Sbjct: 309 IPVEELFKLLKEGH-------RMDKPAN--CTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359

Query: 322 TGL 324
             +
Sbjct: 360 DRI 362

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  112 bits (282), Expect = 2e-27
 Identities = 78/300 (26%), Positives = 133/300 (44%), Gaps = 66/300 (22%)

Query: 61  KLLGKGSHGSVYKAVLRG---------RQVAVK--KPSKNQEISQEVDNEIEILSKIHS- 108
           K LG+G+ G V  A   G          +VAVK  K    ++   ++ +E+E++  I   
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTL---------------YDVLHSNNRPLNWGRRI 153
             ++NLLG         ++VE+ S G L               Y+  H+    L+    +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 154 RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDNFRFRS 211
             A QVA+ +E L S+    IHRD+ + NVL+  +   ++ DFGLA R    +D ++  +
Sbjct: 195 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLA-RDIHHIDYYKKTT 251

Query: 212 --------TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PS 262
                     P       D  Y      + ++DV+SFG+LL EI +      +G SP P 
Sbjct: 252 NGRLPVKWMAPE---ALFDRIY------THQSDVWSFGVLLWEIFT------LGGSPYPG 296

Query: 263 I-VDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           + V+    L+K+G        R+  P +     +L ++   C  +   +RP+ K++V+ L
Sbjct: 297 VPVEELFKLLKEGH-------RMDKPSN--CTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  110 bits (278), Expect = 3e-27
 Identities = 51/240 (21%), Positives = 86/240 (35%), Gaps = 25/240 (10%)

Query: 16  STNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAV 75
                 V       +  +    K I     D          +   + LGKG     ++  
Sbjct: 6   DPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRR----YVRGRFLGKGGFAKCFEIS 61

Query: 76  LR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE 129
                   A K   K+        +++  EI I   +    +V   GF  D+    +V+E
Sbjct: 62  DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121

Query: 130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF 189
                +L ++       L          Q+    + LH     +IHRD+K  N+ ++ + 
Sbjct: 122 LCRRRSLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDL 178

Query: 190 NARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKT-----DVFSFGILL 244
             ++GDFGLA +   D  R +     GT     P Y+ P+ LS K      DV+S G ++
Sbjct: 179 EVKIGDFGLATKVEYDGERKKVL--CGT-----PNYIAPEVLSKKGHSFEVDVWSIGCIM 231

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  111 bits (279), Expect = 4e-27
 Identities = 71/284 (25%), Positives = 123/284 (43%), Gaps = 45/284 (15%)

Query: 60  QKLLGKGSHGSVYKAVLRGR-----QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
            K++G G  G V    L+        VA+K  K    ++  ++   E  I+ +   P ++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            L G    SK  ++V E+M NG+L   L  ++      + + +   +A  ++ L S+M  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL-SDM-G 167

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN-----------FRFRSTPPAGTIGYL 221
            +HRD+ + N+LI+ N   ++ DFGL  R   D+              R T P   I Y 
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLG-RVLEDDPEAAYTTRGGKIPIRWTSPE-AIAY- 224

Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD 281
                     ++ +DV+S+GI+L E++S  +      S   ++      + +G       
Sbjct: 225 -------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK----AVDEGY------ 267

Query: 282 PRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
            R+PPP D P     L  + + C +  R  RP  ++IV  L  L
Sbjct: 268 -RLPPPMDCP---AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  110 bits (276), Expect = 5e-27
 Identities = 72/308 (23%), Positives = 130/308 (42%), Gaps = 71/308 (23%)

Query: 61  KLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRL 111
           K LG+G  G V KA             VAVK  K + +    +++ +E  +L +++ P +
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVL-----------------------HSNNRPLN 148
           + L G  +     LL+VE+   G+L   L                       H + R L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 149 WGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDN 206
            G  I  A Q+++ ++ L      ++HRD+ + N+L+      ++ DFGL+ R     D+
Sbjct: 149 MGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLS-RDVYEEDS 205

Query: 207 FRFRS--------TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGF 258
           +  RS                  D  Y      +T++DV+SFG+LL EI++      +G 
Sbjct: 206 YVKRSQGRIPVKWMAIE---SLFDHIY------TTQSDVWSFGVLLWEIVT------LGG 250

Query: 259 SP-PSI-VDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKE 316
           +P P I  +    L+K G        R+  P +    +++  + ++C +   ++RP   +
Sbjct: 251 NPYPGIPPERLFNLLKTGH-------RMERPDN--CSEEMYRLMLQCWKQEPDKRPVFAD 301

Query: 317 IVDWLTGL 324
           I   L  +
Sbjct: 302 ISKDLEKM 309

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  110 bits (277), Expect = 7e-27
 Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 47/291 (16%)

Query: 61  KLLGKGSHGSVYKAVLRGR-------QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRL 111
           + LG G+ G VY+  + G        QVAVK      +++   +   E  I+SK +   +
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVL------HSNNRPLNWGRRIRLALQVAKAVEI 165
           V  +G S  S  R +++E M+ G L   L       S    L     + +A  +A   + 
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 166 LHSEMPPIIHRDIKSANVLIDR---NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           L  E    IHRDI + N L+        A++GDFG+A R       +R     G    L 
Sbjct: 197 L-EEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRAGYYRK----GGCAMLP 249

Query: 223 PCYVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSP-PSIVDW-AAPLIKKGK 275
             ++ P+       ++KTD +SFG+LL EI S       G+ P PS  +      +  G 
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL------GYMPYPSKSNQEVLEFVTSGG 303

Query: 276 ILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
                  R+ PPK+      +  I  +C +   E RP+   I++ +   ++
Sbjct: 304 -------RMDPPKN--CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  109 bits (274), Expect = 7e-27
 Identities = 51/149 (34%), Positives = 83/149 (55%), Gaps = 11/149 (7%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVN 113
           +     LG G+ G VYKA  +  G   A K   +K++E  ++   EIEIL+    P +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 114 LLG-FSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL-QVAKAVEILHSEM 170
           LLG + +D K  L +++EF   G +  ++   +R L   + I++   Q+ +A+  LHS+ 
Sbjct: 81  LLGAYYHDGK--LWIMIEFCPGGAVDAIMLELDRGLTEPQ-IQVVCRQMLEALNFLHSKR 137

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLA 199
             IIHRD+K+ NVL+    + RL DFG++
Sbjct: 138 --IIHRDLKAGNVLMTLEGDIRLADFGVS 164

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  108 bits (272), Expect = 8e-27
 Identities = 64/297 (21%), Positives = 111/297 (37%), Gaps = 68/297 (22%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKI-HSPR 110
           F E + +G G  GSV+K V R  G   A+K+   P       Q    E+   + +     
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 111 LVNLLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRPLNWG--RRIR-LALQVAKAVEIL 166
           +V     +    D +L+  E+ + G+L D +  N R +++     ++ L LQV + +  +
Sbjct: 73  VVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 167 HSEMPPIIHRDIKSANVLIDRN-------------------FNARLGDFGLALRCGVDNF 207
           HS    ++H DIK +N+ I R                       ++GD G   R      
Sbjct: 132 HSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----- 184

Query: 208 RFRSTPPAGTIGYLDPCYVTP----DNLS--TKTDVFSFGILLLEIISCRKAIDIGFSPP 261
               + P    G  D  ++      +N +   K D+F+  + ++               P
Sbjct: 185 ----SSPQVEEG--DSRFLANEVLQENYTHLPKADIFALALTVVCAAG-------AEPLP 231

Query: 262 SIVD-WAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
              D W    I++G++     PRIP        + L       +    ERRPS   +
Sbjct: 232 RNGDQWHE--IRQGRL-----PRIPQVLSQEFTELLK----VMIHPDPERRPSAMAL 277

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  109 bits (274), Expect = 9e-27
 Identities = 60/291 (20%), Positives = 127/291 (43%), Gaps = 62/291 (21%)

Query: 61  KLLGKGSHGSVYKAVLRGR------QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           K+LG G+ G+VYK +           VA+K  + + + + ++E+ +E  +++ + +P + 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            LLG    S    L+ + M  G L D +  +   +     +   +Q+AK +  L  +   
Sbjct: 81  RLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRR- 137

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT----- 227
           ++HRD+ + NVL+    + ++ DFGLA        +         +G  +  Y       
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLA--------KL--------LGAEEKEYHAEGGKV 181

Query: 228 ------PDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSP-PSIVDWAAP-LIKKG 274
                  +++     + ++DV+S+G+ + E+++       G  P   I       +++KG
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTF------GSKPYDGIPASEISSILEKG 235

Query: 275 KILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           +       R+P P    I    + +I V+C     + RP  +E++   + +
Sbjct: 236 E-------RLPQPPICTI---DVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  108 bits (272), Expect = 9e-27
 Identities = 65/283 (22%), Positives = 118/283 (41%), Gaps = 57/283 (20%)

Query: 63  LGKGSHGSVYKAVLRGR----QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           LG G+ GSV + V R R     VA+K  K    +  ++E+  E +I+ ++ +P +V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
               ++  +LV+E    G L+  L      +       L  QV+  ++ L  E    +HR
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKN-FVHR 134

Query: 177 DIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT--------- 227
           D+ + NVL+     A++ DFGL+        +         +G  D  Y           
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLS--------KA--------LGADDSYYTARSAGKWPLK 178

Query: 228 ---PDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV 279
              P+ +     S+++DV+S+G+ + E +S  +        P ++      I++GK    
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIEQGK---- 230

Query: 280 FDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
              R+  P + P    +L  +   C     E RP    +   +
Sbjct: 231 ---RMECPPECP---PELYALMSDCWIYKWEDRPDFLTVEQRM 267

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  108 bits (273), Expect = 1e-26
 Identities = 62/230 (26%), Positives = 112/230 (48%), Gaps = 21/230 (9%)

Query: 29  SSKTSQKQEKPIKIQHFDYSDLEAATNG------FSEQKLLGKGSHGSVYKAVLR--GRQ 80
           S +T Q +  P +        L+  +        F   + LG+GS+GSVYKA+ +  G+ 
Sbjct: 1   SLETVQLRNPPRRQ----LKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQI 56

Query: 81  VAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLG-FSNDSKDRLLVV-EFMSNGTLYD 138
           VA+K+     ++ QE+  EI I+ +  SP +V   G +  ++   L +V E+   G++ D
Sbjct: 57  VAIKQVPVESDL-QEIIKEISIMQQCDSPHVVKYYGSYFKNTD--LWIVMEYCGAGSVSD 113

Query: 139 VLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
           ++   N+ L       +     K +E LH      IHRDIK+ N+L++   +A+L DFG+
Sbjct: 114 IIRLRNKTLTEDEIATILQSTLKGLEYLHFM--RKIHRDIKAGNILLNTEGHAKLADFGV 171

Query: 199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEII 248
           A +  + +   +     GT  ++ P  +     +   D++S GI  +E+ 
Sbjct: 172 AGQ--LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMA 219

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  111 bits (278), Expect = 1e-26
 Identities = 71/306 (23%), Positives = 111/306 (36%), Gaps = 54/306 (17%)

Query: 57  FSEQKLLGKGSHGSVYKA-VLRGRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNL 114
              +K+LG GS G+V      +GR VAVK+   +         EI++L++    P ++  
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--DIALMEIKLLTESDDHPNVIRY 74

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRR------IRLALQVAKAVEILHS 168
                  +   + +E   N  L D++ S N      +       I L  Q+A  V  LHS
Sbjct: 75  YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133

Query: 169 EMPPIIHRDIKSANVLID-------------RNFNARLGDFGLA--LRCGVDNFRFRSTP 213
               IIHRD+K  N+L+               N    + DFGL   L  G  +FR     
Sbjct: 134 LK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191

Query: 214 PAGTIGYLDP-------CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDW 266
           P+GT G+  P          T   L+   D+FS G +   I+S       G  P      
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK------GKHPFGDKYS 245

Query: 267 AAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSC----RERRPSMKEIVD--W 320
               I +G      D         ++ +     A   +         +RP+  +++    
Sbjct: 246 RESNIIRGIF--SLDEMKCLHDRSLIAE-----ATDLISQMIDHDPLKRPTAMKVLRHPL 298

Query: 321 LTGLSK 326
               SK
Sbjct: 299 FWPKSK 304

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  108 bits (272), Expect = 1e-26
 Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 33/215 (15%)

Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKKPS--KNQEISQEVDNEIEILSKIHSPRLV 112
           +  Q+++G G+   V  A    +  +VA+K+ +  K Q    E+  EI+ +S+ H P +V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 113 NLLG-FSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVA-------KAV 163
           +    F    +  L LV++ +S G++ D++            +     +A       + +
Sbjct: 77  SYYTSFVVKDE--LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFG----LALRCGVDNFRFRSTPPAGTIG 219
           E LH      IHRD+K+ N+L+  + + ++ DFG    LA    +   + R T   GT  
Sbjct: 135 EYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT-FVGT-- 189

Query: 220 YLDPCYVTP------DNLSTKTDVFSFGILLLEII 248
              PC++ P           K D++SFGI  +E+ 
Sbjct: 190 ---PCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  108 bits (272), Expect = 1e-26
 Identities = 70/306 (22%), Positives = 125/306 (40%), Gaps = 66/306 (21%)

Query: 61  KLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRL 111
           + LG+G+ G V+ A             VAVK  K        ++   E E+L+ +    +
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA-RKDFQREAELLTNLQHEHI 79

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSN---------------NRPLNWGRRIRLA 156
           V   G   D    ++V E+M +G L   L ++                  L   + + +A
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDNFRFRS--- 211
            Q+A  +  L S+    +HRD+ + N L+  N   ++GDFG++ R     D +R      
Sbjct: 140 SQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMS-RDVYSTDYYRVGGHTM 196

Query: 212 -----TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSIVD 265
                 PP      +   +      +T++DV+SFG++L EI +       G  P   + +
Sbjct: 197 LPIRWMPPE---SIMYRKF------TTESDVWSFGVILWEIFTY------GKQPWFQLSN 241

Query: 266 W-AAPLIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTG 323
                 I +G++L         P+  P   K++  + + C +   ++R ++KEI   L  
Sbjct: 242 TEVIECITQGRVL-------ERPRVCP---KEVYDVMLGCWQREPQQRLNIKEIYKILHA 291

Query: 324 LSKLVP 329
           L K  P
Sbjct: 292 LGKATP 297

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  109 bits (274), Expect = 1e-26
 Identities = 78/307 (25%), Positives = 124/307 (40%), Gaps = 74/307 (24%)

Query: 61  KLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIEILSKIHS-PR 110
           K+LG G+ G V  A   G        QVAVK  K   +    + + +E+++++++ S   
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSN----------------------NRPLN 148
           +VNLLG    S    L+ E+   G L + L S                          L 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 149 WGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDN 206
           +   +  A QVAK +E L  +    +HRD+ + NVL+      ++ DFGLA R      N
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLA-RDIMSDSN 227

Query: 207 FRFRS--------TPP-AGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIG 257
           +  R           P +      +  Y      + K+DV+S+GILL EI S      +G
Sbjct: 228 YVVRGNARLPVKWMAPES----LFEGIY------TIKSDVWSYGILLWEIFS------LG 271

Query: 258 FSP-PSIVDWA--APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSM 314
            +P P I   A    LI+ G        ++  P      +++ +I   C      +RPS 
Sbjct: 272 VNPYPGIPVDANFYKLIQNGF-------KMDQPFY--ATEEIYIIMQSCWAFDSRKRPSF 322

Query: 315 KEIVDWL 321
             +  +L
Sbjct: 323 PNLTSFL 329

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  108 bits (272), Expect = 2e-26
 Identities = 47/214 (21%), Positives = 80/214 (37%), Gaps = 35/214 (16%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE--VDNEIEILSKIHSPRLVNLLG 116
            +LG+G+  +V++   +  G   A+K  +    +        E E+L K++   +V L  
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 117 FSNDSKDRL--LVVEFMSNGTLYDVLHSNNRPLNWGRR--IRLALQVAKAVEILHSEMPP 172
              ++  R   L++EF   G+LY VL   +          + +   V   +  L      
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132

Query: 173 IIHRDIKSANVLI----DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
           I+HR+IK  N++     D     +L DFG A     D   F S    GT       Y+ P
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSL--YGT-----EEYLHP 184

Query: 229 DNLST-------------KTDVFSFGILLLEIIS 249
           D                   D++S G+      +
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  109 bits (273), Expect = 2e-26
 Identities = 45/275 (16%), Positives = 88/275 (32%), Gaps = 39/275 (14%)

Query: 26  QTQSSKTSQKQEKPIKIQHF-DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR------- 77
               S      E   K+      ++ +  +       LLG+G+   VY+A          
Sbjct: 35  SKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKN 94

Query: 78  GRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGT 135
            ++  +K  KP+   E        +E L        +            +LV E  S GT
Sbjct: 95  KQKFVLKVQKPANPWEFYIGT-QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153

Query: 136 LYDVL----HSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI------ 185
           L + +    ++  + +  G  I  A+++   +E +H     IIH DIK  N ++      
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLE 211

Query: 186 -----DRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVF 238
                D +    L D G +  ++       F +     T G+     ++    + + D F
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK--CETSGFQCVEMLSNKPWNYQIDYF 269

Query: 239 SFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK 273
                +  ++        G       +      + 
Sbjct: 270 GVAATVYCMLF-------GTYMKVKNEGGECKPEG 297

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  109 bits (274), Expect = 2e-26
 Identities = 50/209 (23%), Positives = 81/209 (38%), Gaps = 35/209 (16%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE--VDNEIEILSKIHSPRLVNLLG 116
            +LG+G+  +V++   +  G   A+K  +    +        E E+L K++   +V L  
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 117 FSNDSKDRL--LVVEFMSNGTLYDVL--HSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
              ++  R   L++EF   G+LY VL   SN   L     + +   V   +  L      
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132

Query: 173 IIHRDIKSANVLI----DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
           I+HR+IK  N++     D     +L DFG A     D   F S    GT       Y+ P
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSL--YGT-----EEYLHP 184

Query: 229 DNLST-------------KTDVFSFGILL 244
           D                   D++S G+  
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  108 bits (271), Expect = 2e-26
 Identities = 78/303 (25%), Positives = 119/303 (39%), Gaps = 66/303 (21%)

Query: 61  KLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIEILSKIHS-PR 110
           K LG+G+ G V +A   G       R VAVK  K        + + +E++IL  I     
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 111 LVNLLGF-SNDSKDRLLVVEFMSNGTLYDVL---------------HSNNRPLNWGRRIR 154
           +VNLLG  +      +++VEF   G L   L                     L     I 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 155 LALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDNFRFRS- 211
            + QVAK +E L S     IHRD+ + N+L+      ++ DFGLA R      ++  +  
Sbjct: 153 YSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLA-RDIYKDPDYVRKGD 209

Query: 212 -------TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSI 263
                    P       D  Y      + ++DV+SFG+LL EI S      +G SP P +
Sbjct: 210 ARLPLKWMAPE---TIFDRVY------TIQSDVWSFGVLLWEIFS------LGASPYPGV 254

Query: 264 VDWA--APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
                    +K+G        R+  P       ++    + C      +RP+  E+V+ L
Sbjct: 255 KIDEEFCRRLKEGT-------RMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

Query: 322 TGL 324
             L
Sbjct: 306 GNL 308

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  106 bits (268), Expect = 3e-26
 Identities = 61/283 (21%), Positives = 114/283 (40%), Gaps = 46/283 (16%)

Query: 60  QKLLGKGSHGSVYKAVLRGR-----QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
            + +G+G  G V++ +          VA+K  K   +  + ++   E   + +   P +V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 113 NLLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
            L+G    +++ + ++ E  + G L   L      L+    I  A Q++ A+  L     
Sbjct: 80  KLIGVI--TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-ESKR 136

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN---------FRFRSTPPAGTIGYLD 222
             +HRDI + NVL+  N   +LGDFGL+ R   D+            +   P  +I +  
Sbjct: 137 -FVHRDIAARNVLVSSNDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPE-SINF-- 191

Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP 282
                    ++ +DV+ FG+ + EI+        G     ++      I+ G+       
Sbjct: 192 ------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG----RIENGE------- 234

Query: 283 RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           R+P P + P     L  +  +C      RRP   E+   L+ +
Sbjct: 235 RLPMPPNCP---PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  107 bits (270), Expect = 3e-26
 Identities = 59/283 (20%), Positives = 118/283 (41%), Gaps = 44/283 (15%)

Query: 60  QKLLGKGSHGSVYKAVLRGR------QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRL 111
            K+LG G  G+V+K V           V +K  +    ++  Q V + +  +  +    +
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V LLG    S    LV +++  G+L D +  +   L     +   +Q+AK +  L  E  
Sbjct: 78  VRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL-EEHG 135

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN---------FRFRSTPPAGTIGYLD 222
            ++HR++ + NVL+      ++ DFG+A     D+            +      +I +  
Sbjct: 136 -MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE-SIHF-- 191

Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP 282
                    + ++DV+S+G+ + E+++       G     + D    L++KG+       
Sbjct: 192 ------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD----LLEKGE------- 234

Query: 283 RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           R+  P+   I    + ++ V+C       RP+ KE+ +  T +
Sbjct: 235 RLAQPQICTI---DVYMVMVKCWMIDENIRPTFKELANEFTRM 274

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  106 bits (268), Expect = 3e-26
 Identities = 68/285 (23%), Positives = 112/285 (39%), Gaps = 46/285 (16%)

Query: 60  QKLLGKGSHGSVYKAVLRGR-----QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
            ++LG+G  G VY+ V          VAVK  K     +  ++  +E  I+  +  P +V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 113 NLLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
            L+G     ++   ++ E    G L   L  N   L     +  +LQ+ KA+  L S   
Sbjct: 77  KLIGII--EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN- 133

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN---------FRFRSTPPAGTIGYLD 222
             +HRDI   N+L+      +LGDFGL+ R   D             +   P   I +  
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLS-RYIEDEDYYKASVTRLPIKWMSPES-INF-- 188

Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP 282
                    +T +DV+ F + + EI+S  K          ++     +++KG        
Sbjct: 189 ------RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG----VLEKGD------- 231

Query: 283 RIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
           R+P P   P     L  +  RC       RP   E+V  L+ + +
Sbjct: 232 RLPKPDLCP---PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  106 bits (268), Expect = 3e-26
 Identities = 65/318 (20%), Positives = 117/318 (36%), Gaps = 72/318 (22%)

Query: 41  KIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGR-------QVAVK--KPSKNQE 91
           K++    S +          + LG+   G VYK  L G         VA+K  K      
Sbjct: 2   KLKEISLSAVRF-------MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP 54

Query: 92  ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSN-------- 143
           + +E  +E  + +++  P +V LLG     +   ++  + S+G L++ L           
Sbjct: 55  LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGS 114

Query: 144 -------NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDF 196
                     L     + L  Q+A  +E L S    ++H+D+ + NVL+    N ++ D 
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYL-SSH-HVVHKDLATRNVLVYDKLNVKISDL 172

Query: 197 GLALRC--GVDNFRFRS--------TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLE 246
           GL  R     D ++             P      +   +      S  +D++S+G++L E
Sbjct: 173 GLF-REVYAADYYKLLGNSLLPIRWMAPE---AIMYGKF------SIDSDIWSYGVVLWE 222

Query: 247 IISCRKAIDIGFSP-PSIVDW-AAPLIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRC 303
           + S       G  P     +     +I+  +        +P P D P     +  + + C
Sbjct: 223 VFS------YGLQPYCGYSNQDVVEMIRNRQ-------VLPCPDDCP---AWVYALMIEC 266

Query: 304 VRSCRERRPSMKEIVDWL 321
                 RRP  K+I   L
Sbjct: 267 WNEFPSRRPRFKDIHSRL 284

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  111 bits (278), Expect = 4e-26
 Identities = 61/270 (22%), Positives = 115/270 (42%), Gaps = 26/270 (9%)

Query: 60  QKLLGKGSHGSVYKAVLRGR-----QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
            + +G+G  G V++ +          VA+K  K   +  + ++   E   + +   P +V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            L+G   ++    +++E  + G L   L      L+    I  A Q++ A+  L      
Sbjct: 455 KLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL-ESKR- 511

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
            +HRDI + NVL+  N   +LGDFGL+ R   D+  ++++     I ++ P  +     +
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570

Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD-PI 291
           + +DV+ FG+ + EI+        G     ++      I+ G+       R+P P + P 
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG----RIENGE-------RLPMPPNCP- 618

Query: 292 VRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
               L  +  +C      RRP   E+   L
Sbjct: 619 --PTLYSLMTKCWAYDPSRRPRFTELKAQL 646

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  108 bits (272), Expect = 4e-26
 Identities = 42/305 (13%), Positives = 94/305 (30%), Gaps = 71/305 (23%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVK--------------------------KPSKNQEI 92
            +LG+    +  +A     G    V                           +  KNQ+ 
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 93  SQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF-------MSNGTLYDVLHS--- 142
           ++     I     +  P+   ++    D +D  ++  F        +  T  +VL S   
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 143 NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC 202
            ++ L    R++L LQV + +  LH     ++H  ++  ++++D+     L  F   +R 
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 203 GVDNFRFRSTPPAGTIGYLDPCYVT-----PDNLSTKTDVFSFGILLLEIISCRKAIDIG 257
           G  +                   +      P  ++   D ++ G+ +  I          
Sbjct: 262 G-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC-------A 313

Query: 258 FSP---PSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSM 314
             P    + +  +  + +           IP P   ++   L           +E R   
Sbjct: 314 DLPNTDDAALGGSEWIFRS-------CKNIPQPVRALLEGFLRYP--------KEDRLLP 358

Query: 315 KEIVD 319
            + ++
Sbjct: 359 LQAME 363

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  106 bits (267), Expect = 4e-26
 Identities = 69/291 (23%), Positives = 111/291 (38%), Gaps = 61/291 (20%)

Query: 60  QKLLGKGSHGSVYKAVLRGR-----QVAVK--KPSKNQEISQEVD--NEIEILSKIHSPR 110
            + LG GS G V +            VAVK  KP    +     D   E+  +  +    
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 111 LVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           L+ L G        + +V E    G+L D L  +      G   R A+QVA+ +  L  E
Sbjct: 83  LIRLYGVV--LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL--E 138

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
               IHRD+ + N+L+      ++GDFGL         R         +   D  YV  +
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLM--------RA--------LPQNDDHYVMQE 182

Query: 230 NL-----------------STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK 272
           +                  S  +D + FG+ L E+ +  +   IG +   I+     + K
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK---IDK 239

Query: 273 KGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT 322
           +G+       R+P P+D P     +  + V+C     E RP+   + D+L 
Sbjct: 240 EGE-------RLPRPEDCPQ---DIYNVMVQCWAHKPEDRPTFVALRDFLL 280

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  109 bits (274), Expect = 1e-25
 Identities = 64/286 (22%), Positives = 118/286 (41%), Gaps = 57/286 (19%)

Query: 60  QKLLGKGSHGSVYKAVLRGR----QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
              LG G+ GSV + V R R     VA+K  K    +  ++E+  E +I+ ++ +P +V 
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G    ++  +LV+E    G L+  L      +       L  QV+  ++ L  E    
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKN-F 457

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT------ 227
           +HR++ + NVL+     A++ DFGL+        +         +G  D  Y        
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLS--------KA--------LGADDSYYTARSAGKW 501

Query: 228 ------PDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI 276
                 P+ +     S+++DV+S+G+ + E +S  +        P ++      I++GK 
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIEQGK- 556

Query: 277 LSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
                 R+  P + P    +L  +   C     E RP    +   +
Sbjct: 557 ------RMECPPECP---PELYALMSDCWIYKWEDRPDFLTVEQRM 593

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  105 bits (265), Expect = 2e-25
 Identities = 68/298 (22%), Positives = 117/298 (39%), Gaps = 61/298 (20%)

Query: 61  KLLGKGSHGSVYKAVLRGR-------QVAVK--KPSKNQEISQEVDNEIEILSKIHSPRL 111
             LG+G+ G V+ A             VAVK  K +      Q+   E E+L+ +    +
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR-QDFQREAELLTMLQHQHI 105

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVL--------------HSNNRPLNWGRRIRLAL 157
           V   G   + +  L+V E+M +G L   L                   PL  G+ + +A 
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 158 QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA---------LRCGVDNFR 208
           QVA  +  L       +HRD+ + N L+ +    ++GDFG++            G     
Sbjct: 166 QVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223

Query: 209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSIVDW- 266
            R  PP      L   +      +T++DV+SFG++L EI +       G  P   + +  
Sbjct: 224 IRWMPPE---SILYRKF------TTESDVWSFGVVLWEIFTY------GKQPWYQLSNTE 268

Query: 267 AAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
           A   I +G+        +  P+      ++  I   C +   ++R S+K++   L  L
Sbjct: 269 AIDCITQGR-------ELERPRA--CPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  105 bits (263), Expect = 2e-25
 Identities = 60/203 (29%), Positives = 108/203 (53%), Gaps = 24/203 (11%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPS--KNQEISQEVDNEIEILSKIHSPRLV 112
           F++ + +GKGS G V+K +     + VA+K     + ++  +++  EI +LS+  SP + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 113 NLLG-FSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
              G +  D+K  L +++E++  G+  D+L     PL+  +   +  ++ K ++ LHSE 
Sbjct: 84  KYYGSYLKDTK--LWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEK 139

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
              IHRDIK+ANVL+  +   +L DFG+A     D    R+T   GT     P ++ P+ 
Sbjct: 140 --KIHRDIKAANVLLSEHGEVKLADFGVA-GQLTDTQIKRNT-FVGT-----PFWMAPEV 190

Query: 231 LS-----TKTDVFSFGILLLEII 248
           +      +K D++S GI  +E+ 
Sbjct: 191 IKQSAYDSKADIWSLGITAIELA 213

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  105 bits (264), Expect = 3e-25
 Identities = 46/192 (23%), Positives = 77/192 (40%), Gaps = 11/192 (5%)

Query: 15  ISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKA 74
           I T  N              +          +    +     FS+ + +G GS G+VY A
Sbjct: 14  IPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFA 73

Query: 75  VLR--GRQVAVKK----PSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV 128
                   VA+KK      ++ E  Q++  E+  L K+  P  +   G     +    +V
Sbjct: 74  RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG-CYLREHTAWLV 132

Query: 129 -EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR 187
            E+   G+  D+L  + +PL       +     + +  LHS    +IHRD+K+ N+L+  
Sbjct: 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSE 189

Query: 188 NFNARLGDFGLA 199
               +LGDFG A
Sbjct: 190 PGLVKLGDFGSA 201

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  105 bits (264), Expect = 3e-25
 Identities = 73/363 (20%), Positives = 135/363 (37%), Gaps = 80/363 (22%)

Query: 9   ESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSH 68
           ESA   ++T  + +   +   +      ++   + +     LE   N     + +G+G+ 
Sbjct: 4   ESAAVTLTTLPSELLLDRLHPN---PMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAF 60

Query: 69  GSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           G V++A   G         VAVK  K   + ++  +   E  ++++  +P +V LLG   
Sbjct: 61  GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120

Query: 120 DSKDRLLVVEFMSNGTLYDVLHSN-----------------------NRPLNWGRRIRLA 156
             K   L+ E+M+ G L + L S                          PL+   ++ +A
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180

Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDNFRFRSTPP 214
            QVA  +  L       +HRD+ + N L+  N   ++ DFGL+ R     D ++      
Sbjct: 181 RQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLS-RNIYSADYYK------ 231

Query: 215 AGTIGYLDPCYVTP----------DNL-STKTDVFSFGILLLEIISCRKAIDIGFSP-PS 262
           A     +      P           N  +T++DV+++G++L EI S       G  P   
Sbjct: 232 ADGNDAI------PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY------GLQPYYG 279

Query: 263 IVDW-AAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
           +        ++ G         +  P++     +L  +   C       RPS   I   L
Sbjct: 280 MAHEEVIYYVRDGN-------ILACPEN--CPLELYNLMRLCWSKLPADRPSFCSIHRIL 330

Query: 322 TGL 324
             +
Sbjct: 331 QRM 333

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  105 bits (263), Expect = 4e-25
 Identities = 38/320 (11%), Positives = 89/320 (27%), Gaps = 78/320 (24%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN-------------------- 98
            +LG+    +  +A  +  G    V  P   +                            
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 99  ---------EIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM----SNGTLYDVLHS--- 142
                      +++      +++ +     D         +     +  T  +VL S   
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 143 NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC 202
            ++ L    R++L LQV + +  LH     ++H  ++  ++++D+     L  F   +R 
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 203 GVDNFRFRSTPPAGTIGYLDPCYVTPDNL-----------STKTDVFSFGILLLEIISCR 251
           G           + + G+  P                   +   D ++ G+++  I    
Sbjct: 257 G------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC-- 308

Query: 252 KAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERR 311
                   P          +   + +      IP P   ++   L           +E R
Sbjct: 309 -----ADLP----ITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYP--------KEDR 351

Query: 312 PSMKEIVD--WLTGLSKLVP 329
               + ++      L   + 
Sbjct: 352 LLPLQAMETPEYEQLRTELS 371

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  103 bits (260), Expect = 4e-25
 Identities = 67/294 (22%), Positives = 120/294 (40%), Gaps = 71/294 (24%)

Query: 59  EQKLLGKGSHGSVYKAVLRGR----QVAVK--KP-SKNQEISQEVDNEIEILSKIHSPRL 111
           E K LG G+ G+V K   + +     VAVK  K  + +  +  E+  E  ++ ++ +P +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V ++G   +++  +LV+E    G L   L   NR +     I L  QV+  ++ L  E  
Sbjct: 81  VRMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYL--EES 136

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT---- 227
             +HRD+ + NVL+     A++ DFGL+        +         +   +  Y      
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLS--------KA--------LRADENYYKAQTHG 180

Query: 228 --------PDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSP------PSIVDWAA 268
                   P+ +     S+K+DV+SFG+L+ E  S       G  P        +     
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY------GQKPYRGMKGSEVTA--- 231

Query: 269 PLIKKGKILSVFDPRIPPPKD-PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
            +++KG+       R+  P   P   +++  +   C     E RP    +   L
Sbjct: 232 -MLEKGE-------RMGCPAGCP---REMYDLMNLCWTYDVENRPGFAAVELRL 274

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  103 bits (258), Expect = 9e-25
 Identities = 57/249 (22%), Positives = 105/249 (42%), Gaps = 22/249 (8%)

Query: 60  QKLLGKGSHGSVYKAV--LRGRQVAVK--KP--SKNQEISQEVDNEIEILSKIHSPRLVN 113
              LG G   +VY A   +   +VA+K       + +E  +  + E+   S++    +V+
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           ++    +     LV+E++   TL + + S+  PL+    I    Q+   ++  H     I
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR--I 132

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA-GTIGYLDPCYVTPDNLS 232
           +HRDIK  N+LID N   ++ DFG+A    +       T    GT+ Y  P     +   
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSI----VDWAAPLIKKGKILSVFDPRIPPPK 288
             TD++S GI+L E++      + G +  SI    +  + P      + +     IP   
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFN-GETAVSIAIKHIQDSVP-----NVTTDVRKDIPQSL 244

Query: 289 DPIVRKQLA 297
             ++ +   
Sbjct: 245 SNVILRATE 253

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  103 bits (259), Expect = 1e-24
 Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 14/179 (7%)

Query: 32  TSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN 89
           +         +   D S L      F   +L+G G++G VYK      G+  A+K     
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 90  QEISQEVDNEIEILSKI-HSPRLVNLLG-----FSNDSKDRL-LVVEFMSNGTLYDVLHS 142
            +  +E+  EI +L K  H   +    G           D+L LV+EF   G++ D++ +
Sbjct: 61  GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120

Query: 143 -NNRPLNWGRRIRLAL-QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
                L     I     ++ + +  LH     +IHRDIK  NVL+  N   +L DFG++
Sbjct: 121 TKGNTLK-EEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 176

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  103 bits (259), Expect = 1e-24
 Identities = 39/313 (12%), Positives = 82/313 (26%), Gaps = 60/313 (19%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS----QEVDNEIEILSKI-------- 106
           + L  G    V+           A+K  +   E S    + +       +++        
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 107 ----------------HSPRLVNLLGFSND--SKDRLLVVEFMS-----NGTLYDVLHSN 143
                             P    L    +D    + LL++   S       +  D ++  
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 144 NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG 203
                      L  Q+ +    L S+   ++H      N+ I  +    LGD     + G
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

Query: 204 VDNFRFRSTPPAGTIGYLDPCYVTPDNL--STKTDVFSFGILLLEIISCRKAIDIGFSPP 261
                 R    +  + Y    ++       +   + +  G+ +  +  C        +P 
Sbjct: 246 T-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW-CLFLPFGLVTPG 299

Query: 262 SIVDWAAPL---IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
               W  P         +       +P     ++ + L           R RR    E +
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF--------DRRRRLLPLEAM 351

Query: 319 D--WLTGLSKLVP 329
           +      L   + 
Sbjct: 352 ETPEFLQLQNEIS 364

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  105 bits (264), Expect = 2e-24
 Identities = 61/293 (20%), Positives = 98/293 (33%), Gaps = 42/293 (14%)

Query: 61  KLLGKGSHGSVYKAV--LRGRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLL- 115
           + LG G  G V + +    G QVA+K  +   + +  +    EI+I+ K++ P +V+   
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79

Query: 116 -----GFSNDSKDRLLVVEFMSNGTLYDVL--HSNNRPLNWGRRIRLALQVAKAVEILHS 168
                     +   LL +E+   G L   L    N   L  G    L   ++ A+  LH 
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139

Query: 169 EMPPIIHRDIKSANVLIDRNFNAR---LGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
               IIHRD+K  N+++          + D G A                GT       Y
Sbjct: 140 NR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEF--VGT-----LQY 189

Query: 226 VTPDNLSTK-----TDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF 280
           + P+ L  K      D +SFG L  E I+       GF  P + +W        K+    
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECIT-------GF-RPFLPNWQPVQWHG-KVREKS 240

Query: 281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSW 333
           +  I    D          +               ++  WL  +         
Sbjct: 241 NEHIVVYDDL---TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG 290

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  103 bits (258), Expect = 2e-24
 Identities = 56/230 (24%), Positives = 106/230 (46%), Gaps = 25/230 (10%)

Query: 26  QTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAV 83
           + Q  +      +  K+      D E       +   LG G+ G V+K   +  G  +A 
Sbjct: 11  EQQRKRLEAFLTQKQKVGELKDDDFE-------KISELGAGNGGVVFKVSHKPSGLVMAR 63

Query: 84  KK--PSKNQEISQEVDNEIEILSKIHSPRLVNLLG-FSNDSKDRLLVVEFMSNGTLYDVL 140
           K         I  ++  E+++L + +SP +V   G F +D  +  + +E M  G+L  VL
Sbjct: 64  KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL 122

Query: 141 HSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
               R P     ++  ++ V K +  L  +   I+HRD+K +N+L++     +L DFG++
Sbjct: 123 KKAGRIPEQILGKV--SIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS 179

Query: 200 LRCGVDNFR--FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEI 247
            +  +D+    F      GT  Y+ P  +   + S ++D++S G+ L+E+
Sbjct: 180 GQL-IDSMANSF-----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 99.6 bits (248), Expect = 5e-23
 Identities = 44/212 (20%), Positives = 88/212 (41%), Gaps = 27/212 (12%)

Query: 57  FSEQKLLGKG--SHGSVYKA--VLRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSP 109
           +    ++GKG     +V  A     G  V V++    + + E+   +  E+ +    + P
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 110 RLVNLLG-FSNDSKDRLLVV-EFMSNGTLYDVLHSN-NRPLNWGRRIRLAL-QVAKAVEI 165
            +V     F  D++  L VV  FM+ G+  D++ ++    +N    I   L  V KA++ 
Sbjct: 87  NIVPYRATFIADNE--LWVVTSFMAYGSAKDLICTHFMDGMNELA-IAYILQGVLKALDY 143

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDP 223
           +H      +HR +K++++LI  +    L        +       R     P  ++     
Sbjct: 144 IHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK--VL 199

Query: 224 CYVTPDNLS-------TKTDVFSFGILLLEII 248
            +++P+ L         K+D++S GI   E+ 
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 98.8 bits (246), Expect = 5e-23
 Identities = 46/246 (18%), Positives = 86/246 (34%), Gaps = 30/246 (12%)

Query: 84  KKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSN 143
             P  +         +I  +    +   V  L  S+      + ++      L D ++  
Sbjct: 96  DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155

Query: 144 NR--PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR 201
                   G  + + +Q+A+AVE LHS+   ++HRD+K +N+    +   ++GDFGL   
Sbjct: 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213

Query: 202 CGVDNFRFRSTPPAGTIGYLD-----PCYVTPDNLS-----TKTDVFSFGILLLEIISCR 251
              D        P               Y++P+ +       K D+FS G++L E++   
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL--- 270

Query: 252 KAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERR 311
                 FS           ++  K      P +   K P       ++    +      R
Sbjct: 271 ----YSFSTQMERVRIITDVRNLKF-----PLLFTQKYPQEHM---MVQ-DMLSPSPTER 317

Query: 312 PSMKEI 317
           P   +I
Sbjct: 318 PEATDI 323

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 14/61 (22%), Positives = 30/61 (49%), Gaps = 4/61 (6%)

Query: 57  FSEQKLLGKGSHGSVYKA--VLRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           F   + +G+G  G V++A   +     A+K+      +   ++V  E++ L+K+  P +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 113 N 113
            
Sbjct: 68  R 68

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 99.4 bits (248), Expect = 6e-23
 Identities = 56/239 (23%), Positives = 105/239 (43%), Gaps = 24/239 (10%)

Query: 25  HQTQSSKTSQKQEKPIKIQH----------FDYSDLEAATNGFSEQ----KLLGKGSHGS 70
           H    SK   K + P    +          +    +E       +     + LG G+ G 
Sbjct: 7   HHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGV 66

Query: 71  VYKAVLR--GRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV 127
           V++ V +  GR    K  +    + +  V NEI I++++H P+L+NL     D  + +L+
Sbjct: 67  VHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126

Query: 128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR 187
           +EF+S G L+D + + +  ++    I    Q  + ++ +H     I+H DIK  N++ + 
Sbjct: 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCET 184

Query: 188 NFNARL--GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILL 244
              + +   DFGLA +   D    + T    T  +  P  V  + +   TD+++ G+L 
Sbjct: 185 KKASSVKIIDFGLATKLNPDE-IVKVT--TATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 97.3 bits (243), Expect = 1e-22
 Identities = 65/253 (25%), Positives = 108/253 (42%), Gaps = 25/253 (9%)

Query: 60  QKLLGKGSHGSVYKAV-LR-GRQVAVK--KP--SKNQEISQEVDNEIEILSKIHSPRLVN 113
            ++LG G    V+ A  LR  R VAVK  +   +++         E +  + ++ P +V 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 114 LL--GFSNDSKDRL--LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           +   G +      L  +V+E++   TL D++H+   P+   R I +     +A+   H  
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQN 135

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA-GTIGYLDPCYVTP 228
              IIHRD+K AN++I      ++ DFG+A            T    GT  YL P     
Sbjct: 136 G--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSI----VDWAAPLIKKGKILSVFDPRI 284
           D++  ++DV+S G +L E+++       G SP S+    V             S     +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIP------PSARHEGL 246

Query: 285 PPPKDPIVRKQLA 297
               D +V K LA
Sbjct: 247 SADLDAVVLKALA 259

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 22/196 (11%)

Query: 60  QKLLGKGSHGSVYKA--VLRGRQVAVK---KPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
            K +GKG+   V  A  +L GR+VA+K   K   N    Q++  E+ I+  ++ P +V L
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
                  K   L++E+ S G ++D L ++ R +          Q+  AV+  H +   I+
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCHQKR--IV 136

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS-- 232
           HRD+K+ N+L+D + N ++ DFG +    V           G      P Y  P+     
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGA-----PPYAAPELFQGK 188

Query: 233 ----TKTDVFSFGILL 244
                + DV+S G++L
Sbjct: 189 KYDGPEVDVWSLGVIL 204

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 99.5 bits (248), Expect = 2e-22
 Identities = 57/243 (23%), Positives = 95/243 (39%), Gaps = 16/243 (6%)

Query: 7   KAESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKG 66
             E    V    + S            Q   +P++I+H    D       +   + LG G
Sbjct: 115 VDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDH------YDIHEELGTG 168

Query: 67  SHGSVYKAVLR--GRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVNLLGFSNDSKD 123
           + G V++   R  G   A K      E  +E V  EI+ +S +  P LVNL     D  +
Sbjct: 169 AFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228

Query: 124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANV 183
            +++ EFMS G L++ +   +  ++    +    QV K +  +H      +H D+K  N+
Sbjct: 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENI 286

Query: 184 LIDRNFNARL--GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFG 241
           +     +  L   DFGL           + T   GT  +  P       +   TD++S G
Sbjct: 287 MFTTKRSNELKLIDFGLTAHLD-PKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVG 343

Query: 242 ILL 244
           +L 
Sbjct: 344 VLS 346

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 97.1 bits (242), Expect = 3e-22
 Identities = 59/252 (23%), Positives = 106/252 (42%), Gaps = 17/252 (6%)

Query: 5   SCKAESAISVISTNSNSVATHQTQSSKTS-QKQEKPIKIQHFDYSDLEAATNGFSE---- 59
           S    +    + +N++       +S +TS    + P     FD+  + A     +     
Sbjct: 32  SRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTV 91

Query: 60  --QKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVNL 114
              ++LG G  G V+K      G ++A K         +E V NEI +++++    L+ L
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
                   D +LV+E++  G L+D +   +  L     I    Q+ + +  +H     I+
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--IL 209

Query: 175 HRDIKSANVLIDRNFNARL--GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           H D+K  N+L       ++   DFGLA R      + +     GT  +L P  V  D +S
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVN--FGTPEFLAPEVVNYDFVS 266

Query: 233 TKTDVFSFGILL 244
             TD++S G++ 
Sbjct: 267 FPTDMWSVGVIA 278

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 98.4 bits (245), Expect = 5e-22
 Identities = 43/246 (17%), Positives = 86/246 (34%), Gaps = 36/246 (14%)

Query: 62  LLGKGSHGSVYKA---VLRGRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
            +  G  G +Y A    + GR V +K    S + E       E + L+++  P +V +  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 117 FSNDSKDRL-----LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           F   +         +V+E++   +L        + L     I   L++  A+  LHS   
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSI-- 201

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            +++ D+K  N+++      +L D G   R              GT G+  P  V     
Sbjct: 202 GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN------SFGYLYGTPGFQAPEIVR-TGP 253

Query: 232 STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI 291
           +  TD+++ G  L  +       + G     + +                 +       +
Sbjct: 254 TVATDIYTVGRTLAALTLDLPTRN-GRYVDGLPEDDPV------------LKTYDSYGRL 300

Query: 292 VRKQLA 297
           +R+ + 
Sbjct: 301 LRRAID 306

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 95.0 bits (237), Expect = 9e-22
 Identities = 44/188 (23%), Positives = 83/188 (44%), Gaps = 9/188 (4%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           + LG+G  G V++ V     +    K           V  EI IL+      +++L    
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
              ++ +++ EF+S   +++ ++++   LN    +    QV +A++ LHS    I H DI
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDI 128

Query: 179 KSANVLIDRNFNARL--GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTD 236
           +  N++     ++ +   +FG A +    +  FR         Y  P     D +ST TD
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLL--FTAPEYYAPEVHQHDVVSTATD 185

Query: 237 VFSFGILL 244
           ++S G L+
Sbjct: 186 MWSLGTLV 193

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 51/194 (26%), Positives = 95/194 (48%), Gaps = 15/194 (7%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVK---KPSKNQEISQEVDNEIEILSKI-HSPRLVNL 114
           K LG+G    V + + +  G++ A K   K  + Q+   E+ +EI +L      PR++NL
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYD-VLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
                ++ + +L++E+ + G ++   L      ++    IRL  Q+ + V  LH     I
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--I 152

Query: 174 IHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
           +H D+K  N+L+       + ++ DFG++ + G      R     GT  YL P  +  D 
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREI--MGTPEYLAPEILNYDP 209

Query: 231 LSTKTDVFSFGILL 244
           ++T TD+++ GI+ 
Sbjct: 210 ITTATDMWNIGIIA 223

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 19/197 (9%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVK-------KPSKNQEISQEVDNEIEILSKIHSPRL 111
           + LG G    V K   +  G + A K       + S+     +E++ E+ IL ++    +
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           + L     +  D +L++E +S G L+D L      L+         Q+   V  LH++  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYLHTKK- 135

Query: 172 PIIHRDIKSANVLI-DRNFNA---RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
            I H D+K  N+++ D+N      +L DFGLA     D   F++    GT  ++ P  V 
Sbjct: 136 -IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNI--FGTPEFVAPEIVN 191

Query: 228 PDNLSTKTDVFSFGILL 244
            + L  + D++S G++ 
Sbjct: 192 YEPLGLEADMWSIGVIT 208

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 58/245 (23%), Positives = 97/245 (39%), Gaps = 52/245 (21%)

Query: 33  SQKQEKPIKIQHFDYSDLEAATNGFSEQ----KLLGKGSHGSVYKAVLR--GRQVAVK-- 84
           S  + K          D         ++    K LG G+ G V  A  R   ++VA++  
Sbjct: 109 SLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII 168

Query: 85  -------KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLY 137
                    ++  + +  V+ EIEIL K++ P ++ +  F  D++D  +V+E M  G L+
Sbjct: 169 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELF 227

Query: 138 DVLHSNNRPLNWGRRI------------RLALQVAKAVEILHSEMPPIIHRDIKSANVLI 185
           D             ++                Q+  AV+ LH     IIHRD+K  NVL+
Sbjct: 228 D-------------KVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLL 272

Query: 186 ---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP---CYVTPDNLSTKTDVFS 239
              + +   ++ DFG +   G  +         GT  YL P     V     +   D +S
Sbjct: 273 SSQEEDCLIKITDFGHSKILGETSLMRTL---CGTPTYLAPEVLVSVGTAGYNRAVDCWS 329

Query: 240 FGILL 244
            G++L
Sbjct: 330 LGVIL 334

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 96.0 bits (239), Expect = 2e-21
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 30/227 (13%)

Query: 36  QEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS 93
           Q K ++ Q             F + ++LG+G  G V+   ++  G+  A KK +K +   
Sbjct: 173 QWKWLEAQPMGEDW-------FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK 225

Query: 94  -QEVD---NEIEILSKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLN 148
            +       E +IL+K+HS  +V+L  ++ ++K  L LV+  M+ G +    H  N   +
Sbjct: 226 RKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIR--YHIYNVDED 282

Query: 149 WGR----RIRL-ALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG 203
                  R      Q+   +E LH     II+RD+K  NVL+D + N R+ D GLA    
Sbjct: 283 NPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLA---- 336

Query: 204 VDNFRFRSTPP--AGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEII 248
           V+    ++     AGT G++ P  +  +      D F+ G+ L E+I
Sbjct: 337 VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 93.6 bits (233), Expect = 3e-21
 Identities = 66/355 (18%), Positives = 116/355 (32%), Gaps = 88/355 (24%)

Query: 26  QTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKA--VLRGRQVAV 83
           +        +     + ++                  LG G+ G V+ A    + ++V V
Sbjct: 4   EEPPKAVELEGLAACEGEYSQKYSTM---------SPLGSGAFGFVWTAVDKEKNKEVVV 54

Query: 84  K---------KPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNG 134
           K                   +V  EI ILS++    ++ +L    +     LV+E   +G
Sbjct: 55  KFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG 114

Query: 135 T-LYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL 193
             L+  +  + R L+      +  Q+  AV  L  +   IIHRDIK  N++I  +F  +L
Sbjct: 115 LDLFAFIDRHPR-LDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKL 171

Query: 194 GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK------TDVFSFGILLLEI 247
            DFG A         F +    GT       Y  P+ L          +++S G+ L  +
Sbjct: 172 IDFGSAAYLERGKL-FYTF--CGT-----IEYCAPEVLMGNPYRGPELEMWSLGVTLYTL 223

Query: 248 ISC-------RKAIDIGFSPPSIV-DWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVI 299
           +          + ++    PP +V      L+    +L    P                 
Sbjct: 224 VFEENPFCELEETVEAAIHPPYLVSKELMSLVS--GLLQP-VP----------------- 263

Query: 300 AVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSW--NGFNNPCLMVETVGRPVEV 352
                    ERR +++++V              W     N      E V R  + 
Sbjct: 264 ---------ERRTTLEKLVT-----------DPWVTQPVNLADYTWEEVFRVNKP 298

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 49/227 (21%), Positives = 90/227 (39%), Gaps = 53/227 (23%)

Query: 53  ATNGFSEQ----KLLGKGSHGSVYKAVLR--GRQVAVK----------KPSKNQEISQEV 96
           +T+GF E     ++LG+G    V + + +   ++ AVK             + QE+ +  
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 97  DNEIEILSKIHS-PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI-- 153
             E++IL K+   P ++ L      +    LV + M  G L+D              +  
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD-------------YLTE 117

Query: 154 ----------RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG 203
                     ++   + + +  LH     I+HRD+K  N+L+D + N +L DFG + +  
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175

Query: 204 VDNFRFRSTPPAGTIGYLDP------CYVTPDNLSTKTDVFSFGILL 244
                 R     GT  YL P                + D++S G+++
Sbjct: 176 PGEK-LREV--CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 51/212 (24%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVD---NEIEILSKIHSPRLVNLL 115
            +LGKGS G V K   R   ++ AVK  +K    +++      E+E+L K+  P ++ L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI------------RLALQVAKAV 163
               DS    +V E  + G L+D              I            R+  QV   +
Sbjct: 88  EILEDSSSFYIVGELYTGGELFD-------------EIIKRKRFSEHDAARIIKQVFSGI 134

Query: 164 EILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGY 220
             +H     I+HRD+K  N+L+   +++ + ++ DFGL+      N + +     GT   
Sbjct: 135 TYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDR--IGT--- 186

Query: 221 LDPCYVTPDNL----STKTDVFSFG----ILL 244
               Y+ P+ L      K DV+S G    ILL
Sbjct: 187 --AYYIAPEVLRGTYDEKCDVWSAGVILYILL 216

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 92.3 bits (230), Expect = 4e-21
 Identities = 64/278 (23%), Positives = 116/278 (41%), Gaps = 41/278 (14%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKK--PSKNQEISQEVDNEIEI-LSKIHSPRL 111
                 LG+G++G V K      G+ +AVK+   + N +  + +  +++I +  +  P  
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68

Query: 112 VNLLG-FSNDSKDRLLVVEFM--SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           V   G    +  D  + +E M  S    Y  +    + +      ++A+ + KA+E LHS
Sbjct: 69  VTFYGALFREG-DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDP--- 223
           ++  +IHRD+K +NVLI+     ++ DFG++  L   V          AG   Y+ P   
Sbjct: 128 KLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-----AGCKPYMAPERI 181

Query: 224 -CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP 282
              +     S K+D++S GI ++E+   R         P    W  P  +  ++      
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILR--------FP-YDSWGTPFQQLKQV-----V 227

Query: 283 RIPPPKDPIVRKQLAVIAVRCVRSC----RERRPSMKE 316
             P P+ P    + +   V     C     + RP+  E
Sbjct: 228 EEPSPQLP--ADKFSAEFVDFTSQCLKKNSKERPTYPE 263

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 93.2 bits (232), Expect = 4e-21
 Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 28/218 (12%)

Query: 48  SDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKK--PSKNQEISQEVDNEIEI- 102
              +       +   +G+G++GSV K V +  G+ +AVK+   + +++  +++  ++++ 
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74

Query: 103 LSKIHSPRLVNLLG-FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI------RL 155
           +     P +V   G    +  D  + +E M + +           L     I      ++
Sbjct: 75  MRSSDCPYIVQFYGALFREG-DCWICMELM-STSFDKFYKYVYSVL--DDVIPEEILGKI 130

Query: 156 ALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTP 213
            L   KA+  L   +  IIHRDIK +N+L+DR+ N +L DFG++  L   VD+       
Sbjct: 131 TLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTRD- 185

Query: 214 PAGTIGYLDP----CYVTPDNLSTKTDVFSFGILLLEI 247
            AG   Y+ P       +      ++DV+S GI L E+
Sbjct: 186 -AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 92.3 bits (230), Expect = 5e-21
 Identities = 57/243 (23%), Positives = 110/243 (45%), Gaps = 30/243 (12%)

Query: 20  NSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-- 77
           +  A      + + Q  + P + +     D       F   K+LG+GS  +V  A     
Sbjct: 2   DGTAAEPRPGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVLARELAT 54

Query: 78  GRQVAVKKPSKNQEISQE-----VDNEIEILSKIHSPRLVNLLGFSNDSKDRL-LVVEFM 131
            R+ A+K   K + I +E     V  E +++S++  P  V L  F+    ++L   + + 
Sbjct: 55  SREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYA 112

Query: 132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNA 191
            NG L   +           R   A ++  A+E LH +   IIHRD+K  N+L++ + + 
Sbjct: 113 KNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK--GIIHRDLKPENILLNEDMHI 169

Query: 192 RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK-----TDVFSFGILLLE 246
           ++ DFG A     ++ + R+    GT       YV+P+ L+ K     +D+++ G ++ +
Sbjct: 170 QITDFGTAKVLSPESKQARANSFVGT-----AQYVSPELLTEKSACKSSDLWALGCIIYQ 224

Query: 247 IIS 249
           +++
Sbjct: 225 LVA 227

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 44/200 (22%), Positives = 88/200 (44%), Gaps = 28/200 (14%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           + LG G+ G V+    R  G +  +K     ++Q   ++++ EIE+L  +  P ++ +  
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRR-----IRLALQVAKAVEILHSEMP 171
              D  +  +V+E    G L + + S                 L  Q+  A+   HS+  
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVS--AQARGKALSEGYVAELMKQMMNALAYFHSQH- 144

Query: 172 PIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
            ++H+D+K  N+L      +   ++ DFGLA      +    +   AGT       Y+ P
Sbjct: 145 -VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNA--AGT-----ALYMAP 195

Query: 229 D----NLSTKTDVFSFGILL 244
           +    +++ K D++S G+++
Sbjct: 196 EVFKRDVTFKCDIWSAGVVM 215

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 19/197 (9%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVK-------KPSKNQEISQEVDNEIEILSKIHSPRL 111
           + LG G    V K   +  G + A K       + S+     +E++ E+ IL ++  P +
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           + L     +  D +L++E +S G L+D L      L+         Q+   V  LH++  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYLHTKK- 135

Query: 172 PIIHRDIKSANVL-IDRNFNA---RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
            I H D+K  N++ +D+N      +L DFGLA     D   F++    GT  ++ P  V 
Sbjct: 136 -IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNI--FGTPEFVAPEIVN 191

Query: 228 PDNLSTKTDVFSFGILL 244
            + L  + D++S G++ 
Sbjct: 192 YEPLGLEADMWSIGVIT 208

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 57/253 (22%), Positives = 99/253 (39%), Gaps = 32/253 (12%)

Query: 9   ESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSH 68
           E   S ++ +       Q       + +E  ++   F+              K++G+G+ 
Sbjct: 27  ELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEI------------LKVIGRGAF 74

Query: 69  GSVYKAVLR--GRQVAVKKPSKNQEISQ-EVD---NEIEILSKIHSPRLVNLLGFSNDSK 122
             V    ++  G+  A+K  +K   + + EV     E ++L       +  L  F+   +
Sbjct: 75  SEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDE 133

Query: 123 DRL-LVVEFMSNGTLYDVLHSNNRPLNWGR-RIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           + L LV+E+   G L  +L      +     R  LA ++  A++ +H      +HRDIK 
Sbjct: 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRL--GYVHRDIKP 190

Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP------CYVTPDNLSTK 234
            N+L+DR  + RL DFG  L+   D    RS    GT  YL P                 
Sbjct: 191 DNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGP 249

Query: 235 T-DVFSFGILLLE 246
             D ++ G+   E
Sbjct: 250 ECDWWALGVFAYE 262

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 59/263 (22%), Positives = 97/263 (36%), Gaps = 52/263 (19%)

Query: 16  STNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQ----KLLGKGSHGSV 71
           S N  + A     +     +      +   D     AA   F ++     ++G+G    V
Sbjct: 51  SANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVV 110

Query: 72  YKAVLR--GRQVAVK---------KPSKNQEISQEVDNEIEILSKIHS-PRLVNLLGFSN 119
            + V R  G + AVK          P + +E+ +    E  IL ++   P ++ L+    
Sbjct: 111 RRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170

Query: 120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI------------RLALQVAKAVEILH 167
            S    LV + M  G L+D              +             +   + +AV  LH
Sbjct: 171 SSSFMFLVFDLMRKGELFD-------------YLTEKVALSEKETRSIMRSLLEAVSFLH 217

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP---- 223
           +    I+HRD+K  N+L+D N   RL DFG +          R     GT GYL P    
Sbjct: 218 ANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LREL--CGTPGYLAPEILK 272

Query: 224 --CYVTPDNLSTKTDVFSFGILL 244
                T      + D+++ G++L
Sbjct: 273 CSMDETHPGYGKEVDLWACGVIL 295

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 93.2 bits (232), Expect = 2e-20
 Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 15/229 (6%)

Query: 24  THQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQV 81
            H +       + +       F  S     +  +   K LG G++G V     +    + 
Sbjct: 6   HHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVER 65

Query: 82  AVKKPSKNQEISQEVD---NEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYD 138
           A+K   K    +        E+ +L  +  P ++ L  F  D ++  LV+E    G L+D
Sbjct: 66  AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125

Query: 139 VLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI---DRNFNARLGD 195
            +    +  N      +  QV   V  LH     I+HRD+K  N+L+   +++   ++ D
Sbjct: 126 EIIHRMK-FNEVDAAVIIKQVLSGVTYLHKH--NIVHRDLKPENLLLESKEKDALIKIVD 182

Query: 196 FGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILL 244
           FGL+          +     GT  Y+ P  V       K DV+S G++L
Sbjct: 183 FGLSAVFENQK---KMKERLGTAYYIAP-EVLRKKYDEKCDVWSIGVIL 227

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 50/223 (22%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQE----------------------- 95
             +GKGS+G V  A         A+K  SK + I Q                        
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 96  ----VDNEIEILSKIHSPRLVNLLG-FSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNW 149
               V  EI IL K+  P +V L+    + ++D L +V E ++ G + +V     +PL+ 
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSE 136

Query: 150 GRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF 209
            +       + K +E LH +   IIHRDIK +N+L+  + + ++ DFG++      +   
Sbjct: 137 DQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL 194

Query: 210 RSTPPAGTIGYLDPCYVTPDNLS--------TKTDVFSFGILL 244
            +T   GT     P ++ P++LS           DV++ G+ L
Sbjct: 195 SNT--VGT-----PAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 33/201 (16%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNL 114
             LG G+ G V      L G +VAVK  ++ +    ++  ++  EI+ L     P ++ L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
               +   D  +V+E++S G L+D +  + R +      RL  Q+  AV+  H  M  ++
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCHRHM--VV 133

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD-----PCYVTPD 229
           HRD+K  NVL+D + NA++ DFGL+           +    G   +L      P Y  P+
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLS-----------NMMSDG--EFLRTSCGSPNYAAPE 180

Query: 230 NLS------TKTDVFSFGILL 244
            +S       + D++S G++L
Sbjct: 181 VISGRLYAGPEVDIWSCGVIL 201

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 22/231 (9%)

Query: 29  SSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKK- 85
           SS +S KQ   + I        +A  N       +G G+ G V+K   R  G  +AVK+ 
Sbjct: 2   SSGSSGKQTGYLTI---GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM 58

Query: 86  -PSKNQEISQEVDNEIEILSK-IHSPRLVNLLG-FSNDSKDRLLVVEFMSNGTLYDVLHS 142
             S N+E ++ +  +++++ K    P +V   G F  ++ D  + +E M           
Sbjct: 59  RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT-DVFIAMELMGTCAEKLKKRM 117

Query: 143 NNR-PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR 201
               P     ++   + + KA+  L  +   +IHRD+K +N+L+D     +L DFG++  
Sbjct: 118 QGPIPERILGKM--TVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGIS-G 173

Query: 202 CGVDNFRFRSTPPAGTIGY-----LDPCYVTPDNLSTKTDVFSFGILLLEI 247
             VD+     +  AG   Y     +DP   T  +   + DV+S GI L+E+
Sbjct: 174 RLVDDKAKDRS--AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 58/218 (26%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVK---------KPSKNQEISQEVDNEIEILSKIHSP 109
           K LG G+ G V  A  R   ++VA+K           ++  + +  V+ EIEIL K++ P
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI------------RLAL 157
            ++ +  F  D++D  +V+E M  G L+D             ++                
Sbjct: 76  CIIKIKNFF-DAEDYYIVLELMEGGELFD-------------KVVGNKRLKEATCKLYFY 121

Query: 158 QVAKAVEILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPP 214
           Q+  AV+ LH     IIHRD+K  NVL+   + +   ++ DFG +   G  +   R+   
Sbjct: 122 QMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL-- 176

Query: 215 AGTIGYLDPCYVTPDNLSTKT--------DVFSFGILL 244
            GT     P Y+ P+ L +          D +S G++L
Sbjct: 177 CGT-----PTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 50/222 (22%), Positives = 99/222 (44%), Gaps = 25/222 (11%)

Query: 9   ESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSH 68
           +     +  N N            ++ ++  +K + ++              K++G+G+ 
Sbjct: 35  DLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEV------------VKVIGRGAF 82

Query: 69  GSVYKAVLR--GRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPRLVNLLGFSNDSK 122
           G V     +   +  A+K  SK + I +        E +I++  +SP +V L  ++    
Sbjct: 83  GEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDD 141

Query: 123 DRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSA 181
             L +V+E+M  G L +++ + + P  W R    A +V  A++ +HS     IHRD+K  
Sbjct: 142 RYLYMVMEYMPGGDLVNLMSNYDVPEKWAR-FYTA-EVVLALDAIHSM--GFIHRDVKPD 197

Query: 182 NVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           N+L+D++ + +L DFG  ++   +    R     GT  Y+ P
Sbjct: 198 NMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISP 238

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 92.9 bits (231), Expect = 3e-20
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 21/221 (9%)

Query: 36  QEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS 93
           Q K ++ Q    +        F + ++LGKG  G V    +R  G+  A KK  K +   
Sbjct: 172 QWKWLERQPVTKNT-------FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 224

Query: 94  -QEVD---NEIEILSKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLN 148
            +      NE +IL K++S  +V+L  ++ ++KD L LV+  M+ G L   ++   +   
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGF 283

Query: 149 WGRRIRL-ALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF 207
              R    A ++   +E LH E   I++RD+K  N+L+D + + R+ D GLA+       
Sbjct: 284 PEARAVFYAAEICCGLEDLHRE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 340

Query: 208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEII 248
                   GT+GY+ P  V  +  +   D ++ G LL E+I
Sbjct: 341 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 90.3 bits (225), Expect = 3e-20
 Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 41/206 (19%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVNLLGF 117
           ++LG G+   V+    R  G+  A+K   K+       ++NEI +L KI    +V L   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI------------RLALQVAKAVEI 165
              +    LV++ +S G L+D             RI             +  QV  AV+ 
Sbjct: 75  YESTTHYYLVMQLVSGGELFD-------------RILERGVYTEKDASLVIQQVLSAVKY 121

Query: 166 LHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           LH     I+HRD+K  N+L    + N    + DFGL+ +   +      +   GT GY+ 
Sbjct: 122 LHEN--GIVHRDLKPENLLYLTPEENSKIMITDFGLS-KMEQNGIM---STACGTPGYVA 175

Query: 223 PCYVTPDNLSTKTDVFSFG----ILL 244
           P  +     S   D +S G    ILL
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILL 201

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 92.4 bits (230), Expect = 3e-20
 Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 16/193 (8%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSK----NQEISQEVDNEIEILSKIHSPRLVNL 114
           ++LGKGS G V     +  G++ AVK  SK     +   + +  E+++L ++  P ++ L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
             F  D     LV E  + G L+D + S  R  +     R+  QV   +  +H     I+
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNK--IV 148

Query: 175 HRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
           HRD+K  N+L+    ++ N R+ DFGL+          +     GT  Y+ P  V     
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAP-EVLHGTY 204

Query: 232 STKTDVFSFGILL 244
             K DV+S G++L
Sbjct: 205 DEKCDVWSTGVIL 217

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 48/201 (23%), Positives = 79/201 (39%), Gaps = 24/201 (11%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE------VDNEIEILSKIHSPRLV 112
           +++GKG    V + + R  G+Q AVK     +  S        +  E  I   +  P +V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNW------GRRIRLALQVAKAVEIL 166
            LL   +      +V EFM    L   +                  +R   Q+ +A+   
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR---QILEALRYC 146

Query: 167 HSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           H     IIHRD+K   VL+   + +   +LG FG+A++ G            GT  ++ P
Sbjct: 147 HDN--NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAP 202

Query: 224 CYVTPDNLSTKTDVFSFGILL 244
             V  +      DV+  G++L
Sbjct: 203 EVVKREPYGKPVDVWGCGVIL 223

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 89.5 bits (223), Expect = 4e-20
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 34/217 (15%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVK-------KPSKNQEISQEVDNEIEILSKIHSPRL 111
           + LG G    V K   +  G++ A K         S+     +E++ E+ IL +I  P +
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           + L     +  D +L++E +S G L+D L      L      +   Q+   V  LHS+  
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFDFLAEKES-LTEDEATQFLKQILDGVHYLHSKR- 128

Query: 172 PIIHRDIKSANVLI----DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
            I H D+K  N+++      N   +L DFG+A +       F++    GT  ++ P  V 
Sbjct: 129 -IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNI--FGTPEFVAPEIVN 184

Query: 228 PDNLSTKTDVFSFG----ILLLEIISCRKAIDIGFSP 260
            + L  + D++S G    ILL            G SP
Sbjct: 185 YEPLGLEADMWSIGVITYILL-----S------GASP 210

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 92.6 bits (230), Expect = 4e-20
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 26/215 (12%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS-QEVD---NEIEILSKIHS-- 108
           FS  +++G+G  G VY       G+  A+K   K +    Q      NE  +LS + +  
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250

Query: 109 -PRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
            P +V +  ++  + D+L  +++ M+ G L+  L S +   +       A ++   +E +
Sbjct: 251 CPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHM 308

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
           H+    +++RD+K AN+L+D + + R+ D GLA     D  + +     GT GY+ P  +
Sbjct: 309 HNR--FVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVL 362

Query: 227 TPDNLSTKT-DVFSFGILLLEIISCRKAIDIGFSP 260
                   + D FS G +L +++        G SP
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLR-------GHSP 390

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 89.6 bits (223), Expect = 5e-20
 Identities = 53/251 (21%), Positives = 104/251 (41%), Gaps = 28/251 (11%)

Query: 60  QKLLGKGSHGSVYKA--VLRGRQVAVK--KP--SKNQEISQEVDNEIEILSKIHSPRLVN 113
           ++L+G+G  G VY+A   +R R VA+K      S +      +  E     ++  P +V 
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           +  F        + +  ++   L  +L     PL   R + +  Q+  A++  H+     
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG--A 155

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA-GTIGYLDPCYVTPDNLS 232
            HRD+K  N+L+  +  A L DFG+A      + +        GT+ Y+ P   +  + +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPERFSESHAT 213

Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFS--PPSI----VDWAAPLIKKGKILSVFDPRIPP 286
            + D+++   +L E ++        +     S+    ++ A P        S   P IP 
Sbjct: 214 YRADIYALTCVLYECLTGSPP----YQGDQLSVMGAHINQAIPR------PSTVRPGIPV 263

Query: 287 PKDPIVRKQLA 297
             D ++ + +A
Sbjct: 264 AFDAVIARGMA 274

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 89.9 bits (223), Expect = 7e-20
 Identities = 52/237 (21%), Positives = 84/237 (35%), Gaps = 55/237 (23%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVK------KPSKNQEISQEVDNEIEILSKIHSPRLV 112
             +G+GS+G V  A+        A+K          N +  + +  E+ ++ K+H P + 
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI------------------- 153
            L     D +   LV+E    G L D L+           +                   
Sbjct: 92  RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151

Query: 154 --------------------RLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL 193
                                +  Q+  A+  LH++   I HRDIK  N L   N +  +
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEI 209

Query: 194 --GDFGLALRCGVDNF--RFRSTPPAGTIGYLDP--CYVTPDNLSTKTDVFSFGILL 244
              DFGL+      N    +  T  AGT  ++ P     T ++   K D +S G+LL
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 88.4 bits (220), Expect = 8e-20
 Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 20/195 (10%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  A   +    VAVK     +  +  + +  EI I   ++   +V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
              +   + L +E+ S G L+D +  +   +      R   Q+   V  LH     I HR
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHGIG--ITHR 129

Query: 177 DIKSANVLIDRNFNARLGDFGL-ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           DIK  N+L+D   N ++ DFGL  +    +  R  +    GT       YV P+ L  + 
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGT-----LPYVAPELLKRRE 183

Query: 235 -----TDVFSFGILL 244
                 DV+S GI+L
Sbjct: 184 FHAEPVDVWSCGIVL 198

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 88.9 bits (221), Expect = 9e-20
 Identities = 61/266 (22%), Positives = 95/266 (35%), Gaps = 49/266 (18%)

Query: 1   MGYLSCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQ 60
           MG        +  ++   S+    +   ++K +  +EK      +               
Sbjct: 1   MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQV------------G 48

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQ-------EISQEVDNEIEILSKIHS--P 109
            LLG G  GSVY    V     VA+K   K++            V  E+ +L K+ S   
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 110 RLVNLLGFSNDSKDRLLVVEFMSN-GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
            ++ LL +       +L++E       L+D +      L          QV +AV   H+
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHN 167

Query: 169 EMPPIIHRDIKSANVLIDRN-FNARLGDFGLALRCGVDNFRFRSTP---PAGTIGYLDPC 224
               ++HRDIK  N+LID N    +L DFG            + T      GT       
Sbjct: 168 CG--VLHRDIKDENILIDLNRGELKLIDFGSG------AL-LKDTVYTDFDGT-----RV 213

Query: 225 YVTPDNLS------TKTDVFSFGILL 244
           Y  P+ +           V+S GILL
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILL 239

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 42/208 (20%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVK---KPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           + LGKG+   V + V +  G + A K       +    Q+++ E  I  K+  P +V L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI------------RLALQVAKAV 163
               +     LV + ++ G L++              I                Q+ +++
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFE-------------DIVAREFYSEADASHCIQQILESI 118

Query: 164 EILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGY 220
              HS    I+HR++K  N+L+    +    +L DFGLA+    D+  +     AGT GY
Sbjct: 119 AYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGF--AGTPGY 173

Query: 221 LDPCYVTPDNLSTKTDVFSFG----ILL 244
           L P  +  D  S   D+++ G    ILL
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILL 201

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 49/153 (32%), Positives = 76/153 (49%), Gaps = 22/153 (14%)

Query: 60  QKL--LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN-----EIEILSKIHSPR 110
           +K+  +G+GS+G V+K   R  G+ VA+KK  ++++    V       EI +L ++  P 
Sbjct: 6   EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED--DPVIKKIALREIRMLKQLKHPN 63

Query: 111 LVNLLGFSND---SKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
           LVNLL    +    K RL LV E+  + T+   L    R +       +  Q  +AV   
Sbjct: 64  LVNLL----EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
           H      IHRD+K  N+LI ++   +L DFG A
Sbjct: 119 HKHN--CIHRDVKPENILITKHSVIKLCDFGFA 149

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 49/197 (24%), Positives = 85/197 (43%), Gaps = 19/197 (9%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVK-------KPSKNQEISQEVDNEIEILSKIHSPRL 111
           + LG G    V K   +  G Q A K       K S+     ++++ E+ IL +I  P +
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           + L     +  D +L++E ++ G L+D L      L          Q+   V  LHS   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ- 134

Query: 172 PIIHRDIKSANVLI----DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
            I H D+K  N+++          ++ DFGLA +       F++    GT  ++ P  V 
Sbjct: 135 -IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNI--FGTPEFVAPEIVN 190

Query: 228 PDNLSTKTDVFSFGILL 244
            + L  + D++S G++ 
Sbjct: 191 YEPLGLEADMWSIGVIT 207

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 56/210 (26%), Positives = 81/210 (38%), Gaps = 49/210 (23%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVNLLGF 117
             +G+GS G V  AV +    + A KK  K      +    EIEI+  +  P ++ L   
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI------------RLALQVAKAVEI 165
             D+ D  LV+E  + G L++             R+            R+   V  AV  
Sbjct: 75  FEDNTDIYLVMELCTGGELFE-------------RVVHKRVFRESDAARIMKDVLSAVAY 121

Query: 166 LHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
            H     + HRD+K  N L      +   +L DFGLA R        R+    GT     
Sbjct: 122 CHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTK--VGT----- 171

Query: 223 PCYVTPDNL----STKTDVFSFG----ILL 244
           P YV+P  L      + D +S G    +LL
Sbjct: 172 PYYVSPQVLEGLYGPECDEWSAGVMMYVLL 201

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 49/209 (23%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVK---KPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
            +LGKGS G V K   R   ++ AVK   K S   + +  +  E+E+L K+  P ++ L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI------------RLALQVAKAV 163
               DS    +V E  + G L+D              I            R+  QV   +
Sbjct: 88  EILEDSSSFYIVGELYTGGELFD-------------EIIKRKRFSEHDAARIIKQVFSGI 134

Query: 164 EILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGY 220
             +H     I+HRD+K  N+L+   +++ + ++ DFGL+      N + +     GT  Y
Sbjct: 135 TYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDR--IGTAYY 189

Query: 221 LDP-----CYVTPDNLSTKTDVFSFGILL 244
           + P      Y        K DV+S G++L
Sbjct: 190 IAPEVLRGTY------DEKCDVWSAGVIL 212

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 51/203 (25%), Positives = 81/203 (39%), Gaps = 37/203 (18%)

Query: 60  QKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHS-PRLVNLLG 116
            K LG+GS     K V +   +  AVK  SK  E       EI  L      P +V L  
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME--ANTQKEITALKLCEGHPNIVKLHE 73

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI------------RLALQVAKAVE 164
             +D     LV+E ++ G L++             RI             +  ++  AV 
Sbjct: 74  VFHDQLHTFLVMELLNGGELFE-------------RIKKKKHFSETEASYIMRKLVSAVS 120

Query: 165 ILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL 221
            +H     ++HRD+K  N+L    + N   ++ DFG A     DN   ++  P  T+ Y 
Sbjct: 121 HMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYA 176

Query: 222 DPCYVTPDNLSTKTDVFSFGILL 244
            P  +  +      D++S G++L
Sbjct: 177 APELLNQNGYDESCDLWSLGVIL 199

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 90.1 bits (224), Expect = 2e-19
 Identities = 58/243 (23%), Positives = 100/243 (41%), Gaps = 32/243 (13%)

Query: 25  HQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQ----KLLGKGSHGSVYKAVLR--G 78
           H   SS       + I I    Y  +        E     + LG G++G V     +   
Sbjct: 4   HHHHSSGRENLYFQGIAINPGMY--VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61

Query: 79  RQVAVKKPSKNQ--------------EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR 124
            + A+K   K+Q              +  +E+ NEI +L  +  P ++ L     D K  
Sbjct: 62  SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121

Query: 125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVL 184
            LV EF   G L++ + + ++  +      +  Q+   +  LH     I+HRDIK  N+L
Sbjct: 122 YLVTEFYEGGELFEQIINRHK-FDECDAANIMKQILSGICYLHKH--NIVHRDIKPENIL 178

Query: 185 I---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFG 241
           +   +   N ++ DFGL+      +++ R     GT  Y+ P  V     + K DV+S G
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFS-KDYKLRDR--LGTAYYIAP-EVLKKKYNEKCDVWSCG 234

Query: 242 ILL 244
           +++
Sbjct: 235 VIM 237

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 40/260 (15%), Positives = 77/260 (29%), Gaps = 52/260 (20%)

Query: 62  LLGKGSHGSVYKAV--LRGRQVAVK----KPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
             G       ++A+     RQVA+     +     ++ QE  +    LS+I  P +  +L
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
              +     L+V E++  G+L +V        +    IR    +A A +  H     +  
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVAD---TSPSPVGAIRAMQSLAAAADAAHRA--GVAL 152

Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKT 235
                + V +  + +  L                   P A                  + 
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATM-------------PDANP----------------QD 183

Query: 236 DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD--PIVR 293
           D+   G  L  ++           P       + L            +   P D    + 
Sbjct: 184 DIRGIGASLYALLV-------NRWPLPEAGVRSGL---APAERDTAGQPIEPADIDRDIP 233

Query: 294 KQLAVIAVRCVRSCRERRPS 313
            Q++ +A R V+     R +
Sbjct: 234 FQISAVAARSVQGDGGIRSA 253

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 56/250 (22%), Positives = 99/250 (39%), Gaps = 40/250 (16%)

Query: 16  STNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAV 75
            T +    +  + ++  +      +     D S+ +A ++ F  +  LG+G+   VY+  
Sbjct: 14  GTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCK 73

Query: 76  LR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN 133
            +   +  A+K   K  +  + V  EI +L ++  P ++ L        +  LV+E ++ 
Sbjct: 74  QKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132

Query: 134 GTLYDVLHSNNRPLNWGRRI------------RLALQVAKAVEILHSEMPPIIHRDIKSA 181
           G L+D             RI                Q+ +AV  LH     I+HRD+K  
Sbjct: 133 GELFD-------------RIVEKGYYSERDAADAVKQILEAVAYLHEN--GIVHRDLKPE 177

Query: 182 NVL-IDRNFNARL--GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVF 238
           N+L      +A L   DFGL+          ++    GT GY  P  +       + D++
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTV--CGTPGYCAPEILRGCAYGPEVDMW 234

Query: 239 SFG----ILL 244
           S G    ILL
Sbjct: 235 SVGIITYILL 244

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 88.7 bits (220), Expect = 4e-19
 Identities = 56/251 (22%), Positives = 106/251 (42%), Gaps = 30/251 (11%)

Query: 9   ESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSH 68
           E   S +    N +   +     TS+ ++  +  + F+              K++G+G+ 
Sbjct: 40  ECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEI------------LKVIGRGAF 87

Query: 69  GSVYKAVLR--GRQVAVKKPSKNQEISQ-EVD---NEIEILSKIHSPRLVNLLGFSNDSK 122
           G V    L+   +  A+K  +K + + + E      E ++L    S  +  L  ++    
Sbjct: 88  GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDD 146

Query: 123 DRL-LVVEFMSNGTLYDVLHSNNRPLNWGR-RIRLALQVAKAVEILHSEMPPIIHRDIKS 180
           + L LV+++   G L  +L      L     R  LA ++  A++ +H      +HRDIK 
Sbjct: 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVHQL--HYVHRDIKP 203

Query: 181 ANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKT----- 235
            N+L+D N + RL DFG  L+  +++   +S+   GT  Y+ P  +              
Sbjct: 204 DNILMDMNGHIRLADFGSCLK-LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPEC 262

Query: 236 DVFSFGILLLE 246
           D +S G+ + E
Sbjct: 263 DWWSLGVCMYE 273

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 77/366 (21%), Positives = 125/366 (34%), Gaps = 100/366 (27%)

Query: 13  SVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVY 72
           S+++             +     +++      +                LLGKG  G+V+
Sbjct: 1   SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRL------------GPLLGKGGFGTVF 48

Query: 73  KA--VLRGRQVAVKKPSKNQEISQEVDN-------EIEILSKIHS----PRLVNLLGFSN 119
               +    QVA+K   +N+ +     +       E+ +L K+ +    P ++ LL +  
Sbjct: 49  AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108

Query: 120 DSKDRLLVVEFMSNGT-LYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
             +  +LV+E       L+D +      L  G       QV  A++  HS    ++HRDI
Sbjct: 109 TQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSRG--VVHRDI 165

Query: 179 KSANVLID-RNFNARLGDFGLALRCGVDNFRFRSTP---PAGTIGYLDPCYVTPDNLSTK 234
           K  N+LID R   A+L DFG               P     GT       Y  P+ +S  
Sbjct: 166 KDENILIDLRRGCAKLIDFGSG------AL-LHDEPYTDFDGT-----RVYSPPEWISRH 213

Query: 235 ------TDVFSFGILL-------------LEIISCRKAIDIGFSPPSIVDWAAPLIKKGK 275
                   V+S GILL              EI+          SP         LI+  +
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPD-----CCALIR--R 266

Query: 276 ILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLSKLVPLHSW 333
            L+   P                            RPS++EI+   W+   ++ VPL+  
Sbjct: 267 CLAP-KP--------------------------SSRPSLEEILLDPWMQTPAEDVPLNPS 299

Query: 334 NGFNNP 339
            G   P
Sbjct: 300 KGGPAP 305

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 86.6 bits (215), Expect = 6e-19
 Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 20/195 (10%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLG 116
           + LG+G++G V  A   +    VAVK     +  +  + +  EI I   ++   +V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
              +   + L +E+ S G L+D +  +   +      R   Q+   V  LH     I HR
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHGIG--ITHR 129

Query: 177 DIKSANVLIDRNFNARLGDFGL-ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK- 234
           DIK  N+L+D   N ++ DFGL  +    +  R  +    GT       YV P+ L  + 
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGT-----LPYVAPELLKRRE 183

Query: 235 -----TDVFSFGILL 244
                 DV+S GI+L
Sbjct: 184 FHAEPVDVWSCGIVL 198

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 86.5 bits (215), Expect = 7e-19
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 30/157 (19%)

Query: 60  QKL--LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN---------EIEILSKI 106
           + L  +G+GS+G V K   +  GR VA+KK        +  D+         EI++L ++
Sbjct: 28  ENLGLVGEGSYGMVMKCRNKDTGRIVAIKK------FLESDDDKMVKKIAMREIKLLKQL 81

Query: 107 HSPRLVNLLGFSND---SKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
               LVNLL    +    K R  LV EF+ + T+ D L      L++    +   Q+   
Sbjct: 82  RHENLVNLL----EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIING 136

Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
           +   HS    IIHRDIK  N+L+ ++   +L DFG A
Sbjct: 137 IGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFA 171

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 86.2 bits (214), Expect = 7e-19
 Identities = 47/204 (23%), Positives = 88/204 (43%), Gaps = 31/204 (15%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVK-----KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
            LLG+GS+G V +        + AVK     K  +       V  EI++L ++    ++ 
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 114 LLG-FSNDSKDRL-LVVEFMSNGT--LYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
           L+    N+ K ++ +V+E+   G   + D +     P+          Q+   +E LHS+
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHG--YFCQLIDGLEYLHSQ 128

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
              I+H+DIK  N+L+      ++   G+A  L     +   R++   G+     P +  
Sbjct: 129 G--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS--QGS-----PAFQP 179

Query: 228 PDNLS-------TKTDVFSFGILL 244
           P+  +        K D++S G+ L
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTL 203

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 87.4 bits (217), Expect = 1e-18
 Identities = 46/208 (22%), Positives = 82/208 (39%), Gaps = 41/208 (19%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVK---KPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           + LGKG+   V + V    G++ A         +    Q+++ E  I   +  P +V L 
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI------------RLALQVAKAV 163
              ++     L+ + ++ G L++              I                Q+ +AV
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFE-------------DIVAREYYSEADASHCIQQILEAV 123

Query: 164 EILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGY 220
              H     ++HR++K  N+L+    +    +L DFGLA+    +   +     AGT GY
Sbjct: 124 LHCHQM--GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF--AGTPGY 179

Query: 221 LDPCYVTPDNLSTKTDVFSFG----ILL 244
           L P  +  D      D+++ G    ILL
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILL 207

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 33/232 (14%)

Query: 29  SSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKP 86
           S      + + +   HF+              + +GKGS G V         +  A+K  
Sbjct: 1   SMPPVFDENEDVNFDHFEI------------LRAIGKGSFGKVCIVQKNDTKKMYAMKYM 48

Query: 87  SKNQEISQ-EVDN---EIEILSKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLH 141
           +K + + + EV N   E++I+  +  P LVNL  +S   ++ + +VV+ +  G L   L 
Sbjct: 49  NKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQ 107

Query: 142 SNNR-PLNWGRRIRL-ALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
            N          ++L   ++  A++ L ++   IIHRD+K  N+L+D + +  + DF +A
Sbjct: 108 QNVHFKEE---TVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIA 162

Query: 200 LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS--TKT-DVFSFGILLLEII 248
                +    + T  AGT  Y+ P   +    +  +   D +S G+   E++
Sbjct: 163 AMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 42/208 (20%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVK---KPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
           + LGKG+   V + V +  G + A K       +    Q+++ E  I  K+  P +V L 
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI------------RLALQVAKAV 163
               +     LV + ++ G L++              I                Q+ +++
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFE-------------DIVAREFYSEADASHCIQQILESI 141

Query: 164 EILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGY 220
              HS    I+HR++K  N+L+    +    +L DFGLA+    D+  +     AGT GY
Sbjct: 142 AYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGF--AGTPGY 196

Query: 221 LDPCYVTPDNLSTKTDVFSFG----ILL 244
           L P  +  D  S   D+++ G    ILL
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILL 224

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 33/201 (16%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNL 114
             LG G+ G V      L G +VAVK  ++ +    ++  ++  EI+ L     P ++ L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
               +   D  +V+E++S G L+D +  N R L+     RL  Q+   V+  H  M  ++
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGR-LDEKESRRLFQQILSGVDYCHRHM--VV 138

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD-----PCYVTPD 229
           HRD+K  NVL+D + NA++ DFGL+           +    G   +L      P Y  P+
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLS-----------NMMSDG--EFLRTSCGSPNYAAPE 185

Query: 230 NLS------TKTDVFSFGILL 244
            +S       + D++S G++L
Sbjct: 186 VISGRLYAGPEVDIWSSGVIL 206

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 49/209 (23%)

Query: 60  QKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSK-IHSPRLVNLLG 116
           ++ +G GS+    + + +    + AVK   K++    E   EIEIL +    P ++ L  
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLKD 83

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI------------RLALQVAKAVE 164
             +D K   +V E M  G L D             +I             +   + K VE
Sbjct: 84  VYDDGKYVYVVTELMKGGELLD-------------KILRQKFFSEREASAVLFTITKTVE 130

Query: 165 ILHSEMPPIIHRDIKSANVL-IDRNFNA---RLGDFGLALRCGVDNFRFRSTPPAGTIGY 220
            LH++   ++HRD+K +N+L +D + N    R+ DFG A +   +N    +  P  T   
Sbjct: 131 YLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT--- 183

Query: 221 LDPCYVTPDNLSTKT-----DVFSFGILL 244
               +V P+ L  +      D++S G+LL
Sbjct: 184 --ANFVAPEVLERQGYDAACDIWSLGVLL 210

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 83.9 bits (208), Expect = 5e-18
 Identities = 61/322 (18%), Positives = 112/322 (34%), Gaps = 80/322 (24%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE-VDNEIEILSKIHS-PRLVNLLG 116
            +LG+G+H  V   +     ++ AVK   K     +  V  E+E+L +      ++ L+ 
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRI------------RLALQVAKAVE 164
           F  +     LV E M  G++                I             +   VA A++
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILS-------------HIHKRRHFNELEASVVVQDVASALD 125

Query: 165 ILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLA--LRCGVDNFRFRSTP---PAG 216
            LH++   I HRD+K  N+L    ++    ++ DF L   ++   D     +     P G
Sbjct: 126 FLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183

Query: 217 TIGY-----LDPCYVTPDNLSTKTDVFSFG----ILL----------LEIISCRKAIDIG 257
           +  Y     ++           + D++S G    ILL                 +     
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243

Query: 258 FSPPSIVDWAAPLIKKGKILSVFD----PRI-PPPKDPIVRKQLAVIAVRCVRSCRERRP 312
                + +     I++GK    F       I    KD ++ K L   A        ++R 
Sbjct: 244 ACQNMLFE----SIQEGKY--EFPDKDWAHISCAAKD-LISKLLVRDA--------KQRL 288

Query: 313 SMKEIVD--WLTGLSKLVPLHS 332
           S  +++   W+ G +    L +
Sbjct: 289 SAAQVLQHPWVQGCAPENTLPT 310

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 34/201 (16%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNL 114
           + LG+GS G V  A      ++VA+K  S+      ++   V+ EI  L  +  P ++ L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
                   D ++V+E+ + G L+D +    R +      R   Q+  A+E  H     I+
Sbjct: 75  YDVITTPTDIVMVIEY-AGGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCHRHK--IV 130

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD-----PCYVTPD 229
           HRD+K  N+L+D N N ++ DFGL+           +    G   +L      P Y  P+
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLS-----------NIMTDG--NFLKTSCGSPNYAAPE 177

Query: 230 NLS------TKTDVFSFGILL 244
            ++       + DV+S GI+L
Sbjct: 178 VINGKLYAGPEVDVWSCGIVL 198

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 59/257 (22%), Positives = 103/257 (40%), Gaps = 40/257 (15%)

Query: 16  STNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAV 75
            +   SV     ++ +   K+ +                  F   K LG GS G V    
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQ-------FDRIKTLGTGSFGRVMLVK 61

Query: 76  LR--GRQVAVKKPSKNQEISQ-EVD---NEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE 129
            +  G   A+K   K + +   +++   NE  IL  ++ P LV L     D+ +  +V+E
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121

Query: 130 FMSNGTLYDVLHSNNRPLNWGRRIRL-ALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN 188
           +++ G ++  L    R        R  A Q+    E LHS    +I+RD+K  N+LID+ 
Sbjct: 122 YVAGGEMFSHLRRIGRFSE--PHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQ 177

Query: 189 FNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK-----TDVFSFGIL 243
              ++ DFG A R     +    TP            + P+ + +K      D ++ G+L
Sbjct: 178 GYIQVTDFGFAKRVKGRTWTLCGTPE----------ALAPEIILSKGYNKAVDWWALGVL 227

Query: 244 LLEIISCRKAIDIGFSP 260
           + E+ +       G+ P
Sbjct: 228 IYEMAA-------GYPP 237

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 81.4 bits (202), Expect = 3e-17
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 45/219 (20%)

Query: 60  QKL--LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN---------EIEILSKI 106
           +KL  +G+G++G+V+KA  R     VA+K+      +  + D+         EI +L ++
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKR------VRLDDDDEGVPSSALREICLLKEL 58

Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
               +V L    +  K   LV EF     L     S N  L+         Q+ K +   
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
           HS    ++HRD+K  N+LI+RN   +L +FGLA        R    P    +       V
Sbjct: 118 HSRN--VLHRDLKPQNLLINRNGELKLANFGLA--------RAFGIP----VRCYSAEVV 163

Query: 227 T-----PDNL------STKTDVFSFGILLLEIISCRKAI 254
           T     PD L      ST  D++S G +  E+ +  + +
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 50/258 (19%), Positives = 95/258 (36%), Gaps = 55/258 (21%)

Query: 16  STNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQ-----KLLGKGSHGS 70
              + ++     Q      +Q     ++    S L+   N   +      ++LG G +G 
Sbjct: 22  QPPTPALPHPPAQPPPPPPQQFPQFHVK----SGLQIKKNAIIDDYKVTSQVLGLGINGK 77

Query: 71  VYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHS-PRLVNLLGFSNDSKDR--- 124
           V +   +    + A+K          +   E+E+  +    P +V ++    +       
Sbjct: 78  VLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133

Query: 125 -LLVVEFMSNGTLYDVLHSNNRPLNWGRRI--------------RLALQVAKAVEILHSE 169
            L+V+E +  G L+              RI               +   + +A++ LHS 
Sbjct: 134 LLIVMECLDGGELFS-------------RIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 180

Query: 170 MPPIIHRDIKSANVL-IDRNFNA--RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
              I HRD+K  N+L   +  NA  +L DFG A      N    +  P  T  Y+ P  +
Sbjct: 181 N--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTT--PCYTPYYVAPEVL 235

Query: 227 TPDNLSTKTDVFSFGILL 244
            P+      D++S G+++
Sbjct: 236 GPEKYDKSCDMWSLGVIM 253

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 73/304 (24%), Positives = 122/304 (40%), Gaps = 67/304 (22%)

Query: 29  SSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPS 87
                    K IK+   D    E     ++  K++G GS G V++A L    +VA+KK  
Sbjct: 14  KLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK-- 71

Query: 88  KNQEISQEVDN---EIEILSKIHSPRLVNLLGF---SNDSKDRL---LVVEFMSNGTLYD 138
               + Q+      E++I+  +  P +V+L  F   + D KD +   LV+E++   T+Y 
Sbjct: 72  ----VLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYR 126

Query: 139 VLHSNNRPLNW--GRRIRLAL-QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNA-RLG 194
                 +         I+L + Q+ +++  +HS    I HRDIK  N+L+D      +L 
Sbjct: 127 ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLI 184

Query: 195 DFGLALRCGVDNFRFRSTPPAGTIGYLDPC---YVTPDNL------STKTDVFSFGILLL 245
           DFG A           +  P   + Y+  C   Y  P+ +      +T  D++S G ++ 
Sbjct: 185 DFGSAK-------ILIAGEP--NVSYI--CSRYYRAPELIFGATNYTTNIDIWSTGCVMA 233

Query: 246 EIISCRKAIDIGFS-------------PPSIVDWAA----------PLIKKGKILSVFDP 282
           E++   + +  G S              PS                P I+      VF P
Sbjct: 234 ELMQ-GQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRP 292

Query: 283 RIPP 286
           R PP
Sbjct: 293 RTPP 296

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 79.1 bits (196), Expect = 1e-16
 Identities = 43/152 (28%), Positives = 66/152 (43%), Gaps = 21/152 (13%)

Query: 60  QKL--LGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDN---------EIEILSKIH 107
             L  +G+G++G VYKA    G   A+KK      I  E ++         EI IL ++ 
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKK------IRLEKEDEGIPSTTIREISILKELK 58

Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
              +V L    +  K  +LV E +    L  +L      L         LQ+   +   H
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
                ++HRD+K  N+LI+R    ++ DFGLA
Sbjct: 118 DRR--VLHRDLKPQNLLINREGELKIADFGLA 147

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 73/280 (26%), Positives = 121/280 (43%), Gaps = 74/280 (26%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN---EIEILSKIHSPRL 111
           +++ K++G GS G VY+A L   G  VA+KK      + Q+      E++I+ K+    +
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK------VLQDKRFKNRELQIMRKLDHCNI 109

Query: 112 VNLLGF---SNDSKDRL---LVVEFMSNGTLYDVLHSNNR-----PLNWGRRIRLAL-QV 159
           V L  F   S + KD +   LV++++   T+Y V    +R     P+     ++L + Q+
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVI---YVKLYMYQL 165

Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRNFNA-RLGDFGLALRCGVDNFRFRSTPPAGTI 218
            +++  +HS    I HRDIK  N+L+D +    +L DFG A        +     P   +
Sbjct: 166 FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK-------QLVRGEP--NV 214

Query: 219 GYLDPC---YVTPDNL------STKTDVFSFGILLLEIISCRKAIDIGFS---------- 259
            Y+  C   Y  P+ +      ++  DV+S G +L E++   + I  G S          
Sbjct: 215 SYI--CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIK 271

Query: 260 ---PPSIVDWAA----------PLIKKGKILSVFDPRIPP 286
               P+                P IK      VF PR PP
Sbjct: 272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 311

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 79.1 bits (196), Expect = 2e-16
 Identities = 50/152 (32%), Positives = 76/152 (50%), Gaps = 21/152 (13%)

Query: 60  QKL--LGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDN---------EIEILSKIH 107
           QKL  +G+G++G VYKA    GR VA+K+      I  + ++         EI +L ++H
Sbjct: 24  QKLEKVGEGTYGVVYKAKDSQGRIVALKR------IRLDAEDEGIPSTAIREISLLKELH 77

Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
            P +V+L+   +  +   LV EFM    L  VL  N   L   +      Q+ + V   H
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
                I+HRD+K  N+LI+ +   +L DFGLA
Sbjct: 137 QHR--ILHRDLKPQNLLINSDGALKLADFGLA 166

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 45/209 (21%), Positives = 83/209 (39%), Gaps = 47/209 (22%)

Query: 60  QKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHS-PRLVNLLG 116
           +++LG G +G V +   R  G++ A+K        S +   E++   +    P +V +L 
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGPHIVCILD 89

Query: 117 FSNDSKDR----LLVVEFMSNGTLYDVLHSNNRPLNWGRRI--------------RLALQ 158
              +        L+++E M  G L+              RI               +   
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGELFS-------------RIQERGDQAFTEREAAEIMRD 136

Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPA 215
           +  A++ LHS    I HRD+K  N+L    +++   +L DFG A     +        P 
Sbjct: 137 IGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPC 190

Query: 216 GTIGYLDPCYVTPDNLSTKTDVFSFGILL 244
            T  Y+ P  + P+      D++S G+++
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 64/253 (25%), Positives = 116/253 (45%), Gaps = 26/253 (10%)

Query: 7   KAESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKG 66
           K  +A     + S S  +   +   +  K +  + +  F+Y             KLLGKG
Sbjct: 112 KQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYL------------KLLGKG 159

Query: 67  SHGSVYKAVLR--GRQVAVKKPSKNQEISQ-EVDN---EIEILSKIHSPRLVNLLGFSND 120
           + G V     +  GR  A+K   K   +++ EV +   E  +L     P L  L  +S  
Sbjct: 160 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQ 218

Query: 121 SKDRL-LVVEFMSNGTLYDVLH-SNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
           + DRL  V+E+ + G L+   H S  R  +  R      ++  A++ LHSE   +++RD+
Sbjct: 219 THDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDL 275

Query: 179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVF 238
           K  N+++D++ + ++ DFGL  + G+ +     T   GT  YL P  +  ++     D +
Sbjct: 276 KLENLMLDKDGHIKITDFGLC-KEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWW 333

Query: 239 SFGILLLEIISCR 251
             G+++ E++  R
Sbjct: 334 GLGVVMYEMMCGR 346

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 51/194 (26%), Positives = 78/194 (40%), Gaps = 21/194 (10%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           K +G G+ G        L    VAVK   +   I + V  EI     +  P +V      
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
                  +++E+ S G LY+ + +  R  +         Q+   V   HS    I HRD+
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLSGVSYCHSMQ--ICHRDL 142

Query: 179 KSANVLIDRNFNARL--GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK-- 234
           K  N L+D +   RL   DFG +    + +   +ST   GT     P Y+ P+ L  +  
Sbjct: 143 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKST--VGT-----PAYIAPEVLLRQEY 194

Query: 235 ----TDVFSFGILL 244
                DV+S G+ L
Sbjct: 195 DGKIADVWSCGVTL 208

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 45/218 (20%), Positives = 94/218 (43%), Gaps = 42/218 (19%)

Query: 63  LGKGSHGSVYKAVLR----GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLG-F 117
           +G+G++G VYKA  +     +  A+K+  +   IS     EI +L ++  P +++L   F
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQ-IEGTGISMSACREIALLRELKHPNVISLQKVF 87

Query: 118 SNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLA--------LQVAKAVEILHS 168
            + +  ++ L+ ++  +  L+ ++  +       + ++L          Q+   +  LH+
Sbjct: 88  LSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146

Query: 169 EMPPIIHRDIKSANVLIDRNFNAR----LGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC 224
               ++HRD+K AN+L+      R    + D G A              P   +  LDP 
Sbjct: 147 NW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS---------PLKPLADLDPV 195

Query: 225 YVT-----PDNL------STKTDVFSFGILLLEIISCR 251
            VT     P+ L      +   D+++ G +  E+++  
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 47/152 (30%), Positives = 78/152 (51%), Gaps = 17/152 (11%)

Query: 60  QKL--LGKGSHGSVYKAVLR--GRQVAVKK-PSKNQEISQE-VDN----EIEILSKIHSP 109
           +KL  LG+G   +VYKA  +   + VA+KK    ++  +++ ++     EI++L ++  P
Sbjct: 13  EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72

Query: 110 RLVNLLG-FSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
            ++ LL  F    K  + LV +FM    L  ++  N+  L         L   + +E LH
Sbjct: 73  NIIGLLDAFG--HKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
                I+HRD+K  N+L+D N   +L DFGLA
Sbjct: 130 QHW--ILHRDLKPNNLLLDENGVLKLADFGLA 159

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 78.4 bits (194), Expect = 4e-16
 Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 50/227 (22%)

Query: 60  QKL--LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN---------EIEILSKI 106
           +KL  +G+G+ G V+KA  R  G++VA+KK      +  E +          EI+IL  +
Sbjct: 20  EKLAKIGQGTFGEVFKARHRKTGQKVALKK------VLMENEKEGFPITALREIKILQLL 73

Query: 107 HSPRLVNLLG-------FSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQ 158
               +VNL+          N  K  + LV +F  +  L  +L +           R+   
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 132

Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTI 218
           +   +  +H     I+HRD+K+ANVLI R+   +L DFGLA        R  S       
Sbjct: 133 LLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLA--------RAFSLAKNSQP 182

Query: 219 GYLDPCYVT-----PDNL------STKTDVFSFGILLLEIISCRKAI 254
                  VT     P+ L          D++  G ++ E+ + R  I
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 30/167 (17%)

Query: 54  TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKK----PS-KNQEISQEVDNEIEILSKI 106
            + F  +++ G+G+ G+V     +  G  VA+KK    P  +N+E+       ++ L+ +
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-----IMQDLAVL 76

Query: 107 HSPRLVNLLGF--SNDSKDR-----LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL-- 157
           H P +V L  +  +   +DR      +V+E++ + TL+    +  R           L  
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR---QVAPPPILIK 132

Query: 158 ----QVAKAVEILHSEMPPIIHRDIKSANVLIDR-NFNARLGDFGLA 199
               Q+ +++  LH     + HRDIK  NVL++  +   +L DFG A
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 77.7 bits (192), Expect = 6e-16
 Identities = 41/194 (21%), Positives = 76/194 (39%), Gaps = 26/194 (13%)

Query: 22  VATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GR 79
           +A H      T + Q +         +    + + +     LG+G++G VYKA+      
Sbjct: 1   MAHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNE 60

Query: 80  QVAVKKPSKNQEISQEVDN---------EIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF 130
            VA+K+      I  E +          E+ +L ++    ++ L    + +    L+ E+
Sbjct: 61  TVAIKR------IRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114

Query: 131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN 190
             N  L   +  N   ++         Q+   V   HS     +HRD+K  N+L+  +  
Sbjct: 115 AEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDA 170

Query: 191 AR-----LGDFGLA 199
           +      +GDFGLA
Sbjct: 171 SETPVLKIGDFGLA 184

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 39/152 (25%), Positives = 65/152 (42%), Gaps = 21/152 (13%)

Query: 60  QKL--LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN--------EIEILSKIH 107
            KL  LG+G++ +VYK   +     VA+K+      I  E +         E+ +L  + 
Sbjct: 5   IKLDKLGEGTYATVYKGKSKLTDNLVALKE------IRLEHEEGAPCTAIREVSLLKDLK 58

Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
              +V L    +  K   LV E++    L   L      +N         Q+ + +   H
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
            +   ++HRD+K  N+LI+     +L DFGLA
Sbjct: 118 RQK--VLHRDLKPQNLLINERGELKLADFGLA 147

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 76.0 bits (188), Expect = 2e-15
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 23/154 (14%)

Query: 60  QKL--LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN---------EIEILSKI 106
           QK+  +G+G++G VYKA  +  G  VA+KK      I  + +          EI +L ++
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKK------IRLDTETEGVPSTAIREISLLKEL 59

Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIR-LALQVAKAVEI 165
           + P +V LL   +      LV EF+    L   + ++         I+    Q+ + +  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
            HS    ++HRD+K  N+LI+     +L DFGLA
Sbjct: 119 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA 150

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 40/186 (21%), Positives = 79/186 (42%), Gaps = 22/186 (11%)

Query: 25  HQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVA 82
           H      + ++      I++    D       +  + L+G+GS+G VY A  +   + VA
Sbjct: 2   HHHHHHSSGRENLYFQGIKNVHVPD------NYIIKHLIGRGSYGYVYLAYDKNTEKNVA 55

Query: 83  VKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLL-----GFSNDSKDRLLVVEFMSNG 134
           +KK     ++    + +  EI IL+++ S  ++ L             +  +V+E     
Sbjct: 56  IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--D 113

Query: 135 T-LYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL 193
           + L  +  +    L       +   +      +H     IIHRD+K AN L++++ + ++
Sbjct: 114 SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIHES--GIIHRDLKPANCLLNQDCSVKV 170

Query: 194 GDFGLA 199
            DFGLA
Sbjct: 171 CDFGLA 176

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 44/204 (21%), Positives = 83/204 (40%), Gaps = 22/204 (10%)

Query: 7   KAESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKG 66
           +  S      + S      + Q   +      P     +   D       +  + L+G G
Sbjct: 11  QHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPD------RYEIRHLIGTG 64

Query: 67  SHGSVYKAV--LRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNLL-----G 116
           S+G V +A   L  R VA+KK     ++    + +  EI IL++++   +V +L      
Sbjct: 65  SYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK 124

Query: 117 FSNDSKDRLLVVEFMSNGT-LYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
                 +  +V+E     +    +  +    L       L   +   V+ +HS    I+H
Sbjct: 125 DVEKFDELYVVLEIA--DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVHSA--GILH 179

Query: 176 RDIKSANVLIDRNFNARLGDFGLA 199
           RD+K AN L++++ + ++ DFGLA
Sbjct: 180 RDLKPANCLVNQDCSVKVCDFGLA 203

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 37/170 (21%), Positives = 65/170 (38%), Gaps = 23/170 (13%)

Query: 57  FSEQKLLGKGSHGSVYKAV-LRGRQVAVKK---PSKNQEISQEVDN---------EIEIL 103
           ++ Q+ +  GS+G+V   V   G  VA+K+      +      + +         EI +L
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83

Query: 104 SKIHSPRLVNLL-----GFSNDSKDRLLVVEFMSNGT-LYDVLHSNNRPLNWGRRIRLAL 157
           +  H P ++ L                LV E M   T L  V+H     ++         
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQYFMY 141

Query: 158 QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF 207
            +   + +LH     ++HRD+   N+L+  N +  + DF LA     D  
Sbjct: 142 HILLGLHVLHEA--GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 75.3 bits (186), Expect = 4e-15
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 16/197 (8%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQ-EVD---NEIEILSKIHSPR 110
           F   + LG GS G V+    R  GR  A+K   K   +   +V+   +E  +LS +  P 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRL-ALQVAKAVEILHSE 169
           ++ + G   D++   ++++++  G L+ +L  + R  N     +  A +V  A+E LHS+
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN--PVAKFYAAEVCLALEYLHSK 125

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
              II+RD+K  N+L+D+N + ++ DFG A       +        GT  Y+ P  V+  
Sbjct: 126 --DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-----CGTPDYIAPEVVSTK 178

Query: 230 NLSTKTDVFSFGILLLE 246
             +   D +SFGIL+ E
Sbjct: 179 PYNKSIDWWSFGILIYE 195

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 22/159 (13%)

Query: 60  QKL--LGKGSHGSVYKAVLR--GRQVAVKK--PSKNQEISQEVDN----EIEILSKIHS- 108
           + +  +G G++G+VYKA     G  VA+K             +      E+ +L ++ + 
Sbjct: 12  EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF 71

Query: 109 --PRLVNLL----GFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIR-LALQVA 160
             P +V L+        D + ++ LV E +    L   L     P      I+ L  Q  
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL 130

Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
           + ++ LH+    I+HRD+K  N+L+      +L DFGLA
Sbjct: 131 RGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLA 167

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 74.1 bits (181), Expect = 1e-14
 Identities = 45/336 (13%), Positives = 95/336 (28%), Gaps = 77/336 (22%)

Query: 36  QEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKK---------P 86
           Q+ P+   H         T      + +G+G  G V++ +     VA+K           
Sbjct: 7   QKGPVPFSHCL------PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVN 60

Query: 87  SKNQEISQEVDNEIEILSKIH---------SPRLVNLLGFS------------------- 118
             +Q+  +E+  EI I  ++          +   + L                       
Sbjct: 61  GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120

Query: 119 -----NDSKDRL------LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
                ND  D        +V+EF   G   D+     +  +      +  Q+  ++ +  
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAE 178

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN---------FRFRSTPPAGTI 218
           + +    HRD+   NVL+ +    +L          + +         +        G +
Sbjct: 179 ASLR-FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIV 237

Query: 219 GYLDPCYVTPD---NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK 275
            + D          +   + D++                   + P S V W   L  K  
Sbjct: 238 VFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGE------YHPYSNVLWLHYLTDKML 291

Query: 276 ILSVFDPRIPPPKDPIVRKQLAVIAVR--CVRSCRE 309
               F  +   P    +++++           S  +
Sbjct: 292 KQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATD 327

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 36/163 (22%), Positives = 64/163 (39%), Gaps = 43/163 (26%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHS-PRLVNLLGF 117
           ++LG G +G V +   +    + A+K          +   E+E+  +    P +V ++  
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDV 79

Query: 118 SNDSKDR----LLVVEFMSNGTLYDVLHSNNRPLNWGRRI--------------RLALQV 159
             +        L+V+E +  G L+              RI               +   +
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFS-------------RIQDRGDQAFTEREASEIMKSI 126

Query: 160 AKAVEILHSEMPPIIHRDIKSANVL-IDRNFNA--RLGDFGLA 199
            +A++ LHS    I HRD+K  N+L   +  NA  +L DFG A
Sbjct: 127 GEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 24/156 (15%)

Query: 60  QKL--LGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDN--------EIEILSKIH 107
           ++L  LG G++ +VYK + +  G  VA+K+      +  + +         EI ++ ++ 
Sbjct: 8   KQLEKLGNGTYATVYKGLNKTTGVYVALKE------VKLDSEEGTPSTAIREISLMKELK 61

Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSN--GTLYDVLHSNNRPLNWGRRI--RLALQVAKAV 163
              +V L    +      LV EFM N      D     N P      +      Q+ + +
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
              H     I+HRD+K  N+LI++    +LGDFGLA
Sbjct: 122 AFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLA 155

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 32/163 (19%)

Query: 60  QKL--LGKGSHGSVYKAV---LRGRQVAVKKPSKNQEISQEVDN---------EIEILSK 105
           + +  +G+G++G V+KA      GR VA+K+      +  +            E+ +L  
Sbjct: 14  ECVAEIGEGAYGKVFKARDLKNGGRFVALKR------VRVQTGEEGMPLSTIREVAVLRH 67

Query: 106 IHS---PRLVNLL----GFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIR-LA 156
           + +   P +V L         D + +L LV E +    L   L     P      I+ + 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126

Query: 157 LQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
            Q+ + ++ LHS    ++HRD+K  N+L+  +   +L DFGLA
Sbjct: 127 FQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 167

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 20/206 (9%)

Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           +   K +G G+ G V  A   +  R VA+KK   P +NQ  ++    E+ ++  ++   +
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86

Query: 112 VNLL------GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           + LL          + +D  +V+E M    L  V+      L+  R   L  Q+   ++ 
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKH 142

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS    IIHRD+K +N+++  +   ++ DFGLA   G        TP   T  Y  P  
Sbjct: 143 LHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEV 197

Query: 226 VTPDNLSTKTDVFSFGILLLEIISCR 251
           +         D++S G ++ E+I   
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGG 223

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 71.9 bits (176), Expect = 7e-14
 Identities = 57/266 (21%), Positives = 95/266 (35%), Gaps = 30/266 (11%)

Query: 67  SHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL 126
             G++   +   R   V   +K     Q  D    I   +           S+ S   + 
Sbjct: 110 KFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169

Query: 127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID 186
                               L     I  + QVAK +E L S     IHRD+ + N+L+ 
Sbjct: 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLS 227

Query: 187 RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL-----STKTDVFSFG 241
                ++ DFGLA R    +  +           L   ++ P+ +     + ++DV+SFG
Sbjct: 228 EKNVVKICDFGLA-RDIYKDPDYV----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 282

Query: 242 ILLLEIISCRKAIDIGFSP-PSIVDWAA--PLIKKGKILSVFDPRIPPPKDPIVRKQLAV 298
           +LL EI S      +G SP P +         +K+G        R+  P       ++  
Sbjct: 283 VLLWEIFS------LGASPYPGVKIDEEFCRRLKEGT-------RMRAPDY--TTPEMYQ 327

Query: 299 IAVRCVRSCRERRPSMKEIVDWLTGL 324
             + C      +RP+  E+V+ L  L
Sbjct: 328 TMLDCWHGEPSQRPTFSELVEHLGNL 353

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 31/99 (31%), Positives = 42/99 (42%), Gaps = 11/99 (11%)

Query: 61  KLLGKGSHGSVYKAVLRG-------RQVAVK--KPSKNQEISQEVDNEIEILSKIHS-PR 110
           K LG+G+ G V +A   G       R VAVK  K        + + +E++IL  I     
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 111 LVNLLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNRPLN 148
           +VNLLG        L+V+ EF   G L   L S      
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 126

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 37/225 (16%)

Query: 40  IKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVD 97
           + +  FDY             KLLGKG+ G V     +  GR  A+K   K   I+    
Sbjct: 2   VTMNDFDY------------LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA---K 46

Query: 98  NEIE-------ILSKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLH-SNNRPLN 148
           +E+        +L     P L  L  ++  + DRL  V+E+ + G L+   H S  R   
Sbjct: 47  DEVAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELF--FHLSRERVFT 103

Query: 149 WGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDN 206
             R      ++  A+E LHS    +++RDIK  N+++D++ + ++ DFGL   C  G+ +
Sbjct: 104 EERARFYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGL---CKEGISD 158

Query: 207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCR 251
                T   GT  YL P  +  ++     D +  G+++ E++  R
Sbjct: 159 GATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 56/263 (21%), Positives = 106/263 (40%), Gaps = 23/263 (8%)

Query: 3   YLSCKAESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAA---TNGFSE 59
           Y   +    + +            +  +K     +  +  Q +     ++       +  
Sbjct: 7   YYCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQN 66

Query: 60  QKLLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLVNL 114
            K +G G+ G V  A      R VA+KK   P +NQ  ++    E+ ++  ++   +++L
Sbjct: 67  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126

Query: 115 L------GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           L          + +D  LV+E M +  L  V+      L+  R   L  Q+   ++ LHS
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS 182

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               IIHRD+K +N+++  +   ++ DFGLA   G        TP   T  Y  P  +  
Sbjct: 183 A--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILG 237

Query: 229 DNLSTKTDVFSFGILLLEIISCR 251
                  D++S G ++ E++  +
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHK 260

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 41/154 (26%), Positives = 75/154 (48%), Gaps = 16/154 (10%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           + + + +G G++G+V  AV    G +VA+KK   P +++  ++    E+ +L  +    +
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 112 VNLL------GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           + LL         +D  D  LV+ FM    L  ++      L   R   L  Q+ K +  
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRY 143

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
           +H+    IIHRD+K  N+ ++ +   ++ DFGLA
Sbjct: 144 IHAA--GIIHRDLKPGNLAVNEDCELKILDFGLA 175

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 46/175 (26%), Positives = 77/175 (44%), Gaps = 38/175 (21%)

Query: 46  DYSDLEAATNGFSEQ------KLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQE 95
           +Y D E+    +  Q      + LG+G +  V++A+      +V VK   P K ++I +E
Sbjct: 21  EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE 80

Query: 96  V---------DNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP 146
           +          N I +   +  P           S+   LV E ++N     +     + 
Sbjct: 81  IKILENLRGGPNIITLADIVKDP----------VSRTPALVFEHVNNTDFKQLY----QT 126

Query: 147 LNWGRRIRLAL-QVAKAVEILHSEMPPIIHRDIKSANVLIDR-NFNARLGDFGLA 199
           L     IR  + ++ KA++  HS    I+HRD+K  NV+ID  +   RL D+GLA
Sbjct: 127 LT-DYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLA 178

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 42/185 (22%), Positives = 86/185 (46%), Gaps = 22/185 (11%)

Query: 25  HQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAV--LRGRQVA 82
           H    +  +    + ++ Q FD          ++    +G+G++G V  A   L   +VA
Sbjct: 3   HHHHMAAAAAAGPEMVRGQVFDVGP------RYTNLSYIGEGAYGMVCSAYDNLNKVRVA 56

Query: 83  VKK--PSKNQEISQEVDNEIEILSKIHSPRLVNLLG-FSNDSKDRL----LVVEFMSNGT 135
           +KK  P ++Q   Q    EI+IL +     ++ +       + +++    +V + M   T
Sbjct: 57  IKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ET 114

Query: 136 -LYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLG 194
            LY +L +    L+         Q+ + ++ +HS    ++HRD+K +N+L++   + ++ 
Sbjct: 115 DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKIC 170

Query: 195 DFGLA 199
           DFGLA
Sbjct: 171 DFGLA 175

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 37/154 (24%), Positives = 73/154 (47%), Gaps = 17/154 (11%)

Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           +     +G G++GSV  A+    G +VA+KK   P +++  ++    E+ +L  +    +
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85

Query: 112 VNLL------GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           + LL          +  D  LV+ FM    L  ++       +  +   L  Q+ K ++ 
Sbjct: 86  IGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGL---KFSEEKIQYLVYQMLKGLKY 141

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
           +HS    ++HRD+K  N+ ++ +   ++ DFGLA
Sbjct: 142 IHSA--GVVHRDLKPGNLAVNEDCELKILDFGLA 173

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 53/184 (28%), Positives = 93/184 (50%), Gaps = 16/184 (8%)

Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK---PSKNQEISQEVDNEIEILSKIHS-PR 110
           +   K LGKG++G V+K++    G  VAVKK     +N   +Q    EI IL+++     
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70

Query: 111 LVNLLGF--SNDSKDRLLVVEFMSNGT-LYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
           +VNLL    +++ +D  LV ++M   T L+ V+ +N   L    +  +  Q+ K ++ LH
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH 126

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
           S    ++HRD+K +N+L++   + ++ DFGL+ R  V+  R  +  P       +     
Sbjct: 127 SG--GLLHRDMKPSNILLNAECHVKVADFGLS-RSFVNIRRVTNNIPLSINENTENFDDD 183

Query: 228 PDNL 231
              L
Sbjct: 184 QPIL 187

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 69.3 bits (170), Expect = 5e-13
 Identities = 46/240 (19%), Positives = 91/240 (37%), Gaps = 51/240 (21%)

Query: 61  KLLGKGSHGSVYKAV--LRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSP--------- 109
           + LG G   +V+ A   +    VA+K    ++  ++  ++EI++L +++           
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 110 --RLVNLLG---FSNDSKDRL-LVVEFMSNGTLYDVLHSNNR---PLNWGRRIRLALQVA 160
              ++ LL        +   + +V E +    L  ++        PL + ++I  + Q+ 
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQI--SKQLL 141

Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDR------NFNARLGDFGLALRCGVDNFRFRSTPP 214
             ++ +H     IIH DIK  NVL++           ++ D G A  C  D         
Sbjct: 142 LGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTN---- 194

Query: 215 AGTIGYLDPC-YVTPDNL-----STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA 268
                 +    Y +P+ L         D++S   L+ E+I+     D  F P     +  
Sbjct: 195 -----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG----DFLFEPDEGHSYTK 245

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 69.2 bits (170), Expect = 5e-13
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 34/221 (15%)

Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK--PSKNQEISQEVDNEIEILSKIHSPRLV 112
           F  + LLG+G++G V  A     G  VA+KK  P      +     EI+IL       ++
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72

Query: 113 NLL-----GFSNDSKDRLLVVEFMSNGT-LYDVLHSNNRPLNWGRRIRLAL-QVAKAVEI 165
            +          +  +  ++ E M   T L+ V+ +    L+    I+  + Q  +AV++
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQ--MLS-DDHIQYFIYQTLRAVKV 127

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LH     +IHRD+K +N+LI+ N + ++ DFGLA    +D     ++ P G    +   +
Sbjct: 128 LHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLA--RIIDESAADNSEPTGQQSGMVE-F 182

Query: 226 V------------TPDNLSTKTDVFSFGILLLEIISCRKAI 254
           V            T    S   DV+S G +L E+   R+ I
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 68.2 bits (167), Expect = 7e-13
 Identities = 34/149 (22%), Positives = 68/149 (45%), Gaps = 12/149 (8%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQEVDNEIEILSKIH-SPRLVNLLGF 117
           + +G+GS G +++   +L  +QVA+K   +  +  Q + +E      +     + N+  F
Sbjct: 16  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-LRDEYRTYKLLAGCTGIPNVYYF 74

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
             +    +LV++ +   +L D+L    R  +       A Q+   V+ +H +   +++RD
Sbjct: 75  GQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK--SLVYRD 131

Query: 178 IKSANVLIDRNFNAR-----LGDFGLALR 201
           IK  N LI R  +       + DFG+   
Sbjct: 132 IKPDNFLIGRPNSKNANMIYVVDFGMVKF 160

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 68.5 bits (168), Expect = 9e-13
 Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 18/155 (11%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRL 111
           +     +G G++GSV  A     G +VAVKK   P ++   ++    E+ +L  +    +
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90

Query: 112 VNLL------GFSNDSKDRLLVVEFMSNGT-LYDVLHSNNRPLNWGRRIRLALQVAKAVE 164
           + LL          +  D  LV   M  G  L +++      L       L  Q+ + ++
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQ--KLTDDHVQFLIYQILRGLK 146

Query: 165 ILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
            +HS    IIHRD+K +N+ ++ +   ++ DFGLA
Sbjct: 147 YIHSA--DIIHRDLKPSNLAVNEDCELKILDFGLA 179

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 58/238 (24%), Positives = 97/238 (40%), Gaps = 40/238 (16%)

Query: 24  THQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQV 81
           T  T S   +      +K+  F++              +LGKGS G V  +  +      
Sbjct: 1   TTNTVSKFDNNGNRDRMKLTDFNF------------LMVLGKGSFGKVMLSERKGTDELY 48

Query: 82  AVKKPSKNQEISQEVDNEIE-------ILSKI-HSPRLVNLLGFSNDSKDRL-LVVEFMS 132
           AVK   K   + Q  D+++E       +L+     P L  L      + DRL  V+E+++
Sbjct: 49  AVKILKK-DVVIQ--DDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVN 104

Query: 133 NGTLYDVLHSNNR-PLNWGRRIRL-ALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN 190
            G L   +    R            A ++A  +  L S+   II+RD+K  NV++D   +
Sbjct: 105 GGDLMYHIQQVGRFKEP---HAVFYAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGH 159

Query: 191 ARLGDFGLALRC--GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLE 246
            ++ DFG+   C   + +     T   GT  Y+ P  +         D ++FG+LL E
Sbjct: 160 IKIADFGM---CKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 25/162 (15%)

Query: 57  FSEQKLLGKGSHGSVYKAV--LRGRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVN 113
           + + K LG G +G V+ AV     ++VA+KK    + +  +    EI+I+ ++    +V 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72

Query: 114 LL--------------GFSNDSKDRLLVVEFMSNGT-LYDVLHSNNRPLNWGRRIRLALQ 158
           +               G   +     +V E+M   T L +VL     PL          Q
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQG--PLLEEHARLFMYQ 128

Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLID-RNFNARLGDFGLA 199
           + + ++ +HS    ++HRD+K AN+ I+  +   ++GDFGLA
Sbjct: 129 LLRGLKYIHSA--NVLHRDLKPANLFINTEDLVLKIGDFGLA 168

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 35/147 (23%), Positives = 66/147 (44%), Gaps = 10/147 (6%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQEVDNEIEILSKIH-SPRLVNLLGF 117
           + +G GS G +Y    +  G +VA+K      +  Q +  E +I   +     +  +   
Sbjct: 15  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-LHIESKIYKMMQGGVGIPTIRWC 73

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
             +    ++V+E +   +L D+ +  +R  +    + LA Q+   +E +HS+    IHRD
Sbjct: 74  GAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--NFIHRD 130

Query: 178 IKSANVLIDRNFNA---RLGDFGLALR 201
           +K  N L+          + DFGLA +
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAKK 157

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 38/240 (15%)

Query: 26  QTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAV 83
             + +         + I +F++             ++LGKGS G V  A ++  G   AV
Sbjct: 6   SKEGNGIGVNSSNRLGIDNFEF------------IRVLGKGSFGKVMLARVKETGDLYAV 53

Query: 84  KKPSKNQEISQEVDNEIE-------ILSKIHS-PRLVNLLGFSNDSKDRL-LVVEFMSNG 134
           K   K   I Q  D+++E       ILS   + P L  L      + DRL  V+EF++ G
Sbjct: 54  KVLKK-DVILQ--DDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGG 109

Query: 135 TLYDVLH-SNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL 193
            L    H   +R  +  R    A ++  A+  LH +   II+RD+K  NVL+D   + +L
Sbjct: 110 DLM--FHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKL 165

Query: 194 GDFGLALRC--GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCR 251
            DFG+   C  G+ N    +T   GT  Y+ P  +         D ++ G+LL E++   
Sbjct: 166 ADFGM---CKEGICNGVTTAT-FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 66/262 (25%), Positives = 112/262 (42%), Gaps = 52/262 (19%)

Query: 9   ESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSH 68
            SA             H+ +++  +   EK + I++F+              K+LG G++
Sbjct: 21  TSADGGDGGEQLLTVKHELRTANLTGHAEK-VGIENFEL------------LKVLGTGAY 67

Query: 69  GSVY---KAVLR--GRQVAVKKPSKNQEISQEVDNEIE-------ILSKI-HSPRLVNLL 115
           G V+   K      G+  A+K   K   + +      E       +L  I  SP LV L 
Sbjct: 68  GKVFLVRKISGHDTGKLYAMKVLKKATIVQK--AKTTEHTRTERQVLEHIRQSPFLVTLH 125

Query: 116 GFSNDSKDRL-LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAK--------AVEIL 166
            ++  ++ +L L++++++ G L+  L          +R R      +        A+E L
Sbjct: 126 -YAFQTETKLHLILDYINGGELFTHLS---------QRERFTEHEVQIYVGEIVLALEHL 175

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
           H     II+RDIK  N+L+D N +  L DFGL+ +  V +   R+    GTI Y+ P  V
Sbjct: 176 HKL--GIIYRDIKLENILLDSNGHVVLTDFGLS-KEFVADETERAYDFCGTIEYMAPDIV 232

Query: 227 TPDNLS-TKT-DVFSFGILLLE 246
              +    K  D +S G+L+ E
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYE 254

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 55/242 (22%), Positives = 103/242 (42%), Gaps = 47/242 (19%)

Query: 24  THQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVY---KAVLR--G 78
             +   +   ++  +      F+              K+LG+GS G V+   K       
Sbjct: 5   IKEIAITHHVKEGHEKADPSQFEL------------LKVLGQGSFGKVFLVKKISGSDAR 52

Query: 79  RQVAVKKPSKNQEIS-QEVDNEIE--ILSKIHSPRLVNLLGFSNDSKDRL-LVVEFMSNG 134
           +  A+K   K        V  ++E  IL +++ P +V L  ++  ++ +L L+++F+  G
Sbjct: 53  QLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGG 111

Query: 135 TLYDVLHSNNRPLNWGRRIRLALQVAK--------AVEILHSEMPPIIHRDIKSANVLID 186
            L+  L          + +    +  K        A++ LHS    II+RD+K  N+L+D
Sbjct: 112 DLFTRLS---------KEVMFTEEDVKFYLAELALALDHLHSL--GIIYRDLKPENILLD 160

Query: 187 RNFNARLGDFGLALRC--GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILL 244
              + +L DFGL       +D+ +   +   GT+ Y+ P  V     +   D +SFG+L+
Sbjct: 161 EEGHIKLTDFGL---SKESIDHEKKAYS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLM 216

Query: 245 LE 246
            E
Sbjct: 217 FE 218

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 50/194 (25%)

Query: 50  LEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKK-----PSKNQEIS--QEVD--N 98
           LE ++  +S  K LG GS G V +      G++ A+KK       KN+E+   + +D  N
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVN 61

Query: 99  EIEILSKIHSPRLVNLLGFSNDSKDRL--------------------------LVVEFMS 132
            I+++   ++                                           +++E++ 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 133 NGTLYDVLHSNNRPLNWGRRIRLAL------QVAKAVEILHSEMPPIIHRDIKSANVLID 186
           + TL+ VL S  R    GR I + L      Q+ +AV  +HS    I HRDIK  N+L++
Sbjct: 122 D-TLHKVLKSFIRS---GRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVN 175

Query: 187 RNFNA-RLGDFGLA 199
              N  +L DFG A
Sbjct: 176 SKDNTLKLCDFGSA 189

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 58/234 (24%), Positives = 109/234 (46%), Gaps = 40/234 (17%)

Query: 28  QSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKK 85
           + +K     +  +KI+ F               K+LGKGS G V+ A  +   +  A+K 
Sbjct: 2   ELNKERPSLQIKLKIEDFIL------------HKMLGKGSFGKVFLAEFKKTNQFFAIKA 49

Query: 86  PSKNQEISQEVDNEIE-------ILSK-IHSPRLVNLLGFSNDSKDRL-LVVEFMSNGTL 136
             K   +    D+++E       +LS     P L ++   +  +K+ L  V+E+++ G L
Sbjct: 50  LKK-DVVLM--DDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDL 105

Query: 137 YDVLHSNNR-PLNWGRRIRL-ALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLG 194
              + S ++  L+   R    A ++   ++ LHS+   I++RD+K  N+L+D++ + ++ 
Sbjct: 106 MYHIQSCHKFDLS---RATFYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIA 160

Query: 195 DFGLALRC--GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLE 246
           DFG+   C   +      +T   GT  Y+ P  +     +   D +SFG+LL E
Sbjct: 161 DFGM---CKENMLGDAKTNT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 45/205 (21%), Positives = 87/205 (42%), Gaps = 32/205 (15%)

Query: 7   KAESAISVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKG 66
             E+     +  S      +  +++ S K    + +Q FD              +++G+G
Sbjct: 16  TTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDL------------LRVIGRG 63

Query: 67  SHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIE-------ILSKI-HSPRLVNLLG 116
           S+  V    L+   R  A++   K + ++   D +I+       +  +  + P LV L  
Sbjct: 64  SYAKVLLVRLKKTDRIYAMRVVKK-ELVND--DEDIDWVQTEKHVFEQASNHPFLVGLH- 119

Query: 117 FSNDSKDRL-LVVEFMSNGTLYDVLH-SNNRPLNWGRRIRLALQVAKAVEILHSEMPPII 174
               ++ RL  V+E+++ G L    H    R L        + +++ A+  LH     II
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPEEHARFYSAEISLALNYLHER--GII 175

Query: 175 HRDIKSANVLIDRNFNARLGDFGLA 199
           +RD+K  NVL+D   + +L D+G+ 
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMC 200

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 65.6 bits (161), Expect = 6e-12
 Identities = 53/241 (21%), Positives = 99/241 (41%), Gaps = 50/241 (20%)

Query: 27  TQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVY---KAVLR--GRQV 81
           +  +  ++  EK I+ + F+              ++LGKG +G V+   K      G+  
Sbjct: 2   SSETSVNRGPEK-IRPECFEL------------LRVLGKGGYGKVFQVRKVTGANTGKIF 48

Query: 82  AVKKPSKNQEISQEVDNEIE-------ILSKIHSPRLVNLLGFSNDSKDRL-LVVEFMSN 133
           A+K   K   +      +         IL ++  P +V+L+ ++  +  +L L++E++S 
Sbjct: 49  AMKVLKKAMIVRNA--KDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSG 105

Query: 134 GTLYDVLHSNNRPLNWGRRIRLALQVAK--------AVEILHSEMPPIIHRDIKSANVLI 185
           G L+  L          R        A         A+  LH +   II+RD+K  N+++
Sbjct: 106 GELFMQLE---------REGIFMEDTACFYLAEISMALGHLHQK--GIIYRDLKPENIML 154

Query: 186 DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLL 245
           +   + +L DFGL      D     +    GTI Y+ P  +     +   D +S G L+ 
Sbjct: 155 NHQGHVKLTDFGLCKESIHDGTVTHTF--CGTIEYMAPEILMRSGHNRAVDWWSLGALMY 212

Query: 246 E 246
           +
Sbjct: 213 D 213

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 34/147 (23%), Positives = 61/147 (41%), Gaps = 12/147 (8%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQEVDNEIEILSKIH-SPRLVNLLGF 117
           K +G G+ G +     +     VA+K         Q    E     ++     +  +  F
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL-EYRFYKQLGSGDGIPQVYYF 73

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
               K   +V+E +   +L D+    +R  +    + +A+Q+   +E +HS+   +I+RD
Sbjct: 74  GPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK--NLIYRD 130

Query: 178 IKSANVLIDRNFNAR-----LGDFGLA 199
           +K  N LI R  N       + DF LA
Sbjct: 131 VKPENFLIGRPGNKTQQVIHIIDFALA 157

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 43/174 (24%), Positives = 78/174 (44%), Gaps = 32/174 (18%)

Query: 38  KPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE 95
            P+ +Q FD              +++G+GS+  V    L+   R  A+K   K + ++  
Sbjct: 4   DPLGLQDFDL------------LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK-ELVND- 49

Query: 96  VDNEIE-------ILSKI-HSPRLVNLLGFSNDSKDRL-LVVEFMSNGTLYDVLH-SNNR 145
            D +I+       +  +  + P LV L      ++ RL  V+E+++ G L    H    R
Sbjct: 50  -DEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLM--FHMQRQR 105

Query: 146 PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
            L        + +++ A+  LH     II+RD+K  NVL+D   + +L D+G+ 
Sbjct: 106 KLPEEHARFYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMC 157

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 35/200 (17%)

Query: 13  SVISTNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVY 72
            +++ N         Q +          K   F +             K++GKGS G V 
Sbjct: 9   ELMNANPAPPPAPSQQINLGPSSNPH-AKPSDFHF------------LKVIGKGSFGKVL 55

Query: 73  KAVLR--GRQVAVKKPSKNQEISQEVDNEIE-------ILSK-IHSPRLVNLLGFSNDSK 122
            A  +      AVK   K + I +    E +       +L K +  P LV L  FS  + 
Sbjct: 56  LARHKAEEVFYAVKVLQK-KAILK--KKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTA 111

Query: 123 DRL-LVVEFMSNGTLYDVLHSNNR-PLNWGRRIRL-ALQVAKAVEILHSEMPPIIHRDIK 179
           D+L  V+++++ G L+  L            R R  A ++A A+  LHS    I++RD+K
Sbjct: 112 DKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASALGYLHSLN--IVYRDLK 166

Query: 180 SANVLIDRNFNARLGDFGLA 199
             N+L+D   +  L DFGL 
Sbjct: 167 PENILLDSQGHIVLTDFGLC 186

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 59/249 (23%), Positives = 104/249 (41%), Gaps = 36/249 (14%)

Query: 16  STNSNSVATHQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAV 75
            T +    T  T S   +      +K+  F++              +LGKGS G V  + 
Sbjct: 314 GTKAPEEKTANTISKFDNNGNRDRMKLTDFNFL------------MVLGKGSFGKVMLSE 361

Query: 76  LR--GRQVAVKKPSKNQEISQEVDNEIE-------ILSKI-HSPRLVNLLGFSNDSKDRL 125
            +      AVK   K   + Q  D+++E       +L+     P L  L      + DRL
Sbjct: 362 RKGTDELYAVKILKK-DVVIQ--DDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRL 417

Query: 126 -LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVL 184
             V+E+++ G L   +    R       +  A ++A  +  L S+   II+RD+K  NV+
Sbjct: 418 YFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSK--GIIYRDLKLDNVM 474

Query: 185 IDRNFNARLGDFGLALRC--GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGI 242
           +D   + ++ DFG+   C   + +     T   GT  Y+ P  +         D ++FG+
Sbjct: 475 LDSEGHIKIADFGM---CKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGV 530

Query: 243 LLLEIISCR 251
           LL E+++ +
Sbjct: 531 LLYEMLAGQ 539

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 39/147 (26%), Positives = 70/147 (47%), Gaps = 10/147 (6%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQEVDNEIEILSKIH-SPRLVNLLGF 117
           + +G GS G +Y    +    +VA+K  +   +  Q +  E +I   +     + N+  F
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKIYRILQGGTGIPNVRWF 71

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
             +    +LV++ +   +L D+ +  +R L+    + LA Q+   VE +HS+    +HRD
Sbjct: 72  GVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRD 128

Query: 178 IKSANVLIDRNFNAR---LGDFGLALR 201
           IK  N L+     A    + DFGLA +
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAKK 155

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 31/177 (17%), Positives = 74/177 (41%), Gaps = 35/177 (19%)

Query: 61  KLLGKGSHGSVYKAV----------LRGRQVAVKKPSKNQEISQEVD--------NEIEI 102
               + + G +Y+A            + ++ ++K  +K+  +  E +         ++  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 103 LSKIHSPRLV---NLLGF-SNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLAL 157
             K++S  L+     +GF  +  K R LV+  +   +L   L  + +  L+    +++A 
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVAC 166

Query: 158 QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNAR--LGDFGLALRCGVDNFRFRST 212
           ++  A+E LH      +H ++ + N+ +D    ++  L  +G A       FR+  +
Sbjct: 167 RLLDALEFLHEN--EYVHGNVTAENIFVDPEDQSQVTLAGYGFA-------FRYCPS 214

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 48/189 (25%), Positives = 84/189 (44%), Gaps = 23/189 (12%)

Query: 31  KTSQKQEKPIKIQHFD-------YSDLEAATNGFSEQKLLGKGSHGSVYKAV--LRGRQV 81
            +S K+E+ +    +D         + E   + +    L+GKGS G V KA   +    V
Sbjct: 23  MSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWV 82

Query: 82  AVKKPSKNQEISQEVDNEIEILSKI--HSP----RLVNLLG-FSNDSKDRL-LVVEFMSN 133
           A+K     +    +   E+ +L  +  H       +V+L   F    ++ L LV E +S 
Sbjct: 83  AIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF--MFRNHLCLVFEMLSY 140

Query: 134 GTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI--DRNFN 190
             LYD+L + N R ++     + A Q+  A+  L +    IIH D+K  N+L+   +   
Sbjct: 141 -NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA 199

Query: 191 ARLGDFGLA 199
            ++ DFG +
Sbjct: 200 IKIVDFGSS 208

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 36/152 (23%), Positives = 73/152 (48%), Gaps = 18/152 (11%)

Query: 61  KLLGKGSHGSVYKAV--LRGRQVAVKKPSKNQEISQEVDNEIEILSKI------HSPRLV 112
           K++GKGS G V KA      + VA+K     +   ++   EI IL  +      ++  ++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 113 NLLG-FSNDSKDRL-LVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSE 169
           ++L  F    ++ + +  E +S   LY+++  N  +  +     + A  + + ++ LH  
Sbjct: 163 HMLENF--TFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219

Query: 170 MPPIIHRDIKSANVLIDRNFNA--RLGDFGLA 199
              IIH D+K  N+L+ +   +  ++ DFG +
Sbjct: 220 --RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 34/166 (20%), Positives = 69/166 (41%), Gaps = 28/166 (16%)

Query: 61  KLLGKGSHGSVYKA-------VLRGRQVAVK-KPSKNQEISQEV--------DNEIEILS 104
             +G+G  G +Y A       V       VK +PS N  +  E+          +I+   
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 105 KIHSPRLV---NLLGF----SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLAL 157
           +    + +      G      N    R ++++   +  L  +  +N +  +    ++L+L
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTVLQLSL 159

Query: 158 QVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNAR--LGDFGLALR 201
           ++   +E +H      +H DIK++N+L++     +  L D+GLA R
Sbjct: 160 RILDILEYIHEH--EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 32/164 (19%), Positives = 64/164 (39%), Gaps = 27/164 (16%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVK----KPSKNQEISQEVD-----NEIEILSKIHSP 109
           K +G G  G +Y A    +  + A      +  +N  +  E+       + + + K    
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102

Query: 110 RLVNLLGF----------SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQV 159
           + ++ LG                 R +V+E +  G     +   N        ++L +++
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGIRM 160

Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRNFNAR--LGDFGLALR 201
              +E +H      +H DIK+AN+L+      +  L D+GL+ R
Sbjct: 161 LDVLEYIHEN--EYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 45/257 (17%), Positives = 84/257 (32%), Gaps = 75/257 (29%)

Query: 61  KLLGKGSHGSVYKA--VLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHS--------PR 110
           + LG G   +V+ +  +   + VA+K     +  ++   +EI +L  + +          
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 111 LVNLLG-FSNDSKD---RLLVVEFMSNGTLYDVLHSNNR---PLNWGRRIRLALQVAKAV 163
           +V LL  F     +     +V E + +  L   +  +N    PL   ++I    QV + +
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKI--IQQVLQGL 159

Query: 164 EILHSEMPPIIHRDIKSANVLI-------------------------------------- 185
           + LH++   IIH DIK  N+L+                                      
Sbjct: 160 DYLHTKC-RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 186 -----------DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
                            ++ D G A  C V       T    T  Y     +     +T 
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHF---TEDIQTRQYRSLEVLIGSGYNTP 273

Query: 235 TDVFSFGILLLEIISCR 251
            D++S   +  E+ +  
Sbjct: 274 ADIWSTACMAFELATGD 290

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 34/167 (20%), Positives = 68/167 (40%), Gaps = 17/167 (10%)

Query: 60  QKLLGKGSHGSVYKAV--LRGRQVAVKKPSKNQEISQEVDNEIEILSKI-----HSPRLV 112
            + +G G+ G V         +  AVK     ++ ++    E +IL KI     ++  +V
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 113 NLLG-FSNDSKDRL-LVVEFMSNGTLYDVLHSNN-RPLNWGRRIR-LALQVAKAVEILHS 168
              G F     D + L+ E +   +LY+++  NN    +    I+   +++ KA+  L  
Sbjct: 100 KYHGKF--MYYDHMCLIFEPLGP-SLYEIITRNNYNGFH-IEDIKLYCIEILKALNYLRK 155

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPA 215
               + H D+K  N+L+D  +  +       +  G     +R+    
Sbjct: 156 M--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 36/149 (24%), Positives = 59/149 (39%), Gaps = 33/149 (22%)

Query: 60  QKLLGKGSHGSVYKAV---LRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
              LG+G+ G V + +     GR VAVK         +   +EI++L  ++         
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLN--------- 69

Query: 117 FSNDSKDRLLVVE----FMSNG-----------TLYDVLHSNN-RPLNWGRRIR-LALQV 159
            + D       V+    F  +G           + YD +  N   P      IR +A Q+
Sbjct: 70  -TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFR-LDHIRKMAYQI 127

Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRN 188
            K+V  LHS    + H D+K  N+L  ++
Sbjct: 128 CKSVNFLHSNK--LTHTDLKPENILFVQS 154

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.7 bits (115), Expect = 4e-06
 Identities = 71/505 (14%), Positives = 141/505 (27%), Gaps = 171/505 (33%)

Query: 25  HQTQSSKTSQKQ----------EKPIKIQHFDYSDLEAATNG-FSEQ---KLLGKGSHGS 70
           H     +T + Q          E    + +FD  D++       S++    ++       
Sbjct: 4   HHHMDFETGEHQYQYKDILSVFEDAF-VDNFDCKDVQDMPKSILSKEEIDHIIMSKD--- 59

Query: 71  VYKAVLRGRQVAVKKPSKNQEISQE-VDNEIE-----ILSKIHSPRLVNLLGFSNDSKDR 124
              AV    ++     SK +E+ Q+ V+  +      ++S I             + +  
Sbjct: 60  ---AVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIK-----------TEQRQP 105

Query: 125 -LLVVEFMSNGTLYDVLHSNNRPLNWG--RRIRLALQVAKAVEILHSEMPPIIHRDIKSA 181
            ++   ++      D L+++N+        R++  L++ +A+  L               
Sbjct: 106 SMMTRMYIEQ---RDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPA-----------K 151

Query: 182 NVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK--TDVFS 239
           NVLID       G  G     G      ++              V  D   +        
Sbjct: 152 NVLID-------GVLG----SG------KTW-------------VALDVCLSYKVQCKMD 181

Query: 240 FGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVI 299
           F I  L + +C     +             L    K+L   DP      D     +L + 
Sbjct: 182 FKIFWLNLKNCNSPETV-------------LEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228

Query: 300 AVRCVRSCRERRPSMKE--------IVD--WLTGLSKLVPLHSWNGFNNPCLMVETVGRP 349
           +++      E R  +K         ++        +       WN FN  C ++ T    
Sbjct: 229 SIQ-----AELRRLLKSKPYENCLLVLLNVQ----NAKA----WNAFNLSCKILLT---- 271

Query: 350 VEVRKTQEGGIAGENLDLLDG-KLSRMSMKDSRRVYSDLGLRSNLMELMA---GMDEEHE 405
                T+   +     D L     + +S+       +       +  L+        + +
Sbjct: 272 -----TRFKQVT----DFLSAATTTHISLDHHSMTLTP----DEVKSLLLKYLDCRPQ-D 317

Query: 406 FRGEADGVEPSIKS--AKQVSSSSHGSGRYLYKGRVRSHAHGNDKGRGSRLRR------- 456
              E     P   S  A+ +         + +           DK     L         
Sbjct: 318 LPREVLTTNPRRLSIIAESIRDGLATWDNWKH--------VNCDK-----LTTIIESSLN 364

Query: 457 NLSIGDGSELFSG----RDDAMIPI 477
            L   +  ++F         A IP 
Sbjct: 365 VLEPAEYRKMFDRLSVFPPSAHIPT 389

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 35/148 (23%), Positives = 58/148 (39%), Gaps = 33/148 (22%)

Query: 61  KLLGKGSHGSVYKAVLRGR---QVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
             LG+G+ G V + +   R   QVA+K      +  +    EI +L KI           
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIK---------- 74

Query: 118 SNDSKDRLLVVE----FMSNG-----------TLYDVLHSNN-RPLNWGRRIR-LALQVA 160
             D +++ L V     F  +G             ++ L  NN +P      +R +A Q+ 
Sbjct: 75  EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYP-LPHVRHMAYQLC 133

Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDRN 188
            A+  LH     + H D+K  N+L   +
Sbjct: 134 HALRFLHENQ--LTHTDLKPENILFVNS 159

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	487
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.68
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.23
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.04
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.86
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.69
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.63
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.61
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.49
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.45
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.3
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.23
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.06
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.92
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.85
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.72
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.69
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.62
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.57
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.53
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.48
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.47
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.43
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.43
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.96
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.77
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.53
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.94
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.16
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.65

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.6e-57  Score=449.04  Aligned_cols=266  Identities=26%  Similarity=0.432  Sum_probs=213.1

Q ss_pred             HHhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      +...++|.+.+.||+|+||.||+|++++ .||||+++..   ....+.|.+|++++++++|||||+++|++.+ +.++||
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            4445788999999999999999998876 5999987643   3445789999999999999999999999875 468999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      ||||++|+|.++|......+++..+..|+.|++.||+|||++  +||||||||+||||+.++.+||+|||+|+.......
T Consensus       110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~--~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK--NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            999999999999988777799999999999999999999999  999999999999999999999999999987654433


Q ss_pred             ccccCCCCCCCccCCccccCC---CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTP---DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ........||+.|||||++.+   ..|+.++|||||||+||||+||+.||........+..    .+..+    ...+..
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~----~~~~~----~~~p~~  259 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF----MVGRG----YASPDL  259 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH----HHHTT----CCCCCS
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH----HHhcC----CCCCCc
Confidence            334456789999999999864   3589999999999999999999999963222222211    11111    111111


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCC
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP  329 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  329 (487)
                       ...+..++.++.+|+.+||+.||++|||+.||++.|+.|+..+|
T Consensus       260 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          260 -SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             -TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             -ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence             22445678899999999999999999999999999998876543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.2e-57  Score=448.73  Aligned_cols=261  Identities=22%  Similarity=0.398  Sum_probs=219.0

Q ss_pred             hcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      .++|.+.+.||+|+||.||+|++.       +..||||+++... ...+.|.+|++++++++|||||+++|+|.+.+.++
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            357889999999999999999874       5689999987653 34578999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEE
Q 011384          126 LVVEFMSNGTLYDVLHSNN------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL  193 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL  193 (487)
                      ||||||++|+|.++|...+            ..+++..++.|+.|++.||.|||++  +||||||||+||||+.++.+||
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ--HFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCccCHhhEEECCCCcEEE
Confidence            9999999999999997642            4699999999999999999999999  9999999999999999999999


Q ss_pred             cccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhh
Q 011384          194 GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIK  272 (487)
Q Consensus       194 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~  272 (487)
                      +|||+++.....+.........||+.|||||++.+..|+.++|||||||++|||+| |+.||.. .....+..    .+.
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~----~i~  244 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIE----CIT  244 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHH----HHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHH----HHH
Confidence            99999987655444334445579999999999999999999999999999999998 8999863 22222221    122


Q ss_pred             cCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCCC
Q 011384          273 KGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPL  330 (487)
Q Consensus       273 ~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~  330 (487)
                      .+.         ..+.|..+++++.+|+.+||+.||++|||+++|+++|+.+.+..|.
T Consensus       245 ~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~  293 (299)
T 4asz_A          245 QGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV  293 (299)
T ss_dssp             HTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCC
T ss_pred             cCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCc
Confidence            222         1234556778999999999999999999999999999998765443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.3e-56  Score=448.28  Aligned_cols=258  Identities=24%  Similarity=0.409  Sum_probs=210.2

Q ss_pred             hcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      .++|.+.+.||+|+||.||+|++.       +..||||+++... ...+.|.+|+++|++++|||||+++|+|.+.+.+|
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            357888999999999999999874       5789999987653 34578999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcE
Q 011384          126 LVVEFMSNGTLYDVLHSNN--------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNA  191 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~v  191 (487)
                      ||||||++|+|.+++....              .++++..++.|+.|++.||.|||++  +||||||||+||||+.++.+
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL--HFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEETTTEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC--CeecccccHhhEEECCCCcE
Confidence            9999999999999997532              3599999999999999999999999  99999999999999999999


Q ss_pred             EEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhh
Q 011384          192 RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPL  270 (487)
Q Consensus       192 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~  270 (487)
                      ||+|||+++.+...+.....+...||+.|||||++.+..++.++|||||||+||||+| |+.||.. .....+..    .
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~----~  272 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ-LSNTEAID----C  272 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-SCHHHHHH----H
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC-CCHHHHHH----H
Confidence            9999999987655544434456789999999999999999999999999999999999 8999863 22222221    1


Q ss_pred             hhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          271 IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       271 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      +..+.         ..+.|..+++++.+|+.+||+.||++|||++||+++|+.+...
T Consensus       273 i~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          273 ITQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            22221         2234456778999999999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.4e-56  Score=442.83  Aligned_cols=253  Identities=23%  Similarity=0.366  Sum_probs=214.0

Q ss_pred             CcccceeecccCceEEEEEEEC-------CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ++++.+.||+|+||.||+|.+.       ++.||||+++..  ....+.|.+|+.++++++|||||+++|+|.+.+.++|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4667889999999999999873       578999998754  2345789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcE
Q 011384          127 VVEFMSNGTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNA  191 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~v  191 (487)
                      |||||++|+|.++|....               ..+++..++.|+.||+.||.|||++  +||||||||+||||+.++.+
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH--HVVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCE
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--CCCCCCccccceEECCCCCE
Confidence            999999999999996532               3589999999999999999999999  99999999999999999999


Q ss_pred             EEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhh
Q 011384          192 RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPL  270 (487)
Q Consensus       192 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~  270 (487)
                      ||+|||+++.+...+.....+...||+.|||||++.++.|+.++|||||||+||||+| |+.||.. .....+..    .
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~-~~~~~~~~----~  259 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVVE----M  259 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-CCHHHHHH----H
T ss_pred             EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC-CCHHHHHH----H
Confidence            9999999987655544444556789999999999999999999999999999999998 8888863 33222222    1


Q ss_pred             hhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          271 IKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       271 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      +..+         ...+.+..++.++.+|+.+||+.||.+|||+.||++.|+.+
T Consensus       260 i~~~---------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          260 IRNR---------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHcC---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            2221         12234566788999999999999999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-54  Score=437.03  Aligned_cols=254  Identities=23%  Similarity=0.247  Sum_probs=209.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      .+.|...++||+|+||.||+|++.  |+.||||+++....    ..+|+.+++.++|||||+++++|.+.+.+|||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            456889999999999999999987  88999999876533    246999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC-cEEEcccccceecCCCCcc--
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF-NARLGDFGLALRCGVDNFR--  208 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~~~~~~~--  208 (487)
                      +||+|.++|...+ .+++..+..|+.||+.||+|||++  +||||||||+||||+.++ .+||+|||+++.+......  
T Consensus       133 ~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~  209 (336)
T 4g3f_A          133 EGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTR--RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS  209 (336)
T ss_dssp             TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence            9999999998765 499999999999999999999999  999999999999999987 6999999999876543321  


Q ss_pred             -cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          209 -FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       209 -~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...........    +.. +.       .....
T Consensus       210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----i~~-~~-------~~~~~  277 (336)
T 4g3f_A          210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK----IAS-EP-------PPIRE  277 (336)
T ss_dssp             ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH----HHH-SC-------CGGGG
T ss_pred             eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH----HHc-CC-------CCchh
Confidence             122345799999999999999999999999999999999999999974333222211    111 11       00012


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .++.+++++.+|+.+||++||.+|||+.||++.|.....
T Consensus       278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            345677899999999999999999999999998876554

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.2e-54  Score=438.14  Aligned_cols=247  Identities=22%  Similarity=0.399  Sum_probs=204.2

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ++|.+++.||+|+||.||+|++.  |+.||||++...   ....+.+.+|++++++++|||||++++++.+.+.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999987  899999998654   3345679999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          130 FMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       130 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+||+|.++|... +..+++..++.|+.||+.||.|||++  +||||||||+||||+.++.+||+|||+++.+..... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  180 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR--KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-  180 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCCHHHEEECCCCCEEEcccccceeecCCcc-
Confidence            99999999999764 34579999999999999999999999  999999999999999999999999999986543221 


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                       .....+||+.|||||++.+..|+.++|||||||++|||++|+.||... ..   .+...... .+.        . ++.
T Consensus       181 -~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-~~---~~~~~~i~-~~~--------~-~~~  245 (350)
T 4b9d_A          181 -LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-SM---KNLVLKII-SGS--------F-PPV  245 (350)
T ss_dssp             -HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-SH---HHHHHHHH-HTC--------C-CCC
T ss_pred             -cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CH---HHHHHHHH-cCC--------C-CCC
Confidence             223457999999999999999999999999999999999999999632 11   12111111 111        1 123


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..++.++.+||.+||+.||.+|||++|+++
T Consensus       246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            4567789999999999999999999999997

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.6e-54  Score=432.44  Aligned_cols=247  Identities=21%  Similarity=0.302  Sum_probs=212.0

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||+|++.  ++.||||++.+..    ...+.+.+|++++++++|||||+++++|.+.+.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999987  8899999987542    33467999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      |||+||+|.+++.+.+ .+++..+..++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+|+.+......
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~--~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            9999999999998765 499999999999999999999999  9999999999999999999999999999987655444


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||... ....+   ... +..+.          ...
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~---~~~-i~~~~----------~~~  253 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEGLI---FAK-IIKLE----------YDF  253 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHH---HHH-HHHTC----------CCC
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHH---HHH-HHcCC----------CCC
Confidence            4556679999999999999999999999999999999999999999632 11111   111 11111          123


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..+++++.+|+.+||++||.+|||++|++.
T Consensus       254 p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          254 PEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             CcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence            3456788999999999999999999998753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.5e-54  Score=433.25  Aligned_cols=247  Identities=23%  Similarity=0.361  Sum_probs=210.0

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ..|...+.||+|+||.||+|++.  |+.||||++.... ...+.+.+|+++|++++|||||+++++|.+.+.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46999999999999999999997  8899999986443 23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      ++|+|.+++.+.  .+++..+..|+.||+.||.|||++  +||||||||+||||+.++.+||+|||+++.+.....  ..
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~  227 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RR  227 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CB
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--cc
Confidence            999999999864  399999999999999999999999  999999999999999999999999999987654332  34


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ...+||+.|||||++.+..|+.++|||||||++|||++|+.||... .......    .+..     ...+  ..+....
T Consensus       228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~----~i~~-----~~~~--~~~~~~~  295 (346)
T 4fih_A          228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMK----MIRD-----NLPP--RLKNLHK  295 (346)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHH----HHHH-----SSCC--CCSCGGG
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CHHHHHH----HHHc-----CCCC--CCCcccc
Confidence            5678999999999999999999999999999999999999999632 2211111    1111     1111  1223456


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +++++.+|+.+||+.||.+|||++|+++
T Consensus       296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          296 VSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            7889999999999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.6e-54  Score=429.14  Aligned_cols=266  Identities=26%  Similarity=0.350  Sum_probs=207.0

Q ss_pred             cCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC----ceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK----DRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~~~lV~Ey  130 (487)
                      ++|.+.+.||+|+||.||+|+++|+.||||++.........+..|+..+.+++|||||+++++|.+.+    .+||||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey   82 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence            46888999999999999999999999999999876554444556777778899999999999998654    57999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE------MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~------~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      |++|+|.++|....  ++++.+.+++.|++.||+|||++      .++||||||||+||||+.++.+||+|||+++....
T Consensus        83 ~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  160 (303)
T 3hmm_A           83 HEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             CTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             CCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence            99999999998754  99999999999999999999975      34899999999999999999999999999987654


Q ss_pred             CCcc--cccCCCCCCCccCCccccCCC------CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCch----------hhhh
Q 011384          205 DNFR--FRSTPPAGTIGYLDPCYVTPD------NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS----------IVDW  266 (487)
Q Consensus       205 ~~~~--~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~----------~~~~  266 (487)
                      ....  .......||+.|||||++.+.      .++.++|||||||+||||+||+.|+........          ....
T Consensus       161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~  240 (303)
T 3hmm_A          161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE  240 (303)
T ss_dssp             TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred             CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence            4322  122345799999999999764      357799999999999999999887753221110          0000


Q ss_pred             hhhhhhcCccccccCCCCCCC-CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          267 AAPLIKKGKILSVFDPRIPPP-KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       267 ~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ....+.    ...+++.++.. .+..++..+.+|+.+||+.||.+|||+.||++.|+.+..
T Consensus       241 ~~~~~~----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          241 MRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHT----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHh----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            111111    11222333221 123577889999999999999999999999999998764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.6e-54  Score=437.20  Aligned_cols=267  Identities=28%  Similarity=0.362  Sum_probs=221.6

Q ss_pred             cchhhHHHhhcCcccceeecccCceEEEEEEECC-------eEEEEEEcCCCh--hhHHHHHHHHHHHHhCCC-CCceee
Q 011384           45 FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQ--EISQEVDNEIEILSKIHS-PRLVNL  114 (487)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~g-------~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~h-pnIv~l  114 (487)
                      ++.+.++...++|.+.+.||+|+||.||+|.+.+       +.||||++....  ...+.|.+|+++|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4445666777899999999999999999998753       579999987643  344679999999999965 899999


Q ss_pred             EEEEeCC-CceEEEEEecCCCCHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccC
Q 011384          115 LGFSNDS-KDRLLVVEFMSNGTLYDVLHSN---------------NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI  178 (487)
Q Consensus       115 ~~~~~~~-~~~~lV~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DI  178 (487)
                      +|+|.+. ..++||||||++|+|.++|...               ...+++..++.++.||+.||.|||++  +||||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~--~iiHRDL  211 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDL  211 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT--TCCCSCC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC--CeecCcc
Confidence            9999764 5689999999999999999753               23489999999999999999999999  9999999


Q ss_pred             CCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCC
Q 011384          179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIG  257 (487)
Q Consensus       179 kp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~  257 (487)
                      ||+|||++.++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987765544444556689999999999999999999999999999999998 89998643


Q ss_pred             CCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          258 FSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .....+..    .+..+         ...+.|..+++++.+|+.+||+.||.+|||+.||++.|+.+.+
T Consensus       292 ~~~~~~~~----~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          292 KIDEEFCR----RLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             CCSHHHHH----HHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHH----HHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            22222221    22222         1223445677889999999999999999999999999987643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.4e-53  Score=419.94  Aligned_cols=245  Identities=25%  Similarity=0.393  Sum_probs=199.1

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC----CCceEEE
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSND----SKDRLLV  127 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~lV  127 (487)
                      |.+.+.||+|+||.||+|.+.  +..||||++...   ....+.|.+|++++++++|||||+++++|.+    ...+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            367788999999999999987  788999987643   3345679999999999999999999999865    3457999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc-CCcEEEcccccceecCCCC
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-NFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||++|+|.+++.+.+ .+++..+..|+.||+.||+|||++.++||||||||+||||+. ++.+||+|||+|+..... 
T Consensus       108 mEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-  185 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-  185 (290)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence            99999999999998754 599999999999999999999999223999999999999984 789999999999753322 


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                         .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||........+..    .+..+        ..+.
T Consensus       186 ---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~----~i~~~--------~~~~  249 (290)
T 3fpq_A          186 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR----RVTSG--------VKPA  249 (290)
T ss_dssp             ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH----HHTTT--------CCCG
T ss_pred             ---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHH----HHHcC--------CCCC
Confidence               2334689999999999875 699999999999999999999999964322222211    11111        1111


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+..+++++.+|+.+||+.||.+|||++|+++
T Consensus       250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            223345578999999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.6e-53  Score=414.19  Aligned_cols=243  Identities=26%  Similarity=0.387  Sum_probs=194.2

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||+|++.  ++.||||++.+..    .....+.+|++++++++|||||++++++.+.+.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            58999999999999999999986  8899999986542    23467999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||| +|+|.+++.+.+ .+++..+..++.||+.||+|||++  +|+||||||+|||++.++.+||+|||+|+......  
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRH--KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--  166 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence            999 679999998765 499999999999999999999999  99999999999999999999999999997654332  


Q ss_pred             cccCCCCCCCccCCccccCCCCC-CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                       .....+||+.|||||++.+..+ +.++|||||||++|||++|+.||... .   ...... .+..+.          .+
T Consensus       167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-~---~~~~~~-~i~~~~----------~~  230 (275)
T 3hyh_A          167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-S---IPVLFK-NISNGV----------YT  230 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-S---HHHHHH-HHHHTC----------CC
T ss_pred             -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-C---HHHHHH-HHHcCC----------CC
Confidence             2345689999999999998876 57999999999999999999999632 1   111111 112211          12


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+..+++++.+|+.+||+.||++|||++|+++
T Consensus       231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            33456788999999999999999999999997

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=434.91  Aligned_cols=247  Identities=24%  Similarity=0.370  Sum_probs=209.9

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ..|...+.||+|+||.||+|++.  |+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999997  8899999886543 33456899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      +||+|.+++....  +++..+..|+.||+.||+|||++  +||||||||+||||+.++.+||+|||+|+.+.....  ..
T Consensus       231 ~gG~L~~~i~~~~--l~e~~~~~~~~qil~aL~ylH~~--~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~  304 (423)
T 4fie_A          231 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RR  304 (423)
T ss_dssp             TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CB
T ss_pred             CCCcHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHC--CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--cc
Confidence            9999999997653  99999999999999999999999  999999999999999999999999999987654332  34


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ...+||+.|||||++.+..|+.++|||||||++|||++|+.||... .+.....    .+..     ...+.  ......
T Consensus       305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~----~i~~-----~~~~~--~~~~~~  372 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMK----MIRD-----NLPPR--LKNLHK  372 (423)
T ss_dssp             CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHH----HHHH-----SCCCC--CSCTTS
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CHHHHHH----HHHc-----CCCCC--Cccccc
Confidence            5678999999999999999999999999999999999999999632 2211111    1111     11111  122345


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ++.++.+||.+||+.||.+|||+.|+++
T Consensus       373 ~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          373 VSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            7789999999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-52  Score=418.31  Aligned_cols=245  Identities=23%  Similarity=0.295  Sum_probs=199.3

Q ss_pred             cCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ++|.+++.||+|+||.||+|++.     ++.||||++.+..   .....+.+|++++++++|||||++++++.+++.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56999999999999999999873     6789999887542   223468889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      |||||+||+|.+++.+.+ .+++..+..++.||+.||+|||++  +|+||||||+|||++.++.+||+|||+|+......
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            999999999999998765 499999999999999999999999  99999999999999999999999999998654332


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                      .  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||... ....+   ...+ ..+.          .
T Consensus       181 ~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-~~~~~---~~~i-~~~~----------~  243 (304)
T 3ubd_A          181 K--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-DRKET---MTMI-LKAK----------L  243 (304)
T ss_dssp             C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHH---HHHH-HHCC----------C
T ss_pred             c--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-CHHHH---HHHH-HcCC----------C
Confidence            2  344578999999999999999999999999999999999999999632 22121   1111 1111          1


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCC-----HHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPS-----MKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~eil~  319 (487)
                      +.+..+++++.+|+.+||+.||.+|||     ++|+++
T Consensus       244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            234457788999999999999999998     467764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9e-51  Score=404.96  Aligned_cols=247  Identities=23%  Similarity=0.369  Sum_probs=188.7

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC--------
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK--------  122 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--------  122 (487)
                      ++|++++.||+|+||.||+|++.  ++.||||++...  ....+.+.+|++++++++|||||+++++|.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45999999999999999999987  889999987643  344567999999999999999999999987544        


Q ss_pred             ----ceEEEEEecCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccc
Q 011384          123 ----DRLLVVEFMSNGTLYDVLHSNNR--PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDF  196 (487)
Q Consensus       123 ----~~~lV~Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DF  196 (487)
                          .+|+|||||++|+|.+++.....  ..++..++.|+.||+.||+|||++  +||||||||+|||++.++.+||+||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~--~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC--cCccccCcHHHeEECCCCcEEEccC
Confidence                36899999999999999986542  255677889999999999999999  9999999999999999999999999


Q ss_pred             ccceecCCCCcc----------cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhh
Q 011384          197 GLALRCGVDNFR----------FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDW  266 (487)
Q Consensus       197 Gla~~~~~~~~~----------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~  266 (487)
                      |+|+.+......          ...+..+||+.|||||++.+..|+.++|||||||++|||++   ||....   .....
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---~~~~~  236 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---ERVRT  236 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---HHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---HHHHH
Confidence            999876543211          12234579999999999999999999999999999999997   664211   11110


Q ss_pred             hhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          267 AAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       267 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      . ..+..        ...+ +.....++.+.+|+.+||+.||.+|||+.|+++
T Consensus       237 ~-~~~~~--------~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          237 L-TDVRN--------LKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             H-HHHHT--------TCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H-HHHhc--------CCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0 01111        1111 122334556788999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.4e-48  Score=399.22  Aligned_cols=263  Identities=22%  Similarity=0.293  Sum_probs=202.7

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCc
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKD  123 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~  123 (487)
                      +....++|.+.+.||+|+||.||+|+++     ++.||||++..... ...+.+|+++++.+ +||||++++++|.+.+.
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            3345688999999999999999999863     57899998876543 35688999999998 69999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC-CcEEEcccccceec
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN-FNARLGDFGLALRC  202 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~-~~vkL~DFGla~~~  202 (487)
                      +|+|||||++|+|.+++.    .+++..+..++.||+.||+|||++  ||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        95 ~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~--gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQF--GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC--CeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            999999999999999984    399999999999999999999999  99999999999999876 79999999999765


Q ss_pred             CCCCcc--------------------------cccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCC
Q 011384          203 GVDNFR--------------------------FRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAID  255 (487)
Q Consensus       203 ~~~~~~--------------------------~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~  255 (487)
                      ......                          ...+..+||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            432110                          112345799999999999875 58999999999999999999999997


Q ss_pred             CCCCCchhhhhhhhhhh----------cCc-c-----------------ccccC---C---------CCCCCCChHHHHH
Q 011384          256 IGFSPPSIVDWAAPLIK----------KGK-I-----------------LSVFD---P---------RIPPPKDPIVRKQ  295 (487)
Q Consensus       256 ~~~~~~~~~~~~~~~~~----------~~~-i-----------------~~~~~---~---------~~~~~~~~~~~~~  295 (487)
                      .+...............          .+. +                 ....+   +         ....+....++++
T Consensus       249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            55432221111000000          000 0                 00000   0         0001112345678


Q ss_pred             HHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          296 LAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       296 l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +.+|+.+||+.||.+|||++|+++
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhc
Confidence            999999999999999999999996

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-48  Score=401.44  Aligned_cols=261  Identities=22%  Similarity=0.332  Sum_probs=202.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeC------CC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSND------SK  122 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~~  122 (487)
                      .++|.+++.||+|+||.||+|++.  |+.||||++....   ...+.+.+|+++|+.++|||||++++++..      ..
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            367999999999999999999987  8999999987543   334678899999999999999999998753      36


Q ss_pred             ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                      .+|||||||+ |+|.+++...+ .+++..+..++.||+.||.|||++  +||||||||+|||++.++.+||+|||+++.+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~~--~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHSA--QVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            7899999995 68999997654 599999999999999999999999  9999999999999999999999999999866


Q ss_pred             CCCC--cccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc------
Q 011384          203 GVDN--FRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK------  273 (487)
Q Consensus       203 ~~~~--~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~------  273 (487)
                      ....  ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||........+.... .....      
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~-~~~g~p~~~~~  287 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM-MVLGTPSPAVI  287 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH-HHHCCCCGGGT
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHH-HhcCCCChHHh
Confidence            4332  12234557899999999998875 56999999999999999999999996432211111110 00000      


Q ss_pred             -----Ccc---ccccCCCCCCCC---ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          274 -----GKI---LSVFDPRIPPPK---DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       274 -----~~i---~~~~~~~~~~~~---~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                           ...   ...+.+..+.+.   .+.++.++.+|+.+||+.||.+|||+.|+++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                 000   000011111110   1234678999999999999999999999986

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7e-48  Score=416.46  Aligned_cols=250  Identities=20%  Similarity=0.288  Sum_probs=211.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      .++|.+.+.||+|+||.||+|+++  |+.||||++.... ...+.+.+|+++|+.++|||||+++++|.+...+||||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            368999999999999999999987  8899999886543 3456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC--CcEEEcccccceecCCCCcc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN--FNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~--~~vkL~DFGla~~~~~~~~~  208 (487)
                      |+||+|.++|......+++..+..++.||+.||.|||++  +|+||||||+|||++.+  +.+||+|||+++.+..... 
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~--~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~-  312 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-  312 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE-
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc-
Confidence            999999999976666799999999999999999999999  99999999999999854  8999999999988754432 


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                        ....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .....    .+..+      +..++.+.
T Consensus       313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-~~~~~----~i~~~------~~~~~~~~  379 (573)
T 3uto_A          313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLR----NVKSC------DWNMDDSA  379 (573)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHH----HHHTT------CCCCCSGG
T ss_pred             --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHH----HHHhC------CCCCCccc
Confidence              2345799999999999999999999999999999999999999963221 11111    11111      11222233


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...+++++.+||.+||+.||.+|||+.|+++
T Consensus       380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          380 FSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3456788999999999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.8e-47  Score=383.35  Aligned_cols=282  Identities=34%  Similarity=0.614  Sum_probs=240.1

Q ss_pred             cccchhhHHHhhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeC
Q 011384           43 QHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSND  120 (487)
Q Consensus        43 ~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  120 (487)
                      ..+++.++...+++|...+.||+|+||.||+|.+. ++.||||+..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            34566677778899999999999999999999987 8899999877543 345779999999999999999999999999


Q ss_pred             CCceEEEEEecCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccc
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSNN---RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFG  197 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFG  197 (487)
                      .+..++||||+++++|.+++....   ..+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR--AIIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC--CeecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999996543   3589999999999999999999999  99999999999999999999999999


Q ss_pred             cceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCC--chhhhhhhhhhhcCc
Q 011384          198 LALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSP--PSIVDWAAPLIKKGK  275 (487)
Q Consensus       198 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~--~~~~~~~~~~~~~~~  275 (487)
                      ++................||+.|+|||.+.+..++.++|||||||++|||++|+.||......  .....|.......+.
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            998655433333344556899999999998888999999999999999999999999754332  233445555555666


Q ss_pred             cccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          276 ILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       276 i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      +...+++......+..++..+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            667777777777888999999999999999999999999999999987754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-46  Score=378.02  Aligned_cols=286  Identities=35%  Similarity=0.600  Sum_probs=246.7

Q ss_pred             ccccccchhhHHHhhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChh--hHHHHHHHHHHHHhCCCCCceeeEE
Q 011384           40 IKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVNLLG  116 (487)
Q Consensus        40 ~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~  116 (487)
                      ..+..|++.++....++|.+.+.||+|+||.||+|.+. ++.||||++.....  ....+.+|+++++.++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            35667899999999999999999999999999999875 88999999876532  2236899999999999999999999


Q ss_pred             EEeCCCceEEEEEecCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCCCcEEEccCCcEE
Q 011384          117 FSNDSKDRLLVVEFMSNGTLYDVLHSNN---RPLNWGRRIRLALQVAKAVEILHSE-MPPIIHRDIKSANVLIDRNFNAR  192 (487)
Q Consensus       117 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~gL~yLH~~-~~~ivH~DIkp~NILld~~~~vk  192 (487)
                      ++.+....++||||+++++|.+++....   .++++..++.++.|++.||.|||+. .++|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            9999999999999999999999998643   3599999999999999999999997 34899999999999999999999


Q ss_pred             EcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCC----CCCCCchhhhhhh
Q 011384          193 LGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAID----IGFSPPSIVDWAA  268 (487)
Q Consensus       193 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~----~~~~~~~~~~~~~  268 (487)
                      |+|||++......... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.    ..........|..
T Consensus       175 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             eccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            9999999876543322 3445679999999999988889999999999999999999999996    2233445566666


Q ss_pred             hhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          269 PLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       269 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .......+....+.......+...+..+.+++.+||+.||.+|||+.+|+++|+....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            6667777777777778888889999999999999999999999999999999987543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.4e-47  Score=410.18  Aligned_cols=246  Identities=20%  Similarity=0.286  Sum_probs=203.4

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHH---HHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQ---EVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~---~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      ++|.++++||+|+||.||+|++.  |+.||||++.+...    ...   ....++.+++.++|||||+++++|.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999987  88999999865321    112   2344567778889999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      ||||||+||+|.++|.+.+ .+++..+..|+.||+.||.|||++  +||||||||+||||+.+|.+||+|||+|+.+...
T Consensus       269 lVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~--gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            9999999999999998765 499999999999999999999999  9999999999999999999999999999876543


Q ss_pred             CcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                          .....+||+.|||||++.. ..|+.++|||||||++|||++|+.||........ ..... .....          
T Consensus       346 ----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i~~-~i~~~----------  409 (689)
T 3v5w_A          346 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDR-MTLTM----------  409 (689)
T ss_dssp             ----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHHHH-HHHHC----------
T ss_pred             ----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH-hhcCC----------
Confidence                2345689999999999974 5799999999999999999999999964322211 11111 11111          


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCC-----HHHHHH
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPS-----MKEIVD  319 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~eil~  319 (487)
                      ....+..++.++.+||.+||+.||.+|++     ++||++
T Consensus       410 ~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            12234567789999999999999999998     788876

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.7e-45  Score=365.97  Aligned_cols=281  Identities=33%  Similarity=0.583  Sum_probs=233.4

Q ss_pred             cccccchhhHHHhhcCcccc------eeecccCceEEEEEEECCeEEEEEEcCCC-----hhhHHHHHHHHHHHHhCCCC
Q 011384           41 KIQHFDYSDLEAATNGFSEQ------KLLGKGSHGSVYKAVLRGRQVAVKKPSKN-----QEISQEVDNEIEILSKIHSP  109 (487)
Q Consensus        41 ~~~~~~~~~~~~~~~~y~~~------~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~-----~~~~~~~~~Ei~~l~~l~hp  109 (487)
                      ....|++.++..++++|...      +.||+|+||.||+|.+.++.||||++...     ....+.+.+|+.++++++||
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            45678999999999998887      99999999999999999999999987643     23456799999999999999


Q ss_pred             CceeeEEEEeCCCceEEEEEecCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc
Q 011384          110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS--NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR  187 (487)
Q Consensus       110 nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~  187 (487)
                      ||+++++++.+.+..++||||+++++|.+++..  ...++++..++.++.|++.||.|||+.  +|+|+||||+|||++.
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dlkp~Nili~~  168 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN--HHIHRDIKSANILLDE  168 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECT
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEcC
Confidence            999999999999999999999999999999974  234699999999999999999999999  9999999999999999


Q ss_pred             CCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhh
Q 011384          188 NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA  267 (487)
Q Consensus       188 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~  267 (487)
                      ++.+||+|||++................||+.|+|||.+.+ .++.++|||||||++|+|++|..||...........+.
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  247 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK  247 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence            99999999999987654433333445679999999998875 57899999999999999999999997544443333332


Q ss_pred             hhhhhcC-ccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          268 APLIKKG-KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       268 ~~~~~~~-~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      ....... .+...+++.+ ...+..++..+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          248 EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            2222111 1222333333 3356788899999999999999999999999999998874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.3e-47  Score=390.79  Aligned_cols=320  Identities=20%  Similarity=0.336  Sum_probs=203.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .++|.+.+.||+|+||.||+|++.     +..||||++...  ....+.+.+|+.++++++||||+++++++.+....++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            457999999999999999999874     567999998754  3445679999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++++|.+++...+..+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++......
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            9999999999999988776799999999999999999999999  99999999999999999999999999997654432


Q ss_pred             cc-cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          207 FR-FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       207 ~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      .. .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||... ....+..    .+..         ..
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~-~~~~~~~----~i~~---------~~  267 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIK----AVDE---------GY  267 (373)
T ss_dssp             ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC-CHHHHHH----HHHT---------TE
T ss_pred             ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC-CHHHHHH----HHHc---------CC
Confidence            11 11222345788999999998999999999999999999998 99998632 1111111    1111         11


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCCCCCCCCCCCCcceeeccCCcccccccccCCcccch
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSWNGFNNPCLMVETVGRPVEVRKTQEGGIAGEN  364 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~p~~~~e~~~~~~~~~~~~~~g~~~~~  364 (487)
                      ..+.+..++..+.+|+.+||+.||.+||++.+|++.|+.+........        .......++.... ..........
T Consensus       268 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~~~--------~~~~~~~~~~~~~-~~~~~~~~~~  338 (373)
T 2qol_A          268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLK--------IITSAAARPSNLL-LDQSNVDITT  338 (373)
T ss_dssp             ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGGGG--------SBCCC----CCCE-EC--------
T ss_pred             CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCccccc--------cccCCCCCCcccc-cCCCCccccC
Confidence            122334567889999999999999999999999999998864311100        0000000110000 0011112223


Q ss_pred             hhhhhcccccccccCccccccccchhhHHHHHhhcc
Q 011384          365 LDLLDGKLSRMSMKDSRRVYSDLGLRSNLMELMAGM  400 (487)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (487)
                      ......|++.+.|..+...|+..|+.+  ++..+.|
T Consensus       339 ~~~~~~w~~~~~~~~~~~~~~~~~~~~--~~~~~~~  372 (373)
T 2qol_A          339 FRTTGDWLNGVWTAHCKEIFTGVEYSS--CDTIAKI  372 (373)
T ss_dssp             ------------------------------------
T ss_pred             CCCHHHHHHhccchHHHHHHHhcCCCc--HHHHhcc
Confidence            344556888899999999999999998  6666554

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5e-46  Score=372.03  Aligned_cols=264  Identities=29%  Similarity=0.455  Sum_probs=209.1

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  124 (487)
                      .++....++|.+.+.||+|+||.||+|.+.++.||||++....   ...+.+.+|++++++++||||+++++++.+....
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            3444556789999999999999999999999999999987543   3346789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCC--eeeccCCCCcEEEccCCcEEEcccccce
Q 011384          125 LLVVEFMSNGTLYDVLHSNNR--PLNWGRRIRLALQVAKAVEILHSEMPP--IIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~gL~yLH~~~~~--ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      ++||||+++++|.+++.....  .+++..++.++.|++.||+|||+.  +  |+||||||+|||++.++.+||+|||+++
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR--NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS--SSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC--CCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            999999999999999986542  389999999999999999999999  8  9999999999999999999999999987


Q ss_pred             ecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccccc
Q 011384          201 RCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF  280 (487)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~  280 (487)
                      ......  .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||... ........   ....       
T Consensus       188 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~-~~~~~~~~---~~~~-------  254 (309)
T 3p86_A          188 LKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-NPAQVVAA---VGFK-------  254 (309)
T ss_dssp             ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHH---HHHS-------
T ss_pred             cccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHH---HHhc-------
Confidence            543322  1234467999999999999999999999999999999999999999632 21111111   1000       


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccC
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLV  328 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~  328 (487)
                        ......+..++.++.+|+.+||+.+|.+|||+.+|++.|+.+....
T Consensus       255 --~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          255 --CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             --CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             --CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence              1112234456788999999999999999999999999999887543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.2e-46  Score=379.51  Aligned_cols=258  Identities=24%  Similarity=0.378  Sum_probs=215.6

Q ss_pred             hhcCcccceeecccCceEEEEEEEC---------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhC-CCCCceeeEEEEeC
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR---------GRQVAVKKPSKNQ--EISQEVDNEIEILSKI-HSPRLVNLLGFSND  120 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~---------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~  120 (487)
                      ..++|.+.+.||+|+||.||+|.+.         +..||||++....  ...+.+.+|+.+++.+ +||||++++++|.+
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3578999999999999999999863         3569999987643  3446799999999999 89999999999999


Q ss_pred             CCceEEEEEecCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI  185 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl  185 (487)
                      .+.+|+||||+++|+|.+++....               ..+++..++.++.||+.||.|||++  +|+||||||+|||+
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll  236 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CeeccccchhhEEE
Confidence            999999999999999999998643               3489999999999999999999999  99999999999999


Q ss_pred             ccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhh
Q 011384          186 DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIV  264 (487)
Q Consensus       186 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~  264 (487)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.. .....+.
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~-~~~~~~~  315 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELF  315 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHH
Confidence            9999999999999987654443333445567899999999999999999999999999999999 8888863 2222221


Q ss_pred             hhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          265 DWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       265 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .    .+..         ......+..++.++.+|+.+||+.||.+|||+.||++.|+.+..
T Consensus       316 ~----~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          316 K----LLKE---------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             H----HHHT---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H----HHhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1    1111         11223344567889999999999999999999999999988754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=365.80  Aligned_cols=261  Identities=26%  Similarity=0.425  Sum_probs=214.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCC-ChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSK-NQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||+|++.. .....+.+.+|++++++++||||+++++++.+....++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            357999999999999999999987  88999998765 345567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc-
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF-  209 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~-  209 (487)
                      +++++|.+++......+++..++.++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||++.......... 
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence            999999999998666799999999999999999999999  99999999999999999999999999997664332211 


Q ss_pred             -----------ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccc
Q 011384          210 -----------RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILS  278 (487)
Q Consensus       210 -----------~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~  278 (487)
                                 ......||+.|+|||.+.+..++.++|||||||++|||++|..|+..............        ..
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~--------~~  238 (310)
T 3s95_A          167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV--------RG  238 (310)
T ss_dssp             -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH--------HH
T ss_pred             ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh--------hc
Confidence                       11245799999999999999999999999999999999999988864322111100000        00


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccC
Q 011384          279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLV  328 (487)
Q Consensus       279 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~  328 (487)
                      .....    .+..++..+.+|+.+||+.||.+|||+.+|+++|+.+...+
T Consensus       239 ~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          239 FLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             HHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            11111    12344567899999999999999999999999999987643

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.6e-45  Score=359.00  Aligned_cols=257  Identities=24%  Similarity=0.379  Sum_probs=217.5

Q ss_pred             hhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ..++|.+.+.||+|+||.||+|.+. +..||||++.......+.+.+|++++++++||||+++++++.+....++||||+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            4578999999999999999999988 568999999887766788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      ++++|.+++...+..+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++......... ..
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~  162 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH--QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SS  162 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT--TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-EC
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCcCcceEEECCCCCEEEccCccceecchhhhh-cc
Confidence            99999999987666699999999999999999999999  9999999999999999999999999999866544322 33


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      ....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...... ....   . ...         ......+.
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~---~-~~~---------~~~~~~~~  228 (268)
T 3sxs_A          163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-EVVL---K-VSQ---------GHRLYRPH  228 (268)
T ss_dssp             CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHH---H-HHT---------TCCCCCCT
T ss_pred             cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-HHHH---H-HHc---------CCCCCCCC
Confidence            44567888999999988889999999999999999999 99888632211 1111   1 111         11112233


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .+++.+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            456789999999999999999999999999998864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.6e-45  Score=359.42  Aligned_cols=256  Identities=24%  Similarity=0.368  Sum_probs=216.8

Q ss_pred             hcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      .++|.+.+.||+|+||.||+|.+. ++.||||++.......+.+.+|++++++++||||+++++++.+....++||||++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            467999999999999999999995 7889999998877667889999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccC
Q 011384          133 NGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       133 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      +++|.+++......+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........ ....
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~  165 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSST  165 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTT
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC--CeecCCcchheEEEcCCCCEEecccccccccccccc-cccc
Confidence            9999999987777799999999999999999999999  999999999999999999999999999975543321 2234


Q ss_pred             CCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ...+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||... .......   .. ..         ......+..
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~-~~~~~~~---~~-~~---------~~~~~~~~~  231 (269)
T 4hcu_A          166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVE---DI-ST---------GFRLYKPRL  231 (269)
T ss_dssp             STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHH---HH-HT---------TCCCCCCTT
T ss_pred             CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC-CHHHHHH---HH-hc---------CccCCCCCc
Confidence            4567889999999998899999999999999999999 88888632 2111111   11 11         111223334


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            56789999999999999999999999999988753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.1e-45  Score=371.24  Aligned_cols=269  Identities=24%  Similarity=0.331  Sum_probs=215.8

Q ss_pred             HHhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCc----eEE
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKD----RLL  126 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~----~~l  126 (487)
                      ....++|.+.+.||+|+||.||+|.+.++.||||++.........+..|+.++++++||||+++++++.+...    +++
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           20 YFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             EETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             ccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            3445789999999999999999999999999999998776666677889999999999999999999987543    699


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCeeeccCCCCcEEEccCCcEEEccccc
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE--------MPPIIHRDIKSANVLIDRNFNARLGDFGL  198 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--------~~~ivH~DIkp~NILld~~~~vkL~DFGl  198 (487)
                      ||||+++|+|.+++....  +++..++.++.|++.||.|||+.        .++|+||||||+|||++.++.+||+|||+
T Consensus       100 v~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             EEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence            999999999999998754  99999999999999999999976        33899999999999999999999999999


Q ss_pred             ceecCCCCcccccCCCCCCCccCCccccCCC-----CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCch-----------
Q 011384          199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD-----NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS-----------  262 (487)
Q Consensus       199 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~-----------  262 (487)
                      ++...............||+.|+|||.+.+.     .++.++|||||||++|||++|+.||........           
T Consensus       178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  257 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP  257 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred             ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence            9876654433334456899999999999873     446688999999999999999999974322111           


Q ss_pred             -hhhhhhhhhhcCccccccCCCCCCC-CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          263 -IVDWAAPLIKKGKILSVFDPRIPPP-KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       263 -~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                       ...+.. ....    ....+.+... ....++.++.+|+.+||+.||.+|||+.+|++.|+.+.+
T Consensus       258 ~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          258 SLEDMQE-VVVH----KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             CHHHHHH-HHTT----SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhhhhh-hhhc----ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             011100 0000    0111111111 123467789999999999999999999999999998865

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=370.32  Aligned_cols=258  Identities=22%  Similarity=0.369  Sum_probs=213.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .++|.+.+.||+|+||.||+|.+.     +..||||++...  ....+.+.+|+.++++++||||+++++++.+....++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467999999999999999999984     456999998764  3445679999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++++|.+++......+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.......
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL--GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence            9999999999999987766799999999999999999999999  99999999999999999999999999998765432


Q ss_pred             c-ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          207 F-RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       207 ~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      . ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||... .......    .+.         ...
T Consensus       206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-~~~~~~~----~~~---------~~~  271 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM-TNRDVIS----SVE---------EGY  271 (325)
T ss_dssp             -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS-CHHHHHH----HHH---------TTC
T ss_pred             cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC-CHHHHHH----HHH---------cCC
Confidence            2 122333457889999999998889999999999999999999 99998632 1111111    111         112


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      ..+.+..++.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       272 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          272 RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            2234456778899999999999999999999999999988653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.1e-46  Score=382.81  Aligned_cols=262  Identities=22%  Similarity=0.325  Sum_probs=216.2

Q ss_pred             hHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce
Q 011384           49 DLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  124 (487)
                      .+....++|.+.+.||+|+||.||+|.+.  ++.||||++....  .....+.+|++++++++||||+++++++.+....
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            33445578999999999999999999996  8899999987542  3335688999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||+++|+|.+++...+..+++..++.++.|++.||+|||++  +|+||||||+|||++.++.+||+|||+++....
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK--CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            999999999999999987666699999999999999999999999  999999999999999999999999999976543


Q ss_pred             CCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ...........+++.|+|||.+....++.++|||||||++|||++ |..||... .......    .+..         .
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~-~~~~~~~----~~~~---------~  331 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL-SNQQTRE----FVEK---------G  331 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS-CHHHHHH----HHHT---------T
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHH----HHHc---------C
Confidence            322211222345778999999988889999999999999999998 88888632 2212111    1111         1


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ...+.+..++.++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            1223445567889999999999999999999999999988754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.5e-45  Score=361.59  Aligned_cols=248  Identities=25%  Similarity=0.398  Sum_probs=209.2

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            468999999999999999999875  8899999876433 3346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +++++|.+++....  +++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++........  .
T Consensus        99 ~~~~~L~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~--~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  172 (297)
T 3fxz_A           99 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (297)
T ss_dssp             CTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred             CCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--c
Confidence            99999999998763  99999999999999999999999  999999999999999999999999999977654332  2


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.........    ......+        ......+.
T Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~~--------~~~~~~~~  240 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL----YLIATNG--------TPELQNPE  240 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHHC--------SCCCSCGG
T ss_pred             cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCC--------CCCCCCcc
Confidence            34568999999999999999999999999999999999999999632211111    1111111        11122345


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .++..+.+|+.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            67788999999999999999999999996

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.2e-45  Score=371.88  Aligned_cols=268  Identities=28%  Similarity=0.359  Sum_probs=219.3

Q ss_pred             ccchhhHHHhhcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhC-CCCCcee
Q 011384           44 HFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKI-HSPRLVN  113 (487)
Q Consensus        44 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~  113 (487)
                      .+....++...++|.+.+.||+|+||.||+|.+.       ++.||||++....  ...+.+.+|++++.++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            3555666777889999999999999999999853       4789999987643  3346799999999999 8899999


Q ss_pred             eEEEEeCCCc-eEEEEEecCCCCHHHHHHhCCC-----------------------------------------------
Q 011384          114 LLGFSNDSKD-RLLVVEFMSNGTLYDVLHSNNR-----------------------------------------------  145 (487)
Q Consensus       114 l~~~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~-----------------------------------------------  145 (487)
                      +++++.+.+. .++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999987654 8999999999999999976432                                               


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          146 ------------------PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       146 ------------------~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                                        .+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                              289999999999999999999999  999999999999999999999999999976654443


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                      ........||+.|+|||++.+..++.++|||||||++|||++ |+.||...........    .+..+         ...
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----~~~~~---------~~~  315 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR----RLKEG---------TRM  315 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH----HHHHT---------CCC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH----HHHcC---------CCC
Confidence            334455678999999999998899999999999999999998 9999864333322221    11111         112


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ..+..++.++.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       316 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          316 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            2334466789999999999999999999999999987753

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.9e-45  Score=361.25  Aligned_cols=258  Identities=21%  Similarity=0.348  Sum_probs=213.4

Q ss_pred             HHhhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ....++|.+.+.||+|+||.||++.+. +..||||++.......+.+.+|++++++++||||+++++++.+....++|||
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            344568999999999999999999988 6689999998876667889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |+++++|.+++......+++..++.++.|++.||.|||++  +|+|+||||+|||++.++.+||+|||++........ .
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~  176 (283)
T 3gen_A          100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T  176 (283)
T ss_dssp             CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-H
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCCccceEEEcCCCCEEEcccccccccccccc-c
Confidence            9999999999987555699999999999999999999999  999999999999999999999999999976543321 1


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                      ......+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||.... ......    .+..         ......
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~-~~~~~~----~~~~---------~~~~~~  242 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAE----HIAQ---------GLRLYR  242 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHH----HHHT---------TCCCCC
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC-hhHHHH----HHhc---------ccCCCC
Confidence            2334567889999999998889999999999999999998 998986322 111111    1111         111222


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      +..++..+.+|+.+||+.+|.+|||+.++++.|..+.
T Consensus       243 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence            3345678999999999999999999999999998764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-45  Score=369.04  Aligned_cols=262  Identities=24%  Similarity=0.390  Sum_probs=216.4

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEECC-------eEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSND  120 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~g-------~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  120 (487)
                      +....++|.+.+.||+|+||.||+|.+.+       +.||||++...  ....+.+.+|+.++++++||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            44556889999999999999999999864       78999998754  3345679999999999999999999999999


Q ss_pred             CCceEEEEEecCCCCHHHHHHhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeecc
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSNN-----------------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD  177 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~D  177 (487)
                      .+..++||||+++++|.+++....                       ..+++..++.++.||+.||.|||++  +|+|||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--~ivH~D  199 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRD  199 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSC
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCC
Confidence            999999999999999999998642                       4699999999999999999999999  999999


Q ss_pred             CCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCC
Q 011384          178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDI  256 (487)
Q Consensus       178 Ikp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~  256 (487)
                      |||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999976544332223345678999999999998889999999999999999999 8888863


Q ss_pred             CCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          257 GFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      . ......    ..+..+..         ...+..++.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       280 ~-~~~~~~----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          280 M-AHEEVI----YYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             S-CHHHHH----HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             C-ChHHHH----HHHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            2 111111    11122111         123345667899999999999999999999999999988653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-45  Score=368.62  Aligned_cols=251  Identities=19%  Similarity=0.225  Sum_probs=211.2

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||+|.+.........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            3578999999999999999999987  78999999887766667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc--CCcEEEcccccceecCCCCcc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR--NFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~--~~~vkL~DFGla~~~~~~~~~  208 (487)
                      +++++|.+++......+++..++.++.|++.||.|||+.  +|+||||||+|||++.  ++.+||+|||++.......  
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--
Confidence            999999999987666799999999999999999999999  9999999999999987  7899999999998765432  


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                       ......||+.|+|||.+.+..++.++|||||||++|+|++|..||...... ..   ..... .+..      ..+...
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~---~~~i~-~~~~------~~~~~~  226 (321)
T 1tki_A          159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QI---IENIM-NAEY------TFDEEA  226 (321)
T ss_dssp             -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HH---HHHHH-HTCC------CCCHHH
T ss_pred             -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-HH---HHHHH-cCCC------CCChhh
Confidence             123356899999999999888899999999999999999999999642211 11   11111 1110      011111


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...++.++.+|+.+||+.||.+|||+.|+++
T Consensus       227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          227 FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1235678999999999999999999999998

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1e-44  Score=366.00  Aligned_cols=245  Identities=23%  Similarity=0.359  Sum_probs=207.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++...   ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            467999999999999999999985  889999987653   334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++++|.+++...+ .+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.......  
T Consensus        94 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQK--RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--  168 (328)
T ss_dssp             CCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--
T ss_pred             ECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--
Confidence            9999999999997764 499999999999999999999999  99999999999999999999999999997654332  


Q ss_pred             cccCCCCCCCccCCccccCCCCCC-cchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLS-TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                       ......||+.|+|||.+.+..+. .++|||||||++|+|++|+.||.... ....   .. .+..+.          ..
T Consensus       169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~---~~-~i~~~~----------~~  232 (328)
T 3fe3_A          169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKEL---RE-RVLRGK----------YR  232 (328)
T ss_dssp             -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHH---HH-HHHHCC----------CC
T ss_pred             -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-HHHH---HH-HHHhCC----------CC
Confidence             23456899999999999888774 79999999999999999999996321 1111   11 111111          11


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+..++.++.+|+.+||+.||.+|||++|+++
T Consensus       233 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          233 IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            23346678999999999999999999999996

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.6e-44  Score=357.19  Aligned_cols=262  Identities=23%  Similarity=0.341  Sum_probs=204.8

Q ss_pred             hhcCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHh--CCCCCceeeEEEEeC----CCceEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSK--IHSPRLVNLLGFSND----SKDRLL  126 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~----~~~~~l  126 (487)
                      ..++|.+.+.||+|+||.||+|.+.++.||||++.....  ..+..|.+++..  ++||||+++++++.+    ....++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGH--HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccc--hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            457899999999999999999999999999999876533  455666666666  799999999998654    345799


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeeeccCCCCcEEEccCCcEEEccccc
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH--------SEMPPIIHRDIKSANVLIDRNFNARLGDFGL  198 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~~~ivH~DIkp~NILld~~~~vkL~DFGl  198 (487)
                      ||||+++|+|.+++...  .+++..++.++.|++.||.|||        +.  +|+||||||+|||++.++.+||+|||+
T Consensus        84 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~--~ivH~Dlkp~Nill~~~~~~kl~Dfg~  159 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP--AIAHRDLKSKNILVKKNGQCCIADLGL  159 (301)
T ss_dssp             EECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC--EEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             ehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC--CeecCCCChHhEEEcCCCCEEEeeCCC
Confidence            99999999999999654  4999999999999999999999        78  999999999999999999999999999


Q ss_pred             ceecCCCCcc--cccCCCCCCCccCCccccCCC------CCCcchhhhhHHHHHHHHHhC----------CcCCCCCCCC
Q 011384          199 ALRCGVDNFR--FRSTPPAGTIGYLDPCYVTPD------NLSTKTDVFSFGILLLEIISC----------RKAIDIGFSP  260 (487)
Q Consensus       199 a~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDVwSlGvvl~eLltG----------~~pf~~~~~~  260 (487)
                      ++........  .......||+.|+|||.+.+.      .++.++|||||||++|||++|          ..||......
T Consensus       160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~  239 (301)
T 3q4u_A          160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN  239 (301)
T ss_dssp             CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence            9765443322  112345799999999999876      345799999999999999999          7777533222


Q ss_pred             chhhhhhhhhhhcCccccccCCCCCC-CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          261 PSIVDWAAPLIKKGKILSVFDPRIPP-PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       261 ~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      .............    ....+.++. ..+..++.++.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus       240 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          240 DPSFEDMRKVVCV----DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SCCHHHHHHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcchhhhhHHHhc----cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            2111111111111    011111111 12345788999999999999999999999999999865

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=8.1e-45  Score=359.25  Aligned_cols=270  Identities=23%  Similarity=0.362  Sum_probs=210.9

Q ss_pred             hcCcccceeecccCceEEEEEEE------CCeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeC--CCce
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVL------RGRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSND--SKDR  124 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~------~g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~  124 (487)
                      .++|++.+.||+|+||.||+|.+      .++.||||++.... ...+.+.+|++++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46799999999999999999985      37899999987653 344679999999999999999999999854  3568


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  166 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence            999999999999999988766799999999999999999999999  999999999999999999999999999976544


Q ss_pred             CCcc-cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhh----hhcCccccc
Q 011384          205 DNFR-FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL----IKKGKILSV  279 (487)
Q Consensus       205 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~----~~~~~i~~~  279 (487)
                      .... .......+++.|+|||.+.+..++.++|||||||++|||++|..|+....  ..........    .....+...
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP--AEFMRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH--HHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh--HHHHhhhcCccccchhHHHHHHH
Confidence            3221 12234457788999999998999999999999999999999998875311  0000000000    000000111


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       280 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      +......+.+..++.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            112223344556778999999999999999999999999999988654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.9e-45  Score=366.65  Aligned_cols=256  Identities=23%  Similarity=0.429  Sum_probs=207.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC--Ce----EEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GR----QVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~----~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++    +||+|.+....  ...+.+.+|+.++++++||||++++++|.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            357999999999999999999975  33    46888876432  34578999999999999999999999998764 78


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +|++|+++|+|.+++......+++..++.|+.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++.....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC--CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            99999999999999998777799999999999999999999999  9999999999999999999999999999876555


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ..........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||... ....+..    .+.         ...
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~----~~~---------~~~  236 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISS----ILE---------KGE  236 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHH----HHH---------TTC
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC-CHHHHHH----HHH---------cCC
Confidence            44434445567889999999999999999999999999999999 99998632 2222211    111         111


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ..+.+..++.++..|+.+||+.+|.+|||+.+|++.|+.+..
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            223345567789999999999999999999999999988754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.4e-44  Score=352.65  Aligned_cols=250  Identities=27%  Similarity=0.434  Sum_probs=199.2

Q ss_pred             hcCcccceeecccCceEEEEEEECCeEEEEEEcCCCh-----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~-----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      .++|.+.+.||+|+||.||+|.+.++.||||++....     ...+.+.+|+++++.++||||+++++++.+....++||
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            4689999999999999999999999999999876542     22467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC---eeeccCCCCcEEEcc--------CCcEEEcccc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP---IIHRDIKSANVLIDR--------NFNARLGDFG  197 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~---ivH~DIkp~NILld~--------~~~vkL~DFG  197 (487)
                      ||+++++|.+++...  .+++..++.++.|++.||.|||+.  +   |+||||||+|||++.        ++.+||+|||
T Consensus        86 e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~--~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           86 EFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDE--AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             ECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHS--SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            999999999998643  599999999999999999999999  7   999999999999986        6789999999


Q ss_pred             cceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccc
Q 011384          198 LALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKIL  277 (487)
Q Consensus       198 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~  277 (487)
                      ++.......    .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....   ..        
T Consensus       162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~---~~--------  225 (271)
T 3dtc_A          162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-LAVA---YG--------  225 (271)
T ss_dssp             C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-HHHH---HH--------
T ss_pred             ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHH---Hh--------
Confidence            997554332    2245799999999999988899999999999999999999999963211 1111   10        


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                       ........+.+..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       226 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          226 -VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence             1111222234455678899999999999999999999999999764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.6e-44  Score=358.17  Aligned_cols=260  Identities=23%  Similarity=0.353  Sum_probs=208.3

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCC----ChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSK----NQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~----~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||+|++..    .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            3568999999999999999999986  78999998743    23445678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++++|.+++...+ ++++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.......
T Consensus        89 v~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDM--RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            999999999999998764 599999999999999999999999  99999999999999999999999999987554322


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                      . .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........    ....... .     .+....
T Consensus       166 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~----~~~~~~~-~-----~~~~~~  234 (294)
T 4eqm_A          166 L-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI----AIKHIQD-S-----VPNVTT  234 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH----HHHHHSS-C-----CCCHHH
T ss_pred             c-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHhhc-c-----CCCcch
Confidence            1 123345799999999999999999999999999999999999999963221111    1111111 0     011111


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCC-CHHHHHHHHhcccc
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRP-SMKEIVDWLTGLSK  326 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RP-s~~eil~~L~~l~~  326 (487)
                      .....++..+.+++.+||+.||.+|| +++++.+.|..+..
T Consensus       235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            12334667899999999999999999 89999999988754

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=365.72  Aligned_cols=263  Identities=25%  Similarity=0.330  Sum_probs=215.5

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEE-------CCeEEEEEEcCCCh--hhHHHHHHHHHHHHhC-CCCCceeeEEEEe
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVL-------RGRQVAVKKPSKNQ--EISQEVDNEIEILSKI-HSPRLVNLLGFSN  119 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~-------~g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~  119 (487)
                      ++...++|.+.+.||+|+||.||+|.+       .+..||||++....  ...+.+.+|+.+++++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            445567899999999999999999997       25679999987542  3346799999999999 9999999999999


Q ss_pred             CCCceEEEEEecCCCCHHHHHHhCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeecc
Q 011384          120 DSKDRLLVVEFMSNGTLYDVLHSNNR----------------------PLNWGRRIRLALQVAKAVEILHSEMPPIIHRD  177 (487)
Q Consensus       120 ~~~~~~lV~Ey~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~D  177 (487)
                      +.+..++||||+++|+|.+++.....                      .+++..++.++.||+.||.|||+.  +|+|||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~D  197 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRD  197 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT--TEEETT
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CcccCC
Confidence            99999999999999999999986542                      379999999999999999999999  999999


Q ss_pred             CCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCC
Q 011384          178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDI  256 (487)
Q Consensus       178 Ikp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~  256 (487)
                      |||+|||++.++.+||+|||++................||+.|+|||.+.+..++.++|||||||++|+|++ |..||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999976654433333344567889999999988899999999999999999998 9999864


Q ss_pred             CCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          257 GFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      .........    ....         ....+.+..++.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       278 ~~~~~~~~~----~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          278 IPVDANFYK----LIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             CCCSHHHHH----HHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CCcHHHHHH----HHhc---------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            333222221    1111         112223445678899999999999999999999999999987654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.1e-44  Score=357.46  Aligned_cols=262  Identities=25%  Similarity=0.331  Sum_probs=206.2

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChh---hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      ...++|.+.+.||+|+||.||+|.+. ++.||||++.....   ....+.+|++++++++||||+++++++.+....++|
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            34578999999999999999999986 88999998875432   336788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||++ ++|.+.+......+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........
T Consensus        98 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A           98 FEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH--RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             EECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             EcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            99997 489999988777799999999999999999999999  999999999999999999999999999987653322


Q ss_pred             ccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCc-----------
Q 011384          208 RFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK-----------  275 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~-----------  275 (487)
                        ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.............. ......           
T Consensus       175 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          175 --SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS-ILGTPNPREWPQVQELP  251 (311)
T ss_dssp             -----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH-HHCCCCTTTSGGGTTSH
T ss_pred             --cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HHCCCChHHhhhhhccc
Confidence              2344578999999999876 5689999999999999999999999975443333222111 110000           


Q ss_pred             -----cccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          276 -----ILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       276 -----i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                           ..............+.++.++.+|+.+||+.||.+|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                 00000000000011234568899999999999999999999996

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.4e-44  Score=368.09  Aligned_cols=250  Identities=21%  Similarity=0.282  Sum_probs=207.6

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh-------hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCc
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE-------ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKD  123 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~-------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  123 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++.....       ..+.+.+|+.++++++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3568999999999999999999987  88999998765422       24679999999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC----cEEEcccccc
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF----NARLGDFGLA  199 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~----~vkL~DFGla  199 (487)
                      .++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+.  +|+||||||+|||++.++    .+||+|||++
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~--givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            999999999999999997654 599999999999999999999999  999999999999998776    7999999999


Q ss_pred             eecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccc
Q 011384          200 LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV  279 (487)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~  279 (487)
                      .......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....   . .+..+.    
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-~~~~---~-~i~~~~----  234 (361)
T 2yab_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETL---A-NITAVS----  234 (361)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHH---H-HHHTTC----
T ss_pred             eEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-HHHH---H-HHHhcC----
Confidence            8765432   23456799999999999999999999999999999999999999964221 1111   1 111111    


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       280 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        ..++.+....++.++.+|+.+||..||.+|||+.|+++
T Consensus       235 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          235 --YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             --CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              01111111245678999999999999999999999985

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.6e-44  Score=359.38  Aligned_cols=260  Identities=23%  Similarity=0.387  Sum_probs=216.8

Q ss_pred             HHhhcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS  121 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  121 (487)
                      ....++|.+.+.||+|+||.||+|.+.       +..||||++...  ....+.+.+|++++++++||||+++++++.+.
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            344678999999999999999999872       478999998754  33446789999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHHhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccC
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNN-----------------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI  178 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DI  178 (487)
                      ...++||||+++++|.+++....                       ..+++..++.++.|++.||.|||++  +|+||||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~di  176 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM--KLVHRDL  176 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT--TEECCCC
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC--CCccccc
Confidence            99999999999999999998643                       2389999999999999999999999  9999999


Q ss_pred             CCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCC
Q 011384          179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIG  257 (487)
Q Consensus       179 kp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~  257 (487)
                      ||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||...
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987655444334445678899999999988889999999999999999999 99888632


Q ss_pred             CCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          258 FSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                       .......    .+..+         .....+..++.++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       257 -~~~~~~~----~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          257 -PPERLFN----LLKTG---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             -CGGGHHH----HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CHHHHHH----HhhcC---------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             2222221    11111         1122344567889999999999999999999999999987643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=370.73  Aligned_cols=263  Identities=26%  Similarity=0.376  Sum_probs=218.3

Q ss_pred             HHhhcCcccceeecccCceEEEEEEEC---------CeEEEEEEcCCC--hhhHHHHHHHHHHHHhC-CCCCceeeEEEE
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLR---------GRQVAVKKPSKN--QEISQEVDNEIEILSKI-HSPRLVNLLGFS  118 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~---------g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  118 (487)
                      +...++|.+.+.||+|+||.||+|.+.         +..||||++...  ......+.+|+++++++ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            344578999999999999999999863         257999998764  33446789999999999 999999999999


Q ss_pred             eCCCceEEEEEecCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcE
Q 011384          119 NDSKDRLLVVEFMSNGTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANV  183 (487)
Q Consensus       119 ~~~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NI  183 (487)
                      .+.+..++||||+++|+|.+++....               ..+++..++.++.|++.||.|||+.  +|+||||||+||
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NI  222 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNV  222 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCcceE
Confidence            99999999999999999999998643               3599999999999999999999999  999999999999


Q ss_pred             EEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCch
Q 011384          184 LIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPS  262 (487)
Q Consensus       184 Lld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~  262 (487)
                      |++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|+|++ |..||... ....
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~-~~~~  301 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE  301 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHH
Confidence            999999999999999986654433334445578899999999999999999999999999999999 88888632 2222


Q ss_pred             hhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCC
Q 011384          263 IVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP  329 (487)
Q Consensus       263 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  329 (487)
                      +..    .+..+         .....+..++.++.+|+.+||+.||.+|||+.+|++.|+.+.....
T Consensus       302 ~~~----~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          302 LFK----LLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             HHH----HHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HHH----HHHcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            111    11111         1122334567789999999999999999999999999998875443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=353.80  Aligned_cols=266  Identities=19%  Similarity=0.267  Sum_probs=215.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC--ceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSK--DRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~~~lV  127 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++....  ...+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            467999999999999999999997  8899999987543  23467889999999999999999999998765  77999


Q ss_pred             EEecCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE----ccCCcEEEccccccee
Q 011384          128 VEFMSNGTLYDVLHSNN--RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI----DRNFNARLGDFGLALR  201 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl----d~~~~vkL~DFGla~~  201 (487)
                      |||+++++|.+++....  ..+++..++.++.|++.||.|||+.  +|+||||||+|||+    +.++.+||+|||+++.
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999998643  3399999999999999999999999  99999999999999    7888899999999987


Q ss_pred             cCCCCcccccCCCCCCCccCCccccC--------CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVT--------PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK  273 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~  273 (487)
                      .....   ......||+.|+|||.+.        +..++.++|||||||++|||++|+.||.....+.............
T Consensus       166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             cCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            65433   233457999999999886        5678999999999999999999999997443333322222222211


Q ss_pred             Cc---cc---------ccc--CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          274 GK---IL---------SVF--DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       274 ~~---i~---------~~~--~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ..   +.         ..+  ........+..++..+.+|+.+||+.||.+|||++|+++.....
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            10   00         000  11222345678899999999999999999999999999987654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=9.6e-45  Score=386.02  Aligned_cols=261  Identities=24%  Similarity=0.365  Sum_probs=220.5

Q ss_pred             hHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           49 DLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .++....+|.+.+.||+|+||.||+|.+.  +..||||++.......+.|.+|+.++++++||||++++++|.+....++
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            34455678999999999999999999997  7899999998776667889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          127 VVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      ||||+++|+|.+++... ...+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||+++.....
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            99999999999999863 34599999999999999999999999  9999999999999999999999999999876433


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ... ......+++.|+|||.+....++.++|||||||++|||++ |+.||.. .....+..    .+.         ...
T Consensus       372 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~-~~~~~~~~----~~~---------~~~  436 (495)
T 1opk_A          372 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYE----LLE---------KDY  436 (495)
T ss_dssp             CEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHH----HHH---------TTC
T ss_pred             cee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC-CCHHHHHH----HHH---------cCC
Confidence            222 2334456789999999998889999999999999999999 8888863 22222221    111         122


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ..+.+..++.++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            233445677889999999999999999999999999988753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.1e-44  Score=378.95  Aligned_cols=254  Identities=26%  Similarity=0.382  Sum_probs=213.1

Q ss_pred             HHhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC-ceEEEEE
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK-DRLLVVE  129 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-~~~lV~E  129 (487)
                      +...++|.+.+.||+|+||.||+|.+.++.||||+++... ..+.+.+|++++++++||||+++++++.+.. ..++|||
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3445789999999999999999999999999999988765 4578999999999999999999999987665 7899999


Q ss_pred             ecCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          130 FMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      |+++|+|.+++...+. .+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||+++.....   
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence            9999999999987543 479999999999999999999999  9999999999999999999999999999754322   


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                        .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||... .......    .+..         ....+
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-~~~~~~~----~i~~---------~~~~~  406 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVP----RVEK---------GYKMD  406 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS-CTTTHHH----HHHT---------TCCCC
T ss_pred             --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHH----HHHc---------CCCCC
Confidence              122367889999999999999999999999999999998 99998632 2222221    1111         12223


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .+..++.++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            445677899999999999999999999999999988753

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.1e-45  Score=357.84  Aligned_cols=261  Identities=24%  Similarity=0.358  Sum_probs=220.3

Q ss_pred             hHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           49 DLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      +++...++|.+.+.||+|+||.||+|.+.  +..||||++.......+.+.+|++++++++||||+++++++.+....++
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            34456788999999999999999999997  7899999998877777889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          127 VVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      ||||+++++|.+++... ...+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||++......
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH--TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC--CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            99999999999999863 34599999999999999999999999  9999999999999999999999999999765433


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||... ........    +         ....
T Consensus       165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~-~~~~~~~~----~---------~~~~  229 (288)
T 3kfa_A          165 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYEL----L---------EKDY  229 (288)
T ss_dssp             SSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHH----H---------HTTC
T ss_pred             ccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHH----H---------hccC
Confidence            322 2334467889999999998899999999999999999999 88888632 22222111    1         1112


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ....+..+++.+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence            223344567889999999999999999999999999987653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6e-44  Score=351.35  Aligned_cols=251  Identities=25%  Similarity=0.431  Sum_probs=206.6

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhh--------HHHHHHHHHHHHhCCCCCceeeEEEEeCCCc
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEI--------SQEVDNEIEILSKIHSPRLVNLLGFSNDSKD  123 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~--------~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  123 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++......        .+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            467999999999999999999985  889999987643221        167899999999999999999999997765 


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--eeeccCCCCcEEEccCCc-----EEEccc
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP--IIHRDIKSANVLIDRNFN-----ARLGDF  196 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~--ivH~DIkp~NILld~~~~-----vkL~DF  196 (487)
                       ++||||+++++|.+.+......+++..++.++.|++.||.|||+.  +  |+||||||+|||++.++.     +||+||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ--NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS--SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC--CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence             799999999999999987777799999999999999999999999  8  999999999999987776     999999


Q ss_pred             ccceecCCCCcccccCCCCCCCccCCccccC--CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC
Q 011384          197 GLALRCGVDNFRFRSTPPAGTIGYLDPCYVT--PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG  274 (487)
Q Consensus       197 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  274 (487)
                      |++.....     ......||+.|+|||.+.  ...++.++|||||||++|+|++|+.||........ . ......   
T Consensus       174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~-~~~~~~---  243 (287)
T 4f0f_A          174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-K-FINMIR---  243 (287)
T ss_dssp             TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-H-HHHHHH---
T ss_pred             Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-H-HHHHHh---
Confidence            99864332     233457999999999984  44578999999999999999999999964322211 1 111111   


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       275 ~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                            ........+..++.++.+|+.+||+.||.+|||+++|++.|+.+
T Consensus       244 ------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 ------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                  11222334456678899999999999999999999999999764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2e-44  Score=358.63  Aligned_cols=262  Identities=24%  Similarity=0.312  Sum_probs=217.3

Q ss_pred             HHhhcCcccceeecccCceEEEEEEE-------CCeEEEEEEcCCCh--hhHHHHHHHHHHHHhC-CCCCceeeEEEEeC
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVL-------RGRQVAVKKPSKNQ--EISQEVDNEIEILSKI-HSPRLVNLLGFSND  120 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~-------~g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~  120 (487)
                      +...++|.+.+.||+|+||.||+|.+       .++.||||++....  ...+.+.+|+.+++++ +||||+++++++.+
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            34457899999999999999999986       25789999987553  3446799999999999 99999999999999


Q ss_pred             CCceEEEEEecCCCCHHHHHHhCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcE
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSNNR-----------------PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANV  183 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NI  183 (487)
                      .+..++||||+++|+|.+++.....                 .+++..++.++.|++.||.|||+.  +|+||||||+||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Ni  176 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNI  176 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCccceE
Confidence            9999999999999999999986542                 489999999999999999999999  999999999999


Q ss_pred             EEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCch
Q 011384          184 LIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPS  262 (487)
Q Consensus       184 Lld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~  262 (487)
                      |++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||........
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            999999999999999977655443333444567889999999988899999999999999999999 8988864332222


Q ss_pred             hhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          263 IVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       263 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      ....    ...         ......+..++.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       257 ~~~~----~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          257 FYKM----IKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             HHHH----HHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHH----hcc---------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            2211    111         111222345667899999999999999999999999999887543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-44  Score=348.86  Aligned_cols=256  Identities=24%  Similarity=0.369  Sum_probs=215.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      .++|.+.+.||+|+||.||+|.+. ++.||+|++.......+.+.+|++++++++||||+++++++.+....++||||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            467999999999999999999986 7789999998876666889999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccC
Q 011384          133 NGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       133 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      +++|.+++......+++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++........ ....
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~  163 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSST  163 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTT
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCchheEEECCCCCEEEcccccccccccccc-cccc
Confidence            9999999988766799999999999999999999999  999999999999999999999999999875543221 1233


Q ss_pred             CCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.... ......    .+..+         .....+..
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~----~i~~~---------~~~~~~~~  229 (267)
T 3t9t_A          164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVE----DISTG---------FRLYKPRL  229 (267)
T ss_dssp             STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHH----HHHTT---------CCCCCCTT
T ss_pred             cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC-HHHHHH----HHhcC---------CcCCCCcc
Confidence            4567889999999988889999999999999999999 888886321 111111    11111         11122334


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            56789999999999999999999999999988753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.6e-44  Score=363.25  Aligned_cols=251  Identities=23%  Similarity=0.294  Sum_probs=206.8

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh--hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE--ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~--~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++.....  ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999987  88999998764432  33668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |+++++|.+++.... .+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++..+.......
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~--givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            999999999997654 499999999999999999999999  99999999999999999999999999998665444333


Q ss_pred             ccCCCCCCCccCCccccCCCCC-CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                      ......||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||............   . .        ........
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~---~-~--------~~~~~~~~  230 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---W-K--------EKKTYLNP  230 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH---H-H--------TTCTTSTT
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---H-h--------cccccCCc
Confidence            3445689999999999987765 77899999999999999999999743332221110   0 0        01111112


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...++.++.+|+.+||+.||.+|||+.|+++
T Consensus       231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          231 WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            2456778899999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.7e-44  Score=379.96  Aligned_cols=263  Identities=25%  Similarity=0.412  Sum_probs=219.0

Q ss_pred             hhhHHHhhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           47 YSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        47 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      ...++...++|.+.+.||+|+||.||+|.++ +..||||++.......+.+.+|++++++++||||+++++++. ....+
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            4455666788999999999999999999997 788999999877666788999999999999999999999987 56789


Q ss_pred             EEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          126 LVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||+++....
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--NYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            9999999999999997532 3589999999999999999999999  999999999999999999999999999976543


Q ss_pred             CCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      .... ......+++.|+|||.+....++.++|||||||++|||++ |+.||.. .....+..    .+..         .
T Consensus       337 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~-~~~~~~~~----~i~~---------~  401 (454)
T 1qcf_A          337 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIR----ALER---------G  401 (454)
T ss_dssp             HHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHH----HHHH---------T
T ss_pred             Ccee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC-CCHHHHHH----HHHc---------C
Confidence            2211 2233457889999999998899999999999999999999 9988863 22222211    1111         1


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      ...+.+..++.++.+|+.+||+.||.+|||+++|++.|+.+...
T Consensus       402 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            12233456778999999999999999999999999999988653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=361.29  Aligned_cols=249  Identities=20%  Similarity=0.293  Sum_probs=206.5

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh-------hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE-------ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~-------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  124 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++.....       ..+.+.+|+.++++++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            457999999999999999999987  88999998764321       356799999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC----cEEEcccccce
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF----NARLGDFGLAL  200 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~----~vkL~DFGla~  200 (487)
                      ++||||+++++|.+++.... .+++..++.++.|++.||.|||+.  +|+||||||+|||++.++    .+||+|||++.
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHHHC--CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            99999999999999997654 599999999999999999999999  999999999999998877    89999999998


Q ss_pred             ecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccccc
Q 011384          201 RCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF  280 (487)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~  280 (487)
                      ......   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...... ....   .. ...      
T Consensus       167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~---~~-~~~------  232 (326)
T 2y0a_A          167 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLA---NV-SAV------  232 (326)
T ss_dssp             ECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHH---HH-HHT------
T ss_pred             ECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHH---HH-Hhc------
Confidence            765332   233467999999999999999999999999999999999999999632211 1111   11 110      


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ....+......++..+.+|+.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          233 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            011111111235678999999999999999999999997

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.8e-44  Score=354.54  Aligned_cols=256  Identities=22%  Similarity=0.371  Sum_probs=201.0

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  124 (487)
                      ...++|.+.+.||+|+||.||+|.+.     +..||+|+....  ....+.+.+|+.++++++||||+++++++. .+..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            34578999999999999999999885     356999987754  334567999999999999999999999985 4568


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecccccHHHEEECCCCCEEECccccccccCc
Confidence            999999999999999987766799999999999999999999999  999999999999999999999999999976543


Q ss_pred             CCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.... ......    .+..+         
T Consensus       169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~-~~~~~~----~i~~~---------  233 (281)
T 1mp8_A          169 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIG----RIENG---------  233 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHHH----HHHTT---------
T ss_pred             ccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC-HHHHHH----HHHcC---------
Confidence            322 12334467889999999988889999999999999999997 888886322 222111    11111         


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      ...+.+..++..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          234 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            112234456788999999999999999999999999998764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.4e-44  Score=354.21  Aligned_cols=262  Identities=25%  Similarity=0.470  Sum_probs=201.5

Q ss_pred             HhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ...++|.+.+.||+|+||.||+|.+.+ .||||++...   ....+.+.+|+.++++++||||+++++++. ....++||
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~   98 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT   98 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence            445789999999999999999998766 5999988654   334467999999999999999999999764 55689999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++++|.+++......+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.........
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK--SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC--CcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            99999999999987767799999999999999999999999  9999999999999999999999999998765433322


Q ss_pred             cccCCCCCCCccCCccccC---CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVT---PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      .......||+.|+|||.+.   +..++.++|||||||++|+|++|+.||........+..    ....+..    .+.. 
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~----~~~~-  247 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE----MVGRGSL----SPDL-  247 (289)
T ss_dssp             -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHH----HHHHTSC----CCCT-
T ss_pred             ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHH----Hhccccc----Ccch-
Confidence            2334457999999999986   56788899999999999999999999974333222222    1222111    1111 


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ......++.++.+|+.+||+.+|.+|||+.+|++.|+.+.+
T Consensus       248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            11233567889999999999999999999999999998753

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.3e-44  Score=361.56  Aligned_cols=246  Identities=22%  Similarity=0.288  Sum_probs=207.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++|.+.+.||+|+||.||+|...  ++.||||++.+..    .....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            367999999999999999999986  8899999987542    2346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+++|+|.+++...+ .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            99999999999998654 499999999999999999999999  999999999999999999999999999975432221


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                        ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ....   ...+ ..+.          ..
T Consensus       161 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~---~~~i-~~~~----------~~  223 (337)
T 1o6l_A          161 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERL---FELI-LMEE----------IR  223 (337)
T ss_dssp             --CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHH---HHHH-HHCC----------CC
T ss_pred             --cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC-HHHH---HHHH-HcCC----------CC
Confidence              2345689999999999999999999999999999999999999996321 1111   1111 1111          11


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      .+..++.++.+|+.+||+.||.+||     ++++|++
T Consensus       224 ~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            2345678899999999999999999     8999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=9e-44  Score=351.40  Aligned_cols=266  Identities=15%  Similarity=0.171  Sum_probs=215.2

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++..... ...+.+|+.+++.+ +|+|++++++++.+....++|||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            3568999999999999999999974  89999998765432 35688899999999 89999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc-----EEEcccccceecCC
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN-----ARLGDFGLALRCGV  204 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~-----vkL~DFGla~~~~~  204 (487)
                      |+ +++|.+++...+..+++..++.++.|++.||.|||++  +|+||||||+|||++.++.     +||+|||++.....
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~  163 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  163 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence            99 9999999998776799999999999999999999999  9999999999999987766     99999999987654


Q ss_pred             CCcc-----cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccc
Q 011384          205 DNFR-----FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV  279 (487)
Q Consensus       205 ~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~  279 (487)
                      ....     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ........ ...  
T Consensus       164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~-~~~--  239 (298)
T 1csn_A          164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYERIGEK-KQS--  239 (298)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHHHHHH-HHH--
T ss_pred             ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH-HHHHHHhh-ccC--
Confidence            3221     12345679999999999999999999999999999999999999997533222211 11111110 000  


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCC
Q 011384          280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP  329 (487)
Q Consensus       280 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  329 (487)
                        .. .......++.++.+|+.+||+.||.+|||+++|++.|+.+.....
T Consensus       240 --~~-~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          240 --TP-LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             --SC-HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             --cc-HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence              00 000112356789999999999999999999999999998876543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.9e-43  Score=349.23  Aligned_cols=260  Identities=23%  Similarity=0.283  Sum_probs=206.4

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ++|.+.+.||+|+||.||+|.+.  ++.||||++...   ......+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999986  788999987643   2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |+++ +|.+.+......+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++........  
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~--~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--  156 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc--
Confidence            9965 77777776566799999999999999999999999  999999999999999999999999999987643322  


Q ss_pred             ccCCCCCCCccCCccccCCCC-CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC---cc---ccccC-
Q 011384          210 RSTPPAGTIGYLDPCYVTPDN-LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG---KI---LSVFD-  281 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~---~i---~~~~~-  281 (487)
                      ......||+.|+|||.+.+.. ++.++|||||||++|+|++|..||..+.................   ..   ....+ 
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            234457899999999998765 79999999999999999999988765443322222111111000   00   00000 


Q ss_pred             --------CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          282 --------PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       282 --------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                              ........+.++.++.+|+.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                    00011122346788999999999999999999999996

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.5e-44  Score=360.37  Aligned_cols=262  Identities=21%  Similarity=0.338  Sum_probs=198.9

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEECC--e---EEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLRG--R---QVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS  121 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~g--~---~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  121 (487)
                      +....++|.+.+.||+|+||.||+|.+..  .   .||||++...   ....+.+.+|++++++++||||+++++++...
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            34456789999999999999999998762  2   7999998754   33457799999999999999999999999877


Q ss_pred             Cce------EEEEEecCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc
Q 011384          122 KDR------LLVVEFMSNGTLYDVLHSNN-----RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN  190 (487)
Q Consensus       122 ~~~------~lV~Ey~~~gsL~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~  190 (487)
                      ...      ++||||+++++|.+++....     ..+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR--NFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTSC
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC--CcccCCCCcceEEEcCCCC
Confidence            655      99999999999999996422     2599999999999999999999999  9999999999999999999


Q ss_pred             EEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhh
Q 011384          191 ARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAP  269 (487)
Q Consensus       191 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~  269 (487)
                      +||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||... ........   
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-~~~~~~~~---  251 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-ENAEIYNY---  251 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHH---
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc-ChHHHHHH---
Confidence            99999999976654433323344567889999999999999999999999999999999 88888632 22222111   


Q ss_pred             hhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       270 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      . ..         ......+..++.++.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       252 ~-~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          252 L-IG---------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             H-HT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             H-hc---------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            1 11         111223445667899999999999999999999999999988764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.6e-44  Score=348.71  Aligned_cols=250  Identities=20%  Similarity=0.340  Sum_probs=208.1

Q ss_pred             hcCcccceeecccCceEEEEEEECCeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC--CceEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS--KDRLLVV  128 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~lV~  128 (487)
                      .++|.+.+.||+|+||.||+|++.++.||||++...   ....+.+.+|+.++++++||||+++++++.+.  ...++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            357999999999999999999999999999998754   33446799999999999999999999999887  7889999


Q ss_pred             EecCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCC--eeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          129 EFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPP--IIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~~~--ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      ||+++++|.+++..... .+++..++.++.|++.||.|||+.  +  ++||||||+|||++.++.++|+|||++....  
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL--EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--  164 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS--SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC--CCceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence            99999999999987543 589999999999999999999999  7  9999999999999999999999988764322  


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCc---chhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLST---KTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~---ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~  282 (487)
                           .....||+.|+|||.+.+..++.   ++|||||||++|||++|+.||..... ...   ......         .
T Consensus       165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~---~~~~~~---------~  226 (271)
T 3kmu_A          165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-MEI---GMKVAL---------E  226 (271)
T ss_dssp             -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-HHH---HHHHHH---------S
T ss_pred             -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-HHH---HHHHHh---------c
Confidence                 23357899999999998765544   79999999999999999999963211 111   111111         1


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       283 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      ......+..++.++.+++.+||+.||.+|||++++++.|+.+.
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            1222334456788999999999999999999999999998875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.4e-44  Score=364.64  Aligned_cols=251  Identities=21%  Similarity=0.281  Sum_probs=200.8

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      .++|.+.+.||+|+||.||++.+.  ++.||||++.......+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   98 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA   98 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence            468999999999999999999986  889999998877666678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc--EEEcccccceecCCCCccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN--ARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~--vkL~DFGla~~~~~~~~~~  209 (487)
                      ++|+|.+++...+ .+++..++.++.|++.||.|||++  +|+||||||+|||++.++.  +||+|||+++......   
T Consensus        99 ~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~--~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---  172 (361)
T 3uc3_A           99 SGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---  172 (361)
T ss_dssp             CSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred             CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC---
Confidence            9999999997654 499999999999999999999999  9999999999999987765  9999999986433222   


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcc-hhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTK-TDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~k-sDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                      ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..................         .....+.
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~---------~~~~~~~  243 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS---------VKYSIPD  243 (361)
T ss_dssp             --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT---------TCCCCCT
T ss_pred             CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc---------CCCCCCC
Confidence            2334579999999999988877655 89999999999999999999754443333332221111         1112222


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...++.++.+|+.+||+.||.+|||+.|+++
T Consensus       244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          244 DIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            2345678999999999999999999999997

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-43  Score=355.35  Aligned_cols=272  Identities=23%  Similarity=0.336  Sum_probs=207.9

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHh--CCCCCceeeEEEEeCC----
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSK--IHSPRLVNLLGFSNDS----  121 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~----  121 (487)
                      .......++|.+.+.||+|+||.||+|.+.++.||||++.....  ..+..|.+++..  ++||||+++++++.+.    
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            33445567899999999999999999999999999999865543  344455555554  4999999999999877    


Q ss_pred             CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeeeccCCCCcEEEccCCcEEEcc
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE------MPPIIHRDIKSANVLIDRNFNARLGD  195 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~------~~~ivH~DIkp~NILld~~~~vkL~D  195 (487)
                      ...++||||+++|+|.+++...  .+++..++.++.|++.||.|||+.      .++|+||||||+|||++.++.+||+|
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             CceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence            6789999999999999999765  399999999999999999999976      34899999999999999999999999


Q ss_pred             cccceecCCCCcc--cccCCCCCCCccCCccccCCCCCCcc------hhhhhHHHHHHHHHhC----------CcCCCCC
Q 011384          196 FGLALRCGVDNFR--FRSTPPAGTIGYLDPCYVTPDNLSTK------TDVFSFGILLLEIISC----------RKAIDIG  257 (487)
Q Consensus       196 FGla~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~k------sDVwSlGvvl~eLltG----------~~pf~~~  257 (487)
                      ||++..+......  .......||+.|+|||.+.+...+..      +|||||||++|||++|          ..||...
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            9999766443321  11234579999999999988766655      9999999999999999          4454322


Q ss_pred             CCCchhhhhhhhhhhcCccccccCCCCCCC-CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          258 FSPPSIVDWAAPLIKKGKILSVFDPRIPPP-KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      ................    ....+.++.. .+..++.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       266 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCI----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             SCSSCCHHHHHHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCCCCchhhhHHHHhh----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            1111111111111111    1111211111 1237889999999999999999999999999999988754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.7e-45  Score=371.40  Aligned_cols=257  Identities=24%  Similarity=0.333  Sum_probs=210.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  124 (487)
                      .++|.+.+.||+|+||.||+|.+.       +..||||++...  ......+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467999999999999999999853       568999998753  34446789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC---cEEEcc
Q 011384          125 LLVVEFMSNGTLYDVLHSNN------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF---NARLGD  195 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~---~vkL~D  195 (487)
                      ++||||+++|+|.+++....      ..+++..++.++.|++.||.|||++  +|+||||||+|||++.++   .+||+|
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChhhEEEecCCCCceEEECC
Confidence            99999999999999997643      3589999999999999999999999  999999999999998554   599999


Q ss_pred             cccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcC
Q 011384          196 FGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKG  274 (487)
Q Consensus       196 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~  274 (487)
                      ||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |..||... ....+..    .+..+
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~-~~~~~~~----~i~~~  302 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-SNQEVLE----FVTSG  302 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHH----HHHTT
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHH----HHHcC
Confidence            999975543332223334568999999999998899999999999999999998 88888632 2111111    11111


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       275 ~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                               .....+..++..+.+|+.+||+.+|.+|||+.+|++.|+.+..
T Consensus       303 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          303 ---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence                     1122334566789999999999999999999999999988764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=353.71  Aligned_cols=255  Identities=31%  Similarity=0.485  Sum_probs=205.7

Q ss_pred             cCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCC
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNG  134 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~g  134 (487)
                      ++|.+.+.||+|+||.||+|.+.++.||||++.... ..+.+.+|++++++++||||+++++++.+  ..++||||++++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~   84 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG   84 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT-HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred             hHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh-HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence            578999999999999999999999999999987543 34678999999999999999999999874  479999999999


Q ss_pred             CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCCCeeeccCCCCcEEEccCCc-EEEcccccceecCCCCcc
Q 011384          135 TLYDVLHSNNR--PLNWGRRIRLALQVAKAVEILHS---EMPPIIHRDIKSANVLIDRNFN-ARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       135 sL~~~l~~~~~--~l~~~~~~~i~~qi~~gL~yLH~---~~~~ivH~DIkp~NILld~~~~-vkL~DFGla~~~~~~~~~  208 (487)
                      +|.+++.....  .+++..++.++.|++.||.|||+   +  +|+||||||+|||++.++. +||+|||++......   
T Consensus        85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~--~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK--ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSS--CCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCC--CeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            99999986542  47889999999999999999999   6  9999999999999988876 799999998654322   


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                        .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+  .. ..         ....+.
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~-~~---------~~~~~~  225 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW--AV-HN---------GTRPPL  225 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH--HH-HT---------TCCCCC
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH--HH-hc---------CCCCCc
Confidence              23346999999999999999999999999999999999999999643222211111  11 11         111223


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCCCC
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLH  331 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~  331 (487)
                      +..++..+.+|+.+||+.||.+|||+.+|++.|+.+....+..
T Consensus       226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  268 (307)
T 2eva_A          226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA  268 (307)
T ss_dssp             BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred             ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence            3456678999999999999999999999999999988766543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.4e-43  Score=354.34  Aligned_cols=259  Identities=24%  Similarity=0.325  Sum_probs=213.5

Q ss_pred             cccchhhHHHhhcC----------cccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCC
Q 011384           43 QHFDYSDLEAATNG----------FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSP  109 (487)
Q Consensus        43 ~~~~~~~~~~~~~~----------y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hp  109 (487)
                      ..+++++++.+++.          |...+.||+|+||.||+|.+.  |+.||||++.... ...+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45677777776654          788889999999999999986  8899999876543 3346789999999999999


Q ss_pred             CceeeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC
Q 011384          110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF  189 (487)
Q Consensus       110 nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~  189 (487)
                      ||+++++++......++||||+++++|.+++...  .+++..++.++.|++.||.|||+.  +|+||||||+|||++.++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~  178 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQ--GVIHRDIKSDSILLTLDG  178 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCC
Confidence            9999999999999999999999999999998754  499999999999999999999999  999999999999999999


Q ss_pred             cEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhh
Q 011384          190 NARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP  269 (487)
Q Consensus       190 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~  269 (487)
                      .+||+|||++........  ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.... .....   ..
T Consensus       179 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~-~~~~~---~~  252 (321)
T 2c30_A          179 RVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS-PVQAM---KR  252 (321)
T ss_dssp             CEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHH---HH
T ss_pred             cEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHH---HH
Confidence            999999999977654322  2345679999999999999999999999999999999999999996322 11111   11


Q ss_pred             hhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       270 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      + ..     ...+.  ......++.++.+++.+||+.||.+|||+.++++
T Consensus       253 ~-~~-----~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          253 L-RD-----SPPPK--LKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             H-HH-----SSCCC--CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             H-hc-----CCCCC--cCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1 11     11111  1123356778999999999999999999999997

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.7e-43  Score=356.11  Aligned_cols=264  Identities=17%  Similarity=0.171  Sum_probs=212.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEEe
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++..... ...+.+|+++++++ +||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            468999999999999999999975  88999998765432 34688999999999 999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc-----EEEcccccceecCCC
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN-----ARLGDFGLALRCGVD  205 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~-----vkL~DFGla~~~~~~  205 (487)
                      + +++|.+++......+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.     +||+|||+++.+...
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK--NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred             C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence            9 9999999987666799999999999999999999999  9999999999999998887     999999999876443


Q ss_pred             Cccc-----ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccccc
Q 011384          206 NFRF-----RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF  280 (487)
Q Consensus       206 ~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~  280 (487)
                      ....     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .............. +.....
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~-~~~~~~~~~~i~~~-~~~~~~  241 (330)
T 2izr_A          164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK-ADTLKERYQKIGDT-KRATPI  241 (330)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-CSSHHHHHHHHHHH-HHHSCH
T ss_pred             CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc-cccHHHHHHHHHhh-hccCCH
Confidence            2211     1245689999999999999999999999999999999999999997432 22222211111110 000000


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCC
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP  329 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  329 (487)
                           ......++ ++.+++..||+.+|.+||++++|++.|+.+.....
T Consensus       242 -----~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          242 -----EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             -----HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             -----HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence                 00011234 89999999999999999999999999988765443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.1e-44  Score=364.48  Aligned_cols=251  Identities=22%  Similarity=0.331  Sum_probs=208.5

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ...++|.+.+.||+|+||.||+|.+.  ++.||||++...   ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            44578999999999999999999986  889999998654   2344678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC---CcEEEcccccceecC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN---FNARLGDFGLALRCG  203 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~---~~vkL~DFGla~~~~  203 (487)
                      ||||+++++|.+.+.... .+++..++.++.||+.||.|||+.  +|+||||||+|||++.+   +.+||+|||++....
T Consensus       106 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999999999997654 599999999999999999999999  99999999999999765   459999999997654


Q ss_pred             CCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ...   ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+.    ..+..+..      .
T Consensus       183 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~----~~i~~~~~------~  248 (362)
T 2bdw_A          183 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLY----AQIKAGAY------D  248 (362)
T ss_dssp             TCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHH----HHHHHTCC------C
T ss_pred             CCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHH----HHHHhCCC------C
Confidence            332   23346799999999999999999999999999999999999999963221 1111    11111111      1


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+.+....++.++.+|+.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          249 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            122223456788999999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.1e-44  Score=377.80  Aligned_cols=262  Identities=23%  Similarity=0.388  Sum_probs=212.6

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ..++...++|.+.+.||+|+||.||+|.+. +..||||++.......+.+.+|++++++++||||+++++++.+ ...++
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            444555678999999999999999999998 5679999998766666789999999999999999999999977 67899


Q ss_pred             EEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          127 VVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      ||||+++|+|.+++... +..+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||+++.....
T Consensus       256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            99999999999999752 34599999999999999999999999  9999999999999999999999999999765433


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ... ......+++.|+|||.+....++.++|||||||++|||++ |+.||.. .....+..    .+..         ..
T Consensus       334 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-~~~~~~~~----~i~~---------~~  398 (452)
T 1fmk_A          334 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLD----QVER---------GY  398 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHH----HHHT---------TC
T ss_pred             cee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC-CCHHHHHH----HHHc---------CC
Confidence            211 2233457889999999998899999999999999999999 8888863 22222111    1111         12


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      ..+.+..++..+.+|+.+||+.||.+|||+++|++.|+.+...
T Consensus       399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            2234456778999999999999999999999999999988654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=371.23  Aligned_cols=252  Identities=21%  Similarity=0.300  Sum_probs=208.2

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ...++|.+.+.||+|+||.||+|.+.  ++.||+|++....   ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            34578999999999999999999986  8899999876543   334678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc---cCCcEEEcccccceecC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCG  203 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld---~~~~vkL~DFGla~~~~  203 (487)
                      ||||+++|+|.+.+...+ .+++..+..++.||+.||.|||++  +|+||||||+|||++   .++.+||+|||++....
T Consensus        88 v~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~--givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQM--GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            999999999999998765 499999999999999999999999  999999999999998   45789999999997654


Q ss_pred             CCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+.    ..+..+..      .
T Consensus       165 ~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-~~~~----~~i~~~~~------~  231 (444)
T 3soa_A          165 GEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLY----QQIKAGAY------D  231 (444)
T ss_dssp             TTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHH----HHHHHTCC------C
T ss_pred             CCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-HHHH----HHHHhCCC------C
Confidence            4322  23456899999999999999999999999999999999999999963221 1111    11122111      1


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+.+....+++++.+|+.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          232 FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            222233456788999999999999999999999997

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-43  Score=348.69  Aligned_cols=259  Identities=21%  Similarity=0.344  Sum_probs=212.9

Q ss_pred             CcccceeecccCceEEEEEEEC--C---eEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce-EEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--G---RQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR-LLV  127 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g---~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~-~lV  127 (487)
                      .|...++||+|+||.||+|.+.  +   ..||+|++....  ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4677799999999999999863  2   369999887543  3446789999999999999999999999876665 999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+.+++|.+++......+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ--KFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            999999999999988677799999999999999999999999  999999999999999999999999999975543221


Q ss_pred             --ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          208 --RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       208 --~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                        ........+|+.|+|||.+.+..++.++|||||||++|+|++|..|+..............    .         ...
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~----~---------~~~  246 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA----Q---------GRR  246 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH----T---------TCC
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh----c---------CCC
Confidence              1123345688999999999999999999999999999999997777654444433332111    1         111


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCC
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP  329 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  329 (487)
                      .+.+..++..+.+|+.+||+.||.+|||+.++++.|+.+...+.
T Consensus       247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            22334566789999999999999999999999999999876544

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.9e-44  Score=358.52  Aligned_cols=266  Identities=23%  Similarity=0.398  Sum_probs=218.1

Q ss_pred             cchhhHHHhhcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeE
Q 011384           45 FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLL  115 (487)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~  115 (487)
                      +..++++...++|.+.+.||+|+||.||+|++.       ++.||||++....  .....+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            445566677789999999999999999999865       5789999987543  3345789999999999999999999


Q ss_pred             EEEeCCCceEEEEEecCCCCHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc
Q 011384          116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNN---------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID  186 (487)
Q Consensus       116 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld  186 (487)
                      +++.+....++||||+++++|.+++....         ..+++..++.++.|++.||.|||++  +|+||||||+|||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~NIli~  172 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVA  172 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCSGGGEEEC
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC--CCccCCCccceEEEc
Confidence            99999999999999999999999997521         3579999999999999999999999  999999999999999


Q ss_pred             cCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhh
Q 011384          187 RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVD  265 (487)
Q Consensus       187 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~  265 (487)
                      .++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||.. ........
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~  251 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLR  251 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHH
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-CCHHHHHH
Confidence            999999999999976544333223344567899999999998889999999999999999999 7788753 22212111


Q ss_pred             hhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          266 WAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       266 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                          .+..+.         ....+..++..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       252 ----~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          252 ----FVMEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             ----HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ----HHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence                111111         112334567789999999999999999999999999988743

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.8e-44  Score=362.62  Aligned_cols=256  Identities=21%  Similarity=0.358  Sum_probs=207.6

Q ss_pred             hcCcccceeecccCceEEEEEEEC--Ce----EEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GR----QVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~----~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      .++|.+.+.||+|+||.||+|.+.  +.    +||+|.+....  .....+.+|+.++++++||||+++++++. ....+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            357999999999999999999985  33    38888765432  22356788999999999999999999986 45689


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +||||+++|+|.+++......+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++.....
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH--GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT--TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC--CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            99999999999999987656799999999999999999999999  9999999999999999999999999999876554


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ..........+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||... ........    +..+.         
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~----~~~~~---------  234 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDL----LEKGE---------  234 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CTTHHHHH----HHTTC---------
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc-CHHHHHHH----HHcCC---------
Confidence            44334455678889999999998899999999999999999999 99998642 22222221    11111         


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ....+..++.++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          235 RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            112233355678899999999999999999999999998864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.2e-44  Score=363.98  Aligned_cols=271  Identities=17%  Similarity=0.214  Sum_probs=211.2

Q ss_pred             hhcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCChhh------------HHHHHHHHHHHHhCCCCCcee
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQEI------------SQEVDNEIEILSKIHSPRLVN  113 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~~~------------~~~~~~Ei~~l~~l~hpnIv~  113 (487)
                      ..++|.+.+.||+|+||.||+|.+.       ++.||||++......            ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            4568999999999999999999885       367999987655321            122445666777889999999


Q ss_pred             eEEEEeCC----CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc--c
Q 011384          114 LLGFSNDS----KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID--R  187 (487)
Q Consensus       114 l~~~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld--~  187 (487)
                      +++++.+.    ...++||||+ +++|.+++......+++..++.++.||+.||.|||+.  +|+||||||+|||++  .
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~--~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH--EYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEESSC
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--CeEEecCCHHHEEEecCC
Confidence            99998765    4579999999 9999999988767799999999999999999999999  999999999999999  8


Q ss_pred             CCcEEEcccccceecCCCCccc-----ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCch
Q 011384          188 NFNARLGDFGLALRCGVDNFRF-----RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS  262 (487)
Q Consensus       188 ~~~vkL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~  262 (487)
                      ++.+||+|||+++.+.......     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            8999999999998765432211     11334599999999999999999999999999999999999999974333333


Q ss_pred             hhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCCC
Q 011384          263 IVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPL  330 (487)
Q Consensus       263 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~  330 (487)
                      .......... ..+...+++.+.   ...++.++.+++..||+.+|.+||++.+|++.|+.+......
T Consensus       270 ~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          270 YVRDSKIRYR-ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS  333 (364)
T ss_dssp             HHHHHHHHHH-HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHhh-hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            2222111111 111222222211   123457899999999999999999999999999888765443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.6e-44  Score=355.20  Aligned_cols=267  Identities=21%  Similarity=0.369  Sum_probs=211.7

Q ss_pred             cCcccceeecccCceEEEEEEE------CCeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCC--Cce
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVL------RGRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDS--KDR  124 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~  124 (487)
                      +.|++.+.||+|+||.||+|.+      .++.||||++....  .....+.+|+++++.++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            5689999999999999999985      37899999987543  2346789999999999999999999999876  678


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||++.....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  178 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR--QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  178 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC--CcccCCCchheEEEcCCCCEEECcccccccccC
Confidence            999999999999999977666799999999999999999999999  999999999999999999999999999987654


Q ss_pred             CCcc-cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhh---hhhhcCcccccc
Q 011384          205 DNFR-FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA---PLIKKGKILSVF  280 (487)
Q Consensus       205 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~---~~~~~~~i~~~~  280 (487)
                      .... .......||..|+|||.+.+..++.++|||||||++|+|++|..|+.....  .......   .......+...+
T Consensus       179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA--LFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH--HHHHHHCSCCGGGHHHHHHHHH
T ss_pred             CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh--HHhhccCCcccccCHHHHHHHH
Confidence            4322 223445788899999999888899999999999999999999988642110  0000000   000000011111


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      ......+.+..++.++.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            222233345567789999999999999999999999999998763

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9.3e-44  Score=361.66  Aligned_cols=253  Identities=20%  Similarity=0.259  Sum_probs=195.4

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .....++|.+.+.||+|+||.||+|.+.  ++.||||++.... ..+.+.+|++++++++||||+++++++.+....++|
T Consensus        48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            3455678999999999999999999997  6789999987654 346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc---CCcEEEcccccceecCC
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR---NFNARLGDFGLALRCGV  204 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~~~~~  204 (487)
                      |||+++++|.+++...+ .+++..++.++.|++.||.|||+.  +|+||||||+|||++.   ++.+||+|||++.....
T Consensus       127 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHEN--GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             ECCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             EEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            99999999999997654 499999999999999999999999  9999999999999975   88999999999876543


Q ss_pred             CCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........    .+..+.      ...
T Consensus       204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----~i~~~~------~~~  270 (349)
T 2w4o_A          204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR----RILNCE------YYF  270 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHH----HHHTTC------CCC
T ss_pred             cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHH----HHHhCC------Ccc
Confidence            22   23346799999999999999999999999999999999999999964332211111    111111      111


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+....++.++.+|+.+||+.||.+|||+.++++
T Consensus       271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            22233456788999999999999999999999997

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.8e-43  Score=347.48  Aligned_cols=259  Identities=22%  Similarity=0.317  Sum_probs=202.2

Q ss_pred             cCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChh---hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ++|.+.+.||+|+||.||+|.+. ++.||||++.....   ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57999999999999999999987 88999998865432   236788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +++ +|.+++......+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++........  .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  156 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--K  156 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--c
Confidence            975 99999987666799999999999999999999999  999999999999999999999999999976543221  2


Q ss_pred             cCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC---cc-----ccccC
Q 011384          211 STPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG---KI-----LSVFD  281 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~---~i-----~~~~~  281 (487)
                      .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||............. ......   ..     ....+
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF-RILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HHHCCCCTTTSTTGGGSTTCC
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHHCCCChhhchhhhcccccc
Confidence            2345789999999998764 58999999999999999999999996432211111111 100000   00     00011


Q ss_pred             CCCC-------CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          282 PRIP-------PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       282 ~~~~-------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +.+.       ......++.++.+|+.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1111       0112346778999999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.2e-43  Score=349.18  Aligned_cols=261  Identities=23%  Similarity=0.356  Sum_probs=209.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEe-CCCceE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSN-DSKDRL  125 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-~~~~~~  125 (487)
                      ..+|.+.+.||+|+||.||+|.+.     ...||+|.+...  ....+.+.+|+.++++++||||+++++++. .....+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            456899999999999999999875     235899987753  334567899999999999999999999864 556789


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +||||+++++|.+++......+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++......
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCchheEEECCCCCEEECccccccccccc
Confidence            99999999999999987777799999999999999999999999  9999999999999999999999999999765433


Q ss_pred             Cc--ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          206 NF--RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       206 ~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ..  ........+|+.|+|||.+.+..++.++|||||||++|+|++|..|+..+..........    ..+         
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----~~~---------  248 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQG---------  248 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH----HTT---------
T ss_pred             chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH----hcC---------
Confidence            21  112334567889999999998899999999999999999999665554343333322211    111         


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCC
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP  329 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  329 (487)
                      .....+..++..+.+++.+||+.||.+|||+.++++.|+.+...+.
T Consensus       249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            1112233456789999999999999999999999999998876543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.5e-44  Score=350.15  Aligned_cols=262  Identities=23%  Similarity=0.381  Sum_probs=216.1

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ++++...++|.+.+.||+|+||.||+|.+. +..||||++.......+.+.+|++++++++||||+++++++.+ +..++
T Consensus         6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A            6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence            344555678999999999999999999988 5689999998776667889999999999999999999999875 45899


Q ss_pred             EEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          127 VVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      ||||+++++|.+++.... ..+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||++......
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            999999999999997532 2599999999999999999999999  9999999999999999999999999999876543


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ... ......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||... .......    .+..         ..
T Consensus       163 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~----~~~~---------~~  227 (279)
T 1qpc_A          163 EYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQ----NLER---------GY  227 (279)
T ss_dssp             CEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHH----HHHT---------TC
T ss_pred             ccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc-CHHHHHH----HHhc---------cc
Confidence            322 2334567889999999988889999999999999999999 88888632 2111111    1111         11


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      ....+..++.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            1223345678899999999999999999999999999887643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.7e-44  Score=356.02  Aligned_cols=244  Identities=23%  Similarity=0.309  Sum_probs=197.6

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++...   ......+..|+..+.++ +||||++++++|.+....++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            3467999999999999999999996  889999987643   23334455566666555 99999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+ +++|.+++...+..+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.......
T Consensus       135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ--GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            99999 7799999988777799999999999999999999999  99999999999999999999999999997765432


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                         ......||+.|+|||++.+ .++.++|||||||++|||++|..++...    ...    ..+..+        ..+.
T Consensus       212 ---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~----~~~~~~--------~~~~  271 (311)
T 3p1a_A          212 ---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGW----QQLRQG--------YLPP  271 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHH----HHHTTT--------CCCH
T ss_pred             ---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHH----HHHhcc--------CCCc
Confidence               2344579999999999876 7899999999999999999998766421    110    111111        1111


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+..++.++.+|+.+||+.||.+|||+.|+++
T Consensus       272 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            122345678999999999999999999999996

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.5e-44  Score=358.82  Aligned_cols=261  Identities=26%  Similarity=0.369  Sum_probs=215.1

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEECC-------eEEEEEEcCCCh--hhHHHHHHHHHHHHhC-CCCCceeeEEEEe
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQ--EISQEVDNEIEILSKI-HSPRLVNLLGFSN  119 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~g-------~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~  119 (487)
                      ++...++|.+.+.||+|+||.||+|.+.+       ..||+|++....  ...+.+.+|+.+++++ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            44556889999999999999999999852       479999987643  3456789999999999 8999999999999


Q ss_pred             CCCceEEEEEecCCCCHHHHHHhC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc
Q 011384          120 DSKDRLLVVEFMSNGTLYDVLHSN-------------NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID  186 (487)
Q Consensus       120 ~~~~~~lV~Ey~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld  186 (487)
                      +.+..++||||+++|+|.+++...             ...+++..++.++.|++.||.|||+.  +|+||||||+|||++
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGCEEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC--CcccCCcccceEEEC
Confidence            999999999999999999999752             24589999999999999999999999  999999999999999


Q ss_pred             cCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhh
Q 011384          187 RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVD  265 (487)
Q Consensus       187 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~  265 (487)
                      .++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|+|++ |..||...........
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  278 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK  278 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence            999999999999976554433333444567889999999988889999999999999999998 8888864332222221


Q ss_pred             hhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          266 WAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       266 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                          ....         ......+..++..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus       279 ----~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          279 ----LVKD---------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             ----HHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHhc---------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence                1111         1112223345678999999999999999999999999998764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.7e-44  Score=359.13  Aligned_cols=261  Identities=25%  Similarity=0.383  Sum_probs=215.7

Q ss_pred             hhcCcccceeecccCceEEEEEEEC---------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhC-CCCCceeeEEEEeC
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR---------GRQVAVKKPSKNQ--EISQEVDNEIEILSKI-HSPRLVNLLGFSND  120 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~---------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~  120 (487)
                      ..++|.+.+.||+|+||.||+|.+.         +..||||++....  .....+.+|+++++++ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3578999999999999999999873         4679999987643  3456789999999999 99999999999999


Q ss_pred             CCceEEEEEecCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI  185 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl  185 (487)
                      .+..++||||+++++|.+++....               ..+++..++.++.|++.||.|||+.  +|+||||||+|||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--KCIHRDLAARNVLV  190 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCccceEEE
Confidence            999999999999999999998643               2489999999999999999999999  99999999999999


Q ss_pred             ccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhh
Q 011384          186 DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIV  264 (487)
Q Consensus       186 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~  264 (487)
                      +.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||... ....+.
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~  269 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF  269 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC-CHHHHH
Confidence            9999999999999987655443333445567899999999988889999999999999999999 88888632 211211


Q ss_pred             hhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCC
Q 011384          265 DWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP  329 (487)
Q Consensus       265 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  329 (487)
                      .    .+..+         .....+..++.++.+++.+||+.+|.+|||+.+|++.|+.+....+
T Consensus       270 ~----~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          270 K----LLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             H----HHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             H----HHhcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            1    11111         1112334566789999999999999999999999999998865433

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.2e-44  Score=358.62  Aligned_cols=256  Identities=23%  Similarity=0.422  Sum_probs=205.0

Q ss_pred             hcCcccceeecccCceEEEEEEEC--Ce----EEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GR----QVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~----~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++    +||+|.+...  ......+.+|+.++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            467999999999999999999985  43    3677876543  334578999999999999999999999998765 78


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +|++|+++|+|.+++......+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++......
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC--CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence            99999999999999988777799999999999999999999999  9999999999999999999999999999876544


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ..........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||... ....+..    .+.         ...
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-~~~~~~~----~~~---------~~~  236 (327)
T 3lzb_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISS----ILE---------KGE  236 (327)
T ss_dssp             ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHH----HHH---------TTC
T ss_pred             cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHH----HHH---------cCC
Confidence            43333444567889999999999999999999999999999999 99998632 2222221    111         111


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ..+.+..++.++.+|+.+||+.||.+|||+.||++.|+.+..
T Consensus       237 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            223345567789999999999999999999999999998864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8.9e-44  Score=354.35  Aligned_cols=267  Identities=28%  Similarity=0.361  Sum_probs=217.7

Q ss_pred             cchhhHHHhhcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhC-CCCCceee
Q 011384           45 FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKI-HSPRLVNL  114 (487)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l  114 (487)
                      +....+....++|.+.+.||+|+||.||+|.+.       ++.||||++....  .....+.+|+.++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            444555666789999999999999999999852       5789999987643  3346789999999999 78999999


Q ss_pred             EEEEeCCC-ceEEEEEecCCCCHHHHHHhCCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccC
Q 011384          115 LGFSNDSK-DRLLVVEFMSNGTLYDVLHSNNR---------------PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI  178 (487)
Q Consensus       115 ~~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~---------------~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DI  178 (487)
                      ++++...+ ..++||||+++++|.+++.....               .+++..++.++.|++.||.|||+.  +|+||||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~di  174 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDL  174 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT--TCCCSCC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC--CcccccC
Confidence            99987754 48999999999999999986543               288999999999999999999999  9999999


Q ss_pred             CCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCC
Q 011384          179 KSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIG  257 (487)
Q Consensus       179 kp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~  257 (487)
                      ||+|||++.++.+||+|||++................||+.|+|||.+.+..++.++|||||||++|+|++ |+.||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999976654433333445568899999999998899999999999999999998 99998643


Q ss_pred             CCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          258 FSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ........    .+..+.         ....+..++.++.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       255 ~~~~~~~~----~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          255 KIDEEFCR----RLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             CCSHHHHH----HHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhHHHHH----HhccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            32222221    111111         112233456789999999999999999999999999988753

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-44  Score=350.55  Aligned_cols=258  Identities=23%  Similarity=0.362  Sum_probs=212.9

Q ss_pred             hcCcccce-eecccCceEEEEEEEC----CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           54 TNGFSEQK-LLGKGSHGSVYKAVLR----GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~-~LG~G~~g~Vy~~~~~----g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .++|.+.. .||+|+||.||+|.+.    +..||||++...  ....+.+.+|++++++++||||+++++++. .+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEE
Confidence            45666666 9999999999999863    678999998864  344577999999999999999999999994 556899


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++++|.+++......+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||++.......
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC--CEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            9999999999999987666799999999999999999999999  99999999999999999999999999998765433


Q ss_pred             cc-cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          207 FR-FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       207 ~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      .. .......+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||.... ......    .+..+         .
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~~~----~i~~~---------~  230 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMA----FIEQG---------K  230 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHH----HHHTT---------C
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-HHHHHH----HHhcC---------C
Confidence            22 12233457899999999988889999999999999999998 999986432 222221    11111         1


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccC
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLV  328 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~  328 (487)
                      ....+..++.++.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus       231 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          231 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            12234456788999999999999999999999999999886543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-43  Score=365.05  Aligned_cols=250  Identities=21%  Similarity=0.322  Sum_probs=208.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||+|++.... .....+.+|+++++.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999986  7889999887653 3445789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc--CCcEEEcccccceecCCCCcc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR--NFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~--~~~vkL~DFGla~~~~~~~~~  208 (487)
                      +++++|.+++......+++..++.++.||+.||.|||+.  +|+||||||+|||++.  ++.+||+|||++........ 
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-  206 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-  206 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecccchHHeEEecCCCCceEEEecccceecCCCcc-
Confidence            999999999987666799999999999999999999999  9999999999999974  47799999999987654332 


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                        .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....   .. +....      .......
T Consensus       207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~---~~-i~~~~------~~~~~~~  273 (387)
T 1kob_A          207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-LETL---QN-VKRCD------WEFDEDA  273 (387)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHH---HH-HHHCC------CCCCSST
T ss_pred             --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-HHHH---HH-HHhCC------CCCCccc
Confidence              2234799999999999999999999999999999999999999964221 1111   11 11111      1122223


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...++.++.+|+.+||+.||.+|||+.++++
T Consensus       274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            3456788999999999999999999999996

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.2e-44  Score=363.85  Aligned_cols=246  Identities=23%  Similarity=0.304  Sum_probs=202.2

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .++|.+.+.||+|+||.||+|++.  ++.||||++.+..    .....+.+|..++..+ +||||+++++++.+...+|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            468999999999999999999987  7899999987542    2345688899999988 79999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++|+|.+++...+ .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++......
T Consensus       102 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDK--GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            999999999999998764 499999999999999999999999  99999999999999999999999999987533222


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                        ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+   ...+ ..+.          .
T Consensus       179 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~---~~~i-~~~~----------~  241 (353)
T 3txo_A          179 --VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDL---FEAI-LNDE----------V  241 (353)
T ss_dssp             ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHH---HHHH-HHCC----------C
T ss_pred             --ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC-HHHH---HHHH-HcCC----------C
Confidence              13445689999999999998889999999999999999999999996422 1111   1111 1111          1


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCH------HHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSM------KEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~------~eil~  319 (487)
                      ..+..++.++.+|+.+||+.||.+||++      ++|++
T Consensus       242 ~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            2234467789999999999999999998      77876

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.8e-43  Score=359.63  Aligned_cols=271  Identities=21%  Similarity=0.244  Sum_probs=215.6

Q ss_pred             ccccccchhhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCC-----CCCce
Q 011384           40 IKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIH-----SPRLV  112 (487)
Q Consensus        40 ~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~-----hpnIv  112 (487)
                      .....+.+.+.....++|.+.+.||+|+||.||+|.+.  ++.||||++.........+..|+.+++.+.     ||||+
T Consensus        20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            35566777888888899999999999999999999995  889999999877777778889999999997     99999


Q ss_pred             eeEEEEeCCCceEEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc----
Q 011384          113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR----  187 (487)
Q Consensus       113 ~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~----  187 (487)
                      ++++++...+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.  +|+||||||+|||++.    
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM--SLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCTTCC
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCcccEEEcccccc
Confidence            9999999999999999999 999999998644 4599999999999999999999999  9999999999999975    


Q ss_pred             ---------------------CCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHH
Q 011384          188 ---------------------NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLE  246 (487)
Q Consensus       188 ---------------------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~e  246 (487)
                                           ++.+||+|||++......     .....||+.|+|||.+.+..++.++|||||||++|+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                 788999999999764432     234579999999999999999999999999999999


Q ss_pred             HHhCCcCCCCCCCCchhhhhhhhhh------------hcCccccccCC----CCCCCCC----------------hHHHH
Q 011384          247 IISCRKAIDIGFSPPSIVDWAAPLI------------KKGKILSVFDP----RIPPPKD----------------PIVRK  294 (487)
Q Consensus       247 LltG~~pf~~~~~~~~~~~~~~~~~------------~~~~i~~~~~~----~~~~~~~----------------~~~~~  294 (487)
                      |++|+.||........ ........            ...........    ..+....                ...++
T Consensus       252 ll~g~~pf~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (360)
T 3llt_A          252 LYTGSLLFRTHEHMEH-LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE  330 (360)
T ss_dssp             HHHSSCSCCCSSHHHH-HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred             HHHCCCCCCCCcHHHH-HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence            9999999964321111 11000000            00000000000    0000000                01126


Q ss_pred             HHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          295 QLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       295 ~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+.+|+.+||+.||.+|||+.|+++
T Consensus       331 ~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          331 LFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhc
Confidence            7889999999999999999999985

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.9e-43  Score=358.22  Aligned_cols=254  Identities=23%  Similarity=0.329  Sum_probs=206.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh------hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ------EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++....      ...+.+.+|+.+++.++||||+++++++.+....+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            467999999999999999999986  8899999875432      13567999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc---EEEcccccc
Q 011384          126 LVVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN---ARLGDFGLA  199 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~---vkL~DFGla  199 (487)
                      +||||+++++|.+.+..   .+..+++..++.++.||+.||.|||++  +|+||||||+|||++.++.   +||+|||++
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN--NIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999999988864   334589999999999999999999999  9999999999999986654   999999999


Q ss_pred             eecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccc
Q 011384          200 LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV  279 (487)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~  279 (487)
                      ........  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...  ....   . ..+..+..   
T Consensus       181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~---~-~~i~~~~~---  249 (351)
T 3c0i_A          181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT--KERL---F-EGIIKGKY---  249 (351)
T ss_dssp             EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHHH---H-HHHHHTCC---
T ss_pred             eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHHH---H-HHHHcCCC---
Confidence            87654322  234567999999999999999999999999999999999999999632  1111   1 11111111   


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhc
Q 011384          280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG  323 (487)
Q Consensus       280 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~  323 (487)
                         .........++.++.+|+.+||+.||.+|||+.++++  ++..
T Consensus       250 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          250 ---KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             ---CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             ---CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence               0010011235678999999999999999999999997  4543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.4e-43  Score=358.95  Aligned_cols=244  Identities=25%  Similarity=0.374  Sum_probs=205.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++....    .....+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            367999999999999999999985  8899999876532    2235789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+ +|+|.+++...+ .+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++....... 
T Consensus        88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~--givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRH--KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred             EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence            9999 789999887654 499999999999999999999999  99999999999999999999999999997654332 


Q ss_pred             ccccCCCCCCCccCCccccCCCCC-CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                        ......||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||.........              ..+.. ...
T Consensus       163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--------------~~i~~-~~~  225 (336)
T 3h4j_B          163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF--------------KKVNS-CVY  225 (336)
T ss_dssp             --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB--------------CCCCS-SCC
T ss_pred             --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH--------------HHHHc-CCC
Confidence              2345679999999999988776 78999999999999999999999743222110              01111 111


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+..++.++.+|+.+||+.||.+|||++||++
T Consensus       226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            234456788999999999999999999999997

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=350.71  Aligned_cols=247  Identities=25%  Similarity=0.336  Sum_probs=198.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh---------------------------hHHHHHHHHHHHH
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---------------------------ISQEVDNEIEILS  104 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~---------------------------~~~~~~~Ei~~l~  104 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++.....                           ..+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            367999999999999999999986  88999998765421                           1246889999999


Q ss_pred             hCCCCCceeeEEEEeC--CCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCc
Q 011384          105 KIHSPRLVNLLGFSND--SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSAN  182 (487)
Q Consensus       105 ~l~hpnIv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~N  182 (487)
                      +++||||+++++++.+  ....++||||+++++|.+++..  ..+++..++.++.|++.||.|||+.  +|+||||||+|
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~N  167 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQ--KIIHRDIKPSN  167 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHH
Confidence            9999999999999986  5678999999999999886543  3599999999999999999999999  99999999999


Q ss_pred             EEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCC---CCcchhhhhHHHHHHHHHhCCcCCCCCCC
Q 011384          183 VLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN---LSTKTDVFSFGILLLEIISCRKAIDIGFS  259 (487)
Q Consensus       183 ILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDVwSlGvvl~eLltG~~pf~~~~~  259 (487)
                      ||++.++.+||+|||++........  ......||+.|+|||.+.+..   ++.++|||||||++|+|++|+.||.... 
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-  244 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-  244 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred             EEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc-
Confidence            9999999999999999987654332  234567999999999998765   3778999999999999999999996321 


Q ss_pred             CchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          260 PPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       260 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                         ...... .+..+        ....+....++.++.+|+.+||+.||.+|||+.||++
T Consensus       245 ---~~~~~~-~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          245 ---IMCLHS-KIKSQ--------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             ---HHHHHH-HHHHC--------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---HHHHHH-HHhcc--------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence               111111 11111        1111222346678999999999999999999999985

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.3e-43  Score=363.77  Aligned_cols=251  Identities=21%  Similarity=0.288  Sum_probs=205.6

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .++|.+.++||+|+||.||+|++.  ++.||||++.+..    .....+.+|..++.++ +||||++++++|.+...+|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            457999999999999999999987  7889999987542    2234578899999887 89999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++|+|.+++...+ .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++......
T Consensus       131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~--givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            999999999999998754 499999999999999999999999  99999999999999999999999999997533222


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCch----hhhhhhhhhhcCccccccCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS----IVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~----~~~~~~~~~~~~~i~~~~~~  282 (487)
                        ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........    ........+..+.       
T Consensus       208 --~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------  278 (396)
T 4dc2_A          208 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------  278 (396)
T ss_dssp             --CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-------
T ss_pred             --CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-------
Confidence              134557899999999999999999999999999999999999999964322111    1111111111111       


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhhhcCCCCCCH------HHHHH
Q 011384          283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSM------KEIVD  319 (487)
Q Consensus       283 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~------~eil~  319 (487)
                         ...+..++.++.+|+.+||+.||.+||++      .+|++
T Consensus       279 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          279 ---IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             ---cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence               12344567889999999999999999985      67765

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-43  Score=353.74  Aligned_cols=243  Identities=23%  Similarity=0.363  Sum_probs=206.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++|.+.+.||+|+||.||+|+..  ++.||+|++.+..    ...+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            357999999999999999999986  8899999987542    2346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+++|+|.+++.... .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.....  
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence            99999999999998765 499999999999999999999999  9999999999999999999999999999765432  


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                         .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....    ......+.. +.          ..
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~-~~----------~~  221 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----MKTYEKILN-AE----------LR  221 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHH-CC----------CC
T ss_pred             ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHh-CC----------CC
Confidence               3346899999999999999999999999999999999999999964221    111111111 11          11


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      .+..++.++.+|+.+||+.||.+||     ++++|++
T Consensus       222 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          222 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            2345667899999999999999999     8899885

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2e-43  Score=352.19  Aligned_cols=266  Identities=21%  Similarity=0.321  Sum_probs=203.7

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEe
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSN  119 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  119 (487)
                      .++....++|.+.+.||+|+||.||+|.+.     +..||||++...   ....+.+.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            344455678999999999999999999874     347999998744   334467899999999999999999999998


Q ss_pred             CCC-----ceEEEEEecCCCCHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC
Q 011384          120 DSK-----DRLLVVEFMSNGTLYDVLHS-----NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF  189 (487)
Q Consensus       120 ~~~-----~~~lV~Ey~~~gsL~~~l~~-----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~  189 (487)
                      +..     ..++||||+++++|.+++..     ....+++..++.++.|++.||.|||+.  +|+||||||+|||++.++
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR--NFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT--TCCCCCCSGGGEEECTTS
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCcceEEEcCCC
Confidence            765     34999999999999999953     335699999999999999999999999  999999999999999999


Q ss_pred             cEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhh
Q 011384          190 NARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAA  268 (487)
Q Consensus       190 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~  268 (487)
                      .+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||... ........  
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~--  261 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-QNHEMYDY--  261 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHH--
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHHH--
Confidence            999999999976654332223344567889999999999999999999999999999999 77887532 22222111  


Q ss_pred             hhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCC
Q 011384          269 PLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP  329 (487)
Q Consensus       269 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  329 (487)
                        ...+         .....+..++.++.+++.+||+.||.+|||+.+|++.|+.+...+|
T Consensus       262 --~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          262 --LLHG---------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             --HHTT---------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             --HHcC---------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence              1111         1122334566789999999999999999999999999998876543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.6e-43  Score=355.10  Aligned_cols=250  Identities=22%  Similarity=0.295  Sum_probs=205.7

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      ++|.+.+.||+|+||.||+|++.  ++.||||++.+.    ......+.+|+.++.++ +||||+++++++.+...+|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57999999999999999999987  789999998753    23446688999999988 899999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+++|+|.+++...+ .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++...... 
T Consensus        89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-  164 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-  164 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence            99999999999998754 499999999999999999999999  99999999999999999999999999997533222 


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCch----hhhhhhhhhhcCccccccCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS----IVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~----~~~~~~~~~~~~~i~~~~~~~  283 (487)
                       .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........    ........+..+.        
T Consensus       165 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--------  235 (345)
T 3a8x_A          165 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------  235 (345)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--------
T ss_pred             -CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--------
Confidence             134456899999999999999999999999999999999999999964222111    1111111111111        


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCH------HHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSM------KEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~------~eil~  319 (487)
                        ...+..++.++.+|+.+||+.||.+||++      .+|++
T Consensus       236 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          236 --IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             --CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence              12334567789999999999999999995      66664

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.3e-43  Score=371.30  Aligned_cols=261  Identities=20%  Similarity=0.280  Sum_probs=212.6

Q ss_pred             chhhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCCCceeeEEEEe
Q 011384           46 DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSPRLVNLLGFSN  119 (487)
Q Consensus        46 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  119 (487)
                      .+.++....++|.+.++||+|+||.||+|++.  ++.||||++.+...    ....+.+|+.++..++||||++++++|.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            34455566789999999999999999999987  78899999875322    1234889999999999999999999999


Q ss_pred             CCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       120 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                      +...+|+||||+++|+|.+++......+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~--giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL--HYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC--CeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            99999999999999999999988656699999999999999999999999  9999999999999999999999999999


Q ss_pred             eecCCCCcccccCCCCCCCccCCccccC-----CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC
Q 011384          200 LRCGVDNFRFRSTPPAGTIGYLDPCYVT-----PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG  274 (487)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  274 (487)
                      +....... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.... .....   ..+....
T Consensus       223 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~-~~~~~---~~i~~~~  297 (437)
T 4aw2_A          223 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETY---GKIMNHK  297 (437)
T ss_dssp             EECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHH---HHHHTHH
T ss_pred             hhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC-hhHHH---Hhhhhcc
Confidence            77654332 2344568999999999987     5678999999999999999999999997422 11111   1111100


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCC--CCCHHHHHH
Q 011384          275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRER--RPSMKEIVD  319 (487)
Q Consensus       275 ~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--RPs~~eil~  319 (487)
                      .     ...++ .....++.++.+|+.+||..+|++  ||+++||++
T Consensus       298 ~-----~~~~p-~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          298 E-----RFQFP-TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             H-----HCCCC-SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             c-----cccCC-cccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            0     00111 112346788999999999988888  999999997

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=355.79  Aligned_cols=272  Identities=24%  Similarity=0.355  Sum_probs=204.7

Q ss_pred             hcCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEe-----CCCceEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN-----DSKDRLLVV  128 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-----~~~~~~lV~  128 (487)
                      .++|.+.+.||+|+||.||+|++.++.||||++............|+..+..++||||+++++++.     ....+++||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~   91 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM   91 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence            468999999999999999999999999999998765443333334444455689999999998553     233568999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE-------MPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-------~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      ||+++|+|.+++....  +++..++.++.|++.||.|||+.       .++|+||||||+|||++.++.+||+|||++..
T Consensus        92 e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~  169 (336)
T 3g2f_A           92 EYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR  169 (336)
T ss_dssp             CCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceee
Confidence            9999999999997765  68999999999999999999987       33899999999999999999999999999987


Q ss_pred             cCCCCc------ccccCCCCCCCccCCccccCC-------CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhh
Q 011384          202 CGVDNF------RFRSTPPAGTIGYLDPCYVTP-------DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA  268 (487)
Q Consensus       202 ~~~~~~------~~~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~  268 (487)
                      +.....      ........||+.|+|||.+.+       ..++.++|||||||++|||++|..||..+...........
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  249 (336)
T 3g2f_A          170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ  249 (336)
T ss_dssp             CSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTH
T ss_pred             cccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhh
Confidence            643221      112234579999999999987       3456789999999999999999888765443222111000


Q ss_pred             hhhhcC---------ccccccCCCCCC--CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          269 PLIKKG---------KILSVFDPRIPP--PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       269 ~~~~~~---------~i~~~~~~~~~~--~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      ......         .......+.++.  .....++.++.+|+.+||+.||.+|||+.|+++.|+.+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            000000         000111122222  12345788999999999999999999999999999998754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.8e-43  Score=360.55  Aligned_cols=248  Identities=23%  Similarity=0.320  Sum_probs=207.0

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||+|++.+..    .....+.+|+++++.++||||++++++|.+....|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            367999999999999999999987  7889999886542    2346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+.+|+|.+++.... .+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++..+.... 
T Consensus        94 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  169 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQ--RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-  169 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence            99999999999998754 499999999999999999999999  99999999999999999999999999998764332 


Q ss_pred             ccccCCCCCCCccCCccccCC---CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTP---DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                        ......||+.|+|||++..   ..++.++|||||||++|||++|+.||....... ........ ...          
T Consensus       170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~-~~~----------  235 (384)
T 4fr4_A          170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTF-ETT----------  235 (384)
T ss_dssp             --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHHH-HHC----------
T ss_pred             --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHHH-hhc----------
Confidence              3455689999999999874   458999999999999999999999997433222 11111111 110          


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCC-HHHHHH
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPS-MKEIVD  319 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-~~eil~  319 (487)
                      ....+..++.++.+|+.+||+.||.+||+ +++|++
T Consensus       236 ~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            11234456788999999999999999998 788775

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.4e-43  Score=342.36  Aligned_cols=255  Identities=22%  Similarity=0.347  Sum_probs=210.5

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||+|++...   ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            4578999999999999999999987  789999987643   33446788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc---EEEcccccceecCC
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN---ARLGDFGLALRCGV  204 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~---vkL~DFGla~~~~~  204 (487)
                      |||+++++|.+.+.... .+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.   +||+|||++.....
T Consensus        84 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           84 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            99999999999887654 499999999999999999999999  9999999999999976655   99999999976553


Q ss_pred             CCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ..   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...... ...    ..+..+..      ..
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~----~~~~~~~~------~~  226 (284)
T 3kk8_A          161 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLY----AQIKAGAY------DY  226 (284)
T ss_dssp             SC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH----HHHHHTCC------CC
T ss_pred             Cc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-HHH----HHHHhccc------cC
Confidence            32   233467999999999999999999999999999999999999999642211 111    11111111      12


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                      +.+....++.++.+|+.+||+.||.+|||+.++++  +|...
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          227 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence            22223456778999999999999999999999997  55544

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=8.5e-44  Score=350.33  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=206.2

Q ss_pred             hcCcccceeecccCceEEEEEEEC--C-------eEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCc
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--G-------RQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKD  123 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g-------~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  123 (487)
                      .++|.+.+.||+|+||.||+|.+.  +       ..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            467999999999999999999876  2       569999987543 345779999999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc--------EEEcc
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN--------ARLGD  195 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~--------vkL~D  195 (487)
                      .++||||+++++|.+++......+++..++.++.|++.||.|||++  +|+||||||+|||++.++.        +||+|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D  164 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD  164 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC--CeECCCcCcceEEEecCCcccccccceeeecc
Confidence            9999999999999999988766699999999999999999999999  9999999999999998877        99999


Q ss_pred             cccceecCCCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC
Q 011384          196 FGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG  274 (487)
Q Consensus       196 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  274 (487)
                      ||++......      ....||+.|+|||.+.+ ..++.++|||||||++|||++|..|+.............    .. 
T Consensus       165 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~----~~-  233 (289)
T 4fvq_A          165 PGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY----ED-  233 (289)
T ss_dssp             CCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HT-
T ss_pred             CcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh----hc-
Confidence            9998544322      12347889999999987 678999999999999999999766655333222211111    00 


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       275 ~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                            ...++    ...+.++.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       234 ------~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          234 ------RHQLP----APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             ------TCCCC----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             ------cCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                  11111    1234568899999999999999999999999998864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.4e-43  Score=347.82  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=207.4

Q ss_pred             hhcCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      ..++|.+.+.||+|+||.||+|.+.     +..||||++...  ....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            3567999999999999999999864     235999998764  33457799999999999999999999998754 568


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +||||+++++|.+++......+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||++......
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            99999999999999987666799999999999999999999999  9999999999999999999999999998765433


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      .. .......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||...... ....    .+..+         .
T Consensus       167 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-~~~~----~~~~~---------~  231 (281)
T 3cc6_A          167 DY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-DVIG----VLEKG---------D  231 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-GHHH----HHHHT---------C
T ss_pred             cc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-HHHH----HHhcC---------C
Confidence            22 12334567889999999988889999999999999999998 99998632221 1111    11111         1


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      ..+.+..+++.+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          232 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence            11233446678999999999999999999999999998764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.8e-44  Score=371.74  Aligned_cols=256  Identities=22%  Similarity=0.336  Sum_probs=210.0

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCCCceeeEEEEeCC
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSPRLVNLLGFSNDS  121 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  121 (487)
                      .++....++|.+.+.||+|+||.||+|++.  ++.||+|++.+...    ....+.+|+.+++.++||||++++++|.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344555679999999999999999999997  78899999865322    224588999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      ..+|+||||+++|+|.+++...  .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~--givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            9999999999999999999765  399999999999999999999999  999999999999999999999999999987


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCCC----CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccc
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPDN----LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKIL  277 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~  277 (487)
                      ...... ......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||..... ...   ...+.....  
T Consensus       218 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~---~~~i~~~~~--  290 (410)
T 3v8s_A          218 MNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGT---YSKIMNHKN--  290 (410)
T ss_dssp             CCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-HHH---HHHHHTHHH--
T ss_pred             eccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-hhH---HHHHHhccc--
Confidence            654432 2344578999999999998765    78899999999999999999999974221 111   111111000  


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHHHhhhhcCCC--CCCHHHHHH
Q 011384          278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRER--RPSMKEIVD  319 (487)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--RPs~~eil~  319 (487)
                           .+..+....++.++.+|+.+||+.+|.+  ||+++||++
T Consensus       291 -----~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          291 -----SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             -----HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             -----cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence                 0111222346788999999999999998  999999997

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.9e-43  Score=348.33  Aligned_cols=260  Identities=23%  Similarity=0.367  Sum_probs=202.6

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCC----ChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSK----NQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~----~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++..    .......+.+|+.++++++||||+++++++.+.+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            3457999999999999999999985  88999998874    23445678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          127 VVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      ||||+++++|.+++..   ....+++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++....
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC--CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999999864   445699999999999999999999999  99999999999999999999999999987654


Q ss_pred             CCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ....  ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||......  ...... .+..+        .
T Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~-~~~~~--------~  254 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCK-KIEQC--------D  254 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC--HHHHHH-HHHTT--------C
T ss_pred             CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh--HHHHHH-Hhhcc--------c
Confidence            3321  223457899999999999999999999999999999999999998643221  111111 11111        1


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      .+......++.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       255 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            11112234667899999999999999999999999999998754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.4e-43  Score=351.11  Aligned_cols=271  Identities=24%  Similarity=0.338  Sum_probs=214.0

Q ss_pred             hhhHHHhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHh--CCCCCceeeEEEEeCCC--
Q 011384           47 YSDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSK--IHSPRLVNLLGFSNDSK--  122 (487)
Q Consensus        47 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~l~~~~~~~~--  122 (487)
                      ........++|.+.+.||+|+||.||+|++.++.||||++....  ...+.+|++++..  ++||||+++++++....  
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            33345566789999999999999999999999999999987543  3567889999887  79999999999998876  


Q ss_pred             --ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeeeccCCCCcEEEccCCcEE
Q 011384          123 --DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH--------SEMPPIIHRDIKSANVLIDRNFNAR  192 (487)
Q Consensus       123 --~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~~~ivH~DIkp~NILld~~~~vk  192 (487)
                        ..++||||+++++|.+++...  .+++..++.++.|++.||.|||        +.  +|+||||||+|||++.++.+|
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~--~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP--AIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC--EEECSCCSGGGEEECTTSCEE
T ss_pred             cceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC--CeeeCCCCHHHEEECCCCCEE
Confidence              789999999999999999875  3999999999999999999999        77  999999999999999999999


Q ss_pred             EcccccceecCCCCccc--ccCCCCCCCccCCccccCCCC------CCcchhhhhHHHHHHHHHhC----------CcCC
Q 011384          193 LGDFGLALRCGVDNFRF--RSTPPAGTIGYLDPCYVTPDN------LSTKTDVFSFGILLLEIISC----------RKAI  254 (487)
Q Consensus       193 L~DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~------~s~ksDVwSlGvvl~eLltG----------~~pf  254 (487)
                      |+|||++..........  ......||+.|+|||.+.+..      ++.++|||||||++|||++|          ..||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            99999997665433211  234557999999999998763      23689999999999999999          5666


Q ss_pred             CCCCCCchhhhhhhhhhhcCccccccCCCCCCC-CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          255 DIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP-KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      ................+..    ....+.++.. ....++..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       268 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          268 YDLVPSDPSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             TTTSCSSCCHHHHHHHHTT----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cccCcCcccHHHHHHHHHH----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            5332211111111111111    1112222211 1236788999999999999999999999999999988653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-43  Score=355.56  Aligned_cols=259  Identities=22%  Similarity=0.380  Sum_probs=207.3

Q ss_pred             hhcCcccceeecccCceEEEEEEECC------eEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLRG------RQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~g------~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  124 (487)
                      ...+|.+.+.||+|+||.||+|.+..      ..||||++...  ......+.+|+.++++++||||+++++++.+....
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            34678899999999999999998752      35999998754  33445789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.....
T Consensus       122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM--NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999999999999988766799999999999999999999999  999999999999999999999999999976543


Q ss_pred             CCc-ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCC
Q 011384          205 DNF-RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       205 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~  282 (487)
                      ... ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||... ....+..    .+..         
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~-~~~~~~~----~~~~---------  265 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVMK----AIND---------  265 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHH----HHHT---------
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC-CHHHHHH----HHHC---------
Confidence            321 112223456889999999998899999999999999999999 99998532 1111111    1111         


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       283 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      ....+.+..++..+.+|+.+||+.+|.+||++.+|++.|+.+...
T Consensus       266 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          266 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            111223445678899999999999999999999999999887643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=358.37  Aligned_cols=250  Identities=23%  Similarity=0.325  Sum_probs=199.2

Q ss_pred             hhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCC--CCceeeEEEEeCCCceEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKN---QEISQEVDNEIEILSKIHS--PRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~l  126 (487)
                      ..++|.+.+.||+|+||.||++.+. ++.||||++...   ......+.+|+.++.+++|  |||+++++++.+....++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            4567999999999999999999886 788999987643   3344678999999999976  999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      |||+ .+++|.+++.... .+++..++.++.|++.||.|||+.  +|+||||||+|||++ ++.+||+|||++.......
T Consensus        87 v~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~--~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           87 VMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            9994 5889999998764 599999999999999999999999  999999999999997 6789999999997765443


Q ss_pred             cccccCCCCCCCccCCccccCC-----------CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCc
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTP-----------DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK  275 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~  275 (487)
                      .........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....  .... .        
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~-~--------  230 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISK-L--------  230 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHH-H--------
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--HHHH-H--------
Confidence            3333445679999999999864           6789999999999999999999999963221  1111 1        


Q ss_pred             cccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          276 ILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       276 i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                       ...+++......+...+.++.+|+.+||+.||.+|||+.++++
T Consensus       231 -~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          231 -HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             -HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence             1122222333344445678999999999999999999999997

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=361.46  Aligned_cols=251  Identities=23%  Similarity=0.320  Sum_probs=202.1

Q ss_pred             ccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCCC
Q 011384           58 SEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNG  134 (487)
Q Consensus        58 ~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~g  134 (487)
                      ...+.||+|+||.||+|.+.  ++.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            33678999999999999986  8899999987653 44568999999999999999999999999999999999999999


Q ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE--ccCCcEEEcccccceecCCCCcccccC
Q 011384          135 TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI--DRNFNARLGDFGLALRCGVDNFRFRST  212 (487)
Q Consensus       135 sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl--d~~~~vkL~DFGla~~~~~~~~~~~~~  212 (487)
                      +|.+++......+++..++.++.||+.||.|||+.  +|+||||||+|||+  +.++.+||+|||++.......   ...
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~  246 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM--YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLK  246 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCC
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccc
Confidence            99999987666699999999999999999999999  99999999999999  567899999999998765433   233


Q ss_pred             CCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHH
Q 011384          213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV  292 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  292 (487)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||........+.    .+... .      ..+.......+
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~----~i~~~-~------~~~~~~~~~~~  315 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN----NILAC-R------WDLEDEEFQDI  315 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHHT-C------CCSCSGGGTTS
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhc-c------CCCChhhhccC
Confidence            4579999999999998899999999999999999999999996432211111    11111 0      01111122346


Q ss_pred             HHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          293 RKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       293 ~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                      +.++.+|+.+||+.||.+|||+.|+++  +|...
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            678999999999999999999999998  55543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-43  Score=355.89  Aligned_cols=264  Identities=23%  Similarity=0.297  Sum_probs=207.5

Q ss_pred             hHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC------hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC
Q 011384           49 DLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN------QEISQEVDNEIEILSKIHSPRLVNLLGFSND  120 (487)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~------~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  120 (487)
                      .+....++|.+.+.||+|+||.||+|.+.  +..||+|++...      ....+.+.+|++++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            34566788999999999999999999986  778999987643      2345679999999999999999999999999


Q ss_pred             CCceEEEEEecCCCCHHHHHHhC---------------------------------------CCCCCHHHHHHHHHHHHH
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSN---------------------------------------NRPLNWGRRIRLALQVAK  161 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~qi~~  161 (487)
                      ....++||||+++|+|.+++...                                       ...+++..++.++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999998520                                       112467788899999999


Q ss_pred             HHHHHHhCCCCeeeccCCCCcEEEccCC--cEEEcccccceecCCCCc--ccccCCCCCCCccCCccccCC--CCCCcch
Q 011384          162 AVEILHSEMPPIIHRDIKSANVLIDRNF--NARLGDFGLALRCGVDNF--RFRSTPPAGTIGYLDPCYVTP--DNLSTKT  235 (487)
Q Consensus       162 gL~yLH~~~~~ivH~DIkp~NILld~~~--~vkL~DFGla~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~--~~~s~ks  235 (487)
                      ||.|||+.  +|+||||||+|||++.++  .+||+|||++..+.....  ........||+.|+|||.+.+  ..++.++
T Consensus       180 ~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          180 ALHYLHNQ--GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHHT--TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHHC--CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999999  999999999999998766  899999999986543221  112345679999999999875  6789999


Q ss_pred             hhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHH
Q 011384          236 DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMK  315 (487)
Q Consensus       236 DVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~  315 (487)
                      |||||||++|||++|+.||.........    ...... .      .....+....++.++.+|+.+||+.||.+|||+.
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~----~~~~~~-~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  326 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTI----SQVLNK-K------LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM  326 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHC-C------CCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHH----HHHHhc-c------cccCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence            9999999999999999999632221111    111111 0      1112222234678899999999999999999999


Q ss_pred             HHHH--HHhccc
Q 011384          316 EIVD--WLTGLS  325 (487)
Q Consensus       316 eil~--~L~~l~  325 (487)
                      ++++  +|..+.
T Consensus       327 ~~l~hp~~~~~~  338 (345)
T 3hko_A          327 RALQHPWISQFS  338 (345)
T ss_dssp             HHHHSHHHHTTS
T ss_pred             HHhcChhhccCh
Confidence            9998  666654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-42  Score=358.32  Aligned_cols=269  Identities=16%  Similarity=0.237  Sum_probs=207.6

Q ss_pred             hcCcccceeeccc--CceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           54 TNGFSEQKLLGKG--SHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G--~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .++|.+.+.||+|  +||.||+|.+.  ++.||||++...   ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999997  889999998654   3344678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          127 VVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      ||||+++++|.+++... ...+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||.+......
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH  181 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence            99999999999999764 34599999999999999999999999  9999999999999999999999999998654322


Q ss_pred             Ccc-----cccCCCCCCCccCCccccCC--CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc----C
Q 011384          206 NFR-----FRSTPPAGTIGYLDPCYVTP--DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK----G  274 (487)
Q Consensus       206 ~~~-----~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~----~  274 (487)
                      ...     .......||+.|+|||.+.+  ..++.++|||||||++|||++|+.||...................    .
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (389)
T 3gni_B          182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS  261 (389)
T ss_dssp             TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred             cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence            211     11223478999999999987  578999999999999999999999997433332222111100000    0


Q ss_pred             ------------------cccccc---------CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          275 ------------------KILSVF---------DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       275 ------------------~i~~~~---------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                                        .+...+         ......+.+..++.++.+|+.+||+.||.+|||+.|+++  +|+.+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred             ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence                              000000         000011233456778999999999999999999999996  35443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.7e-43  Score=357.71  Aligned_cols=243  Identities=24%  Similarity=0.294  Sum_probs=207.0

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++|.+.+.||+|+||.||+|++.  ++.||||++.+..    ...+.+.+|+++++.++||||+++++++.+....|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367999999999999999999986  8899999986543    2346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+++|+|.+++...+ .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.....  
T Consensus       120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            99999999999998754 499999999999999999999999  9999999999999999999999999999875432  


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                         .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ...   ... .+..+.          ..
T Consensus       195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~---~~~-~i~~~~----------~~  256 (350)
T 1rdq_E          195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQ---IYE-KIVSGK----------VR  256 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHH---HHH-HHHHCC----------CC
T ss_pred             ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-HHH---HHH-HHHcCC----------CC
Confidence               234579999999999999999999999999999999999999996321 111   111 111111          11


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCC-----HHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPS-----MKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~eil~  319 (487)
                      .+..++.++.+|+.+||+.||.+||+     +++|++
T Consensus       257 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            23456788999999999999999998     888876

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.7e-43  Score=341.86  Aligned_cols=247  Identities=26%  Similarity=0.413  Sum_probs=187.3

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++.....    ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            357999999999999999999984  88999999865432    236789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+++++|.+++.....++++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++........
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH--GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            999999999999988766799999999999999999999999  999999999999999999999999999976543322


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                        ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........             .....  ..
T Consensus       168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~--~~  230 (278)
T 3cok_A          168 --KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK-------------VVLAD--YE  230 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CCSSC--CC
T ss_pred             --cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH-------------Hhhcc--cC
Confidence              22345789999999999988899999999999999999999999974332211110             00111  12


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+..++.++.+|+.+||+.||.+|||++++++
T Consensus       231 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            23446678999999999999999999999996

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.7e-43  Score=352.66  Aligned_cols=248  Identities=23%  Similarity=0.352  Sum_probs=198.0

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC-------
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK-------  122 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-------  122 (487)
                      .++|.+.+.||+|+||.||+|++.  ++.||||++...  ....+.+.+|++++++++||||++++++|.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457999999999999999999996  889999987643  334578999999999999999999999986543       


Q ss_pred             --------------------------------------------------ceEEEEEecCCCCHHHHHHhCC--CCCCHH
Q 011384          123 --------------------------------------------------DRLLVVEFMSNGTLYDVLHSNN--RPLNWG  150 (487)
Q Consensus       123 --------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~--~~l~~~  150 (487)
                                                                        ..++||||+++++|.+++....  ...++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              2799999999999999998643  235666


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc----------cccCCCCCCCcc
Q 011384          151 RRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR----------FRSTPPAGTIGY  220 (487)
Q Consensus       151 ~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~----------~~~~~~~gt~~Y  220 (487)
                      .++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++.........          .......||+.|
T Consensus       165 ~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHHHhC--CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            7899999999999999999  9999999999999999999999999999876544211          122345799999


Q ss_pred             CCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHH
Q 011384          221 LDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIA  300 (487)
Q Consensus       221 ~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li  300 (487)
                      +|||.+.+..++.++|||||||++|||++|..|+.      .... ........        . .+......+.++.+|+
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~------~~~~-~~~~~~~~--------~-~~~~~~~~~~~~~~li  306 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM------ERVR-IITDVRNL--------K-FPLLFTQKYPQEHMMV  306 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH------HHHH-HHHHHHTT--------C-CCHHHHHHCHHHHHHH
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh------HHHH-HHHHhhcc--------C-CCcccccCChhHHHHH
Confidence            99999999999999999999999999999866542      1111 11111111        1 1112234567789999


Q ss_pred             HHhhhhcCCCCCCHHHHHH
Q 011384          301 VRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       301 ~~cl~~dP~~RPs~~eil~  319 (487)
                      .+||+.||.+|||+.|+++
T Consensus       307 ~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          307 QDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHCSSGGGSCCHHHHHH
T ss_pred             HHHccCCCCcCCCHHHHhh
Confidence            9999999999999999997

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-43  Score=359.62  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=205.9

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCce
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~  124 (487)
                      ...++|.+.+.||+|+||.||+|++.  ++.||||++.+..    .....+..|..++..+ +||||+++++++.+...+
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            44578999999999999999999986  8899999987542    2345678899999876 999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      |+||||+++|+|.+++...+ .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++....
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            99999999999999998754 499999999999999999999999  999999999999999999999999999975432


Q ss_pred             CCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ...  .....+||+.|+|||.+.+..++.++|||||||++|||++|+.||... ....+.   . .+..+.         
T Consensus       171 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-~~~~~~---~-~i~~~~---------  234 (345)
T 1xjd_A          171 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-DEEELF---H-SIRMDN---------  234 (345)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHH---H-HHHHCC---------
T ss_pred             CCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC-CHHHHH---H-HHHhCC---------
Confidence            221  244568999999999999999999999999999999999999999632 111111   1 111111         


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHH-HHHH
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMK-EIVD  319 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~-eil~  319 (487)
                       ...+..++.++.+|+.+||+.||.+||++. +|++
T Consensus       235 -~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          235 -PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence             123345678899999999999999999987 6653

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.5e-44  Score=356.25  Aligned_cols=268  Identities=21%  Similarity=0.322  Sum_probs=212.8

Q ss_pred             cccceeecccCceEEEEEEE------CCeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCC--CceEE
Q 011384           57 FSEQKLLGKGSHGSVYKAVL------RGRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDS--KDRLL  126 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~------~g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~--~~~~l  126 (487)
                      |.+.+.||+|+||.||++.+      .++.||||++....  .....+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48999999999999999876      37889999987653  3456799999999999999999999999874  56899


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++++|.+++....  +++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||++.......
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  188 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQ--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  188 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhC--CccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence            999999999999997754  99999999999999999999999  99999999999999999999999999998765433


Q ss_pred             cc-cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc-hhhhhhhhhhhcCccccccCCCC
Q 011384          207 FR-FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP-SIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       207 ~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~-~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      .. .......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||....... ....+.........+...+....
T Consensus       189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (318)
T 3lxp_A          189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE  268 (318)
T ss_dssp             SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred             cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence            21 12334568889999999998889999999999999999999999986321100 00000000000111122222333


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccC
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLV  328 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~  328 (487)
                      ..+.+..++.++.+|+.+||+.||.+|||+.+|++.|+.+...+
T Consensus       269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            34455667789999999999999999999999999999886543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.6e-43  Score=361.62  Aligned_cols=250  Identities=20%  Similarity=0.353  Sum_probs=195.3

Q ss_pred             hcCcccc-eeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHH-hCCCCCceeeEEEEeC----CCceE
Q 011384           54 TNGFSEQ-KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILS-KIHSPRLVNLLGFSND----SKDRL  125 (487)
Q Consensus        54 ~~~y~~~-~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~-~l~hpnIv~l~~~~~~----~~~~~  125 (487)
                      .++|.+. +.||+|+||.||++.+.  ++.||||++...    ..+.+|+.++. ..+||||++++++|..    ...+|
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            3567766 79999999999999987  788999998754    45677888874 5589999999998865    56789


Q ss_pred             EEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc---CCcEEEccccccee
Q 011384          126 LVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR---NFNARLGDFGLALR  201 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~~  201 (487)
                      +||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.  +|+||||||+|||++.   ++.+||+|||+++.
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            9999999999999998753 4599999999999999999999999  9999999999999987   78999999999986


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      .....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+..+..     
T Consensus       214 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~i~~~~~-----  284 (400)
T 1nxk_A          214 TTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTRIRMGQY-----  284 (400)
T ss_dssp             CC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-CSHHHHHHHTCC-----
T ss_pred             cCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-HHHHHHHHcCcc-----
Confidence            54332   234567999999999999999999999999999999999999999743322110 001111111111     


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                       .++.+....++.++.+|+.+||+.||.+|||+.+|++
T Consensus       285 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          285 -EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             -CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             1222223456788999999999999999999999998

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.1e-43  Score=347.99  Aligned_cols=251  Identities=27%  Similarity=0.378  Sum_probs=203.2

Q ss_pred             hcCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC-CceEEEEEecC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS-KDRLLVVEFMS  132 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-~~~~lV~Ey~~  132 (487)
                      .++|.+.+.||+|+||.||++.+.++.||||++.... ..+.+.+|++++++++||||+++++++.+. ...++||||++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   98 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   98 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence            4679999999999999999999999999999987654 346789999999999999999999987654 47899999999


Q ss_pred             CCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          133 NGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       133 ~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      +++|.+++..... .+++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++......     .
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~  171 (278)
T 1byg_A           99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----Q  171 (278)
T ss_dssp             TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCcceEEEeCCCcEEEeecccccccccc-----c
Confidence            9999999976432 388999999999999999999999  9999999999999999999999999998654332     2


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      ....+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.... ......    .+..         ......+.
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-~~~~~~----~~~~---------~~~~~~~~  237 (278)
T 1byg_A          172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVP----RVEK---------GYKMDAPD  237 (278)
T ss_dssp             ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-GGGHHH----HHTT---------TCCCCCCT
T ss_pred             cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC-HHHHHH----HHhc---------CCCCCCcc
Confidence            23467889999999988889999999999999999998 998886321 111111    1111         11223344


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          238 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            567889999999999999999999999999988753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.4e-43  Score=355.99  Aligned_cols=271  Identities=24%  Similarity=0.348  Sum_probs=214.9

Q ss_pred             hcCcccceeecccCceEEEEEEE------CCeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEe--CCCce
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVL------RGRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSN--DSKDR  124 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~------~g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~  124 (487)
                      .++|.+.+.||+|+||.||+|.+      .++.||||++.... ...+.+.+|++++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            35799999999999999999985      37889999987654 34467999999999999999999999886  45668


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||++.....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR--RCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            999999999999999987555699999999999999999999999  999999999999999999999999999987654


Q ss_pred             CCcc-cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhh--hhhhhhcCccccccC
Q 011384          205 DNFR-FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDW--AAPLIKKGKILSVFD  281 (487)
Q Consensus       205 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~--~~~~~~~~~i~~~~~  281 (487)
                      .... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||....... ...+  .........+...+.
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-LRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHCC----CCHHHHHHHHHH
T ss_pred             CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh-hhhcccccccccHHHHHHHhh
Confidence            3322 23344568899999999998888999999999999999999999986321100 0000  000000001111222


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      .....+.+..++.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            2333345566788999999999999999999999999999988653

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.9e-43  Score=351.35  Aligned_cols=250  Identities=21%  Similarity=0.271  Sum_probs=206.7

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh-------hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCc
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE-------ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKD  123 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~-------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  123 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++.....       ..+.+.+|+.++++++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3467999999999999999999986  78999998765321       35679999999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC----cEEEcccccc
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF----NARLGDFGLA  199 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~----~vkL~DFGla  199 (487)
                      .++||||+++++|.+++.... .+++..++.++.|++.||.|||+.  +|+||||||+|||++.++    .+||+|||++
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~--~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            999999999999999997654 599999999999999999999999  999999999999999887    7999999999


Q ss_pred             eecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccc
Q 011384          200 LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV  279 (487)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~  279 (487)
                      .......   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...... ...   .. +....    
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~---~~-i~~~~----  234 (321)
T 2a2a_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETL---AN-ITSVS----  234 (321)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHH---HH-HHTTC----
T ss_pred             eecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-HHH---HH-HHhcc----
Confidence            7765432   234457999999999999999999999999999999999999999632211 111   11 11110    


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       280 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        ...+......++..+.+|+.+||+.||.+|||+.++++
T Consensus       235 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          235 --YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             --CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             --cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              01111111234678999999999999999999999997

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=381.30  Aligned_cols=263  Identities=23%  Similarity=0.375  Sum_probs=217.5

Q ss_pred             hhhHHHhhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           47 YSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        47 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      ...++...++|.+.+.||+|+||.||+|.+. +..||||++.......+.|.+|++++++++||||+++++++.+ ...+
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            3445556678999999999999999999998 5679999998766666789999999999999999999999977 6789


Q ss_pred             EEEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          126 LVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      |||||+++|+|.+++... +..+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++....
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            999999999999999752 34599999999999999999999999  999999999999999999999999999976543


Q ss_pred             CCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ... .......++..|+|||.+....++.++|||||||++|||++ |+.||... ....+..    .+..         .
T Consensus       416 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~-~~~~~~~----~i~~---------~  480 (535)
T 2h8h_A          416 NEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLD----QVER---------G  480 (535)
T ss_dssp             HHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC-CHHHHHH----HHHT---------T
T ss_pred             Cce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHH----HHHc---------C
Confidence            211 12233457889999999998899999999999999999999 88888632 2212211    1111         1


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      ...+.+..++..+.+||.+||+.||++|||+++|++.|+.+...
T Consensus       481 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          481 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            12233456778899999999999999999999999999987643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=369.05  Aligned_cols=260  Identities=20%  Similarity=0.272  Sum_probs=210.7

Q ss_pred             chhhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCCCCceeeEEEEe
Q 011384           46 DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHSPRLVNLLGFSN  119 (487)
Q Consensus        46 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  119 (487)
                      .+.+.....++|.+.+.||+|+||.||++++.  ++.||||++.+...    ....+.+|..++..++||||++++++|.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            44555666789999999999999999999986  88999999875322    2245889999999999999999999999


Q ss_pred             CCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       120 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                      +.+.+|+||||+++|+|.+++.+.+..+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||++
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL--GYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecccCHHHeeecCCCCEEEeechhh
Confidence            99999999999999999999987655699999999999999999999999  9999999999999999999999999999


Q ss_pred             eecCCCCcccccCCCCCCCccCCccccC-------CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh
Q 011384          200 LRCGVDNFRFRSTPPAGTIGYLDPCYVT-------PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK  272 (487)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~  272 (487)
                      +....... .......||+.|+|||++.       ...++.++|||||||++|||++|+.||..... ...   ...+..
T Consensus       210 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~---~~~i~~  284 (412)
T 2vd5_A          210 LKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-AET---YGKIVH  284 (412)
T ss_dssp             EECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-HHH---HHHHHT
T ss_pred             eeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-HHH---HHHHHh
Confidence            87654332 2334568999999999987       45689999999999999999999999964221 111   111111


Q ss_pred             cCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCC---CCHHHHHH
Q 011384          273 KGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERR---PSMKEIVD  319 (487)
Q Consensus       273 ~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R---Ps~~eil~  319 (487)
                      ...  ..   .++ ..+..++.++.+||.+||+ +|.+|   |+++||++
T Consensus       285 ~~~--~~---~~p-~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          285 YKE--HL---SLP-LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHH--HC---CCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             ccc--Cc---CCC-ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            000  00   011 1223467889999999999 99998   58999986

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.7e-43  Score=351.51  Aligned_cols=246  Identities=21%  Similarity=0.311  Sum_probs=197.0

Q ss_pred             hcCcccceeecccCceEEEEEEE-----CCeEEEEEEcCCCh-----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCc
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVL-----RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKD  123 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~-----~g~~vAvK~~~~~~-----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~  123 (487)
                      .++|.+.+.||+|+||.||++..     .++.||+|++.+..     .....+.+|+.+++.++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35799999999999999999987     37899999987642     233567889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      .|+||||+++++|.+++...+ .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~--~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQK--GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhC--CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            999999999999999998654 489999999999999999999999  99999999999999999999999999986543


Q ss_pred             CCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ....  ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... ..   ....+.. +.        
T Consensus       173 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~---~~~~i~~-~~--------  237 (327)
T 3a62_A          173 HDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-KK---TIDKILK-CK--------  237 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HH---HHHHHHH-TC--------
T ss_pred             cCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-HH---HHHHHHh-CC--------
Confidence            2221  23446799999999999999999999999999999999999999964221 11   1111111 11        


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                        ...+..++.++.+|+.+||+.||.+||     ++.++++
T Consensus       238 --~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 --LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             --CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence              122345677899999999999999999     7888887

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.2e-43  Score=348.49  Aligned_cols=259  Identities=23%  Similarity=0.326  Sum_probs=208.8

Q ss_pred             HHHhhcCcccce-eecccCceEEEEEEEC----CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCC
Q 011384           50 LEAATNGFSEQK-LLGKGSHGSVYKAVLR----GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDS  121 (487)
Q Consensus        50 ~~~~~~~y~~~~-~LG~G~~g~Vy~~~~~----g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  121 (487)
                      +....++|.+.+ .||+|+||.||+|.+.    ++.||||++....   ...+.+.+|+++++.++||||+++++++ +.
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            334456788888 9999999999999653    5789999987543   2356799999999999999999999999 55


Q ss_pred             CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      +..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||++..
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhC--CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            67899999999999999998754 499999999999999999999999  999999999999999999999999999987


Q ss_pred             cCCCCcc-cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccc
Q 011384          202 CGVDNFR-FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSV  279 (487)
Q Consensus       202 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~  279 (487)
                      ....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||... ....+..    .+..+     
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~----~~~~~-----  236 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-KGSEVTA----MLEKG-----  236 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHH----HHHTT-----
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHH----HHHcC-----
Confidence            6543322 12233457789999999988888999999999999999999 99998632 2212111    11111     


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       280 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                          .....+..++.++.+++.+||+.||.+||++.+|++.|+.+-.
T Consensus       237 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          237 ----ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                1122344567889999999999999999999999999988743

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.8e-43  Score=352.93  Aligned_cols=260  Identities=22%  Similarity=0.328  Sum_probs=198.9

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce--
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR--  124 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~--  124 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++....    .....+.+|+.++++++||||+++++++......  
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            3578999999999999999999975  8899999987542    3345789999999999999999999998765543  


Q ss_pred             --EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          125 --LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       125 --~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                        |+||||+++++|.+++...+ .+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++...
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             ccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence              99999999999999998654 499999999999999999999999  9999999999999999999999999999765


Q ss_pred             CCCCcc-cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          203 GVDNFR-FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       203 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      ...... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||......    ............     
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~----~~~~~~~~~~~~-----  237 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV----SVAYQHVREDPI-----  237 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHCCCC-----
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhcCCCC-----
Confidence            443221 1223456899999999999999999999999999999999999999632211    111111111100     


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHH-HHHhcccc
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV-DWLTGLSK  326 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil-~~L~~l~~  326 (487)
                        .+......++.++.+|+.+||+.||.+||++.+++ +.|..+..
T Consensus       238 --~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          238 --PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             --CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             --CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence              00011123567899999999999999999755554 45555443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.3e-43  Score=360.51  Aligned_cols=249  Identities=23%  Similarity=0.323  Sum_probs=199.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCC--CCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKN---QEISQEVDNEIEILSKIH--SPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++|.+.+.||+|+||.||++.+. ++.||||++...   ......+.+|+.++++++  ||||+++++++.....+++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            356999999999999999999887 788999987643   344567999999999996  59999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      || +.+++|.+++.... .+++..++.++.||+.||.|||+.  +|+||||||+|||++ ++.+||+|||++..+.....
T Consensus       135 ~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~--~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTT--TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             Ee-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            99 56889999998765 589999999999999999999999  999999999999995 57999999999987654433


Q ss_pred             ccccCCCCCCCccCCccccCC-----------CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcc
Q 011384          208 RFRSTPPAGTIGYLDPCYVTP-----------DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI  276 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i  276 (487)
                      ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||......  . ...         
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~-~~~---------  277 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--I-SKL---------  277 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--H-HHH---------
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--H-HHH---------
Confidence            323445679999999999865           36889999999999999999999999632211  1 111         


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          277 LSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...+++......+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          278 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            1122222222333344678999999999999999999999997

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=7.7e-43  Score=355.79  Aligned_cols=247  Identities=21%  Similarity=0.282  Sum_probs=205.6

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~  125 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++.+..    ...+.+..|..++..+ +||||+++++++.+.+.+|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3468999999999999999999997  6789999987542    2346688899999988 8999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +||||+++|+|.+++...+ .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.....
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            9999999999999998754 499999999999999999999999  9999999999999999999999999999753322


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      ..  .....+||+.|+|||.+.+..++.++|||||||++|||++|+.||... ....+   ...+.. +.          
T Consensus       175 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-~~~~~---~~~i~~-~~----------  237 (353)
T 2i0e_A          175 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-DEDEL---FQSIME-HN----------  237 (353)
T ss_dssp             TC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHH---HHHHHH-CC----------
T ss_pred             Cc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC-CHHHH---HHHHHh-CC----------
Confidence            21  344568999999999999999999999999999999999999999632 11111   111111 11          


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCC-----HHHHHH
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPS-----MKEIVD  319 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~eil~  319 (487)
                      ...+..++.++.+|+.+||+.||.+||+     +++|++
T Consensus       238 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            1233456788999999999999999995     577775

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.5e-43  Score=354.30  Aligned_cols=268  Identities=17%  Similarity=0.193  Sum_probs=204.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCChhh------------HHHHHHHHHHHHhCCCCCceeeEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKNQEI------------SQEVDNEIEILSKIHSPRLVNLLG  116 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~~~~------------~~~~~~Ei~~l~~l~hpnIv~l~~  116 (487)
                      .++|.+.+.||+|+||.||+|.+.     +..||||+.......            ...+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            468999999999999999999984     578999987754321            134677889999999999999999


Q ss_pred             EEeC----CCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC--c
Q 011384          117 FSND----SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF--N  190 (487)
Q Consensus       117 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~--~  190 (487)
                      ++.+    ....++||||+ +++|.+++...+ .+++..++.++.||+.||.|||+.  +|+||||||+|||++.++  .
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHEN--EYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEESSSTTS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCcCHHHEEEccCCCCc
Confidence            9887    67889999999 999999997665 599999999999999999999999  999999999999998887  9


Q ss_pred             EEEcccccceecCCCCcc-----cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhh
Q 011384          191 ARLGDFGLALRCGVDNFR-----FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD  265 (487)
Q Consensus       191 vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~  265 (487)
                      +||+|||+++.+......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  271 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ  271 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence            999999999876433211     112345799999999999999999999999999999999999999964322222111


Q ss_pred             hhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCC
Q 011384          266 WAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP  329 (487)
Q Consensus       266 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  329 (487)
                      ........ .+...+....   ....++.++.+++.+||+.||.+|||+.+|++.|+.+....+
T Consensus       272 ~~~~~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  331 (345)
T 2v62_A          272 TAKTNLLD-ELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLG  331 (345)
T ss_dssp             HHHHHHHH-TTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCC
T ss_pred             HHHHhhcc-cccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCccc
Confidence            11111100 0000000000   011355789999999999999999999999999998765433

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.8e-43  Score=354.91  Aligned_cols=243  Identities=24%  Similarity=0.347  Sum_probs=202.2

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      +.|...+.||+|+||.||+|.+.  ++.||||++...    ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45999999999999999999975  889999987643    223357899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+. |+|.+++......+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.....    
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEECCCCCEEEeeccCceecCC----
Confidence            9996 689998876566799999999999999999999999  999999999999999999999999999876542    


Q ss_pred             cccCCCCCCCccCCccccC---CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVT---PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                        .....||+.|+|||++.   ...++.++|||||||++|||++|+.||.....    ...........         .+
T Consensus       207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~----~~~~~~~~~~~---------~~  271 (348)
T 1u5q_A          207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNE---------SP  271 (348)
T ss_dssp             --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSC---------CC
T ss_pred             --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcC---------CC
Confidence              23457999999999984   56789999999999999999999999863221    11111111111         11


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...+..++..+.+|+.+||+.||.+|||++++++
T Consensus       272 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            1123345678999999999999999999999997

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-43  Score=358.35  Aligned_cols=259  Identities=24%  Similarity=0.383  Sum_probs=200.6

Q ss_pred             cCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC-CCceEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSND-SKDRLL  126 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~l  126 (487)
                      ..|.+.+.||+|+||.||+|.+.     +..||||.+...  ....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            34778899999999999999874     236899988653  3445789999999999999999999998754 457899


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++++|.+++......+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||+++.+....
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC--CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999988777799999999999999999999999  99999999999999999999999999997654332


Q ss_pred             cc--cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          207 FR--FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       207 ~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ..  .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||. +.........    +..+.        
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~-~~~~~~~~~~----~~~~~--------  313 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-DVNTFDITVY----LLQGR--------  313 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT-TSCSSCHHHH----HHTTC--------
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCC-CCCHHHHHHH----HHcCC--------
Confidence            11  12234467889999999998999999999999999999999 455554 3333222221    11111        


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCC
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP  329 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  329 (487)
                       ....+..++..+.+++.+||+.||.+|||+.+|++.|+.+...+.
T Consensus       314 -~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          314 -RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence             112234566789999999999999999999999999998876544

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1e-42  Score=340.87  Aligned_cols=253  Identities=23%  Similarity=0.332  Sum_probs=206.4

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC-hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN-QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ..++|.+.+.||+|+||.||+|.+.  +..||+|++... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            3467999999999999999999987  668999987654 2345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE---ccCCcEEEcccccceecCCCC
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl---d~~~~vkL~DFGla~~~~~~~  206 (487)
                      |+++++|.+++.... .+++..++.++.|++.||.|||++  +|+|+||||+|||+   +.++.+||+|||++.......
T Consensus        87 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           87 LCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             ccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            999999999997754 499999999999999999999999  99999999999999   788999999999997765433


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                         ......||+.|+|||.+.+. ++.++|||||||++|+|++|+.||.........    . .+..+..      ..+.
T Consensus       164 ---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~-~~~~~~~------~~~~  228 (277)
T 3f3z_A          164 ---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM----L-KIREGTF------TFPE  228 (277)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----H-HHHHCCC------CCCH
T ss_pred             ---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH----H-HHHhCCC------CCCc
Confidence               23445799999999998754 899999999999999999999999642211111    1 1111110      0110


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhc
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG  323 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~  323 (487)
                      .....++..+.+|+.+||+.||.+|||+.++++  +++.
T Consensus       229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred             hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence            001135678999999999999999999999986  4544

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.3e-42  Score=337.83  Aligned_cols=261  Identities=18%  Similarity=0.199  Sum_probs=209.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEE-eCCCceEEEEEe
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS-NDSKDRLLVVEF  130 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~~~lV~Ey  130 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++..... ...+.+|+.+++.++|++++..+.++ .+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence            578999999999999999999975  89999998765433 24688999999999998877666655 566778999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE---ccCCcEEEcccccceecCCCCc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl---d~~~~vkL~DFGla~~~~~~~~  207 (487)
                      + +++|.+++......+++..++.++.|++.||.|||++  +|+||||||+|||+   +.++.+||+|||++........
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence            9 9999999987666799999999999999999999999  99999999999999   5889999999999987654432


Q ss_pred             cc-----ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc--hhhh-hhhhhhhcCccccc
Q 011384          208 RF-----RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP--SIVD-WAAPLIKKGKILSV  279 (487)
Q Consensus       208 ~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~--~~~~-~~~~~~~~~~i~~~  279 (487)
                      ..     ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.......  .... ........ .    
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~----  238 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-P----  238 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-C----
T ss_pred             ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-c----
Confidence            11     1245579999999999999999999999999999999999999997432211  1111 11100000 0    


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccC
Q 011384          280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLV  328 (487)
Q Consensus       280 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~  328 (487)
                           .......++.++.+|+.+||+.||.+|||+.+|++.|+.+....
T Consensus       239 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          239 -----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             -----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -----hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence                 00011235578999999999999999999999999999886543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.4e-42  Score=340.42  Aligned_cols=248  Identities=26%  Similarity=0.444  Sum_probs=204.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++|.+.+.||+|+||.||+|.+.  +..||||++....    .....+.+|+.++++++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467999999999999999999987  6789999876542    2245789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+++++|.+++.... .+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||++......  
T Consensus        88 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~--~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTT--TCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence            99999999999998754 499999999999999999999999  9999999999999999999999999988543322  


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                        ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... .....    .+..          ....
T Consensus       163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~----~~~~----------~~~~  225 (279)
T 3fdn_A          163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-QETYK----RISR----------VEFT  225 (279)
T ss_dssp             -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHH----HHHH----------TCCC
T ss_pred             --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-HHHHH----HHHh----------CCCC
Confidence              22345789999999999999999999999999999999999999963211 11111    1111          1112


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhc
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG  323 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~  323 (487)
                      .+..++..+.+|+.+||+.||.+|||++||++  ||..
T Consensus       226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~  263 (279)
T 3fdn_A          226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  263 (279)
T ss_dssp             CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred             CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence            33446678999999999999999999999998  4544

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.3e-42  Score=339.20  Aligned_cols=251  Identities=23%  Similarity=0.292  Sum_probs=207.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++...  ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467999999999999999999986  889999987643  2345778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |+++++|.+++.... .+++..++.++.|++.||.|||+.  +++|+||||+||+++.++.+||+|||++..........
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             ecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            999999999987543 499999999999999999999999  99999999999999999999999999997654433222


Q ss_pred             ccCCCCCCCccCCccccCCCCC-CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                      ......||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||...........    .....        ......
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~--------~~~~~~  230 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS----DWKEK--------KTYLNP  230 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH----HHHTT--------CTTSTT
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH----Hhhhc--------ccccCc
Confidence            3445679999999999987765 7799999999999999999999975433222111    00100        011112


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...++..+.+|+.+||+.||.+|||+.+|++
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          231 WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            2356778999999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.2e-42  Score=348.23  Aligned_cols=260  Identities=23%  Similarity=0.337  Sum_probs=190.2

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++....  .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467999999999999999999886  8899999876442  234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          130 FMSNGTLYDVLHSNN-----RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       130 y~~~gsL~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      |++ ++|.+++....     ..+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN--KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            997 59999986531     3589999999999999999999999  999999999999999999999999999987643


Q ss_pred             CCcccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC--c----c-
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG--K----I-  276 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~--~----i-  276 (487)
                      ...  ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........... ........  .    . 
T Consensus       161 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          161 PVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL-IFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             CCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCSCCTTTCGGGG
T ss_pred             Ccc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCChhHhhhhh
Confidence            322  23345789999999999764 689999999999999999999999964322111111 11100000  0    0 


Q ss_pred             -ccccCCCCCC------------CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          277 -LSVFDPRIPP------------PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       277 -~~~~~~~~~~------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                       .....+.+..            .....++.++.+|+.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence             0000001100            011234578999999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.9e-43  Score=353.78  Aligned_cols=240  Identities=25%  Similarity=0.339  Sum_probs=203.5

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh---------hHHHHHHHHHHHHhCCCCCceeeEEEEeCC
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---------ISQEVDNEIEILSKIHSPRLVNLLGFSNDS  121 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~---------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  121 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++.....         ....+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4568999999999999999999876  88999998775431         234577899999999999999999999999


Q ss_pred             CceEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          122 KDRLLVVEFMSNG-TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       122 ~~~~lV~Ey~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      ...++||||+.+| +|.+++.... .+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLK--DIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence            9999999999777 9999998764 499999999999999999999999  99999999999999999999999999998


Q ss_pred             ecCCCCcccccCCCCCCCccCCccccCCCCC-CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccc
Q 011384          201 RCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV  279 (487)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~  279 (487)
                      ......   ......||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||...      .             ..
T Consensus       179 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~------~-------------~~  236 (335)
T 3dls_A          179 YLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL------E-------------ET  236 (335)
T ss_dssp             ECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG------G-------------GG
T ss_pred             ECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH------H-------------HH
Confidence            765433   2233579999999999988876 88999999999999999999999621      0             00


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       280 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .....  ..+..++.++.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          237 VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11111  112235678999999999999999999999997

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.6e-42  Score=340.27  Aligned_cols=265  Identities=18%  Similarity=0.195  Sum_probs=206.0

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEE-eCCCceEEEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS-NDSKDRLLVVE  129 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~-~~~~~~~lV~E  129 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||+...... ...+.+|+.+++.++|++++..+.++ .+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            4578999999999999999999975  88999998654432 24578899999999988877776655 66777899999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE---ccCCcEEEcccccceecCCCC
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl---d~~~~vkL~DFGla~~~~~~~  206 (487)
                      |+ +++|.+++......+++..++.++.|++.||.|||+.  +|+||||||+|||+   +.++.+||+|||++.......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            99 9999999987666799999999999999999999999  99999999999999   788999999999998765433


Q ss_pred             cc-----cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          207 FR-----FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       207 ~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      ..     .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........... ...... ....    
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~-~~~~----  236 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISE-KKMS----  236 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH-HHHHHH-HHHH----
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh-hhhhhc-cccc----
Confidence            21     122356799999999999999999999999999999999999999974322211110 000000 0000    


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccC
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLV  328 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~  328 (487)
                      .. .......++.++.+|+.+||+.||.+|||+.+|++.|+.+....
T Consensus       237 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          237 TP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             SC-HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ch-hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence            00 00011234578999999999999999999999999999886543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=346.83  Aligned_cols=262  Identities=20%  Similarity=0.301  Sum_probs=207.3

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC-hhhHHHHHHHHHHHHhCCCCCceeeEEEEe----CCCceE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN-QEISQEVDNEIEILSKIHSPRLVNLLGFSN----DSKDRL  125 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~----~~~~~~  125 (487)
                      ..++|.+.+.||+|+||.||++...  ++.||||++... ....+.+.+|+++++.++||||+++++++.    .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            3468999999999999999999975  889999987543 445577899999999999999999999986    345779


Q ss_pred             EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          126 LVVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                      +||||+++++|.+++..   .+..+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++...
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999999976   455699999999999999999999999  9999999999999999999999999998654


Q ss_pred             CCCCcc-------cccCCCCCCCccCCccccCCCC---CCcchhhhhHHHHHHHHHhCCcCCCCCCCC-chhhhhhhhhh
Q 011384          203 GVDNFR-------FRSTPPAGTIGYLDPCYVTPDN---LSTKTDVFSFGILLLEIISCRKAIDIGFSP-PSIVDWAAPLI  271 (487)
Q Consensus       203 ~~~~~~-------~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDVwSlGvvl~eLltG~~pf~~~~~~-~~~~~~~~~~~  271 (487)
                      ......       .......||+.|+|||.+.+..   ++.++|||||||++|+|++|+.||...... .....      
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------  258 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL------  258 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH------
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH------
Confidence            321110       0011235799999999987654   688999999999999999999998521100 01100      


Q ss_pred             hcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCC
Q 011384          272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP  329 (487)
Q Consensus       272 ~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  329 (487)
                             ........+.+..++.++.+|+.+||+.||.+|||+.+|++.|+.+....|
T Consensus       259 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          259 -------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             -------HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             -------HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence                   000111222334567889999999999999999999999999998865433

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=358.28  Aligned_cols=268  Identities=19%  Similarity=0.250  Sum_probs=215.5

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC--ceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSK--DRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~~~lV  127 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++....  ...+.+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            467999999999999999999997  8899999987543  23467889999999999999999999998765  67999


Q ss_pred             EEecCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE----ccCCcEEEccccccee
Q 011384          128 VEFMSNGTLYDVLHSNN--RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI----DRNFNARLGDFGLALR  201 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl----d~~~~vkL~DFGla~~  201 (487)
                      |||+++++|.+++....  ..+++..++.++.|++.||.|||+.  +|+||||||+|||+    +.++.+||+|||+++.
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC--CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            99999999999997633  2399999999999999999999999  99999999999999    7788899999999987


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCC--------CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTP--------DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK  273 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~  273 (487)
                      .....   ......||+.|+|||.+.+        ..++.++|||||||++|||++|+.||.....+.............
T Consensus       166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            65432   2344679999999999864        456789999999999999999999997433333222222222221


Q ss_pred             Cc--------------cccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          274 GK--------------ILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       274 ~~--------------i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ..              +...-........+..++..+.+++.+||+.||++||++.++++.+..+..
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            10              000001122234557889999999999999999999999999999887754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-42  Score=349.30  Aligned_cols=264  Identities=22%  Similarity=0.250  Sum_probs=199.9

Q ss_pred             HHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh------hHHHHHHHHHHHHhCCCCCceeeEEEEeCCC
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE------ISQEVDNEIEILSKIHSPRLVNLLGFSNDSK  122 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~  122 (487)
                      ....++|.+.+.||+|+||.||+|.+.  ++.||||++.....      ....+.+|+++++.++||||+++++++.+..
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344678999999999999999999986  78999999875322      1246789999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                      ..++||||+++ +|.+++......+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++...
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC--CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            99999999976 99999987766799999999999999999999999  9999999999999999999999999999765


Q ss_pred             CCCCcccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc--Cccc--
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK--GKIL--  277 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~--~~i~--  277 (487)
                      .....  ......||+.|+|||.+.+. .++.++|||||||++|+|++|..||........+..........  ..+.  
T Consensus       163 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (346)
T 1ua2_A          163 GSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM  240 (346)
T ss_dssp             TSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred             cCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence            43322  23456789999999998764 57999999999999999999998886432211111111100000  0000  


Q ss_pred             ----cccCCCCCCCC-----ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          278 ----SVFDPRIPPPK-----DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       278 ----~~~~~~~~~~~-----~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                          ..+........     ...++.++.+|+.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence                00000000001     1334678999999999999999999999997

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.3e-42  Score=340.80  Aligned_cols=255  Identities=22%  Similarity=0.333  Sum_probs=205.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-------hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-------EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  124 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++....       ...+.+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357999999999999999999997  8899999876432       1357799999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC----cEEEcccccce
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF----NARLGDFGLAL  200 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~----~vkL~DFGla~  200 (487)
                      ++||||+++++|.+++.... .+++..++.++.|++.||.|||+.  +++|+||||+||+++.++    .+||+|||++.
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            99999999999999997654 499999999999999999999999  999999999999998877    89999999997


Q ss_pred             ecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccccc
Q 011384          201 RCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF  280 (487)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~  280 (487)
                      ......   ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...   . .+...      
T Consensus       161 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~---~-~~~~~------  226 (283)
T 3bhy_A          161 KIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-ETL---T-NISAV------  226 (283)
T ss_dssp             ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHH---H-HHHTT------
T ss_pred             eccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-HHH---H-HhHhc------
Confidence            654332   223456999999999999999999999999999999999999998642211 111   1 11110      


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhccc
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLS  325 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l~  325 (487)
                      ...........++..+.+|+.+||+.||.+|||+.++++  +++.+.
T Consensus       227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          227 NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            001111111234678999999999999999999999998  566554

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.1e-43  Score=352.06  Aligned_cols=246  Identities=23%  Similarity=0.319  Sum_probs=182.1

Q ss_pred             ceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCC-CCCceeeEEEEeCCCceEEEEEecCCCCH
Q 011384           60 QKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIH-SPRLVNLLGFSNDSKDRLLVVEFMSNGTL  136 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL  136 (487)
                      .+.||+|+||.||+|.+.  ++.||||++...  ....+.+|+.+++.+. ||||+++++++.+....++||||+++++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            378999999999999997  789999998654  3467789999999997 99999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC---cEEEcccccceecCCCCcccccCC
Q 011384          137 YDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF---NARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       137 ~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~---~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      .+++.... .+++..++.++.|++.||.|||++  +|+||||||+|||++.++   .+||+|||++........  ....
T Consensus        94 ~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~  168 (325)
T 3kn6_A           94 FERIKKKK-HFSETEASYIMRKLVSAVSHMHDV--GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKT  168 (325)
T ss_dssp             HHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccc
Confidence            99998764 599999999999999999999999  999999999999997665   899999999976544322  2344


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc---hhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPP---SIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~---~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      ..||+.|+|||.+.+..++.++|||||||++|+|++|+.||.......   ..... ...+..+..      ....+...
T Consensus       169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~i~~~~~------~~~~~~~~  241 (325)
T 3kn6_A          169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI-MKKIKKGDF------SFEGEAWK  241 (325)
T ss_dssp             ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHH-HHHHTTTCC------CCCSHHHH
T ss_pred             cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHH-HHHHHcCCC------CCCccccc
Confidence            578999999999999999999999999999999999999997432211   11111 111111111      11111113


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .++.++.+|+.+||+.||.+|||+.++++
T Consensus       242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             TSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            46788999999999999999999999885

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.3e-42  Score=351.61  Aligned_cols=255  Identities=15%  Similarity=0.128  Sum_probs=210.2

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEE-----E--CCeEEEEEEcCCChhhHHHHHHHHHHHHhCC---CCCceeeEEE
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAV-----L--RGRQVAVKKPSKNQEISQEVDNEIEILSKIH---SPRLVNLLGF  117 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~-----~--~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~  117 (487)
                      .+++...++|.+.+.||+|+||.||+|.     .  .++.||||++....  ...+..|++++..++   |+||+.++++
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            3445566889999999999999999994     2  37899999987653  357788889988887   8999999999


Q ss_pred             EeCCCceEEEEEecCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc------
Q 011384          118 SNDSKDRLLVVEFMSNGTLYDVLHS----NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR------  187 (487)
Q Consensus       118 ~~~~~~~~lV~Ey~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~------  187 (487)
                      +...+..++||||+++|+|.+++..    ....+++..++.++.||+.||+|||++  +|+||||||+|||++.      
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~--~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC--EIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEECGGGTCC-
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC--CeecCCCCHHHEEecccccCcc
Confidence            9999999999999999999999975    345699999999999999999999999  9999999999999998      


Q ss_pred             -----CCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCch
Q 011384          188 -----NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS  262 (487)
Q Consensus       188 -----~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~  262 (487)
                           ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  293 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC  293 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence                 899999999999766533333345567899999999999999999999999999999999999999853221100


Q ss_pred             hhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCC-CHHHHHHHHhccc
Q 011384          263 IVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRP-SMKEIVDWLTGLS  325 (487)
Q Consensus       263 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP-s~~eil~~L~~l~  325 (487)
                                      .+...+...   ..++.+.+++..||+.+|.+|+ ++.++.+.|+.+.
T Consensus       294 ----------------~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          294 ----------------KPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             ----------------EECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             ----------------eechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence                            011111111   1356788999999999999995 6888888777654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.8e-42  Score=369.11  Aligned_cols=256  Identities=22%  Similarity=0.358  Sum_probs=206.9

Q ss_pred             HHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--------------hhHHHHHHHHHHHHhCCCCCceee
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--------------EISQEVDNEIEILSKIHSPRLVNL  114 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--------------~~~~~~~~Ei~~l~~l~hpnIv~l  114 (487)
                      ....++|.+.+.||+|+||.||+|.+.  ++.||||++....              ...+.+.+|+.++++++||||+++
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            345678999999999999999999986  7889999876542              234678999999999999999999


Q ss_pred             EEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC---cE
Q 011384          115 LGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF---NA  191 (487)
Q Consensus       115 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~---~v  191 (487)
                      ++++.+....++|||||++|+|.+.+.... .+++..++.++.||+.||.|||+.  +|+||||||+|||++.++   .+
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKH--NIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCcHHHEEEecCCCCccE
Confidence            999999999999999999999999997654 499999999999999999999999  999999999999998775   69


Q ss_pred             EEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhh
Q 011384          192 RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI  271 (487)
Q Consensus       192 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~  271 (487)
                      ||+|||++.......   ......||+.|+|||.+. ..++.++|||||||++|+|++|..||.... ...+..    .+
T Consensus       189 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~----~i  259 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN-DQDIIK----KV  259 (504)
T ss_dssp             EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHH----HH
T ss_pred             EEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHH----HH
Confidence            999999998765432   234567999999999987 468999999999999999999999996322 111111    11


Q ss_pred             hcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       272 ~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                      ..+..      ..+.+....++.++.+|+.+||+.||.+|||+.|+++  |+...
T Consensus       260 ~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          260 EKGKY------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             HHCCC------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred             HcCCC------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence            11111      0111111235678999999999999999999999997  56554

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=378.79  Aligned_cols=256  Identities=23%  Similarity=0.364  Sum_probs=206.4

Q ss_pred             hcCcccce-eecccCceEEEEEEEC----CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           54 TNGFSEQK-LLGKGSHGSVYKAVLR----GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~-~LG~G~~g~Vy~~~~~----g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .+++.+.. .||+|+||.||+|.+.    +..||||+++..  ....+.+.+|++++++++||||++++++|.+ +..++
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  412 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML  412 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence            34455555 8999999999999874    457999998764  3345789999999999999999999999987 56899


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++|+|.+++......+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.+....
T Consensus       413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            9999999999999987766799999999999999999999999  99999999999999999999999999997654332


Q ss_pred             cc-cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          207 FR-FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       207 ~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      .. .......+++.|+|||++.+..++.++|||||||++|||++ |+.||... ....+..    .+..+         .
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-~~~~~~~----~i~~~---------~  556 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMA----FIEQG---------K  556 (613)
T ss_dssp             -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CSHHHHH----HHHTT---------C
T ss_pred             ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHH----HHHcC---------C
Confidence            21 11223346789999999998899999999999999999998 99998642 2222222    11221         1


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ..+.+..++.++.+|+.+||+.+|.+||++.+|++.|+.+..
T Consensus       557 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            223445677899999999999999999999999999988653

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.1e-43  Score=354.40  Aligned_cols=266  Identities=17%  Similarity=0.241  Sum_probs=210.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC----------CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCcee----------
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR----------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN----------  113 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~----------g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~----------  113 (487)
                      .++|.+.+.||+|+||.||+|.+.          ++.||||++...    ..+.+|++++++++||||++          
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            468999999999999999999885          578999998765    45788999999999999887          


Q ss_pred             -----eEEEEeC-CCceEEEEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc
Q 011384          114 -----LLGFSND-SKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID  186 (487)
Q Consensus       114 -----l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld  186 (487)
                           +++++.. ....++||||+ +++|.+++... ...+++..++.++.|++.||.|||++  +|+||||||+|||++
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN--EYVHGNVTAENIFVD  193 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCCGGGEEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCCHHHEEEc
Confidence                 6777765 67889999999 99999999875 34699999999999999999999999  999999999999999


Q ss_pred             cCC--cEEEcccccceecCCCCcc-----cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCC
Q 011384          187 RNF--NARLGDFGLALRCGVDNFR-----FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFS  259 (487)
Q Consensus       187 ~~~--~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~  259 (487)
                      .++  .+||+|||+++.+......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            998  8999999999765533211     112345799999999999999999999999999999999999999974432


Q ss_pred             Cch-hhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCCCC
Q 011384          260 PPS-IVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLH  331 (487)
Q Consensus       260 ~~~-~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~  331 (487)
                      ... +..........  ........   .....++.++.+|+.+||+.||.+|||+++|++.|+.+.......
T Consensus       274 ~~~~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  341 (352)
T 2jii_A          274 NTEDIMKQKQKFVDK--PGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS  341 (352)
T ss_dssp             CHHHHHHHHHHHHHS--CCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             CHHHHHHHHHhccCC--hhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence            221 22111111110  01111110   011234678999999999999999999999999999987655433

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.9e-42  Score=338.15  Aligned_cols=249  Identities=25%  Similarity=0.405  Sum_probs=208.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||+|.+.  +..||||++....    .....+.+|+++++.++||||+++++++.+....++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999986  7789999886532    22467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+++++|.+++...+ .+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||++......   
T Consensus        94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHER--KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---  167 (284)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---
T ss_pred             EeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCHHHEEEcCCCCEEEecccccccCccc---
Confidence            9999999999998754 499999999999999999999999  9999999999999999999999999998665432   


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                       ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......    ...... ...      +    ...
T Consensus       168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~-~~~------~----~~~  231 (284)
T 2vgo_A          168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT----ETHRRI-VNV------D----LKF  231 (284)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHH-HTT------C----CCC
T ss_pred             -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh----HHHHHH-hcc------c----cCC
Confidence             223457999999999999999999999999999999999999999642211    111111 111      1    123


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhccc
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLS  325 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l~  325 (487)
                      +..++.++.+++.+||+.||.+|||++++++  ++....
T Consensus       232 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          232 PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            3456678999999999999999999999997  565443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=347.05  Aligned_cols=269  Identities=23%  Similarity=0.368  Sum_probs=213.2

Q ss_pred             hcCcccceeecccCceEEEEEEE------CCeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC--ce
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVL------RGRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSK--DR  124 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~------~g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~--~~  124 (487)
                      .++|.+.+.||+|+||.||++.+      .++.||||++.... ...+.+.+|++++++++||||+++++++....  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            45699999999999999999985      37899999987643 34567999999999999999999999987654  78


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||++.....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK--RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  197 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--CEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence            999999999999999988766799999999999999999999999  999999999999999999999999999987654


Q ss_pred             CCcc-cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhh----hhhcCccccc
Q 011384          205 DNFR-FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP----LIKKGKILSV  279 (487)
Q Consensus       205 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~----~~~~~~i~~~  279 (487)
                      .... .......++..|+|||.+.+..++.++|||||||++|+|++|..|+....  .........    ......+...
T Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP--AEFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH--HHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH--HHHHHhhccccchhhhHHHHHHH
Confidence            4322 12234567888999999988888999999999999999999998875210  000000000    0000000111


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       280 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      +......+.+..++.++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            11122223445677889999999999999999999999999988754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.2e-43  Score=367.00  Aligned_cols=246  Identities=22%  Similarity=0.288  Sum_probs=197.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++...    ......+.+|+.+++.++||||++++++|.+.+.+++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999986  789999988643    22335678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      |||+++++|.+++.... .+++..+..++.||+.||.|||+ .  +|+||||||+|||++.++.+||+|||+++......
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcC--CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            99999999999997754 49999999999999999999998 8  99999999999999999999999999987533222


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......   .. ....          .
T Consensus       304 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~---~i-~~~~----------~  366 (446)
T 4ejn_A          304 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFE---LI-LMEE----------I  366 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHH---HH-HHCC----------C
T ss_pred             c--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-HHHHHH---HH-HhCC----------C
Confidence            1  2345689999999999999999999999999999999999999996322 111111   11 1111          1


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      ..+..++.++.+|+.+||+.||.+||     +++|+++
T Consensus       367 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            12334667899999999999999999     9999997

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=349.52  Aligned_cols=265  Identities=19%  Similarity=0.279  Sum_probs=200.5

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhH--HHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS--QEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~--~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ++|.+.+.||+|+||.||+|.+.  ++.||||++.......  ..+.+|+++++.++||||+++++++.+....++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999986  7899999887543322  2456799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      ++ ++|.+++...+..+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........  .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~  156 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ--KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--T  156 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--c
Confidence            96 599999988777799999999999999999999999  999999999999999999999999999975543321  2


Q ss_pred             cCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCc---c---------c
Q 011384          211 STPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGK---I---------L  277 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~---i---------~  277 (487)
                      .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ..............   +         .
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            334578999999999876 56899999999999999999999999643221 11111111100000   0         0


Q ss_pred             cccCCCCCC----CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhccc
Q 011384          278 SVFDPRIPP----PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLS  325 (487)
Q Consensus       278 ~~~~~~~~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l~  325 (487)
                      ....+....    ...+.++.++.+|+.+||+.||.+|||++|+++  |+..+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence            000000000    011235678899999999999999999999997  555544

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2e-42  Score=366.07  Aligned_cols=249  Identities=23%  Similarity=0.409  Sum_probs=209.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++|.+.+.||+|+||.||+|.+.  |+.||||++....    .....+.+|+.+++.++||||+++++++.+....++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            367999999999999999999986  8899999987542    2346789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+++++|.+++...+ .+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++....... 
T Consensus        95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~--givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-  170 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-  170 (476)
T ss_dssp             EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CCCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence            99999999999997654 499999999999999999999999  99999999999999999999999999998765432 


Q ss_pred             ccccCCCCCCCccCCccccCCCCC-CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                        .....+||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||..... .....    .+..+.          .
T Consensus       171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~----~i~~~~----------~  233 (476)
T 2y94_A          171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-PTLFK----KICDGI----------F  233 (476)
T ss_dssp             --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-HHHHH----HHHTTC----------C
T ss_pred             --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-HHHHH----HHhcCC----------c
Confidence              2345689999999999998765 7899999999999999999999974322 11111    111111          1


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhc
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG  323 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~  323 (487)
                      ..+..++.++.+|+.+||+.||.+|||+.+|++  ++..
T Consensus       234 ~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          234 YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence            123345678999999999999999999999997  6654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-42  Score=344.77  Aligned_cols=258  Identities=19%  Similarity=0.284  Sum_probs=201.7

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++....    ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3478999999999999999999986  8899999987542    234678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++++|.+++...+ .+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||++.......
T Consensus       112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAA--GATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            999999999999998754 499999999999999999999999  99999999999999999999999999987654332


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                      .. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....    . .....+....       ....
T Consensus       189 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~-~~~~~~~~~~-------~~~~  255 (309)
T 2h34_A          189 LT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL----S-VMGAHINQAI-------PRPS  255 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH----H-HHHHHHHSCC-------CCGG
T ss_pred             cc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH----H-HHHHHhccCC-------CCcc
Confidence            21 23345799999999999999999999999999999999999999963211    1 1111111100       0011


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCC-CHHHHHHHHhcccc
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRP-SMKEIVDWLTGLSK  326 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RP-s~~eil~~L~~l~~  326 (487)
                      ..+..++.++.+|+.+||+.||.+|| +++++++.|+....
T Consensus       256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence            22334567899999999999999999 89999999987754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=343.52  Aligned_cols=258  Identities=22%  Similarity=0.286  Sum_probs=199.7

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ++|.+.+.||+|+||.||+|.+.  ++.||||++....   ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            67999999999999999999987  8899999876543   234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |+++++|.+++.... .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........  
T Consensus        83 ~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHKH--NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--  157 (311)
T ss_dssp             CCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             eCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--
Confidence            999999998887654 499999999999999999999999  999999999999999999999999999976553322  


Q ss_pred             ccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhh----------hhhcCcccc
Q 011384          210 RSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP----------LIKKGKILS  278 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~----------~~~~~~i~~  278 (487)
                      ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...............          .........
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence            2334578999999999876 56799999999999999999999999643222111111000          000000000


Q ss_pred             ccCCCCCCCC--------ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          279 VFDPRIPPPK--------DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       279 ~~~~~~~~~~--------~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .  ..++.+.        .+.++..+.+|+.+||+.||.+|||++++++
T Consensus       238 ~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          238 G--VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             T--CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             c--CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0  0111100        1245677999999999999999999999996

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-42  Score=353.10  Aligned_cols=251  Identities=22%  Similarity=0.332  Sum_probs=205.0

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++.+...   ...+|++++.++ +||||+++++++.+....|+|||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            4567999999999999999999987  88999999876533   245688888887 79999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC----CcEEEcccccceecCCC
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN----FNARLGDFGLALRCGVD  205 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~----~~vkL~DFGla~~~~~~  205 (487)
                      |+++|+|.+++...+ .+++..+..++.||+.||.|||++  +|+||||||+|||+..+    +.+||+|||++......
T Consensus        97 ~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~--givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           97 LMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             CCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            999999999998764 499999999999999999999999  99999999999998443    35999999999876543


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      ..  ......||+.|+|||.+.+..++.++|||||||++|+|++|..||..... ....... ..+..+..      .+.
T Consensus       174 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~-~~i~~~~~------~~~  243 (342)
T 2qr7_A          174 NG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEIL-ARIGSGKF------SLS  243 (342)
T ss_dssp             TC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHH-HHHHHCCC------CCC
T ss_pred             CC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHH-HHHccCCc------ccC
Confidence            32  23456899999999999887889999999999999999999999974321 1111111 12222221      122


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ......++.++.+|+.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2233457788999999999999999999999987

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.7e-43  Score=350.57  Aligned_cols=257  Identities=24%  Similarity=0.342  Sum_probs=205.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  124 (487)
                      .++|.+.+.||+|+||.||+|.+.       +..||||++...  ......+.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            467999999999999999999842       568999998643  34456789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc---CCcEEEcc
Q 011384          125 LLVVEFMSNGTLYDVLHSNN------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR---NFNARLGD  195 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~---~~~vkL~D  195 (487)
                      ++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.  +|+||||||+|||++.   +..+||+|
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--~i~H~dlkp~NIli~~~~~~~~~kl~D  186 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGD  186 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC--CeecCcCCHhHEEEecCCCcceEEECc
Confidence            99999999999999998653      3489999999999999999999999  9999999999999984   45699999


Q ss_pred             cccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcC
Q 011384          196 FGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKG  274 (487)
Q Consensus       196 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~  274 (487)
                      ||++................||+.|+|||.+.+..++.++|||||||++|+|++ |+.||... .......    .+..+
T Consensus       187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~----~~~~~  261 (327)
T 2yfx_A          187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-SNQEVLE----FVTSG  261 (327)
T ss_dssp             CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHH----HHHTT
T ss_pred             cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc-CHHHHHH----HHhcC
Confidence            999875543332223334567899999999988889999999999999999998 88888632 1111111    11111


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       275 ~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .         ....+..++..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       262 ~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          262 G---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            1         112234566789999999999999999999999999987754

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-42  Score=353.71  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=206.9

Q ss_pred             hcCcccceeecccCceEEEEEEE-----CCeEEEEEEcCCCh-----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVL-----RGRQVAVKKPSKNQ-----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSK  122 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~-----~g~~vAvK~~~~~~-----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~  122 (487)
                      .++|.+.+.||+|+||.||+|.+     .++.||||++....     .....+.+|+++++.+ +||||+++++++.+..
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46799999999999999999998     47899999887532     2335677899999999 6999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                      ..++||||+++++|.+++.... .+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||+++..
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            9999999999999999998754 499999999999999999999999  9999999999999999999999999999865


Q ss_pred             CCCCcccccCCCCCCCccCCccccCCC--CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccccc
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTPD--NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF  280 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~  280 (487)
                      ...... ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||...................       
T Consensus       210 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------  281 (355)
T 1vzo_A          210 VADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------  281 (355)
T ss_dssp             CGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-------
T ss_pred             ccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-------
Confidence            433221 23345799999999999863  47899999999999999999999997544333333222222111       


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                          ..+.+..++..+.+|+.+||+.||.+||     +++++++
T Consensus       282 ----~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          282 ----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ----CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence                1223445677899999999999999999     9999987

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.2e-43  Score=359.10  Aligned_cols=243  Identities=23%  Similarity=0.284  Sum_probs=194.0

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHH-HHhCCCCCceeeEEEEeCCCceEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEI-LSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~-l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .++|.+.+.||+|+||.||+|++.  ++.||||++.+..    .....+.+|..+ ++.++||||+++++++.+.+.+|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999987  7789999986543    223456677776 467899999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++|+|.+++...+ .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++......
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            999999999999998754 489999999999999999999999  99999999999999999999999999987533222


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                      .  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .   ......+.. +.          .
T Consensus       194 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~---~~~~~~i~~-~~----------~  256 (373)
T 2r5t_A          194 S--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-T---AEMYDNILN-KP----------L  256 (373)
T ss_dssp             C--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-H---HHHHHHHHH-SC----------C
T ss_pred             C--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-H---HHHHHHHHh-cc----------c
Confidence            1  3345689999999999999999999999999999999999999996321 1   111111111 11          1


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKE  316 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e  316 (487)
                      ..+..++.++.+|+.+||+.||.+||++.+
T Consensus       257 ~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          257 QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            123346678999999999999999999753

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-42  Score=363.11  Aligned_cols=193  Identities=25%  Similarity=0.349  Sum_probs=155.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC-----CCc
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSND-----SKD  123 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----~~~  123 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++...   ....+.+.+|+++++.++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999886  789999988653   3345678999999999999999999999843     356


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      +|+||||+ +++|.+++.... .+++..++.++.||+.||.|||+.  +|+||||||+||||+.++.+||+|||+++...
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~--~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVHSA--GILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             EEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhC--CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            89999998 579999997654 599999999999999999999999  99999999999999999999999999998654


Q ss_pred             CCCcc-------------------------cccCCCCCCCccCCcccc-CCCCCCcchhhhhHHHHHHHHHhC
Q 011384          204 VDNFR-------------------------FRSTPPAGTIGYLDPCYV-TPDNLSTKTDVFSFGILLLEIISC  250 (487)
Q Consensus       204 ~~~~~-------------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDVwSlGvvl~eLltG  250 (487)
                      .....                         ...+...||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            32110                         123345789999999986 456799999999999999999994

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.3e-43  Score=350.00  Aligned_cols=254  Identities=25%  Similarity=0.405  Sum_probs=205.9

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeE--EEEEEcCCC--hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQ--VAVKKPSKN--QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~--vAvK~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      ++|.+.+.||+|+||.||+|.+.  +..  ||||.+...  ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57999999999999999999875  554  489987643  23345789999999999 999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEE
Q 011384          128 VEFMSNGTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNAR  192 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vk  192 (487)
                      |||+++++|.+++....               ..+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+|
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~~~~~~k  182 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAK  182 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECGGGCEE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCccceEEEcCCCeEE
Confidence            99999999999997653               3699999999999999999999999  999999999999999999999


Q ss_pred             EcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhh
Q 011384          193 LGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLI  271 (487)
Q Consensus       193 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~  271 (487)
                      |+|||++......   .......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.... ......    .+
T Consensus       183 L~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-~~~~~~----~~  254 (327)
T 1fvr_A          183 IADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYE----KL  254 (327)
T ss_dssp             ECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHH----HG
T ss_pred             EcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc-HHHHHH----Hh
Confidence            9999998643221   12334467889999999988888999999999999999998 999986321 111111    11


Q ss_pred             hcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       272 ~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      ..         ......+..++.++.+|+.+||+.+|.+|||+.++++.|..+...
T Consensus       255 ~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          255 PQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             GG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hc---------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            11         112223445678899999999999999999999999999887653

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-42  Score=340.70  Aligned_cols=248  Identities=24%  Similarity=0.368  Sum_probs=197.6

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .++|.+.+.||+|+||.||++...  +..||+|++....  ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            357999999999999999999986  7899999876543  335789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE---ccCCcEEEcccccceecC
Q 011384          130 FMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCG  203 (487)
Q Consensus       130 y~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl---d~~~~vkL~DFGla~~~~  203 (487)
                      |+++++|.+.+..   .+..+++..++.++.|++.||.|||+.  +|+||||||+|||+   +.++.+||+|||++....
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC--CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999999864   235699999999999999999999999  99999999999999   456789999999997654


Q ss_pred             CCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ...   ......||+.|+|||.+. ..++.++|||||||++|+|++|+.||... .......   .....       .+.
T Consensus       179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~-~~~~~~~---~~~~~-------~~~  243 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT-SLEEVQQ---KATYK-------EPN  243 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHH---HHHHC-------CCC
T ss_pred             Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC-CHHHHHh---hhccC-------Ccc
Confidence            332   234567999999999986 56899999999999999999999999632 1111111   11100       011


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ... ....+++++.+|+.+||+.||.+|||+.||++
T Consensus       244 ~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          244 YAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111 11124567889999999999999999999996

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.4e-43  Score=341.75  Aligned_cols=248  Identities=25%  Similarity=0.427  Sum_probs=207.4

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeC---------
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND---------  120 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~---------  120 (487)
                      ....+|.+.+.||+|+||.||+|.+.  ++.||||++....   ..+.+|++++++++||||+++++++..         
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            34567999999999999999999997  8899999987653   356789999999999999999998854         


Q ss_pred             -------CCceEEEEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEE
Q 011384          121 -------SKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNAR  192 (487)
Q Consensus       121 -------~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vk  192 (487)
                             ....++||||+++++|.+++... ...+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+|
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK--KLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCCHHHEEEcCCCCEE
Confidence                   34579999999999999999753 34699999999999999999999999  999999999999999999999


Q ss_pred             EcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh
Q 011384          193 LGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK  272 (487)
Q Consensus       193 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~  272 (487)
                      |+|||++.......   ......||+.|+|||.+.+..++.++|||||||++|+|++|..|+..      .... .....
T Consensus       163 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~------~~~~-~~~~~  232 (284)
T 2a19_B          163 IGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE------TSKF-FTDLR  232 (284)
T ss_dssp             ECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH------HHHH-HHHHH
T ss_pred             ECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh------HHHH-HHHhh
Confidence            99999997765432   23345799999999999999999999999999999999999987741      1111 11111


Q ss_pred             cCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          273 KGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       273 ~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .        ..+    +..++.++.+++.+||+.||.+|||+.++++.|..+..
T Consensus       233 ~--------~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          233 D--------GII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             T--------TCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             c--------ccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            1        111    22345678999999999999999999999999988764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.6e-42  Score=344.02  Aligned_cols=255  Identities=21%  Similarity=0.293  Sum_probs=204.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCC-CCCceeeEEEEeC--CCceEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIH-SPRLVNLLGFSND--SKDRLLVV  128 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~--~~~~~lV~  128 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++....  .+.+.+|+.++++++ ||||+++++++.+  ....++||
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            367999999999999999999885  8899999987543  367899999999997 9999999999987  66789999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC-cEEEcccccceecCCCCc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF-NARLGDFGLALRCGVDNF  207 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~~~~~~  207 (487)
                      ||+++++|.+++..    +++..++.++.|++.||.|||+.  +|+||||||+|||++.++ .+||+|||++....... 
T Consensus       113 e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-  185 (330)
T 3nsz_A          113 EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-  185 (330)
T ss_dssp             ECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred             eccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence            99999999998853    88999999999999999999999  999999999999999776 89999999998665433 


Q ss_pred             ccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhh---------hcCc--
Q 011384          208 RFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI---------KKGK--  275 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~---------~~~~--  275 (487)
                        ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||..+..............         ....  
T Consensus       186 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          186 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             --ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence              2344579999999999887 6789999999999999999999999965443222111110000         0000  


Q ss_pred             ------------cccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          276 ------------ILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       276 ------------i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                                  ....+........+..++.++.+|+.+||+.||.+|||++|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                        00001111122233346788999999999999999999999997

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.6e-42  Score=338.06  Aligned_cols=242  Identities=23%  Similarity=0.356  Sum_probs=200.3

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++...   ......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3567999999999999999999996  889999987753   33456788999999999 99999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC---------------
Q 011384          127 VVEFMSNGTLYDVLHSN---NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN---------------  188 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~---------------  188 (487)
                      ||||+++++|.+++...   ...+++..++.++.|++.||.|||++  +|+||||||+|||++.+               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEC-----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC--CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999999763   24599999999999999999999999  99999999999999844               


Q ss_pred             ----CcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchh
Q 011384          189 ----FNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSI  263 (487)
Q Consensus       189 ----~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~  263 (487)
                          ..+||+|||++......      ....||+.|+|||.+.+. .++.++|||||||++|+|++|..++...   ...
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~  237 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQW  237 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHH
T ss_pred             cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHH
Confidence                47999999999776432      234699999999999876 5678999999999999999998776421   111


Q ss_pred             hhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          264 VDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       264 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .     .+..+.         ....+..++.++.+|+.+||+.||.+|||+.++++
T Consensus       238 ~-----~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          238 H-----EIRQGR---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             H-----HHHTTC---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H-----HHHcCC---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            1     111111         11233346678999999999999999999999996

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=347.36  Aligned_cols=261  Identities=21%  Similarity=0.316  Sum_probs=193.0

Q ss_pred             hHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC-hhhHHHHHHHHHHHHhCC-CCCceeeEEEEe-----
Q 011384           49 DLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN-QEISQEVDNEIEILSKIH-SPRLVNLLGFSN-----  119 (487)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~-~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~-----  119 (487)
                      .++....+|.+.+.||+|+||.||+|.+.  ++.||||++... ......+.+|+.++.++. ||||+++++++.     
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~  101 (337)
T 3ll6_A           22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE  101 (337)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred             eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence            33444568999999999999999999984  889999987544 344567899999999996 999999999984     


Q ss_pred             ---CCCceEEEEEecCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--eeeccCCCCcEEEccCCcEE
Q 011384          120 ---DSKDRLLVVEFMSNGTLYDVLHS--NNRPLNWGRRIRLALQVAKAVEILHSEMPP--IIHRDIKSANVLIDRNFNAR  192 (487)
Q Consensus       120 ---~~~~~~lV~Ey~~~gsL~~~l~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~--ivH~DIkp~NILld~~~~vk  192 (487)
                         .....++||||+. |+|.+++..  ....+++..++.++.|++.||.|||+.  +  |+||||||+|||++.++.+|
T Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ--KPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS--SSCCBCCCCCGGGCEECTTSCEE
T ss_pred             cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC--CCCEEEccCCcccEEECCCCCEE
Confidence               3345799999995 799998865  445699999999999999999999999  7  99999999999999999999


Q ss_pred             EcccccceecCCCCcc----------cccCCCCCCCccCCcccc---CCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCC
Q 011384          193 LGDFGLALRCGVDNFR----------FRSTPPAGTIGYLDPCYV---TPDNLSTKTDVFSFGILLLEIISCRKAIDIGFS  259 (487)
Q Consensus       193 L~DFGla~~~~~~~~~----------~~~~~~~gt~~Y~aPE~~---~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~  259 (487)
                      |+|||++.........          .......||+.|+|||.+   .+..++.++|||||||++|+|++|+.||.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            9999999765433211          011134689999999998   566789999999999999999999999963221


Q ss_pred             CchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCC
Q 011384          260 PPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP  329 (487)
Q Consensus       260 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  329 (487)
                      ..                 ........+.....+..+.+|+.+||+.||.+|||+.++++.|+.+....+
T Consensus       259 ~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          259 LR-----------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             HH-----------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            11                 111111112223344568899999999999999999999999998876443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=344.14  Aligned_cols=261  Identities=24%  Similarity=0.300  Sum_probs=198.6

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh------hhHHHHHHHHHHHHhCC---CCCceeeEEEEeC
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ------EISQEVDNEIEILSKIH---SPRLVNLLGFSND  120 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~------~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~  120 (487)
                      ...++|.+.+.||+|+||.||+|.+.  ++.||||++....      .....+.+|+++++.++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            44679999999999999999999975  8899999876321      22346677888777764   9999999999977


Q ss_pred             CC-----ceEEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEc
Q 011384          121 SK-----DRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLG  194 (487)
Q Consensus       121 ~~-----~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~  194 (487)
                      ..     ..++||||+. ++|.+++.... ..+++..++.++.|++.||+|||+.  +|+||||||+|||++.++.+||+
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCTTTEEECTTSCEEEC
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEcCCCCEEEe
Confidence            55     4799999996 69999998754 3499999999999999999999999  99999999999999999999999


Q ss_pred             ccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC
Q 011384          195 DFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG  274 (487)
Q Consensus       195 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  274 (487)
                      |||++.......   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||............. ......
T Consensus       163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~-~~~~~~  238 (308)
T 3g33_A          163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF-DLIGLP  238 (308)
T ss_dssp             SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH-HHHCCC
T ss_pred             eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHhCCC
Confidence            999987554322   2334578999999999999999999999999999999999999996432221111111 110000


Q ss_pred             ---ccc-------cccCCCCCC---CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          275 ---KIL-------SVFDPRIPP---PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       275 ---~i~-------~~~~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                         .+.       ..+.+..+.   ...+.++..+.+|+.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence               000       000000000   011235678999999999999999999999996

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.5e-42  Score=366.01  Aligned_cols=255  Identities=23%  Similarity=0.361  Sum_probs=204.8

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ...++|.+.+.||+|+||.||+|.+.  +..||||++....   .....+.+|+.+++.++||||++++++|.+....++
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34567999999999999999999986  7889999876542   234678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc---CCcEEEcccccceecC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR---NFNARLGDFGLALRCG  203 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~~~~  203 (487)
                      |||||++|+|.+.+.... .+++..++.++.||+.||.|||++  +|+||||||+|||++.   ++.+||+|||++....
T Consensus       114 v~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKH--NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             EEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            999999999999987654 499999999999999999999999  9999999999999976   4559999999997765


Q ss_pred             CCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ...   ......||+.|+|||++. ..++.++|||||||++|+|++|..||.... ...+..    .+..+..      .
T Consensus       191 ~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~----~i~~~~~------~  255 (494)
T 3lij_A          191 NQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT-DQEILR----KVEKGKY------T  255 (494)
T ss_dssp             TTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHH----HHHHTCC------C
T ss_pred             CCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHH----HHHhCCC------C
Confidence            432   234567999999999986 568999999999999999999999996322 111111    1111111      1


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                      ...+....++.++.+|+.+||+.||.+|||+.++++  ||...
T Consensus       256 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          256 FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            111122346788999999999999999999999997  56554

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=347.30  Aligned_cols=261  Identities=23%  Similarity=0.358  Sum_probs=203.6

Q ss_pred             ccccchhhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEE
Q 011384           42 IQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFS  118 (487)
Q Consensus        42 ~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  118 (487)
                      +..++..++....++|.+.+.||+|+||.||+|.+.  ++.||||++.........+.+|+.+++++ +||||+++++++
T Consensus        11 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             -----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             chhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            344555666667889999999999999999999994  88999999877666667899999999999 899999999998


Q ss_pred             eC------CCceEEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcE
Q 011384          119 ND------SKDRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNA  191 (487)
Q Consensus       119 ~~------~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~v  191 (487)
                      ..      ....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.  +|+|+||||+|||++.++.+
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH--KVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTCCE
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCcHHHEEEcCCCCE
Confidence            76      467899999999999999998642 4699999999999999999999999  99999999999999999999


Q ss_pred             EEcccccceecCCCCcccccCCCCCCCccCCccccC-----CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhh
Q 011384          192 RLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT-----PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDW  266 (487)
Q Consensus       192 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~  266 (487)
                      ||+|||++........  ......||+.|+|||.+.     ...++.++|||||||++|+|++|+.||..... ...   
T Consensus       169 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~---  242 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-MRA---  242 (326)
T ss_dssp             EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-HHH---
T ss_pred             EEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-HHH---
Confidence            9999999876543211  223457999999999987     45789999999999999999999999863211 111   


Q ss_pred             hhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          267 AAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       267 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .... ...        ..+...+..++..+.+|+.+||+.||.+|||+.++++
T Consensus       243 ~~~~-~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          243 LFLI-PRN--------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHH-HHS--------CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHh-hcC--------ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            1111 111        0111122345678999999999999999999999997

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.1e-42  Score=341.53  Aligned_cols=249  Identities=22%  Similarity=0.319  Sum_probs=204.7

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh-hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE-ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ..++|.+.+.||+|+||.||++.+.  ++.||||++..... ....+.+|+.++++++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3467999999999999999999986  88999999876533 34568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE---ccCCcEEEcccccceecCCCC
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl---d~~~~vkL~DFGla~~~~~~~  206 (487)
                      |+++++|.+++...+ .+++..++.++.|++.||.|||+.  +|+|+||||+|||+   +.++.+||+|||++.......
T Consensus        87 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  163 (304)
T 2jam_A           87 LVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHEN--GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI  163 (304)
T ss_dssp             CCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred             cCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence            999999999997654 499999999999999999999999  99999999999999   778999999999986543221


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                          .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... ....    ..+..+..      ....
T Consensus       164 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~----~~i~~~~~------~~~~  228 (304)
T 2jam_A          164 ----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLF----EKIKEGYY------EFES  228 (304)
T ss_dssp             ----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHH----HHHHHCCC------CCCT
T ss_pred             ----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHH----HHHHcCCC------CCCc
Confidence                1223589999999999999999999999999999999999999863221 1111    11111111      1222


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +....++.++.+|+.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          229 PFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            333456788999999999999999999999997

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.8e-42  Score=338.57  Aligned_cols=249  Identities=21%  Similarity=0.356  Sum_probs=208.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++|.+.+.||+|+||.||++.+.  ++.||+|++...    ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467999999999999999999997  788999987643    33456789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+++++|.+++.... .+++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++........
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            99999999999987654 499999999999999999999999  999999999999999999999999999977543322


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                        ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........    .. .+..+.          ..
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~-~~~~~~----------~~  233 (294)
T 2rku_A          171 --RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----YL-RIKKNE----------YS  233 (294)
T ss_dssp             --CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HH-HHHTTC----------CC
T ss_pred             --ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HH-HHhhcc----------CC
Confidence              23446799999999999988899999999999999999999999964221111    11 111111          11


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHh
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLT  322 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~  322 (487)
                      .+..++..+.+|+.+||+.||.+|||++++++  ++.
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~  270 (294)
T 2rku_A          234 IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT  270 (294)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred             CccccCHHHHHHHHHHcccChhhCcCHHHHhhChhee
Confidence            23345678999999999999999999999997  454

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5e-42  Score=363.98  Aligned_cols=255  Identities=23%  Similarity=0.372  Sum_probs=207.5

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++...   ......+.+|++++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467999999999999999999986  889999987543   22346789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc---cCCcEEEcccccceecCC
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGV  204 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld---~~~~vkL~DFGla~~~~~  204 (487)
                      |||+.+++|.+.+.... .+++..++.++.||+.||.|||++  +|+||||||+|||++   .++.+||+|||++.....
T Consensus       100 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            99999999999997654 499999999999999999999999  999999999999995   456799999999875543


Q ss_pred             CCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ..   ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ...+..    .+..+..      ..
T Consensus       177 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~----~i~~~~~------~~  241 (486)
T 3mwu_A          177 NT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-EYDILK----RVETGKY------AF  241 (486)
T ss_dssp             C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHH----HHHHTCC------CS
T ss_pred             CC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHH----HHHhCCC------CC
Confidence            32   2344679999999999875 58999999999999999999999996321 111111    1111111      11


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLS  325 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l~  325 (487)
                      ..+....++.++.+|+.+||+.||.+|||+.++++  |+....
T Consensus       242 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            12223456788999999999999999999999998  566543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.6e-42  Score=339.76  Aligned_cols=251  Identities=27%  Similarity=0.411  Sum_probs=199.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeC-----------
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND-----------  120 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-----------  120 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++.......+.+.+|+.++++++||||+++++++.+           
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            467999999999999999999985  8899999997776667789999999999999999999998864           


Q ss_pred             --CCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccc
Q 011384          121 --SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL  198 (487)
Q Consensus       121 --~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGl  198 (487)
                        ....++||||+++++|.+++......+++..++.++.|++.||.|||++  +|+|+||||+|||++.++.+||+|||+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC--CeecccCCHHhEEEcCCCCEEEeeCcc
Confidence              3567999999999999999987766688999999999999999999999  999999999999999999999999999


Q ss_pred             ceecCCCCc------------ccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhh
Q 011384          199 ALRCGVDNF------------RFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD  265 (487)
Q Consensus       199 a~~~~~~~~------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~  265 (487)
                      +........            ........||+.|+|||.+.+. .++.++|||||||++|+|++   ||..+...   ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~---~~  236 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER---VN  236 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---HH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH---HH
Confidence            875532210            1122345789999999999864 68999999999999999998   44321111   11


Q ss_pred             hhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          266 WAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       266 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ... .+..      ....++...+..++..+.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~-~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          237 ILK-KLRS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHH-HHHS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHH-hccc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            111 1111      1223344455566788999999999999999999999997

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.8e-42  Score=340.97  Aligned_cols=257  Identities=23%  Similarity=0.309  Sum_probs=201.5

Q ss_pred             hcCcccceeecccCceEEEEEEEC---C--eEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR---G--RQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~---g--~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  124 (487)
                      .++|.+.+.||+|+||.||+|.+.   +  ..||||++...    ....+.+.+|++++++++||||+++++++.+.. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357999999999999999999863   2  26899988753    234567899999999999999999999998765 8


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++.....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK--RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC--CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            899999999999999987655699999999999999999999999  999999999999999999999999999987654


Q ss_pred             CCcc-cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCC
Q 011384          205 DNFR-FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       205 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~  282 (487)
                      .... .......+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||.... .....   .....         .
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~---~~~~~---------~  240 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-GSQIL---HKIDK---------E  240 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHH---HHHHT---------S
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-HHHHH---HHHHc---------c
Confidence            4322 12234567889999999988888999999999999999999 999986321 11111   11111         1


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       283 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ....+.+..++.++.+++.+||+.||.+|||+.+++++|+.+..
T Consensus       241 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          241 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            11222344567889999999999999999999999999988753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.6e-42  Score=340.28  Aligned_cols=251  Identities=25%  Similarity=0.361  Sum_probs=203.8

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ...++|.+.+.||+|+||.||+|.+.  ++.||||++..... ...+.+|+.+++.++||||+++++++.+....++|||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            44578999999999999999999987  88999999876533 4678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |+++++|.+++......+++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++........  
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--  180 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM--RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--  180 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--
Confidence            9999999999986556799999999999999999999999  999999999999999999999999999976543321  


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...... .   ..... ...       .......+
T Consensus       181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~---~~~~~-~~~-------~~~~~~~~  248 (314)
T 3com_A          181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-R---AIFMI-PTN-------PPPTFRKP  248 (314)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-H---HHHHH-HHS-------CCCCCSSG
T ss_pred             ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-H---HHHHH-hcC-------CCcccCCc
Confidence            234457999999999999989999999999999999999999998632111 1   11111 110       01111223


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..++..+.+|+.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            456788999999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7e-42  Score=361.13  Aligned_cols=258  Identities=22%  Similarity=0.308  Sum_probs=195.4

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC-----
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK-----  122 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----  122 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++...   ....+.+.+|+.+++.++||||+++++++....     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            3578999999999999999999886  889999998753   344567889999999999999999999996553     


Q ss_pred             -ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          123 -DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       123 -~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                       ..|+||||+++ +|.+.+..   .+++..+..++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++.
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~--~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             CeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence             46999999965 57777643   389999999999999999999999  999999999999999999999999999976


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhh-------------
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA-------------  268 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~-------------  268 (487)
                      .....   ..+...||+.|+|||++.+..++.++|||||||++|||++|+.||..............             
T Consensus       214 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          214 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             ---CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             cCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            54332   33456899999999999999999999999999999999999999964321111111000             


Q ss_pred             -----hhhhcC------ccccccCCCCCC---CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          269 -----PLIKKG------KILSVFDPRIPP---PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       269 -----~~~~~~------~i~~~~~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                           ......      .....+...+..   ......+.++.+|+.+||+.||.+|||++|+++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 000000      000000000000   001123678999999999999999999999996

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7.4e-42  Score=367.88  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=210.0

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++.+..    .....+.+|+++++.++||||+++++++.+...+|+
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3467999999999999999999986  8899999986532    234568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          127 VVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      ||||+++|+|.+++...+ ..+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||++......
T Consensus       262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~--gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            999999999999997643 3599999999999999999999999  9999999999999999999999999999876543


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||............. ..+..          .+
T Consensus       340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~-~~i~~----------~~  405 (576)
T 2acx_A          340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE-RLVKE----------VP  405 (576)
T ss_dssp             C---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH-HHHHH----------CC
T ss_pred             c---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH-HHhhc----------cc
Confidence            2   2234589999999999999899999999999999999999999997543222111111 11111          11


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      ...+..++.++.+|+.+||+.||.+||     +++||++
T Consensus       406 ~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            223445678999999999999999999     7899986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.5e-42  Score=340.22  Aligned_cols=245  Identities=27%  Similarity=0.435  Sum_probs=206.5

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      +.|...+.||+|+||.||+|.+.  ++.||||++...  ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            56999999999999999999886  789999987654  33457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +++++|.+++...  .+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||++........  .
T Consensus       102 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  175 (303)
T 3a7i_A          102 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K  175 (303)
T ss_dssp             CTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--C
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCChheEEECCCCCEEEeecccceecCcccc--c
Confidence            9999999999753  499999999999999999999999  999999999999999999999999999977654322  2


Q ss_pred             cCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          211 STPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.... ......    .+..+         .....+.
T Consensus       176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~----~~~~~---------~~~~~~~  241 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH-PMKVLF----LIPKN---------NPPTLEG  241 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHH----HHHHS---------CCCCCCS
T ss_pred             cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC-HHHHHH----HhhcC---------CCCCCcc
Confidence            345679999999999999999999999999999999999999986321 111111    11111         1112233


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .++..+.+|+.+||+.||.+|||+.+|++
T Consensus       242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          242 NYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             SCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            45678999999999999999999999997

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.8e-42  Score=352.31  Aligned_cols=262  Identities=23%  Similarity=0.265  Sum_probs=192.7

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCC-CCCceeeEEEEeCCC--c
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIH-SPRLVNLLGFSNDSK--D  123 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~--~  123 (487)
                      ...++|.+.+.||+|+||.||+|.+.  ++.||||++...   ......+.+|+.+++.+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            44678999999999999999999986  889999987643   344567889999999997 999999999997544  6


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      +|+||||++ ++|.+++...  .+++..+..++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSG--GLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            899999997 5999999874  499999999999999999999999  99999999999999999999999999998653


Q ss_pred             CCC-------------------cccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchh
Q 011384          204 VDN-------------------FRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSI  263 (487)
Q Consensus       204 ~~~-------------------~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~  263 (487)
                      ...                   .....+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||........+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            211                   1112334579999999999986 67899999999999999999999999643221111


Q ss_pred             hhhhhhhhhcCccc---------------------cccCCCCCCC------------CChHHHHHHHHHHHHhhhhcCCC
Q 011384          264 VDWAAPLIKKGKIL---------------------SVFDPRIPPP------------KDPIVRKQLAVIAVRCVRSCRER  310 (487)
Q Consensus       264 ~~~~~~~~~~~~i~---------------------~~~~~~~~~~------------~~~~~~~~l~~Li~~cl~~dP~~  310 (487)
                      .... .........                     ..........            ....++.++.+|+.+||+.||.+
T Consensus       241 ~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~  319 (388)
T 3oz6_A          241 ERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK  319 (388)
T ss_dssp             HHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence            1110 000000000                     0000000000            01134568999999999999999


Q ss_pred             CCCHHHHHH
Q 011384          311 RPSMKEIVD  319 (487)
Q Consensus       311 RPs~~eil~  319 (487)
                      |||++|+++
T Consensus       320 R~t~~e~l~  328 (388)
T 3oz6_A          320 RISANDALK  328 (388)
T ss_dssp             SCCHHHHTT
T ss_pred             CCCHHHHhC
Confidence            999999996

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.8e-42  Score=346.14  Aligned_cols=258  Identities=21%  Similarity=0.338  Sum_probs=208.2

Q ss_pred             chhhHHHhhcCcccc-eeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhC-CCCCceeeEEEE
Q 011384           46 DYSDLEAATNGFSEQ-KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKI-HSPRLVNLLGFS  118 (487)
Q Consensus        46 ~~~~~~~~~~~y~~~-~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~  118 (487)
                      .+...+...++|.+. +.||+|+||.||+|.+.  ++.||||++....   .....+.+|+.++..+ +||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            344456667788887 89999999999999987  8899999877532   3356789999999999 569999999999


Q ss_pred             eCCCceEEEEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc---CCcEEEc
Q 011384          119 NDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR---NFNARLG  194 (487)
Q Consensus       119 ~~~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~---~~~vkL~  194 (487)
                      .+....++||||+++++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+|||++.   ++.+||+
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~--givH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CeecCcCChHHEEEecCCCCCcEEEe
Confidence            9999999999999999999998643 35699999999999999999999999  9999999999999987   7899999


Q ss_pred             ccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC
Q 011384          195 DFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG  274 (487)
Q Consensus       195 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  274 (487)
                      |||++.......   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........    . .. 
T Consensus       177 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i-~~-  247 (327)
T 3lm5_A          177 DFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----I-SQ-  247 (327)
T ss_dssp             CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----H-HH-
T ss_pred             eCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH----H-Hh-
Confidence            999998764332   22345799999999999999999999999999999999999999964222111111    1 10 


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       275 ~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                           .......+....++..+.+|+.+||+.||.+|||++++++
T Consensus       248 -----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          248 -----VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             -----TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -----cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence                 1112222333456788999999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.2e-41  Score=364.81  Aligned_cols=251  Identities=24%  Similarity=0.329  Sum_probs=209.2

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++|...+.||+|+||.||+|++.  ++.||||++.+..    .....+.+|++++++++||||+++++++.+...+|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367999999999999999999986  8899999986543    2235788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          128 VEFMSNGTLYDVLHSN---NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      |||+++|+|.+++...   ...+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.+..
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~--gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc--CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999999764   24599999999999999999999999  999999999999999999999999999987654


Q ss_pred             CCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................. +          
T Consensus       342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~-~----------  408 (543)
T 3c4z_A          342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-Q----------  408 (543)
T ss_dssp             TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-C----------
T ss_pred             CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-c----------
Confidence            322  233458999999999999999999999999999999999999999754332222222211111 1          


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCH-----HHHHH
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSM-----KEIVD  319 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~-----~eil~  319 (487)
                      ....+..++.++.+|+.+||+.||.+||++     ++|++
T Consensus       409 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            112334567889999999999999999965     67765

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.3e-42  Score=346.21  Aligned_cols=251  Identities=21%  Similarity=0.352  Sum_probs=209.8

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ..++|.+.+.||+|+||.||++.+.  ++.||+|++...    ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            3468999999999999999999987  778999987643    3345678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++++|.+++.... .+++..++.++.|++.||.|||++  +|+|+||||+|||++.++.+||+|||++.......
T Consensus       119 v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             EECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC--CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            999999999999987654 499999999999999999999999  99999999999999999999999999998764332


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                      .  ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||......    .... .+..+.      .    
T Consensus       196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~-~~~~~~------~----  258 (335)
T 2owb_A          196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----ETYL-RIKKNE------Y----  258 (335)
T ss_dssp             C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHH-HHHHTC------C----
T ss_pred             c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH----HHHH-HHhcCC------C----
Confidence            2  234467999999999999888999999999999999999999999642211    1111 111111      1    


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhc
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG  323 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~  323 (487)
                      ..+..++.++.+|+.+||+.||.+|||+.++++  ++..
T Consensus       259 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          259 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            123345678899999999999999999999997  5544

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.5e-42  Score=359.81  Aligned_cols=252  Identities=27%  Similarity=0.361  Sum_probs=195.8

Q ss_pred             HHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh---------hHHHHHHHHHHHHhCCCCCceeeEEEEe
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---------ISQEVDNEIEILSKIHSPRLVNLLGFSN  119 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~---------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~  119 (487)
                      ....++|.+.+.||+|+||.||+|.+.  ++.||||++.....         ....+.+|+.++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            455789999999999999999999987  78999998765321         1224789999999999999999999986


Q ss_pred             CCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC---CcEEEccc
Q 011384          120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN---FNARLGDF  196 (487)
Q Consensus       120 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~---~~vkL~DF  196 (487)
                      .. ..++||||+++++|.+++.... .+++..++.++.|++.||.|||++  +|+||||||+|||++.+   +.+||+||
T Consensus       211 ~~-~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~--~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          211 AE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             SS-EEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             cC-ceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChHhEEEecCCCcceEEEeec
Confidence            54 5799999999999999887654 599999999999999999999999  99999999999999754   45999999


Q ss_pred             ccceecCCCCcccccCCCCCCCccCCccccCC---CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc
Q 011384          197 GLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP---DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK  273 (487)
Q Consensus       197 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~  273 (487)
                      |+++......   ......||+.|+|||++.+   ..++.++|||||||++|+|++|+.||............    +..
T Consensus       287 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~----i~~  359 (419)
T 3i6u_A          287 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----ITS  359 (419)
T ss_dssp             STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH----HHT
T ss_pred             ccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH----Hhc
Confidence            9997654322   2345679999999999864   56788999999999999999999999754333332221    111


Q ss_pred             CccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          274 GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       274 ~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..      .........++..+.+|+.+||+.||.+|||+.++++
T Consensus       360 ~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          360 GKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             TCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCC------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            110      0001111235678999999999999999999999997

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.4e-42  Score=339.87  Aligned_cols=250  Identities=25%  Similarity=0.346  Sum_probs=202.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEe--CCCceEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSN--DSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~~l  126 (487)
                      .++|.+.+.||+|+||.||++.+.  ++.||+|++...   ....+.+.+|+.++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467999999999999999999986  789999988653   344567899999999999999999999874  4667899


Q ss_pred             EEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-----eeeccCCCCcEEEccCCcEEEccccc
Q 011384          127 VVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPP-----IIHRDIKSANVLIDRNFNARLGDFGL  198 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~-----ivH~DIkp~NILld~~~~vkL~DFGl  198 (487)
                      ||||+++++|.+++..   ....+++..++.++.|++.||.|||+.  +     |+|+||||+|||++.++.+||+|||+
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR--SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc--cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            9999999999999975   334599999999999999999999999  8     99999999999999999999999999


Q ss_pred             ceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccc
Q 011384          199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILS  278 (487)
Q Consensus       199 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~  278 (487)
                      +........  ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||... ....+.    ..+..+..  
T Consensus       163 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~----~~i~~~~~--  233 (279)
T 2w5a_A          163 ARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKELA----GKIREGKF--  233 (279)
T ss_dssp             HHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHH----HHHHHTCC--
T ss_pred             heeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc-CHHHHH----HHHhhccc--
Confidence            876543221  112246899999999999889999999999999999999999998632 111111    11122211  


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHH
Q 011384          279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL  321 (487)
Q Consensus       279 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L  321 (487)
                             ...+..++.++.+++.+||+.||.+|||+.+|++.+
T Consensus       234 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          234 -------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             -------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence                   123335677899999999999999999999999754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9.6e-42  Score=336.37  Aligned_cols=245  Identities=24%  Similarity=0.372  Sum_probs=198.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC----CCceE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSND----SKDRL  125 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~  125 (487)
                      +.|.+.+.||+|+||.||+|.+.  +..||+|++...   ....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            45888999999999999999986  678999987643   3345678999999999999999999998865    35589


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--eeeccCCCCcEEEc-cCCcEEEcccccceec
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP--IIHRDIKSANVLID-RNFNARLGDFGLALRC  202 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~--ivH~DIkp~NILld-~~~~vkL~DFGla~~~  202 (487)
                      +||||+++++|.+++.... .+++..++.++.|++.||.|||+.  +  |+|+||||+|||++ .++.+||+|||++...
T Consensus       106 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTR--TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTS--SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHcC--CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            9999999999999998754 499999999999999999999999  7  99999999999997 7899999999998644


Q ss_pred             CCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCC
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~  282 (487)
                      ....    .....||+.|+|||.+. +.++.++|||||||++|+|++|+.||...........    ....+        
T Consensus       183 ~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~--------  245 (290)
T 1t4h_A          183 RASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR----RVTSG--------  245 (290)
T ss_dssp             CTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH----HHTTT--------
T ss_pred             cccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHH----HHhcc--------
Confidence            3221    22356999999999887 4589999999999999999999999964332222211    11111        


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       283 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+...+...+.++.+|+.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          246 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1111122334467999999999999999999999996

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.5e-42  Score=347.66  Aligned_cols=260  Identities=26%  Similarity=0.358  Sum_probs=200.7

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ++|.+.+.||+|+||.||+|.+.  ++.||||++...   ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            57999999999999999999987  889999987543   2334568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |+++++|.+++.... .+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++........  
T Consensus       105 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  179 (331)
T 4aaa_A          105 FVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--  179 (331)
T ss_dssp             CCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             cCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHC--CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--
Confidence            999988888776544 499999999999999999999999  999999999999999999999999999976543322  


Q ss_pred             ccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhh----------hhhhcCcc-c
Q 011384          210 RSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA----------PLIKKGKI-L  277 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~----------~~~~~~~i-~  277 (487)
                      ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||..............          ..+..... .
T Consensus       180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (331)
T 4aaa_A          180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA  259 (331)
T ss_dssp             ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred             ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence            23345789999999999875 689999999999999999999999974332222111110          00000000 0


Q ss_pred             cccCCCCCCCC-----ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          278 SVFDPRIPPPK-----DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       278 ~~~~~~~~~~~-----~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ....+.+....     .+.+++.+.+|+.+||+.||.+|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            01111111111     1245778999999999999999999999997

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.6e-41  Score=335.62  Aligned_cols=250  Identities=20%  Similarity=0.343  Sum_probs=206.4

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----------hhHHHHHHHHHHHHhCC-CCCceeeEEEEe
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----------EISQEVDNEIEILSKIH-SPRLVNLLGFSN  119 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----------~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~  119 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++....          ...+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999986  7899999876432          22356889999999995 999999999999


Q ss_pred             CCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          120 DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       120 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                      +....++||||+++++|.+++.... .+++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~  171 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFS  171 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCcceEEEcCCCcEEEecccch
Confidence            9999999999999999999998654 499999999999999999999999  9999999999999999999999999999


Q ss_pred             eecCCCCcccccCCCCCCCccCCccccC------CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc
Q 011384          200 LRCGVDNFRFRSTPPAGTIGYLDPCYVT------PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK  273 (487)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~  273 (487)
                      .......   ......|++.|+|||.+.      ...++.++|||||||++|+|++|+.||..... ..   .. ..+..
T Consensus       172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~---~~-~~~~~  243 (298)
T 1phk_A          172 CQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-ML---ML-RMIMS  243 (298)
T ss_dssp             EECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HH---HH-HHHHH
T ss_pred             hhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-HH---HH-HHHhc
Confidence            7765332   234467999999999884      45678999999999999999999999863211 11   11 11111


Q ss_pred             CccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          274 GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       274 ~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +.      .....+....++..+.+|+.+||+.||.+|||+.++++
T Consensus       244 ~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          244 GN------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             TC------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CC------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            11      11222233457788999999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.5e-42  Score=345.26  Aligned_cols=261  Identities=20%  Similarity=0.270  Sum_probs=195.1

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh---hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++.....   ....+.+|+.++++++||||+++++++.+....++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            3467999999999999999999876  88999999875432   235678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc-----cCCcEEEcccccceec
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID-----RNFNARLGDFGLALRC  202 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld-----~~~~vkL~DFGla~~~  202 (487)
                      |||++ ++|.+++.... .+++..++.++.||+.||.|||++  +|+||||||+|||++     .++.+||+|||++...
T Consensus       112 ~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSR--RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            99997 59999998765 499999999999999999999999  999999999999994     4556999999999765


Q ss_pred             CCCCcccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc--Ccc---
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK--GKI---  276 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~--~~i---  276 (487)
                      .....  ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...................  ...   
T Consensus       188 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (329)
T 3gbz_A          188 GIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV  265 (329)
T ss_dssp             C-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             CCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence            43321  23445789999999999874 48999999999999999999999996432221111111100000  000   


Q ss_pred             --ccccCCCCCC---C-----CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          277 --LSVFDPRIPP---P-----KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       277 --~~~~~~~~~~---~-----~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        ...+....+.   .     .+..++.++.+|+.+||+.||.+|||+.|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence              0000000000   0     01124578899999999999999999999996

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.4e-41  Score=352.59  Aligned_cols=197  Identities=23%  Similarity=0.356  Sum_probs=166.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC-----Cc
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS-----KD  123 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~  123 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++...   ....+.+.+|+++++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999987  789999998753   33446789999999999999999999999766     56


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      .|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++...
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH~~--givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIHES--GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC--CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence            899999995 59999997654 599999999999999999999999  99999999999999999999999999998765


Q ss_pred             CCCcc--------------------cccCCCCCCCccCCcccc-CCCCCCcchhhhhHHHHHHHHHhCCcCC
Q 011384          204 VDNFR--------------------FRSTPPAGTIGYLDPCYV-TPDNLSTKTDVFSFGILLLEIISCRKAI  254 (487)
Q Consensus       204 ~~~~~--------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDVwSlGvvl~eLltG~~pf  254 (487)
                      .....                    ...+...||+.|+|||.+ ....++.++|||||||++|||++|..||
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            43211                    123556899999999986 5567899999999999999999864444

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.7e-42  Score=341.87  Aligned_cols=257  Identities=21%  Similarity=0.308  Sum_probs=197.8

Q ss_pred             hcCcccc-eeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEE
Q 011384           54 TNGFSEQ-KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        54 ~~~y~~~-~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      .+.|.+. +.||+|+||.||+|.+.  ++.||||++.... .....+.+|++++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4568774 78999999999999875  8899999986543 3456789999999985 7999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc---EEEcccccceecCCC
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN---ARLGDFGLALRCGVD  205 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~---vkL~DFGla~~~~~~  205 (487)
                      ||+++++|.+++.... .+++..++.++.|++.||.|||++  +|+||||||+|||++.++.   +||+|||++......
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNK--GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            9999999999998754 499999999999999999999999  9999999999999988766   999999998655322


Q ss_pred             Cc-----ccccCCCCCCCccCCccccCC-----CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchh----------hh
Q 011384          206 NF-----RFRSTPPAGTIGYLDPCYVTP-----DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSI----------VD  265 (487)
Q Consensus       206 ~~-----~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~----------~~  265 (487)
                      ..     ........||+.|+|||.+..     ..++.++|||||||++|+|++|+.||.........          ..
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence            11     111223469999999999875     45789999999999999999999999743221100          00


Q ss_pred             hhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          266 WAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       266 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .....+..+..      .++......++.++.+|+.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          248 MLFESIQEGKY------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHCCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhccCc------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            01111111111      1110001235678999999999999999999999997

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.5e-42  Score=365.88  Aligned_cols=254  Identities=26%  Similarity=0.397  Sum_probs=209.3

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++...    ......+.+|+.++++++||||+++++++.+....++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4567999999999999999999986  889999987543    2345779999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE---ccCCcEEEcccccceecC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCG  203 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl---d~~~~vkL~DFGla~~~~  203 (487)
                      ||||+.+++|.+.+.... .+++..++.++.|++.||.|||++  +|+||||||+|||+   +.++.+||+|||++....
T Consensus       104 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             EECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            999999999999997654 499999999999999999999999  99999999999999   467899999999997654


Q ss_pred             CCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ....   .....||+.|+|||.+.+ .++.++|||||||++|+|++|+.||.... ...+..    .+..+..      .
T Consensus       181 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~----~i~~~~~------~  245 (484)
T 3nyv_A          181 ASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN-EYDILK----KVEKGKY------T  245 (484)
T ss_dssp             CCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHH----HHHHCCC------C
T ss_pred             cccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC-HHHHHH----HHHcCCC------C
Confidence            3321   223469999999999876 68999999999999999999999996322 111111    1111111      1


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                      ...+....++.++.+|+.+||+.||.+|||+.++++  |+...
T Consensus       246 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          246 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            122223457788999999999999999999999997  66554

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=9.1e-42  Score=347.32  Aligned_cols=262  Identities=21%  Similarity=0.332  Sum_probs=206.6

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .++|.+.+.||+|+||.||+|.+.  +..||+|++...  ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            467999999999999999999997  889999988754  3445679999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      |+++++|.+++...+ .+++..+..++.|++.||.|||+ .  +|+||||||+|||++.++.+||+|||++......   
T Consensus       112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence            999999999998754 49999999999999999999998 5  7999999999999999999999999998654322   


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhh------------hcCc-
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI------------KKGK-  275 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~------------~~~~-  275 (487)
                       ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...... ..........            ..+. 
T Consensus       186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK-ELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH-HHHHHHC--------------------
T ss_pred             -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhcccccccCCCCCCCcccCCCc
Confidence             223457999999999999999999999999999999999999999642211 1000000000            0000 


Q ss_pred             -----------------cccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhc
Q 011384          276 -----------------ILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG  323 (487)
Q Consensus       276 -----------------i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~  323 (487)
                                       +........+......++.++.+|+.+||+.||.+|||++++++  ++..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence                             00000011111112335678999999999999999999999997  4443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.9e-42  Score=349.34  Aligned_cols=268  Identities=20%  Similarity=0.272  Sum_probs=201.5

Q ss_pred             cchhhHHHhhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCC------------hhhHHHHHHHHHHHHhCCCCCc
Q 011384           45 FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKN------------QEISQEVDNEIEILSKIHSPRL  111 (487)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~------------~~~~~~~~~Ei~~l~~l~hpnI  111 (487)
                      ....++....++|.+.+.||+|+||.||+|.+. ++.||||++...            ....+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            345677888999999999999999999999876 889999987542            1223678999999999999999


Q ss_pred             eeeEEEEeC-----CCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc
Q 011384          112 VNLLGFSND-----SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID  186 (487)
Q Consensus       112 v~l~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld  186 (487)
                      +++++++..     ....++||||++ |+|.+.+......+++..++.++.|++.||.|||+.  +|+||||||+|||++
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA--GVVHRDLHPGNILLA  168 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEC
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--cCEecCCChHHEEEc
Confidence            999999843     346799999997 699999987766799999999999999999999999  999999999999999


Q ss_pred             cCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhh
Q 011384          187 RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVD  265 (487)
Q Consensus       187 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~  265 (487)
                      .++.+||+|||++.......   ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  245 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK  245 (362)
T ss_dssp             TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999996543322   2344578999999999877 6789999999999999999999999974321111111


Q ss_pred             hhhhhhhcCc-----------cccccCC---CCCC----CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          266 WAAPLIKKGK-----------ILSVFDP---RIPP----PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       266 ~~~~~~~~~~-----------i~~~~~~---~~~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      . ........           ....+..   ..+.    ...+.++..+.+|+.+||+.||.+|||+.|+++
T Consensus       246 i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          246 I-VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             H-HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H-HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            1 00000000           0000000   0010    112234677999999999999999999999996

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.1e-42  Score=352.23  Aligned_cols=265  Identities=22%  Similarity=0.257  Sum_probs=200.2

Q ss_pred             HHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeC--------
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND--------  120 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--------  120 (487)
                      +...++|.+.+.||+|+||.||+|.+.  ++.||||++..+..   ...+|+++++.++||||++++++|..        
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            455688999999999999999999985  88999998865532   23479999999999999999999843        


Q ss_pred             ------------------------------CCceEEEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH
Q 011384          121 ------------------------------SKDRLLVVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILH  167 (487)
Q Consensus       121 ------------------------------~~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH  167 (487)
                                                    ....++||||++ ++|.+.+..   .+..+++..++.++.||+.||.|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                          334789999997 588877753   4456999999999999999999999


Q ss_pred             hCCCCeeeccCCCCcEEEc-cCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHH
Q 011384          168 SEMPPIIHRDIKSANVLID-RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLL  245 (487)
Q Consensus       168 ~~~~~ivH~DIkp~NILld-~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~  245 (487)
                      +.  +|+||||||+|||++ .++.+||+|||+++.+....   ......||+.|+|||.+.+. .++.++|||||||++|
T Consensus       159 ~~--gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          159 SL--GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             TT--TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HC--cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            99  999999999999998 68899999999998764433   23445789999999998775 4899999999999999


Q ss_pred             HHHhCCcCCCCCCCCchhhhhhhhhh--------h-cCccccccCCCCC-----CCCChHHHHHHHHHHHHhhhhcCCCC
Q 011384          246 EIISCRKAIDIGFSPPSIVDWAAPLI--------K-KGKILSVFDPRIP-----PPKDPIVRKQLAVIAVRCVRSCRERR  311 (487)
Q Consensus       246 eLltG~~pf~~~~~~~~~~~~~~~~~--------~-~~~i~~~~~~~~~-----~~~~~~~~~~l~~Li~~cl~~dP~~R  311 (487)
                      ||++|+.||........+........        . ........-+...     ...+..++.++.+|+.+||+.||.+|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            99999999974332222221111000        0 0000000001110     01233456789999999999999999


Q ss_pred             CCHHHHHH--HHhcc
Q 011384          312 PSMKEIVD--WLTGL  324 (487)
Q Consensus       312 Ps~~eil~--~L~~l  324 (487)
                      ||+.|+++  +++.+
T Consensus       314 ~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          314 INPYEAMAHPFFDHL  328 (383)
T ss_dssp             CCHHHHHTSGGGHHH
T ss_pred             CCHHHHhcCHHHHHH
Confidence            99999996  45444

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.8e-42  Score=349.56  Aligned_cols=253  Identities=23%  Similarity=0.387  Sum_probs=205.7

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---------hhHHHHHHHHHHHHhC-CCCCceeeEEE
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---------EISQEVDNEIEILSKI-HSPRLVNLLGF  117 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---------~~~~~~~~Ei~~l~~l-~hpnIv~l~~~  117 (487)
                      .....++|.+.+.||+|+||.||+|.+.  |+.||||++....         ...+.+.+|+.+++++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3455678999999999999999999986  8899999876432         1235688999999999 89999999999


Q ss_pred             EeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccc
Q 011384          118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFG  197 (487)
Q Consensus       118 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFG  197 (487)
                      +......++||||+++++|.+++.... .+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~--gi~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHAN--NIVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEEEecC
Confidence            999999999999999999999998654 499999999999999999999999  99999999999999999999999999


Q ss_pred             cceecCCCCcccccCCCCCCCccCCccccCC------CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhh
Q 011384          198 LALRCGVDNFRFRSTPPAGTIGYLDPCYVTP------DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI  271 (487)
Q Consensus       198 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~  271 (487)
                      ++..+....   ......||+.|+|||++.+      ..++.++|||||||++|+|++|+.||..... ....    ..+
T Consensus       246 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~----~~i  317 (365)
T 2y7j_A          246 FSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-ILML----RMI  317 (365)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHH----HHH
T ss_pred             cccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-HHHH----HHH
Confidence            997765432   2345689999999999853      3578899999999999999999999963211 1111    111


Q ss_pred             hcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       272 ~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+..      ....+....++..+.+|+.+||+.||.+|||+.++++
T Consensus       318 ~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          318 MEGQY------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHTCC------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhCCC------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11110      0000011134567999999999999999999999997

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.3e-41  Score=332.43  Aligned_cols=245  Identities=23%  Similarity=0.403  Sum_probs=197.2

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++....    ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            468999999999999999999986  8899999886542    2345789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||+++++|.+++.... .+++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++....... 
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-  165 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHH--CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCChhhEEECCCCCEEEeecccccccCCCc-
Confidence            99999999999997754 499999999999999999999999  99999999999999999999999999987654322 


Q ss_pred             ccccCCCCCCCccCCccccCCCCC-CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                        ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ....    ..+..+.          .
T Consensus       166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~----~~~~~~~----------~  228 (276)
T 2h6d_A          166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-PTLF----KKIRGGV----------F  228 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHH----HHHHHCC----------C
T ss_pred             --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-HHHH----HHhhcCc----------c
Confidence              2234578999999999988765 6899999999999999999999863211 1111    1111111          1


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+..++..+.+++.+||+.||.+|||+.+|++
T Consensus       229 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          229 YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            123345678999999999999999999999998

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.6e-42  Score=353.32  Aligned_cols=257  Identities=12%  Similarity=0.099  Sum_probs=188.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhC--CCCCceeeE-------EEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKI--HSPRLVNLL-------GFS  118 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l--~hpnIv~l~-------~~~  118 (487)
                      ..+|.+.+.||+|+||.||+|.+.  ++.||||++....    ...+.+.+|+.++..+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            445999999999999999999986  8899999988643    3345677885544444  699988755       444


Q ss_pred             eCC-----------------CceEEEEEecCCCCHHHHHHhCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCeee
Q 011384          119 NDS-----------------KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRR------IRLALQVAKAVEILHSEMPPIIH  175 (487)
Q Consensus       119 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~------~~i~~qi~~gL~yLH~~~~~ivH  175 (487)
                      ...                 ...|+||||++ ++|.+++...+..+++..+      +.++.||+.||+|||++  +|+|
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--~ivH  217 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK--GLVH  217 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT--TEEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC--CCcc
Confidence            332                 23799999998 8999999875445666666      77889999999999999  9999


Q ss_pred             ccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCC--CCCCcchhhhhHHHHHHHHHhCCcC
Q 011384          176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP--DNLSTKTDVFSFGILLLEIISCRKA  253 (487)
Q Consensus       176 ~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVwSlGvvl~eLltG~~p  253 (487)
                      |||||+|||++.++.+||+|||+++......     ....+|+.|+|||.+.+  ..++.++|||||||++|||++|+.|
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998654321     13456799999999987  6789999999999999999999999


Q ss_pred             CCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          254 IDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       254 f~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                      |....... ...+     ...............+....++..+.+|+.+||+.||.+|||+.++++  ++..+
T Consensus       293 f~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          293 FGLVTPGI-KGSW-----KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             TTBCCTTC-TTCC-----CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CCCcCccc-ccch-----hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            97432211 0000     000001111112222333467789999999999999999999999986  45443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.5e-41  Score=344.48  Aligned_cols=262  Identities=20%  Similarity=0.256  Sum_probs=200.8

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeC--------
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSND--------  120 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--------  120 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++....   .....+.+|+++++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            367999999999999999999985  8899999876442   223578899999999999999999999876        


Q ss_pred             CCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      .+..++||||+++ +|.+.+......+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN--KILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence            3468999999965 88888887666799999999999999999999999  99999999999999999999999999998


Q ss_pred             ecCCCCc--ccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh-----
Q 011384          201 RCGVDNF--RFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK-----  272 (487)
Q Consensus       201 ~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~-----  272 (487)
                      .+.....  ........||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||........ .........     
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSITPE  251 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChh
Confidence            6643221  122344578999999999876 4579999999999999999999999874322111 111110000     


Q ss_pred             ------cCccccccCCCCC--CCCChH-----HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          273 ------KGKILSVFDPRIP--PPKDPI-----VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       273 ------~~~i~~~~~~~~~--~~~~~~-----~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                            .......+.....  ......     .++.+.+|+.+||+.||.+|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence                  0000000000000  000001     1456889999999999999999999997

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.4e-41  Score=338.04  Aligned_cols=259  Identities=22%  Similarity=0.315  Sum_probs=207.1

Q ss_pred             HhhcCcccceeecccCceEEEEEEE---CCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCC------CceeeEEEEeCCC
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVL---RGRQVAVKKPSKNQEISQEVDNEIEILSKIHSP------RLVNLLGFSNDSK  122 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~---~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hp------nIv~l~~~~~~~~  122 (487)
                      ...++|.+.+.||+|+||.||+|.+   .++.||||++.......+.+.+|+++++.++|+      +++++++++.+.+
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            3457899999999999999999987   278999999988777678899999999998765      4999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc--------------
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR--------------  187 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~--------------  187 (487)
                      ..++||||+ +++|.+++...+ .++++..++.++.|++.||.|||++  +|+||||||+|||++.              
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN--KLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC--CCcCCCCCHHHEEEeccccccccCCccccc
Confidence            999999999 889999998754 3689999999999999999999999  9999999999999987              


Q ss_pred             -----CCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCch
Q 011384          188 -----NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS  262 (487)
Q Consensus       188 -----~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~  262 (487)
                           ++.+||+|||++......     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                 668999999999764432     2345789999999999999999999999999999999999999974322111


Q ss_pred             hhhhhhhhhh--------cCccccc---------------------cCC-CCCCCCChHHHHHHHHHHHHhhhhcCCCCC
Q 011384          263 IVDWAAPLIK--------KGKILSV---------------------FDP-RIPPPKDPIVRKQLAVIAVRCVRSCRERRP  312 (487)
Q Consensus       263 ~~~~~~~~~~--------~~~i~~~---------------------~~~-~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP  312 (487)
                      ... ......        .......                     ..+ ......+...++++.+|+.+||+.||.+||
T Consensus       243 ~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          243 LAM-MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHH-HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHH-HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            111 100000        0000000                     000 000112345788999999999999999999


Q ss_pred             CHHHHHH
Q 011384          313 SMKEIVD  319 (487)
Q Consensus       313 s~~eil~  319 (487)
                      |+.|+++
T Consensus       322 t~~ell~  328 (339)
T 1z57_A          322 TLREALK  328 (339)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999996

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5e-41  Score=351.06  Aligned_cols=197  Identities=21%  Similarity=0.318  Sum_probs=176.0

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhC------CCCCceeeEEEEeCCCce
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI------HSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l------~hpnIv~l~~~~~~~~~~  124 (487)
                      ...+|.+.+.||+|+||.||+|.+.  ++.||||++.........+.+|+++++.+      +|+||+++++++......
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            3567999999999999999999986  78999999988877777888899998887      577999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc--EEEccccccee
Q 011384          125 LLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN--ARLGDFGLALR  201 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~--vkL~DFGla~~  201 (487)
                      ++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.  +||+|||++..
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN--RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH--TEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence            99999995 69999997654 4599999999999999999999999  9999999999999999887  99999999976


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCC
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIG  257 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~  257 (487)
                      ....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       252 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          252 EHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             TTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            4432     33457999999999999999999999999999999999999998643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.5e-41  Score=334.18  Aligned_cols=250  Identities=22%  Similarity=0.325  Sum_probs=188.9

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh--h-HHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE--I-SQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~--~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++.....  . ...+..+...++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            3578999999999999999999984  88999999875422  2 23345555568888999999999999999999999


Q ss_pred             EEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          128 VEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      |||++ ++|.+++..   .+..+++..++.++.|++.||.|||++. +|+||||||+|||++.++.+||+|||++.....
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL-SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS-CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC-CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            99997 588887754   4556999999999999999999999842 899999999999999999999999999976543


Q ss_pred             CCcccccCCCCCCCccCCcccc----CCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccccc
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYV----TPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF  280 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~  280 (487)
                      ..   ......||+.|+|||.+    ....++.++|||||||++|+|++|+.||.....+....   ......       
T Consensus       163 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~-------  229 (290)
T 3fme_A          163 DV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL---KQVVEE-------  229 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH---HHHHHS-------
T ss_pred             cc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH---HHHhcc-------
Confidence            32   22334799999999996    55678999999999999999999999996422221111   111111       


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        ..+......++.++.+|+.+||+.||.+|||+.++++
T Consensus       230 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          230 --PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             --CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence              1111122346778999999999999999999999997

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.8e-42  Score=374.30  Aligned_cols=247  Identities=24%  Similarity=0.339  Sum_probs=200.2

Q ss_pred             eeecccCceEEEEEEEC----CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR----GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~----g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|+||.||+|.+.    ++.||||+++...   ...+.+.+|++++++++||||+++++++.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            57999999999999763    5789999987543   335789999999999999999999999975 458999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc-ccccC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF-RFRST  212 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~-~~~~~  212 (487)
                      |+|.+++.... .+++..++.++.||+.||.|||++  +|+||||||+||||+.++.+||+|||+++.+..... .....
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~--~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  530 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  530 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHC--CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence            99999997654 499999999999999999999999  999999999999999999999999999976654322 12233


Q ss_pred             CCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ...+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ....+..    .+..         ......+..
T Consensus       531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-~~~~~~~----~i~~---------~~~~~~p~~  596 (635)
T 4fl3_A          531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-KGSEVTA----MLEK---------GERMGCPAG  596 (635)
T ss_dssp             ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHH----HHHT---------TCCCCCCTT
T ss_pred             CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHH----HHHc---------CCCCCCCCC
Confidence            4467889999999998899999999999999999998 99998632 2222211    1111         112234456


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      ++.++.+|+.+||+.||++||++.+|++.|+.+.
T Consensus       597 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          597 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            7789999999999999999999999999998764

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1e-41  Score=337.50  Aligned_cols=250  Identities=25%  Similarity=0.301  Sum_probs=201.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||+|++.... ...+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            468999999999999999999997  7899999887543 3457889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +++++|.+++......+++..++.++.|++.||.|||+.  +++|+||||+|||++.++.+||+|||++.......  ..
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  173 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK--RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QK  173 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCHHHEEECCCCCEEEEECCCCccccccc--cc
Confidence            999999999987556699999999999999999999999  99999999999999999999999999875322111  11


Q ss_pred             cCCCCCCCccCCcccc-----CCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          211 STPPAGTIGYLDPCYV-----TPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~-----~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      .....||+.|+|||.+     ....++.++|||||||++|+|++|+.||......    ......... .       ...
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-~-------~~~  241 (302)
T 2j7t_A          174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLKIAKS-D-------PPT  241 (302)
T ss_dssp             -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHS-C-------CCC
T ss_pred             cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH----HHHHHHhcc-C-------Ccc
Confidence            2345789999999998     4667899999999999999999999998632211    111111111 0       011


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...+..++.++.+|+.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1223456788999999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.4e-42  Score=340.55  Aligned_cols=261  Identities=20%  Similarity=0.290  Sum_probs=188.2

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      ...++|.+.+.||+|+||.||+|.+.  ++.||||++....  .....+.+|+.++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34578999999999999999999874  8899999886542  3346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          128 VEFMSNGTLYDVLHS-------NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~-------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      |||+++++|.+++..       ....+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+|||++.
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC--CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            999999999999974       234599999999999999999999999  99999999999999999999999999986


Q ss_pred             ecCCCCc---ccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcc
Q 011384          201 RCGVDNF---RFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKI  276 (487)
Q Consensus       201 ~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i  276 (487)
                      .......   ........||+.|+|||.+.. ..++.++|||||||++|+|++|+.||...........    ... +..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~-~~~  244 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML----TLQ-NDP  244 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH----HHT-SSC
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH----Hhc-cCC
Confidence            5543221   111234579999999999865 4689999999999999999999999964322111111    111 110


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          277 LSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...............++.++.+|+.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0000000111122345678999999999999999999999996

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.4e-41  Score=332.87  Aligned_cols=253  Identities=21%  Similarity=0.262  Sum_probs=203.2

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-----hhHHHHHHHHHHHHhCCCCCceeeEEEEe--CCCce
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHSPRLVNLLGFSN--DSKDR  124 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~  124 (487)
                      .++|.+.+.||+|+||.||++.+.  ++.||||++....     .....+.+|++++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999985  7899999987542     33467999999999999999999999984  45678


Q ss_pred             EEEEEecCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          125 LLVVEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      ++||||++++ |.+++.. ....+++..++.++.|++.||.|||++  +|+|+||||+|||++.++.+||+|||++....
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            9999999876 7777765 345699999999999999999999999  99999999999999999999999999998765


Q ss_pred             CCCcccccCCCCCCCccCCccccCCCCC--CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTPDNL--STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~--s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      ............||+.|+|||.+.+...  +.++|||||||++|+|++|+.||....    ...... .+..+.      
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~-~i~~~~------  229 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN----IYKLFE-NIGKGS------  229 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHH-HHHHCC------
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch----HHHHHH-HHhcCC------
Confidence            4333333445679999999999986543  779999999999999999999996321    111111 111111      


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                          ...+..++..+.+|+.+||+.||.+|||+.++++  ++...
T Consensus       230 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          230 ----YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             ----CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             ----CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence                1123345678999999999999999999999997  56554

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-41  Score=339.87  Aligned_cols=258  Identities=22%  Similarity=0.327  Sum_probs=201.4

Q ss_pred             cchhhHHHhhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCC--CCCceeeEEEE
Q 011384           45 FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKN---QEISQEVDNEIEILSKIH--SPRLVNLLGFS  118 (487)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~  118 (487)
                      +.+..+....++|.+.+.||+|+||.||++.+. ++.||||++...   ......+.+|++++.+++  ||||+++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            444445566788999999999999999999887 788999988543   344577899999999997  59999999999


Q ss_pred             eCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccc
Q 011384          119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL  198 (487)
Q Consensus       119 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGl  198 (487)
                      .+....++||| +.+++|.+++.... .+++..++.++.|++.||.|||+.  +|+||||||+|||++ ++.+||+|||+
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~-~~~~kL~Dfg~  172 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIV-DGMLKLIDFGI  172 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCcccEEEE-CCeEEEeeccc
Confidence            99999999999 55889999998764 599999999999999999999999  999999999999996 48999999999


Q ss_pred             ceecCCCCcccccCCCCCCCccCCccccCC-----------CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhh
Q 011384          199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTP-----------DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA  267 (487)
Q Consensus       199 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~  267 (487)
                      +................||+.|+|||.+.+           ..++.++|||||||++|+|++|+.||......  ... .
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~-~  249 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISK-L  249 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHH-H
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH--HHH-H
Confidence            976654433223344579999999999876           46788999999999999999999999632211  111 1


Q ss_pred             hhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          268 APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       268 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                               ...+++......+...+.++.+|+.+||+.||.+|||+.++++
T Consensus       250 ---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          250 ---------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             ---------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                     1111222222233344678999999999999999999999997

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1e-41  Score=341.60  Aligned_cols=251  Identities=27%  Similarity=0.357  Sum_probs=199.6

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh---------hHHHHHHHHHHHHhCCCCCceeeEEEEeC
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---------ISQEVDNEIEILSKIHSPRLVNLLGFSND  120 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~---------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  120 (487)
                      ...++|.+.+.||+|+||.||+|.+.  ++.||||++.....         ....+.+|++++++++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            34568999999999999999999986  78999998865421         12358899999999999999999999977


Q ss_pred             CCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc---EEEcccc
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN---ARLGDFG  197 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~---vkL~DFG  197 (487)
                      .. .++||||+++++|.+++.... .+++..++.++.|++.||.|||++  +|+||||||+|||++.++.   +||+|||
T Consensus        87 ~~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           87 ED-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             SS-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             Cc-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            65 899999999999999997654 599999999999999999999999  9999999999999987654   9999999


Q ss_pred             cceecCCCCcccccCCCCCCCccCCccccC---CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC
Q 011384          198 LALRCGVDNFRFRSTPPAGTIGYLDPCYVT---PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG  274 (487)
Q Consensus       198 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  274 (487)
                      ++.......   ......||+.|+|||.+.   ...++.++|||||||++|+|++|+.||........+...    +..+
T Consensus       163 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~  235 (322)
T 2ycf_A          163 HSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----ITSG  235 (322)
T ss_dssp             TCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH----HHHT
T ss_pred             cceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH----HHhC
Confidence            997654322   112346899999999973   567899999999999999999999999754333332221    1111


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       275 ~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..      .........++.++.+|+.+||+.||.+|||+.++++
T Consensus       236 ~~------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          236 KY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cc------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            11      0000011234678999999999999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-41  Score=344.94  Aligned_cols=256  Identities=20%  Similarity=0.268  Sum_probs=196.2

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC------
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK------  122 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------  122 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++...   ....+.+.+|+++++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            468999999999999999999986  889999998543   334467899999999999999999999997663      


Q ss_pred             ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                      .+|+||||+ +++|.+++...  .+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQA  178 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence            459999999 88999999874  499999999999999999999999  9999999999999999999999999999875


Q ss_pred             CCCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhh----------h
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL----------I  271 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~----------~  271 (487)
                      ...     .+...+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||........+.......          +
T Consensus       179 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  253 (367)
T 1cm8_A          179 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  253 (367)
T ss_dssp             CSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             ccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            432     334578999999999877 678999999999999999999999996432211111110000          0


Q ss_pred             hcC---ccccccC---CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          272 KKG---KILSVFD---PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       272 ~~~---~i~~~~~---~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...   .....+.   ..--......++.++.+|+.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            000   0000000   00000112345678999999999999999999999998

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.8e-41  Score=343.10  Aligned_cols=261  Identities=23%  Similarity=0.308  Sum_probs=194.5

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC------
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK------  122 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------  122 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++...   ......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999886  889999988653   334467889999999999999999999997665      


Q ss_pred             ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                      ..++||||++ ++|.+.+..   .+++..+..++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++...
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             ceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHC--CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            6799999996 588888863   389999999999999999999999  9999999999999999999999999999765


Q ss_pred             CCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhh--------------
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAA--------------  268 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~--------------  268 (487)
                      ....   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..............              
T Consensus       178 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          178 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            4322   23346799999999999999999999999999999999999999964321111110000              


Q ss_pred             ----hhhhcCc------cccccCCC-CC--CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhc
Q 011384          269 ----PLIKKGK------ILSVFDPR-IP--PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG  323 (487)
Q Consensus       269 ----~~~~~~~------i~~~~~~~-~~--~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~  323 (487)
                          .......      ....+... .+  .......+.++.+|+.+||+.||.+|||++|+++  ++..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence                0000000      00000000 00  0011234778999999999999999999999998  5543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.3e-41  Score=343.75  Aligned_cols=256  Identities=18%  Similarity=0.280  Sum_probs=206.8

Q ss_pred             hcCcccceeecccCceEEEEEEECCeEEEEEEcCCChhh------------------HHHHHHHHHHHHhCCCCCceeeE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEI------------------SQEVDNEIEILSKIHSPRLVNLL  115 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~------------------~~~~~~Ei~~l~~l~hpnIv~l~  115 (487)
                      .++|.+.+.||+|+||.||+|.+.++.||||++......                  .+.+.+|+.++++++||||++++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            468999999999999999999999999999987644221                  17899999999999999999999


Q ss_pred             EEEeCCCceEEEEEecCCCCHHHH------HHhC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEcc
Q 011384          116 GFSNDSKDRLLVVEFMSNGTLYDV------LHSN-NRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDR  187 (487)
Q Consensus       116 ~~~~~~~~~~lV~Ey~~~gsL~~~------l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~  187 (487)
                      +++.+.+..++||||+++++|.++      +... ...+++..++.++.|++.||.|||+ .  +|+|+||||+|||++.
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDK  187 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS--CEECCCCCGGGEEECT
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC--CEeecCCChHhEEEcC
Confidence            999999999999999999999998      6542 4569999999999999999999999 8  9999999999999999


Q ss_pred             CCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCC-CCCc-chhhhhHHHHHHHHHhCCcCCCCCCCCchhhh
Q 011384          188 NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD-NLST-KTDVFSFGILLLEIISCRKAIDIGFSPPSIVD  265 (487)
Q Consensus       188 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~-ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~  265 (487)
                      ++.+||+|||++......    ......||+.|+|||.+.+. .++. ++|||||||++|+|++|+.||...........
T Consensus       188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  263 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN  263 (348)
T ss_dssp             TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred             CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            999999999999765433    23456799999999999887 5666 99999999999999999999975433222222


Q ss_pred             hhhhhhhcCcccccc------CC---CCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          266 WAAPLIKKGKILSVF------DP---RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       266 ~~~~~~~~~~i~~~~------~~---~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .    +..+......      .+   .........++.++.+|+.+||+.||.+|||+.++++
T Consensus       264 ~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          264 N----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             H----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             H----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1    1111110000      00   0000011446778999999999999999999999996

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=345.72  Aligned_cols=263  Identities=22%  Similarity=0.345  Sum_probs=205.6

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  124 (487)
                      .+.+...++|.+.+.||+|+||.||+|.+.+ .||+|++....   ...+.+.+|+.++++++||||+++++++.+....
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            3444456789999999999999999999876 49999876532   2235678899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ++||||+++++|.+++...+..+++..++.++.|++.||.|||+.  +|+||||||+|||++ ++.+||+|||++.....
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            999999999999999988766799999999999999999999999  999999999999998 67999999999865432


Q ss_pred             CC---cccccCCCCCCCccCCccccCC---------CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh
Q 011384          205 DN---FRFRSTPPAGTIGYLDPCYVTP---------DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK  272 (487)
Q Consensus       205 ~~---~~~~~~~~~gt~~Y~aPE~~~~---------~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~  272 (487)
                      ..   .........||+.|+|||.+..         ..++.++|||||||++|||++|+.||..... ....   . ...
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~---~-~~~  256 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-EAII---W-QMG  256 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-HHHH---H-HHH
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHH---H-Hhc
Confidence            11   1112234568999999999875         3578899999999999999999999963221 1111   1 111


Q ss_pred             cCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          273 KGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       273 ~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      .+.     .+.   .....++.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       257 ~~~-----~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          257 TGM-----KPN---LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             TTC-----CCC---CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             cCC-----CCC---CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            111     111   11123456789999999999999999999999999998754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.4e-42  Score=356.34  Aligned_cols=243  Identities=16%  Similarity=0.222  Sum_probs=192.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCC----ChhhHHHHHHHH---HHHHhCCCCCceeeE-------EE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSK----NQEISQEVDNEI---EILSKIHSPRLVNLL-------GF  117 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~----~~~~~~~~~~Ei---~~l~~l~hpnIv~l~-------~~  117 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++..    .....+.+.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467999999999999999999975  88999999763    334457889999   555566899999998       66


Q ss_pred             EeCCCc-----------------eEEEEEecCCCCHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCee
Q 011384          118 SNDSKD-----------------RLLVVEFMSNGTLYDVLHSNNR------PLNWGRRIRLALQVAKAVEILHSEMPPII  174 (487)
Q Consensus       118 ~~~~~~-----------------~~lV~Ey~~~gsL~~~l~~~~~------~l~~~~~~~i~~qi~~gL~yLH~~~~~iv  174 (487)
                      +.+.+.                 .|+||||+ +|+|.+++...+.      .+++..++.|+.||+.||+|||++  +|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~iv  228 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLV  228 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT--TEE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC--Cee
Confidence            665542                 78999999 6899999986432      233588889999999999999999  999


Q ss_pred             eccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCC-----------CCCcchhhhhHHHH
Q 011384          175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD-----------NLSTKTDVFSFGIL  243 (487)
Q Consensus       175 H~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDVwSlGvv  243 (487)
                      ||||||+|||++.++.+||+|||+++....     ......| +.|+|||.+.+.           .++.++|||||||+
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            999999999999999999999999976432     2334567 999999999887           89999999999999


Q ss_pred             HHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HH
Q 011384          244 LLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WL  321 (487)
Q Consensus       244 l~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L  321 (487)
                      +|||++|+.||..........             ....      ....++.++.+|+.+||+.||.+|||+.++++  ++
T Consensus       303 l~elltg~~Pf~~~~~~~~~~-------------~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f  363 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSE-------------WIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY  363 (377)
T ss_dssp             HHHHHHSSCCC------CCSG-------------GGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred             HHHHHHCCCCCcccccccchh-------------hhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence            999999999996322111110             0000      11234578999999999999999999999997  55


Q ss_pred             hcc
Q 011384          322 TGL  324 (487)
Q Consensus       322 ~~l  324 (487)
                      ..+
T Consensus       364 ~~~  366 (377)
T 3byv_A          364 EQL  366 (377)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            544

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.5e-41  Score=330.92  Aligned_cols=249  Identities=21%  Similarity=0.314  Sum_probs=199.9

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ++|....+||+|+||.||+|.+.  +..||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34666779999999999999985  7889999876543 34567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc-CCcEEEcccccceecCCCCcc
Q 011384          132 SNGTLYDVLHSNN--RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-NFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       132 ~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ++++|.+++....  ..+++..++.++.|++.||.|||+.  +|+|+||||+|||++. ++.+||+|||++........ 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC--CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            9999999998653  3467889999999999999999999  9999999999999987 89999999999976543221 


Q ss_pred             cccCCCCCCCccCCccccCCCC--CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDN--LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                       ......||+.|+|||.+.+..  ++.++|||||||++|+|++|+.||......... .+....       .    ....
T Consensus       179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~-------~----~~~~  245 (295)
T 2clq_A          179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFKVGM-------F----KVHP  245 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHHHHH-------H----CCCC
T ss_pred             -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHhhcc-------c----cccc
Confidence             233457999999999987643  789999999999999999999998632111111 000000       0    1112


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+..++.++.+|+.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            234456778999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.7e-41  Score=342.11  Aligned_cols=270  Identities=19%  Similarity=0.227  Sum_probs=195.5

Q ss_pred             hHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCc---
Q 011384           49 DLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKD---  123 (487)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~---  123 (487)
                      ......++|.+.+.||+|+||.||+|.+.  ++.||||++.........+.+|++.+..++||||+++++++.....   
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            34566789999999999999999999986  8899999887765555677888999999999999999999865333   


Q ss_pred             ----eEEEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCeeeccCCCCcEEEcc-CCcEEE
Q 011384          124 ----RLLVVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILH--SEMPPIIHRDIKSANVLIDR-NFNARL  193 (487)
Q Consensus       124 ----~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH--~~~~~ivH~DIkp~NILld~-~~~vkL  193 (487)
                          .++||||+++ +|.+.+..   ....+++..++.++.|++.||.|||  +.  +|+||||||+|||++. ++.+||
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~--~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV--NVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT--CCBCSCCCGGGEEEETTTTEEEE
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC--CeecCcCCHHHEEEeCCCCcEEE
Confidence                7899999976 66555442   4456899999999999999999999  88  9999999999999996 899999


Q ss_pred             cccccceecCCCCcccccCCCCCCCccCCccccCCCC-CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh
Q 011384          194 GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN-LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK  272 (487)
Q Consensus       194 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~  272 (487)
                      +|||++.......   ......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||..................
T Consensus       174 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  250 (360)
T 3e3p_A          174 CDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC  250 (360)
T ss_dssp             CCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             eeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence            9999997655432   233457899999999987654 899999999999999999999999743322222111110000


Q ss_pred             -----------cCccccccCC-C-----CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          273 -----------KGKILSVFDP-R-----IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       273 -----------~~~i~~~~~~-~-----~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                                 .......... .     .........+.++.+|+.+||+.||.+|||+.|+++  ||..+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence                       0000000000 0     001122235788999999999999999999999997  45444

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-40  Score=342.12  Aligned_cols=260  Identities=18%  Similarity=0.184  Sum_probs=205.8

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCC--------CCCceeeEEEEe---
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIH--------SPRLVNLLGFSN---  119 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~--------hpnIv~l~~~~~---  119 (487)
                      ..++|.+.+.||+|+||.||+|++.  ++.||||++.......+.+.+|+.+++.++        |+||+++++++.   
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            4578999999999999999999886  889999999887777788999999999985        788999999987   


Q ss_pred             -CCCceEEEEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC--------
Q 011384          120 -DSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF--------  189 (487)
Q Consensus       120 -~~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~--------  189 (487)
                       +....++||||+ +++|.+.+... ...+++..++.++.||+.||.|||++. +|+||||||+|||++.++        
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~-givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC-RIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT-CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHeeEeccchhhhhhhh
Confidence             566789999999 66776666543 356999999999999999999999853 799999999999998775        


Q ss_pred             -----------------------------------------cEEEcccccceecCCCCcccccCCCCCCCccCCccccCC
Q 011384          190 -----------------------------------------NARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP  228 (487)
Q Consensus       190 -----------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~  228 (487)
                                                               .+||+|||++......     .....||+.|+|||++.+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHT
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcC
Confidence                                                     7999999999765432     334579999999999999


Q ss_pred             CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCch---hhh--hhhhh--------hhcC-----------ccccccCCC-
Q 011384          229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS---IVD--WAAPL--------IKKG-----------KILSVFDPR-  283 (487)
Q Consensus       229 ~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~---~~~--~~~~~--------~~~~-----------~i~~~~~~~-  283 (487)
                      ..++.++|||||||++|||++|+.||........   ...  .....        +..+           .+....... 
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            9999999999999999999999999974332211   000  00000        0000           000000000 


Q ss_pred             --------CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          284 --------IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       284 --------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                              -....+..++..+.+|+.+||+.||.+|||+.||++
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                    001345678889999999999999999999999996

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1e-40  Score=340.55  Aligned_cols=261  Identities=20%  Similarity=0.272  Sum_probs=203.0

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC-----Cc
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS-----KD  123 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~  123 (487)
                      ..++|.+.+.||+|+||.||+|.+.  +..||||++...  ......+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3468999999999999999999986  788999998743  33446789999999999999999999999754     46


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      .++||||+. ++|.+++....  +++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++....
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEcccC-cCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHC--CeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            899999996 59999997653  99999999999999999999999  99999999999999999999999999998765


Q ss_pred             CCCcc-cccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC-------
Q 011384          204 VDNFR-FRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG-------  274 (487)
Q Consensus       204 ~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~-------  274 (487)
                      ..... .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||........+..... .....       
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~  258 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG-ILGSPSQEDLNC  258 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHH-HHCSCCHHHHHT
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHH-HhCCCCHHHHHH
Confidence            43221 12344589999999998654 4589999999999999999999999964332222211110 00000       


Q ss_pred             -------ccccccCCCCCC---CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          275 -------KILSVFDPRIPP---PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       275 -------~i~~~~~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                             ............   .....++.++.+|+.+||+.||.+|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   000000000000   011234678999999999999999999999997

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.6e-41  Score=370.08  Aligned_cols=247  Identities=21%  Similarity=0.276  Sum_probs=207.1

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~  125 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++.+..    ...+.+..|..++..+ +||||+.+++++.+.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3568999999999999999999987  6789999987542    2345688899999988 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      |||||+++|+|.+++...+ .+++..++.|+.||+.||.|||+.  +|+||||||+||||+.++.+||+|||+++.....
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~--gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            9999999999999998764 499999999999999999999999  9999999999999999999999999999864333


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+   ...+. .+        .  
T Consensus       496 ~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~---~~~i~-~~--------~--  558 (674)
T 3pfq_A          496 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDEL---FQSIM-EH--------N--  558 (674)
T ss_dssp             TC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHH---HHHHH-SS--------C--
T ss_pred             Cc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC-HHHH---HHHHH-hC--------C--
Confidence            22  3445789999999999999999999999999999999999999996421 1111   11111 11        1  


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCH-----HHHHH
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSM-----KEIVD  319 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~-----~eil~  319 (487)
                      ...+..++.++.+|+.+||+.||.+||++     ++|++
T Consensus       559 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            12344577899999999999999999997     77765

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.3e-40  Score=342.14  Aligned_cols=206  Identities=24%  Similarity=0.299  Sum_probs=178.9

Q ss_pred             cchhhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCC-CC-----CceeeEE
Q 011384           45 FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIH-SP-----RLVNLLG  116 (487)
Q Consensus        45 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~-hp-----nIv~l~~  116 (487)
                      +.....+...++|.+.+.||+|+||.||+|.+.  ++.||||++.........+..|+.++..++ |+     +|+++++
T Consensus        44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            334455566789999999999999999999987  789999999887776778889999998885 44     4999999


Q ss_pred             EEeCCCceEEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc--cCCcEEE
Q 011384          117 FSNDSKDRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID--RNFNARL  193 (487)
Q Consensus       117 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld--~~~~vkL  193 (487)
                      ++......++||||++ ++|.+++.... ..+++..++.++.|++.||.|||....+|+||||||+|||++  .++.+||
T Consensus       124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             EEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             eeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence            9999999999999995 59999998753 459999999999999999999995322999999999999994  4788999


Q ss_pred             cccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCC
Q 011384          194 GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDI  256 (487)
Q Consensus       194 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~  256 (487)
                      +|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       203 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          203 VDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             CCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999876432     2346799999999999999999999999999999999999999974

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.5e-41  Score=347.49  Aligned_cols=263  Identities=22%  Similarity=0.277  Sum_probs=197.1

Q ss_pred             hhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC------ceE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK------DRL  125 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~------~~~  125 (487)
                      ...+|.+.+.||+|+||.||+|.+. +..||+|++......   ..+|+++++.++||||++++++|....      ..+
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            3457999999999999999999996 667999987654322   246999999999999999999985433      378


Q ss_pred             EEEEecCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc-cCCcEEEccccccee
Q 011384          126 LVVEFMSNGTLYDVLH---SNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID-RNFNARLGDFGLALR  201 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld-~~~~vkL~DFGla~~  201 (487)
                      +||||++++ |.+.+.   .....+++..++.++.||+.||.|||++  +|+||||||+|||++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            999999764 444332   2345699999999999999999999999  999999999999999 799999999999987


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhh-------h-
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI-------K-  272 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~-------~-  272 (487)
                      .....   ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........+........       . 
T Consensus       192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            64332   23345789999999998765 589999999999999999999999974332222221111000       0 


Q ss_pred             -cCccccccCCCCCC-----CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          273 -KGKILSVFDPRIPP-----PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       273 -~~~i~~~~~~~~~~-----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                       ........-+.+..     ..+..++.++.+|+.+||+.||.+|||+.|+++  +++.+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence             00000000011110     112235678999999999999999999999997  45444

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.9e-41  Score=367.64  Aligned_cols=259  Identities=23%  Similarity=0.384  Sum_probs=209.3

Q ss_pred             hHHHhhcCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC
Q 011384           49 DLEAATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS  121 (487)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~  121 (487)
                      +.+...++|.+.+.||+|+||.||+|.+.     +..||||+....  ....+.+.+|+.++++++||||+++++++.+ 
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence            34445678999999999999999999985     356999987753  3344679999999999999999999999854 


Q ss_pred             CceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      +..++||||+++|+|.+++......+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||+++.
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--CccccccchHhEEEeCCCCEEEEecCCCee
Confidence            568999999999999999987766799999999999999999999999  999999999999999999999999999976


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCcccccc
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVF  280 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~  280 (487)
                      ...... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||... .......    .+..+      
T Consensus       541 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~-~~~~~~~----~i~~~------  608 (656)
T 2j0j_A          541 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIG----RIENG------  608 (656)
T ss_dssp             CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHH----HHHHT------
T ss_pred             cCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHH----HHHcC------
Confidence            543322 12334567889999999998899999999999999999997 88888632 2111111    11111      


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                         ...+.+..++..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus       609 ---~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          609 ---ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence               112234456788999999999999999999999999998764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5e-41  Score=355.93  Aligned_cols=262  Identities=21%  Similarity=0.236  Sum_probs=208.5

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCC-CCceeeEEEEeCCCceEEEEEe
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHS-PRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++..... ...+.+|+++++.++| +++..+..++.+....+|||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~   84 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL   84 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence            478999999999999999999986  88999998665433 2457889999999987 5566666677788888999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE---ccCCcEEEcccccceecCCCCc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl---d~~~~vkL~DFGla~~~~~~~~  207 (487)
                      + +++|.+++......+++..++.|+.||+.||.|||++  +|+||||||+||||   +.++.+||+|||+++.+.....
T Consensus        85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence            9 9999999987666799999999999999999999999  99999999999999   6889999999999987654332


Q ss_pred             c-----cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCC
Q 011384          208 R-----FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       208 ~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~  282 (487)
                      .     .......||+.|+|||.+.+..++.++|||||||+||||++|+.||......... .....+... .+...+. 
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~i~~~-~~~~~~~-  238 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEK-KVATSIE-  238 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH-HHHHHHHHH-HHHSCHH-
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH-HHHHHHhhc-cccccHH-
Confidence            1     1122567999999999999999999999999999999999999999743322211 111111110 0000000 


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       283 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                          .....++.++.+|+..||+.+|++||++.+|++.|+.+..
T Consensus       239 ----~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          239 ----ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             ----HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ----HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                0111345789999999999999999999999999988754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4e-41  Score=350.84  Aligned_cols=262  Identities=23%  Similarity=0.287  Sum_probs=198.3

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC------CceE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDS------KDRL  125 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~~~~  125 (487)
                      ..+|...+.||+|+||.||+|++.  ++.||||++.....   .+.+|+++++.++||||++++++|...      ..++
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            346999999999999999999996  88999998865432   234799999999999999999988432      2367


Q ss_pred             EEEEecCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC-CcEEEccccccee
Q 011384          126 LVVEFMSNGTLYDVLH---SNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN-FNARLGDFGLALR  201 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~-~~vkL~DFGla~~  201 (487)
                      +||||+++ +|.+.+.   .....+++..++.++.||+.||.|||+.  +|+||||||+|||++.+ +.+||+|||+++.
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            99999975 6766664   3445699999999999999999999999  99999999999999965 6789999999987


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhh-------h-
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI-------K-  272 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~-------~-  272 (487)
                      +....   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........+......+-       . 
T Consensus       207 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          207 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             CCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             cccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            64332   22345789999999998765 789999999999999999999999974332222222211100       0 


Q ss_pred             -cCccccccCCCCCC-----CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          273 -KGKILSVFDPRIPP-----PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       273 -~~~i~~~~~~~~~~-----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                       .........+.+..     ..+..++.++.+|+.+||+.||.+|||+.|+++  ++..+
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence             00000010111110     012345678999999999999999999999996  45444

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=337.52  Aligned_cols=242  Identities=28%  Similarity=0.392  Sum_probs=193.3

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh-------hHHHHHHHHHHHHhC----CCCCceeeEE
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE-------ISQEVDNEIEILSKI----HSPRLVNLLG  116 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~-------~~~~~~~Ei~~l~~l----~hpnIv~l~~  116 (487)
                      .+...++|.+.+.||+|+||.||+|.+.  ++.||||++.....       ....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            4456688999999999999999999885  78999999875532       223466799999998    8999999999


Q ss_pred             EEeCCCceEEEEEe-cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc-cCCcEEEc
Q 011384          117 FSNDSKDRLLVVEF-MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID-RNFNARLG  194 (487)
Q Consensus       117 ~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld-~~~~vkL~  194 (487)
                      ++.+.+..++|||| +.+++|.+++...+ .+++..++.++.|++.||.|||+.  +|+||||||+|||++ .++.+||+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSR--GVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHH--TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCChhhEEEeCCCCeEEEE
Confidence            99999999999999 78999999998754 499999999999999999999999  999999999999999 78999999


Q ss_pred             ccccceecCCCCcccccCCCCCCCccCCccccCCCCC-CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc
Q 011384          195 DFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK  273 (487)
Q Consensus       195 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~  273 (487)
                      |||++.......    .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...      ..    ... 
T Consensus       183 dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~----~~~-  247 (312)
T 2iwi_A          183 DFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QE----ILE-  247 (312)
T ss_dssp             CCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HH----HHH-
T ss_pred             EcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HH----Hhh-
Confidence            999998765432    334579999999999876665 45899999999999999999998621      00    000 


Q ss_pred             CccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          274 GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       274 ~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..          ...+..++.++.+|+.+||+.||.+|||+.++++
T Consensus       248 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          248 AE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             TC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00          1123345678999999999999999999999997

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.5e-41  Score=329.73  Aligned_cols=254  Identities=23%  Similarity=0.360  Sum_probs=205.2

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ...++|.+.+.||+|+||.||+|.+.  ++.||||++....   .....+.+|++++++++||||+++++++.+....++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            44568999999999999999999986  8899999876432   345678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC---CcEEEcccccceecC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN---FNARLGDFGLALRCG  203 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~---~~vkL~DFGla~~~~  203 (487)
                      ||||+++++|.+.+.... .+++..++.++.|++.||.|||+.  +++|+||||+|||++.+   +.+||+|||++....
T Consensus        99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            999999999999987654 499999999999999999999999  99999999999999754   469999999986544


Q ss_pred             CCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ...   ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.... ....   .. .+..+..      .
T Consensus       176 ~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~---~~-~~~~~~~------~  240 (287)
T 2wei_A          176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-EYDI---LK-RVETGKY------A  240 (287)
T ss_dssp             CCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHH---HH-HHHHCCC------C
T ss_pred             CCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC-HHHH---HH-HHHcCCC------C
Confidence            322   1223458899999999875 48999999999999999999999986321 1111   11 1111111      1


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhc
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG  323 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~  323 (487)
                      ...+....++.++.+++.+||+.||.+|||+.++++  +++.
T Consensus       241 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence            111112345678999999999999999999999998  5544

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.3e-40  Score=337.10  Aligned_cols=261  Identities=23%  Similarity=0.287  Sum_probs=200.2

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC-----Cc
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS-----KD  123 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~  123 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++...  ......+.+|++++++++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3578999999999999999999987  889999998643  33446788999999999999999999988754     67


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      .++||||+. ++|.+++...  .+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++....
T Consensus        89 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~--~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            899999996 6999999874  499999999999999999999999  99999999999999999999999999998664


Q ss_pred             CCCccc--------ccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC
Q 011384          204 VDNFRF--------RSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG  274 (487)
Q Consensus       204 ~~~~~~--------~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  274 (487)
                      ......        ......||+.|+|||.+.. ..++.++|||||||++|+|++|+.||........... ........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~  242 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL-IFGIIGTP  242 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH-HHHHhCCC
Confidence            322110        1223578999999998754 6789999999999999999999999964321111110 00000000


Q ss_pred             c------------cccccC--CCCCC----CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          275 K------------ILSVFD--PRIPP----PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       275 ~------------i~~~~~--~~~~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .            ....+.  +..+.    ...+.++.++.+|+.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0            000000  00000    011245678999999999999999999999997

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.4e-40  Score=331.35  Aligned_cols=262  Identities=20%  Similarity=0.260  Sum_probs=201.6

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC---CeEEEEEEcCCCh---hhHHHHHHHHHHHHhC---CCCCceeeEEEEe---
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR---GRQVAVKKPSKNQ---EISQEVDNEIEILSKI---HSPRLVNLLGFSN---  119 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~---g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~---  119 (487)
                      ...++|.+.+.||+|+||.||+|.+.   ++.||||++....   .....+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            34578999999999999999999983   7889999876432   1223566777777766   8999999999987   


Q ss_pred             --CCCceEEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccc
Q 011384          120 --DSKDRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDF  196 (487)
Q Consensus       120 --~~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DF  196 (487)
                        .....++||||++ ++|.+++.... ..+++..++.++.|++.||.|||+.  +|+|+||||+|||++.++.+||+||
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCHHHeEEcCCCCEEEecC
Confidence              5667899999997 69999998743 3499999999999999999999999  9999999999999999999999999


Q ss_pred             ccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC--
Q 011384          197 GLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG--  274 (487)
Q Consensus       197 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~--  274 (487)
                      |++.......   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||....................  
T Consensus       165 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          165 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             cccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            9987654322   33456799999999999999999999999999999999999999974322211111110000000  


Q ss_pred             ccc-------cccC---CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          275 KIL-------SVFD---PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       275 ~i~-------~~~~---~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+.       ..+.   ..........++..+.+|+.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000       0000   00001122346778999999999999999999999996

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.4e-40  Score=334.31  Aligned_cols=259  Identities=22%  Similarity=0.276  Sum_probs=205.0

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--C-eEEEEEEcCCChhhHHHHHHHHHHHHhCCCCC------ceeeEEEEeCCC
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--G-RQVAVKKPSKNQEISQEVDNEIEILSKIHSPR------LVNLLGFSNDSK  122 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g-~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpn------Iv~l~~~~~~~~  122 (487)
                      ...++|.+.+.||+|+||.||+|.+.  + ..||||++.......+.+.+|+.+++.++|++      ++.+++++....
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            34578999999999999999999986  3 68999999887777788999999999997765      899999999999


Q ss_pred             ceEEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE----------------
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI----------------  185 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl----------------  185 (487)
                      ..++||||+ +++|.+.+.... ..+++..++.++.||+.||.|||++  +|+||||||+|||+                
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN--QLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEeccccccccccccccc
Confidence            999999999 667777776543 5699999999999999999999999  99999999999999                


Q ss_pred             ---ccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCch
Q 011384          186 ---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS  262 (487)
Q Consensus       186 ---d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~  262 (487)
                         +.++.+||+|||++......     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence               56789999999999764332     2345799999999999999999999999999999999999999974322111


Q ss_pred             hhhhhhhhhh--------cCccccc-------cC--------------C-CCCCCCChHHHHHHHHHHHHhhhhcCCCCC
Q 011384          263 IVDWAAPLIK--------KGKILSV-------FD--------------P-RIPPPKDPIVRKQLAVIAVRCVRSCRERRP  312 (487)
Q Consensus       263 ~~~~~~~~~~--------~~~i~~~-------~~--------------~-~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP  312 (487)
                      ... ......        .......       +.              + ..........+.++.+|+.+||+.||.+||
T Consensus       248 ~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          248 LVM-MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHH-HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHH-HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            111 100000        0000000       00              0 000112335677899999999999999999


Q ss_pred             CHHHHHH
Q 011384          313 SMKEIVD  319 (487)
Q Consensus       313 s~~eil~  319 (487)
                      |+.|+++
T Consensus       327 t~~e~l~  333 (355)
T 2eu9_A          327 TLAEALL  333 (355)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.8e-40  Score=335.50  Aligned_cols=254  Identities=20%  Similarity=0.335  Sum_probs=179.0

Q ss_pred             hcCcccc-eeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeC----CCceEE
Q 011384           54 TNGFSEQ-KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND----SKDRLL  126 (487)
Q Consensus        54 ~~~y~~~-~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~l  126 (487)
                      .++|.+. ++||+|+||.||+|.+.  ++.||||++........+   ....++.+.||||+++++++..    ....++
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e---~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  103 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE---VDHHWQASGGPHIVCILDVYENMHHGKRCLLI  103 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHH---HHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHH---HHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence            4678885 47999999999999997  889999998776443332   2334567799999999999875    445899


Q ss_pred             EEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc---CCcEEEcccccceec
Q 011384          127 VVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR---NFNARLGDFGLALRC  202 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~~~  202 (487)
                      ||||+++|+|.+++.... ..+++..++.++.|++.||.|||++  +|+||||||+|||++.   ++.+||+|||++...
T Consensus       104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH--NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            999999999999998754 4699999999999999999999999  9999999999999976   455999999999765


Q ss_pred             CCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCC
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~  282 (487)
                      ...    ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........... .....      .....
T Consensus       182 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~------~~~~~  250 (336)
T 3fhr_A          182 TQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-MKRRI------RLGQY  250 (336)
T ss_dssp             --------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred             ccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-HHHhh------hcccc
Confidence            432    22345789999999999888899999999999999999999999964322111000 00000      01111


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhc
Q 011384          283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG  323 (487)
Q Consensus       283 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~  323 (487)
                      ..+.+....++.++.+|+.+||+.||.+|||+.++++  |+..
T Consensus       251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            2222333456788999999999999999999999998  5543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=9.3e-41  Score=342.09  Aligned_cols=255  Identities=20%  Similarity=0.265  Sum_probs=183.3

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCC------C
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDS------K  122 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~------~  122 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++...   ....+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999876  889999998653   33456788999999999999999999998754      5


Q ss_pred             ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          123 DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       123 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                      ..++|+||+ +++|.+++...  .+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++..
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~--givH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence            679999999 78999998763  499999999999999999999999  9999999999999999999999999999764


Q ss_pred             CCCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc--------
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK--------  273 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~--------  273 (487)
                      ...     .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........+.... .....        
T Consensus       183 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~-~~~g~p~~~~~~~  256 (367)
T 2fst_X          183 ADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL-RLVGTPGAELLKK  256 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HHHCSCCHHHHTT
T ss_pred             ccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHhCCCCHHHHHH
Confidence            322     334579999999999887 678999999999999999999999996432211111110 00000        


Q ss_pred             ---CccccccC--CCCCC-C---CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          274 ---GKILSVFD--PRIPP-P---KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       274 ---~~i~~~~~--~~~~~-~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                         ......+.  +..+. .   ....++.++.+|+.+||+.||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence               00000000  00000 0   01124577899999999999999999999996

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.3e-40  Score=330.30  Aligned_cols=252  Identities=23%  Similarity=0.354  Sum_probs=181.3

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHH-HHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIE-ILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~-~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++...  ......+..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            468999999999999999999997  899999988654  233445666666 677789999999999999999999999


Q ss_pred             EecCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          129 EFMSNGTLYDVLHS----NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       129 Ey~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      ||+++ +|.+++..    ....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++.....
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  178 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL-KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD  178 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH-SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC-CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence            99975 88888763    2456999999999999999999999842 799999999999999999999999999876543


Q ss_pred             CCcccccCCCCCCCccCCcccc----CCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccccc
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYV----TPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF  280 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~  280 (487)
                      ..   ......||+.|+|||.+    .+..++.++|||||||++|+|++|+.||..........   .      .+....
T Consensus       179 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~------~~~~~~  246 (327)
T 3aln_A          179 SI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL---T------QVVKGD  246 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------C------CCCCSC
T ss_pred             cc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH---H------HHhcCC
Confidence            22   22334799999999998    45678999999999999999999999996422111100   0      011111


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+.+.......++..+.+|+.+||+.||.+|||+.+|++
T Consensus       247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            122222223456788999999999999999999999987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8e-40  Score=335.14  Aligned_cols=256  Identities=19%  Similarity=0.276  Sum_probs=197.3

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce---
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR---  124 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~---  124 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++...   ......+.+|+.+++.++||||+++++++......   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3578999999999999999999986  889999998753   33356788999999999999999999999887665   


Q ss_pred             ---EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          125 ---LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       125 ---~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                         ++||||+. ++|.+.+.   ..+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++..
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence               99999996 68888774   3499999999999999999999999  999999999999999999999999999975


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC------
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG------  274 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~------  274 (487)
                      ....     .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||....................      
T Consensus       194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            4432     334578999999999887 6789999999999999999999999964321111111100000000      


Q ss_pred             -------ccccccCCCCCC---CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          275 -------KILSVFDPRIPP---PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       275 -------~i~~~~~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                             .....+......   ...+.++.++.+|+.+||+.||.+|||+.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                   000000000000   011234678999999999999999999999996

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=328.85  Aligned_cols=249  Identities=21%  Similarity=0.359  Sum_probs=183.6

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh--h-HHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE--I-SQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~--~-~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++.....  . .+.+..+..+++.++||||+++++++.+....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467999999999999999999996  88999999875432  2 233445556788889999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      ||+ ++.+..++......+++..++.++.|++.||.|||+ .  +|+|+||||+|||++.++.+||+|||++....... 
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence            999 566776666545569999999999999999999998 6  89999999999999999999999999986554332 


Q ss_pred             ccccCCCCCCCccCCccccC-----CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVT-----PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~  282 (487)
                        ......||+.|+|||.+.     ...++.++|||||||++|+|++|+.||..........   ...... .     .+
T Consensus       180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~-~-----~~  248 (318)
T 2dyl_A          180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL---TKVLQE-E-----PP  248 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH---HHHHHS-C-----CC
T ss_pred             --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHH---HHHhcc-C-----CC
Confidence              223457999999999984     4567899999999999999999999997432221111   111111 0     11


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       283 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..  +....++.++.+|+.+||+.||.+|||+.+|++
T Consensus       249 ~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 LL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            11  112235678999999999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.3e-41  Score=337.40  Aligned_cols=244  Identities=25%  Similarity=0.355  Sum_probs=201.0

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh-------hHHHHHHHHHHHHhCC--CCCceeeEE
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE-------ISQEVDNEIEILSKIH--SPRLVNLLG  116 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~-------~~~~~~~Ei~~l~~l~--hpnIv~l~~  116 (487)
                      .+.....++|.+.+.||+|+||.||+|++.  ++.||||++.....       ....+.+|+.++++++  ||||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            344556788999999999999999999985  88999998765432       2245778999999996  599999999


Q ss_pred             EEeCCCceEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc-cCCcEEEc
Q 011384          117 FSNDSKDRLLVVEFMSN-GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID-RNFNARLG  194 (487)
Q Consensus       117 ~~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld-~~~~vkL~  194 (487)
                      ++.+.+..++|||++.+ ++|.+++...+ .+++..++.++.|++.||.|||+.  +|+||||||+|||++ .++.+||+
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC--CcEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999999976 89999998754 499999999999999999999999  999999999999999 78999999


Q ss_pred             ccccceecCCCCcccccCCCCCCCccCCccccCCCCC-CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc
Q 011384          195 DFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK  273 (487)
Q Consensus       195 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~  273 (487)
                      |||++......    ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||...      ..    .. .
T Consensus       193 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~------~~----~~-~  257 (320)
T 3a99_A          193 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EE----II-R  257 (320)
T ss_dssp             CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HH----HH-H
T ss_pred             eCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh------hh----hh-c
Confidence            99999876533    2334579999999999877665 67899999999999999999998631      00    00 0


Q ss_pred             CccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          274 GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       274 ~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..          ..+..++.++.+|+.+||+.||.+|||+++|++
T Consensus       258 ~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          258 GQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            100          112235678999999999999999999999996

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.6e-40  Score=334.75  Aligned_cols=259  Identities=19%  Similarity=0.241  Sum_probs=202.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCC-----------CCCceeeEEEEeC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIH-----------SPRLVNLLGFSND  120 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~-----------hpnIv~l~~~~~~  120 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++.........+.+|+.++++++           ||||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            468999999999999999999985  889999999887777788999999999886           8999999999876


Q ss_pred             CC----ceEEEEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc------cCC
Q 011384          121 SK----DRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID------RNF  189 (487)
Q Consensus       121 ~~----~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld------~~~  189 (487)
                      ..    ..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++. +|+||||||+|||++      ..+
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~-~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT-CEECSCCSGGGEEEEEEETTTTEE
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC-CEEecCCChHHeEEeccCCCcCcc
Confidence            44    689999999 88999999863 345999999999999999999999942 899999999999994      344


Q ss_pred             cEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCch--hhhhh
Q 011384          190 NARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS--IVDWA  267 (487)
Q Consensus       190 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~--~~~~~  267 (487)
                      .+||+|||++......     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........  .....
T Consensus       176 ~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          176 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence            8999999999765432     2345799999999999999999999999999999999999999974321110  00000


Q ss_pred             hhhh---------------------hcCccccccCC-C---------CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHH
Q 011384          268 APLI---------------------KKGKILSVFDP-R---------IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKE  316 (487)
Q Consensus       268 ~~~~---------------------~~~~i~~~~~~-~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e  316 (487)
                      ..+.                     ........+.. .         .....+..++.++.+|+.+||+.||.+|||+.|
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            0000                     00000000000 0         011345678899999999999999999999999


Q ss_pred             HHH
Q 011384          317 IVD  319 (487)
Q Consensus       317 il~  319 (487)
                      |++
T Consensus       331 ll~  333 (373)
T 1q8y_A          331 LVN  333 (373)
T ss_dssp             HHT
T ss_pred             Hhh
Confidence            997

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=344.64  Aligned_cols=261  Identities=17%  Similarity=0.233  Sum_probs=182.0

Q ss_pred             cCccc-ceeecccCceEEEEEEEC----CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEe--CCCceEEE
Q 011384           55 NGFSE-QKLLGKGSHGSVYKAVLR----GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN--DSKDRLLV  127 (487)
Q Consensus        55 ~~y~~-~~~LG~G~~g~Vy~~~~~----g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~--~~~~~~lV  127 (487)
                      +.|.+ .++||+|+||.||+|.+.    ++.||||++..... ...+.+|+.++++++||||+++++++.  .....++|
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            34665 568999999999999975    67899999876533 356889999999999999999999994  46788999


Q ss_pred             EEecCCCCHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE----ccCCcEEEcc
Q 011384          128 VEFMSNGTLYDVLHSN--------NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI----DRNFNARLGD  195 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl----d~~~~vkL~D  195 (487)
                      |||+. ++|.+++...        ...+++..++.++.||+.||.|||+.  +|+||||||+|||+    +.++.+||+|
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--CEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            99996 5888887531        12499999999999999999999999  99999999999999    6778999999


Q ss_pred             cccceecCCCCc-ccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCc--------hhhh
Q 011384          196 FGLALRCGVDNF-RFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPP--------SIVD  265 (487)
Q Consensus       196 FGla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~--------~~~~  265 (487)
                      ||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.......        ....
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            999976543221 1123446799999999999874 58999999999999999999999996432210        0000


Q ss_pred             hhhhhhhc---Cccc------------cccC-CCCCC--------CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          266 WAAPLIKK---GKIL------------SVFD-PRIPP--------PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       266 ~~~~~~~~---~~i~------------~~~~-~~~~~--------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .....+..   ..+.            ..+. .....        ......+.++.+|+.+||+.||.+|||++|+++
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000   0000            0000 00000        000011457889999999999999999999997

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.7e-40  Score=328.15  Aligned_cols=265  Identities=20%  Similarity=0.307  Sum_probs=194.8

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC-hhhHHHHHHHHHHHHhCCCCCceeeEEEEe-----------
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN-QEISQEVDNEIEILSKIHSPRLVNLLGFSN-----------  119 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~-----------  119 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++... ....+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999997  889999987654 344577899999999999999999999874           


Q ss_pred             ---CCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc-cCCcEEEcc
Q 011384          120 ---DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID-RNFNARLGD  195 (487)
Q Consensus       120 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld-~~~~vkL~D  195 (487)
                         +....++||||++ ++|.+++...  ++++..++.++.|++.||.|||+.  +|+||||||+|||++ .++.+||+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCCCCeEEEcc
Confidence               3467899999997 6999999653  499999999999999999999999  999999999999997 567999999


Q ss_pred             cccceecCCCCc-ccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh-
Q 011384          196 FGLALRCGVDNF-RFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK-  272 (487)
Q Consensus       196 FGla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~-  272 (487)
                      ||++........ ........+|+.|+|||.+.. ..++.++|||||||++|||++|+.||.................. 
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999976543211 111223467999999998765 67899999999999999999999999743221111111000000 


Q ss_pred             -c-------Cccc-----cccCCCCC-CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhc
Q 011384          273 -K-------GKIL-----SVFDPRIP-PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG  323 (487)
Q Consensus       273 -~-------~~i~-----~~~~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~  323 (487)
                       .       ..+.     ....+..+ ......++.++.+|+.+||+.||.+|||+.++++  ++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI  311 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence             0       0000     00000000 0011235678999999999999999999999997  5553

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=330.71  Aligned_cols=254  Identities=19%  Similarity=0.271  Sum_probs=197.0

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCc-----
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKD-----  123 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~-----  123 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++...   ......+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            468999999999999999999986  889999998653   2334678899999999999999999999987654     


Q ss_pred             -eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceec
Q 011384          124 -RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       124 -~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~  202 (487)
                       .++||||+. ++|.+++..   .+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++...
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence             499999996 588877642   499999999999999999999999  9999999999999999999999999998654


Q ss_pred             CCCCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhh----------
Q 011384          203 GVDNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLI----------  271 (487)
Q Consensus       203 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~----------  271 (487)
                      ...     .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||........+........          
T Consensus       177 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  251 (353)
T 3coi_A          177 DAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  251 (353)
T ss_dssp             ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred             CCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence            322     234578999999999887 6789999999999999999999999974321111111000000          


Q ss_pred             hc-------CccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          272 KK-------GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       272 ~~-------~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..       ..+.....+.+ ......++.++.+|+.+||+.||.+|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          252 NDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             SCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00       00000000111 1123456788999999999999999999999996

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.9e-40  Score=342.38  Aligned_cols=250  Identities=23%  Similarity=0.355  Sum_probs=191.0

Q ss_pred             hhcCcccceeecccCceE-EEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEEe
Q 011384           53 ATNGFSEQKLLGKGSHGS-VYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~-Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ...+|...++||+|+||. ||++...++.||||++.....  ..+.+|+++++.+ +||||+++++++.+....|+||||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            345689999999999998 555666799999999865432  2356899999999 899999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc-----CCcEEEcccccceecCCC
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-----NFNARLGDFGLALRCGVD  205 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~-----~~~vkL~DFGla~~~~~~  205 (487)
                      +. |+|.+++......+.+..++.++.||+.||.|||+.  +|+||||||+|||++.     ...+||+|||+++.....
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL--NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT--TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC--cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            95 699999987765566667789999999999999999  9999999999999953     235889999999766533


Q ss_pred             Ccc-cccCCCCCCCccCCccccC---CCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCcccccc
Q 011384          206 NFR-FRSTPPAGTIGYLDPCYVT---PDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVF  280 (487)
Q Consensus       206 ~~~-~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~  280 (487)
                      ... .......||+.|+|||++.   ...++.++|||||||++|||++ |..||..... .. ...   .....      
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-~~-~~~---~~~~~------  245 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-RQ-ANI---LLGAC------  245 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-HH-HHH---HTTCC------
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-HH-HHH---HhccC------
Confidence            211 1234467999999999998   4567889999999999999999 8888853211 11 110   11100      


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ... ....+...+..+.+|+.+||+.||.+|||+.+|++
T Consensus       246 ~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          246 SLD-CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCT-TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Ccc-ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            000 11123456777899999999999999999999995

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.1e-39  Score=337.01  Aligned_cols=251  Identities=24%  Similarity=0.341  Sum_probs=189.0

Q ss_pred             hcCcccceeecccCceEEEEE-EECCeEEEEEEcCCChhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEEEEec
Q 011384           54 TNGFSEQKLLGKGSHGSVYKA-VLRGRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~-~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      .+.|...+.||+|+||.||.+ ...|+.||||++....  .+.+.+|+.++.++ +||||+++++++.+....++||||+
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            345677899999999999754 4459999999886543  35678899999876 8999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCC------CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC-------------CcEE
Q 011384          132 SNGTLYDVLHSNNRP------LNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN-------------FNAR  192 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~------l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~-------------~~vk  192 (487)
                      . |+|.+++......      .++..++.++.||+.||.|||+.  +|+||||||+|||++.+             +.+|
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC--CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            5 6999999864421      12234577999999999999999  99999999999999754             4899


Q ss_pred             EcccccceecCCCCccc--ccCCCCCCCccCCccccCC-------CCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCch
Q 011384          193 LGDFGLALRCGVDNFRF--RSTPPAGTIGYLDPCYVTP-------DNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPS  262 (487)
Q Consensus       193 L~DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~  262 (487)
                      |+|||++..........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||....... 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            99999998765433211  1234579999999999976       568999999999999999999 888986332211 


Q ss_pred             hhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          263 IVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       263 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                       .....     +.   ...+......+..++.++.+|+.+||+.||.+|||+.+|++
T Consensus       248 -~~i~~-----~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 -SNIIR-----GI---FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             -HHHHH-----TC---CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHhc-----CC---CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence             11111     10   00111222335678899999999999999999999999985

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.1e-38  Score=315.56  Aligned_cols=229  Identities=17%  Similarity=0.148  Sum_probs=186.6

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++.||||++....    ...+.+.+|+.++.+++||||+++++++.+.+..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            3467999999999999999999997  8999999987652    334778999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++++|.+++...   .....+..++.|++.||.|||++  +|+||||||+|||++.++.+||++++         
T Consensus       109 v~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~--givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRA--GVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHC--CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            99999999999999542   45567888999999999999999  99999999999999999999998543         


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC-
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP-  285 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-  285 (487)
                                   |++|       ++.++|||||||++|||++|+.||........+...          ...+..... 
T Consensus       175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~----------~~~~~~~~~~  224 (286)
T 3uqc_A          175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----------ERDTAGQPIE  224 (286)
T ss_dssp             -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----------CBCTTSCBCC
T ss_pred             -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----------HHHhccCCCC
Confidence                         3332       689999999999999999999999743322211000          000000000 


Q ss_pred             -CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          286 -PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       286 -~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                       ......++.++.+|+.+||+.||.+| |+.|+++.|+.+..
T Consensus       225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence             01123466789999999999999999 99999999998764

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5e-39  Score=349.84  Aligned_cols=257  Identities=23%  Similarity=0.330  Sum_probs=200.8

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC------CCc
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSND------SKD  123 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~~~  123 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||++...  ....+.+.+|++++++++||||+++++++..      ...
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999885  889999988754  3445678999999999999999999998765      677


Q ss_pred             eEEEEEecCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCc---EEEccccc
Q 011384          124 RLLVVEFMSNGTLYDVLHSNN--RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFN---ARLGDFGL  198 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~---vkL~DFGl  198 (487)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.   +||+|||+
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~--gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN--RIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT--TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            899999999999999998643  3589999999999999999999999  9999999999999987654   99999999


Q ss_pred             ceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc-----
Q 011384          199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK-----  273 (487)
Q Consensus       199 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~-----  273 (487)
                      +.......   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.....+   ..|.......     
T Consensus       171 a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~---~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          171 AKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP---VQWHGKVREKSNEHI  244 (676)
T ss_dssp             CCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH---HHSSTTCC------C
T ss_pred             cccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch---hhhhhhhhcccchhh
Confidence            97654332   234568999999999999999999999999999999999999999643221   1111111100     


Q ss_pred             -------CccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHH
Q 011384          274 -------GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV  318 (487)
Q Consensus       274 -------~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil  318 (487)
                             +.+........+......++..+.+|+.+||+.||.+|||+.+++
T Consensus       245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence                   000000011122234566889999999999999999999998854

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-38  Score=349.52  Aligned_cols=238  Identities=20%  Similarity=0.295  Sum_probs=194.5

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC---CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCc---
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR---GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKD---  123 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~---g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~---  123 (487)
                      ...++|.+.+.||+|+||.||+|.+.   ++.||||++...  ......+.+|++++++++||||+++++++.+.+.   
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            34578999999999999999999984   789999988643  3344678999999999999999999999987665   


Q ss_pred             --eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          124 --RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       124 --~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                        .||||||+++++|.+++..   .+++..++.++.||+.||.|||++  +|+||||||+|||++.+ .+||+|||++..
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~--giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSI--GLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             ceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC--CCeecccChHHeEEeCC-cEEEEecccchh
Confidence              7999999999999988754   599999999999999999999999  99999999999999886 899999999976


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      ....      ....||+.|+|||++.+. ++.++|||||||++|+|++|..||......                     
T Consensus       231 ~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------------------  282 (681)
T 2pzi_A          231 INSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------------------  282 (681)
T ss_dssp             TTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------------------
T ss_pred             cccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc---------------------
Confidence            5432      345799999999998765 489999999999999999998877521000                     


Q ss_pred             CCCCC-CCChHHHHHHHHHHHHhhhhcCCCCCC-HHHHHHHHhcc
Q 011384          282 PRIPP-PKDPIVRKQLAVIAVRCVRSCRERRPS-MKEIVDWLTGL  324 (487)
Q Consensus       282 ~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs-~~eil~~L~~l  324 (487)
                       .++. .....++..+.+|+.+||+.||.+||+ ++++.+.|..+
T Consensus       283 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          283 -GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence             0011 111234578999999999999999995 66676666654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.4e-37  Score=308.48  Aligned_cols=232  Identities=19%  Similarity=0.348  Sum_probs=182.5

Q ss_pred             hcCcccc-eeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHH-HhCCCCCceeeEEEEeC----CCceE
Q 011384           54 TNGFSEQ-KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEIL-SKIHSPRLVNLLGFSND----SKDRL  125 (487)
Q Consensus        54 ~~~y~~~-~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l-~~l~hpnIv~l~~~~~~----~~~~~  125 (487)
                      .++|.+. +.||+|+||.||++.+.  ++.||||++...    ..+.+|+.++ +.++||||+++++++..    ....+
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            3567776 88999999999999985  889999998754    4567888888 66699999999999876    67789


Q ss_pred             EEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc---CCcEEEccccccee
Q 011384          126 LVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR---NFNARLGDFGLALR  201 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~~  201 (487)
                      +||||+++++|.+++.... ..+++..++.++.|++.||.|||+.  +|+||||||+|||++.   ++.+||+|||++..
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            9999999999999998753 4699999999999999999999999  9999999999999998   78899999999864


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      ..                        +..++.++|||||||++|||++|+.||........... ..        .....
T Consensus       170 ~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-~~--------~~~~~  216 (299)
T 3m2w_A          170 TT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MK--------TRIRM  216 (299)
T ss_dssp             CT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-SC--------CSSCT
T ss_pred             cc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-HH--------HHHhh
Confidence            32                        13467899999999999999999999964222111000 00        00000


Q ss_pred             CC--CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          282 PR--IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       282 ~~--~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                      ..  .+.+....++.++.+|+.+||+.||.+|||+.++++  ++...
T Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            11  111011345788999999999999999999999997  55443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-38  Score=328.18  Aligned_cols=240  Identities=16%  Similarity=0.222  Sum_probs=182.7

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCC-CCce---------e--
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHS-PRLV---------N--  113 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~h-pnIv---------~--  113 (487)
                      .....|...++||+|+||.||+|.+.  ++.||||++....    ...+.+.+|+.+++.++| +|..         .  
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            34456888999999999999999987  8999999887332    234679999999999987 3211         1  


Q ss_pred             ----------eEEEEeC-----CCceEEEEEecCCCCHHHHHH------hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 011384          114 ----------LLGFSND-----SKDRLLVVEFMSNGTLYDVLH------SNNRPLNWGRRIRLALQVAKAVEILHSEMPP  172 (487)
Q Consensus       114 ----------l~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~  172 (487)
                                ++.++..     ....+++|+++ +++|.+++.      .....+++..++.++.|++.||.|||++  +
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~  231 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--G  231 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT--T
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC--C
Confidence                      1111111     22456777766 689999984      2244588889999999999999999999  9


Q ss_pred             eeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCcccc----------CCCCCCcchhhhhHHH
Q 011384          173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV----------TPDNLSTKTDVFSFGI  242 (487)
Q Consensus       173 ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~s~ksDVwSlGv  242 (487)
                      |+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          ....++.++|||||||
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            999999999999999999999999998765432     344577 999999999          5566889999999999


Q ss_pred             HHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          243 LLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       243 vl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ++|||++|+.||...... ...            ...+..      ...++.++.+|+.+||+.||.+|||+.++++
T Consensus       306 il~elltg~~Pf~~~~~~-~~~------------~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAAL-GGS------------EWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGG-SCS------------GGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHCCCCCCCcchh-hhH------------HHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            999999999999632111 100            011110      1124578999999999999999999888865

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.5e-38  Score=320.65  Aligned_cols=240  Identities=17%  Similarity=0.211  Sum_probs=186.5

Q ss_pred             hcCcccceeecccCceEEEEEEECCeEEEEEEcCCCh---------hhHHHHHHHHHHHHhCC---------CCCceeeE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQ---------EISQEVDNEIEILSKIH---------SPRLVNLL  115 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~---------~~~~~~~~Ei~~l~~l~---------hpnIv~l~  115 (487)
                      .++|.+.+.||+|+||.||+|++.++.||||++....         ...+.+.+|+.+++.++         ||||++++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            4679999999999999999999999999999876542         22367889999998886         77777776


Q ss_pred             EEE-----------------e-------------CCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Q 011384          116 GFS-----------------N-------------DSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI  165 (487)
Q Consensus       116 ~~~-----------------~-------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~y  165 (487)
                      +.+                 .             +....|+||||+++|++.+.+.+  ..+++..++.++.||+.||.|
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence            653                 2             26789999999999977776644  348999999999999999999


Q ss_pred             HH-hCCCCeeeccCCCCcEEEccCC--------------------cEEEcccccceecCCCCcccccCCCCCCCccCCcc
Q 011384          166 LH-SEMPPIIHRDIKSANVLIDRNF--------------------NARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPC  224 (487)
Q Consensus       166 LH-~~~~~ivH~DIkp~NILld~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE  224 (487)
                      || +.  +|+||||||+|||++.++                    .+||+|||+++.....       ...||+.|+|||
T Consensus       177 lH~~~--~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE  247 (336)
T 2vuw_A          177 AEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDED  247 (336)
T ss_dssp             HHHHH--CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSG
T ss_pred             HHHhC--CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChh
Confidence            99 89  999999999999999887                    8999999999865432       237999999999


Q ss_pred             ccCCCCCCcchhhhhHHHH-HHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccc--cccCCCCCCCCChHHHHHHHHHHH
Q 011384          225 YVTPDNLSTKTDVFSFGIL-LLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKIL--SVFDPRIPPPKDPIVRKQLAVIAV  301 (487)
Q Consensus       225 ~~~~~~~s~ksDVwSlGvv-l~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~~~l~~Li~  301 (487)
                      .+.+.. +.++||||||++ .+++++|..||..       ..|.......  +.  .........+....+++++.+|+.
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~dli~  317 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-------VLWLHYLTDK--MLKQMTFKTKCNTPAMKQIKRKIQEFHR  317 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-------HHHHHHHHHH--HHHTCCCSSCCCSHHHHHHHHHHHHHHH
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCcc-------hhhhhHHHHh--hhhhhccCcccchhhhhhcCHHHHHHHH
Confidence            998766 899999998777 7778888888741       1111111000  00  011111222234568999999999


Q ss_pred             HhhhhcCCCCCCHHHHH-H
Q 011384          302 RCVRSCRERRPSMKEIV-D  319 (487)
Q Consensus       302 ~cl~~dP~~RPs~~eil-~  319 (487)
                      +||+.|     |++|++ +
T Consensus       318 ~~L~~d-----sa~e~l~~  331 (336)
T 2vuw_A          318 TMLNFS-----SATDLLCQ  331 (336)
T ss_dssp             HGGGSS-----SHHHHHHH
T ss_pred             HHhccC-----CHHHHHhc
Confidence            999976     999998 5

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=2.5e-31  Score=286.93  Aligned_cols=184  Identities=18%  Similarity=0.132  Sum_probs=130.4

Q ss_pred             eecccCceEEEEEEE--CCeEEEEEEcCCC-----------hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEE
Q 011384           62 LLGKGSHGSVYKAVL--RGRQVAVKKPSKN-----------QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        62 ~LG~G~~g~Vy~~~~--~g~~vAvK~~~~~-----------~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      .++.|++|.+..++.  -|..|+||.+.+.           ....++|.+|+++|+++ .|+||++++++++++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            345666666665543  3889999987653           12335799999999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||++|++|.++|...+ +++..   +|+.||+.||+|||++  |||||||||+||||+.++.+||+|||+++.......
T Consensus       321 MEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~--GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQ--GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             EECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHT--TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred             EecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHC--CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence            99999999999998765 47664   4889999999999999  999999999999999999999999999986654322


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAI  254 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf  254 (487)
                        .....+||+.|||||++.+ .+..++|+||+|++++++.++..++
T Consensus       395 --~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          395 --WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             --CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             --cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence              2234579999999999975 4677899999999998876655443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=4.4e-28  Score=260.14  Aligned_cols=186  Identities=17%  Similarity=0.232  Sum_probs=145.3

Q ss_pred             CcccceeecccCceEEEEEEECCeEEEEEEcCCCh---------hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQ---------EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~---------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .+...++||+|+||.||+|.+.++.+++|+.....         ...+.+.+|++++++++||||+++..++...+..|+
T Consensus       337 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          337 RKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             -----------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             cCCCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            34556799999999999998889999999754321         113458999999999999999966666667777899


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||+++++|.+++..         +..++.|++.||.|||++  +|+||||||+|||++.  .+||+|||+++......
T Consensus       417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~--gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKN--DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHT--TEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHC--cCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            9999999999999875         457999999999999999  9999999999999998  99999999998765432


Q ss_pred             ccc-----ccCCCCCCCccCCccccCC--CCCCcchhhhhHHHHHHHHHhCCcCC
Q 011384          207 FRF-----RSTPPAGTIGYLDPCYVTP--DNLSTKTDVFSFGILLLEIISCRKAI  254 (487)
Q Consensus       207 ~~~-----~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVwSlGvvl~eLltG~~pf  254 (487)
                      ...     ......||+.|+|||++..  ..|+..+|+||..+-.++-+.++.++
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            111     1124579999999999976  56788899999999998888777654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=9.2e-24  Score=208.21  Aligned_cols=145  Identities=16%  Similarity=0.164  Sum_probs=117.0

Q ss_pred             hhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChh-------------------hHHHHHHHHHHHHhCCCCCce
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQE-------------------ISQEVDNEIEILSKIHSPRLV  112 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~-------------------~~~~~~~Ei~~l~~l~hpnIv  112 (487)
                      ....|.+.+.||+|+||.||+|.+. ++.||||++.....                   ....+.+|++++++++  | +
T Consensus        88 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~  164 (282)
T 1zar_A           88 SGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L  164 (282)
T ss_dssp             TTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred             CCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence            3456777899999999999999996 88999999864321                   3456899999999999  4 5


Q ss_pred             eeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEE
Q 011384          113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNAR  192 (487)
Q Consensus       113 ~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vk  192 (487)
                      ++++++.. +..++||||+++++|.+ +.     .  .....++.|++.||.|||+.  +|+||||||+|||++ ++.+|
T Consensus       165 ~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-----~--~~~~~i~~qi~~~l~~lH~~--giiHrDlkp~NILl~-~~~vk  232 (282)
T 1zar_A          165 AVPKVYAW-EGNAVLMELIDAKELYR-VR-----V--ENPDEVLDMILEEVAKFYHR--GIVHGDLSQYNVLVS-EEGIW  232 (282)
T ss_dssp             SSCCEEEE-ETTEEEEECCCCEEGGG-CC-----C--SCHHHHHHHHHHHHHHHHHT--TEECSCCSTTSEEEE-TTEEE
T ss_pred             CcCeEEec-cceEEEEEecCCCcHHH-cc-----h--hhHHHHHHHHHHHHHHHHHC--CCEeCCCCHHHEEEE-CCcEE
Confidence            55555443 55699999999999988 42     1  22456999999999999999  999999999999999 99999


Q ss_pred             EcccccceecCCCCcccccCCCCCCCccCCccccC
Q 011384          193 LGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT  227 (487)
Q Consensus       193 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~  227 (487)
                      |+|||+++.               +..|+|||++.
T Consensus       233 l~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          233 IIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             ECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             EEECCCCeE---------------CCCCCHHHHHH
Confidence            999999853               33467888864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=1.4e-20  Score=182.87  Aligned_cols=134  Identities=18%  Similarity=0.222  Sum_probs=106.7

Q ss_pred             cccceeecccCceEEEEEEE--CCeE--EEEEEcCCChh-------------------------hHHHHHHHHHHHHhCC
Q 011384           57 FSEQKLLGKGSHGSVYKAVL--RGRQ--VAVKKPSKNQE-------------------------ISQEVDNEIEILSKIH  107 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~--~g~~--vAvK~~~~~~~-------------------------~~~~~~~Ei~~l~~l~  107 (487)
                      |.+.+.||+|+||.||+|.+  .|+.  ||||++.....                         ....+.+|++++.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999998  5888  99998654311                         1136889999999998


Q ss_pred             CCCc--eeeEEEEeCCCceEEEEEecCC-C----CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeeeccCC
Q 011384          108 SPRL--VNLLGFSNDSKDRLLVVEFMSN-G----TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH-SEMPPIIHRDIK  179 (487)
Q Consensus       108 hpnI--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~~~ivH~DIk  179 (487)
                      |+++  +.++++    ...+|||||+.+ |    +|.+....    .++..+..++.|++.+|.||| +.  +|+|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~--givHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEA--ELVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTS--CEECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHC--CEEeCCCC
Confidence            8754  444443    356899999942 4    77766432    234567789999999999999 89  99999999


Q ss_pred             CCcEEEccCCcEEEcccccceec
Q 011384          180 SANVLIDRNFNARLGDFGLALRC  202 (487)
Q Consensus       180 p~NILld~~~~vkL~DFGla~~~  202 (487)
                      |+|||++.  .++|+|||++...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999988  9999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.68  E-value=2e-17  Score=168.80  Aligned_cols=132  Identities=14%  Similarity=0.173  Sum_probs=99.1

Q ss_pred             cccceeecccCceEEEEEEEC-CeEEEEEEcCCChh---------------hH--------HHHHHHHHHHHhCCCCCce
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQE---------------IS--------QEVDNEIEILSKIHSPRLV  112 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~---------------~~--------~~~~~Ei~~l~~l~hpnIv  112 (487)
                      |.+...||+|++|.||+|... |+.||||++.....               ..        -...+|+..|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            999999999999999999986 89999998643210               00        1124577777777555442


Q ss_pred             --eeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC-
Q 011384          113 --NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF-  189 (487)
Q Consensus       113 --~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~-  189 (487)
                        ..+++.    ..+|||||++|++|.++..     .  +....++.|++.+|.+||+.  |||||||||.|||++.++ 
T Consensus       177 vp~p~~~~----~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH~~--gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          177 VPEPIAQS----RHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLAKH--GLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             CCCEEEEE----TTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHHHT--TEECSCCSTTSEEEEEEEC
T ss_pred             CCeeeecc----CceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHHHC--CCcCCCCCHHHEEEeCCCC
Confidence              333322    2379999999988865432     2  23456889999999999999  999999999999998776 


Q ss_pred             ---------cEEEccccccee
Q 011384          190 ---------NARLGDFGLALR  201 (487)
Q Consensus       190 ---------~vkL~DFGla~~  201 (487)
                               .+.|+||+-+..
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEE
T ss_pred             cccccccccceEEEEeCCccc
Confidence                     489999997744

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=7.8e-13  Score=127.64  Aligned_cols=143  Identities=14%  Similarity=0.117  Sum_probs=114.6

Q ss_pred             HhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCCh-hhHHHHHHHHHHHHhCC-CCCceeeEEEEeCCCceEEEEE
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQ-EISQEVDNEIEILSKIH-SPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ..-..|.+...++.|+.+.||++...++.+++|+..... .....+.+|+++++.+. +..+.++++++.+.+..|+|||
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            344679888999999999999998778999999986532 22346889999999884 6778899999998888999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM---------------------------------------  170 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~---------------------------------------  170 (487)
                      |++|.+|.+.+.      +......++.+++.+|..||+..                                       
T Consensus        91 ~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T 3tm0_A           91 EADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             CCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred             ecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence            999999987632      11223468889999999999810                                       


Q ss_pred             ------------------CCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          171 ------------------PPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       171 ------------------~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                                        +.++|+|++|.|||++.+..+.|+||+.+.
T Consensus       165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                              258999999999999876666799998763

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.26  E-value=2.3e-11  Score=116.30  Aligned_cols=135  Identities=16%  Similarity=0.126  Sum_probs=100.1

Q ss_pred             cCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCC--ceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPR--LVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ..|.+..+.+.|..+.||++... |..++||+....  ....+.+|+.+++.+.+.+  +.++++++...+..++||||+
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            34555444445666999999765 678999987654  2245788999999886544  566899888888899999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM-----------------------------------------  170 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----------------------------------------  170 (487)
                      +|.+|.  ...    .+.   ..++.+++..|..||+..                                         
T Consensus        98 ~G~~l~--~~~----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDLL--SSH----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEETT--TSC----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCcccC--cCc----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            998884  211    222   256777888888888741                                         


Q ss_pred             ---------------CCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          171 ---------------PPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       171 ---------------~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                                     +.++|+|++|.|||++.+..+.|+||+.+.
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                           129999999999999877667799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.23  E-value=3.9e-11  Score=121.39  Aligned_cols=142  Identities=14%  Similarity=0.285  Sum_probs=109.8

Q ss_pred             cccceeecccCceEEEEEEECCeEEEEEEcC--CCh--hhHHHHHHHHHHHHhCC--CCCceeeEEEEeCC---CceEEE
Q 011384           57 FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPS--KNQ--EISQEVDNEIEILSKIH--SPRLVNLLGFSNDS---KDRLLV  127 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~--~~~--~~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~---~~~~lV  127 (487)
                      ....+.|+.|.++.||++...+..+++|+..  ...  .....+.+|+.+++.+.  +..+++++.++.+.   +..++|
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             CceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            3456889999999999998888899999876  432  22356888999999997  45688999998876   447999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE--------------------------------------  169 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--------------------------------------  169 (487)
                      |||++|..+.+..   -..++...+..++.+++..|+.||..                                      
T Consensus       120 me~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          120 MEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9999998775421   12377888889999999999999973                                      


Q ss_pred             ------------------CCCeeeccCCCCcEEEccCCc--EEEccccccee
Q 011384          170 ------------------MPPIIHRDIKSANVLIDRNFN--ARLGDFGLALR  201 (487)
Q Consensus       170 ------------------~~~ivH~DIkp~NILld~~~~--vkL~DFGla~~  201 (487)
                                        .+.++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              136899999999999987653  68999998854

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.04  E-value=1.6e-10  Score=114.18  Aligned_cols=185  Identities=23%  Similarity=0.226  Sum_probs=124.5

Q ss_pred             ceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCC-CCC--ceeeEEEEeCCC---ceEEEEEecCC
Q 011384           60 QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIH-SPR--LVNLLGFSNDSK---DRLLVVEFMSN  133 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~-hpn--Iv~l~~~~~~~~---~~~lV~Ey~~~  133 (487)
                      .+.++.|.+..||++.   ..+++|+.... .....+.+|+++++.+. +..  +..++.+.....   ..|+||++++|
T Consensus        25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN---RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CCEEEECSSEEEEEST---TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             eEecCCCCcceEEEEC---CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            4679999999999863   67889986543 34567899999998883 332  445555544433   34789999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE--------------------------------------------  169 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--------------------------------------------  169 (487)
                      .+|.+....   .++...+..++.+++..|+.||+.                                            
T Consensus       101 ~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  177 (304)
T 3sg8_A          101 VPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY  177 (304)
T ss_dssp             EECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred             eECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence            988764432   277888888899999999999861                                            


Q ss_pred             ------------CCCeeeccCCCCcEEEcc--CCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCC-----CC
Q 011384          170 ------------MPPIIHRDIKSANVLIDR--NFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP-----DN  230 (487)
Q Consensus       170 ------------~~~ivH~DIkp~NILld~--~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~  230 (487)
                                  .+.++|+|++|.||+++.  +..+.|+||+.+....... ........ . .-..|+....     +.
T Consensus       178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~-~-~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMED-D-EEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCT-T-TSCCHHHHHHHHHHHTC
T ss_pred             HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhh-c-cccCHHHHHHHHHHcCC
Confidence                        024799999999999988  5668899999886532211 10000000 0 0012221100     01


Q ss_pred             C---------CcchhhhhHHHHHHHHHhCCcCC
Q 011384          231 L---------STKTDVFSFGILLLEIISCRKAI  254 (487)
Q Consensus       231 ~---------s~ksDVwSlGvvl~eLltG~~pf  254 (487)
                      .         ....+.|+++.++|.+.+|..++
T Consensus       255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            1         12368999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.69  E-value=2.4e-07  Score=91.58  Aligned_cols=136  Identities=20%  Similarity=0.218  Sum_probs=98.0

Q ss_pred             cceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCC---CceeeEEEEe-CCCceEEEEEecCCC
Q 011384           59 EQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSP---RLVNLLGFSN-DSKDRLLVVEFMSNG  134 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~l~~~~~-~~~~~~lV~Ey~~~g  134 (487)
                      ..+.++.|....||+.   +..++||+... ......+.+|++++..+.+.   .+.+++.++. ..+..++||||++|.
T Consensus        23 ~v~~l~~G~~n~v~~v---g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV---NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             CEEEEEECSSEEEEEE---TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eeeecCCCcceeEEEE---CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            3567889999999988   78899998543 33456789999999999652   3667777774 455678999999998


Q ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 011384          135 TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE---------------------------------------------  169 (487)
Q Consensus       135 sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---------------------------------------------  169 (487)
                      .|.+....   .++......++.+++..|+.||+.                                             
T Consensus        99 ~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  175 (306)
T 3tdw_A           99 ILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR  175 (306)
T ss_dssp             ECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred             ECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence            88764221   145555555666666666666542                                             


Q ss_pred             -------------CCCeeeccCCCCcEEEcc---CCc-EEEccccccee
Q 011384          170 -------------MPPIIHRDIKSANVLIDR---NFN-ARLGDFGLALR  201 (487)
Q Consensus       170 -------------~~~ivH~DIkp~NILld~---~~~-vkL~DFGla~~  201 (487)
                                   .+.++|+|++|.|||++.   ++. +.|+||+.+..
T Consensus       176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         124699999999999987   355 58999998754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.61  E-value=4.6e-07  Score=87.19  Aligned_cols=137  Identities=18%  Similarity=0.208  Sum_probs=99.6

Q ss_pred             CcccceeecccCce-EEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCC-CCCceeeEEEEeCCCceEEEEEec
Q 011384           56 GFSEQKLLGKGSHG-SVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIH-SPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        56 ~y~~~~~LG~G~~g-~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      .|.. +.+..|..+ .||+....  +..++||+....  ....+.+|...|+.+. +--+.++++++.+.+..++|||++
T Consensus        26 g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l  102 (272)
T 4gkh_A           26 GYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI  102 (272)
T ss_dssp             TCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             CCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence            3443 345556555 69987665  567899986543  3456888999998884 334778899999888999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM-----------------------------------------  170 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----------------------------------------  170 (487)
                      +|.++.+.....     ......++.+++..|.-||...                                         
T Consensus       103 ~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          103 PGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             CSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             CCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            999888776432     1223446667777777777531                                         


Q ss_pred             ---------------CCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          171 ---------------PPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       171 ---------------~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                                     +.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                           017999999999999987777899999874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.45  E-value=4.3e-07  Score=91.22  Aligned_cols=79  Identities=5%  Similarity=0.135  Sum_probs=57.6

Q ss_pred             cceee-cccCceEEEEEEEC--------CeEEEEEEcCCChh----hHHHHHHHHHHHHhCCC---CCceeeEEEEeCC-
Q 011384           59 EQKLL-GKGSHGSVYKAVLR--------GRQVAVKKPSKNQE----ISQEVDNEIEILSKIHS---PRLVNLLGFSNDS-  121 (487)
Q Consensus        59 ~~~~L-G~G~~g~Vy~~~~~--------g~~vAvK~~~~~~~----~~~~~~~Ei~~l~~l~h---pnIv~l~~~~~~~-  121 (487)
                      ..+.| +.|....+|+....        +..+++|+......    ....+.+|+.+++.+..   ..+.+++.++.+. 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            34678 88999999998765        67899998765431    12457888888888842   4577888887765 


Q ss_pred             --CceEEEEEecCCCCHH
Q 011384          122 --KDRLLVVEFMSNGTLY  137 (487)
Q Consensus       122 --~~~~lV~Ey~~~gsL~  137 (487)
                        ...++||||++|..|.
T Consensus       104 ~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTSSCEEEEECCCCBCCC
T ss_pred             ccCCceEEEEecCCCChh
Confidence              3568999999886543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.30  E-value=7.6e-06  Score=81.04  Aligned_cols=138  Identities=14%  Similarity=0.185  Sum_probs=81.1

Q ss_pred             ceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCC--CCCceeeEE------EEeCCCceEEEEEec
Q 011384           60 QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIH--SPRLVNLLG------FSNDSKDRLLVVEFM  131 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~--hpnIv~l~~------~~~~~~~~~lV~Ey~  131 (487)
                      .+.|+.|..+.||++...+..+++|+.....   ..+..|+.++..+.  .-.+.+++.      +....+..++||+|+
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             EEECC----CEEEEEEETTEEEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eeeccccccCcEEEEEeCCCCEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            4567667789999998887789999987643   33444555555542  112333332      123456678999999


Q ss_pred             CCCCHH-----------H---HHHh--CCC--C---------CCHHHH-------------------------------H
Q 011384          132 SNGTLY-----------D---VLHS--NNR--P---------LNWGRR-------------------------------I  153 (487)
Q Consensus       132 ~~gsL~-----------~---~l~~--~~~--~---------l~~~~~-------------------------------~  153 (487)
                      +|..+.           .   .++.  ...  +         ..|...                               .
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            986432           1   1111  110  0         112110                               0


Q ss_pred             HHHHHHHHHHHHHHh-----------CCCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          154 RLALQVAKAVEILHS-----------EMPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       154 ~i~~qi~~gL~yLH~-----------~~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      .+...+..++.+|+.           ..+.++|+|+++.|||++.++.+.|+||+.+.
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            111223345666653           12389999999999999888899999999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.23  E-value=5.4e-06  Score=84.55  Aligned_cols=74  Identities=15%  Similarity=0.147  Sum_probs=49.8

Q ss_pred             cceeecccCceEEEEEEE--CCeEEEEEEcCCCh--------hhHHHHHHHHHHHHhCCC--CC-ceeeEEEEeCCCceE
Q 011384           59 EQKLLGKGSHGSVYKAVL--RGRQVAVKKPSKNQ--------EISQEVDNEIEILSKIHS--PR-LVNLLGFSNDSKDRL  125 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~--~g~~vAvK~~~~~~--------~~~~~~~~Ei~~l~~l~h--pn-Iv~l~~~~~~~~~~~  125 (487)
                      ..+.||.|.++.||++..  .++.|+||......        .....+..|.++++.+..  |. +.+++.+.  ....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccE
Confidence            357899999999999964  36789999754321        122456778899887742  33 44555443  34568


Q ss_pred             EEEEecCCC
Q 011384          126 LVVEFMSNG  134 (487)
Q Consensus       126 lV~Ey~~~g  134 (487)
                      +||||+++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.06  E-value=2.2e-05  Score=77.75  Aligned_cols=137  Identities=15%  Similarity=0.219  Sum_probs=93.8

Q ss_pred             ccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCC---CCCceeeEEEEeCCCceEEEEEecCCC
Q 011384           58 SEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIH---SPRLVNLLGFSNDSKDRLLVVEFMSNG  134 (487)
Q Consensus        58 ~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~~~~~~~~~lV~Ey~~~g  134 (487)
                      ...+.|+.|.+..+|+....+..++||+....  ....+..|++.|+.+.   ...+++++.++...+..++||||+++.
T Consensus        39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             CEEEEECCSSSSEEEEEESSSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eeeEEeCCccceeeeEEEECCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            44678999999999999877889999987543  3467888999998883   367888999988888899999999987


Q ss_pred             CHH--------HHH---HhCCC--C-------------------CCHHHHH---HHH----------------HHHHHHH
Q 011384          135 TLY--------DVL---HSNNR--P-------------------LNWGRRI---RLA----------------LQVAKAV  163 (487)
Q Consensus       135 sL~--------~~l---~~~~~--~-------------------l~~~~~~---~i~----------------~qi~~gL  163 (487)
                      .+.        ..|   +....  .                   -+|....   ++.                ..++..+
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            541        122   22111  0                   1333221   011                1122111


Q ss_pred             -HHHH--hCCCCeeeccCCCCcEEEccCCcEEEcccc
Q 011384          164 -EILH--SEMPPIIHRDIKSANVLIDRNFNARLGDFG  197 (487)
Q Consensus       164 -~yLH--~~~~~ivH~DIkp~NILld~~~~vkL~DFG  197 (487)
                       ..|.  ...+.+||+|+.+.|++++.++ +.|+||.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             2342  2245899999999999999887 8899984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.92  E-value=6.9e-05  Score=77.06  Aligned_cols=73  Identities=11%  Similarity=0.152  Sum_probs=46.9

Q ss_pred             cceeecccCceEEEEEEECCeEEEEEEcC-------CC-h--hhHHHHHHHHHHHHh-CCCCCceeeEEEEeCCCceEEE
Q 011384           59 EQKLLGKGSHGSVYKAVLRGRQVAVKKPS-------KN-Q--EISQEVDNEIEILSK-IHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~-------~~-~--~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      ..+.||.|..+.||++...++.++||...       .. .  .....+..|+..+.. .....+.+++.+.  ....++|
T Consensus        38 ~i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            45789999999999997777889999322       11 1  022234444433322 2234566777765  4567999


Q ss_pred             EEec-CC
Q 011384          128 VEFM-SN  133 (487)
Q Consensus       128 ~Ey~-~~  133 (487)
                      |||+ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.85  E-value=5.4e-05  Score=74.08  Aligned_cols=72  Identities=15%  Similarity=0.187  Sum_probs=46.2

Q ss_pred             cceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCc-eeeEEEEeCCCceEEEEEec-CCCCH
Q 011384           59 EQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL-VNLLGFSNDSKDRLLVVEFM-SNGTL  136 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~Ey~-~~gsL  136 (487)
                      -.+.|+.|....+|++    ..+++|+........-...+|+.+++.+...++ .++++++.  ..-++|+||+ ++.+|
T Consensus        22 ~i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           22 GPLERLGGLTNLVFRA----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             SCEEEESCSSEEEEEE----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEEC
T ss_pred             ceeEcCCcccccccee----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCccC
Confidence            3688999999999998    678889876542221223568877777743233 45555443  3347899999 66444

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.72  E-value=0.00029  Score=68.31  Aligned_cols=78  Identities=15%  Similarity=0.216  Sum_probs=57.3

Q ss_pred             cCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChh-hHHHHHHHHHHHHhCCC---CCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQE-ISQEVDNEIEILSKIHS---PRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~-~~~~~~~Ei~~l~~l~h---pnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ......+.+|.|..+.||+.... |+.|+||+...... ....|..|+..|+.+.-   ..+.+++++..    -++|||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~----~~lv~e   90 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD----RTLAME   90 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET----TEEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccC----ceEEEE
Confidence            45677889999999999999986 78999998664432 23467889999988842   23556665532    379999


Q ss_pred             ecCCCCH
Q 011384          130 FMSNGTL  136 (487)
Q Consensus       130 y~~~gsL  136 (487)
                      |++++..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987643

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.69  E-value=0.00024  Score=66.01  Aligned_cols=139  Identities=13%  Similarity=0.092  Sum_probs=91.9

Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      .||.++|...+.+++++++|.++.|.+.+|.-+-... .-..+=+.|..|++..+|.|-+.+ ..+.             
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR-QPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc-cCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            4899999998899999999999999999887762210 111333457899999999988764 1110             


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                       .....+.+||... ...+.+.=|||||+++|..+--..|                                ...+..++
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~--------------------------------e~eE~eLS  143 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK--------------------------------ENEERELS  143 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC--------------------------------TTEEECCC
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC--------------------------------cccchhhC
Confidence             1123455777653 3456788999999999987743222                                22233456


Q ss_pred             HHHHHHHHHhhhh-------------------------cCCCCCCHHHHHHHH
Q 011384          294 KQLAVIAVRCVRS-------------------------CRERRPSMKEIVDWL  321 (487)
Q Consensus       294 ~~l~~Li~~cl~~-------------------------dP~~RPs~~eil~~L  321 (487)
                      +.|..||..|..-                         .+..|+++++|++.=
T Consensus       144 ~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C  196 (229)
T 2yle_A          144 PPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLC  196 (229)
T ss_dssp             HHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHH
T ss_pred             HHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHH
Confidence            6777777777655                         346889999999754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.62  E-value=0.00032  Score=68.86  Aligned_cols=140  Identities=16%  Similarity=0.143  Sum_probs=79.9

Q ss_pred             ceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCC--ceeeEEE------EeCCCceEEEEEec
Q 011384           60 QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPR--LVNLLGF------SNDSKDRLLVVEFM  131 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~l~~~------~~~~~~~~lV~Ey~  131 (487)
                      .+.|+.|....+|+....+..+++|+..... ....+..|+.++..+...+  +.+++..      ....+..+++++|+
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~-~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l  105 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  105 (322)
T ss_dssp             EEEECC---EEEEEEEESSCCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             eeccCCCcccceEEEEeCCccEEEEEeCCCC-CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence            4567788889999998876689999877631 2234566777777763212  2333321      12234568999999


Q ss_pred             CCCCHH-----------H---HHHhC--C--CC----CC---HHHHHH------------HHHHHHHHHHHHHhC-----
Q 011384          132 SNGTLY-----------D---VLHSN--N--RP----LN---WGRRIR------------LALQVAKAVEILHSE-----  169 (487)
Q Consensus       132 ~~gsL~-----------~---~l~~~--~--~~----l~---~~~~~~------------i~~qi~~gL~yLH~~-----  169 (487)
                      +|..+.           .   .++..  .  .+    ..   |...+.            +...+...+..++..     
T Consensus       106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~  185 (322)
T 2ppq_A          106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  185 (322)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence            886431           1   11111  1  00    11   111000            001134455556532     


Q ss_pred             CCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          170 MPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       170 ~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      ..+++|+|+.+.|||++.+..+.|+||+.+.
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            1278999999999999887666899998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.57  E-value=0.00062  Score=67.35  Aligned_cols=138  Identities=12%  Similarity=0.106  Sum_probs=74.2

Q ss_pred             ceeecccCceE-EEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCC--CCceeeEEEEeCCCceEEEEEecCCCC
Q 011384           60 QKLLGKGSHGS-VYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHS--PRLVNLLGFSNDSKDRLLVVEFMSNGT  135 (487)
Q Consensus        60 ~~~LG~G~~g~-Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~lV~Ey~~~gs  135 (487)
                      .+.|+.|+... +|+.... ++.+++|.......  ..+..|+.++..+..  -.+.+++.+..+.+  ++|||++.+..
T Consensus        23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             ECC--------CCEEEECTTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            35566666555 6777764 77888887554321  234456677666632  34566776644433  78999998777


Q ss_pred             HHHHHHhCC-------------------------CCCCHHHHH-------HHH-------------HHHHHHHHHHHh--
Q 011384          136 LYDVLHSNN-------------------------RPLNWGRRI-------RLA-------------LQVAKAVEILHS--  168 (487)
Q Consensus       136 L~~~l~~~~-------------------------~~l~~~~~~-------~i~-------------~qi~~gL~yLH~--  168 (487)
                      +.+.+....                         ..++.....       .+.             ..+...+..|..  
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654432110                         011111110       000             011122223311  


Q ss_pred             --CCCCeeeccCCCCcEEEccC----CcEEEccccccee
Q 011384          169 --EMPPIIHRDIKSANVLIDRN----FNARLGDFGLALR  201 (487)
Q Consensus       169 --~~~~ivH~DIkp~NILld~~----~~vkL~DFGla~~  201 (487)
                        ..+.++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence              12379999999999999874    6899999998754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.53  E-value=0.00024  Score=72.15  Aligned_cols=137  Identities=15%  Similarity=0.160  Sum_probs=82.9

Q ss_pred             ceeecccCceEEEEEEEC---------CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCC-ceeeEEEEeCCCceEEEEE
Q 011384           60 QKLLGKGSHGSVYKAVLR---------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPR-LVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~---------g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~lV~E  129 (487)
                      .+.|..|-...+|++...         ++.|++|+..........+.+|.++++.+...+ ..++++++.++    +|||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e  130 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ  130 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence            467777889999998874         368999987543333456678999998874322 35677766542    8999


Q ss_pred             ecCCCCHH--------------HHHH---hC----CCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 011384          130 FMSNGTLY--------------DVLH---SN----NRPLN--WGRRIRLALQVAK-------------------AVEILH  167 (487)
Q Consensus       130 y~~~gsL~--------------~~l~---~~----~~~l~--~~~~~~i~~qi~~-------------------gL~yLH  167 (487)
                      |++|..|.              +.|.   ..    +....  +.++.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            99986542              1111   11    11122  3445555544322                   233333


Q ss_pred             h----C--CCCeeeccCCCCcEEEccC----CcEEEcccccce
Q 011384          168 S----E--MPPIIHRDIKSANVLIDRN----FNARLGDFGLAL  200 (487)
Q Consensus       168 ~----~--~~~ivH~DIkp~NILld~~----~~vkL~DFGla~  200 (487)
                      .    .  ...++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2    1  1268999999999999876    789999998874

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.48  E-value=0.00024  Score=73.99  Aligned_cols=74  Identities=14%  Similarity=0.126  Sum_probs=49.7

Q ss_pred             cceeecccCceEEEEEEECC--eEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCc-eeeEEEEeCCCceEEEEEecCCCC
Q 011384           59 EQKLLGKGSHGSVYKAVLRG--RQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL-VNLLGFSNDSKDRLLVVEFMSNGT  135 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~g--~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~Ey~~~gs  135 (487)
                      ..+.|+.|-...+|++...+  ..+++|+........-...+|+.++..+...++ .++++++.  +  .+||||++|.+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            35678889999999999876  889999875432111112578999998865554 56777763  2  35999998754


Q ss_pred             H
Q 011384          136 L  136 (487)
Q Consensus       136 L  136 (487)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.47  E-value=0.00018  Score=74.29  Aligned_cols=72  Identities=14%  Similarity=0.165  Sum_probs=50.8

Q ss_pred             cceeecccCceEEEEEEEC---------CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCc-eeeEEEEeCCCceEEEE
Q 011384           59 EQKLLGKGSHGSVYKAVLR---------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL-VNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~---------g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~  128 (487)
                      ..+.|+.|-...||++...         ++.+++|+.... .....+.+|+.++..+...++ .++++.+.+    .+|+
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4578888999999999875         468999988442 112455679999888853333 567776643    3899


Q ss_pred             EecCCCC
Q 011384          129 EFMSNGT  135 (487)
Q Consensus       129 Ey~~~gs  135 (487)
                      ||++|.+
T Consensus       152 e~l~G~~  158 (429)
T 1nw1_A          152 EYIPSRP  158 (429)
T ss_dssp             CCCCEEE
T ss_pred             EEeCCcc
Confidence            9998643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.43  E-value=0.00072  Score=66.51  Aligned_cols=139  Identities=13%  Similarity=0.112  Sum_probs=80.9

Q ss_pred             ceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCC--CCceeeEEE-----EeCCCceEEEEEec
Q 011384           60 QKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHS--PRLVNLLGF-----SNDSKDRLLVVEFM  131 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~-----~~~~~~~~lV~Ey~  131 (487)
                      ...|+ |....||++... |+.+++|+..........+..|+.++..+..  -.+++++..     ....+..++||+|+
T Consensus        31 ~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             CEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             EEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            45677 888999998765 5679999987543344567778888887742  224444443     12234567899999


Q ss_pred             CCCCHH-----------HH---HHh--CC------CCCCHHHH----HHHH---------------HHHHHHHHHHHh--
Q 011384          132 SNGTLY-----------DV---LHS--NN------RPLNWGRR----IRLA---------------LQVAKAVEILHS--  168 (487)
Q Consensus       132 ~~gsL~-----------~~---l~~--~~------~~l~~~~~----~~i~---------------~qi~~gL~yLH~--  168 (487)
                      +|..+.           ..   ++.  ..      ...++...    ..++               ..+...+..+..  
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            875431           11   111  10      01222111    0011               111112233322  


Q ss_pred             ---CCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          169 ---EMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       169 ---~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                         ..+.++|+|+++.|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               112689999999999998 4 899999987643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.43  E-value=0.00017  Score=72.62  Aligned_cols=72  Identities=15%  Similarity=0.157  Sum_probs=46.0

Q ss_pred             ceeecccCceEEEEEEECC----------eEEEEEEcCCChhhHHHHHHHHHHHHhCCCCC-ceeeEEEEeCCCceEEEE
Q 011384           60 QKLLGKGSHGSVYKAVLRG----------RQVAVKKPSKNQEISQEVDNEIEILSKIHSPR-LVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~g----------~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~lV~  128 (487)
                      .+.|+.|....+|++...+          +.+++|+.............|.++++.+...+ ..++++.+.    -++||
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~  113 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE  113 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence            5678888899999998764          68999987654332223467888888774333 446665542    26899


Q ss_pred             EecCCCC
Q 011384          129 EFMSNGT  135 (487)
Q Consensus       129 Ey~~~gs  135 (487)
                      ||++|..
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.96  E-value=0.0043  Score=61.72  Aligned_cols=72  Identities=10%  Similarity=0.184  Sum_probs=45.4

Q ss_pred             ceeeccc--CceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCC---CCCceeeEEE------EeCCCceEEEE
Q 011384           60 QKLLGKG--SHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIH---SPRLVNLLGF------SNDSKDRLLVV  128 (487)
Q Consensus        60 ~~~LG~G--~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~l~~~------~~~~~~~~lV~  128 (487)
                      .+.+..|  ....||+....+..+++|+......     ..|+.++..+.   -|++++++..      ....+..++||
T Consensus        26 ~~~l~~G~g~~N~vy~v~~~~g~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~  100 (339)
T 3i1a_A           26 AQFIQGGADTNAFAYQADSESKSYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAY  100 (339)
T ss_dssp             EEEETTTSCSSCEEEEEECSSCEEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred             eEEeeccCccccceEEEEeCCCCEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEE
Confidence            4555433  3689999987655999998665432     34555665552   2324555432      23356678999


Q ss_pred             EecCCCCH
Q 011384          129 EFMSNGTL  136 (487)
Q Consensus       129 Ey~~~gsL  136 (487)
                      +|++|..+
T Consensus       101 ~~i~G~~~  108 (339)
T 3i1a_A          101 PFIHAPNG  108 (339)
T ss_dssp             ECCCCCBT
T ss_pred             eccCCCcC
Confidence            99998765

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.53  E-value=0.0032  Score=64.79  Aligned_cols=74  Identities=12%  Similarity=0.137  Sum_probs=49.8

Q ss_pred             cceeecccCceEEEEEEEC---------CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCC-ceeeEEEEeCCCceEEEE
Q 011384           59 EQKLLGKGSHGSVYKAVLR---------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPR-LVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~---------g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~l~~~~~~~~~~~lV~  128 (487)
                      ..+.|..|-...+|+....         ++.|++|+........-...+|..+++.+...+ ..++++.+.    -++||
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3567877889999999886         578999987553222222457888888774322 355665442    27899


Q ss_pred             EecCCCCH
Q 011384          129 EFMSNGTL  136 (487)
Q Consensus       129 Ey~~~gsL  136 (487)
                      +|++|..|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.94  E-value=0.067  Score=54.30  Aligned_cols=29  Identities=24%  Similarity=0.350  Sum_probs=24.5

Q ss_pred             CeeeccCCCCcEEE------ccCCcEEEcccccce
Q 011384          172 PIIHRDIKSANVLI------DRNFNARLGDFGLAL  200 (487)
Q Consensus       172 ~ivH~DIkp~NILl------d~~~~vkL~DFGla~  200 (487)
                      .++|+|+.+.|||+      +.+..++|+||.++.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            36799999999999      345679999999874

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.16  E-value=0.48  Score=43.67  Aligned_cols=116  Identities=13%  Similarity=0.192  Sum_probs=79.6

Q ss_pred             CCCCCceeeEEEEeCCCceEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEE
Q 011384          106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNG-TLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVL  184 (487)
Q Consensus       106 l~hpnIv~l~~~~~~~~~~~lV~Ey~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NIL  184 (487)
                      ..||+++.. .+-.+.+.+.+.++.-+.+ ++.. +.    .++...+++++..|+....+++..    +|--|.|+||+
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~~r----~tf~L~P~NL~  111 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNRTR----YTFVLAPDELF  111 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGGSS----EECCCSGGGEE
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhcCc----eEEEEecceEE
Confidence            367888876 5666666666666655422 3333 32    278889999999998877555544    68899999999


Q ss_pred             EccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCC
Q 011384          185 IDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAID  255 (487)
Q Consensus       185 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~  255 (487)
                      ++.++.+++.-.|+-..                   ++|     ...+...=+-.+=|++..+++++..|.
T Consensus       112 f~~~~~p~i~~RGik~~-------------------l~P-----~~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNV-------------------VDP-----LPVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTTSCEEESCCEETTT-------------------BSC-----CCCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EcCCCCEEEEEccCccC-------------------CCC-----CCCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999987775311                   122     122333344468889999999887775

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.65  E-value=1.2  Score=41.12  Aligned_cols=116  Identities=13%  Similarity=0.117  Sum_probs=77.3

Q ss_pred             CCCCCceeeEEEEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCeeeccCCCCcEE
Q 011384          106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVE-ILHSEMPPIIHRDIKSANVL  184 (487)
Q Consensus       106 l~hpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~-yLH~~~~~ivH~DIkp~NIL  184 (487)
                      ..||++  --.+-.+.+.+.+.++.-+++.=...+.    .++...+++++.+|+.... +++    .-+|--|.|+||+
T Consensus        47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~~----~r~tf~l~P~NL~  116 (219)
T 4ano_A           47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHSA----RRLIFIVCPENLM  116 (219)
T ss_dssp             GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCCS----SSEECCCCGGGEE
T ss_pred             ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhhh----CceeEEEeCceEE
Confidence            367887  3444567777777777664443333443    2788899999998887655 444    3478889999999


Q ss_pred             EccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCC
Q 011384          185 IDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAID  255 (487)
Q Consensus       185 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~  255 (487)
                      ++.++.+++.-.|+-..                   ++|..     .+..-=+-.+=|++..++.++..|.
T Consensus       117 f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          117 FNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             ECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999988776321                   22321     2222233357788888888877664

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	487
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-65
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-61
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-59
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-59
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-58
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-58
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-57
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-56
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-54
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-54
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-53
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-52
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-51
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-51
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-51
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-51
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-50
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-50
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-49
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-47
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-46
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-46
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-45
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-42
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-37
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-36
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-36
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-33
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-33
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-29
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-29
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-15

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (537), Expect = 1e-65
 Identities = 67/279 (24%), Positives = 132/279 (47%), Gaps = 19/279 (6%)

Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVD---NEIEILSKIHSPRLVN 113
            +  + +G GS G+VYK    G  VAVK  +      Q++    NE+ +L K     ++ 
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
            +G+S  +    +V ++    +LY  LH         + I +A Q A+ ++ LH     I
Sbjct: 69  FMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH--AKSI 125

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN--- 230
           IHRD+KS N+ +  +   ++GDFGLA      +   +    +G+I ++ P  +   +   
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185

Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP 290
            S ++DV++FGI+L E+++ +      +S  +  D    ++ +G +     P +   +  
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQIIFMVGRGYL----SPDLSKVRSN 237

Query: 291 IVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
              K +  +   C++  R+ RP   +I+  +  L++ +P
Sbjct: 238 CP-KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 7e-61
 Identities = 62/267 (23%), Positives = 113/267 (42%), Gaps = 19/267 (7%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
               + LG G  G V+        +VAVK   +          E  ++ ++   RLV L 
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPII 174
                 +   ++ E+M NG+L D L + +   L   + + +A Q+A+ +  +       I
Sbjct: 75  AVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--RNYI 131

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           HRD+++AN+L+    + ++ DFGLA R   DN           I +  P  +     + K
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190

Query: 235 TDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRK 294
           +DV+SFGILL EI++  +    G + P ++      +++G             +     +
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN----LERGY---------RMVRPDNCPE 237

Query: 295 QLAVIAVRCVRSCRERRPSMKEIVDWL 321
           +L  +   C +   E RP+   +   L
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-59
 Identities = 60/266 (22%), Positives = 110/266 (41%), Gaps = 17/266 (6%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
            +  K LG G  G V     R    VA+K   +      E   E +++  +   +LV L 
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 65

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
           G     +   ++ E+M+NG L + L          + + +   V +A+E L       +H
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLH 123

Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKT 235
           RD+ + N L++     ++ DFGL+ R  +D+    S      + +  P  +     S+K+
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182

Query: 236 DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQ 295
           D+++FG+L+ EI S  K     F+     +     I +G  L  + P +   K       
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQGLRL--YRPHLASEK------- 229

Query: 296 LAVIAVRCVRSCRERRPSMKEIVDWL 321
           +  I   C     + RP+ K ++  +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSNI 255

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  195 bits (497), Expect = 2e-59
 Identities = 65/302 (21%), Positives = 130/302 (43%), Gaps = 34/302 (11%)

Query: 42  IQHFDYSDLEAATNGFSE---------QKLLGKGSHGSVYKAVLR-----GRQVAVK--K 85
           I  F + D   A   F++         ++++G G  G V    L+        VA+K  K
Sbjct: 4   IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63

Query: 86  PSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR 145
               ++  ++  +E  I+ +   P +++L G    S   +++ EFM NG+L   L  N+ 
Sbjct: 64  SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123

Query: 146 PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD 205
                + + +   +A  ++ L       +HRD+ + N+L++ N   ++ DFGL+     D
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 206 N---FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS 262
                   +      I +  P  +     ++ +DV+S+GI++ E++S  +      +   
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241

Query: 263 IVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT 322
           +++     I++       D R+PPP D      L  + + C +  R  RP   +IV+ L 
Sbjct: 242 VINA----IEQ-------DYRLPPPMD--CPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288

Query: 323 GL 324
            +
Sbjct: 289 KM 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 4e-59
 Identities = 70/292 (23%), Positives = 116/292 (39%), Gaps = 27/292 (9%)

Query: 60  QKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSN 119
           Q+ +GKG  G V++   RG +VAVK  S  +E S   + EI     +    ++  +   N
Sbjct: 8   QESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 67

Query: 120 DSKDRL----LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM----- 170
                     LV ++  +G+L+D L+     +     I+LAL  A  +  LH E+     
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125

Query: 171 -PPIIHRDIKSANVLIDRNFNARLGDFGLALRC--GVDNFRFRSTPPAGTIGYLDP---- 223
            P I HRD+KS N+L+ +N    + D GLA+R     D          GT  Y+ P    
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185

Query: 224 --CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIG------FSPPSIVDWAAPLIKKGK 275
               +       + D+++ G++  EI        I       +      D +   ++K  
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245

Query: 276 ILSVFDPRIPP-PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
                 P IP   +     + +A I   C  +    R +   I   L+ LS+
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-58
 Identities = 72/267 (26%), Positives = 114/267 (42%), Gaps = 23/267 (8%)

Query: 57  FSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
               + +GKG  G V     RG +VAVK   KN   +Q    E  +++++    LV LLG
Sbjct: 9   LKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQAFLAEASVMTQLRHSNLVQLLG 67

Query: 117 FSNDSKDRL-LVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQVAKAVEILHSEMPPII 174
              + K  L +V E+M+ G+L D L S  R  L     ++ +L V +A+E L       +
Sbjct: 68  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFV 125

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           HRD+ + NVL+  +  A++ DFGL           +       + +  P  +     STK
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALREKKFSTK 180

Query: 235 TDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRK 294
           +DV+SFGILL EI S  +          +V          ++   +    P    P V +
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---------RVEKGYKMDAPDGCPPAVYE 231

Query: 295 QLAVIAVRCVRSCRERRPSMKEIVDWL 321
               +   C       RPS  ++ + L
Sbjct: 232 ----VMKNCWHLDAAMRPSFLQLREQL 254

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 4e-58
 Identities = 59/266 (22%), Positives = 111/266 (41%), Gaps = 23/266 (8%)

Query: 63  LGKGSHGSVYKAVLR----GRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVNLLG 116
           LG G+ GSV + V R       VA+K  K    +  ++E+  E +I+ ++ +P +V L+G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHR 176
                   +LV+E    G L+  L      +       L  QV+  ++ L       +HR
Sbjct: 77  VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE--EKNFVHR 133

Query: 177 DIKSANVLIDRNFNARLGDFGLA-LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKT 235
           D+ + NVL+     A++ DFGL+      D++    +     + +  P  +     S+++
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 193

Query: 236 DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQ 295
           DV+S+G+ + E +S  +        P ++ +    I++GK              P    +
Sbjct: 194 DVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQGK---------RMECPPECPPE 240

Query: 296 LAVIAVRCVRSCRERRPSMKEIVDWL 321
           L  +   C     E RP    +   +
Sbjct: 241 LYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 1e-57
 Identities = 66/271 (24%), Positives = 116/271 (42%), Gaps = 17/271 (6%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
            +  + +G G  G V+        +VA+K   +     ++   E E++ K+  P+LV L 
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 66

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIH 175
           G   +     LV EFM +G L D L +          + + L V + +  L      +IH
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--ACVIH 124

Query: 176 RDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKT 235
           RD+ + N L+  N   ++ DFG+  R  +D+    ST     + +  P   +    S+K+
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183

Query: 236 DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQ 295
           DV+SFG+L+ E+ S  K      S   +V+     I  G  L  + PR+           
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEVVED----ISTGFRL--YKPRLAST-------H 230

Query: 296 LAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
           +  I   C +   E RP+   ++  L  +++
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (484), Expect = 1e-57
 Identities = 67/311 (21%), Positives = 124/311 (39%), Gaps = 47/311 (15%)

Query: 46  DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVK--KPSKNQEISQEV 96
               LE   N     + +G+G+ G V++A             VAVK  K   + ++  + 
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 97  DNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR----------- 145
             E  ++++  +P +V LLG     K   L+ E+M+ G L + L S +            
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 146 ------------PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL 193
                       PL+   ++ +A QVA  +  L       +HRD+ + N L+  N   ++
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKI 181

Query: 194 GDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKA 253
            DFGL+      ++       A  I ++ P  +  +  +T++DV+++G++L EI S    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 254 IDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPS 313
              G +   ++ +    ++ G IL+      P         +L  +   C       RPS
Sbjct: 242 PYYGMAHEEVIYY----VRDGNILA-CPENCPL--------ELYNLMRLCWSKLPADRPS 288

Query: 314 MKEIVDWLTGL 324
              I   L  +
Sbjct: 289 FCSIHRILQRM 299

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  186 bits (474), Expect = 3e-56
 Identities = 67/287 (23%), Positives = 117/287 (40%), Gaps = 19/287 (6%)

Query: 43  QHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEI 100
              +Y   E      + +  LG G +G VY+ V +     VAVK   ++    +E   E 
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 64

Query: 101 EILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR-PLNWGRRIRLALQV 159
            ++ +I  P LV LLG         ++ EFM+ G L D L   NR  ++    + +A Q+
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124

Query: 160 AKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG 219
           + A+E L       IHRD+ + N L+  N   ++ DFGL+ R    +           I 
Sbjct: 125 SSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 181

Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV 279
           +  P  +  +  S K+DV++FG+LL EI +   +   G                 ++  +
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------------SQVYEL 228

Query: 280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
            +      +     +++  +   C +     RPS  EI      + +
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 4e-56
 Identities = 64/267 (23%), Positives = 115/267 (43%), Gaps = 19/267 (7%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLL 115
              +  LG+G  G V+        +VA+K         +    E +++ K+   +LV L 
Sbjct: 19  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLY 78

Query: 116 GFSNDSKDRLLVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPII 174
              ++ +   +V E+MS G+L D L     + L   + + +A Q+A  +  +       +
Sbjct: 79  AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYV 135

Query: 175 HRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTK 234
           HRD+++AN+L+  N   ++ DFGLA R   DN           I +  P        + K
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194

Query: 235 TDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRK 294
           +DV+SFGILL E+ +  +    G     ++D     +++G            P  P   +
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----VERGY---------RMPCPPECPE 241

Query: 295 QLAVIAVRCVRSCRERRPSMKEIVDWL 321
            L  +  +C R   E RP+ + +  +L
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 5e-54
 Identities = 66/320 (20%), Positives = 127/320 (39%), Gaps = 42/320 (13%)

Query: 50  LEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVK--KPSKNQEISQEVDNEIEILSK 105
           +E   + F +   LG G+ G V+K   +  G  +A K         I  ++  E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            +SP +V   G      +  + +E M  G+L  VL    R +      ++++ V K +  
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTY 119

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           L  +   I+HRD+K +N+L++     +L DFG++ +         +    GT  Y+ P  
Sbjct: 120 LREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPER 174

Query: 226 VTPDNLSTKTDVFSFGILLLEIISCRKAI------------------DIGFSPPSIVDWA 267
           +   + S ++D++S G+ L+E+   R  I                  D   +PP      
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 268 APLIKKG-------KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSC----RERRPSMKE 316
            PL   G        I  + D  +  P   +     ++     V  C       R  +K+
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294

Query: 317 IVD--WLTGL-SKLVPLHSW 333
           ++   ++    ++ V    W
Sbjct: 295 LMVHAFIKRSDAEEVDFAGW 314

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 6e-54
 Identities = 62/271 (22%), Positives = 115/271 (42%), Gaps = 25/271 (9%)

Query: 59  EQKLLGKGSHGSVYKAVLR----GRQVAVK---KPSKNQEISQEVDNEIEILSKIHSPRL 111
           E K LG G+ G+V K   +     + VAVK     + +  +  E+  E  ++ ++ +P +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V ++G   +++  +LV+E    G L   L   NR +     I L  QV+  ++ L     
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE--ES 126

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLA-LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             +HRD+ + NVL+     A++ DFGL+      +N+    T     + +  P  +    
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP 290
            S+K+DV+SFG+L+ E  S  +    G     +      +++KG+               
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA----MLEKGE---------RMGCPA 233

Query: 291 IVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
              +++  +   C     E RP    +   L
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 6e-54
 Identities = 57/286 (19%), Positives = 122/286 (42%), Gaps = 24/286 (8%)

Query: 51  EAATNGFSEQKLLGKGSHGSVYKAVLRG------RQVAVK--KPSKNQEISQEVDNEIEI 102
           E   +  + QK++G G  G VYK +L+         VA+K  K    ++   +   E  I
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 103 LSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
           + +     ++ L G  +  K  +++ E+M NG L   L   +   +  + + +   +A  
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122

Query: 163 VEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA-LRCGVDNFRFRSTPPAGTIGYL 221
           ++ L +     +HRD+ + N+L++ N   ++ DFGL+ +        + ++     I + 
Sbjct: 123 MKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 222 DPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD 281
            P  ++    ++ +DV+SFGI++ E+++  +      S               +++   +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------------HEVMKAIN 227

Query: 282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL 327
                P        +  + ++C +  R RRP   +IV  L  L + 
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 1e-53
 Identities = 70/329 (21%), Positives = 122/329 (37%), Gaps = 47/329 (14%)

Query: 26  QTQSSKTSQKQEKPIKIQHFDY-SDLEAATNGFSEQKLLGKGSHGSVYKAVLRG------ 78
             Q + +S  +   +  + ++Y    E         K+LG G+ G V  A   G      
Sbjct: 7   MVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGV 66

Query: 79  -RQVAVK--KPSKNQEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSNG 134
             QVAVK  K   +    + + +E+++++++     +VNLLG    S    L+ E+   G
Sbjct: 67  SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG 126

Query: 135 TLYDVLHSNNR----------------------PLNWGRRIRLALQVAKAVEILHSEMPP 172
            L + L S                          L +   +  A QVAK +E L      
Sbjct: 127 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KS 184

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
            +HRD+ + NVL+      ++ DFGLA     D+           + ++ P  +     +
Sbjct: 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 244

Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV 292
            K+DV+S+GILL EI S       G    +                +        +    
Sbjct: 245 IKSDVWSYGILLWEIFSLGVNPYPGIPVDAN------------FYKLIQNGFKMDQPFYA 292

Query: 293 RKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
            +++ +I   C      +RPS   +  +L
Sbjct: 293 TEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 5e-53
 Identities = 64/276 (23%), Positives = 105/276 (38%), Gaps = 25/276 (9%)

Query: 57  FSEQKLLGKGSHGSVYKAVL-----RGRQVAVKKPSKN----QEISQEVDNEIEILSKIH 107
               + LG GS G V +        +   VAVK    +     E   +   E+  +  + 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
              L+ L G         +V E    G+L D L  +      G   R A+QVA+ +  L 
Sbjct: 70  HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128

Query: 168 SEMPPIIHRDIKSANVLIDRNFNARLGDFGLA-LRCGVDNFRFRSTPPAGTIGYLDPCYV 226
           S     IHRD+ + N+L+      ++GDFGL       D+             +  P  +
Sbjct: 129 S--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 227 TPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP 286
                S  +D + FG+ L E+ +  +   IG +   I+      I K         R+P 
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK----IDKE------GERLPR 236

Query: 287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT 322
           P+D    + +  + V+C     E RP+   + D+L 
Sbjct: 237 PED--CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 3e-52
 Identities = 65/295 (22%), Positives = 113/295 (38%), Gaps = 41/295 (13%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR-------GRQVAVK--KPSKNQEISQEVDNEIEILSKI- 106
            S  K LG G+ G V +A             VAVK  KPS +    + + +E+++LS + 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 107 HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH-----------------SNNRPLNW 149
           +   +VNLLG        L++ E+   G L + L                   +   L+ 
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 150 GRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF 209
              +  + QVAK +  L S+    IHRD+ + N+L+      ++ DFGLA     D+   
Sbjct: 145 EDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP 269
                   + ++ P  +     + ++DV+S+GI L E+ S   +   G    S       
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK------ 256

Query: 270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
                    +               ++  I   C  +   +RP+ K+IV  +   
Sbjct: 257 ------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 4e-52
 Identities = 60/275 (21%), Positives = 114/275 (41%), Gaps = 25/275 (9%)

Query: 60  QKLLGKGSHGSVYKAVL-----RGRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
            +++G+G  G VY   L     +    AVK      +     +   E  I+     P ++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 113 NLLGFSNDSKDR-LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           +LLG    S+   L+V+ +M +G L + + +          I   LQVAK ++ L     
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA--SK 149

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
             +HRD+ + N ++D  F  ++ DFGLA  +     +     T     + ++    +   
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209

Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD 289
             +TK+DV+SFG+LL E+++         +   I  +    + +G+            + 
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY----LLQGR---------RLLQP 256

Query: 290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
                 L  + ++C     E RPS  E+V  ++ +
Sbjct: 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 8e-52
 Identities = 59/278 (21%), Positives = 128/278 (46%), Gaps = 24/278 (8%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR------GRQVAVK--KPSKNQEISQEVDNEIEILSKIHS 108
           F + K+LG G+ G+VYK +           VA+K  + + + + ++E+ +E  +++ + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P +  LLG    S    L+ + M  G L D +  +   +     +   +Q+AK +  L  
Sbjct: 71  PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 128

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               ++HRD+ + NVL+    + ++ DFGLA   G +   + +      I ++    +  
Sbjct: 129 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187

Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              + ++DV+S+G+ + E+++       G     I      +++KG+           P+
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----ILEKGE---------RLPQ 234

Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
            PI    + +I V+C     + RP  +E++   + +++
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 1e-51
 Identities = 60/271 (22%), Positives = 113/271 (41%), Gaps = 24/271 (8%)

Query: 61  KLLGKGSHGSVYKAVLR-----GRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLVN 113
           + +G+G  G V++ +          VA+K  K   +  + ++   E   + +   P +V 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
           L+G   +     +++E  + G L   L      L+    I  A Q++ A+  L S     
Sbjct: 73  LIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES--KRF 129

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           +HRDI + NVL+  N   +LGDFGL+ R   D+  ++++     I ++ P  +     ++
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188

Query: 234 KTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR 293
            +DV+ FG+ + EI+        G     ++      I+ G+           P  P   
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IENGE---------RLPMPPNCP 235

Query: 294 KQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
             L  +  +C      RRP   E+   L+ +
Sbjct: 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-51
 Identities = 64/270 (23%), Positives = 112/270 (41%), Gaps = 28/270 (10%)

Query: 60  QKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVD---NEIEILSKIHSPRLVNL 114
              +G+GS  +VYK +      +VA  +    +    E      E E+L  +  P +V  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 115 LGF----SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
                      K  +LV E M++GTL   L    + +          Q+ K ++ LH+  
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRT 132

Query: 171 PPIIHRDIKSANVLI-DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
           PPIIHRD+K  N+ I     + ++GD GLA           +    GT  ++ P     +
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-E 187

Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD 289
                 DV++FG+ +LE+ +          P S    AA + ++     V     P   D
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEY-------PYSECQNAAQIYRR-----VTSGVKPASFD 235

Query: 290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVD 319
            +   ++  I   C+R  ++ R S+K++++
Sbjct: 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 5e-51
 Identities = 71/308 (23%), Positives = 128/308 (41%), Gaps = 47/308 (15%)

Query: 39  PIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLRG----RQVAVK--KPSKNQEI 92
           P      D++D          Q ++G+G+ G V KA ++        A+K  K   +++ 
Sbjct: 1   PTIYPVLDWND-------IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD 53

Query: 93  SQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLH---------- 141
            ++   E+E+L K+ H P ++NLLG         L +E+  +G L D L           
Sbjct: 54  HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 113

Query: 142 -----SNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDF 196
                S    L+  + +  A  VA+ ++ L       IHRD+ + N+L+  N+ A++ DF
Sbjct: 114 FAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADF 171

Query: 197 GLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDI 256
           GL+    V     + T     + ++    +     +T +DV+S+G+LL EI+S       
Sbjct: 172 GLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228

Query: 257 GFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKE 316
           G +   + +         K+   +    P   D  V      +  +C R     RPS  +
Sbjct: 229 GMTCAELYE---------KLPQGYRLEKPLNCDDEVYD----LMRQCWREKPYERPSFAQ 275

Query: 317 IVDWLTGL 324
           I+  L  +
Sbjct: 276 ILVSLNRM 283

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 8e-51
 Identities = 67/280 (23%), Positives = 119/280 (42%), Gaps = 31/280 (11%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVK---KPSKNQEISQEVDNEIEILSKIHSPRL 111
           +     +G GS+G   K   +  G+ +  K     S  +   Q + +E+ +L ++  P +
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 112 VNLLGFSNDSKDRLL--VVEFMSNGTLYDVLHSNNR---PLNWGRRIRLALQVAKAVEIL 166
           V       D  +  L  V+E+   G L  V+    +    L+    +R+  Q+  A++  
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 167 HS---EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           H        ++HRD+K ANV +D   N +LGDFGLA     D    ++     T  Y+ P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TPYYMSP 183

Query: 224 CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR 283
             +   + + K+D++S G LL E+ +        FS   +       I++GK       R
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAG----KIREGKF-----RR 233

Query: 284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WL 321
           IP      + +    I  R +      RPS++EI++   +
Sbjct: 234 IPYRYSDELNE----IITRMLNLKDYHRPSVEEILENPLI 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 4e-50
 Identities = 63/273 (23%), Positives = 106/273 (38%), Gaps = 22/273 (8%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVK--KPSKNQEISQEVDNEIEILSKIHSPRLV 112
           +   + LG+G++G V  AV R     VAVK     +  +  + +  EI I   ++   +V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
              G   +   + L +E+ S G L+D +   +  +      R   Q+   V  LH     
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           I HRDIK  N+L+D   N ++ DFGLA     +N         GT+ Y+ P  +      
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 233 T-KTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI 291
               DV+S GI+L  +++     D     PS         K+ K       +I      +
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWD----QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239

Query: 292 VRKQLAVIAVRCVRSCRERRPSMKEIVD--WLT 322
           +         + +      R ++ +I    W  
Sbjct: 240 LH--------KILVENPSARITIPDIKKDRWYN 264

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (433), Expect = 5e-50
 Identities = 59/277 (21%), Positives = 108/277 (38%), Gaps = 33/277 (11%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS----QEVDNEIEILSKIHSPR 110
           FS+ + +G GS G+VY A        VA+KK S + + S    Q++  E+  L K+  P 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            +   G         LV+E+        +   + +PL       +     + +  LHS  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH- 134

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             +IHRD+K+ N+L+      +LGDFG A      +    +    GT  ++ P  +   +
Sbjct: 135 -NMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGTPYWMAPEVILAMD 187

Query: 231 ---LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP 287
                 K DV+S GI  +E+   +        PP     A   +       +     P  
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERK--------PPLFNMNAMSALYH-----IAQNESPAL 234

Query: 288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLT 322
           +     +        C++   + RP+ + ++   ++ 
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (428), Expect = 1e-49
 Identities = 66/275 (24%), Positives = 118/275 (42%), Gaps = 30/275 (10%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSK----NQEISQEVDNEIEILSKIHSPR 110
           F   + LGKG  G+VY A  +     +A+K   K       +  ++  E+EI S +  P 
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           ++ L G+ +D+    L++E+   GT+Y  L       +  R      ++A A+   HS+ 
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHSK- 125

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             +IHRDIK  N+L+      ++ DFG ++         R T   GT+ YL P  +    
Sbjct: 126 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRM 180

Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP 290
              K D++S G+L  E +  +        PP   +      K+         R+      
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGK--------PPFEANTYQETYKRIS-------RVEFTFPD 225

Query: 291 IVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG 323
            V +    +  R ++    +RP ++E+++  W+T 
Sbjct: 226 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-49
 Identities = 64/273 (23%), Positives = 111/273 (40%), Gaps = 26/273 (9%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKK-PSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
             LG G+ G VYKA  +      A K   +K++E  ++   EI+IL+    P +V LL  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
                +  +++EF + G +  V+    RPL   +   +  Q   A+  LH     IIHRD
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--KIIHRD 135

Query: 178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL-----S 232
           +K+ N+L   + + +L DFG++          R     GT  ++ P  V  +        
Sbjct: 136 LKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193

Query: 233 TKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV 292
            K DV+S GI L+E+           +P  ++          KI     P +  P     
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHH-ELNPMRVLL---------KIAKSEPPTLAQPSR--W 241

Query: 293 RKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG 323
                    +C+    + R +  +++   ++T 
Sbjct: 242 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 4e-49
 Identities = 60/286 (20%), Positives = 123/286 (43%), Gaps = 33/286 (11%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR-------GRQVAVK--KPSKNQEISQEVDNEIEILSKIH 107
            +  + LG+GS G VY+ V +         +VA+K    + +     E  NE  ++ + +
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNR---------PLNWGRRIRLALQ 158
              +V LLG  +  +  L+++E M+ G L   L S            P +  + I++A +
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 159 VAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTI 218
           +A  +  L++     +HRD+ + N ++  +F  ++GDFG+       ++  +       +
Sbjct: 142 IADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199

Query: 219 GYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILS 278
            ++ P  +     +T +DV+SFG++L EI +  +    G S   ++ +    + +G +  
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----VMEGGL-- 253

Query: 279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL 324
                    K       L  +   C +   + RPS  EI+  +   
Sbjct: 254 -------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-47
 Identities = 71/282 (25%), Positives = 138/282 (48%), Gaps = 26/282 (9%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVN 113
           ++  + +G+G+ G+VY A+    G++VA+++ +  Q+  +E + NEI ++ +  +P +VN
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 114 LLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPI 173
            L       +  +V+E+++ G+L DV+      ++ G+   +  +  +A+E LHS    +
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN--QV 137

Query: 174 IHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLST 233
           IHRDIKS N+L+  + + +L DFG   +  +   + + +   GT  ++ P  VT      
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 234 KTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR 293
           K D++S GI+ +E+I         +   + +     +   G       P +  P+   + 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP----YLNENPLRALYLIATNGT------PELQNPEK--LS 243

Query: 294 KQLAVIAVRCVRSCRERRPSMKEIVD--WLTG---LSKLVPL 330
                   RC+    E+R S KE++   +L     LS L PL
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPL 285

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 1e-46
 Identities = 80/306 (26%), Positives = 122/306 (39%), Gaps = 40/306 (13%)

Query: 45  FDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVK--KPSKNQEISQE 95
           +D S  E   +     K LG+G+ G V +A           R VAVK  K        + 
Sbjct: 3   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62

Query: 96  VDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVV-EFMSNGTLYDVLHSNNR-------- 145
           + +E++IL  I H   +VNLLG        L+V+ EF   G L   L S           
Sbjct: 63  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122

Query: 146 -------PLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGL 198
                   L     I  + QVAK +E L S     IHRD+ + N+L+      ++ DFGL
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGL 180

Query: 199 ALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGF 258
           A     D    R       + ++ P  +     + ++DV+SFG+LL EI S   +    +
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---Y 237

Query: 259 SPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
               I +     +K+G        R P    P + +      + C      +RP+  E+V
Sbjct: 238 PGVKIDEEFCRRLKEGT-----RMRAPDYTTPEMYQ----TMLDCWHGEPSQRPTFSELV 288

Query: 319 DWLTGL 324
           + L  L
Sbjct: 289 EHLGNL 294

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  163 bits (414), Expect = 1e-46
 Identities = 59/276 (21%), Positives = 118/276 (42%), Gaps = 23/276 (8%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE-VDNEIEILSKIHSPRLVNLLGF 117
           + LG G+ G V++ V +  GR    K  +    + +  V NEI I++++H P+L+NL   
Sbjct: 35  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
             D  + +L++EF+S G L+D + + +  ++    I    Q  + ++ +H     I+H D
Sbjct: 95  FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH--SIVHLD 152

Query: 178 IKSANVLIDRNFNAR--LGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKT 235
           IK  N++ +    +   + DFGLA +   D     +T    T  +  P  V  + +   T
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYT 209

Query: 236 DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQ 295
           D+++ G+L   ++S       G      +      +K+       D          V  +
Sbjct: 210 DMWAIGVLGYVLLSGLSPFA-GEDDLETLQ----NVKRC------DWEFDEDAFSSVSPE 258

Query: 296 LAVIAVRCVRSCRERRPSMKEIVD--WLTGLSKLVP 329
                   ++    +R ++ + ++  WL G    + 
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  161 bits (409), Expect = 5e-46
 Identities = 62/298 (20%), Positives = 119/298 (39%), Gaps = 29/298 (9%)

Query: 33  SQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ 90
            Q   +P++I+H      +   + +   + LG G+ G V++   R  G   A K      
Sbjct: 10  KQYYPQPVEIKH------DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH 63

Query: 91  EISQE-VDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNW 149
           E  +E V  EI+ +S +  P LVNL     D  + +++ EFMS G L++ +   +  ++ 
Sbjct: 64  ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 123

Query: 150 GRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI--DRNFNARLGDFGLALRCGVDNF 207
              +    QV K +  +H      +H D+K  N++    R+   +L DFGL         
Sbjct: 124 DEAVEYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181

Query: 208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA 267
              +T   GT  +  P       +   TD++S G+L   ++S           P   +  
Sbjct: 182 VKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL--------SPFGGEND 230

Query: 268 APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG 323
              ++   + S  D  +       + +       + + +    R ++ + ++  WLT 
Sbjct: 231 DETLR--NVKSC-DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-45
 Identities = 72/303 (23%), Positives = 129/303 (42%), Gaps = 45/303 (14%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR---------GRQVAVK--KPSKNQEISQEVDNEIEILSK 105
               K LG+G+ G V  A              +VAVK  K    ++   ++ +E+E++  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 106 I-HSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRP---------------LNW 149
           I     ++NLLG         ++VE+ S G L + L +   P               L+ 
Sbjct: 75  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134

Query: 150 GRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF 209
              +  A QVA+ +E L S     IHRD+ + NVL+  +   ++ DFGLA      ++  
Sbjct: 135 KDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP 269
           ++T     + ++ P  +     + ++DV+SFG+LL EI +   +   G     +      
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK---- 248

Query: 270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP 329
           L+K+G             K      +L ++   C  +   +RP+ K++V+    L ++V 
Sbjct: 249 LLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED---LDRIVA 296

Query: 330 LHS 332
           L S
Sbjct: 297 LTS 299

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 3e-45
 Identities = 59/283 (20%), Positives = 114/283 (40%), Gaps = 29/283 (10%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE----VDNEIEILSKIHSPR 110
           F   K+LG+GS  +V  A      R+ A+K   K   I +     V  E +++S++  P 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
            V L     D +     + +  NG L   +       +         ++  A+E LH   
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHG-- 126

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             IIHRD+K  N+L++ + + ++ DFG A     ++ + R+    GT  Y+ P  +T  +
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP 290
               +D+++ G ++ ++++         +   I       I K +    F  +  P    
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQ----KIIKLEY--DFPEKFFPKARD 239

Query: 291 IVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVPLHSW 333
           +V K L + A         +R   +E+  +    +     H +
Sbjct: 240 LVEKLLVLDA--------TKRLGCEEMEGYGPLKA-----HPF 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 1e-43
 Identities = 50/262 (19%), Positives = 100/262 (38%), Gaps = 20/262 (7%)

Query: 60  QKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
            + LG+G  G V++ V     +    K           V  EI IL+      +++L   
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
               ++ +++ EF+S   +++ ++++   LN    +    QV +A++ LHS    I H D
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS--HNIGHFD 127

Query: 178 IKSANVLID--RNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKT 235
           I+  N++    R+   ++ +FG A +    +             Y  P     D +ST T
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 236 DVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQ 295
           D++S G L+  ++S         +   I++     I   +                +  +
Sbjct: 185 DMWSLGTLVYVLLSGINPFL-AETNQQIIE----NIMNAE------YTFDEEAFKEISIE 233

Query: 296 LAVIAVRCVRSCRERRPSMKEI 317
                 R +   R+ R +  E 
Sbjct: 234 AMDFVDRLLVKERKSRMTASEA 255

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (380), Expect = 2e-42
 Identities = 64/290 (22%), Positives = 113/290 (38%), Gaps = 26/290 (8%)

Query: 47  YSDLEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVK--KPSKNQEISQEVDNEIEI 102
           +   E   + +  + +LG G+   V  A  +   + VA+K       +     ++NEI +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 103 LSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKA 162
           L KI  P +V L           L+++ +S G L+D +             RL  QV  A
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDA 119

Query: 163 VEILHSEMPPIIHRDIKSANVLI---DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIG 219
           V+ LH     I+HRD+K  N+L    D +    + DFGL+      +     +   GT G
Sbjct: 120 VKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPG 174

Query: 220 YLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV 279
           Y+ P  +     S   D +S G++   ++           PP   +  A L +  +IL  
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY--------PPFYDENDAKLFE--QILKA 224

Query: 280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLSKL 327
            +     P    +           +    E+R + ++ +   W+ G + L
Sbjct: 225 -EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTAL 273

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  148 bits (375), Expect = 6e-42
 Identities = 62/280 (22%), Positives = 115/280 (41%), Gaps = 26/280 (9%)

Query: 54  TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSK----NQEISQEVDNEIEILSKIH 107
           ++ +   ++LG G    V+ A      R VAVK        +         E +  + ++
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 108 SPRLVNLLGF----SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
            P +V +       +       +V+E++   TL D++H    P+   R I +     +A+
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQAL 124

Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD-NFRFRSTPPAGTIGYLD 222
              H     IIHRD+K AN++I      ++ DFG+A       N   ++    GT  YL 
Sbjct: 125 NFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP 282
           P     D++  ++DV+S G +L E+++        F+  S V  A   +++       DP
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVRE-------DP 231

Query: 283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRP-SMKEIVDWL 321
             P  +   +   L  + ++ +    E R  +  E+   L
Sbjct: 232 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  148 bits (374), Expect = 9e-42
 Identities = 54/280 (19%), Positives = 113/280 (40%), Gaps = 36/280 (12%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKK----------PSKNQEISQEVDNEIEILS 104
           +  +++LG+G    V + + +   ++ AVK             + QE+ +    E++IL 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 105 KIHS-PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
           K+   P ++ L      +    LV + M  G L+D L      L+     ++   + + +
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEVI 123

Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
             LH     I+HRD+K  N+L+D + N +L DFG + +        +     GT  YL P
Sbjct: 124 CALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAP 178

Query: 224 ------CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKIL 277
                           + D++S G+++  +++          PP        +++   I+
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS--------PPFWHRKQMLMLR--MIM 228

Query: 278 SVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
           S  + +   P+       +  +  R +    ++R + +E 
Sbjct: 229 SG-NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 8e-40
 Identities = 54/288 (18%), Positives = 114/288 (39%), Gaps = 31/288 (10%)

Query: 60  QKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKI-HSPRLVNLLG 116
            ++LG G +G V +   +    + A+K          +   E+E+  +    P +V ++ 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVD 72

Query: 117 ----FSNDSKDRLLVVEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMP 171
                    K  L+V+E +  G L+  +    ++         +   + +A++ LHS   
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 130

Query: 172 PIIHRDIKSANVLIDRNFN---ARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
            I HRD+K  N+L          +L DFG A      N          T  Y+ P  + P
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187

Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
           +      D++S G+++  ++             +I       I+ G+         P P+
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFY-SNHGLAISPGMKTRIRMGQ------YEFPNPE 240

Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLSKL--VPLHS 332
              V +++ ++    +++   +R ++ E ++  W+   +K+   PLH+
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHT 288

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 8e-39
 Identities = 62/296 (20%), Positives = 103/296 (34%), Gaps = 29/296 (9%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKK------PSKNQEISQEVDNEIEILSKIHSPRLV 112
             LG+G   +VYKA  +   + VA+KK            I++    EI++L ++  P ++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            LL       +  LV +FM        +  N+  L         L   + +E LH     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL- 231
           I+HRD+K  N+L+D N   +L DFGLA   G  N  +  T    T  Y  P  +    + 
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARMY 178

Query: 232 STKTDVFSFGILLLEIISCR------------KAIDIGFSPPSIVDWAAPLIKKGKILSV 279
               D+++ G +L E++                 I      P+   W         +   
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 280 FDPRIPPPK-DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLSKLVPLHS 332
             P IP           L  +           R +  + +   + +      P   
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 294

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  137 bits (346), Expect = 1e-37
 Identities = 41/279 (14%), Positives = 90/279 (32%), Gaps = 22/279 (7%)

Query: 60  QKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGF 117
            + +G+GS G +++       +QVA+K   +  + + ++ +E      +     +  + +
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 118 SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD 177
                   ++V  +   +L D+L    R  +       A Q+   V+ +H     +++RD
Sbjct: 69  FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE--KSLVYRD 126

Query: 178 IKSANVLIDRNF-----NARLGDFGLALRC-----GVDNFRFRSTPPAGTIGYLDPCYVT 227
           IK  N LI R          + DFG+                     +GT  Y+      
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186

Query: 228 PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP 287
               S + D+ + G + +  +        G  P   +  A    K  +I           
Sbjct: 187 GREQSRRDDLEALGHVFMYFLR-------GSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239

Query: 288 KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK 326
                 ++             +  P    +    + + +
Sbjct: 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-37
 Identities = 64/296 (21%), Positives = 110/296 (37%), Gaps = 28/296 (9%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVK---KPSKNQEISQEVDNEIEILSKIHSPRL 111
           F + + +G+G++G VYKA  +  G  VA+K     ++ + +      EI +L +++ P +
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V LL   +      LV EF+       +  S    +          Q+ + +   HS   
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            ++HRD+K  N+LI+     +L DFGLA   GV   R  +              +     
Sbjct: 123 -VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYY 180

Query: 232 STKTDVFSFGILLLEIISCR------------KAIDIGFSPPSIVDWAAPLIKKGKILSV 279
           ST  D++S G +  E+++ R              I      P  V W  P +        
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW--PGVTSMPDYKP 238

Query: 280 FDPRIPPPKDPIVRKQLAVIAVRCVRSC----RERRPSMKEIVD--WLTGLSKLVP 329
             P+        V   L       +         +R S K  +   +   ++K VP
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (344), Expect = 2e-37
 Identities = 52/272 (19%), Positives = 94/272 (34%), Gaps = 22/272 (8%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           + +G GS G +Y       G +VA+K      +   ++  E +I   +     +  + + 
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 119 NDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDI 178
               D  ++V  +   +L D+ +  +R  +    + LA Q+   +E +HS+    IHRD+
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDV 129

Query: 179 KSANVLI---DRNFNARLGDFGLA-----LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
           K  N L+    +     + DFGLA      R         +    GT  Y          
Sbjct: 130 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 189

Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK-D 289
            S + D+ S G +L+               P     AA   +K + +S      P     
Sbjct: 190 QSRRDDLESLGYVLMYFNLGS--------LPWQGLKAATKRQKYERISEKKMSTPIEVLC 241

Query: 290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWL 321
                + A     C     + +P    +    
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  136 bits (343), Expect = 2e-37
 Identities = 57/279 (20%), Positives = 108/279 (38%), Gaps = 22/279 (7%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR-GRQVAVKK---PSKNQEISQEVDNEIEILSKIHSPRLV 112
           +   + +G+G++G VYKA    G   A+KK     +++ I      EI IL ++    +V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 113 NLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPP 172
            L    +  K  +LV E + +  L  +L      L         LQ+   +   H     
Sbjct: 64  KLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD--RR 120

Query: 173 IIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLS 232
           ++HRD+K  N+LI+R    ++ DFGLA   G+   ++                +     S
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYS 179

Query: 233 TKTDVFSFGILLLEIISCR------------KAIDIGFSPPSIVDWA--APLIKKGKILS 278
           T  D++S G +  E+++                I      P+  +W     L K     +
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI 317
           V++P         + +    +  + ++    +R + K+ 
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 6e-37
 Identities = 55/290 (18%), Positives = 111/290 (38%), Gaps = 30/290 (10%)

Query: 54  TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKK--PSKNQEISQEVDNEIEILSKIHSP 109
              ++    +G+G++G V  A       +VA+KK  P ++Q   Q    EI+IL +    
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 110 RLVNLLGF----SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
            ++ +       + +    + +V  +    LY +L    + L+         Q+ + ++ 
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLKY 124

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS-TPPAGTIGYLDP- 223
           +HS    ++HRD+K +N+L++   + ++ DFGLA     D+      T    T  Y  P 
Sbjct: 125 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 224 CYVTPDNLSTKTDVFSFGILLLEIISCR------------KAIDIGFSPPSIVDWAAPLI 271
             +     +   D++S G +L E++S R              I      PS  D    + 
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 272 KKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSC----RERRPSMKEI 317
            K +   +  P         +       A+  +         +R  +++ 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 6e-37
 Identities = 56/291 (19%), Positives = 106/291 (36%), Gaps = 38/291 (13%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVK-------KPSKNQEISQEVDNEIEILSKIH 107
           +   + LG G    V K   +  G Q A K       K S+     ++++ E+ IL +I 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 108 SPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILH 167
            P ++ L     +  D +L++E ++ G L+D   +    L          Q+   V  LH
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLH 130

Query: 168 SEMPPIIHRDIKSANVLIDRN----FNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDP 223
           S    I H D+K  N+++          ++ DFGLA +    N         GT  ++ P
Sbjct: 131 SLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAP 185

Query: 224 CYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR 283
             V  + L  + D++S G++   ++S       G +    +           + +V +  
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLA---------NVSAV-NYE 234

Query: 284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI--------VDWLTGLSK 326
                             R +    ++R ++++          D    LS 
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSS 285

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 1e-36
 Identities = 52/269 (19%), Positives = 109/269 (40%), Gaps = 27/269 (10%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE----VDNEIEILSK-IHSP 109
           F   K+LGKGS G V+ A  +   +  A+K   K+  +  +       E  +LS     P
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 110 RLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE 169
            L ++       ++   V+E+++ G L   +  +    +  R    A ++   ++ LHS 
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHS- 121

Query: 170 MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPD 229
              I++RD+K  N+L+D++ + ++ DFG+     + + +       GT  Y+ P  +   
Sbjct: 122 -KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQ 178

Query: 230 NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD 289
             +   D +SFG+LL E++  +     G     +       I+       +   +     
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEELFHS----IRMDNP--FYPRWLEKEAK 231

Query: 290 PIVRKQLAVIAVRCVRSCRERRPSMKEIV 318
            ++         +      E+R  ++  +
Sbjct: 232 DLLV--------KLFVREPEKRLGVRGDI 252

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  134 bits (338), Expect = 2e-36
 Identities = 65/291 (22%), Positives = 123/291 (42%), Gaps = 40/291 (13%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS----QEVDNEIEILSKIHSPR 110
           F   + LG GS G V+    R  GR  A+K   K   +     +  ++E  +LS +  P 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 111 LVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM 170
           ++ + G   D++   ++++++  G L+ +L  + R  N   +   A +V  A+E LHS  
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK-FYAAEVCLALEYLHS-- 122

Query: 171 PPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDN 230
             II+RD+K  N+L+D+N + ++ DFG A       +        GT  Y+ P  V+   
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-----CGTPDYIAPEVVSTKP 177

Query: 231 LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP 290
            +   D +SFGIL+ E+++         +     +     I   ++   F P        
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFY-DSNTMKTYE----KILNAEL--RFPPFFNEDVKD 230

Query: 291 IVRKQLAVIAVRCVRSCRER----RPSMKEI--------VDWLTGLSKLVP 329
           ++ + +        R   +R    +   +++        V W   LS+ + 
Sbjct: 231 LLSRLI-------TRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIE 274

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  135 bits (340), Expect = 3e-36
 Identities = 48/254 (18%), Positives = 95/254 (37%), Gaps = 21/254 (8%)

Query: 55  NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN-------QEISQEVDNEIEILSK 105
           N FS  +++G+G  G VY       G+  A+K   K        + ++      + ++S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 106 IHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
              P +V +    +       +++ M+ G L+  L   +   +       A ++   +E 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEH 122

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYL-DPC 224
           +H+    +++RD+K AN+L+D + + R+ D GLA     D  + +     GT GY+    
Sbjct: 123 MHN--RFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEV 176

Query: 225 YVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI 284
                   +  D FS G +L +++         F      D          +        
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTLTMAVELPDSF 232

Query: 285 PPPKDPIVRKQLAV 298
            P    ++   L  
Sbjct: 233 SPELRSLLEGLLQR 246

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 1e-35
 Identities = 64/280 (22%), Positives = 104/280 (37%), Gaps = 42/280 (15%)

Query: 60  QKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-------EISQEVDNEIEILSKIHS-- 108
             LLG G  GSVY  +       VA+K   K++            V  E+ +L K+ S  
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68

Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
             ++ LL +       +L++E            +    L          QV +AV   H+
Sbjct: 69  SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 128

Query: 169 EMPPIIHRDIKSANVLIDRN-FNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVT 227
               ++HRDIK  N+LID N    +L DFG         +    T   GT  Y  P ++ 
Sbjct: 129 C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIR 182

Query: 228 PDNLSTK-TDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP 286
                 +   V+S GILL +++            P         I +G++   F  R+  
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGD--------IPF---EHDEEIIRGQVF--FRQRVSS 229

Query: 287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL 324
               ++R         C+      RP+ +EI +  W+  +
Sbjct: 230 ECQHLIR--------WCLALRPSDRPTFEEIQNHPWMQDV 261

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 5e-35
 Identities = 54/294 (18%), Positives = 108/294 (36%), Gaps = 33/294 (11%)

Query: 61  KLLGKGSHGSVYKAVLR---GRQVAVK---KPSKNQEISQEVDNEIEILSKI---HSPRL 111
             +G+G++G V+KA      GR VA+K     +  + +      E+ +L  +     P +
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 112 VNLLGFSNDSKDR-----LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
           V L      S+        LV E +       +       +       +  Q+ + ++ L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
           HS    ++HRD+K  N+L+  +   +L DFGLA    + +F+   T    T+ Y  P  +
Sbjct: 133 HSH--RVVHRDLKPQNILVTSSGQIKLADFGLA---RIYSFQMALTSVVVTLWYRAPEVL 187

Query: 227 TPDNLSTKTDVFSFGILLLEIISCR------------KAIDIGFSPPSIVDWAAPLIKKG 274
              + +T  D++S G +  E+   +              I      P   DW   +    
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247

Query: 275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLSK 326
           +       +        + +    + ++C+     +R S    +   +   L +
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 4e-34
 Identities = 59/250 (23%), Positives = 100/250 (40%), Gaps = 18/250 (7%)

Query: 55  NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQE----VDNEIEILSKIHS 108
           N F   KLLGKG+ G V     +  GR  A+K   K   I+++       E  +L     
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P L  L            V+E+ + G L+  L    R     R      ++  A+E LHS
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHS 123

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               +++RDIK  N+++D++ + ++ DFGL      D    +     GT  YL P  +  
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLED 179

Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
           ++     D +  G+++ E++  R           + +    LI   +I   F   + P  
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFE----LILMEEI--RFPRTLSPEA 232

Query: 289 DPIVRKQLAV 298
             ++   L  
Sbjct: 233 KSLLAGLLKK 242

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-33
 Identities = 55/294 (18%), Positives = 106/294 (36%), Gaps = 36/294 (12%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVK---KPSKNQEISQEVDNEIEILSKIHSPRL 111
           + +   +G+G+ G V+KA  R  G++VA+K     ++ +        EI+IL  +    +
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 112 VNLLGFSNDSKDR--------LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
           VNL+                  LV +F  +     + +            R+   +   +
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLLNGL 130

Query: 164 EILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA--LRCGVDNFRFRSTPPAGTIGYL 221
             +H     I+HRD+K+ANVLI R+   +L DFGLA       ++   R T    T+ Y 
Sbjct: 131 YYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 222 DPCYVTPD-NLSTKTDVFSFGILLLEIIS-------------CRKAIDIGFSPPSIVDWA 267
            P  +  + +     D++  G ++ E+ +                   +  S    V   
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 268 APLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSC----RERRPSMKEI 317
               +  + L +   +    KD +        A+  +         +R    + 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 2e-33
 Identities = 56/288 (19%), Positives = 102/288 (35%), Gaps = 36/288 (12%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNL 114
           +++ K++G GS G VY+A L   G  VA+KK  +++      + E++I+ K+    +V L
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRL 78

Query: 115 LGF------SNDSKDRLLVVEFMSNGTLYDVLH--SNNRPLNWGRRIRLALQVAKAVEIL 166
             F        D     LV++++         H     + L          Q+ +++  +
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138

Query: 167 HSEMPPIIHRDIKSANVLIDRN-FNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           HS    I HRDIK  N+L+D +    +L DFG A +          +             
Sbjct: 139 HS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAPELI 194

Query: 226 VTPDNLSTKTDVFSFGILLLEIISCR------------KAIDIGFSPPSIVDWAAPLIKK 273
               + ++  DV+S G +L E++  +              I      P+        +  
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI--REMNP 252

Query: 274 GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSC----RERRPSMKEI 317
                 F      P   + R +    A+             R +  E 
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (319), Expect = 3e-33
 Identities = 65/289 (22%), Positives = 110/289 (38%), Gaps = 32/289 (11%)

Query: 55  NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEIS----QEVDNEIEILSKIHS 108
           + F   K LG GS G V     +  G   A+K   K + +     +   NE  IL  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 109 PRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS 168
           P LV L     D+ +  +V+E+++ G ++  L       +       A Q+    E LHS
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
               +I+RD+K  N+LID+    ++ DFG A R     +        GT   L P  +  
Sbjct: 160 L--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEALAPEIILS 212

Query: 229 DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK 288
              +   D ++ G+L+ E+            P  I +     I  GK+   F        
Sbjct: 213 KGYNKAVDWWALGVLIYEMA-AGYPPFFADQPIQIYEK----IVSGKV--RFPSHFSSDL 265

Query: 289 DPIVRKQLAVIAVRCVRSCRERRPSMKEI--------VDWLTGLSKLVP 329
             ++R  L V   +   +    +  + +I         DW+    + V 
Sbjct: 266 KDLLRNLLQVDLTKRFGN---LKNGVNDIKNHKWFATTDWIAIYQRKVE 311

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 2e-32
 Identities = 60/292 (20%), Positives = 106/292 (36%), Gaps = 30/292 (10%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVK---KPSKNQEISQEVDNEIEILSKIHSPRL 111
           + + + +G+G++G+V+KA  R     VA+K       ++ +      EI +L ++    +
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMP 171
           V L    +  K   LV EF           S N  L+         Q+ K +   H    
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCH--SR 120

Query: 172 PIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL 231
            ++HRD+K  N+LI+RN   +L +FGLA   G+   R  S                    
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 232 STKTDVFSFGILLLEIISCR-------------KAIDIGFSPPSIVDWAAPLIKKGKILS 278
           ST  D++S G +  E+ +               K I      P+   W  P + K     
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW--PSMTKLPDYK 237

Query: 279 VFDPRIPPPKDPIVRKQLAVIAVRCVRSC----RERRPSMKEIVD--WLTGL 324
            +           V  +L       +++       +R S +E +   + +  
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 6e-30
 Identities = 48/294 (16%), Positives = 104/294 (35%), Gaps = 32/294 (10%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVK---KPSKNQEISQEVDNEIEILSKIHSPRL 111
           + + + +G G++G+V  AV    G +VA+K   +P +++  ++    E+ +L  +    +
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 112 VNLLGFSNDSKDRLLVVEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHS 168
           + LL      +      +F                +  L   R   L  Q+ K +  +H+
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139

Query: 169 EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTP 228
                 HRD+K  N+ ++ +   ++ DFGLA +   +     +              +  
Sbjct: 140 AGII--HRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNW 193

Query: 229 DNLSTKTDVFSFGILLLEIISCR------------KAIDIGFSPPSIVDWAAPLIKKGKI 276
              +   D++S G ++ E+I+ +            K I      P           + K 
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253

Query: 277 LSVFDPRIPPPKDPIVRKQLAVIAVRCVRSC----RERRPSMKEIVD--WLTGL 324
                P +       +    + +AV  +        E+R +  E +   +   L
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-29
 Identities = 50/287 (17%), Positives = 110/287 (38%), Gaps = 34/287 (11%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVK---KPSKNQEISQEVDNEIEILSKIHSPRL 111
           +     +G G++GSV  A     G +VAVK   +P ++   ++    E+ +L  +    +
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 112 VNLLGF-----SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEIL 166
           + LL       S +  + + +V  +    L +++    + L       L  Q+ + ++ +
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 137

Query: 167 HSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYV 226
           HS    IIHRD+K +N+ ++ +   ++ DFGLA     +   + +T             +
Sbjct: 138 HSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIML 191

Query: 227 TPDNLSTKTDVFSFGILLLEIISCR------------KAIDIGFSPPSIVDWAAPLIKKG 274
              + +   D++S G ++ E+++ R            K I      P          +  
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSC----RERRPSMKEI 317
           +       ++P      V      +AV  +        ++R +  + 
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 8e-29
 Identities = 66/303 (21%), Positives = 122/303 (40%), Gaps = 41/303 (13%)

Query: 25  HQTQSSKTSQKQEKPIKIQHFDYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-----GR 79
           H+ +++  +   EK + I++F+              K+LG G++G V+          G+
Sbjct: 7   HELRTANLTGHAEK-VGIENFEL------------LKVLGTGAYGKVFLVRKISGHDTGK 53

Query: 80  QVAVKKPSK-----NQEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLVVEFMSN 133
             A+K   K       + ++    E ++L  I  SP LV L           L++++++ 
Sbjct: 54  LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 113

Query: 134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARL 193
           G L+  L    R            ++  A+E LH     II+RDIK  N+L+D N +  L
Sbjct: 114 GELFTHLSQRER-FTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVL 170

Query: 194 GDFGLALRCGVDNFRFRSTPPAGTIGYL--DPCYVTPDNLSTKTDVFSFGILLLEIISCR 251
            DFGL+    V +   R+    GTI Y+  D             D +S G+L+ E+++  
Sbjct: 171 TDFGLSKEF-VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-- 227

Query: 252 KAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERR 311
                G SP ++        +  + +   +P  P     + +  +     R +    ++R
Sbjct: 228 -----GASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQ----RLLMKDPKKR 278

Query: 312 PSM 314
              
Sbjct: 279 LGC 281

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  112 bits (280), Expect = 3e-28
 Identities = 59/319 (18%), Positives = 114/319 (35%), Gaps = 49/319 (15%)

Query: 46  DYSDLEAATNGFSEQ------KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVD 97
           +Y D E+    +  Q      + LG+G +  V++A+      +V VK     ++  +++ 
Sbjct: 20  EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIK 77

Query: 98  NEIEILSKI-HSPRLVNLLGFSNDSKDRL--LVVEFMSNGTLYDVLHSNNRPLNWGRRIR 154
            EI+IL  +   P ++ L     D   R   LV E ++N     +     + L       
Sbjct: 78  REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRF 133

Query: 155 LALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-NFNARLGDFGLALRCGVDNFRFRSTP 213
              ++ KA++  HS    I+HRD+K  NV+ID  +   RL D+GLA              
Sbjct: 134 YMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNV 188

Query: 214 PAGTIGYLDP-CYVTPDNLSTKTDVFSFGILLLEIISCR-------------KAIDIGFS 259
              +  +  P   V         D++S G +L  +I  +               I     
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248

Query: 260 PPSIVDWAA----------PLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRE 309
              + D+              I        ++  +      +V  +      + +R   +
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308

Query: 310 RRPSMKEIVD--WLTGLSK 326
            R + +E ++  +   + K
Sbjct: 309 SRLTAREAMEHPYFYTVVK 327

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (274), Expect = 3e-27
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 20/206 (9%)

Query: 57  FSEQKLLGKGSHGSVYKAVLR--GRQVAVK---KPSKNQEISQEVDNEIEILSKIHSPRL 111
           +   K +G G+ G V  A      R VA+K   +P +NQ  ++    E+ ++  ++   +
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 112 VNLLGF------SNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEI 165
           ++LL          + +D  LV+E M       +    +      R   L  Q+   ++ 
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD----HERMSYLLYQMLCGIKH 134

Query: 166 LHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCY 225
           LHS     IHRD+K +N+++  +   ++ DFGLA   G     F  TP   T  Y  P  
Sbjct: 135 LHSAGI--IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEV 189

Query: 226 VTPDNLSTKTDVFSFGILLLEIISCR 251
           +         D++S G ++ E++  +
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHK 215

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (248), Expect = 1e-23
 Identities = 38/209 (18%), Positives = 76/209 (36%), Gaps = 19/209 (9%)

Query: 61  KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFS 118
           + LG G   +V+ A        VA+K    ++  ++  ++EI++L +++           
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 119 NDSKDRLLVV---------------EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAV 163
            +   +LL                 E +    L  +    +R +      +++ Q+   +
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 164 EILHSEMPPIIHRDIKSANVLIDRN-FNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLD 222
           + +H     IIH DIK  NVL++       L    +A       +    T    T  Y  
Sbjct: 139 DYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 223 PCYVTPDNLSTKTDVFSFGILLLEIISCR 251
           P  +         D++S   L+ E+I+  
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 71.4 bits (174), Expect = 4e-15
 Identities = 21/159 (13%), Positives = 49/159 (30%), Gaps = 35/159 (22%)

Query: 61  KLLGKGSHGSVYKAVL-RGRQVAVK-------------------KPSKNQEISQEVDNEI 100
           KL+G+G   +V+     +  +  VK                       +    +   NE 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 101 EILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVA 160
             L K+    +  +  +  ++    +++E +               +       +   + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNA----VLMELIDAK--------ELYRVRVENPDEVLDMIL 113

Query: 161 KAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA 199
           + V   +     I+H D+   NVL+       + DF  +
Sbjct: 114 EEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIIDFPQS 149

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	487
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.73
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.22
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.87
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.19
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.0
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.98

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-55  Score=428.75  Aligned_cols=266  Identities=25%  Similarity=0.432  Sum_probs=212.4

Q ss_pred             HHhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           51 EAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        51 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      +...++|.+.+.||+|+||.||+|++++ .||||++...   ....+.|.+|++++++++|||||++++++.+ +.+++|
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            3445789999999999999999998765 5999998643   3445789999999999999999999999865 468999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      ||||++|+|.+++...+..+++..+..++.||+.||+|||++  +||||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~--~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC--CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999999987767799999999999999999999999  999999999999999999999999999977654443


Q ss_pred             ccccCCCCCCCccCCccccCCC---CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPD---NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      ........||+.|||||++.+.   .++.++|||||||++|||+||+.||........+..    ....+..    .+. 
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~----~~~~~~~----~p~-  230 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF----MVGRGYL----SPD-  230 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH----HHHHTSC----CCC-
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHH----HHhcCCC----CCc-
Confidence            3344567899999999998653   579999999999999999999999964322222211    1111111    111 


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccccCC
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKLVP  329 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  329 (487)
                      ....+..+++++.+|+.+||+.||.+|||+++|++.|+.+.+.+|
T Consensus       231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            112344567889999999999999999999999999999887654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=422.22  Aligned_cols=255  Identities=25%  Similarity=0.361  Sum_probs=208.9

Q ss_pred             cCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      ++|.+.+.||+|+||.||+|.+. ++.||||++.......++|.+|++++++++||||++++|+|.+.+..++||||+++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~   84 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   84 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence            57899999999999999999997 67899999988777778899999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      |+|.+++......+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||+++........ ....
T Consensus        85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~--~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~  161 (263)
T d1sm2a_          85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTG  161 (263)
T ss_dssp             CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred             CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc--ceeecccchhheeecCCCCeEecccchheeccCCCce-eecc
Confidence            999999988777799999999999999999999999  9999999999999999999999999999876544322 2334


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVR  293 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  293 (487)
                      ..||+.|+|||++.+..++.++|||||||++|||+|+..|+........+...    +..+         .....+..++
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~----i~~~---------~~~~~p~~~~  228 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----ISTG---------FRLYKPRLAS  228 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH----HHHT---------CCCCCCTTSC
T ss_pred             eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH----HHhc---------CCCCCccccC
Confidence            57899999999999999999999999999999999976666544333332221    1111         1122344567


Q ss_pred             HHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          294 KQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       294 ~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      +++.+|+.+||+.||.+|||+++|++.|+++.
T Consensus       229 ~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            88999999999999999999999999998875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-54  Score=427.42  Aligned_cols=261  Identities=25%  Similarity=0.377  Sum_probs=223.4

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      ++...++|.+.+.||+|+||.||+|++.  ++.||||+++.+....++|.+|++++++++|||||+++++|.+.+..++|
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence            3445578999999999999999999996  78999999988777778899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          128 VEFMSNGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ||||++|+|.+++.. ....+++..++.++.|++.||.|||++  +|+||||||+||||+.++.+||+|||+++......
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC--CcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            999999999999975 345699999999999999999999999  99999999999999999999999999998665433


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                      .. ......|++.|+|||++.+..++.++|||||||++|||++|..||..+.....+...    +.         .....
T Consensus       170 ~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~----i~---------~~~~~  235 (287)
T d1opja_         170 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----LE---------KDYRM  235 (287)
T ss_dssp             SE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----HH---------TTCCC
T ss_pred             ce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHH----Hh---------cCCCC
Confidence            22 334456899999999999999999999999999999999988887654443333221    11         12233


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      +.+..+++++.+|+.+||+.||.+|||+.+|+++|+.+..
T Consensus       236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            4455677899999999999999999999999999988743

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-54  Score=418.37  Aligned_cols=251  Identities=23%  Similarity=0.298  Sum_probs=208.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .++|++.+.||+|+||.||+|++.  ++.||||++....  ...+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            357999999999999999999986  8899999976543  234568999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      ||++|+|.+++...+ .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.+...+...
T Consensus        84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~--~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHc--CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            999999999997654 599999999999999999999999  99999999999999999999999999998765544443


Q ss_pred             ccCCCCCCCccCCccccCCCCC-CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                      ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||............   . .        ........
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~---~-~--------~~~~~~~~  228 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---W-K--------EKKTYLNP  228 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH---H-H--------TTCTTSTT
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH---H-h--------cCCCCCCc
Confidence            4556789999999999988776 57899999999999999999999743332221110   1 1        11111122


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ...+++++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         229 WKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            3456788999999999999999999999975

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=418.40  Aligned_cols=259  Identities=23%  Similarity=0.399  Sum_probs=216.8

Q ss_pred             hHHHhhcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           49 DLEAATNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        49 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      +++...++|.+.+.||+|+||.||+|.++ ++.||||++.......+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence            34445678999999999999999999998 6789999998877777889999999999999999999998865 457999


Q ss_pred             EEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          128 VEFMSNGTLYDVLHSN-NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      |||+++|+|.+++... ...+++..++.|+.||+.||.|||++  +|+||||||+||||+.++.+||+|||+++.+....
T Consensus        86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~--~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCccchhheeeecccceeeccccceEEccCCc
Confidence            9999999999987542 23599999999999999999999999  99999999999999999999999999998775443


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                      .. ......||+.|+|||++..+.++.++|||||||++|||+||..|+........+...    +..         ....
T Consensus       164 ~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~----i~~---------~~~~  229 (272)
T d1qpca_         164 YT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN----LER---------GYRM  229 (272)
T ss_dssp             EE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHT---------TCCC
T ss_pred             cc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH----HHh---------cCCC
Confidence            22 344567999999999999889999999999999999999977776544333332221    111         1222


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      +.+..+++++.+|+.+||+.||++|||+++|++.|+.+
T Consensus       230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            33456778899999999999999999999999988764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.3e-53  Score=418.91  Aligned_cols=256  Identities=21%  Similarity=0.377  Sum_probs=203.1

Q ss_pred             cCcccceeecccCceEEEEEEEC--C---eEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--G---RQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g---~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      ++|++.++||+|+||.||+|.+.  +   ..||||++...  ....+.|.+|++++++++|||||+++|+|.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            45778899999999999999985  2   25899987653  34456799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      ||||++|+|.+++......+++..++.++.||+.||.|||++  +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM--NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC--CCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence            999999999999988777799999999999999999999999  999999999999999999999999999987654322


Q ss_pred             cc---ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          208 RF---RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       208 ~~---~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ..   ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||.. .....+..    .+..         .
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~----~i~~---------~  249 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVIN----AIEQ---------D  249 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHH----HHHT---------T
T ss_pred             cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHHH----HHHc---------C
Confidence            11   1223467999999999999999999999999999999998 7888853 22222221    1111         1


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ...+.+..++.++.+|+.+||+.||.+|||+.||++.|+.+.+
T Consensus       250 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         250 YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            2233445677889999999999999999999999999988653

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=415.28  Aligned_cols=247  Identities=25%  Similarity=0.386  Sum_probs=210.2

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ++|.+.+.||+|+||.||+|.+.  |+.||||++.... ...+.+.+|++++++++|||||++++++.+.+.+|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999976  8899999876543 34467999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      ++|+|.+++.+.  .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.+.....  ..
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~--~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~  173 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR  173 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CB
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCcHHHeEECCCCcEeeccchhheeeccccc--cc
Confidence            999999988765  499999999999999999999999  999999999999999999999999999987654332  34


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||......    .........+        ....+.+..
T Consensus       174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~~~~~~--------~~~~~~~~~  241 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYLIATNG--------TPELQNPEK  241 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHHC--------SCCCSSGGG
T ss_pred             cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH----HHHHHHHhCC--------CCCCCCccc
Confidence            4568999999999999999999999999999999999999999632211    1111111111        111233456


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ++.++.+|+.+||+.||.+|||+.|+++
T Consensus       242 ~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            7889999999999999999999999985

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-53  Score=409.12  Aligned_cols=252  Identities=22%  Similarity=0.385  Sum_probs=217.2

Q ss_pred             cCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      ++|++.+.||+|+||+||+|+++ ++.||||+++......+.|.+|+.++++++||||++++|+|.+.+.+++||||+++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~   83 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN   83 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence            68999999999999999999997 66899999988777778899999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccccCC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTP  213 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  213 (487)
                      |+|.+++......+++..+++++.|++.||.|||++  +|+||||||+|||++.++.+||+|||+++........ ....
T Consensus        84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~--~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~  160 (258)
T d1k2pa_          84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVG  160 (258)
T ss_dssp             EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT--TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCC
T ss_pred             CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc--CcccccccceeEEEcCCCcEEECcchhheeccCCCce-eecc
Confidence            999999887666799999999999999999999999  9999999999999999999999999999766544332 3445


Q ss_pred             CCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChHH
Q 011384          214 PAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIV  292 (487)
Q Consensus       214 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  292 (487)
                      ..||+.|+|||.+.+..++.++|||||||++|||+| |+.||.. ....++..    .+..+         ...+.+..+
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~-~~~~~~~~----~i~~~---------~~~~~p~~~  226 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAE----HIAQG---------LRLYRPHLA  226 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHH----HHHTT---------CCCCCCTTC
T ss_pred             cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC-CCHHHHHH----HHHhC---------CCCCCcccc
Confidence            679999999999999999999999999999999998 7888863 22222221    11111         122334466


Q ss_pred             HHHHHHHHHHhhhhcCCCCCCHHHHHHHHhc
Q 011384          293 RKQLAVIAVRCVRSCRERRPSMKEIVDWLTG  323 (487)
Q Consensus       293 ~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~  323 (487)
                      ++++.+|+.+||+.||++|||+++|++.|..
T Consensus       227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         227 SEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            7889999999999999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-53  Score=409.72  Aligned_cols=243  Identities=25%  Similarity=0.418  Sum_probs=207.9

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||+|++.  ++.||||++.+..    ...+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46999999999999999999996  7899999876432    33467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      |||++|+|.+++...+ .+++..++.++.||+.||+|||++  +|+||||||+|||++.++.+||+|||++.......  
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~--~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--  160 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--  160 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC--CeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence            9999999999998754 499999999999999999999999  99999999999999999999999999997654332  


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||... .......    .+..+          ....
T Consensus       161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~----~i~~~----------~~~~  223 (263)
T d2j4za1         161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-TYQETYK----RISRV----------EFTF  223 (263)
T ss_dssp             --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHH----HHHTT----------CCCC
T ss_pred             --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC-CHHHHHH----HHHcC----------CCCC
Confidence              23457999999999999999999999999999999999999999632 2211111    11111          1123


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..+++++.+|+.+||+.||.+|||++|+++
T Consensus       224 p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         224 PDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            4457789999999999999999999999997

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=411.88  Aligned_cols=258  Identities=22%  Similarity=0.385  Sum_probs=210.7

Q ss_pred             hcCcccceeecccCceEEEEEEECC------eEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLRG------RQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~g------~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      .+.|++.++||+|+||.||+|.+++      ..||||++...  ......|.+|++++++++|||||+++|++.+....+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            4578899999999999999998762      36999998654  334467899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +||||+.+++|.+++......+++..++.++.|++.||.|||++  +|+||||||+||||+.++.+||+|||+++.+...
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~--~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM--NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc--ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999999988777799999999999999999999999  9999999999999999999999999999876443


Q ss_pred             Cc-ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          206 NF-RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      .. ........||+.|+|||++.++.++.++|||||||++|||++|..|+..+.....+...    +.         ...
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~----i~---------~~~  230 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA----IN---------DGF  230 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HH---------TTC
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH----Hh---------ccC
Confidence            22 22233456899999999999999999999999999999999987777654443333221    11         122


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      ..+.+..++.++.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus       231 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            334455677899999999999999999999999999988754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-52  Score=409.30  Aligned_cols=249  Identities=24%  Similarity=0.325  Sum_probs=208.6

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC-hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN-QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      +.|++.+.||+|+||.||+|++.  ++.||||++... ....+.+.+|++++++++|||||++++++.+.+..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999986  789999998654 344577899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      ++|+|.+++.+...++++..+..++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~--~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~  167 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRR  167 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CEEEeecChhheeECCCCCEEEEechhhhccCCCc--ccc
Confidence            99999999877666799999999999999999999999  99999999999999999999999999997654321  133


Q ss_pred             CCCCCCCccCCccccC-----CCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          212 TPPAGTIGYLDPCYVT-----PDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                      ....||+.|+|||++.     ...|+.++|||||||++|||++|+.||.... +....   ..... +.       ....
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~-~~~~~---~~i~~-~~-------~~~~  235 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-PMRVL---LKIAK-SE-------PPTL  235 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC-GGGHH---HHHHH-SC-------CCCC
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC-HHHHH---HHHHc-CC-------CCCC
Confidence            4578999999999984     4467899999999999999999999996432 22211   11111 11       1112


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+..+++++.+|+.+||+.||.+|||++|+++
T Consensus       236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            234567889999999999999999999999985

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-52  Score=409.13  Aligned_cols=257  Identities=23%  Similarity=0.382  Sum_probs=211.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMS  132 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~  132 (487)
                      .++|++.+.||+|+||.||+|+++ ++.||||++.......+.|.+|+.++++++|||||+++++|.+ +..++||||++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            467999999999999999999997 5689999998777777889999999999999999999999965 56799999999


Q ss_pred             CCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          133 NGTLYDVLHS-NNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       133 ~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      +|+|..++.. ....+++..++.++.||+.||+|||++  +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~--~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~  171 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TAR  171 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh--heecccccceEEEECCCCcEEEcccchhhhccCCCc-eee
Confidence            9999998865 234599999999999999999999999  999999999999999999999999999986643332 234


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ....||+.|+|||++..+.++.++|||||||++|||++|..|+..+.....+...+    .         .....+.+..
T Consensus       172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i----~---------~~~~~~~~~~  238 (285)
T d1fmka3         172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV----E---------RGYRMPCPPE  238 (285)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----H---------TTCCCCCCTT
T ss_pred             ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH----H---------hcCCCCCCcc
Confidence            45679999999999999999999999999999999999887776554443333221    1         1122334556


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      +++++.+|+.+||+.||++|||+++|+++|+.....
T Consensus       239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            788999999999999999999999999999876543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-52  Score=407.83  Aligned_cols=254  Identities=23%  Similarity=0.390  Sum_probs=211.7

Q ss_pred             hcCccccee-ecccCceEEEEEEEC----CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           54 TNGFSEQKL-LGKGSHGSVYKAVLR----GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        54 ~~~y~~~~~-LG~G~~g~Vy~~~~~----g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .++|.+... ||+|+||.||+|.++    +..||||+++..  ....+.|.+|++++++++|||||+++|+|.+ +.+|+
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            356777775 999999999999875    447999998754  3445789999999999999999999999975 46899


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      |||||++|+|.+++......+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||+++.+....
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~--~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            9999999999999987666799999999999999999999999  99999999999999999999999999998776543


Q ss_pred             cc-cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          207 FR-FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       207 ~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      .. .......||+.|+|||++..+.++.++|||||||++|||+| |+.||.. .....+..    .+..+         .
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~-~~~~~~~~----~i~~~---------~  229 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK-MKGPEVMA----FIEQG---------K  229 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCTHHHHH----HHHTT---------C
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCC-CCHHHHHH----HHHcC---------C
Confidence            22 22334578999999999998999999999999999999998 8999863 23333222    12222         1


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ..+.+..+++++.+|+.+||+.||++|||+.+|++.|+..
T Consensus       230 ~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2234456778999999999999999999999999988754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-52  Score=417.05  Aligned_cols=256  Identities=26%  Similarity=0.357  Sum_probs=212.3

Q ss_pred             HhhcCcccceeecccCceEEEEEEECC-------eEEEEEEcCCC--hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCC
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKN--QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDS  121 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~g-------~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~  121 (487)
                      ...++|.+.+.||+|+||.||+|++.+       ..||||++...  ......+.+|+.++.++ +|||||+++++|.+.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            345689999999999999999998752       36999987654  33346789999999998 899999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHHhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCC
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNN----------------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK  179 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIk  179 (487)
                      +..++|||||++|+|.++|....                      ..+++..++.++.|++.||+|||++  +|||||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~--~IiHRDlK  191 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLA  191 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT--TEEETTCS
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCc
Confidence            99999999999999999997643                      2489999999999999999999999  99999999


Q ss_pred             CCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCC
Q 011384          180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGF  258 (487)
Q Consensus       180 p~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~  258 (487)
                      |+|||++.++.+||+|||+++...............||+.|||||.+.++.++.++|||||||++|||+| |+.||....
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987655544434455678999999999999999999999999999999998 888886332


Q ss_pred             CCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHh
Q 011384          259 SPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLT  322 (487)
Q Consensus       259 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~  322 (487)
                      ....+..    .+..         ....+.+..+++++.+||.+||+.||++|||++||+++|.
T Consensus       272 ~~~~~~~----~~~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         272 VDANFYK----LIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CSHHHHH----HHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHH----HHhc---------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            2222222    1111         2233445567789999999999999999999999999984

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-52  Score=406.45  Aligned_cols=249  Identities=26%  Similarity=0.375  Sum_probs=195.3

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC--CCceEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSND--SKDRLLV  127 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--~~~~~lV  127 (487)
                      ++|.+.+.||+|+||.||+|++.  |+.||||++...   ....+.+.+|++++++++|||||++++++.+  ...+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57999999999999999999986  889999988654   3344678999999999999999999999865  4568999


Q ss_pred             EEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---CCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          128 VEFMSNGTLYDVLHS---NNRPLNWGRRIRLALQVAKAVEILHSEM---PPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~---~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                      ||||++|+|.+++.+   .+..+++..++.++.||+.||.|||++.   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999864   3456999999999999999999999871   1399999999999999999999999999987


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      +.....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.. .....+..    .+..+..     
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~----~i~~~~~-----  231 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAG----KIREGKF-----  231 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHH----HHHHTCC-----
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHH----HHHcCCC-----
Confidence            653322  23456899999999999999999999999999999999999999963 22222111    1122211     


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                          .+.+..+++++.+|+.+||+.||.+|||+.||++
T Consensus       232 ----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 ----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                1233456788999999999999999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=411.90  Aligned_cols=247  Identities=21%  Similarity=0.298  Sum_probs=205.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+.+.||+|+||.||+|++.  ++.||||++.+..    ...+.+.+|++++++++||||+++++++.+.+.+|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56999999999999999999986  8899999986532    23467999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      |||++|+|.+++...+ .+++..++.++.|++.||+|||++  +|+||||||+|||++.++.+||+|||+++.+......
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~--~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccc--cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            9999999999988765 499999999999999999999999  9999999999999999999999999999877654444


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+.   . .+..++          ...
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-~~~~~~---~-~i~~~~----------~~~  229 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIF---Q-KIIKLE----------YDF  229 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHH---H-HHHTTC----------CCC
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc-CHHHHH---H-HHHcCC----------CCC
Confidence            3445568999999999999999999999999999999999999999742 111111   1 111111          123


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +..+++++.+||.+||+.||.+|||++|++.
T Consensus       230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            3456788999999999999999999999765

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.7e-52  Score=413.52  Aligned_cols=250  Identities=22%  Similarity=0.308  Sum_probs=195.2

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ..+.|.+.+.||+|+||.||+|.+.  ++.||||++.+..  .....+.+|+.++++++|||||++++++.+++.+|+||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4577999999999999999999986  7899999987543  23356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc---cCCcEEEcccccceecCCC
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld---~~~~vkL~DFGla~~~~~~  205 (487)
                      |||++|+|.+++...+ .+++..+..++.||+.||.|||++  +|+||||||+|||+.   .++.+||+|||+++.....
T Consensus        87 E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~--~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          87 QLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             eccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhhc--eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            9999999999997754 599999999999999999999999  999999999999994   5789999999999765433


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......    .+..+      ....+
T Consensus       164 ~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-~~~~~~----~i~~~------~~~~~  229 (307)
T d1a06a_         164 S---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN-DAKLFE----QILKA------EYEFD  229 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHH----HHHTT------CCCCC
T ss_pred             C---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC-HHHHHH----HHhcc------CCCCC
Confidence            2   2334679999999999999999999999999999999999999996321 111111    11111      11233


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      .+....+++++.+|+.+||+.||.+|||++|+++
T Consensus       230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            3344567889999999999999999999999997

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-52  Score=416.46  Aligned_cols=264  Identities=20%  Similarity=0.334  Sum_probs=209.0

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ..++|.+.+.||+|+||.||+|++.  |+.||+|+++..  ......+.+|+.++++++|||||+++++|.+...+|+||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4578999999999999999999986  889999987643  344568999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      |||++|+|.+++.+.+ .+++..++.++.|++.||.|||+ +  +|+||||||+|||++.++.+||+|||+|+.+...  
T Consensus        84 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             ECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             EcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            9999999999998765 49999999999999999999996 6  8999999999999999999999999999765432  


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc-----------Cc-
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK-----------GK-  275 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~-----------~~-  275 (487)
                        ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...................           +. 
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence              2334689999999999999999999999999999999999999997543221111000000000           00 


Q ss_pred             -----------------cccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhc
Q 011384          276 -----------------ILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG  323 (487)
Q Consensus       276 -----------------i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~  323 (487)
                                       +........+......++.++.+|+.+||+.||.+|||++|+++  ||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                             00000000011111234678999999999999999999999997  4543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-51  Score=407.91  Aligned_cols=261  Identities=25%  Similarity=0.405  Sum_probs=216.6

Q ss_pred             HHHhhcCcccceeecccCceEEEEEEECC-------eEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEEeC
Q 011384           50 LEAATNGFSEQKLLGKGSHGSVYKAVLRG-------RQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFSND  120 (487)
Q Consensus        50 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~g-------~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~  120 (487)
                      ++.-.++|.+.+.||+|+||.||+|++.+       +.||||++....  ...+.|.+|++++++++||||++++++|.+
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            33446789999999999999999999753       689999987543  335679999999999999999999999999


Q ss_pred             CCceEEEEEecCCCCHHHHHHhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeecc
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSNN-----------------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRD  177 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~D  177 (487)
                      ....++||||+++|+|.+++....                       ..+++..++.++.|++.||+|||++  +|||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~--~ivHrD  165 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRD  165 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSC
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC--CeEeeE
Confidence            999999999999999999996432                       2488999999999999999999999  999999


Q ss_pred             CCCCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCC
Q 011384          178 IKSANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIG  257 (487)
Q Consensus       178 Ikp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~  257 (487)
                      |||+|||+|.++.+||+|||+++.+.........+...||+.|+|||.+.+..++.++|||||||++|||++|..|+..+
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999999999999999999998765554444455678999999999999999999999999999999999997554434


Q ss_pred             CCCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          258 FSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      .....+...    +..+.         ..+.+..++.++.+|+.+||+.+|.+||||.||+++|+++.
T Consensus       246 ~~~~e~~~~----v~~~~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         246 MAHEEVIYY----VRDGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             SCHHHHHHH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCHHHHHHH----HHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            433333221    22222         12234456778999999999999999999999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=403.50  Aligned_cols=246  Identities=24%  Similarity=0.359  Sum_probs=201.3

Q ss_pred             eeecccCceEEEEEEEC----CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEecCC
Q 011384           61 KLLGKGSHGSVYKAVLR----GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFMSN  133 (487)
Q Consensus        61 ~~LG~G~~g~Vy~~~~~----g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~~  133 (487)
                      +.||+|+||.||+|.++    ++.||||++....   ...+.|.+|++++++++|||||+++++|.++ ..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            57999999999999874    3679999986432   2346799999999999999999999999754 57899999999


Q ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc-cccC
Q 011384          134 GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR-FRST  212 (487)
Q Consensus       134 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~-~~~~  212 (487)
                      |+|.+++.... .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.+...... ....
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~--~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhC--CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            99999998764 499999999999999999999999  9999999999999999999999999999876544322 2234


Q ss_pred             CCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCChH
Q 011384          213 PPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPI  291 (487)
Q Consensus       213 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  291 (487)
                      ...||+.|+|||.+.+..++.++|||||||++|||+| |+.||.. .....+..    .+..+         ...+.+..
T Consensus       169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~----~i~~~---------~~~~~p~~  234 (277)
T d1xbba_         169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTA----MLEKG---------ERMGCPAG  234 (277)
T ss_dssp             --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHH----HHHTT---------CCCCCCTT
T ss_pred             ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHH----HHHcC---------CCCCCCcc
Confidence            4579999999999999999999999999999999998 8888863 22222221    12221         22334456


Q ss_pred             HHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          292 VRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       292 ~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ++.++.+|+.+||+.||.+|||+++|++.|+..
T Consensus       235 ~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            778999999999999999999999999887653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-51  Score=399.72  Aligned_cols=245  Identities=25%  Similarity=0.394  Sum_probs=198.0

Q ss_pred             cccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC----CCceEEE
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSND----SKDRLLV  127 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~----~~~~~lV  127 (487)
                      |++.+.||+|+||+||+|++.  +..||+|++...   ....+.+.+|++++++++|||||+++++|.+    ...+|+|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            366778999999999999987  778999987643   3344678999999999999999999999864    3457999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc-cCCcEEEcccccceecCCCC
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID-RNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld-~~~~vkL~DFGla~~~~~~~  206 (487)
                      |||+++|+|.+++.+.. .+++..++.++.||+.||+|||++.++|+||||||+|||++ .++.+||+|||+++..... 
T Consensus        91 mE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-  168 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-  168 (270)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred             EeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence            99999999999998754 49999999999999999999999922399999999999996 5789999999999754332 


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                         ......||+.|+|||++.+ .++.++|||||||++|||++|+.||........+..    .+..+        ..+.
T Consensus       169 ---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~----~i~~~--------~~~~  232 (270)
T d1t4ha_         169 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR----RVTSG--------VKPA  232 (270)
T ss_dssp             ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH----HHTTT--------CCCG
T ss_pred             ---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH----HHHcC--------CCCc
Confidence               2234579999999999875 599999999999999999999999964322222221    11111        1111


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+..+++++.+|+.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            223345678999999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.1e-51  Score=412.49  Aligned_cols=249  Identities=20%  Similarity=0.290  Sum_probs=210.5

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ++|.+.+.||+|+||.||+|++.  |+.||||++.... ...+.+.+|++++++++|||||++++++.+.+.+|+|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            58999999999999999999986  8899999987654 34467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc--CCcEEEcccccceecCCCCccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR--NFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~--~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      ++|+|.+++......+++..++.++.||+.||.|||++  +||||||||+|||++.  ++.+||+|||+++.+.....  
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~--~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--  181 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--  181 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC--
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeeeeechhHeeeccCCCCeEEEeecchheecccccc--
Confidence            99999999976666799999999999999999999999  9999999999999954  57899999999987654432  


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                       .....||+.|+|||++.+..++.++|||||||++|||++|+.||... ......   ..+ ..+.      ...+....
T Consensus       182 -~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~---~~i-~~~~------~~~~~~~~  249 (350)
T d1koaa2         182 -VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-NDDETL---RNV-KSCD------WNMDDSAF  249 (350)
T ss_dssp             -EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHH---HHH-HHTC------CCSCCGGG
T ss_pred             -cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-CHHHHH---HHH-HhCC------CCCCcccc
Confidence             23457999999999999999999999999999999999999999632 222211   111 1111      11222233


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+++++.+|+.+||+.||.+|||++|+++
T Consensus       250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         250 SGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            456788999999999999999999999997

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.3e-51  Score=405.14  Aligned_cols=242  Identities=23%  Similarity=0.305  Sum_probs=202.1

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      .|+..+.||+|+||.||+|++.  ++.||||++....    ...+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4999999999999999999986  7889999876542    234578999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      ||++|+|..++... .++++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||++.....     
T Consensus        96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~--~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----  167 (309)
T ss_dssp             CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred             ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhC--CEeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence            99999997766554 4599999999999999999999999  999999999999999999999999999975432     


Q ss_pred             ccCCCCCCCccCCccccCC---CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTP---DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPP  286 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  286 (487)
                       .....||+.|+|||++.+   ..|+.++|||||||++|||++|+.||..... .   .........         ..+.
T Consensus       168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-~---~~~~~i~~~---------~~~~  233 (309)
T d1u5ra_         168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-M---SALYHIAQN---------ESPA  233 (309)
T ss_dssp             -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-H---HHHHHHHHS---------CCCC
T ss_pred             -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-H---HHHHHHHhC---------CCCC
Confidence             234579999999999864   3589999999999999999999999863211 1   111111111         1112


Q ss_pred             CCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          287 PKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       287 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..+..+++++.+|+.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            223456788999999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-51  Score=400.01  Aligned_cols=255  Identities=22%  Similarity=0.386  Sum_probs=202.0

Q ss_pred             hhcCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      ..++|.+.+.||+|+||.||+|++.     +..||||++...  ....+.+.+|++++++++||||+++++++.+ +..+
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~   83 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW   83 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCE
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEE
Confidence            3468999999999999999999885     346899987643  3345679999999999999999999999964 5789


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +||||+++|+|.+++......+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.+...
T Consensus        84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~--~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc--CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999999887777799999999999999999999999  9999999999999999999999999999865543


Q ss_pred             CcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                      .. ...+...||+.|+|||.+.+..++.++|||||||++|||++ |..||.. .....+..    .+..+         .
T Consensus       162 ~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~----~i~~~---------~  226 (273)
T d1mp8a_         162 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIG----RIENG---------E  226 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHH----HHHTT---------C
T ss_pred             cc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHH----HHHcC---------C
Confidence            32 23455678999999999999999999999999999999998 7777753 23322222    11111         1


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      ..+.+..+++++.+|+.+||+.||.+|||+.||++.|+.+.
T Consensus       227 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            12345567789999999999999999999999999998764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7e-51  Score=412.34  Aligned_cols=249  Identities=22%  Similarity=0.333  Sum_probs=211.5

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      ++|.+++.||+|+||.||+|++.  |+.||||++.... .....+.+|++++++++|||||+++++|.+.+.+|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999986  8899999887653 34467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc--cCCcEEEcccccceecCCCCccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID--RNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld--~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      ++|+|.+.+...+.++++..++.++.||+.||.|||++  +|+||||||+||||+  .++.+||+|||++..+....   
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~--~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---  183 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---  183 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecccccccccccccCCCeEEEeecccceecCCCC---
Confidence            99999998887766799999999999999999999999  999999999999997  57899999999998776543   


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ......   . .+..+      ....+....
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-~~~~~~---~-~i~~~------~~~~~~~~~  252 (352)
T d1koba_         184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-DDLETL---Q-NVKRC------DWEFDEDAF  252 (352)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHH---H-HHHHC------CCCCCSSTT
T ss_pred             ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHH---H-HHHhC------CCCCCcccc
Confidence            233457999999999999999999999999999999999999999632 111111   1 11111      112233344


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..++.++.+|+.+||+.||.+|||+.|+++
T Consensus       253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            567789999999999999999999999986

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=400.83  Aligned_cols=249  Identities=21%  Similarity=0.296  Sum_probs=208.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh-------hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCce
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ-------EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDR  124 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~-------~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~  124 (487)
                      .++|.+.+.||+|+||.||+|++.  |+.||||++.+..       ...+.+.+|++++++++|||||+++++|.+...+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            468999999999999999999986  8899999875431       2357799999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC----cEEEcccccce
Q 011384          125 LLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF----NARLGDFGLAL  200 (487)
Q Consensus       125 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~----~vkL~DFGla~  200 (487)
                      |+|||||++|+|.+++...+ .+++..++.++.|++.||+|||+.  +|+||||||+|||++.++    .+||+|||++.
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~--~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhc--ceeecccccceEEEecCCCcccceEecchhhhh
Confidence            99999999999999998764 499999999999999999999999  999999999999998776    59999999998


Q ss_pred             ecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccccc
Q 011384          201 RCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF  280 (487)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~  280 (487)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ......   . .+..+.     
T Consensus       166 ~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-~~~~~~---~-~i~~~~-----  232 (293)
T d1jksa_         166 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETL---A-NVSAVN-----  232 (293)
T ss_dssp             ECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHH---H-HHHTTC-----
T ss_pred             hcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC-CHHHHH---H-HHHhcC-----
Confidence            765433   334568999999999999999999999999999999999999999632 111111   1 111111     


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                       ...+.+.+..++.++.+|+.+||+.||.+|||++|+++
T Consensus       233 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 -YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             11111222346678999999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=403.70  Aligned_cols=255  Identities=24%  Similarity=0.467  Sum_probs=208.9

Q ss_pred             cCcccceeecccCceEEEEEEEC--Ce----EEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GR----QVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~----~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~l  126 (487)
                      .+|+++++||+|+||.||+|.+.  |+    +||||++...  ....+.|.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999886  32    6899987643  33457899999999999999999999999875 5678


Q ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCC
Q 011384          127 VVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDN  206 (487)
Q Consensus       127 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~  206 (487)
                      ++||+.+++|.+.+......+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.+....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~--~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc--CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            8999999999999988777899999999999999999999999  99999999999999999999999999998776554


Q ss_pred             cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCC
Q 011384          207 FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIP  285 (487)
Q Consensus       207 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  285 (487)
                      .........||+.|+|||.+.++.++.++|||||||++|||+| |..||. +.....+..    .+..+         ..
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~-~~~~~~~~~----~i~~~---------~~  231 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISS----ILEKG---------ER  231 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT-TSCGGGHHH----HHHHT---------CC
T ss_pred             ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCC-CCCHHHHHH----HHHcC---------CC
Confidence            4434445678999999999999999999999999999999999 566664 333333222    12221         22


Q ss_pred             CCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          286 PPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       286 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .+.+..++.++.+|+.+||+.||.+|||+.||++.|..+..
T Consensus       232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            33455677899999999999999999999999999887753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-51  Score=396.49  Aligned_cols=250  Identities=26%  Similarity=0.384  Sum_probs=203.4

Q ss_pred             hcCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeC-CCceEEEEEecC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND-SKDRLLVVEFMS  132 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~lV~Ey~~  132 (487)
                      .++|++.+.||+|+||.||+|.++|+.||||+++.+. ..+.+.+|++++++++||||++++|+|.+ .+.+++||||++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             HHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            3578899999999999999999999999999997654 34779999999999999999999999865 456899999999


Q ss_pred             CCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccccc
Q 011384          133 NGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFRS  211 (487)
Q Consensus       133 ~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  211 (487)
                      +|+|.+++.... ..+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++.....     .
T Consensus        85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~--~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~  157 (262)
T d1byga_          85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----Q  157 (262)
T ss_dssp             TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC--ceeccccchHhheecCCCCEeecccccceecCCC-----C
Confidence            999999997532 3589999999999999999999999  9999999999999999999999999999765432     2


Q ss_pred             CCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCCh
Q 011384          212 TPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKDP  290 (487)
Q Consensus       212 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  290 (487)
                      ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||. .....++...+    ..         ....+.+.
T Consensus       158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~-~~~~~~~~~~i----~~---------~~~~~~~~  223 (262)
T d1byga_         158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRV----EK---------GYKMDAPD  223 (262)
T ss_dssp             ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT-TSCGGGHHHHH----TT---------TCCCCCCT
T ss_pred             ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCC-CCCHHHHHHHH----Hc---------CCCCCCCc
Confidence            33568999999999998999999999999999999998 566654 33333333221    11         12233455


Q ss_pred             HHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          291 IVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       291 ~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      .+++++.+|+.+||+.||.+|||+.+|+++|+.++
T Consensus       224 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            66788999999999999999999999999998875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=399.97  Aligned_cols=265  Identities=28%  Similarity=0.355  Sum_probs=206.8

Q ss_pred             chhhHHHhhcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCC--hhhHHHHHHHHHHHHhC-CCCCceeeE
Q 011384           46 DYSDLEAATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKN--QEISQEVDNEIEILSKI-HSPRLVNLL  115 (487)
Q Consensus        46 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~  115 (487)
                      +...++...++|.+.+.||+|+||.||+|.+.       ++.||||++...  ....+.+.+|+.++.++ +|+||+.++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            33444555678999999999999999999874       367999998754  33446788888888777 689999999


Q ss_pred             EEEeCC-CceEEEEEecCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCC
Q 011384          116 GFSNDS-KDRLLVVEFMSNGTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIK  179 (487)
Q Consensus       116 ~~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIk  179 (487)
                      +++.+. ..+++|||||++|+|.+++....               ..+++..++.++.||+.||.|||++  +|||||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~--~ivHrDlK  161 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLA  161 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC--CCcCCcCC
Confidence            988664 46899999999999999997532               3489999999999999999999999  99999999


Q ss_pred             CCcEEEccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCc-CCCCCC
Q 011384          180 SANVLIDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRK-AIDIGF  258 (487)
Q Consensus       180 p~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~-pf~~~~  258 (487)
                      |+||||+.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++|.. ||....
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987665544444556789999999999999999999999999999999999865 554322


Q ss_pred             CCchhhhhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          259 SPPSIVDWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       259 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      ....+..    .+..+         ...+.+..+++++.+|+.+||+.||.+|||++||+++|+.+.
T Consensus       242 ~~~~~~~----~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         242 IDEEFCR----RLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             CSHHHHH----HHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHH----HHhcC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            2222221    12221         122334456788999999999999999999999999998764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=394.67  Aligned_cols=254  Identities=22%  Similarity=0.318  Sum_probs=201.9

Q ss_pred             cCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      ++|++.+.||+|+||.||+|++.     ...||||++.+.    ....+.|.+|++++++++||||++++|+|.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            57999999999999999999874     236899987653    33446799999999999999999999999764 678


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +||||+++|+|.+.+......+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||+++.+...
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~--~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK--RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC--CEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            99999999999999887666799999999999999999999999  9999999999999999999999999999876554


Q ss_pred             Ccc-cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          206 NFR-FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       206 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                      ... .......|++.|+|||.+.+..++.++|||||||++|||+| |+.||.. ........   ....         ..
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~---~i~~---------~~  231 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILH---KIDK---------EG  231 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHH---HHHT---------SC
T ss_pred             CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHH---HHHh---------CC
Confidence            332 23334568889999999999999999999999999999998 8888852 22222221   1111         12


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcc
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGL  324 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l  324 (487)
                      ...+.+..++.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus       232 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            22334456678899999999999999999999999998764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=400.07  Aligned_cols=246  Identities=23%  Similarity=0.300  Sum_probs=209.2

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      -++|.+++.||+|+||.||+|++.  ++.||||++.+..    ...+.+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            357999999999999999999986  8899999987542    2346789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      ||||++|+|.+++...+ .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~--~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhc--CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            99999999999998765 499999999999999999999999  999999999999999999999999999986543322


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                        .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ...+.    ..+..+.          ..
T Consensus       161 --~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-~~~~~----~~i~~~~----------~~  223 (337)
T d1o6la_         161 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLF----ELILMEE----------IR  223 (337)
T ss_dssp             --CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHH----HHHHHCC----------CC
T ss_pred             --ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-HHHHH----HHHhcCC----------CC
Confidence              3445789999999999999999999999999999999999999996422 21111    1111111          12


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCC-----HHHHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPS-----MKEIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~eil~  319 (487)
                      .+..+++++.+||.+||++||.+||+     +++|++
T Consensus       224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            34457788999999999999999995     888876

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-50  Score=402.05  Aligned_cols=253  Identities=19%  Similarity=0.240  Sum_probs=212.5

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEec
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~  131 (487)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||+++........+.+|+++|+.++|||||++++++.+.+.+|+|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            468999999999999999999986  889999999887776678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccC--CcEEEcccccceecCCCCccc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRN--FNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~--~~vkL~DFGla~~~~~~~~~~  209 (487)
                      ++|+|.+++...+..+++..++.|+.||+.||.|||++  +|+||||||+|||++.+  ..+||+|||+++......   
T Consensus        84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~--~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---  158 (321)
T d1tkia_          84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---  158 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--CCCcccccccceeecCCCceEEEEcccchhhccccCC---
Confidence            99999999987766799999999999999999999999  99999999999999854  589999999998765433   


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      ......+|+.|+|||.+.+..++.++|||||||++|+|++|..||...... .   ....+. .+..      .++.+..
T Consensus       159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~---~~~~i~-~~~~------~~~~~~~  227 (321)
T d1tkia_         159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-Q---IIENIM-NAEY------TFDEEAF  227 (321)
T ss_dssp             EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-H---HHHHHH-HTCC------CCCHHHH
T ss_pred             cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-H---HHHHHH-hCCC------CCChhhc
Confidence            223357899999999999999999999999999999999999999743211 1   111111 1110      1111111


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHh
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLT  322 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~  322 (487)
                      ..+++++.+|+.+||..||.+|||++|+++  ||.
T Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~  262 (321)
T d1tkia_         228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK  262 (321)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence            235678999999999999999999999997  454

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-49  Score=390.43  Aligned_cols=258  Identities=22%  Similarity=0.343  Sum_probs=204.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC----hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC----c
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN----QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK----D  123 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~  123 (487)
                      .++|.+.+.||+|+||.||+|++.  ++.||||++...    ......+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            578999999999999999999986  899999998653    334467899999999999999999999987644    3


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      .|+||||+++++|.+++...+ ++++..++.++.||+.||.|||++  +|+||||||+|||++.++.++|+|||.+....
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~--~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhC--CccCccccCcccccCccccceeehhhhhhhhc
Confidence            789999999999999987765 499999999999999999999999  99999999999999999999999999987554


Q ss_pred             CCC-cccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCC
Q 011384          204 VDN-FRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDP  282 (487)
Q Consensus       204 ~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~  282 (487)
                      ... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.... +   ..........+.       
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-~---~~~~~~~~~~~~-------  231 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-P---VSVAYQHVREDP-------  231 (277)
T ss_dssp             ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-H---HHHHHHHHHCCC-------
T ss_pred             cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-H---HHHHHHHHhcCC-------
Confidence            332 2223445689999999999999999999999999999999999999996321 1   111222222111       


Q ss_pred             CCCCCCChHHHHHHHHHHHHhhhhcCCCCC-CHHHHHHHHhccc
Q 011384          283 RIPPPKDPIVRKQLAVIAVRCVRSCRERRP-SMKEIVDWLTGLS  325 (487)
Q Consensus       283 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP-s~~eil~~L~~l~  325 (487)
                      ..+......+++++.+|+.+||+.||.+|| |++++++.|.++.
T Consensus       232 ~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         232 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            111122345678899999999999999999 8999999887653

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.8e-49  Score=394.94  Aligned_cols=242  Identities=24%  Similarity=0.370  Sum_probs=206.9

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+++.||+|+||.||+|+++  |+.||||++.+..    ...+.+.+|+.++++++|||||++++++.+.+.+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46999999999999999999986  8899999986532    23467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      |||+||+|..++..... +++..+..++.||+.||.|||++  +|+||||||+||||+.++.+||+|||+++.....   
T Consensus        84 E~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH~~--~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             eecCCcccccccccccc-ccccHHHHHHHHHHHhhhhhccC--cEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence            99999999999987654 89999999999999999999999  9999999999999999999999999999876532   


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||... .....   ... +..+.          ...
T Consensus       158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~---~~~-i~~~~----------~~~  220 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-NTMKT---YEK-ILNAE----------LRF  220 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHH---HHH-HHHCC----------CCC
T ss_pred             --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc-CHHHH---HHH-HHcCC----------CCC
Confidence              33568999999999999999999999999999999999999999632 11111   111 11111          123


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      +..+++++.+++.+||+.||.+||     |+++|++
T Consensus       221 p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         221 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            345678899999999999999996     8999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=395.05  Aligned_cols=263  Identities=24%  Similarity=0.402  Sum_probs=218.1

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhCCCCCceeeEEEE
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKIHSPRLVNLLGFS  118 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~l~~~~  118 (487)
                      ++++...++|.+.+.||+|+||.||+|.+.       +..||||+++...  .....|.+|++++++++||||++++++|
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            344555678999999999999999999875       4689999987543  3335689999999999999999999999


Q ss_pred             eCCCceEEEEEecCCCCHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC
Q 011384          119 NDSKDRLLVVEFMSNGTLYDVLHSNN---------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF  189 (487)
Q Consensus       119 ~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~  189 (487)
                      ......++||||+++|+|.+++....         ..+++..+..++.|++.||.|||++  +|+||||||+|||++.++
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~--~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCSGGGEEECTTC
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC--CeeeceEcCCceeecCCc
Confidence            99999999999999999999986421         3478999999999999999999999  999999999999999999


Q ss_pred             cEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhh
Q 011384          190 NARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP  269 (487)
Q Consensus       190 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~  269 (487)
                      ++||+|||+++.+.............||+.|+|||.+.+..++.++|||||||++|||+||+.++..+........    
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~----  246 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR----  246 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH----
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH----
Confidence            9999999999876555444445556799999999999999999999999999999999999755443443333322    


Q ss_pred             hhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          270 LIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       270 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      .+..+.         ..+.+..++..+.+|+.+||+.+|++|||+++|++.|+...
T Consensus       247 ~i~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         247 FVMEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHhCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            111211         12234456788999999999999999999999999998764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=394.64  Aligned_cols=260  Identities=25%  Similarity=0.326  Sum_probs=217.2

Q ss_pred             HhhcCcccceeecccCceEEEEEEEC-------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhC-CCCCceeeEEEEeCC
Q 011384           52 AATNGFSEQKLLGKGSHGSVYKAVLR-------GRQVAVKKPSKNQ--EISQEVDNEIEILSKI-HSPRLVNLLGFSNDS  121 (487)
Q Consensus        52 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~  121 (487)
                      .-.++|.+.+.||+|+||.||+|++.       ++.||||++....  .....+.+|+.+++.+ +|||||+++++|.+.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            34578999999999999999999873       4689999987543  3445789999999999 799999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHHhCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEE
Q 011384          122 KDRLLVVEFMSNGTLYDVLHSNN-----------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVL  184 (487)
Q Consensus       122 ~~~~lV~Ey~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NIL  184 (487)
                      ...++|||||++|+|.+++....                 ..+++..+..++.||+.||+|||++  +++||||||+|||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~--~ivHrDLKp~NIl  177 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNIL  177 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--Ceeeccccccccc
Confidence            99999999999999999997532                 2589999999999999999999999  9999999999999


Q ss_pred             EccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhh
Q 011384          185 IDRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIV  264 (487)
Q Consensus       185 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~  264 (487)
                      ++.++.+||+|||+++...............||+.|+|||.+....++.++|||||||++|||+|++.|+..+.......
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999987765544445566789999999999999999999999999999999999666655444433221


Q ss_pred             hhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          265 DWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       265 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      .   ..+..         ......+..++.++.+||.+||+.||.+|||+++|++.|++..
T Consensus       258 ~---~~i~~---------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         258 Y---KMIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             H---HHHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H---HHHhc---------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence            1   11111         1222334456788999999999999999999999999998653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=394.24  Aligned_cols=270  Identities=26%  Similarity=0.330  Sum_probs=206.0

Q ss_pred             cCcccceeecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC----ceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK----DRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~~~lV~Ey  130 (487)
                      ++|.+.+.||+|+||.||+|+++|+.||||++............|+..+.+++||||++++++|.+.+    ..|+||||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey   82 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence            56888999999999999999999999999998766554444455666667889999999999997654    57899999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeeeccCCCCcEEEccCCcEEEcccccceecCC
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSE------MPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGV  204 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~------~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~  204 (487)
                      |++|+|.+++.+..  +++..++.++.|++.||.|||+.      .++|+||||||+||||+.++.+||+|||+++....
T Consensus        83 ~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~  160 (303)
T d1vjya_          83 HEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             CTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             ccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence            99999999998754  99999999999999999999973      13999999999999999999999999999987654


Q ss_pred             CCcc--cccCCCCCCCccCCccccCCCC------CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhh-h-----hhhhh
Q 011384          205 DNFR--FRSTPPAGTIGYLDPCYVTPDN------LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIV-D-----WAAPL  270 (487)
Q Consensus       205 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~------~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~-~-----~~~~~  270 (487)
                      ....  .......||+.|+|||++.+..      ++.++|||||||+||||+||..|+.......... .     .....
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T d1vjya_         161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE  240 (303)
T ss_dssp             TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred             CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence            4322  2334568999999999987653      5678999999999999999988775322111000 0     00000


Q ss_pred             hhcCccccccCCCCCCCC-ChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhcccc
Q 011384          271 IKKGKILSVFDPRIPPPK-DPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSK  326 (487)
Q Consensus       271 ~~~~~i~~~~~~~~~~~~-~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~  326 (487)
                      .........+++.++... +......+.+|+.+||+.||.+|||+.||++.|+.+..
T Consensus       241 ~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            000000111222222211 23466789999999999999999999999999988764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.7e-49  Score=384.61  Aligned_cols=249  Identities=20%  Similarity=0.349  Sum_probs=208.1

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----------hhHHHHHHHHHHHHhCC-CCCceeeEEEEeC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----------EISQEVDNEIEILSKIH-SPRLVNLLGFSND  120 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----------~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~  120 (487)
                      .++|.+.+.||+|+||.||+|++.  ++.||||++.+..          ...+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368999999999999999999985  8999999876532          12346889999999997 9999999999999


Q ss_pred             CCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      ++..|+|||||++|+|.+++...+ ++++..++.++.||+.||+|||++  +|+||||||+|||++.++.+||+|||+++
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHc--CCcccccccceEEEcCCCCeEEccchhee
Confidence            999999999999999999998755 599999999999999999999999  99999999999999999999999999998


Q ss_pred             ecCCCCcccccCCCCCCCccCCccccCC------CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC
Q 011384          201 RCGVDNFRFRSTPPAGTIGYLDPCYVTP------DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG  274 (487)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  274 (487)
                      ......   ......||+.|+|||++.+      ..++.++||||+||++|||++|+.||.... ....    ...+..+
T Consensus       159 ~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-~~~~----~~~i~~~  230 (277)
T d1phka_         159 QLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-QMLM----LRMIMSG  230 (277)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHH----HHHHHHT
T ss_pred             EccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC-HHHH----HHHHHhC
Confidence            765433   2345689999999999853      346889999999999999999999997322 1111    1111111


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          275 KILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       275 ~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      +      ...+.+....+++++.+|+.+||+.||.+|||++||++
T Consensus       231 ~------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         231 N------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             C------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             C------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1      12233344568889999999999999999999999985

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=395.86  Aligned_cols=255  Identities=25%  Similarity=0.414  Sum_probs=209.0

Q ss_pred             cCcccceeecccCceEEEEEEEC--Ce--EEEEEEcCCC--hhhHHHHHHHHHHHHhC-CCCCceeeEEEEeCCCceEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GR--QVAVKKPSKN--QEISQEVDNEIEILSKI-HSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~--~vAvK~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      ++|++.+.||+|+||.||+|+++  +.  .||||++...  ....+.+.+|+++++++ +|||||+++++|.+.+.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            57888999999999999999986  33  5788876543  23446799999999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEE
Q 011384          128 VEFMSNGTLYDVLHSN---------------NRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNAR  192 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vk  192 (487)
                      |||+++|+|.++|...               ...+++..+++++.||+.||.|||+.  +|+||||||+|||++.++.+|
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~--~iiHrDlkp~NIL~~~~~~~k  167 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAK  167 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECGGGCEE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC--CccccccccceEEEcCCCceE
Confidence            9999999999999753               35699999999999999999999999  999999999999999999999


Q ss_pred             EcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh
Q 011384          193 LGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK  272 (487)
Q Consensus       193 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~  272 (487)
                      |+|||+++......   ......||+.|+|||.+....++.++|||||||++|||++|..|+..+.....+...+    .
T Consensus       168 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i----~  240 (309)
T d1fvra_         168 IADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL----P  240 (309)
T ss_dssp             ECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG----G
T ss_pred             Eccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH----H
Confidence            99999997544332   2234568999999999999999999999999999999999876554444433333221    1


Q ss_pred             cCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          273 KGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       273 ~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      .         ....+.+..+++++.+||.+||+.||++|||++||++.|+++...
T Consensus       241 ~---------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         241 Q---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             G---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             h---------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            1         112234456778999999999999999999999999999888653

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-49  Score=391.61  Aligned_cols=253  Identities=24%  Similarity=0.404  Sum_probs=209.0

Q ss_pred             ceeecccCceEEEEEEECC-----eEEEEEEcCC--ChhhHHHHHHHHHHHHhCCCCCceeeEEEEeC-CCceEEEEEec
Q 011384           60 QKLLGKGSHGSVYKAVLRG-----RQVAVKKPSK--NQEISQEVDNEIEILSKIHSPRLVNLLGFSND-SKDRLLVVEFM  131 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~g-----~~vAvK~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~-~~~~~lV~Ey~  131 (487)
                      .++||+|+||.||+|++..     ..||||+++.  +....+.|.+|++++++++||||++++|++.+ +...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            5789999999999999852     2589999864  34445789999999999999999999999865 55789999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc--c
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR--F  209 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~--~  209 (487)
                      ++|+|.+++......+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++.+......  .
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~--~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc--CcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence            99999999988777789999999999999999999999  9999999999999999999999999999876543322  2


Q ss_pred             ccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCCC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPKD  289 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  289 (487)
                      ......||+.|+|||.+....++.++|||||||++|||++|+.||........+....    ..+.         ....+
T Consensus       190 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i----~~g~---------~~~~p  256 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGR---------RLLQP  256 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH----HTTC---------CCCCC
T ss_pred             ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcCC---------CCCCc
Confidence            2334578999999999999999999999999999999999988887655444333221    1111         12233


Q ss_pred             hHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          290 PIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       290 ~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                      ..+++++.+|+.+||+.||++|||+.||++.|+.+...
T Consensus       257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            45678899999999999999999999999999988654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=391.73  Aligned_cols=257  Identities=26%  Similarity=0.383  Sum_probs=210.3

Q ss_pred             hhcCcccceeecccCceEEEEEEEC---------CeEEEEEEcCCCh--hhHHHHHHHHHHHHhC-CCCCceeeEEEEeC
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR---------GRQVAVKKPSKNQ--EISQEVDNEIEILSKI-HSPRLVNLLGFSND  120 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~---------g~~vAvK~~~~~~--~~~~~~~~Ei~~l~~l-~hpnIv~l~~~~~~  120 (487)
                      ..++|.+++.||+|+||.||+|+..         +..||||+++...  ....++.+|+..+.++ +|||||+++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            3468999999999999999999864         2469999987653  3446788999999888 89999999999999


Q ss_pred             CCceEEEEEecCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEE
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSNN---------------RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLI  185 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILl  185 (487)
                      +...++|||||++|+|.+++....               ..+++..++.++.||+.||+|||+.  +||||||||+|||+
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~--~ivHrDiKp~NiLl  168 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVLV  168 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC--CEEeeeecccceee
Confidence            999999999999999999997543               3589999999999999999999999  99999999999999


Q ss_pred             ccCCcEEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHh-CCcCCCCCCCCchhh
Q 011384          186 DRNFNARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIIS-CRKAIDIGFSPPSIV  264 (487)
Q Consensus       186 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~pf~~~~~~~~~~  264 (487)
                      +.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++ |..||. +.....+.
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~-~~~~~~~~  247 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-GVPVEELF  247 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHHH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC-CCCHHHHH
Confidence            9999999999999987765544444556689999999999999999999999999999999998 566664 33322222


Q ss_pred             hhhhhhhhcCccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          265 DWAAPLIKKGKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       265 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                      .    .+..         ....+.+..+++++.+|+.+||+.||.+|||+.||++.|+++.
T Consensus       248 ~----~i~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         248 K----LLKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             H----HHHT---------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H----HHHc---------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            1    2222         1222344557788999999999999999999999999998874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.5e-48  Score=397.00  Aligned_cols=246  Identities=20%  Similarity=0.287  Sum_probs=202.6

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh----hHHHHH---HHHHHHHhCCCCCceeeEEEEeCCCceE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE----ISQEVD---NEIEILSKIHSPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~----~~~~~~---~Ei~~l~~l~hpnIv~l~~~~~~~~~~~  125 (487)
                      ++|.+.+.||+|+||.||+|++.  |+.||||++.+...    ....+.   .|+++++.++|||||++++++.+.+.+|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            67999999999999999999986  88999998764321    122333   4577777889999999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      +|||||++|+|.+++.... .+++..++.++.||+.||.|||++  +||||||||+|||++.++.+||+|||+++.+...
T Consensus        84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~--~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHC--CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            9999999999999998764 489999999999999999999999  9999999999999999999999999999876543


Q ss_pred             CcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCC
Q 011384          206 NFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRI  284 (487)
Q Consensus       206 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  284 (487)
                          ......||+.|+|||++.. ..++.++|||||||++|||++|+.||........ ..... .          ....
T Consensus       161 ----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~-~----------~~~~  224 (364)
T d1omwa3         161 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDR-M----------TLTM  224 (364)
T ss_dssp             ----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHHH-H----------SSSC
T ss_pred             ----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH-h----------cccC
Confidence                2345689999999999875 5689999999999999999999999974332221 11110 0          0111


Q ss_pred             CCCCChHHHHHHHHHHHHhhhhcCCCCCC-----HHHHHH
Q 011384          285 PPPKDPIVRKQLAVIAVRCVRSCRERRPS-----MKEIVD  319 (487)
Q Consensus       285 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-----~~eil~  319 (487)
                      ....+..+++++.+||.+||+.||.+|||     ++||++
T Consensus       225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            22334457788999999999999999999     688886

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=394.01  Aligned_cols=250  Identities=20%  Similarity=0.338  Sum_probs=201.3

Q ss_pred             hcCcccc-eeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHh-CCCCCceeeEEEEeC----CCceE
Q 011384           54 TNGFSEQ-KLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSK-IHSPRLVNLLGFSND----SKDRL  125 (487)
Q Consensus        54 ~~~y~~~-~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~-l~hpnIv~l~~~~~~----~~~~~  125 (487)
                      .++|.+. +.||+|+||.||+|++.  ++.||||++...    ..+.+|++++.+ .+|||||+++++|.+    ...+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            3578876 46999999999999986  789999998764    456789998765 489999999999865    45689


Q ss_pred             EEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc---CCcEEEccccccee
Q 011384          126 LVVEFMSNGTLYDVLHSNN-RPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR---NFNARLGDFGLALR  201 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~~  201 (487)
                      +|||||+||+|.+++...+ ..+++..++.|+.||+.||.|||+.  +|+||||||+|||++.   ++.+||+|||+++.
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~--~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc--CCccccccccccccccccccccccccccceeee
Confidence            9999999999999998643 4699999999999999999999999  9999999999999975   46799999999987


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      .....   ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||........ .......+..      ..
T Consensus       164 ~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~~~~i~~------~~  233 (335)
T d2ozaa1         164 TTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMKTRIRM------GQ  233 (335)
T ss_dssp             CCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCS------CS
T ss_pred             ccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHHHHHHhc------CC
Confidence            65443   23456899999999999999999999999999999999999999964322111 1111101110      11


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..++.+....+++++.+|+.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            12222233457889999999999999999999999997

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.8e-49  Score=396.31  Aligned_cols=242  Identities=25%  Similarity=0.311  Sum_probs=207.0

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~  128 (487)
                      ++|.+++.||+|+||.||+|+++  |+.||||++.+..    ...+.+.+|+++++.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999986  8899999986532    23467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcc
Q 011384          129 EFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       129 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~  208 (487)
                      ||+.+|+|.+++...+ .+++..++.++.||+.||.|||++  +||||||||+|||++.++.+||+|||+++.+...   
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~--~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhC--CEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence            9999999999998765 499999999999999999999999  9999999999999999999999999999876532   


Q ss_pred             cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCCC
Q 011384          209 FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPPK  288 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  288 (487)
                        .....||+.|||||++.+..++.++|||||||++|||++|+.||... .+....   . .+..+.          ...
T Consensus       195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~---~-~i~~~~----------~~~  257 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-QPIQIY---E-KIVSGK----------VRF  257 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHH---H-HHHHCC----------CCC
T ss_pred             --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc-CHHHHH---H-HHhcCC----------CCC
Confidence              23468999999999999999999999999999999999999999632 211111   1 111111          112


Q ss_pred             ChHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          289 DPIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       289 ~~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                      +..+++++.+|+.+||+.||.+|+     |+++|++
T Consensus       258 p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            345678899999999999999994     8999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=385.54  Aligned_cols=268  Identities=24%  Similarity=0.323  Sum_probs=204.2

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh---hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE---ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~---~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ++|++++.||+|+||.||+|++.  ++.||||++.....   ....+.+|++++++++|||||++++++.+.+.+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999986  88999999865432   34678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      |+.++.+..........+++..++.++.|++.||.|||++  +||||||||+|||++.++.+||+|||+++.......  
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~--~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--  157 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--  157 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC--CEEccccCchheeecccCcceeccCCcceeccCCcc--
Confidence            9976444444445556699999999999999999999999  999999999999999999999999999976654332  


Q ss_pred             ccCCCCCCCccCCccccCCCC-CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC-----cccc--ccC
Q 011384          210 RSTPPAGTIGYLDPCYVTPDN-LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG-----KILS--VFD  281 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~-----~i~~--~~~  281 (487)
                      ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||....................     ....  ...
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            344568999999999877765 48899999999999999999999964321111111100000000     0000  000


Q ss_pred             CCCCC----C---CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcccc
Q 011384          282 PRIPP----P---KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGLSK  326 (487)
Q Consensus       282 ~~~~~----~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l~~  326 (487)
                      ...+.    .   ....++.++.+|+.+||+.||.+|||++|+++  ||+.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence            00000    0   01234578899999999999999999999997  4555433

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=389.98  Aligned_cols=245  Identities=23%  Similarity=0.372  Sum_probs=205.2

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh----hhHHHHHHHHHHHH-hCCCCCceeeEEEEeCCCceEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ----EISQEVDNEIEILS-KIHSPRLVNLLGFSNDSKDRLLV  127 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~----~~~~~~~~Ei~~l~-~l~hpnIv~l~~~~~~~~~~~lV  127 (487)
                      ++|.+.+.||+|+||+||+|++.  ++.||||++.++.    ...+.+..|+.++. .++|||||++++++.+++.+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999996  8999999987542    22345667777765 68999999999999999999999


Q ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCc
Q 011384          128 VEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNF  207 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~  207 (487)
                      ||||++|+|.+++.... .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~--~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            99999999999998755 499999999999999999999999  999999999999999999999999999976543322


Q ss_pred             ccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCCCCCC
Q 011384          208 RFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPRIPPP  287 (487)
Q Consensus       208 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  287 (487)
                        ..+...||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+..    .+..+.          ..
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~-~~~~~~~----~i~~~~----------~~  221 (320)
T d1xjda_         159 --KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-DEEELFH----SIRMDN----------PF  221 (320)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHH----HHHHCC----------CC
T ss_pred             --cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC-CHHHHHH----HHHcCC----------CC
Confidence              345568999999999999999999999999999999999999999632 2222111    111111          12


Q ss_pred             CChHHHHHHHHHHHHhhhhcCCCCCCHH-HHHH
Q 011384          288 KDPIVRKQLAVIAVRCVRSCRERRPSMK-EIVD  319 (487)
Q Consensus       288 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~-eil~  319 (487)
                      .+..+++++.+|+.+||+.||.+|||+. ++++
T Consensus       222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            3445678899999999999999999985 6764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-48  Score=382.54  Aligned_cols=255  Identities=22%  Similarity=0.243  Sum_probs=194.6

Q ss_pred             cceeecccCceEEEEEEEC--CeEEEEEEcCCChh------hHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           59 EQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE------ISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~------~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      .+++||+|+||+||+|++.  |+.||||++.....      ..+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3679999999999999986  78999999865432      124688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +.++++..++. .+..+++..+..++.||+.||+|||++  +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~--~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~  156 (299)
T d1ua2a_          82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--A  156 (299)
T ss_dssp             CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--C
T ss_pred             hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcc--ceecccCCcceEEecCCCccccccCccccccCCCcc--c
Confidence            98876665554 445699999999999999999999999  999999999999999999999999999976554332  2


Q ss_pred             cCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC---------cccccc
Q 011384          211 STPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG---------KILSVF  280 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~---------~i~~~~  280 (487)
                      .....||+.|+|||++... .++.++|||||||++|||++|..||........+... .......         ......
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i-~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI-FETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHHHCCCCTTTSSSTTSSTTCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH-HHhcCCCChhhccchhccchhh
Confidence            3345799999999998754 6799999999999999999999888633221111111 1110000         000000


Q ss_pred             C-CCCCCC----CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          281 D-PRIPPP----KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       281 ~-~~~~~~----~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      . ...+..    ....+++++.+|+.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0 000000    01234678999999999999999999999996

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=379.26  Aligned_cols=238  Identities=25%  Similarity=0.347  Sum_probs=198.2

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChh-------hHHHHHHHHHHHHhCC--CCCceeeEEEEeCCC
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQE-------ISQEVDNEIEILSKIH--SPRLVNLLGFSNDSK  122 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~-------~~~~~~~Ei~~l~~l~--hpnIv~l~~~~~~~~  122 (487)
                      .++|.+.+.||+|+||.||+|++.  ++.||||++.+...       ....+.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            468999999999999999999986  88999998764321       1234678999999986  899999999999999


Q ss_pred             ceEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc-CCcEEEcccccce
Q 011384          123 DRLLVVEFMSN-GTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-NFNARLGDFGLAL  200 (487)
Q Consensus       123 ~~~lV~Ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla~  200 (487)
                      ..++||||+.+ +++.+++.... .+++..++.++.||+.||.|||++  +|+||||||+|||++. ++.+||+|||+++
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~--~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC--CCccccCcccceEEecCCCeEEECccccce
Confidence            99999999976 57888887654 499999999999999999999999  9999999999999985 4799999999997


Q ss_pred             ecCCCCcccccCCCCCCCccCCccccCCCCC-CcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccc
Q 011384          201 RCGVDNFRFRSTPPAGTIGYLDPCYVTPDNL-STKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSV  279 (487)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~  279 (487)
                      .....    ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||...   ..+        ..+.+   
T Consensus       160 ~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~i--------~~~~~---  221 (273)
T d1xwsa_         160 LLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---EEI--------IRGQV---  221 (273)
T ss_dssp             ECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HHH--------HHCCC---
T ss_pred             ecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---hHH--------hhccc---
Confidence            65433    2345689999999999987765 56789999999999999999999631   011        11111   


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          280 FDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       280 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                             ..+..++.++.+|+.+||+.||.+|||++|+++
T Consensus       222 -------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 -------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                   122345678999999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=378.81  Aligned_cols=261  Identities=19%  Similarity=0.249  Sum_probs=199.9

Q ss_pred             hcCcccceeecccCceEEEEEEEC---CeEEEEEEcCCC---hhhHHHHHHHHHHHHhC---CCCCceeeEEEEeC----
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR---GRQVAVKKPSKN---QEISQEVDNEIEILSKI---HSPRLVNLLGFSND----  120 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~---g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l---~hpnIv~l~~~~~~----  120 (487)
                      .++|.+++.||+|+||.||+|++.   ++.||||++...   ......+.+|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999984   567999987542   22223466777777665   89999999998853    


Q ss_pred             -CCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccc
Q 011384          121 -SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLA  199 (487)
Q Consensus       121 -~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla  199 (487)
                       ....+++|||+.++.+..........+++..++.++.|++.||+|||++  +|+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~--~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CEEecCCCccEEEEcCCCCeeecchhhh
Confidence             3467999999988777666666666799999999999999999999999  9999999999999999999999999998


Q ss_pred             eecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC-----
Q 011384          200 LRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG-----  274 (487)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~-----  274 (487)
                      .......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........+...........     
T Consensus       164 ~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         164 RIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            7544332   34567899999999999999999999999999999999999999964322111111111000000     


Q ss_pred             ---ccc-ccc---CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          275 ---KIL-SVF---DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       275 ---~i~-~~~---~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                         ... ...   ...........+++.+.+|+.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence               000 000   000011123346678999999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.6e-47  Score=373.22  Aligned_cols=260  Identities=22%  Similarity=0.257  Sum_probs=199.9

Q ss_pred             cCcccceeecccCceEEEEEEEC-CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEEe
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      ++|.+.+.||+|+||.||+|+++ ++.||||++....   ...+.+.+|+.++++++||||+++++++.+.+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            58999999999999999999987 7899999987543   2346899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCcccc
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRFR  210 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  210 (487)
                      +.++.+..+.. ....+++..+..++.||+.||+|||+.  +||||||||+|||++.++.+||+|||++........  .
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~--~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~  156 (286)
T d1ob3a_          82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--K  156 (286)
T ss_dssp             CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhccC--cEEecCCCCceeeEcCCCCEEecccccceecccCcc--c
Confidence            97765555554 445699999999999999999999999  999999999999999999999999999976554332  2


Q ss_pred             cCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhh-----------hhcCcccc
Q 011384          211 STPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL-----------IKKGKILS  278 (487)
Q Consensus       211 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~-----------~~~~~i~~  278 (487)
                      .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||................           ....+...
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence            3445789999999998765 56999999999999999999999996432111111111000           00000000


Q ss_pred             cc---CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          279 VF---DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       279 ~~---~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..   .+.........+++++.+|+.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00   000011122345678999999999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=370.44  Aligned_cols=262  Identities=20%  Similarity=0.281  Sum_probs=197.5

Q ss_pred             hhcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC-----
Q 011384           53 ATNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK-----  122 (487)
Q Consensus        53 ~~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~-----  122 (487)
                      ..++|.+++.||+|+||.||+|.+.  |+.||||++...   ....+.+.+|+++|++++|||||+++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            3578999999999999999999986  889999998753   334567899999999999999999999997654     


Q ss_pred             -ceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccccccee
Q 011384          123 -DRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALR  201 (487)
Q Consensus       123 -~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~  201 (487)
                       .+|+||||+ +.+|..++...  .+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~--~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhC--CCcccccCcchhhcccccccccccccceec
Confidence             469999999 66888877654  399999999999999999999999  999999999999999999999999999987


Q ss_pred             cCCCCcccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhh-------hhhc
Q 011384          202 CGVDNFRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP-------LIKK  273 (487)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~-------~~~~  273 (487)
                      ....     .+...||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...............       ....
T Consensus       171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            5432     3456799999999998764 5689999999999999999999999643211111000000       0000


Q ss_pred             C------cccc---ccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          274 G------KILS---VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       274 ~------~i~~---~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                      .      ....   .............+++++.+|+.+||+.||.+|||++||++  ||+.+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            0      0000   00000001122345678899999999999999999999998  45444

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-45  Score=362.63  Aligned_cols=260  Identities=18%  Similarity=0.201  Sum_probs=201.7

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCcee-eEEEEeCCCceEEEEEec
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVN-LLGFSNDSKDRLLVVEFM  131 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~-l~~~~~~~~~~~lV~Ey~  131 (487)
                      ++|++.+.||+|+||.||+|++.  ++.||||++..... ..++..|+++++.++|+|++. +.+++.+.+..++||||+
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~   85 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   85 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence            57999999999999999999986  88999998765433 245788999999998776555 455667788889999999


Q ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEc---cCCcEEEcccccceecCCCCcc
Q 011384          132 SNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLID---RNFNARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       132 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld---~~~~vkL~DFGla~~~~~~~~~  208 (487)
                       +++|.+.+......+++..+..++.|++.||+|||++  +|+||||||+|||++   .+..+||+|||+++.+......
T Consensus        86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          86 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             -CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC--CeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence             6688888877667799999999999999999999999  999999999999985   4567999999999876543321


Q ss_pred             -----cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccCCC
Q 011384          209 -----FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFDPR  283 (487)
Q Consensus       209 -----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  283 (487)
                           .......||+.|+|||.+.+..++.++|||||||++|||++|+.||............ ..... ....    ..
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~-~~~~~-~~~~----~~  236 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-ERISE-KKMS----TP  236 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H-HHHHH-HHHH----SC
T ss_pred             cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH-HHhhc-ccCC----CC
Confidence                 1234557999999999999999999999999999999999999999643322211111 00000 0000    00


Q ss_pred             CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccc
Q 011384          284 IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLS  325 (487)
Q Consensus       284 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~  325 (487)
                       .......+++++.+++.+||+.+|++||++++|.+.|+.+.
T Consensus       237 -~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         237 -IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             -HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             -hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence             00012245678999999999999999999999988887653

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-45  Score=370.71  Aligned_cols=261  Identities=23%  Similarity=0.279  Sum_probs=196.6

Q ss_pred             CcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCceeeEEEEeC------CCceEEE
Q 011384           56 GFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRLVNLLGFSND------SKDRLLV  127 (487)
Q Consensus        56 ~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~~~~~lV  127 (487)
                      +|+..++||+|+||+||+|++.  ++.||||++.....   .+.+|++++++++||||++++++|..      ...+++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            5778899999999999999996  88999999876543   23479999999999999999999853      3347899


Q ss_pred             EEecCCCCHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC-cEEEcccccceecCC
Q 011384          128 VEFMSNGTLYDVLH--SNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF-NARLGDFGLALRCGV  204 (487)
Q Consensus       128 ~Ey~~~gsL~~~l~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~~~  204 (487)
                      ||||+++.+..+..  .....+++..++.++.||+.||+|||++  +|+||||||+|||++.++ .+||+|||++..+..
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~--~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~  175 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  175 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc--CCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence            99997654443332  3445699999999999999999999999  999999999999999775 899999999987654


Q ss_pred             CCcccccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhh-------hh--cC
Q 011384          205 DNFRFRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPL-------IK--KG  274 (487)
Q Consensus       205 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~-------~~--~~  274 (487)
                      ..   ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........+.......       ..  ..
T Consensus       176 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         176 GE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             TS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             Cc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            33   2344689999999998775 468999999999999999999999996433222211111000       00  00


Q ss_pred             ccccccCCCC-----CCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhcc
Q 011384          275 KILSVFDPRI-----PPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTGL  324 (487)
Q Consensus       275 ~i~~~~~~~~-----~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~l  324 (487)
                      ......-+..     .......+++++.+|+.+||+.||.+|||+.|+++  ||+.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            0000000000     01122346778999999999999999999999997  45554

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5e-45  Score=360.21  Aligned_cols=263  Identities=16%  Similarity=0.183  Sum_probs=210.8

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCCC-CCceeeEEEEeCCCceEEEEEe
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIHS-PRLVNLLGFSNDSKDRLLVVEF  130 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~~~lV~Ey  130 (487)
                      .++|.+++.||+|+||.||+|++.  ++.||||++..... ...+.+|+++++.++| +|++.+++++.+....++||||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            468999999999999999999986  88999998765432 3457889999999976 8999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEcc-----CCcEEEcccccceecCCC
Q 011384          131 MSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDR-----NFNARLGDFGLALRCGVD  205 (487)
Q Consensus       131 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~-----~~~vkL~DFGla~~~~~~  205 (487)
                      + +++|.+++...+..+++..+..++.|++.||+|||++  +|+||||||+|||++.     ++.+||+|||+++.+...
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~--giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC--CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence            9 7899999988777799999999999999999999999  9999999999999964     578999999999876433


Q ss_pred             Ccc-----cccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCcccccc
Q 011384          206 NFR-----FRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVF  280 (487)
Q Consensus       206 ~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~  280 (487)
                      ...     .......||+.|||||.+.+..++.++|||||||++|||++|+.||............ ...... +.... 
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~-~~i~~~-~~~~~-  236 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEK-KQSTP-  236 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HHHHHH-HHHSC-
T ss_pred             ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH-HHHHhc-cCCCC-
Confidence            211     1233457999999999999999999999999999999999999999743333222211 111110 00000 


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHHHHhccccc
Q 011384          281 DPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVDWLTGLSKL  327 (487)
Q Consensus       281 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~~L~~l~~~  327 (487)
                          .......+++++..++..|+..+|++||+++.+.+.|+.+...
T Consensus       237 ----~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~  279 (293)
T d1csna_         237 ----LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  279 (293)
T ss_dssp             ----HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ----hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence                0001123457899999999999999999999999888776543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-45  Score=357.04  Aligned_cols=260  Identities=22%  Similarity=0.248  Sum_probs=207.0

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~~~~lV~E  129 (487)
                      ++|++++.||+|+||+||+|++.  ++.||||+++..   ......+.+|+.+++.++||||++++++|.+....++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999986  788999987543   3345789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCCCccc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVDNFRF  209 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~  209 (487)
                      ++.+++|..++... ..+++..++.++.|++.||+|||++  +|+||||||+|||++.++.+||+|||.++.......  
T Consensus        82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~--~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--  156 (292)
T d1unla_          82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--  156 (292)
T ss_dssp             CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--
T ss_pred             eccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcC--CEeeecccCcccccccCCceeeeecchhhcccCCCc--
Confidence            99998888877655 4599999999999999999999999  999999999999999999999999999987654432  


Q ss_pred             ccCCCCCCCccCCccccCCCC-CCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc---------------
Q 011384          210 RSTPPAGTIGYLDPCYVTPDN-LSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK---------------  273 (487)
Q Consensus       210 ~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~---------------  273 (487)
                      ......+++.|+|||.+.... ++.++|||||||++|||++|+.||..+................               
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            233456788999999987765 6899999999999999999999986544333222111111000               


Q ss_pred             CccccccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          274 GKILSVFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       274 ~~i~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                      ..........-.......+++.+.+|+.+||+.||.+|||++||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000001111223456678999999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=367.04  Aligned_cols=250  Identities=25%  Similarity=0.347  Sum_probs=206.2

Q ss_pred             cCcccceeecccCceEEEEEEEC-----CeEEEEEEcCCCh-----hhHHHHHHHHHHHHhCCC-CCceeeEEEEeCCCc
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR-----GRQVAVKKPSKNQ-----EISQEVDNEIEILSKIHS-PRLVNLLGFSNDSKD  123 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~-----g~~vAvK~~~~~~-----~~~~~~~~Ei~~l~~l~h-pnIv~l~~~~~~~~~  123 (487)
                      ++|++++.||+|+||.||+|+..     |+.||||++++..     ...+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999872     6789999886432     234678899999999976 899999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      .++||||+.+|+|.+++...+. +++..+..++.||+.||.|||++  +|+||||||+|||++.++.+||+|||+++.+.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH~~--~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhhcC--CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            9999999999999999987654 78899999999999999999999  99999999999999999999999999998765


Q ss_pred             CCCcccccCCCCCCCccCCccccCCC--CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcCccccccC
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTPD--NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKGKILSVFD  281 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~i~~~~~  281 (487)
                      ..... ......|++.|++||.+.+.  .++.++|||||||+||||++|+.||..................         
T Consensus       181 ~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~---------  250 (322)
T d1vzoa_         181 ADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---------  250 (322)
T ss_dssp             GGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH---------
T ss_pred             ccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc---------
Confidence            44332 23446799999999999765  4688999999999999999999999755443333222211111         


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhhhhcCCCCC-----CHHHHHH
Q 011384          282 PRIPPPKDPIVRKQLAVIAVRCVRSCRERRP-----SMKEIVD  319 (487)
Q Consensus       282 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~eil~  319 (487)
                        ...+.+..++.++.+|+.+||++||.+||     |++|+++
T Consensus       251 --~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         251 --SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             --CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             --CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence              11223446788999999999999999999     4889886

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.3e-44  Score=362.52  Aligned_cols=254  Identities=21%  Similarity=0.291  Sum_probs=201.0

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCC-CCCceeeEEEEeC--CCceEEEEE
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIH-SPRLVNLLGFSND--SKDRLLVVE  129 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~--~~~~~lV~E  129 (487)
                      ++|.+++.||+|+||+||+|++.  ++.||||+++...  .+.+.+|+++|+.++ ||||++++++|..  ...+++|||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            57999999999999999999986  8899999987653  367889999999995 9999999999874  456899999


Q ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCC-cEEEcccccceecCCCCcc
Q 011384          130 FMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNF-NARLGDFGLALRCGVDNFR  208 (487)
Q Consensus       130 y~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~~~~~~~  208 (487)
                      ||.+++|..+.    +.+++..++.++.||+.||.|||++  +|+||||||+|||++.++ .+||+|||++.......  
T Consensus       113 ~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~--gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--  184 (328)
T d3bqca1         113 HVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--  184 (328)
T ss_dssp             CCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--
T ss_pred             ecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhc--ccccccccccceEEcCCCCeeeecccccceeccCCC--
Confidence            99999997653    3499999999999999999999999  999999999999998654 69999999998765433  


Q ss_pred             cccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhh---------hhhcCc---
Q 011384          209 FRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAP---------LIKKGK---  275 (487)
Q Consensus       209 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~---------~~~~~~---  275 (487)
                       ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||..+............         ......   
T Consensus       185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         185 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             -cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence             23456799999999998765 4799999999999999999999999755432211110000         000000   


Q ss_pred             ---ccc--------ccCCCCCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          276 ---ILS--------VFDPRIPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       276 ---i~~--------~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                         ...        .............+++++.+|+.+||+.||.+|||++|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               000        00111122233456788999999999999999999999996

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-45  Score=367.76  Aligned_cols=262  Identities=20%  Similarity=0.257  Sum_probs=197.4

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC--hhhHHHHHHHHHHHHhCCCCCceeeEEEEeCCC----ceE
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--QEISQEVDNEIEILSKIHSPRLVNLLGFSNDSK----DRL  125 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~~----~~~  125 (487)
                      +.+|.+++.||+|+||.||+|++.  |+.||||++.+.  ....+.+.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457999999999999999999986  889999998754  334567899999999999999999999987643    235


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecCCC
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCGVD  205 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~  205 (487)
                      ++++|+.+|+|.+++...  .+++..++.++.|++.||+|||++  +||||||||+|||++.++.+||+|||++......
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~--~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            556667799999999765  399999999999999999999999  9999999999999999999999999999866543


Q ss_pred             Ccc-cccCCCCCCCccCCccccCC-CCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhh-----------
Q 011384          206 NFR-FRSTPPAGTIGYLDPCYVTP-DNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIK-----------  272 (487)
Q Consensus       206 ~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~-----------  272 (487)
                      ... .......||+.|+|||.+.. ..++.++||||+||++|+|++|+.||..................           
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T d1pmea_         163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  242 (345)
T ss_dssp             GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence            322 22345679999999999855 46689999999999999999999999643211111100000000           


Q ss_pred             --cCccccccCCCCCCC---CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          273 --KGKILSVFDPRIPPP---KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       273 --~~~i~~~~~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        ..............+   ..+.++.++.+|+.+||+.||.+|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000000000000110   11234567999999999999999999999996

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=358.75  Aligned_cols=262  Identities=20%  Similarity=0.259  Sum_probs=193.7

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeC--------
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSND--------  120 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~--------  120 (487)
                      -++|++++.||+|+||+||+|++.  |+.||||++....   .....+.+|+++|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            368999999999999999999986  8899999876442   234678899999999999999999998855        


Q ss_pred             CCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          121 SKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       121 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      ....|+||||+.++.+. ........+++..++.++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++.
T Consensus        89 ~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~--~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN--KILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             --CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccC--CEEecCcCchheeecCCCcEEeeecceee
Confidence            34579999999776554 4444445699999999999999999999999  99999999999999999999999999997


Q ss_pred             ecCCCCcc--cccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhc----
Q 011384          201 RCGVDNFR--FRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKK----  273 (487)
Q Consensus       201 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~----  273 (487)
                      ........  .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... .............    
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLALISQLCGSITPE  244 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTT
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-HHHHHHHHHhcCCCChh
Confidence            66543221  122335799999999998765 689999999999999999999999863221 1111111111000    


Q ss_pred             -------CccccccCCCCCCCCC-------hHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          274 -------GKILSVFDPRIPPPKD-------PIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       274 -------~~i~~~~~~~~~~~~~-------~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                             ......+.........       ...+.++.+|+.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence                   0000000000000000       112456788999999999999999999997

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-43  Score=359.36  Aligned_cols=256  Identities=22%  Similarity=0.295  Sum_probs=189.8

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCC---hhhHHHHHHHHHHHHhCCCCCceeeEEEEeC------CCc
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN---QEISQEVDNEIEILSKIHSPRLVNLLGFSND------SKD  123 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~------~~~  123 (487)
                      ++|++++.||+|+||+||+|++.  |+.||||++...   ......+.+|+.++++++||||++++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999987  899999998654   3344578999999999999999999999964      367


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      +|+|||||.+ +|.+.+.   ..+++..++.++.||+.||.|||+.  ||+||||||+|||++.++.+|++|||+++...
T Consensus        97 ~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~--giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             eEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhc--ccccccCCccccccccccceeeechhhhhccc
Confidence            8999999965 4555553   3489999999999999999999999  99999999999999999999999999987654


Q ss_pred             CCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhh----------------
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWA----------------  267 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~----------------  267 (487)
                      ...   ......+|+.|+|||++.+..++.++||||+||++|+|++|+.||.............                
T Consensus       171 ~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         171 TSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             ccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            332   3445679999999999999999999999999999999999999986332111100000                


Q ss_pred             --hhhhhcC------ccccccCCC---CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH
Q 011384          268 --APLIKKG------KILSVFDPR---IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD  319 (487)
Q Consensus       268 --~~~~~~~------~i~~~~~~~---~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~  319 (487)
                        .......      .....+...   .........+.++.+|+.+||+.||++|||++||++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence              0000000      000000000   011122446788999999999999999999999996

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-43  Score=356.58  Aligned_cols=261  Identities=18%  Similarity=0.232  Sum_probs=196.6

Q ss_pred             hcCcccceeecccCceEEEEEEEC--CeEEEEEEcCCCh---hhHHHHHHHHHHHHhCCCCCceeeEEEEeCC-----Cc
Q 011384           54 TNGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQ---EISQEVDNEIEILSKIHSPRLVNLLGFSNDS-----KD  123 (487)
Q Consensus        54 ~~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~l~~~~~~~-----~~  123 (487)
                      .++|.+.+.||+|+||+||+|++.  |+.||||++....   ...+.+.+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            568999999999999999999986  8999999987543   3345788999999999999999999998633     34


Q ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEcccccceecC
Q 011384          124 RLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDFGLALRCG  203 (487)
Q Consensus       124 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~  203 (487)
                      .+++++|+.+|+|.+++...  .+++..++.++.||+.||+|||++  +|+||||||+|||++.++.+|++|||++....
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~--giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhC--CCcccccCCccccccccccccccccchhcccC
Confidence            46777888899999999654  499999999999999999999999  99999999999999999999999999986543


Q ss_pred             CCCcccccCCCCCCCccCCccccCCC-CCCcchhhhhHHHHHHHHHhCCcCCCCCCCCchhhhhhhhhhhcC--------
Q 011384          204 VDNFRFRSTPPAGTIGYLDPCYVTPD-NLSTKTDVFSFGILLLEIISCRKAIDIGFSPPSIVDWAAPLIKKG--------  274 (487)
Q Consensus       204 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~~~~~~~~~~~~~--------  274 (487)
                      .     ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||....................        
T Consensus       173 ~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         173 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             G-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             c-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            2     23456799999999987765 468999999999999999999999963321111100000000000        


Q ss_pred             --cccccc--CCCCCCC----CChHHHHHHHHHHHHhhhhcCCCCCCHHHHHH--HHhc
Q 011384          275 --KILSVF--DPRIPPP----KDPIVRKQLAVIAVRCVRSCRERRPSMKEIVD--WLTG  323 (487)
Q Consensus       275 --~i~~~~--~~~~~~~----~~~~~~~~l~~Li~~cl~~dP~~RPs~~eil~--~L~~  323 (487)
                        ......  ....+..    ....+++++.+|+.+||+.||.+|||++|+++  ||..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence              000000  0000000    01234678899999999999999999999997  4543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8e-39  Score=323.78  Aligned_cols=258  Identities=19%  Similarity=0.201  Sum_probs=193.6

Q ss_pred             cCcccceeecccCceEEEEEEEC--CeEEEEEEcCCChhhHHHHHHHHHHHHhCC-----------CCCceeeEEEEeC-
Q 011384           55 NGFSEQKLLGKGSHGSVYKAVLR--GRQVAVKKPSKNQEISQEVDNEIEILSKIH-----------SPRLVNLLGFSND-  120 (487)
Q Consensus        55 ~~y~~~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~-----------hpnIv~l~~~~~~-  120 (487)
                      .+|++++.||+|+||.||+|++.  |+.||||++++.....+.+.+|+.+++.++           |+||+++++++.. 
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            35999999999999999999986  899999999988776778899999998885           4789999998754 


Q ss_pred             -CCceEEEEEecCCCCHHHHH--HhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCcEEEccCC------c
Q 011384          121 -SKDRLLVVEFMSNGTLYDVL--HSNNRPLNWGRRIRLALQVAKAVEILHS-EMPPIIHRDIKSANVLIDRNF------N  190 (487)
Q Consensus       121 -~~~~~lV~Ey~~~gsL~~~l--~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~~~ivH~DIkp~NILld~~~------~  190 (487)
                       ....+++++++..+......  ......+++..+..++.|++.||.|||+ .  +|+||||||+|||++.++      .
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccce
Confidence             35566777776555433222  3344568999999999999999999998 6  999999999999998665      3


Q ss_pred             EEEcccccceecCCCCcccccCCCCCCCccCCccccCCCCCCcchhhhhHHHHHHHHHhCCcCCCCCCCCch--hhhhhh
Q 011384          191 ARLGDFGLALRCGVDNFRFRSTPPAGTIGYLDPCYVTPDNLSTKTDVFSFGILLLEIISCRKAIDIGFSPPS--IVDWAA  268 (487)
Q Consensus       191 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvvl~eLltG~~pf~~~~~~~~--~~~~~~  268 (487)
                      ++++|||.+......     .....||+.|+|||.+.+..++.++||||+||++++|++|+.||........  ..+...
T Consensus       171 ~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         171 IKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence            999999998765432     3446799999999999999999999999999999999999999864321110  000000


Q ss_pred             h---------------------hhhcCccccccCCC----------CCCCCChHHHHHHHHHHHHhhhhcCCCCCCHHHH
Q 011384          269 P---------------------LIKKGKILSVFDPR----------IPPPKDPIVRKQLAVIAVRCVRSCRERRPSMKEI  317 (487)
Q Consensus       269 ~---------------------~~~~~~i~~~~~~~----------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ei  317 (487)
                      .                     ..........+...          .........+.++.+|+.+||+.||.+|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            0                     00000000000000          0123456788899999999999999999999999


Q ss_pred             HH
Q 011384          318 VD  319 (487)
Q Consensus       318 l~  319 (487)
                      ++
T Consensus       326 L~  327 (362)
T d1q8ya_         326 VN  327 (362)
T ss_dssp             HT
T ss_pred             hc
Confidence            86

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=4.9e-24  Score=195.61  Aligned_cols=162  Identities=19%  Similarity=0.272  Sum_probs=121.1

Q ss_pred             cccceeecccCceEEEEEEEC-CeEEEEEEcCCCh-------------------hhHHHHHHHHHHHHhCCCCCceeeEE
Q 011384           57 FSEQKLLGKGSHGSVYKAVLR-GRQVAVKKPSKNQ-------------------EISQEVDNEIEILSKIHSPRLVNLLG  116 (487)
Q Consensus        57 y~~~~~LG~G~~g~Vy~~~~~-g~~vAvK~~~~~~-------------------~~~~~~~~Ei~~l~~l~hpnIv~l~~  116 (487)
                      +.+.+.||+|+||.||+|++. |+.||||++....                   ........|+..+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            457899999999999999976 8999999754311                   11134567899999999999999887


Q ss_pred             EEeCCCceEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCcEEEccCCcEEEccc
Q 011384          117 FSNDSKDRLLVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEMPPIIHRDIKSANVLIDRNFNARLGDF  196 (487)
Q Consensus       117 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~ivH~DIkp~NILld~~~~vkL~DF  196 (487)
                      +..    .+++|||+++..+.+        ++...+..++.|++.+|.|||++  +|+||||||+|||++++ .++|+||
T Consensus        82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~--giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHR--GIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHT--TEECSCCSTTSEEEETT-EEEECCC
T ss_pred             ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhC--CEEEccCChhheeeeCC-CEEEEEC
Confidence            643    379999998865532        44555678999999999999999  99999999999999865 5899999


Q ss_pred             ccceecCCCCcccccCCCCCCCccCCc------cccCCCCCCcchhhhhHHHHH
Q 011384          197 GLALRCGVDNFRFRSTPPAGTIGYLDP------CYVTPDNLSTKTDVFSFGILL  244 (487)
Q Consensus       197 Gla~~~~~~~~~~~~~~~~gt~~Y~aP------E~~~~~~~s~ksDVwSlGvvl  244 (487)
                      |++......+..          .|...      +.+ ...|+.++|+||+.--+
T Consensus       147 G~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             CCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            999765433211          11111      111 24578899999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.73  E-value=3e-08  Score=92.74  Aligned_cols=147  Identities=14%  Similarity=0.144  Sum_probs=104.6

Q ss_pred             hhHHHhhcCcccceeecccCceEEEEEEECCeEEEEEEcCCChh-hHHHHHHHHHHHHhCC-CCCceeeEEEEeCCCceE
Q 011384           48 SDLEAATNGFSEQKLLGKGSHGSVYKAVLRGRQVAVKKPSKNQE-ISQEVDNEIEILSKIH-SPRLVNLLGFSNDSKDRL  125 (487)
Q Consensus        48 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~-~~~~~~~Ei~~l~~l~-hpnIv~l~~~~~~~~~~~  125 (487)
                      .+++..-..|...+..+.++.+.||+....++.++||+...... ....+.+|+..+..+. +--+.+++.++.+++..+
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            34556666787777665555679999887888889998764432 2345778888887774 444678888888888899


Q ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 011384          126 LVVEFMSNGTLYDVLHSNNRPLNWGRRIRLALQVAKAVEILHSEM-----------------------------------  170 (487)
Q Consensus       126 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----------------------------------  170 (487)
                      +||++++|.++.+.....   .   ....++.+++..++.||+..                                   
T Consensus        87 lv~~~l~G~~~~~~~~~~---~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE---Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC---S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEeccccccccccccc---c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            999999998886654321   1   12334555666666666431                                   


Q ss_pred             ----------------------CCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          171 ----------------------PPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       171 ----------------------~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                                            +.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  017899999999999987667799998774

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.22  E-value=2.1e-06  Score=79.38  Aligned_cols=73  Identities=15%  Similarity=0.162  Sum_probs=53.0

Q ss_pred             eecccCc-eEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCC--CCceeeEEEEeCCCceEEEEEecCCCCH
Q 011384           62 LLGKGSH-GSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHS--PRLVNLLGFSNDSKDRLLVVEFMSNGTL  136 (487)
Q Consensus        62 ~LG~G~~-g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~l~~~~~~~~~~~lV~Ey~~~gsL  136 (487)
                      .+..|.. +.||+.... +..+++|.......  ..+..|...++.+..  ..+.+++.++.+.+..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH--hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4555554 689998877 55688898665432  346778888877643  3467788888888889999999988654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.87  E-value=3e-05  Score=76.80  Aligned_cols=75  Identities=13%  Similarity=0.109  Sum_probs=48.7

Q ss_pred             ceeecccCceEEEEEEEC--CeEEEEEEcCCC--------hhhHHHHHHHHHHHHhCC-C--CCceeeEEEEeCCCceEE
Q 011384           60 QKLLGKGSHGSVYKAVLR--GRQVAVKKPSKN--------QEISQEVDNEIEILSKIH-S--PRLVNLLGFSNDSKDRLL  126 (487)
Q Consensus        60 ~~~LG~G~~g~Vy~~~~~--g~~vAvK~~~~~--------~~~~~~~~~Ei~~l~~l~-h--pnIv~l~~~~~~~~~~~l  126 (487)
                      .+.||.|....||++...  ++.|+||.....        .....+...|++.|+.+. +  ..+++++.+.  ....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            467899999999999764  668999964321        112234566888887662 2  3455666553  345589


Q ss_pred             EEEecCCCCH
Q 011384          127 VVEFMSNGTL  136 (487)
Q Consensus       127 V~Ey~~~gsL  136 (487)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.19  E-value=0.00038  Score=68.43  Aligned_cols=73  Identities=14%  Similarity=0.175  Sum_probs=51.4

Q ss_pred             cceeecccCceEEEEEEEC---------CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCc-eeeEEEEeCCCceEEEE
Q 011384           59 EQKLLGKGSHGSVYKAVLR---------GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL-VNLLGFSNDSKDRLLVV  128 (487)
Q Consensus        59 ~~~~LG~G~~g~Vy~~~~~---------g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~l~~~~~~~~~~~lV~  128 (487)
                      .++.|+.|-.-.+|++...         .+.|.+++...... .-...+|..+++.+.-.++ .++++++.+    .+|+
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3578888999999999864         24577787664333 3456678999888853344 577777754    6899


Q ss_pred             EecCCCCH
Q 011384          129 EFMSNGTL  136 (487)
Q Consensus       129 Ey~~~gsL  136 (487)
                      ||++|..|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.00  E-value=0.001  Score=63.38  Aligned_cols=68  Identities=12%  Similarity=0.074  Sum_probs=46.8

Q ss_pred             CceEEEEEEEC-CeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCc--eeeEE-----EEeCCCceEEEEEecCCC
Q 011384           67 SHGSVYKAVLR-GRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL--VNLLG-----FSNDSKDRLLVVEFMSNG  134 (487)
Q Consensus        67 ~~g~Vy~~~~~-g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnI--v~l~~-----~~~~~~~~~lV~Ey~~~g  134 (487)
                      ---.||++... |..|++|+........+++..|+..+..|...++  +..+.     .+......+.++++++|.
T Consensus        34 ~EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          34 YENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ccceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            34589999876 7789999987765566778889988888743222  21111     233456678899999764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.98  E-value=0.0014  Score=61.81  Aligned_cols=154  Identities=14%  Similarity=0.081  Sum_probs=82.5

Q ss_pred             chhhHHHhhcCccccee-----ecccCceEEEEEEECCeEEEEEEcCCChhhHHHHHHHHHHHHhCCCCCc--eeeEE--
Q 011384           46 DYSDLEAATNGFSEQKL-----LGKGSHGSVYKAVLRGRQVAVKKPSKNQEISQEVDNEIEILSKIHSPRL--VNLLG--  116 (487)
Q Consensus        46 ~~~~~~~~~~~y~~~~~-----LG~G~~g~Vy~~~~~g~~vAvK~~~~~~~~~~~~~~Ei~~l~~l~hpnI--v~l~~--  116 (487)
                      +.++++..-.+|.+.++     |..|---..|+....+..+++|+..... ...++..|++++..+...++  ...+-  
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~~   82 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRK   82 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccceec
Confidence            44666666677766433     4456667889999887789999986532 23455667777777643222  11111  


Q ss_pred             ----EEeCCCceEEEEEecCCCCHH--------------HHHHh--CC--C----CC------------------CHHHH
Q 011384          117 ----FSNDSKDRLLVVEFMSNGTLY--------------DVLHS--NN--R----PL------------------NWGRR  152 (487)
Q Consensus       117 ----~~~~~~~~~lV~Ey~~~gsL~--------------~~l~~--~~--~----~l------------------~~~~~  152 (487)
                          +.........++.++.+....              ..++.  ..  .    ..                  .....
T Consensus        83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (316)
T d2ppqa1          83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL  162 (316)
T ss_dssp             TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred             CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence                112234456677776653221              01110  00  0    00                  00011


Q ss_pred             HHHHHHHHHHHHHHHhC--CCCeeeccCCCCcEEEccCCcEEEcccccce
Q 011384          153 IRLALQVAKAVEILHSE--MPPIIHRDIKSANVLIDRNFNARLGDFGLAL  200 (487)
Q Consensus       153 ~~i~~qi~~gL~yLH~~--~~~ivH~DIkp~NILld~~~~vkL~DFGla~  200 (487)
                      ...+..+...+.-.+..  ..++||+|+.++||+++.+...-|+||+.+.
T Consensus       163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            12222222222332221  1279999999999999988777899999874